key: cord- -qocuprwb authors: hayasaka, daisuke; shirai, kenji; aoki, kotaro; nagata, noriyo; simantini, dash sima; kitaura, kazutaka; takamatsu, yuki; gould, ernest; suzuki, ryuji; morita, kouichi title: tnf-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following japanese encephalitis virus infection date: - - journal: plos one doi: . /journal.pone. sha: doc_id: cord_uid: qocuprwb japanese encephalitis virus (jev) causes acute central nervous system (cns) disease in humans, in whom the clinical symptoms vary from febrile illness to meningitis and encephalitis. however, the mechanism of severe encephalitis has not been fully elucidated. in this study, using a mouse model, we investigated the pathogenetic mechanisms that correlate with fatal jev infection. following extraneural infection with the jaoars strain of jev, infected mice exhibited clinical signs ranging from mild to fatal outcome. comparison of the pathogenetic response between severe and mild cases of jaoars -infected mice revealed increased levels of tnf-α in the brains of severe cases. however, unexpectedly, the mortality rate of tnf-α ko mice was significantly increased compared with that of wt mice, indicating that tnf-α plays a protective role against fatal infection. interestingly, there were no significant differences of viral load in the cns between wt and tnf-α ko mice. however, exaggerated inflammatory responses were observed in the cns of tnf-α ko mice. although these observations were also obtained in il- ko mice, the mortality and enhanced inflammatory responses were more pronounced in tnf-α ko mice. our findings therefore provide the first evidence that tnf-α has an immunoregulatory effect on pro-inflammatory cytokines in the cns during jev infection and consequently protects the animals from fatal disease. thus, we propose that the increased level of tnf-α in severe cases was the result of severe disease, and secondly that immunopathological effects contribute to severe neuronal degeneration resulting in fatal disease. in future, further elucidation of the immunoregulatory mechanism of tnf-α will be an important priority to enable the development of effective treatment strategies for japanese encephalitis. japanese encephalitis virus (jev), which belongs to the genus flavivirus in the family flaviviridae, is a causative agent of acute central nervous system (cns) disease in humans and domestic animals [ ] . pigs and birds are amplifiers or reservoir hosts of jev in the environment, providing a source of virus for blood feeding culex spp. mosquitoes [ ] which may subsequently feed on and infect humans. japanese encephalitis (je) is a major public health issue in asia and the asia-pacific region [ , ] . annually, , - , cases and , - , deaths are reported and more than % of survivors may suffer from neurological disability [ ] . human infections are largely subclinical with a rate varying from : to : [ , ] . the clinical symptoms vary from mild to severe disease including a non-specific febrile illness, meningitis, encephalitis and meningoencephalitis, the latter being observed in the most severe cases [ ] [ ] [ ] . . following an incubation period of - days, patients may develop fever, headache, vomiting, rigor and nausea [ , ] . subsequently, encephalitic cases develop neurological symptoms including seizure, tremor, photophobia, decreased sensorium, generalized and localized paresis, movement disorder [ , ] . signs of meningeal irritation such as neck stiffness may be present. these clinical features are not unique to je, thus, laboratory diagnosis is required to distinguish it from other neurological disorders. the variety of disease symptoms and the prognosis in je cases appears to be dependent on complex interactions between viral and host factors [ ] . in particular, host factors appear to be important determinants of disease severity and a number of specific proinflammatory cytokines and chemokines are observed in severe je cases [ ] . for example, it has been demonstrated that increased levels of tnf-α in cerebrospinal fluid (csf) and serum correlated with cases of severe disease [ ] . however, how these biological cytokines and chemokines contribute to the severe disease has not been fully elucidated. therefore, understanding the mechanism of the specific host response in severe cases is an important priority to develop a specific treatment for the infectious disease. the laboratory mouse model is commonly employed to study the cns pathology induced by encephalitic flaviviruses [ ] [ ] [ ] . in common with human cases, mice develop relatively similar neurological dysfunction and the pathologic changes in infected mouse brains are similar to those observed in human cases [ , ] . although extraneural infection frequently does not result in detectable viremia or virus burden in mice, it is believed that initial virus replication occurs in dendritic cells (dcs) such as langerhans cells at the site of infection, and the infected dcs migrate to draining lymph nodes [ ] . virus then invades the cns and hosts develop cns disease, although the mechanism by which the blood-brain-barrier is crossed is not completely understood [ ] [ ] [ ] [ ] [ ] [ ] [ ] . cns pathology is the consequence of viral infection of the affected cells and the resulting inflammatory responses in the cns. flavivirus variants may induce different degrees of pathology, however, the host immune response is likely to be a more critical determinant of clinical outcome [ ] . inflammatory responses mainly contribute to virus clearance and recovery from fatal disease. for example, cd + t cells are reported to have an important function in controlling virus infection [ ] [ ] [ ] [ ] [ ] [ ] , although one report showed only a subsidiary contribution of cd + t cells in jev infection [ ] . on the other hand, in recent studies it was suggested that immunopathological mechanisms may contribute to the severity of outcome following some encephalitic flavivirus infections [ , [ ] [ ] [ ] [ ] . for example, it was reported that cd + t cell function enhances pathogenicity during wnv and mvev infections [ , ] . furthermore, in tick-borne encephalitis virus (tbev)-infected mice the inflammatory response was reported to contribute significantly to the fatal outcome [ ] . microglia are the resident macrophages in the brain and are activated in response to a number of different pathological states [ ] . following jev infection, activated microglia play a significant role in the development of pathology by producing pro-inflammatory cytokines such as il- , il- and tnf-α [ , ] . although these pro-inflammatory cytokines have dual roles, acting both as protectors and degenerators of neurons [ ] , tnf-α is believed to be one of the key factors that mediate immunopathology in the cns during encephalitic flavivirus infection. for example, it was suggested that tnf-α directly mediates neuronal apoptosis by the engagement of tnf receptor (tnfr ), the tnfr-associated death domain (tradd) and neuronal death contributes to glial activation and subsequent neuroinflammation [ , , ] . it was also shown that tnf-α and il- β mediate rantes gene expression for the recruitment of immune cells and glutamate released by jev-infected microglia, involves tnf-α signaling and contributes to neuronal death [ , ] . on the other hand, other studies have shown that tnf-α has a protective role against wnv infections and restricts wnv pathogenesis by promoting trafficking of mononuclear leukocytes into the cns [ , ] . furthermore, neuronal tnf-α expression during wnv encephalitis may be an adaptive response to diminish cxcl -induced death [ ] . at this stage of our knowledge, therefore, the precise role of the tnf-α response in encephalitic flaviviral pathogenesis remains to be clarified. immunomodulatory cytokines also affect disease outcome of encephalitic flavivirus infection. il- is reported to have an effect on immunoregulation [ ] . it was suggested that il- mediates protection from acute encephalitis and plays a central role in determining the clinical outcome of jev infection [ ] . insufficient anti-inflammatory cytokine production of il- and il- in the brain is associated with increased tissue pathology [ ] . il- displays a neuroprotective function during jev infection and regulates deleterious effects of proinflammatory cytokines [ ] . furthermore, an experiment using il- ko mice showed that il- signaling plays a negative role in immunity against wnv infection and blockade of il- signaling helps to control viral infection [ ] . thus, the precise role of the il- response following encephalitic flavivirus infection also remains to be resolved. in general, evaluation of virus pathogenicity and virulence in mouse models utilizes either the subcutaneous or intradermal route of infection. this is considered to be a reproducible model of natural human infections following the bite of an infected mosquito or tick and in the past, death was used as an index of pathogenesis [ ] . however, it is known that peripheral infections with some strains of encephalitic flaviviruses do not exhibit normal dose response curves based on mortality. although this was first reported in the 's [ ] , the reason for these apparent discrepancies were not fully understood. we previously showed that the oshima strain of tbev caused dose independent mortality and the fatality rate did not increase more than % with increasing virus challenge doses from to plaque forming unit (pfu) [ ] . in our study of tbev, we suggested that the variation of fatal outcome in individual mice appeared to be due to variation in individual host responses [ ] . the purpose of this study was to investigate the host factors that influence disease severity following jev infection in a mouse model. in particular, we focused on the variation of disease outcome in individual mice following extraneural infection with jev. we first compared the pathogenicity of two jev strains, which cause either dose-dependent or doseindependent mortality responses. we next compared severe or mild cases of mice infected with jev exhibiting doseindependent mortality and investigated the specific host responses such as tnf-α and il- expression in the cns. we also examined the roles of the specific cytokines observed in severe cases using appropriate knockout (ko) mice. the animal experiments were performed in accordance with the recommendations in the fundamental guidelines for proper conduct of animal experiment and related activities in academic research institutions under the jurisdiction of the ministry of education, culture, sports, science and technology. the experimental protocols were approved by the animal care and use committee of the nagasaki university (approval number: - - / - ). the jath strain of jev was kindly provided by tomohiko takasaki, national institute of infectious disease, japan. stocks of jev jaoars and jath viruses were obtained from cell culture medium of baby hamster kidney (bhk) cells infected with viruses previously prepared in suckling mouse brains [ ] . the bhk cells were maintained in eagle's minimal essential medium (emem; nissui pharmaceutical co.) containing % fetal calf serum (fcs) and antibiotics. c bl/ j (b ) mice were purchased from japan slc corporation. b background il- -/-mice were purchased from jackson laboratory, usa [ ] . tnf -/-mice were kindly provided by yoichiro iwakura, research institute for biomedical sciences, tokyo university of science [ ] . these mice were mated in the facility of nagasaki university. five to six week old mice were subcutaneously inoculated with a range of - pfu of jev diluted in emem containing % fcs. mock infected mice were inoculated with emem from the supernatant medium of bhk cells. mice were weighed daily and observed for clinical signs including behavioral symptoms and signs of paralysis. thirteen days post infection (pi), dying and recovering mice were distinguished by the degree of weight ratio, and namely mice exhibiting more than % or less than % weight loss were recognized as dying or recovering mice, respectively. following subcutaneous inoculation with pfu of jev, mice were euthanized and blood, spleen, brain and spinal cord were collected following perfusion with cold phosphate-buffered saline (pbs). brains were dissected to provide four separate fractions, ie the brain cortex, thalamus, cerebellum and brainstem. until they were used, these tissues were stored at - ° c. each tissue was homogenized in ten volumes of pbs containing % fcs and diluted with emem with % fcs. virus titers were determined by plaque forming assays using bhk cells and were expressed as pfu/g tissue [ ] . mouse brains and spleens were collected after perfusion with cold pbs. freshly isolated brains and spleens were immediately immersed in rnalater (ambion). total rna was extracted using rneasy lipid tissue mini kit (qiagen) according to the manufacturer's instructions. the expression levels of cytokines were measured by real time-pcr as demonstrated previously [ ] . the copy numbers were calculated as a ratio of the copy numbers of internal control glyceraldehyde- -phosphate dehydrogenate. mice inoculated with jev were anesthetized and perfused with % phosphate-buffered formalin. fixed tissues were routinely embedded in paraffin, sectioned, and stained with hematoxylin and eosin. immunohistochemical detection of the jev antigens was performed as described previously [ ] . rabbit polyclonal antibody against e protein was used to detect jev antigens. brains were collected from four mice in each group of dying and recovering mice at days pi. the brains were homogenized and passaged in bhk cells for days. viral rna was extracted from the supernatant medium of the bhk cells using qiaquick pcr purification kit (qiagen) according to manufacturer's protocol. reverse transcription was performed by using superscript iii reverse transcriptase (invitrogen) and random hexamers. pcr was performed to cover the whole genome sequence using takara ex taq dna polymerase (takara bio inc.). the cycle sequencing reaction was performed by using bigdye terminator v . cycle sequencing kit (life technologies) and the dna sequence was determined with applied biosystems dna analyzer (life technologies). serum samples were collected from infected mice. the levels in the serum were measured by using competitive enzyme immunoassay and sandwich enzyme-linked immunosorbent assay kits for corticosterone (assaypro), tnfα and il- , il- (endogen) according to the manufacturer's instructions. recovery of leukocytes was performed by applying previously described methods [ , ] . briefly, after perfusion with cold pbs, brains and thymus were removed and placed on ice in rpmi containing % fcs (nissui pharmaceutical co.). brains were strained and homogenized gently with a µm cell strainer (bd biosciences). after washing with rpmi, the cell suspension was layered onto a % and % percoll gradient (ge healthcare bio-sciences ab) and centrifuged at × g for min at ° c. the leukocytes were collected from between the % and % interface. thymocytes and splenocytes were also recovered from these mice. cells were strained with a µm cell strainer (bd biosciences) and lysed with rbc lysis buffer (sigma-aldrich). after washing, cells were resuspended in rpmi medium. isolated cells were counted and kept on ice until the staining procedure. brain leukocytes were washed and blocked with rat anti-mouse cd / (fc receptor) (beckman coulter) in facs buffer (pbs containing . % bsa and . % sodium azide). cells were stained with a mixture of different fluorescentlabeled antibodies directed at surface phenotypic markers, cd -fitc, f / -pe, nk . -percp-cy . , cd -pe-cy , cd -apc, cd -alexa fluor , cd e-efluor (beckman coulter) and then fixed with % paraformaldehyde overnight. the stained cells were analyzed by galios™ flow cytometer (beckman coulter). leukocytes were recognized by characteristic size (forward scatter), granularity (side scatter) and cd expression. thymocytes were recognized by their characteristic size and cd + cd + double positive cells were recognized by the expression of cd + and cd + . kruskal-wallis test, and mann whitney test were used for statistical analysis to assess the significant differences of viral loads, expression levels of cytokines, and numbers of leukocytes. gehan-breslow-wilcoxon test was performed to assess the survival curves of jev-infected mice groups. p value < . was considered statistically significant. in this study, we used inbred b mice to minimize the influence of the genetic background of individuals. subcutaneous infection with jaoars did not lead to a normal dose dependent curve of mortality ( figure a ). the mortality rate was not significantly increased when challenge doses ranged from to pfu per mouse, although the infectivity in the mice increased sequentially ( figure a ). on the other hand, jath infection exhibited a dose dependent mortality curve and the infectivity in the mice was consistent with the mortality ( figure a ). these observations indicate that individual jaoars -infected mice exhibit a variable prognosis independent of virus challenge dose, whereas all jath -infected mice died. because a virus challenge dose of pfu of either jaoars or jath induced % infectivity ( figure a ), this dose was used for all further investigations to compare the pathogenesis. jaoars -infected mice did not start to die until days pi and the mean survival time (mst) was . ± . days ( figure b ). mice that died exhibited generalized clinical signs involving slowness in movement, ataxia, piloerection and anorexia. continuous weight loss was observed in mice that died, whereas survivors regained weight from to days pi onwards ( figure c ). on the other hand, jath -infected mice started to die at days pi and all mice had died by days pi ( figure b ) following continuous weight loss ( figure c ). mst was . ± . days and was significantly shorter than that of jaoars -infected mice (mann whitney test, p= . ). thus, we hypothesized that the cause of fatal disease was different between jaoars and jath -infected mice. infectious virus was detectable in the brain cortex and thalamus at days pi in both jaoars and jath infected mice without significant difference in titer ( figure d ). however, at days pi viral loads of jath -infected mice were significantly higher than those of jaoars -infected mice in every region of the brain cortex, thalamus, brainstem, cerebellum and spinal cord ( figure d ). it is important to note that viral load in the brain cortex was higher than in other regions of the cns in both jaoars and jath -infected mice ( figure d ), indicating that the brain cortex is the main target region for jev infection. thus, we next examined the cytokine levels in the brain cortex to compare the immune responses. the levels of tnf-α, ifn-γ, il- and il- , but not il- and il- were significantly higher in jath infected mice than in jaoars -infected mice ( figure e , figure s a ). the cytokine levels of tnf-α, ifn-γ, il- and il- were very low or undetectable in mock-infected mice and in infected mice at days pi ( figure e ). corresponding to the viral loads, histopathological examination showed that a large number of neurons displayed jev antigens and severe cuffing was observed in the brain cortex of jath -infected mice at day pi ( figure f ). jaoars -infected mice also exhibited jev antigen-positive neurons and cuffing, but at lower levels than those observed in jath -infected mice ( figure f ). mock-infected mice showed no jev antigen-positive neurons or inflammatory reactions ( figure f ). these results confirm that during the early phase of infection, jath -infected mice developed severe encephalitis with extensive neuronal infection which contrasts with the less extensive neuronal infection induced in jaoars -infected mice. infectious virus was either not detectable or very limited in spleens (data not shown). interestingly, the levels of tnf-α and il- in spleens were up-regulated in jaoars -infected mice at and days pi, however, they were not elevated in jath -infected mice ( figure s b ). the levels of ifn-γ, il- , il- and il- were not significantly different between jaoars and jath -infected mice ( figure s b ). these observations suggest that i) inflammatory responses in peripheral organs were different from those in the cns, and ii) jath infection induced no significant expression of tnf-α in the spleen. in view of the observation that individual mice displayed different disease progress when infected with jaoars under identical conditions, we attempted to identify specific factors relating to disease severity outcome. initially, we mice were recorded for days and no mice died after days. infectivity was determined by anti-jev igg antibody seroconversion for more than : of igg elisa titer. (b and c) b mice were subcutaneously infected with pfu of jaoars (n= ) and jath (n= ). survival curves p: gehan-breslow-wilcoxon test. (c) the averages ratio of weight change of living mice at the time points compared with those of day following subcutaneous infections with pfu of jaoars (n= ) and jath (n= ). error bars represent the standard deviations. (d) viral loads in distinct regions of the cns following subcutaneous infections with pfu of jaoars (day : n= , day : n= ) and jath (day : n= , day : n= ). p: mann whitney test. (e) mrna levels of tnf-α, ifnγ, il- and il- quantified by real-time pcr in the brain cortex of b mice infected with pfu of jaoars (day : n= , day : n= ), jath (day : n= , day : n= ) and mock (n= ). p: mann whitney test. (f) histopathological features of brain cortex in b mice infected with pfu of jaoars and jath at days pi. jev antigens were detected using e-protein specific jev antibody (insets). each experiment represents six and four mice infected with jaoars and jath , respectively. jaoars infected mice showed slight inflammatory infiltration in meninges. in brain cortex, a few degenerated cells were presented (arrow) and were virus antigen-positive cells. in jath -infected mice, severe inflammatory reactions were seen in meninges and perivascular area (asterisks). many virus antigen-positive cells were detected in degenerated neuronal cells of the cortex (arrows). doi: . /journal.pone. .g attempted to discriminate severe and mild disease groups during the observation period by following the progression of weight change of individual mice. we discriminated dying and recovering mice based on whether they showed less than . or more than . of the weight ratio at days pi ( figure c ). it was difficult to predict if mice would survive or die between . and . of the designated weight ratio, because within this window both dead mice and survivors were recorded. having established this defining parameter between severe and mild disease groups, we then attempted to examine specific factors relating to disease severity. we initially considered the possibility that the divergence of disease severity might be due to the selection of quasispecies variants from the jaoars virus population in the cns. accordingly, we compared the virus sequences recovered from the brains of dying and recovering mice (figure a) . however, no specific virus sequence differences were detected in viruses from either the severe or mild disease severity groups (dsg) (figure a) . furthermore, recovered viruses from either severe or mild dsg exhibited similar mortality patterns to those of the parent jaoars virus ( figure b) . noticeably, the viruses recovered from severe dsg mice did not induce % lethal infection in subsequent mouse virulence tests ( figure b ). these results indicate that quasispecies variants of jaoars did not contribute to the divergence of disease progression observed in all experiments with this virus; thus, other factors such as host response seem most likely to be the determinants of disease severity. we next compared the viral loads in the cns between severe and mild dsg in jaoars -infected mice at days pi. viral loads in brain cortex, thalamus and brainstem but not cerebellum and spinal cord were significantly higher in severe dsg mice than in mild dsg ( figure a ). however, in the brain cortex, the variance of virus titer in the mild dsg mice ranged from the minimal detection limit to pfu/g of tissue, whereas all mice exhibited more than pfu/g of tissue in the severe dsg ( figure a ). these results imply that . % ( / ) of mice in the mild dsg produced high viral loads similar to those in the severe dsg. thus, it is likely that high viral infection alone is not a critical determinant of severe disease and additional factors contribute to the fatal encephalitis. therefore, to compare the specific immune responses in severe cases, we further subdivided the mice into three subgroups, severe group (sg), mild group with high viral load (> pfu/g of tissue) (mhg) or low viral load (< pfu/g of tissue) (mlg), and compared their cytokine levels in the brain cortex ( figure b ). all groups exhibited increased levels of inflammatory cytokines of tnf-α, il- , ifn-γ and il- , but not il- and il- in the brain cortex compared with the uninfected group (ug) ( figure b) . interestingly, the level of tnf-α in the sg was significantly increased when compared with those in the mhg and mlg ( figure b ). the level of il- in the sg was also significantly higher than in the mlg ( figure b ). although the difference was not significant, the level tended to be higher than that recorded in the mhg ( figure b ). on the other hand, ifn-γ did not show significant differences between the three groups, and il- levels in the sg were lower than in the mhg ( figure b ). histopathological examination revealed inflammatory infiltration with mononuclear cells in the brain cortex of both severe and mild cases of jaoars -infected mice ( figure a to c). in severe cases, jev antigens were detected in neurons, and degenerated neurons were observed in a wide area of the brain cortex and medulla ( figure a ). on the other hand, in mild cases, there was variation of pathological features in some jaoars -infected mice. other mild cases showed neuronal infections similar to those observed in severe cases but there was little neuronal degeneration in the brain cortex ( figure b ). other mice exhibited very limited evidence of neuronal infection and neuronal degeneration ( figure c ). mock-infected mice showed none of these pathological changes ( figure d ). in summary, both neuronal infection and cns pathology were associated with severe disease outcome. in particular, increased levels of tnf-α and il- in the brains appeared to be associated with severe disease, although it was not clear whether the increased levels were the cause or result of severe disease. interestingly, the levels of tnf-α in the spleens of sg and ug mice were similar and relatively low, whereas the levels of both mhg and mlg mice were significantly higher ( figure s a ). il- levels in sg, mhg and mlg mice were high compared with those in ug mice. no significant differences were observed between the sg, mhg and mlg ( figure s a ). on the other hand, the ifn-γ level in sg mice was lower than those recorded in the ug, mhg and mlg ( figure s a ). there were no significant differences of il- , il- and il- levels between ug, sg, mhg and mlg mice ( figure s a ). some mice in the sg showed high levels of tnf-α in the serum, although no significant difference was observed when compared with other groups ( figure s b ). il- in the serum of sg mice was significantly increased compared with ug and mhg mice ( figure s b ). corticosterone levels in the serum were also significantly increased in sg mice compared with other groups ( figure s b ). corticosterone, a major glucocorticoid hormone, is a strong immunosuppressant and is elevated under stress response conditions such as those preceding death [ , ] . furthermore, severe cases resulting from infection with jaoars exhibited a significant reduction of cd + and cd + doubly-positive cells in the thymus ( figure s c ). thymic depletion and body weight loss are the main features of the systemic stress response [ , ] . these observations therefore suggest that sg mice exhibited a severe systemic stress response accompanied by immune suppression. thus, the roles of inflammatory cytokines appeared to be different in peripheral and cns tissues. to investigate in more detail, the role of tnf-α and il- during jev infection, we infected tnf-α ko and il- ko b comparison of viral genome sequences (nucleotide and corresponding amino acid -in parentheses) between recovered viruses from brains of severe (s , s , s and s ) and mild (m , m , m and m ) cases of jaoars -infected b mice. (b) weight changes of b mice infected with pfu of recovered viruses from severe (s , s , s and s ) and mild (m replaced to m , m , m and m ) cases. five mice in each group were inoculated subcutaneously and observed for days. closed and open symbols identify mice that died or survived, respectively, during observation period. mice with jaoars , and observed the disease courses compared with those of infected fully immunocompetent b mice. unexpectedly, the mortality rates of tnf-α ko and il- ko mice were increased compared with those of wt mice ( . %, . % and . %, respectively) ( figure a ). msts of fatal cases in tnf-α ko and il- ko mice ( . ± . and . ± . days) were significantly shorter than those of wt mice ( . ± . days) (p= . and p= . , respectively). consequently, these observations indicate that tnf-α and il- protect significant proportions of mice from fatal infection by pathogenic jaoars virus. importantly, tnf-α had a particularly pronounced protective effect. following inoculation with jaoars virus, there were no significant differences of infectious viral loads in the brain cortex between wt, il- ko and tnf-α ko at , and days pi ( figure b ). however within individual mice in each mouse group the range of viral infectivity varied from the lowest detection limit to pfu/g of tissue at and days pi ( figure b) . it therefore appears that the increased mortality in il- ko and tnf-α ko mouse was not simply due to the increased viral loads in the brains, but other factors must also have contributed to the fatal disease in these ko mice. it was difficult to distinguish between dying and recovering mice on the basis of their clinical signs at to days pi. however, high viral loads in the brain cortex appeared to be necessary for fatal outcome. thus, we compared the inflammatory responses in the brain cortex of mice that contained high viral loads with more than pfu per g of tissue ( figure b) . surprisingly, tnf-α ko mice exhibited significantly enhanced levels of ifn-γ, il- β, il- , il- , il- and il- in the brain when compared with the wt and il- ko mice at and days pi ( figure c and figure s a ). furthermore, at days pi, the levels of il- and il- were higher in tnf-α ko ( figure s b ). il- ko mice also exhibited the increased levels of ifnγ, il- β, il- , il- and il- compared with those of wt mice at days pi, although the differences were smaller than those between tnf-α ko and wt mice ( figure c ). uninfected mice showed some significant differences of cytokine levels between the three groups, but the levels were very low compared with infected mice and were not significant ( figure s c) . furthermore, the levels of perforin, granzyme b and fasl at days pi, and granzyme a at days pi were significantly increased in tnf-α ko mice compared with those of wt mice ( figure d and figure s d ), whereas il- ko mice exhibited the increased level of perforin at days pi ( figure d ). these cytokines are associated with immune-mediated neurodegeneration. these findings suggest that immunopathological effects in the cns contribute to the accelerated mortality in tnf-α ko mice infected with jaoars . thus, il- and in particular tnf-α mediate immunomodulatory effects against such inflammatory responses. histopathological examination of tnf-α ko mice revealed severe neuronal loss in extensive areas of brain cortex when compared with wt mice (figure a and b) . however, the proportion of infiltrated cells involving leukocytes (cd ), t cells (cd , cd or cd ), b cells (cd ), nk cells (nk . ) and macrophages (f / ) did not appear to differ significantly between tnf-α ko and wt mice ( figure c ). these observations suggest that the increased levels of cytokines in tnf-α ko mice were due to qualitative differences of their expression in inflammatory cells, rather than quantitative increases of infiltrating cytokine producing cells. in the spleens of mock-infected mice, there were no significant differences of ifn-γ levels between wt, il- and tnf-α ko mice ( figure s a ). however, following jaoars infection the levels of ifn-γ in tnf-α ko mice were significantly increased compared with those of wt mice at and days pi ( figure s b and c) . on the other hand, il- and il- levels in tnf-α ko mice were significantly higher than those of wt and il- ko mice during mock infection ( figure s a ) and following jaoars infections ( figure s b to d) . also, the level of il- in tnf-α ko was decreased compared with wt and il- ko mice at days pi ( figure s b) . these observations suggest that the patterns of cytokine levels observed in spleens were different from those of the brain and therefore that peripheral responses are unlikely to contribute to the increased disease severity in tnf-α ko mice. although the high virulence of jath is probably attributable to viral factors, we attempted to assess whether or not tnf-α might also contribute significantly to the pathogenicity observed following infection with jath virus. accordingly, mice were inoculated with jath virus at a challenge dose of pfu per mouse, all wt, il- ko and tnf-α ko mouse groups died. however, tnf-α ko mice presented with significantly shorter survival times than b wt mice ( . ± . days and . ± . days, respectively, mann whitney test: p= . ) ( figure a ). it is important to note that viral loads in the brains were not significantly different for either wt, tnf-α ko or il- ko mice at and days pi ( figure b ). tnf-α ko mice exhibited significantly increased levels of ifn-γ and il- in the brains compared with wt and/or il- ko mice at and days pi following jath inoculation ( figure c and d) . however, levels of il- and il- in the brains were not increased when wt and tnf-α ko groups at and or days pi were compared ( figure c ). moreover, levels of perforin, granzyme a, granzyme b and fasl were not increased in tnf-α ko when compared with wt mice at days pi. however, histopathological data showed that tnf-α ko mice presented with severe acute necrotic changes in the brain cortex compared which was not the case for wt and il- ko mice at days pi ( figure d ). in the spleens, similar to the jaoars infection, the levels of ifn-γ, il- and il- in il- ko and tnf-α ko mice were significantly increased compared with those of wt mice at days pi following jath infection, whereas the level of il- was decreased in tnf-α ko ( figure s b) . these results suggest that the shorter survival time of jath -infected tnf-α ko mice when compared with wt mice may be partially attributable to an immunopathological effect, whereas direct neuronal infection is likely to be the main cause of neurodegeneration in jath -infected mice. this study provides the first evidence that tnf-α has an immunoregulatory effect on pro-inflammatory cytokines in the cns during jev infection and this results in protection from fatal disease due to infection with this virus. following jaoars virus infection, tnf-α ko mice exhibited significantly increased mortality rates when compared with wt mice. although it has been suggested that tnf-/-mice show developmental defects of the humoral immune system pfu of jath at days pi. jev antigens were detected using e-protein specific jev antibody (insets). each experiment represents four, five and six mice of wt, tnf-α ko and il- ko mice, respectively. the b wt and il- ko mice showed severe inflammatory reactions in the brain cortex. on other hand, the tnf-a ko mice exhibited acute necrotic changes with slight inflammatory reactions in the brain cortex. including a lack of primary b cell follicles [ , , ] , tnf-α ko mice that we used in this study did not show significant depletion in the anti-jev igm response (data not shown) or in cytokine expression ( figure s ). in addition, no significant increases of viral propagation were observed in the peripheral and cns tissues. interestingly, there were no significant differences of viral load in the cns between wt and tnf-α ko mice. however, high inflammatory responses were observed in the cns of tnf-α ko mice. in particular, perforin, granzyme a, granzyme b and fasl, which are known to be associated with immune-mediated neurodegeneration, were significantly increased in the brains of tnf-α ko mice when compared with those of wt mice. these observations suggest that immunopathological effects contribute to the severe neuronal degeneration and fatal disease in tnf-α ko mice. il- ko mice also exhibited increased mortality and upregulated levels of inflammatory cytokines in the cns compared with wt mice and in common with tnf-α ko mice, there were no significant differences in viral loads. however, it is important to note that the levels of inflammatory cytokines of tnf-α ko mice and the resultant mortality were dramatically higher than those observed in il- ko mice. il- has an immunoregulatory function on various cells in the innate immune system including cytotoxic and helper t cells, nk cells and b cells [ ] . il- signaling has a negative role in immunity against wnv infection [ ] . it is also known that tnf-α is a critical regulatory cytokine exerting homeostatic and pathological effects in the csf [ ] . therefore, our data imply that tnf-α mediates greater efficacy of immunoregulatory function during jev infection. in preparatory studies of jev infection, we attempted to inject tnf-α intravenously or intracerebrally after jev inoculation to examine whether or not this improved the disease outcome. however, there was no significant improvement in the condition of the mice or protection from death. administration of anti-mouse tnf-α antibody also showed no improvement of disease outcome. although we cannot totally exclude the possibility that failure of tnf-α administration to improve disease outcome, may have been the result of the technical design of the experiments, different responses of tnf-α in the cns when compared with peripheral tissues may partly explain our observations. therefore, further investigation of the immunoregulatory mechanism of tnf-α in vivo and in vitro will be required to understand the basis of the immunopathological effects observed during jev infection. in this study, we focused on the variation of disease severity in mice following jaoars infection to detect specific responses that may be associated with severe disease. thus, we discriminated severe and mild cases of mice by their weight ratio at days pi. using this simple and effective approach, we had previously shown that specific immune responses were detected in severe disease cases when compared with mild cases following tbev infection [ ] . loss of appetite probably caused the weight loss due to decreased food and water intake. however, undernourishment did not appear to be the simple cause of death, because our preliminary data showed that an infusion of glucose solution to compensate for weight loss did not prevent fatal disease. we first considered whether or not viral quasispecies could account for the diversity of disease outcome. our results did not support this possibility. we also identified specific immune responses including tnf-α and il- up-regulation in the brains of severe cases when compared with mild cases. in human cases, an increased level of tnf-α in the csf appears to correlate with je disease severity [ ] . therefore, this jevinfected mouse model appears to be a reproducible model of severe je disease in human cases. furthermore, from the results of increased fatality in tnf-α ko mice, we propose that increased levels of tnf-α in the brains of severe cases in wt mice were probably produced in response to the disease severity, to alleviate the pathological impact of the encephalitis. it has been reported that immunopathological effects do contribute to flavivirus encephalitis [ ] . cytolytc leukocytes such as cd + t cells induce cytopathology during some encephalitic flavivirus infections [ ] [ ] [ ] and these leukocytes kill virus-infected cells using two distinct mechanisms viz., fas and granular exocytosis which involve perforin, granzyme a and b [ ] [ ] [ ] [ ] . in tnf-α ko mice, we showed that the increased levels of inflammatory cytokines including fas and the granular exocytosis correlated with severe encephalitis and fatal outcome. however, in wt mice, the apparent immunopathological features were not observed in dying mice days pi. although it was difficult to identify dying and surviving mice before days pi by their clinical signs, jaoars -infected mice showed varying levels of fas and granular exocytosis in the brains at days pi and some of them exhibited similar or higher levels compared with the tnfα ko mice ( figure s d ). thus, fatal cases may exhibit severe encephalitis caused by immunopathological responses during the early phase of infection and thereafter severe clinical signs may appear in some mice. jaoars -infected mice exhibited a variety of immune responses and different prognoses in individual mice. however, it was not clear how the immune response differentiated between dying and recovering mice. in order to explain these variable immune responses, we previously showed that specific t cell receptor (tcr) repertoires were present in dying mice during tbev infection [ ] . furthermore, we also showed that specific tcr repertoires were detected in the dying mice compared with the recovering mice following jaoars infection (shirai, et al., unpublished results). these data raise the possibility that there may be a variety of specific t cell clones effecting either protective or pathogenetic functions in dying and recovering mice. dose independent mortality induced by encephalitic flaviviruses has been recognized but has been an unresolved problem since the 's [ , ] . recently, it was suggested that induction of more vigorous innate immune responses might control early virus dissemination following increasing infectious challenge doses of virus [ , , ] . we have also recently discovered that interferon alpha receptor knockout induces dose-dependent mortality following extraneural infection with jaoars (hayasaka, et al., unpublished results) . in addition, we previously reported that late death following tbev infection appears to be a key feature of dose independent mortality within the encephalitic flaviviruses [ ] . in the current study, jaoars -infected mice also displayed increased times to death and the variation of acquired immune responses which either showed protective or pathological effects, appeared to be correlated with severe disease. therefore, we propose that in addition to innate immune response, subsequent acquired immune responses, which varied contingently in individuals, appeared to be a determining factor associated with dose-independent mortality. interestingly, jath -infected mice did not show increased levels of tnf-α in the spleen at and days pi. however, it is uncertain if the low level of tnf-α in the spleen directly contributed to the subsequent cns infection and the neuropathogenesis during jath infection. it is important to note that there were amino acid differences in the genomic sequences of jath and jaoars . therefore, it will be important to determine whether or not specific amino acid substitutions can influence tnf-α expression and thus contribute to the pathogenesis of the lethal process during jath infection. in conclusion, jath -infected mice developed severe encephalitis and all mice died due to severe infections of the cns (figure ). on the other hand, jaoars -infected mice exhibited varying degrees of encephalitis and different prognoses (figure ). we therefore propose that fatal outcome is attributable both to immunopathological changes in addition to high levels of cns infection. at this stage we cannot define the critical factors involved in the immunopathogenetic process ( figure ). furthermore, up-regulation of tnf-α and il- in the brain appear to be important determinants of the pathogenetic response ( figure ). clearly, further elucidation of the contribution of immunopathology and the suppressive impact of tnf-α, are important priorities to enable the development of effective treatment strategies for je. figure s . cytokine levels of spleen in b mice infected with jaoars and jath . (a) mrna levels of il- and il- quantified by real-time pcr in the brain cortex of b mice infected with pfu of jaoars (day : n= , day : n= ), jath (day : n= , day : n= ) and mock (n= ). p: mann whitney test. (b) mrna levels of tnf-α, ifnγ, il- , il- , il- and il- quantified by real-time pcr in the spleen of b mice infected with pfu of jaoars (day : n= , day : n= ), jath (day : n= , day : n= ) and mock (n= ). p: mann whitney test. (tif) figure s . cytokine levels of spleen in severe and mild cases of jaoars -infected mice. (a) mrna levels of tnf-α, il- , ifnγ, il- , il- and il- quantified by real-time pcr in the brain cortex of jaoars -infected b mice at days pi. uninfected group: u (n= ), severe group: s (n= ), mild group with high viral load of > pfu/g of brain tissue: mh (n= ), mild group with low viral load of < pfu/g of brain tissue: ml (n= ). p: kruskal-wallis test, p: mann whitney test. (b) the levels of il- , tnf-α and corticosterone measured by enzyme-linked immunosorbent assay in the plasma of jaoars -infected b mice at days pi uninfected group (u group, n= ), severe group (s group, n= ), mild group with high viral load of > pfu/g of brain tissue (mh group, n= ), mild group with low viral load of < pfu/g of brain tissue (ml group, n= ). p: kruskal-wallis test, p: mann whitney test. (c) cd and cd expressions of thymocytes from mock, mild and severe cases of jaoars -infected b mice at days pi. each experiment represents four and fifteen mice of severe and mild cases, respectively. (tif) flaviviruses. in: dm knipepm howleyde griffinra lambse straus. fields virology past, present, and future of japanese encephalitis natural japanese encephalitis virus infection among humans in west and east japan shows the need to continue a vaccination program overview: japanese encephalitis new initiatives for the control of japanese encephalitis by vaccination: minutes of a who/cvi meeting immunobiology of japanese encephalitis virus proinflammatory cytokines and chemokines in humans with japanese encephalitis correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in japanese encephalitis patients flavivirus encephalitis: pathological aspects of mouse and other animal models a preliminary neuropathological study of japanese encephalitis in humans and a mouse model comparative study of mouse brains infected with japanese encephalitis virus by intracerebral or intraperitoneal inoculation west nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection pathogenesis of neurotropic arbovirus infections flaviviruses. in: dm knipepm howleyde griffinra lambma martin. fields virology interleukin- beta but not tumor necrosis factor is involved in west nile virus-induced langerhans cell migration from the skin in c bl/ mice tick-borne encephalitis tickborne flaviviruses: dissecting host immune responses and virus countermeasures pathogenesis of west nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion encephalitis caused by flaviviruses neuronal cxcl directs cd + t-cell recruitment and control of west nile virus encephalitis a temporal role of type i interferon signaling in cd + t cell maturation during acute west nile virus infection role of cd + t cells in control of west nile virus infection cd + t cells use trail to restrict west nile virus pathogenesis by controlling infection in neurons cd -cd ligand interactions promote trafficking of cd + t cells into the brain and protection against west nile virus encephalitis cxcr mediates region-specific antiviral t cell trafficking within the central nervous system during west nile virus encephalitis pivotal role of antibody and subsidiary contribution of cd + t cells to recovery from infection in a murine model of japanese encephalitis immunopathology of flavivirus infections cd + tcells mediate immunopathology in tick-borne encephalitis cd + t cells mediate recovery and immunopathology in west nile virus encephalitis lack of both fas ligand and perforin protects from flavivirusmediated encephalitis in mice role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases proinflammatory mediators released by activated microglia induces neuronal death in japanese encephalitis the involvement of microglial cells in japanese encephalitis infections tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in japanese encephalitis tumor necrosis factor receptor- -induced neuronal death by tradd contributes to the pathogenesis of japanese encephalitis tnf-alpha and il- beta mediate japanese encephalitis virus-induced rantes gene expression in astrocytes glutamate released by japanese encephalitis virus-infected microglia involves tnf-alpha signaling and contributes to neuronal death tumor necrosis factor alpha protects against lethal west nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system the immune adaptor molecule sarm modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts west nile virus pathogenesis tnf-alphadependent regulation of cxcr expression modulates neuronal survival during west nile virus encephalitis interleukin- and related cytokines and receptors immunomodulatory cytokines determine the outcome of japanese encephalitis virus infection in mice an insufficient antiinflammatory cytokine response in mouse brain is associated with increased tissue pathology and viral load during japanese encephalitis virus infection kinetics of cytokine profile during intraperitoneal inoculation of japanese encephalitis virus in balb/c mice model il- signaling blockade controls murine west nile virus infection steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis influence of age on the susceptibility of mice to infection with certain neurotropic viruses mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses distribution and characterization of tick-borne encephalitis viruses from siberia and far-eastern asia interleukin- -deficient mice develop chronic enterocolitis failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice accumulation of t-cells with selected t-cell receptors in the brains of japanese encephalitis virus-infected mice participation of both host and virus factors in induction of severe acute respiratory syndrome (sars) in f rats infected with sars coronavirus pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses virus infection as a stressor: influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of mhpg and tryptophan the thymus is a common target organ in infectious diseases immune and inflammatory responses in tnf alpha-deficient mice: a critical requirement for tnf alpha in the formation of primary b cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response peyer's patch organogenesis is intact yet formation of b lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its -kda receptor interleukin- and the interleukin- receptor tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system fas and perforin pathways as major mechanisms of t cell-mediated cytotoxicity two distinct pathways of specific killing revealed by perforin mutant cytotoxic t lymphocytes molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes tcell clones expressing different t-cell receptors accumulate in the brains of dying and surviving mice after peripheral infection with far eastern strain of tick-borne encephalitis virus chimeric live, attenuated vaccine against japanese encephalitis (chimerivax-je): phase clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated japanese encephalitis antigen we thank tomohiko takasaki key: cord- - qb ym w authors: yang, runkuan; zhu, shengtao; tonnessen, tor inge title: ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries date: - - journal: j inflamm (lond) doi: . /s - - - sha: doc_id: cord_uid: qb ym w ethyl pyruvate (ep) is a simple derivative of pyruvic acid, which is an important endogenous metabolite that can scavenge reactive oxygen species (ros). treatment with ep is able to ameliorate systemic inflammation and multiple organ dysfunctions in multiple animal models, such as acute pancreatitis, alcoholic liver injury, acute respiratory distress syndrome (ards), acute viral myocarditis, acute kidney injury and sepsis. recent studies have demonstrated that prolonged treatment with ep can ameliorate experimental ulcerative colitis and slow multiple tumor growth. it has become evident that ep has pharmacological anti-inflammatory effect to inhibit multiple early inflammatory cytokines and the late inflammatory cytokine hmgb release, and the anti-tumor activity is likely associated with its anti-inflammatory effect. ep has been tested in human volunteers and in a clinical trial of patients undergoing cardiac surgery in usa and shown to be safe at clinical relevant doses, even though ep fails to improve outcome of the heart surgery, ep is still a promising agent to treat patients with multiple inflammatory organ injuries and the other clinical trials are on the way. this review focuses on how ep is able to ameliorate multiple organ injuries and summarize recently published ep investigations. [figure: see text] pyruvate is the final product of glycolysis and the starting substrate for the tricarboxylic acid (tca) cycle, and this important metabolic intermediate is also an effective scavenger of hydrogen peroxide and other ros [ , ] . pharmacological administration of pyruvate is able to improve organ function in animal models of oxidantmediated cellular injury [ , ] ; however, pyruvate is unstable in aqueous solutions and this certainly limits its therapeutic potential. ep, a simple derivative of pyruvic acid, is also an ros scavenger, but exerts pharmacological effects, such as the anti-inflammatory effects, which are quite distinct from those exerted by pyruvate anion [ , ] . treatment with ep has been shown to improve survival and/or ameliorate multiple organ dysfunctions in a wide variety of preclinical models of critical illnesses [ , ] . up to date, about ep related papers have been published; about new papers published after have not been summarized and reviewed. this review focuses on how ep is able to ameliorate inflammatory injures of multiple vital organs and summarizes new findings from recently published ep investigations. acute pancreatitis (ap) is a relatively common disease, its severe form is potentially fatal and sap is associated with high mortality, ranging from - % [ ] [ ] [ ] [ ] [ ] [ ] . the inflammatory cytokines play a crucial role in the pathogenesis of sap [ , , ] ; furthermore, the damaged pancreatic acinar cells and the activated inflammatory cells produce a large amount of oxygen radicals in ap, and these ros molecules can damage the lipid membranes of pancreatic acinar cells, they can also injure the capillary endothelium in the circulation to accelerate the progress of sap [ ] . currently, therapeutic efforts are limited to supportive measures, because no effective specific treatment exists. the effect of ep on acute pancreatitis ep has been repeatedly reported to ameliorate sap in different animal models [ , , , ] . ep treatment [ep source in this review was all from sigma-aldrich unless otherwise noted. ep dissolved in commercially available ringer's lactate solution (rls). commercially available rls was used as the control solution. ep ( mg/kg) was intraperitoneally injected every h for h)] significantly ameliorates pancreatic injury and necrosis [ , ] ; ep therapy also markedly reduces pancreatic expression of tnf-α, il- , hmgb and nf-kb dna binding [ , ] ; treatment with ep reduces the number of inflammatory cell infiltration and decreases the pancreatic level of lipid peroxidation, which is a parameter of ros [ ] . because early inflammatory cytokines (such as tnf-α and il- ), late inflammatory mediator hmgb and ros play a significant role in the pathogenesis of sap [ , , , ] , and ep can reduce the levels of these inflammatory cytokines and scavenge ros. therefore, ep may attenuate pancreatic injury during sap. the effect of ep on severe acute pancreatitis related multiple organ injuries about - % of all acute pancreatitis patients develop sap in clinical practice, and the mortality rate in sap is - % [ ] . sap starts as a local inflammation of pancreatic tissue that induces the development of multiple extrapancreatic organs dysfunction [ , ] . during sap, the concentrations of both early (tnf-α, il- ) and late inflammatory cytokines are significantly increased [ , [ ] [ ] [ ] [ ] , these cytokines play a significant role in the pathogenesis of sap [ , ] . the late inflammatory cytokine hmgb is particularly important because extracellular hmgb can aggravate the pancreatic inflammatory process [ ] and hmgb can also contribute to multiple distant organ injuries in the following experimental models as well: hmgb contributes to liver injury in ischemia-reperfusion [ ] . exogenous hmgb injection is able to induce liver injury in normal mice [ ] . hmgb impairs hepatocyte regeneration during acetaminophen hepatotoxicity and blockade of hmgb improves hepatocyte regeneration in acetaminophen overdose-induced fatal liver injury [ ] . anti-hmgb treatment protects against apap hepatotoxicity in rats [ ] . hmgb also contributes to renal ischemia reperfusion injury [ ] , sepsis-induced kidney injury [ ] and severe acute pancreatitis related kidney injury [ ] . hmgb is also found to significantly contribute to hemorrhagic shock related acute lung injury (ali) [ ] ; hypoxia-induced ali [ ] and severe acute pancreatitis related ali [ ] . hmgb is also an important factor that not only significantly contributes to gut mucosal injury [ ] , but also mediates gut bacterial translocation (bt) [ ] , and blockade of hmgb can even prevent gut bt [ ] . gut mucosal injury and intestinal bt in sap is particularly important because the intestine is the biggest reservoir of bacteria in the body and leakage of bacteria or microbial products, notably lps, from the lumen of the gut into the systemic circulation, which drives the development of systemic inflammation and multiple organ dysfunction syndrome (mods) in experimental models [ ] . sap frequently induces gut barrier dysfunction [ , , , ] . the small intestine becomes damaged by intestinal ischemia-reperfusion during sap [ , ] , and the failure of gut barrier is associated with bt [ ] , which is evident in sap [ , , , ] . sap patients have significantly increased serum lps [ ] , . % of the sap patients have bacteraemia and these bacteria are highly likely gut-derived opportunistic pathogens [ ] . furthermore, bt and infected pancreatic necrosis in acute necrotizing pancreatitis derive from small bowel rather than from the colon [ ] . bt and/or gut derived lps play a critical role in the development of systemic inflammatory response syndrome (sirs) and mods during sap [ , ] , because bt not only contributes to pancreatic infection [ , ] , but also induces/triggers sirs/sepsis in critical illness [ , ] . the profound sirs/sepsis can lead to mods and mortality in sap [ , , , ] , this is one of the underlying mechanisms that ap frequently affects extrapancreatic organs [ , ] , and the incidence of mods in sap is not available but certainly higher than the - % of mortality rate in sap [ ] . systemic inflammation with multi-organ dysfunction is the cause of death in a murine ligation-induced sap, and sirs and mods can lead to the preponderance of mortality ( %) in this lethal sap model [ ] while bile duct ligation does not have mortality, even though obstructive jaundice is prone to sepsis [ ] . therefore, the gut is thought to act as the starter of sirs [ ] and hmgb may be an important factor that links gut barrier dysfunction and mods during sap. ep ( mg/kg was intraperitoneally injected every h for h) can ameliorate sap related multiple organ injuries [ , , ] at least partly because ep not only reduces the inflammation in these organs [ , , ] , but also inhibits nearly % of the hepatic tissue hmgb to release [ ] and other related cells to release hmgb [ , ] , thereby decreases the circulating hmgb level in sap [ , ] . thus, hmgb is an important factor that not only directly contributes to multiple organ injuries, but also mediates gut bt to trigger/induce systemic inflammation/sepsis, the latter can lead to mods. currently, the circulating hmgb level is thought to be reliable to predict the severity of sap [ , ] , this is likely because hmgb is linked to multiple organ injuries during sap [ , , ] , the liver is an important source of circulating hmgb [ ] , and the circulating hmgb level could reflect the severity of liver injury, which is one of the important parameters for diagnosing sap [ , ] . sap associated bt was reduced by % following ep treatment [ ] breaking the link between bt and mods. therefore, ep could be a better treatment option against sap related multiple organ injuries in experimental models [ , , ] . the liver is the largest organ in the body, hepatocytes account for - % of the hepatic cytoplasmic mass and non-parenchymal cells make up - % of the hepatic cytoplasmic mass [ ] . kupffer cells (kcs) are the most abundant mononuclear phagocytes in the body and a predominant source of inflammatory cytokines released into the systemic circulation [ ] . the amount of cytokines released from the liver represents about % of the total cytokine content in the body [ ] , suggesting that the liver is the major contributor of the circulating cytokines. alcoholic hepatitis is associated with considerable morbidity; % of patients with the severe alcoholic hepatitis die within days of the onset [ ] . general measures for treatment include abstinence from alcohol and supportive care. alcoholic hepatitis is reversible if the patient stops drinking, it usually takes several months to resolve, however, abstinence from alcohol is difficult, and the treatment is still challenging. in an experimental murine model, alcohol induces fatty change and piecemeal necrosis; alcohol administration also induces significantly increased hepatic lipid peroxidation, nf-kb activation, tnf-α mrna expression; furthermore, alcohol administration induces a large amount of gut bt, which can serve as the "second hit" to contribute to the alcoholic liver injury. all of these alcohol-induced effects are ameliorated by treatment with ep ( mg/kg was intraperitoneally injected every h for h) instead of ringers lactate solution, suggesting that ep ameliorates hepatic inflammatory response and hepatic lipid peroxidation, and resultantly decreases hepatocellular injury duo to acute alcoholic intoxication [ ] . obstructive jaundice and cholangitis are common diseases that are prone to sepsis that can lead to mortality [ ] . in an experimental murine model of common bile duct ligation model [ ] , obstructive jaundice induces evident hepatocellular necrosis and significantly increased circulating alt and total bilirubin levels. obstructive jaundice also induces increased hepatic lipid peroxidation and increased hepatic expression of transcripts for tnf-α, il- , and inos. furthermore, bile duct ligation also induces a large amount of gut bt, which can serve as the "second hit" to contribute to the liver injury. all of these changes can be significantly attenuated by delayed treatment with ep ( mg/kg was intraperitoneally injected every h for h) instead of rls, suggesting that ep ameliorates hepatic inflammation, lipid peroxidation and necrosis in obstructive jaundice [ ] . in addition, ep treatment increases nf-kb dna binding, which often modulates inflammation when hepatic necrosis is not evident [ ] but modulates regeneration when hepatic necrosis is evident [ ] , this concept has been proved in acetaminophen hepatotoxicity in which massive hepatocyte necrosis is a predominant feature [ , ] . therefore, it is likely that ep enhances nf-kb dna binding to improve hepatocyte regeneration in obstructive jaundice. ep ameliorates acute liver injury secondary to severe acute pancreatitis sap frequently affects the liver and the inflamed liver play a significant role in the pathogenesis of sap [ , , ] . in a lethal experimental sap murine model, sap induces significantly increased hepatic lipid peroxidation, nf-kb activation, hepatic expression of transcripts for tnf-α, il- , inos and cox- [ ] . sap also induces focal hepatocyte necrosis and a large number of inflammatory cell infiltration [ , , ] , all of these changes can be significantly decreased by delayed treatment with ep instead of ringers lactate solution [ ] . in particular, sap can induce the loss of nearly % of hepatic tissue hmgb tested by western blot using whole hepatic tissue, and this effect can be reversed by ep treatment ( mg/kg intraperitoneally injected every h for h) [ ] , suggesting that the liver is an important resource of the circulating hmgb , and ep is a potent hmgb inhibitor [ ] . in another sap rat model, sap induces significantly increased hepatic lipid peroxidation, hepatic nf-kb dna binding and hepatic expression of transcripts for tnf-α, il- and hmgb [ ] , all of these changes can be significantly reduced by ep treatment ( mg/kg intraperitoneally injected every h for h) [ ] . fatty liver is common world widely, and its treatment is problematic. in a high-fat induced rat model, the fatty liver induces increased serum alt and increased hepatic tnf-α level; these changes can be significantly decreased by ep intake (supplemented in . % drinking water for weeks) but ep does not affect the development of a fatty liver [ ] , suggesting that ep can protect against inflammation induced liver cell damage but ep cannot prevent the development of fatty liver in animal experiment. hepatic ischemia-reperfusion (i/r) is a pivotal clinical problem occurring in many clinical conditions such as transplantation, trauma and hemorrhagic shock [ ] . hepatic i/r induces significantly increased hepatic expression of tnf-α, il- , hmgb and nf-kb activation, and hepatic i/r also induces markedly increased hepatic expression of bcl- , bax, beclin- and lc , which play an important role in the regulation of intrinsic pathway of apoptosis and autophagy, all of these changes are significantly reduced by ep treatment ( h before the ischemia procedure, a single dose of ep was intraperitoneally injected to animals in the mg/kg group, the mg/kg group and the mg/kg group, liver tissue samples were obtained h, h and h after i/r), suggesting that ep ameliorates hepatic i/r injury via its antiinflammatory and its anti-apoptosis effect. drug-induced acute fatal liver injury is the leading cause of acute liver failure (alf) in the developed countries [ ] [ ] [ ] [ ] , and alf has a high mortality and the treatment is still quite challenging [ ] . concanavalin a induces autoimmune hepatitis with significantly increased hepatic expression of tnf-α, il- , il- , hmgb and nf-kb activation, ep treatment ( h before the con a injection, a single dose of ep was intraperitoneally injected to the animals in the mg/kg ep group and the mg/kg ep group; liver tissue samples were obtained h, h and h after con a injection) reduces all of these changes and resultantly ameliorates concanavalin induced autoimmune hepatitis [ ] , which can be fatal. d-galactosamine induces acute fatal liver injury with significantly increased serum tnf-α, hmgb , ifngamma and endotoxin, all of these changes can be significantly decreased by ep treatment (a single dose of mg/kg ep was intraperitoneally injected h after alf induction, samples were taken h after ep injection), therefore, ep can ameliorate acute fatal liver injury induced by d-galactosammine [ ] . acute-on-chronic liver failure (aclf) rats have significantly increased serum endotoxin, tnf-α, hmgb , ifn-gamma and il- , ep administration ( mg/kg was intraperitoneally injected at h, h, h, h after the induction of aclf, and samples were taken h after the induction of aclf) decreases all of these changes to protect against aclf in rats [ ] . acetaminophen is the leading cause of drug induced alf, and ep treatment ( mg/kg was intraperitoneally injected every h for h) can reduce liver injury at early phase by its potent anti-inflammatory effect [ ] . diabetes can lead to an increased oxidative stress that significantly contributes to diabetes-induced liver injury [ ] . diabetes induces significantly increased total antioxidant status and hepatic peroxidation. ep therapy ( mg/kg was intraperitoneally injected twice a day for days) (instead of ringer solution) significantly decreases all of these changes and resultantly ameliorates diabetes-induced liver injury in a streptozocin induced diabetic rat model [ ] . the effect of ep on acute lung injuries ep on sap related acute lung injury acute lung injury (ali), also addressed as mild acute respiratory distress syndrome (mards), is a significant health problem associated with high mortalities [ , ] ; mards is also a severe complication and a major feature of mods to sap [ ] . in patients with ap, up to % of all deaths occur prior to admission to hospitals, and mards is the predominant cause of death in these cases [ ] . in sap, the mards is the main contributing factor to early deaths, i.e. within the first week after admission [ ] . the inflammatory mediators and the profound sirs are thought to play a key role in the development of mards [ , , ] because the significantly increased serum inflammatory mediators activate alveolar macrophages to release chemotactic mediators that play an important role in recruiting neutrophils, which work together with the elevated circulating pro-inflammatory mediators to severely damage alveolar epithelium and microvascular endothelium, and resultantly causes the increased permeability of the alveolar-capillary barrier and pulmonary edema. this theory is supported by the following evidence in which the alveolar-capillary barrier is severely injured and the pulmonary permeability is significantly increased in an experimental acute necrotizing pancreatitis [ ] . the antiinflammatory agent ep ( mg/kg intraperitoneally injected every h for h) markedly decreases the lung permeability and alleviates pulmonary edema at least partly by reducing pulmonary inflammation and neutrophils infiltration in a couple of experimental sap models with acute lung injury [ , , , ] . increased local and systemic levels of il- are associated with inflammatory process, including neutrophil infiltration of the alveolar space, resulting in lung injury [ ] . ep treatment reduces the il- -induced release of il- and decreases il- induced neutrophil adhesion to the lung epithelial cells [ ] , and this anti-inflammatory effect is via akt and nf-kb p pathway [ ] . therefore, ep reduces secretory and adhesive potential of lung epithelial cells under inflammatory conditions [ , ] . the effect of ep on endotoxin-induced acute lung injury lps intravenous injection induces significantly increased plasma tnf-α, il- ; lps administration also induces significantly increased expression of ho- and inos in lung tissue. in addition, lps also induces lung edema and infiltration of neutrophils, all of these changes can be reduced by ep treatment (intravenously infused for h into the animals in the following different ep concentration groups: , and mg/kg, and lung tissue samples were harvested h after ep administration) [ ] . in a murine model, lps intratracheal administration significantly increases the release of tnf-α, il- , il- and hmgb into bronchoalveolar lavage, all of these changes can be markedly decreased by ep treatment ( mg/kg was intraperitoneally injected at h, h, h and h after the induction of ali), and early administration of ep can improve survival [ ] . prolonged exposure to hyperoxia results in ali, accompanied by significantly increased levels of proinflammatory cytokines and a large number of leukocyte infiltration in the lungs [ ] . hmgb plays a critical role in mediating hyperoxia induced ali through the recruitment of leukocytes into the lung [ ] , a single dose of ep treatment ( mg/kg intraperitoneal injection prior to hyperoxia exposure, and lung tissue samples were taken h after hyperoxia exposure) attenuates the hyperoxia induced ali probably by inhibiting hmgb secretion from hyperoxic macrophages [ ] , suggesting that ep may treat oxidative inflammatory lung injury in patients receiving hyperoxia through mechanical ventilation. in cultured macrophages, lps stimulates the macrophages to release tnf-α, il- , and hmgb , and these changes can be effectively prevented by ep treatment (cells were incubated with mm ep for h) [ ] . lps stimulates macrophages to release hmgb and up-regulates inos expression, ep treatment (cells were incubated with mm ep for h) can reverse these effects by inducing heme oxygenase- (ho- ) via a p makp-and nrf dependent pathway [ ] . hmgb is a ubiquitous nuclear protein that can be actively secreted by immunocompetent cells, including monocytes, macrophages and neutrophils, and this highly conservative nuclear protein is an important late inflammatory mediator in sepsis [ ] . hmgb can also be passively released by dying cells or necrotic tissue [ ] . hmgb plays an important role in modulating inflammatory cascade in activated macrophages: hmgb stimulates macrophages to release tnf-α and il- , while hmgb neutralizing antibody can block tnf-α release [ , ] and knocking-out hmgb receptor can reverse il- release [ ] . in macrophages cultures, lps stimulates macrophages to release high concentrations of early inflammatory cytokines such as tnf-α, il- and il- and the late mediator hmgb [ ] [ ] [ ] , and ep treatment reduces these changes by specifically inhibiting the activation of p mitogen activated protein kinase and nf-kb, two signalling pathways that are critical for cytokines release [ ] . sepsis is a serious clinical syndrome, which is mediated by an early (such as tnf-α and il- ) and late (such as hmgb ) pro-inflammatory cytokine response to infection [ ] . delayed treatment with ep ( mg/kg intraperitoneally injected h, h, h, and h after cecal puncture, the experiment finished h after cecal puncture) significantly increases survival and markedly reduces circulating levels of hmgb in mice with sepsis [ ] . ep increases survival and decreases serum hmgb by up-regulation of ho- level in septic animals [ ] . in an established septic animal model, sepsis induces significantly increased plasma tnf-α, il- and il- ; sepsis also increases hepatic lactate, lactate/pyruvate levels and down-regulates hepatic atp and energy charge levels; all of these effects can be reversed in the septic mice treated with a single dose of ep ( mg/kg intraperitoneal injection, and the liver samples were taken h after ep injection), suggesting that ep protects against sepsis by regulating energy metabolism and inhibiting systemic inflammation [ ] . in addition, ep improves sepsis outcome by reducing mitochondrial swelling and dysfunction in experimental sepsis [ ] . septic patients have significantly increased serum hmgb levels, which can induce endothelial cell hyperpermeability via bax and bcl- regulated apoptosis, ep can reverse these detrimental effects to prevent endothelial cell injury in experimental sepsis [ ] . furthermore, ep can effectively reduce vascular endothelial inflammation and this effect at least partly depends on the attenuation of endoplasmic reticulum stress [ ] . acute kidney injury (aki) is a common serious complication of sap and sepsis. endotoxin and ros play an important role in the pathogenesis of aki and sap. sepsis is a common cause of acute renal failure (arf), and the incidence of sepsis increases markedly after age of [ ] . sepsis induces significantly increased plasma tnf-α, creatinine and causes tubular damage and multiple organ injury, sepsis also induces increased mrna for tnf-α, tissue factor, pai- , and urokinase-like plasminogen activator; all of these changes can be significantly decreased by ep treatment (a single dose of mg/kg was intraperitoneally injected h after cecal puncture and experiment finished h after cecal puncture), therefore, ep attenuates sepsis-induced arf in an animal model [ ] . diabetic nephropathy is a common complication [ ] . diabetic rats have increased laminin, type iv collagen and fibronectin deposition in the glomeruli and these animals also have albuminuria and increased nadphdependent ros generation; all of these changes can be significantly decreased by ep treatment ( mg/kg intraperitoneally injected every other day for weeks) [ ] , suggesting that ep might be a novel therapy to treat diabetic nephropathy. cisplatin-induced nephrotoxicity is common in clinical practice. cisplatin induces significantly increased perfusion pressure, serum urea, creatinine, total oxidant status and tissue lipid peroxidation, all of these changes can be significantly decreased by ep therapy ( mg/kg was intraperitoneally injected once a day for days) [ ] , suggesting that ep has a protective effect against cisplatin nephrotoxicity. inflammation plays important roles in the pathogenesis of coxsackievirus b (cvb )-induced acute viral myocarditis (avmc) [ ] . cvb virus induces increased levels of hmgb , tnf-α, il- , il- in the heart and serum of the avmc mice, and all of these changes can be significantly decreased by ep treatment ( mg/kg/ day and mg/kg/day intraperitoneally injected on day , day and day post infection), and this protective effect is associated with inhibition of hmgb /rage/nf-kb pathway [ ] . hmgb is a late inflammatory cytokine that triggers and amplifies the inflammation cascade following ischemia/reperfusion (i/r), and ep can inhibit hmgb release in i/r models [ ] . i/r procedure induces increased levels of hmgb , tnf-α, il- , these changes can be significantly reduced by ep treatment (a single dose of ep with mg/kg concentration was intravenously injected prior to the h reperfusion) instead of pbs, the accumulation of hmgb is deleterious to the heart following myocardial i/r [ ] . in another rat cardiac i/r model, ep treatment significantly preserves cardiac function, enhances tissue atp levels, attenuates myocardial oxidative injury and reduces apoptosis following myocardial ischemia [ ] . in another regional heart i/r rat model, ep therapy (a single dose of mg/kg was intraperitoneally injected h prior to the . h i/r procedure) inhibits i/r-induced nf-kb translocation and neutrophil activation in myocardium, ep also decreases the serum levels of inflammatory cytokines, and resultantly ep improves cardiac function and reduces infarct size after regional i/r injury [ ] . in another prolonged rat myocardial ischemia model, ep therapy enhances myocardial atp levels, attenuates myocardial oxidative injury, and resultantly decreases infarct size and preserves cardiac function [ ] . the effect of ep on acute brain injury ep attenuates traumatic brain injury in a rat model of unilateral cortical contusion injury (cci), ep treatment ( mg/kg was intraperitoneally injected h, h and h after brain injury, brain samples were harvested h after brain injury) significantly decreases the number of dead/dying cells in the ipsilateral hippocampus and improves recovery of beamwalking, neurological scores after injury, suggesting that ep treatment after cci is neuroprotective and improves neurobehavioral recovery [ ] . traumatic brain injury (tbi) can cause brain cell death/dying, and the/dead/ dying cells can release nuclear protein hmgb that can activate inflammatory pathways, therefore, the hmgb inhibitor ep ( mg/kg was intraperitoneally injected at min, h, h after brain injury, and brain samples were harvested h after brain injury) significantly decreases the expressions of hmgb , tlr , nf-kb dna binding and inflammatory mediators, such as, tnf-α, il- and il- . ep treatment also ameliorates beam walking performance, brain edema and cortical apoptotic cell death, suggesting that the protective effects of ep maybe mediated by the reduction of hmgb /tlr /nf-kb-mediated inflammatory response in the injured rat brain [ ] . many tbi survivors sustain neurological disability and cognitive impairment due to the lack of defined therapy to reduce tbi-induced long-term brain damage, ep ( mg/kg was intraperitoneally injected at min, h, h, h, h, h after brain injury, and brain samples were taken days after brain injury) confers longterm neuroprotection against tbi, possibly via breaking the vicious cycle among matrix metalloproteinase- mediated blood-brain barrier disruption, neuroinflammation and long-lasting brain damage [ ] . experimental tbi is known to produce an acute increase in cerebral glucose utilization, followed rapidly by a generalized cerebral metabolic depression. early administration of ep ( mg/kg was intraperitoneally injected at h, h, h, h after brain injury, and brain samples were harvested after brain injury) enhances cerebral glucose metabolism and neuronal survival, therefore, ep therapy is able to attenuate cerebral metabolic depression and neuronal loss after traumatic brain injury [ ] . intracerebral haemorrhage (ich) is a devastating disease with no specific treatment. increasing evidence indicates that inflammatory response plays an important role in ich-induced brain damage [ , ] . in a murine model of ich, ep treatment ( concentrations of ep at mg/kg, mg/kg and mg/kg were intraperitoneally injected to animals in separate groups at h, h, h after the induction of ich, and brain samples were harvested h after the induction of ich) reduces brain edema and improves neurological function after ich. ep also protects neurons from haemoglobin-induced cell death in vitro and neuronal cell degeneration in ich mice. ep exerts anti-inflammatory effects via inhibiting microglia activation, nf-kb activation and decreasing tnf-α, il- production. these results indicate that ep protects ich induced brain damage via anti-cell death and antiinflammatory actions [ ] . in another rat ich model, ep treatment ( mg/kg was intraperitoneally injected at h, h and h after the induction of ich, and brain samples were harvested h after the induction of ich) significantly reduces inflammatory cell infiltration and expression of il- , matrix metalloproteinase- in the perihematoma after ich. ep therapy also shows less brain edema, less haemorrhage and greater neurobehavioral function. the results suggest that ep ameliorates inflammatory damage after ich via hmgb -rage signalling pathway [ ] . subarachnoid hemorrhage (sah) is also a devastating disease with no specific treatment [ ] . in a rat model of sah, ep treatment (a single dose of ep at mg/kg concentration was intraperitoneally injected h after the induction of sah, and brain samples were harvested h after the induction of sah) inhibits microglia activation and reduces the expression of inflammatory cytokines tnf-α and il- ; ep therapy also inhibits apoptosis and prevents the disruption of tight junction proteins to stabilize the bbb [ ] . in a rat cerebral ischemia model, ep administration (intraperitoneally injected at the doses of , , and mg/kg at h and h after the brain ischemia injury, and the size of infarct was assessed after days of reperfusion) significantly reduces infarct volume and also suppresses the infarct volume related motor impairment, neurological deficits, microglial activation and inflammatory cytokine expression. furthermore, the neuroprotective effect is still evident even when the ep treatment is given as late as h after the cerebral ischemia induction, suggesting that ep can protect against cerebral ischemia injury with a wide therapeutic window [ ] . neonatal hypoxic-ischemic (hi) brain injury causes severe brain damage in newborns. following hi injury, rapidly accumulating oxidants injure neurons and interrupt ongoing developmental processes [ ] . ep therapy (a single dose of ep at mg/kg was intraperitoneally injected min after hi brain injury, and brain samples were harvested at h, h, h, h, h, h, days and weeks after hi brain injury) and the insulin-like growth factor- (igf- ) treatment protect the neonatal rats brain against hi injury and improve neurological performance and these effects are additive [ ] . inflammatory bowel disease is characterized by overproduction of inflammatory mediators and reactive oxygen that induce intestinal damage and chronic inflammation. inflammatory bowel disease is common but the treatment is still challenging [ , ] . in a rat tnbs-induced colitis model, ep treatment ( mg/kg, mg/kg and mg/kg were orally administered to separate groups once a day for days) significantly recovers the mucosal cytoarchitecture by reducing neutrophil infiltration and decreasing the levels of multiple inflammatory mediators (il- , il- , il- , il- , inos) [ ] . ep therapy ( mg/ kg was intraperitoneally injected once a day for days) also ameliorates experimental colitis in mice by inhibiting the hmgb -th and th /tcl responses [ ] . as inflammation is linked to cancer growth, the antiinflammatory agent ep is expected to have anti-tumor activity, and ep administration ( mg/kg and mg/kg intraperitoneally injected once a day for days) significantly inhibits hepatic tumor growth [ ] . the low-cost ep ( mg/kg intraperitoneally injected twice a day for weeks) elicits a potent immune-based antitumor response through inhibition of indoleamine , -dioxygenase (ido), a key tolerogenic enzyme for many human tumors [ ] . ep treatment ( mg/kg intraperitoneally injected once a day for weeks) inhibits tumor angiogenesis by inhibition of the nf-kb signalling pathway [ ] . hmgb and rage are significantly expressed in gastric adenocarcinoma, and ep treatment ( mg/kg and mg/kg intraperitoneally injected once a day for weeks) inhibits gastric cancer growth via regulation of the hmgb -rage and akt pathways [ ] . ep administration (cultured cancer cells were treated with ep at mm and mm for up to h) also inhibits growth and invasion of gallbladder cancer cells via down-regulation of the hmgb -rage axis [ ] . hepatocellular carcinoma (hcc) develops in response to chronic hepatic injury. although p is usually regarded as a tumor suppressor, its constant activation can promote pro-tumorigenic inflammation, at least in part, via inducing hmgb release. ep administration ( mg/kg was intraperitoneally injected once every other day for weeks) prevents tumorigenesis in rat livers by restoring p , and ep treatment does not affect p -mediated hepatic apoptosis [ ] . furthermore, ep treatment (cultured cancer cells were treated with mm, mm ep up to h) induces apoptosis and cell-cycle arrest in g phase in hepatocellular carcinoma cells [ ] . in addition, ep treatment (cultured cancer cells were treated with mm, mm, mm ep up to h) defangs some malignancy-associated properties of prostate cancer cells including proliferation, invasion and anchorage-independent growth [ ] . taken together, ep may have a potential as a new multi-functional compound for cancer therapy. ep does not inhibit nuclear translocation of nf-kb family members but attenuates nf-kb dna binding in an experimental colitis model [ ] , more specifically, ep inhibits nf-kb activation by alkylating a critical cysteine residue (cys ) in the p subunit of the nf-kb heterodimer, and alkylation of cys interferes with dna-binding by the transcription factor [ , ] . ep also interacts with nf-kb subunits, rel a and p to inhibit their functions at multiple points, for example, ep is able to inhibit the nuclear association of rel a after tnf-α treatment [ ] . at least some of the antiinflammatory effects ep are related to its ability to scavenge ros, since ep is an anti-oxidant [ , , ] , and oxidative stress is able to activate nf-kb-dependent gene transcription [ , , ] . ep not only prevents nuclear-to-cytoplasmic translocation of hmgb [ ] , but also inhibits cytoplasmic hmgb to be released extracellularly [ ] . moreover, ep inhibits hmgb release from primary microglial cells via direct intracellular ca ( +) chelation [ ] , and ep also regulates inflammation and exerts a neuroprotective effect via dual functions, chelating intracellular zn ( +) and promoting nad replenishment [ ] . ep administration on translational/clinical practice ep therapy has been confirmed to be effective and safe in multiple sap animal models and multiple liver injury models, it would be reasonable to focus on sap and alcoholic hepatitis clinical trials next step. intravenous infusion is used to administer ep (from critical therapeutics inc, lexington, ma, usa) to healthy volunteers and high-risk patients undergoing coronary artery bypass graft and/or cardiac valvular surgery with cardiopulmonary bypass. ep ( mg/kg) was administered intravenously starting after the induction of general anesthesia followed by more doses of mg/kg administered every h. ep treatment did not reduce major complications within or days of surgery. ep solution has a ph of less than , so ep administration may contribute to acidosis, however, no significant safety concerns were discovered during the clinical trial because the adverse event profile for patients receiving ep (n = ) was similar to that of patients receiving placebo (n = ). ep administration has been proved to be safe in a large number of experimental animals, no severe side effect has been reported. ep is a novel anti-inflammatory agent and ros scavenger, this safe and low-cost compound is able to treat multiple inflammatory organ injuries and systemic inflammation in experimental animal models. ep also has a potential to inhibit multiple tumor growth, and this anti-tumor activity may be associated with its anti-inflammatory effect. the biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds central role of neutrophil in the pathogenesis of severe acute pancreatitis protective effect of ethyl pyruvate on pancreas injury in rats with severe acute pancreatitis early jejunal feeding initiation and clinical outcomes in patients with severe acute pancreatitis ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis role of free radicals in the development of severe acute pancreatitis acute lung injury in acute pancreatitis-awaiting the big leap systemic inflammation with multiorgan dysfunction is the cause of death in murine ligation-induced acute pancreatitis delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box levels in rats ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis therapeutic treatment with ethyl pyruvate attenuates the severity of liver injury in rats with severe acute pancreatitis high-mobility group box protein and its role in severe acute pancreatitis the nuclear factor hmgb mediates hepatic injury after murine liver ischemia-reperfusion hmgb b box increases the permeability of caco- enterocytic monolayers and impairs intestinal barrier function in mice high mobility group b impairs hepatocyte regeneration in acetaminophen hepatotoxicity diet restriction inhibits apoptosis and hmgb oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity glycyrrhizic acid ameliorates hmgb -mediated cell death and inflammation after renal ischemia reperfusion injury glutamine administration ameliorates sepsis-induced kidney injury by downregulating the highmobility group box protein- -mediated pathway in mice blokade of high mobility group box- protein attenuates experimental severe acute pancreatitis induction of acute lung inflammation in mice with hemorrhagic shock and reperfusion: role of hmgb ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expressions downregulation of hmgb protects against the development of acute lung injury after severe acute pancreatitis neutralization of hmgb is associated with bacterial translocation during acetaminophen hepatotoxicity leaky gut hypothesis: a historical perspective bacteraemia in patients with acute pancreatitis as revealed by s ribosomal rna gene-based technique bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon role of the gut barrier in acute pancreatitis the crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat effect of traditional chinese medicine on intestinal mucosal permeability in early phase of severe acute pancreatitis bacterial translocation in acute pancreatitis mesenteric lymph: the bridge to future management of critical illness physiology and pathophysiology of liver inflammation, damage and repair kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats ethyl pyruvate ameliorates acute alcoholic-induced liver injury and inflammation in mice ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis ringer's lactate improves liver recovery in a murine model of acetaminophen toxicity drug hepatotoxicity: environmental factors the effect of ethyl pyruvate supplement on rat fatty liver induced by a high-fat diet ethyl pyruvate ameliorates hepatic ischemiareperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy ethyl pyruvate reduces liver injury at early phase but impairs regeneration at late phase in acetaminophen overdose ethyl pyruvate pretreatment attenuates concanavalin a-induced autoimmune hepatitis in mice ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with d-galactosamine-induced acute liver failure ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats protective effect of ethyl pyruvate on liver injury in diabetic strptozotocin-induced rats fatal acute pancreatitis occurring outside of the hospital: clinical and social characteristics pancreatitis-associated acute lung injury: new insights lung injury in acute pancreatitis: mechanism, prevention, and the therapy acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies ethyl pyruvate reduces lung injury matrix metalloproteinases and cytokines and improves survival in experimental model of severe acute pancreatitis ethyl pyruvate significantly inhibits tumor necrosis factor-α interleukin- and high mobility group box releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated acute lung injury pre-or post-treatment with ethanol and ethyl pyruvate results in distinct anti-inflammatory response of human lung epithelial cells triggered by interleukin- ethanol, ethyl and sodium pyruvate decrease the inflammatory response of human lung epithelial cells via akt and nf-kb in vitro but have low impact on hepatocellular cells ethyl pyruvate reduces acute lung injury via regulation of inos and ho- expression in endotoxemic rats ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model inhibition of extracellular hmgb attenuates hyperoxia-induced inflammatory acute lung injury ethyl pyruvate inhibited hmgb expression induced by lps in macrophages ethyl pyruvate induces heme oxygenase- through p mitogen-activated protein kinase activation by depletion of glutathione in raw . cells and improves survival in septic animals ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation hmgb modulates inflammatory responses in lps-activated macrophages a critical cysteine is required for hmgb binding to toll-like receptor and activation of macrophage cytokine release ethyl pyruvate protects against sepsis by regulating energy metabolism ethyl pyruvate reduces hepatic mitochondrial swelling and dysfunction in a rat model of sepsis expression of hmgb in septic serum induces vascular endothelial hyperpermeability endoplasmic reticulum stress mediates the anti-inflammatory effect of ethyl pyruvate in endothelial cells ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity ethyl pyruvate attenuated coxackievirus b -induced acute viral myocarditis by suppressing of hmgb /rage/nf-kb pathway role of high-mobility group box in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion ethyl pyruvate has anti-inflammatory and delayed myocardial protective effects after regional ischemia/reperfusion injury ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat beneficial effects of ethyl pyruvate through inhibiting high-mobility group box expression and tlr /nfkb pathway after traumatic brain injury in the rat ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after traumatic experimental brain injury ethyl pyruvate ameliorates intracerebral hemorrhage-induced brain injury through anti-cell death and anti-inflammatory mechanisms blockade of high mobility group box- signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window combination treatment with ethyl pyruvate and igf-i exerts neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic encephalopathy ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the hmgb -th and th /tc responses intestinal antiinflammatory activity of calcium pyruvate in the tnbs model of rat colitis: comparison with ethyl pyruvate ethyl pyruvate administration inhibits hepatic tumor growth immunotherapeutic suppression of indoleamine , -dioxygenase and tumor growth with ethyl pyruvate ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of nf-kb signaling pathway inhibition effects of ethyl pyruvate administration on human gastric cancer growth via regulation of hmgb -rage and akt pathways in vitro and in vivo ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of hmgb -rage axis p promotes inflammation-associated hepatocarcinogenesis by inducing hmgb release ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of hmgb -rage and akt pathways exploring glyoxalase expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties ethyl pyruvate decreases hmgb release and ameliorates murine colitis interaction of ethyl pyruvate in vitro with nf-kb subunits, rel a and p ethyl pyruvate inhibits hmgb phosphorylation and release by chelating calcium neuroprotective effect of ethyl pyruvate against zn ( +) toxicity via nad replenishment and direct zn αα +) chelation not applicable. this investigation was partly supported by sigrid juselius funding in finland and south-eastern norway regional health authority, grant number . data sharing not applicable to this article as no datasets were generated or analyzed during the current study. author contributions rky designed and drafted the manuscript. stz carried out literature search and drafted the manuscript. tit drafted and revised the manuscript. all authors read and approved the final manuscript. the authors declare that they have no competing interests. not applicable.ethics approval and consent to participate not applicable.• we accept pre-submission inquiries • our selector tool helps you to find the most relevant journal submit your next manuscript to biomed central and we will help you at every step: key: cord- -me rhkcg authors: nör, jacques e.; polverini, peter j. title: role of endothelial cell survival and death signals in angiogenesis date: journal: angiogenesis doi: . /a: sha: doc_id: cord_uid: me rhkcg angiogenesis, the process of new microvessel development, is encountered in a select number of physiological processes and is central to the pathogenesis of a wide variety of diseases. there is now convincing evidence that regulated patterns of endothelial cell survival and death, a process known as apoptosis, play a central role in the periodic remodeling of the vasculature, and in the timely evolution and regression of angiogenic responses. in this review we discuss the current evidence suggesting a role for inducers and inhibitors of angiogenesis as well as other mediators that modify endothelial cells functions in the survival and death of endothelial cells. we also discuss how dysregulation of apoptosis can lead to aberrant angiogenesis as demonstrated in the pathogenesis of retinopathy of prematurity and cancer. angiogenesis and apoptosis are biological processes that are indispensable for normal organ and tissue homeostasis. programmed cell death, also known as apoptosis, maintains normal tissue and organ homeostasis by removing super¯uous, damaged or senescent cells. mounting evidence suggests that apoptosis is also involved in the homeostasis of the vascular system. recent studies suggest that endothelial cell apoptosis is necessary for repair of damaged blood vessels and for sprouting and branching of capillaries during angiogenesis. events that govern the survival and death of endothelial cells have emerged as major factors that contribute to angiogenic responses during embryonic development, in the maintenance of organ and tissue homeostasis in adult organisms, and in pathological conditions such as tumor development. in this review we will brie¯y summarize the literature on apoptosis and angiogenesis, and examine more closely the current knowledge about how the death machinery contributes to vascular remodeling and angiogenesis. lastly, we will show how disruption of the apoptotic program can contribute to the unrelenting and persistent angiogenesis that is the hallmark of angiogenesis dependent diseases. programmed cell death is necessary for the development and survival of multicellular organisms. every second, hundreds of thousands of cells are generated in the human body and a similar number of them die [ ] . the overwhelming majority of these cells die by apoptosis, a morphologically stereotyped series of cellular events that result in the deletion of cells without in¯ammation [ , ] . the process of programmed cell death was ®rst described in in the neuronal system of the developing toad embryo [ ] . however, it was only in that the term apoptosis was proposed to de®ne this genetically regulated form of cell death [ ] . programmed cell death involves expression of genes and protein synthesis, and is distinguished from necrosis where cell injury and or in¯ammation results in membrane damage and cell lysis. apoptosis is a key component of a number of physiological processes. it accounts for the death of cells necessary for tissue remodeling, for the cell loss that accompanies atrophy of adult tissues following endocrine stimuli, and the removal of cells no longer needed at the late stages of wound healing [ , , ] . apoptosis is the mechanism by which autoreactive lymphocytes are eliminated during development or after termination of immune responses [ ] . it also eliminates excessive neutrophils that are produced continuously in the bone marrow [ , ] . apoptosis also maintains organ and tissue homeostasis by eliminating cells that are potentially destructive. disruption of the function of a cell caused by viral infection generates a signal that induces apoptosis of infected cells in order to eliminate the virus from the organism [ ] . perhaps one of the best examples of how apoptosis guards against intrusion by potentially harmful cell populations is the protective role that this process plays in the prevention of cancer. apoptosis is an ecient mechanism designed to recognize and eliminate cells that have acquired genetic lesions that are potentially lethal to the host [ ] . in this context, cell death is a physiologically protective event. in summary, apoptosis is a mechanism that regulates the reshaping of tissues and organs, insures the survival of the ®ttest cells and their optimal adaptation to the environment, and eliminates infected, damaged, or cells at risk for neoplastic conversion [ , , , ] . at the cellular level, apoptosis is characterized by a predictable, well-choreographed series of morphological and biochemical events. cells undergoing apoptosis shrink in volume, detach their neighbors, lose their microvilli, and detach from one another [ ] . the outer membrane bulges (blebs), the chromatin condenses into dense granular caps, and the nuclear membrane eventually breaks down. at this stage, surface convolution takes place and the cell is disassembled into a series of condensed membrane-bound, apoptotic bodies that are phagocytosed by macrophages or by other adjacent cells [ ] . the events that initiate the apoptotic program are tightly regulated by an intricate system of controls and checkpoints that are designed to minimize accidental or inappropriate activation of the death cascade. although it is well recognized that apoptosis plays a central role in numerous in physiological and pathological processes, the genetic and biochemical signals that comprise the cell death machinery are still remain to be de®ned. we will begin this review with an overview of what is currently known about the molecular regulation of apoptosis and the intracellular and extracellular signals that initiate this cascade. each cell possesses its own death machinery, which can be activated on demand. our understanding of the molecular events that control apoptosis emerged from studies in the nematode caenorhabditis elegans [ , ] . during development of c. elegans, cells are generated of which undergo apoptosis [ ] . genetic studies in this worm led to the identi®cation and ordering of key components of the cell death machinery. the apoptotic program is a highly conserved mechanism that is mediated by regulators, adaptors, and executioners (eectors) of apoptosis [ , ] . figure shows a comparison of intracellular pathways that control apoptosis in nematodes and mammals. in c. elegans, upstream signals promote the binding of egl- (regulator) protein to ced- (regulator) that, in its turn, releases ced- (adapter). unbound ced- induces proteolytic cleavage of ced- (executioner) and a series of downstream events culminating in cell death [ ± ] . in humans, the bcl- family of proteins is composed of at least members that are critical regulators of apoptotic pathways and function to either inhibit or to promote cell death [ ± ] . these proteins are located within the intracellular membranes of mitochondria, the nucleus, and endoplasmic reticulum and are believed to form ion-channels/pores when these proteins form homo and/or heterodimers [ , ] . the pro-apoptotic proteins bad and bid (human homologues of the nematode egl- ) regulate the activity of the antiapoptotic bcl- and bcl-x l (homologues of ced- ). bad and bid lack membrane anchoring domains and move from cytosol to the surface of membranous organelles, where they can bind to other members of the bcl- family [ ] . for example, the dimerization of bad with bcl- mediates downstream events that result in apoptosis [ ] . therefore, this step of the apoptotic pathway is dynamically controlled by the`regulated' translocation of mobile proteins such as bid and bad, and their binding to anchored proteins such as bcl- and bcl-x l . none of the known antiapoptotic bcl- family members (regulators) interacts directly with caspases figure . mechanisms that control cell survival and death in the nematode c. elegans and in mammals. the current understanding of genetic pathways of apoptosis is described for c. elegans (top) and mammals (bottom). both, the nematode genes and their mammal homologues, are functionally characterized as regulators, adaptors, or executioners of apoptosis. symbols: inhibition (a), activation (!). modi®ed from vaux and korsmeyer [ ] . (executioners) [ , ] . the function of adaptors (also called caspase activators) is necessary to transduce proapoptotic signals from regulators to the caspases [ ] . for example, apaf- is a human homologue of ced- [ ] that oligomerizes and activates procaspase- when it is not bound to antiapoptotic proteins of the bcl- family [ , ] . therefore, antiapoptotic members of the bcl- family may inhibit caspa se activation by preventing oligomerization of the adapter protein apaf- the key executioners of apoptosis are caspases, a family of cysteine proteases that are normally present in the cell as proenzymes that require proteolytic cleavage to become activated [ , ] . based on their sites of action in the apoptotic pathway, these proteases were divided into upstream caspases (initiator caspases) and downstream caspases (eector caspases) [ ] . in mammals, apaf- is dissociated from pro-survival bcl- family members and activated by datp and cytosolic cytochrome c, a protein that is released from the mitochondria during apoptosis [ , , ] . upon activation, apaf- undergoes a conformational change, which enhances its ability to interact with caspase- (an initiator caspase) through its caspase recruitment domain (card) [ , , , , ] . upon this interaction, caspase- is processed by autocatalysis and subsequently activates downstream eector caspases such as caspase- [ , , ] . when the downstream caspases are activated, they cleave icad (inhibitor of caspase activated dnase), allowing cad (caspase activated dnase) to enter the nucleus and degrade chromosomal dna [ ± ] . a number of cytokines and extracellular proteins initiate apoptosis by signaling through speci®c cell membrane receptors [ ] . the best characterized death receptors are cd (also known as fas) and tnfr (also termed p ), that belong to the tumor necrosis factor (tnf) receptor gene superfamily [ , , ] . they have cysteine-rich extracellular domains and a cytoplasmic sequence termed the`death domain' (dd) [ , ] . binding of the cd ligand or tnf to their respective receptors activates fadd (adapter or caspase activator) that engages procaspase- molecules in a death-inducing signaling complex (disc) [ ] . the aggregation of several procaspase- molecules mediates their auto-processing and activation [ , ] . active caspase- signals through caspase- [ ] and triggers downstream death-inducing events similar to the ones described above. peptides that speci®cally inhibit caspase activity (e.g. zvad-fmk, zdevd-fmk) have been shown to prevent dna fragmentation and enhance cell survival in vitro and in vivo [ ± ]. the use of caspase inhibitors for treatment of diseases that are caused by excessive apoptosis is already being evaluated in clinical trials. however, there are still several unanswered questions regarding their ecacy and safety for therapeutic use [ ] . therapeutic strategies designed to target the recently discovered caspase-independent pathways of apoptotic death may eventually prove to be a more reliable and safer alternative to the use of caspase inhibitors [ ± ]. during the early stages of embryogenesis a primary vascular plexus develops from endothelial cell precursors or angioblasts by a process termed vasculogenesis [ , ] . subsequently, these cells proliferate and organize into primitive blood vessels establishing the initial vascular network. vascular endothelial growth factor (vegf) and its receptors vegfr- , vegfr- are important molecules in the initial phase of vascular development. knockout mice lacking any one of these genes die before day . of embryonic development by absence or delayed endothelial cell dierentiation and failure of vasculogenesis [ , ] . after the primary vascular plexus is formed, endothelial cells start to proliferate and form new capillaries [ ] . the emerging vascular plexus is rapidly remodeled to resemble a mature system by a process termed angiogenesis. this term was ®rst used in to describe the formation of new blood vessels from pre-existing capillaries in the placenta [ ] . recent studies have demonstrated the presence of endothelial cell precursors in peripheral blood as well as the ability of these cells to target sites of active angiogenesis [ ] . these ®ndings raise the possibility that vasculogenesis and angiogenesis may not be as distinct from one another as once thought. despite their low turnover (measured in years) in adult tissues, endothelial cells still retain the capacity to divide and form new blood vessels in response to speci®c stimuli [ ] . capillary blood vessels consist of endothelial cells and pericytes that are programmed to form a complete capillary network when stimulated by mediators of angiogenesis [ ] . the process of angiogenesis starts with proteolytic degradation of interstitial tissue and the basement membrane of the parent vessel. this is followed by a series of well orchestrated events in which endothelial cells migrate towards the angiogenic stimulus and divide [ ] . endothelial cells elongate and align to form a sprout, and the lumen is formed by a curvature inside each endothelial cell [ ] . individual sprouts elongate and eventually join with each other forming loops through which blood begins to¯ow. pericytes originating from migrating and dedierentiation of arterial smooth muscle cells, position themselves along the original sprouts and reposition themselves in the basement membrane that invest newly formed capillaries [ , ] . the acquisition of a coating with pericytes has been recently described as the end of the`plasticity window' in which the vascular architecture is ®ne tuned according to the availability of oxygen [ ] . a tightly controlled balance between cell proliferation and cell death dictates tissue integrity and tissue homeostasis. traditionally, regression of neovascular responses has been associated with inhibition of endothelial cell proliferation, migration, and adhesion [ ] . only recently has the role of endothelial cell survival and death signals in sustaining and disrupting neovascularization been recognized. it is now well established that key regulators of angiogenesis function, at least in part, by modulating the survival of endothelial cells during the processes of vessel repair and angiogenesis. for the purposes of discussion we have divided the regulators of angiogenesis in two broad groups according to their role in endothelial cell survival and death: inducers of endothelial cell apoptosis and enhancers of endothelial cell survival (table ) . many but not all of these mediators we will describe below have been shown to function as either antiangiogenic or proangiogenic factors. when viewed in this context perhaps all mediators of angiogenesis will eventually be found to function as either inducers of endothelial cell death or survival factors. tsp is the ®rst member of a family of multifunctional extracellular matrix (ecm) glycoproteins [ ± ]. it is intimately associated with matrix surrounding blood vessels where it is able to interact with a variety of growth factors, matrix molecules and cations [ ± ]. tsp has been implicated in several steps in the angiogenic response [ , ± ] . it potently inhibits endothelial cell proliferation [ ± ], migration [ , ] and induces vascular disassembly. endothelial cell sprouting is enhanced by exposure to anti-tsp antibodies [ , ] , and endothelial cells transduced with antisense tsp [ ] exhibit an enhanced ability to form sprout-like structure on arti®cial matrices in vitro. the potent anti-angiogenic activity of tsp has been localized to two domains within the central stock region of the molecule: the procollagen homology region and the properdin-like type i repeats [ , ± ] . the antiangiogenic eect of tsp involves signalling through the endothelial cell membrane receptor cd [ ] . recent data suggest that the antiangiogenic eect of tsp is mediated in part by its ability to induce endothelial cell apoptosis. tsp as well as peptide fragments derived from its antiangiogenic domains have been shown to induce apoptosis of human umbilical vein endothelial cells (huvecs) in vitro [ ] . angiostatin a kda internal fragment of plasminogen that contains the ®rst four disul®de-linked kringle structures was puri®ed from plasma of mice bearing a lewis lung carcinoma, sequenced and named angiostatin [ ± ]. it was characterized as a speci®c inhibitor of endothelial cell proliferation in vitro and suppressor of tumor growth and metastatic dissemination in vivo [ , , ] . angiostatin can be generated by the hydrolysis of circulating plasminogen by a macrophage-derived metalloelastase [ ] , matrilysin and gelatinase b [ ] , or stromelysin [ ] . the antiangiogenic function of angiostatin is believed to be mediated, at least in part, by its ability to induce apoptotic death of endothelial cells [ , ] . treatment of endothelial cells with angiostatin resulted in decreased cell numbers without signi®cant eects on dna synthesis, suggesting that the decreased proliferation rates observed in cells exposed to angiostatin were due to enhanced endothelial cell apoptosis [ , ] . the domains responsible for angiostatin pro-apoptotic function appear to reside in kringle domains , and [ ] . tumor necrosis factor (tnf) is a multifunctional cytokine secreted by activated macrophages [ ± ] and t cells [ ] . tnf is an important mediator of in¯ammatory processes and immune responses, where it was shown to induce tumor regression by hemorrhagic necrosis [ , ] . tnf's function in tumor serum albumin accutin extracellular atp alkyllyso-phospholipid et -ome -methoxyestradiol regression has been attributed to its cytotoxic eect on endothelial cells that results in disruption of the tumor capillary bed [ ] . several studies have shown that binding of tnf to endothelial cells results in their apoptotic death [ ± ]. the ability of tnf to induce endothelial cell apoptosis is enhanced by concomitant exposure to inhibitors of protein synthesis [ ± ]. this suggested that tnf might also protect endothelial cells from apoptosis by utilizing a pathway(s) that is dependent on protein synthesis [ ] . in fact, tnf was shown to induce expression of the antiapoptotic protein a (a bcl- homologue) and where overexpression of a was shown to inhibit apoptosis when endothelial cells were exposed to tnf and actinomycin d [ ] . the recent ®nding that overexpression of bcl- further supports this tnf associated protective mechanism. bcl-x l also protects endothelial cells from tnf-mediated apoptosis after sensitization with cyclohexamide [ ] . tnf seems to mediate a multitude of intracellular signal transduction pathways that are triggered upon its binding to endothelial cell membrane receptors. these include activation of: (a) nf-jb, which mediates expression of il- , vegf, and e-selectin in endothelial cells [ ± ]; (b) protein kinase c, which leads to the upregulation of a expression and subsequent enhancement of cell survival [ ] ; (c) sp , which mediates expression of vegfr- [ ] ; and (d) ceramides and c-jun, which result in endothelial cell death [ , ] . despite extensive research, the eects of tnf in endothelial cells are still unclear. while some reports demonstrate that tnf induces endothelial cell apoptosis, other investigations have shown that tnf is angiogenic [ , , ] . there are a number of possible explanations for these con¯icting results. (a) tnf's ability to induce angiogenesis in vivo may be due to the synthesis of angiogenic factors such as il- , vegf or bfgf or macrophages [ , ] . (b) responses mediated by tnf are dose-dependent. while tnf stimulates angiogenesis at low concentrations [ ] , it inhibits it in higher concentrations [ ] . this suggests that the induction of endothelial cell death or survival depends on the expression levels of tnf that accumulate extracellularly, which in turn determines whether it transmits a death signal or survival signal to endothelial cells. transforming growth factor-b (tgf-b) tgf-b has been shown to induce apoptosis of huvec in vitro by downregulating bcl- expression [ ] . choi and ballerman have demonstrated that tgf-b induces apoptosis of renal glomerular endothelial cells and capillary sprouting in vitro [ ] . the authors found that endothelial cell sprouting is inhibited in dominant negative mutants if tgf-b type ii receptors are blocked. they concluded that tgf-b-induced endothelial cell apoptosis is necessary for capillary morphogenesis [ ] . escherichia coli endotoxins (lps) cause acute pulmonary endothelial cell injury in vivo [ ] and endothelial cell apoptosis in vitro [ ] . recently, a study has associated lps with the pathogenesis of endotoxic shock syndrome that is characterized by generalized in¯ammation, circulatory collapse and death [ ] . co-injection of lps with its putative eector (tnf-a) induces endothelial cell apoptosis that is associated with enhanced expression of the pro-apoptotic lipid ceramide [ ] . the ability of lps to induce apoptosis of cultured sheep pulmonary artery endothelial cells was attenuated by collagen [ ] and by overexpression of the heat shock protein- (hsp- ) [ ] . vitamin c and e have also been shown to prevent lps-mediated apoptosis in huvec [ ] . the protective eect of these vitamins was associated with enhanced expression of the antiapoptotic protein bcl- and decreased expression of the pro-apoptotic protein bax [ ] . several other inducers of endothelial cell apoptosis have been described in the literature. interferon-c induces apoptosis of normal endothelial cells through activation of the protein kinase c pathway [ ] . amyloid b-peptide, a molecule involved in neuronal degeneration observed in the brain of patients with alzheimer's disease, has been implicated in the induction of endothelial cell apoptosis [ ] . it was suggested that amyloid b-peptide-induced endothelial cell apoptosis might be directly involved with the vascular damage frequently observed in these patients [ ] . cholesterol oxides are molecules involved in the initiation and progression of atherosclerosis [ ] . physiological concentrations of cholesterol oxides induce apoptosis of endothelial cells and cause damage to the vessel wall [ ] . this observation might explain, at least in part, the role of cholesterol oxides in the etiology of vascular injury in vivo [ ] . accutin, a rgd containing small peptide from the disintegrin family, was recently puri®ed from the viper venom of agkistrodon acutus [ ] . in vitro, accutin induces apoptosis of endothelial cells by inhibiting their adhesion to ®brinogen, ®bronectin, or vitronectin [ ] . furthermore, accutin is anti-angiogenic when evaluated in the chick chorioallantoic membrane (cam) assay. it was suggested that the mechanisms responsible for this anti-angiogenic eect involve selective blockade of the endothelial cell integrin a v b and consequent induction of apoptosis [ ] . endothelial cell injury is a component of the`increased pulmonary edema' that manifests in patients with acute respiratory distress syndrome (ards) [ ] . dawicki and collaborators showed that extracellular atp and adenosine induce apoptosis of pulmonary artery endothelial cells [ ] . they speculate that atp released from activated platelets and cells undergoing cytolysis in ards patients causes apoptosis of lung endothelium, and thereby exacerbates pulmonary injury [ ] . pharmacological agents can also induce endothelial cell apoptosis. alkyllyso-phospholipid et -ome, a putative anti-tumor drug, induces apoptosis when added to the culture medium of human umbilical vein endothelial cells [ ] . moreover, -methoxyestradiol, an endogenous estrogen metabolite of the oral contraceptive -ethylestradiol, induces apoptosis of bovine pulmonary artery endothelial cells in vitro and inhibits angiogenesis in vivo [ ] . lastly, an important role for accessory cells and changes in blood¯ow in endothelial cell apoptosis and capillary regression has been proposed in a series of studies by richard lang and colleagues [ ± ] . during regression of the pupillary membrane, a transient capillary network found in the anterior chamber of the developing rodent eye, macrophages initiate apoptosis of endothelial cells which leads to capillary regression. this selective ablation of endothelial cells results in vessel obstruction and a block in plasma¯ow within the clogged capillary segment. endothelial cells then die in a`synchronous' manner because they are deprived of essential survival factors present in plasma. recently this group has determined that the major survival factor in plasma that is responsible for maintaining the integrity of this embryonic organ is vegf. the signi®cance of vegf as a survival factor will be discussed in greater detail below. in , vascular permeability factor (vpf) was iden-ti®ed in tumors and characterized as an endothelial factor that enhances the permeability of microvessels to circulating molecules [ ] . in , two independent groups reported the cloning and sequencing of an endothelial cell speci®c mitogen with heparin binding properties that was called vascular endothelial growth factor (vegf) [ ± ]. further sequencing and characterization led to the conclusion that vpf and vegf shared the same biological functions and were encoded by the same gene. alternative splicing of vegf mrna originates ®ve human vegf isoforms, of which vegf is the predominant molecular species [ , ] . vegf has been extensively characterized as a potent permeability factor [ ] , endothelial cell speci®c mitogen and chemoattractant [ , ] an angiogenic factor [ , ] , and a mediator of adhesion of natural killer cells to tumor endothelium by inducing expression of vcam- and icam- [ ] . more recently, the role of vegf as an enhancer of endothelial cell survival has been investigated. vegf was shown to protect endothelial cells from apoptosis induced by tnf by inducing upregulation of b integrin and ®bronectin [ ] . it was proposed that the sustained endothelial cell survival observed in cells exposed to vegf was mediated by their enhanced adhesion to matrix [ , ] . at approximately the same time, another group of investigators determined that vegf enhanced the survival of microvascular endothelial cells cultured in hydrophobic polystyrene [ ] . interestingly, the mechanism suggested for vegf-induced endothelial survival in this experimental design was dependent on vitronectin and a b integrin, not a b . the ability to enhance endothelial cell survival was speci®c to vegf, since other angiogenic factors such as bfgf were tested and did not exhibit the same eect [ ] . the mechanisms underlying vegf's survival function are starting to be unveiled. vegf was shown to upregulate expression of the antiapoptotic protein bcl- and its homologue a in endothelial cells in vitro [ , ] . overexpression of bcl- was sucient to enhance endothelial cell survival and protect against apoptosis induced by growth factor deprivation [ , ] . vegf-mediated bcl- upregulation in endothelial cells unequivocally potentiates angiogenic responses in vitro and in vivo [ ] . vegf's survival signal was shown to be mediated by the flk- /kdr receptor and engagement of the phosphatidylinositol -kinase/akt transduction pathway [ ] . another group has characterized vegf's survival function for endothelial cells cultured in collagen as dependent on the activation of the mitogen activated protein kinase [mapk], rather than the akt/pkb, signaling pathway [ ] . one of the most potent stimuli for vegf secretion and angiogenesis is oxygen deprivation. hypoxia is associated with a variety of responses at the cellular and tissue level. reduced levels of oxygen induce glycolysis to enhance energy production. it also enhances erythropoietin synthesis to increase the oxygen carrying capacity of the blood, and vegf secretion which enhances tissue oxygenation by increasing vessel permeability and promoting neovascularization. an important component of the transcriptional response to hypoxia is the transcription factor hif- . this hypoxia-inducible transcription factor functions by controlling the expression of a series of target genes that regulate tissue oxygenation in a number of physiological and pathological settings. recent work from several laboratories has established a key role for hif- in the hypoxic response during embryonic development and angiogenesis [ ± ]. for example teratocarcinomas derived from embryonic stem cells null for hif- a exhibited a dramatic reduction in growth and vascularization [ ± ] . this ®nding correlated with a reduced capacity of these cells to release vegf. furthermore it was shown that hif- a null mutant embryos exhibited a complete lack of cephalic vascularization, reduced numbers of somites and abnormal neural fold formation. carmeliet and collaborators have reported that embryonic stem cells null for hif- a showed reduced hypoxia-induced expression of vegf. this was associated with a reduction in the formation of large, mature vessels and impaired vascular function [ ] . the consequences of aberrant expression of hifa have been revealed in several recent reports that examined the molecular basis of unregulated angiogenesis in the hereditary cancer syndrome, the von hippel-lindau (vhl) disease [ ± ] . individuals aected by this disorder develop hemangioblastomas in the retina, cerebellum and spine as well as the adrenals and kidney. interestingly, individuals with this disease exhibit a molecular and biochemical phenotype reminiscent of oxygen deprivation. it was recently reported [ ] that the vhl gene binds to the transcription factors hif- a and hif- a where it targets them for destruction. cells lacking the vhl gene cannot degrade these two transcription factors. this in turn drives excessive vegf synthesis and angiogenesis. although a number of questions remain, these recent observations suggest that vegf may utilize a number of dierent molecular pathways to enhance the survival of endothelial cells. the fgf family consists of nine structurally related polypeptides. bfgf was originally puri®ed from the bovine pituitary gland [ ] , sequenced, and characterized as an angiogenic factor [ ] . araki and colleagues in [ ] were the ®rst to implicate fgf as a survival factor for endothelial cells. enhanced activity of protein kinase c was associated with the ability of bfgf to protect endothelial cells against apoptosis induced by growth factor deprivation [ ] or ionizing radiation in vitro and in vivo [ ± ]. in contrast, tyrosine phosphorylation, but not protein kinase c activation, was shown to mediate bfgf's protective eect [ ] . the role of bfgf in endothelial cell survival was further characterized by the ®nding that its removal from culture medium of murine aortic endothelial cells was sucient to activate the pro-apoptotic cysteine protease interleukin- b-converting enzyme (ice) and mediate dna fragmentation [ ] . more, recently, the anti-apoptotic function of bfgf was associated with its ability to enhance expression of bcl- [ ] . endothelial cells rapidly undergo apoptosis when their interactions with the extracellular matrix are inhibited, in a process called`anoikis' [ ] . integrins were identi®ed as key transducers of extracellular matrix signals that were required for maintaining cell survival [ ] . there is increasing evidence that integrins also play a critical role in the regulation of angiogenesis by modulating endothelial cell survival [ ± ] . the ®nding that a v b is preferentially expressed in newly formed microvessels and that monoclonal antibodies to a v b induce endothelial cell apoptosis restricted to these vessels was immediately considered a major breakthrough as a potential anti-angiogenic tumor therapy [ ± ] . the authors hypothesized that if a v b ligation is prevented; the endothelial cells will no longer receive necessary survival signals from the ecm and undergo apoptosis by default. the signaling pathways that mediate endothelial cell survival upon activation of a v b have been extensively studied. ligation of endothelial cell a v b during angiogenesis promotes a speci®c signal that leads to inhibition of p expression and its inducible partner p waf (mediator of cell cycle arrest), and suppression of the pro-apoptotic bax pathway [ ] . the activation of the transcription factor nf-jb was shown to be dependent on the gtp-binding protein ras and the tyrosine kinase src, and is necessary for a v b -mediated endothelial cell survival [ ] . another study has identi®ed the activation of the phosphatidylcholine-speci®c phospholipase c and production of diacylglycerol (dag) as essential components of integrin mediated survival signals in endothelial cells [ ] . exposure of human endothelial cells to gamma interferon (ifn-gamma) was shown to inhibit the a v b -mediated survival pathway and to induce endothelial cell apoptosis in vitro [ ] . treatment of patients with ifn-gamma also resulted in enhanced endothelial cell apoptosis in metastatic melanoma [ ] . inactivation of the integrin pathway during endothelial cell apoptosis may be due to cleavage of its cytoplasmic domain. calpain-mediated proteolysis of the b cytoplasmic domain was observed during apoptosis of human umbilical vein endothelial cells, and its inhibition with sodium orthovanadate (a phosphatase inhibitor) rescued these cells from apoptosis [ ] . nitric oxide is a multifunctional molecule that is synthesized by endothelial cells in low doses through the activity of the enzyme nitric oxide synthase (enos) [ , ] . inhibition of no was associated with enhanced endothelial cell apoptosis in con¯uent cultures of bovine aortic endothelial cells [ ] . the authors suggested that no has an important role in maintaining vascular homeostasis and architecture [ ] . enhanced endothelial cell apoptosis has been associated with the pathogenesis of atherosclerosis [ , ] . the incidence of coronary disease in post-menopausal women increases concomitantly with a decrease in the synthesis of estrogens, and the administration of this hormone is being considered one of the most eective anti-atherogenic therapies available for women [ ] . estradiol, a key estrogen metabolite, has been now characterized as a potent anti-apoptotic mediator for endothelial cells. estradiol protected endothelial cells against apoptosis induced by tnf-a [ ] . it was also shown that estradiol's anti-apoptotic function was mediated by increased tyrosine phosphorylation of a focal adhesion kinase that stabilized focal adhesion contacts [ ] . adrenomedullin, a potent vasorelaxant/hypotensive peptide, was shown to suppress serum deprivationinduced apoptosis of rat endothelial cells via a camp-independent mechanism [ ] . human umbilical vein and microvascular endothelial cell apoptosis were inhibited by physiological concentrations of serum albumin [ ] . the authors suggested that the removal of excessive blood vessels in remodeling tissues might be mediated by a reduced supply of serum albumin to the endothelial cells. lastly, the inhibitor of apoptosis protein family (iaps) has received considerable attention over the past years [ ] . initially discovered in baculoviruses they appear to be highly conserved across several species including humans [ , ] . the iaps appear to suppress apoptosis through direct caspase inhibition (primarily caspase and ) and by modulation of the transcription factor nf-jb [ ] . although a role for the iaps in endothelial survival and angiogenesis has yet to be established, given the wide spread distribution of these proteins, it would not be entirely surprising to ®nd that they play a role in endothelial cell survival and angiogenesis. in response to angiogenic stimuli, endothelial cells undergo a series of tightly controlled events that result in sprouting and development of a capillary network and the remodeling of established vessels. when newly formed blood vessels are no longer necessary, they undergo regression. figure depicts the process of programmed cell in both angiogenesis and angiosuppression. traditionally, the initiation of angiogenesis has been described as involving degradation of basement membrane followed by proliferation and migration of endothelial cells to form a capillary loop. in , choy and ballermann [ ] raised the intriguing possibility that capillary morphogenesis depended on the selective apoptosis of endothelial cells mediated by transforming growth factor-b (tgf-b ). this homodymeric polypeptide is strongly expressed in sites of tissue morphogenesis [ ] . it has been shown to induce angiogenesis in vivo [ ] and endothelial cell sprouting in vitro [ ] . during the process of capillary morphogenesis, tgf-b mediates secretion of plasminogen activator that cleaves the proenzyme plasminogen and activates plasmin, which in turn degrades ecm proteins [ ] . this results in detachment and apoptosis of endothelial cells from selective areas of the developing capillary, and allows for the initiation of a new capillary loop [ , ] . targeted apoptosis of endothelial cells seem to have an important physiological role in allowing for the communication between the newly formed capillary and their`parent' venules. the role of endothelial cell proliferation and migration in the pathogenesis of angiogenesis-dependent diseases and the mediators responsible for aberrant angiogenic responses have been extensively characterized. more recently researchers have turned their attention to characterizing the impact of endothelial survival and death signals in pathological angiogenesis. the accumulated evidence to date suggests that disruption in the cell death machinery is central to the pathogenesis of a number of angiogenesis-dependent diseases (figure ). two excellent examples of this phenomenon are retinopathy of prematurity, that is caused by excessive endothelial cell apoptosis in its initial stages [ ] ; and (b) cancer, that is associated with an unrelenting angiogenic response [ ] . these two diseases were selected for discussion here because there is a considerable body of literature about their pathogenesis. however, it is anticipated that in time new data will emerge linking changes in the survival pro®le of endothelial cells to other angiogenesis dependent diseases. with increasing survival of premature infants weighing less than g, the incidence of retinopathy of prematurity-induced blindness has also increased steadily [ ] . the pathogenesis of retinopathy of prematurity has been directly associated to the fact that premature infants are placed in oxygen chambers and exposed to a hyperoxic environment to provide enough oxygen for their immature lungs [ ] . the exposure of the immature retina to hyperoxia results in excessive apoptosis of endothelial cells [ , , ] . when the lungs of the infant mature, the transition to room air causes excessive retinal neovascularization that is mediated by the relative ischemia in the retina resulting from the initial figure . the balance expression of endothelial survival and death signals characterizes physiological angiogenesis. (a) during the initiation phase of a physiological angiogenic response there is an increase in the level of proangiogenic factors coincidental with a reduction in the level of angiogenesis inhibitors. this temporary shift to the angiogenic phenotype is accompanied by a transient upregulation in survival signals that is induced by proangiogenic factors. also, the number of endothelial cells undergoing apoptosis is reduced due to the diminished level of angiogenesis inhibitors and/or increased resistance of endothelial cells to the pro-apoptotic eects of angiogenesis inhibitors. once the metabolic demands of the tissue have been met, i.e., during the reparative phase of tissue injury, the level of proangiogenic mediators in the tissue decreases while the level of angiogenesis inhibitors begin to rise. this results in increased endothelial cell apoptosis, and the rapid regression of neovessels. (b) in angiogenesis dependent diseases the angiogenic phenotype is prolonged resulting in a protracted angiogenic response. the reduction in the level of angiogenic inhibitors along with a relative or absolute increase in the level of proangiogenic factors results in prolonged upregulation of endothelial cell survival signals and a marked decrease in endothelial cells undergoing apoptosis. we propose that prolonged upregulation of survival signals and/or a reducing in death signals contributes to sustained neovascularization that characterizes angiogenesis dependent diseases. disruption of blood supply [ , ± ] . the resulting aberrant neovascularization is the cause of the severe ocular disease observed frequently in these infants, including blindness [ ] . the pathogenesis of retinopathy of prematurity has been extensively studied at the molecular level, and vegf is believed to play a major role in this process. it is known that vegf is very responsive to subtle changes in oxygen tension. for example, its expression levels are increased in hypoxic areas and result in local induction of neovascularization that re-establishes normal oxygen supply [ , , ] . recent reports demonstrated that vegf expression is downregulated soon after the level of oxygen rises in the retina [ , , , ] , and precedes blood vessel regression caused by endothelial cell apoptosis [ ] . when the child starts breathing room air, the retina becomes hypoxic because most blood vessels have been previously disrupted. in attempt to re-establish normal oxygen tension to the area, vegf is upregulated above physiological levels and causes excessive neovascularization that is responsible for the ocular pathology [ , , , ] . this knowledge provides a better rationale for administrating exogenous vegf in infants prior to exposing them to the hyperoxic environment of oxygen chambers in an attempt to prevent endothelial cell apoptosis and maintain the retinal vasculature [ , , ] . this clinical setting underlines the important function of vegf as an angiogenic mediator and endothelial cell survival factor. it also demonstrates that this growth factor provides a signal that is necessary to sustain endothelial cell survival in vivo and that its premature downregulation results in the disruption of established as well as newly formed microvessels. judah folkman and colleagues ®rst proposed the hypothesis that`solid tumors are angiogenesis-dependent' in [ ] . since then the validity of this statement has been widely con®rmed [ ] . the observation that tumors grow as`cylinders' and enter into dormancy unless they acquire a new blood supply strengthened the concept that tumors were angiogenesis dependent [ , ] . a recent study con®rmed this hypothesis by demonstrating the existence of an inverse relation between spontaneous apoptosis of tumor cells and intratumoral microvessel density [ ] . the intense competition for limited oxygen and nutrient supplies, as well as for physical space inside the mass of a solid tumor, generates a hostile microenvironment for normal and neoplastic cells. however, it is clear that tumor cells have developed mechanisms for enhancing their survival and enabeling them to grow in nutrient deprived environments. a question arises with regards to normal endothelial cells that populate tumor-associated blood vessels. how do they survive in this hostile environment and sustain tumor neovascularization? tumor-associated endothelial cells receive a continuous input of survival signals from the ecm and depend on these signals to remain viable and functional. these conclusions are supported by the ®ndings obtained in two elegant experiments from eli keshet's laboratory. vegf expression was`shut down' with an inducible vegf expression system (`tet-o ') in xenografted glioma tumors in nude mice. the authors observed that upon vegf withdrawal endothelial cells became apoptotic, tumor neovascularization decreased, and extensive tumor necrosis took place [ ] . in a second model system, these investigators demonstrated that castration of scid mice bearing an androgendependent tumor resulted in decreased intratumoral expression of vegf and tumor regression [ ] . the observation that endothelial cells began to undergo apoptosis before neoplastic cells con®rmed the hypothesis that tumor-associated endothelial cells require speci®c survival signals mediated by vegf to remain viable. these ®ndings reported above suggest that tumor regression mediated by withdrawal of vegf is not due to inhibition of endothelial cell proliferation. the turnover of tumor-associated endothelial cells is thought to occur over several days or weeks. however, in this study the tumors started to regress after h. therefore, the lack of endothelial cell proliferation and migration cannot be the only mechanism responsible for the vascular regression observed in these tumors. an alternative hypothesis is that vegf is required for maintaining endothelial cells survival and to sustain tumor angiogenesis. when this positive`survival' signal is eliminated endothelial cells become more responsive to inhibitors of angiogenesis leading to endothelial cell apoptosis, vessel disassembly, and tumor regression ( figure ). angiogenesis is absolutely necessary for embryonic morphogenesis and for maintaining tissue and organ homeostasis in adult organisms. disruption of this biological process has been unequivocally associated with several diseases that are now described as being angiogenesis-dependent. traditionally, angiogenic mediators have been categorized as promoting endothelial cell proliferation, migration, and adhesion. there is now compelling evidence that angiogenesis is modulated by a tightly controlled series of cellular and biochemical events that determine whether endothelial cells survive or die. the events that govern the survival and death of endothelial cells signi®cantly in¯uence the stability and duration of an angiogenic response. after all, angiogenesis would be of little bene®t to developing organisms or adult tissues undergoing repair if endothelial cells did not survive and eventually die in a predetermined manner. similarly, in pathological settings such as in neoplasia, tumor cells would be unable to withstand the onslaught of nutrient deprivation and physiological signals designed to cause their demise if endothelial cells were not able to organize into a microvascular network. thus as we look to develop novel strategies designed to retard pathological angiogenic responses or enhance physiological angiogenesis, we will have to consider factors that in¯uence endothelial cell survival as an integral component of any therapeutic strategy. . this diagram depicts how aberrant expression of endothelial survival and death signals might contribute to the unrelenting angiogenesis that is a hallmark of tumor development. in (a) vascular remodeling is a feature of normal microvascular homeostasis. in this setting the levels of inducers and inhibitors of angiogenesis are in balance. the proportion of long-lived endothelial cells populating established vessels is balanced by those endothelial cells undergoing periodic, selective apoptosis. with the emergence of neoplastic cell populations (b) the level of inducers begin to rise in association with a reduction in the level of inhibitors of angiogenesis. this is re¯ected in a greater number of longlived endothelial cells and fewer endothelial cells undergoing apoptosis. lastly in (c) as tumor neovascularization is accelerated coincidental with an increase in the tumor mass, the level of stimulators of angiogenesis that enhance endothelial cell survival greatly exceed the level of inhibitors and thus death signals. as a consequence death signals are minimized and long-lived endothelial cells accumulate in even greater numbers. we predict this would result in a more sustained and stable vascular supply to the tumor and contribute to tumor growth and progression. cell death in development apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview apoptotic pathways: the roads to ruin untersuchungen uÈ ber die entwicklungsgeschichte der geburtsshelferkroete (alytes obstertricians) apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics the role of apoptosis in wound healing apoptosis in the pathogenesis and treatment of disease analysis of hematopoiesis in max transgenic mice that exhibit sustained elevations of blood granulocytes and monocytes cell suicide for beginners conversion of lytic to persistent alphavirus infection by the bcl- cellular oncogene the origin of programmed cell death mechanisms and genes of cellular suicide mechanisms and functions of cell death genetics of programmed cell death in c. elegans past, present and future post-embryonic cell lineages of the nematode, caenorhabditis elegans nunÄ ez g. interaction and regulation of subcellular localization of ced- by ced- interaction of ced- with ced- and ced- ± a molecular framework for cell death interaction between the c. elegans cell death regulators ced- and ced- nunÄ ez g. caenorhabditis elegans egl- disrupts the interaction of ced- with ced- and promotes ced- activation bcl- and the regulation of programmed cell death bcl- family: regulators of cell death bcl- family proteins double identity for proteins of the bcl- family bid: a novel bh domainonly death agonist caspases: enemies within apaf- , a human protein homologous to c. elegans ced- , participates in cytochrome c-dependent activation of caspase- caspase- , bcl-xl, and apaf- form a ternary complex bcl-x l interacts with apaf- and inhibits apaf- -dependent caspase- activation nunÄ ez g. wd- repeat region regulates apaf- self-association and procaspase- activation autoactivation of procaspase- by apaf- -mediated oligomerization caspases: the proteases of the apoptotic pathway mitochondria and apoptosis cytochrome c and datpdependent formation of apaf- /caspase- complex initiates an apoptotic protease cascade regulation of cell death protease caspase- by phosphorylation multiple species of cpp and mch are the major active caspases present in apoptotic cells a caspase-activated dnase that degrades dna during apoptosis, and its inhibitor icad cleavage of cad inhibitor in cad activation and dna degradation during apoptosis molecular cloning and characterization of human caspase-activated dnase death receptors: signaling and modulation the tnf receptor superfamily of cellular and viral proteins: activation, costimulation, and death a novel domain within the kd tnf receptor signals cell death flice is activated by association with the cd death-inducing signaling complex (disc) autoproteolytic activation of pro-caspases by oligomerization synthetic activation of caspases: arti®cial death switches pro-caspase- is a major physiologic target of caspase- flice, a novel fadd-homologous ice/ced- -like protease, is recruited to the cd (fas/apo- ) death±inducing signaling complex bcl-x(l) can inhibit apoptosis in cells that have undergone fas-induced protease activation a caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis caspase inhibition reduces apoptosis and increases survival of nigral transplants caspases: key mediators of apoptosis the bcl- protein family: arbiters of cell survival defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by bcl- enforced dimerization of bax results in its translocation, mitochondrial dysfunction and apoptosis mechanisms of angiogenesis heterozygous embryonic lethality induced by targeted inactivation of the vegf gene role of thē t- tyrosine kinase in regulating the assembly of vascular endothelium isolation of putative progenitor endothelial cells for angiogenesis progress in applied microcirculation increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro angiogenesis in vitro rat aortic smooth muscle cells become perycites during angiogenesis in vitro what is the role of endothelial cells in angiogenesis? a plasticity window for blood vessel remodelling is de®ned by pericyte coverage of the preformed endothelial network and is regulated by pdgf-b and vegf the pathophysiology of angiogenesis the structural and functional properties of thrombospondin the structure of endothelial cell thrombospondin. characterization of the heparin-binding domains diversity of function is inherited in matricellular proteins: an appraisal of thrombospondin- a tumor suppressordependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin peptides derived from two separate domains of the matrix protein thrombospondin- have anti-angiogenic activity thrombospondin synthesis and function in wound repair unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo thrombospondin- , an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium thrombospondin exerts an antiangiogenic eect on cord formation by endothelial cells in vitro the functions of thrombospondin and its involvement in physiology and pathophysiology thrombospondin- speci®c inhibition of endothelial cell proliferation by thrombospondin platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor downregulation of endothelial cell thrombospondin enhances in vitro angiogenesis endothelial cell mitogenesis induced by lpa: inhibition by thrombospondin- and thrombospondin- recombinant truncated thrombospondin- monomer modulates endothelial cell plasminogen activator inhibitor accumulation and proliferation in vitro evidence that tenascin and thrombospondin- modulate sprouting of endothelial cells modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparinbinding domain and synthetic peptides from the type i repeats of thrombospondin expression and analysis of cooh-terminal deletions of the human thrombospondin molecule thrombospondin- suppresses tumorigenesis and angiogenesis in serum-and anchorageindependent nih t cells cd mediates the in vitro inhibitory eects of thrombospondin- on endothelial cells thrombospondin and type i repeat peptides of thrombospondin speci®cally induce apoptosis of endothelial cells angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth kringle domains of human angiostatin. characterization of the anti-proliferative activity on endothelial cells macrophage-derived metalloelastase is responsible for the generation of angiostatin in lewis lung carcinoma angiostatin-converting enzyme activities of human matrilysin (mmp- ) and gelatinase b/type iv collagenase (mmp- ) generation of an angiostatin-like fragment from plasminogen by stromelysin- (mmp- ) angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif rgd multiple forms of angiostatin induce apoptosis in endothelial cells tumour-necrosis factor from the rabbit. ii. production by monocytes tumor necrosis factor, other cytokines and disease macrophages induce apoptosis in normal cells in vivo simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal t cells after induction with il- and anti-t tumor necrosis factor: an updated review of its biology tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro alveolar epithelial cells regulate the induction of endothelial cell apoptosis induction of endothelial cell apoptosis by tnf alpha: modulation by inhibitors of protein synthesis activation and injury of endothelial cells by cytokines inhibition of tumor necrosis factor signal transduction in endothelial cells by dimethylaminopurine endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the bcl- family member, a bcl- and bcl-xl serve an anti-in¯ammatory function in endothelial cells through inhibition of nf-kappab nf-kappa b and i kappa b alpha: an inducible regulatory system in endothelial activation transcriptional regulation of endothelial cell adhesion molecules: nf-kappa b and cytokine-inducible enhancers h o and tumor necrosis factor-alpha induce dierential binding of the redox-responsive transcription factors ap- and nf-kappab to the interleukin- promoter in endothelial and epithelial cells involvement of interleukin- , vascular endothelial growth factor, and basic ®broblast growth factor in tumor necrosis factor alpha-dependent angiogenesis tumor necrosis factoralpha regulates expression of vascular endothelial growth factor receptor- and of its co-receptor neuropilin- in human vascular endothelial cells programmed cell death induced by ceramide macrophageinduced angiogenesis is mediated by tumour necrosis factoralpha tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. possible roles of sp- transforming growth factor beta induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl- inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-b receptors endotoxin and lung injury collagen is a survival factor against lps-induced apoptosis in cultured sheep pulmonary artery endothelial cells lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation the heat-shock response attenuates lipopolysaccharide-mediated apoptosis in cultured sheep pulmonary artery endothelial cells vitamin c and e prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of bcl- and bax the dierential response to interferon gamma by normal and transformed endothelial cells amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells angiotoxicity and arteriosclerosis due to contaminants of usp-grade cholesterol induction of apoptosis in endothelial cells treated with cholesterol oxides evidence for apoptosis in advanced human atheroma. colocalization with interleukin- beta-converting enzyme accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as an integrin a v b antagonist and inducing apoptosis role of mesenchymal cell death in lung remodeling after injury extracellular atp and adenosine cause apoptosis of pulmonary artery endothelial cells programmed cell death in response to alkyllysophospholipids in endothelial cells -methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and fas expression macrophages are required for cell death and tissue remodeling in the developing mouse eye apoptosis during macrophage-dependent tissue remodelling a relationship between¯ow and apoptosis during programmed capillary regression is revealed by vital analysis vegf deprivationinduced apoptosis is a component of programmed capillary regression tumor cells secrete a vascular permeability factor that promotes accumulation of ascites¯uid pituitary follicular cells secrete a novel heparin-binding growth factor speci®c for vascular endothelial cells isolation and characterization of a newly identi®ed endothelial cell mitogen produced by att- cells isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells vascular endothelial growth factor vascular endothelial growth factor (vegf) and its receptors vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor- promote rat aortic angiogenesis in vitro vascular endothelial growth factor is a secreted angiogenic mitogen tumors: wounds that do not heal. similarities between tumor stroma generation and wound healing dierential endothelial migration and proliferation to basic ®broblast growth factor and vascular endothelial growth factor during angiogenesis, vascular endothelial growth factor and basic ®broblast growth factor regulate natural killer cell adhesion to tumor endothelium vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals the extracellular matrix as a cell survival factor vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaold formation vascular endothelial growth factor induces expression of the antiapoptotic proteins bcl- and a in vascular endothelial cells vascular endothelial growth factor (vegf)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of bcl- expression bcl- gene prevents apoptosis of basic ®broblast growth factor-deprived murine aortic endothelial cells vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol -kinase/akt signal transduction pathway. requirement for flk- /kdr activation distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis hypoxia-inducible factor- modulates gene expression in solid tumors and in¯uences both angiogenesis and tumor growth hif- a is required for solid tumor formation and embryonic vascularization role of hif-a in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis the tumor suppressor protein vhl targets hypoxia-inducible factors for oxygen-dependent proteolysis structure of the vhl-elonginc-elonginb complex: implications for vhl tumor suppressor function rbx , a conponent of the vhl tumor suppressor complex and scf ubiquitin ligase primary structure of bovine pituitary basic ®broblast growth factor (fgf) and comparison with the amino-terminal sequence of bovine brain acidic fgf nucleotide sequence of a bovine clone encoding the angiogenic protein, basic ®broblast growth factor apoptosis of vascular endothelial cells by ®broblast growth factor deprivation role of protein kinase c in the inhibition by ®broblast growth factor of apoptosis in serum-depleted endothelial cells basic ®broblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo radiation-induced apoptosis in microvascular endothelial cells angiogenic stimuli are essential for survival of vascular endothelial cells in threedimensional collagen lattice involvement of interleukin- beta-converting enzyme in apoptosis of bfgf-deprived murine aortic endothelial cells fibroblast growth factor- inhibits endothelial cell apoptosis by bcl- -dependent and independent mechanisms role of integrins in angiogenesis integrin alpha v beta antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels requirement of vascular integrin alpha v beta for angiogenesis integrins, angiogenesis and vascular cell survival cleavage of the cytoplasmic domain of the integrin beta subunit during endothelial cell apoptosis suppression of p activity and p waf /cip expression by vascular cell integrin a v b during angiogenesis nf-kappab mediates alphavbeta integrin-induced endothelial cell survival relationships between phosphatidylcholine-speci®c phospholipase c and integrins in cell-substratum adhesion and apoptosis in vascular endothelial cells evidence for the involvement of endothelial cell integrin alphavbeta in the disruption of the tumor vasculature induced by tnf and ifn-gamma endothelial cytosolic proteins bind to the untranslated region of endothelial nitric oxide synthase mrna: regulation by tumor necrosis factor alpha role of nitric oxide in the control of apoptosis in the microvasculature role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. possible dysfunction of a pertussis toxin-sensitive g protein b-estradiol inhibits apoptosis of endothelial cells estrogen and coronary heart disease in women estrogenreceptor-mediated inhibition of human endothelial cell apoptosis. estradiol as a survival factor adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells serum albumin is a speci®c inhibitor of apoptosis in human endothelial cells iap family of proteins-suppressors of apoptoisis an apoptosis inhibiting baculovirus gene with a zinc ®nger-like motif an apoptosis inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with cys/his sequence motifs iaps block apoptotic events induced by caspase- and cytochrome c by direct inhibition of distinct caspases enhanced expression of tgf-beta and c-fos mrnas in the growth plates of developing human long bones transforming growth factor type beta: rapid induction of ®brosis and angiogenesis in vivo and stimulation of collagen formation in vitro phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix disruption of epithelial cell±matrix interactions induces apoptosis conditional switching of vascular endothelial growth factor (vegf) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by vegf withdrawal angiogenesis in cancer, vascular, rheumatoid and other disease retinopathy of prematurityinduced blindness: birth weight-speci®c survival and the new epidemic vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization hypoxic regulation of vascular endothelial growth factor in retinal cells regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity ocular sequelae in extremely premature infants at years of age retinal vascular endothelial growth factor (vegf) mrna expression is altered in relation to neovascularization in oxygen induced retinopathy identi®cation of a human vpf/vegf untranslated region mediating hypoxia-induced mrna stability tumor angiogenesis: therapeutic implications the relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour angiogenic factors spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor key: cord- -to g he authors: spentzas, thomas; shapley, rebekah kh; aguirre, carlos acuna; meals, elizabeth; lazar, lauren; rayburn, mark s; walker, brett s; english, b keith title: ketamine inhibits tumor necrosis factor secretion by raw . murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant staphylococcus aureus date: - - journal: bmc immunol doi: . / - - - sha: doc_id: cord_uid: to g he background: infections caused by community-associated strains of methicillin-resistant staphylococcus aureus (ca-mrsa) are associated with a marked and prolonged host inflammatory response. in a sepsis simulation model, we tested whether the anesthetic ketamine inhibits the macrophage tnf response to antibiotic-exposed ca-mrsa bacteria via its antagonism of n-methyl-d-aspartate (nmda) receptors. raw . cells were stimulated for hrs with ( )to ( )cfu/ml inocula of either of two prototypical ca-mrsa isolates, usa strain lac and usa strain mw , in the presence of either vancomycin or daptomycin. one hour before bacterial stimulation, ketamine was added with or without mk- (dizocilpine, a chemically unrelated non-competitive nmda receptor antagonist), apv (d- -amino- -phosphono-valerate, a competitive nmda receptor antagonist), nmda, or combinations of these agents. supernatants were collected and assayed for tnf concentration by elisa. results: raw . cells exposed to either lac or mw in the presence of daptomycin secreted less tnf than in the presence of vancomycin. the addition of ketamine inhibited macrophage tnf secretion after stimulation with either of the ca-mrsa isolates (lac, mw ) in the presence of either antibiotic. the nmda inhibitors, mk- and apv, also suppressed macrophage tnf secretion after stimulation with either of the antibiotic-exposed ca-mrsa isolates, and the effect was not additive or synergistic with ketamine. the addition of nmda substrate augmented tnf secretion in response to the ca-mrsa bacteria, and the addition of apv suppressed the effect of nmda in a dose-dependent fashion. conclusions: ketamine inhibits tnf secretion by mrsa-stimulated raw . macrophages and the mechanism likely involves nmda receptor antagonism. these findings may have therapeutic significance in mrsa sepsis. infections caused by community-associated strains of methicillin-resistant staphylococcus aureus (ca-mrsa) present a major public health problem because of recent increases in the incidence of these infections [ , ] . in a report, the centers for disease control concluded that staphylococcus aureus is now the most important cause of serious and fatal infection in the united states [ ] . the prototypical usa strain, mw , (cdc nomenclature for this strain of mrsa) was first isolated in from a midwest child with fatal ca-mrsa pneumonia [ ] . in , the prototypical usa ca-mrsa strain, lac, was isolated from los angeles county patients with skin and soft tissue infections, severe pneumonia and sepsis. recently, concerns about ca-mrsa infections were heightened after reports of severe invasive staphylococcal infections in some patients infected with the novel h n influenza a virus [ , ] . ca-mrsa isolates express many virulence factors [ , ] , including several cytolysins: α-toxin, γ-toxin, panton-valentine leukocidin (pvl), phenol-soluble modulins (psms), δ-toxin and, unlike traditional hospital-associated (ha-mrsa) isolates, may express superantigens such as tsst- [ ] . these bacterial components can stimulate massive cytokine release and lead to septic shock, acute respiratory distress syndrome (ards) and death. it is likely that strategies designed to modulate the excessive and prolonged host inflammatory response could improve the outcome of fulminant mrsa infections. monocytes and macrophages play important roles in host defense against staphylococci and other pyogenic bacteria [ ] , but excessive systemic or local production of inflammatory mediators by macrophages could be deleterious in patients with severe staphylococcal infections. we previously reported that raw . murine macrophages exposed to any of a series of six pediatric clinical isolates of s. aureus (two ca-mrsa, two ha-mrsa, and two methicillin-susceptible strains) in the presence of daptomycin (vs. vancomycin) secreted less tnf and accumulated less inducible nitric oxide synthase (inos) protein [ ] . vancomycin is a cell-wall active antibiotic that triggers bacterial lysis; it is the antibiotic most commonly used to treat severe mrsa infections in children [ ] . daptomycin is a novel antibiotic that is rapidly bactericidal against staphylococci but does not appear to cause rapid bacterial lysis; the mechanism of its action is not certain but it is reported to trigger depolarization of the bacterial membranes and inhibition of both dna and rna synthesis [ , ] . the rapid lysis of staphylococci, streptococci and other pyogenic bacteria exposed to cell-wall active antibiotics such as beta-lactams and vancomycin results in exaggerated release of bacterial products and an augmented and potentially harmful host inflammatory response [ , ] . therefore, optimal treatment of sepsis and other severe bacterial infections might include the use of antibiotics and/or other medications that blunt the host inflammatory response and dampen the cytokine cascade [ ] . ketamine is one of the recommended anesthetics in pediatric septic shock [ ] [ ] [ ] , which is frequently caused by staphylococci [ , ] . the reasoning for ketamine's use in staphylococcal septic shock is its blood pressure supporting effect. it increases cardiac output and blood pressure, possibly via a catecholamine release mechanism [ , ] . some data suggest that ketamine has anti-inflammatory effects [ ] [ ] [ ] [ ] . for example, it has been reported that ketamine suppresses macrophage tnf secretion in response to gram-negative bacterial lps in vivo and in vitro [ , , ] . there is also one report that ketamine suppresses tnf production by human whole blood in vitro after exposure to staphylococcal enterotoxin b [ ] . the mechanisms responsible for the anti-inflammatory effects of ketamine are not known [ ] [ ] [ ] [ ] .the present study examined the hypothesis that ketamine could suppress macrophage tnf production in response to whole bacteria, in this case clinical isolates of methicillin-resistant staphylococcus aureus (mrsa). given the important role of tnf in sepsis [ ] [ ] [ ] [ ] , and the importance of staphylococcal sepsis in children, such suppression could have a therapeutic impact. although membrane-bound toll-like receptors (tlr and tlr ) are essential for lipopolysaccharide (lps)induced tnf production [ ] , this is not the case for staphylococcus aureus. because s. aureus is able to "attack" or form pores in macrophages, tnf secretion occurs even in the absence of tlr and tlr sensors (possibly via nod and nod , intracytoplasmic sensors of peptidoglycan-derived muropeptides) [ ] . therefore, another mechanism independent of toll-like receptors must exist for ketamine's anti-inflammatory action, at least in staphylococcal infections. we also tested the effects of two chemically unrelated nmda receptor antagonists, the anti-convulsant mk- (dizocilpine) [ , ] , a non-competitive inhibitor of nmda receptors, and apv (d- -amino- -phosphonovalerate), a competitive nmda receptor antagonist [ , ] , as well as the nmda substrate itself, on macrophage tnf secretion in response to antibiotic-treated ca-mrsa bacteria. for these studies, we utilized two well-characterized clinical isolates: lac (los angeles county), representative of the usa group of organisms and closely related to the dominant ca-mrsa clone associated with soft tissue infections and serious invasive disease in the memphis area [ ] , and mw , a clinical isolate from a midwestern child with fatal ca-mrsa sepsis [ ] , representative of the usa group of organisms that constitute the other main lineage of ca-mrsa isolates in the united states. bacteria were grown to late logarithmic phase at °c in tryptic soy broth (becton dickinson and co., sparks, md) and washed three times in endotoxin-free phosphate-buffered saline. concentrations were determined by colony counts. a range of concentrations of bacteria ( - cfu/ml) was studied, based upon our previously published data with other ca-mrsa strains [ ] and our preliminary experiments using lac and mw (data not shown). minimum inhibitory concentrations (mics) for these strains were determined by the microbiology laboratory at le bonheur children's hospital using the e-test method: both strains were fully susceptible to vancomycin and daptomycin (lac: mic vancomycin . μg/ml; daptomycin . μg/ml; mw : mic vancomycin < . μg/ml; daptomycin . μg/ml). cell culture raw . murine macrophage-like cells were purchased from the atcc and cultured in dulbecco's modified eagle's medium (mediatech inc., herndon, va) supplemented with % fetal bovine serum (hyclone, logan, ut) and mm glutamine (gibco, carlsbad, ca). experiments were done in -well tissue culture plates (becton dickinson, lincoln park, nj) with × cells per well. either vancomycin or daptomycin was added to the cell cultures immediately before the addition of live staphylococci ( - cfu/ml). cells were then incubated for hours. daptomycin was obtained from cubist pharmaceuticals (lexington, ma). vancomycin was purchased via the department of pharmacy at le bonheur children's hospital (lbch) from hospira (lake forest, il). clinically achievable concentrations of each of the antibiotics, as previously tested in our laboratory [ ] , were used ( μg/ml). these experiments were repeated in parallel in the presence of ketamine ( μm) and/or mk- (dizocilpine, μm), apv (d- -amino- -phosphonovalerate, μm ("low") or mm ("high"), or nmda ( μm). the modulation of mrsa-stimulated macrophage tnf production by ketamine was subsequently examined also at a range of concentrations of μΜ, μΜ, μΜ and μΜ. the selected concentration ( μm) is based on the achievable anesthetic concentrations [ ] [ ] [ ] [ ] and on the pre-existing literature related to ketamine's tnf suppressive effect on murine macrophage models when stimulated by lps [ ] [ ] [ ] ] . the concentrations for the other factors were selected from the available literature, mk- [ ] [ ] [ ] , apv and nmda [ ] have previously been studied in cell culture models and have been shown to not cause cytotoxicity at the tested concentrations. ketamine and/or mk- or apv or nmda were added to the macrophage cultures one hour prior to bacterial challenge. the source of ketamine was ketalar ® , a racemic mixture ( : ) of optically active isomers (r and l) of this drug, purchased from the lbch pharmacy. emphasis in the experiment was placed on correlation with the clinical situation; thus racemic ketamine, the most commonly clinically used product, was selected. dizocilpine (mk- ), apv and nmda were purchased from sigma chemical co. (st. louis, mo). after incubation, cell-free supernatants were collected and assayed for tnf concentrations by using a solid-phase sandwich enzyme-linked immunosorbent assay as specified by the manufacturer (ebioscience, san diego, ca). tnf is a key cytokine produced by macrophages during mrsa stimulation. in our preliminary studies, we also measured secretion of other cytokines and found that il- , il- , and no secretion were strongly correlated with tnf secretion in response to these bacteria (r = . , . and . , respectively). we focused on tnf secretion for these studies. the tested concentrations of vancomycin, daptomycin, ketamine, mk- , apv, and nmda had no effect on the viability of the raw . cells, as determined by visual inspection of the monolayer, low power microscopic inspection of the monolayer and exclusion of . % trypan blue dye. for the single comparison experiments (ketamine or mk or apv), tnf secretion measurements were validated with an average of at least three well replicates and each of the experiments was repeated at least three times (a total of at least nine samples). the four preliminary runs and all the exposures (total of ) where the inocula were different from to cfus/ml at the verifying colony count were excluded from the final analysis. experiments with different exposure times ( , , , hours) were conducted to determine whether the inhibition increased over time. in the multiple comparison experiments (ketamine and mk synergistic action), tnf was measured from at least four well replicates. all experiments were performed separately for lac and for mw mrsa strains. there is an intrinsic experimental variation of absolute values of tnf production (up to %) because of cell culture and macrophage growth characteristics. the design was composed of factorial multiple measurements and the results were analyzed according to a mixed linear model, (glimmix) sas . (sas institute, cary, nc) and r . . and ggplot software. we set pre-planned (a priori) contrasts, i.e., we set all our comparisons in advance of multiple setting experiments. significant differences were presumed at a probability value of p < . . the results were graphed using error bars with % confidence intervals. differences in the means were estimated either with asymptotic techniques for normally distributed data or bootstrapping techniques for non-normally distributed data. ca-mrsa strains mw and lac stimulated less tnf secretion by raw . murine macrophages in the presence of daptomycin than in the presence of vancomycin as previously observed with two usa ca-mrsa strains isolated from memphis children with invasive staphylococcal infections [ ] , macrophages exposed to either of the two prototypical ca-mrsa strains studied (the usa strain, lac, or the usa strain, mw ) secreted significantly less tnf in the presence of daptomycin as compared with vancomycin (more than % reduction in each strain; figure ). macrophage tnf secretion in response to mw was , ± , pg/ ml in the presence of vancomycin and , ± , pg/ml in the presence of daptomycin, a reduction of %, significant at p < . . similarly, macrophage tnf secretion in response to lac in the presence of vancomycin was , ± , pg/ml, and , ± , pg/ml in the presence of daptomycin, a reduction of %, significant at p < . . we previously reported similar findings in six s. aureus clinical isolates (including two pediatric ca-mrsa isolates of the usa group), suggesting that this effect of daptomycin is conserved in many different s. aureus isolates. the addition of ketamine ( μΜ) to macrophage cell cultures inhibited tnf secretion in response to vancomycin-or daptomycin-exposed ca-mrsa isolates ( figure ) . the effect was similar on both strains, lac and mw , in the presence of vancomycin (upper panel) or daptomycin (lower panel). in the initial experiments we analyzed the effect of one hour pre-incubation with ketamine on the macrophage response to vancomycin-exposed ca-mrsa bacteria (mw and lac). in response to vancomycinexposed mw , pre-incubation with ketamine reduced macrophage tnf secretion by approximately % (p < . ), i.e., from , ± pg/ml to , ± pg/ml. pre-incubation with ketamine led to a similar reduction ( %; p < . ) in macrophage tnf secretion response after stimulation with vancomycinexposed lac (from , ± pg/ml to , ± pg/ml). we next studied the effect of ketamine pre-incubation on macrophage tnf secretion after stimulation with daptomycin-exposed mw or lac. once again, the addition of ketamine resulted in significant inhibition of macrophage tnf secretion in response to mw ( , ± , pg/ml to , ± pg/ml, a reduction of approximately %; p < . ) or lac (approximately % reduction, p < . ; figure ). adding ketamine after the mrsa inocula did not alter the response. figure the ca-mrsa isolates lac (usa ) and mw (usa ) stimulated less tnf secretion by raw . murine macrophages when exposed to daptomycin (dap) than when exposed to vancomycin (van). lac or mw were added to raw . cells at a final concentration of to cfu/ml (retrospective confirmation) in the presence of either vancomycin or daptomycin at μg/ml. cells were incubated for hours; supernatants were collected and analyzed for tnf content by an enzyme-linked immunosorbent assay (elisa). results are depicted as means with % confidence intervals shown as "error bars" (see methods). the "*" indicates significance at p < . . control represents the mean tnf macrophage production by macrophages not stimulated with bacteria. mrsa mw and lac exposed to ketamine one hour prior to stimulation, ketamine ( μm) was added to the indicated wells. cells were then incubated for hours; supernatants were collected and analyzed for tnf content by elisa. results are depicted as means with % confidence intervals shown as "error bars" (see methods). the "*" indicates significance at p < . . control represents the mean tnf macrophage production by macrophages not stimulated with bacteria. the nmda inhibitor mk- (dizocilpine) inhibited macrophage tnf secretion after stimulation with antibiotic-exposed ca-mrsa strains pre-incubation of raw . cells for one hour with the nmda receptor antagonist, mk- ( μΜ), also inhibited tnf secretion by these cells after stimulation with antibiotic-exposed ca-mrsa strains (mw or lac, figure ). in response to stimulation with mw in the presence of vancomycin, pre-incubation with mk- significantly inhibited tnf secretion by these cells, i.e., from , ± , pg/ml to , ± , pg/ml (approximately % reduction; p < . , figure , upper panel). mk- also inhibited macrophage tnf secretion in response to vancomycin-exposed lac, causing a % reduction (figure , upper panel) . pre-incubation with mk- also significantly inhibited macrophage tnf secretion in response to daptomycin-treated mw or lac (figure , lower panel). in response to stimulation with mw in the presence of daptomycin, pre-incubation with mk- inhibited tnf secretion by these cells by approximately % (from , ± pg/ml to , ± pg/ml, p < . ). mk- inhibited macrophage tnf secretion in response to daptomycin-exposed lac by approximately % (from , ± pg/ml to , ± pg/ml, p < . ). pre-incubation of raw . cells with combinations of mk- and ketamine did not affect the magnitude of inhibition of macrophage tnf secretion observed in the presence of ketamine (or mk- ) alone. figure depicts results for macrophages stimulated with vancomycin-or daptomycin-exposed mw ; responses to antibiotic-exposed lac were similar (data not shown). one hour prior to stimulation, either ketamine at μm, mk- at μΜ, or both were added to the indicated wells. cells were then incubated for hours; supernatants were collected and analyzed for tnf content by elisa. lane (control) represents the mean tnf production by macrophages not stimulated with bacteria. the mean includes wells exposed to ketamine, mk- , both ketamine and mk- , and neither. in the absence of bacteria, tnf secretion was minimal and was not affected by ketamine and/or mk- . nmda augments macrophage tnf secretion in response to antibiotic-treated ca-mrsa bacteria: both ketamine and a competitive nmda receptor antagonist, apv, block this effect we further examined the role of nmda receptors in modulating the macrophage tnf response to the ca-mrsa bacteria by studying the effects of a competitive nmda receptor antagonist, apv, and the effects of the nmda substrate itself ( figure ). we found that apv (at either μm or mm) also inhibited macrophage tnf secretion in response to vancomycin-exposed mw (p < . , figure ). the magnitude of the inhibition was comparable to that observed with either ketamine or mk- (and, as in the case of mk- , was not additive or synergistic with ketamine). furthermore, the addition of the nmda substrate ( μm) resulted in a marked augmentation of the macrophage tnf response to the antibiotic-treated ca-mrsa bacteria (p < . ), and this effect was blocked by ketamine and by the competitive nmda receptor antagonist, apv ( figure ). we next studied the effects of a range of concentrations of ketamine and found that inhibition of macrophage tnf secretion in response to vancomycinexposed lac or mw was consistently observed at concentrations of ketamine at the lowest concentration tested ( μm) and was greater at concentrations of - μm ( figure ). we also examined the kinetics of inhibition of macrophage tnf secretion by incubating raw . cells for , , , and hours after exposure to ketamine at a concentration of μm hour prior to stimulation with vancomycin-exposed lac or mw . we found that the magnitude of suppression of tnf secretion was similar at all times studied (figure ). we found that exposure of murine macrophages to ketamine inhibited tnf secretion by - % after stimulation with ca-mrsa bacteria in the presence of antibiotics. the magnitude of the effect was comparable in response to both mw (usa ) and lac (usa ) bacteria and was similar in the presence of either vancomycin (a lytic antibiotic associated with a greater tnf response to the bacteria) or daptomycin (a non-lytic antibiotic associated with a blunted tnf response to the bacteria). our data suggest that ketamine administration to macrophages stimulated by ca-mrsa is associated with blunting of the tnf response to these virulent pathogens, and suggest that these findings may have therapeutic significance in mrsa sepsis. furthermore, these data confirm and extend our previous observations that ca-mrsa bacteria exposed to daptomycin (versus vancomycin) trigger less tnf secretion by macrophages. the potentially beneficial antiinflammatory effects of daptomycin and ketamine were additive (figures , ) . bacteria were added at a final concentration of to cfu/ml (retrospective confirmation) in the presence of vancomycin at μg/ml. one hour prior to stimulation, apv ("low" concentration of μm or "high" concentration of mm), ketamine ( μm), or nmda ( μm) were added, alone or in combination, as indicated. cells were then incubated for hours; supernatants were collected and analyzed for tnf content by elisa. the control lane represents the mean tnf macrophage production by macrophages not stimulated with bacteria. the mean includes wells exposed to apv, ketamine, or nmda alone or in combination. in the absence of bacteria, tnf secretion was minimal and was not affected by apv, ketamine, or nmda. lanes - depict mean tnf secretion by macrophages exposed to vancomycin-treated mw alone (lane ) or in the presence of the indicated concentrations of apv, ketamine, and/or nmda (lanes - ). tnf secretion was reduced by approximately - % when macrophages were pre-incubated with apv, ketamine, or apv + ketamine (lanes [ ] [ ] [ ] [ ] [ ] . the magnitude of inhibition by ketamine and high-dose apv was similar and there were no additive or synergistic effect observed with combinations of ketamine and apv. addition of nmda ( μΜ) led to a substantial increase in the amount of tnf secreted in response to the mw strain (lane ), and this augmented response was blocked by both apv and ketamine. the "*" on " .control" and " .nmda+lo_apv" bars indicates significance at p < . . the "**" on " .control_mw " and " .nmda" bars indicates differences between the pretreated wells, and that tnf production after mrsa stimulation with nmda substrate ( .nmda) is significantly higher than that at the baseline mrsa stimulation ( .control_mw ) at p < . . an improved understanding of the pathogenesis of sepsis and other life-threatening infections caused by ca-mrsa bacteria could expedite the development of novel strategies for the diagnosis, treatment, and/or prevention of these serious infections. ca-mrsa infections often are associated with severe and prolonged host inflammatory responses [ ] [ ] [ ] [ ] . prompt antibiotic treatment of these and other serious bacterial infections is indicated, but paradoxically has the potential to trigger excessive release of bacterial products and the subsequent augmentation of the host inflammatory response [ , ] . macrophages are important sources of many of the proinflammatory cytokines (including il- β, il- , il- , il- , and tnf) secreted in response to staphylococci and other gram-positive bacteria [ , , ] . although the cytokine cascade is essential for normal host defense, excessive or inappropriate inflammation can be harmful. therefore we need an improved understanding of these interactions in order to develop better adjunctive therapies for patients with severe bacterial infections. in a previous study, we found that exposure of either of two ca-mrsa strains isolated from memphis children (or any of four other s. aureus isolates from children with invasive staphylococcal infections) to daptomycin (compared with vancomycin) led to a less pronounced macrophage inflammatory response, characterized by diminished secretion of tnf and reduced accumulation of the inducible nitric oxide synthase (inos) [ ] . in this study, we found that this differential effect of daptomycin (versus vancomycin) was also observed when macrophages were stimulated with either of the two prototypical ca-mrsa strains most widely studied today: the usa isolate, mw , and the usa isolate, lac. importantly, ketamine pre-incubation inhibited macrophage tnf secretion in response to both ca-mrsa strains in the presence of daptomycin as well as in the presence of vancomycin, and the greatest suppression of tnf secretion was noted in the presence of both daptomycin and ketamine. the mechanism(s) responsible for the anti-inflammatory properties of ketamine are not known, but its neurological and psychotropic actions are believed primarily to be mediated by antagonism of nmda receptors [ , ] . glutamate is the brain's primary excitatory neurotransmitter. nmda receptors are found in many cell bacteria were added at a final concentration of to cfu/ml (retrospective confirmation) in the presence of vancomycin at μg/ml. the ketamine concentration was μm. results are depicted as percentile reduction with % confidence intervals, i.e., the percent of tnf reduction at the specific exposure time that occurs in comparison to inoculation without ketamine at the same time. the "*" indicates statistically significant difference at p < . . types, including blood lymphocytes, lung macrophages, and multiple hematopoietic precursors in bone marrow cells [ , , , ] . both ketamine and the chemically unrelated anticonvulsant dizocilpine (mk- ) are noncompetitive antagonists of the nmda receptor, one of the three known glutamate receptors [ , , ] . apv is a competitive inhibitor of the classical nmda receptor and acts on the nr component of the receptor ( , ) . we found that mk- and apv also inhibited macrophage tnf secretion in response to antibiotictreated mw or lac cells. the magnitude of the inhibition by mk- (approximately %) and apv ( - %) was comparable to that observed with ketamine ( - %), and combinations of mk- and ketamine or of apv and ketamine did not exhibit additive or synergistic inhibition of tnf secretion. furthermore, adding nmda led to augmented macrophage tnf secretion in response to antibiotic-treated ca-mrsa bacteria, and the nmda receptor antagonist, apv, blocked this effect. the suppression of tnf induced by ketamine was observed across a range of concentrations and throughout the incubation period. our study has its limitations. to translate the present findings, we are currently working on a clinical model to assess the clinical significance of ketamine's anti-inflammatory effects in patients with bacterial sepsis. although studies of the effect of ketamine on macrophage responses to purified bacterial components such as gram-negative lipopolysaccharide (lps) or gram-positive lipoteichoic acid (lta) are instructive [ , , ] , we argue that characterization of the macrophage responses to whole organisms is more likely to provide clinical insights. indeed, the pioneering experiments of carswell and old that identified tnf used whole bacteria as stimuli in macrophage sepsis simulation settings [ ] , and we have previously demonstrated that macrophage responses to live, antibiotic-treated staphylococci serve as a powerful model system. furthermore, the model examines the effect of ketamine only in the presence of antibiotics (either vancomycin or daptomycin). in practice, this is a common clinical scenario. our data suggest that clinically achievable concentrations of both ketamine and daptomycin could potentially inhibit the excessive macrophage inflammatory response that is observed in patients with severe staphylococcal infections. in the battle of sepsis everything counts. adjunctive therapies of sepsis are greatly needed. studies in animal models and clinical trials will be required to determine whether the anti-inflammatory effects of ketamine and/or other agents that block nmda receptors could be beneficial in the treatment of severe staphylococcal infections. emergence of community-associated methicillin-resistant staphylococcus aureus at a memphis, tennessee children's hospital methicillin-resistant s. aureus infections among patients in the emergency department invasive methicillin-resistant staphylococcus aureus infections in the united states prevention: four pediatric deaths from community-acquired methicillin-resistant staphylococcus aureus-minnesota and north dakota emergence of communityacquired methicillin-resistant staphylococcus aureus strain usa as a spentzas et al cause of necrotising community-onset pneumonia infection with community-onset staphylococcus aureus and influenza virus in hospitalized children community-associated methicillinresistant staphylococcus aureus skin infections: advances toward identifying the key virulence factors saer binds a consensus sequence within virulence gene promoters to advance usa pathogenesis extreme pyrexia and rapid death due to staphylococcus aureus infection: analysis of cases monocytes/macrophages and sepsis diminished macrophage inflammatory response to staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin severe invasive community-associated methicillin-resistant staphylococcus aureus infections in previously healthy children bactericidal action of daptomycin against stationary-phase and nondividing staphylococcus aureus cells daptomycin structure and mechanism of action revealed pathogen recognition and inflammatory signaling in innate immune defenses modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis septic shock role of early fluid resuscitation in pediatric septic shock clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock scope and epidemiology of pediatric sepsis suppressive effects of ketamine on macrophage functions repeated injection of mk : an animal model of schizophrenia? ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood ketamine suppresses proinflammatory cytokine production in human whole blood in vitro ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model tumor necrosis, cachexia, shock, and inflammation: a common mediator microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock tnf-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma overview of tnf superfamily: a chest full of potential therapeutic targets toll-like receptor functions as a pattern recognition receptor for diverse bacterial products adib-conquy m: contribution of phagocytosis and intracellular sensing for cytokine production by staphylococcus aureus-activated macrophages synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the nmethyl-d-aspartate receptor antagonist ap pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs differential dependence of ltd on glutamate receptors in the auditory cortical synapses of cortical and thalamic inputs anti-inflammatory cytokine profile and mortality in febrile patients development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samples ketamine infusions: pharmacokinetics and clinical effects kicman at: detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry pharmacokinetics of ketamine in man expression of a functional n-methyl-daspartate-type glutamate receptor by bone marrow megakaryocytes new in vitro model of traumatic neuronal injury: evaluation of secondary injury and glutamate receptor-mediated neurotoxicity glutamate acting on nmda receptors stimulates neurite outgrowth from cerebellar granule cells panton-valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant staphylococcus aureus disease toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production association between staphylococcus aureus strains carrying gene for panton-valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients is panton-valentine leukocidin the major virulence determinant in community-associated methicillin-resistant staphylococcus aureus disease? glutamate modulation of human lymphocyte growth: in vitro studies systemic administration of mk- protects against ischemia-induced hippocampal neurodegeneration in the gerbil an endotoxin-induced serum factor that causes necrosis of tumors ketamine inhibits tumor necrosis factor secretion by raw . murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant staphylococcus aureus english's laboratory is supported by cubist pharmaceuticals (the makers of daptomycin), but cubist did not fund this project. the authors would like to thank andrea patters for her editorial assistance, thomas t. spentzas for his help with the graphics and dr sunny anand for reviewing the manuscript. the authors declare that they have no competing interests. key: cord- -n xv l authors: plötz, frans b.; vreugdenhil, harriet a.; slutsky, arthur s.; zijlstra, jitske; heijnen, cobi j.; van vught, hans title: mechanical ventilation alters the immune response in children without lung pathology date: - - journal: intensive care med doi: . /s - - - sha: doc_id: cord_uid: n xv l objective: this study was undertaken to examine the hypothesis that mechanical ventilation in association with anesthesia would alter the cytokine profile in infants without preexisting lung pathology. design and setting: prospective observational study in pediatric intensive care unit in a university hospital. patients: twelve infants who were subjected to an uncomplicated diagnostic cardiac catheterization procedure were studied. all subjects were ventilated with a volume control mode, . fio( ), cmh( )o peep, and ml/kg tidal volume. volatile (servoflurane) anesthetics were given. measurements and results: tracheal aspirates and blood samples were obtained before and after h of mechanical ventilation. in tracheal aspirates and in supernatants of stimulated whole-blood cultures cytokine concentrations were measured. in the tracheal aspirates the immune balance was characterized by a proinflammatory response pattern, with a significant increase in tnf-α and il- concentrations; concentrations of anti-inflammatory mediators remained very low. the functional capacity of peripheral blood leukocytes to produce inf-γ, tnf-α, and il- in vitro was significantly decreased. this was accompanied by a significant decrease in the killing activity of natural killer cells. conclusions: two hours of servoflurane and mechanical ventilation using a tidal volume of ml/kg is associated with remarkable changes in the immune response in infants without preexisting lung pathology undergoing cardiac catheterization. in the lungs the immune balance favors a proinflammatory response pattern without detectable concentrations of anti-inflammatory mediators. the th immune response by peripheral blood leukocytes was decreased. the observed change in th /th balance in favor of th cytokine activity may be a systemic adaptation to the proinflammatory milieu in the lung. blood leukocytes to produce inf-γ, tnf-α, and il- in vitro was significantly decreased. this was accompanied by a significant decrease in the killing activity of natural killer cells. conclusions: two hours of servoflurane and mechanical ventilation using a tidal volume of ml/kg is associated with remarkable changes in the immune response in infants without preexisting lung pathology undergoing cardiac catheterization. in the lungs the immune balance favors a proinflammatory response pattern without detectable concentrations of antiinflammatory mediators. the th immune response by peripheral blood leukocytes was decreased. the observed change in th /th balance in favor of th cytokine activity may be a systemic adaptation to the proinflammatory milieu in the lung. it has become clear that alterations in the immune balance may prevent an appropriate and effective response to various stimuli [ , ] . cd + t-cells can be divided functionally into th and th cells based on their cytokine profiles [ ] . th cells secrete interferon (ifn) γ while th cells secrete interleukin (il) , il- , il- , and il- . macrophages secrete proinflammatory and anti-inflammatory cytokines such as il- β, tumor necro-sis factor (tnf) α, il- , and il- . for example, an alteration in the th /th balance, resulting in a th dominance, is thought to contribute to enhanced pulmonary disease in respiratory syncytial virus bronchiolitis [ ] . on the other hand, new evidence indicates that a disturbance of the balance between proinflammatory mediators and anti-inflammatory mediators may initiate or amplify the inflammatory response in patients with the acute respiratory distress syndrome (ards) [ , ] . for example, the ratio of il- β to il- receptor antagonist is markedly elevated in patients with ards, favoring the unopposed proinflammatory activity of il- β. the observation that low intrapulmonary concentrations of il- and il- receptor antagonist at the onset of ards are associated with a poor outcome suggests that a lack of inhibitory cytokines is correlated with a poor prognosis. it has also been suggested that mechanical ventilation produces alterations in the immune balance [ ] . experimental studies have demonstrated that mechanical ventilation results in an inflammatory reaction in the lungs and that the degree of inflammation depends on the ventilatory strategy and mode [ , , , , ] . this inflammatory reaction may not be limited to the lungs but may initiate or propagate multiple system organ failure [ , , ] . a possible explanation for the spillover of inflammatory mediators as a result of mechanical ventilation is loss of compartmentalization [ ] . the important concept of compartmentalization refers to the fact that the inflammatory response remains compartmentalized in the area of the body were it is produced [ , ] . haitsma et al. [ ] have shown in rats that injurious ventilatory strategies, although not conclusive, disturb the compartmentalization of the early cytokine response in both the lung and the systemic circulation [ ] . infants who undergo cardiac catheterization may have multiple risk factors that may affect the inflammatory milieu in their lungs, including mechanical ventilation, exposure to anesthetic agents, and the stress of the procedure. the present study was designed to examine the hypothesis that mechanical ventilation in association with anesthesia would alter the cytokine profile in the lungs, and/or systemic circulation, of patients without preexisting lung pathology. the study included children (median age . years, range - ) who were undergoing a diagnostic cardiac catheterization procedure. the children had a history of a congenital heart disease, some of whom had been (partially) corrected: atrial-ventricular septal defect, transposition of the great arteries [ ] , aortic valve insufficiency, ventricular septal defect [ ] , tetralogy of fallot, coarctation of aorta, tricuspid atresia, pulmonary atresia [ ] , double outlet right ventricle. patients with a history of allergic or respiratory diseases, known chromosomal or immunological disorders, and patients recently hospitalized or mechanically ventilated were excluded. all subjects were intubated and ventilated with a volume control mode and a fractional inspiratory oxygen of . , a maximum peak inspiratory pressure of . ± . cm h o, a mean positive end-expiratory pressure (peep) of . ± . cm h o, and a mean tidal volume of . ± . ml/kg (measured body weight). the end-tidal co was maintained between - mmhg. if peep, inspiratory oxygen concentration, or tidal volume needed to be adjusted to maintain an adequate oxygenation or to maintain normocapnia, the patient was excluded from the study. heart rate and blood pressure of the individual patients remained constant during the procedure. all patients received servoflurane ( . %) anesthetic during the procedure. the study was approved by the medical ethics committee, and parents gave informed consent. tracheal aspirates and blood samples were obtained immediately after intubation, before the start of mechanical ventilation, and after h of mechanical ventilation. tracheal aspirates were obtained as previously described [ ] . the suction catheter was rinsed with . ml sterile normal saline and added to the suction trap. the aspirate was placed immediately on ice. thereafter % dithiothreitol ( %; µl per ml aspirate) was added, and the samples were centrifuged at rpm for min. supernatants were stored at - °c until analysis. blood samples were drawn from a venous catheter. heparinized blood was diluted : in rpmi- medium (roswell park memorial institute life technologies, grand island, n.y., usa), and whole-blood cultures were set up. the whole-blood culture stimulated with lipopolysaccharide (lps) is a suitable ex vivo method to study monocyte cytokine production under conditions in which many of the physiologically relevant cellular interactions remain intact [ , ] . to induce lymphocyte cytokine production (il- , ifn-γ) anti-cd , and anti-cd , ( : ) plus anti-cd ( : ) monoclonal antibodies (clb, amsterdam, the netherlands) were added, and cultures were incubated for h at °c in % co in air. all cultures were performed in quadruplicate. to induce the production of monocyte il- , il- , tnf-α, lps (difco laboratories, detroit, mich., usa) ( ng/ml) was added to the diluted blood samples and cultures were incubated for h at °c in % co in air. to induce monocyte il- production lps ( ng/ml) was added, and cultures were incubated for h at °c in % co in air. to induce monocyte il- production lps ( ng/ml) and ifn-γ ( ng/ml) were added, and cultures were incubated for h at °c in % co . addition of ifn-γ results in a more optimal il- response in the presence of lps. cytokine assays tnf-α, il- , il- , il- , il- , il- , and ifn-γ were measured via enzyme-linked immunosorbent assay (clb). the detection limit was - pg/ml for tnf-α, . pg/ml for il- , pg/ml for il- , - pg/ml for il- , - pg/ml for il- , pg/ml for il- , and - pg/ml for ifn-γ. when cytokines were not detectable, the minimum detectable level was used in the calculations. the composition of peripheral leukocytes was determined by analyzing the forward-sideward scatter. for lymphocyte subset analysis, whole blood was incubated with conjugated monoclonal antibodies under saturating conditions specific for cd , cd , cd , and cd / (simultest, becton and dickinson, mountain view, calif., usa). subsequently, red blood cells were lysed and samples were analyzed with a flow cytometer (facs-star+, becton and dickinson). the difference between negative and positive fluorescence was determined by measuring unstained cells and cells stained with an irrelevant isotype control body. natural killer cell activity natural killer cell (nk) cell activity was analyzed by determining the capacity of peripheral blood cells to kill cr-labeled k target cells as described previously [ ] . cortisol was measured by a chemiluminescence immunoassay performed on the fully automated advia centaur immunoanalyzer (bayer, leverkusen, germany). all values were expressed as mean ±sd and were analyzed by the nonparametric wilcoxon signed-rank test. differences were considered significant at the level of p< . . the concentrations of tnf-α in the supernatant of the tracheal aspirates increased significantly h after me-chanical ventilation (p= . ; fig. ). there was a trend towards an increase in il- levels (p= . ; fig. ). il- concentrations showed high interindividual variation both before and after mechanical ventilation. the concentrations of the anti-inflammatory cytokines il- and ifn-γ remained unchanged just above the detection level (fig. ). the capacity of lymphocytes to produce cytokines was determined in whole-blood cultures stimulated with anti-cd /cd [ , ] . after h of mechanical ventilation a significant decrease in ifn-γ production was observed in the cultured supernatants (p= . ), but no significant changes in il- concentrations were observed (fig. ) . the capacity of monocytes to produce cytokines was determined in whole-blood cultures stimulated with lps. after h of mechanical ventilation there was a decrease in the production of proinflammatory cytokines il- (p< . ) and tnf-α by peripheral blood monocytes (p< . ; fig. ). il- concentrations showed high interindividual variation before and after mechanical ventilation. the amount of il- and il- produced by monocytes was unaltered in all patients as a result of h of mechanical ventilation (fig. ) . we observed significant changes in the cellular composition of the whole-blood samples. there was a increase in the percentage of granulocytes (p< . ) and a decrease in the percentage of lymphocytes (p< . ; table ). the percentage of cd and cd increased slightly but significantly (p< . ). the percentage of cd / tended to decrease (table ) . as a result of h of mechanical ventilation the killing capacity of nk cells to lyse k target cells decreased significantly (p< . ). the mean percentage of activity decreased from . ± . to . ± . . this remarkable decrease in killing capacity of nk cells cannot be explained by a decrease in the total numbers of nk cells (table ) . the major finding of the present study is that exposing infants with normal lung function to h of volatile anesthetics, mechanical ventilation, and cardiac catheterization is associated with remarkable changes in immune responses. we observed a proinflammatory response in the lungs with a significant increase in tnf-α, while antiinflammatory cytokine concentrations in tracheal aspirates remained virtually unchanged, just above the detection level. in addition, the functional capacity of peripheral blood leukocytes to produce proinflammatory cytokines in vitro was significantly decreased, in particular ifn-γ, tnf-α, and il- . this was accompanied by a significant decrease in the activity of nk cells. this indicates that this procedure is associated with a change in the th /th balance with a decreased th immune response. a major question from our study is which aspect of the total procedure consisting of exposure to volatile anesthetics, ventilation, and catheterization is responsible for the observed changes in the inflammatory response of our patients. a recent review article summarized the effect of anesthetic agents on the immune response and concluded that there is little evidence to support the concept of clinically relevant immune modulation by anesthetics during major surgery [ ] . no clinical study has examined the effect of servoflurane on the immune response in infants and young children. experimental studies have shown that during mechanical ventilation of uninjured lungs several volatile anesthetics may augment gene expression of proinflammatory cytokines in rat alveolar macrophages [ ] . however, servoflurane was not associated with a significant increase in gene expression of proinflammatory cytokines or with concentrations of tnf-α in the lavage fluid of these rats over that with mechanical ventilation alone [ ] . kotani et al. [ ] demonstrated in mechanically ventilated adult patients that intravenous propofol or volatile isoflurane produced a similar increase in gene expression of all proinflammatory cytokines on alveolar macrophages. this is remarkable since the route of administration of these anesthetics are completely different. one would have expected that by directly acting on alveolar macrophages the volatile anesthetic -isoflurane -would induce faster and probably more pronounced gene expression. it therefore remains questionable whether these clinical observed effects are all attributable to general anesthesia. any effect of anesthesia is likely to be overwhelmed by the neuroendocrine stress response during major sur-gery [ ] . however, in our study the response of the hypothalamo-pituitary-adrenal axis to the catheterization procedure is probably negligible. serum cortisol levels measured before and after mechanical ventilation were similar. other factors such as hemorrhage, hypotension, ischemia/reperfusion, and blood transfusion, which may affect immune competence during major surgery, were negligible in our study. thus the catheterization procedure can therefore not considered to be major surgery. we are therefore left with the possibility that the changes in the immune response in our study were the result of mechanical ventilation, although we are aware that definitive conclusions cannot be made. several experimental studies have reported that injurious ventilatory strategies increase tnf-α mrna expression and lung lavage levels of tnf-α protein [ , , ] . in these studies tidal volumes were very high ( ml/kg), and/or there was preexisting lung injury. pretreatment with intratracheal instillation of anti-tnf-α antibodies improved oxygenation, reduced infiltration of leukocytes, and ameliorated pathological findings [ ] . the results of the experimental studies clearly demonstrated that tnf-α plays a pivotal role in initiating an inflammatory cascade induced by mechanical ventilation. the lung macrophage may be the critical mechanosensor cell capable of producing tnf-α in response to stretching mechanical forces [ ], although there is evidence that the pulmonary epithelium may also be a key player in this regard [ ] . it is remarkable, however, that such a significant proinflammatory response was observed with the ventilatory strategy we adopted. our patients had normal lungs, and a tidal volume of ml/kg should not cause overdistention, since the patients would not have the marked heterogeneities in pulmonary compliance that exist in patients with ards [ , ] . this is supported by the observation that peak inspiratory pressures remained low ( . ± . cmh o) throughout the -h period. to our knowledge, only one other study has examined the effect of mechanical ventilation on release of cytokines in patients with normal lung function [ ] . wrigge et al. [ ] observed that after h of mechanical ventilation plasma levels of pro-and anti-inflammatory mediators remained low and did not differ from baseline. unfortunately, the local production of cytokines in the lung was not measured. the observed effects in our study may be explained by a two-hit hypothesis in which any one factor by itself does not induce an effect, but a combination of factors act synergistically to cause the changes in immune response, i.e., mechanical ventilation and volatile anesthetics. it remains speculative what causes the onset of the peripheral immune response. one of the mechanisms could be that tnf-α produced locally in the lung causes leukocyte redistribution from the systemic circulation into the alveolar space [ , ] . mechanical ventilation may recruit t cell subsets with distinctive properties with respect to homing and trafficking into inflamed sites [ ] . we observed that the functional capacity of peripheral blood leukocytes to produce proinflammatory cytokines in vitro was significantly decreased, in particular inf-γ, tnf-α, and il- . ifn-γ is associated with a th response, which is considered to be beneficial in terms of an appropriate and effective response to various stimuli, including trauma, infection, and perhaps mechanical ventilation [ ] . ifn-γ is also important in stimulating the cytolytic activity of nk cells and cd + cytotoxic t lymphocytes. the decrease in ifn-γ production was also accompanied by a significant decrease in the killing activity of nk cells. the altered th /th balance in favor of th cytokine activity may be a systemic adaptation to the proinflammatory milieu in the lung. in conclusion, h of servoflurane and mechanical ventilation with a tidal volume of ml/kg is associated with remarkable changes in the immune response in infants without preexisting lung pathology undergoing cardiac catheterization. in the lungs a proinflammatory response pattern dominates without detectable concentrations of anti-inflammatory mediators. we observed a decrease in the th immune response by peripheral blood leukocytes. the altered th /th balance in favor of th cytokine activity may be a systemic adaptation to the proinflammatory milieu in the lung. further studies possibly using different anesthetic agents, different operative procedures, and different ventilatory strategies are needed to establish the mechanisms and clinical relevance of our findings. cytokines and the acute respiratory distress syndrome (ards): a question of balance dominance of t-helper -type cytokines after severe injury human th and th subsets: doubt no more anti-il- treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic t lymphocyte activity in mice challenged with respiratory syncytial virus the acute respiratory distress syndrome ventilator-induced lung inflammation: is it always harmful? injurious ventilatory strategies increase cytokines and c-fos m-rna expression in an isolated rat lung model role of high-frequency ventilation in surfactant-depleted lung injury as measured by granulocytes inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation multiple system organ failure: is mechanical ventilation a contributing factor? effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized clinical trial mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge loss of compartmentalization of alveolar tumor necrosis factor after lung injury ventilator-induced lung injury measurement of interleukin in bronchoalveolar lavage from preterm ventilated infants a convenient whole blood culture system for studying the regulation of tumor necrosis factor release by bacterial lipopolysaccharide monocyte il- production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one year follow-up study the authors thank the pediatric cardiologists and cardioanesthetists for their technical assistance. key: cord- -xs qigg authors: kıray, hülya; lindsay, susan l.; hosseinzadeh, sara; barnett, susan c. title: the multifaceted role of astrocytes in regulating myelination date: - - journal: exp neurol doi: . /j.expneurol. . . sha: doc_id: cord_uid: xs qigg astrocytes are the major glial cell of the central nervous system (cns), providing both metabolic and physical support to other neural cells. after injury, astrocytes become reactive and express a continuum of phenotypes which may be supportive or inhibitory to cns repair. this review will focus on the ability of astrocytes to influence myelination in the context of specific secreted factors, cytokines and other neural cell targets within the cns. in particular, we focus on how astrocytes provide energy and cholesterol to neurons, influence synaptogenesis, affect oligodendrocyte biology and instigate cross-talk between the many cellular components of the cns. astrocytes were long considered secondary to neurons in central nervous system (cns) function, and erroneously dismissed as "brain glue" (glia is the greek term for glue). research over the past two decades, however, has shown astrocytic roles extending to a range of brain functions far beyond basic physical and metabolic neuronal support (sofroniew and vinters, ) . astrocytic regulation of myelination was first hypothesised by műller in , who claimed that the demyelinating disease, multiple sclerosis (ms), was rooted in astrocytic dysfunction (müller, ; williams et al., ) . evidence has since continued to grow supporting the premise that astrocytes could be important in regulating myelination (sofroniew and vinters, ; williams et al., ; barnett and linington, ; moore et al., ) . glial fibrillary acidic protein (gfap) has been used extensively in the study of astrocytes. increased gfap expression has been associated with astrocyte reactivity in cns lesions and is a pathological hallmark of disease and/or injury. fig. illustrates astrocytes immunolabelled with gfap and nestin, another marker thought to label reactive astrocytes (kamphuis et al., ) . in experimental allergic encephalomyelitis (eae), a widely used animal model of ms, where demyelination is induced by myelin antigens, administered together with adjuvant that contains bacterial components (traugott and lebon, ; tsukada et al., ; villarroya et al., ) , gfap expression was seen on more numerous and much larger astrocytic processes in chronic lesions compared to normal appearing white matter (webster et al., ; eng et al., ) . thus, the degree of gfap immunoreactivity appears to reflect the level of reactive astrogliosis. this was reviewed in detail by sofroniew and vinters ( ) , who described a continuum of phenotypic changes, that range from mild to severe, the latter resulting in glial scar formation (sofroniew and vinters, ; nash et al., a) . attempts have also been made to define the astrocyte phenotype in more detail along this continuum (liberto et al., ) . it has been suggested that mild astrogliosis is associated with astrocyte "activation" and severe astrogliosis is associated with "reactivity", with the former promoting recovery of cns function after injury and the latter walling off the injured area and preventing repair (liberto et al., ) . although activated astrocytes have been associated with less detrimental effects on the cns and reactive astrocytes as more damaging, it is clear that these properties are not all or nothing and reactive astrocytes can fig. . expression of astrocyte reactivity markers. rat neurosphere-derived astrocytes cultured on pll-coated glass coverslips express the reactivity markers gfap (green) and nestin (red). astrocytic effects on re/myelination can be classified into main groups. they contribute to re/myelination by: ) providing an energy source (lactate) and cholesterol for neurons. glucose taken up by endothelial cells lining the blood brain barrier is later transferred to astrocytes which transform it to glycogen, which can then be used to produce lactate. ) playing a role in synaptic signal transmission by regulating the fluid, ph/ion (e.g. potassium, k + ), glio/neurotransmitter homeostasis and contributing to synapse modulation through secreted molecules, such as thrombospondins (thbss) . ) affecting the survival, proliferation and maturation of oligodendrocytes by secreting growth factors, some of which are regulated by iron homeostasis provided by astrocytes. chemokines may also influence oligodendrocyte membrane ensheathment of axons. ) altering reactivity status through their release of chemokines/cytokines, which in turn affects the cross-talk between all neural cells including microglia. also be beneficial to cns repair. interestingly, in studies using gfap null mice, it was seen that animals had abnormal myelination, nonmyelinated axons in the optic nerve with an age related reduction in myelin thickness (liedtke et al., ) . non-conservative mutations in the gfap gene have also been linked to the white matter brain disorder, alexander disease (brenner et al., ; li et al., ) . therefore, the evidence for direct or indirect astrocytic roles on re/myelination has been established both by in vitro and in vivo studies. considering the limitations in the current treatments for demyelinating cns diseases and injuries, it is crucial to identify other approaches to regulate myelination in search of novel strategies for repair. astrocytes have been shown to promote myelination through their supportive roles on neuron survival and maintenance of neuronal activity, and their direct action on proliferation, differentiation and migration of oligodendrocytes (fig. ) . this review will focus on the interaction of astrocytes with neural cells to synergistically promote myelination. it is apparent that astrocytes can affect myelination under a range of normal and pathological conditions, but it is important to understand how this is regulated. many molecules can trigger or even regulate astrogliosis, including large polypeptide growth factors and cytokines (john et al., ; moore et al., ) , mediators of innate immunity such as lipopolysaccharide (lps) and other toll-like receptor ligands (farina et al., ) , neurotransmitters (bekar et al., ) , purines, reactive oxygen species, and molecules related to hypoxia and glucose deprivation (swanson et al., ) . for the purpose of this review we will focus on cytokines and chemokines. although these compounds are primarily considered in the context of chemotaxis in immune cells, here we will highlight their roles on astrocyte activation and reactivity. these molecules can be produced in an autocrine or paracrine fashion by various cell types in the cns including neurons, oligodendrocyte lineage cells, microglia, pericytes and endothelial cells. not only do these factors influence astrocyte phenotype but they also can affect a range of neural and immune cell types. . . astrocyte activation (mild astrogliosis): a pro-reparative phenotype? astrocytes can be activated directly or indirectly. for example, in response to injury, microglia become activated and release the cytokine interleukin β (il- β, herx et al., ) , which is an early injury signal (auron, ) . the delay of astrocyte activation in mice lacking il- β, as well as in mice lacking il- type receptor suggests that microglial activation is necessary for astrocyte activation (herx et al., ) . it has also been suggested that ciliary neurotrophic factor (cntf; a member of the il- family of cytokines)treated astrocytes in vitro had a phenotype that was more supportive of cns repair and thus are, by definition, activated (albrecht et al., ; . under cntf treatment, astrocytes upregulate expression of classical reactivity markers such as gfap, vimentin, and clusterin, show cellular and nuclear hypertrophy, and increase their proliferation rate (winter et al., ; levison et al., ; ; hudgins and levison, ) . there is a growing body of evidence for the promotion of neuronal survival by cytokine-activated astrocytes, potentially through secretion of various neurotrophic growth factors in the vicinity of neurons including nerve fig. . simplified schematic of the effects of cytokine-activated astrocytes on re/myelination. astrocytes can be influenced by various cytokines to change their reactivity status to one that falls within the continuum of phenotypes, namely more activated or reactive; both of which will secrete factors that can modulate myelination in a positive or negative way. astrocytes with more severe reactivity present increased gfap expression, proliferation rate, and cellular hypertrophy with a more stellate morphology. the milder "activated" astrocytes can secrete a range of factors including; neurotrophic factors, growth factors, and cytokines that will stimulate re/myelination by promoting neuronal survival, neurite outgrowth, neurogenesis, and/ or oligodendrocyte precursor cell (opc) survival, proliferation, and/or maturation. conversely astrocytes that tend to have a more severe "reactive" phenotype, possibly induced by proinflammatory cytokines/cns tissue damage, may secrete cytokines and chemokines that lead to myelin and oligodendrocyte damage in vitro, suppress remyelination, delay disease recovery in experimental autoimmune encephalomyelitis (eae), and suppress myelination in myelinating embryonic rat mixed spinal cord cultures. however, these reactive scar forming astrocytes can also protect cns tissue by preventing immune cells from invading and exerting a pro-inflammatory response and have been shown to even ameliorate eae. growth factor (ngf), brain-derived neurotrophic factor (bdnf), activity dependent neurotrophic factor (adnf), hepatocyte growth factor (hgf), leukaemia inhibitory factor (lif), fibroblast growth factor- (fgf- ) and cntf (schwartz and nishiyama, ; rudge et al., ; uchida et al., ; dreyfus et al., ; messersmith et al., ; albrecht et al., ; fig. ). moreover, cultured spinal cord astrocytes, treated with cntf, support the survival of a significantly greater number of ventral spinal motor neurons and promote neurite outgrowth better than unstimulated astrocytes (albrecht et al., ) . other researchers have shown that cytokine-activated astrocytes can promote neurogenesis, possibly by stimulating the differentiation of neural stem cells (nscs) residing in the subventricular zone and the dentate gyrus in adult animals (liberto et al., ) . because these multipotent nscs can migrate beyond their sites of origin and can later differentiate into oligodendrocytes, neurons and microglia, they have the potential to enhance recovery from cns injury and disease. importantly, activated astrocytes have also shown positive effects on myelination. our own investigations have shown that cntf activated astrocytes can promote the percentage of myelinated fibres in cns rat cultures (nash et al., b) . further evidence of this has been shown in mice infected with the a- strain of the mouse hepatitis virus (mhv-a ), an animal model for ms (jordan et al., , messersmith et al., . these animals have been shown to secrete increased levels of cntf during the remyelination phase and cntf mrna is induced in the remyelinating regions in cells exhibiting astrocytic features (albrecht et al., ) . it is suggested that the increase in il- β levels at early stages of cns pathology stimulates the induction of cntf mrna and protein in astrocytes (stöckli et al., ; guthrie et al., ; dallner et al., ; liberto et al., ) , a phenomenon which appears to be important for remyelination (herx et al., ) . this could be due to fgf- signalling as cntf treatment elevates astrocytic levels of fgf- mrna significantly, whereas, il- β shows no effect (albrecht et al., ) . since fgf- can enhance opc proliferation (albrecht et al., ) , it may produce more opcs for subsequent myelination (redwine et al., ; messersmith et al., ) . moreover, if the gp receptor, the ubiquitous signal transducer for cntf and all il- family members, is genetically removed from astrocytes, astrocyte survival was poor, there was a reduction in the development of astrogliosis, and larger areas of demyelination formed with a greater proinflammatory t cell response (haroon et al., ) . therefore, cntf seems to be an important cytokine involved in astrocyte reactivity and myelination. interestingly, il- β can also stimulate the astrocytic production of another il- family cytokine, lif, (aloisi et al., ) , which has been shown to promote survival and differentiation of oligodendrocytes (khan and de vellis, ; mayer et al., ; bugga et al., ) . lif also decreases disease severity when exogenously administered in both chronic and relapsing-remitting eae mice (aloisi et al., ; butzkueven et al., ; ishibashi et al., ) . positive effects of lif on the survival and maturation of oligodendrocytes also provides evidence for the positive roles of lif on myelination (khan and de vellis, ; mayer et al., ; bugga et al., ) . however, other pro-inflammatory cytokines such as tumour necrosis factoralpha (tnf-α) and interferon-gamma (ifn-γ) have also been shown to potentiate reactive astrogliosis (yong et al., john et al., as discussed below. in contrast to their positive effects on myelination, astrocytes can also have a more detrimental effect on cns repair via the secretion of chemokines/cytokines when in a more severe, reactive state (fig. ) . one such cytokine is tnf-α, which has been shown to induce myelin and oligodendrocyte damage in vitro (selmaj and raine, ) . tnf-α mrna expression in ms plaques positively correlates with the extent of demyelination and has been shown to be present in microglia/macrophages and to a smaller percentage of astrocytes (bitsch et al., ) . on the other hand, studies have shown tnf-α expression is mainly associated with gfap positive fibrous astrocytes in chronic active ms lesions at the lesion edge (hofman et al., ) as well as foamy macrophages and endothelial cells (selmaj et al., ) . however, the fact that astrocytes appear as the major or minor tnf-α expressing cell types in ms lesions might be because astrocytes internalize the protein in a receptor-mediated manner (aránguez et al., ; kuhlmann et al., ) rather than producing it themselves as suggested by hofman et al. ( ) and bitsch et al. ( ) . moreover, it is possible that astrocytes require a longer period of time to become reactive upon injury and only produce tnf-α first at the lesion edge of acute ms plaques and later both at the lesion edge and in the lesion centre of chronic active plaques (selmaj et al., ) . in situ hybridisation for tnf-α mrna has been detected in gfap-positive astrocytes in mice suffering from pneumococcal meningitis (izadpanah et al., ) which also suggests that astrocytes can indeed produce tnf-α in cns pathologies. since tnf-α effects the maturation of oligodendrocytes (cammer and zhang, ) , remyelination failure in the cns lesions could be because tnf-α prevents the in situ differentiation of oligodendrocytes. interestingly, direct cell contact between pre-oligodendrocytes (preols) and astrocytes has been shown to be a prerequisite for tnf to induce apoptosis in preols of rodent mixed glial cultures (kim et al., ) . nevertheless, it is possible that tnf-α increases production of pdgf in demyelinated spinal cord lesions of mhv-a -injected mice (redwine and armstrong, ; frost et al., ) as suggested by the increase of pdgf-β transcription and pdgf-αβ protein levels in embryonic human astrocytes upon tnf-α treatment (silberstein et al., ) . therefore, astrocytes might have a positive role on remyelination both by producing tnf-α and by secreting pdgf upon stimulation with tnf-α. pdgf could in turn support the survival and enhance the proliferation of opcs in demyelinating lesions (woodruff et al., ; vana et al., ) . consequently, it is yet difficult to conclude whether reactive astrocytes associated with increased tnf-α levels in cns lesions are predominantly stimulatory or inhibitory to remyelination. ifn-γ, another cytokine found in ms plaques, has been reported to not only activate astrocytes, but is also expressed by reactive astrocytes and by immune cells that astrocytes have stimulated (pulver et al., ; traugott and lebon, ; miljkovic et al., ; hashioka et al., ; ionescu et al., ) . similar to tnf-α, ifn-γ has been shown to suppress remyelination and to delay disease recovery in transgenic eae mice, where ifn-γ expression by astrocytes was stimulated temporally in the recovery stage (lin et al., ) . astrocyte-directed expression of ifn-γ in transgenic mice has also resulted in regional hypomyelination and selective disruption of brain histogenesis, which led to ataxia and shorter life span (laferla et al., ) . furthermore, knocking down ifn-γ receptor expression in astrocytes three days before immunization suppressed eae and demyelination by inhibiting inflammatory cell infiltration (ding et al., ) . these animals presented lower mean clinical scores even when the receptor silencing was initiated after disease onset or at disease peak (ding et al., ) . despite the abovementioned evidence suggesting inhibitory roles for reactive astrocytes on myelination, hindinger et al. ( ) have proposed that ifn-γ signalling in astrocytes is indispensable for the alleviation of eae since levels of demyelination and axonal loss are increased during acute eae in mice with an astrocytic expression of a dominant negative allele for ifn-γ receptor. nevertheless, their approach blocked ifn-γ signalling in astrocytes without decreasing the expression of ifn-γ receptor, which would lower the levels of ifn-γ available for immunoregulatory cells; whereas, ding et al. ( ) have knocked down the expression of the receptor itself. therefore, blocking or lowering ifn-γ signalling in astrocytes with a carefully planned strategy might provide new disease-modifying treatments that will limit demyelination. reactive astrocytes also secrete c-x-c motif chemokine (cxcl , ransohoff et al., ) , particularly around active ms lesions (omari et al., ; carter et al., ) . cxcl mrna expression increases significantly during peak disease and decreases during the recovery phases in animal models of ms (godiska et al., ; glabinski et al., ; fife et al., ) . a direct effect of cxcl on the inhibition of myelination was shown in dissociated rat spinal cord cells plated on astrocytes treated with cxcl and its neutralizing antibody. in these experiments cxcl identified by microarray analysis, was upregulated in an astrocyte phenotype that was inhibitory to cns myelination in vitro. specifically, cxcl appeared to inhibit oligodendrocyte process extension (nash et al., b) . consequently, cytokines stand out as an important family of molecules to activate astrocytes and to initiate different forms of astrocyte reactivity that could be either beneficial or inhibitory for the cns milieu in terms of re/myelination. it should be noted that the secretion of such pro-inflammatory cytokines that can contribute to the lack of remyelination within ms plaques is not restricted to reactive astrocytes since other glial and inflammatory cell types will also secrete them. moreover, the up regulation of such cytokines by reactive astrocytes can also be protective for cns injury. for example, the astrocytic scar can restrict leukocyte migration from within areas of damaged tissue into the otherwise healthy non damaged cns tissue in close proximity to the scar protecting it from immune mediated damage (faulkner et al., ; okada et al., ; herrmann et al., ; voskuhl et al., ). a vital supportive role played by astrocytes following injury is the provision of an energy source, which is important if axons are to be myelinated. this energy is metabolized from glucose which enters the brain via the endothelial cells lining the blood brain barrier (bbb), which are in close contact with astrocytes. unlike endothelial cells, astrocytes biochemically transform glucose into glycogen, the principal source of stored energy in all cell types (pellegri et al., ; pfeiffer-guglielmi et al., ) . in addition, it has been suggested that astrocytes under low glucose concentrations can degrade stored glycogen into lactate which in turn increases extracellular lactate levels to provide energy for nearby axons when deprivation occurs after injury (tekkök et al., ) . the lactate derived from astroglial glycogen via glycolysis is transferred directly to the axon at the node of ranvier (hirrlinger and nave, ) . the importance of lactate during demyelination is only just emerging. whether astrocytes maintain the energy levels of only axons as previously thought, or if this extends to oligodendrocytes as well, is an interesting concept. oligodendrocytes are known to consume lactate at higher levels than other cns cells, therefore making them an important user of any lactate production. furthermore, promotion of myelination via oligodendrocytes has been shown when endogenous lactate is applied (rinholm and bergersen, ) therefore at least some astrocytic lactate production may be targeted to myelinating oligodendrocytes (sánchez-abarca et al., ; rinholm et al., ) . however, energy regulation in the cns is more complex as recent evidence has shown that oligodendrocytes in turn can transfer glycolysis products such as lactate to axons via monocarboxylic acid transporters (mct , mct ), which reside in internodal myelin and the axonal compartment (fünfschilling et al., ) . cholesterol is essential to every cell in the body as it is an important component of cellular membranes. in the cns it is vital for normal brain development, is a precursor to many signalling molecules such as steroid hormones, and importantly, is a major structural component of myelin sheaths (siegel et al., ) . the bbb prevents the transport of either hepatic or dietary cholesterol, meaning that cholesterol must be derived by de novo synthesis within the cns (orth and bellosta, ) . astrocytes are proposed to be one of the primary cellular sources of cholesterol (pfrieger and ungerer, ) and mediate its secretion by their expression of several apolipoproteins, molecules that bind cholesterol (boyles et al., ; lin et al., ; xu et al., ; kurumada et al., ) . there is sufficient evidence to suggest that there is horizontal transfer of cholesterol (boyles et al., ; lin et al., ; xu et al., ; kurumada et al., ) with both astrocytes and oligodendrocytes producing cholesterol to maintain myelin sheath formation and neurons. this transfer between cells is critically relevant to neurodegenerative diseases, since the availability of cholesterol is thought to be an essential rate limiting factor to myelin production (may et al., ; liu et al., ) . therefore, in addition to their roles in providing energy to neurons, astrocytes also emerge as important cholesterol-suppliers in the cns, which is vital for myelination. a further function of astrocytes is the removal of excitotoxic molecules from the extracellular space, thus supporting neuronal survival. they can actively remove excitotoxic glutamate and convert it to glutamine by increasing their levels of glutamate transporters and glutamine synthetase (faden et al., ; eng et al., ; krum et al., ) , thereby preventing neuronal cell death during brain pathology. astrocytes can also release gliotransmitters such as glutamate, purine, gaba and d-serine into the synaptic cleft upon excitation by changes in neuronal synaptic activity and can thereby regulate neuronal excitability (parpura et al., ; bezzi et al., ; mothet et al., ; coco et al., ; halassa et al., ) . neurotransmitter released from the neuronal synapse can reach adjacent astrocytes, stimulating increases in intracellular ca + concentrations, which then leads to the secretion of gliotransmitters (porter and mccarthy, ) . these regulatory molecules then can feedback to presynaptic nerve terminals to modulate synaptic neurotransmission (araque et al., ) . these observations have even given rise to the currently accepted 'tripartite synapse' hypothesis, where astrocytes form an active, integral regulatory component of the synapse (araque et al., ; halassa et al., ) . recently, electron microscopy has also shown microglia interacting with neuronal synapses (tremblay et al., ) and playing a role in synapse maturation, synaptic remodelling, and synaptic activity (ji et al., ) . evidence has shown that microglia secrete immune factors that play an important role in synaptic connections and illustrates the complexity of cross-talk between neural cells and the immune system. these researchers have suggested a change in name from tripartite synapse to the quad-partite synapse (schafer et al., ; wu et al., ) . in addition to playing a role in synaptic signal transmission, astrocytes can also modulate synapses. it has been demonstrated that astrocytes secrete molecules such as thrombospondins that might be required for the formation, function and pruning of developing synapses (ullian et al., ; christopherson et al., ) . both presynaptic and postsynaptic activity in purified rat retinal ganglion cultures have been enhanced in the presence of astrocytes; and immunohistochemistry of rat brain cryosections from various developmental stages have shown that glial generation precedes the appearance of synapses (ullian et al., ) . astrocytes might also be functional in synaptic remodelling and pruning in healthy or diseased adult cns (barres, ) . because synaptic signal transmission can trigger astrocytes to secrete the cytokine lif, which in turn increases the number of myelinated axons in dorsal root ganglion cultures co-cultured with oligodendrocytes (ishibashi et al., ) , the support and maintenance of healthy signal transmission appears important for the regulation of myelination. furthermore, astrocytes may contribute to synaptic transmission by supporting maintenance of the synaptic interstitial fluid by regulating ion, ph and transmitter homeostasis. astrocyte processes contain transporters for potassium uptake and aquaporin water channels (nielsen et al., ; rash et al., ; amiry-moghaddam et al., ; solenov et al., ) , which maintain the transmitter homeostasis of the synaptic interstitial fluid (steinhäuser et al., ; gundersen et al., ; mennerick et al., ; bergles and jahr, ; fujita et al., ) . connexin channels and connexin proteins are important candidates which play a role in the regulation of neuronal activity and survival. for example, astroglial connexins decrease neuronal excitability by removing extracellular potassium and glutamate; while also providing metabolic supply to neurons (wallraff et al., ; rouach et al., ; froger et al. ; pannasch et al., ) . on the other hand, the elevation of connexin expression at lesion sites in cns pathologies might also be associated with other, possibly protective, roles (nagy et al., ; koulakoff et al., ; kuchibhotla et al., ; mei et al., ; karpuk et al., ) . studies using connexin knockout animals allude to the importance of connexins in promoting communication between astrocytes and between astrocytes and oligodendrocytes on myelin integrity. myelin damage has been observed in cx , cx /cx and cx /cx single/double knockout mice (menichella et al., ; odermatt et al., ; lutz et al., ; tress et al., ) . interestingly, the level of oligodendrocyte gap junction connexins cx and cx were reduced both within and around lesions during early stages of inflammatory demyelination in eae mice, (traugott and lebon, ; tsukada et al., ; villarroya et al., ; meeuwsen et al., ) . these mice also presented decreased expression of cx , the major astrocytic partner of cx , when spinal cord sections were analysed immunohistochemically (markoullis et al., ) . cx expression was increased at late eae stages, where remyelination was observed, leading to the suggestion that astrocytic protein cx might play an important role in recovery from neuroinflammation (markoullis et al., ) . in the s advancements were made on the ability to grow purified cultures of glial cells, with raff and colleagues in particular developing techniques to purify opcs from the optic nerve, a tissue devoid of neuronal cell bodies (raff et al., ) . with the development of these culture techniques it was shown that astrocytes play important roles in opc differentiation (noble and murray, ; noble et al., ; raff et al., ; noble et al., ) and in the rate of oligodendrocyte axonal ensheathment (watkins et al., ) . further in vitro studies, where conditioned medium collected from primary astrocyte monolayers was incubated with other neural cells, showed enhanced neuronal survival, proliferation of opcs, and protection of oligodendrocytes from stress (noble and murray, ; yoshida et al., ; yamamuro et al., ; zhu et al., ; arai and lo, ) . it is likely that astrocytes support opc survival and proliferation by providing soluble factors such as platelet derived growth factor (pdgf) and fgf- (bögler et al., ; ferrara et al., ; pringle et al., ) . astrocytes are important providers of secreted growth factors, for both neuronal and glial proliferation and survival. for example, cntf, although shown to be important in the activation of astrocytes, is constitutively expressed by white matter astrocytes, and is a key player in opc survival and maturation in vitro and in vivo as discussed earlier (stöckli et al., ; dallner et al., ; stankoff et al., ; cao et al., ) . cntf has also been reported to enhance the migration of subventricular zone-derived progenitors (vernerey et al., ) , protect oligodendrocytes from apoptosis, and decrease myelin destruction in demyelinating pathological conditions (linker et al., ) . in studies when cntf was injected subcutaneously at the remyelination phase of cuprizoneinduced demyelination, an increase was seen in myelin oligodendrocyte glycoprotein (mog) expression in the cerebral cortex (salehi et al., ) . moreover, intraperitoneal injections of cntf and intravenously transplanted mesenchymal stem cells that overexpress cntf resulted in a reduced loss of neurons and disease severity, and increased neuronal functional recovery in eae mice (kuhlmann et al., ; lu et al., ) . however, in these experiments it is difficult to see if the effect is on the activation status of the astrocytes as discussed above, or the direct effect on the opc. astrocytes have also been shown to exhibit a crucial role in opc remyelination via their iron exporter ferroportin (fpn) in mice, where focal demyelination was induced by the injection of lysophosphatidylcholine (lpc) into their spinal cords (schulz et al., ) . in these astrocyte-specific fpn ko mice, fewer remyelinating axons and a reduction in opc proliferation were observed following lpc-induced demyelination compared to control animals. this could either be due to direct effects on opcs through limited iron supply or indirect effects via iron-deficient microglia, which expressed significantly lower levels of tnf-α and il- β when stimulated by lps compared to control microglia (schulz et al., ) . because the expression of fgf- and insulin-like growth factor- (igf- ) was significantly upregulated by il- β and tnf-α, respectively, and the expression of transforming growth factor beta (tgf-β) was stimulated by il- β in purified astrocyte cultures, it has been suggested that iron-deprivation in the milieu would lower the expression of il- β and tnf-α in microglia and thus lead to reduced growth factor expression in astrocytes, which would in turn render opc proliferation and possibly differentiation (schulz et al., ) . as discussed throughout this review astrocytes can play important roles not just in myelination during development, but also in remyelination in adult tissue after cns injury. their reparative roles might be related to their level of reactivity, so it is important to identify markers that can define these different astrocyte phenotypes although at present these are not easy to define. one approach is to use microarrays. as described, nash et al. ( b) identified cxcl as inhibitory to myelination, but others using a lower-scale cdna array that contained probes for cytokines, chemokines, growth factors and their receptors have identified other pro-inflammatory cytokines including tnf-α, il- β, or ifn-γ (meeuwsen et al., ) . another large array was carried out on gfp-astrocytes purified at various time points after the onset of two models of disease, namely ischemic stroke (middle cerebral artery occlusion) and neuroinflammation induced by lps injection (zamanian et al., ) . the resulting data suggested that astrocytes could present different mrna expression profiles depending on the insult despite the presence of reactive gliosis in both types of cns damage. however, although there was upregulation of a core set of genes (lipocalin and serpina n), it was clear that changes in the astrocyte after injury are highly heterogeneous, and that changes in astrocyte activity may depend on the injury type. hopefully, more specific markers of "good" or "bad" astrocytes for cns repair will be identified and allow more specific identification of how these astrocytes influence repair. there is abundant evidence to suggest that astrocytes contribute to re/myelination mainly by: ) providing the right conditions for neurons to myelinate by i) supplying neurons with energy and cholesterol, ii) removing excitotoxic molecules from the extracellular environment, and iii) regulating the fluid, ion, ph, and neuro/gliotransmitter homeostasis. ) playing a role in the survival, proliferation, maturation and function of oligodendrocytes and the migration of opcs into the lesioned areas in the cns. ) influencing microglia. the manner by which astrocytes affect myelination can often be seen to correlate with its level of reactivity. astrocyte reactivity can be induced by the milieu of cytokines present after injury, which can be beneficial or inhibitory in re/myelination depending on the context and severity of the injury. due to the lack of gliosis-specific markers, there are currently no clear guidelines which allow different astrocytic reactivity phenotypes to be classified. however, if markers can be identified that classify the continuum of astrocyte phenotypes, it may aid in the design of new treatments targeting phenotypes that are more suited to regeneration and remyelination, and therefore benefit in the treatment of demyelinating diseases. ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor- , to increase motor neuron survival astrocytes produce cntf during the remyelination phase of viral-induced spinal cord demyelination to stimulate fgf- production cntf-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors regulation of leukemia inhibitory factor synthesis in cultured human astrocytes delayed k+ clearance associated with aquaporin- mislocalization: phenotypic defects in brains of alphasyntrophin-null mice astrocytes protect oligodendrocyte precursor cells via mek/erk and pi k/akt signaling glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons tripartite synapses: glia, the unacknowledged partner the receptor for tumor necrosis factor on murine astrocytes: characterization, intracellular degradation, and regulation by cytokines and theiler's murine encephalomyelitis virus the interleukin receptor: ligand interactions and signal transduction myelination: do astrocytes play a role? the mystery and magic of glia: a perspective on their roles in health and disease locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo synaptic activation of glutamate transporters in hippocampal astrocytes prostaglandins stimulate calcium-dependent glutamate release in astrocytes tumour necrosis factor alpha mrna expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type- astrocyte (o- a) progenitor cells apolipoprotein e associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system mutations in gfap, encoding glial fibrillary acidic protein, are associated with alexander disease analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor lif receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival maturation of oligodendrocytes is more sensitive to tnf alpha than is survival of precursors and immature oligodendrocytes transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury induction of the genes for cxcl and cxcl is dependent on ifn-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro thrombospondins are astrocytesecreted proteins that promote cns synaptogenesis storage and release of atp from astrocytes in culture cntf and cntf receptor alpha are constitutively expressed by astrocytes in the mouse brain silencing ifn-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity expression of neurotrophins in the adult spinal cord in vivo an acidic protein isolated from fibrous astrocytes expression of glutamate uptake transporters after dibutyryl cyclic amp differentiation and traumatic injury in cultured astrocytes the role of excitatory amino acids and nmda receptors in traumatic brain injury astrocytes are active players in cerebral innate immunity reactive astrocytes protect tissue and preserve function after spinal cord injury bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen cxcl (ifn-gamma-inducible protein- ) control of encephalitogenic cd + t cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis inhibition of cytokine-induced connexin hemichannel activity in astrocytes is neuroprotective pdgf and fgf regulate oligodendrocyte progenitor responses to demyelination differential expressions of glycine transporter and three glutamate transporter mrna in the hippocampus of gerbils with transient forebrain ischemia glycolytic oligodendrocytes maintain myelin and long-term axonal integrity synchronous synthesis of alpha-and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis chemokine expression in murine experimental allergic encephalomyelitis selective excitatory amino acid uptake in glutamatergic nerve terminals and in glia in the rat striatum: quantitative electron microscopic immunocytochemistry of exogenous (d)-aspartate and endogenous glutamate and gaba astroglial ciliary neurotrophic factor mrna expression is increased in fields of axonal sprouting in deafferented hippocampus the tripartite synapse: roles for gliotransmission in health and disease gp -dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells stat is a critical regulator of astrogliosis and scar formation after spinal cord injury central nervous system-initiated inflammation and neurotrophism in trauma: il- beta is required for the production of ciliary neurotrophic factor ifn-γ signaling to astrocytes protects from autoimmune mediated neurological disability adapting brain metabolism to myelination and long-range signal transduction tumor necrosis factor identified in multiple sclerosis brain ciliary neurotrophic factor stimulates astroglial hypertrophy in vivo and in vitro cultured adult porcine astrocytes and microglia express functional interferon-γ receptors and exhibit toxicity towards sh-sy y cells astrocytes promote myelination in response to electrical impulses brain parenchymal tnf-α and il- β induction in experimental pneumococcal meningitis microglia: an active player in the regulation of synaptic activity cytokines: powerful regulators of glial cell activation expression of viral and myelin gene transcripts in a murine cns demyelinating disease caused by a coronavirus gfap isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of alzheimer disease neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity regulation of an oligodendrocyte progenitor cell line by the interleukin- family of cytokines astrocytes promote tnf-mediated toxicity to oligodendrocyte precursors neurons control the expression of connexin and connexin in mouse cortical astrocytes changes in astroglial glt- expression after neural transplantation or stab wounds synchronous hyperactivity and intercellular calcium waves in astrocytes in alzheimer mice continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis stage-specific association of apolipoprotein a-i and e in developing mouse retina regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferongamma acute exposure to cntf in vivo induces multiple components of reactive gliosis ciliary neurotrophic factor stimulates nuclear hypertrophy and increases the gfap content of cultured astrocytes gfap mutations in alexander disease pro-regenerative properties of cytokine-activated astrocytes gfap is necessary for the integrity of cns white matter architecture and long-term maintenance of myelination immunoreactive apolipoprotein e is a widely distributed cellular protein. immunohistochemical localization of apolipoprotein e in baboon tissues interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress cntf is a major protective factor in demyelinating cns disease: a neurotrophic cytokine as modulator in neuroinflammation cholesterol involvement in the pathogenesis of neurodegenerative diseases overexpression of cntf in mesenchymal stem cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice deletion of astrocyte connexins and leads to a dysmyelinating phenotype and hippocampal ca vacuolation disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis neuronal lrp functionally associates with postsynaptic proteins and is required for normal motor function in mice ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli astroglial connexin immunoreactivity is specifically altered at β-amyloid plaques in β-amyloid precursor protein/presenilin mice connexins are critical for normal myelination in the cns components of glial responses to exogenous and synaptic glutamate in rat hippocampal microcultures fibroblast growth factor (fgf ) and fgf receptor expression in an experimental demyelinating disease with extensive remyelination astrocytes stimulate interleukin- and interferon-gamma production in vitro how factors secreted from astrocytes impact myelin repair d-serine is an endogenous ligand for the glycine site of the n-methyl-d-aspartate receptor pathologische anatomie und pathogenese elevated connexin immunoreactivity at sites of amyloid plaques in alzheimer's disease astrocyte phenotypes and their relationship to myelination functional duality of astrocytes in myelination specialized membrane domains for water transport in glial cells: highresolution immunogold cytochemistry of aquaporin- in rat brain purified astrocytes promote the in vitro division of a bipotential glial progenitor cell platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type- astrocyte progenitor cell the complex relationship between cell division and the control of differentiation in oligodendrocyte-type- astrocyte progenitor cells isolated from perinatal and adult rat optic nerves connexin (cx )-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of cx and display vacuolized myelin in the cns conditional ablation of stat or socs discloses a dual role for reactive astrocytes after spinal cord injury cxc chemokine receptors on human oligodendrocytes: implications for multiple sclerosis cholesterol: its regulation and role in central nervous system disorders astroglial networks scale synaptic activity and plasticity glutamatemediated astrocyte-neuron signalling cloning, localization and induction of mouse brain glycogen synthase immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies cholesterol metabolism in neurons and astrocytes astrocytic neurotransmitter receptors in situ and in vivo pdgf a chain homodimers drive proliferation of bipotential (o- a) glial progenitor cells in the developing rat optic nerve cultured human fetal astrocytes can be induced by interferon-gamma to express hla-dr a glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture astrocyte expression of mrna encoding cytokines ip- and je/mcp- in experimental autoimmune encephalomyelitis direct immunogold labeling of aquaporin- in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord in vivo proliferation of oligodendrocyte progenitors expressing pdgfalphar during early remyelination in situ expression of fibroblast growth factor receptors by oligodendrocyte progenitors and oligodendrocytes in adult mouse central nervous system neuroscience: the wrap that feeds neurons regulation of oligodendrocyte development and myelination by glucose and lactate astroglial metabolic networks sustain hippocampal synaptic transmission changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/ astrocyte cocultures to kainic acid ciliary neurotrophic factor role in myelin oligodendrocyte glycoprotein expression in cuprizone-induced multiple sclerosis mice oligodendrocytes use lactate as a source of energy and as a precursor of lipids the "quad-partite" synapse: microgliasynapse interactions in the developing and mature cns iron efflux from astrocytes plays a role in remyelination neurotrophic factor gene expression in astrocytes during development and following injury tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions basic neurochemistry: molecular, cellular and medical aspects cytokine-regulated expression of platelet-derived growth factor gene and protein in cultured human astrocytes astrocytes: biology and pathology sevenfold-reduced osmotic water permeability in primary astrocyte cultures from aqp- -deficient mice, measured by a fluorescence quenching method ciliary neurotrophic factor (cntf) enhances myelin formation: a novel role for cntf and cntf-related molecules properties of gaba and glutamate responses in identified glial cells of the mouse hippocampal slice regional distribution, developmental changes, and cellular localization of cntf-mrna and protein in the rat brain transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity interferon-gamma and ia antigen are present on astrocytes in active chronic multiple sclerosis lesions microglial interactions with synapses are modulated by visual experience panglial gap junctional communication is essential for maintenance of myelin in the cns tumor necrosis factor and interleukin- in the csf and sera of patients with multiple sclerosis histological investigation of spinal cord lesions in the spinal hyperostotic mouse (twy/twy): morphological changes in anterior horn cells and immunoreactivity to neurotropic factors control of synapse number by glia plateletderived growth factor promotes repair of chronically demyelinated white matter ciliary neurotrophic factor controls progenitor migration during remyelination in the adult rodent brain baumann n. myelin-induced experimental allergic encephalomyelitis in lewis rats: tumor necrosis factor alpha levels in serum and cerebrospinal fluid immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord reactive astrocytes form scar-like perivascular barriers to leukocytes during adoptive immune inflammation of the cns the impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating cns coculture system immunocytochemical study of myelinassociated glycoprotein (mag), basic protein (bp), and glial fibrillary acidic protein (gfap) in chronic relapsing experimental allergic encephalomyelitis (eae) astrocytes-friends or foes in multiple sclerosis? a role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult cns and their response following cns demyelination microglia: dynamic mediators of synapse development and plasticity profile and regulation of apolipoprotein e (apoe) expression in the cns in mice with targeting of green fluorescent protein gene to the apoe locus possible involvement of astrocytes in neuroprotection by the cognitive enhancer t- gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo neurotrophic effects of conditioned media of astrocytes isolated from different brain regions on hippocampal and cortical neurons genomic analysis of reactive astrogliosis astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via pi -k/akt signal pathway this work was funded by the wellcome trust (hk, wt ), medical research council (sl, mr/j / ) and medical research scotland (sh, phd- - ). key: cord- -dfaxj bv authors: cavaillon, jean-marc; eisen, damon; annane, djilalli title: is boosting the immune system in sepsis appropriate? date: - - journal: crit care doi: . /cc sha: doc_id: cord_uid: dfaxj bv a relative immunosuppression is observed in patients after sepsis, trauma, burns, or any severe insults. it is currently proposed that selected patients will benefit from treatment aimed at boosting their immune systems. however, the host immune response needs to be considered in context with pathogen-type, timing, and mainly tissue specificity. indeed, the immune status of leukocytes is not universally decreased and their activated status in tissues contributes to organ failure. accordingly, any new immune-stimulatory therapeutic intervention should take into consideration potentially deleterious effects in some situations. refinements of supportive care of patients with severe sepsis have decreased their overall mortality, but no adjuvant drug therapy has emerged despite strenuous efforts in the field. twenty years have passed since the first patients with sepsis were included in clinical trials based on the understanding that tnf orchestrates the inflammatory response and should be the target for therapeutic intervention. in response to the failure of therapies aiming to target either the up-stream microbial activators or the effector molecules of the inflammatory cascade, a new concept has emerged of boosting the immune system to counter immunosuppression that develops in patients who survive the initial, hyperinflammatory period of sepsis [ ] . inflammation is a highly sophisticated and complex response that fundamentally 'aims' to protect the host. in this review, we argue against the promulgation of what we believe is a misleading perception of sepsis inducing secondary immunosuppression. the possible negative consequences of immune system-boosting therapy are paradoxical properties have also been reported for il- , the prototypic anti-inflammatory cytokine. its proinflammatory activity been established in human volunteers receiving endotoxin injection [ ] . our own in vitro studies showed that adherence of human monocytes modulated the effect of il- on expression of genes, including 'suppressor of cytokine stimulation' (socs) molecules, in the opposite direction as compared with non-adherent cells [ ] . these observations illustrate the statement by moore and colleagues that 'il- can effect very different outcomes depending on timing, dose, and location of expression. in some scenarios, the expected immuno-suppressive activities are observed, while in others, il- enhances immune or inflammatory responses' [ ] . among other cytokines classified as antiinflammatory, transforming growth factor-beta (tgfβ) may behave as pro-inflammatory mediator as tgfβtransgenic mice are more sensitive to lps-induced shock [ ] and some of its inflammatory activities reflect its capacity to favor the differentiation of t helper (th) and production of the pro-inflammatory il- . the classification of non-cytokine inflammatory mediators also relies on an overly simplistic division between proand anti-inflammatory properties. this is well illustrated by prostaglandin e (pge ), a key mediator of infectious immunopathology. on one hand, pge induces fever, increases vascular permeability, increases vasodilatation, and causes pain while also inhibiting production of tnf, increasing production of il- , inhibiting -lipoxygenase and leukotriene a generation, and inducing lipoxygenase and the generation of the lipoxins involved in inflammation resolution. on the other hand, pge has inhibitory properties on macrophages, neutrophils, th lymphocytes, natural killer (nk) cells, and cytotoxic lymphocytes but activates mast cells, th , th , and regulatory t lymphocytes (t reg ) [ ] . this panoply of pge -stimulated events amply demonstrates the inability to simply characterize the activities of this and the other molecules mentioned as pro-or anti-inflammatory. in an early anti-tnf monoclonal antibody intervention study, a significant improvement in day survival was observed between the antibody-treated group and the placebo group [ ] . although this was not a prespecified primary outcome, it is interesting to see that the treatment targeting tnf consisting of a single early injection was beneficial within a short period of time after sepsis onset, reinforcing the idea that tnf plays a key deleterious role in the early events of sepsis. once anti-tnf treatments were better targeted to the sickest patients by adding biological inclusion parameters (plasma il- level), survival was significantly improved on day [ ] . synergistic effects between immune modulators are a key characteristic of their effect. this explains how a non-lethal dose of one cytokine can lead to mortality when injected with a non-lethal dose of another cytokine. similarly, it may explain how the removal of some inflammatory mediators by coupled plasma filtrationadsorption was protective in an endotoxin-shock model while levels of circulating bio-active tnf were unaffected [ ] . clear demonstrations of cytokine-mediated tissue damage exist. nevertheless, because of their ambiguous role mentioned above, identification of their precise role during sepsis has led to controversy. in animal models of sepsis, the role of tnf may vary depending upon the type of infection [ ] . many model parameters influence conclusions of the relative role of the different mediators studied. identical cytokines have been found to be protective or deleterious depending upon the model. this has been the case for ifnγ [ ] and granulocytemacrophage colony-stimulating factor (gm-csf) [ ] among others (for example, il- , il- , 'tnf-related apoptosis-inducing ligand' (trail), and tgfβ). host-protective innate immune responses and consequent inflammation are inextricably linked and overlapping. consequently, the same cellular actors are key elements defending the host against infection while simultaneously contributing to deleterious events. for example, neutrophil extracellular traps that catch and kill bacteria and fungi are associated with the release of elements such as histones and mitochondria that behave like damage-associated molecular patterns perpetuating the inflammatory process. beneficial or deleterious roles of the same leukocyte subset have been reported depending upon the experimental model. for example, a peritonitis model using nude mice (lacking t cells) suggested that t lymphocytes contribute to protective immune responses [ ] . by contrast, in an escherichia coli sepsis murine model, t lymphocytes markedly contributed to severity [ ] . similarly, t reg improved survival in polymicrobial sepsis [ ] whereas, in another report, reduced t reg activity led to improved survival [ ] . the 'half angel/half devil' role of nk cells during severe infection is also described. nk cells contribute to systemic inflammation during polymicrobial sepsis but play a critical protective role in host defense against staphylococcus aureus lung infection (as reviewed in [ ] ). although apoptosis of dendritic cells (dcs) is particularly increased during sepsis, they are protective in murine polymicrobial sepsis [ ] . transcriptomic analysis of dcs in trauma patients shows a large number of upregulated inflammatory genes, suggesting their contribution to systemic inflammation and organ failure [ ] . apoptosis of lymphocytes, dcs, and nk cells is a hallmark of sepsis. hotchkiss and colleagues [ ] provided key experiments demonstrating that lymphocyte apoptosis was deleterious and its prevention highly protective. in addition to the depletion of apoptotic lymphocytes that contribute to the alteration of the immune status, apoptotic t cells themselves can further produce an immunosuppressive milieu following their release of tgfβ [ ] . in contrast, the apoptosis of neutrophils is reduced. interestingly, injection of apoptotic neutrophils in lps-challenged mice with or undergoing cecal ligature puncture improved outcomes [ ] . this may be due to the capacity of apoptotic neutrophils to limit the production of il- and tnf by lps-activated monocytes and to favor the production of il- and tgfβ [ ] . favoring neutrophil apoptosis while differentially preventing that of lymphocytes and dcs would represent a considerable interventional challenge! in sepsis, apoptosis does not only affect immune cells. apoptosis of epithelial cells, endothelial cells, neurons, and cardiac myocytes is reported with crucial effects of loss of altered barrier function ( figure ): in the lungs -acute lung injury and adult respiratory response syndrome [ ] ; in the kidneys -acute kidney injury [ ] . enhanced translocation of bacteria and bacterial products occurs consequent on intestinal epithelial cell apoptosis [ ] , contributing to the concept of the gut as the motor of multiple organ failure (mof). sepsis-induced cardiac myocyte apoptosis produces altered contractility and cardiac dysfunction [ ] . apoptosis of endothelial cells [ ] induces vascular leakage. finally, microglial and neuronal apoptosis may follow autonomic failure that precedes shock and mof [ ] . in addition to epithelial apoptosis, tight junction alterations enhance organ dysfunction. it has been demonstrated that nitric oxide favors disruption of epithelial cell tight junctions in numerous organs, including liver, gut, and lung. leukotrienes favor protein extravasation as shown in the kidney of septic mice [ ] . still, cytokines remain the main orchestrators of these tissue injuries. in a model of acute kidney injury, it was nicely demonstrated that inflammatory cytokines, including tnf and il- , cause small intestine and liver injury [ ] . among others, il- a is critical for generation of intestinal ischemia/reperfusion injury and subsequent liver and kidney injury [ ] . all together, the altered functions of epithelial cells, endothelial cells, neurons, and cardiac myocytes contribute to mof that may influence outcomes in sepsis more than altered immune status. the concomitant occurrence of inflammation, anti-infectious response, and altered immune status in sepsis when roger bone coined the concepts of systemic inflammatory response syndrome (sirs) and compensatory anti-inflammatory response syndrome (cars), he conceived that one or the other would be predominating figure during sepsis, many types of cells (but not neutrophils) display enhanced apoptosis, leading to various deleterious consequences. aki, acute kidney injury; ali/ards, acute lung injury/acute respiratory distress syndrome; nk, natural killer. [ ] . however, we contend that cars should be considered an adapted compartmentalized response with the aim of silencing some acute pro-inflammatory genes and maintaining the expression of certain genes involved in the anti-infectious process. despite our views [ ] , authors still propose a two-wave concept with sirs appearing before cars, although they admit that 'rigorous examination of previous studies provides evidence that both proinflammatory and opposing anti-inflammatory response(s) occur concomitantly in sepsis' [ ] . tamayo and colleagues [ ] studied a large panel of circulating cytokines in patients with sirs or sepsis, concluding that both pro-and anti-inflammatory mediators play roles from the very beginning of this life-threatening condition. similarly, meta-analysis of transcriptomic studies including individuals led to the conclusion that 'the arbitrary distinction of separating sepsis into proinflammatory and anti-inflammatory phases is not supported by gene-expression data' [ ] . immune status has been studied frequently by measuring tnf or other inflammatory cytokine production by circulating monocytes in response to lps [ ] . we studied patients undergoing abdominal aortic surgery, showing that reduced expression of human leukocyte antigen (hla)-dr on cd high monocytes occurs during surgery [ ] . similarly, hla-dr expression was already reduced on monocytes taken very soon after severe trauma at accident scenes [ ] . altered tnf production capacity of circulating cells in response to tlr or tlr agonists is also observed very soon after injurious insults, such as on admission of patients after cardiac arrest [ ] . even if soon after the initial insult the intensity of the inflammatory response reaches its peak, there is a persistent inflammation associated with altered immune status in surviving patients [ ] . the more severe the insult, the more profound is the alteration and the more chance the patients have to develop adverse clinical outcome. the immune status of leukocytes during sepsis and sirs varies depending on the compartment in which they reside terms such as 'immunoparalysis, immunosuppression, and anergy' are far too extreme to describe the immune status of circulating leukocytes in patients with sepsis or sirs. altered immune status of circulating leukocytes is not globally present. indeed, some functions like phagocytosis remain unaltered [ ] , and ex vivo cytokine production in response to heat-killed s. aureus (hksa) remains unchanged in patients with sepsis [ ] compared with healthy controls. this is in full agreement with the observation that lps primes hksa-induced tnf production in macrophage cell lines instead of leading to cross-tolerance [ ] . while the concept of endotoxin tolerance is considered to partially mimic the alteration of immune status in sepsis, it is worth mentioning that cross-tolerance between microbial agonists is not invariant. for example, candida albicans and fungal cell wall β-glucan also prime lps-induced proinflammatory cytokine production [ ] . these observations led us to propose the concept of leukocyte reprogramming [ ] to explain the fact that tolerised macrophages retain anti-infectious properties. in addition, in tissues, there are numerous examples to illustrate the hyper-activity of these cells. for example, in mice with polymicrobial sepsis alone or as a 'second hit' after traumatic hemorrhage, it was nicely demonstrated by chaudry's group [ ] that the ex vivo production of tnf or il- after lps activation was significantly reduced among peripheral blood mononuclear cells and splenic macrophages but that it was enhanced in alveolar and kupffer cells. similarly, in a murine model of trauma, the cytokine productive capacity of kupffer cells and alveolar macrophages was enhanced [ ] . indeed, macrophage functions differ depending on the compartment from which they derive. we established [ ] that the specific cytokine and cellular microenvironment within the lung was responsible for this particular resistance of alveolar macrophages to endotoxin tolerance, which can also be observed in human alveolar macrophages [ ] . similarly, in kidneys, in response to a second challenge with lps, the expression of tnf and inducible nitric oxide synthase was further enhanced [ ] . this may explain why unilateral nephrectomy could be protective in a murine peritonitis model and after lps injection [ ] . most importantly, despite the fashionable concept of m /m macrophages, the response of macrophages to il- and ifnγ is in fact completely different depending upon their origin [ ] . as a consequence of this great heterogeneity of immune cells within different compartments, each tissue behaves independently, contributing to the global inflammatory response with a specific pattern, as illustrated by differential cytokine expression in liver, lungs, heart, brain, muscle, kidney, intestine, and spleen [ ] . another example of the different behavior of leukocytes in various compartments is the frequent occurrence of hemophagocytosis (> %) directly observed in the bone marrow of the critically ill [ ] . this phenomenon is associated with extreme production of inflammatory cytokines. accordingly, it has been proposed that when hemophagocytosis is diagnosed in critical care patients, aggressive immunosuppressive therapy be undertaken without delay [ ] . differences between cells harvested from different compartments after sepsis have also been reported for spleen and peritoneal myeloid dcs [ ] . the major differences between compartments are further illustrated by the fact that gene deficiency may differentially affect outcomes of infection. for example, il- deficiency protects against francisella tularensis pulmonary infection but aggravates cutaneous infection [ ] . similarly, we showed that scavenger receptor-a (sr-a), 'macrophage associated receptor with a collagenous base' (marco), cd , or tlr deficiency protect mice against peritoneal s. aureus infection while these deficiencies aggravated pneumonia [ ] . interestingly, when streptococcus pneumoniae was the pathogen used to colonize the murine nasopharynx, marco ko mice (but not sr-a ko mice) had significantly impaired clearance of pneumococcal colonization [ ] . furthermore, inflammatory foci cells may not behave similarly to cells from other healthy compartments. for example, it was shown that neutrophils derived from sputum of patients with chronic bronchitis or cystic fibrosis are insensitive to inhibitory effects of il- in contrast to circulating neutrophils [ ] . the concomitant presence of inflammation within tissues and altered immune status within the hematopoietic compartment is short-lived in murine models rendering them inappropriate to study patients with concomitant sepsis and cars [ ] . in addition, mice are highly resistant to bacteria like s. aureus and their serum contains factors that limit inflammatory response intensity as compared with human serum [ ] . a most provocative report comparing transcriptomic patterns of circulating cells from trauma patients, human endotoxemia-model participants, and murine-model equivalents revealed total absence of correlation [ ] . when most therapeutic approaches have been validated in preclinical studies performed with murine models, one understands why those were not the most appropriate ones. the scientific community needs to reconsider models used to validate therapeutic approaches. if murine responses do not resemble human processes, maybe other species, like the pig, should be preferred. porcine monocytes and lps-activated macrophages are closer to their human counterparts than murine cells [ ] . of course, murine models remain valuable to further decipher the mechanisms of sepsis. the best example is the two-hit model, which demonstrated that the nature of the first hit and its severity, the nature of the infection, and the route of infection may influence the outcome in a completely opposite direction [ ] . are patients with sepsis dying of immune failure -dissecting the arguments used to describe compensatory immunosuppression occurring after sepsis? the clinical observations used to argue that immunosuppression occurs in sepsis patients surviving the initial inflammatory cascade [ ] are in essence that patients develop nosocomial infections due to opportunistic pathogens, including reactivated chronic viral infections, and that patients who die after sepsis have unresolved foci of infection. these underpinning observations require further consideration. representing bacteria such as enterococcus faecium, stentrophomonas maltophilia, and pseudomonas aeruginosa along with candida as 'opportunistic pathogens' overstates the role of sepsis-induced immune dysregulation as the primary cause of nosocomial infection in these patients. these multiply-instrumented, high-intensity care, bed-bound, vulnerable patients often have breaches in their integument and mucous membranes (airways, surgical sites, indwelling catheters) and perturbed microbiomes from antibiotic treatments. overgrowth of antibioticresistant microorganisms and barrier defects predispose them to secondary infections, even without overt defects in their immune defenses [ ] . these are all organisms of normal virulence that cause nosocomial infections in sepsis patients because of the selection pressure of potent antibiotics and the presence of biofilm affected/colonized intravascular and urinary catheters. additionally, reactivation of herpes simplex virus (hsv) and cytomegalovirus (cmv) may have some clinical relevance in critically ill patients. cmv-emia is quite common in patients with sepsis ( % in some studies) and is at least associated with worse outcome in icu patients in recent meta-analyses. whether cmv could cause immune compromise itself, be a reflection of immune compromise, or simply be an indicator of poor outcome in patients with sepsis remains unclear [ ] . reactivation of oro-labial hsv is extremely common in sepsis, and hsv can frequently be detected in respiratory secretions. however, only one study has reliably investigated lower respiratory tract infection in critically ill, immunocompetent patients, showing that % of patients with ventilator-associated pneumonia (vap) had bronchopneumonitis due to hsv [ ] . in % of these patients, the vap appeared to be due to hsv alone. however, acyclovir treatment had no impact on the outcome in patients with hsv bronchopneumonitis [ ] . of greater relevance to predisposition to nosocomial infection in sepsis patients remaining in icus for prolonged periods are physical breaches in innate immune system barriers. intravascular catheters, endotracheal tubes with consequently increased dead space, and increased gastric ph due to peptic ulcer prophylaxis regimens are all, along with broad-spectrum antibiotics, potent promoters of nosocomial infection. post-mortems (pms) identifying unresolved infection foci are not reliable proof that patients are dying of sepsis. pneumonia is frequently present in patients in whom supportive care is withdrawn due to failure to thrive. where pneumonia has been found more frequently at pm than was appreciated ante-mortem, the extent of pulmonary involvement was not quantified [ ] . in this series, there was clear agreement by clinical and pm assessment that mof was the commonest cause of death [ ] . these data call into question the relevance of unresolved, pm infection in patients dying in the icu as a direct indicator of immunosuppression following as a direct consequence of previous sepsis. if the patients die with infectious foci and altered immune status, it does not mean they die because of them. because of the monocyte deactivation in sepsis, it was proposed to restore it with the use of either ifnγ or gm-csf, two cytokines that counteract endotoxin tolerance. the first attempt was successfully performed in nine septic patients who received subcutaneous ifnγ that restored ex vivo cytokine production and hla-dr expression by monocytes [ ] . the authors claimed that overall mortality was lower in the treated group compared with historical controls. in mechanically ventilated trauma patients, ifnγ was aerosolized. however, in a previous phase iii study in burn patients, ifnγ had failed to protect patients from infection or decrease mortality [ ] . we must recall that ifnγ injection increases mortality in animal models of polymicrobial infection [ ] . all together, these data have limited the routine use of ifnγ in icu patients, although a dutch clinical trial is ongoing. gm-csf has been demonstrated to be able to restore some immune status parameters. however, a metaanalysis concluded that gm-csf did not significantly reduce in-hospital mortality, although it significantly increased infection recovery [ ] . although no adverse effects were reported, it is worth recalling a case report of a patient who developed a fatal adult respiratory distress syndrome after gm-csf treatment [ ] . in animal models, gm-csf favors lps-induced lung inflammation, amplifying lps-induced bronchoconstriction [ ] . gm-csf favors production of tnf and il- . in a recent study, it was confirmed that gm-csf synergizes with lps, promoting il- β secretion [ ] . lethal injection of lps in gm-csf receptor ko mice led to far lower mortality among these mice as compared to wild type mice. given all the efforts made by some authors to convince the scientific community of the use of gm-csf, it is challenging to read the conclusion of this present paper given that gm-csf has been previously underestimated as a target for therapeutic intervention in many bacterial infections and inflammatory disorders associated with the production of il- β. il- is another cytokine that is promoted for the treatment of sepsis and that is supported by murine and human ex vivo tissue data [ , ] . one can conjecture that systemic treatment with il- may act in undesired places, as illustrated by the following: il- worsens graft-versus-host-induced tissue inflammation [ ] ; favors inflammation in colitis [ ] , contributes to arthritis severity [ ] ; upregulates chemokines, ifnγ, macrophage recruitment, and lung inflammation [ ] ; and, finally, increases production of inflammatory cytokines by monocytes and t cells [ ] . many other cytokines (for example, il- , il- , il- , and tnf) can boost the immune system and are reported to be beneficial in murine sepsis models. however, one wonders whether systemic treatment with any immunostimulating cytokine may act on tissue leukocytes boosting the inflammatory process while boosting immune status as well. in this perspective, the attempt to treat peripheral mononuclear cells of sepsis patients ex vivo with il- before re-injecting them is an interesting approach that prevents the delivery of this cytokine to the bloodstream, allowing it to act strictly on the desired cells [ ] . in this study, the mortality was % in the extracorporeally treated group of patients (n = ) but was % in the patients receiving standard treatment (n = ). rather than repeating the mistakes of past experimental treatments for sepsis in which therapies were developed after successful preclinical models that may be far from mimicking human disease, it would be ideal to proceed in the future with new treatments in which extensive human data are available prior to embarking on expensive licensure studies. furthermore, identifying currently licensed drugs with tolerable safety profiles as potential sepsis agents leap-frogs costly drug development and early-phase human studies. in animal models, extant licensed drugs, such as chloroquine [ ] and androstenenediol [ ] , have successfully restored immune status. most interestingly, in the latter case, the treatment protected mice against polymicrobial sepsis and boosted altered ex vivo cytokine production observed with peripheral blood cells and spleen macrophages, dampening production observed with alveolar macrophages and kupffer cells. a similar compartmentalized adapted specificity was reported with estradiol [ ] . other approaches involve pro-resolving lipid mediators [ ] , although it is uncertain whether they may also adversely boost immune status. the recently recognized aspirin-triggered lipoxins, anti-inflammatory mediators of inflammation resolution, make aspirin a possible inexpensive agent for both prevention and treatment of sepsis. considerable observational cohort data show improvements in mortality in patients with sepsis pretreated with aspirin [ ] . this approach is being prospectively studied as part of an aspirin primary prevention trial. could other immunomodulatory approaches be considered with less putative dangerous consequences on inflamed tissues. this may be the case of thymosin-α . indeed, a very promising study demonstrated its efficiency to improve clinical outcome in patients with severe sepsis [ ] , after a preliminary investigation had demonstrated a better performance with respect to organ failure scores in thymosin-α -treated patients with sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria [ ] . however, one must call for caution since thymosin-α can also favor the production of inflammatory cytokines and nitric oxide and further increases the percentage of t reg cells [ , ] . still, very little is known of its effect on leukocytes present in different compartments. the cell surface molecules containing in their intracytoplasmic domain an immunoreceptor tyrosine-based inhibition motif -such as programmed death- (pd- ), b and t lymphocyte attenuator (btla), and cytotoxic t-lymphocyte antigen (ctla- ) -could also be interesting targets for new therapeutic approaches. the expression of pd- on t cells and its ligand (pd-l ) on monocytes is upregulated in critically ill [ ] or septic shock [ ] patients. increased expressions were associated with increased occurrence of secondary nosocomial infections and mortality after septic shock [ ] . not only are pd- -deficient mice markedly protected from the lethality of sepsis, accompanied by a decreased bacterial burden and suppressed inflammatory cytokine response [ ] , but also blockade of pd- or pd-l improves survival in a murine model of sepsis, reverses immune dysfunction, inhibits lymphocyte apoptosis, and attenuates organ dysfunction [ ] [ ] [ ] . the relevance of these observations in human settings is still needed. ctla- is a high-avidity receptor for cd and cd . enhanced ctla- expression was demonstrated more frequently in patients with sepsis than in non-infected critically ill patients or control subjects [ ] , and blocking ctla- improved survival in bacterial and fungal experimental sepsis [ , ] . however, the use of such an approach seems tricky since, in animal models at high dose, anti-ctla- could worsen survival [ ] , and the use of abatacept (a soluble ctla- dimerized with an fc fragment of immunoglobulin) led to increased survival in invasive pneumococcal infection [ ] . similarly, btla expression is enhanced in patients with sirs or sepsis [ ] and, in a murine model of sepsis, btla-deficient mice displayed an enhanced resistance [ ] . in contrast, these mice displayed enhanced susceptibility to endotoxin-induced shock [ ] . accordingly, the exact role of btla needs to be further deciphered before strategies targeting btla could be proposed to treat patients with sepsis. new therapeutic approaches to treat sepsis should take into consideration that the immune status of leukocytes in the peripheral blood might be quite different from those present in inflamed tissues. we believe that a systemic approach to immune stimulation is not appropriate if immune cells are boosted generally, independent of their location. an ideal drug would limit the overzealous inflammatory process that leads to organ failure and favor homeostatic responsiveness of leukocytes ( figure ). this is the challenge we have to address if we wish to avoid further decades of disillusionment. figure new therapeutic interventions should address both the events in the tissues that lead to organ failure and the altered immune status of leukocytes restricted to some specific compartments. cars: compensatory anti-inflammatory response syndrome; cmv: cytomegalovirus; ctla- : cytotoxic t-lymphocyte antigen ; dc: dendritic cell; gm-csf: granulocyte-macrophage colony-stimulating factor; hksa: heat-killed staphylococcus aureus hsv: herpes simplex virus; ifnγ: interferon-gamma lps: lipopolysaccharide; marco: macrophage-associated receptor with a collagenous base; mof: multiple organ failure; nk: natural killer pd- : programmed death- ; pd-l : programmed death- ligand prostaglandin e ; pm: post-mortem; sirs: systemic inflammatory response syndrome; sr-a: scavenger receptor-a; tgfβ: transforming growth factor-beta th: t helper; tlr: toll-like receptor; tnf: tumor necrosis factor; t reg : regulatory t lymphocyte; vap: ventilator-associated pneumonia immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach paradoxical anti-inflammatory actions of tnf-alpha: inhibition of il- and il- via tnf receptor in macrophages and dendritic cells tnf suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis interleukin receptor signaling regulates duba expression and facilitates toll-like receptor -driven antiinflammatory cytokine production systemic interferon-gamma suppresses the development of endotoxin-induced uveitis in mice proinflammatory effects of il- during human endotoxemia adib-conquy m: adherence modifies the regulation of gene expression induced by interleukin- a: interleukin- and the interleukin- receptor hepatic over-expression of tgf-beta promotes lps-induced inflammatory cytokine secretion by liver cells and endotoxemic shock regulation of immune responses by prostaglandin e efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. a randomized, controlled, double-blind, multicenter clinical trial. tnf-alpha mab sepsis study group assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, mak f, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study continuous plasmafiltration coupled with sorbent adsorption in a rabbit model of endotoxic shock neutralization of tumor necrosis factor in preclinical models of sepsis interferon-gamma increases mortality following cecal ligation and puncture granulocytemacrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice role of t cells for cytokine production and outcome in a model of acute septic peritonitis role of t cells in a murine model of escherichia coli sepsis adoptive transfer of in vitro-stimulated cd + cd + regulatory t cells increases bacterial clearance and improves survival in polymicrobial sepsis neutralization of interleukin- or transforming growth factor-beta decreases the percentages of cd + cd + foxp + regulatory t cells in septic mice, thereby leading to an improved survival natural killer (nk) cells in antibacterial innate immunity: angels or devils cd c + dendritic cells are required for survival in murine polymicrobial sepsis altered gene expression patterns in dendritic cells after severe trauma: implications for systemic inflammation and organ injury overexpression of bcl- in transgenic mice decreases apoptosis and improves survival in sepsis tgf-beta released by apoptotic t cells contributes to an immunosuppressive milieu apoptotic cells protect mice against lipopolysaccharide-induced shock lipopolysaccharide induces rapid production of il- by monocytes in the presence of apoptotic neutrophils silencing of fas, but not caspase- , in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers mechanisms of decreased intestinal epithelial proliferation and increased apoptosis in murine acute lung injury apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy adrenomedullin and adrenomedullin binding protein- attenuate vascular endothelial cell apoptosis in sepsis apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis cytokines induce small intestine and liver injury after renal ischemia or nephrectomy critical role of interleukin- a in murine intestinal ischemia-reperfusion injury sepsis: a new hypothesis for pathogenesis of the disease process immunodepression in sepsis and sirs assessed by ex vivo cytokine production is not a generalized phenomenon: a review pro-and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock genome-wide transcription profiling of human sepsis: a systematic review dysregulation of in vitro cytokine production by monocytes during sepsis adib-conquy m: differential down-regulation of hla-dr on monocyte subpopulations during systemic inflammation immune paralysis in trauma patients, implications for pre-hospital intervention successful cardiopulmonary resuscitation after cardiac arrest as a 'sepsis like' syndrome persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. correlation to cd and cd antigen expression upregulation of myd s and sigirr, molecules inhibiting toll-like receptor signaling, in monocytes from septic patients staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma candida albicans infection affords protection against reinfection via functional reprogramming of monocytes reprogramming of circulatory cells in sepsis and sirs androstenediol ameliorates alterations in immune cells cytokine production capacity in a two-hit model of trauma-hemorrhage and sepsis cytokine productive capacity of alveolar macrophages and kupffer cells after femoral fracture and blunt chest trauma in a murine trauma model lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin* priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung endotoxin tolerance': tnf-alpha hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state reduction of risk following endotoxin injection in unilaterally nephrectomized rats delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines complementary organ expression of il- vs il- and csf- activities in normal and lps injected mice hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice differing effects of interleukin- on cutaneous and pulmonary francisella tularensis live vaccine strain infection adib-conquy m: protective or deleterious role of scavenger receptors sr-a and cd on host resistance to staphylococcus aureus depends on the site of infection marco is required for tlr -and nod -mediated responses to streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx autocrine modulation of il- production by sputum neutrophils in chronic bronchial sepsis characterization and modulation of the immunosuppressive phase of sepsis resilience to bacterial infection: difference between species could be due to proteins in serum genomic responses in mouse models poorly mimic human inflammatory diseases pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide influence of systemic inflammatory response syndrome on host resistance against bacterial infections the late phase of sepsis is characterized by an increased microbiological burden and death rate cytomegalovirus infection in critically ill patients: a systematic review herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation macroscopic postmortem findings in surgical intensive care patients with sepsis monocyte deactivation in septic patients: restoration by ifng treatment interferon-gamma in the prevention of severe burn-related infections: a european phase iii multicenter trial. the severe burns study group granulocyte-colony stimulating factor (g-csf) and granulocyte-macrophage colony stimulating factor (gm-csf) for sepsis: a meta-analysis treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome granulocyte/ macrophage-colony-stimulating factor (gm-csf) regulates lung innate immunity to lipopolysaccharide through akt/erk activation of nfkappa b and ap- in vivo gm-csf signalling boosts dramatically il- production il- restores lymphocyte functions in septic patients interleukin worsens graft-versus-host disease interleukin- receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis blockade of the interleukin- receptor inhibits collagen-induced arthritis and is associated with reduction of t cell activity and proinflammatory mediators systemic administration of tlr agonist induces il- expression and il- -dependent cxcr ligand production in the lung interleukin induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes the experience of surgical infections treatment with extracorporal immunotherapy chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage infection regulates pro-resolving mediators that lower antibiotic requirements acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis the efficacy of thymosin alpha for severe sepsis (etass): a multicenter, single-blind, randomized and controlled trial thymosin alpha -and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenemresistant bacteria involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha effect of thymosin alpha- on subpopulations of th , th , th , and regulatory t cells (tregs) in vitro programmed death expression as a marker for immune and physiological dysfunction in the critically ill surgical patient upregulation of programmed death- on t cells and programmed death ligand- on monocytes in septic shock patients programmed death- levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients pd- expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis delayed administration of anti-pd- antibody reverses immune dysfunction and improves survival during sepsis pd-l blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction pd-l blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients dose-dependent effect of anti-ctla- on survival in sepsis blockade of the negative co-stimulatory molecules pd- and ctla- improves survival in primary and secondary fungal sepsis inhibition of t cells provides protection against early invasive pneumococcal disease b and t lymphocyte attenuator expression on cd + t-cells associates with sepsis and subsequent infections in icu patients btla expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction b and t lymphocyte attenuator inhibits lps-induced endotoxic shock by suppressing toll-like receptor signaling in innate immune cells cite this article as: cavaillon et al.: is boosting the immune system in sepsis appropriate? critical care key: cord- - ascbu authors: eigler, a.; loher, f.; endres, s. title: suppression der synthese des tumornekrosefaktors date: journal: internist (berl) doi: . /s sha: doc_id: cord_uid: ascbu klinische studien aus den vergangenen jahren belegen die zentrale rolle des tumornekrosefaktors (tnf) im pathophysiologischen geschehen der rheumatoiden arthritis und des morbus crohn. die vorliegende arbeit gibt einen Überblick über die regulation der synthese und die vielfältigen wirkungen dieses zytokins. so wurden erhöhte tnf-konzentrationen bei verschiedenen infektiösen und entzündlichen erkrankungen sowie in verbindung mit speziellen therapien nachgewiesen. darauf aufbauend werden experimentelle therapeutische strategien zur hemmung der tnf-bildung dargestellt. klinische studien aus den vergangenen jahren belegen die zentrale rolle des tumornekrosefaktors (tnf) im pathophysiologischen geschehen der rheumatoiden arthritis und des morbus crohn.die vorliegende arbeit gibt einen Überblick über die regulation der synthese und die vielfältigen wirkungen dieses zytokins.so wurden erhöhte tnf-konzentrationen bei verschiedenen infektiösen und entzündlichen erkrankungen sowie in verbindung mit speziellen therapien nachgewiesen.darauf aufbauend werden experimentelle therapeutische strategien zur hemmung der tnf-bildung dargestellt. tumornekrosefaktor · rheumatoide arthritis · morbus crohn · zytokine · signaltransduktion der tumornekrosefaktor-α (tnf-α) nimmt eine dominierende rolle im so genannten zytokinnetzwerk und damit in der pathogenese zahlreicher infektiöser und entzündlicher erkrankungen ein. tnf wurde nach seiner fähigkeit benannt, bei versuchstieren in transplantierten tumoren eine hämorrhagische nekrose zu verursachen [ ] . zehn jahre nach beschreibung dieser eigenschaft wurde tnf-α aufgereinigt und sequenziert [ ] und das gen von verschiedenen arbeitsgruppen parallel kloniert [ , , ] . seither sind zahlreiche biologische eigenschaften dieses zytokins identifiziert worden, zusätzlich zur lyse von tumorzellen und zur induktion von kachexie, die ursprünglich zur erkennung von tnf geführt hatten [ ] . schon im jahre war von dem new yorker chirurgen coley beobachtet worden, dass schwere infektionen in manchen fällen zur regression eines malignen tumors führten [ , ] [ ] . die tnf-wirkungen werden durch quervernetzung membrangebundener rezeptormoleküle vermittelt (tnf-rezeptor i, tnfri, p ; tnf-rezeptor ii, tnfrii, p ; [ ] ). in der tnfri-knockout-maus wurde eine resistenz gegenüber dem endotoxinschock demonstriert, andererseits war eine infektion mit listeria monocytogenes letal [ ] . die extrazellulären anteile beider tnf-rezeptoren liegen auch als lösliche form im serum vor, können weiterhin tnf binden und damit die akuten wirkungen des tnf abschwächen [ , ] . unter bestimmten bedingungen konservieren diese natürlichen tnf-inhibitoren jedoch auch tnf [ , , ] . nach bindung an die membranständigen rezeptoren übt tnf eine reihe unterschiedlicher wirkungen aus (abb. ). die signaltransduktion distal des tnf-rezeptors wird unter anderem von phospholipasen c [ ] und sphin-gomyelinasen vermittelt, die ceramide aus sphingomyelin freisetzen und ceramidabhängige proteinkinasen aktivieren [ ] . nachdem die gabe von anti-tnf-antikörpern in tierexperimenten des septischen schocks positive ergebnisse erbracht hatten, wurden hohe erwartungen an eine therapie des septischen schocks beim menschen geweckt. diese wurden jedoch nicht erfüllt. dagegen wurden bei chronisch entzündlichen erkrankungen -der rheumatoiden arthritis und dem morbus crohn -eindrucksvolle erfolge mit anti-tnf-antikörpern und mit tnf-rezeptorfusionsproteinen erzielt. auf diese studienergebnisse gehen weitere arbeiten in diesem heft näher ein. die empfindlichste methode, um zirkulierendes tnf nachzuweisen, basiert auf der extrem hohen bindungsaffinität und -spezifität des p -tnf-rezeptors. bei gesunden probanden konnte mit dieser methode kein tnf im plasma nachgewiesen werden [ ] . die nachweisgrenze dieses assays ist attomolar ( - mol/l), das entspricht . tnf-trimeren oder femtogramm in ml plasma. im gegensatz dazu werden bei akuten erkrankungen wie dem septischen schock tnf-konzentrationen im nanomolaren bereich ( - mol/l) nachgewiesen. die synthese des tnf wird in monozyten und makrophagen durch unterschiedliche exogene substanzen wie z. b. endotoxin und β-glukane sowie auch durch endogene mediatoren wie il- induziert. hohe konzentrationen von tnf im plasma konnten bei zahlreichen infektiösen und entzündlichen erkrankungen nachgewiesen werden (tabelle ). hohe konzentrationen von tnf wurden auch in therapieassoziierten syndromen nachgewiesen wie der gabe von interleukin- (il- ) zur therapie von soliden tumoren und nach der applikation von anti-cd -antikörpern zur therapie der akuten abstoßungsreaktion nach organtransplantation. die hemmung der bildung [ ] oder der aktivität [ ] von tnf während der gabe von anti-cd -antikörpern schwächt deren nebenwirkungen ab. ein nutzen durch tnf-antagonismus erscheint somit grundsätzlich bei den in der tabelle aufgeführten erkrankungen möglich. [ ] . thalidomid verkürzt die halbwertszeit der tnf-rna [ ] . antisense-oligonukleotide führen zu einer spezifischen hemmung der tnf-translation [ ] . dabei müssen jedoch spezielle experimentelle bedingungen geschaffen werden, da oligonukleotide sonst auch zu einer induktion der tnf-synthese führen können [ ] . in den folgenden abschnitten wird näher auf strategien zur hemmung der tnf-synthese eingegangen, die im tierexperiment oder schon beim menschen in klinischen studien untersucht worden sind. im jahre konnten kunkel et al. [ ] erstmals zeigen, dass substanzen, die zy- klisches adenosinmonophosphat erhöhen, die tnf-synthese in murinen makrophagen hemmen. diese stoffe umfassen phosphodiesteraseinhibitoren, die den abbau von camp verhindern, und prostaglandine, die die adenylylzyklase über g-proteine aktivieren und auf diese weise zu einer verstärkten camp-bildung führen. darüber werden die campabhängigen proteinkinasen a aktiviert, was in einer phosphorylierung von zielproteinen wie etwa camp-responsiveelements (cre)-bindungsproteinen mündet. diese transkriptionsfaktoren binden an spezifische sequenzen in der promotorregion bestimmter gene. eine entsprechende cre-spezifische sequenz wurde in der '-flankierenden region des tnf-gens beschrieben [ ] . die expression des tnf ist weiterhin abhängig von der aktivierung des transkriptionsfaktors nf-κb (nuclear factor-κb). mehrere nf-κb-bindende regionen wurden in der promotorregion des tnf-gens identifiziert [ ] . nf-κb ist physiologischer weise an seinen spezifischen inhibitor iκb im zytosol gebunden. im falle einer aktivierung dissoziiert dieser komplex, und nf-κb gelangt in den zellkern. die aktivierung von nf-κb kann durch antioxidantien gehemmt werden [ ] . eine hemmung der interaktion des nf-κb mit seinem motiv wurde für pentoxifyllin [ ] berichtet, einem unspezifischen phosphodiesteraseinhibitor. unter den klinisch eingesetzten phosphodiesterasehemmern ist pento-xifyllin die substanz, die am eingehendsten bezüglich der tnf-hemmenden wirkungen untersucht wurde. so wurden patienten, die anti-cd -monoklonale-antikörper zur behandlung einer akuten transplantatabstoßungsreaktion erhielten, zur hemmung der nebenwirkung durch tnf mit pentoxifyllin behandelt [ , ] . als interessante alternative zum einsatz des unspezifischen phosphodiesterasehemmstoffes pentoxifyllin, erscheint der spezifische typ-iv-phosphodiesteraseinhibitor rolipram, der -mal wirksamer die tnf-synthese hemmt [ ] . die typ-iv-phosphodiesterase überwiegt in monozyten [ ] und bildet daher einen guten angriffspunkt für die hemmung camp-abhängiger funktionen dieser zellen. außerdem konnte für die kombination von rolipram mit prostaglandinen (prostaglandin e und prostazyklinanaloga) eine synergistische wirkung in bezug auf die camp-erhöhende [ ] und die tnf-hemmende wirkung [ ] gezeigt werden. diese synergie könnte relevant für den einsatz von rolipram bei lokalen entzündungsprozessen mit hohen interstitiellen konzentrationen an prostaglandin e sein. die entzündungshemmende wirkung von camp-erhöhenden substanzen wird jedoch nicht nur über eine hemmung der tnf-synthese vermittelt. so wird z. b. auch das antiinflammatorische zytokin il- durch camp-erhöhung verstärkt exprimiert [ , ] . mehrere tierexperimentelle arbeiten belegen die wirksamkeit einer spezifischen hemmung der phosphodiesterase in vivo. in einem rattenmodell der experimentellen autoimmunenzephalo- [ ] . die therapeutische wirkung wurde in einem primatenmodell (marmoset-affen) der autoimmunenzephalomyelitis bestätigt [ ] . weiterhin konnte durch die therapie mit rolipram die suppression der tnf-synthese und ein Überlebensvorteil in einem rattenmodell des ards gezeigt werden [ ] . in einem mausmodell der kollageninduzierten arthritis konnte rolipram eine hemmung der tnf-synthese und einen therapieerfolg erzielen [ ] . die autoren konnten die wirksamkeit von rolipram in einem maus-kolitis-modell nachweisen [ ] . rolipram wurde in den frühen er jahren synthetisiert [ ] , als antidepressivum in klinischen studien untersucht, aber nicht bis zur marktreife gebracht. rolipram wurde nie beim menschen mit der absicht untersucht, die tnf-synthese zu hemmen. derzeit werden von mehreren pharmazeutischen unternehmen spezifische typ-iv-phosphodiesterasehemmstoffe entwickelt oder bereits in klinischen studien eingesetzt. Überwiegend werden im rahmen dieser studien patienten mit asthma bronchiale untersucht. erstmals wurde gezeigt, dass ein teil der antiinflammtorischen wirkung von thalidomid (früher contergan ® ) über eine hemmung der tnf-synthese (abb. ) vermittelt wird [ ] . thalidomid wurde bei mehreren erkrankungen eingesetzt, die mit erhöhten tnf-konzentrationen einhergehen. so liegen arbeiten zur therapie der chronischen graft-versus-host-erkrankung,der chronischen polyarthritis, der sarkoidose und des hiv-assoziierten wasting-syndroms vor (Übersicht in [ ] ). zwei kürzlich erschienene offene klinische studien zur gabe von thalidomid bei patienten mit steroidabhängigem m. crohn beschrieben ein klinisches ansprechen schon nach wochen in % und % der behandelten patienten. in einem kritischen editorial wurden diese ergebnisse vorsichtig positiv bewertet und ein möglicher einsatz bei patienten gesehen, die infliximab nicht vertragen [ ] . eindringlich wurde jedoch aufgrund der bekannten teratogenität von thalidomid vor einem unkritischen einsatz gewarnt. die gabe von thalidomid darf nur unter strengsten kontrollmaßnahmen erfolgen und auch unter dieser vorgabe erst nach vorliegen von positiven ergebnissen von randomisierten, kontrollierten klinischen studien. interleukin- wurde ursprünglich als ein produkt einer bestimmten untergruppe von t-helferzellen (th -zellen) identifiziert, das die proliferation, entwicklung und funktion einer anderen t-helferzellgruppe (th -zellen) hemmt [ ] . il- wird von verschiedenen zellen wie b-zellen, b-zell-lymphomen, monozyten, keratinozyten und mastzellen gebildet. entsprechend des ursprünglichen namens -zytokinsynthese-inhibierender faktor -hemmt il- die produktion verschiedener proinflammatorischer zytokine, insbesondere tnf und il- in monozyten und makrophagen. ein protektiver effekt für il- konnte in einem mausmodell der letalen endotoxinämie gezeigt werden.auch in einem kolitismodell der maus wurde ein therapieerfolg mit il- erreicht [ ] . in gesunden probanden hemmt il- die ex-vivo-synthese proinflammatorischer zytokine. nach endotoxingabe bei freiwilligen probanden wurde eine verminderte tnf-konzentration nach il- ob und welche der hier aufgezeigten strategien zur hemmung des tnf klinische relevanz erlangen werden, ist derzeit noch nicht abzusehen. insbesondere die meist nur mündlichen berichte von gehäuftem auftreten von lymphomen und karzinomen unter therapie mit anti-tnf-antikörpern dämpfen die euphorie, die diese innovative therapieform ausgelöst hat. für tumornekrosefaktor (tnf) ist durch therapiestudien bei menschen eine notwendige mediatorrolle bei m. crohn und bei chronischer polyarthritis belegt. der therapieerfolg von blockierenden antikörpern und rezeptorfusionsproteinen unterstreicht die bedeutung der suche nach weiteren therapeutischen angriffspunkten an diesem zytokin. eine vielzahl körpereigener mediatoren und exogener wirkstoffe wurden identifiziert, die die synthese von tnf in therapeutischen dosierungen hemmen. dass diese synthesehemmung auch einen günstigen einfluss auf den erkrankungsverlauf nimmt, wurde im vergangenen jahr in pilotstudien zur gabe von thalidomid bei m. crohn gezeigt. aus der großen gruppe der tnf-synthesehemmenden substanzen sind spezifische phosphodiesteraseinhibitoren (vom typ iv) in der klinischen entwicklung am weitesten fortgeschritten. sie werden derzeit in phase-iii-studien für patienten mit asthma bronchiale geprüft. falls sie zur zulassung kommen, wird eine indikationsausweitung auf andere tnf-vermittelte erkrankungen untersucht werden. an endotoxin-induced serum factor that causes necrosis of tumors human tumor necrosis factor.production, purification, and characterization human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin cloning and expression in escherichia coli of the gene for human tumour necrosis factor molecular cloning of the complementary dna for human tumor necrosis factor cachectin and tumor necrosis factor as two sides of the same biological coin the treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and bacillus prodigiosus structure of tumour necrosis factor the tumor necrosis factor ligand and receptor families mice deficient for the kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to l.monocytogenes infection a tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity two tumor necrosis factor-binding proteins purified from human urine.evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors stabilization of the bioactivity of tumor necrosis factor by its soluble receptors soluble tumor necrosis factor (tnf) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both tnf carriers and tnf antagonists cytokine-binding proteins: stimulating antagonists tumor necrosis factor induces rapid production of ' 'diacylglycerol by a phosphatidylcholine-specific phospholipase c functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling receptor-mediated label-transfer assay (relay) -a novel method for the detection of plasma tumor necrosis factor at attomolar concentrations pentoxifylline suppresses okt -induced tumor necrosis factor-α formation in renal transplant recipients evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of okt -associated acut clinical syndrome dexamethasone and pentoxifylline inhibit endotoxininduced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway thalidomide exerts its inhibitory action on tumor necrosis factorα by enhancing messenger rna degradation specific suppression of human tumor necrosis factor-α synthesis by antisense oligodeoxynucleotides oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin prostaglandin e regulates macrophage-derived tumor necrosis factor gene expression signal transduction and gene regulation: the nuclear response to camp function and activation of nf-κb in the immune system nuclear factor kappab -an oxidative stressresponsive transcription factor of eukaryotic cells (a review) cooperative inhibition of nf-kappa b and tat-induced superactivation of human immunodeficiency virus type long terminal repeat pentoxifylline reduces the first-dose reactions following okt the specific type iv phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells phosphodiesterase inhibitors: new opportunities for the treatment of asthma enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids cicaprost and the specific type iv phosphodiesterase inhibitor rolipram synergize in suppression of tumor necrosis factor-α synthesis up-regulation of monocytic il- by tumor necrosis factor-a and camp elevating drugs anti-inflammatory activities of camp-elevating agents: enhancement of interleukin- synthesis and concurrent suppression of tumor necrosis factor production the antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis prevention of autoimmune demyelination in non-human primates by a camp-specific phosphodiesterase inhibitor effects of rolipram on responses to acute and chronic antigen exposure in monkeys suppression of tnf-alpha expression, inhibition of th activity, and amelioration of collagen-induced arthritis by rolipram specific type iv phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice potential antidepressant activity of rolipram and other selective cyclic adenosine ' , '-monophosphate phosphodiesterase inhibitors thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes new life in a sleeper: thalidomide and crohn's disease two types of mouse t helper cell.iv.th clones secrete a factor that inhibits cytokine production by th clones role of interleukin- in a murine model of dextran sulfate sodium-induced colitis key: cord- -jne jqf authors: macparland, sonya a.; ma, xue-zhong; chen, limin; khattar, ramzi; cherepanov, vera; selzner, markus; feld, jordan j.; selzner, nazia; mcgilvray, ian d. title: lipopolysaccharide and tumor necrosis factor alpha inhibit interferon signaling in hepatocytes by increasing ubiquitin-like protease (usp ) expression date: - - journal: j virol doi: . /jvi. - sha: doc_id: cord_uid: jne jqf inflammation may be maladaptive to the control of viral infection when it impairs interferon (ifn) responses, enhancing viral replication and spread. dysregulated immunity as a result of inappropriate innate inflammatory responses is a hallmark of chronic viral infections such as, hepatitis b virus and hepatitis c virus (hcv). previous studies from our laboratory have shown that expression of an ifn-stimulated gene (isg), ubiquitin-like protease (usp) is upregulated in chronic hcv infection, leading to impaired hepatocyte responses to ifn-α. we examined the ability of inflammatory stimuli, including tumor necrosis factor alpha (tnf-α), lipopolysaccharide (lps), interleukin- (il- ) and il- to upregulate hepatocyte usp expression and blunt the ifn-α response. human hepatoma cells and primary murine hepatocytes were treated with tnf-α/lps/il- /il- and usp , phosphorylated (p)-stat and myxovirus (influenza virus) resistance (mx ) expression was determined. treatment of huh . cells and primary murine hepatocytes with lps and tnf-α, but not il- or il- , led to upregulated usp expression and induced an ifn-α refractory state, which was reversed by usp knockdown. liver inflammation was induced in vivo using a murine model of hepatic ischemia/reperfusion injury. hepatic ischemia/reperfusion injury led to an induction of usp expression in liver tissue and promotion of lymphocytic choriomeningitis replication. these data demonstrate that certain inflammatory stimuli (tnf-α and lps) but not others (il- and il- ) target usp expression and thus inhibit ifn signaling. these findings represent a new paradigm for how inflammation alters hepatic innate immune responses, with usp representing a potential target for intervention in various inflammatory states. importance inflammation may prevent the control of viral infection when it impairs the innate immune response, enhancing viral replication and spread. blunted immunity as a result of inappropriate innate inflammatory responses is a common characteristic of chronic viral infections. previous studies have shown that expression of certain interferon-stimulated genes is upregulated in chronic hcv infection, leading to impaired hepatocyte responses. in this study, we show that multiple inflammatory stimuli can modulate interferon stimulated gene expression and thus inhibit hepatocyte interferon signaling via usp induction. these findings represent a new paradigm for how inflammation alters hepatic innate immune responses, with the induction of usp representing a potential target for intervention in various inflammatory states. i nterferon (ifn) is a key endogenous mediator of viral clearance by the innate immune response. one excellent example of this is hepatitis c virus (hcv) infection of the liver ( ) . interferon signaling drives the expression of multiple interferon-stimulated genes (isgs), which mediate viral clearance. isgs, however, can also be induced by other factors, including inflammatory stimuli such as tumor necrosis factor alpha (tnf-␣) ( ) . hcv infection, which induces chronic inflammation of the liver, is associated with high serum tnf-␣ ( , ) . interestingly, anti-tnf-␣ treatment has been shown to lead to an improved virologic response to ifn-␣/ribavirin antiviral therapy for hcv ( ) , while other data show safety of combined treatment but no effect on hcv viral loads of hcv treatment-naive individuals ( ) . the purpose of the present study is to define an important causal link between inflammation and the host hepatic innate immune response, with broad viral relevance. our recent work in the host innate immune response to chronic hcv infection suggested an association between hepatocytes and the liver resident immune cells that drive liver inflam-mation ( ) ( ) ( ) . there is a dichotomous response to chronic hcv infection in the liver, and this response predicts who will and who will not respond to exogenous ifn-␣ treatment. in patients that do not respond to therapy with ifn/ribavirin, hepatocytes have strong preactivation of the ifn-response, with high expression of a subset of isgs ( ) ( ) ( ) . in patients exhibiting a sustained virologic response on therapy with ifn/ribavirin, tissue macrophages show a high expression of isgs ( , ) . the expression of isgs in macrophages or hepatocytes is more predictive of treatment outcome than il b polymorphisms ( ) ; this finding suggests a link between hepatic inflammatory cell activation and viral clearance. liver kupffer cell inflammatory responses are induced by and play a role in the control and clearance of multiple viral infections of the liver ( , ) . although the mechanisms underlying these patterns are undoubtedly complex, the association between liver macrophages and hepatocytes raises the question of how the hepatocytes react to the cytokines produced by the macrophages (and other inflammatory cells). if isg expression in hepatocytes reflects a response to inflammatory stimuli, then how the liver responds to a viral infection will be modulated by the inflammatory milieu. in hcv infection, we have found that the isg /usp pathway is an important regulatory pathway. both isg and usp are isgs that are strongly upregulated in the livers of ifn treatment-resistant patients ( ) ( ) ( ) . isg is a ubiquitin-like protein that is strongly upregulated by ifn and conjugates to multiple cellular proteins ( , ) . usp is an isg -specific protease that is also upregulated by ifn-␣ ( , ) . both isg and usp have been suggested to blunt type ifn signaling ( , ( ) ( ) ( ) . in addition to its ability to remove isg from its conjugated proteins, usp has been shown to bind to the type ifn receptor and blunt ifn signaling ( ) . upregulation of usp may represent a negative-feedback loop counteracting the effects of type ifn. furthermore, knockdown of usp increases both isg induction and anti-hcv activity of ifn-␣ ( ) , and data have shown that ifn-␣ treatment given to mice in vivo increases hepatic usp and blunts the effect of a subsequent dose of ifn-␣ ( ) . the mechanisms controlling usp expression in the liver are poorly understood but will have relevance to understanding innate immune mechanisms in chronic viral infection. although the majority of work on usp has centered on its upregulation by type ifn, interferon stimulated genes have multiple upregulatory stimuli other than ifn-␣ ( , ) . for example, inflammatory stimuli, e.g., endotoxin and lipopolysaccharide (lps), have been shown to upregulate usp in peritoneal exudate macrophages ( ) . if similar stimuli lead to increased usp expression in hepatocytes, then this pathway could represent a novel link between inflammatory and innate immune responses in the liver. the present study is based on the hypothesis that liver inflammation will directly impact hepatocyte expression of usp and therefore will impact ifn signaling. this link will have relevance to multiple diseases, since inflammatory stimuli such as tnf-␣ and lps have been shown to play roles in many liver diseases, including viral hepatitis ( ) ( ) ( ) . the link may also help to explain our observations in chronic hcv infection, since chronic hcv infection is characterized by increased serum tnf-␣ ( , ), increased hepatocyte usp , and impaired ifn responsiveness ( ) . quite apart from hcv, the importance of the link between hepatic inflammation and innate immune response lies in the downstream effects of the impairment of innate immunity. we speculate that by blocking ifn-␣ signaling, usp expression may lead to an enhanced susceptibility to infection with interferon-sensitive viruses and enhanced viral proliferation. support for this notion is found in a mouse study in which expression of usp in macrophages led to lower ifn responsiveness, leading to locally restricted replication of vsv ( ) . in the present study, treatment of hepatic cells with lps and tnf-␣, but not il- or il- , led to upregulated usp expression in hepatocytes. the enhanced usp expression was associated with decreased ifn-␣-stimulated expression of p-stat and isgs, a phenomenon reversed by usp knockdown. as an in vivo correlate of our in vitro findings, experimentally induced hepatic ischemia/reperfusion injury induced usp mrna expression in liver and enhanced lymphocytic choriomeningitis (lcmv) replication, an effect not seen in usp Ϫ/Ϫ mice. these data demonstrate that certain inflammatory stimuli (tnf-␣ and lps), as well as ischemic injury, but not other cytokines (il- and il- ) can lead to enhanced hepatocyte usp expression and thereby inhibit ifn signaling. these findings lend new knowledge to our understanding of how inflammation can modulate hepatic innate immune responses, with usp representing a potential target for intervention to reverse any proviral effect of inflammation. phorylated-stat (p-stat- ; cell signaling technology, boston, ma), rabbit polyclonal anti-stat- (santa cruz biotechnology), goat polyclonal anti-ube antibody (santa cruz biotechnology), or mouse monoclonal anti-actin (sigma) antibodies, followed by anti-mouse or anti-rabbit igg conjugated to horseradish peroxidase (calbiochem, billerica, ma). an enhanced chemiluminescence detection kit (amersham pharmacia biotech, uppsala, sweden) was used to determine the levels of protein expression. flow cytometric quantification of usp expression in huh . cells. usp expression on huh . cells treated with lps or tnf was quantified by using flow cytometry as previously described ( ) . briefly, cells were fixed, permeabilized, and stained with mouse anti-human usp polyclonal antibody (abnova) or a relevant isotype-matched control antibody. staining was detected with a secondary goat anti-mouse igg labeled with fluorescein isothiocyanate (fitc; santa cruz biotechnology). the cells were acquired using a facscalibur cytometer (bd biosciences, san jose, ca). a minimum of , events were collected. the resulting data were analyzed using flowjo software (tree star, inc.). the experiments were repeated four times. sirna targeting murine usp and ube l. usp small interfering rna (sirna) is a pool of three target-specific -to -nucleotide (nt) sirnas designed to knock down usp gene expression that was obtained from santa cruz biotechnology. the ube l sirna used was a pool of three to five target-specific -to -nt sirnas designed to knockdown mouse ube l gene expression and was obtained from santa cruz. usp and ube l sirna was transfected into ϫ primary murine hepatocytes according to the manufacturer's instructions using the santa cruz sirna reagent system sc- (santa cruz) and as previously described ( ) . inhibition of inflammatory signaling in primary mouse hepatocytes. to inhibit lps-or tnf-␣-stimulated nf-b activation, primary mouse hepatocytes were incubated with the following inhibitors for min prior to h of stimulation with lps or tnf-␣: p , a protein kinase a inhibitor ( ); nsc , a jak inhibitor ( ); p , a protein kinase c inhibitor ( ); pd , a mitogen-activated protein kinase kinase inhibitor ( ); silibinin, an inhibitor of ikk␣ ( ) ; and wortmannin, a phosphatidylinositide -kinase inhibitor ( ) . the concentrations, sources, and main targets of these inhibitors are described in table . after lps or tnf-␣ stimulation, hepatocytes were harvested and usp and il- ␤ (a surrogate of nf-b activation) mrna expression was evaluated as described below. rna isolation and quantitative real-time pcr analysis. huh . cells and primary murine hepatocytes were treated with ifn-␣ ( u/ml), tnf-␣ ( ng/ml), lps ( ng/ml), il- ( ng/ml), or il- ( ng/ ml) over a -h time course, and usp expression was determined by quantitative pcr (qpcr) as previously described ( , ) . briefly, total rna was prepared from cells using the trizol reagent (invitrogen) according to the manufacturer's instructions. the reverse transcription reactions of the extracted rna were performed with a first-strand cdna synthesis kit (amersham pharmacia biotech) according to the manufacturer's directions. first, g of extracted rna was added in a total volume of l of combined cdna reaction reagents with random hexamer oligonucleotides as the first-strand primer in a . -ml reaction tube. samples were heated to °c for min, chilled on ice for min, and incubated at °c for h, followed by a -min incubation at °c. the specific primers for all of the detected genes for the pcrs were based on genbank-published sequences: mus musculus ubiquitin-specific peptidase (usp ; nm_ ) forward primer ( =-tacagcagagagcagcagga) and reverse primer ( =-cacatgtcggagcttgctaa); mus musculus myxovirus (influenza virus) resistance (mx ; nr_ ) forward primer ( =-tctgaggagagccagacaat- =) and reverse primer ( =-actctggtccccaatgacag); mouse hypoxanthine guanine phosphoribosyltransferase (hprt; nm_ ) forward primer ( =-tcagt caacgggggacataaa) and reverse primer ( =-ggggctgtac tgcttaaccag); mus musculus il- ␤ (nm_ ) forward primer ( =-gaaatgccaccttttgacagtg) and reverse primer ( =-tgg atgctctcatcaggacag); homo sapiens ifn-␣ b (ifna b; ay ) forward primer ( =-gcttgggatgagaccctccta) and reverse primer ( =-cccaccccctgtatcacac); homo sapiens ifn-␥ (ifng; nm_ ) forward primer ( =-tcggtaactgacttgaatg tcca) and reverse primer ( =-tcgcttccctgttttagctgc); homo sapiens actin, beta-like (actbl ; nm_ ) forward primer ( =-gtctgccttggtagtggataatg) and reverse primer ( =-tcgagg acgccctatcatgg); homo sapiens ubiquitin specific peptidase (usp ; nm_ ) forward primer ( =-aggagaagcgtccctt tcca) and reverse primer ( =-tggtccttaatcaggttccagag); and homo sapiens myxovirus (influenza virus) resistance- (mx ; nm_ ) forward primer ( =-ggtggtccccagtaatgtgg) and reverse primer ( =-cgtcaagattccgatggtcct). quantitative real-time pcr was performed on an abi prism ht machine (applied biosystems, foster city, ca) with sybr green realtime pcr master mix (applied biosystems) according to the directions provided by the manufacturer. all of the rna samples and controls were assayed in duplicate. real-time pcr conditions were as follows: min at °c, followed by cycles of s at °c and s at °c monitor fluorescence in sybr channel during a °c annealing/extension step. the results were analyzed by using applied biosystems sds . software (applied biosystems). experimental hepatic ischemia/reperfusion injury model. hepatic ischemia/reperfusion injury (hiri) was simulated as before ( ) . partial ( %) hepatic ischemia was induced for min in mice, after which the surgical clamps were removed. control (sham) animals underwent anesthesia and laparotomy alone. animals were euthanized or h after ischemia/reperfusion, the affected liver segments were removed, and target gene expression was determined by qpcr in whole liver tissue. lcmv strain we was propagated in l cells (atcc ccl- ) as previously described ( ) . in additional experiments, after min hiri or sham laparotomy, mice were infected with ϫ pfu of lcmv we by intravenous tail vein injection. the ischemic liver lobes were harvested at day postinfection. snap-frozen liver tissue samples were homogenized in ␣-mem (multicell, usa) supplemented with % fbs, l-glutamine, and u of penicillin/ml plus g of streptomycin/ml using the tissuelyser lt system (qiagen, netherlands). viral titers were examined on mc cells (atcc crl- ) using a focus-forming assay as previously described ( ) . statistical analysis. all data were analyzed using prism version . software (graphpad software, san diego, ca). statistically significant differences in fig. e were calculated by using a two-tailed student t test (prism software). the impact of hiri on lcmv replication (see fig. a and b) was evaluated by one-way analysis of variance with the tukey's post hoc test. usp is induced in hepatocytes by lps and tnf-␣ but not by il- and il- . we have previously shown that usp can modulate the type ifn response ( ) . we sought to determine whether inflammatory stimuli could increase usp expression in hepatocytes. liver tissue inflammation is mediated by both proand anti-inflammatory stimuli, acting through diverse pathways. we therefore compared the effects of three proinflammatory stimuli (tnf-␣, lps, and il- ) and one anti-inflammatory stimulus (il- ), all four signaling through independent receptors and signaling cascades ( , ) . in a -h time course experiment, usp mrna expression was measured after stimulation with lps ( ng/ml), tnf-␣ ( ng/ml), il- ( ng/ml), or il- ( ng/ml). usp mrna expression was induced by tnf-␣ and lps but not by il- or il- ( fig. a) . meanwhile, neither tnf-␣ nor lps treatments had a marked effect on mx mrna expression (fig. b) , indicating that the effects we observe are not due to a generalized upregulation of isgs or to type ifn signaling. tnf-␣ and lps treatment also led to augmented usp protein expression by western blotting (fig. c ) and by intracellular staining (fig. d to f). treatment of huh . cells with tnf-␣ or lps induced expression of usp in . % Ϯ . % and . % Ϯ . %, respectively, compared to untreated controls in which usp expression was . % Ϯ . % (fig. fi) . usp induction was also demonstrated with a significant shift in the mean fluorescence intensity of usp staining after tnf-␣ or lps simulations (fig. fii ). in these assays, the degree of protein expression did not correlate completely with mrna expression, a finding that is consistent with many genes in the liver ( ) in that the degree of mrna induction was higher than the observed usp protein expression. however, the functional effects we observed in terms of ifn-␣ responses were robust. tnf-␣ and lps block ifn-␣ signaling in huh . hepatoma cells. to determine whether inflammatory stimuli such as tnf-␣ and lps can interfere with type ifn signaling, we sought to determine whether pretreatment of hepatoma cells with tnf-␣ or lps blocked ifn-␣ signaling. huh . cells were treated with tnf-␣ ( ng/ml) or lps ( ng/ml) for h. the cells were subsequently treated with ifn-␣ for h. we chose h to measure mx expression based on previous descriptions of ifn-stimulated mx induction in the literature ( ) and based on our observations with primary mouse hepatocytes. control cells were left untreated, followed by a -h ifn-␣ treatment at h. after the -h ifn-␣ treatment, the cells were harvested, and mx expression was measured by qpcr as a measure of ifn-inducible gene expression. as expected, a -h exposure to ifn-␣ strongly induced mx expression, whereas a -h exposure to tnf-␣ and lps did not (fig. , columns , , and ). both tnf-␣ and lps pretreatment inhibited the effect of h of exposure to ifn-␣ (fig. , columns , , and ), indicating that ifn-␣ signaling was impaired in the presence of these inflammatory stimuli. having shown that certain inflammatory stimuli both increase hepatocyte usp and blunt ifn-␣ signaling, we next sought to determine whether the blunting of ifn-␣ signaling is mediated via increased usp . we addressed this question by selective knockdown of usp mrna. thus, huh . cells transfected with usp sirna or control sirna were treated with lps ( ng/ml), tnf-␣ ( ng/ml), and/or ifn-␣ ( iu/ml) for h or pretreated with lps ( ng/ml) or tnf-␣ ( ng/ml) for h and then either left untreated or treated with ifn-␣ ( iu/ml) for h (a -h time point was selected for optimal expression of pstat in huh . cells). the expression of pstat , stat , and isg conjugates (as a marker of usp knockdown), usp , and actin was detected by western blotting. as seen in fig. a , usp expression was largely knocked down in cells transfected with usp sirna. ifn-␣-induced phosphorylation of stat- was inhibited by pretreatment (for h) with tnf-␣ or lps (fig. a , sirna control lanes f and h versus lane d), but this effect is reversed by knockdown of usp (fig. a , sirna usp , lanes f and h versus lane d). of note, usp knockdown did not increase pstat in response to ifn-␣ before h; these findings are consistent with previous observations ( ) . we next wanted to confirm whether our findings from hepatoma cells would hold true in primary mouse hepatocytes. with this in mind, primary murine hepatocytes from usp ϩ/ϩ mice were isolated, transfected with usp sirna or control sirna, and then exposed to ifn-␣ ( iu/ml), lps ( ng/ml), or tnf-␣ ( ng/ml) for h. after a washing step, the cells were treated with ifn-␣ for an additional h. mx isg mrna expression was measured by qpcr (normalized to expression of the hprt housekeeping gene) as an index of downstream ifn-␣ effect. ifn-␣, lps, and tnf-␣ treatment blocked the effect of the final dose of ifn-␣ (fig. b, columns , , , and ) . however, knockdown of usp reversed this effect and augmented the effect of ifn-␣ (fig. b, columns , , , and ) . the data from this experiment are consistent with those obtained with human huh . cells (data not shown). thus, the ability of tnf-␣ and lps to block ifn signaling is seen in both primary and immortalized hepatocytes. as noted earlier, usp has dual roles: it both strips isg from its target proteins and impairs type ifn signaling independent of its protease activity ( ) . to determine whether the usp -dependent blunting of hepatocyte ifn signaling was due to its ability to strip isg from its conjugates, we blocked the process of isgylation by knockdown of the isg e enzyme, ube l. murine hepatocyte ube l was knocked down via transfection with sirna specific for ube l. usp ϩ/ϩ murine hepatocytes transfected with ube l sirna or control sirna were stimulated with ifn-␣ ( iu/ml), lps ( ng/ml), or tnf-␣ ( ng/ml) for h and then treated with an additional dose of ifn-␣ for h. knockdown was measured in the hepatocytes transfected with ube l sirna by western blotting probing for ube l expression and isg conjugate formation (fig. a) . next, to examine the effect of this knockdown on isg induction, wild-type murine hepatocytes transfected with ube l sirna or control sirna were stimulated with tnf-␣ ( ng/ml) and lps ( ng/ml) for h and then restimulated with ifn-␣ ( iu/ ml) for h, at which time mx isg mrna expression was measured by qpcr. as seen in fig. a , ube l knockdown was achieved, resulting in a decrease in isg conjugates. however, as seen in fig. b , we observed that neither the presence nor the relative absence of isg conjugation impacted the ability of tnf-␣ and lps to block ifn-␣ signaling since there was no change in isg expression after h of ifn-␣ treatment when usp ϩ/ϩ hepatocytes transfected with anti-ube l sirna were compared to hepatocytes transfected with irrelevant sirna (fig. b , sirna control, columns , , and , and ube l sirna, columns , , and ). these results are consistent with there being no role for isgylation (and, thus, for the ability of usp to strip isg from its protein conjugates) in the ability of tnf-␣ and lps to block type ifn signaling in hepatocytes, and this finding is in agreement with previous data showing that usp blocks ifn signaling independent of its enzymatic activity ( ) . we next sought to determine whether tnf-␣ and lps could induce usp expression in hepatocytes via the induction of ifn-␣. as observed in fig. a , stat phosphorylation shows distinct activation profiles with ifn-␣ stimulation compared to tnf-␣ or lps stimulation (fig. a , sirna control and sirna usp , lanes b and c compared to lane d). although these data strongly suggest that the effect of lps and tnf-␣ stimulation are a result of direct induction of isgs and not secondary to the induction of ifn-␣, we wanted to confirm whether lps and tnf-␣ could induce type or type ifn (ifn-␣ or ifn-␥) in primary murine hepatocyte. thus, primary murine hepatocytes were treated with ifn-␣ ( u/ml), lps ( ng/ml), or tnf-␣ ( ng/ml) for , , , or h; they were then lysed and assessed for ifn-␣, ifn-␥, and usp expression by qpcr. we observed that neither ifn-␣, lps, nor tnf-␣ induce much, if any, hepatocyte expression of ifn-␣ or ifn-␥, although the same doses induce strong expression of usp (fig. ) . thus, the induction of isgs by lps and tnf-␣ is very unlikely to reflect the induction of hepatocyte type or type ifn, which suggests that the observed usp induction is not due to type or type ifn secretion and autocrine stimulation of the ifn-␣ receptor. experimental hepatic ischemia/reperfusion induces usp expression and enhances lcmv replication. we then assessed whether tissue-wide hepatic inflammatory stress increases liver usp expression, as an in vivo confirmation of our in vitro findings. this was approached by inducing partial ( %) hepatic ischemia/reperfusion injury (hiri) for min in mice, euthanizing the animals at or h (time points relevant to our in vitro time course) and measuring induction of usp by qpcr. we chose hiri as a very well-characterized inflammatory stress, known to be driven both by tnf-␣ and lps ( ) . as seen in fig. a , hiri alone induced usp mrna expression in whole livers by Ͼ fold that of untreated animals. thus, in vivo liver inflammation leads to increased usp expression at the organ level. after determining that hiri induces usp expression, we next wanted to examine the impact of hiri on viral control. thus, we induced % hiri for min prior to lcmv we infection of usp ϩ/ϩ and usp Ϫ/Ϫ mice. as seen in fig. b , hiri led to a significant increase in lcmv viral titers in usp ϩ/ϩ mice, an effect that was not observed in usp Ϫ/Ϫ mice. having shown that lps/ tnf-␣ stimulation increases hepatocyte usp expression, we then sought to determine whether we could pharmacologically inhibit the induction of usp by lps and tnf-␣. we focused on small-molecule agents that have been linked to the nf-b signaling pathway, because of the central role of this pathway in inflammatory activation in response to a large number of inflammatory mediators, including lps and tnf-␣ ( ) . we were particularly interested in inhibitors, such as silibinin, that in addition have been linked to clinical suppression of hepatic viral production (in the case of silibinin and hcv) ( , ) . thus, we preincubated primary mouse hepatocytes for min with various inhibitors of lps and tnf-␣ signaling and measured their impact on usp induction, while simultaneously measuring expression of proinflammatory cytokine il- ␤ mrna, since nf-b is also known to promote il- ␤ transcription ( , ) . as seen in fig. a and as table , tnf-␣ induced expression of usp was potently downregulated by all inhibitors tested, and this inhibition coincided with impaired il- ␤ mrna expression (fig. b) . meanwhile, only two inhibitors potently (Ͼ %) inhibited usp expression as well as il- ␤ mrna expression in response to lps stimulation; nsc (an inhibitor of jak ) and silibinin (an inhibitor of ikk␣) (fig. a and b and table ). these data suggest that the induction of usp by tnf-␣ and lps, and pos-sibly other inflammatory stimuli, is promoted by nf-〉 signaling and that hepatocyte usp expression in particular-compared to il- ␤-may be an attractive target for pharmacologic manipulation in the setting of liver inflammation. in this study we examined the role of various inflammatory stimuli in the induction of usp and the downstream establishment inflammatory stimuli, we examined the induction of stat- phosphorylation in huh . cells with or without usp knockdown (a) and the expression of isg mrna (mx ) in primary mouse hepatocytes and the ability of usp knockdown to restore isg induction after lps and tnf-␣ stimulation (b). (a) huh . cells were transfected with anti-usp sirna or control irrelevant sirna. huh . cells were then pretreated with lps ( ng/ml), tnf-␣ ( ng/ml), or ifn-␣ ( u/ml) or left untreated for h and then exposed to ifn-␣ or left untreated for an additional h. as controls, huh . cells were treated with lps, tnf-␣, and ifn-␣ for h only. the expression of usp , pstat , stat , and isg conjugates and actin proteins was measured by western blotting. (b) primary murine hepatocytes from usp ϩ/ϩ mice were isolated, transfected with anti-usp sirna or control irrelevant sirna, and pretreated with ifn-␣ ( iu/ml), lps ( ng/ml), or tnf-␣ ( ng/ml) for h (ifn-␣ pre, lps pre, or tnf-␣ pre, respectively). after being washed, the cells were cultured in the presence or absence of ifn-␣ for h (ifn-␣ final). mx isg mrna expression was measured by qpcr and normalized to the expression of the hprt housekeeping gene. the data were generated from pooled triplicate experiments analyzed in duplicate. error bars represent the sem for duplicate pcrs. of an ifn-␣ refractory state. we used multiple methods to show that certain inflammatory stimuli, including lps and tnf-␣ are able to induce the expression of usp , which results in downstream downregulation of ifn-␣-induced isg expression. the role of usp in the ifn-␣ refractory state has been previously demonstrated by human and mouse usp knockdown studies ( , ( ) ( ) ( ) . other inflammatory stimuli, including il- and il- , did not induce usp or impair expression of isgs, including usp . in vivo, hepatic inflammatory stress (ischemia/reperfusion injury) led to increased hepatic usp gene expression that was associated with poor control of lcmv infection. thus, the hepatic inflammatory milieu, contributed to by individual inflammatory cytokines and stimuli, modulates usp expression. these results demonstrate one mechanism by which liver inflammation directly impacts the hepatocellular innate immune response. usp is known to be induced by multiple inflammatory stimuli in macrophages ( ) and lymphocytes ( ) . our findings in hepatocytes are consistent with work done by other groups in immune cells. for example, lps treatment of a murine macro- phage cell line upregulates usp in an irf -dependent manner ( ) . the cytokine specificity of our results is also consistent with finding that il- alone is not able to induce usp in murine t cells ( ) . only when t cells were treated with il- and another proinflammatory cytokine, such as transforming growth factor ␤, il- ␤, and il- , was usp expression induced ( ) . these data point out that usp can be induced by inflammatory stimuli in multiple cell types in the absence of ifn. usp is therefore well positioned to act as the mediator of "cross talk" between innate immunity and inflammatory responses. in the present study, we show that increased usp expression following exposure of hepatocytes by inflammatory stimuli blunts the ifn response. the binding of usp with the ifn-␣ receptor has been shown to inhibit the interaction of stat- with the ifn-␣ receptor and thus block downstream ifn signaling ( , ) . our data are consistent with this mechanism, since the blunting of hepatocyte ifn signaling after exposure to inflammatory stimuli is independent of usp -mediated removal of isg from its target proteins. the degree of tnf-␣ and lps-induced ifn-␣ refractoriness was not changed by ube l knockdown, although isgylation was considerably reduced. however, other mechanisms may also be at play. recent work has demonstrated that usp has the ability to deubiquitinate the transforming growth factor-activated kinase (tak ) complexes required for nf-b activation in t cells and that overexpression of usp leads to decreased nuclear activation and impaired formation of tak complexes ( ) . usp -mediated nf-b inhibition may be of importance not only for t cell adaptive immunity but also for liver inflammation. the role of tak in innate and adaptive immunity has been previously demonstrated ( ) , and studies have also shown that tak deletion interferes with hepatocyte homeostasis and leads to hepatic injury ( ) . thus, increased hepatocyte usp in response to inflammatory stimuli may constitute a negative-feedback cycle with relevance to multiple aspects of the liver's response to infection. our in vivo experiments demonstrated that inflammation resulting from ischemia/reperfusion injury induces usp expression, which coincides with diminished lcmv control in mouse livers. the general finding that liver inflammation promotes lcmv production is in agreement with work showing that polymicrobial sepsis, characterized by high tnf-␣ and inflammation, leads to increased susceptibility to lcmv infection ( ) . in our present study, hepatic ischemia/reperfusion injury did not enhance lcmv production in usp knockout mice. these data are intended as proof-of-concept but do suggest that the role of usp in hepatic viral infection and inflammation deserves further investigation. our in vitro and in vivo findings suggest a new model for how inflammation alters hepatic innate immune responses. in this model, liver inflammation leads to increased hepatocyte usp , which in turn makes the liver more susceptible to infections targeting the hepatocyte, such as hcv. this mechanism may help to explain the clinical observation that hcv infection of a transplanted, hcv-naive liver graft (that has gone through an ischemia/reperfusion cycle) is more aggressive than the original infection and that the severity of the reinfection correlates with the severity of the ischemia/reperfusion injury suffered during the transplant ( , ) . however, we have also found that usp is necessary but not sufficient on its own to induce an ifn-␣ refractory state ( ) . with this in mind, we hypothesize that the innate immune response and its ability to control ifn-sensitive viruses will depend on cumulative effect of multiple intrahepatic signals, including the induction of usp . if these results are to be translated into a clinical setting, then one approach is to target usp induction pharmacologically. using multiple inhibitors of tnf-␣/lps signaling, we found that two inhibitors, silibinin (an inhibitor of ikk␣) and nsc (a jak inhibitor) possess the ability to inhibit tnf-␣ and lps-induced usp expression and proinflammatory effects. these findings raise the possibility of pharmacologically targeting usp expression during inflammatory events to prevent the establishment of an ifn-␣ refractory state. previously, inhibition of jak signaling led to a protection of mouse livers from ischemic insult ( ) . as well, silibinin has been shown to reduce of hcv liver graft reinfection ( ) and enhance hcv clearance in ifn-␣ nonresponders ( ) via multiple mechanisms, including by direct inhibition of hcv ns b rna polymerase ( ) . usp modulation may be one mechanism by which silibinin exerts its anti-hcv effects. the present study focuses on a relatively small number of inflammatory stimuli; while tnf-␣ and lps are important to a large number of liver diseases, they are far from being the only drivers of the hepatic inflammatory response and tissue levels of usp are likely influenced by other stimuli as well. for example, we previously demonstrated that increased usp expression in the liver is and enhances lcmv replication. to examine the in vivo effect of an inflammatory stimulus on usp expression and viral replication, a hepatic ischemia/reperfusion model was used. (a) partial ( %) hepatic ischemia was induced for min, after which the portal vascular clamp was removed. control animals (sham) underwent anesthesia and a laparotomy alone. animals were euthanized and h after ischemia/reperfusion (i/r), and the affected liver segments were removed. usp mrna expression was determined by qpcr in whole liver tissue and normalized to hypoxanthine-guanine phosphoribosyltransferase (hprt) expression. data are expressed as means Ϯ the sem with n ϭ to mice/group. a p value of Ͻ . was considered significant. (b) after min of hiri or sham laparotomy, mice were infected with ϫ pfu of lcmv we. liver lobes were harvested at day postinfection. viral titers were examined on mc cells using a focus-forming assay. data are expressed as means Ϯ the sem with n ϭ to mice/group. a p value of Ͻ . was considered significant. inhibition of nf-b activation impairs lps-and tnf-␣-stimulated usp induction. to investigate the link between lps/tnf-␣ stimulation and usp induction, inhibitors of nf-b activation were added to primary mouse hepatocytes for min prior to stimulation with ng of tnf-␣/ml or ng of lps/ml for h (the inhibitor names, targets, and concentrations used are given in table ). inhibitor-treated cells were also left unstimulated as a control. as a control for usp induction, hepatocytes were stimulated with u of ifn-␣/ml for h. usp (a) and il- ␤ (b) mrna expression levels were evaluated by pcr and normalized to the hprt housekeeping gene expression prior to determining the fold increase versus mock-treated samples. the data were generated from pooled triplicate experiments analyzed in duplicate. error bars represent the sem for duplicate pcrs. predictive of patients with chronic hcv infection who will not respond to ifn-based anti-hcv therapy ( ) . although we found that tnf-␣ hepatic mrna expression was increased in treatment nonresponders, it was relatively more increased in treatment responders ( ) . we suspect that whereas increased tnf-␣ does contribute to usp expression, there are other stimuli, for example, lps and perhaps the recently described interferon-lambda ( ) , that also modulate hepatic usp expression. we propose that the ultimate usp expression is due to the liver's coordinate response to multiple stimuli. the finding that hepatic usp expression is modulated by inflammatory stimuli is a new paradigm for the interaction of the liver inflammatory microenvironment and viral infection. taken together, these data may suggest that usp represents a good target for intervention in numerous inflammatory states and in the clinical setting of hcv-related liver transplantation. hiri-induced upregulation of usp could lead to worsened outcomes posttransplant, including a quicker, more aggressive reinfection of the new organ with higher hcv rna titers. we suggest that the finding that ifn responses and usp expression are tightly linked to the hepatic inflammatory response helps to explain the finding that tnf-␣ antibody treatment improves treatment outcomes of chronic hcv with treatment combinations, including ifn-␣ ( ). mechanism of action of interferon and ribavirin in treatment of hepatitis c interferon, mx, and viral countermeasures hepatitis c virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis c etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis c virus infection: a phase randomized, double-blind, placebocontrolled study safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis c virus infection hepatic celltype specific gene expression better predicts hcv treatment outcome than il b genotype hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis c viral infection cell-type-specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis c infection tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-idependent manner in mice the role of kupffer cells in hepatitis b and hepatitis c virus infections alpha interferon induces long-lasting refractoriness of jak-stat signaling in the mouse liver through induction of usp /ubp the isg /usp ubiquitin-like pathway (isgylation system) in hepatitis c virus infection and resistance to interferon therapy silencing of usp potentiates the antiviral activity of interferon against hepatitis c virus infection ubp is a novel regulator of interferon signaling independent of its isg isopeptidase activity usp -based negative feedback control is induced by type i and type iii interferons and specifically inactivates interferon alpha response gene induction pathways mediated by distinct irfs during viral infection lipopolysaccharide activates the expression of isg -specific protease ubp via interferon regulatory factor tumor necrosis factor-alpha in liver ischemia/reperfusion injury the role of intestinal endotoxin in liver injury: a long and evolving history viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic hcv infection enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus complete replication of hepatitis c virus in cell culture tnf-alpha-induced sphingosine -phosphate inhibits apoptosis through a phosphatidylinositol -kinase/ akt pathway in human hepatocytes oncostatin m is a potent inducer of hepcidin, the iron regulatory hormone lipopolysaccharide, immune activation, and liver abnormalities in hiv/hepatitis b virus (hbv)-coinfected individuals receiving hbv-active combination antiretroviral therapy protein interferon-stimulated gene conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis hepatitis c virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro protein-kinase inhibitor-( - )-amide peptide analogs with standard and nonstandard amino-acid substitutions for phenylalanine- : inhibition of campdependent protein-kinase bone marrow-derived myofibroblasts promote colon tumorigenesis through the il- /jak /stat pathway nonmuscle myosin is regulated during smooth muscle contraction pd- is a specific inhibitor of the activation of mitogen-activated protein-kinase kinase in-vitro and in-vivo silibinin inhibits constitutive and tnf alpha-induced activation of nf-b and sensitizes human prostate carcinoma du cells to tnf alpha-induced apoptosis wortmannin is a potent phosphatidylinositol -kinase inhibitor: the role of phosphatidylinositol , , -trisphosphate in neutrophil responses protective strategies against ischemic injury of the liver interleukin- determines viral clearance or persistence in vivo quantification of lymphocytic choriomeningitis virus with an immunological focus assay in -well or -well plates dubbing down innate immunity malignant pirates of the immune system a comparison of selected mrna and protein abundances in human liver kinetic differences in the induction of interferon stimulated genes by interferon-alpha and interleukin b are altered by infection with hepatitis c virus nf-b in the liver-linking injury, fibrosis, and hepatocellular carcinoma successful prevention of hepatitis c virus (hcv) liver graft reinfection by silibinin mono-therapy differential in vitro effects of intravenous versus oral formulations of silibinin on the hcv life cycle and inflammation dexamethasone inhibits il- ␤ gene expression in lps-stimulated raw . cells by blocking nf-b/rel and ap- activation nf-b regulates il- ␤ transcription through a consensus nf-b binding site and a nonconsensus cre-like site usp inhibits nf-b and nfat activation during th differentiation by deubiquitinating the tak -tab complex essential function for the kinase tak in innate and adaptive immune responses disruption of tak in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis polymicrobial sepsis increases susceptibility to chronic viral infection and exacerbates cd ϩ t cell exhaustion recipient age affects long-term outcome and hepatitis c recurrence in old donor livers following transplantation prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis c infection after liver transplantation the ubiquitin specific protease usp is necessary but not sufficient for a hepatocyte ifn refractory state: variable roles in type i and type iii ifn responsiveness blockade of janus kinase- signaling ameliorates mouse liver damage due to ischemia and reperfusion silibinin is a potent antiviral agent in patients with chronic hepatitis c not responding to pegylated interferon/ribavirin therapy a variant upstream of ifnl (il b) creating a new interferon gene ifnl is associated with impaired clearance of hepatitis c virus we thank dong er zhang for the gift of the usp Ϫ/Ϫ mice. s.a.m. thanks the casl/cihr hepatology fellowship program and the national cihr research training program in hepatitis c for financial support. key: cord- -t gecuw authors: beloumi, dhekra; blasco, agustín; muelas, raquel; santacreu, maría antonia; garcía, maría de la luz; argente, maría-josé title: inflammatory correlated response in two lines of rabbit selected divergently for litter size environmental variability date: - - journal: animals (basel) doi: . /ani sha: doc_id: cord_uid: t gecuw simple summary: animal welfare is a priority objective for the livestock industry. litter size environmental variability has been related to environmental sensitivity. a divergent selection experiment for environmental variance of litter size variance was carried out successfully in rabbits over thirteen generations. the low line showed a lower inflammatory response and susceptibility to infectious disorders than the high line. in conclusion, the decrease of environmental sensitivity seems to increase the adaptation of the animal to the environment, and thus, its welfare. abstract: a divergent selection experiment for environmental variance of litter size variance was carried out in rabbits over thirteen generations. the aim of this study was to evaluate the inflammatory response in the two lines of the experiment, in order to analyse the effect of selection on susceptibility to diseases after challenging to stressful situations, such as h after the first delivery. a total of females were used in this study, from each line. the line selected for litter size heterogeneity (the high line) showed lower white blood leukocyte count (wbc; − . × ( )/µl), lower percentage of basophils (− . %), higher concentration of tnf-α (+ . pg/ml), and greater concentration of crp (+ . µg/ml) than the line selected for litter size homogeneity (the low line). the high line had also higher concentrations of bilirubin, cholesterol, gamma-glutamyl transferase (ggt) and alkaline phosphatase (alp) compared to the low line (difference between lines were + . µmol/l, + . µmol/l, + . u/l and + . u/l, respectively). the high line showed higher inflammatory response than the low line, in accordance with a larger susceptibility to infectious disorders. in conclusion, the line selected to increase litter size environmental variability seems to have poor capacity coping with environmental stressors. therefore, selection for litter size environmental variability can be a useful way to improve animal welfare. in the last few decades, animal welfare has become a priority objective for farmers and the livestock industry [ ] . animal welfare is defined as the capacity of animals to cope with their environment [ ] . susceptibility to stress and diseases are closely related to this adaptation [ ] , playing an important role for the immune system in this process [ ] . inflammation is the immune system's response that is triggered in response to microbial invasion or tissue damage in order to maintain the body's homeostasis [ ] . inflammation is a complex process which involves a high number of molecules [ ] . the cytokines interleukin- (il- ) and tumour necrosis factor alpha (tnf-α), together with the acute-phase protein c-reactive protein (crp), are mainly used as inflammatory biomarkers. levels of these biomarkers help to detect the presence of inflammation and severity of disease [ ] [ ] [ ] [ ] . the liver has an important role in the synthesis of acute-phase proteins, such as crp, in response to cytokines such as il- , tnf-α and il- β [ ] . moreover, liver metabolism has been related to the inflammatory process [ ] . in prolific species such as pigs, rabbits and mice, environmental variability in body weight and in litter size has been related to immune response and resistance to diseases (see review by lung [ ] ). a divergent selection experiment for environmental variance of litter size at birth was performed in rabbits. after ten generations of selection, the lines showed a remarkable divergent response ( . kits in the low line vs. . kits in the high one) [ ] . in a previous study, argente [ ] found lower basal levels of cortisol and crp in females selected for litter size homogeneity (the low line) than those selected for litter size heterogeneity (the high line). after, vaccination against viral haemorrhagic disease and myxomatosis, the low line showed a better immune response than the high one [ ] . this would indicate better ability to cope with environmental stressors, such as infections, in the homogenous line. the objective of this study was to evaluate the inflammatory response in the two lines of the divergent selection experiment for litter size environmental variance, in order to analyse the effect of selection on susceptibility to diseases after stressful situations, such as h after the first delivery. for this purpose, additional inflammatory and biochemical markers to the ones studied by argente [ ] were measured in the thirteenth generation of the experiment. all experimental procedures were approved by the miguel hernández university of elche research ethics committee, according to council directives / /ec and / /eu (reference number /vsc/pea/ ). a divergent selection experiment on environmental variability of litter size was carried out over thirteen generations. selection was based on the phenotypic variance of litter size of each doe, after correcting litter size for both year-season and parity-lactation status (first parity, and lactating or not at mating in other parities) [ ] . a total of seventy-eight primiparous female rabbits from the thirteenth generation, from the line selected for litter size heterogeneity (the high line) and from the line selected for litter size homogeneity (the low line), were used in this experiment. all the animals were reared in the farm of the miguel hernández university of elche (spain). the rabbits were fed a standard commercial diet ( % crude protein, % fibre, . % fat, nutricun elite gra ® , de heus nutrición animal, la coruña, spain). food and water were provided ad libitum. does were housed in individual cages ( . cm × cm × cm) under a constant photoperiod of h continuous light: h continuous darkness, and with controlled ventilation. the experiment took place from march to july. table shows the distributions of does and their liveweight per month. the temperature ranged from . • c to . • c. reproduction was organized in discrete generations. all does were mated at the same age, i.e., at weeks of age. following the blood-sampling procedure described in [ ] , two blood samples of ml were drawn from the central artery of each doe's ear h after the first delivery at twenty-two weeks of age. delivery is a stressful event to does which may have an influence on haematological and biochemical parameters. the first blood sample was collected into a tube with tripotassium ethylenediaminetetraacetic acid (k -edta). this sample was divided into two aliquots. one aliquot was used for haematology, and the other one was centrifuged (at rpm for min) in order to determine concentrations of c-reactive protein (crp), interleukin (il- ), tumour necrosis factor alpha (tnf-α), and cortisol. the plasma samples obtained by centrifugation were stored at − • c until further analysis. the second blood sample was collected into a lithium heparin tube. after centrifugation, the concentrations of bilirubin, cholesterol, alkaline phosphatase (alp), gamma glutamyl transpeptidase (ggt), albumin (alb), bile acid (ba), and blood urea nitrogen (bun) were assessed. haematological parameters such as white blood leukocyte count (wbc) and the percentage of lymphocytes, neutrophils, monocytes, basophils and eosinophils were done by the haematology analyser abacus junior vet (diatron, austria). c-reactive protein (crp) concentration was quantified using a commercially available elisa kit for rabbits (catalogue number - ; life diagnostics inc., west chester, pa, usa). interleukine (il- ) concentration was analysed using a commercially available elisa kit for rabbits (catalogue number csb e rb; cusabio, houston, tx, usa). the concentration of tumour necrosis factor alpha (tnf-α) was quantified using a commercially available elisa kit for rabbits (catalogue number el rb ; elabscience, houston, tx, usa). cortisol plasma concentration was performed using an available elisa kit for rabbits (catalogue number csb e rb; cusabio, houston, tx, usa). plasma concentrations of bilirubin, cholesterol, alkaline phosphatase, gamma glutamyl transferase, albumin, bile acid, and blood urea nitrogen were evaluated using the vetscan ® mammalian liver profile rotor from abaxis company. data were analysed using the following model: where ms i is the month of blood sampling effect with five levels, l is the line effect with two levels (high and low line), b is the regression coefficient, x ijk is the covariate weight and e ijk is the residual term. residuals were assumed to be independently normally distributed with the same variance. a bayesian analysis was used, with bounded flat priors for all unknown parameters. marginal posterior distributions were estimated for all unknowns using gibbs sampling. marginal posterior distributions of the differences between lines were computed with the program rabbit, developed by the institute for animal science and technology (valencia, spain). monte carlo markov chains of , iterations, with a burn-in period of , , and only one out of every samples was saved for inferences. convergence was tested using the z criterion of geweke, and monte carlo sampling errors were computed using time-series procedures. bayesian statistic gives a new approach to the description of the uncertainly against classical statistics. for example, we can provide the difference between lines (d h-l ) and the precision of our estimation, finding the shortest interval with % probability of containing the true value, that can be asymmetric around the estimation (this is called the highest posterior density interval at % probability). notice that in the bayesian context, there is nothing like 'significance' [ ] , but we can calculate the actual probability of the difference between the high and low line |d h-l | being higher than zero; this is much more informative than p-values and significance (see blasco [ ] for details). we consider that there is enough evidence for the high and the low lines being different when the probability of this difference in absolute value |d h-l | is more than %. however, this is not a significance test, but a way to help the discussion, since we have all actual probabilities of the differences between lines and the reader can consider other probability as being relevant enough to differentiate both lines. table shows the features of the estimated marginal posterior distributions of the differences between lines (d h-l ) for the haematological parameters. the high line had lower white blood leukocyte count (wbc; − . × /µl, p = . ) and lower percentage of basophils than the low line (− . %, p = . ). we did not observe differences between lines for the percentages of lymphocytes, neutrophils, monocytes, and eosinophils. according to table , the high line showed higher concentration of tnf-α (+ . pg/ml, p = . ) and greater concentrations of crp in comparison with the low line (+ . µg/ml, p = . ). concentrations of interleukin (il- ) and cortisol were similar in both lines (p = . and p = . , respectively). features of the marginal posterior distributions of the differences between the high and the low lines for biochemical parameters are given in table . the concentrations of bilirubin and ggt were higher in the high line than the low line (p = . and p = . , respectively). cholesterol and alp levels were also higher in the high line than in the low one (+ . µmol/l and + . u/l, p > . ). there is some evidence of differences between lines in ba (p = . ). no differences between the high and low lines were found for alb and bun (p = . and p = . ). haematological parameters provide valuable information on the health status of the animal. in the present study, we evaluated the haematological profile in the two lines at h after the first delivery. we found that there was no difference between lines, except for wbc and the percentage of basophils. the wbc values obtained were within the normal range for rabbits ( . − . × /l), reported by [ ] . total leucocyte counts are involved in the immunity reaction and defence of the organism [ , ] . susceptible rabbits to acute infections may have a decrease in wbc count [ , ] . on the other hand, basophils are essential for linking innate and adaptive immunity [ ] . therefore, a higher basal concentration of wbc and basophils in the low line would be related to better disease resistance and good immunity. lymphocytes and neutrophils are important for the immune system. neutrophils provide the first line defence against infection in innate immune response [ ] . lymphocytes are involved in humoral and cell-mediated immunity response [ ] . in a previous study, argente [ ] found a higher basal concentration of neutrophils and lower concentration of lymphocytes in the low line. however, no differences between lines were found in this study. we would like to note that sample collection was carried out at different environmental stress conditions, i.e., at first mating in the previous study and at h after the first delivery in the current study, and that could affect the values of immunological parameters. cortisol concentration was used as a biochemical indicator of stress and pain [ ] . in the present study, the cortisol concentrations in the high and the low lines were higher than the normal range of cortisol concentration ( . - . µg/dl) for rabbits reported by [ ] . this may be due to the moment of recording. indeed, the samples were collected h after parturition. it is known that parturition is considered one of the most stressful and painful events for the dam [ ] . such a stressful event could increase the cortisol concentration up to several hours postpartum [ ] . this finding implies that both lines were under similar level of stress. it is well known that a high level of stress leads to dysregulation of the immune system, [ ] increasing predisposition to disease [ ] . inflammation is a biological response of the immune system that can be triggered by variety of factors, including pathogens and damaged cells [ ] . in order to evaluate the inflammatory process in both divergent lines, i.e., their susceptibility to diseases, we assessed the plasma levels of two cytokines, interleukin- and tumour necrosis factor alpha, and c-reactive protein. interleukin- (il- ) is a pro-inflammatory cytokine partly produced by the combined action of il- β and tnf-α and has an effect on inflammation and the immune response [ ] . tnf-α is a cytokine with pro-inflammatory activities produced by macrophages and have an important role in the innate defence mechanism [ ] . a higher susceptibility to diseases is related to a higher concentration of tfn-α [ ] . both divergent lines were exposed to the same environment. however, the high line showed higher concentration of tnf-α than the low line. a high level of tfn-α agrees with higher inflammatory response in the high line, and therefore a higher susceptibility to diseases in this line. c-reactive protein (crp) is an acute-phase protein and an important etiological factor in inflammation [ ] . its production is mainly hepatic, by hepatocytes as a response to stimulation with il- , tnf-α and il- β (reviewed by stoner et al. [ ] ). thus, crp level in blood is considered an inflammatory biomarker [ ] . female rabbits of the high line showed greater crp concentration. a higher basal crp concentration in this line would confirm a higher sensitivity to disease, to the presence of chronic inflammation, and to a lesser tolerance to usual microorganisms in the farm microenvironment [ , , ] . we note that selection for litter size environmental variability increased the difference in cpr between lines from eighth generation ( . µg/ml [ ] to thirteenth generation ( . µg/ml), in agreement with a correlated response to selection for litter size environmental variability on the animal's susceptibility to diseases. infection and inflammation seem to have consequences on liver metabolism in order to reduce this inflammation [ ] . we assessed the biochemical indicator relationship between liver health and inflammation in both lines. delivery is a stressful event to does which could affect to biochemical parameters concentrations. however, the levels of bilirubin, cholesterol, alp, gct, ba, alb, and bun in our lines were within the wide range of values reported in rabbits by [ , ] ( . - . µmol/l, . - . µmol/l, . - . iu/l, . - . iu/l, . - . µmol/l, - g/l, and . - . , respectively). when we compared both lines, the concentrations of bilirubin and cholesterol were higher in the high line. according to fan et al. [ ] , the increase in the concentration of cholesterol in rodents is a response to the production of inflammatory cytokines (mainly tnf-α and il- ). bilirubin is an endogenous antioxidant which promotes lipid peroxidation prevention [ ] . inoguchiet et al. [ ] reported that bilirubin plays a protective role against chronic inflammation. together, it seems that greater basal concentrations of cholesterol and bilirubin are related to higher sensitivity to inflammation and susceptibility to diseases in the high line. gamma glutamyl transferase (ggt) is an inflammation regulator which increases first in the case of a hepatic disorder [ ] . females from the high line showed higher ggt concentration than those from the low line; this would suggest a liver dysfunction and high susceptibility to diseases [ ] . the high line has a higher alkaline phosphatase (alp) concentration than the low line. alp is a good indicator of liver diseases and general health [ ] . an increased concentration of alp is an indication of liver dysfunction and a disruption in the inflammatory system [ ] . these results agree with the greater susceptibility to diseases of this line. recently a genome-wide association study was performed on our lines, identifying several genes with functionality in the immune system and stress [ ] . this finding corroborates the decisive role of the immune system in the environmental variation of litter size. our study shows the high line having higher inflammatory response under stressful situations such as h after delivery, and consequently this line displays a greater susceptibility to diseases and stress. therefore, selection for litter size environmental variability can be a useful way to improve animal welfare. robustesse et canalisation: vision de généticiens welfare assessment and relevant ethical decisions: key concepts bien-être animal: context, definition, évaluation inflammation as "common soil" of the multifactorial diseases inflammation: the common pathway of stress-related rethinking il- and crp: why they are more than inflammatory biomarkers, and why it matters sex differences in the association between stressor-evoked interleukin- reactivity and c-reactive protein correlation of c-reactive protein to severity of symptoms in acute influenza a infection serum c-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors plasma crp level is positively associated with the severity of covid- inflammatory biomarkers for predicting cardiovascular disease the protective role of bilirubin in human beings genetics and genomics of uniformity and resilience in livestock and aquaculture species: a review selection for environmental variance of litter size in rabbit correlated response to selection for litter size environmental variability in rabbit's resilience the laboratory rabbit bayesian data analysis for animal scientists blood reference intervals for rabbits (oryctolagus cuniculus) from routine diagnostic samples. best immung von blutreferenzwerten für kaninchen (oryctolagus cuniculus) aus routine diagnostic proben leucocyte alterations associated with continual subacute blood loss haematology of normal trypanosome infected muturu cattle in southeastern nigeria hematological assessment in pet rabbits blood sample collection and blood cell identification a robust rabbit line increases leucocyte counts at weaning and reduces mortality by digestive disorder during fattening new insights into roles of basophils in initiating t helper type immunity. chin. herb neutrophil mobilization and clearance in the bone marrow clinical profile of sheep fed non-conventional feeds containing phenols and condensed tannins effect of caustic paste disbudding, using local anaesthesia with and without analgesia, on behaviour and cortisol of calves clinical biochemistry and hematology pain and discomfort caused by parturition in cows and sows postpartum ketoprofen treatment does not alter stress biomarkers in cows and calves experiencing assisted and unassisted parturition: a randomised controlled trial neuroendocrine regulation of immunity stress-induced immune dysfunction: implications for health il- in inflammation, immunity, and disease tnf-α in tuberculosis: a cytokine with a split personality a high plasma concentration of tnf-α is associated with dementia in centenarians c-reactive protein: risk marker or mediator in atherothrombosis? hypertension childhood trauma and adulthood inflammation: a meta-analysis of peripheral c-reactive protein, interleukin- and tumour necrosis factor-α acute phase reactants in infections: evidence-based review and a guide for clinicians immune response from a resource allocation perspective. front oxidative stress and nlrp -inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine the relationship between serum bilirubin and inflammatory bowel disease. hindawi mediat. inflamm. , bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes: a new aspect on old molecule reference values for heamatological and biochemical parameters in saanen goats breeding in afyonkarahisar province gamma-glutamyl transferase: a predictive biomarker of cellular antioxidant in adequacy and disease risk serum activity of alanine amino transferase (alt) as an indicator of health and disease van den ingh, t.s. hepatocyte derived micro rnas as sensitive serum biomarkers of hepatocellular injury in labrador retrievers identification of functional mutations associated with environmental variance of litter size in rabbits this article is an open access article distributed under the terms and conditions of the creative commons attribution (cc by) license animals , , key: cord- -d tilk v authors: baker, rahaf; liew, jean w.; simonson, paul d.; soma, lori a.; starkebaum, gordon title: macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab date: - - journal: clin rheumatol doi: . /s - - - sha: doc_id: cord_uid: d tilk v macrophage activation syndrome (mas) is a rare and potentially fatal condition characterized by excessive activation and uncontrolled proliferation of t lymphocytes and macrophages, leading to overwhelming systemic inflammation and cytokine release. mas has been reported with viral infections, autoimmune disorders, malignancies, and medications. we describe a case of a patient with axial spondyloarthritis (axspa) treated with adalimumab, who presented with mas. to the editor: macrophage activation syndrome (mas) is a rare and potentially fatal condition characterized by excessive activation and uncontrolled proliferation of t lymphocytes and macrophages, leading to overwhelming systemic inflammation and cytokine release. mas has been reported with viral infections, autoimmune disorders, malignancies, and medications. we describe a case of a patient with axial spondyloarthritis (axspa) treated with adalimumab, who presented with mas. a -year-old middle eastern man with long-standing hla-b -positive axspa on adalimumab presented with several days of persistent fevers. axspa had been diagnosed on the basis of a history of recurrent iritis, patellar tendon enthesitis, and inflammatory lower back pain. the back pain, although initially responsive, became refractory to non-steroidal antiinflammatory medications and a sacroiliac joint steroid injection. adalimumab was started in april , and for the next rahaf baker and jean w. liew contributed equally to this work. key points • mas is a rare condition of systemic inflammation with high mortality; having a strong index of suspicion can lower mortality in these patients. • medications, including tnf inhibitors, should be considered as possible triggers for mas. • consider high-dose steroids and anakinra, either alone or in combination, for the treatment of mas. if a medication is suspected, remove the offending agent. . months, he had dramatic improvement in his inflammatory back pain, and no extra-articular manifestations. in june , he presented to the hospital and endorsed days of high fevers with mild lower chest discomfort and cough. he described unremitting fevers that occurred multiple times daily, which were associated with significant weakness and rigors. the review of systems was otherwise negative. he had no other pertinent past medical history or medications. his family history was non-contributory. his social history was notable for moving to the usa from saudi arabia years ago with recent, frequent travel around the usa and mexico. he had traveled to las vegas for a work conference a few days prior to his presentation. on admission, his temperature was . °c, blood pressure was / mm/hg, and pulse was beats per minute. he was ill-appearing and his physical exam was otherwise only notable for splenomegaly with tenderness on palpation. his initial labs revealed lymphopenia (absolute lymphocyte count cells/μl), mild anemia (hemoglobin g/dl), thrombocytopenia ( , cells/μl), and transaminitis (ast u/l, alt u/l). erythrocyte sedimentation rate (esr) was mm/h and c-reactive protein (crp) was mg/dl. an extensive infectious disease workup was undertaken, with all tests reported as negative (table ) . computed tomography (ct) of the chest, abdomen, and pelvis showed mild splenomegaly with residual thymic tissue and no lymphadenopathy. after a week of hospitalization, the patient remained febrile despite treatment with antipyretics. he developed a transient, faint, erythematous maculopapular rash over his trunk. further labs demonstrated elevated ferritin ( mg/dl), fibrinogen ( mg/dl), and triglycerides ( mg/dl). crp peaked at mg/dl. a diagnosis of mas was considered. on the seventh day of hospitalization, he was started on anakinra mg twice daily without adequate fever control; thus, oral prednisone mg daily was added. he quickly defervesced with improvement of his condition, labs, and inflammatory markers (fig. ) . a bone marrow biopsy, which was obtained on hospital day , showed erythroid hyperplasia and hemophagocytic histiocytes without evidence of malignancy (fig. ) . soluble interleukin- receptor levels, however, were low. after an -day hospitalization, he was discharged on prednisone mg daily and anakinra mg once daily. adalimumab was completely discontinued. upon outpatient follow-up, he had continued symptomatic improvement with normalization of the esr, crp, ferritin, and fibrinogen. he was tapered off prednisone over months but his inflammatory back pain returned. mas is a potentially fatal syndrome that can present in patients with inflammatory conditions and is considered to be similar to hemophagocytic lymphohistiocytosis (hlh) [ , ] . the finding of abundant activated hemophagocytic macrophages, or histiocytes, has led to their classification as a histiocytic disorder [ ] . the underlying pathogenesis of mas is poorly understood, but it is proposed to be triggered by an inciting event such as infection, malignancy, autoimmune conditions, or drugs, that leads to immune dysregulation [ ] . the resultant overwhelming cytokine storm drives phagocytosis of blood cell precursors and the infiltration of macrophages into tissues, causing multiorgan dysfunction. currently, there are no diagnostic criteria for mas in adults, and the proposed classification criteria rely on our understanding from the pediatric population [ ] . the findings of high fevers, cytopenias, hyperferritinemia, and hypertriglyceridemia should alert the clinician to the possibility of mas. although significantly elevated ferritin is specific for hlh in pediatrics, it is not as specific to hlh or mas in the adult population [ ] . evidence of hemophagocytic cells on bone marrow biopsy is not required for diagnosis and is not always found on presentation in mas. the most consistent diagnosis for our patient was mas, as he had high persistent fevers without an infectious cause, lymphopenia and anemia, marked hyperferritinemia, hypertriglyceridemia, splenomegaly, and the presence of hemophagocytes on bone marrow biopsy. the diagnosis of adult-onset still's disease (aosd) was excluded due to his axspa [ ] . the leading explanations for his mas were adalimumab, an undetected viral infection, or his underlying axspa. infection, particularly viral, is the most common reported cause of mas cited in the literature [ ] . our patient had extensive infectious workup that was negative; however, his mas may have been triggered by an undetected virus. in rheumatologic conditions, mas has been associated with underlying activity of systemic juvenile idiopathic arthritis and aosd, and in rare cases of systemic lupus erythematosus [ ] . spa is rarely associated with mas; only three were found in our review of the literature ( table ). of these three cases, only one occurred in the absence of tnf inhibitor use or clear source of infection [ ] . our patient had well-controlled spa that was stable prior to presentation; therefore, we felt that spa was a less likely trigger for his mas. recently, mas has been reported more frequently in association with tnf inhibitor use, although it is unclear whether this is due to heightened clinician awareness or increasing incidence. on our literature review, we found reports of mas associated with etanercept, infliximab, or adalimumab (table ) . of the two cases that described the timing of mas relative to tnf inhibitor administration, one was in a patient with ra months after discontinuation of etanercept, and one was in aosd months after initiation of adalimumab [ , ] . four of the cases reported had associated infections, including visceral leishmaniasis, disseminated histoplasmosis, liver abscess, or primary ebv, which were felt to be the primary trigger for mas, though the tnf inhibitor was implicated as a contributing risk factor for the infection [ , , ] . it is plausible that adalimumab triggered mas in our patient as he presented at . months after initiation of adalimumab, which is consistent with the timeline from other case reports, and he had no obvious infection. the pathogenesis of mas secondary to tnf inhibitors is unknown. these medications have been successful in treating some refractory cases of mas, but their use may also rarely induce or aggravate autoimmune diseases, or trigger mas in the setting of infection [ ] . it has been proposed that tnf inhibitor blockade of macrophage activity is coupled with a compensatory immune system activation and rebound cytokine response [ ] . this leads to an overall immune system dysregulation and may trigger hemophagocytosis. the explanation for this paradoxical effect on immune response will require further research. as for the treatment of mas, we note that in mas associated with tnf inhibitors only, six of the eight patients had clinical and laboratory improvement after treatment with highdose corticosteroids. two patients died despite receiving highdose corticosteroids; however, these patients presented with severe or late systemic disease that was previously not well controlled on prednisone [ , ] . in the cases of mas with an associated infection, three of the four patients received highdose corticosteroids in addition to treatment of underlying infection, and all four patients responded well and survived [ , , ] . in the three reported cases of mas in spa, all three patients received high-dose prednisone and clinically stabilized [ , ] . dual treatment with high-dose steroids and anakinra, an il- receptor antagonist, induced remission in our patient. both agents have been shown to rapidly induce remission and ameliorate the cytokine storm in refractory and severe cases of mas [ ] . anakinra was trialed first in our patient given his prolonged and high fevers, but given the antibiotics (amoxicillin, clavulonic acid, erythromycin), iv immunoglobulin ( g/kg), and methylprednisolone boluses followed by prednisone healing of abscess *the tnf inhibitor was a likely risk factor for the infection, which likely triggered the onset of mas ebv, epstein barr virus; pcr, polymerase chain reaction duration of symptoms and the likely presence of other cytokines besides il- , it alone was not sufficient in inducing remission. in conclusion, it is important to recognize mas as a possible life-threatening complication of autoimmune and inflammatory diseases. currently, the diagnosis of mas relies heavily on the pediatric diagnostic criteria, and the treatment on case reports and case series in adults. it is important to increase awareness of this rare disease among clinicians in order to prevent mortality and improve outcomes of these patients. disclosures none. publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis how i treat hemophagocytic lymphohistocytosis in the adult patient revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages macrophage activation syndrome in the era of biologic therapy marked hyperferritinemia does not predict for hlh in the adult population mechanisms, biomarkers and targets for adult-onset still's disease ankylosing spondylitis presenting with macrophage activation syndrome syndrome d'activation macrophagique sous biothérapies: deux cas macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis macrophage activation syndrome after etanercept treatment visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset still's disease a rare trigger for macrophage activation syndrome syndrome d'activation macrophagique apres traitement par infliximab pour maladie de crohn fistulisee key: cord- -al gxjw authors: calder, philip c. title: n− fatty acids, inflammation, and immunity— relevance to postsurgical and critically iii patients date: journal: lipids doi: . /s - - -z sha: doc_id: cord_uid: al gxjw excessive or inappropriate inflammation and immunosuppression are components of the response to surgery, trauma, injury, and infection in some individuals and these can lead, progressively, to sepsis and septic shock. the hyperinflammation is characterized by the production of inflammatory cytokines, arachidonic acid-derived eicosanoids, and other inflammatory mediators, while the immunosuppression is characterized by impairment of antigen presentation and of t helper cell type- responses. long-chain n− fa from fish oil decrease the production of inflammatory cytokines and eicosanoids. they act both directly (by replacing arachidonic acid as an eicosanoid substrate and by inhibiting arachidonic acid metabolism) and indirectly (by altering the expression of inflammatory genes through effects on transcription factor activation). thus, long-chain n− fa are potentially useful anti-inflammatory agents and may be of benefit in patients at risk of developing sepsis. as such, an emerging application of n− fa is in surgical or critically ill patients where they may be added to parenteral or enteral formulas. parenteral or enteral nutrition including n− fa appears to preserve immune function better than standard formulas and appears to partly prevent some aspects of the inflammatory response. studies to date are suggestive of clinical benefits from these approaches, especially in postsurgical patients. the systemic inflammatory response syndrome is the name given to the uncontrolled inflammatory response to insult or injury involving excessive production of inflammatory cytokines such as tumor necrosis factor (tnf)-α, interleukin (il)- β, il- , and il- ( , ) . sepsis has been defined as "the systemic inflammatory response syndrome that occurs during infection" ( ) . sepsis is the leading cause of death in critically ill patients in western countries. using records from for state hospitals in the united states it was estimated that there were more than , cases of sepsis with a . % mortal-ity rate ( , deaths) and a total cost of almost us$ billion ( ) . death from septic shock is the result of multiple organ failures and represents the extreme end of a continuum of events of increasing severity and decreasing likelihood of survival ( , ; fig. ). the systemic inflammatory response syndrome, sepsis, and septic shock may together be termed as "septic syndromes." the involvement of inflammatory cytokines in septic syndromes has been long recognized and vervloet et al. ( ) wrote "these mediators [i.e., inflammatory cytokines] are largely, if not completely, responsible for the clinical signs and symptoms of the septic response to bacterial infection." in support of this idea, patients with sepsis were found to have markedly elevated circulating concentrations of tnf-α, tnf receptor , il- β, il- receptor antagonist (il- ra), and il- , and those patients with the highest concentrations were more likely to die ( ) ( ) ( ) ( ) . in addition, circulating white cells from septic patients exhibited high levels of activated nuclear factor kappa b (nfκb), a transcription factor that promotes the expression of numerous genes associated with inflammation, and again levels of activated nfκb were higher in those patients who went on to die ( ) . animal studies also support a role for inflammatory cytokines in the septic response. these studies have often used bacterial endotoxin (also called lipopolysaccharide) as a surrogate for infection, although endotoxin is a fragment of the gram-negative bacterial cell wall and not a viable organism. mice injected with endotoxin exhibit high circulating concentrations of tnf-α, il- β, il- , and il- , and survival of these animals can be improved by administering anti-cytokine antibodies ( , ) , cytokine receptor antagonists ( ) , or anti-inflammatory cytokines such as il- ( ) , or by knocking out the tnf-α receptor ( ) . despite this evidence, it is important to note that some studies report that many septic patients do not show detectable or elevated circulating concentrations of tnf-α or il- β ( ) ( ) ( ) ( ) . furthermore, it appears that inflammatory cytokines do play a beneficial role in sepsis. for example, in some animal models, blocking tnf-α increases mortality ( ) ( ) ( ) , while a tnf-α antagonist increased mortality in a clinical trial ( ) . thus, the situation regarding the pathological role of inflammatory cytokines in sepsis is unclear; it may be that a little is beneficial but that excess is harmful and that complete blocking negates the beneficial effects. another consideration is that there may be large between-individual differences in the generation of inflammatory cytokines, in the sensitivity to the harmful effects of these cytokines, and in the effects of blocking these cytokines. thus, there may be significant variation in the susceptibility of individuals to exhibit the systemic inflammatory response syndrome and to progress toward septic shock. this may partly relate to the extent and site of the initial injury, partly to the nature and site of the infection, if any, and partly to aspects of the patient's well-being prior to receiving the injury (e.g., nutritional state). it is now recognized that genetics may also play a role. in fact there are likely to be genetic variations in many aspects of the septic response to infection and injury. these most likely relate to adaptations of various population groups to withstand infection and injury in different ecological settings. in the context of this article, genetic variations in the propensity to produce inflammatory cytokines are of relevance. it is now recognized that there are single base variations in genes or in their promoter regions called single nucleotide polymorphisms or snps (pronounced "snips"). snps have been described for tnf-α, tnf-β, il- β, il- , il- , tnf receptors, il- receptors, il- ra, and for many other genes involved in the septic response ( ) . these snps are of functional significance since they partly determine the extent of expression of the gene once it is activated ( ) . thus tnf-α production by monocytes in response to endotoxin is higher in individuals who have a g rather than an a at - in the tnf-α gene promoter region ( ) . intriguingly, tnf-α production is also affected by a polymorphism in the tnf-β gene: tnf-α production by monocytes in response to endotoxin was higher if there was an a at + in the tnf-β gene than if there was a g ( ) . genotypes affecting tnf-α production appear to be of relevance with respect to sepsis mortality. for example, possession of a g at - in the tnf-α gene was found in % of patients with septic shock compared with % of controls, and among patients with septic shock this polymorphism was significantly more common among patients who died ( % vs. % among survivors) ( ) . in controlling for age, it was identified that, for the same clinical score, patients with a g at - of the tnf-α gene had a . -fold higher risk of death than those without a g ( ) . in another study, patients with sepsis who were homozygous for a at + in the tnfβ gene displayed significantly higher plasma tnf-α concentrations than heterozygotes or homozygotes for g, and they showed % mortality compared with % for heterozygotes and % for g homozygotes ( ) . in a more recent study, postoperative patients who were homozygous for a at + in the tnf-β gene had a . -fold higher risk of developing severe complications than heterozygotes ( ) . furthermore, among the patients who developed sepsis, those who were homozygous for a at + in the tnf-β gene were more likely to die ( vs. % for heterozygotes and % for homozygotes for g) ( ) . these findings raise the possibility of being able to identify patients at high risk of complications and mortality on the basis of genetic polymorphisms. although there has been much focus on the potential detrimental role of inflammatory cytokines in sepsis, other mediators including arachidonic acid-derived eicosanoids, reactive oxygen species, nitric oxide, and adhesion molecules are involved in the pathological processes that accompany critical illness. prostaglandin (pg) e is implicated in sepsis, burns, and critical illness ( , ) , while leukotriene (lt) b and oxidants released by neutrophils are involved in acute respiratory distress syndrome [see kollef and schuster ( ) ]. in addition to hyperinflammation, patients with sepsis also display immunosuppression ( ) ( ) ( ) . there are reports that septic patients have high circulating concentrations of the antiinflammatory cytokine il- and that these are strongly correlated with mortality ( , ) . note that this is contrary to the predicted effect of il- since this cytokine down-regulates tnf-α production and its early administration is protective in murine endotoxemia ( ) ( ) ( ) . however, the apparently harmful effect of il- may relate to the timing of its production. lymphocytes from patients with burns or trauma produce low levels of the t helper (th) -type cytokines [e.g., interferon (ifn)-γ] associated with host defense against bacteria and viruses but high levels of the th -and treg-type cytokines (il- , il- ) associated with inhibition of host defense against bacteria and viruses ( , ) . there also appears to be decreased monocyte expression of human leukocyte antigens (hla) ( ) ( ) ( ) ( ) , the proteins involved in antigen presentation to t cells, and this is associated with impaired ability of monocytes to stimulate t cells ( ) . interestingly, il- downregulates both th -type cytokine production and hla expression ( , ) , and this might be the origin of the harmful effect of this cytokine in septic patients. recent studies have revealed impaired proliferative or secretory functions of t cells from patients with sepsis, trauma, or burns ( , ) . the traditional view is that the immunosuppressed phase of septic syndromes lags behind the hyperinflammatory phase (fig. ) ; that is, initially sepsis is characterized by increased generation of inflammatory mediators (the systemic inflammatory response syndrome), but as it persists there is a shift toward an anti-inflammatory, immunosuppressed state sometimes called the compensatory anti-inflammatory response syndrome. however, some recent studies challenge this and suggest that the hyperinflammatory and immunosuppressed states coexist. some authors report that immunosuppression is present at the onset of sepsis ( , , ) , rather than being a later compensatory response. for example, tschaikowsky et al. ( ) identified that significantly decreased monocyte expression of hla-dr was evident at the onset of severe sepsis in postsurgical patients; in survivors there was some recovery of expression but in nonsurvivors there was a further decrease or even a permanent suppression of hla-dr expression. these authors identified that the timing of the peak of the systemic inflammatory reaction (identified as the time of maximum c-reactive protein concentration) coincided with the timing of the lowest monocyte expression of hla-dr. from this they concluded that decreases in monocyte hla-dr expression occur simultaneously with "signs of hyperinflammation" and as early as the onset of severe sepsis ( ) . thus, it appears that immune cells and cytokines have both detrimental and protective roles in patients as they move through the stages of sepsis. however, the traditional view that hyperinflammation precedes immunosuppression, as shown in figure , may be a simplification of the real situation, and this increases the challenge to finding interventions that might benefit high-risk patients. human immune and inflammatory cells are rich in polyunsaturated fa (pufa), especially arachidonic acid ( : n- ) [see calder ( ) ]. classically the influence of pufa on immunity and inflammation has been viewed as relating to their influence on eicosanoid generation ( ) ( ) ( ) ( ) . arachidonic acid is the principal substrate for cyclooxygenase (cox) and lipoxygenase (lox) enzymes giving rise to -series pg and thromboxanes (tx) or -hydroxyeicosatetraenoic acids (hete) and -series lt, respectively. these mediators have cell-and stimulus-specific sources and frequently have opposing effects (table ). for example, pge is produced mainly by monocytes, macrophages, and, to a lesser extent, neutrophils and inhibits the production of tnf-α and il- β [see miles et al. ( ) and references therein; , ] and il- ( , ) , while ltb is produced mainly by neutrophils, other granulocytes, and, to a lesser extent, monocytes and macrophages and increases the production of tnf-α and il- β [see rola-pleszczynski et al. ( ) and references therein]. thus, the overall physiological (or pathophysiological) outcome will depend upon the cells present, the nature of the stimulus, the timing of eicosanoid generation, the concentrations of different eicosanoids generated, and the sensitivity of target cells and tissues to the eicosanoids generated. recent studies have demonstrated that pge induces cox- in fibroblasts cells and so upregulates its own production ( ), induces production of il- by macrophages ( ) it is frequently considered that the effects of arachidonic acid are solely related to its role as an eicosanoid precursor. cell culture studies have shown that arachidonic acid acti- vates nfκb in a monocytic cell line ( ) , and induces tnf-α, il- α and il- β in osteoblasts ( ), il- in macrophages ( ) and osteoblasts ( ) , and cox- in fibroblasts ( ) , and it appears that these effects are exerted directly by arachidonic acid rather than by an eicosanoid metabolite. what is evident from these studies is that arachidonic acid may be able to regulate inflammatory mediator production in its own right and, if so, that it has effects that are sometimes the opposite of those of pge , for example, with respect to tnf-α production. a series of cell culture-based studies with human endothelial cells has suggested that another n- fa, linoleic acid ( : n- ), may also play a role in inflammation through activation of nfκb and increased production of tnf-α, il- , and other inflammatory mediators ( ) ( ) ( ) ( ) ( ) ( ) ( ) . increased consumption of long-chain n- pufa, usually as components of fish oil, by humans results in increased amounts of epa ( : n- ) and dha ( : n- ) in cells involved in immunity and inflammation [see calder ( ) ]. the incorporation of these fa from the diet into immune/inflammatory cells of humans is near-maximal within a few weeks ( , ) and occurs in a dose-dependent manner ( ) . incorporation of epa and dha into human cells is partly at the expense of arachidonic acid [see calder ( ) ], and the functional significance of this is that it decreases the amount of arachidonic acid available as a substrate for eicosanoid synthesis. thus, fish oil supplementation of the human diet has been shown to result in decreased production of pge ( - ), txb ( ), ltb and -hete ( , ) , and lte ( ) by inflammatory cells. however, the mechanism of the effect of long-chain n- fa on eicosanoid generation extends beyond simply decreasing the amount of arachidonic acid substrate. for example, epa competitively inhibits metabolism of arachidonic acid by cox ( - ) and -lox ( , ) . in vitro studies also report that dha can inhibit cox activity ( , ) but not that of -lox ( , ) . interestingly, however, both epa and dha suppressed cytokine-induction of cox- and -lox gene expression in cultured bovine chondrocytes and in human osteoarthritic cartilage explants ( , ) . by inhibiting cox and lox activities and by suppressing the up-regulation of the genes for these enzymes in response to inflammatory stimuli, long-chain n- fa act to oppose generation of eicosanoids from arachidonic acid. the final element of the effects of longchain n- fa on eicosanoid production is the ability of epa to act as a substrate for cox and lox enzymes, so giving rise to a different family of eicosanoids: the -series pg and tx, the series lt, and the hydroxyeicosapentaenoic acids (hepe). epa, which appears to be a good substrate for -lox ( , ) , is also a substrate for cox enzymes ( , ) . thus, fish oil supplementation of the human diet has been shown to result in increased production of ltb , lte , and -hepe by inflammatory cells ( ) ( ) ( ) , although generation of pge has been more difficult to demonstrate ( ) . the functional significance of this is that the mediators formed from epa are believed to be less potent than those formed from arachidonic acid. for example, ltb is -to -fold less potent as a neutrophil chemotactic agent than ltb ( , ) . recent studies have compared the effects of pge and pge on production of cytokines by cell lines and by human cells. bagga et al. ( ) reported that pge was a less potent inducer of cox- gene expression in fibroblasts and of il- production by macrophages. pge and pge had equivalent inhibitory effects upon production of tnf-α ( , ) and il- β ( ) by human mononuclear cells stimulated with endotoxin and upon production of ifn-γ production by mononuclear cells stimulated with mitogen ( , ) . however, il- production appeared to be less sensitive to pge than pge ( ) . studies using the isolated, perfused rabbit lung have identified contrasting effects of arachidonic acid-and epa-derived eicosanoids. infusion of escherichia coli hemolysin caused hypertension mediated by txb and increased vascular leakage mediated by -series lt ( ) . inclusion of arachidonic acid in the perfusate increased txb and -series lt generation, arterial pressure, and vascular leakage ( , ). in contrast, inclusion of epa in the perfusate decreased txb and -series lt generation, decreased arterial pressure and vascular leakage, and increased generation of txb and -series lt ( ) . perfusion with fish oil attenuated the hypertension induced by calcium ionophore ( ) . compared with soybean oil infusion, fish oil decreased the concentration of ltc by % and increased the concentration of ltc from barely detectable to very similar to that of ltc ( ) . in addition to long-chain n- fa modulating the generation of eicosanoids from arachidonic acid and to epa acting as substrate for the generation of alternative eicosanoids, recent studies have identified a novel group of mediators, termed e-series resolvins, formed from epa by cox- that appear to exert anti-inflammatory actions ( ) ( ) ( ) . in addition, dha-derived mediators termed d-series resolvins, docosatrienes, and neuroprotectins also produced by cox- have been identified, and these too appear to be anti-inflammatory ( ) ( ) ( ) . this is an exciting new area of n- fa and inflammatory mediators, and the implications for a variety of conditions may be of great importance. cell culture studies investigating the direct effects of arachidonic acid on inflammatory mediator production have also investigated effects of long-chain n- fa. epa did not activate nfκb in a monocytic cell line ( ), while epa and dha inhibited endotoxin-stimulated production of il- and il- by cultured human endothelial cells ( , ) . more recent studies showed that epa did not induce tnf-α, il- β, or il- α ( ) or il- ( ) in osteoblasts, and even countered the upregulating effect of arachidonic acid ( ) ; that epa and dha could totally abolish cytokine-induced up-regulation of tnf-α, il- α, and il- β in cultured bovine chondrocytes and in human osteoarthritic cartilage explants ( , ) ; and that epa or fish oil inhibited endotoxin-induced tnf-α production by monocytes ( ) ( ) ( ) ( ) . epa was also less potent than arachidonic acid in inducing cox- expression by fibroblasts and il- expression by macrophages ( ) . epa prevented nfκb activation by tnf-α in cultured pancreatic cells, an effect that involved decreased degradation of the in-hibitory subunit of nfκb (iκb), perhaps through decreased phosphorylation ( ) . similarly, epa or fish oil decreased endotoxin-induced activation of nfκb in human monocytes ( , , ) , and this was associated with decreased iκb phosphorylation ( , ) , perhaps due to decreased activation of mitogen-activated protein kinases ( ) . these observations suggest direct effects of long-chain n- fa on inflammatory gene expression via inhibition of activation of the transcription factor nfκb. animal feeding studies with fish oil support the observations made in cell culture with respect to the effects of long-chain n- fa on nfκb activation and inflammatory cytokine production. compared with feeding corn oil, fish oil lowered nfκb activation in endotoxin-activated murine spleen lymphocytes ( ) . feeding fish oil to mice decreased ex vivo production of tnf-α, il- β, and il- by endotoxin-stimulated macrophages and decreased circulating tnf-α, il- β, and il- concentrations in mice injected with endotoxin [sadeghi et al. ( ) and references therein]. several studies in humans involving supplementation of the diet with fish oil have demonstrated decreased production of tnf-α, il- β, and il- by endotoxin-stimulated monocytes or mononuclear cells (a mixture of lymphocytes and monocytes) ( ) ( ) ( ) ) . the study of caughey et al. ( ) reported a significant inverse correlation between the epa content of mononuclear cells and the ability of those cells to produce tnf-α and il- β in response to endotoxin. recent studies have confirmed the ability of dietary fish oil to decrease production of tnf-α ( ) and il- ( , ) by human mononuclear cells. furthermore, these studies provide for the first time information on the dose-response relationship between dietary intake of long-chain n- fa and production of these cytokines. it should be noted that there are also several studies that fail to show effects of dietary long-chain n- fa on production of inflammatory cytokines in humans [see calder ( ) for references]. it is not clear what the reason for this is, but the dose of n- fa used and other technical factors are likely to be contributing factors. one other factor that has recently been identified is polymorphisms in genes affecting cytokine production ( ) . it was found that the effect of dietary fish oil on cytokine production by human mononuclear cells was dependent on the nature of the - tnf-α and the + tnf-β polymorphisms. this study raises the possibility of being able to identify those who are more likely and those who are less likely to experience specific anti-inflammatory effects of fish oil. thus, examination of fa composition and of eicosanoid profiles, cell and tissue culture work, and animal and human feeding studies have revealed a range of anti-inflammatory actions of long-chain n- fa ( table ). these may be of benefit in sepsis, particularly during the "early" hyperinflammatory phase. the benefits of fish oil in animal models of experimental endotoxemia have been clearly demonstrated. for example, dietary fish oil or fish oil infused intravenously significantly enhanced survival of guinea pigs to intraperitoneal endotoxin compared with safflower oil ( , ) . dietary fish oil resulted in a decreased concentration of circulating postendotoxin eicosanoids (pge , txb , -keto-pgf α ) in rats and in decreased eicosanoid generation by alveolar macrophages ( , ) . furthermore, compared with dietary safflower oil, fish oil resulted in lower circulating tnf-α, il- β, and il- concentrations following endotoxin administration to mice ( ) . dietary fish oil also appears to decrease sensitivity to inflammatory cytokines ( , ) . fish oil decreased endotoxininduced metabolic perturbations in guinea pigs and rats ( , ) and improved heart and lung function and decreased lung edema in endotoxic rats ( , ( ) ( ) ( ) and pigs ( ) ( ) ( ) . in addition to effects on production of inflammatory eicosanoids and inflammatory cytokines, long-chain n- fa decreased generation of arachidonic acid-derived partial replacement of arachidonic acid in cell membrane phospholipids eicosanoids (many with inflammatory actions) inhibition of arachidonic acid metabolism by phospholipase a , cox, and -lox decreased induction of cox- , -lox, and -lox-activating protein however, it is the effects of lower amounts of long-chain n- fa that are of relevance to the patient setting. several studies in humans, typically providing long-chain n- fa as fish oil, and investigating aspects of cell-mediated immunity have been performed. phagocytic uptake of escherichia coli appears unaffected by dietary long-chain n- fa in humans ( ) ( ) ( ) ( ) . one study reported that fish oil decreased expression of hla-dp, -dq, and -dr on human monocytes ( ), suggesting impaired ability to present antigen, but there have been no studies attempting to confirm this finding. meydani et al. ( ) reported that fish oil providing . g epa plus dha per day decreased t-lymphocyte proliferation in older but not younger women. however, that study also reported increased oxidative stress in the older subjects ( ) , and it may be that the effect of n- fa was due to excessive lipid peroxidation. several other studies report no effect of various doses of longchain n- fa on lymphocyte proliferation ( , , ) , although there are studies reporting a decrease ( , ) . one recent study reported that long-chain n- fa caused a dosedependent increase in proliferation of t cells ( ) . it is noteworthy that the fish oil used was given in combination with an antioxidant mix. this might be important in terms of preventing excessive lipid peroxidation and so in determining the overall effect of n- fa. the study by meydani et al. ( ) also reported decreased production of il- in the older women, but this effect has not been confirmed by others in either older ( ) , young ( , ) , or mixed-age ( , ) subjects. a recent study reported a dose-dependent increase in ifn-γ production following n- fa supplementation as fish oil ( ) . that antioxidants were given in combination with fish oil may have been important in generating this finding. thus, the effects of long-chain n- fa on aspects of cellmediated immunity are rather unclear, although recent human studies suggest that adverse immune effects are not exerted at modest doses (see previous discussion for references) and that enhanced t-cell responses (proliferation and ifn-γ production) may occur at modest doses so long as antioxidants are also given ( ) . in terms of sepsis, the true test of immunocompetence occurs when live pathogens are administered. this is a different situation from using endotoxin that is not living and that therefore does not require a robust cell-mediated immune response to eliminate it. as indicated previously, it is clear that long-chain n- fa protect against the deleterious effects of endotoxin. however, the situation regarding live pathogens is much less clear. this is because animal studies, frequently using high intakes of n- fa, report opposing findings. infusion of fish oil into rats also receiving low-dose endotoxin decreased the number of viable bacteria in mesenteric lymph nodes and liver ( ) . fish oil did not decrease bacterial translocation across the gut, and so the authors concluded that fish oil must have improved bacterial killing. compared with linoleic acid-rich vegetable oils, fish oil fed to rats before exposure to live bacteria ( , ) resulted in increased survival, which was associated with decreased production of pge . more recently, infusion of fish oil after induction of sepsis by cecal ligation and puncture decreased mortality (and pge production) compared with vegetable oil ( ) . intragastric administration of fish oil into chow-fed rats before cecal ligation and puncture improved survival compared with saline or vegetable oil infusion ( ) . compared with vegetable oil feeding to mice, fish oil feeding increased survival to an intramuscular injection of klebsiella pneumoniae ( ) . the findings from these studies ( ) ( ) ( ) ( ) ( ) ( ) contrast with those reporting that fish oil feeding decreases the survival of mice to oral salmonella typhimurium ( ) and to intraperitoneal listeria monocytogenes ( ) , of guinea pigs to mycobacterium tuberculosis ( ) , and of neonatal rabbits to staphylococcus aureus ( ) . thus, animal studies do not provide a clear picture of the effect of high-dose fish oil on ability to survive an infectious challenge. there are few human studies that address exposure to long-chain n- fa and infection; most intervention studies performed to date have been too small and of too short duration to monitor infection as an outcome. however, it is worth noting that an epidemic of measles in greenland triggered by its introduction to a naive population by an infected danish sailor showed the same characteristics as previous epidemics in other naive populations ( ) . this suggests that the very n- fa-rich diet of the greenland inuits did not worsen their response to the virus and this could indicate that these fa do not increase infectious susceptibility in humans. surgery is typically accompanied by an inflammatory response that may be exaggerated in some patients, especially if the surgery is major. if the patient is exposed to pathogenic organisms and is unable to cope with these, then sepsis may develop. artificial nutrition is frequently used post-surgery and this may involve parenteral (i.e., intravenous) infusions, especially where the gastrointestinal tract is not fully functional (e.g., post-abdominal surgery). lipids are included in parenteral nutrition to provide an alternative source of calories to glucose and the lipid source used most frequently has been soybean oil, which is rich in the n- fa linoleic acid, although it also contains a proportion of α-linolenic acid ( : n- ). a meta-analysis of total parenteral nutrition suggested that inclusion of lipids might be detrimental (p = . for lipids vs. no lipids) ( ) , at least in very ill patients. it is not clear why this is, although a number of in vitro experiments have shown that soybean oil-based lipid emulsions can exert immunosuppressive effects [see calder et al. ( ) for references], which would clearly be detrimental in patients at risk of infection and sepsis. clinical trials provide conflicting evidence, some showing some immunosuppressive effects ( , ) and others not ( ) ( ) ( ) , at least in some patient groups. the concern about potential harm, the view of sepsis as a hyperinflammatory state followed by an immunosuppressed state (fig. ) , and the idea that n- fa might be "proinflammatory and immunosuppressive" has led to the development of alternative lipid emulsions for parenteral applications. emulsions using a mix of medium-chain triglycerides and soybean oil or based upon olive oil instead of soybean oil have been developed, but these will not be discussed here. however, of relevance to the present discussion is the development of emulsions that include fish oil as a partial replacement for soybean oil. several such emulsions have been tested in surgical patients. intravenous infusion of a lipid emulsion containing fish oil for d into patients who had undergone major abdominal surgery resulted in much higher ltc production by blood leukocytes stimulated ex vivo at d postoperation ( ) . in another study, patients who had undergone abdominal surgery received soybean oil or a mix of medium-chain triglycerides, soybean oil, and fish oil ( : : , by vol) for d post surgery ( ) . leukocytes from these patients produced more ltb and ltb isomers at postoperative days and . patients who had undergone major gastrointestinal surgery received a medium-chain triglyceride/soybean oil mix ( : , vol/vol) or a mix of medium-chain triglycerides, soybean oil, and fish oil ( : : , by vol) for d postsurgery ( ) . patients receiving fish oil got (days and ) and g (days , , and ) of long-chain n- fa per day. neutrophils from these patients produced less ltb and more ltb at postoperative days and . plasma tnf-α concentrations were lower in the fish oil group at day , while plasma il- concentrations were lower at day . the study did not report clinical outcomes. a more recent study infused a fish oil-rich formula on the day before abdominal surgery and on days to following abdominal surgery ( ) . on days and the patients also received standard total parenteral nutrition that included g of fat/d (n = ; n = in the control group). tnf-α production by endotoxin-stimulated whole blood tended to be lower at postoperative day in the fish oil group, but this was not significant. serum il- concentrations were significantly lower at days , , and in the fish oil group. monocyte expression of hla-dr was preserved in the fish oil group but declined at postsurgery days and in the control group. no differences in infection rates or mortality were observed. however, postoperative stay in intensive care tended to be shorter in the fish oil group ( . vs. . d) as did total hospital stay ( . vs. . days), although neither of these was a significant effect. postoperative stay on medical wards was significantly shorter in the fish oil group. another recent study compared the effects of lipid-free total parenteral nutrition or parenteral nutrition including % soybean oil or . % soybean oil plus . % fish oil for d after large bowel surgery ( ) . there were no differences between the groups with respect to the numbers of circulating lymphocytes, b cells, cd + cells, cd + cells, or natural killer cells before surgery or at days and postsurgery, although these were affected by surgery itself. there were no differences between groups with respect to t-lymphocyte proliferation, but il- production was increased in the fish oil group and the postsurgery decline in ifn-γ production was prevented by fish oil. these studies indicate that inclusion of fish oil in parenteral nutrition regimens for gastrointestinal surgical patients modulates generation of inflammatory eicosanoids ( ) ( ) ( ) and cytokines ( , ) and may help to counter the surgery-induced declines in antigen-presenting cell activity ( ) and t cell cytokine production ( ) . importantly, these studies do not reveal deleterious immunologic effects of fish oil infusion in these patients. furthermore, the only one of these fairly small studies to have examined hard end points like length of hospital stay suggests some clinical benefit from fish oil infusion in these patients ( ) . however, larger studies are required to evaluate the effects of this approach on complication rates, hospital stay, and mortality rate. a very recent report from a larger cohort of patients receiving parenteral nutrition postsurgery does indicate benefit of inclusion of fish oil in the regimen ( ) . patients received fish oil postoperatively (n = ) or controls received a : medium-chain triglyceride-soybean oil mix (n = ). there were no differences between the two groups with respect to the proportions of patients who died or developed wound infections or with respect to length of hospital stay. however, the proportion of patients who were readmitted to intensive care ( %) was significantly lower in the fish oil than in the control group ( %). a group of patients also received the fish oil-containing emulsion for d preoperatively (n = ). here there were a number of very significant benefits. this group showed a significantly decreased need for mechanical ventilation ( vs. % in the control group), a significantly shorter length of hospital stay ( vs. d) , significantly less need for readmission to intensive care ( vs. %), and a significantly lower mortality rate ( vs. %) ( ) . this study demonstrates a benefit from the inclusion of long-chain- fa in parenteral nutrition regimens used in abdominal surgery patients. however, it also demonstrates a much greater benefit if the fa are additionally provided before surgery, which, of course, is only possible in elective surgery. the greater benefit of preoperative infusion of longchain n- fa may relate to better incorporation of the fa into leukocytes and other tissues. enteral nutrition is an alternative form of artificial nutrition. it describes provision of nutrients directly into the gastrointestinal tract via a tube and is sometimes referred to as "tube feeding." enteral nutrition is used in patients with a functional gastrointestinal tract and is considered preferable to parenteral nutrition. the influence of enteral feeds including long-chain n- fa in their composition has been examined in surgical patients, generally in those who have undergone surgery to remove cancerous regions of the intestine. these studies have frequently used an enteral formula named impact ® (novartis, basel, switzerland), which contains arginine, long-chain n- fa, and nucleotides, each of which is lacking from control formulas. thus, any effects observed cannot be ascribed to a particular component of impact. the effect of impact on immunoinflammatory outcomes in surgical patients has been widely examined. daly et al. ( ) reported that impact results in time-dependent incorporation of epa into mononuclear cells and that this is associated with a timedependent decrease in pge production. studies have reported that impact increases phagocytosis by monocytes but not by neutrophils ( , ) , increases t-cell proliferation ( ) and cell-mediated immunity ( , ) , and decreases circulating concentrations of il- ( , ) . several of these studies report significantly improved clinical outcomes related to lower infection rate ( , , , ) and decreased length of hospital stay ( , , ) . studies of impact and similar enteral formulas investigating clinical outcomes in postsurgical patients have been subject to meta-analyses ( ) ( ) ( ) , which conclude that this approach to enteral nutrition significantly decreases infectious complications and length of hospital stay in elective surgery patients. it is possible that the modulation of inflammation and the improvements in immune function reported in these patients receiving impact contribute to the improved clinical outcomes. however, it is not possible to ascribe these benefits to long-chain n- fa. critically ill patients frequently require artificial support, depending upon the extent of organ damage or failure, and this will include nutritional support. the influence of enteral feeds including long-chain n- fa has been examined in critically ill patients; again, many of these studies have involved impact. a study in intensive care unit patients (a mix of trauma, sepsis, and major surgery patients) reported that impact resulted in higher t-cell proliferation at days and ( ), while a study of severe trauma patients reported greater hla-dr expression at day ( ) . these studies did not report improvements in clinical outcomes. studies of impact and similar enteral formulas investigating clinical outcomes in trauma and critically ill patients have been subject to metaanalysis ( ) ( ) ( ) . the most recent of these concluded that this approach to enteral nutrition decreases length of hospital stay but has no effect on infectious complications or mortality in critically ill patients ( ) . another trial performed in patients with moderate and severe acute respiratory distress syndrome used an enteral preparation that differed mainly in lipid source from the control ( ) . the control group of patients (n = ) received a formula in which the lipid source was % corn oil plus % soy lecithin. the experimental group (n = ) received a lipid source that was % canola oil, % medium-chain triglycerides, % borage oil, % fish oil, and % soy lecithin. the experimental formula also contained more vitamin c and vitamin e than the control and it contained β-carotene, taurine, and carnitine, which the control formula did not. patients receiving the experimental formula got about g of epa, g of dha, g of γ-linolenic acid, . g of vitamin c, iu of vitamin e, and . mg of β-carotene per day for d. by d the numbers of total leukocytes and of neutrophils in the alve-olar fluid declined significantly in the experimental group and were lower than in the control group. arterial oxygenation and gas exchange were improved in the experimental group. these patients had a significantly decreased requirement for supplemental oxygen, decreased time on ventilation support ( . vs. . d), and a shorter length of stay in intensive care ( . vs. . d) . total length of hospital stay tended to be shorter in the experimental group ( . vs. . d). significantly fewer patients in the experimental group developed new organ failure ( vs. %). the mortality rate was % in the experimental group and % in the control group, but this difference was not statistically significant. more recently, new data from this study have become available ( ) . patients receiving the experimental formula had significantly lower concentrations of il- in their alveolar fluid and tended to have lower concentrations of ltb and tnf-α. it is possible that the lower concentrations of ltb and il- , both of which are potent leukocyte chemoattractants, may have been responsible for the lower neutrophil infiltration reported in the experimental group, and indeed neutrophil counts were significantly associated with these concentrations ( ) . this study establishes that the experimental treatment decreases production of inflammatory mediators and infiltration of inflammatory leukocytes and that this can result in significant clinical improvement in extremely ill patients. because of the many differences in composition between the experimental and control formulas used it is not possible to ascribe the effects and benefits to any particular nutrient. however, the effects on ltb , il- and tnf-α concentrations are consistent with effects of long-chain n- fa reported elsewhere. recently, data from studies using parenteral nutrition with fish oil in sepsis patients have become available ( , ) . patients received a standard soybean oil-based emulsion or an emulsion containing fish oil for ( ) or ( ) d. blood leukocyte counts and serum c-reactive protein concentration tended to be lower, and production of ltb by stimulated neutrophils was significantly higher in patients receiving long-chain n- fa ( ). production of tnf-α, il- β, il- , il- , and il- by endotoxin-stimulated mononuclear cells did not increase during infusion of the fish oil-containing emulsion whereas production of the four proinflammatory cytokines was markedly elevated during the first d of soybean oil infusion ( ) . these studies establish that infusion of long-chain n- fa into patients with sepsis can modulate inflammatory mediator production and related inflammatory processes. however, the impact of this on hard clinical outcomes in these patients is not yet clear. in summary, long-chain n- pufa from fish oil decrease the production of inflammatory cytokines and eicosanoids. they act both directly, by replacing arachidonic acid as an eicosanoid substrate and by inhibiting arachidonic acid metabolism, and indirectly, by altering the expression of inflammatory genes through effects on transcription factor activation. thus, long-chain n- pufa are potentially useful anti-inflammatory agents and may be of benefit in patients at risk of developing sepsis. an emerging application of n- pufa is in surgical or critically ill patients where they may be added to parenteral or enteral formulas. parenteral or enteral nutrition including n- pufa appears to preserve immune function better than standard formulas and appears to partly prevent some aspects of the inflammatory response. studies to date are suggestive of clinical benefits from these approaches, especially in postsurgical patients. definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis strategies for the treatment of sepsis epidemiology of severe sepsis in the united states: analysis of incidence, outcome, and associated costs of care has the mortality of septic shock changed with time? the epidemiology of the systemic inflammatory response syndrome derangements of coagulation and fibrinoloysis in critically ill patients with sepsis and septic shock tumor necrosis factor and interleukin- in the serum of children with severe infectious purpura procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock predictive value of nuclear factor κb activity and plasma cytokine levels in patients with sepsis passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin anti-cachectin/tnf monoclonal antibodies prevent septic shock during lethal bacteraemia a recombinant human receptor antagonist to interkeukin improves survival after lethal endotoxemia in mice interleukin- controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia mice deficient for the kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to l. monocytogenes infection plasma tumor necrosis factor and mortality in critically ill septic patients persistently elevated soluble tumor necrosis factor receptor and interleukin- receptor antagonist levels in critically ill patients increased soluble interleukin- type ii receptor concentrations in postoperative patients and in patients with sepsis syndrome cytokine signalling-regulation of the immune response in normal and critically ill states anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia potential hazards of combination immunotherapy in the treatment of experimental septic shock tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice treatment of septic shock with the tumor necrosis factor receptor:fc fusion protein gene polymorphisms, inflammatory diseases and cancer tumour necrosis factor (tnf) gene polymorphism influences tnf-alpha production in lipopolysaccharide (lps)-stimulated whole blood cell culture in healthy humans association of tumor necrosis factor (tnf) and class ii major histocompatibility complex alleles with the secretion of tnf-alpha and tnf-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus association of tnf , a tnf-α promoter polymorphism, with septic shock susceptibility and mortality a genetic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis are postoperative complications genetically determined by tnf-β ncoi gene polymprophism? the role of prostaglandin e in immune suppression following injury ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage the acute respiratory distress syndrome delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma the effects of injury on the adaptive immune response sepsis syndromes: understanding the role of innate and acquired immunity major injury leads to predominance of the t helper- lymphocyte phenotype and diminished interleukin- production associated with decreased resistance to infection anti-inflammatory cytokines interleukin reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia interleukin protects mice from lethal endotoxemia the cooperative effects of tnf-α and ifn-γ are determining factors in the ability of il- to protect mice from lethal endotoxemia monocyte hla-dr antigen expression characterises clinical outcome in the trauma patients changes in major histocompatibility complex class ii expression in monocytes and t cells of patients developing infection after surgery monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients dysregulation of in vitro cytokine production by monocytes during sepsis net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin- as a major functional deactivator of human monocytes selective defects of t lymphocyte function in patients with lethal intraabdominal infection relationships between t lymphocyte apoptosis and anergy following trauma sepsis after major visceral surgery is associated with sustained and interferon-γ-resistant defects of monocyte cytokine production coincidence of proand anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-dr expression, procalcitonin, c-reactive protein, and changes in t-cell subsets in septic and postoperative patients n- polyunsaturated fa, inflammation and immunity: pouring oil on troubled waters or another fishy tale? dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview polyunsaturated fatty acids, inflammation and immunity dietary modification of inflammation with lipids n- polyunsaturated fatty acids and inflammation: from molecular biology to the clinic vitro effects of eicosanoids derived from different -carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures the modulatory effects of prostaglandin-e on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype prostaglandin e inhibits tnf production in murine bone marrow-derived dendritic cells prostaglandin e is a potent inhibitor of human interleukin production in murine bone marrow-derived dendritic cells differential regulation of cytokine and cytokine receptor genes by paf, ltb and pge differential effects of prostaglandin derived from ω- and ω- polyunsaturated fatty acids on cox- expression and il- secretion lipid mediator class switching during acute inflammation: signals in resolution endogenous anti-inflammatory mediators from arachidonate in human neutrophils lipoxin a analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis reduced inflammation and tissue damage in transgenic rabbits overexpressing -lipoxygenase and endogenous anti-inflammatory lipid mediators the inhibition of t-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism in vitro effects of eicosanoids derived from different -carbon fatty acids on t helper type and t helper type cytokine production in human whole-blood cultures nuclear factor κb is activated by arachidonic acid but not by eicosapentaenoic acid fatty acids and cytokine mrna expression in human osteoblastic cells: a specific effect of arachidonic acid arachidonic acid-induced il- expression is mediated by pkc-α activation in osteoblastic cells linoleic acid activates nuclear transcription factor-kappa b (nf-kappa b) and induces nf-kappa b-dependent transcription in cultured endothelial cells fatty acid-induced activation of vascular endothelial cells linoleic acid potentiates tnf-mediated oxidative stress, disruption of calcium homeostasis, and apoptosis of cultured vascular endothelial cells unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells effect of linoleic acid on endothelial cell inflammatory mediators linoleic acid-induced vcam- expression in human microvascular endothelial cells is mediated by the nf-kappa b-dependent pathway linoleic acid-stimulated vascular adhesion molecule- expression in endothelial cells depends on nuclear factor-κb activation the effects of short-and long-term supplementation with fish oil on the incorporation of n- polyunsaturated fatty acids into cells of the immune system in healthy volunteers encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions the effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function the effect of dietary supplementation with n- polyunsaturated fatty acids on the synthesis of interleukin- and tumor necrosis factor by mononuclear cells oral (n- ) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women the effect on human tumor necrosis factor a and fatty acids from vegetable oil or fish oil prostaglandin e production and t-cell function after fish-oil supplementation: response to antioxidant co-supplementation effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function dietary ω- polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils n- fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo and in vivo manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach interaction between peroxidase and cyclooxygenase activities in prostaglandin-endoperoxide synthase eicosapentaenoic acid inhibits prostaglandin d generation by inhibiting cyclo-oxygenase- in cultured human mast cells effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of -lipoxygenase pathway products by ionophore-activated human neutrophils effect of docosahexaenoic acid (dha) on arachidonic acid metabolism and platelet function docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis n- fatty acids specifically modulate catabolic factors involved in articular cartilage degradation pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n- fatty acids fatty acid substrate specificities of human prostaglandin-endoperoxide h synthase- and - structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxidase h synthase- separation and quantification of pge following derivatization with panacyl bromide by high pressure liquid chromatography with fluorometric detection human neutrophil chemotactic and degranulating activities of leukotriene b (ltb ) derived from eicosapentaenoic acid characterization and biologic properties of , -dihydroxy derivatives of eicosapentaenoic acid, including leukotriene-b and the double lipoxygenase product synthesis of -series and -series leukotrienes in the lung microvasculature challenged with escherichia coli hemolysin: critical dependence on exogenous free fatty acid supply impact of arachidonic acid versus eicosapentaenoic acid on exotoxin-induced lung vascular leakage-relation to -series versus -series leukotriene generation alteration of n- fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction anti-inflammatory lipid signals generated from dietary n- fatty acids via cyclooxygenase- and transcellular processing: a novel mechanism for nsaid and n- pufa therapeutic actions novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega- fatty acids via cyclooxygenase -nonsteroidal antiinflammatory drugs and transcellular processing resolvins: a family of bioactive products of omega- fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals novel docosatrienes and s-resolvins generated from docosahexaenoic acid in urine brain, human blood and glial cells: autocoids in anti-inflammation novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression neuroprotectin d : a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress the omega- fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin- fish oil decreases macrophage tumor necrosis factor gene transcription by altering the nfκb activity modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω- fatty acid is associated with differential cyclooxygenase- protein expression and is independent of interleukin- nf-κb inhibition by ω- fatty acids modulates lps-stimulated macrophage tnf-α transcription eicosapentaenoic acid prevents lps-induced tnf-α expression by preventing nf-κb activation the anti-catabolic effects of n- fatty acids fish oil modulates macrophage p / mitogen-activated protein kinase activity induced by lipopolysaccharide fish oil suppressed cytokines and nuclear factor kappab induced by murine aids virus infection dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice n- pufa supplementation, monocyte pca expression and interleukin- production inhibition of tumour necrosis factor-α and interleukin- production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects the ability of fish oil to suppress tumor necrosis factor-α production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor α production enhanced survival to endotoxin in guinea pigs fed iv fish oil emulsion endotoxin challenge after menhaden oil diet: effects on survival of guinea pigs effects of continuous tube feeding of dietary fat emulsions on eicosanoid production and on fatty acid composition during an acute septic shock in rats eicosapentaenoic acid reduces pulmonary edema in endotoxemic rats influence of butter and of corn, coconut and fish oils on the effects of recombinant human tumour necrosis factor-α in rats attenuation of the febrile response in guinea pigs by fish oil enriched diets diets enriched with n- fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs long-term feeding with structured lipid composed of medium-chain and n- fatty acids ameliorates endotoxic shock in guinea-pigs effects of eicosapentaenoic and γ-linolenic acids (dietary lipids) on pulmonary surfactant composition and function during porcine endotoxemia dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoids biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats effects of a fish oil diet on pig's cardiopulmonary response to bacteremia effects of endotoxin on pigs prefed omega- vs omega- fatty acids-enriched diets select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs fatty acids and lymphocyte functions the effect of highly purified eicosapentaenoic and docosahexaenoic acids on monocyte phagocytosis in man influence of dietary supplementation with long-chain n- or n- polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults lack of effect of foods enriched with plant-or marine-derived n- fatty acids on human immune function the influence of different combinations of γ-linolenic acid, stearidonic acid and epa on immune function in healthy young male subjects fish oil supplementation inhibits the expression of major histocompatibility complex class ii molecules and adhesion molecules on human monocytes effect of long-term fish oil supplementation on vitamin e status and lipid peroxidation in women dietary supplementation with omega polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin beta content but not monokine secretion in healthy and insulin dependent diabetic individuals dietary supplementation with γ-linolenic acid or fish oil decreases t lymphocyte proliferation in healthy older humans fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model dietary omega- fatty acids decrease mortality and kupffer cell prostaglandin e production in a rat model of chronic sepsis the fatty acid composition of maternal diet affects lung prostaglandin e levels and survival from group b streptococcal sepsis in neonatal rat pups parenteral supplementation with a fish oil emulsion prolongs survival and improves lymphocyte function during sepsis essential fatty acids influence survival in stress dietary fish oil supplementation in experimental gram negative infection and in cerebral malaria in mice fish oil decreases natural rresistance of mice to infection with salmonella typhimurium dietaey fish oil reduces survival and impairs bacterial clearance in c h/hen mice challenged with listeria monocytogenes influence of dietary (n- ) polyunsaturated fatty acids on leukotriene b and prostaglandin e synthesis and the time course of experimental tuberculosis in guinea pigs effect of dietary (n- ) and (n- ) fatty acids on in vivo pulmonary bacterial clearance by neonatal rabbits analysis of the incubation period for measles in the epidemic in greenland in using a variance components model total parenteral nutrition in the critically ill patient: a meta-analysis inhibition of lymphocyte proliferation in vitro by two lipid emulsions with different fatty acid compositions a prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients effect of different types of total parenteral nutrition on t-lymphocyte subpopulations and nk cells effects of different lipid emulsions on lymphocyte function during total parenteral nutrition intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation the effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in postoperative trauma impact of omega- fatty acid enriched tpn on leukotriene synthesis by leukocytes after major surgery influence of a total parenteral nutrition enriched with ω- fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery immunomodulation by perioperative administration of n- fatty acids impact of fish oil enriched total parenteral nutrition on dna synthesis, cytokine release and receptor expression by lymphocytes in the postoperative period perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients clinical outcome and immunology of postoperative arginine fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calories/low fat iv solutions immune and nutritional effects of early enteral nutrition after major abdominal operations enteral nutrition with supplemental arginine, rna, and omega- fatty acids in patients after operation: immunologic, metabolic, and clinical outcome a prospective, randomised clinical trial on perioperative feeding with an arginine-, omega- fatty acid-, and rna-enriched enteral diet: effect on host response and nutritional status perioperative immunonutrition in patients undergoing cancer surgery enteral nutritional supplementation with key nutrients in patients with critical illness and cancer-a meta-analysis of randomized controlled clinical trials immunonutrition in the critically ill: a systematic review of clinical outcome should immunonutrition become routine in critically ill patients? a systematic review of the evidence effect of enteral nutrition on in vitro tests of immune function in icu patients: a preliminary report influence of arginine, omega- fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma and the enteral nutrition in ards study group ( ) effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome ) ω- vs, ω- lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation parenteral nutrition with fish oil modulates cytokine response in patients with sepsis key: cord- -m wqk rh authors: rook, graham a. w.; taverne, janice; playfair, john h. l. title: evaluation of tnf as antiviral, antibacterial and antiparasitic agent date: journal: biotherapy doi: . /bf sha: doc_id: cord_uid: m wqk rh nan the toxic effects associated with release of tnf during acute infections have been well publicised. they are very striking, but make little "biological sense" in evolutionary terms. however it is now becoming clear that tnf plays an important role in resistance to infection, and the toxic effects may represent protective mechanisms which have got out of control. in this paper we first review the evidence for this protective role and the mechanisms which are likely to be involved, and then consider whether it may be possible to exploit the beneficial effects without concomitant toxicity. protective effects in vivo deduced from effects of neutralizing antibody to tnf a lethal infection with listeria monocytogenes causes detectable levels of tnf to appear in the serum of mice, whereas a sublethal infection does not [ ] . nevertheless tnf plays a role in these sublethally infected animals, because neutralising antibody raised against murine tnf will exacerbate the disease [ ] [ ] [ ] and mg of rabbit antibody to murine tnf given hours before infection with . ld of l. monocytogenes resulted in % mortality by days. on the other hand such antibody had little effect if given on day or later, suggesting that the protective role of tnf is mostly during the early phase of the infection. similarly neutralising anti-tnf caused enhanced proliferation of m. boris (bcg) in mice if given early, before the classical t cell-dependent granulomata have formed [ ] . this effect of antibody to tnf is not confined to experiments with facultative intracellular bacteria, since infections with plasmodium vinckei [ ] and leishmania major [ ] were also exacerbated. direct evidence for the protective role of tnf in vivo has been obtained by the injection of recombinant tnf. this has been found to limit infection with leishmania major [ ] , plasmodium spp. [ , ] , trypanosoma cruzi [ ] , toxoplasma gondii [ ] and mycobacterium avium [ ] , and to accelerate clearance of legionella pneumophila [ ] . it will also protect mice from streptococcus pneumoniae and from klebsiella [ ] . moreover, it was observed that c h/hej mice, which produce little cytokine in response to the lps of gram negative bacteria, were -fold more susceptible to a lethal infection with escherichia coli than the congenic, lps-sensitive c h/hen mice. the c h/hej mice could be protected from > ld 's by pretreatment with a combination of il- and tnf [ ] . therefore, in this model of gram negative infection the tnf itself seems to be protective. conversely, tnf can be an essential component of a lethal pathway which accompanies gram negative septicaemia, and neutralisation of tnf, rather than administration of yet more of the cytokine, was protective in a baboon model [ ] . such apparent discrepancies indicate that the timing and dose of tnf may be critical. there is evidence for this in other models. thus tnf can protect mice from lymphocytic choriomeningitis virus (lcm) if it is given before severe inflammation has developed in the brain, but causes accelerated death if given after this has occurred [ ] . the timing of the administration of tnf to mice infected with trypanosoma musculi is also critical, though the reverse of the situations described above. in the case early treatment seems to result in increased growth of the parasite, while if given late, after the parasitaemia has stabilised, the tnf can enhance clearance [ ] . in order to make sense of these apparently conflicting observations, it is necessary to consider the source of tnf during infection, and the mechanisms by which tnf may exert its protective effects. tnf plays a protective role during infection with such a wide variety of organisms, that it is not surprising to find a similarly wide distribution of microbial components able to induce its production. the lipopolysaccharides (lps) of the gram negative organisms are the most studied, but the somewhat analogous lipoteichoic acids (lta) of gram positive cocci [ ] and phosphatidyl inositol mannosides (lipoarabinomannan or lam) of the mycobacteria [ ] are equally potent. other bacterial components which appear to have this property include the toxic shock syndrome toxin of staphylococci (tsst- ) [ ] , a streptococcal cell wall preparation [ ] , and muramyl dipeptide (mdp), a synthetic analogue of part of the ubiquitous bacterial cell wall peptidogylcan appears to prime for enhanced release of tnf by other bacterial components [ ] . perhaps all micro-organisms trigger release of tnf, and in addition to the organisms already discussed above, legionella [ ], listeria [ ] , malaria parasites [ ] , and candida [ ] all have this property though the active components have not been identified. in the case of malaria, both the blood-stage parasite and released antigens are active, and there is some evidence that the latter may be predominantly glycolipid in nature and act as t-independent antigens [ ] . it remains possible that some organisms do not have the ability to trigger release of tnf. however there have been sporadic reports of lymphokines able to cause release of tnf by pathways which do not appear to involve triggering of appropriately activated cells by a microbial component. if this is so, tnf could be involved in protection against organisms which lack a tnf "trigger". similarly it is possible that membraneassociated tnf is involved in local events which do not require release of free tnf. macrophages and monocytes infected with hiv spontaneously release tnf [ , ] . moreover, the free virus is able to trigger tnf release from uninfected monocytes by cross-linking membrane cd [ ] . the importance of these observations is discussed later. many workers have investigated the possibility that tnf is directly toxic for microorganisms. most of the results have been negative, and remain unpublished. however tnf has been reported to be toxic for trypanosoma musculi in vitro [ ] . tnf can indirectly cause killing of organisms by activating phagocytes. there is strong evidence that tnf can prime neutrophils, so that they subsequently give an exaggerated burst of superoxide or h production when exposued to stimuli such as zymosan [ ] , phorbol myristate acetate (pma) or f-met-leu-phe [ ] . the increased oxidative response to zymosan [ ] , and to opsonised amoebae [ ] was attributed to increased expression of cr [ ] which may also be responsible for the increase in adhesion of tnf-exposed neutrophils to endothelial cells [ ] . these priming effects are rapid. increased adhesion to endothelial cells [ ] is apparent within minutes of exposure to tnf, and priming for enhanced superoxide production is apparent within mins. longer exposure to tnf ( mins to several hours) increased phagocytosis of latex, and adcc [ ] , and in some reports, leads directly to superoxide or h release without any further stimulus [ , ] . however some release of lactate dehydrogenase (ldh) is seen at this time [ ] , implying cell death, so the interpretation is not clear. perhaps the neutrophils are triggered to release tnf while phagocytosing their dying colleagues. nevertheless this may not be an in vitro artefact, and such events could presumably occur in vivo. neutrophils exposed to tnf for several hours in this way are able to disrupt endothelial cell monolayers in vitro [ ] . whatever the details of the activation pro-cess, it is clearly rapid, and can result in enhanced clearance of candida [ ] , and legionella [ ] . there is a report that platelets can also be activated by tnf. if platelets are incubated overnight with schistosomulae in the presence of tnf, the percentage killing is increased, though tnf is not itself toxic to the larvae [ ] . exposure to tnf will cause inhibition of multiplication of trypanosoma cruzi in murine peritoneal macrophages. the tnf can be added after infection has taken place [ ] . other workers found that the effect was not seen using lps-insensitive c h/hej macrophages, and that it could be blocked by adding catalase [ ] . they suggested that the inhibition was dependent on release of h from the tnf-activated cells by contaminating lps. tnf did not inhibit growth of t. cruzi in human fibroblasts [ ] , perhaps because these cells do not make h . tnf had no effect on the intracellular growth of toxoplasma gondii [ ] . nevertheless the same group detected a protective effect of tnf during infection with t. gondii in vivo [ ] , suggesting that direct activation of macrophages is likely to be only one of several protective pathways enhanced by tnf. bermudez and young report that tnf will cause kill of aids-derived strains of mycobacterium avium by human monocytederived macrophages, and by murine peritoneal macrophages in vitro [ ] , while gamma interferon caused increased growth of the organisms in both human and murine cells. these findings are in conflict with much previously published data. gamma interferon induced total stasis of m. tuberculosis [ ] and of m. avium strains not derived from patients with aids (unpublished observations) in murine peritoneal cells. on the other hand tnf had no effect at all on growth of m. tuberculosis in these cell types (rook et al., unpublished) though a small effect is seen using bone-marrow-derived murine macrophages (s. kaufmann, personal communication). therefore, either the aidsderived strains are quite different, or technical problems are significant. as outlined earlier, tnf does exert some protective effect against m. avium in vivo [ ] , but for reasons to be explained below, this does not constitute evidence that its mode of action is by direct activation of the macrophages. as in the case of toxoplasma [ ] , there is more than one mechanism at work. tnf is able to activate nk cells [ ] , and it has been suggested that in synergy with unidentified microbial components, tnf causes release of gamma interferon from these cells [ ] . this could be an important pathway providing the source of gamma interferon in scid mice [ ] , and a simple rationale for the role of tnf in the early t cell-independent phase of response to listeria [ , ] , and bcg [ ] in vivo. moreover it provides a possible explanation for the protective effect of tnf against m. avium [ ] and toxoplasma [ ] in mice. this pathway "makes sense" from an evolutionary point of view, because it means that ifn-gamma is available early after infection, before the t cell response has developed. it will clearly be essential to check whether it is involved in the experiments in mice where tnf or anti-tnf administered early after infection, are found to modify the disease [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] . it should be noted that if this is how tnf protects mice against m. avium, it is irrelevant to human infections with mycobacteria, since all authors agree that ifn-gamma has no effect on the growth of mycobacteria in human macrophages [ ] . tnf increases the killing of schistosomulae by eosinophils [ ] but a study of direct influences of tnf on degranulation, enzyme release, and oxidative metabolism of eosinophils revealed minimal effects so the mechanism of the tnf-enhanced cytotoxicity is not known [ ] . basophils and mast cells tnf does not appear to activate these cell types [ ] . other sections of this issue deal in detail with the immunomodulatory and pro-inflammatory effects of tnf, and the relationships between tnf and the production of other cytokines and mediators. clearly these topics are all relevant to its role in protection against infection, but they are not reviewed again here. only certain important experiments directly involving infection are outlined. exposure of hep- cells (derived from a human carcinoma of the larynx) to tnf renders them resistant to invasion by salmonella typhimurium [ ] and inhibits intracellular growth of chlamydia trachomatis [ ] . the latter effect is partly reversed by neutralising antibodies to ifn-beta, and also by addition of tryptophan. the authors concluded that the tnf induced secretion of ifn-beta, which in synergy with the tnf augmented tryptophan-depleting enzyme activity. tnf did not inhibit growth of t. cruzi in human fibroblasts [ ] . the ability of tnf to influence cells not belonging to the immune system is particularly relevant in the context of viral infections. several cell lines have been shown to be protected from viral cytopathic effect by tnf, and virus yield and viral protein synthesis were reduced. cell lines in which these effects were observed include hep- , human embryonic lung fibroblasts (hel & wi- ), and mouse embryonic fibroblasts (mef) [ ] , and human lung (a ) and renal ( ) carcinomas [ ] . susceptibility to the tnf-mediated effect was not related to the transformed phenotype, or to inherent sensitivity to the cytotoxic effect of tnf [ ] . tnf will protect from both rna (emcv and vsv) and dna viruses (adenovirus- , hsv- ) and acts synergistically with gamma interferon [ ] . in at least one cell line the protection is mediated indirectly via induction of ifn-beta [ ] though this is probably not so in every case, and several pathways may exist. tnf inhibits activation of human b cells by epstein-barr virus in the presence of macrophages. this seems to be due to production by the macrophages of an unidentified soluble factor [ ] , and might represent a useful role for tnf in malaria, which can act as a cofactor with ebv in the genesis of b cell (burkitt's) lymphoma. thus the a human lung carcinoma is rendered sensitive to the cytotoxic effect of tnf by infection with adenovirus or vsv [ ] , and similar observations have been made with herpes virus [ ] and hiv [ ] . it seems likely that this mechanism can be either protective or severely disabling depending on how many cells in any one vital organ are infected, and so killed, at the time when tnf is released or administered. this could also partly explain the detrimental effect of late administration of tnf to mice infected with lcm virus [ ] . it is possible that the ability of tnf to kill some transformed or virus-infected cells is part of a broader property enabling it to destroy cells which are functionally disturbed. we have found recently that if l fibroblasts are infected with m. tuberculosis (which they take up in large numbers) they become sensitive to killing by very low levels of tnf in the absence of emetine or actinomycin d. the intracellular mycobacteria do not cause any obvious alterations in protein synthesis, (assessed by s-methionine labelling, followed by analysis of the sds-page-separated proteins in a beta scanner), but when such cells are exposed to a normally non-toxic level of tnf, protein synthesis ceases promptly (filley, rook et al., in preparation) . this phenomenon is also seen using a normally tnf-resistant subclone of the l line supplied by dr. n. matthews. since neutralising antibody to tnf exacerbates infection with listeria or m. boris (bcg) if given early, before granulomata have formed [ , , ] , it was suggested that induction of granuloma formation might be a function of tnf. in fact these experiments could equally be explained by the tnf/nk cell/ifn-gamma pathway described earlier. nevertheless it has been shown that tnf conjugated to sepharose beads can cause granuloma formation in mouse lungs [ ] . induction of tolerance to tnf treatment of rats with a single low intravenous dose of tnf protected them from a potentially lethal dose given hours later. similarly it protected against the lethal effects of lps, or caecal ligation and puncture [ ] . this suggests that tnf could conceivably be used prophylactically in patients in whom septicaemic episodes were anticipated. the mode of action may be tachyphylaxis. on the other hand tnf is known to lead secondarily to production of il- [ ] , and this cytokine induces a pattern of acute phase response involving protease inhibitors, caeruloplasmin and haptoglobin, which may have an antiinflammatory effect [ ] . endogeneously raised levels of tnf correlating with bad clinical outcome in vivo in numerous clinical situations high serum levels of tnf correlate with a poor clinical outcome. these include septicaemia [ ] , and the adult respiratory distress syndrome (ards) [ ] . similarly in malaria tnf has been implicated in severe disease [ ] , and in such complications as anaemia [ ] , and abortion [ ] , and in cerebral malaria in a mouse model [ ] . this has given rise to suggestions for the treatment of gram-negative shock, severe malaria, etc., with regimes aimed at reducing tnf levels, either directly by antibodies or inhibitors, or indirectly by vaccine-induced immunity against the triggering molecules [ ] . in patients with aids high levels of tnf correlate with encephalopathy [ ] . although tnf is reported to kill hiv-infected cells [ ] the consequences of the interaction of these cells with tnf may not be protective. several authors agree that tnf increases virus yield from hiv-infected cells in vitro [ , [ ] [ ] [ ] [ ] , and the mechanism is partly understood [ ] . therefore administration of tnf to individuals infected with hiv may be contraindicated, and there is a report that tnf caused rising levels of circulating hiv antigen in patients undergoing a trial of tnf therapy for kaposi's sarcoma [ ] . since hiv also induces tnf production [ ] [ ] [ ] , this positive feedback may constitute a significant part of the pathogenesis of the disease. it is also interesting that tuberculosis is an early complication of hiv, (unlike m. avium infection which occurs late when t cells are depleted), and seems to lead to fur-ther aggravation of the hiv infection. perhaps this is attributable to synergistic induction of tnf by hiv [ ] [ ] [ ] and by mycobacterial lipoarabinomannan [ ] leading to further activation of the virus. detrimental consequences of administered tnf administration of tnf can induce cachexia, anaemia, inflammation and haemorrhagic necrosis [ ] . however, the systemic toxicity of tnf is greatly increased in the presence of il- or lps [ ] . this may be one of the obstacles which prevents its use in the treatment of infection, since these substances are likely to be present in relevant patients. moreover microbial products, and certain types of inflammatory response "prepare" tissue sites so that they become exquisitely sensitive to tnf, and liable to undergo haemorrhagic necrosis in its presence [ ] [ ] [ ] . this "preparation" of an inflamed site probably involves changes in the properties of endothelial cells (reviewed in [ ] ), and can be brought about both by t cell-independent (lps, [ ] ) and t cell-dependent (low doses of soluble mycobacterial antigen [ ] ) responses to microbial products. this phenomenon probably explains the shwartzman reaction (discussed in [ ] ) in which a skin site prepared by an injection of lps undergoes necrosis if a further dose of lps is given intravenously hours later. this tendency for sites of microbial inflammation to undergo necrosis in the presence of tnf is largely a vascular phenomenon. however, it could be further aggravated if the infection involved resulted in the cells of the relevant organ becoming themselves sensitive to the cytotoxic effects of tnf as described earlier for virus-infected [ , , ] and tuberculosis-infected cells. this has been postulated as the basis of fulminant hepatitis [ ] and a combination of necrotising vasculitis and death of infected cells could help to explain the very rapidly fatal effect of tnf administered late to mice with lcm virus [ ] . should we conclude that the treatment of infectious disease with tnf will be impossible, in spite of the conclusive evidence that this cytokine is an essential part of the normal response to infection? the situation is not quite that bleak. obviously it will be essential to avoid activating hiv, or triggering shock, shwartzman reactions, or fulminant haemorrhagic necrosis of infected organs or foci. on the other hand several recent studies revealed that we know very little about the circumstances under which tnf is or is not toxic. rodents can be desensitised to the toxic effects of tnf [ , ] but we do not yet know whether such desensitisation also eliminates all the many protective effects of the cytokine. still more remarkable is the observation that monophosphoryl lipid a (a non-toxic derivative of lps) will induce serum levels of tnf in mice infected with listeria monocytogenes which are comparable to the levels induced by lps itself, and yet whereas the result is fatal in the lps-treated animals, it is not in those receiving the monophosphoryl compound [ ] . again this implies that the toxicity of tnf involves other agonists, or can be blocked by regulatory substances, but we do not know which, or whether the protective effects would be similarly decreased. there is clearly much scope for further experiment. production of tumor necrosis factor during murine listeriosis endogeneous tumour necrosis factor (cachectin) is essential to host resistance against listeria monocytogenes infection tumor necrosis factor is involved in the t cell-independent pathway of macrophage activation in scid mice the inducing role of tumor necrosis factor in the ment of bactericidal granulomas during bcg infection application of anti-tnf to plasmodium vinckei-infected mice is followed by an increase of parasitaemia tumour necrosis factor plays a protective role in experimental murine cutaneous leismaniasis recombinant tumour necrosis factor inhibits malaria parasite /n vivo but not in vitro inhibition of murine malaria (plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole effect of recombinant tumour necrosis factor on acute infection in mice with toxoplasma gondii or trypanosoma cruzi treatment of experimental disseminated mycobacterium avium complex infection in mice with recombinant il- and tumor necrosis factor protective effects of tumor necrosis factor in experimental legioneua pneumophila infections of mice via activation of pmn function effects of tnf in bacterial infections pretreatment with recombinant murine turnout necrosis factor alpha/cachectin and murine interleukin alpha protects mice from lethal bacterial infection anti-cachectin/tnf monoclonal antibodies prevent septic shock during lethal bacteraemia tumour necrosis factor inhibits the development of viral meningitis or induces rapid death depending on the severity of inflammation at the time of administration effect of tumour necrosis factor on growth of trypanosoma musculi in vivo and in vitro antitumour effects of streptococcal lipoteichoic acids on meth a fibrosarcoma lipoarabinomannan from mycobacterium tuberculosis induces the production of turnout necrosis factor from human and murine macrophages toxic shock syndrome toxin as an inducer of human tumor necrosis factors and gamma interferon release of tumour necrosis factor (tnf) into mouse peritoneal fluids by ok , a streptococcal preparation production of tumour necrosis factor in nude mice by muramyl peptides associated with bacterial vaccines soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo tumor necrosis factor induction by candida albicans from human natural killer cells and monocytes the malaria vaccine: anti-parasite or anti-disease? purified blood monocytes from hiv -infected patients produce high levels of tnf alpha and il- groopman je. production of tumor necrosis factor alpha and interteukin beta by monocytic cells infected with human immunodeficiency virus interleukin- and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type binding to the cd receptor stimulation of neurophils by tumour necrosis factor biochemical mechanisms in the priming of neutrophils by tumour necrosis factor tumor necrosis factor alpha potentiates neutrophil antimicrobial and candida albicans and associated increases in oxygen radical production and lysosomal enzyme release stimulation of the adherence of neutrophils to the umbilical vein endothelium by human recombinant tumour necrosis factor activation of human polymorphonuclear functions by interferon gamma and tumor necrosis factors receptor binding and activation of polymorphonuclear neutrophils by tumour necrosis factor alpha growth inhibition of candida albicans by human polymorphonuclear neutrophils: activation by interferon gamma and tumor necrosis factor recombinant tumour necrosis factors mediate platelet cytotoxicity to schistosoma mansoni larvae activity of recombinant tumour necrosis factor on toxoplasma gondii and trypanosoma cruzi recombinant tumour necrosis factor enhances macrophage destruction of trypanosoma cruzi in the presence of bacterial endotoxin tumour necrosis factor, alone or in combination with il- , but not ifn-gamma, is associated with macrophage killing of mycobacterium avium complex activation of macrophages to inhibit proliferation of mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages in vivo and in vitro induction of natural killer cells by cloned human tumour necrosis factor tumour necrosis factor enhances eosinophil toxicity of schistosoma mansoni larvae modulation of human peripheral blood eosinophit function by tumour necrosis factor alpha comparative effect of recombinant il- , - , - , - , and - , ifn-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histaminereleasing factors on the secretion of histamine from basophils in vitro treatment of hep- cells with human tumour necrosis factor alpha and human interferons reduces invasiveness of salmonella typhimuriuml reversion of the antichlamydial effect of tumour necrosis factor by tryptophan and antibodies to beta interferon antiviral effect of recombinant tumour necrosis factor in vitro tumour necrosis factors alpha and beta inhibit virus replication and synergise with interferons the in vitro antiviral activity of tumor necrosis factor (tnf) in wish cells is mediated by ifn-beta induction tumour necrosis factor selectively inhibits activation of human b cells by epstein-barr virus human tumour necrosis factor alpha kills herpesvirus-infected, but not normal cells cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (hiv): enhancement of hiv replication the role of monokines in granuloma formation in mice: the ability of interleukin- and tumour necrosis factor alpha to induce lung granulomas prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor circulating interleukin during an infusion of tumour necrosis factor and interferon gamma hepatocyte-stimulating factor iii shares structural and functional identity with leukemiainhibitory factor association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease tnf in bronchopulmonary secretions of patients with adult respiratory distress syndrome elevated tumor necrosis factor alpha and interleukin- serum levels as markers for complicated plasmodium facciparum malaria tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis tumor necrosis factor in malariainduced abortion tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected t-cell clone augmentation of human immunodeficiency virus type i gene expression by tumor necrosis factor alpha tumor necrosis factor enhances replication of human immunodeficiency virus (hiv) in vitro tumor necrosis factor alpha activates human immunodeflciency virus type through induction of nuclear factor binding to the nf-kappa b sites in the long terminal repeat intravenous recombinant tumor necrosis factor in the treatment of aids-related kaposi's sarcoma cachectin/tumor necrosis factor induces cachexia, anaemia, and inflammation interleukin-i potentiates the lethal effect of tumour necrosis factor alpha/cachectin in mice synergy between tumour necrosis factor and bacterial products causes haemorrhagic necrosis and lethal shock in normal mice the role of gamma-interferon, vitamin d metabolites and tumour necrosis factor in the pathogenesis of tuberculosis the role of cytokines in the immunopathology of tuberculosis and the regulation of agalactosyl igg tnf as an activator of vascular endothelium does tumor necrosis factor play a role in the pathogenesis of fulminant hepatitis? med hypotheses sensitisation and desensitisation to lethal effects of tumour necrosis factor and il- induction of tumour necrosis factor, ifngamma, and acute lethality in mice by toxic and non-toxic forms of lipid a key: cord- -h txbd p authors: kim, sena; joe, yeonsoo; surh, young-joon; chung, hun taeg title: differential regulation of toll-like receptor-mediated cytokine production by unfolded protein response date: - - journal: oxid med cell longev doi: . / / sha: doc_id: cord_uid: h txbd p the ability of the host immune response is largely mediated by the proinflammatory cytokine production. physiological and pathological conditions of endoplasmic reticulum (er) trigger unfolded protein response and contribute to the development or pathology of inflammatory diseases. under er stress, unfolded protein response (upr) signaling pathways participate in upregulating inflammatory cytokine production via nf-kappab, mapk, and gsk- β. moreover, it has been suggested that er stress crosstalks with toll-like receptor (tlr) signaling pathway to promote the production of proinflammatory cytokines. in addition, tlr stimulation can lead to upr activation to promote inflammation. in this review, we will cover how proinflammatory cytokine production by upr signaling can be induced or amplified in the presence or absence of tlr activation. the endoplasmic reticulum (er) is a crucial site involved in maintaining cellular functions, such as synthesis, modification, releases and translocation of proteins, biosynthesis of steroids, cholesterol and other lipids, metabolism of carbohydrates, and storage of calcium [ ] [ ] [ ] . numerous physiological and pathological conditions including imbalance in the er folding capacity, accumulation of misfolded proteins, altered cellular metabolism, hypoxia, oxidative stress, infection, disruption of er calcium ion balance, or n-linked glycosylation, can trigger the er stress and initiate the unfolded protein response (upr) to restore er homeostasis and ensure cell survival [ , ] . however, if the er stress cannot be resolved, the upr will initiate er stress-associated programmed cell death to protect the organism by removing the stressed cells. when er stress occurred in a cell, three individual er-resident transmembrane branches of upr begin with the dissociation from er chaperon bip/grp , followed by homodimerization and autophosphorylation of protein kinase rna-like endoplasmic reticulum kinase (perk) and inositol-requiring enzyme α (ire α) to activate the cytoplasmic kinase domains [ , ] . in contrast, activating transcription factor (atf ) is translocated to the golgi apparatus and then activated via proteolytic cleavage [ ] . activated perk phosphorylates eif α, which transiently attenuates global mrna translation, therefore reducing protein flux into the er. interestingly, certain mrnas contain small orfs in their ′utr such as activating transcription factor (atf ) can escape inhibition of translation. as a sustained translational inhibition is not compatible with cell survival, atf induces gadd , a regulatory subunit of protein phosphatase (pp ) acting as regulator of phosphorylation of eif α, to restore mrna translation. atf also induces the expression of the transcription factor ddit /chop, which is involved in er stress-mediated apoptosis. ire α has functions of endoribonuclease and serine-threonine kinase. an endoribonuclease activity of ire α is a specific splicing of the xbp mrna, which allow the translation of the spliced xbp (xbp s) transcriptional factor. xbp s has a major role in the induction of a wide variety of chaperones or proteins involved in proteinrefolding, er-associated degradation system, lipid metabolism, and proinflammatory responses [ ] . after dissociation from bip, atf is transported via coat protein copii-covered vesicles to the golgi compartment, where it undergoes intramembrane proteolysis by the golgi enzyme site protease (s p) and s p to produce active n-terminal fragment that translocate to the nucleus. active n-terminal fragment patf -n directly induces the expressions of er capacity and folding-related genes (such as grp , grp , gadd , and xbp ) ( figure ). toll-like receptor (tlrs) can recognize pathogenassociated molecular patterns (pamps) and dangerassociated molecular patterns (damps) and induce tlrmediated intracellular signaling cascades to eliminate the pathogens through the production of proinflammatory cytokines including tnf-α, il- , il- β, and il- , but its uncontrolled activation can damage the host [ ] . sustained proinflammatory cytokine productions often contribute to the development of many inflammatory and autoimmune diseases. upon ligands binding to tlrs, tlrs recruit adaptor proteins, myeloid differentiation primary response (myd ), and/or tir domain-containing adapterinducing interferon-β (trif) and transduce signals through interleukin- receptor-associated kinase (irak), tnf receptor-associated factor (traf), tgf-β-activated kinase (tak ), and receptor-interacting protein (rip ). in general, the myd -dependent response mediates the induction of proinflammatory cytokine, whereas the trif-dependent response mediates the induction of type ifn response. traf interacts with both myd and trif, but it differentially regulates mapk signaling pathway and type i ifn signaling pathway, respectively [ ] . tlr and activation elicit traf ubiquitination which is the key to selective proinflammatory cytokine production through mapk activation or type i ifn response through interferon regulatory factor (irf ). traf ubiquitination by traf and ubiquitin ligase ciap / resulted in mapk activation and induction of proinflammatory cytokines in a myd -dependent manner [ ] . blockade of traf ubiquitination inhibits proinflammatory cytokine production through suppression of mapk activation without anti-inflammatory cytokine production, il- , and type i ifn responses. thus, myd -dependent signaling cascades by tlr stimulation result in the activation of nf-kappab and mapk, which are the central mediators of cytokine production ( figure ). er stress has been shown to regulate proinflammatory cytokine production, which are mediated by tlr signaling cascade components such as nf-kappab, mapk, and gsk- β. studies have demonstrated that various metabolic syndromes are associated with chronic metabolic inflammation and impairment of er function and established a link between inflammatory responses through the tlr signaling and er stress response [ ] [ ] [ ] [ ] . in recent studies on inflammatory diseases due to er stress, inflammation was observed in models of tunicamycin-induced acute liver failure and various cancers [ , ] . these reports may indicate the link between er stress and inflammation, but the regulation of tlr-mediated proinflammatory cytokine production by upr signaling is not completely understood. ozcan et al. found a mechanism of er stress-induced inflammation in white adipose tissue in high-fat diet-induced obese mice [ ] . according to a study, it was provided that ire α aggravates inflammation and the phenotypes of obesity through the switching of m -m macrophage polarization in a cell-autonomous manner [ , ] . in addition, er stress shares tlr-mediated signaling components with pro-and anti-inflammatory cytokine productions, leading to the activation of nf-kappab and mapks. the xbp deletion or chemical chaperone treatment in macrophages alleviates proinflammatory cytokine production by lps. in this review, we discuss er stress and tlr-mediated signaling pathways for the regulation of proinflammatory cytokine production that linked er stress to inflammation. upr is an important modulator in the induction of inflammatory cytokines, and upr activation was shown to be sensitive to inflammation [ ] . it has been well established that nf-kappab activation is required for the induction of proinflammatory cytokines and has been linked to upr [ , [ ] [ ] [ ] . the perk-induced inhibition of translation results in decreased translation of iκb, which is a negative regulator of the nf-kappab, therefore leading to greater activation and translocation of nf-kappab transcription factor to the nucleus [ , ] . a kinase activity of ire α directly triggers iκb phosphorylation in a traf -dependent manner, which results in the activation of nf-kappab [ ] . atf also activates nf-kappab via phosphorylation of the akt [ ] . these results indicate that upr is sufficient to induce the proinflammatory mediator production such as il- , il- β, tnf-α, and il- through nf-kappab activation. mapks (jnk, p , and erk) are also important inflammatory signaling molecules that induce inflammatory cytokines in response to er stress [ , ] . chen et al. showed that hiv protease inhibitors (pis) induce proinflammatory cytokines, tnf-α, and il- through er stress-mediated erk activation, and these effects are diminished in chop knockout macrophages [ ] . thus, chop is responsible for hiv pi-induced erk activation and proinflammatory cytokine production. the ire α can activate jnk in a traf dependent manner, leading to the increased expression of proinflammatory cytokines through activator protein (ap ) [ ] . mijosek et al. demonstrated that er stress induces phosphorylation of erk, p , and jnk through mainly perk and atf pathways in human primary bronchial epithelial cells resulting in increased expressions of il- and il- [ ] . mapk signaling pathways are involved in regulating the expression of inflammatory cytokines and er stress-induced inflammatory cytokine productions that are also dependent upon the mapk activation ( figure ). tlr in proinflammatory cytokine production for the eradication of invading microbial pathogens. fritz et al. demonstrated that tlr and nod and nod agonists lead to promote the production of proinflammatory cytokine in human monocytes and dendritic cells [ ] . roles of tlrs and nod /nod on innate immune response have been proposed, but the nod /nod signaling during er stress-induced inflammation is not clear. under er stress condition, ire α branch in er transmembrane is oligomerized and autophosphorylated. activated ire α binds traf (tnf receptor-associated factor ) to induce proinflammatory cytokine production via nf-kappab signaling [ ] . yan and liu showed that chemical er stress inducers, thapsigargin and dithiothreitol, induced proinflammatory cytokine il- in a nod / -dependent manner. in addition, brucella abortus strain rb induces il- production through traf -, nod / -, and rip -dependent signaling pathway and could be abolished by er stress inhibitor, tauroursodeoxycholic acid (tudca), or an ire α kinase inhibitor. recently, yan and liu demonstrated that leucine-rich repeat kinase -(lrrk -) dependent nod activation by er stress has a new positive regulator of rip in inducing inflammatory cytokine in macrophages [ ] . therefore, these studies suggest that nod / activation with tlr is a new mechanism for er stress-induced proinflammatory cytokines. inflammasome regulates il- β and il- expression and maturation [ ] . studies have revealed that upr-induced nf-kappab activation and ros generation are responsible for il- β and il- secretions [ ] . kim and il- β production in rb -infected or er stress inducertreated bmdm, but not lps + atp-treated bmdm [ ] . brucella abortus strain rb induces immune signaling through the induction of er stress. notably, er stressinduced mitochondrial damage was required for the noncanonical nlrp inflammasome activation, which was mediated by ire α, caspase- , bid, and mitochondrial content release (mitochondrial-derived damage associated molecular patterns, mtdmap) in an asc-independent manner. overall, er stress regulates il- β and il- production during chemical stress or microbial infection through canonical and noncanonical inflammasome activation. numerous studies have demonstrated that gsk- β is a key regulator of inflammatory cytokine production in er stress and tlr signaling [ , ] . gsk- β was found to strongly promote the production of proinflammatory cytokines by tlr-induced myd -dependent and myd -independent pathways, and the inhibition of gsk- β was shown to protect the host from several inflammatory diseases such as colitis, arthritis, and sepsis-induced organ failure [ ] . studies by martin et al. reported that stimulation of monocytes or peripheral blood mononuclear cells with tlr , tlr , tlr , or tlp agonists induces substantial increases in il- production while suppressing the release of proinflammatory cytokines after gsk- β inhibition [ ] . in addition, lps-induced gsk- β activation induces nf-kappab activation and inhibits c/ebpβ, creb, and ap- transcriptional activities, diminishing the production of the antiinflammatory cytokine, il- . moreover, the inhibition of gsk- β suppresses stat activity resulting in reduced levels of il- in lps-treated mice and lps-cultured primary glial cells [ , ] . er stress was also associated with increased activity of gsk- β through the reduction of serine phosphorylation and promotion tyrosine phosphorylation by akt inhibition and ire α activation, respectively [ , , ] . the pi k-akt pathway has been shown to negatively regulate proinflammatory cytokine production through gsk- β inactivation [ ] . guha and mackman showed that the inhibition of pi k-akt pathway enhances lps-induced tnf-α production through mapks (erk, p , and jnk) and nuclear translocation of nf-kappab which induces the transactivation of p through gsk- β activation [ ] . likewise, the inhibition of gsk- β with licl reduces lps-induced tnfα in pbmcs and thp- monocytic cells, suggesting that gsk- β positively regulates proinflammatory cytokine, tnf-α, through the reduction of transactivation of p without nuclear translocation of nf-kappab. therefore, the activation of gsk- β by er stress-mediated pi k-akt inhibition enhances the nf-kappab-dependent inflammatory cytokine production. recently, kim et al. demonstrated that gsk- β has a role in inducing inflammatory cytokine during er stress [ ] . the authors showed that the production of the proinflammatory cytokines il- β and il- is triggered by the er stress inducers thapsigargin and tunicamycin or lps in a gsk- β-dependent manner. however, tnf-α is regulated by ire α-mediated xbp splicing, independently of gsk- β ( figure ). these findings provide evidence for previously uncharacterized functions for gsk- β on er stress in the regulation of the immune response. recent studies have shown that er stress influences toll-like receptor-mediated intracellular signaling cascades involved in the activation of innate and adaptive immune responses [ , , ] . mahadevan et al. demonstrated that tlr ko bmdm treated with er stress inducers shows decreased production of proinflammatory cytokines (il- , il- p , and tnf-α) compared with wt bmdm [ ] . on the other hand, tlr ko bmdm exposed to er stress shows no decreased production of proinflammatory cytokine and increases the production of mip- α, mip- β, and mcp- , suggesting that tlr may normally function as a negative regulator in response to er stress-induced proinflammatory cytokine responses. on the other hand, shimasaki et al. showed that er stress enhances tlr -dependent proinflammatory cytokine production (tnf-α, il- , and il- ) through atf mediated tlr upregulation [ ] . these data suggest that er stress-related proteins affect proinflammatory cytokine production through modulating tlr signaling. toll-like receptor-mediated activation of intracellular signaling pathways results in increased production of proinflammatory cytokines including tnf-α, il- , and il- β. similarly, the activation of tlr ligands affects upr signaling pathways. microbial infection and tlr ligand treatment lead to the induction of upr-related protein activation and gene expression, suggesting that upr appears to closely interact with host immune response [ ] [ ] [ ] . it was demonstrated that tlr and tlr activate ire α-xbp axis without perk phosphorylation and atf activation and promote the production of proinflammatory cytokines [ ] . in addition, xbp -deficient macrophages reduce il- production in response to tlr agonists or infection with pathogen [ ] . these evidences suggest that tlr-mediated ire α activation is intimately linked with inflammatory signaling pathways. several reports have shown that the concomitant treatment of tlr ligands and er stress-inducing chemicals synergize the production of proinflammatory cytokines (ilβ and il- ) [ , ] . this amplified cytokine production can be regulated at the level of both the transcription and translation. according to some reports, this synergism depends on the p , erk, and gsk- β activations. mijosek et al. demonstrated that er stress-mediated p and erk activation is able to boost the production of inflammatory cytokines such as il- and il- in tlr-(tlr , tlr , and tlr ) stimulated airway epithelial cells. this synergic effect is mainly mediated by the activation of p and erk via perk and up-regulated p expression via atf [ ] . on the other hand, pharmacological activation of xbp or overexpressing xbp s with the er stress inducers synergistically augments tlr-mediated il- and tnf-α productions. in addition, kim et al. showed that er stress inducer significantly augments lps-induced proinflammatory cytokines (i.e., tnf-α, il- β, and il- ) and gsk- β activity in raw . macrophages and bmdm [ ] . rao et al. demonstrated that kupffer cells isolated from -pba-treated ischemic liver or atf -downregulated kupffer cells from ischemic liver produce significantly less tnf-α and il- after stimulation with lps [ ] . thus, atf activation in ischemic liver induces enhancement of proinflammatory cytokine production of macrophage in response to tlr . thus, the er stress and tlr activation synergize the production of proinflammatory cytokines. some reports have shown that immune-enhancing drugs can boost the immune response to protect septic patients with the later immunosuppressive stage. given that er stress can restore cytokine production under endotoxin tolerance, it may be helpful to use er stress induction to increase the cytokine production in the immune-depressed state. thus, it is possible that er stress under endotoxin tolerance condition might restore the immune capability to defend the host from infection. indeed, er stress inducers enhance clearance of bacteria through recovery of immune response under endotoxin tolerance condition (unpublished data). thus, er stress figure : interactions of downstream pathways of ire α for the transcriptional regulation of il- β and tnf-α in response to er stress. er stress-induced ire α activation differentially regulates il- β and tnf-α through gsk- β activation and xbp splicing, respectively. ire αmediated gsk- β activation induces transcription of il- β but inhibits xbp splicing. thus, sb , a gsk- β inhibitor, selectively inhibits il- β gene expression and increases tnf-α production in response to er stress. in contrast, ire α-mediated xbp activation results in the transcription of tnf-α. stf , ire α rnase inhibitor, suppresses tnf-α production without affecting il- β production. in addition, activation of xbp by er stress inducers synergistically augments lps-mediated tnf-α production. likewise, gsk-β activation by er stress inducer augments lps-mediated il- β. the inflammatory response due to er stress is frequently observed in the development of nonmalignant immunological disorders, such as rheumatoid arthritis and neurodegenerative diseases [ ] . evidences have shown that er stress enhances tlr-induced intracellular cascades to produce proinflammatory cytokines (table ) . however, more research is needed to understand the role of er stress in host immune responses and to exploit this knowledge to design new drugs for patients with various inflammatory and metabolic diseases. overall, this review emphasizes that the er stress-induced inflammatory cytokine productions are shared with tlr-mediated signaling pathways and taking advantage of er stress may be used as therapeutic option to prevent inflammatory diseases and protect secondary infection in septic patients through recovery of immune responses. the authors declare that there are no conflicts of interest regarding the publication of this article. chapter five -endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration endoplasmic reticulum stress and unfolded protein response in infection by intracellular parasites the role of er stress in lipid metabolism and lipotoxicity misfolded proteins, endoplasmic reticulum stress and neurodegeneration the unfolded protein response, degradation from the endoplasmic reticulum, and cancer endoplasmic reticulum stress, unfolded protein response, and cancer cell fate activation of mammalian unfolded protein response is compatible with the quality control system operating in the endoplasmic reticulum the interplay between endoplasmic reticulum stress and inflammation inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics different modes of ubiquitination of the adaptor traf selectively activate the expression of type i interferons and proinflammatory cytokines essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex endoplasmic reticulum stress and the inflammatory basis of metabolic disease endoplasmic reticulum stress and inflammation in obesity and diabetes xbp links er stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease s-nitrosylation links obesityassociated inflammation to endoplasmic reticulum dysfunction endoplasmic reticulum stress-activated glycogen synthase kinase β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure liver inflammation and metabolic signaling in apc min/+ mice: the role of cachexia progression chemical chaperones reduce er stress and restore glucose homeostasis in a mouse model of type diabetes the metabolic er stress sensor ire α suppresses alternative activation of macrophages and impairs energy expenditure in obesity er stress promotes inflammation through re-wired macrophages in obesity emerging functions of the unfolded protein response in immunity er stress-induced inflammation: does it aid or impede disease progression a molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress from endoplasmicreticulum stress to the inflammatory response endoplasmic reticulum stress pathway perk-eif α confers radioresistance in oropharyngeal carcinoma by activating nf-κb er stress activates nf-κb by integrating functions of basal ikk activity, ire and perk a new paradigm: innate immune sensing of viruses via the unfolded protein response activation of the akt-nf-κb pathway by subtilase cytotoxin through the atf branch of the unfolded protein response er stress depresses nf-κb activation in mesangial cells through preferential induction of c/ebpβ the unfolded protein response in immunity and inflammation hiv protease inhibitor lopinavir-induced tnf-α and il- expression is coupled to the unfolded protein response and erk signaling pathways in macrophages coronavirus infection, er stress, apoptosis and innate immunity endoplasmic reticulum stress is a danger signal promoting innate inflammatory responses in bronchial epithelial cells synergistic stimulation of human monocytes and dendritic cells by toll-like receptor and nod -and nod -activating agonists nod and nod signalling links er stress with inflammation lrrk enhances nod / -mediated inflammatory cytokine production by promoting rip phosphorylation il- β processing in host defense: beyond the inflammasomes dysregulated il- β secretion in autoinflammatory diseases: a matter of stress? endoplasmic reticulum stress is sufficient for the induction of il- β production via activation of the nf-κb and inflammasome pathways endoplasmic reticulum stress activates the inflammasome via nlrp -and caspase- -driven mitochondrial damage allosteric inhibition of the ire α rnase preserves cell viability and function during endoplasmic reticulum stress toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase glycogen synthase kinase β in toll-like receptor signaling glycogen synthase kinase : a point of convergence for the host inflammatory response ifn-γ suppresses il- production and synergizes with tlr by regulating gsk and creb/ ap- proteins central role of glycogen synthase kinase- β in endoplasmic reticulum stress-induced caspase- activation endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol -kinase/akt and increased glycogen synthase kinase- β in mouse insulinoma cells the phosphatidylinositol -kinase-akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells endoplasmic reticulum stress-induced ire α activation mediates cross-talk of gsk- β and xbp- to regulate inflammatory cytokine production the molecular chaperone grp contributes to toll-like receptor -mediated innate immune response to hepatitis c virus in hepatocytes cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells endoplasmic reticulum stress increases the expression and function of toll-like receptor- in epithelial cells bacteria, the endoplasmic reticulum and the unfolded protein response: friends or foes? diverse roles of endoplasmic reticulum stress sensors in bacterial infection initiation of innate immune responses by surveillance of homeostasis perturbations tlr activation of the transcription factor xbp regulates innate immune responses in macrophages atf mediates a proinflammatory synergy between er stress and tlr activation in the pathogenesis of liver ischemia-reperfusion injury key: cord- -kl ev authors: garcia, elisa; aguilar-cevallos, jorge; silva-garcia, raul; ibarra, antonio title: cytokine and growth factor activation in vivo and in vitro after spinal cord injury date: - - journal: mediators inflamm doi: . / / sha: doc_id: cord_uid: kl ev spinal cord injury results in a life-disrupting series of deleterious interconnected mechanisms encompassed by the primary and secondary injury. these events are mediated by the upregulation of genes with roles in inflammation, transcription, and signaling proteins. in particular, cytokines and growth factors are signaling proteins that have important roles in the pathophysiology of sci. the balance between the proinflammatory and anti-inflammatory effects of these molecules plays a critical role in the progression and outcome of the lesion. the excessive inflammatory th and th phenotypes observed after sci tilt the scale towards a proinflammatory environment, which exacerbates the deleterious mechanisms present after the injury. these mechanisms include the disruption of the spinal cord blood barrier, edema and ion imbalance, in particular intracellular calcium and sodium concentrations, glutamate excitotoxicity, free radicals, and the inflammatory response contributing to the neurodegenerative process which is characterized by demyelination and apoptosis of neuronal tissue. traumatic spinal cord injury (sci) is a complex, lifedisrupting medical condition due to the detrimental effects on social, familiar, and personal life, which include in the majority of cases permanent paralysis due to the low regenerative capacity of the central nervous system (cns). sci triggers a series of interconnected mechanisms that can be divided into the primary and secondary injury. the direct and immediate physical disruption of neurons, glial cells, and blood vessels makes up the primary injury. in turn, the secondary injury consists of a cascade of autodestructive cellular and molecular mechanisms that exacerbate the primary injury and lead to an enlargement of the initial area of trauma [ ] [ ] [ ] [ ] . several mechanisms take part in this latter phase of the injury, including vascular disruption, increased blood-spinal cord barrier permeability, ionic dysregulation, edema, excessive intracellular calcium concentration, glutamate excitotoxicity, lipid peroxidation, an autoreactive inflammatory reaction, and apoptosis [ ] . ultimately, the sum of these processes causes cell death, demyelination, and axonal degeneration at the epicenter of injury and the surrounding regions. these cellular and molecular changes that occur early after sci alter gene expression profiles, which is characterized by a significant upregulation of genes with roles in transcription, inflammation, and signaling proteins [ ] . evidence suggests that the consequent inflammation mediated by cytokines, growth factors, and related molecules plays a role in both the damage and repair of injured neural tissue [ ] [ ] [ ] . the critical balance between these processes plays a major participation in the progression and outcome of a neurodegenerative process [ ] . cytokines encompass a large family of small signaling proteins involved in intercellular communication that are normally associated with the immune response and its mediators of inflammation modulation but have pleiotropic effects in the physiology of health and disease including cellular growth, survival, and differentiation. these molecules, which can be classified as peptides, proteins, or glycoproteins, are secreted by numerous cells and can be grouped into a proinflammatory or antiinflammatory category on the basis of the final balance of their effects [ ] . subsequently, growth factors are proteins synthesized by a wide variety of cells that stimulate cellular survival, chemotaxis, proliferation, and differentiation [ , ] . the aim of this review is to expose the role of cytokines and growth factors within the pathogenesis of sci, since the study of these molecules could bring to light novel potential therapeutic targets that could reduce the degenerative processes that occur after sci. cord injury barrier. the blood-cns vascular barriers consist of complexes of adherence junction proteins and tight junctions, astrocyte endfeet, perivascular microglia, pericytes, and continuous capillary endothelial cells embedded in the basement membrane that separate and protect the cns from metabolites and neurotoxic substances present in the systemic circulation [ ] [ ] [ ] . this infrastructure allows the blood brain barrier (bbb) and blood spinal cord barrier (bscb) to regulate the transport of molecules, the interaction between the cns and the immune system, and helps maintaining homeostasis in the brain and spinal cord. one of the earliest events ensuing traumatic sci is the disruption of the bscb by a mechanical force that destroys neural tissue and tears neuronal and endothelial cell membranes [ ] . the resulting inflammatory response disturbs the microenvironment of the spinal cord, alters vascular permeability, facilitates the entry of peripheral immune cells, and exposes the adjacent noninjured tissue to potentially noxious molecules [ , ] . these molecules include early inflammatory cytokines such as interleukin (il- ) and tumor necrosis factor (tnf ); in addition, they might include nitric oxide (no • ), reactive oxygen species (ros), elastase, and matrix metalloproteinase- (mmp- ) [ ] . the importance of the bscb is evidenced by the positive correlation between increased barrier disruption and improved motor locomotion days after sci [ ] [ ] [ ] . an additional consequence of such disruption is a series of regulatory changes in the transport systems for selective cytokines that may induce regenerative or destructive effects. in particular, there is an upregulation of the transport system of tnf after sci that remains saturable despite bscb disruption. the increase of tnf takes place before other cytokines in sci and is mediated by the receptor-based transport composed by tnfr (p ) and tnfr (p ) [ ] . tnf has a role in inflammation, myelin destruction, apoptotic neuronal cell death, and astrocyte toxicity. nevertheless, this cytokine is also capable of stimulating neurite outgrowth, secretion of growth factors, and tissue remodeling [ ] . it has been suggested that tnf has a dual role: deleterious in the acute phase, but beneficial in the chronic phase after sci [ ] . similarly, leukemia inhibitory factor (lif) utilizes a transport system mediated by lifr (gp ), which is upregulated by barrier disruption, but remains saturable despite this event [ , ] . lif is involved in the activation of microglia/macrophages and in the proinflammatory response in sci [ ] . contrastingly, lif has been shown to prevent oligodendrocyte apoptosis in mice with sci after overhemisection, notably contralateral to the spinal cord lesion, through the induction of the jak/stat and akt signaling pathways as well as by potentiating the expression of the antiapoptotic molecule, ciap . reduced oligodendrocyte apoptosis after sci with lif administration resulted in a substantial decrease in demyelination shown by the preservation of lamellated myelin surrounding viable axons and deposition of the degraded myelin basic protein. the data suggest that lif signals survival in oligodendrocytes after sci, prevents the secondary wave of demyelination, and thereby reduces inhibitory myelin deposits and enhance locomotor recovery [ ] . imbalance. immediately after contusive sci, the rupture of the blood-cns barrier causes water to accumulate in the extracellular compartment and results in the production of neural tissue edema [ , ] . this is a process that may aggravate the initial injury and result in paraplegia or even death [ ] . the subsequent increment in vascular permeability and the formation of edema could also be in part mediated by the vascular endothelial growth factor (vegf) and proto-oncogene tyrosine-protein kinase (src/c-src) which exists downstream of vegf [ ] . it is worth noting that administration of vegf has resulted in an increase in permeability of the bscb from the acute to chronic phase, which is interesting since it is regarded to be a component involved in angiogenesis, neurogenesis, and locomotor recovery [ ] . as the secondary injury progresses, this fluid accumulation in the cns becomes characterized by ionic imbalance, which consists of an increase in the intracellular concentration of na + and ca + , in conjunction with an elevated extracellular concentration of k + and mg + [ ] [ ] [ ] . consequently, the na + and ca + ions attract water molecules into the cell and cause edema. the resulting fluid accumulation then propels the compression of adjacent tissues and the development of ischemia, which leads to more autodestructive phenomena such as free-radical production, lipid peroxidation, and inflammation. it is important to note that the edema that occurs after contusive sci is directly related to the initial trauma and motor dysfunction experienced by the affected individual [ , ] . astrocytes are the principal regulators of water transport in the cns, where they are additionally linked to the maintenance of ion homeostasis, spatial buffering of extracellular potassium, calcium signal transduction, adult neurogenesis, and neurotransmitter uptake and release [ ] [ ] [ ] . a molecule expressed in astrocyte endfeet, astrocyte processes, and the basolateral membrane of ependymal cells is aquaporin (aqp ), the predominant water channel in the cns [ ] . recent studies indicate that aqp regulates the beforementioned astrocytic functions [ ] . moreover, the absence of aqp has been shown to reduce proinflammatory cytokines in astrocytes such as tnf and interleukin- (il- ) after cns injury [ ] . it is important to mention that the role of aqp in the resolution of edema is still under debate [ ] . nevertheless, evidence demonstrates that aqp has an essential role in the formation and distribution of edema and that it is intrinsically involved in the development of the inflammatory process after an insult to the cns [ ] . on the other hand, neurons regulate synaptic transmission and neural plasticity by the activation of membrane receptors and channels in adjacent neurons. released neurotransmitters can bind to inhibitory (gaba)ergic receptors or excitatory glutamate receptors such as amino- -hydroxy- -methyl- -isoxazolepropionic acid (ampa), n-methyl-daspartate (nmda), kainate, and metabotropic receptors [ ] . in the locomotor networks of the spinal cord, ca + activated, apamin-sensitive k + channels (sk) control the firing of constituent neurons and regulate the locomotor rhythm. voltagegated ca + channels (vgccs), such as n-type ca + channels, are considered the main activators of sk channels [ ] , which during early development play a role in neurite outgrowth and functional neuromuscular synapse organization [ ] . nmda receptors, besides controlling evoked neurotransmitter release, also play a role in the activation of sk channels in dendrites [ , ] . sk channels have been found to regulate hippocampal synaptic plasticity, learning, and memory, particularly sk channels [ ] . synaptic transmission involves ca + and employs calmodulin (cam) dependent kinases (camkiiv), protein kinase c, protein kinase a, ip kinase, ca + -dependent phosphatase calcineurin b, cyclic amp phosphodiesterase, adenylyl cyclase, lca + -dependent neuronal nitric oxide synthase (nos), and calpains, which are ca + activated proteases [ , ] . in the first few minutes following sci, oxidative stress, lipid peroxidation, and membranous deposition of protein aggregates take place. these processes impair ca + pumps and cell membrane channels, including those present in the endoplasmic reticulum. this downregulation is evidenced by an increased concentration of cytosolic ca + from extracellular pools and intracellular ca + storages [ ] . in normal conditions, the energy-dependent ca + buffering system within axons removes the excess ca + . however, when adenosine triphosphate (atp) is depleted by the excessive energy demands of demyelination, this normal ca + buffering fails and the level of intracellular ca + rises until it becomes toxic [ ] . the result is the chaotic activation of processes such as proliferation, differentiation, apoptosis, and gene transcription in cells [ ] . in addition to the before-mentioned channels, axons also have a high concentration of voltage-gated na + channels spread along the length of their bodies. thus, when axonal demyelination occurs, there is a dramatic increase in na + influx into the cell during the action potential propagation. the elimination of such an excess concentration of intracellular na + can come at a steep metabolic expense in a similar fashion to ca + removal, since the na + /k + atpase maintains the na + electrochemical gradient by atp consumption [ , ] . when atp levels fall below a certain threshold, there is a concomitant increase in the intra-axonal concentration of na + and ca + . consequently, glutamate is released, and the na + /ca + exchanger, which normally pumped out ca + in exchange for na + , is reversed [ , ] . it is also important to mention that the subsequent release of atp after the lesion increases in peritraumatic areas for or more hours [ ] . this excessive release of atp by the traumatized tissue after sci is followed by the activation of high affinity purinergic p x receptors. it is important to note that the p x receptors may also contribute to the excessive influx of ca + since they are upregulated in response to the atp release induced by sci. this might explain why spinal cord neurons respond to atp with excessive firing, followed by irreversible increases in ca + that end up in cell death [ , ] . furthermore, p x rs have been associated with cells of the immune system that mediate cytotoxic cell death (because of changes in transmembrane ion fluxes, swelling, and vacuolation) and those that mediate inflammatory responses, including proinflammatory mediators such as il- and tnf [ , ] . glutamate receptors are involved in the excitatory neurotransmission of the mammalian cns, where they participate in various changes in the efficacy of synaptic transmission, and induce excitotoxic damage in a variety of acute and chronic neurological disorders [ , ] . the process of excitotoxicity refers to the excessive receptor activation by this excitatory amino acid that results in neuronal death [ ] . just min after sci, glutamate levels at the epicenter and surrounding regions become six times higher than physiological levels due to the overstimulation of ionotropic receptors and the massive increase of intracellular ca + and na + . this glutamate influx provokes overexcitation and endotoxicity by the secondary increase of intracellular ca + and the activation ca + dependent signaling pathways as previously mentioned [ ] [ ] [ ] . moreover, the augmented expressions of genes related to neurotransmitter receptors (nmda, ampa, ach, gaba, glur, and kainate) increase demyelination and oligodendrocyte destruction [ , ] . an important mechanism for the reduction of excessive extracellular glutamate is the activity of glutamate transporters such as glial glutamate transporter (glt- ) and glutamate aspartate transporter (glast), which are primarily expressed by astrocytes [ ] . unfortunately, the excitotoxicity induced by the extracellular glutamate concentration is enhanced by the reduced uptake by astrocytes and the microglia release tnf , il- , and ros that exacerbated the neural damage [ ] . tnf and il- have been shown to cause oligodendrocyte death when the latter are placed in coculture with both astrocytes and microglia. both cytokines inhibit glutamate transporters in astrocytes and thus expose oligodendrocytes to an excessive glutamate concentration. it is important to note that antagonists of ampa/kainate glutamate receptors such as nbqx ( , -dioxo- -nitro- -sulfamoilbenzo(f)quinoxalina) and cnqx ( -cyano- -nitroquinoxaline- , -dione) blocked il- toxicity towards oligodendrocytes [ ] . tnf causes excitotoxicity through a series of interconnected, deleterious mechanisms. first, microglia release this cytokine in the inflammatory response, which induces additional release of tnf . in turn, it causes the release of glutamate that acts on metabotropic receptors of microglia and stimulates more tnf release. subsequently, astrocytes are stimulated to release glutamate, which is not effectively transported back into the soma. lastly, the rise in the excitatory/inhibitory ratio causes the excessive ca + entry and excitotoxic neuronal death previously described. the consequent neuronal death caused by the excessive glutamate concentrations further stimulates microglia to remain in an active state, which includes the production and release of tnf in a vicious cycle [ ] . tnf potentiates cytotoxicity by glutamate through an increased localization of glutamate receptors such as ampa and nmda while decreasing inhibitory gaba receptors on neurons [ ] , which explains why nbqx blocked tnf toxicity to oligodendrocytes [ ] . in the destruction of neurons, nerve fibers, glial cells, and blood vessels at the site of injury, where approximately % of neurofilament constitutive proteins are degraded in h, and % are lost within h after the injury [ ] . proteins such as cathepsin b, y, and s, members of the cysteine lysosomal proteases and papain superfamily, have been linked to neurofilament destruction. this link results from the fact that cathepsin b can degrade myelin basic protein, cathepsin y can produce a bradykinin, and cathepsin s can degenerate extracellular molecules through inflammatory mediators. in particular, only cathepsin s is able to retain its activity after prolonged incubation at neutral ph, more than h [ , ] . the expression of this protease is restricted to cells of the mononuclear phagocytic system such as microglia and macrophages [ ] . a basement membrane heparan sulfate proteoglycan (hspg), perlecan, which was found to promote mitogenesis and angiogenesis, can be degraded by cathepsin s in vitro. hspgs have roles in adhesion, protease binding sites, and growth factor regulation as is the case for basic fibroblast growth factor (bfgf) [ ] . furthermore, cathepsin s degrades laminin, fibronectin, collagens, and elastin at acidic or neutral ph [ ] . it is known that tnf , interferon-(ifn ), il- , and granulocyte macrophage colony stimulating factor (gmcsf) stimulate the release of active cathepsin s into an environment with a neutral ph [ ] . subsequently, a change in lipid metabolism and the homeostasis of lipid mediators is an alternate route by which genes are thought to modulate the susceptibility of nervous tissue to trauma. interestingly, altered protein cleavage, one of the main driving forces of protein aggregation in neurodegenerative disorders, can be further enhanced by trauma occurring in the presence of specific lipid-binding proteins, important molecules in charge of the distribution of lipids and the transport of cholesterol among cells in the cns. apolipoprotein e (apoe) is one particular example of this phenomenon, since a reduction in its availability causes a reduction in the recovery after neurotrauma or an ischemic insult. apoe fragments are produced by traumainduced proteolytic cleavage, which, in turn, might disrupt the cytoskeleton by the phosphorylation of tau and the promotion of neurofibrillary tangles. at the same time, apoe increases the inflammatory effect of neurotrauma by a significant increase of il- , tnf , and no • in the injured tissue [ , ] . radicals. microvascular disruption, ionic imbalance, increased intracellular calcium levels, glutamate excitotoxicity, mitochondrial dysfunction, arachidonic acid breakdown, and the activation of inos contribute to the formation of free radicals (fr) [ ] . fr are reactive molecules produced by the metabolism of the cell that possess an unpaired electron, which easily reacts with biomolecules by oxidizing them [ ] . a fr is made up of sulphur (s), nitrogen (n), chloride (cl), or carbon (c). these elements associate with oxygen and form other fr such as no • . metals such as fe, mn, co, ni, and cu can also be considered fr since they have unpaired electrons [ , ] . many of these molecules are either reactive oxygen species (ros) such as delta and sigma oxygen ( the mechanical reduction of the superoxide anion mediated by nad(p)h oxidases causes the anion to react with no and form a neurotoxic compound known as peroxynitrite [ ] . at physiologic ph, peroxynitrite first reacts with proteins and phospholipids and then breaks down into other cytotoxic products such as no • , nitrogen dioxide (no ), and oh − radicals. hall and braughler demonstrated the occurrence of early posttraumatic lipid peroxidation (lp) as early as min after injury. lp is a mechanism that disrupts the normal structure and function of the lipid bilayers that surround the cell and membrane-bound organelles. when peroxynitrite or other fr takes an electron off a polyunsaturated lipid, it generates a lipid radical (l • ) that can further interact with molecular oxygen and yield a lipid peroxyl radical (loo • ). then, if the resulting lipid peroxyl radical loo • is not reduced by antioxidants, lp associated with sci induces early damage to the spinal microvascular endothelium (within - h). as a direct consequence of this damage, there are crater formation, platelet adherence, leucocyte presence, and the formation of microemboli, events that are concurrent with the reduced blood flow to the white matter of the spinal cord. the damage to the myelin sheath unhinged a demyelination process that is the particularity of a neurodegenerative process [ ] . the cns is particularly sensitive to lp because of its high content of peroxidation-susceptible lipids (arachidonic, linoleic, and docosahexaenoic acid) and the primarily radical-mediated oxidative protein damage. considering the timeframe of the injury, the oxidative damage to dna and lipids, in addition to protein nitration, is observed within the first week after injury [ ] [ ] [ ] [ ] [ ] [ ] [ ] . one of the degradation products of peroxynitrite, no • , alters the mitochondrial electron transport chain and induces the production of fr. these molecules have direct deleterious effect on enzymes with iron-sulfur clusters in their catalytic core, such as ubiquinone succinate [ ] . after sci, the concentration of no • increases to times more than baseline levels and reaches its peak at h. meanwhile, there is an increased production of inducible nitric oxide synthase (inos) and peroxynitrite [ ] . the resulting elevated no • concentration induces cell damage and lipid peroxidation, increases vascular permeability, and causes edema [ ] . hence, due to its involvement in the previous processes, no • participates in the development of the excessive glutamate and calcium concentrations that induce excitotoxicity [ ] . it is known that no • is produced by different synthases. however, only inos is capable of producing a high concentration of no • for a prolonged period of time [ ] . collectively, astrocytes, neutrophils, monocytes, and microglia induce the expression of inos at the presence of proinflammatory stimuli such as lipopolysaccharide (lps), ultraviolet radiation (uv), and tnf , il- , il- , and ifn [ ] . in some studies, the expressions of inos and its protein activity were found h, h, h, and h after sci [ , , ] . the inflammatory response is a characteristic phenomenon of innate immunity that does not require a previous exposition to the agent but does increase substantially with subsequent expositions as the response becomes specific and direct. cellular immunity consists of specialized cells that can recognize, endocyte, and eliminate different types of microorganisms or noxious substances. on the other hand, the humoral response is composed by soluble macromolecules that circulate in the blood and extracellular liquid that acts upon the pathogen [ , ] . sci presents different patterns of gene expression depending on the cell type and activation phase [ ] . numerous studies have suggested that the inflammatory response in sci is beneficial, because it can eliminate tissue debris and induce the release of various neurotrophic factors [ , , ] . nevertheless, this inflammatory response tends to go out of control when it exacerbates autoreactive mechanisms that cause neural destruction. traumatic sci triggers inflammatory reactions in which various types of cells, cytokines, and neuroprotective/neuroregenerative molecules are involved [ ] . . . . cells of the inflammatory response. immediately after the rupture of the blood-spinal cord barrier, the consequent inflammatory response involves the participation of chemical mediators, and resident (astrocytes and microglia) and peripheral (macrophages, lymphocytes) immune cells [ , ] . additionally, oligodendrocytes, neurons, and endothelial cells participate in the cellular response after sci [ ] , in which microglia and endothelial cells function as antigenpresenting cells (apc) [ ] . throughout the inflammatory response, the infiltration of immune cells is the principal contributor to neural degeneration [ ] . these cells are guided to the lesion site from the periphery by the effect of chemokines and cytokines that are mainly released by microglia, astrocytes, and peripheral macrophages, which make up the principal resource of these molecules in the lesion site [ , [ ] [ ] [ ] [ ] . the released cytokines include il- , il- , il- , tnf , gm-csf, and lif [ ] . the neurons of human patients expressed these molecules, min after sci, and microglia, h after the lesion; however, the expression decreased by the nd day [ ] . similar results were obtained in mice and rats since the expression by local neurons was found at h, and at h by microglia, which decreased to baseline on day after sci [ ] . the expression of tnf and il- by microglia and astrocytes was identified - min after the lesion. the peak expression was at h for tnf and h for il- [ ] . after sci, two waves of cellular infiltration have been characterized. the first wave consists of polymorphonuclear leukocytes (pmn) that predominate throughout the first hours following the lesion. they are activated by il- , interleukin- (il- ), and il- in particular [ ] and might be mainly recruited by chemokine (c-c motif) ligand (ccl ), chemokine (c-x-c motif) ligand (cxcl ), and chemokine (c-x-c motif) ligand (cxcl , also called macrophage inflammatory protein -alpha (mip -alpha)) [ ] . these cells become apparent in the walls of veins and venules adjacent to the lesion in the first - h and can be observed inside the tissue - h after the lesion. it has been found that these cells represent % of the infiltrating cells h after the injury [ ] . the inflammatory response is evidenced by the increased quantity of leukocytes in the cerebrospinal fluid, the infiltration of pmn in the lesion site, the increment in the leukotriene levels (ltb in particular), and the activity of myeloperoxidase. in addition, a significant increase in the expression of intercellular adhesion molecule (icam- ) can be identified, which favors the infiltration of neutrophils from the first to h after the lesion [ ] . the second wave of infiltration is characterized by the presence of monocytes and macrophages, which can be observed around - days after sci [ ] . various chemokines are known to mediate macrophage infiltration such as ccl , cxcl , and cxcl [ ] . this demonstrates how important the recruitment of macrophages is after an injury to the cns [ , ] . activated microglia become evident in the first day after sci [ ] ; moreover, there is a peak in the proliferation and recruitment of microglia from day to day [ , ] . the overexpression of lif has been found to cause a dramatic increase in the proliferation of microglia/macrophages and astrocyte activation [ ] . the pathological proliferation of macrophages and microglia might contribute to the subsequent exacerbation of the initial damage [ , ] , even though macrophages have an important role in the clearing of denatured dendrites [ ] . microglia at the injury site rapidly express the alarmin il- , while infiltrating neutrophils and macrophages produce il- which plays a role in the infiltrating mechanism of these cells. interestingly, the expression of il- mediates the suppression of the survival factor tox (tox high mobility group box family member ) in oligodendrocytes, which in the absence of such cytokine would provide protection of this cell population, and functional recovery after sci [ ] . diverse studies have reported that the recruitment of leukocytes to the injured spinal cord is a physiological response that is associated with the production of cytokines and protein kinases that are involved in the repair of the site of lesion. neutrophils, for example, are the first cells to be recruited with the objective of clearing the lesion site from possible pathogens and cellular debris through phagocytosis. however, the activation of these cells also induces the release of a significant amount of neurotoxins such as ros, rns, chemokines, and a variety of enzymes that promote tissular destruction [ , , ] . the taoka report provides evidence demonstrating that after sci the maximum peak of neutrophil migration perfectly correlates with the extent of the damage and the motor alterations observed after the lesion [ ] . the infiltration of monocytes and macrophages after sci has for its objective the removal of cellular debris and the stimulation of new blood vessel and parenchymal cell formation. the infiltration of these cells regulates the activation and proliferation of t lymphocytes since they play the role of apc [ ] . microglia are pluripotent cells capable of developing different phenotypes proportional to the severity of the lesion, which determines the intensity of the inflammatory response, the quantity of recruited cells, and the magnitude of the immunological response. this can be explained by the interaction between microglia and t lymphocytes, since it induces an antigen specificity that regulates the immune response and the subsequent phases [ ] . microglial cells are distributed throughout the cns, where they serve as a pathological sensor that is activated in response to noxious stimuli such as physical trauma or vascular obstruction [ ] . activated microglia migrate to the site of injury, proliferate, and transform from the resting phenotype (ramified cells) to amoeboid phagocytic cells [ ] . in fact, after sci, activated microglia can be seen at the epicenter of the lesion initially at h [ ] . in addition, there is an upregulation of surface receptors such as cr (complement receptor type ) and mhc ii (major histocompatibility complex) whose implications are covered in several papers of our group. these activated microglia can then release a series of cytokines, chemokines, and enzymes, which are proportional to the activating stimulus as mentioned previously. the series encompass il- , il- , tnf , tgf- (transformation growth factor- ), m-csf [ ] , inos, ngf (neural growth factor), nt- (neurotrophin- ), and bndf (brain neuronal derived factor) [ , ] . interestingly, monocyte derived microglia and macrophages might be able to induce regeneration by the secretion of neurotrophic factors, particularly tgf- [ ] . activated microglia and macrophages have been implicated in the secondary pathology that accompanies traumatic or autoimmune injuries to the brain and spinal cord [ ] . the associated implications usually refer to the activation of these cells towards an inflammatory m phenotype; however, these cells can also be activated towards an m macrophage phenotype that responds to il- and il- . this contrasting phenotype is characterized by the production of several extracellular matrix proteins that may promote tissue remodeling, repair, neurotrophic support, and axonal regeneration [ ] [ ] [ ] [ ] . taking into account the excessive release of glutamate and the feedback of the inflammatory response after sci, it is no surprise that microglia acquire a reactive phenotype that expresses very low quantities of the mhc ii molecules and is not capable of maintaining an adequate interaction with t lymphocytes [ , ] . the m phenotype is characterized by the excessive release of no • , il- , il- , and tnf , which leads to toxicity. in these conditions, astrocytes and postsynaptic neurons show signs of damage, evidenced by the expression of ros, which can induce apoptosis [ ] . nevertheless, activated microglia remove the cellular debris after the lesion and are capable of promoting revascularization in the site of injury, which facilitates the release of trophic factors and nutrients for the survival and proliferation of infiltrating cells in the lesion site [ ] . furthermore, microglia are capable of expressing glutamate transporters, which apparently help buffer the excessive concentrations of glutamate, and consequently protect cells from toxicity [ , ] . it is important to take the before-mentioned into account since activated microglia and peripheral macrophages make up the majority of inflammatory cells present in the site of lesion, especially since these cells are morphologically different and respond to different modulatory signals [ ] in an early response of the innate immunity to the lesions of the cns, which have diverse etiologies such as ischemia and neurotrauma [ , ] . therefore, given that in the brain and the spinal cord there is a considerable heterogeneity of macrophages, the relative contribution of one population of cells in the local inflammatory reaction can dictate whether a cascade of events initiates as a regenerative or a destructive process. this all depends on the macrophage phenotype activated, particularly microglia [ ] . in regard to t-lymphocyte infiltration in humans, it might be detected months after the injury, and b-lymphocytes are not usually found [ ] . on the other hand, mice models present both cell types days after sci, with a peak at days [ ] . lymphocytes are the cells that modulate the intensity of the inflammatory response. traditionally, their participation after sci has been linked with the damage to neural tissue since they are capable of producing proinflammatory cytokines such as inf and il- . on one hand, inf is linked directly to neuronal destruction since it induces the expression of other proinflammatory cytokines (tnf , il- , il- , and il- ), and proinflammatory molecules such as ros and inos, since it participates in the induction of transcription factors including nf (nuclear factor kappa beta) and ap- (activator protein- ) [ , , ] . in addition, inf is known to participate in the induction of a cytolytic response by tcd + (cd, cluster of differentiation) since it is the principal inductor of mhci through the phosphorylation of stat (signal transducers and activators of transcription- ) [ ] . moreover, the chemoattractant, c-x-c motif chemokine (cxcl ) recruits cd th cells via the cxcr a receptor [ ] . after the induction of protective autoreactivity, which is a strategy based on the modulation of the immune response by neural derived peptides, diverse studies have reported that the presence of t lymphocytes with a th phenotype in the lesion site favors functional recovery [ ] [ ] [ ] . this is due to their ability to synthesize ngf, bdnf, and diverse neurotrophins (nt , nt , and nt ) [ , ] . in a classical th activation pattern, however, the inflammatory response after sci can be responsible for the necrosis of the lesion site and the surrounding area [ ] [ ] [ ] . to further explore this phenomenon the cytokine expression was analyzed in comparison to sham animals and the dominant phenotype was found to be th and th predominantly according to expectations [ , ] . this is due to its important role in the generation of free radicals, cytokines, and chemokines that exacerbate the damage to the neural tissue for weeks or even months. it is important to point out that this noxious effect occurs when the immune response is not modulated, since it is correlated with excitotoxicity, lipid peroxidation, and the development of an autoreactive response towards neural constituents [ , , , , ] . contrastingly, this response can either increase the damage to the neural tissue, promote protection [ ] [ ] [ ] [ ] , or even promote restoration of the injured tissue [ , , ] as a function of neuromodulation. the autoreactivity observed after sci is characterized by the specific immune response, with lymphocytes being the only cells capable of specifically recognizing the antigens, and initiating the adaptive immune response. despite the existence of mechanisms by which these autoreactive t cells are eliminated or inactivated, these are not sufficient, and consequently they can be found in practically every healthy individual. thus, autoreactivity can be part of a normal immune response that can find its origin in several infectious and inflammatory diseases. however, when this mechanism is excessive, the result is an autoimmune disease [ ] [ ] [ ] . there are multiple diseases that are considered to be autoimmune or to have an autoimmune component. multiple sclerosis (ms) is one of such diseases. it is an inflammatory, demyelinating disease, in which an autoimmune response to mbp [ ] has been reported. interestingly, after sci, an autoreactive phenomenon similar to the pathophysiology of ms can be observed. consequently, it is well-known that the lymphocyte role after sci is fundamental, because these cells are responsible for the generation of autoimmunity in individuals with genetic susceptibility [ , , ] . these events can become chronic if the proinflammatory environment is not regulated. if not regulated, the response would involve the participation of other immune cells, other signaling pathways, and other patterns of gene expression. the persistent influx of immune cells from the systemic circulation as neutrophils, macrophages, lymphocytes, basophils, and eosinophils is correlated with additional elevation of proinflammatory cytokine levels and neural tissue destruction that would unavoidably make tissue recovery more difficult [ , , ]. cytokines comprise a large family of small signaling proteins that affect nearly every biological process including embryonic development, disease, nonspecific infection response, cognitive functions, aging, cellular growth, survival, and differentiation [ , ] . these "cytokines," which can be classified as peptides, proteins, or glycoproteins, encompass interferons, interleukins, the chemokine family, the tumor necrosis factor family, adipokines, and mesenchymal growth factors [ , ] . these molecules are produced by one cell and go on to act on another cell in order to bring a change in the function of the target cell. the difference with hormones is that cytokines are products of most cells while not being of a particular tissue or cell. the majority of cytokines function by binding to specific cell surface receptors; this action triggers intracellular signaling and activates transcription factors such as ap- and nf [ ] . interestingly, the diverse properties of a single cytokine can be explained by the following mechanisms: the first mechanism involves the presence of the receptor of a certain cytokine in one particular type of cell (e.g., il- receptor on mast cells) [ ] . the second mechanism is explained by the presence of the receptor to a specific cytokine on most cells (e.g., activation of nf by il- , or tnf induction of cox- ). the third mechanism encompasses the ability of cytokines to induce or function as coactivators (e.g., il- induces ifn when il- is present, but when it is not, il- induces fas ligand) [ ] . despite the fact that cytokines are studied in every discipline of biology, the effects of these molecules are mostly studied in the realm of inflammation, immunology, cancer, and atherosclerosis [ ] . in these areas, cytokines can be grouped into a proinflammatory or anti-inflammatory category on the basis of the resulting balance of their added effects [ ] . in the cns, cytokines have homeostatic physiologic and neuromodulatory functions. surprisingly, they also have the capability of contributing to neuronal damage and destruction when their concentration exceeds a certain threshold. one of the reasons as to why they cause such damage and destruction lies in the uncontrolled inflammatory response observed after sci, which emphasizes the reason behind the augmented study of these molecules in inflammation-related research. the upregulation of these cytokines, as well as the consequent cellular infiltration they cause, plays a crucial role in the determination of the extent of the secondary tissue damage and neural degeneration observed after the injury [ , , ] . therefore, taking into account that the production and release of proinflammatory cytokines and chemokines (table ) is the first inflammatory event that develops after sci, the importance of these molecules becomes clear [ , ] . in regard to the realm of inflammatory cytokines, there is a clear diversity in their functions. for starters, certain molecules are capable of inducing vascular permeability and cellular fluid loss, which include components of the complement cascade (c a and c a), which in turn cause the release of histamine, prostaglandins, and leukotrienes from resident mast cells. specific inflammatory cytokines such as tnf , il- , and il- are synthetized by various cells in the cns and are known as mediators of the peripheral immune response [ , ] il- (i) high levels h ai, concentrations remain during days and decrease days ai (i) neuroinflammatory regulation in various pathological conditions (ii) confers regenerative properties to macrophages (iii) controls free radical production in peripheral macrophages and microglia [ , [ ] [ ] [ ] [ ] [ ] [ ] [ ] il- (i) detected day ai (i) macrophage activation onto m phenotype [ , ] ip- /cxcl (i) expressed locally [ , [ ] [ ] [ ] mediators of inflammation [ , [ ] [ ] [ ] mcp /ccl (i) detected from h ai with pl at h and remains low up to days ai (i) macrophage and pmn infiltration mediator [ , , , , ] min: minutes; ai: after injury; pl: peak levels. mediators of inflammation [ ] [ ] [ ] . on one hand, tnf immediately recruits neutrophils to the site of the lesion by the induction of adhesion molecules such as icam- and vcam- (vascular cell adhesion molecule- ), as it stimulates the release of il- , which is a chemotactic factor for neutrophils. furthermore, tnf alters the permeability of endothelial cells and damages the blood-spinal cord barrier. moreover, this cytokine is able to exert cytotoxic activity towards oligodendrocytes and contributes to demyelination. in addition, tnf also stimulates the proliferation and hypertrophy of astrocytes, hereby promoting the formation of the fibroglial scar, which acts as a barrier to a possible regeneration of the cns as a biological measure of last resort in response to an uncontrolled chronic inflammation [ ] [ ] [ ] . on the other hand, studies have shown that a direct injection of il- into the spinal cord leads to enhanced vascular permeability and lymphocyte recruitment. subsequently, il- has been found to promote the activation and infiltration of macrophages and microglia [ , ] . in fact, it is known that il- is a major player in chemokine infiltration, because it has the ability to interact with other cytokines and neurotrophic factors [ , ] . interestingly, several studies have revealed that the continuous inhibition of il- is detrimental to functional recovery because it also participates in axonal regeneration and gliosis, in line with the role of tnf in chronic inflammation [ , ] . thus, it is important to take into account that the mediation of the early inflammatory tissue damage may actually worsen the functional outcome [ ] . this leads to a conflict, since the role of inflammation after sci appears to be contradictory when the beforementioned and following points are taken into account [ ] . on one hand, proinflammatory cytokines, il- and il- , are beneficial at low concentrations due to their induction of neurotrophin expression and the mediation of leukocyte activation/recruitment to the injury site by the induction of adhesion molecules in the cell surface such as icam- , p-selectin, and e-selectin [ , ] . on the other hand, at higher concentrations, these inflammatory cytokines activate transcription factors such as nf , ap , and atf, factors that stimulate the expression of neurotoxic genes, including cox- , inos, and proinflammatory proteases in different target cells [ , , ] . pan found that the mrnas of cytokines such as tnf , il- , il- , and il- could be detected min after injury. from these cytokines, il- and il- continually reached peak levels until the h but were not present from the to h after sci. in addition, by h after contusive sci, significantly increased mrna levels of il- a and il- were clearly detected by qrt-pcr [ , ] . digging further into the time frame of expression, western blot studies found that the mature form of il- is expressed by the h. this evidence suggests that the inflammatory cytokine is released very quickly after tissue damage. the expression of these genes was identified h after contusive rat sci by cdna microarrays [ ] . the procedure was then repeated in spinal cord injury patients, and the same results were observed [ ] . moreover, hayashi found that after sci the mrnas of cytokines such as tnf and il- were upregulated in as little as - h after the lesion [ , , ] . on another note, tnf mrna peaked quickly min after the injury and fell slightly by the min. tnf mrna remained elevated by day after sci, returned to a low level by day , and was not detected by day [ ] . il- mrna increased slowly, reached peak levels by - h, and fell by h [ ] . it is important to note that the levels of these mrnas were nearly undetectable in sham-injured animals. another study found that, between h and h after sci, the gene expression of proinflammatory cytokines such as il- , il- , il- , and their receptors was strongly upregulated [ ] . tnf and il- induce both il- and tnf mrnas. consequently, the downregulation of the signaling of il- and tnf reduces the induction of il- mrna [ ] . this suggests that the activity of these cytokines contributes to their own mrna regulation [ , ] . from the h and up to h, tnf , il- , il- , and lif were found to be strongly upregulated in and around the contused area. these cytokines were produced at the same time range. it is worth noting that another wave of expression was observed for tnf and il- at days, which correlates with an increased blood-spinal cord barrier function [ ] . in particular, the overexpression of lif has been found to cause a dramatic increase in the proliferation of microglia/macrophages and astrocytic activation [ ] . tnf is released significantly faster than other proinflammatory cytokines, because this is stored in a preformed state on the cell surface and in the granules of mast cells. it is not a surprise that role of this cytokine is similar to that of il- given the facts stated above [ ] . it is important to note that tnf is the principal promoter of wallerian degeneration since it activates resident schwann cells in the peripheral nervous system and facilitates macrophage recruitment into the injury site [ ] . in addition, these macrophages release proteases, fr, and cytokines [ ] . similar to the facts stated above, the extracellular expression of tnf [ ] in the surrounding white matter was detected h posterior to contusion sci, with a peak that took place from day to day [ ] . thus far, the time frames of expression have been described. the following information regards the receptors of such molecular products. from the two subtypes of tnf receptor that exist, each subtype has a different distribution and presence that depends on the particular cell type. for instance, tnf-r is expressed constitutively on most cell types, whereas the expression of tnf-r in astrocytes requires induction by tnf , il- , and ifn [ ] . a large amount of evidence indicates that tnf-r augments neuronal death and tnf-r promotes neuroprotection [ ] . what has been observed in the lesion concludes that the expression of tnf-r and tnf-r is increased within min after traumatic sci in adult rats and reaches its peak at h for tnf-r and h for tnf-r . the expression of both receptor subtypes then goes on to decline after day and day , respectively [ ] . it is important to note that these receptors are initially found on the epicenter of the lesion site. posteriorly, they spread radially towards distant areas during their peak expression and later become confined to the lesion area. these receptors are expressed by several cells, which include neurons, oligodendrocytes, and astrocytes [ , ] . these cells might work individually or synergistically to mediate the biological activity of tnf , which makes an interesting research topic, given that these receptors are known to be involved in antiapoptotic activities through the tnf-r/nf signal transduction pathway [ ] . on a last note, tnf participation in the expression of inos in microglial cells [ ] causes an exacerbated neural destruction as a direct consequence of the induction of the nf pathway, which can then contribute to the expression of ifn . ifn within the nervous system is classically associated with the inflammatory response after injury as mentioned in the previous paragraph [ ] . this molecule is believed to be normally involved as one component of the physiological response to tissue damage and trauma. cd + and cd + t cells together with natural killer (nk) cells are the major sources of ifn . nevertheless, evidence shows that this cytokine is also produced within the nervous system by neurons and glial cells in the absence of infiltrating immune cells [ ] . in various animal models, ifn promotes macrophage signaling, production of proinflammatory cytokines and chemokines, recruitment of macrophages to the cns, and the activation of cns resident and infiltrating apc populations. moreover, ifn is also the most potent inductor of mhci, and it is upregulated in the cns after injury [ ] . in low concentrations, ifn may participate in the homeostasis of the synaptic circuitry [ , ] . as previously mentioned, ifn is involved in the upregulation of mhc i, which has been shown to play an important role in the synaptic plasticity process following axotomy. furthermore, ifn has been shown to regulate phosphorylation and nuclear translocation of signal transducer and activator of transcription (stat ) and to influence neuronal excitability by the expression of the peripheral nerve-type sodium channel gene pn [ ] . it is important to note that several studies found that ifn and il- had the highest levels of gene expression, since this indicates that the phenotype found after sci is predominantly th and th and the ifn release could be detected from h to weeks, depending on microenvironment [ , ] . interleukin- (il- ) is primarily produced by th cells and has an important role in inflammation and autoimmune disease [ ] . a key regulator in its production is il- . nevertheless, tgf-and interleukin- (il- ) are also capable of stimulating il- production. similarly, interleukin- (il- ) is also able to promote il- production just as interleukin- (il- ) does. in one study, serum levels of il- , il- , and il- were increased in large quantities h after sci, had a peak at h, and had a positive correlation with increased il- [ ] . signal transducer and activator of transcription (stat ) and rar-related orphan receptor gamma (ror ) are two transcription factors capable of mediating il- production and th differentiation. as a result, a closed circuit is formed, in which il- , the stat signaling pathway, and il- related cytokines promote neuroinflammation as they costimulate one another. il- expression and production was detected from h to h after contusion injury [ ] . stat is a primary transcription factor of the downstream signaling of il- [ ] . the phosphorylation of stat in this pathway induces a proinflammatory gene expression that correlates with il- quantities in spinal cord neurons and astrocytes. interestingly, through this very same pathway, anti-inflammatory th cells can be suppressed by il- inhibition of foxp expression in a stat dependant manner. it is important to recognize that stat was found higher in the sci rat group, whose expression peaked at h [ ] . it is worth noting that il- antagonistic therapy in rheumatoid arthritis (ra) suggests that the inhibition of the pathological role of il- may be a promising therapeutic approach in humans [ ] . chemokines are functionally related cytokines that induce specific actions in the immune system. they are released in response to an infection, inflammation, or trauma [ ] . chemokines are grouped into two families: the family (cxc), which participates in the recruitment of polymorphonuclear cells, and the family (c-c), which provides the priming signal for macrophages, lymphocytes, eosinophils, and basophils. the family includes gamma-interferon inducible protein (ip- /cxcl ), platelet factor , il- , and melanoma growth stimulatory activity (mgsa/gro/kc) [ ] . in particular, the chemokine cxcl has been shown to inhibit angiogenesis, growth, and chemotaxis of endothelial cells via the cxcr b receptor. consequently, the neutralization of cxcl promotes angiogenesis through the expression of eight genes related to angiogenesis and vasculature remodeling after sci [ ] . an important member of the family is the monocyte chemoattractant protein (mcp- /ccl ). it is detected in astrocytes and perivascular mononuclear cells in experimental allergic encephalomyelitis (eae). mcp- levels are related to the parallel development of clinical disease and macrophage infiltration [ , ] . the same case applies to macrophage inflammatory protein alpha (mip- /ccl ) and macrophage inflammatory protein beta (mip- ) [ ] . their expression has been shown predominantly in myeloid and lymphoid cells [ ] , where an increased expression of mip- , mip- (cxcl / ), and mcp- after sci plays a role in the inflammatory process, since these molecules recruit circulating leukocytes to the injury site [ ] . mcp- mrna was present in the normal spinal cord, was increased h after sci, peaked at h, and returned to a low level by day . mcp- is expressed by astrocytes that surround white matter. in addition, mip- mrna was present in the normal spinal cord, where it increased at h after sci, peaked from to h, decreased by day , remained unchanged until day , and returned to a low level by day . mip- expression in astrocytes was observed from day to day following injury. additionally, the expression of this molecule was found at the contusion site and in rostral and caudal sections to this location. by day after injury, the expression of mip- returned to baseline levels. moreover, ip- mrna presented low levels in the normal spinal cord, increased its levels at h, peaked at h, and remained high up to day after sci. it decreased to baseline levels by day [ ] . another study found the chemokines, mcp- , mip- , mip- , mip- , and ip- , to be expressed locally at min with a peak at h after sci. it is worth noting then that chemokines remain present d after injury-at lower levels-in contrast with the rest of the cytokines [ ] . molecules of the inflammatory response. the changes in gene expression that contribute to the secondary injury are characterized by protracted neuronal loss and neurological dysfunction. therefore, the predominant downregulation of these factors might play a role in cell survival and may lead to the development of novel interventions that promote recovery [ , , ] . in order to develop a viable therapy, it is essential to identify the specific molecular pathways that become altered as a function of time after sci [ ] . for instance, activated macrophages and microglia after cns injury produce various neurotrophic factors and molecules that enhance regeneration [ , ] . however, this response highly depends on the temporal sequence that proceeds the injury [ ] . this consequently indicates that there is a proper and timely regulation of inflammatory reactions that can take place and be of paramount importance to the design of therapeutic strategies involving cytokines, growth factors, or neurotrophins [ , ] . ( ) cytokines. a particular cytokine involved in this beneficial aspect of the inflammatory response is il- . this cytokine exerts an anti-inflammatory effect after cns damage [ ] [ ] [ ] . for instance, endogenous il- has been shown to participate in the regulation of neuroinflammation in various pathologic conditions [ ] [ ] [ ] . this anti-inflammatory cytokine and its receptor subunit il- have a role in spinal cord trauma. this is illustrated by the high level expression of il- h after contusive sci in rats, whose elevated concentration persisted for days but was decreased days after sci. interestingly, on day after sci, an increased expression of il- was observed. this is noteworthy since this interleukin shares the same receptor with il- for signal transduction [ , ] . moreover, the cytokine expression of the contused spinal cord was not significantly affected by il- attenuation for the proinflammatory cytokine levels of il- , il- , and tnf . in fact, the opposite effect was observed, since the event correlated with a marked increase in the extent of macrophage quantity days after sci, which was preceded by an increase in the level of mcp- [ ] . these results suggest that the expression of il- regulates the extent of macrophage activation in the acute phase of the injury [ ] . in addition, il- has been shown to exert a neuroprotective effect against microglia-mediated neuronal toxicity by the regulation of fr formation [ ] . on similar lines, macrophages stimulated with il- are reported to be less neurotoxic and to have an increased regenerative capability. this evidence makes il- injections a possible therapeutic application [ ] . il- and tgf have been reported to act as neuroprotective molecules in a manner similar to il- [ ] . for instance, it has been shown that an intrathecal infusion of tgf is able to enhance axonal growth after spinal contusion through the epidermal growth factor receptor (egfr) that is primarily upregulated by astrocytes surrounding the lesion. here, tgf stimulates proliferation, migration, and transformation to an axon phenotype supportive of growth [ ] . on the other hand, a potential treatment for certain aspects of the secondary injury such as inflammation, excitotoxic damage, and neuronal apoptosis is the administration of il- since its anti-inflammatory effects involve the downregulation of il- , il- , il- , tnf , ifn , matrix metalloproteinase- , nitric oxide synthase, myeloperoxidase, and ros [ ] . in addition, proapoptotic factors such as cytochrome c, bax, and caspase are downregulated by the effects of il- . other effects of this cytokine include the upregulation of antiapoptotic factors such as b-cell lymphoma (bcl- ). furthermore, il- provides trophic support to neurons by its receptor, in addition to increased tissue sparing, neuroprotection, and functional recovery. in the nervous system, il- receptor expression has been found in microglia, astrocytes, and oligodendrocytes acting as antagonist for the production of proinflammatory cytokines [ , ] . in the first moments after sci, the elevated synthesis and release of proinflammatory mediators plays a role in the secondary degeneration [ ] . this might be a therapeutic opportunity. for instance, an antagonist of proinflammatory cytokines such as il- receptor antagonist has demonstrated a neuroprotective effect after global ischemia, excitotoxicity, and traumatic brain injury in rodents [ ] . ( ) growth factors. after mechanical trauma, astrocytes and neurons release fibroblast growth factor (fgf) which is thought to counteract excitotoxic or ischemic damage by the activation of antiapoptotic signals in stressed neurons [ ] . acidic fibroblast growth factor (afgf) is a potent mitogenic and chemotactic agent for vascular endothelial cells, dermal fibroblasts, and epidermal keratinocytes. moreover, it has a role in the regeneration process since it contributes to angiogenesis. in the normal uninjured spinal cord, afgf mrna was found to be present in low levels. after sci (table ) , however, the factor increased in the h, stayed at that level, peaked from day to day , and remained high from day to day [ ] . many therapeutic strategies seek to induce a higher expression of neurotrophic factors. a particular strategy that has shown significant results is the combination of peripheral nerve grafts with afgf after transection sci in rats. this strategy induced higher il- , il- , and il- levels in the graft areas of rat spinal cords. moreover, this strategy has been shown to regulate th cytokine production, m response, and neurotrophic factor production, where the latter can indirectly regulate the inflammatory response and neural destruction [ ] . it is worth noting that the use of afgf with fibrin glue in combination with surgical neurolysis for nonacute sci has been proven feasible and safe in clinical trials which have shown significant improvements in asia motor and sensory scale scores and impairment scales, neurological levels, and functional independence measures, months after treatment [ ] . bdnf detected h ai, increases up to weeks, and decreases weeks ai (i) m macrophage phenotype induction (ii) production of several extracellular matrix proteins for tissue remodeling and repair, neurotrophic support, and axonal regeneration (iii) increases growth, angiogenic, and axonal guidance factors [ , , , ] afgf detected h ai, pl - days, and remains elevated up to - days ai (i) potent mitogenic and chemotactic agent for vascular endothelial cells, dermal fibroblasts, and epidermal keratinocytes (ii) promotes th cytokine and neurotrophic factor production and m response [ , ] bfgf detected h ai, pl at day , remains elevated - days, and returns to low levels - days ai (i) angiogenesis [ ] tgf-detected at h ai (i) immunosuppressant (ii) tissue stabilization and structural preservation (iii) neural regeneration and repair [ ] min: minutes; ai: after injury; pl: peak levels. after the injury, the expression of basic fibroblast growth factor (bfgf), another growth factor involved in angiogenesis, was found in astrocytes localized at the site of contusion and in the surrounding white matter. unlike afgf, bfgf mrna was not detected in the uninjured spinal cord. it was only detected h after sci, in increased quantities at h, and at its peak days after sci. afterwards, it remained high from day to day , only to return to a low level by days to [ ] . before going further, it is important to note that growth factors such as tgf-may act as immunosuppressants. moving on, h after sci, genes related to growth and differentiation became present. these included tgf-, nerve growth factor (vgf), platelet derived growth factor (pdgf-), galanin, and neuropeptide y. these genes have been suggested as aids in tissue stabilization, structural preservation, repair, and regeneration after sci. for instance, increased pdgf and vgf levels after sci may prevent the death of axotomized neurons and a decrease in their energy metabolism [ ] . subsequently, the increased abundance of galanin and neuropeptide-y transcripts may produce an antinociceptive effect in the injured spinal cord [ ] . moreover, it is known that cannabinoid receptor (cb ) is colocalized with the neuropeptide cck. in this relationship, the neuropeptide acts as an endogenous opioid antagonist [ ] . therefore, the downregulation of cb and the expression of the cck precursor might help explain why there is a relative resistance of neuropathic pain to the analgesic action of morphine in sci patients [ ] . similar results have been found in several transcripts, and the previously mentioned genes have shown an increased abundance in comparison to sham animals [ , , ] . ( ) neurotrophins. neurotrophins constitute a family of molecules that has assumed a central role in studies dealing with recovery after sci [ ] . four members of this family are involved in neuron survival and the regeneration process after sci: ngf, brain derived neurotrophic factor (bdnf), neurotrophin- (nt- ), and nt- / . neurotrophins emit signals when they bind to low and high affinity receptors in the membrane of their target cells. for instance, the low affinity p receptor binds all neurotrophins [ ] . another signaling method used by neurotrophins is carried out by three high affinity tyrosine kinase receptors, collectively known as trk receptors. trka, trkb, and trkc compose the trk family of tyrosine-protein kinases. these three receptors mediate the biological properties of the ngf family of neurotrophins. trka is the particular receptor for ngf, while trkb serves as a receptor for both bdnf and nt- . lastly, trkc is the primary receptor for nt- . however, this particular neurotrophin can activate trka and trkb receptors when present in high concentrations [ ] . through semiquantitative rt-pcr in a spinal cord contusion model, it was found that the expression of neurotrophin family members and their receptors was significantly diminished h after the lesion. yet, in contrast to this pattern of trk receptor expression, p ntr showed a significant upregulation after contusive sci [ ] . interestingly, an increase in bndf was observed up to weeks after compression sci with a decrease weeks afterwards [ ] . similarly, an increased expression of growth, angiogenic, and axonal guidance factors, as well as extracellular matrix molecules, can be observed in the chronic phase (days to years) following sci [ , ] . the series of interconnected deleterious mechanisms of the secondary injury is orchestrated by the expression of specific genes, in particular those of signaling proteins such as cytokines, chemokines, and growth factors. the balance between the proinflammatory and anti-inflammatory effects of these molecules plays an important role in the progression and outcome of the degenerative process. most of these cytokines have a dual role in a range between beneficial and injurious, depending on time and the cell implicated in secondary injury after sci. the excessive and uncontrolled inflammatory response after sci enhances the damage role of these cytokines, which surpasses the regenerative effects of anti-inflammatory cytokines and growth factor. consequently, therapies that focus on promoting the antiinflammatory properties of cytokines and growth factors should be a priority. current and future surgery strategies for spinal cord injuries secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade sensorimotor rehabilitation: at the crossroads of basic and clinical translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury degenerative and regenerative mechanisms governing spinal cord injury molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival il- gene deletion protects oligodendrocytes after spinal cord injury through upregulation of the survival factor tox neuroinflammation: a common pathway in cns diseases as mediated at the blood-brain barrier microarray analysis of expression of cell death-associated genes in rat spinal cord cells exposed to cyclic tensile stresses in vitro cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain growth factors are essential for nervous system development and function role of growth factors on periodontal repair role of the tlr pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats effects of peripheral inflammation on the bloodspinal cord barrier the blood-spinal cord barrier: morphology and clinical implications the role of hemorrhage following spinal-cord injury inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced mri blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing distribution and time course of protein extravasation in the rat spinal cord after contusive injury cytokine transport across the injured blood-spinal cord barrier the dual role of tumor necrosis factor-alpha in the pathophysiology of spinal cord injury receptor-mediated transport of lif across blood-spinal cord barrier is upregulated after spinal cord injury potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury effects of mk on evoked potentials, spinal cord blood flow and cord edema in acute spinal cord injury in rats pathophysiology of blood-spinal cord barrier in traumatic injury and repair src family kinase inhibitor pp improves motor function by reducing edema after spinal cord contusion in rats role of hypoxia-induced vegf in blood-spinal cord barrier disruption in chronic spinal cord injury alterations in tissue mg ++ , na + and spinal cord edema following impact trauma in rats potassium and calcium changes in injured spinal cords role of l-and n-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury radiopacity of intracerebral hemorrhage correlates with perihemorrhagic edema selective vasopressin- a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and gfap, v ar and aqp expression after focal traumatic brain injury the neurobiology of glia in the context of water and ion homeostasis involvement of aquaporin in astrocyte function and neuropsychiatric disorders aquaporin and brain diseases regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy differential regulation of synaptic transmission by pre-and postsynaptic sk channels in the spinal locomotor network the n-type voltage-gated calcium channel: when a neuron reads a map smallconductance ca + -activated k + channel type (sk ) modulates hippocampal learning, memory, and synaptic plasticity calcium signalling: dynamics, homeostasis and remodelling local calcium signaling in neurons remyelination after spinal cord injury: is it a target for repair? calcium signalling in lymphocyte activation and disease molecular mechanisms of calcium-dependent excitotoxicity cellular defenses against excitotoxic insults physiological and pathological functions of p x receptor in the spinal cord systemic administration of an antagonist of the atp-sensitive receptor p x improves recovery after spinal cord injury a reassessment of p x receptor inhibition as a neuroprotective strategy in rat models of contusion injury glutamate receptors in the mammalian central nervous system glutamate transporters/na + , k + -atpase involving in the neuroprotective effect as a potential regulatory target of glutamate uptake tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity mechanical and thermal allodynia in chronic central pain following spinal cord injury calcium homeostasis following traumatic neuronal injury excitotoxicity: bridge to various triggers in neurodegenerative disorders dna microarray analysis of the contused spinal cord: effect of nmda receptor inhibition recent advances in the pharmacologic treatment of spinal cord injury knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate the microanatomy of spinal cord injury: a review interleukin- promotes oligodendrocyte death through glutamate excitotoxicity actions of tnfon glutamatergic synaptic transmission in the central nervous system cdna microarray analysis of spinal cord injury and regeneration related genes in rat cathepsin s and related lysosomal endopeptidases inflammatory mediators regulate cathepsin s in macrophages and microglia: a role in attenuating heparan sulfate interactions perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis sex steroids, apoe genotype and the innate immune system intron- retention/splicing controls neuronal expression of apolipoprotein e in the cns role of hydrogen sulfide in secondary neuronal injury an introduction to free radical biochemistry oxidative damage to rna: mechanisms, consequences, and diseases oxidative stress and neurobiology of demyelination antioxidant therapies in traumatic brain and spinal cord injury further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury mechanoreception at the cellular level: the detection, interpretation, and diversity of responses to mechanical signals the role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein temporal characterization of mitochondrial bioenergetics after spinal cord injury temporal and spatial dynamics of peroxynitrite-induced oxidative damage after spinal cord contusion injury lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function antioxidant therapies for acute spinal cord injury strategies to limit dysmyelination during secondary degeneration following neurotrauma anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization neuroprotective and neurodestructive functions of nitric oxide after spinal cord hemisection involvement of nitric oxide in acute spinal cord injury: an immunocytochemical study using light and electron microscopy in the rat nitric oxide: cellular regulation and neuronal injury mechanisms of increased vascular superoxide production in human diabetes mellitus: role of nad(p)h oxidase and endothelial nitric oxide synthase calcium, nitric oxide, and preeclampsia vitamin e suppression of microglial activation is neuroprotective reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury basic immunology: functions and disorders of the immune system antibodies inflammatory pathways in spinal cord injury inflammation-induced gdnf improves locomotor function after spinal cord injury from basics to clinical: a comprehensive review on spinal cord injury neutralization of the chemokine cxcl enhances tissue sparing and angiogenesis following spinal cord injury cellular inflammatory response after spinal cord injury in sprague-dawley and lewis rats macrophage activation and its role in repair and pathology after spinal cord injury rats and mice exhibit distinct inflammatory reactions after spinal cord injury neuroprotection and acute spinal cord injury: a reappraisal astrocyte roles in traumatic brain injury microglia and inflammation: conspiracy, controversy or control? role of microglia in neurotrauma early expression and cellular localization of proinflammatory cytokines interleukin- , interleukin- , and tumor necrosis factor-in human traumatic spinal cord injury proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved role of neutrophils in spinal cord injury in the rat astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an il- receptor/myd -dependent fashion dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor ccr following infection with a neurotropic coronavirus the systemic response to cns injury microglia: intrinsic immuneffector cell of the brain improved regeneration after spinal cord injury in mice lacking functional t-and b-lymphocytes decreased neural damage after spinal cord injury in tpadeficient mice macrophages and inflammatory damage in spinal cord injury different expression of macrophages and microglia in rat spinal cord contusion injury model at morphological and regional levels targeting the host inflammatory response in traumatic spinal cord injury hematogenous macrophages express cd and distribute to regions of lesion cavitation after spinal cord injury protective autoimmunity: interferon-enables microglia to remove glutamate without evoking inflammatory mediators microglia: a sensor for pathological events in the cns microglia in health and disease expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage microglia: activation and their significance in the central nervous system neurotrophin secretion from cultured microglia the neuropathological and behavioral consequences of intraspinal microglial/macrophage activation alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing transplantation of activated macrophages overcomes central nervous system regrowth failure implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats cutting edge: stat -dependent substrate depletion regulates nitric oxide production ability of rat microglia to uptake extracellular glutamate early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury expression of interleukin- by microglial cells in inflammatory, autoimmune, and degenerative lesions of the rat brain lesional expression of a proinflammatory and antiangiogenic cytokine emap ii confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury the cellular inflammatory response in human spinal cords after injury mechanisms and implications of adaptive immune responses after traumatic spinal cord injury tnf-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation major histocompatibility complex (mhc) class i gene expression in single neurons of the central nervous system: differential regulation by interferon (ifn)-gamma and tumor necrosis factor (tnf)-alpha autoimmune t cells as potential neuroprotective therapy for spinal cord injury posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease innate and adaptive immune responses can be beneficial for cns repair autoimmune t cells protect neurons from secondary degeneration after central nervous system axotomy nerve growth factor production by lymphocytes cross talk between the immune system and the nervous system in response to injury: implications for regeneration involvement of interleukin- and lipocortin- in ischaemic brain damage experimental spinal cord injury: wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration t-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity is neuroinflammation in the injured spinal cord different than in the brain? examining intrinsic differences between the brain and spinal cord effects of cyclosporin-a on immune response, tissue protection and motor function of rats subjected to spinal cord injury concept of autoimmunity following spinal cord injury: possible roles for t lymphocytes in the traumatized central nervous system the therapeutic window after spinal cord injury can accommodate t cellbased vaccination and methylprednisolone in rats neuroprotective autoimmunity: naturally occurring cd + cd + regulatory t cells suppress the ability to withstand injury to the central nervous system protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries b cell selection and susceptibility to autoimmunity human innate b cells: a link between host defense and autoimmunity? the balance of immune responses: costimulation verse coinhibition a comparison of the pathology of primary and secondary progressive multiple sclerosis lymphocytes and autoimmunity after spinal cord injury the paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury post-traumatic inflammation following spinal cord injury il- and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation historical insights into cytokines immunological and inflammatory functions of the interleukin- family il- , an interleukin- -like cytokine that signals via the il- receptor-related protein st and induces t helper type -associated cytokines caspase- -independent, fas/fas ligand-mediated il- secretion from macrophages causes acute liver injury in mice endogenous expression of interleukin- regulates macrophage activation and confines cavity formation after traumatic spinal cord injury immune modulatory therapies for spinal cord injury-past, present and future long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord both positive and negative factors regulate gene expression following chronic facial nerve resection cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice oncostatin m regulation of interleukin- expression in astrocytes osteopontin and its integrin receptor v are upregulated during formation of the glial scar after focal stroke signaling and transcription in t helper development conditioning injury-induced spinal axon regeneration fails in interleukin- knock-out mice a possible antiinflammatory role of angiotensin ii type receptor in immunemediated glomerulonephritis during type receptor blockade improved recovery after spinal cord trauma in icam- and p-selectin knockout mice functional regeneration of sensory axons into the adult spinal cord roles of nf-b in spinal cord injury pathophysiology neuroprotection and its molecular mechanism following spinal cord injury cytokine activity contributes to induction of inflammatory cytokine mrnas in spinal cord following contusion spinal cord trauma and the molecular point of no return neuroimmunology of traumatic spinal cord injury: a brief history and overview sequential mrna expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury cytokine chemokine expression in contused rat spinal cord microglia and macrophage responses in cerebral ischemia tnf alpha-still a therapeutic target anti-tnf therapy in the injured spinal cord differential expression, shedding, cytokine regulation and function of tnfr and tnfr in human fetal astrocytes modulator effects of interleukin- and tumor necrosis factor-on ampainduced excitotoxicity in mouse organotypic hippocampal slice cultures expression of the type and type receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats inos and nitrotyrosine expression after spinal cord injury a single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction interleukin- , interleukin- , and transforming growth factor-differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in cocultures of rat astroglial and microglial cells interleukin- , interleukin- , and interleukin- -receptor antagonist but not transforming growth factorinduce ramification and reduce adhesion molecule expression of rat microglial cells interleukin- and - induce death of activated microglia evidence of an anti-inflammatory role for vasogen's immune modulation therapy neuroprotective role of microglia expressing interleukin- cnsderived interleukin- is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells interleukin- , interleukin- , signal transducer and activator of transcription factor , and allergic asthma characterization of the early neuroinflammation after spinal cord injury in mice il- and th cells the role of il- promotes spinal cord neuroinflammation via activation of the transcription factor stat after spinal cord injury in the rat stat and suppressor of cytokine signaling : potential targets in lung inflammatory responses ly , a humanized anti-interleukin- monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase i randomized, double-blind, placebo-controlled, proofof-concept study csf- gene expression and protein levels in the central nervous system and peripheral immune system of rats with experimental autoimmune encephalomyelitis (eae) do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? expression and characterization of tca : a murine inflammatory protein p ntr: a receptor after all gene profiling in spinal cord injury shows role of cell cycle neuronal death neuronal loss and expression of neurotrophic factors in a model of rat chronic compressive spinal cord injury acid fibroblast growth factor and peripheral nerve grafts regulate th cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords effect of transforming growth factor on spinal motor neurons after axotomy peripheral nerve injury induces endoneurial expression of ifn-, il- and tnf-mrna microglia as a source and target of cytokines expression of mhc class i and -microglobulin in rat spinal motoneurons: regulatory influences by ifn-gamma and axotomy exposure to interferonduring synaptogenesis increases inhibitory activity after a latent period in cultured rat hippocampal neurons interferon--induced changes in synaptic activity and ampa receptor clustering in hippocampal cultures two burgeoning families of platelet factor -related proteins: mediators of the inflammatory response chemokine expression in murine experimental allergic encephalomyelitis selective chemokine mrna accumulation in the rat spinal cord after contusion injury gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study genechip analysis after acute spinal cord injury in rat activated human t cells, b cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? il- promotes neuronal survival following spinal cord injury transforming growth factor transforms astrocytes to a growth-supportive phenotype after spinal cord injury the therapeutic role of interleukin- after spinal cord injury the role of inflammation in cns injury and disease neuronal vulnerability in transgenic mice expressing an inducible dominant-negative fgf receptor acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial behavioral characterization of neuropeptide y knockout mice expression of the cannabinoid receptor cb in distinct neuronal subpopulations in the adult mouse forebrain cholecystokinin/opioid interactions anti-inflammatory and pro-inflammatory roles of tgf-, il- , and il- in immunity and autoimmunity the changing scene of neurotrophic factors structural and functional properties of the trk family of neurotrophin receptors gene expression alterations of neurotrophins, their receptors and prohormone convertases in a rat model of spinal cord contusion the authors declare that there is no conflict of interests regarding the publication of this paper. key: cord- -g s v ra authors: rimstad, espen; reubel, gerhard h.; dean, gregg a.; higgins, joanne; pedersen, niels c. title: cloning, expression and characterization of biologically active feline tumour necrosis factor-α date: - - journal: vet immunol immunopathol doi: . / - ( ) -s sha: doc_id: cord_uid: g s v ra we report the cloning, expression and characterization of biologically active feline tumour necrosis factor-α (ftnf-α). messenger rna was extracted from feline peritoneal macrophage cultures and used to synthesize cdna for polymerase chain reaction (pcr) amplification. the pcr products were cloned into the plasmid vector pcrii and sequenced, showing . % homology with a published ftnf-α gene sequence. subcloning into the vector pgex- t and subsequent expression resulted in a kda fusion protein of ftnf-α and glutathione s-transferase (gst). thrombin cleavage of the fusion protein yielded a kda protein. this protein cross-reacted with a monoclonal anti-human tnf-α antibody in western blotting, but not with a polyclonal anti-murine tnf-α serum. recombinant ftnf-α (rftnf-α) and rftnf-α-gst had a cd( ) of ng ml(− ) and ng ml(− ), respectively, in the l cytotoxicity assay. cats given rftnf-α-gst intravenously manifested the typical biological effects of tnf-α, including fever, depression, and piloerection. the rftnf-α-gst upregulated il- receptor and mhc-ii antigen expression on peripheral blood mononuclear cells stimulated in vitro, but had no effect on tnf-α receptor and mhc-i antigen expression. tumour necrosis factor-alpha (tnf-a ) is a cytokine with multifunctional activity. although its original activity was recognised against tumour cells (carswell et al., ) , it is now known to play an important role in immune and inflammatory responses as well as in the pathogenesis of many human and animal diseases (reviewed by jhattelh, ). tnf-a may also play a crucial role in the pathogenesis of human aids (matsuyama et al., ) . tnf-c~ stimulates human immunodeficiency virus (hiv) replication in both established lymphoid and primary t cell cultures (suzuki et al., ) . this enhanced replication is mediated through tnf-a inducible nuclear factors like nfkb and the kb enhancer elements of the hiv ltr (osborn et al., ) . induction of hiv gene expression is regulated by interactions of dna binding proteins with specific gene sequences (folks et al., ; osborn et al., ; poli et al., ) . the levels of tnf-(w are increased in patients with aids and may upregulate virus replication in an autocrine fashion (poli et al., ). in addition tnf-a, may play an important role in some clinical manifestations of hiv infection; dramatic improvement in aphthous stomatitis and esophagitis is seen in aids patients treated with a tnf-a inhibitor (thalidomide) (nicolau and west, ) . tnf-a! is an important reagent, therefore, for studies of hiv pathogenesis. the nucleotide sequences for human, mouse, sheep, pig, rabbit and cat tnf-a, has previously been reported (pennica et al., ; shirai et al., ; ito et al., ; drews et al., ; mcgraw et al., ; green and sargan, ) . both human and murine recombinant tnf-a proteins have been expressed in different systems, and used in several studies (pennica et al., ; shirai et al., ) . however, recombinant feline tnf-a (rftnf-cu) protein has not been expressed. the aim of this study was to clone the cdna of feline tnf-cu and to express it in e~/zerichia coli in a biologically active form. our goal is to use rftnf-a to study immunodeficiency virus pathogenesis using the feline immunodeficiency virus (fiv) infection model. fiv infection has been shown to be a valid animal model for hiv studies because similar changes in tnf-a! expression have also been observed in fiv infected cats (lawrence et al., ; lehmann et al., ; pedersen, ) . adult specific pathogen free (spf) cats were obtained from the breeding colony of the feline retrovirus research laboratory, university of california, davis. animals were housed in quarters provided by the animal research service, university of california, davis. peritoneal macrophages were obtained by peritoneal saline lavage from two specific pathogen free cats as previously described (stoddart and scott, ; brunner and pedersen, ) . cats were inoculated intraperitoneally with . ml of human diphtheria/pertussis/tetanus vaccine, and the peritoneal cavities lavaged days later. cells were pelleted by centrifugation and resuspended in rpm medium with % fetal bovine serum (fbs ) and cultured for h. adherent cells were determined to be virtually % macrophages by non-specific alpha-naphthyl esterase staining (stoddart and scott, ) . the macrophage cultures were then stimulated with ng ml-' of e. coli lipopolysaccharide (lps ) (sigma, st. louis, mo) for h, and frozen at - °c until further use. the h duration of lps stimulation was based upon the kinetics of tnf-a, production after lps stimulation in macrophages from other animal species (green and sargan, ). messenger rna was extracted both from x o unstimulated and x o lps stimulated macrophages using an mrna extraction kit (micro-fast trac, invitrogen, san diego, ca); . pg mrna from each source was used for cdna synthesis. synthesis of cdna was performed at °c for x min using oligo-dt primers (cdna-cycle kit, invitrogen). the cdna was then used in a polymerase chain reaction (pcr) with a ~ reaction mixture consisting of mm tris-hcl (ph . ), mm kcl, . mm mgcl,, . % gelatine, pm of each dntp, pmol of each primer, and . u of pfu dna polymerase. three primers, making up two pairs p /p and p /p , were constructed from a previously published sequence of feline tnf-a (mcgraw et al., ) : p , gggatccatgagcactgaaagcatgatccg; p , ggggatcccagaa-cactcagatcatcttctc; p , ggctgcagaattcacagggcaat-gatcccaaagta. the primers had restriction sites for bamhi, psti and ecorl in the '-ends to make directionally cloning of the pcr products possible. the forward primer p was located at the start of the ff nf-a gene and the forward primer p at the assumed start of the coding sequences for the mature tnf-cr protein, while the backward primer p was located at the '-end of the coding sequences of the gene. the mixtures were overlaid with ~ mineral oil and heated at °c for min and then cycled times at °c for min, "c for min, °c for min with a final extension at °c for min. the pcr products were subjected to electrophoresis on a . % agarose gel using v cm-' for h in . x tbe-buffer ( xtbe = . m tris-borate, mm edta ) and then stained with ethidium bromide. to assure that stimulated macrophage mrna was the actual source for cdna, cdna derived by reverse transcription of mrna from unstimulated macrophage cultures, as well as feline genomic dna, were extracted and used as targets in separate and parallel pcrs. the amplified fragments generated by both the p /p and p /p primers were separately cloned into the plasmid vector pcri (ta-cloning kit, invitrogen), and the nucleotide sequences were determined by conventional dideoxy sequencing of both strands. the cloned fragment from the amplification with p /p was digested out with bamhi/ecori, and subcloned directly into the expression vector pgex- t (pharmacia, uppsala, sweden). the pgex- t vector has been used previously to express fiv-pl and -p proteins (reid et al., ) . this expression vector contains an open reading frame encoding glutathione s-transferase (gst), followed by unique restriction endonuclease sites for bamhi, smal and ecorz, followed in turn by termination codons in all three frames. a thrombin cleavage site is constructed into the vector between gst and the protein to be expressed (chang, ) . the resulting plasmid, designated pgex-ft nf, was used to transform the e. coli strain xll-blue. a ml overnight terrific-broth (t-broth) culture of e. coli containing pgex-ff nf was diluted : in t-broth and incubated for h at ' c. all bacterial cultures contained ,ug ml-' ampicillin and . ,ug ml-' tetracycline. expression of the recombinant protein was induced by adding isopropyl-p-d-thiogalactopyranoside (iptg) to a concentration of . mm. the culture was further incubated at °c for h and then centrifuged for min at oooxg. the supematant was discarded. the bacterial pellet was resuspended in ml ice-cold phosphate-buffered saline (pbs), and sonicated twice for s; samples were kept on ice. triton-x- was added to a concentration of %, the solution was centrifuged for min at xg, and the supernatant collected. one milliliter of a % slurry of glutathione-agarose beads was added to the supernatant and gently mixed for min at room temperature, followed by three times washing with pbs. the fusion protein was eluted by adding ml of mm tris-cl (ph . ) with mm reduced glutathione. the elution was repeated three times. the purity of the rftnf-cu, the efficiency of the elutions, and its relative molecular size were estimated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (sds-page). the part of the rfi'nf-cr-gst that bound to the glutathione-agarose beads, was washed with thrombin cleavage buffer ( mm tris-cl, ph . , mm nacl, . mm cacl,) and incubated with % thrombin for h at room temperature (chang, ) . the cleaved protein products were analyzed on sds-page. the concentrations of the purified recombinant proteins were analysed as described earlier (bradford, ) . peripheral blood mononuclear cells ( pmbcs) from four different normal donor cats were purified on ficoll-hypaque density gradients, and resuspended in growth medium (rpmi, % fbs, ,ug ml-' concanavalin a (cona) ) to a concentration of o cells ml-'. tenfold increasing concentrations ( , , , and ng ml-' ) of rftnf-a-gst or rfi'nf-a were added to quintriplicate wells and the cells maintained in culture for h before being analyzed for cell surface receptor expression. control wells contained growth medium without cona and no tnf-a. pmbcs from each culture were pelleted by low speed centrifugation, washed twice with pbs containing % fbs and . % sodium azide (pbs/fbs/nan, ). the pelleted cells were then resuspended in one of the following reagents and incubated for min: ( ) ~ of tissue culture supernatant from mouse hybridoma cell line f containing antibodies against the alpha subunit of the feline interleukin- receptor (il- r) (kindly provided by dr. k. ohno, tokyo, japan) (ohno et al., ) ; ( ) ~ of tissue culture supematant from mouse hybridoma cell line . , which contains antibodies to feline mhc class ii antigen (rideout et al., ) ; ( ) ~ of tissue culture supematant from mouse hybridoma w / which contains antibodies against feline mhc class i antigen (pollack et al., ) ; ( ) pg of rftnf-a. control cultures were left untreated. following incubation, cells were pelleted, and washed twice with pbs/ fbs/nan . the tnf-a treated cells were incubated for an additional min with ~ of mouse monoclonal antibody to human tnf-a receptor (biosource international, camarillo, ca), washed twice with pbs/fbs/nan,, and pelleted. cell pellets were then resuspended in ~ of a : dilution of goat f(ab' ) anti-mouse igg-fitc (caltag laboratories, san francisco, ca) and ~ propidium iodide ( mg ml-' ) were added to each tube and the samples incubated at °c for min. samples were then washed twice with pbs/fbs/nan, buffer and cells were analyzed immediately by flow immunocytometry using a nm argon laser, standard filter configuration for two color analysis and consort software (facscan, becton-dickinson, san jose, ca). data were analyzed with lysys software. events were gated on forward and log side scatter light characteristics and dead cells were eliminated from analysis based on propidium iodide staining. live cells were evaluated using log green fluorescence and analysis regions were set such that less than % of control cells were in the positive analysis region. western blot analysis of rffnf-cr and rftnf-a-gst were performed as described earlier (lutz et al., ) . polyclonal rabbit anti-murine tnf-a (genzyme, cambridge, ma) and monoclonal anti-human tnf-a (biosource international, camarillo, ca) were used. two adult new zealand white rabbits were immunised subcutaneously with pg of rftnf-a-gst at weeks and , and with the same amount of rffnf-(y on weeks , , , and . the first dose of antigen was in freund's complete adjuvant, while subsequent doses were in freund's incomplete adjuvant. major antibody activity was demonstrated against both gst and tnf-a component by western blotting. serial dilutions of recombinant proteins were tested for cytotoxic activity using the murine tibroblast cell line l as described (flick and gifford, ) . briefly, l cells were seeded into flat bottomed -well microtiter plates and incubated overnight in eagle's minimum essential medium (mem) supplemented with % fbs. medium was then replaced with mem containing ,ug ml-' actinomycin d (sigma, st. louis, mo), samples were tested in quadruplicates of ~ and incubated for h at °c and % co*. the cell supernatant was removed thereafter and the monolayer stained with crystal violet for min. the absorbance of washed stained cell monolayers was measured at a wavelength of nm using an automatic plate reader (biorad, hercules, ca). medium and recombinant feline immunodeliciency virus p -gst (fiv-rp -gst) were used as a negative control and recombinant mouse tnf-cr (rmtnf-ar, genzyme ) as a positive control. the concentration of ffnf-c~ resulting in % of the absorbance of the controls was considered the % cytotoxic dose ( cdso). recombinant ff nf-a ( ng ml-' ) was incubated with different dilutions of both preimmune and immune rabbit anti-rltnf-a serum for min at room temperature. the ffnf-cu antiserum mixtures were then tested with l cells as described above. the first study involved three groups of adult spf cats, each consisting of two animals. each group was injected i.v. with or pg kg-' of rftnf-cu-gst or pg kg-' of gst dissolved in pbs. the cats were observed for clinical symptoms for a period of h and rectal temperature was measured every min the first h. in a second study, two adult cats were each inoculated intravenously with pg kg-' of rftnf-a-gst dissolved in pbs. clinical symptoms and rectal temperatures were measured , , , , and h following treatment. a bp dna fragment was amplified using primer pair p /p and cdna from lps stimulated macrophages as target (fig. , lane ) . no pcr product was amplified from cdna produced from mrna of unstimulated macrophages (fig. , lane ) . three fragments of . kb, bp and bp were amplified from genomic dna (fig. , lane ) . primer pair p /p amplified a bp dna fragment from cdna of stimulated macrophages (fig. , lane ) . no pcr products were amplified from cdna derived from the mrna of unstimulated macrophages (fig. , lane ) , while an bp fragment was amplified from genomic feline dna (fig. , lane ) . the primers pl /p of lps-stimulated, unstimulated feline macrophages, and genomic dna as targets, respectively. lanes , and : rt-pcr using primers p /p of lps-stimulated. unstimulated feline macrophages, and genomic dna as targets, respectively. sizes of the . kb and bp amplified fragments from genomic feline dna corresponded to the distance between the pi-p and p -p primers in the genomit ftnf-cu nucleotide sequence, respectively. similarly the bp and bp bands amplified from cdna from lps-stimulated macrophages corresponded to the estimated respective sizes of mrna for the pre-and mature-proteins of tnfo!. sequence analysis of the p /p amplified product from cdna from stimulated macrophages showed a . % homology to previously reported genomic dna sequence of ftnf-a gene, and . % homology on the amino acid level. there were % and % sequence homologies between the mrna of ttnf-cu and the respective human and murine tnf-(y genes. the homologies between the deduced amino acid sequence of the mature part of ffnf-a, i.e. between primer pair p /p , to those of human and murine tnf-a, were % and %, respectively. a single band with a molecular size of kda was observed in sds-page gels of the purified fusion protein rftnf-gst expressed by pgex-ffnf (fig. , lane ) . thrombin cleaved the fusion protein into two fragments one with a size of kda, which corresponds to the size of tnf-(u in other species (marmenout et al., ; pennica, et al., ) (fig. , lane ) , the other was retained on the glutathione agarose beads after thrombin cleavage had thus a size of kda, which corresponded to the size of gst (smith et al., ) . the amount of purified rftnf-gst produced was about mg -l bacterial culture medium. however, the amount of rftnf-a after thrombin cleavage was only about one-tenth of this. no cross-reactivity was observed between polyclonal rabbit anti-murine tnf-(y antibodies and rffnf-a in western blot. as predicted from sequence homologies and previous studies (lehmann, et al., ) monoclonal anti-human tnfcr antibodies reacted specifically to both rffnf-gst and rff nf-(r (fig. ) . l mouse tibroblast cells were susceptible to the toxic effects of both rffnfa-gst and rttnf-a (fig. ) . at concentration below ng ml-' the rffnf-a was significantly more toxic than a similar concentration of rftnf-lu-gst. the cds,, for the l cells was estimated to be ng ml-' and ng ml-' for rftnf-cy-gst and the rffnf-a, respectively. the cytotoxic effect of purified rffnf-a on l cells was completely neutralised by a : dilution, and partially neutralised by a : dilution, of rabbit anti rttnf-a! serum. preimmune serum had no inhibitory effect on the cytotoxicity. cats given rff nf-cu-gst, became clinically ill between min and h after treatment. a fever peaked at - h after treatment and disappeared after h and was the most prominent syndrome (fig. ) nously. an increase in the rectal temperature was apparent within h in cats treated with rttnf-cu-gst but not with gst alone. depression, immobility caused by malaise, protrusion of the nictitating membranes, piloerection (especially along the dorsum of neck and back and on the tail) and hemoconcentration. clinical signs peaked at h following treatment and had largely disappeared by h. the clinical signs and their severity were similar in cats given either and pg kg-' of the fusion protein, except for one cat that was treated with pg kg-' of rft nf-a-gst and developed moderately severe hypovolemic shock and signs of cerebellar hypoxemia (disorientation, loss of balance ). these signs appeared h following treatment and lasted for about h before spontaneously resolving. no clinical signs of illness were seen in two control cats that were given only the gst portion of the fusion protein (fig. ) , although some variation was evident between the four individual donor cats, rftnf-a induced a dose related increase of ig r and mhc class ii antigen expression on the cell surface of in vitro stimulated feline pmbcs (fig. ) . at the highest rftnf-cr concentration, this increase was - % for il- r and - % for mhc class ii antigen expression. recombinant ftnf-a had no stimulatory effect in vitro on mhc class i or tnf-cu receptor expression. biologically active recombinant feline tnf-a was expressed in e. coli. the entire itnf-a gene was cloned from cdna by pcr since the feline genomic tnf-a gene is interrupted by three introns, making it difficult to clone a functional tnf-a gene directly from genomic dna. although genomic dna was not used in the experiment the pcr primers were constructed from a tnf-a sequence that was itself derived from genomic dna . the cdna encoding the functional tnf-a gene was derived from mrna by reverse transcription. the mrna was extracted from peritoneal macrophages that were induced to produce high levels of tnf-a (and specific mrna) by e. coli lps stimulation. this procedure allowed for the ultimate construction of a plasmid containing only the relevant portions of the tnf-(r gene in a continuous linear configuration. the protein expression system used the pgex- t vector. the gst fusion protein encoded by the plasmid pgex-itnf had a molecular size of kda of which rftnf was making up kda. this is in about the same size range as human and murine tnf-a (marmenout et al., ) ) and correlates well with the estimated molecular size ( . kda) of the amino acid long mature feline tnf-cw. the reduction in the yield of rffnf-(y after the fusion protein had been cleaved with thrombin could have been caused by the lower solubility of the cleaved protein compared with the fusion protein. a possible obstructive effect of the agarose beads on the efficacy of thrombin cleavage could not be ruled out. analysis of the nucleotide sequence of the cloned mrna encoding for the preprotein of feline tnf-cy showed a homology of . % with the coding sequences of a previously sequenced feline tnf-a gene ) and . % homology at the amino acid level ( . % homology for the mature part). the small nucleotide sequence divergence ( . %) between these two ftnf-a genes reflects either limited genetic variations between individual cats and/or small errors in reverse transcription/pcr. if the differences were due to errors, however, the errors were not sufficient to alter the biological activity of the protein. the fusion protein and rftnf-a, both appeared to be biologically active. both proteins killed tnf-a-sensitive l mouse cells; rftnf-cr-gst had a toxic effect on these cells comparable to rftnf-cx at concentrations above ng ml-', but at levels below ng ml-' rff nf-cu was significantly more toxic than rfinf-(r-gst. this indicated some interference by the gst moiety on the rftnf-cu portion of the molecule. polyclonal rabbit anti-human tnf-a prevented the toxic effect of both rftnf-a-gst and rffnf-a on l cells, again demonstrating that both the cleaved and fused fi'nf-a! proteins were biologically and antigenitally intact. the rftnf-cr-gst was also biologically active when injected intravenously into cats. the onset and the character of clinical signs resembled those observed for tnf-(i! in other species (creagan et al., ) . since i.v. administration of recombinant gst did not induce any clinical signs, it can be deduced that the in vivo effects were caused by the rff nf-a portion of the fusion protein and not by the gst. as expected, it was shown that rftnf-a-gst upregulated the expression of ig r and mhc class ii antigens in normal cultures of feline pmbcs. the induction of ig r and mhc class ii antigen mrna by tnf-a involves the activation of transcriptional factors (maniatis et al., ) . tnf-a activates nfkb proteins that can induce expression of genes possessing kb-like enhancer elements in their regulatory regions (lowenthal et al., b) . included in this group are the genes encoding ig r (lowenthal et al., a) , mhc class ii antigen (pessara and koch, ) , and human, feline and simian immunodeliciency viruses (folks et al., ; osbom et al., ; dewhurst et al., ; poli et al., ; sparger et al., ) . feline tnf-a possessed considerable antigenic cross-reactivity with human, but not with murine tnf-a! in western blotting. the degree of antigenic crossreactivity corresponded with the deduced amino acid sequence of the tnf-cz coding regions of the three species; ffnf-cu showed a genetic homology of % and % with human and murine tnf-a, respectively. in conclusion, our results demonstrate that rff nf-cz could prove to be a useful reagent for the study and treatment of feline disease. studies of the cytokinevirus interactions in the fiv infection of cats could be useful for human aids research. a rapid and sensitive method for the quantification of microgram quantities of proteins utilising the principle of protein dye binding infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus an endotoxininduced serum factor that causes necrosis of tumours thrombin specificity. requirement for a polar amino acid adjacent to the thrombin cleavage site of a polypeptide substrate a phase i clinical trial of recombinant human tumour necrosis factor sequence analysis and acute pathogenicity of molecularly cloned sivsmm_rbj gene sequence of porcine tumour necrosis factor alpha comparison of in vitro cell cytotoxic assays for tumour necrosis factor tumor necrosis factor a induces expression of human immunodeticiency virus in a chronically infected t-cell clone sequence of the cdna encoding ovine tumour necrosis factoralpha: problems with cloning by inverse pcr molecular cloning of the gene encoding rabbit tumour necrosis factor biologic activities and mechanisms of action of tumour necrosis factor-a/cachectin decreased mitogen responsiveness and elevated tumour necrosis factor production in cats shortly after feline immunodeficiency virus infection tumor necrosis factor a levels in cats experimentally infected with feline immunodeticiency virus: effects of immunization and feline leukemia virus infection tumor necrosis factor-alpha activation of the il receptor-alpha gene involves the induction of kappa b-specific dna binding proteins tumor necrosis factor a induces proteins that bind specifically to kb-like enhancer elements and regulate interleukin receptor a-chain gene expression in primary human t-lymphocytes humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus regulation of inducible and tissue-specific gene expression molecular cloning and expression of human tumour necrosis factor and comparison with mouse tumour necrosis factor i . cytokines and hiv infection: is aids a tumour necrosis factor disease ? gene sequence of feline tumour necrosis factor alpha thalidomide: treatment of severe recurrent aphthous stomatitis in patients with aids production of a monoclonal antibody that defines the alpha subunit of the feline il- receptor tumor necrosis factor alpha and interleukin i stimulate the human immunodeficiency virus enhancers by activation of the nuclear factor kb the feline immunodeficiency virus cloning and expression in e. co/i of the cdna for murine tumour necrosis factor tumor necrosis factor a regulates expression of the major histocompatibility complex class ii-associated invariant chain by binding of an nf-kb-like factor to apromotor element tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficient virus expression the detection ofconven-e. rimstad et al. / veterinary immunology and immunopathology (i s) - tional class i and class ii i-e homologue major histocompatibility complex molecules on feline cells immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p and ~ persistent upregulation of mhc class ii antigen expression on t lymphocytes from cats experimentally infected with feline immunodeliciency virus cloning and expression in escherichia coli of the gene for human tumour necrosis factor m, antigen of schistosoma japonicum recognized by resistant wehi /j mice is a parasite glutathione s-transferase regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus isolation and identification of feline peritoneal macrophages for in vitro studies of coronavirus-macrophage interactions augmentation of in vitro hiv replication in peripheral blood mononuclear cells of aids and arc patients by tumour necrosis factor this work was supported by public health service grants ai- - and ca- - . key: cord- - pfk qve authors: kaneko, naoe; kurata, mie; yamamoto, toshihiro; morikawa, shinnosuke; masumoto, junya title: the role of interleukin- in general pathology date: - - journal: inflamm regen doi: . /s - - - sha: doc_id: cord_uid: pfk qve interleukin- , an inflammatory cytokine, is considered to have diverse physiological functions and pathological significances and play an important role in health and disease. in this decade, interleukin- family members have been expanding and evidence is accumulating that highlights the importance of interleukin- in linking innate immunity with a broad spectrum of diseases beyond inflammatory diseases. in this review, we look back on the definition of “inflammation” in traditional general pathology and discuss new insights into interleukin- in view of its history and the molecular bases of diseases, as well as current progress in therapeutics. in terms of general pathology, inflammation is one of the adaptive responses to various injuries including physical, chemical, and biological factors. the roman encyclopedist a. cornelius celsus described four cardinal signs of inflammation in one concise sentence: "now the signs of an inflammation are four: redness (rubour) and swelling (tumour), with heat (calour) and pain (dolour)" [ ] . a century and a half later, galen added a fifth sign: "disturbance of function" (funcio laesa) [ ] . the classical signs of inflammation are considered to be related to cells and tissues responding to pathological cell injury caused by internal stimuli, including damage-associated products and metabolites, and external stimuli, including bacteria and viruses [ ] [ ] [ ] [ ] . the host bears the receptors that facilitate recognition of these damage-associated molecular patterns (damps) and/ or pathogen-associated molecular patterns (pamps) that are not host-derived. these receptors are termed pattern recognition receptors (prrs) [ ] . prrs directly or indirectly detect infection and/or noxious chemicals, resulting in inflammation that is coupled with the induction of immune responses and a tissue reparative component [ ] . the signal transduction triggered by these prrs leads to the acute inflammatory mediator expressions that regulate the elimination of pathogens and infected cells [ , ] . there are several known prrs: toll-like receptors (tlrs), rig-i-like receptors (rlrs), nod-like receptors (nlrs), and c-type lectin receptors (clrs). the majority of nod-like receptors such as nlrp , nlrp , nlrc , nlrp , and nlrp can interact with apoptosis-associated speck-like protein containing a caspase-recruitment domain (asc) and caspase- , and the resulting complex is a sensor of cell injury called "inflammasome", an interleukin (il)- β-processing platform that plays a crucial role in il- β maturation and secretion from cells. other pyrin-domain (pyd)-containing proteins such as aim , ifi- , and pyrin are also known to form inflammasomes. among them, nlrp inflammasomes monitor membrane integrity and pore-forming toxins, crystals, and many other noxious stimuli and are involved in il- β processing and maturation [ ] [ ] [ ] [ ] . it is now widely accepted that an inflammatory response is the extreme end of a spectrum that ranges from a homeostatic state of inflammation to a stress response and finally inflammation [ , ] . the homeostatic state of inflammation, which is not inflammation from the perspective of general pathology, was suggested to be maintained by prrs expressed in stromal and/or immune cells, detecting endogenous ligands in parenchymal cells and/or pathogens, leading to chronic inflammatory responses ranging from the basal homeostatic state to disease-causing inflammation [ , ] . in addition to several forms of inflammation including classical inflammation, homeostatic inflammation, a distinct nomenclature for low-grade inflammation, such as para-inflammation (an adaptive response against stress or malfunction) and meta-inflammation (metabolically triggered inflammation), has been proposed [ ] [ ] [ ] . as discussed above, there are various factors involved in forms of inflammation; in particular, since il- is a downstream cytokine of the sensor of cell injury, the inflammasome, it is important for regulating inflammation and tissue damage beyond inflammation [ ] . il- is a master regulator of inflammation via controlling a variety of innate immune processes [ ] . from a historical point of view, il- has a wide range of biological functions, which include acting as a leukocytic pyrogen, a mediator of fever and a leukocytic endogenous mediator, and an inducer of several components of the acute-phase response and lymphocyte-activating factor (laf) [ , ] . laf was later shown to be a macrophage-derived immune mediator acting on t-and b-lymphocytes and was designated as il- in the second international lymphokine workshop held in switzerland in [ , ] . in addition, serum blocking factors in breast cancer patients identified by the leukocyte adherence inhibition test were reported. the serum adherence-promoting factors were regulated by il- [ ] [ ] [ ] . to date, the tumor microenvironment has been characterized by dominant immunosuppression, being infiltrated by tumor immunosuppressive myeloid-derived suppressor cells (mdscs), regulatory t cells (tregs), and tumor-associated macrophages (tams) [ , ] . il- is capable of inducing the recruitment of tams and mdscs, which promote tumor development in breast cancer [ ] . currently, human sequence algorithm technologies suggest that the il- family comprises a total of members with similar or distinct biological effects [ , ] . il- α, il- β, il- ra, il- , il- , il- α, il- β, il- γ, il- ra il- , and il- have been identified and characterized (table ) [ ] . among them, il- α, il- β, il- , il- , and il- are receptor-agonistic, and il- ra, il- ra, and il- are receptor-antagonistic. il- is the only anti-inflammatory cytokine. although the function of each il- family member is now being investigated, il- is the most characterized among these members. there are two individual forms of il- , il- α and il- β, isolated from two distinct cdnas, but they are indistinguishable in terms of their biological functions [ ] . although the homology between il- α and il- β is not high ( %) in terms of amino acid sequences, il- α and il- β are structurally similar and show the same functions by sharing a common receptor, il- type receptor (il- r ), and both have the same central β-barrel along with adjoining loops [ , ] . the difference between il- α and il- β is an n-terminal extension of residues beyond the n-terminus of il- α and il- β [ ] . the molecular weight of each precursor is approximately kda, and il- α and il- β are processed by specific proteases to mature forms. the n-terminal domain of il- α contains a nuclear localization sequence (nls) and shows transcription activity [ ] . il- α is produced as a -amino acid (aa) precursor protein. for transcription of the il- α gene, transcription factor specificity protein (sp ) activates the il- α promoter activity in the ′-upstream gc box (− to − bp) [ ] and nf-κb, which is also activated by il- α itself, and stimulates the consensus promoter region (− to − bp) to induce its own gene expression and production in an autocrine manner [ ] . the precursor of il- α translocates into the nucleus to bind to chromatin and also exists in a membrane-anchored form. upon stress responses, il- α is processed by ca + -dependent protease calpain or other proteases, such as cytotoxic t-lymphocytes (ctl)/natural killer (nk)-granzyme-b, mast cell chymase, or neutrophil elastase to the c-terminal aa as mature il- α [ ] . the il- α processing separates nls from its precursor, which is not linked to secretion or cell death [ ] ; however, il- α is a key danger signal that induces inflammation on release from necrotic cells [ ] . the il- α precursor triggers il- r on resident macrophages in necrotic tissues, producing il- β as well as chemokines as post-necrotic inflammation [ ] . il- β is produced as a -aa precursor protein and processed by caspase- , which is also known as il- β-converting enzyme (ice), activated in inflammasomes, to the c-terminal aa as mature il- β [ , , , ] . the il- β precursor is also processed by other serine proteases [ ] . neutrophils derived from caspase- -deficient mice release mature il- β processed by elastase in response to lipopolysaccharide (lps) stimulation [ ] . the neutrophil proteases, such as elastase, chymases, granzyme a, cathepsin g, and proteinase- , cleave the il- β precursor into a secreted, biologically active form [ ] [ ] [ ] . these alternatively cleaved forms of functional il- β were detected in synovial fluid of a patient with inflammatory polyarthritis and gout [ ] . occasionally, massive neutrophil infiltration appeared in excess-inflammation-damaged tissues and organs, such as in septic shock or systemic inflammatory response syndrome. thus, the nlrp inflammasome-related inflammation induced by a variety of factors described above may be a target of anti-il- therapy [ ] . currently, a two-step model of the initiation of nlrp inflammasome activation is suggested. the first step mediates transcriptional and post-translational priming of nlrp (step ), and the second step is activation of inflammasomes (step ). step is the first synthesis of a biologically inactive il- β precursor by nf-κb binding to the consensus binding site (− to − bp) to transcribe the il- β gene. step is processing into mature, biologically active il- β by caspase- activated by a cytosolic activation platform called inflammasome [ , ] . the inflammasome is a large protein complex, which consists of prrs, such as nlrs, aim , rig-i or pyrin, an adaptor protein asc, and caspase- . among them, the nlrp inflammasome is a prototype inflammasome, which has been reported to be activated by a wide range of pamps and damps [ , ] . various nlrp -activating pamps have been reported, i.e., bacteria-derived rna or dna, pore-forming toxins, lethal toxins, flagellin/rod proteins, muramyl dipeptide (mdp), m protein, virus-derived rna or dna, fungus-derived β-glucans, hypha mannan, zymosan, and protozoon-derived hemozoin [ ] . nlrp -activating damps have also been reported, i.e., self-derived glucose, β-amyloid, hyaluronan, atp, cholesterol crystals, monosodium urate (msu) crystals, calcium pyrophosphate dihydrate (cppd) crystals, environment-derived alum, asbestos, silica, alloy particles, uv radiation, and skin irritants [ ] ; however, their diverse physiological and chemical signals leading to the direct activation of nlrp have not been fully elucidated. instead, efflux of potassium has been identified as the common activator of most known nlrp step signals [ , ] . the nlrp activation by potassium efflux suggested to lead nlrp -nek interaction to drive inflammasome activation [ ] [ ] [ ] . the mechanism underlying the secretion of il- β has been suggested to overlap with il- α secretion [ ] . also, mitochondrial and phagosomal reactive oxygen species (ros) have been proposed to activate the nlrp inflammasome. alternatively, non-canonical pathways of nlrp -inflammasome activation associated with proinflammatory caspases, caspase- , caspase- , and caspase- have been proposed. in this process, lps is recognized by the caspase-recruitment domain (card) of respective caspases, leading to activation [ ] [ ] [ ] [ ] . caspase- or proteases in neutrophils are also processed and activate il- β. several prrs, such as nlrp , nlrp , nlrc , pyrin, and aim , convert the assembly of the adaptor molecule asc into a high-molecular-weight complex, called the pyroptosome [ ] . then, the caspase- precursor is recruited to the pyroptosome to also form helical structures, which enable its proximity-induced proteolytical auto-activation. with caspase- precursor maturation into the active p /p heterotetramer, it cleaves the il- β precursor, leading to pyroptotic cell death. this cell death is mediated by the caspase- -dependent cleavage of gasdermin-d (gsdmd) [ ] [ ] [ ] . in turn, the mature n-terminal fragment of gsdmd translocates to the inner leaflet of the plasma membrane to form round and pore-like structures of approximately nm in diameter [ ] [ ] [ ] [ ] . tissue distributions of interleukin- il- α and il- β are expressed in a wide range of tissues and a variety of cells, especially in macrophages in lymphoid organs including the thymus, spleen, lymph nodes, peyer's patches, and bone marrow. in non-lymphoid organs, il- α and il- β are expressed in tissue macrophages in the lung, digestive tract, and liver. they are also expressed in cellular subepithelial endometrial tissue of the uterus, in the glomeruli, in outer cortical areas of the kidney, and in various specific cell types, including neutrophils, keratinocytes, epithelial and endothelial cells, lymphocytes, smooth muscle cells, and fibroblasts [ , ] . there are two cell surface il- receptors, il- r and il- type receptor (il- r ), a decoy receptor. il- binds to il- r , which requires the formation of a heterodimer with the il- type receptor (il- r ) (also known as il- racp) accompanied by adaptor il- receptor-associated kinase (irak) and myeloid differentiation primary response protein (myd ) [ ] . il- r initiates inflammatory responses when binding to the ligands il- α and il- β and has been reported to be expressed by tlymphocytes, fibroblasts, epithelial cells, and endothelial cells. il- r , which does not initiate signal transduction, is expressed in a variety of hematopoietic cells, especially in b-lymphocytes, mononuclear phagocytes, polymorphonuclear leukocytes, and bone marrow cells. notably, expression levels of il- r and il- r are different among the cell types; for example, neutrophils predominantly express il- r . as a result, much higher concentrations of il- β are required to activate neutrophils, whereas low concentrations of il- β are sufficient to activate endothelial cells. the il- r -mediated signaling pathways also differ according to the cell types [ , ] . il- r is a co-receptor for il- r , responsible for signaling after binding ligands il- α and il- β, and has been reported to be ubiquitously expressed by all cells responsive to il- . il- r b is a brain-specific isoform of il- r generated by alternative splicing, and it has been reported to be expressed in the brain, cerebellum, and spinal cord [ ] . activated il- is incapable of functioning until recognized by cell surface receptors. the complex contains a motif of gtpase activity and activates gtpase-activating protein and protein kinases [ ] [ ] [ ] . in contrast, il- r is thought to reduce the biological response to il- . the proximity of the two cytoplasmic domains of il- r and il- r is thought to initiate signal transduction by the hydrolysis of gtp. this is followed by c-jun n-terminal kinase (jnk) and p map kinase [ ] . irak and tumor necrosis factor (tnf) receptor-associated factor (traf) activate nf-κb, as well as p , jnks, extracellular signal-regulated kinases (erks), and mitogen-activated protein kinases (mapks) [ ] . the nf-κb activation pathway is dependent on the iκ-b kinase (ikk) complex, composed of ikkα, ikkβ, and nf-κb essential modulator (nemo), via associations with tak , tak , traf , and traf in the il- r -signaling pathway [ ] . these signals play important roles in both acute and chronic inflammation in various diseases [ ] . single nucleotide mutation of the cias gene results in nlrp mutation, which induces constituted inflammasome activation causing cryopyrin-associated periodic syndrome (caps). this is termed autoinflammatory disease, including familial cold autoinflammatory syndrome (fcas), muckle-wells syndrome (mws), and neonatal-onset multisystem inflammatory disease (nomid)/chronic infantile neurologic, cutaneous, and arthritis (cinca) syndrome, which leads to greater il- β secretion without any damps or pamps [ ] [ ] [ ] [ ] [ ] [ ] . the most common autoinflammatory disease is familial mediterranean fever (fmf). fmf is autosomal recessive; however, mutations in the causative mefv gene, encoding mutated pyrin, leads to active pyrin inflammasome [ ] . inflammatory diseases like those above, characterized by the enhanced secretion of il- β, include a group of autoinflammatory diseases such as nlrp autoinflammatory syndrome; hyperimmunoglobulinemia d and periodic fever syndrome (hids)/mevalonate kinase deficiency (mkd); pyogenic arthritis, pyoderma gangrenosum, and acne (papa) syndrome; pyoderma gangrenosum, acne, and suppurative hidradenitis (pash) syndrome; pyogenic arthritis, acne, pyoderma gangrenosum, and suppurative hidradenitis (papash); majeed syndrome; and tnf-receptor- -associated syndrome (traps) [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] . on deficiency of the il- -receptor antagonist (dira), excess il- β induces other proinflammatory cytokines and chemokines [ ] . excess stress responses disrupt body homeostasis under physiological conditions and lead to excess cytokine production. nlrp inflammasomes have also been reported to be involved in low-grade subclinical inflammation induced by chronic exposure to high levels of free fatty acids and glucose, leading to increased apoptosis and impaired insulin secretion of β-cells in obese type diabetes mellitus (t d) patients [ ] [ ] [ ] . indeed, islet amyloid polypeptide (iapp) oligomers activated nlrp inflammasomes to induce significant il- β production by infiltrating macrophages in an in vivo study [ , ] . higher concentrations of glucose activate nf-κb and il- precursors in cells [ ] . minimally oxidized low-density lipoproteins stimulate tlr , which triggers il- β expression [ , ] , and accumulations of islet amyloid polypeptides are deposited and mediate nlrp inflammasome activation in islet macrophages [ ] . another oligomer of amyloid, amyloid β, can induce il- β via nlrp inflammasomes in a process involving the phagocytosis of amyloid β in glial cells in patients with alzheimer's disease (ad) and subsequent lysosomal damage and release of cathepsin b [ ] . ros are considered to be involved in the activation of nlrp inflammasomes, and it was suggested that direct interaction between amyloidogenic peptide and nlrp could initiate nlrp inflammasome formation in a cell-free system [ , ] . both il- α and il- β gene polymorphisms have been reported to be associated with central obesity and metabolic syndrome in a population with coronary heart disease in an epidemiologic study [ ] . thus, these diseases are il- dependent cytokinopathies (interleukinoneopathies). besides the above diseases, numerous inflammatory diseases related to excess il- signaling have also been identified [ ] [ ] [ ] . for example, high il- β levels in humans and mice result in increased th -dominant immunopathology, and il- β expression was limited to macrophages and neutrophils, which account for a large proportion of the cd α cells in the cervix upon chlamydia muridarum infection [ ] . consequently, il- β promotes the differentiation of monocytes into conventional dendritic cells (dcs) and m -like macrophages and supports the proliferation of activated b-lymphocytes and their differentiation into plasma cells [ ] [ ] [ ] . il- in combination with il- promoted not only the expansion of nk cells but also cd + cd + t-lymphocytes [ ] . il- β generated by activated antigen-presenting cells (apcs) induced type immune responses, which produced ctl and led to the polarization of cd + t -lymphocytes towards t-helper cell type (th ) [ , ] . il- β plays a role in resolving acute inflammation resulting in the initiation of adaptive anti-tumor responses; however, chronic inflammatory conditions increase the risk of developing cancer [ ] . in human breast cancer, higher expression of il- β is associated with tumor invasiveness and aggressive tumor biology [ ] . expression of il- α, il- β, and their receptors in human breast cancer tissues results in the activation of a population of cells and subsequently contributes to angiogenesis, tumor proliferation, and tumor invasion in the microenvironment [ ] . in a spontaneous mmtv-pymt mouse mammary gland tumor model, mature il- β levels in primary mammary tumors and metastasis sites were significantly elevated, being associated with inflammasome activation and the infiltration of myeloid cells in tumor microenvironments. in this model, cd b + gr + and cd b + gr − myeloid cell populations were also significantly increased in both tumor tissues [ ] . il- β generated in a tissue with a tumor microenvironment dominated by tams promotes tumor growth and metastasis in breast cancer [ , ] . il- , by promoting mdscs and sustaining the immunosuppressive activity of tams, contributes to the suppression of effective adaptive anti-tumor immune responses [ ] . actually, the sphingolipid sphingosine- -phosphate (s p) on tams promotes lymphangiogenesis and lung metastasis via nlrp /il- β in mouse breast cancer model [ ] . for example, obesity induces an increase in tumor-infiltrating mdscs with activated nlrc inflammasome, leading to il- β production, which drives tumor progression through adipocyte-mediated vascular endothelial growth factor (vegf) a expression and angiogenesis [ ] . a recent report showed that il- β orchestrates tumor-promoting inflammation in patients with high-risk her -negative breast cancer who would benefit from il- -blocking therapeutics with anakinra (described later on). the report indicates that while anakinra downregulates gene expressions for il- β, il- r , il- r , and il- r , increased gene expressions of nk cells and ctls are observed [ ] . although il- has been well-characterized, il- and other il- family members have been less comprehensively investigated. il- can be processed by caspase- and proteinase- as well as il- β, to be activated [ ] [ ] [ ] . considering the pathogenesis of il- -related diseases, il- could be involved [ ] . il- was originally identified as interferon (ifn)-γ-inducing factor [ ] . il- is the most structurally related to il- β. il- is synthesized as a -kda inactivated precursor and is cleaved by caspase- to a biologically active -kda mature form [ , ] . although il- β is biologically active within the pg/ml range, il- requires - ng/ml and sometimes higher levels for in vitro activation [ , ] . since the il- precursor is expressed ubiquitously in tissues [ ] , il- signaling is thought to be regulated concentration-dependently. mature il- forms a signaling complex with the il- receptor alpha chain (il- rα) with low affinity. if the cell expresses an il- receptor β chain (il- rβ), a high affinity complex is formed like the il- r accessory chain il- r . the complex of the heterodimer recruits myd through the toll-il- receptor (tir), four iraks, and traf- , leading to the degradation of i-κb and activation of nf-κb, as that for il- signaling [ ] . il- is involved in regulation of the th response by modulating the production of ifn-γ. for example, in synergy with either il- or il- , which upregulates the expression of the il- rβ co-receptor, il- induces the production of ifn-γ by t cells [ ] . il- induces ifn-γ production by nk cells, and nk cells express ccr and produce high levels of ifn-γ [ ] . the combination of il- and il- induced high levels of ifn-γ upon hypoglycemia, intestinal inflammation, and inanition [ ] . some human autoimmune diseases are associated with the elevated production of ifn-γ and il- . autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis (ra), type- diabetes mellitus, crohn's disease and psoriasis, and graft versus host disease are thought to be mediated by il- [ ] . so far, several anti-il- therapies have been reported. an anti-il- , multicenter, randomized, single-blind, placebo-controlled, parallel-group, phase iia trial for the treatment of t d was reported whereby anti-il- monoclonal antibody, gsk , was well-tolerated; however, the anti-il- therapy did not lead to any improvements in glucose control [ ] . interleukin- binding protein (il- bp) was purified from urine by chromatography on il- beads that abolished il- induction of ifn-γ, il- , and activation of nf-κb in vitro [ ] . the il- inhibition using il- bp significantly decreased mdscs in the tumor microenvironment in a preclinical osteosarcoma mouse model [ ] . il- bp (tadekinig α®) was successful in the treatment of still's disease and nlrc -mutated autoinflammatory macrophage activation syndrome (mas), for which anti-il- treatment had failed [ , ] . several inhibitors of il- signaling have been clinically approved (fig. ) . one is a recombinant human intrinsic il- receptor antagonist (il- ra), anakinra [ ] . anakinra is the pharmaceutical name of a recombinant form of intrinsic human il- ra, a . -kda protein consisting of amino acid residues. il- ra was first reported in as a bioactive il- inhibitor of - kda in the supernatants of human monocyte culture, and it was independently identified as an il- inhibitor from the urine of febrile patients [ , ] . anakinra was the first biological drug of a selective il- r antagonist to receive approval from the us food and drug administration (fda). since anakinra is an il- receptor antagonist, it can prevent the activity of both il- α and il- β by competitively blocking their binding to il- r and il- r . anakinra has been applied for a wide range of diseases including autoinflammatory diseases, non-cancer inflammatory diseases, and malignancies [ ] . to date, no serious adverse effect of anakinra has been reported [ ] . another is rilonacept (ril on' a sept), a soluble decoy receptor (fig. ) . rilonacept is a recombinant fusion protein consisting of the extracellular portion of human il- r and il- r fused with the fc portion of human igg [ ] [ ] [ ] . rilonacept binds to both il- α and il- β with high affinity and inhibits the activity of both with a long-term inhibitory effect. rilonacept was first approved by the fda for the treatment of caps in . subcutaneous injection with a loading dose and a weekly injection of half the loading dose was administered [ ] . there are no known severe adverse effects of rilonacept due to il- signaling inhibition. these drugs could modulate the immune response. the most common side effects (> % of treated patients) are inflammation of the upper respiratory tract or sinuses, headache, and redness at the injection site [ ] . the third is canakinumab (fig. ) . canakinumab, a specific human monoclonal igg antibody targeting il- β, is intravenously or subcutaneously infused to neutralize the bioactivity of human il- β [ , ] . canakinumab does not react with il- α or il- r . therefore, canakinumab is a more specific inhibitor of il- β, expected to have no effect on il- α-dependent host defense [ ] . early clinical trials established the administration of canakinumab every weeks as safe and effective against several inflammatory diseases [ , ] . there are several agents currently undergoing clinical trials. il- α production is a very early step in the sterile inflammatory response at the center of the malignant phenotype that drives angiogenesis, tumor stromal remodeling, tumor invasiveness, metastasis, and cachexia [ , [ ] [ ] [ ] . thus, il- α may be a particularly important target for the treatment of cancer. a neutralizing true human igg κ a b d c fig. interleukin- receptors and inhibitors of il- signaling. a il- r interacts with both il- α and il- β and promotes signal transduction, together with its co-receptor il- r (il- racp). il- ra is a protein that binds to il- r but not il- r , and it is as an inhibitor of il- signaling. il- r is a decoy receptor because it lacks a cytoplasmic segment. b anakinra is a recombinant form of intrinsic human il- ra. it works as an antagonist of il- r , and it is able to inhibit both il- α and il- β. c rilonacept is a recombinant fusion protein including the extracellular protein of human il- r and il- r fused with the fc portion of human igg . it binds to both il- α and il- β with high affinity and has a long-term inhibitory effect. d canakinumab and mabp are monoclonal antibodies against il- β and il- α, respectively. they bind to and neutralize their targets specifically monoclonal antibody specific for human il- α, mabp , has been developed, and it was well-tolerated with no dose-limiting toxicities or immunogenicity [ , ] (fig. ) . mabp treatment for patients with advanced colorectal cancer in a randomized, double-blind, placebocontrolled, phase study revealed that mabp improved clinical performance in patients with advanced colorectal cancer [ ] . mabp is a promising treatment for patients with hidradenitis suppurativa not eligible for the anti-tnf-α antibody adalimumab [ ] . gevokizumab is an anti-il- β monoclonal antibody, igg , which improved glucose control and β-cell function in a diet-induced-obesity mouse model [ ] and in the presence of il- β-driven inflammatory diseases [ ] . ly is a humanized monoclonal antibody (igg ) that binds to il- β to neutralize its activity. its affinity is comparatively high ( . pmol/l). previous clinical studies evaluated not only its safety and pharmacokinetics but also its effects on ra (nct ). weekly treatment of t d patients with ly for months resulted in modest reductions in glycated hemoglobin and blood glucose [ ] . population pharmacokinetics (pk) of ly were characterized using data from t d subjects (study h c-mc-bbdk) who received weekly subcutaneous doses of ly ( . , , and mg) and ra subjects (study h c-mc-bbde) who received five weekly intravenous (iv) doses ( . - . mg/kg) [ ] . no additional study has been reported. amg is a fully human, igg monoclonal antibody that binds to human il- r , inhibiting the activity of il- α and il- β [ ] . patients with osteoarthritis received placebo or amg subcutaneously (sc, or mg) or intravenously (iv, or mg) once every weeks for weeks or received placebo or mg amg sc, once every weeks for weeks; however, there was non-significant but numerically greater improvement in pain compared with the placebo group based on womac pain scores [ ] . amg is now termed medi- which has been studied in not only osteoarthritis, but also chronic obstructive pulmonary disease. in all cases, the benefit is limited [ , ] . ebi- is a protein chimera of il- β and il- receptor antagonists (il- ra or anakinra). ebi- binds to il- r and inhibits il- signaling and has been studied for the treatment of ocular surface inflammatory diseases [ ] . since il- β is known to be processed and activated by caspase- , caspase- could be an indirect target for il- β signaling. to examine this, the highly selective caspase- inhibitor vx- was applied to a rat model of myocardial infarction (mi) and mouse model of ad [ , ] . the recombinant human il- -receptor antagonist anakinra is markedly effective against caps such as mws, fcas, and nomid/cinca. weekly rilonacept treatment markedly improved the clinical symptoms of caps and normalized the levels of saa in those at risk of developing amyloidosis [ , , , ] . in several case reports of patients with fmf, anti-il- treatment with anakinra, canakinumab, or rilonacept in colchicine-resistant patients was highly effective [ ] [ ] [ ] [ ] . it was also reported that there was a rapid and lasting response of pyoderma gangrenosum to targeted treatment with anakinra in a patient with papa syndrome [ ] . anakinra and canakinumab therapies were also reported to be effective in patients with mkd/hids [ ] . in the case of traps, although tnf-α is considered to be mainly involved in clinical manifestations, marked improvement following il- β blockade occurred [ , ] . an open-label, phase ii study was reported whereby patients with active recurrent or chronic traps ( / , %; % ci . % to . %) achieved the primary efficacy endpoint. canakinumab treatment for traps rapidly improved the median time to clinical remission to days ( % ci to days) [ ] . skin findings also promptly improved upon anakinra treatment in a patient with dira [ ] . monotherapy involving canakinumab for the treatment of fmf has been reported [ ] . a nationwide report on il- treatment of patients with fmf revealed that fmf patients ( [ %] female; mean age, . years [range, ) were included; the mean age at onset was . years (range, - ), and the mean colchicine dose was . mg/day (range, . - . ). anakinra was administered to patients, and canakinumab was administered to patients. anti-il- treatment was used in % of colchicine-resistant patients and % of amyloidosis patients. during the mean of . months of treatment (range, - ), the attack frequency per year was significantly decreased (from . to . ; p < . ), and symptoms of . % of colchicine-resistant patients with fmf were ameliorated. in this study, the complete remission rate was % and inefficacy rate was % in patients treated with anakinra, whereas the complete remission rate was % and inefficacy rate was % for patients treated with canakinumab [ ] . although the response rates were not significant (p = . and χ = . ) in the study above [ ] , in our opinion, long-acting canakinumab may be more efficacious than anakinra, considering the necessity of daily subcutaneous anakinra injection because of its short half-time clearance of less than h [ ] . there are suspected etiologies of autoinflammatory disorders, but all lack a known genetic basis. in patients with adult-onset still's disease (aosd), anakinra monotherapy is significantly effective and has become the standard therapy, especially in prednisone-resistant patients. commercially available anti-il- agents (anakinra/kineret®, canakinumab/ ilaris®, or rilonacept/arcalyst®) for patients with treatmentresistant aosd are effective. canakinumab and anakinra were also effective for patients with schnitzler syndrome, an adult-onset autoinflammatory disease characterized by focal urticaria and systemic inflammation including fever with bone and muscle pain, in the first placebo-controlled study, and several clinical trials are currently ongoing [ ] [ ] [ ] [ ] . il- blockade therapy using anakinra is successful in patients with psoriatic arthritis, ankylosing spondylitis, and ra. on the other hand, its efficacy and safety are insufficient, precluding use for patients with systemic lupus erythematosus or sjögren syndrome, and il- β inhibition using canakinumab had no effect on the decline in β-cell function after diabetes onset in patients with type diabetes mellitus resulting from autoimmune-mediated β-cell loss [ ] [ ] [ ] [ ] [ ] . as for ra, the enhanced release of other proinflammatory cytokines such as tnf-α and il- plays important roles in the inflamed synovium of ra patients [ ] . in patients for whom tnf-α blockers are contraindicated, anakinra is effective in controlling the disease activity of ra and has been licensed for treatment at a dose of mg/day by subcutaneous injection every day [ , ] . compared with anakinra, tnf inhibitors, such as the anti-tnf-α monoclonal antibody infliximab, or etanercept that fuse the tnf receptor to the end of the igg antibody, dominate the field of biologics for ra because of the sense of well-being experienced by patients within hours of treatment [ ] . tocilizumab, a humanized anti-il- receptor (il- r) monoclonal antibody, has also been shown to improve the symptoms of patients with ra [ ] . however, those agents are associated with the risk of reactivating bacterial pathogens such as tuberculosis (tb) and malignancies [ ] . notably, no cases of tb reactivation were reported in ra patients after anakinra treatment, whereas cases of tb reactivation were reported in , ra patients after tocilizumab treatment, and and cases of tb reactivation were reported in and ra patients after tnf-inhibitor treatment with golimumab and certolizumab pegol, respectively. this suggests the low risk of tb reactivation in ra patients treated with anti-il- therapy [ ] . anakinra is safe and may be associated with a dose-related survival advantage in patients with septic shock syndrome complicated by acute respiratory distress syndrome, disseminated intravascular coagulation, and renal dysfunction, and subsequent secondary hemophagocytic lymphohistiocytosis (hlh), or macrophage-activating syndrome (mas) [ , ] . for sepsis with mas, anakinra treatment led to significant improvements in hepatobiliary dysfunction and disseminated intravascular coagulation in patients ( . % anakinra vs. . % placebo) and the -day survival rate, with the hazard ratio for death being . ( . - . ; p = . ) for the treatment group on cox regression. the data included adults in the original study cohort, randomized to receive either anakinra or placebo [ ] . for metabolic syndromes il- inhibition by anakinra, rilonacept, or canakinumab is efficacious for gout patients [ ] . il- plays a role in the progression of atherosclerosis as well [ ] . in patients with a history of mi, canakinumab significantly reduced the high-sensitive serum crp concentration from the baseline, as compared with a placebo, without affecting the ldl-cholesterol concentration. a -mg dose of canakinumab resulted in a significantly reduced risk of recurrent cardiovascular events compared with a placebo [ ] . the inhibition of il- with anakinra improved glycemia and the pancreatic β-cell function and reduced systemic inflammation [ ] . although il- β inhibition with canakinumab had similar effects on major cardiovascular events among those with and without diabetes, treatment over a median period of . years did not reduce incident diabetes [ ] . the blockade of il- with anakinra improved glycemia and the β-cell secretory function and reduced markers of systemic inflammation [ ] . anakinra also prevented transthyretin extracellular deposition in the sciatic nerve in a familial amyloidotic polyneuropathy mouse model [ ] . during ischemic disease, such as mi or cerebral infarction, or tissue injury, cell death by necrosis takes place and the il- α precursor is released in sterile inflammation [ ] . when there is no time for the synthesis of il- α, il- α is ready to function as soon as it leaves the dying cell in the first few hours following tissue ischemia or injury [ ] . in fact, animal studies showed that the inhibition of il- is effective in limiting atherosclerosis and cardiovascular events and improving the symptoms of acute mi and ischemic stroke [ , ] . two pilot studies of il- inhibition in st-segment elevation mi revealed a reduced acute inflammatory response and favorable overall performance at the -month follow-up [ ] . il- β is thought to play an important role in cancer invasiveness, progression, and metastases via inflammation in the tumor microenvironment. a further analysis in the canakinumab anti-inflammatory thrombosis outcomes study (cantos), a randomized trial of the role of inhibition of il- β in atherosclerosis, revealed that anti-inflammatory therapy with canakinumab targeting the il- β innate immunity pathway could significantly reduce lung cancer mortality [ ] . moreover, treatment of patients with metastatic breast cancer-related with anakinra eliminates a systemic transcriptional signature of il- -associated inflammation in blood cells. the inflammatory signature in primary breast cancers identifies a subset of patients that could potentially benefit from il- β-targeted therapies [ ] . safety profiles of both anakinra and canakinumab were reported [ ] . in this study, several clinical and therapeutic data on patients treated with either anakinra or canakinumab were retrospectively analyzed. four hundred and seventy-five patients participated; anakinra and canakinumab were prescribed in and treatment courses, respectively. eighty-nine adverse events were recorded; ( . %) were classified as serious adverse events during a mean follow-up of . ± . months. [ ] . in addition, anakinra is applied to metastatic cancer. a trial involving metastatic colorectal cancer patients showed significantly increased survival when anakinra was added to standard chemotherapy for colorectal cancer and patients with her -negative breast cancer [ , ] . the il- blockade will reduce il -driven inflammation and immunosuppression that may contribute to the tumor metastatic table effective anti-il- therapy for inflammatory diseases autoinflammatory diseases: cryopyrin-associated periodic syndrome (caps) [ , ] familial mediterranean fever (fmf) [ ] pyogenic arthritis, pyoderma gangrenosum and acne syndrome (papa) [ ] nlrp autoinflammatory syndrome [ ] tumor necrosis factor receptor- -associated syndrome (traps) [ ] hyperimmunoglobulinemia d and periodic fever syndrome (hids)/ mevalonate kinase deficiency (mkd) [ ] deficiency of the interleukin- -receptor antagonist (dira) [ ] autoimmune diseases: psoriatic arthritis [ ] ankylosing spondylitis [ ] rheumatoid arthritis (ra) [ ] metabolic syndrome: gout [ ] atherosclerosis [ ] type diabetes mellitus (t d) [ ] amyloidosis [ ] neurodegenerative disease: alzheimer's disease (ad) [ ] infections and inflammatory responses: septic shock syndrome [ ] acute respiratory distress syndrome (ards) [ ] disseminated intravascular coagulation (dic) [ ] hemophagocytic lymphohistiocytosis (hlh) [ ] macrophage-activating syndrome (mas) [ ] ischemic diseases: myocardial infarction (mi) [ ] stroke [ ] malignant rumor: breast cancer [ ] microenvironment [ ] . the timeline of therapeutics is summarized in fig. . we described il- as an important cytokine for not only inflammation related to cell injury but also homeostasis of cells, tissues, and organs in view of the general pathology. in addition, we also described recent expanding il- signal-targeting for the treatment of diseases. once the balance of il- signaling is disrupted, it may markedly contribute to the pathogenesis of not only inflammatory disease, but also malignancies. il- -targeted biologics have been expanding, as there are no known serious adverse effects such as lymphoproliferative disorder or virus reactivation like tnf or il- -targeting therapies. therefore, il- is expected to become an attractive molecular target to treat a wide range of diseases such as autoinflammatory diseases, autoimmune diseases, infectious disease, metabolic syndromes, ischemic diseases, and malignant tumors [ , ] (table ) . availability of data and materials not applicable. the manuscript was written by nk and jm, and all authors read and approved the final manuscript. ethics approval and consent to participate not applicable. not applicable. disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by galen to the four cardinal signs of celsus robbins & cotran pathologic basis of disease inflammation and metabolic disorders endoplasmic reticulum stress and the inflammatory basis of metabolic disease inflammatory mechanisms in obesity approaching the asymptote? evolution and revolution in immunology stress, inflammation, and defense of homeostasis pattern recognition receptors and inflammation editorial overview: special section: effects of endogenous immune stimulants: from a defence system against infection to a homeostatic mechanism linking metabolism with inflammation the pyrin-card protein asc is an activating adaptor for caspase- . srinivasula sm the inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proil-β nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of nonmicrobial inflammation and diseases regulation of inflammasome signaling homeostatic inflammation, an emerging concept homeostatic inflammation in innate immunity inflammation, metaflammation and immunometabolic disorders origin and physiological roles of inflammation it's time to redefine inflammation il- family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance immunological and inflammatory functions of the interleukin- family potentiation of the t-lymphocyte response to mitogens. i. the responding cell macrophage sensitivity to endotoxin: genetic control by a single codominant gene biochemical and biological characterization of lymphocyteactivating factor (laf) produced by the murine macrophage cell line, p d interleukin : the first interleukin detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients the inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages blockage of the nlrp inflammasome by mcc improves anti-tumor immune responses in head and neck squamous cell carcinoma targeting inflammasome/il- pathways for cancer immunotherapy il- family nomenclature the interleukin- family: back to the future partial purification of human lymphocyte-activating factor (laf) by ultrafiltration and electrophoretic techniques crystallographic refinement of interleukin β at . a resolution tructure of interleukin at . -a resolution structure and function of interleukin- , based on crystallographic and modeling studies the precursor form of il- α is an intracrine proinflammatory activator of transcription the interaction with sp and reduction in the activity of histone deacetylase are critical for the constitutive gene expression of il- alpha in human melanoma cells molecular analysis of constitutive il- alpha gene expression in human melanoma cells: autocrine stimulation through nf-κb activation by endogenous il- α inflammasome activators induce interleukin- α secretion via distinct pathways with differential requirement for the protease function of caspase- identification of a key pathway required for the sterile inflammatory response triggered by dying cells the interleukin- α precursor is biologically active and is likely a key alarmin in the il- family of cytokines cloning, sequence and expression of two distinct human interleukin- complementary dnas inflammasome-independent regulation of il- -family cytokines treating inflammation by blocking interleukin- in a broad spectrum of diseases expression and alternative processing of il- in human neutrophils rapid and specific conversion of precursor interleukin β (il- β) to an active il- species by human mast cell chymase multiple biological activities of human recombinant interleukin granzyme a is an interleukin beta-converting enzyme processing of precursor interleukin β and inflammatory disease nf-κb regulates il- β transcription through a consensus nf-κb binding site and a nonconsensus cre-like site mechanisms of interleukin- β release activation and regulation of the inflammasomes mechanisms and functions of inflammasomes the inflammasome nlrs in immunity, inflammation, and associated diseases activation of the nalp inflammasome is triggered by low intracellular potassium concentration k + efflux is the common trigger of nlrp inflammasome activation by bacterial toxins and particulate matter a genome-wide crispr (clustered regularly interspaced short palindromic repeats) screen identifies nek as an essential component of nlrp inflammasome activation nek is an essential mediator of nlrp activation downstream of potassium efflux nlrp activation and mitosis are mutually exclusive events coordinated by nek , a new inflammasome component noncanonical inflammasome activation by intracellular lps independent of tlr cytoplasmic lps activates caspase- : implications in tlr -independent endotoxic shock inflammatory caspases are innate immune receptors for intracellular lps caspase- mediates non-canonical activation of the nlrp inflammasome in human myeloid cells bax/bak-induced apoptosis results in caspase- -dependent il- β maturation in macrophages cleavage of gsdmd by inflammatory caspases determines pyroptotic cell death caspase- cleaves gasdermin d for non-canonical inflammasome signalling gasdermin d is an executor of pyroptosis and required for interleukin- β secretion gsdmd membrane pore formation constitutes the mechanism of pyroptotic cell death gsdmd p elicited by caspase- during pyroptosis forms pores in membranes poreforming activity and structural autoinhibition of the gasdermin family inflammasomeactivated gasdermin d causes pyroptosis by forming membrane pores detection of il- alpha and il- beta gene expression by in situ hybridization. tissue localization of il- mrna in the normal c bl/ mouse the interleukin- family: years of discovery mass spectrometric analysis of the endogenous type i interleukin- (il- ) receptor signaling complex formed after il- binding identifies il- racp, myd , and irak- as the stable components mouse neutrophils express the decoy type interleukin- receptor (il- r ) constitutively and in acute inflammatory conditions il- receptor type suppresses collagen-induced arthritis by inhibiting il- signal on macrophages the interleukin- receptor family interleukin- -induced activation of a protein kinase co-precipitating with the type i interleukin- receptor in t cells nf-κb activation by interleukin- (il- ) requires an il- receptor-associated protein kinase activity evidence from sequence information that the interleukin- receptor is a transmembrane gtpase interleukin- (il- ) pathway the interleukin- receptor/toll-like receptor superfamily: signal transduction during inflammation and host defense targeting of tak in inflammatory disorders and cancer tnf and map kinase signalling pathways mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and muckle-wells syndrome de novo cias mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (nomid): a new member of the expanding family of pyrinassociated autoinflammatory diseases chronic infantile neurological cutaneous and articular syndrome is caused by mutations in cias , a gene highly expressed in polymorphonuclear cells and chondrocytes neonatal-onset multisystem inflammatory disease responsive to interleukin- beta inhibition pattern of interleukin- beta secretion in response to lipopolysaccharide and atp before and after interleukin- blockade in patients with cias mutations genetic and molecular basis of inflammasomemediated disease innate immune sensing of bacterial modifications of rho gtpases by the pyrin inflammasome papa, pash and papash syndromes: pathophysiology, presentation and treatment the b . domain of pyrin, the familial mediterranean fever protein, interacts directly with caspase- to modulate il- β production pyrin binds the pstpip /cd bp protein, defining familial mediterranean fever and papa syndrome as disorders in the same pathway clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an nlrp mutation lack of isoprenoid products raises ex vivo interleukin- secretion in hyperimmunoglobulinemia d and periodic fever syndrome clinical, genetic, and therapeutic diversity in patients with severe mevalonate kinase deficiency dramatic improvement following interleukin beta blockade in tumor necrosis factor receptor- -associated syndrome (traps) resistant to anti-tnf-α therapy an autoinflammatory disease with deficiency of the interleukin- -receptor antagonist glucose-induced beta cell production of il- beta contributes to glucotoxicity in human pancreatic islets thioredoxin-interacting protein links oxidative stress to inflammasome activation free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin- receptor i activation of the nlrp inflammasome by islet amyloid polypeptide provides a mechanism for enhanced il- β in type diabetes iapp boosts islet macrophage il- in type diabetes resident macrophages mediate islet amyloid polypeptide-induced islet il- β production and β-cell dysfunction the nalp inflammasome is involved in the innate immune response to amyloid-β iapp/amylin deposition, which is correlated with expressions of asc and il- β in β-cells of langerhans' islets, directly initiates nlrp inflammasome activation amyloid β directly interacts with nlrp to initiate inflammasome activation: identification of an intrinsic nlrp ligand in a cell-free system association of interleukin- gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population pattern of interleukin- β secretion in response to lipopolysaccharide and atp before and after interleukin- blockade in patients with cias mutations autoinflammation: translating mechanism to therapy central delivery of iodine- -labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating alzheimer's disease critical role for interleukin- β (il- β) during chlamydia muridarum genital infection and bacterial replication-independent secretion of il- beta in mouse macrophages negative regulation of cytokine signaling influences inflammation interleukin- β triggers the differentiation of macrophages with enhanced capacity to present mycobacterial antigen to t cells the role of interleukin in human b cell activation: inhibition of b cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen ril -induced proliferation of human circulating nk cells and t lymphocytes: synergistic effects of il and il il- β strikingly enhances antigen-driven cd and cd t-cell responses the nlrp inflammasome in kidney disease and autoimmunity cancer-related inflammation expression of interleukin- β in human breast carcinoma the interleukin- family of cytokines and receptors in human breast cancer: implications for tumor progression cancer: an infernal triangle il- and il- regulatory pathways in cancer progression and therapy s pr on tumor-associated macrophages promotes lymphangiogenesis and metastasis via nlrp /il- β obesity-associated nlrc inflammasome activation drives breast cancer progression il receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer neutrophil proteinase -mediated induction of bioactive il- secretion by human oral epithelial cells activation of interferon-gamma inducing factor mediated by interleukin- beta converting enzyme caspase- processes ifn-gamma-inducing factor and regulates lps-induced ifn-gamma production interleukin- and il- binding protein endotoxin-induced serum factor that stimulates gamma interferon production a novel role for interleukin- in adhesion molecule induction through nf-κb and phosphatidylinositol (pi) -kinase-dependent signal transduction pathways differences in signaling pathways by il- beta and il- gene expression, synthesis, and secretion of interleukin and interleukin beta are differentially regulated in human blood mononuclear cells and mouse spleen cells interferon-gammainducing factor enhances t helper cytokine production by stimulated human t cells: synergism with interleukin- for interferon-gamma production m-csf induces the expression of a membrane-bound form of il- in a subset of human monocytes differentiating in vitro toward macrophages ifn-gammadependent and -independent mechanisms in adverse effects caused by concomitant administration of il- and il- natural killer cells in human autoimmune diseases a study to investigate the efficacy and safety of an anti-interleukin- monoclonal antibody in the treatment of type diabetes mellitus interleukin- binding protein: a novel modulator of the th cytokine response inhibition of il- -mediated myeloid derived suppressor cell accumulation enhances anti-pd efficacy against osteosarcoma cancer prolonged treatment with tadekinig alfa in adult-onset still's disease life-threatening nlrc -associated hyperinflammation successfully treated with il- inhibition interleukin receptor antagonist. a new member of the interleukin family effects of immune complexes on production by human monocytes of interleukin or an interleukin inhibitor identification of a specific interleukin inhibitor in the urine of febrile patients an expanding role for interleukin- blockade from gout to cancer a pilot study to evaluate the safety and efficacy of the longacting interleukin- inhibitor rilonacept (interleukin- trap) in patients with familial cold autoinflammatory syndrome efficacy and safety of rilonacept (interleukin- trap) in patients with cryopyrinassociated periodic syndromes: results from two sequential placebocontrolled studies church ld, mcdermott mf. canakinumab, a fully-human mab against il- for the potential treatment of inflammatory disorders antiinflammatory therapy in clinical care: the cantos trial and beyond il- α secreted by colon cancer cells enhances angiogenesis: the relationship between il- α release and tumor cells' potential for liver metastasis interleukin- α secreted by pancreatic cancer cells promotes angiogenesis and its therapeutic implications il- is required for tumor invasiveness and angiogenesis mabp , a first-in-class true human antibody targeting interleukin- α in refractory cancers: an open-label, phase dose-escalation and expansion study mabp as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase study mabp targeting il- α for moderate to severe hidradenitis suppurativa not eligible for adalimumab: a randomized study xoma , an anti-il- β monoclonal antibody, improves glucose control and β-cell function in the diet-induced obesity mouse model il- β inhibition in cardiovascular complications associated to diabetes mellitus double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous ly , a neutralizing il- β antibody, in patients with type diabetes population pharmacokinetic modeling of ly after multiple intravenous and subcutaneous administrations a phase randomized, double-blind study of amg , a fully human monoclonal antibody to il- r, in patients with rheumatoid arthritis a randomized, double-blind study of amg (a fully human monoclonal antibody to il- r ) in patients with osteoarthritis of the knee a randomised, placebo-controlled trial of anti-interleukin- receptor monoclonal antibody medi in chronic obstructive pulmonary disease preclinical development of ebi- : an il- receptor- inhibitor for the topical ocular treatment of ocular surface inflammatory diseases the highly selective caspase- inhibitor vx- provides additive protection against myocardial infarction in rat hearts when combined with a platelet inhibitor caspase- inhibition alleviates cognitive impairment and neuropathology in an alzheimer's disease mouse model interleukin- -receptor antagonist in the muckle-wells syndrome prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin- receptor antagonist the efficacy of anakinra in an adolescent with colchicine-resistant familial mediterranean fever anti-il- treatment for secondary amyloidosis in an adolescent with fmf and behçet's disease rilonacept for colchicine-resistant or -intolerant familial mediterranean fever: a randomized trial canakinumab for the treatment of autoinflammatory recurrent fever syndromes targeted treatment of pyoderma gangrenosum in papa (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin- receptor antagonist anakinra efficacy of interleukin- -targeting drugs in mevalonate kinase deficiency beneficial response to interleukin receptor antagonist in traps canakinumab treatment for patients with active recurrent or chronic tnf receptor-associated periodic syndrome (traps): an open-label, phase ii study deficiency of interleukin- receptor antagonist responsive to anakinra canakinumab as monotherapy for treatment of familial mediterranean fever -first report in central and eastern europe region nationwide experience with off-label use of interleukin- targeting treatment in familial mediterranean fever patients efficacy and safety of canakinumab in patients with still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups rapid responses to anakinra in patients with refractory adult-onset still's disease adult onset still's disease-the evidence that antiinterleukin- treatment is effective and well-tolerated (a comprehensive literature review) efficacy and safety of canakinumab in schnitzler syndrome: a multicenter randomized placebo-controlled study anakinra for rheumatoid arthritis: a systematic review an open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate open label trial of anakinra in active ankylosing spondylitis over weeks a systematic review of the off-label use of biological therapies in systemic autoimmune diseases interleukin- antagonism in type diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials revolutionary change in rheumatoid arthritis management with biological therapy interleukin- in the pathogenesis and treatment of inflammatory diseases tuberculosis risk in patients treated with nonanti-tumor necrosis factor-α (tnf-α) targeted biologics and recently licensed tnf-α inhibitors: data from clinical trials and national registries blockade of tnf-α rapidly inhibits pain responses in the central nervous system study of active controlled monotherapy used for rheumatoid arthritis, an il- inhibitor (samurai): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab il- ra sepsis syndrome study group. initial evaluation of human recombinant interleukin- receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial therapeutic role of anakinra, an interleukin- receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children interleukin- receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial anti-interleukin- therapy in the management of gout interleukin- β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the canakinumab anti-inflammatory thrombosis outcomes study (cantos) cantos trial group. antiinflammatory therapy with canakinumab for atherosclerotic disease anti-inflammatory therapy with canakinumab for the prevention and management of diabetes interleukin- signaling pathway as a therapeutic target in transthyretin amyloidosis interleukin- -receptor antagonist in type diabetes mellitus the sterile inflammatory response differential release of chromatin-bound il- discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation blocking interleukin- as a novel therapeutic strategy for secondary prevention of cardiovascular events comparative safety of interleukin- blockade with anakinra in patients with st-segment elevation acute myocardial infarction (from the vcu-art and vcu-art pilot studies) effect of interleukin- β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial working group" of systemic autoinflammatory diseases of sir (italian society of rheumatology). safety profile of the interleukin- inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (irafu): a single-arm phase study interleukin- beta-a friend or foe in malignancies? blocking il- : interleukin receptor antagonist in vivo and in vitro treating inflammation by blocking interleukin- in humans all authors declare that they have no competing interests. springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. key: cord- -i on authors: nan title: abstracts dgrh-kongress date: - - journal: z rheumatol doi: . /s - - - sha: doc_id: cord_uid: i on nan im namen der dgrh, der dgorh und der gkjr begrüßen wir sie ganz herzlich zu unserem diesjährigen kongress visualisierung therapeutischer effekte von vasodilatantien beim sekundären raynaud-syndrom mittels fluoreszenzoptischer bildgebung di. stellenwert der gelenksonographie bezüglich diagnose, behandlung und therapiekontrolle der bursitis intermetatarsalis -einer häufig übersehenen differenzialdiagnose. fünf fallbeispiele wegen der deutlich eingeschränkten nierenfunktion konnten therapeutisch keine nsar angewandt werden. wir haben mit × , mg colchicin täglich behandelt. die anfänglich schwerkranke bettlägerige patientin konnte innerhalb von h mobilisiert werden. um eine abschließende sicherung der diagnose einer uratinduzierten sakroiliitis erreichen zu können ist die patientin mit einem dual-energy-ct (dect) untersucht worden. ergebnisse. mit dieser methode konnten gichttophi in beiden sakroiliakalgelenken dargestellt werden, ebenso an beiden mtp -gelenken. schlussfolgerung. aktuell liegen bisher noch keine weiteren berichte vor, dass diese methode auch für die diagnostik einer gicht im bereich der sakroiliakalregion zuverlässige ergebnisse liefern kann. zudem zeigt dieser krankheitsverlauf, dass sich die gicht durchaus primär im bereich des achsenskeletts manifestieren kann und nicht in erster linie an den peripheren gelenken zu entsprechenden beschwerden führen muss. a. glimm , s. werner , s. ohrndorf , c. schwenke , g. schmittat , g. burmester einleitung. typische pathologische veränderung bei der rheumatoiden arthritis (ra) ist die synovialitis. auch bei der osteoarthrose (oa) lassen sich entzündliche veränderungen der gelenke finden. diese können mittels fluoreszenzoptischer bildgebung (foi) und dem gelenkultraschall (us) sichtbar gemacht werden. ziel der studie: vergleich der foi mit dem us bei patienten mit ra und oa. methoden. es wurde bei patienten ( ra, oa) die foi beider hände sowie die us des handgelenks (hg) und der fingergelenke (mcp, pip, dip) der klinisch beschwerdeführenden hand von dorsal und palmar sowohl im b-bild (b-us) als auch mit power-doppler (pd-us) durchgeführt. synovialitis und tenosynovitis im us sowie die intensität des fluoreszenzsignals im bereich der gelenke in der foi wurden qualitativ als auch semiquantitativ nach standardisierten verfahren für den primavistamode (pvm) und drei verschiedene phasen (p - ; [ ] ) bewertet. in der statistischen analyse wurden anschließend sensitivitäten und spezifitäten für die foi bei der ra und oa getrennt für synovialitis und tenosynovitis, dorsal und palmar jeweils für b-us und pd-us als referenzmethode berechnet. ergebnisse. in abhängigkeit von der betrachteten phase zeigen sich für die ra und oa moderate sensitivitäten und spezifitäten. für die ra wurden in der phase des foi die höchsten sensitivitäten mit % für b-us und % für pd-us berechnet. auch bei der oa ergaben sich die höchsten sensitivitäten in der phase des foi mit % für b-us und % für pd-us als referenzmethode. die höchsten spezifitäten für beide diagnosen wurden in der foi in phase erreicht. hierbei lag die spezifität bei der ra für b-us bei % und für pd-us bei %. der höchste spezifitätswert bei der oa sowohl für b-us als pd-us war % (. tab. background. pet is a nuclear imaging technique that depicts functional processes within the body with high sensitivity by detecting annihilation radiation from radioactive decay of a positron-emitting radionuclide that was labeled to a biologically active molecule (tracer) and introduced into the body. f-fluoride ( f) can be used for pet as a bone-seeking agent reflecting bone perfusion and remodeling. we inaugurated a pilot study with simultaneous pet/mr to examine whether addition of pet provides different and additional information in comparison to mri in axspa patients. methods. eleven axspa patients, median age y, disease duration range . - y, mean basdai . , were examined by pet/ -tesla mri minutes after injection of a mean dose of mbq of f using a integrated whole-body pet/mr scanner (siemens biograph mmr®). t-mris were scored blinded to patient's clinical characteristics by two readers ( rheumatologist and radiologist/nuclear medicine specialist) using the berlin mri score and also by recording inflammatory lesions on a vertebral edge (ve) level. in a second step pet/mris were read blindly by the same readers also based on the ve involvement of individual vertebral bodies. results. the procedure was successful in all patients. the resulting mean effective radiation dose per patient was . msv. co-registration of pet/mri fusion images was highly accurate, allowing a precise comparison of mri and pet. in the direct comparison of the mri and pet signal the two readers saw consistent signals in almost % of the sites studied. however, there were areas where signals differed, e.g. within existing syndesmophytes where pet signal was increased but conventional mris showed no signal, or the sternum area and lateral or posterior spinal elements such as facets and spinous processes. conclusion. the new technique of integrated pet/mri provides similar imaging signals as conventional mri. however, we observed differences between the two modalities in areas with less inflammatory activity but where bone metabolism seemed to be active or in areas with blurred resolution on conventional mri. the possibility that pet detects osteoblastic activity in areas where no inflammatory signal is detected with mri seems to be of interest. einleitung. sensitiven bildgebenden verfahren wie der hochauflösenden arthrosonographie kommen bei der detektion initial entzündlicher veränderungen im rahmen der frühdiagnostik der psoriasisarthritis (psa) eine große bedeutung zu. die vorliegende prospektive studie untersucht die diagnostische und prognostische wertigkeit der sonographischen befunde im vergleich zur klinischen untersuchung auf ebene einzelner gelenke bei früher psoriasis-arthritis (psa). methoden. rekrutierung von patienten mit therapienaiver früher psa. sonographie von gelenken mit semiquantitativer graduierung (grad - ) von b-bild (gsus) und power-doppler-aktivität (pdus; baseline, monate). klinische parameter: anzahl druckschmerzhafter und geschwollener gelenke (tjc , sjc ), visuelle analogskala, das -crp, health assessment questionnaire haq. für jede followup-visite erfolgte eine kategorisierung des klinischen ansprechens nach eular-response-kriterien und der für die psa validierten minimal-disease-activity(mda)-kriterien (coates et al.). ergebnisse. baseline patienten, nach monate patienten, erkrankungsdauer ( ± , monate). patienten ohne therapie ( ), mit nsar ( ), steroid i.a. ( ) , dmards ( ), biologicals ( ). bei diagnosestellung zeigte sich eine signifikante korrelation zwischen dem us synovitis score und folgenden klinischen parametern: tjc (r= , ), scj (r= , ), das -crp (r= , ). nach monaten zeigte sich eine gute korrelation zwischen der relativen veränderung des us synovitis scores und der relativen veränderung folgender klinischer parameter: tjc (r= , ), haq (r= , ), pasi (r= , ), das -crp (r= , ). zu baseline waren von gelenken sonographisch auffällig, davon zeigten kein klinisches korrelat (subklinisch). nach monaten zeigten % der initial subklinischen gelenke einen unveränderten befund, % waren sonographisch nicht mehr auffällig und % wurden klinisch manifest. bei den klinischen respondern war der rückgang deutlicher ausgeprägt. schlussfolgerung. der ultraschall-synovitis-score korreliert mit klinischen aktivitätsparametern sowohl zum zeitpunkt der diagnosestellung als auch im krankheitsverlauf unter immunsuppressiver therapie. die subklinischen veränderungen bilden sich unter immunsuppressiver therapie zu einem großen teil zurück, deutlicher bei klinischen respondern. ein geringer anteil der initial subklinischen gelenke wird im verlauf klinisch manifest, in höherem maße bei klinischen non-respondern. t. diekhoff , k. hermann charité -universitätsmedizin berlin, radiologie, berlin einleitung. die gicht ist mit einer prävalenz von , - , % insbesondere in den industrieländern eine häufige erkrankungen, die mit gelenkschmerzen einhergeht. bei typischer symptomatik und laborkonstellation ist die diagnose der arthritis urica oft einfach zu stellen, ein atypisches beschwerdebild kann jedoch gelegentlich die abgrenzung zu anderen erkrankungen erschweren. besonders die kalziumpyrophosphat-kristallarthropathie (cppd oder pseudogicht), die selbst mit sehr variabler symptomatik auftreten kann, ist eine relevante differenzialdiagnose, besonders bei älteren patienten. methoden. mit der dual-energy-computertomographie (de-ct) steht ein modernes, innovatives verfahren zur verfügung, das eine detektion von harnsäurehaltigen weichteilverkalkungen ermöglicht und darüber hinaus eine sichere abgrenzung zu kalziumhaltigen verkalkungen gewährleisten kann. das prinzip der de-ct ist relativ simpel und seit längerem bekannt: die messung des untersuchungsvolumens mit zwei unterschiedlichen röhrenspannungen macht es möglich, einen schwächungskoeffizienten zu errechnen, der spezifisch für das untersuchte material ist. allerdings ermöglichten erst moderne cts mit zwei röntgenröhren die klinische anwendung. in jüngster zeit werden jedoch anstrengungen unternommen, die de-ct auch für ein-röhren-systeme verfügbar zu machen. ergebnisse. mit der de-ct können gichttophi sicher vom knochen aber auch von anderen verkalkungen getrennt und zum beispiel farblich kodiert dargestellt werden. im gegensatz zum konventionellen röntgenbild verspricht die de-ct jedoch nicht nur eine höhere sensitivität für tophöse veränderungen, sondern als schnittbildverfahren auch eine bessere abgrenzung und einordnung von anderen morphologischen veränderungen wie zum beispiel von erosionen. schlussfolgerung. dieser vortrag fasst die vor-und nachteile der de-ct in der detektion und abgrenzung von weichteilverkalkungen bei kristallarthropathien zusammen und gibt darüber hinaus einen ausblick auf zukünftige entwicklungen in diesem gebiet. background. anionic glycosaminoglycans interact with a variety of soluble and membrane bound molecules. chondroitin sulfate was shown to have anti-inflammatory properties but its role in arthritis is controversial. methods. we have analyzed the effect of chondroitin sulfate on collagen induced arthritis starting treatment before and after induction of arthritis and in mice with established arthritis. results. in all of these settings chondroitin sulfate significantly reduced the severity of arthritis. it prevented joint destruction, diminished the inflammatory infiltrate and reduced proinflammatory cytokines in joints and plasma. splenocytes restimulated with collagen produced less il- and more il- and il- . the beneficial effects of chondroitin sulfate were transient and closely correlated to the suppression of the collagen-specific humoral immune response. chondroitin sulfate, but not other glycosaminoglycans induced a direct btk and syk-dependent proliferation of b cells and markedly expanded the number of plasma cells in the spleen. in immunized mice chondroitin sulfate reduced the number of antigen specific plasma cells in the bone marrow and was able to suppress established humoral immune responses. conclusion. displacement of disease inducing plasma cells from the bone marrow might contribute to the beneficial effects of chondroitin sulfate and could be an attractive strategy to suppress antibody mediated autoimmunity. background. in rheumatoid arthritis a functional deterioration of the hpa-axis in form of inadequately low secretion of glucocorticoids in relation to severity of inflammation can be detected. the reasons for this phenomenon are not known. the purpose of this study was to find possible reasons responsible for adrenal insufficiency during arthritis. methods. da rats were immunized with type ii collagen in incomplete freund adjuvant to induce arthritis. plasma corticosterone was evaluated by ria and plasma acth by elisa. adrenal cholesterol was quan-titatively studied by sudan-iii staining and scavenger receptor class bi (sr-bi, the hdl receptor) by immunohistochemistry. fluorescent nbd-cholesterol uptake kinetics were analysed by flow cytometry. ultrastructural morphology of adrenocortical mitochondria and lipid droplets was studied by electron microscopy. results. initially increased corticosterone and acth levels were reduced to baseline levels in the later phase of the disease. serum levels of corticosterone relative to il- β were markedly lower in arthritic than control animals (inadequacy). cholesterol storage in adrenocortical cells and expression of sr-bi did not differ between immunized and control rats. however, number of impaired mitochondria largely increased during the course of arthritis (maximum on day ), and this was paralleled by reduced numbers of activated cholesterol droplets (inhomogenous droplets relevant for generation of glucocorticoids). in addition, number of normal mitochondria positively correlated with serum corticosterone levels. conclusion. this first study on adrenal reasons for inadequate glucocorticoid secretion in arthritis demonstrated impaired mitochondria and altered cholesterol breakdown paralleled by low corticosterone levels in relation to ongoing inflammation. justus-liebig universität gießen, kerckhoff-klinik gmbh, rheumatologie u. klinische immunologie, osteologie, physikalische therapie, bad nauheim, agaplesion markus krankenhaus, akademisches lehrkrankenhaus der johann wolfgang goethe-universität, klinik für orthopädie und unfallchirurgie, frankfurt/main, universitätsklinikum gießen und marburg, orthopädische klinik, labor für experimentelle orthopädie, gießen, universitätsklinikum gießen und marburg, orthopädie und orthopädische chirurgie, gießen, universitätsklinikum erlangen, medizinische klinik , rheumatologie und immunologie, erlangen background. obesity is a risk factor in osteoarthritis (oa), but there is limited information about the interaction between bone formation and adipose tissue-derived factors, the so-called adipokines. adipokines such as adiponectin, resistin or visfatin are associated with the pathogenesis of rheumatoid arthritis (ra) and oa. adipokines are produced also by other cell types than adipocytes in ra and oa joints, for example osteoblasts, osteoclasts or chondrocytes. however, in contrast to their joint-destructive role in ra, their role in oa joint remodeling is unclear. therefore, adipokine expression in osteophyte development and bone forming cells as well as their effect on these cells was analyzed. methods. osteophytes and bone were obtained from oa patients during joint replacement surgery. serial sections of bone tissue were stained (masson trichrome, trap) and scored from grade one (no ossification, mainly connective tissue and cartilage) to five (ossified, mineralized osteophyte, < % connective tissue, ossified remodeling zones). immunohistochemistry against alkaline phosphatase, collagen-type ii, adiponectin, resistin, and visfatin was performed. oa osteoblasts were stimulated with adiponectin and measurements of il- , il- and mcp- were performed in cell culture supernatants. results. adiponectin, resistin and visfatin were detectable in osteoblasts and all osteophyte grades. in non-ossified osteophytes (grade ), especially adiponectin and to a lower extend resistin and visfatin were localized in connective tissue fibroblasts. in ossified osteophytes (grade - ), resistin, visfatin and to a lower extend adiponectin protein expression was co-localized with osteoblasts. resistin and visfatin were expressed by osteoclasts. visfatin was found in chondrocytes of all osteophyte grades ( % of chondrocytes) and adiponectin was detectable in blood vessels. osteoblast stimulation with adiponectin increased the release of the inflammatory mediators il- ( . -fold), il- ( . -fold), and mcp- ( . -fold). zeitschrift für rheumatologie suppl · | conclusion. the expression of adiponectin and visfatin expression in osteophyte connective tissue and cartilage suggests their involvement in early osteophyte formation. resistin and visfatin expression by osteoblasts and osteoclasts in ossified osteophytes indicates a role in bone remodeling of osteophytes at later stages. osteoblasts respond to adiponectin stimulation with the release of inflammatory mediators. therefore, adipokines are most likely involved in osteophyte formation at different stages affecting different cell types of bone remodeling. free fatty acids contribute to promotion of arthritis k. frommer , a. schäffler , s. rehart , a. sachs , u. müller-ladner , e. neumann justus-liebig universität gießen, kerckhoff-klinik gmbh, rheumatologie u. klinische immunologie, osteologie, physikalische therapie, bad nauheim, universitätsklinikum regensburg, klinik und poliklinik für innere medizin i, regensburg, agaplesion markus krankenhaus, akademisches lehrkrankenhaus der johann wolfgang goethe-universität, klinik für orthopädie und unfallchirurgie, frankfurt/main background. obesity is a known risk factor for several arthritic diseases and mechanical stress has been shown not to be the only factor. due to increased levels of free fatty acids (ffa) in obese compared to nonobese individuals and due to the involvement of ffa in inflammatory cardiovascular and metabolic diseases, we hypothesized that ffa play a role in the promotion of arthritic diseases. therefore, we therefore investigated the effect of ffa on various effector cells of arthritis. methods. rheumatoid (ra) synovial fibroblasts (sf), osteoarthritis (oa) sf, psoriatic arthritis (psa) sf, human primary chondrocytes (hch), human osteoblasts (ob), human macrovascular (huvec) and microvascular (hbdmec) endothelial cells were stimulated in vitro with different ffa within their physiological range of concentrations. immunoassays were used to quantify ffa-induced protein secretion. sulfosuccinimidyl oleate sodium (sso) was used to inhibit fatty acid translocase (fat). results. ffa dose-dependently increased the secretion of the proinflammatory factors (il- , il and mcp- ) as well as matrix-degrading enzymes (mmp- and mmp- ) in rasf (e.g. for lauric acid [ µm] with rasf/il- : . -fold increase; il : . fold increase; mcp- : . fold increase; pro-mmp : . -fold increase; mmp- : . fold increase). saturated and unsaturated ffa had similar effects on rasf. however, saturated ffa induced strong secretion of il- in chondrocytes, while unsaturated ffa only had a weaker effect on this cell type. at µm, both saturated and unsaturated ffa significantly increased il- secretion by osteoblasts to a similar degree as for sf. a high concentration of ffa ( µm) significantly induced il- secretion in huvec and hbdmec, whereas a low concentration of ffa ( µm) did not have a significant effect (p> . ) on human endothelial cells. blocking ffa transport into rasf by using sso almost completely abolished the effect of palmitic acid on il- secretion. conclusion. ffa are not only metabolic substrates but can also directly contribute to articular inflammation and degradation mediated by various effector cells of arthritis. our data also show that ffa transport into the cell is required for ffa-induced effects in sf. background. chronically inflamed tissues in ra are characterized by local hypoxia and enhanced angiogenesis. the hypoxia inducible factor (hif)- and (hif)- serve as key regulators of adaptation to hypoxia thereby promoting both angiogenesis and metabolic adaptation of endothelial cells. to investigate the impact of hif- /hif- on the angiogenic and metabolic transcriptome under hypoxia ( % o ) versus normoxia ( % o ) we performed a knockdown of either hif- α or hif- α in human microvascular endothelial cells (hmec). methods. specific knockdown of either hif- α or hif- α was achieved using shrna-technology. angiogenic and metabolic transcriptome of hmecs was studied by performing an agilent human whole genome microarray under normoxia vs hypoxia. significantly regulated genes were allocated to angiogenic and metabolic processes using panther database. results. in comparison to normoxia the incubation of untransduced hmecs under hypoxia resulted in regulated angiogenesis related genes and regulated cellular metabolism related genes. in both hif- α and hif- α knockdown cells, hypoxia was still capable of inducing a differential gene expression pattern, but with a much less pronounced effect compared to control cells. analysis of angiogenesis related processes (vegf-pathway, hif-activation, egfr-pathway) showed that % of the differentially expressed genes are controlled by both hif- and hif- . another % of the regulated genes are controlled by hif- . the remaining % of regulated genes are under control of hif- . the differentially regulated genes involved in the cellular metabolism (atpsynthesis, glycolysis, tca-cycle) were found to be to % controlled by both hif- and hif- . the remaining % are dependent on the presence of hif- . conclusion. hif- and hif- are both key regulators of the adaptation of endothelial cells towards hypoxia with overlapping functions. however, they do differ in their capacity to regulate cellular energy metabolism and angiogenesis. this leads us to conclude that hif- affects angiogenesis via indirect effects on cellular energy metabolism as indicated by the regulation of metabolic transcriptome to one fifth. hif- does more influence angiogenesis directly via regulating the synthesis of proangiogenic factors (as has been previously shown).these findings provide new insights into the divergent regulation of angiogenesis in inflamed (hypoxic) tissues by hif- and hif- and are, therefore, considered to be of clinical relevance in ra. background. membrane bound glucocorticoid receptors (mgr) play a pivotal role in pathogenesis of chronic inflammatory diseases as indicated by clinical observations. patients with sle show high frequencies of mgr positive monocytes, sometimes even higher than found in patients with active ra. with increasing glucocorticoid dosages expression of mgr on monocytes of sle-patients is downregulated, suggesting a negative feedback loop to control glucocorticoid action. these receptors represent an effective target for diagnosis and monitoring of different inflammatory diseases, but a feasible detection method is still necessary. objectives. we compare two methods of high-sensitive immunofluorescence staining -the well established liposome procedure with the commercialized faser-technique. methods. hek t cells were cultured for h with/without µg/ml brefeldin a in a humidified incubator at °c. human cd positive t cells and cd positive monocytes were isolated via magnetic-activated cell sorting and subsequently cultured in rpmi . monocytes were incubated for h with/without µg/ml lps. for liposome based highsensitivity immunofluorescence staining cells were incubated with the monoclonal (digoxigenin conjugated) anti-gr antibody, followed by incubation with anti-digoxigenin/anti-biotin matrix. subsequently biotinylated cy liposomes were added. faser technique was performed as described by the manufacturer (miltenyi biotec). dead cells were excluded by adding pi before cell acquisition, using a bd facs calibur flow cytometer. the acquired data were analyzed using flowjo . . software. results. the human mgr, which cannot be reliably detected with conventional staining methods, is detectable with the liposome procedure as well as with the commercialized faser-apc technique. furthermore, the faser-apc-procedure is more sensitive ( . % vs . %) and more specific ( . % vs. . %) compared to the liposome technique. additionally, minor changes of mgr expression can also be demonstrated with the faser technique. the faser procedure shows technical advantages: the commercially available faser-apc-kit is performed according to a standarized protocol and is less time consuming compared to the liposome procedure. conclusion. the human mgr is easily detectable with the commercialized faser kits, which represent an alternative due to a consistent quality and a standardized production. this method facilitates the analysis of the role that mgr play in the pathogenesis of chronic inflammatory diseases and perhaps provoke new insights in glucocorticoid therapy. background. in previous studies we detected th-positive, catecholamine-producing cells in inflamed hypoxic synovial tissue. therefore, the aim of our study was to investigate the influence of hypoxia induced catecholamines on inflammatory responses in arthritis. methods. synovial cells of rheumatoid arthritis (ra) and osteoarthritis (oa) patients were isolated and cultivated under normoxia or hypoxia with/without stimulating enzyme cofactors of th and inhibitors of th. expression of th and release of cytokines and catecholamines was analyzed. the effect of th+ cells was tested by adoptive transfer into dba/ mice with collagen type ii-induced arthritis (cia). th+ cells were generated from mesenchymal stem cells by defined dopaminergic factors. results. hypoxia increased th protein expression and catecholamine synthesis and decreased release of tnf in oa/ra synovial cells compared to normoxic conditions. this inhibitory effect on tnf was reversed by th inhibition with alpha-methyl-para-tyrosine (αmpt). incubation with specific th cofactors (tetrahydrobiopterin and fe +) increased hypoxia-induced inhibition of tnf, which was also reversed by αmpt. adoptive transfer of th+ cells reduced cia in mice, and hydroxydopamine, which depletes th+ cells, reversed this effect. conclusion. in summary, this study presents that th-dependent catecholamine synthesis exhibits anti-inflammatory effects in human ra synovial cells in vitro, which can be augmented under hypoxic condi-tions. in addition, the anti-inflammatory effect of th+ cells has been presented the first time in experimental arthritis in mice. background. previously, we demonstrated that long-lived plasma cells contribute to the pathogenesis of antibody-mediated diseases and should therefore be considered as a promising therapeutic target in systemic lupus erythematous (sle). in bone marrow stromal cells expressing the chemokine cxcl organize these niches that provide for the plasma cell survival. cxcl is the ligand of cxcr expressed on plasma cells. in this study we investigated the contribution of cxcl -cxcr interaction to the longevity of plasma cells in the murine model of lupus. methods. plasma cells purified from spleens of nzb/w mice were incubated with the cxcr blocker amd and then adoptively transferred to immunodeficient rag −/− mice. after days we analyzed the number of plasma cells in bone marrow. furthermore, ova immunized nzb/w mice were treated intraperitoneally with amd after boost; anti-ova secreting plasma cells in bone marrow were checked on day and after boost. the effect of plasma cell depletion was investigated in nzb/w mice using amd alone or combined with bortebomib for two weeks. results. two weeks after adoptive transfer the number of plasma cells treated with amd was lowered by % in bone. after secondary immunization with ova the amd treatment resulted in a significant reduction of anti-ova secreting plasma cells in bone marrow by % on day and by % on day . after days the number of mhc class ii negative anti-ova secreting plasma cells significantly decreased by % in bone marrow of treated mice. amd efficiently depleted plasma cells including long-lived. after two weeks treatment, total plasma cell number was decreased by % in spleen and % in bone marrow; long-lived plasma cells were reduced by % in spleen and % in bone marrow. the combination of bortezomib with amd in nzb/w significantly enhanced the depletion of long-lived plasma cells compared to monotherapy. conclusion. cxcr blockade with amd can reduce the homing of plasma cells to the bone marrow and the survival of long-lived plasma cells. the combination of bortezomib with amd shows synergistic effects on plasma cell depletion. the findings highlight the importance of the cxcr -cxcl axis for the plasma cell niche. zeitschrift für rheumatologie suppl · | er. tnfr expression defines synovial tissue infiltrating cd + t cells in patients with rheumatoid arthritis k background. one hallmark of rheumatoid arthritis (ra) is the infiltration of the synovial membrane by cd + t cells. it has previously been shown that infiltrating cd + t cells differ from non-infiltrating ones in their increased expression of tnfr . furthermore, tnfr is expressed on a fraction of circulating cd + t cells from ra patients, but not from healthy controls. aim of the study was the characterization of tnfr + cd + t cells in patients with rheumatoid arthritis. methods. peripheral tnfr + cd + t cells from ra patients were analyzed by flow cytometry. the expression of naive and memory t cell markers (cd ra and cd ro), markers for t cell activation (cd , cd and cd ) and of icam- as well as the frequencies of the positive cells were determined. to identify the t helper cell signature of tnfr + cd + t cells, intracellular staining of the th , th and th master transcription factors t-bet, gata- and ror-γt, respectively, was performed. results. peripheral tnfr + cd + t cells have neither a preferential naive nor a memory phenotype, but showed higher expression of the activation markers cd , cd and cd than tnfr -cd + t cells. tnfr + cd + t cells express higher frequencies of the t-bet and rorγt than tnfr -cd + t cells. there is no difference in gata- expression between tnfr positive and negative cd + t cells. functionally, it has been shown that the cytokine tnf acts as chemokine to attract cd + t cells to the rheumatoid joints. beside this direct effect of tnf, there are known indirect effects of tnf including the upregulation of cell adhesion molecules like icam- . therefore, icam- expression of migrating tnfr + t cells was investigated. the results show, that migrating tnfr + t cells recovered from synovial tissue are more frequently icam- positive than non-migrating ones. conclusion. tnfr + expression characterizes cd + t cells functionally capable of infiltrating the rheumatoid synovium in an icam- dependent manner. the results show, that tnfr expression defines a pathogenic subset of activated cd + t cells with th and/or th signature in patients with rheumatoid arthritis. hypoxia increased the production of interleukin- β in lps-primed human monocytes n background. monocytes are major players in the innate immune system and are recruited to sites of inflammation, where the environmental conditions vary extremely compared to the interstitium under physiological conditions. for example, in rheumatoid arthritis the inflamed joints are severely hypoxic. this decreased oxygen level could be a triggering factor for the activation and survival of monocytes. aim of the study was to analyze the influence of hypoxia on lipopolysaccharide (lps)-induced cytokine production in primary human monocytes methods. immunomagnetically separated monocytes from the blood of healthy donors were cultured for h under hypoxic conditions ( % oxygen). results. cytokine measurement in the supernatant with elisa showed increased concentrations of interleukin- β ( . ng/ml vs. . ng/ ml, p= . ) and interleukin- ( . ng/ml vs. . ng/ml, p= . ), but not of tnf, after hypoxia and lps-stimulation. cleavage of the il- β proform to its active form is dependent on the assembly of the inflammasome and the recruitment of caspase- followed by their activation. when inflammasome assembly was blocked with high extracellular k+-buffer or by inhibiting intracellular ca-signalling with the ca-chelator bapta-am, hypoxia induced il- β release was abrogated. similarly, il- β release after culture under hypoxia was also abolished in monocytic thp -cells, which are genetically made deficient for the inflammasome components nlrp and asc. one activating signal for the inflammasome was shown to be the release of reactive oxygen species (ros), since mitochondrial ros staining with mitosox revealed an increased mitochondrial ros release under hypoxic conditions. accordingly, the induction of mitochondrial ros through decoupling of the electron transport chain with rotenone also triggered an increase of il- β release under normoxic conditions. analysis of blood monocyts from ra patients showed no difference in lps and hypoxia induced il- β release compared to healthy controls ( . ng/ml vs. . ng/ml). conclusion. this study shows, that hypoxia leads to the activation of the inflammasome, the recruitment of caspase- and the subsequent cleavage and release of interleukin- β in human primary monocytes. intracellular calcium mobilization and mitochondrial ros production were shown to be essential mechanisms triggering inflammasome assembly. background. cell-derived membrane-coated microparticles have been identified as important mediators in intercellular communication. during the process of apoptosis, dying cells start to dynamically release microparticles. polymorphonuclear neutrophils are the most abundant type of leukocytes, representing - % of all white blood cells. due to their very short lifespan, they are the source of massive amounts of apoptotic cell-derived microparticles (admps). while the interaction between neutrophils and t lymphocytes has been focus of extensive research, the influence of neutrophil-derived microparticles on t cells has not been analysed yet. in this study, we investigated the effect of membrane-coated microparticles released by apoptotic neutrophils on different t helper cell subsets. methods. different cd + t cell subtypes were sorted according to the expression of cd , cd , cd ra and cd ro and co-cultured with admps or apoptotic cell remnants purified from uv-irradiated neutrophils isolated from the peripheral blood of healthy donors. t cells were stimulated by okt and anti-cd antibodies and cell proliferation was measured by h-thymidine incorporation or pkh -staining. secretion of cytokines was quantified by elisa. results. admps released by neutrophils selectively suppressed the proliferation of cd +cd -cd + tc in a dose-dependant manner and prevented the upregulation of cd on the t cell surface, while maintaining the expression of cd . the secretion of tumor necrosis factoralpha (tnfα) by t cells stimulated in the presence of admps was significantly reduced. interestingly, in contrast to admps, the apoptotic cell remnants of neutrophils exerted no effect on t cells. the suppressive effect of admps could be completely abrogated by the addition of interleukin(il)- or il- or by the presence of cd +cd +cd + t cells. conclusion. neutrophil admps suppress the proliferation of cd +cd -cd + t cells under conditions of limiting il- and il- concentrations. this could represent an important mechanism to prevent inappropriate activation and expansion of resting t helper cells in the absence of sufficient stimulation and cytokine production. t. alexander background. recent reports have shown dysregulated micrornas in murine lupus models, among them increased expression of mirna- , which has been demonstrated to target the transcription factor foxo in activated cd + t cells. the loss of foxo activity in t cells is associated with spontaneous t cell activation, clonal expansion and autoantibody production, all of which are present in systemic lupus erythematosus (sle). methods. expression levels of microrna- and foxo were analyzed with rt-pcr in magnetic purified peripheral blood cd + t cells from patients with sle and healthy controls (hc). multicolor flow cytometry was performed to analyze cd + t cell expression for ccr , cd ra, ki- , foxp , the interleukin- receptor-α and phosphorylated stat- a (pstat ). analysis of serum il- levels was performed with elisa in sle patients and hc (r&d systems). results. mirna- was significantly upregulated in cd + t cells from sle patients compared to hc (median expression . × e- vs. . × e- , p= . ) while foxo mrna levels were decreased, yet without reaching statistical significance. analysis of ki- expression revealed an increased percentage of proliferating cd + t cells in sle ( . % vs . %, p= . ). overall, cd + t cellular proliferation in sle was associated with increased frequencies of cd ra-ccr -effector memory t cells and enhanced basal pstat levels (median mfi . vs . , p= . ), suggesting a recent stimulation with common gamma chain(γc)-signaling cytokines. in this regard, tcons from sle samples displayed decreased expression levels for the foxo target gene cd (mfi vs. , p= . ) and serum il- levels were significantly higher in sle compared to hc ( . pg/ml vs. . pg/ml, p= . ). conclusion. mir- expression has been shown to be dependent on stat activation and to promote clonal expansion of activated cd + t cells. our data suggest that enhanced il r/stat signaling mediates induction of mir expression, which in turn promotes the proliferation of tcons in sle. the relative contribution of il r/mir- /foxo axis on the enhanced proliferative capacity of sle tcons remains elusive and merit further investigation. collectively, our data provide new insights in the pathophysiology of t cell hyperactivity in sle and identifies mir- as a candidate target for future therapeutic approaches. background. cell activation and apoptotic cell death leads to the formation of membrane-coated vesicles (mcvs). mcvs have previously been identified as mediators of cell-to-cell communication and carriers of microrna. an impaired clearance of apoptotic debris caused by an increased rate of apoptosis or a defect in phagocytic-cell clearance has been observed in sle patients. in this study, we analyzed the microrna content of activated and apoptotic lymphocytes and their corresponding mcvs from both normal healthy donors (nhds) and sle patients. further we investigated the immunomodulatory effect of mcv uptake by monocytes. methods. microrna content of activated and apoptotic lymphocytes and corresponding mcvs of nhds and sle patients were compared in an agilent microrna array and validated by qpcr. apoptosis was induced by uvb-irradiation. mir- expression in monocytes after uv-mcvs engulfment was determined by qpcr. expression of mir- target protein tab- was analyzed by western blot. results. mir- * levels were decreased after apoptosis induction in lymphocytes and apoptotic mcvs compared to their viable correlates. mir- , mir- a and mir- b were decreased in apoptotic lymphocytes compared to viable ones but increased or not significantly changed in apoptotic mcvs compared to viable mcvs, indicating a directional transport of microrna into mcvs. mir- a was expressed at higher levels in viable sle lymphocytes and mcvs compared to nhds. mir- b expression was decreased in uv-lymphocytes and uv-mcvs of sle patients. functional assays confirmed higher mir- levels and consecutively decreased target protein levels in monocytes after engulfment of uv-mcvs. conclusion. within this study we could show an unequal distribution of distinct microrna into mcvs released by activated or apoptotic lymphocytes. further the microrna content was regulated in whole apoptotic cells after uvb-irradiation. this suggests a directional transport rather than a random distribution. thus, cells regulate their microrna as well as the microrna content within released mcvs. we could show a microrna and protein expression change in phagocytes after mcv engulfment. hence, our results suggest mcvs could serve as a transport vehicle for microrna to mediate cell-to-cell communication and influence intracellular processes in phagocytes. disturbances of this system might contribute to the pathogenesis of sle. results. we found in the spleens of nzb mice -times higher numbers of long-lived plasma cells and megakaryocytes compared to wildtype, in nzw mice equal numbers and in nzb/w mice numbers between those for nzb and nzw or wildtype. moreover, in the spleen a fraction of plasma cells clustered around megakaryocytes. we also detected a missense mutation in the c-mpl gene of nzb mice leading to an amino acid replacement within the essential tpo-binding site. upon tpo stimulation of splenocyte and bone marrow cultures nzb cultures responded significantly stronger resulting in the double amount of megakaryocytes compared to nzw cultures. conclusion. in summary, our data indicate that augmented megakaryopoiesis enables the accumulation of a greater number of autoreactive plasma cells in lupus prone nzb/w mice. thus, we assume that enhanced megakaryopoiesis and higher megakaryocyte numbers are contributing to the development and/or pathogenesis of sle. background. baff is a cytokine important for the stimulation and survival of autoreactive b cells and therefore might play a role in several autoimmune diseases, e.g. autoimmune arthritis. in psoriasis arthritis, baff correlates with disease activity and testosterone, but only in male patients, suggesting a role for sex hormones in the regulation of baff. therefore, we wanted to determine if baff production in rheumatoid arthritis and osteoarthritis fibroblasts was regulated by neuroendocrine mediators. methods. fibroblasts were isolated from synovial tissue of ra (n= ) and oa (n= ) patients and cultured in vitro under different conditions. baff was determined by elisa. results. isolated fibroblasts were cultured in the presence or absence of interferon-gamma (ifn-γ), il- , lipopolysaccharide (lps), tumor necrosis factor (tnf), cpg, poly i:c, and cortisol in different combinations for and hours to determine the optimal stimulation strategy for induction of baff production (measured by elisa in supernatants) in fibroblasts. ifn-γ best induced baff in ra and oa fibroblasts. ifn-γ-induced baff production in fibroblasts was decreased by dihydrotestosterone in a concentration dependent manner. the effect was specifically inhibited by nilutamid, a testosterone receptor antagonist. furthermore, stimulation of beta-adrenoceptor increased, whereas stimulation of alpha-adrenoceptors did not change inf-γ-induced baff in synovial fibroblasts. in general the effects were more pronounced in ra as compared to oa fibroblasts. conclusion. taken together, inf-γ-induced baff production in synovial fibroblasts is decreased by testosterone and increased by betaadrenergic stimuli. therefore, neuroendocrine regulation of inflammation in the inflamed joint might be in part mediated by regulating baff production in synovial fibroblasts. a. grützkau , c. kyogoku , b. smiljanovic , j. grün , r. biesen , t. alexander , f. hiepe , a. radbruch , t. häupl deutsches rheuma-forschungszentrum (drfz), berlin, charité -universitätsmedizin berlin, medizinische klinik mit schwerpunkt rheumatologie und klinische immunologie, berlin background. gene expression profiling experiments using peripheral blood mononuclear cells (pbmcs) revealed a crucial role of type i interferon (ifn) in the pathogenesis of systemic lupus erythematosus (sle). however, it is almost unknown how particular leukocyte subsets contribute to the overall type i ifn signature described for pbmcs. furthermore, a detailed analysis of how ifn signatures differ in autoimmune disease from that observed after viral infection is missing so far. therefore, we compared expression levels of ifn signature genes in peripheral cd + t helper cells and monocyte (mo) subsets isolated from patients with sle, healthy donors (nd) and nd vaccinated against yellow fever by global gene expression profiling. methods. peripheral blood from patients with sle and nd were recruited. same nd were examined before and after immunization by yellow fever vaccine. after sorting cells, isolated rna were applied to affymetrix human genome u plus . array. data analysis was done using bioretis database, genesis software and ingenuity pathway analysis (ipa). results. comparing gene expression profiles of yellow fever immunized individuals and active sle patients it was possible to identify a "common" and an "autoimmune-specific" ifn signature. although major ifn signature genes were commonly expressed in cd + t cells and mo of patients with sle and immunized nd, expression magnitudes of them were higher in patients with sle compared to immunized nd. in sle, in addition to the typical "viral-induced" ifn signature, genes that are involved in apoptosis signaling, antiviral pkr signaling, fcγ receptor-mediated phagocytosis and il- -/il- -/il- -mediated jak/ stat signaling pathways were identified by ipa. conclusion. this study demonstrated that ifn signature in autoimmunity and that in viral infection are quite different in the number of ifn-related genes activated and their expression magnitudes. autoimmunity is characterized by a much stronger expression of ifn signature genes and is obviously modulated by a separate set of co-regulated genes defining the "autoimmune-specific" ifn signature. in summary, "common" and "autoimmune-specific" ifn signature genes are of potential interest as clinical biomarkers in sle diagnostics to differentiate between a disease flare and a viral infection. of peripheral blood lymphocytes (pbl). there is currently no data available about nk cells in gpa. the aim of this study was to evaluate the presence of nk cells in gpa granulomas and their proportions in pbl as a basis for a potential role in gpa. methods. paraffin sections of granulomas of gpa, sarcoidosis and tuberculosis patients were stained with a cd monoclonal antibody. nk cell (cd -cd +) proportions of pbl in gpa patients and healthy controls (hc) were analysed by facs analysis. clinical data was extracted from medical records. results. contrary to granulomas from tuberculosis and sarcoidosis which showed a considerable infiltration by cd positive cells, there was not a single cd positive cell in granulomas from gpa patients. therefore, the tissue destructive character of gpa granulomas is associated with a lack of nk cells. gpa patients with inactive disease [birmingham vasculitis activity score (bvas) = , n= ] possessed a significantly higher nk cell proportion in pbl (mean ± standard deviation: . ± . %) than both gpa patients with active disease (bvas> , n= , mean= . ± . %) (p= . ) and hc (n= , mean= . - . %, p= . ). thus, clinical remission is accompanied by an increase in the nk cell proportion in pbl. interestingly, patients with inactive disease that had "normal" nk cell proportions of less than % of pbl (n= ) showed a more severe disease course than those with more than % of pbl. conclusion. nk cells might, therefore, be helpful to limit granulomatous inflammation. whether nk cell proportion in pbl might be a useful biomarker in gpa, e.g. as predictor for relapses, will be further evaluated in our future studies. v. gerl background. plasmacytoid dendritic cells (pdcs) are considered a crucial element in sle pathogenesis due to their potency to produce high levels of ifn-α. this innate immunological function of pdcs is lost by terminal differentiation into a professional antigen-presenting cell (pdc-derived dc), thereby upregulating costimulatory molecules and downregulating innate characteristics, e.g. bdca- and ifn-α expression. pdc-derived dcs have not been described in vivo yet, probably due to the fact that they lose their specific markers during differentiation. furthermore, pdcs can differentiate into myeloid dcs by various stimuli. in sle, where low expression of bdca- is commonly seen, this differentiation could be relevant and point to such a lineage switch as well as to an activated state of pdcs. aim. to characterize pdc subsets of differentiation/activation in human peripheral blood and to study their impact on autoimmune inflammation in sle. methods. -color-flowcytometric analyses were performed on whole blood of healthy donors and sle patients. pdcs were identified by cd -/cd -/cd -/cd high//bdca- +/hla-dr+ expression and characterized for cd c, bdca- and the macrophage-associated siglec- , expressed on monocytes of active sle patients in an ifn-α dependent manner. cd and cd expression were measured in parallel. results. we found a small subpopulation of siglec- expressing pdcs in human peripheral blood. compared to siglec- negative pdcs, siglec- positive pdcs express significantly lower bdca- and cd , higher hla- dr background. agonistic autoantibodies against the angiotensin ii receptor type (at r) and the endothelin receptor type a (etar) have been identified in patients suffering from systemic sclerosis (ssc). here we examined the expression of at r and etar in human immune cells and pathological effects mediated through these receptors by corresponding autoantibodies (aabs). methods. at r and etar protein expression on peripheral blood mononuclear cells (pbmcs) from healthy individuals and ssc patients was analyzed using flow cytometry, mrna expression was examined by real-time pcr in pbmcs from healthy donors. in addition, pbmcs from healthy donors were stimulated in vitro with affinity-purified immunoglobulin g (igg) fractions from ssc patients positive for at rand etar-aabs, and with igg from healthy donors serving as control. alterations in cell surface marker expression, cytokine secretion and chemotactic motility were analyzed using flow cytometry, elisa, and chemotaxis assays, respectively. results were correlated with characteristics/clinical findings of the igg donors. results. both at r and etar were expressed on human peripheral lymphocytes and monocytes. protein expression of both receptors was decreased in ssc patients when compared to healthy donors and correlated negatively with disease duration. in addition, igg fractions of ssc patients induced t cell migration in an anti-at r and anti-etar aab level-dependent manner. moreover, igg of ssc patients was capable of stimulating pbmcs to produce more il- and ccl than igg of healthy donors. all effects could be significantly abrogated by the application of selective at r and etar antagonists. statistical analysis revealed a negative correlation between ssc igg-induced il- concentrations and disease duration, between ssc igg-induced ccl concentrations and time since onset of lung fibrosis as well as an association of ccl concentrations with vascular complications of the corresponding ssc igg donors. conclusion. we demonstrated the expression of both, at r and etar, on human peripheral t cells, b cells and monocytes and found signs for a chronic receptor activation in ssc patients. the inflammatory and profibrotic effects upon aab stimulation in vitro, and their associations with clinical findings suggest a role for autoantibody-mediated activation of immune cells mediated through the at r and etar in the pathogenesis or even the onset of the disease. the bioenergetic role of hif- and hif- during angiogenesis of human microvascular endothelial cells background. hypoxia and angiogenesis are features of inflamed and injured tissues. the transcription factors hypoxia inducible factor (hif)- and (hif)- regulate the cellular and metabolic responses to reduced oxygen tensions thereby promoting angiogenesis with implications on the pathogenesis of ra. we investigated the effects of a knockdown of either hif- α or hif- α in human microvascular endothelial cells (hmec) on angiogenesis and bioenergetics under hypoxia ( % o ) versus normoxia ( % o ). methods. specific knockdown of either hif- α or hif- α was conducted by shrna-technology. to assess angiogenesis of hmecs both tubuli and node formation under hypoxia versus normoxia were investigated. expression of hypoxia driven genes involved in the metabolic response to hypoxia (gapdh/pgk/glut /ldha) was quantified by realtime rt-pcr. the bioenergetic status of the cells was quantified via atp/adp measurements. results. knockdown of hif- α/hif- α resulted in a loss of hypoxia induced angiogenesis. focusing on bioenergetic aspects, we found hypoxia to significantly induce pgk, ldha and gapdh in control cells. knockdown of hif- α and hif- α, respectively, did not affect the hypoxic induction of pgk and ldha. in hif- α and hif- α knockdown-cells, hypoxia was still capable of inducing gapdh, with a less pronounced effect in hif- α knockdown-cells. hypoxia did not significantly up-regulate glut , neither in control nor in hif- α or hif- α knockdown-cells. the knockdown of hif- α resulted in significantly decreased expression of glut under hypoxia. we also found the atp/ adp ratio to be similar in control, hif- α and hif- α knockdown-cells under normoxia. under hypoxic conditions hif- α knockdown-cells showed significantly reduced atp/adp ratios -indicating that less atp is available -compared to hif- α knockdown-cells. conclusion. hif- α and hif- α are both key regulators of angiogenesis. however, they do differ in their potency to regulate cellular energy metabolism. this leads us to conclude that hif- α does directly influence angiogenesis via regulating the synthesis of proangiogenic factors (as previously shown), whereas hif- α affects angiogenesis via effects on cellular energy metabolism as indicated by the reduced expression of gapdh and the diminished atp/adp ratio. these findings provide new insights into regulation of angiogenesis in inflamed (hypoxic) tissues and are, therefore, considered to be of clinical relevance in ra. low baseline complement levels, autoantibody persistence and delayed thymic reactivation are risk factors for development of relapses after hematopoietic stem cell transplantation for refractory sle background. our previous research has provided the evidence that an autoreactive immune system can be "reset" into a healthy, tolerant state by immunoablative treatment to eradicate pathogenic effector cells, followed by transplantation of hematopoietic progenitor cells (hsct). nevertheless, disease flares may occur in a subset of these patients posttransplantation. here, we longitudinally analyzed the immune reconstitution of these patients to identify markers for favorable long-term responses. methods. since , patients with refractory sle received a cd +selected autologous stem cell transplantation after immunoablation with antithymocyte-globulin (atg) and cyclophosphamide as part of a monocentric phase i/ii clinical trial. autoantibody titers were evaluated with elisa, peripheral t-and b lymphocyte subsets immunophenotyped using multicolor flow cytometry. results. clinical remission (sledai ≤ ) could be achieved in all patients, despite immunosuppressive drug withdrawal, associated with disappearance of anti-dsdna antibodies and marked reduction of protective antibodies in serum. unfortunately, two patients died due to transplant-related infections. from the remaining eight patients, five patients are in long-term clinical remission for up to years after hsct, while three patients suffered a relapse of sle at , and months post-transplantation, respectively. patients with early relapses (≤ months) had decreased baseline complement levels, showed persistence of antinuclear antibodies (ana), less significant reduction in protective antibody levels and had slower repopulation of cd + cd ra+ thymic-derived cd + t cells after hsct (< /µl at months) when compared to long-term responders. in addition, flow cytometric analyses revealed an expansion of circulating plasmablasts and increased coexpression of siglec- on monocytes (as surrogate marker for type-i interferon signature), preceding the clinical flares by ~ months. conclusion. low baseline complement levels, persistence of ana and delayed thymic reactivity post-transplantation could be identified as risk factors for development of lupus flares after hsct. since atg-mediated cell lysis is complement-dependent, we conclude that low serum complement is directly associated with incomplete depletion of immunologic memory cells in these patients, which provides a rationale for complement substitution before immunoablation. moreover, lupus flares may be predicted individually by flow cytometry with plasmablast expansion and recurrence of type-i interferon signature. background. systemic lupus erythematosus (sle) is a chronic autoimmune disease characterized by the generation of pathogenic antibodies directed against a variety of autoantigens. we have previously shown that long-lived autoreactive plasma cells can contribute to chronicity and refractoriness of sle. our study is aimed to develop new methods for depletion of long-lived plasma cells in nzb/w mice, a model of sle. methods. we studied different treatment protocols on plasma cell survival: irradiation-based and more selective depletive treatments. - week-old nzb/w f mice were exposed to three different irradiation doses ( , , and gy in two splitted doses with a -h interval). the following protocols were also investigated: ) two bortezomib (bz) injections ( , mg/kg, i.v.) combined with anti-mouse cd ( mg/kg, i.v.), ) three bortezomib injections combined with anti-mouse cd , ) three bortezomib injections combined with anti-lfa- and anti-vla- antibodies (affecting directly the plasma cell niche; µg, i.p.) in a -d interval, plus anti-mouse cd and anti-b ( µg, i.v.). the plasma cells were analyzed in spleen and bone marrow by facs and elispot. results. the frequency of remaining plasma cells in bone marrow after , and gy irradiation were , and , % respectively, and in spleen were almost , and , %. short-term treatments with agents that affect plasma cells (bortezomib, anti-lfa plus anti-vla ) effectively deplete plasma cells including long-lived plasma cells in spleen and bone marrow of nzb/w mice. because of the b cell hyperactivity in nzb/w mice, we observe a rapid regeneration of autoreactive plasma cells in spleen and bone marrow. therefore, plasma cell depletion protocols were combined with b cell depletion. especially, the combination of plasma cell targeting with bortezomib, anti-lfa and anti-vla with b cell targeting (anti-cd plus anti-b ) interrupted the repopulation of autoreactive plasma cells in spleen and bone marrow. conclusion. very high doses of irradiation result in effective depletion of long-lived plasma cells but lower doses not. depletion of long-lived plasma cells can be achieved by the proteasome inhibitor bortezomib and by targeting both adhesion molecules lfa and vla . the combination with b cell depletion is needed to prevent regeneration of autoreactive plasma cells. varicella-zoster-virus(vzv)-specific lymphocytes and igg antibody avidity in patients with juvenile idiopathic arthritis or rheumatoid arthritis background. varicella zoster virus (vzv) is a herpes virus that establishes a life-long latent infection with risk of reactivation (shingles) particularly in immunosuppressed patients with autoimmune disorders. patients with rheumatoid (ra) or juvenile idiopathic arthritis (jia) have a high risk for disseminating varicella zoster virus (vzv) infection or herpes zoster. this study was aimed to investigate the humoral and cellular immune response to vzv including assessment of igg-anti-vzv avidity and vzv-specific reactivity of lymphocytes in ra (n= ) or jia patients (n= ) on different treatments, including biologic agents, such as anti-tumor-necrosis-factor(tnf)-alpha or anti-interleukin- (il- ) receptor inhibition (tocilizumab), compared to healthy adults (ha) and children (hc). methods. igg-anti-vzv concentrations and avidities were quantified by an adapted elisa. vzv-specific interferon-gamma-producing lymphocytes (spot forming units, sfu/ , , cells) were analyzed by elispot. results. no significant differences in the vzv-igg concentrations or avidities were found between the groups. however, lower igg-anti-vzv concentrations were found in tocilizumab-treated ra compared to ha and ra without biologic agents. ra showed lower median sfu ( / , , cells) than ha ( / , , cells), with lowest sfu in adalimumab-treated ra ( / , , cells). sfu were not altered in tocilizumab-treated ra and after incubation with anti-il- in vitro. no differences regarding igg-anti-vzv concentrations, rai and cellular reactivity were found between jia and hc. conclusion. our study demonstrated that ra and jia patients are still able to maintain humoral and cellular immune responses to vzv despite immunosuppressive therapy or biologic agents. in ra, the role of lower cellular reactivity for risk of herpes zoster has to be considered for recommendations on vaccination. cmv-specific cd + t cells from ra patients contribute to autoimmune disease zeitschrift für rheumatologie suppl · | . increased frequency of lir- (also called cd j or ilt ) on cd + t cells has been associated with autoimmune disease. furthermore, it has been shown that latent cytomegalovirus (cmv) infection contributes to the expansion of cd − t cells. hence we were interested in the influence of cmv infection on the lir expression on t cells in ra patients. methods. we were interested in the role of lir + t cells in ra patients, which potentially contribute to the autoreactive t cell pool, especially in cmv+ patients. therefore, we investigated the expression and function of lir- on cd + t cells in peripheral blood mononuclear cells (pbmc) from patients with rheumatoid arthritis by flow cytometry and cytotoxicity assay. results. flow cytometry analysis revealed higher frequencies of lir- + cd + t cells in cmv seropositive ra (n= , mean%: . ) compared to cmv+ hd (n= , mean%: . , p= . ). using hla-a* /cmvpp dextramers we analyzed cmv-specific cd + t cells. patients with ra had higher frequencies of cvm specific cd + t cells (n= ; mean%: . ) compared to healthy individuals (n= ; mean%: . , p= . ). phenotypically, cmv-specific cd + t cells are mainly cd negative and express lir- . analysis of the cytolytic potential by cd a expression revealed higher numbers of cd a+cd + t cells in ra patients (n= , mean%: , ) compared to healthy donors (n= , mean%: , ). importantly, we found a significant correlation (p= . ) of high numbers of cd +lir- + t cells with high disease activity score (das ) in ra patients without immunosuppressive treatment (n= , r= , ) . tab. . conclusion. this is the first demonstration of significantly increased frequencies of lir- +cd + t cells and of cmv-specific cd + t cells in patients with rheumatoid arthritis. these cells are characterized by a terminally differentiated phenotype. the higher cytolytic potential of cmv-specific t cells likely can be attributed to their function in containing latent cmv infection and to prevent cmv disease, but might potentially contribute to disease severity in ra patients. background. systemic lupus erythematosus (sle) is an autoimmune disease characterized by an acquired il- deficiency, which leads to a homeostatic imbalance between regulatory t cells (treg) and effector t cells (tcon; humrich et al. ). we recently demonstrated that treg homeostasis in lymphoid organs of diseased (nzbxnzw) f mice can be restored by treatment with recombinant il- (il- ) resulting in an amelioration of kidney disease. the aim of this study was to investigate the impact of il- therapy on intrarenal foxp + treg and kidney infiltrating conventional cd + t cells (tcon) in the (nzbxnzw) f mouse model of lupus nephritis. methods. (nzbxnzw) f mice with active nephritis were treated with recombinant il- either for a short period of days or for a longer period of days in total. absolute numbers, phenotype and proliferation of kidney infiltrating cd + t cell subsets were determined by flow cytometry at different time points. results. short-term il- treatment resulted in an enhanced proliferation and increased numbers and frequencies of intrarenal cd +foxp + treg compared to untreated control mice. on the other hand, long term il- treatment did not result in a persistent expansion of the intrarenal foxp + treg population. however, total numbers of kidney infiltrating cd + tcon with a memory/effector phenotpye were diminished and cd + tcon showed markedly reduced signs of cellular activation. conclusion. our data indicate that short term il- treatment is able to expand the size of the intrarenal treg pool. in contrast, long term il- treatment decreases the numbers of kidney infiltrating memory/ effector t cells and reduces cellular hyperactivity suggesting that treg suppress the activation and expansion of infiltrating tcon. these results may in part explain the amelioration of disease induced by treatment with il- and underline the important role of intrarenal treg for the suppression of kidney disease in lupus mice. these results also provide additional important rationales for an il- based immunotherapy of human disease. from transcriptome to protein biomarkers in ra: joint compartment and monocytes outperform serum and whole blood background. a main challenge in disease-management of ra is to establish objective criteria relevant for diagnosis and therapeutic stratification of patients. this study focused on global approaches in dissecting inflammation in ra including transcriptome analyses of synovial tissue and blood monocytes and proteome analyses of synovial fluid and serum. methods. gene-expression profiles from synovial tissues and blood monocytes of ra and osteoarthritis (oa) patients were generated by affymtetrix arrays. elisa and multiplex immunoassays were used for validation of candidate markers at the protein level in synovial fluid (sf) from ra and oa patients and in serum from the same group of patients and healthy donors. results. transcriptome analyses of synovial tissues from ra and oa revealed more than differentially expressed genes. to avoid difficulties in sampling synovial tissue and to avoid fluctuation in cellular composition of various cell types in blood, the transcriptome analyses from peripheral blood was focused on a specific cell population. monocytes were selected as the favourable cell type involved in the production of cytokines, which are often considered as therapeutic targets in ra. comparisons between ra and oa monocytes disclosed differential expression of more than genes. in total, genes that were up-regulated in synovial tissues and/or monocytes were used for validation at the protein level as potential biomarkers for ra. among these biomarkers, chemokines (cxcl , ccl , ip ), adhesion molecules (vcam , icam , e-and p-selectins), proteolytic enzymes (mmp , a at), and the shedding form of cell surface molecules (cd , cd ) background. idiopathic membranous nephropathy (imn) is a common cause of nephrotic syndrome in adults and has recently been identified as an autoimmune-mediated disease [ ] . autoantibodies directed towards the m-type phospholipase a receptor (pla r) are fairly specific for idiopathic mn and only found to a small percentage in sera from patients with secondary mn [ ] . the outcome of patients with imn is quite diverse: about one third of patients have spontaneous remission, another third progress to require dialysis and the last third continue to have proteinuria without progression to renal failure. we performed serological profiles of imn patients in order to compare antibody profiles to antibody frequencies found in the normal healthy population and to hopefully identify factors that help to predict disease course in imn. methods. serum samples of patients with imn were assayed for a variety of autoantibodies by elisa, addressable laser bead immunoassay (albia) and to dsdna by crithidia luciliae assay. results. the prevalence of autoantibodies found in our imn cohort is summarized in tab. . anti-pla r antibodies were found in about % of imn patients whereas the frequency of other antibodies was mostly below %. the one exception is anti-dfs that was found in . % of imn patients. conclusion. the prevalence of anti-pla r positive patients in our imn cohort matches what has been previously described [ ] . the frequency of the other antibodies that we determined is comparable to what has been reported in the normal healthy population. it is important to note that anti-dfs antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases (sard; [ ] ) whereas anti-ro reactivity is often regarded as a marker for sard. the absence of anti-ro and the high prevalence of anti-dfs confirms that imn is a rather organ specific autoimmune disease. background. activity and the quality of movement belong to the most fundamental diagnostic parameters for neurobehavioural analysis but in the past it has been difficult to include this information into pre-clinical murine disease models. here we tested the applicability of a radiofrequency identification (rfid) based automated tracking system in the experimental murine model of ovalbumin induced arthritis. methods. c bl/ mice were immunized twice with cationized ovalbumin in freund's complete adjuvant and onset of arthritis was induced two weeks after the last immunization by direct injection of cationized ovalbumin into the knee joint of the right hind leg. severity of arthritis was assessed through measurement of joint swelling and evaluation of histological changes. additionally mice were implanted with a rfid transponder and throughout the experiment their activity level was monitored by an id-grid sensor plate placed underneath the homecage. results. the joint inflammation in the ovalbumin induced arthritis model showed a quantifiable impact on the activity levels of the mice. our experiments could also show that movement activity correlates with disease severity as evaluated by clinical and immunological parameters. in the past employing behavioral methods was often limiting by group size, observation time and reproducibility and the stress of handling and new surroundings made results difficult to interpret. in our experiments a rfid-based automated tracking system allowed us to monitor individual activity long-term without removal of the mice from their homecage environment. this allowed for the correlation of clinical parameters to behavioral factors and adds another level of analysis to an established murine model. progranulin antibodies in a wide spectrum of autoimmune diseases results. autoantibodies against progranulin, a secreted and direct inhibitor of tnf-α receptors & were frequently identified in primary vasculitides. in detail, progranulin-antibodies were found during the course of disease in giant cell arteritis/polymyalgia rheumatica ( / ), takayasu's arteritis ( / ), classical panarteritis nodosa ( / ), behcet's disease ( / ), in granulomatosis with polyangiitis ( / ), churg-strauss syndrome ( / ) and in microscopic polyangiitis ( / ). in extended screenings progranulin-antibodies were also frequently detected in autoimmune connective tissue disorders, in rheumatoid and psoriatic arthritis and in inflammatory bowel disorders. in contrast progranulin-antibodies were only detected rarely in healthy controls ( / ), patients with obesity ( / ), residents of nursing homes ( / ), not in patients with cutaneously limited psoriasis ( / ), not in patients undergone sepsis ( / ), and not in patients with melanoma ( / ). a significant association of progranulin-antibodies with active disease states in granulomatosis with polyangiitis suggested a pro-inflammatory activity of progranulin-antibodies. this was supported by an observed neutralizing effect of progranulin-antibodies on the levels of circulating progranulin in elisa and western-blot. moreover, functional assays revealed, that progranulin-antibody containing sera render wehi-s cells far more sensitive to effects of administrated tnf-α, providing evidence for the suspected pro-inflammatory effect of progranulin-antibodies. conclusion. progranulin-antibodies occur in a widespread spectrum of autoimmune diseases and have a pro-inflammatory effect by neutralizing the physiologic tnf-blocker progranulin. background. flow cytometry (fcm) is widely used in research for molecular characterization at single cell level. conventional analysis is a semiautomated process of user defined gating and investigation in -d projections. for multiple parameter analysis with hundreds of marker combinations, this manual process is most limiting and impedes high throughput analysis. therefore, we developed a new algorithm for automated and standardized analysis of multiplex fcm data. methods. automation included asinh-transformation of data, cell grouping, population detection and population feature extraction. for grouping of cells, an unbiased unsupervised model based t-mixture approach with expectation maximization (em)-iteration was applied. populations were identified by meta-clustering of several experiments according to position and extension of cell-clusters in multi-dimensional space and by including a general procrustes analysis (gpa) step. for validation, peripheral leukocytes from healthy donors and patients with rheumatoid arthritis (ra) were prepared by hypoosmotic erythrocyte lysis and stained with different sets of lineage-specific antibodies. in parallel, different leukocyte samples were depleted of one of these populations by magnetic beads. qualitative and quantitative characteristics of major populations were compared with conventional manual analysis. results. whole blood leukocytes stained simultaneously with up to markers were correctly distinguished in all major populations including granulocytes, t cells and their subpopulations, monocytes, b cells, and nk-cells. the result was comparable to the "gold standard" of manual evaluation by an expert. the new technology is able to detect subclusters and to characterize so far neglected smaller populations based on the new parameters generated. automated clustering did not require fluorescence compensation of data. cell-grouping is applicable even for large fcm datasets of at least parameters and more than million events. comparing the cell-clusters between ra and healthy controls, differences were detectable in several cell (sub-)populations, stable enough to perform correct classification into controls and disease. conclusion. this new approach reveals promising results for automated and time-saving analysis of large datasets from multiplex fcm. the algorithm avoids operator-induced bias, is able to detect unexpected sub-clusters and to characterize so far neglected populations. this may reveal not only new markers for disease activity but also for therapeutic stratification. background. lasp- localizes at focal adhesions, along stress fibres and leading edges of migrating cells regulating metastatic dissemination of different tumors. since rasf have been implicated in the spreading of disease by leaving cartilage destruction sites, migrating via the bloodstream and re-initiating the destructive process at distant articular cartilage surfaces, the underlying mechanisms are of special interest. therefore, we investigated the role of lasp- in sf migration and its effects on ra. methods. to identify lasp- expression and its sub-cellular distribution in human sf as well as in hind paws of wt and htnftg mice, we performed western blots and immunofluorescence. the migration of sfs derived from wt, lasp- -/-, htnftg and lasp -/-/htnftg mice was studied in a modified scratch assay as well as in live cell imaging studies. furthermore, a transmigration assay using sf from all four genotypes and murine endothelioma cells (bend. ) as an endothelial barrier was carried out. sf transmigration under inflammatory conditions was also evaluated by tnf-alpha stimulation of the endothelial cells in vitro. results. lasp- expression was up regulated in rasf and in sf from htnftg mice compared to healthy controls and was found at structures of cell adhesion and invasion. the scratch assay as well as the live cell imaging studies showed a significantly reduced migration of lasp- ( ng/ml) was applied. in parallel, il- stimulation significantly amplified the expression of anti-apoptotic bcl- in sle treg but not tcon. conclusion. in analogy to our previous findings in lupus-prone mice, treg from sle patients show the classical hallmarks of il- deficiency with loss of cd expression and a homeostatic imbalance between treg and tcon. these findings could be associated with a reduced il- expression by cd + t cells in sle patients. on the other hand, low-dose il- stimulation in vitro could restore these defects, underlying the potential of il- as a novel therapeutic option in sle. the glucocorticoid-dependent modulation of immune-mediated inflammatory arthritis by osteoblasts in mice is t cell independent background. at present, the role of adiponectin in rheumatoid arthritis is still controversial. there is some evidence indicating anti-inflammatory effects, for example adiponectin reduces the tnf release by macrophages. in contrast to its anti-inflammatory role, adiponectin also exerts pro-inflammatory effects locally in joints, inducing for example pro-inflammatory factors and matrix-degrading enzymes in ra synovial fibroblasts. moreover, our immunohistochemical analysis of ra bone tissue showed a co-localization of adiponectin with key cells of bone remodelling (osteoblasts, osteoclasts). however, the role of adiponectin in bone remodelling of ra still needs to be defined. in this study, we therefore focussed on adiponectin and its immunomodulatory properties on ra osteoblasts and osteoclasts. methods. human osteoblasts and osteoclasts were isolated from bone tissue and blood samples of ra patients. immunocytochemistry and rt-pcr were used to analyze the expression of adiponectin and its receptors in osteoblasts and osteoclasts. osteoblasts and osteoclasts were treated with adiponectin ( µg/ml). adiponectin-mediated effects on the cytokine expression in osteoblasts and osteoclasts were analyzed using elisa. results. the expression of adiponectin and its receptors (adipor , adipor , and paqr ) by cultured ra osteoblasts and osteoclasts could be confirmed on translational and transcriptional level. stimulation of primary ra osteoblasts and osteoclasts with adiponectin resulted in an alteration of cytokine release. osteoblasts showed a time-and dose-dependent increase in il- production. furthermore, adiponectin induced the secretion of il- and gro-alpha and significantly increased the il- and mcp- production (il- : -fold, p= . ; mcp- : -fold, p= . ). stimulation with adiponectin resulted in an increase in il- production in pre-osteoclasts ( -fold) but not in osteoclasts. the secretion of il- was increased in pre-osteoclasts ( -fold) and osteoclasts ( -fold). the results of the present study confirm the pro-inflammatory potential of adiponectin in ra. the cytokines released after adiponectin treatment by osteoblasts and osteoclasts promote osteoclastogenesis or the migratory potential of osteoclasts and monocytes. together with the finding that adiponectin is present in the bone compartment of ra suggest an involvement of adiponectin in articular destruction. acknowledgement: funded by the german research society (spp , immu-nobone, ne / - ). novel mechanisms of glucocorticoid therapy in arthritis anti-inflammatory acting glucocorticoids (gcs) are an important component of rheumatoid arthritis (ra) therapy. but their beneficial usefulness, especially in ra therapy, is hampered by severe side effects like glucocorticoid-induced osteoporosis (gio). until now the molecular mechanisms underlying the beneficial and side effects of gc therapy are poorly understood. gcs exert their actions via the glucocorticoid receptor (gr) that alters gene expression by either binding as a dimer to gc response elements in the promoter region of target genes or by interacting with and thus interfering with other transcription factors. for a long time gr dimerization was considered as the molecular base of side effects. interference of pro-inflammatory transcription factors, such as ap- and nf-κb by the gr monomer was believed to contribute to the therapeutic effects of gcs. in a model of gio we previously showed that unexpectedly interaction of the gr monomer with ap- , but not nf-kb in osteoblasts is decisive for bone loss (cell metabolism : ). in contrast, in antigen-induced arthritis (aia), we could demonstrate that gcs act in the acute inflammation of ra via the dimerized gr. particularly, gc therapy suppressed th and th cell derived pro-inflammatory cytokines in a dimerization dependent manner. furthermore th , rather than th cells seem to be the most crucial targets for an efficient gc therapy since il- -/-mice were resistant to gc therapy whereas ifnγ-/-mice responded as efficient as wild type mice to steroid treatment (pnas : ). in a more chronic arthritis model, the k/bxn serum transfer induced arthritis, we demonstrate now that, unexpectedly, dimerization of the gr in non-hematopoietic cells also contributes to the anti-inflammatory effect of gcs. thus, for immunosuppression of arthritis the gr is required in distinct cell types. taken together, for anti-inflammatory actions the gr dimerization dependent gene regulation is decisive in ra, whereas gio depends on the suppression of ap- dependent gene expression. intriguingly for anti-inflammatory activities of gcs immune and non-immune cells are involved. our approaches give new insights into gc action on arthritis and bone that can be translated into new concepts for anti-inflammatory therapies preventing gio. background. new bone formation and ankylosis are a hallmark of ankylosing spondylitis (as). the impact of cytokines and different mechanisms of new bone formation (endochondral vs. membranous) to syndesmophyte formation and joint ankylosis in as are still poorly understood. in order to analyze cartilage hypertrophy -as a potentially important element of endochondral bone formation -and to assess the possible influence of cytokines, we performed an immunohistochemi-cal study of the hyaline articular cartilage of facet joints of as patients in comparison to autopsy controls and patients with osteoarthritis (oa). methods. the cytokines interleukin(il)- , il- and il- , as well as the marker of cartilage hypertrophy runt-related transcription factor (runx ), matrix metalloproteinase (mmp ) and collagen type (col ) were determined in facet joints from patients with as (undergone correction surgery of rigid hyperkyphosis), oa patients (undergone surgery of the lumbar spine, because of neurological deficits) and controls (autopsies without spinal diseases). immunohistochemistry was performed and the entire cartilage area was analyzed for the frequency of positively stained chondrocytes. background. immunization with glucose- -phosphate isomerase (g pi) induces arthritis in susceptible strains of mice. depletion of regulatory t cells (tregs) prior to immunization switches the usually acute, self-limiting course to a non-remitting, destructive arthritis. this provides a possibility to study molecular switches for the transition from acute, self-limiting to chronic, destructive arthritis within one mouse model. to examine the role of fibroblast-like synoviocytes (fls), which are known to modulate immune responses via the production of pro-and anti-inflammatory mediators, the phenotype and function of fls from mice with either acute, self-limiting or non-remitting, destructive arthritis was studied. methods. fls from dba/ mice that developed either the acute or the chronic form of arthritis were isolated from joints over a time course of days. to investigate the phenotype of fls elisa studies as well as zymography have been performed. for the functional clarification of those cells the matrix-associated transepithelial resistance invasion (matrin) assay and a cartilage attachment assay have been used. furthermore, fls have been transferred in vivo into the knee joints of immunodeficient mice and the joints have been scored histologically. results. fls from treg-depleted mice produced significantly more cytokines (e.g. interleukin (il- )) upon stimulation with other cytokines, growth factors and tlr ligands. this increased susceptibility to cytokine stimulation in chronic animals compared to acute ones is observable throughout the disease course ( days). furthermore, the secretion and activity of matrix metalloproteases (mmps) was enhanced in the fls from chronic mice compared to samples from acute ones. additional functional differences include the collagen-destructive potential and the potential to attach and eventually invade wild type cartilage. here, fls from treg-depleted chronic arthritic mice showed a higher invasive and destructive potential. ultimately, fls from treg-depleted mice were able to destroy cartilage in immunodeficient mice. conclusion. our results are compatible with the hypothesis that uninhibited inflammation in the early phase of treg-depleted mice causes the acquisition of an autonomously aggressive phenotype of synoviocytes which contribute to the switch from acute to chronic arthritis even in the absence of late support from t and b lymphocytes. collagen-induced arthritis modulates reactivity to sympathetic neurotransmitter stimuli during osteoclastogenesis of bone marrow-derived macrophages from da rats background. osteoclast(oc)-mediated bone destruction contributes to increased disease burden in rheumatoid arthritis. simultaneously, changes in synovial tissue innervation occur, leading to a reduction in catecholaminergic nerve fibres. studies on sweat gland innervation revealed that catecholaminergic fibres are capable of phenotypic transition to cholinergic nerves. the sympathetic neurotransmitters norepinephrine (ne) and acetylcholine (ach) affect osteoclastogenesis oppositely prompting us to study osteoclastogenesis at different phases of collagen-induced arthritis (cia) in an altered neurotransmitter microenvironment. methods. for induction of experimental arthritis, da rats were immunized with bovine collagen type ii while controls received isotonic nacl solution. to generate oc, bone marrow-derived macrophages (bmm) were isolated and differentiated with recombinant m-csf and rank ligand. the influence of ne and ach stimulation on osteoclast differentiation and activity was compared between arthritic and control animals at the acute ( days post immunization, pi) and the chronic ( days pi) disease state. as the nicotinic α ach receptor subunit is involved in the cholinergic anti-inflammatory reflex, we also applied a specific agonist, arr- . additionally, the gene expression profile for ne and ach neurotransmitter receptors was analyzed. results. ach stimulation generated significantly more osteoclasts in controls ( days pi). arr- mediated effects were similar to ach. ne decreased osteoclastogenesis via β-adrenoceptors and enhanced via α-adrenoceptor stimulation. cells from arthritic animals were less affected by ne and ach stimulation.oc from arthritic animals showed tendentially decreased activity in an enzymatic cathepsin k activity assay. ach and arr- stimulation decreased cathepsin k activity days pi, but the effect disappeared days pi, representing the chronic arthritis state. ne stimulation significantly inhibited enzyme activity days pi, but has little effect under chronic conditions. the receptor gene expression profile changed in the time course of arthritis. days past immunization muscarinic ach receptors m and m were significantly upregulated whereas after days adrenoceptors α d and α b were significantly downregulated. conclusion. we conclude that cia differentially modulates neurotransmitter influence during oc differentiation and activation but the underlying processes remain still unknown. the observed time pointdependent changes in neurotransmitter receptor gene expression may constitute a regulatory mechanism to counteract alterations in the local neurotransmitter composition. background. the generation of memory t lymphocytes allows effective and fast immune responses during antigen re-challenge and represents a hallmark of adaptive immunity. previous work from our group has demonstrated that murine memory cd + t cells reside in specific bone marrow niches and are characterized by the high expression of cd and ly- c. these cells were designated as resting in the context of gene expression and proliferation. here, we aimed to phenotypically and functionally characterize human memory t lymphocytes in peripheral blood and bone marrow of healthy individuals. methods. mononuclear cells were isolated from paired blood and bm samples from individuals undergoing hip replacement surgery. phenotypic analysis and cytokine profile of distinct memory t cell subsets were assessed by flow cytometry. proliferation and cell cycle status were analyzed using ki- and propidium iodide (pi) staining, respectively. results. distinct populations of cd -expressing cd +cd ra-and cd +cd ra-t cells were detected in bone marrow but not in the periphery. ccr and cd l expression was reduced on bone marrow cd +cd +cd ra-and cd +cd +cd ra-t cells compared to their cd -counterparts in bone marrow and peripheral blood. cell cycle analysis and ki- expression levels demonstrated the nonproliferative state of bone marrow memory t cells. furthermore, bone marrow resident memory t cells showed reactivity against various pathogenic agents, such as tetanus, measles and cmv. conclusion. we have identified a population of cd -expressing cd +cd ra-and cd +cd ra-t cells in the bone marrow. despite cd expression, which is generally regarded as early activation marker, the cells were resting in terms of proliferation. bone marrow cd + memory t cells have downregulated ccr and cd l indicating reduced homing capacity to secondary lymphoid organs. our data underline the role of the bone marrow as a major reservoir for resting memory t lymphocytes. therapeutic methods exerted an influence on satisfaction and future expectations in patients with rheumatoid arthritis (ra). methods. when visiting their rheumatologist, patients with ra were asked to complete a questionnaire at home after the consultation and then return it to an independent opinion research centre, where the data was collected and analysed. the form comprised various areas, namely demography, aspects of the diagnosis, medical care, therapeutic measures, and the illness in a personal context. results. patients ( females/ males) from the whole of austria with a particular emphasis on lower austria, upper austria and tyrol completed the questionnaire (of distributed), resulting in a response rate of %. % of the patients lived in settlements of under , inhabitants; a further % in settlements of under , inhabitants.. the rheumatologist attended could be reached within one hour for % of the patients and within minutes for %. in slightly fewer than % of the respondents the diagnosis was made within three months, in % within six months. in %, the diagnosis was made by a rheumatologist. after experiencing the first symptoms, % contacted their general practitioner. a high degree of satisfaction appears to originate from the information supplied by the rheumatologist attended. most patients felt they were involved in decisions regarding their therapy. % of the respondents were employed prior to their illness; as a consequence of the disease % had to leave their jobs. conclusion. the majority of the respondents came from rural areas. the correct diagnosis was made within six months for almost half of the patients questioned. most patients felt well informed by their rheumatologists and involved in therapeutic decision-making. , combinational therapy of synthetic dmards ( . ; . - . ), and biological-monotherapy ( . ; - ). all of these differed significantly on later observation periods. comparing the prescriptions separately by sequential treatments there were no differences in retention rates for the individual dmard classes. regarding retention, in the first treatment synthetic dmards showed the longest retention, but from the second on this was the case for tnfi-combinational treatment and non-tnfi-biologicals (. abb. ) conclusion. traditional dmards are the starting point of therapy and mtx is the anchor drug for the first and all subsequent courses. already at the second sequential course, the combination therapies of mtx+tnfi become numerically more relevant, and their retention is better than mtx. therapie der rheumatoiden arthritis im letzten jahrzehnt -was hat sich verändert? abb. | ev. anzahl eingeschlossener patienten nach einschlussjahren und therapie sowie zeitlichen entwicklungen im das und der eular-response cal features of ra (erosive arthritis with classical radiological features) plus specific laboratory markers (ccp-antibodies). the third patient, a -year-old female presented initially with features of ra and sle simultaneously (alopecia, subcutaneous nodules, leucopenia, positive ccp-antibodies, high titres of ana and dna-antibodies). the fourth patient, a -year-old patient presented with severe polyarthritis in the upper and lower limbs, subcutaneous nodules, fever and cervical lymphadenopathy, she had high titres of ccp-antibodies ( u/ml by a normal range of less than iu/ml), ana of (normal less than ), and dna of iu/ml (normal less than iu/ml). conclusion. the take home massage of this presentation is to be aware of rhupus if the sle patient develops erosive arthritis or subcutaneous nodules, or if the ra patient develops features of sle like leucopenia, active urine sediment, or clinically significant serositis. rhupus seems to be a distinctive entity and should be kept in mind while dealing with patients having ra or sle as it can affect the treatment and outcome. vorgeschichte. bei der abklärung eines akuten thoraxschmerzes sind auch seltene ursachen, so zum beispiel der einbezug thorakaler organe in eine entzündliche systemerkrankung, zu bedenken. anhand eines besonderen falles möchten wir den weg zur diagnose bei einem schwer kranken notfallpatienten zeigen. leitsymptome bei krankheitsmanifestation. ein -jähriger mann wird bereits zum dritten mal mit akuten thoraxschmerzen in die notaufnahme aufgenommen, jeweils war eine kardiale ischämie ausgeschlossen und ambulante diagnostik empfohlen worden. nach der schmerzcharakteristik, der vorgeschichte von rezidivierenden thoraxschmerzen und entsprechenden risikofaktoren wird bei massiver symptomatik jetzt von einem akuten koronarsyndrom ausgegangen und die invasive diagnostik durchgeführt. eine akute koronare ischämie kann jedoch ausgeschlossen werden. fieber, hohe entzündungszeichen, hinfälligkeit und gewichtsverlust von mehr als kg in den letzten wochen lassen dann eine infektbedingte oder tumorbedingte ursache vermuten, abdomensonographie und röntgen-thorax sowie ausführliches labor samt immunologie führen nicht weiter. wegweisende weitere organbefunde finden sich nicht. die behandlung mit antibiotika hat keinerlei effekt auf klinik oder entzündungsparameter. nach tagen wird der krankheitsverlauf kritisch evaluiert, eine nichtinfektiöse ursache der beschwerden wird in betracht gezogen, eine transösophageale echokardiographie wird zum ausschluss einer endokarditis und zur beurteilung der aorta (leitsymptome thoraxschmerzen und fieber!) durchgeführt. dabei zeigen sich die klappen sämtlich unverdächtig, die aorta ascendens weist eine massive echoarme wandverdickung auf. zum sicheren ausschluss eines intramuralen hämatoms wird sofort eine ct der thorakalen aorta durchgeführt, die eine ausgeprägte zirkuläre wandverbreiterung ohne hinweise auf dissektion zeigt. diagnose. riesenzellarteriitis mit aortitis. therapie. steroide, einleitung einer remissionsinduzierenden therapie mit cyclophosphamid boli. weiterer verlauf. innerhalb von tagen ist der patient beschwerdefrei, die entzündungsparameter sind halbiert, der bettlägerige patient lässt sich mobilisieren und verlässt nach tagen die klinik. bei der diffe-renzialdiagnose des akuten thoraxschmerzes sollten eine unklare entzündungsserologie und eine b-symptomatik frühzeitig an eine aortitis denken lassen. in diesem fall fand sich bereits in tee und ct ein ausgeprägter befund, der sich am ehesten durch den langen verlauf vor diagnosestellung erklären lässt. einleitung. die progressive familiär intrahepatische cholestase (pfic) gehört zu einer heterogenen gruppe seltener, autosomal rezessiv vererbter erkrankungen der gallensäurenexkretion mit intrahepatischer cholestase, hohem risiko der leberzirrhose bereits im kindesalter und hepatozellulärem karzinom. das auftreten eines sle bei pfic ist bisher in der literatur nicht beschrieben. methoden. wir berichten über eine jetzt -jährige patientin mit genetisch gesicherter pfic- (defekt der atp abhängigen gallensalz-exportpumpe bsep), biliostomaanlage im kindesalter, therapie mit udca und kontinuierlicher hepatologischer betreuung. / manifestierte sich ein sle mit az-minderung, florider polyarthritis, polyserositis, splenomegalie, anämie und leukozytopenie. die ana waren mit > : homogen erhöht, die dns-ak im elisa mit u/ml, ena und antiphospholipid antikörper waren negativ. eine steroidtherapie wurde mit prednisolon mg/tag begonnen. bei guter verträglichkeit und stabilen cholestaseparametern wurde die therapie um chloroquin mit mg an tagen der woche ergänzt. die betreuung wurde interdisziplinär fortgesetzt. ergebnisse. unter der steroidtherapie waren gelenkbeschwerden und serositis gebessert, das crp, die leukozytopenie und anämie normalisiert. die dns-antikörper fielen auf u/ml, c und c stiegen um %. es persistierten lediglich physiotherapeutisch behandelte muskuläre schmerzen und schonatmung nach pleuritis. bei steroidreduktion unter mg traten die gelenkbeschwerden wieder auf, die dns-antikörper stiegen auf u/ml und c /c fielen um %, das crp blieb normal. die steroiddosis wurde auf mg/tag und die chloroquindosis auf × mg/woche erhöht. neue organkomplikationen im rahmen des sle sind nicht aufgetreten. die gallensäuren waren mit µmol/l (norm < ) im jahr (letzte messung vor manifestation des sle) deutlich erhöht, bei manifestation des sle mit µmol/l bereits deutlich gebessert und unter hoch dosierter steroidtherapie mit , µmol/l nach woche sowie , µmol/l nach monat normalisiert. unter prednisolon mg/tag stiegen sie bei inaktiviertem sle auf µmol/l nach monaten an, bei steroidreduktion unter mg auf µmol/l. nach erneuter steroiddosiserhöhung auf mg prednisolon/tag fielen sie auf µmol/l ab. schlussfolgerung. die pfic- schützt nicht vor der manifestation eines sle. eine behandlung mit steroiden und chloroquin ist auch bei pfic sicher und wirksam. der floride sle und die höher dosierte steroidtherapie senken trotz bestehenden genetischen defekts unabhängig voneinander und synergistisch die gallensäurenspiegel im serum bei genetischer störung der atp-abhängigen sekretionspumpe bsep. augenentzündungen. eine ausgeprägte b-symptomatik mit fieber, nachtschweiß und abgeschlagenheit seit ca. zwei jahren hatte sich jeweils unter der therapie der hörstürze verflüchtigt. die mr-angiographie der aortenwand zeigte den typischen befund eines ausgeprägten wandenhancements der thorakalen aortenwand sowie der supraaortalen gefäße, duplexsonographisch fand sich eine zirkuläre wandverdickung der proximalen und mittleren acc beidseits ohne relevante stenosen. bei fehlendem nachweis zerebraler vaskulitischer oder embolischer veränderungen im kraniellen mrt und bei normalem eeg wurde der cerebrale krampfanfall als gelegenheitsanfall dd im rahmen der hochaktiven grunderkrankung interpretiert. diagnose. takayasu-arteriitis mit assoziiertem cogan-syndrom und rezidivierender polychondritis. therapie. steroidstoß, darunter rasche reduktion der entzündungszeichen und promptes ansprechen der b-symptomatik, beginn einer steroidsparenden therapie mit mtx. bei anhaltender krankheitsaktivität und hohem steroidbedarf wird der patient aktuell mit tocilizumab behandelt. schlussfolgerung. der präsentierte fall zeigt, dass mittels neuer bildgebender verfahren gelegentlich eine großgefäßvaskulitis detektiert werden kann, obwohl das klinische bild (hier: kopfklinik) eine kleingefäßvaskulitis vermuten lässt. das cogan-syndrom ist häufig mit einer großgefäßvaskulitis assoziiert, in diesem fall auch mit einer polychondritis. umgekehrt erweitert sich unser wissen um das befallsmuster der großgefäßvaskulitiden, die zwar überwiegend große, aber auch mittelgroße und kleine gefäße einbeziehen können. in unserem zentrum ist dies der zweite fall einer takayasu-arteriitis mit assoziiertem cogan-syndrom in einem kollektiv von fällen. diagnostik. im rahmen einer vorstellung in unserer rheumatologischen ambulanz zur abklärung eines möglichen sjögren-syndroms, konnte in der lungenfunktionsdiagnostik eine leichte restriktion und Überblähung festgestellt werden. in einem auswärtig durchgeführten mrt der halsweichteile zeigten sich die glandula parotis und submandibularis beidseits inhomogen und kräftig kontrastiert, ebenfalls mehrere grenzwertig große lymphknoten. aufgrund der erneut pathologischen lungenfunktion und dem verdacht auf eine lungenbeteiligung bei sjögren-syndrom erfolgte ein ct-thorax. hier zeigte sich eine zysti-sche rarefizierung vor allem der zentralen lungenanteile, differentialdiagnostisch mit einer langerhans-zell-histiozytose vereinbar. auch erschien der diabetes insipidus passend zur histiozytose. die immunologischen untersuchungen waren unauffällig, insbesondere konnten keine ssa-/ssb-antikörper oder eine hypergammaglobulinämie nachgewiesen werden. somit erschien ein sjögren-syndrom unwahrscheinlich. zur weiteren abklärung erfolgte eine bronchoskopie, in den biopsaten konnte immunhistochemisch eine langerhans-zell-histiozytose nachgewiesen werden. in einer pathologischen nachuntersuchung auswärtiger parotis-biopsate bestätigte sich diese, zudem konnte eine mutation des braf-proto-onkogens nachgewiesen werden. im abschließend durchgeführten pet-ct konnte eine vermehrte kontrastmittelaufnahme des hypophysenstiels, eine vermehrte stoffwechselaktivität der parotis beidseits sowie kutan axillär links diagnostiziert werden. abschließend lag somit eine langerhans-zell-histiozytose mit befall von hypophyse, lunge, parotis, haut, lymphknoten sowie einem fraglichen befall des darms vor. therapie. in absprache mit der adulten langerhans-zell-histiozytose studiengruppe erfolgt nun eine therapie mit cytarabin. weiterer verlauf. der weitere verlauf nach geplantem therapiebeginn bleibt abzuwarten. einleitung. die anti-gbm-erkrankung (goodpasture-syndrom) ist eine prototypische autoimmunerkrankung mit ernster prognose, wenn sie als "pulmorenales syndrom" mit der trias rapid-progressive glomerulonephritis, alveoläre hämorrhagie und nachweis von autoantikörpern gegen glomeruläre basalmembranen (anti-gbm-ak) auftritt. Über weniger aggressive verläufe ist wenig bekannt. in der literatur wird die bedeutung der frühen diagnosestellung für die prognose der patienten betont. wir berichten über eine -jährige patientin, die sich mit abgeschlagenheit, müdigkeit und blutbeimengungen im sputum vorstellt. sie betreibt einen nikotinabusus. methoden. wir sehen eine blasse patientin (hb , mmol/l, normochrom, normozytär), die keine weiteren auffälligen befunde in der körperlichen untersuchung zeigt. die apparative diagnostik mittels endoskopie und sonographie ergibt keine befunde, die die anämie erklären können; in der bronchoskpie zeigt sich das bild einer alveolären hämorrhagie ohne aktive blutungszeichen. neben der ausgeprägten anämie bestehen eine milde proteinurie mit mg/d sowie eine geringe erythrozyturie. die immunologische diagnostik ergibt gering erhöhte anti-gbm-ak, negative ana und anca. die nierenbiopsie zeigt eine rapid-progressive glomerulonephritis mit halbmondbildung in einem glomerulum, zusätzlich können lineare igg-ablagerungen in der immunfluorenz dargestellt werden. es ist ein glomerulum in der biopsie betroffen, die anderen glomeruli sind unauffällig. es bestehen einzelnen erythrozytenzylinder, diffuse entzündungszeichen lassen sich nicht nachweisen. die nachträglich durchgeführte immunfluoreszenz in der lungenbiopsie bestätigt den befund linearer igg-ablagerungen. ergebnisse. in unserem fall sehen wir eine junge patientin in einem relativ guten allgemeinzustand mit gering erhöhten anti-gbm-antikörpern und einer gering ausgeprägten nierenschädigung mit einem befallenen glomerulum in der biopsie. es wird angesichts des jungen alters der patientin und der geringen ausprägung der erkrankung eine therapie mit cyclophosphamid nach dem "euro-lupus-protokoll" von f. hossiau eingeleitet. im verlauf steigt der hb auf , mmol/l, die alveoläre hämorrhagie sistiert und die proteinurie ist rückläufig. schlussfolgerung. das goodpasture-syndrom mit einer inzidenz von , - , / mio. einwohner und jahr ist eine sehr seltene autoimmunerkrankung mit ernster prognose. möglicherweise spielen umweltfaktoren (hier: nikotinabusus) eine rolle für die manifestation der erkrankung. interessant ist, dass die erstbeschreibung im rahmen einer influenza-epidemie -wie auch in diesem jahr bei unserer patientinerfolgte. Über die therapie gibt es wenige informationen. die meisten empfehlungen gibt es zum pulmorenalen-syndrom, über weniger aggressiv verlaufende manifestationen gibt es nur wenige informationen. einleitung. wir berichten über einen -jährigen raucher mit akut aufgetretener polyarthritis und neu aufgetretenem raynaud-phänomen. auffallend war die diskrepanz zwischen nur geringer systemischer entzündungskonstellation und einer hochaktiven polyarthritis mit schwerem raynaud-phänomen. im verlauf kam es zu einer spontanen thrombophlebitis der v. cephalica. methoden. pathologische werte: crp maximal , mg/dl (norm < , ), zellzahl im gelenkpunktat . leukozyten/µl. im normbereich lagen: bsg mm/ h, ana, ena, ds-dns-ak, rheumafaktoren, anca, kälteagglutinine, kryoglobuline, tumorsuche initial ohne befund (ct-thorax, bronchoskopie, ct abdomen und becken, coloskopie, gastroskopie, skelettszintigraphie), fdg pet-ct: zwei suspekte lymphknoten rechts cervical sowie suspekte rechte tonsille. ergebnisse. selbst unter mg prednisolon weiterhin hochaktive polyarthritis. nach unauffälliger initialer tumorsuche veranlassten wir ein fdg-pet ct mit nachweis zweier suspekter lymphknoten rechts cervical sowie einer suspekten rechten tonsille. die biopsie der klinisch sich nur in der palpation diskret induriert darstellenden region ergab ein gering differenziertes, gering verhornendes plattenepithel mit %iger sequenzhomologie mit hpv typ . nach resektion des tumors und radiatio sistierten sowohl die polyarthritis als auch das raynaud-phänomen ohne weiteres rezidiv auch nach absetzen der glukokortikoide. schlussfolgerung. eine akut auftretende hochaktive polyarthritis mit hohem glukokortikoidbedarf in kombination mit einem raynaud-syndrom, auffallend niedriger systemischer entzündungsaktivität und fehlendem autoantikörpernachweis sollte insbesondere bei einem langjährigen raucher anlass zu einer intensiven tumorsuche geben. ein fdg-pet-ct kann bei okkulten tumoren zielführend sein. bemerkenswert ist hier der nachweis von hpv- im tumor als weiterer risikofaktor neben dem zigarettenrauch. methoden. bei der klinischen untersuchung fielen ein beidseits positives menell-zeichen und deutlicher klopfschmerz über dem lumbosakralen Übergang auf. labordiagnostisch konnte ein erhöhtes c-reaktives protein und ein positiver hla-b nachgewiesen werden. der bath ankylosing disease activity (basdai) index betrug , . die beckenübersichtsaufnahme zeigte eine definitive bilaterale sakroiliitis grad gemäß den modifizierten new-york-kriterien. der befund der kontrastmittelunterstützten mrt der iliosakralgelenke bewies das vorliegen einer bilateralen floriden sakroiliitis. bei gesicherter hla-b positiver ankylosierender spondylitis wurde die indikation zur einleitung einer biologikatherapie mit einem tnfα-inhibitor gestellt. während der abklärung von kontraindikationen wurde in der konventionellen röntgen-thorax-aufnahme eine rundliche, glatt begrenzte zystische läsion mit flüssigkeitsspiegeln im rechten mittellappen entdeckt. die weitere abklärung mittels nativer thorax-ct, bronchoskopie und biopsieentnahme bestätigte den verdacht auf eine bronchogene zyste. die erregerdiagnostik in der bronchoalveolären lavage zeigte lediglich eine kontamination mit der residenten standortflora. ergebnisse. in anbetracht der geplanten immunsuppressiven therapie, die mit einem erhöhten infektionsrisiko einhergeht, wurde die bronchogene zyste im september operativ entfernt. zur linderung der beschwerden erhielt die patientin eine schmerztherapie mit nsar. als sich die patientin sechs monate später erneut zur einleitung der biologikatherapie vorstellte, berichtete sie, dass die schmerzen etwa einen monat nach der operativen resektion praktisch verschwunden seien. die klinische untersuchung war unauffällig, der basdai-index lag bei , . auch das zur verlaufskontrolle angefertigte mrt der isg zeigte im vergleich zur voruntersuchung einen deutlichen rückgang der floridität. schlussfolgerung. es handelt sich um den ersten fall einer kompletten klinischen und radiologischen remission einer hla-b -positiven ankylosierenden spondylitis nach operativer entfernung einer bronchogenen zyste als potenziellen entzündlichen fokus. bei der systemischen verlaufsform der erkrankung treten neben kutanen erscheinungen zusätzlich muskuloskeletale, hämatopoetische ( - %), renale (ca. %), kardiale, cerebrale und pulmonale ( - %) manifestationen auf. eine polyserositis ( - %) ist häufig. mit - % werden im sle-schub abdominelle schmerzen beschrieben. nur in seltenen fällen (amerika , %, asien , - , % aller sle-patienten) kommt es zum bild einer lupusassoziierten mesenterialen vaskulitis (lmv). die Ätiologie der lmv ist weitestgehend unklar, eine genetische präsidsposition sowie auslösende faktoren (bakterielle darminfektionen, medikamente wie nsar, phosphodiesterasehemmer) werden diskutiert. pathogenetisch wird eine mesenteriale ischämie durch eine mikroangiopathie (arteriolen, venolen) bei inflammatorischer immunkomplexpräzipitation sowie thrombembolischen ereignissen angenommen. radiologisch/sonographisch zeigt sich ein segmentales darmwandödem mit darmdilatation. endoskopisch dominieren oberflächliche ulzerationen, perifokale hämorrhagien bis hin zur gangrän. eine erhöhte perforationsneigung wird beschrieben. mikroskopische befunde zeigen eine fibrinoide nekrose subseröser gefäße mit leukozytoklasie der gefäßwand bzw. ein submuköses Ödem mit nur diskreter invasion mononukleärer zellen. die prognose der lmv scheint abhängig von genetischer prädisposition, raschem beginn einer immunsuppression sowie restriktivem einsatz operativer interventionen und wird je nach literaturquelle mit einer letalität bis zu % angegeben. background. we report a patient with tma in the context of sle treated successfully with the c inhibitor eculizumab. the patient had sle with lupus nephritis (ln). before she developed tma with renal failure and neurologic manifestations, she was treated with various immunosuppressive regimens for mucocutaneous and musculoskeletal manifestations and later for ln. the diagnosis of atypical hemolytic uremic syndrome (ahus) was made based on the presence of coombs-negative hemolytic anemia, thrombocytopenia, renal failure, seizures due to cerebral ischemia and signs of tma in the renal biopsy. plasma exchange and hemodialysis were started immediately and could stabilize her condition. six weeks after the beginning of plasmapheresis but still severely compromised renal function and thrombocytopenia, complement inhibition with eculizumab became a therapeutic option. after the first infusions, renal function, anemia and thrombocyte counts markedly improved. dialysis could be stopped. extensive genetic testing of mutations associated with the overactivation of the alternative complement pathway was negative. after months, when the patient was still in remission, eculizumab infusion intervals were widened and it was finally stopped after months of treatment. since then, renal function remained stable with nearly normal glomerular filtration rates. background. il- signaling plays an important role in inflammation but is restricted by different regulatory mechanisms. these mechanisms include the decreased availability of gp , the signal transducing chain of the il receptor, on the cell surface. the aim of this study was to determine whether the inflammatory environment in the arthritic joint has an impact on monocytic gp surface expression and the extent to which regulatory processes in the synovial fluid (sf) can be transferred to an in vitro model. flow cytometry and live cell imaging were used to measure the cell surface expression and internalization of gp . stat phosphorylation was monitored by flow cytometry and western blotting. results. the level of cell surface gp expression on sf monocytes was reduced compared to peripheral blood (pb) monocytes from patients with juvenile idiopathic arthritis (jia). this reduction could be reproduced by stimulating pb monocytes from healthy donors with sf and was dependent on p mapk. the induction of p by il- β in pb monocytes interfered with il- signaling due to the reduced cell surface expression of gp . the results suggest that p -mediated pro-inflammatory stimuli induce the downregulation of gp on monocytes and thus restrict gp mediated signal transduction. this regulatory mechanism could be relevant in the inflamed joints of patients with jia. kr. sjia patient characteristics of those who successfully discontinued corticosteroids during canakinumab treatment: secondary analysis from a pivotal phase trial background. interleukin- β (il- β) is a key driver in the pathogenesis of systemic juvenile idiopathic arthritis (sjia). canakinumab (can), a selective fully human anti-il- β monoclonal antibody, has been shown to be efficacious in the treatment of sjia [ ] . corticosteroids (cs) are a mainstay of therapy for sjia, however due to the well-known long-term side effects, reduction of cs dosage is desirable. objectives. to assess patient features associated with cs discontinuation during can therapy. methods. patients ( - years of age) with active sjia received s.c. can ( mg/kg to mg max) every four weeks during the maximum week cs-tapering phase [ ] . cs tapering was to be initiated when at least an adapted acr was achieved and no fever. a -year-old boy presented with nocturnal tingling paresthesia affecting his feet and his calves. no excessive leg movements were noted at night. within a few months, his symptoms worsened. the paresthesia occurred both during the day and at night. moreover, the paresthesia came to be triggered by merely standing up. affecting a sharply demarcated area not corresponding to dermatomes, symptoms resolved promptly with movement. the paresthesia was associated with local skin erubescence in spots that slowly began spreading all over the affected area. symptoms did not occur while the patient was seated. mild painless swelling around both of the ankles was noticed in the evenings. approximately one and a half years after the initial manifestation, painful triphasic color changes of all fingers and toes triggered by cold or stress occurred. the family history was positive only for psoriasis. extensive laboratory studies excluded inflammatory and hematological conditions as well as occlusive arterial diseases known to be associated with secondary raynaud's phenomenon. polyneuropathy and other neurological disorders were excluded as well. inflammatory joint disease suspected from the initial imaging with magnetic resonance of the feet and ankles was not confirmed by repeated investigations and scintigraphy. the only consistent abnormality was a reduced pulse amplitude corresponding to vasospasm, which was revealed by photoplethysmography of toe vessels. additionally, paradoxical amplitude reduction after application of nitroglycerine was seen in finger vessels. placing his hands or feet in cold water did not trigger raynaud's phenomenon. initial treatment with non-steroid anti-inflammatory drugs, topical isosorbiddinitrate and local steroid instillation (suspicion of inflammation of tibialis posterior tendon) was ineffective. systemic therapy with the calcium channel blocker amlodipine was initiated. the initial dosing of mg ( . mg/kg/day) was slowly increased to mg ( . mg/kg/day) which lead to complete resolution of the patient's ailments. after three years of pharmacotherapy and . years in remission, a weaning off the treatment is planned. based on the patient's positive response to calcium channel blocker, we conclude that the lower-leg paresthesia was of vascular origin and can be considered an atypical presentation of raynaud's phenomenon. background. the initial treatments of choice for jdm are high-dose corticosteroids and methotrexate. however, no consensus exists about second line therapeutic options in refractory or recurrent cases. results. we present a -year-old boy who was diagnosed with jdm due to severe proximal muscle weakness, dysphagia, a heliotrope rash, gottron's sign, nail teleangiectasia and a characteristic muscle biopsy. creatine kinase levels were within normal range and no antinuclear antibodies were present. over a period of seven years, the patient was treated with high-dose corticosteroids, methotrexate, intravenous immunoglobulins, oral steroids, mycophenolate mofetil, rituximab and infliximab. despite all treatment efforts, skin and muscle inflammation persisted and the boy developed severe subcutaneous calcifications, rendering him wheelchair-bound. as il- production correlates with disease activity in adult and juvenile dm, treatment with tocilizumab ( mg/kg every weeks) was initiated, leading to a complete resolution of skin inflammation within months. within months of treatment, the disease activity score (das) decreased from to (out of ), the childhood myositis assessment scale (cmas) increased from to (out of ) and the kendall manual muscle test (mmt) increased from to (out of ). in daily life the wheelchair was no longer necessary. treatment was well tolerated but accompanied by a moderate increase in liver transaminase activities. interestingly, therapy with rituximab was associated with a decline in igm levels only, whereas igg and iga stayed markedly elevated. in contrast, following initiation of tocilizumab treatment, igg levels rapidly declined to normal range, emphasizing the role of the humoral immune system in the pathogenesis of dm. conclusion. taken together, treatment of a severely affected jdm patient with tocilizumab was safe, well tolerated and led to a significant improvement in disease activity. further investigations of il- -blocking agents as a treatment option in otherwise therapy-resistant jdm patients are warranted. functional capacity of jia patients with an initial adjustment to an anti-tnf-alpha therapy background. thirty three percent of patients with polyarticular jia are treated with biologics [ ] . despite substantial improvement achieved by anti-tnf-α treatment according to disease activity [ ] patients have joint-specific impairments. this factor should be considered when analyzing the functional effects on joint limitations while performing daily activities. methods. in a prospective study on polyarticular jia patients treated with anti-tnf-α therapies plus functional therapies we study the longitudinal effects on joint function. the measurements include -d gait analysis (eight vicon f cameras, omg, london, balance control (s -check, tst, großhoeflein), pedobarography (emed plate ( sensors/ cm², novel, munich), daily activity assessment (step watch, orthocare innovations, ok usa), acr pedi and joint mobility testing. we here present the cross-sectional data of the first patients ( . ± . yrs, . ± . cm, . ± . kg, pain-level: . ± . / vas, active joints: . ± . , chaq: . ± . ). results. preliminary results demonstrate that the ability to walk is slightly limited. patients have a reduced push off power generation within the ankle joint (patients: . ± . w/kg; healthy controls: . ± . w/ kg). further on they show limited sensory motor control and stability in comparison to patients with an inactive disease status while performing balance tests (patients: sensory index: . ± . , stability-index: . ± . , patients with inactive status: sensory-index: . ± . , stability index: . ± . (p< . ). note: lower indices values are better results. conclusion. it is one of the first studies which show functional joint-specific deficits during every day activities in patients who receive an initial anti-tnfα-therapy. the limited stability and motor control might be due to limited joint integrity in the ankle joint. this is supported by the impaired push off function while walking. the next study step will show possible effects of the anti-tnfα-therapy. background. the role of sport as a therapeutic tool in treating patients with jia is becoming more important recently [ ] . effects of exercise therapy are reviewed beneath others by takken et al. [ ] . they state that short-term effects look promising but the effects of long-term studies remain unknown. methods. the preventive mobility workout (pmw) is a whole body home-exercise-therapy ( min each day) for patients with an inactive diseases status. it counteracts the deficits which were observed during functional studies in the past [ ] . it consists of exercises for muscular strengthening (squads: hamstring to quadriceps ratio), hamstring flexibility (lift and raise), core stability (prone bridge -time-to-failure), shoulder griddle mobility (horizontal extension) and ankle joint integrity (mechanical power while walking . for statistical analysis an anova was calculated and the level of statistical significance was set to p< . . results. preliminary results show a group effect of the pmw for the hamstring to quadriceps ratio (h-q-r) for the right side (p< . ) and a tendency for the left side (p= . ). the h-q-r for the right side has changed in the tg and cg from . ± . to . ± . and from . ± . to . ± . , respectively. it has changed for the left side in the tg and the cg from . ± . to . ± . and from . ± . to . ± . , respectively. all other parameters regarding flexibility or joint integrity show low or no effects. we have re-tested n= out of so far and the pmw training show little training-effects. the preliminary results might be a reasonable proof for long-term effects. a possible reason for the little effects might be that patients are supposed to train every day but the training diaries show that they exercise approximately three times a week. the authors would like to thank the "deutsche kinder-rheumastiftung" for supporting the study. conclusion. we will validate these proposed definitions prospectively in a jia associated uveitis cohort. based on the results, we will weight these measures to develop an overall scoring system. background. minute walk is a primary outcome measure in studies in pulmonary hypertension. currently we have a two of sets of data [ , ] regarding test results in the minute walk test ( mwt) in healthy children with a large span in the norm values in the different age groups. aim of the study was to establish norm values for healthy german children for the minute walk test. methods. the team of an occupational therapist and a study nurse were visiting schools. permission from the parents was give before the test. always just probands from one class were invited to participate. the test were performed according the international guidelines [ ] . the demographic data of the probands were collected and the parents filled out a short survey regarding the physical activity and the health condition. children with chronic diseases, which decrease the stamina were excluded. up till now probands participated from the age to years. of them were female. the mean minute walk continuously increased with age (. tab background. juvenile idiopathic arthritis (jia) is the most common chronic disease in pediatric rheumatology which often results in foot impairments [ ] . patients with jia are reported to have smaller pressure loads underneath the foot while walking [ ] . the aim of the study was to analyze the peak plantar pressure distribution of a well described cohort of jia patients with an active symmetrical ankle joint arthritis and no history of foot involvement. [ ] ) wurden in bezug auf therapie und outcome anhand der wallace-kriterien beurteilt: "active disease" (ad), "inactive disease" (id), "clinical remission under medication" (crm), "clinical remission off medication" (crom; [ ] background. familial mediterranean fever (fmf) is one of the most common autoinflammatory diseases (aid). pathogenomic relevant mutations in the mefv gene show autosomal recessive inheritance, but co-dominant mutations have been described. we aimed to evaluate correlations between ethnic origin, phenotype and genotype for fmf patients in the german aid-net-registry. methods. we used two common scoring systems modified for children (mor et al., pras et al.) to assess disease severity in fmf patients of the aid-net-registry. for the five most frequent mutations, we tested for a correlation of the genotype with the phenotype, mean crp and ethnic origin, respectively. furthermore, we evaluated the applicability of the two severity scores for children. results. among the patients, we detected a total of pyrin mutations and different sequence variants, including one new mutation (p.gly asp). the five most frequent alterations were p.met val ( %, n= ), p.met lle ( %, n= ), p.val ala ( %, n= ), p.glu gln ( %, n= ) and p.met ile ( . %, n= ). ethnic origin could be determined in cases; the prevailing ancestry was turkish ( %, n= ), % (n= ) were lebanese. p.met val in homozygous form ( %, n= ) was correlated with a more severe disease activity, based on the score by mor, as well as with a higher mean crp ( mg/l, n= , mg/l, n= ) compared to patients without this mutation (p= . and p< . , respectively). the score suggested by pras did not yield a significant genotype-phenotype correlation; indeed, the two scoring systems were inconsistent with each other (κ< . ). although a typical distribution of mutations in different ethnic populations was obvious, this trend was not statistically significant, probably due to the divergent number of cases. conclusion. the homozygous p.met val substitution was associated with a more severe disease activity. there was no origin-genotype correlation in this fmf population. the well-known severity scores for children (mor, pras) are inconsistent. the aid-net is working on a new scoring system. . all patients with rp should be investigated by capillaroscopy. capillaroscopy will be classified into "normal", "aspecific changes" or "scleroderma pattern". . all patients who have additional symptoms pointing to a definite connective tissue disease should be evaluated according to disease specific guidelines. . ana-negative and capillaroscopy-negative patients should be followed-up at least every months. . ana positive patients without disease-specific antibodies and with negative capillaroscopy findings should be followed-up at least every months. . ana and disease-specific antibody positive patients should have organ specific evaluation according to symptoms, examination and relevant to that particular disease e.g. patients who are ana and scl- positive may need organ specific evaluation for jssc as per the juvenile systemic sclerosis inception cohort protocol (www.juvenilescleroderma.com). . ana-positive patients, who have no disease specific antibody but have positive capillaroscopy results, should be followed-up at least every months. . ana-negative patients with positive capillaroscopy result should be followed-up at least every months. . the group could not reach an agreement regarding treatment, due to a lack of data for the paediatric age group. the group agreed that implementation of adult recommendations conclusion. the group made a suggestion for a standard of good clinical practice for rp in children. our aim is that this will facilitate a large multicentre prospective follow-up study of children with rp. background. chronic non-bacterial osteomyelitis (cno) is an inflammatory disorder of the skeletal system of unknown etiology. long-term follow-up and response to treatment data have rarely been reported. the aim of the study was to characterize the clinical, radiological, histological and laboratory data at juvenile cno onset, and to analyze the long term treatment response. methods. the course of disease of juvenile patients with non-bacterial inflammatory bone lesions was evaluated retrospectively. clinical, radiological, histological and laboratory data were assessed at disease onset and for a median time of disease of months. results. the mean age at disease onset was . years, the mean time between the first symptoms and the diagnosis of cno was months. % of the patients had multifocal bone lesions. biopsy was performed in patients. only when bone biopsy was taken within months of symptom onset, cellular infiltrates could be observed. at later time points, fibrosis, hyperostosis and bone edema predominated. the initial treatment consisted of non-steroidal anti-inflammatory drugs (nsaids). % of the patients required second line therapy consisting of sulfasalazine and short term oral corticosteroids, % of the patients required bisphosphonates or tnf-blocking agents. the number of clinical lesions decreased to % within . months and reached . % after months of treatment. the number of radiological lesions, however, declined to only . % after months of treatment. in detail analysis of the tre-atment response revealed that initiation of sulfasalazine treatment in nsaid non-responders led to a significant and sustained decline of the clinical, as well as the radiological number of lesions. conclusion. the rapid clinical improvement in cno, following initiation of therapy with nsaids, is not accompanied by a likewise decrease of the number of radiological lesions. treatment with sulfasalazine is effective in childhood cno. background. exercise has a wide variety of beneficial health effects. it stimulates bone formation and maintains bone strength as well as decreases the risk of falls. moreover, exercise at regular intervals is also assumed to positively affect immune functions. conversely, in more than % of the astronauts during/after space flight and under simulated weightlessness immune functions are suppressed. to assess the effects of simulated weightlessness during the nd berlin bedrest study (bbr- ) on immunological parameters. furthermore, to compare the effects of two different exercise performances (resistive vibration exercise and resistance exercise without vibration). methods. physically and mentally healthy male volunteers ( - y) experienced days of six degree head down tilt bed rest. they were randomized to groups: resistive vibration exercise (n= ), resistance exercise without vibration (n= ), inactive controls (n= ). blood samples were taken days before bed rest, on day and after beginning of bed rest. composition of immune cells was analyzed by flow cytometry. cytokines and neuroendocrinologic parameters were analyzed by a multiplex suspension array/ elisa in plasma. general changes over time were identified by paired t-test, exercise-dependent effects by -group repeated measurements anova. results. for all cases pooled, the number of granulocytes (p< . ), nkt cells (p< . ) and hematopoietic stem cells (p< . ) increased during the study; the concentrations of dhea (p< . ) and eotaxin (p< . ) decreased. different impacts of the specific types of exercise on the change over time were shown for lymphocytes, nk cells, nkt cells, tcell subpopulations and the concentrations of ip- and rantes. conclusion. we found immobilization/simulated weightlessness to significantly impact immune cell populations, and cytokine and neuroendocrine factor concentrations. exercise was able to specifically influence immunologic parameters. interestingly, these changes resemble those found during the aging process. background. novel therapies have made remission and low disease activity (lda) achievable goals in ra. we assessed the impact of treatment with subcutaneous abatacept or adalimumab on these goals and on functional and radiographic outcomes in ample (abatacept versus adalimumab comparison in biologic-naïve ra subjects with background methotrexate), the first head-to-head trial of biologics in ra patients with inadequate response to mtx (mtx-ir). methods. ample is a -year, phase iiib, randomized, investigator-blinded study. biologic-naïve ra patients with mtx-ir were randomized to receive mg abatacept weekly or mg adalimumab biweekly, combined with a stable dose of mtx [ ] and radiographic non-progression (defined as change in modified total sharp score ≤ . ) were analysed in patients achieving or not achieving remission or lda at days or . results. baseline clinical characteristics of abatacept and adalimumab treatment groups were balanced, as was clinical, functional and radiographic efficacy and safety at day [ ] . the proportions of patients meeting each of the remission criteria or lda at day were similar for both groups, but significantly more patients achieved das (crp) remission compared to cdai, sdai or rapid remission, and the smallest proportion achieved boolean remission. compared to remission, a higher proportion of patients achieved lda. across all definitions of remission or lda, > % of the patients achieving remission at days and were haq responders at day . more than % of patients achieving remission or lda at days and were radiographic nonprogressors at day . improvement in physical function and radiographic outcomes were consistent between the two treatment groups in both remission and lda populations (. tab. ). conclusion. through year, patients treated with subcutaneous abatacept or adalimumab in ample achieved comparable rates of remission and lda. similar improvements in physical function and radiographic outcomes were observed. these data help to illustrate the relationship between remission, lda and functional and radiographic outcomes independent of treatment with subcutaneous abatacept or adalimumab. background. previous small studies suggest that responses to some immunizations may be attenuated by intravenous abatacept but remain clinically meaningful [ , ] . we investigated the magnitude of response to pneumococcal and influenza vaccination in a larger number of patients receiving subcutaneous (sc) abatacept therapy. the objective of the study was to evaluate the antibody response to the standard -valent pneumococcal polysaccharide vaccine and the - seasonal influenza trivalent vaccine in adult patients with ra on sc abatacept and background dmards. these multicentre, open-label sub-studies of the -valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine enrolled patients in the acquire (pneumococcal and influenza) or attune (pneumococcal) studies. patients were enrolled at any point during their sc abatacept treatment cycle after completion of ≥ months' abatacept treatment. all patients received fixed-dose sc abatacept mg/week with background dmards. a pre-vaccination blood sample was collected and vaccines administered, while continuing background sc abatacept and dmards. after ± days, a post-vacci- background. in real life, dosage increases are common with biologic agents [ ] . intravenous abatacept is administered by patient body weight ( mg/kg) and weeks after the first infusion and every weeks the-reafter [ ] totalling infusions over the first months. no adjustments to this schedule are recommended. abatacept retention rates, efficacy and safety over months in action (abatacept in routine clinical practice) have been reported previously [ , ] this study was designed to assess adherence to recommended dosing of abatacept over the first months in action. methods. action is an ongoing, -year, international, non-interventional, prospective cohort of ra patients treated with intravenous abatacept. all patients on abatacept treatment for ≥ months, and with infusion data available at initiation and at months, were considered in this analysis. good adherence was defined as correct dose by patient body weight and number of actual-to-recommended infusions within the range - % (i.e. - infusions). results. in total, / ( . %) patients received abatacept ≥ months and had the infusion data available. most had established ra and failed ≥ anti-tnf agent ( . %). of patients with body weight data available at initiation, . % received the recommended initial dose, . % a lower dose and . % a higher dose than recommended. good adherence to the abatacept treatment schedule was found in / ( . %) patients. over months, . % of patients received infusions, . % received infusions and . % had infusions. change in dosage over time was assessed in / patients with data available at both time points. the majority of patients ( . %) maintained the recommended dosage. / ( . %) patients received abatacept at the recommended dose for body weight and at the recommended treatment schedule over months. conclusion. in the real-world action study, adherence to the recommended abatacept treatment regimen over months was good. few patients received changes in dose and/or frequency of administration over this time period. background. in rheumatoid arthritis (ra), synovial fibroblasts (sf) secrete large amounts of il- , il- and matrix metalloproteinases (mmps) which are crucial for cartilage destruction. rasfs are sensitive to the action of cannabinoids and they express cannabinoid receptors type i and ii (cb and cb ), the vanilloid receptor (trpv ) as well as endocannabinoid degrading enzymes. cannabinoids are regarded as antiinflammatory and since anandamide (aea) is found in ra synovial fluid we investigated how this endocannabinoid affects adhesion, proliferation, and production of inflammatory mediators of rasf. methods. adhesion was assessed by the xcelligence system. proliferation was quantified by the amount of incorporated fluorescent dye into cellular dna. mmp- and cytokines were detected by elisa. in oasf, aea dose-dependently decreased the il- β induced production of mmp- (by %) in a trpv -mediated manner. il- and il- levels were only weakly modulated. in rasf however, aea decreased il- β induced production of il- ( %), il- ( %) and mmp- ( %). the effects of aea were not inhibited by cb , cb or gpr antagonists but were blocked by the trpv antagonist capsazepine. the inhibitory capacity of aea was enhanced by cyclooxygenase- inhibition in rasfs and oasfs, but was unaltered or even slightly reduced by faah inhibition. aea was even more potent in reducing above mentioned mediators when rasfs but not oasfs were incubated under hypoxic conditions and treated with tnf. furthermore aea increased adhesion of oasfs and rasfs to fibronectin. adhesion was modulated by cb , gpr , and trpv antagonists. combined faah and cyclooxygenase- blocked the stimulatory effect of aea on adhesion. proliferation was decreased by aea in rasfs and oasfs via a cyclooxygenase- but not via cb , cb or trpv dependent mechanism. conclusion. in conclusion, aea promotes an antiinflammatory phenotype of rasfs and oasfs by activating trpv . cb , trpv , and gpr act in concert to modulate adhesion of sfs and this is highly dependent on the intracellular concentration of aea. additionally, cyclooxygenase- metabolites of aea exert their anti-proliferative effects independent of cb and cb . fc. it has been reported that lower levels of czp, compared to ada or ifx, are transferred from treated mothers to the neonate [ ] . this discrepancy may be due to active transport of antibodies across the placenta thought to be mediated by the neonatal fc receptor (fcrn). however, anti-tnf binding to fcrn, and fcrn-mediated transcytosis have not been studied. the objective of this study is to quantify binding of czp, ifx, ada and eta to fcrn and to measure fcrn-mediated transcytosis. a biacore™ assay was used to determine binding of czp, ada and ifx to human fcrn. anti-tnfs were passed over an fcrn-coated chip .mdck-ii cells transfected with human fcrn were used to measure fcrn mediated transcytosis. the anti-tnfs and the control antibody (p ), which possessed a fc modified to prevent binding to fcrn, were biotinylated to allow visualization. the amount of each anti-tnf transcytosed across the cell layer over hours was measured by msd assay. results. ifx ( nm) and ada ( nm) had high binding affinity to fcrn while the binding affinity of eta to fcrn was - -fold lower ( nm). in contrast, czp did not bind to the fcrn with any measurable affinity. the levels of transcytosis seen with ifx and ada were . ng/ml and . ng/ml, respectively (mean of experiments). transcytosis of eta ( . ng/ml) was lower than that of ada and ifx. in contrast, the level of czp transcytosis was significantly lower, at . ng/ml, than that observed with the other anti-tnfs and comparable to the control p ( . ng/ml). conclusion. czp didn't bind to fcrn and thus no fcrn-mediated czp transcytosis was detected. in contrast, ada and ifx had a relatively high binding affinity to fcrn and were actively transcytosed. eta showed lower binding affinity and transcytosis, but fcrn-mediated transport could still be measured. these results explain the previously observed active transport of anti-tnfs across the placenta seen in patients treated with ifx and ada, whereas only low levels were observed with czp [ ]. background. anti-cyclic citrullinated peptide (ccp) status was reported previously as predictive of abatacept response [ ] . predictors of retention with abatacept have not been published previously. this study was designed to identify predictors of abatacept retention after failing ≥ biologic agent. in routine clinical practice) is an ongoing, -year, international, non-interventional, prospective cohort including patients with ra treated with intravenous abatacept [ , ] . patients from canada, germany, greece and italy, where patient numbers were sufficient to explore between-country effects, were included. at data cut-off (february ), all patients had -year follow-up (interim analysis). abatacept discontinuations were reported by the investigator at any time point during follow-up. socio-demographics, disease characteristics and medical history at abatacept initiation, and previous and concomitant treatments were deemed potential predictive variables. clinically relevant variables and those with p≤ . (univariate analysis) were entered into a multivariate cox proportional-hazards regression model, adjusted for clustered data from one investigator. using backwards selection, variables with p≤ . were retained in the final model. . there were no interactions or effects of c-reactive protein level, rheumatoid factor status, type of previous anti-tnf failure, infection at initiation and abatacept monotherapy. sensitivity analysis, including all variables significant in univariate analysis, was consistent. conclusion. in this first report of real-world predictors of abatacept patient retention, anti-ccp positivity and failing < prior anti-tnf agents were associated with higher retention. differences in retention between some countries may reflect specificities in healthcare systems and populations. abatacept, a biologic agent with no contraindications or special warnings for cardiac comorbidity, seems to be a good option for these patients. weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over months when administered with or without an intravenous abatacept loading dose zeitschrift für rheumatologie suppl · | methods. patients from the intent-to-treat populations of the acqui-re [ ] and ample [ ] studies randomized to subcutaneous abatacept plus mtx were included. all patients received fixed-dose subcutaneous abatacept mg/week; in acquire but not ample, patients also received an intravenous loading dose (~ mg/kg based on weight range) on day . for this post-hoc analysis, assessments included acr and haq-di response (improvement ≥ . ) over months, with patients who discontinued considered non-responders. mean changes from baseline over months in das (crp) were assessed in patients with das > . at baseline (last observation carried forward) to account for differences in baseline disease activity between the two studies. results. all patients were biologic naïve at baseline, with mean disease duration of . and . years, das (crp) . and . , and haq-di . and . in acquire and ample, respectively. efficacy was compared throughout the study. for patients treated with subcutaneous abatacept with and without an intravenous loading dose, acr response rates were similar (. tab. ). haq-di response rates were also similar with and without the intravenous loading dose (. tab. ). for the overall populations, mean (standard deviation [sd]) changes from baseline to day in das were − . ( . ) and − . ( . ) in acquire and ample, respectively. for patients with baseline das > . , mean (sd) changes in das from baseline to day were − . ( . ) and − . ( . ) in acquire and ample, respectively. conclusion. time to onset and magnitude of acr and haq-di responses and das improvements were generally similar with subcutaneous abatacept with or without intravenous loading in patients with ra and an inadequate response to mtx. the findings from this posthoc analysis suggest that subcutaneous abatacept can be given effectively without an intravenous abatacept loading dose. background. ra is associated with pain and impairment of physical function, significantly impacting a patient's health-related quality of life (hrqol) and ability to perform daily activities. patient-reported outcomes (pros) related to hrqol and daily activity have become an essential part of assessment in ra. we continue to report here comparative findings from pros assessed with subcutaneous abatacept or adalimumab on background mtx in the first head-to-head study, ample. we compared changes in pros at year in patients with ra treated with abatacept or adalimumab, both on background mtx. methods. ample is a phase iiib, randomized, investigator-blinded study of months' duration. biologic-naïve patients with active ra and inadequate response to mtx were randomized to either mg abatacept weekly or mg adalimumab biweekly in combination with mtx. pros evaluated through day included: hrqol, assessed using short form- (sf- ; including physical and mental component summary subscores [pcs and mcs]); activity limitation over the previous days, using the activity limitation questionnaire (alq; [ ] ); productivity, using the work productivity and activity impairment questionnaire for ra [ ] ; physical and psychosocial independence, captured using items from haq, sf- score; and alq [ ] . other pros previously reported from ample include: patient pain, patient global assessment, fatigue, and physical function [ ] . all efficacy analyses were done using the intent-to-treat population, which included all patients who were randomized and received at least one dose of study drug. baseline characteristics were analysed descriptively and changes in pros from baseline were assessed using ancova. results. baseline demographic and clinical characteristics of the abatacept and adalimumab treatment arms were similar. improvements in all domains of the sf- , including pcs and mcs observed at day parameter baseline woche woche itt-gesamt das , mw ± sd , ± , (n= ) , ± , (n= ) , ± , (n= ) vas da pat., mw ± sd , ± , (n= ) , ± , (n= ) , ± , (n= ) sjc , mw ± sd , ± , (n= ) , ± , (n= ) , ± , (n= ) vas schmerz, mw ± sd zielsetzung der ole-studie beinhaltete die beurteilung der verträglichkeit und der wirksamkeit von czp. die retentionsraten sowie die wirksamkeit wurden bis woche und die verträglichkeitsdaten bis woche beobachtet. in die verträglichkeitsanalyse wurden alle pat einbezogen, die in die ole-studie eintraten und czp erhielten (n= ; n= kombitherapie; n= monotherapie), einschließlich der plazebo/czp-patienten, die die ausgangsstudien erfolgreich abgeschlossen/abgebrochen haben. bezüglich der wirksamkeit wurden folgende analysen vorgenommen: ) czp pat, die die ausgangsstudien erfolgreich beendet haben und zu irgendeinem zeitpunkt während der ausgangsstudien oder ole-studie andere dmards eingenommen haben (n= ; kombitherapie completer); ) czp pat, die die fast ward studie erfolgreich beendet haben und zu keinem zeitpunkt andere dmards eingenommen haben (n= ; monotherapie completer). ergebnisse. verteilung und häufigkeit der unerwünschten ereignisse (ue), einschließlich der reaktionen an der injektionsstelle (ereignisse/ patientenjahre: monotherapie , , kombitherapie , ) und der schwerwiegenden unerwünschten ereignisse (sue) waren mit dem vergleichbar, was bisher für czp berichtet wurde (. tab. ) . das auftreten von schwerwiegenden infektionen (si) und malignitätsraten war niedrig. es wurden todesfälle berichtet: kardiovaskuläre ereignis-se, infektionen, unfall und tumorerkrankung. die retentionsraten der pat, die die ausgangsstudien erfolgreich beendet haben, waren zur w in der czp monotherapie-( / , %) und der czp kombitherapie-gruppe ( / ; %) vergleichbar. der durchschnittliche das - (crp)-wert und dessen abweichung vom baseline-wert der ausgangsstudien zum zeitpunkt des eintrittes in die ole-studie und nach w der monotherapie-completer und der kombitherapie-completer, sowie die zugehörigen haq-werte sind in . tab. dargestellt. schlussfolgerung. vorliegende ole-studie konnte das günstige risiko-nutzen-profil der czp-monotherapie bestätigen. die langzeitwirksamkeitsdaten zeigten keine unterschiede zwischen pat, die czp als monotherapie erhielten und pat, die czp in kombination mit anderen dmards erhielten. background. rheumatoid arthritis (ra) is the most common disease of joints that non-or deficiently treated leads to functional loss and premature cardiovascular death within years. but nearly % of the ra patients fail to treatment with tnfα-inhibitor (tnfi) indicating a switch to rituximab (rtx). the urgency of personalized promising treatment in time presupposes predictive parameter. rheumatoid factor (rf) and anti-citrullinated protein antibodies (acpas; especially accp) are shown to be better diagnostic than less theranostic biomarkers. in that context we investigated the role of antibody subtypes against mutated citrullinated vimentin (amcv) that determine response outcome in rtx-treatment. methods. a cohort of only amcv igg positive ra patients was tested for amcv subtype igm and iga (additionally for rf igg, igm, iga and accp igg) by elisa at baseline (after failure to first approach with tnfi) and at week (after first rtx cycle). responders were characterized by a difference in their das of ≥ . (eular good-response) between baseline and week . the cohort comprises responders (rr) and non-responders to rtx (nrr). results. amcv igg, igm and iga showed higher treatment related decreases compared to rf and accp ig subtypes and additionally even diverged in both groups depending on response outcome: especially amcv iga exhibited a higher mean titer decline of rr by % at lo- wer baseline titers ( . to . u/ml) and a mean titer increase of nrr by nearly % at higher baseline titers ( . to . u/ml). at baseline rr displayed relatively more negative iga titers ( %; n= / ) than nrr, who in return showed more iga positive titers ( %; n= / ). amcv iga positive patients were more likely to show positively for rf iga ( %) and igm ( %), what could be inversely detected for iga negative patients with seronegativity of rf iga ( %) and igm ( %). conclusion. amcv immunoglobulin subtypes showed treatment dependent changes contrary to already known antibodies (accp). especially amcv iga reflects response outcome: amcv iga negativity at baseline and decreasing titers during treatment are predictive for good eular-response to rtx. einleitung. im rahmen der abklärung eines unter tocilizumab-therapie aufgetretenen arzneimittelexanthems erfolgte die bestimmung von c c und c -beide parameter waren erniedrigt. bei recht geringer und nur kurz andauernder ausprägung des exanthems wurde die therapie komplikationslos fortgeführt. die komplementfaktoren wurden im verlauf bestimmt und blieben erniedrigt. im weiteren verlauf erfolgte die konsekutive messung bei weiteren patienten. methoden. nephelometrische bestimmung von c c und c im serum vor und während der therapie mit tocilizumab (jeweils vor der nach wochen anstehenden infusion) bei patienten mit gesicherter rheumatoider arthritis (rf+, ccp+). ergebnisse. c c-und c -komplement wurden bei konsekutiven patienten mit rheumatoider arthritis vor und unter tocilizumab-therapie bestimmt. bei allen patienten fielen sowohl c c, als auch c unter der therapie mit tocilizumab ( mg/kg kg) ab. / patienten hatten eine c c-erniedrigung (bestimmter wert unterhalb des laborinternen normbereichs). / patienten hatten eine c -erniedrigung (bestimmter wert unterhalb des laborinternen normbereichs). drei patientinnen entwickelten unter der therapie ein exanthem, davon hatten eine komplementerniedrigung. keine "offensichtlich" erhöhte infektneigung in abhängigkeit von komplementspiegeln. bei verlängerten infusionsintervallen aufgrund von infekten zeigte sich, dass der effekt von tocilizumab auf die komplementspiegel reversibel ist. durch blockade des il- -rezeptors tocilizumab kann ein erworbener komplementmangel induziert werden. Ähnliche daten wurden im rahmen einer pilotstudie an sle-patienten erhoben, die mit tocilizumab behandelt wurden. der effekt ist bei der rheumatoiden arthritis nicht vorbeschrieben. der genaue umfang des komplementmangels ist bisher nicht untersucht (andere bestandteile der kaskade?) wurde in der sle-studie ausführlicher untersucht. da die verschiedenen komplementbestandteile erniedrigt waren wurde auf eine synthesestörung und nicht auf einen gesteigerten verbrauch geschlossen, was auch in dieser kohorte der fall zu sein scheint. der erworbene komplementmangel könnte einen teil der infektiösen komplikationen unter der therapie erklären. eine korrelation ist aber aufgrund der geringen fallzahl nicht möglich. schlussfolgerung. anhand dieser studie konnte eine exzellente korrelation zwischen den parametern der dxr und des bx verifiziert werden. mittels der neu entwickelten voll digitalisierten bx-technik ist somit eine quantifizierung der periartikulären demineralisation möglich und als surrogatparameter der radiologischen progression bei einer ra eingesetzt werden. jahre, die ra bestand im median seit , jahren. , % der patienten waren mit tnf-alpha-blockern vortherapiert, , % ausschließlich mit dmards. der mittlere das lag zur baseline bei , . zur woche zeigten , % der patienten eine das remission (< , ) und , % bzw. , % der patienten ein gutes bzw. moderates ansprechen gemäß eular-kriterien. Über den beobachtungszeitraum stieg der anteil der tcz-monotherapiepatienten von , % auf , %. die mtx-komedikation sank im gleichen zeitraum um , %. , % der patienten, die tcz zunächst zusammen mit einem dmard erhalten haben, konnten dieses absetzen. tcz zeigte in der mono-und kombinationstherapie eine vergleichbare wirksamkeit: , % bzw. , % der patienten erreichten eine cdai remission (≤ , ). der anteil von patienten ohne glucocorticoid(gc)-begleittherapie stieg über den beobachtungszeitraum um , % auf , % an, der anteil mit einer tagesdosis ≤ mg auf , %. bei , % war eine reduktion der gc-dosis möglich, nur bei , % war eine erhöhung notwendig. bei , % der patienten, die zur bl mit gc behandelt wurden, konnten diese komplett abgesetzt werden. die mittlere gc-tagesdosis verringerte sich kontinuierlich von , (bl) auf , mg/d (w ). schlussfolgerung. diese interimsanalyse der nichtinterventionellen studie ichiban zeigt bei den ersten patienten mit mittelschwerer bis schwerer ra über die bisherige beobachtungsdauer von wochen deutliche verbesserungen der aktivitätsparameter, sowie eine reduktionen der begleitenden dmard-therapien und des bedarfs von glucocorticoiden unter behandlung mit tcz. vergleichbar mit den kontrollierten studien ist die tcz-monotherapie auch unter praxisbedingungen der kombination mit dmards ebenbürtig. diese anhaltende wirksamkeit wird erstmals in rheumatologischen praxisdaten für den langzeitverlauf von , jahren gezeigt. zeitschrift für rheumatologie suppl · | einleitung. die arteriosklerose (as) steht als häufigste todesursache im besonderen fokus der medizinischen forschung. neuere erkenntnisse weisen auf einen starken zusammenhang zwischen parametern der systemischen entzündung und der pathogenese der as hin. patienten mit rheumatoider arthritis (ra) haben daher ein stark erhöhtes kardiovaskuläres risiko. ziel: untersuchung des zusammenhangs zwischen verschiedenen ra-krankheitsspezifischen risikofaktoren und dem auftreten einer arteriosklerose bei ra-patienten. methoden. ra-patienten, davon % weiblich, ± , jahre alt, wurden hinsichtlich der krankheitsaktivität (krankheitsdauer , ± , ; das , ± , ; serum-crp , ± , mg/dl,; anti-ccp-antikörper , ± , u/ml, radiologisches stadium , ± , ; davon , % mit erosionen), sowie klassischer kardiovaskulärer risikofaktoren der as erfasst, welche durch den score-wert (systematic coronary risk evaluation) zusammengefasst wurden. zur as darstellung wurde eine carotis-duplexsonographie mittels eines mhz-schallkopfes (ge vivid pro) durchgeführt. die mittlere intima-media-dicke (imd) der a. carotis communis wurde durch ein softwaregestütztes messverfahren ermittelt. ergebnisse. plaques waren bei patienten ( %) nachweisbar. diese korrelierten mit einer erosiven form der ra (p= , ), einer längeren krankheitsdauer (p= , ) und höheren anti-ccp-antikörpern (p= , ). die mittlere imd betrug , ± , mm. je ausgeprägter die radiologischen veränderungen sind, umso höher war die wahrscheinlichkeit der plagues (p= , ). mittels altersadjustierter partieller korrelationsanalyse wurde der das als altersunabhängiger einflussfaktor auf die imd ermittelt (p= , ). mittel-und hochgradige stenosen zeigten sich bei fünf ra-patienten ( , %), welche ausnahmslos eine erosive verlaufsform aufwiesen. normalbefunde stehen in zusammenhang mit einem crp-wert unter mg/dl (p= , ). auch die traditionellen kardiovaskulären risikofaktoren haben signifikanten einfluss auf as. der score-wert erwies sich als äußerst verlässlicher prädiktor für plaques (p< , ), imd-verdickung (p= , ) und stenosen (p< , ). durch elimination der traditionellen risikofaktoren mittels partieller score-adjustierter korrelationsanalyse bestätigte sich erneut die assoziation von pathologischen ultraschallbefunden mit dem das (p= , ). schlussfolgerung. die erhebung klassischer risikofaktoren bei ra-patienten ist unerlässlich. die nutzung des score-werts als screening-parameter ist besonders effektiv. zusätzlich sollten parameter der krankheitsaktivität von ra zum management von arteriosklerose herangezogen werden. besonders aussagekräftig hierfür sind der das , ein erosiver krankheitsverlauf, die crp-werte und die erkrankungsdauer background. apremilast, an oral small molecule specific inhibitor of phosphodiesterase- , works intracellularly to modulate inflammatory mediators. the palace - trials compared the efficacy and safety of apremilast vs placebo in patients with active psa despite prior dmards and/or biologics. the overall safety and tolerability of apremilast was assessed in a pooled analysis of the palace , and placebo-controlled phases. methods. safety data was pooled from phase , randomized, placebo-controlled studies; patients with active psa despite prior dmards and/or biologics were randomized : : to placebo, apremilast mg bid (apr ), or apremilast mg bid (apr ) stratified by baseline dmard use. at week , patients with < % reduction in swollen and tender joint counts were required to be re-randomized (early escape) to apr or apr (placebo group) or remained on initial apremilast dose through week . stable concurrent dmard therapy was allowed (mtx, sulfasalazine, leflunomide, or combination). the analysis comprises data from the placebo-controlled periods (weeks - ). results. patients were randomized to placebo (n= ), apr (n= ), or apr (n= ) and included in the safety population. baseline demographic and disease characteristics and prior/concurrent therapy were comparable across treatment groups; . % had prior biologic exposure. adverse events (aes) occurred in . % (placebo), . % (apr ), and . % (apr ) of patients. aes occurring in ≥ % of any treatment group were diarrhea, nausea, headache, and urti (. tab. ); most occurred within the first weeks of treatment and nearly half resolved within weeks. of patients with these aes, most ( - %) were mild or moderate. rates of discontinuation due to aes were low: . % (placebo), . % (apr ), and . % (apr ). serious aes occurred in . % (placebo), . % (apr ), and . % (apr ) of patients. one death occurred (apr ) due to multiorgan failure not suspected to be treatment-related. no cases of serious systemic opportunistic infections, lymphoma, vasculitis, or reactivation/de novo tb were reported. there were no clinically meaningful differences between apremilast and placebo in terms of major cardiovascular aes, changes in blood pressure, malignancies, or effects on laboratory measurements. conclusion. apremilast was generally well-tolerated with no new safety concerns identified compared with the known profile. the aim of the current study was to investigate the relationship between worsening of functional status, clinical disease parameters and radiographic spinal progression over two years in patients with early axial spondyloarthritis (axspa). methods. in total, patients with early axspa ( with as and symptom duration ≤ years, and with non-radiographic axspa (nr-ax-spa) and symptom duration ≤ years) from the german spondyloarthritis inception cohort (gespic) were included in the current analysis based on the availability of radiographic data and data on the functional status at baseline and after years of follow-up. spinal radiographs were scored according to the modified stoke ankylosing spondylitis spinal score (msasss). functional status was assessed by the bath ankylosing spondylitis functional index (basfi), and clinical disease activity by the bath ankylosing spondylitis disease activity index (basdai). results. basfi worsening in ≥ point after years (n= , . %) was significantly associated only with higher basdai worsening over years in comparison to those without functional worsening: . ± . vs - . ± . , p< . . basfi worsening by ≥ points (n= , %) was, however, associated not only with basdai change ( . ± . vs - . ± . , p< . ), but also with a higher rate of radiographic spinal progression measured by the proportion of patients with msasss worsening by ≥ units ( . % vs. . % in patients without basfi worsening, p= . ), or with new syndesmophyte formation ( . % vs. . %, p= . ). importantly, in the multivariate analysis both basdai increase and progression of structural damage in the spine remained statistically significantly associated with basfi worsening. no other disease-related parameters (e.g. sex, hla-b positivity, symptom duration etc) were found to be significantly associated with basfi worsening over two years. conclusion. in this prospective study we could demonstrate that only factors were significantly associated with worse functional outcome over two years in patients with early axspa: ) increase of disease activity and ) progression of structural damage. elevated serum vascular endothelial growth factor is highly predictive for radiographic spinal progression in patients with axial spondyloarthritis who are at high risk for progression background. vascular endothelial growth factor (vegf) is an essential mediator of the endochondral ossification and, therefore, might play a pathogenetic role in the process of syndesmophyte formation in axial spondyloarthritis (axspa). the aim of the study was to investigate the role of serum vegf as a predictor of radiographic spinal progression in patients with axspa. methods. altogether patients with definite axspa [ with ankylosing spondylitis (as) and with non-radiographic axspa] from the german spondyloarthritis inception cohort (gespic) were included in the current study. radiographic spinal progression was defined as ) worsening of the modified stoke ankylosing spondylitis spine score (msasss) by ≥ units after years, and ) development of a new syndesmophyte or progression of existing syndesmophytes after years. serum vegf levels were detected at baseline. results. mean baseline vegf values were significantly higher in patients with msasss worsening by ≥ units after years (n= ) as compared to those without progression ( ± vs. ± pg/ml, respectively, p= . ) and in patients with syndesmophyte formation/ progression (n= ) as compared again to those without progression ( ± vs. ± pg/ml, respectively, p= . ). area under the curve (auc) was . , p= . for the msasss worsening ≥ units and . , p= . for syndesmophyte formation/progression. importantly, the performance of vegf as a predictor of radiographic spinal progression was clearly in patients who were already at high risk for such a progression due to the presence of syndesmophytes at baseline (n= ): auc was . , p= . , and . , p= . , respectively. vegf serum level of > pg/ml in high-risk patients had a sensitivity of %, a specificity of %, and an odds ratio (or)= . ( %ci . - . ) as a predictor of msasss worsening by ≥ units over years. the same serum level of results. immediately after the second session of plasmapheresis, therapy with infliximab mg/kg resumed. after weeks of hospitalization with repeated administration of infliximab had good dynamics (bas-dai . , asdas (crp) = . , basfi . ), significantly reduced pain in the joints and spine, stiffness, increased mobility in the joints and spine. the treatment continued: holding plasmapheresis followed by infliximab. after infusions patient experienced a good effect -basdai . , asdas (crp)= . , basfi . . conclusion. plasmapheresis in some patients could be effective by reducing activity and dealing with secondary tnf inhibitors failure, since this procedure deletes the macromolecular blood proteins, including tnf-, igg antibodies, and circulating immune complexes results. there were still signs of osteitis in sacroiliac joints in patients at week , in patient the mri-determined sacroiliitis has resolved completely. the patient has improved clinically and fulfilled asas improvement criteria. there was a minor decrease in sparcc sacroiliitis score (from to ) in patients at week , indicating reduction of inflammation in sacroiliac joints. sparcc sacroiliitis score stayed the same in the remained patient. conclusion. rituximab may be of some benefit in decreasing mri-evident sacroiliitis in patients with highly active as, even in patients in whom tnf-α inhibitors have failed. background. despite the differences in the pathogenesis of ra and as, neck pain is a frequent clinical symptom in both diseases. we evaluated the correlation between subjective reports of neck pain and objective signs of inflammation as assessed by f bone marrow edema (bme) on mri in ra and as patients. methods. stir-mri of the cervical spine of patients ( ra, as) were included. mris were scored by two blinded readers using a recently published mri scoring system, with quantification of the extension of bme in the atlantoaxial region, corpus, facet joints and processus spinosus of all cervical vertebrae, ranging from - points. the presence or absence of degenerative changes was also recorded. conclusion. the majority of patients with ra and as had objective signs of bme but also degenerative changes on mri at different cervical locations. assessment of bme in the atlantoaxial region is important in clinical practice, in addition to degenerative changes, since its presence seems to influence the intensity of neck pain reported by these patients. x. baraliakos , having mri data at w . of these , ten were treated with secukinumab and with placebo in the core study. mris were rescored for this study. asspimri-a scores and the occurrence of vertebral edges (ve) inflammatory and fatty lesions were evaluated by an independent blinded reader. results. all pts completed this exploratory mri substudy. in pts receiving × mg/kg secukinumab followed by × mg/kg (n= ) secukinumab, spinal inflammation was reduced compared to bl at w -similar to the results of the core study -and this reduction was sustained up to w (abb. ). also in pts who had initially received placebo switching to secukinumab at w , mri inflammation at w was reduced. of the ves evaluated, the proportion of ves with inflammatory lesions was reduced from . % (n= ) at bl to . % (n= ) at w and . % (n= ) at w . in contrast, the proportion of fatty lesions at bl ( . %, n= ) remained largely unchanged at w ( . %, n= ) and w ( . %, n= ). secukinumab reduced mri inflammation at w and w . conclusion. mri analysis suggests that the il- a inhibitor secukinumab can reduce spinal inflammation and this effect may be sustained for up to years. unlike reports with tnf blockers, secukinumab appeared to leave the proportion of fatty lesions unchanged. the potential impact of these preliminary findings on radiographic progression under secukinumab therapy will be studied in larger trials. schlussfolgerung. es zeigen sich keine signifikanten unterschiede in der krankheitsaktivität der beiden gruppen (vor einleitung der ada-therapie nach dmard-und nach anti-tnf-versagen). auch bei der patientengruppe mit mehreren vortherapien mit tnf-inhibitoren können keine signifikanten unterschiede in der ausprägung der erkrankung nachgewiesen werden. im trend wurde ein früheres einsetzen der haut-und gelenkmanifestation sowie eine stärkere systemische entzündungsreaktion in den patienten mit vorheriger tnf-therapie festgestellt werden, während die dauer der erkrankung und der bmi mit den charakteristika der patienten mit ausschließlicher dmard-vortherapie vergleichbar sind. long-term ( -week) results of a phase , randomized, controlled trial of apremilast, an oral phosphodiesterase inhibitor, in patients with psoriatic arthritis (palace ) background. apremilast, an oral phosphodiesterase inhibitor, works intracellulary to modulate a network of pro-and anti-inflammatory mediators. the palace study assessed the efficacy and safety of apremilast in patients with active psoriatic arthritis (psa) despite prior dmards and/or biologics. methods. patients were randomized : : to placebo, apremilast mg bid (apr ), or apremilast mg bid (apr ). at week , patients with < % reduction from baseline in swollen/tender joint counts were required to be re-randomized (early escape) to apr or apr (placebo group), or remained on their initial apremilast dose. at week , all remaining placebo patients were re-randomized to apr or apr through week . results. patients were randomized. at week , significantly more apr ( . %; p= . ) and apr patients ( . %; p< . ) achieved an acr vs placebo ( . %). at week , all patients had a minimum weeks of apremilast exposure. response to apremilast was generally maintained over the treatment period. at week , acr was achieved by . % (apr ) and . % (apr ) of patients (table) . exposure-adjusted incidence rates for adverse events (aes), severe aes, and serious aes were comparable between - and - weeks. the proportion of patients remaining on apremilast to week who first reported the most common gi disturbances (e.g., diarrhea, nausea, and vomiting) after week was low (ranging from . - % for apr and - . % for apr ). there were no clinically meaningful laboratory findings with exposure up to weeks. no deaths beyond the previously reported in the - week period were observed in the - week period. no safety signals with respect to major cardiac events, malignancies, and opportunistic infections were observed, consistent with the - week period. no cases of lymphoma, tuberculosis, or tuberculosis reactivations were reported for the -week period (. tab. ). conclusion. apremilast administered to patients with psa beyond weeks continued to demonstrate meaningful clinical response. for patients who completed weeks of the study, acr response rates up to % were observed. apremilast continued to be well tolerated with an acceptable longer-term safety profile. methods. to identify how conventional cd + and cd + t cells and regulatory t cells are recruited into the inflamed kidneys in ln, serum and urine samples of sle patients were analyzed for chemokines using multiplex assays. based on the assay's results a group of corresponding chemokine receptors (ccr - , cxcr and cxcr ) was chosen, whose frequencies on urinary t cells were subsequently determined in patients with acute ln by flowcytometry. results. chemokines (ccl , ccl , ccl , ccl , ccl , ccl , ccl , ccl , cxcl , cxcl , cxcl and cx cl ) were significantly elevated in the urine of patients with active ln when compared to the control group. the other chemokines (ccl , ccl , ccl , cxcl , cxcl ) and cxcl showed no significant differences between the groups. ccr and cxcr were the most prominent receptors on both urinary cd + and cd + t cells, although cd + t cells also expressed high amounts of ccr and ccr . however, when compared to t cells in the blood, urinary cd + t cells showed significantly higher expression of all examined chemokine receptors but ccr while urinary cd + t cells only had higher expression of ccr and ccr . the chemokine receptor expression on cd +foxp +cd -regulatory t cells (treg) differed from conventional cd + t cells as well. treg expressed significantly more ccr and significantly less cxcr . conclusion. ccr and cxcr are the primary receptors in the mechanism of recruiting t cells into the inflamed kidney. key chemokines are ccl , ccl , ccl and ccl as well as cxcl and cxcl . however, at least for cd + t cells, there are secondary pathways of recruitment involving ccr /ccl and ccr /ccl . also, treg recruitment seems to rely more on ccr than that of conventional cd + t cells. methods. observe is a multicenter, retrospective medical chart review study. rheumatologists from german academic and non academic centers who treat > sle patients annually and have > years of practice experience were randomly recruited. physicians identified consecutively all their adult sle patients who had received belimumab as part of usual-care. index date was the first belimumab infusion date. the primary outcome was the change in overall sle disease manifestations months after index date based on physician judgment. the overall response rates as well as reasons for early treatment discontinuation within months were assessed. changes in formal disease area indices, e.g. selena-sledai if available and changes in oral steroid dose are also reported. results. previous analyses from us patients treated with belimumab have described significant clinical improvement across relevant organ systems based on clinical judgment and formal disease activity indices and marked reductions in corticosteroid use in patients that received at least infusions of belimumab. the current study is the first description of patient characteristics and outcomes after months of therapy with belimumab outside of the us. it is also the first time overall responder rates and reasons for discontinuation with belimumab have been described in a real world setting. the study provides insights into the effectiveness and safety of belimumab in an ex-us clinical setting. larger, prospective observational studies are needed to confirm the results. commercial support grant disclosure: research funded glaxosmithkline. background. toll-like receptor (tlr- ) signaling is considered to play an important role in b cell hyperreactivity in sle. b cells from slepatients express significantly more tlr- than those from healthy donors (hd), especially if patients have positive dsdna-antibodies and high disease activity. tlr- stimulation of b cells is tightly linked to their differentiation into plasma blasts and memory cells. the objective of this study was to analyze in a comprehensive manner the effect of tlr- signaling on cytokine production by b cells from sle-patients, in comparison to b cells from hd, and in relation with disease activity. methods. b cells from sle-patients and hd were stimulated in vitro using cpg for hours, and culture supernatants were then tested for cytokines and chemokines (bio-plex). the cytokine responses were compared between both groups. in addition, within sle patients, the patterns of cytokines produced by b cells were compared with indices of disease activity. results. cpg-stimulation significantly increased cytokine production ( out of parameters; p< . ) compared to baseline. striking increases were found for il- ra ( ± pg/ml), il- ( ± pg/ml), il ( ± pg/ml) and ip- ( ± pg/ml; p< . ). there was no significant difference between both groups. remarkably, production of il- , il- , il- , il- p , il , il- , il- a, eotaxin, basic fgf, g-csf, gm-csf, ifn-γ, ip- , mip- α, and vegf correlated inversely with the sledai (p< . ) and even more (additionally il- β, il- ra, mip- β and tnf-α) with anti-dsdna antibody titers. the frequency of cd + memory b cells showed a positive correlation between the production of ip- and tnf-α in sle, whereas the levels of il- β, il- , mip- α, and mip- β showed a positive correlation with cd + b cells in hd. conclusion. the current data indicate hitherto unknown perturbations of cytokine/chemokine production by b cells in active sle. the inverse correlation of cytokines/chemokines produced by b cells from sle patients with sledai and anti-dsdna titer suggests that the known enhanced b cell proliferation and differentiation upon tlr -stimulation possibly diminishes cytokine production. background. several cytokines, including ifn-γ, il- , il- , and il- have been implicated in the pathophysiology of autoimmune disease. il- , a potent inducer of ifn-γ, enhances th responses that are thought to be synergistic and dependent on il- . we tested the hypothesis that intra-renal il- mediates kidney and systemic disease in mrl-faslpr mice. methods. by constructing il- p /il- -/-mrl-faslpr mice and using an ex-vivo gene transfer to deliver il- intra-renally, we determined that il- , independent of il- and/or il- , incites kidney disease in mrl-faslpr mice. moreover, we provide the novel finding that local intra-renal il- mediates systemic disease (lung pathology, systemic auto-abs). results. thus, our data indicate that il- is a potential therapeutic target for immune mediated kidney and systemic disease in mrl-faslpr mice. using a caspase- inhibitor, that inhibits the release of active il- and il- β, we successfully treated kidney (improved renal function, pathology) and systemic disease (skin lesions, lymphadenopathy, and splenomegaly) in mrl-fas lpr mice, while administration of an il- receptor antagonist did not influence disease progression. probing further we found that inhibition of il- activation results in an amelioration of lupusnephritis by a reduction of intra-renal infiltrating leukocytes (macrophages and t cells) and reduced activation of these leukocyte populations. moreover, caspase- inhibition resulted in decreased inf-y and il- production, indicating an altered balance of th and th cell responses in this model. conclusion. taken together, our findings indicate that il- , independent of il- β, il- and/or il- , is the major mediator of kidney and systemic disease mrl-faslpr mice. therefore, caspase- inhibition is a potential therapeutic target for autoimmune disease in the mrl-faslpr mice. background. in the treatment of giant cell arteritis (gca) glucocorticoid-related adverse effects occur frequently, particularly in patients with relapsing disease. a -year-old woman presented with a month history of fever, chills, arthralgias and cephalgias and markedly elevated serum inflammatory markers. whereas further evaluation including ultrasound of the temporal arteries was unremarkable, a positron emission tomography-computed tomography (pet-ct) demonstrated an intense fluorodeoxyglucose uptake of the aorta, the subclavian, carotid and femoral arteries. gca was diagnosed and treatment with high dose prednisone was begun. results. because of disease flares at prednisone dosages below mg/ day and the occurrence of vertebral fractures, cyclophosphamide and methotrexate (mtx) were added as glucocorticoid-sparing agents. as these treatments had to be stopped because of intolerance and mtxpneumonitis, respectively, we started tcz infusions ( mg/kg body weight). the clinical status rapidly improved. after infusions of tcz follow-up pet scan showed resolution of the previously seen uptake and we were able to taper the daily dose of prednisone to mg. treatment was well tolerated. however, the patient developed mild hyperthyroidism with a rapid rise of the initially normal levels of anti-thyroid peroxidase and anti-thyroid antibodies, anti-tsh receptor antibodies remained normal. thyroid function normalized and the antibody-levels fell without further treatment in the following months. in conclusion, this case demonstrates the successful treatment of a patient with relapsing giant cell arteritis with tcz. for the first time, we report the occurrence of a transient autoimmune thyreoiditis possibly induced by tcz. klinik für pädiatrie mit schwerpunkt pneumologie und immunologie, sektion rheumatologie, berlin, vestische kinder-und jugendklinik der universität witten/herdecke deutsches zentrum für kinder-und jugendrheumatologie organización médica de investigación arthr care res ar&t in press sp division of rheumatology diagnosesicherung: a + b) mr-morphologisch myositistypische veränderungen (os) histologie + c) generalisierte myalgien und laborchemisch dtl. elevierter ck, sowie positivem nachweis von ana und jo- -ak, pulmonales ct mit diffusen milchglasinfiltraten, in bronchoalveolärer lavage neutrophile alveolitis. ergebnisse. vormedikationen: a) glukocorticoidmonotherapie, mtx-monotherapie, mtx in kombination mit etanercept, cyclophosphamidboli, und zuletzt intravenöse immunglobuline (ivig) in kombination mit mycophenolatmofetil . b) mtx-monotherapie, mtx in kombination mit glukokortikoiden, cyclophosphamidboli, intermittierend intravenöse immunglobuline, cyclophosphamid per os (fau-ci). c) cyclophosphamidboli jeweils gutes ansprechen des ck-wertes auf jeweilige rituximabgaben mit ebenfalls ansprechen des klinischen bildes mit guter regredienz des aus myalgien resultierenden schmerzniveaus. im fall a keine beatmung mehr notwendig. im fall von c) auch gute regredienz subjektiver dyspnoesymptomatik und besserung wichtiger lungenfunktionsparameter, regredienz ctmorphologischer milchglasinfiltrate, im verlauf fehlender nachweis neutrophilie in bal. weitere rituximabgaben bei a, b und c im verlauf zum remissionserhalt nach jeweiligem klinischem befund production of cytokines by b cells in response to tlr stimulation inversely correlates with disease activity in sle-patients berlin zeitschrift für rheumatologie suppl · | das muskuloskeletale system, eines der am häufigsten betroffenen organsysteme bei sle (bei - % der sle-patienten). das ziel dieser analyse war es um diejenigen parameter zu identifizieren, die zu diesem effekt beigetragen hatten, wurde jeder der einzel-parameter zur untersuchung und symptom-erfassung innerhalb des muskuloskeletalen bilag-organsystems analysiert. die post-hoc-analyse umfasste nur patienten, bei denen ein parameter zu studienbeginn als vorhanden gewertet wurde, und jeder parameter erforderte ≥ patienten-beobachtungen pro kohorte um einen vergleich zu erstellen dadurch wurde die zahl der patienten mit einer initialen beteiligung des muskuloskeletalen systems aufgedeckt, die eine in woche auflösung der manifestation aufwiesen auch im selena-sledai-score war die rate der verbesserung bei dem arthritis-parameter in der belimumab-gruppe mit mg/ kg ( , %; n= ) und mg/kg ( , %; n= ) signifikant höher als die daten weisen darauf hin, dass mg/kg belimumab effektiv auf muskuloskeletale organmanifestationen sind akzeptiert als posterbeitrag auf dem eular klinische forschergruppe für rheumatologie (kfr), freiburg i. br., universitätsklinikum ulm, klinik für dermatologie und allergologie die physikalische therapie (pt) ist ein wesentlicher bestandteil der medizinischen versorgung von ssc-patienten patientenregister des dnss erfasst prospektiv, jährlich klinische verlaufsdaten zur organbeteiligung und therapie von patienten mit systemischer sklerodermie. die mittels freitext erfassten angaben zur verordneten pt wurden ausgewertet hivamat n= ( , %) und hylase n= ( , %) anwendung. die anzahl der verfahren, die die patienten zeitgleich erhielten, variierte zwischen mind. und max. . Über % der patienten erhielten anwendungen gleichzeitig. insgesamt wurden therapiearten genannt. , % der patienten mit gelenkkontrakturen zeigten nach einem jahr physikalischer therapie eine signifikante verbesserung der symptomatik (p= , ) gegenüber den patienten die keine physikalische therapie erhielten. nach drei jahren waren es , % der patienten (p= , ). bei den patienten mit muskelschwäche zeigten % der patienten eine signifikante symptomverbesserung (p= , ) dieser studie kann erstmals gezeigt werden, dass pt-symptome wie gelenkkontrakturen und muskelschwäche bei ssc-patienten signifikant verbessern kann. dennoch erhält weniger als die hälfte der ssc-patienten eine physikalische therapie punkten zur kontrolle einer mmf-therapie in der klinischen praxis zu untersuchen bei patienten ( -mal sle, je -mal systemische sklerose, sharp-syndrom und primäres sjögren-syndrom) die mmf erhielten, wurde , und min nach einnahme von mmf die mpa-konzentrationen im serum per hplc bestimmt. die mpa-auc wurde durch die mathematische methode der bayes %) und in der standarddosis von g/tag bei von patienten ( %) eine mpa-auc von > µg.h/ml. bei zwei patienten wurde nach der messung die dosis adjustiert: eine patientin mit einem sle mit diffus-proliferativer lupusnephritis hatte trotz einer mmf-dosis von g/tag nur eine mpa-auc von , µg.h/ ml. die dosis wurde daraufhin auf g/tag erhöht. der mpa-auc stieg danach auf max. , µg.h/ml und die krankheitsaktivität nahm ab (sledai von auf , proteinurie von auf mg/ h und prednisondosis von auf mg/tag) pharmakokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of bayesian estimator using limited sympling strategies mycophenolic acid area under the curve correlates with disease activity in pupus patients treated with mycophenolate mofetil colony stimulating factor- (csf- ) -neuer aktivitätsmarker der lupusnephritis? brigham and wome's hospital, boston, renal division the authors would like to thank pfizer for supporting the study. furthermore the authors would like to thank the "deutsche kinder-rheumastiftung". einleitung. bei patienten mit früher axialer spondyloarthritis (spa) mit einer krankheitsdauer von< jahren und nachweis von akut-entzündlichen veränderungen in der ganzkörper-magnetresonanztomographie (mrt) in der wirbelsäule und/oder den sakroiliakalgelenken (sig) zu baseline [ ] untersuchten wir die langzeit-effektivität über vier jahre. methoden. in der esther-studie wurden patienten mit etanercept (eta, n= ) vs. sulfasalazin (n= ) behandelt [ ] . ab dem zweiten studienjahr wurden alle patienten mit eta behandelt (einige patienten unterbrachen zwischenzeitlich die therapie (n= ) zur untersuchung der biologika-freien remission und wurden dann (erneut) mit eta behandelt) [ ] . klinische, laborchemische und mrt-daten der patienten, die zu den jeweiligen studienzeitpunkten vorhanden waren, wurden im vierten studienjahr analysiert (as-observed-analyse). ergebnisse. von patienten, die zu baseline eingeschlossen wurden, erreichten , % das ende von jahr (n= ). in der gesamtgruppe zeigte sich ein gutes bis sehr gutes ansprechen, wobei etwa % eine asas partielle remission und etwa - % eine asdas inaktive erkrankung erreichten (. tab. ). der anteil der patienten mit normalem crp ("crp-remission") stieg von , % zu screening auf , % zu woche , während der anteil der patienten mit negativem mrt ("mrt-remission" definiert als fehlen akut-entzündlicher veränderungen in den sig und der wirbelsäule gemäß beider scorer) auf von % auf , % anstieg. , % der patienten zu woche waren sowohl in asas-remission, im status einer asdas inaktiven erkrankung als auch in mrt-remission. das ansprechen nach vier jahren war sehr ähnlich in den gruppen unabhängig davon, ob im ersten jahr sulfasalazin gegen wurde oder die therapie im jahr unterbrochen worden war (ergebnisse werden nicht gezeigt).schlussfolgerung. es zeigte sich ein konstantes und anhaltendes ansprechen bei patienten mit früher axialer spa, die mit etanercept behandelt wurden. das ansprechen scheint besser zu als bei patienten mit etablierter ankylosierender spondylitsi mit einer langen krankheitsdauer (> jahren; [ ] ). einleitung. in einer -wöchigen placebokontrollierten studie mit -wöchiger offener verlängerung bei patienten mit aktiver nichtröntgenologischer axialer spondyloarthritis (nr-axspa) wies adalimumab eine gute effektivität auf [ ] . bei patienten, bei denen es zum wiederauftreten der krankheitsaktivität nach absetzen des medikaments in woche kam, wurde die therapie wiederbegonnen ziel der studie war es, die langzeiteffektivität nach wiederaufnahme der therapie von adalimumab nach stopp über jahre zu evaluieren. methoden. bei ursprünglich in die studie eingeschlossenen patienten wurde die therapie nach wochen beendet und patienten ( % männlich, mittleres alter jahre, range - , mittlere krankheitsdauer vor therapiebeginn jahre, range - , % positiv für hla-b ) hatten, definiert durch erreichen eines % ansprechens gemäß der assessments in spondyloarthritis society-kriterien (asas ), gut auf die therapie angesprochen. bei wiederauftreten von krankheitsaktivität (definiert durch nicht mehr erreichen von asas ) wurde adalimumab mg alle wochen über jahre (woche r ) weitergeführt. die asas kriterien und der bath ankylosing spondylitis disease activity index (basdai) wurden in form einer completer-analyse berechnet. ergebnisse. der patienten mussten wiederbehandelt werden: / ( %) erreichten jahr , / ( %) erreichten jahr und / ( %) der patienten erreichten jahr der wiederbehandlung. nach jahren wiederbehandlung mit adalimumab erreichten / ( %) wieder asas und / ( %) erreichten partielle remission gemäß der asas-kriterien. nach jahren erreichten / ( %) und nach jahren / ( %) asas . asas partielle remission wurde nach jahren von / ( %) und nach jahren von / ( %) patienten erreicht. in der completer analyse fiel der mittlere basdai von , ± , zum zeitpunkt der wiederbehandlung auf , ± , im jahr (p< , ), , ± , (p= , ) im jahr und auf , ± , (p= , ) im jahr der wiederbehandlung ab. schlussfolgerung. in dieser gruppe von patienten mit aktiver nr-axspa, die ein gutes therapieansprechen über wochen mit adalimumab erreicht hatten und die bei wiederauftreten von krankheitsaktivität nach stopp der therapie in woche weiterbehandelt werden mussten, sprach die mehrheit der patienten, die in der studie verblieben, gut und anhaltend auf das fortsetzen der therapie an. tab. | sp- langzeit-effektivität über jahre etanercept-therapie bei patienten mit früher axialer spondyloarthritis. daten zu baseline (bl), jahr (w ), jahr (w ), jahr (w ) und jahr (w ). daten background. secukinumab (ain ) is a new fully human monoclonal antibody (mab) targeting il- a for the treatment of inflammatory diseases. administration of mabs can be associated with immunogenicity via the induction of anti-drug antibodies (adas). adas can lead to unwanted clinical consequences, such as loss of exposure, loss of efficacy due to altered pharmacokinetics and/or functional neutralization and, in the worst case, anaphylactic reaction and immune complex diseases. the assessment of ada formation is therefore a critical component in the assessment of biotherapeutic safety. methods. the immunogenicity assessment strategy for secukinumab follows a three-tiered approach. first, samples are analyzed for presence of ada in a screening assay which takes a % false-positive rate into account. in a second step, screening assay positive samples are tested in a confirmatory assay that identifies true positive responses. finally, true immunogenicity-positive samples are quasi-quantified via titration. a biacore-based assay was used during the early stages of the secukinumab program, and an msd-based bridging assay was applied during the later stages of the program. in addition, pharmacokinetics and clinical efficacy as well as safety data are also evaluated. samples to assess immunogenicity were obtained from individual subjects encompassing clinical studies in different indications during treatment and during follow-up. dosing regimens included single doses such as mg subcutaneously in psoriasis patients as well as multiple × mg/kg doses intravenously in ms patients over a six-month period.results. none of the subjects tested for immunogenicity developed sustained adas. in total, subjects met the definition of treatment-related, transient positive immunogenicity showing low ada titers. none of these subjects had evidence of loss of efficacy, deviating pk behavior or reported anaphylactic reaction or immune complex disease.conclusion. based on the available data, secukinumab appears to carry a low risk of immunogenicity. in the very few transient immunogenicitypositive patients identified so far, there has been no indication of altered pharmacokinetics or loss of efficacy, and no adverse event that could be linked to immunogenicity has been detected. more data from the ongoing phase studies are required to strengthen this encouraging finding in a larger patient population. risikofaktoren für eine aa-amyloidose bei entzündlich-rheumatischen erkrankungen und bei der idiopathischen aa-amyloidose methods. we report a case of an -year-old woman suffering from ulceration and signs of infection of the ulnar aspect of the right forearm due to subcutaneous calcification in association with crest syndrome.results. this case presents an unusual case of extensive subcutaneous calcification in crest syndrome requiring surgical excision due to secondary ulceration, inflammation and infection. while a surgical approach has already been described for calcification in different connective tissue diseases, only scant data of massive subcutaneous calcification related to a forearm in crest syndrome followed by surgical excision exist. conclusion. in crest syndrome, extensive subcutaneous calcification related to the forearm can occur. surgical excision followed by primary wound closure can lead to an excellent postoperative result. background. the whole blood interferon signature (wbifns) is measured in several clinical trials studying inhibitors of interferon alpha (ifn-α) in sle, but failed repeatedly -in contrast to the less sensitive ifnα -to reflect longitudinal changes in lupus activity and to guide dosage finding of rontalizumab. therefore, better ifn biomarkers reflecting disease activity over time and individual response to the inhibition of ifnα are needed to optimize the risk-benefit ratio of ifn-inhibitors. here, we show that the highly sensitive monocyte restricted ifnα response protein siglec- , also known as sialoadhesin or cd , is a useful biomarker to monitor longitudinal changes in disease activity of sle patients. methods. ifn-α and siglec- were measured by delfia and flow cytometry, respectively, in accurately characterized lupus patients over a period of up to months (overall visits). changes of biomarker and changes of disease activity (bilag ) were correlated using spearman rank test (srt). disease courses of selected sle patients were plotted to demonstrate in detail the relations of ifn-biomarkers with disease activity, sle medication and clinical manifestations. background. a -year-old woman was admitted because of sudden attack of convulsion and somnolence situation with positive canca and myeloperoxidase antibodies. cerebral magnetic resonance imaging (mri) showed thickening and marked progression of the dura-meningeal enhancement and edematous changes at pre and post central gyrus left side. based on these findings, it was diagnosed as hypertrophic cranial pachymeningitis related to anca-associated vascultis as unusual presentation. there was only temporarily und partial responce to a -month therapy with cyclophosphamide mg i.v and oral glucocorticosteroids . taking into consideration the severe, life-threatening course of the disease in the case of our patient, the decision was made to use rituximab, a chimeric, monoclonal igg antibody directed against cd , leads to destruction of b cells via complement mediated lysis and antibody dependent cellular cytotoxicity. the first administration of the medication was performed according to the pattern for rheumatoid arthritis patients treated with rituximab, i.e. infusions for mg in -day intervals in combined therapy with glucocorticosteroids. a follow-up mri at months after start with rituximab showed significant regression of the meningeal pathology at temporo-occipatel aspects (pachymeningitis) and completely resolution of edematous changes at pre and post central gyres. the complete clinical remission was achieved by introducing rituximab. conclusion. rituximab seems to be successful therapie for the induction and maintenance of remission in patients with anca-associated vasculitis (aav) with cns involvement (hypertrophic cranial pachymeningitis ) , who had previously failed to respond to standard treatment with cyclophosphamide and steroids and a range of alternative treatments [ , ] . antikörperdiagnostik. mit prednisolon-therapie ( mg/kgkg, mg/ tag) und zusätzlich methotrexat mg wöchentlich war keine anhaltende normalisierung der entzündungsserologie zu erzielen. infliximab ( mg/kg) -wöchentlich i.v. erbrachte nur kurzzeitig eine normalisierung der entzündungswerte, dann trotz weiterer infusionen einen erneuten anstieg der bsg bis auf mm, crp mg/l. nach umstieg auf tocilizumab ( mg / mg/kgkg) alle wochen konnte nach wochen eine bislang anhaltende normalisierung der entzündungsserologie erzielt werden (crp , mg/l, bsg mm . std.). der allgemeinzustand der patientin besserte sich deutlich, der hb-wert normalisierte sich auf , mmol/l. in der kontrastverstärkten sonographie fand sich ein abfall in der kontrastmittelaufnahme der a. carotis communis. die maximale intima-media-dicke reduzierte sich bislang auf , mm. schlussfolgerung. die bisherige standardtherapie der takayasu-arteriitis mit prednisolon und mtx führte auch im vorliegenden fall nicht zur remission. für infliximab fanden wir ein frühzeitiges therapieversagen des sonst erfolgreich beschriebenen ansatzes einer tnf-α-blockade bei riesenzellarteriitis. dennoch gelang mit tocilizumab eine bislang über monate andauernde klinische, sonomorphologische und serologische remissionsinduktion bei monatlicher fortführung der il- -blockierenden therapie. background. cd is the prototypic nk receptor that is also expressed on a unique population of effector cd + cells. these cd -expressing t cells are expanded in rheumatoid arthritis patients and had features of senescent cells. nkg d is another nk receptor over expressed on effector cd + cells in aav patients. cd + as well as nkg d + t cells seem to be involved in tissue injury as they are capable of mediating tcr-independent immune activation. it is hypothesized that il- is able to up regulate the expression of nk cell receptors. interleukin- (il- ) is a proinflammatory cytokine that is over expressed in aav and is linked to the expansion of cd + effector memory t cells (tem). in aav in remission a persistent expansion of these cd + effector memory t cells has been observed. in the present study we assessed the expression cd on cd + t cells of aav and if expression of these molecules was influenced by il- . methods. the distribution of cd + tem and the proportion of cd +cd + t cells and nkg d+ cd + t cells were analysed in aav-patients and hcs by facs. in vitro effects of il- on the expansion of cd + tem and up regulation of cytotoxic markers were assessed in the same way. in addition il- serum levels were measured in patients and hc by elisa. results. we observed an increased proportion of circulating cd +cd + t cells in aav as well as nkg d+ cd + t cells in patients in remission compared to hc ( . vs . p< . and vs . p< . ). % to % of these cells were cd + effector memory t cells. the percentages of the cd +cd + t cells and nkg d+ cd + t cells were constant over time. we also observed elevated il- serum levels in patients in remission compared to hc (p= . ). in vitro stimulation of pbmcs with il- increased not only the proportion of cd + memory cells (cd ro+) but also the expression of cd and nkg d on these cells. conclusion. the driving force behind the persistent expansion of a cytotoxic subset of cd + effector memory t cells expressing cd and nkg d+ and being tcr -independent is likely the increased il- expression in aav patients . ergebnisse. unabhängig von regime der remissionsinduktion und der primären erhaltungstherapie lag am ende der nachbeobachtungsperiode bei % der patienten eine renale remission vor ( %; % pr). % hatten eine persistierende proteinurie von > , g/tag bei stabiler nierenfunktion, % eine persistierende niereninsuffizienz mit erhöhtem kreatinin bei inaktivem sle, bei % wurden eine persistierende aktive ln und/oder renale rezidive beobachtet. vier patienten verstarben. patienten mit langzeit-cr waren gekennzeichnet durch einen niedrigeren tubulointerstitiellen chronizitätsindex in der initialen nierenbiopsie ( , ± , vs. , ± , ; p= , ), eine hochsignifikant geringere proteinurie nach cyc-pulsen ( , ± , vs. , ± , g/tag; p= , ) und niedrigere dsdna-ak ( ± vs. ± u/ml; p< , ) zum zeitpunkt des beginns der erhaltungstherapie. eine proteinurie von < , g/tag nach pulsen cyc zeigte eine sensitivität von % und eine spezifität von % für eine langzeit-cr. schlussfolgerung. eine proteinurie von < . g/tag nach remissionsinduktion mit pulsen cyc sowie ein geringer tubulointerstitieller chronizitätsindex in der nierenbiopsie sind prädiktoren einer anhaltenden kompletten renalen remission bei ln. background. to evaluate and compare clinical efficacy of three biomarkers for interferon activity (measured directly and indirectly) and six traditional biomarkers to indicate current disease activity in sle. methods. ifn-α (delfia), ip- (elisa) and siglec- (flow cytometry) was measured in accurately characterized lupus patients and compared to serum titres of anti-dsdna (elisa and ria), anti-dsdna-ncx elisa, anti-nuc elisa, c and c . disease activity was evaluated using bilag- and a modified sledai- (msle-dai- k). additionally, clinically quiescent patients were monitored for flares over the course of days. results. increased levels of ifn-α, ip- and siglec- were found in %, % and % of active sle patients. ifnα (r= . ; p< . ) and siglec- (r= . ; p< . ) correlated better with bilag- than ip- (r= . ; p= . ), farr assay (r= . ; p= . ), anti-dsdna-ncx elisa (r= . ; p= . ), anti-dsdna elisa (r= . ; p= . ), anti-nuc elisa (r= . ; p= . ), c (r=- . ; p< . ) and c (r=− . ; p= . ). predictors of sle flares were disease duration ≤ months, mild clinical activity (in contrast to no activity), complement c ≤ mg/dl and ifn-α ≥ pg/ml, while only lymphocyte count and age were independent predictors in multivariate analysis. conclusion. ifn-α, ip- and siglec- emerged as beneficial biomarkers for disease activity in lupus patients. therefore, implementation of ifn biomarkers in standard lupus diagnostics should be reappraised, especially in view of emerging anti-ifn-directed therapies. . ) and carried significantly more often other antibodies ( . %; p< . ), which were separated into u rnp-( . %), ro-( . %), pmscl-( . %) antibodies, followed by . % with rheumatoid factors, . % with la-, . % with dsdna-and . % with jo- -and . % with ku-antibodies. the kaplan-meier analysis of the onset of organ involvement revealed a clear inclined position of overlap patients between patients suffering from lcssc and dcssc, especially regarding lung fibrosis and heart involvement. patients suffering from pah, oesophagus involvement and kidney involvement, overlap and lcssc patients showed nearly similar curve progression (log rank < . ). furthermore musculoskeletal involvement was significantly more frequent and more progressive in patients with overlap disease, followed by patients with dcssc and lcssc (log rank < . ). conclusion. these data support the current concept, that ssc-overlap syndromes should be regarded as a separate ssc subset, distinct from lcssc and dcssc, due to a different course of the disease, different proportional distribution of specific autoantibodies and skin/organ involvement. methoden. patienten mit gpa ( mit aktiver und mit in remission befindlicher gpa) wurden durchflusszytometrisch analysiert und mit gesunden verglichen. eine färbung für cd , cd , cd , igd, iga, cd , mhcii, wurde mittels flowjo-software analysiert. die statistische auswertung erfolgte mit "graph pad prism" und p-werte< , wurden als signifikant angesehen. die studie wurde von der ethik-kommission der charité genehmigt. ergebnisse. deutliche unterschiede (p= , ) wurden sowohl für die absolute zahl als auch die frequenz der plasmazellen im peripheren blut der patienten mit gpa mit krankheitsaktivität ( , ± , /µl) im vergleich zu denen mit einem bvas von ( , ± , /µl) oder gesunden ( , ± , /µl) gefunden, ähnlich wie bei sle. bei patienten mit gpa ist außerdem eine signifikante erhöhte anzahl der plasmazellen igapositiv (p= , ). die anzahl der plasmazellen sowie die frequenz der plasmazellen an den b-zellen im blut korrelieren mit dem bvas (r= , ; p< , ). interessanterweise zeigte sich keine expansion der doppelt negativen memory-zellen, die zum beispiel beim sle beschrieben ist. für die naiven b-zellen fand sich ebenfalls ein signifikanter unterschied zwischen patienten mit aktiver erkrankung im vergleich zu gesunden. bei den t-zellen fanden sich nur diskrete veränderungen. schlussfolgerung. die anzahl der plasmazellen ist bei patienten mit aktiver gpa deutlich erhöht, was eine rolle von plasmazell-vermittelten mechanismen in der pathogenese nahelegt. ein großteil dieser plasmazellen ist iga-positiv, diese könnten eine rolle bei der hno-beteiligung spielen. key: cord- - ijxilpb authors: xu, g.l.; yao, l.; rao, s.y.; gong, z.n.; zhang, s.q.; yu, s.q. title: attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p mitogen-activated protein kinase date: - - journal: j ethnopharmacol doi: . /j.jep. . . sha: doc_id: cord_uid: ijxilpb oxymatrine is one of the alkaloids extracted from chinese herb sophora japonica (sophora flavescens ait.) with activities of anti-inflammation, inhibiting immune reaction, antivirus, protecting hepatocytes and antihepatic fibrosis. however, the effect of oxymatrine on acute lung injury (ali) has not been known yet. in this study, the effect of oxymatrine on ali was investigated using an oleic acid-induced ali mouse model. morphological findings showed that the oleic acid group demonstrated a marked lung injury represented by prominent atelectasis, intraalveolar and interstitial patchy hemorrhage, edema, thickened alveolar septum, formation of hyaline membranes and the existence of inflammatory cells in alveolar spaces. while in the oxymatrine/dexamethasone group, these changes were less severe and in the vicinity of the control group. furthermore, pretreatment with oxymatrine significantly alleviated oleic acid-induced lung injury accompanied by reduction of lung index and wet-to-dry weight ratio, decreases in serum tnf-α level and inhibition of phosphorylated p mapk. these findings suggest that oxymatrine has a beneficial effect on acute lung injury induced by oleic acid in mice and may inhibit the production of proinflammatory cytokine, tnf-α, by means of the inhibition of p mapk. acute lung injury (ali) is characterized by an intense pulmonary inflammatory response, with neutrophil accumulation, interstitial edema, disruption of epithelial integrity and leakage of protein into the alveolar space (john et al., ) . acute respiratory distress syndrome (ards) is characterized by increased capillary endothelial permeability that leads to segmental accumulation of high protein content in interstitial edema. fibrin and platelet plugs occlude the microvasculature of the lung and neutrophil sequestration and activation in the interstitium leads to further segmental alveolar damage and flooding. these processes result in decreased pulmonary compliance, compromised gas exchange and extensive intra-pulmonary shunting with concomitant ventilation-perfusion mismatching. at present, ards is often classified as a continuum of injury ranging from the milder form 'acute lung injury (ali)' to the more severe form 'ards' (christopher et al., ) . ali/ards is associated with the development of multiple organ dysfunction syndrome (mods), which plays an important role in the death of patients with sepsis, pneumonia, aspiration of gastric contents, trauma, multiple transfusions and ischemia reperfusion. severe acute respiratory syndrome (sars) is a novel global infectious disease induced by a virus from the family coronaviridae. clinical investigation shows that pathological changes in sars patients are similar to those of acute lung injury, as revealed by alveolar cell collapse, severe exudation, acute inflammatory reaction and hyaline membrane formation (zhong, ; du et al., ) . currently, no corrective therapy is available for the it is generally accepted that the development of mods follows the gradual route of ali-ards-mods. during this pathway, the lung behaves as a central organ and is the first target subject to injury. because pulmonary dysfunction may lead to severe hypoxemia and further other multiple organ dysfunction or failure, the treatment of the above mentioned diseases should concentrate on the development of ali and take measures as soon as possible . the research and development of anti-sars drugs should also comply with this law. potential new therapeutic strategies for sars have been shown to include a wide search for drugs, which is conducive to reduction of lung injury and management of symptoms (zhong, ; du et al., ) . as a traditional chinese medicine, sophora japonica has been used for treatment of many diseases for thousands of years. matrine-like alkaloids have been found to be the chief active components of chinese herb sophora japonica including matrine, oxymatrine, sophocarpine, sophoramine, sophoridine et al. the content of oxymatrine in the composite of sophora japonica is up to . % (qi et al., ) . basic and clinical researches have shown that oxymatrine has the following pharmacological effects: anti-inflammation, inhibiting immune reaction, antivirus, protecting hepatocytes and antihepatic fibrosis (liu et al., (liu et al., , liu and chiou, ; chen et al., ; dong et al., ; xiang et al. ; yang et al., ) . chinese bureau of science and technology had announced during the outbreak of sars that the composite sophora japonica injection has distinct effects in the treatment of sars (zhong, ) . considering the pharmacological effects of oxymatrine, we speculate that oxymatrine may play a central role in the composite injection although the effect of oxymatrine on sars has not been reported to date. in order to test this hypothesis and because the pulmonary pathological changes in sars are similar to those of acute lung injury, the effect of oxymatrine on acute lung injury was investigated using an ali mouse model in this study. we also studied whether the p mapk intracellular signal pathway was involved in the development of ali and discussed whether oxymatrine could become a therapeutic candidate drug for ali, ards and sars. oxymatrine was obtained from yixin pharmaceutical co. ltd. (zhejiang, china) with hplc purity > %. oleic acid was purchased from linfeng chemical co. ltd. (shanghai, china). albumin was obtained from sigma. rabbit polyclonal antibodies for phosphorylated and nonphosphorylated p mapk were provided by cell signaling technology. tween and glycine were purchased from amresco co. polyvinylidene difluoride (pvdf) transfer membranes for western blotting were obtained from roche molecular biochemicals (quebec, canada). protein assay dye reagent was purchased from jiancheng bioengineering co. (nanjing, china) . hrp conjugate goat anti-rabbit igg and pipa lysis buffer were purchased from shengnengbocai biotech inc. (shanghai, china) . mouse tnf-␣ elisa assay kit was obtained from jingmei biotech co. (guangdong, china). all other reagents were of the highest grade available commercially. male kunming strain mice weighing - g were obtained from laboratory animal center, school of medicine, southeast university (nanjing , china). the mice were housed in climate-controlled quarters ( - • c at % humidity) with a h light/dark cycle and free access to food and water. all experiments were conducted according to the "guide for the care and use of laboratory animals", published by the national institutes of health (nih publication - , revised ). mice were randomly assigned into six groups. the oleic acid group received . ml/kg, i.v. of oleic acid (mixed with . % bovine serum albuman). the control group received . ml/kg, i.v. of saline. the three oleic acid + oxymatrine groups were treated with oxymatrine for three consecutive days before oleic acid injection (oxymatrine; . , and mg/kg, i.p.) (xiang et al., ) . the dexamethasone group received intraperitoneal injection of dexamethasone at dose of . mg/kg h before oleic acid injection. the oleic acid and control groups were treated with an equivalent volume of saline instead of oxymatrine. mice were sacrificed h after oleic acid injection. immediately after each animal had been sacrificed, the thorax was opened and the lung was removed en bloc by observers unaware of the nature of the experiment. the left lower lobe was excised and fixed in % buffered formalin. the lungs were embedded in paraffin, and the sections stained with hematoxylin and eosin were examined by light microscopy for evidence of lung injury, as described in the following: alveolar congestion, hemorrhage, edema, infiltration/aggregation of neutrophils in the airspace or vessel wall, thickness of the alveolar wall and hyaline membrane formation. electron microscopy of lungs was carried out on samples fixed in phosphate buffer (ph . ) containing . % glutaraldehyde and post-fixed in osmium tetraoxide. transmission electron micrographs were produced with a hitachi h- electron microscope. the wet weight of the whole lung was weighed on an automatic electric balance and the lung index was calculated according to the following formula: lung index (%) = the wet weight of the whole lung/body weight × %. subsequently, the right lung was excised and weighed to obtain the 'wet' weight. the lung was then dried in an oven at • c for days to obtain the 'dry' weight. to assess tissue edema, the ratio of wet weight to dry weight (w/d ratio) was calculated. the left lung was cut into pieces and subjected to histological examination and electron microscopy observation. blood samples were harvested from the eyes before mice were killed. the blood was allowed to clot for approximately h at room temperature and then centrifuged at × g for min to obtain the serum. the serum was stored at − • c until assayed. the tnf-␣ was quantitated according to the instructions available in elisa kits. the levels in mice samples were calculated from a standard curve generated from recombinant mice tnf-␣. the detection range of this assay for tnf-␣ is - ng/l. samples with a concentration exceeding the limits of the standard curve were repeated after dilution. three mice in each group were adopted min after oleic acid injection. the lungs were frozen in liquid nitrogen for measurements immediately after they were removed. before the assay, the specimens were cleared of fat and debris. all specimens had a wet weight of mg. phenylmethylsulfonylfluoride (pmsf; mmol) was added just before use. the samples were homogenized in l of pipa lysis buffer using a microhomogenizer on ice. all debris and nuclei were removed by centrifugation at × g at • c for min. the supernatant obtained was used as the whole cell lysate. protein concentrations were determined with bovine serum albumin as the reference standard using protein assay dye reagent. an g of proteins were separated by sodium dodecylsulfate-polyacrylamide gel electrophoresis (sds-page). the membranes were first incubated with % nonfat milk in tris-buffered saline (tbs). after washing three times in . % tween -tbs (tbst), the membranes were incubated with p mapk and phosphorylated p mapk antibodies separately ( : ) in tbst over night at • c, and then washed three times in tbst. they were incubated with horseradish peroxidaselinked goat anti-rabbit igg ( : ) for h at room temperature and detected with the tmb substrate for horseradish peroxidase. data from experiments are expressed as mean ± s.e.m. and statistically analyzed using the student's unpaired t-test. a value of p < . was considered significant. light microscopic findings in the lung at h after oleic acid injection demonstrated a marked lung injury resembling those seen in lung of patients with ali/ards, represented by prominent atelectasis, intraalveolar and interstitial patchy hemorrhage, edema, thickened alveolar septum, formation of hyaline membranes and the existence of inflammatory cells in alveolar spaces (fig. a) , which were not observed in the control group (fig. b) . in oleic acid + oxymatrine groups, these changes were less severe than in the oleic acid group and were in the vicinity of the control group (fig. c ). in the oleic acid + dexamethasone group, these changes were not pronounced and were close to the high dose oxymatrinetreated group (fig. d) . as shown in fig. , electron microscopic findings in the lung after oleic acid injection included epithelial cell swelling (endoplasmic reticulum dilation and mitochondria swelling), the existence of blood cells and inflammatory cells in alveolar spaces (fig. b-d) , which were not observed in the control group ( fig. a) . these changes were improved or not evident in oleic acid + oxymatrine/dexamethasone groups ( fig. e and f). values of the lung index and wet-to-dry lung weight ratio (w/d) in various groups of experimental animals were shown in fig. . oleic acid injection resulted in an increase in the lung index and w/d ratio of the lung, as compared to the control (p < . , p < . ). both were attenuated by mg/kg (p < . , p < . ) and mg/kg (p < . , p < . ) oxymatrine treatment. in contrast, . mg/kg oxymatrine did not diminish the above two values significantly although they were lower than the oleic acid group. the lowest level was found in animals receiving dexamethasone treatment. as tnf-␣ plays a pivotal role in mediating oleic acidinduced ali, we also assessed the regulation of tnf-␣ production by oxymatrine (fig. ) . the serum tnf-␣ level in the oleic acid group was significantly higher than that in the control group (p < . ). treatment with oxymatrine inhib- ited the increase in a dose dependent manner and the level at the highest dose reverted to the control level. serum level of tnf-␣ in the dexamethasone group was evidently lower than that in the oleic acid group and similar to the control group. this suggested that tnf-␣ increases induced by oleic acid could be suppressed by oxymatrine. as shown in fig. , the level of p phosphorylation in the oleic acid group was significantly higher than that in the control group. pretreatment with oxymatrine inhibited phosphorylation of p in a dose dependent manner. p phosphorylation in the highest oxymatrine group was similar to that of the control group. in contrast, the total p protein remained unchanged. xiang and colleagues used oxyimatrine to evaluate effect of oxymatrine on fulminant hepatitis and hepatocyte apoptosis in mouse models and oxymatrine was administered at dose of mg/kg intraperitoneally (i.d. × days) (xiang et al., ) . initially, we administered oxymatrine at the dose of mg/kg intraperitoneally twice a day for three consecutive days, resulting in a protective effect that could be easily monitored by macroscopic and/or microscopic observation. then we used, oxymatrine at doses of , . and mg/kg to investigate the relationship between dose and effect. results showed that no protective effects were observed at . mg/kg or below. so , and . mg/kg were ultimately selected as the test dosage. our results showed that a series of pathological changes were observed under light and electron microscopy after an intravenous administration of oleic acid in mice, which mimicked the pathological changes of clinical ali/ards satisfactorily. furthermore, the lung index and wet/dry weight ratio were greater in ali mice than in control group. these findings are in agreement with other reports (kenji et al., ) , demonstrating that the oleic acid-induced ali mouse model is reproducible and our ali model is successful. the underlying mechanism of ali induced by oleic acid is associated with cytokines releases such as tnf-␣, which stimulates monocytes to produce il- .as the core of the cytokine-network, tnf-␣ and il- play important roles not only in the production of other inflammatory cytokines, but also in the migration and adherence of neutrophils to endothelial cells (yoshimi et al., ) , which together with endothelial cell injury by cytokines result in the production of superoxide radicals and subsequently injure alveolar epithelial cells. all these cause ultimate pulmonary dysfunction. in the present study, our data revealed that serum tnf-␣ level was higher in oleic acid group than that in control group. oxymatrine evidently decreased serum tnf-␣ level, lung index as well as wet-to-dry ratio and reduced pulmonary injury induced by oleic acid. these findings not only corroborate the direct relationship between tnf-␣ and ali but also suggest that oxymatrine have a protective effect on oleic acid-induced ali. fig. . ultrastructure of the lung tissue in mice without or with oleic acid injection ( ×). representative photomicrographs showing: epithelial cell swelling (endoplasmic reticulum dilation and mitochondria swelling) (b), the existence of red blood cells (c) and inflammatory cells (d) in alveolar spaces were observed in oleic acid group. these changes were not observed in the control group (a) and improved or not evident in oleic acid + oxymatrine/dexamethasone groups (e, f): a, normal epithelial cell; b, swollen epithelial cell; c, red blood cell in alveolar spaces; d, inflammatory cell in alveolar spaces. fig. . effect of oxymatrine on lung index and wet-to-dry weight ratio (w/d) in mice with lung injury induced by oleic acid. the mice were given oxymatrine ( . , and mg/kg, i.p.) for three consecutive days and dexamethasone ( mg/kg, i.p.) h before injection of oleic acid. the control and oleic acid groups received normal saline. the mice were then sacrificed h after oleic acid administration and lung index, wet-to-dry weight ratio (w/d) were calculated. mean ± s.e.m., n = ; ** p < . when compared with control; # p < . and ## p < . when compared with oleic acid group. fig. . effect of oxymatrine on serum tnf-␣ level in mice with lung injury induced by oleic acid. the mice were given oxymatrine ( . , and mg/kg, i.p.) for three consecutive days and dexamethasone ( mg/kg, i.p.) h before injection of oleic acid. the control and oleic acid groups received normal saline. the mice were then sacrificed h after oleic acid administration and serum tnf-␣ level were determined by elisa assay. mean ± s.e.m., n = ; ** p < . when compared with control; ## p < . when compared with oleic acid group. bands of p map kinase were identified in the five groups, and mean density levels in the five groups were almost the same. phosphorylated p map kinase was augmented in the oleic acid group compared with the control group, whereas expression of phosphorylated p map kinase was markedly attenuated in the oxymatrine group compared with the oleic acid group. it has been reported that oxymatrine concentration is higher in lung and heart than in other organs. this signifies the anti-ali effect of oxymatrine has a pharmcokinetic basis (wang and wang, ) . additionally, dexamethasone as positive control exerted a significant preventive effect on oleic acid-induced ali injury. this might be explained by its potent anti-inflammation effect described as follows: diminution of alveolocapillary permeability; reduction of alveolar epithelial response to pathogen; stability of cell and lysosome membrane; enhancement of surfactant release; prevention of microthrombogenesis and blockade of neutrophil activation (wang et al., ; su et al., ) . under the stimuli of different ali/ards pathogens, a wide and complicated signal transduction process occurs in many different cells. although the detailed mechanism is still unknown, the p mitogen-activated protein kinase (mapk) has been paid special attention. p mapk is a cytokinesuppressive anti-inflammatory drug target first discovered by lee et al. ( ) . most reports demonstrate that p mapk is responsible for regulating inflammatory responses (nick et al., (nick et al., , fang et al., ) . on the other hand, arcaroli et al. ( ) reported that p did not have a central role in the development of ali after either hemorrhage or endotoxemia. thus, the role of p mapk in the development of ali is still uncertained. as a result, p mapk has not been proposed as a valid target for clinical management of ali/ards. in order to examine the role of p mapk in ali, we then analyzed the expression of p mapk and evaluated the effects of oxymatrine. the expression of p map kinase was shown using western blotting analysis. results showed that phosphorylated p map kinase was augmented in the oleic acid group compared with the control group, whereas expression of phosphorylated p map kinase was attenuated in the oxymatrine group compared with the oleic acid group in a concentration-dependent manner. this suggested that the administration of oxymatrine before ali markedly attenuate the activation of p map kinase during lung injury. it has been reported that tnf-␣ is augmented via activation of the p map kinase-related intracellular signal pathway (johnson et al., ; lee et al., ) . oxymatrine markedly attenuated the phosphorylation of p map kinase and disturbed the mechanism for the production of tnf-␣, thus resulting in the lower serum tnf-␣ level. from these findings, we conclude that oxymatrine ameliorates ali by attenuating the production of proinflammatory cytokines, and that this attenuation is associated with suppression of p map kinase activation. in addition, our results confirm that p map kinase does play an important role in the development of oleic acid-induced ali. based on our results and previous reports, we expect that p map kinase may become a promising target for clinical management of ali, although it needs to be supported by further animal experiments and clinical data. reports have shown that there are at least three types of map kinase: extracellular signal-regulated protein kinase (erk / ; p /p ); c-jun n-terminal protein kinase (jnk); p map kinase (davis, ; kyriakis et al., ; bogoyevitch et al., ; han et al., ; raingeaud et al., ; xia et al., ) . the nf-b pathway is also reported to be involved in the process of ali. together with the three types of mapk, nf-b may create a network to regulate inflammatory responses in ali. in this study, we only studied the effect of oxymatrine on p mapk. further study is needed to elucidate whether oxymatrine has modulative effects on other pathways. in china, pure oxymatrine injection has been available in hospital for treatment of hepatitis and tumor for many years. however, it has not been used for ali/ards/sars in clinic. since our results indicate that oxymatrine prevents mice from oleic acid-induced ali, we hope that oxymatrine can be used to treat ali/ards/sars although further research should be carried out on more animal experiments before clinical trials. in this paper, we found oxymatrine had a beneficial effect on ali in mice for the first time. although details of the mechanism of oxymatrine remain to be unraveled, the present results suggest that oxymatrine improves acute lung injury by attenuating the production of tnf-␣, and that this attenuation is associated with suppression of p map kinase activation. role of p map kinase in the development of acute lung injury cellular stresses differentially activated c-jun n-terminal protein kinase and extracellular signal-regulated protein kinase in cultured ventricular myocytes the inhibitory effect of oxymatrine on hepatitis c virus in vitro continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ards) the mitogen-activated protein kinase signal transduction pathway effects of oxymatrine on the serum levels of t helper cell and cytokines and the expression of the s gene in hepatitis b virus s gene transgenic mice: a study on the anti-hepatitis b virus mechanism of oxymatrine targets and studies on anti-sars drugs effect of p mapk on mechanical ventilation-induced lung injury a map kinase targeted by endotoxin and hyperosmolarity in mammalian cells role of p map kinase in the development of acute lung injury human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep effect of methylprednisolone on phospholipase a activity and lung surfactant degradation in acute lung injury in rabbits the stress activated protein kinase subfamily of c-jun kinase a protein kinase involved in the regulation of inflammatory cytokine biosynthesis discussion on acute lung injury and acute respiratory distress syndrome the effect of chinese hepatoprotective medicines on experimental liver injury in mice medicinal herbs for hepatitis c virus infection: a cochrane hepatobiliary systematic review of randomized trials effects of chinese herbal products on mammalian retinal functions selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p mitogenactivated protein kinase role of p mitogen-activated protein kinase in a murine model of pulmonary inflammation progress in studies of matrine and oxymatrine pro-inflammatory cytokines and environmental stress cause p mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide pharmacological effects and clinical application of matrine and oxymatrine effect of dexamethasone on humoral immunity in mice of acute lung injury induced by oleic acid effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis opposing effects of erk and jnk-p map kinase on apoptosis prophylactic and therapeutic effect of oxymatrine on d-galactosamine-induced rat liver fibrosis the effect of fr on pulmonary ischemia-reperfusion injury in rats consensus for the management of severe acute respiratory syndrome key: cord- -rapinodd authors: vidovic, maria; sparacio, shaun m.; elovitz, michal; benveniste, etty n. title: induction and regulation of class ii major histocompatibility complex mrna expression in astrocytes by interferon-γ and tumor necrosis factor-α date: - - journal: j neuroimmunol doi: . / - ( ) -t sha: doc_id: cord_uid: rapinodd astrocytes can function as antigen-presenting cells (apc) upon expression of class ii major histocompatibility complex (mhc) antigens, which are induced by interferon-γ (ifn-γ). previous data from this laboratory had shown that the cytokine tumor necrosis factor-α (tnf-α) enhances ifn-γ-mediated class ii antigen expression on astrocytes. we have now investigated the effect of ifn-γ and tnf-α on class ii mhc mrna expression in astrocytes using northern blot analysis. astrocytes do not constitutively express mrna for class ii mhc. kinetic analysis of class ii mhc mrna expression in ifn-γ-treated cells demonstrated an h time lag, which was followed by an increase over the next h. optimal expression of class ii mrna was detected after a h incubation with ifn-γ. this level of expression was further enhanced by the simultaneous addition of ifn-γ and tnf-α to the astrocytes, while tnf-α alone had no effect on class ii mrna expression. tnf-α does not act by increasing the stability of ifn-γ-induced class ii mrna, indicating its action is not at that specific level of post-transcriptional control. furthermore, astrocyte class ii mrna expression was inhibited when cycloheximide (chx) was added together with ifn-γ or ifn-γ/tnf-α, and when chx was added up to h after treatment with ifn-γ or ifn-γ/tnf-α. these results indicate that astrocyte class ii mrna expression is mediated by newly synthesized proteins induced by ifn-γ and/or ifn-γ/tnf-α. the expression of class ii antigens on astrocytes, and cytokine modulation of their expression, may be important in the initiation and perpetuation of intracerebral immune responses. the non-neuronal cells of the central nervous system (cns) are made up of the macroglia (astrocytes, oligodendrocytes and ependymal cells) and the microglia. collectively, these glial cells perform a variety of active roles during development of the brain (rakic, ; silver and sapiro, ) and subsequently in the maintenance of normal cns physiology (hertz, ; janzer and raft, ) . recent work has suggested that glial cells such as astrocytes and microglia may be involved in immunological events occurring in the brain. the astrocyte can be stimulated to secrete a number of immunoregulatory molecules, including interleukin- (il-i) (fontana et al., ) , interleukin- (il- ) (frei et al., ) , interleukin- (il- ) (frei et al., ; benveniste eta[., ) , prostaglandins (fontana et al., ) , leukotriene (llartung et al., ) , tumor necrosis factor-c~ (tnf-co (robbins et al., ; lieberman et al., ; chung and benveniste, (i) and ifn-c~/, (tedeschi et al., ) . the microglia can also be stimulated to secrete l- (giulian et al., ) , il- (frei et al., ) and tnf-a (frei et al., ) , thus providing the cns with numerous endogenous sources of cytokines necessary, for immunological response. more importantly, the astrocyte and microglia can function as antigen-presenting cells (apc) in the cns (fierz et al., ; frei et al., ) . these cells are able to internalize, process, express and present antigen to encephalitogenic t cells (fontana et al., ) . however, such a function is only possible upon expression of class i major histocompatibility complex (mhc) molecules. indeed, astrocytes can be induced to express class ii antigens both in the cns and in vitro, following exposure to interferon- (ifn-t) (wong et al.. : fierz et al., or virus (massa et al., ) . mhc-encoded class molecules are heterodimerit glycoproteins which have a central role in the regulation of immune responses (benacerraf, ) . the expression of class ii antigens is primarily restricted to b cells, monocytes/macrophages and dendritic cells (hammerling et al., ) , although certain non-lymphoid cells can be induced to express class ii upon exposure to ifnq,, and function as apc. these include pancreatic beta cells (markmann et al.. ) , keratinocytes (gaspari et al., ) , brain endothelial cells (mc-carron et al., ) , and most pertinent to this study, astrocytes (fontana et al., ) . abnormal control in the level of expression of class i genes, and aberrant expression in cells normally class ii negative have been implicated in autoimmune phenomena. because of the importance of class ii mhc antigens, many studies have been directed toward understanding the regulatory mechanisms involved in class ii mhc gene expression. it is generally accepted that induction of class ii gene expression by ifn-y occurs at the transcriptional level (basta et al., ; blanar et al., : fertsch-ruggio et al., : rosa and fel-ious, : amaldi et al., , and that transacting factors interacting with cis-acting dna regulatory elements are involved in the transcriptional regulation of class ii mhc expression (accolla et al., " salter et al., sherman et al., sherman et al., , blanar et al., , ama[di et al., celada et al., ) . these trans-acting regulatory factors have been postulated to function positively or negatively, and to be expressed ubiquitously, or in a tissue-or stage-specific manner. although ifnq, is considered the primary inducer of class ii antigens, there is evidence for other cytokines contributing to class i expression. we have previously shown that tnf-~ enhances ifnq,-induced class ii antigen expression on astrocytes, and that this is a synergistic interaction as tnf-a alone has no effect on class i expression (benveniste et al., ) . the present study was undertaken to extend these previous findings, and to examine, at the molecular level, the effect of fn-y and tnf-a on astrocyte class ii gene expression. we report that astrocytes express class ii mrna h after treatment with ifn- ¢ or fn-t/tni'-~,, indicating a long lag period between exposure to the cytokines and initiation of class ii gene expression. tnf-~ does not act to stabilize ifnq,-induced class ii mrna, suggesting it may act at other levels of post-transcriptional control or at the transcriptional level. furthermore, the expression of class ii mhc mrna was completely inhibited by cycloheximide (chx), suggesting a role for newly synthesized proteins in astrocyte class ii mhc expression. as astrocytes can be stimulated to secrete tnf-a (robbins et al., ; lieberman et al., ; chung and benveniste, ) , and express high affinity tnf-a receptors (benveniste et al., ) , tnf-a can act in an autocrine fashion to enhance class ii gene expression in astrocytes. by modulating class ii gene expression and thereby stimulating the apc function of astrocytes, ifn-y and tnf-a in concert may play a pivotal role in the regulation of intracerebral immune responses. rat recombinant ifn-y (specific activity: x u/mg) was purchased from amgen biologicais (thousand oaks, ca, u.s.a.), and human recombinant tnf-a (specific activity: . x u/mg) was the generous gift of genentech (south san francisco, ca, u.s.a.). monoclonal antibody to glial fibrillary acidic protein (gfap) was obtained from boeringher mannheim (indianapolis, in, u.s.a.), and monoclonal antibody to rat class i mhc antigens (clone ox- ) was from accurate corporation (westbury, ny, u.s.a.). second antibody was affinity-purified goat anti-mouse lg conjugated to fluorescein-isothiocyanate (fitc) from southern biotechnology (birmingham, al, u.s.a.). cycloheximide and actinomycin-d were purchased from sigma chemical company (st. louis, mo, u.s.a.) . primary glial cell cultures were established from neonatal rat cerebra by a modification of the mccarthy and de vellis technique ( ) as previously described (benveniste and merrill, ) . meninges were removed from rat brains prior to glial cell dissociation and culture. culture medium (cm) was duibecco's modified essential medium (dmem), high glucose formula supplemented with glucose to a final concentration of g/l, mm glutamine, . mm non-essential amino acid mixture, . % gentamicin, and % fetal bovine serum (hyclone, logan, ut, u.s.a.). after days in primary culture, oligodendrocytes were separated from the glial cultures by mechanical dislodging, and the astrocytes were obtained by trypsinization ( . % trypsin/ . % edta) and replated at a density of - x cells/ mm tissue culture plate and allowed to adhere for at least h. the cells were counted using trypan blue; cell viability was - %. the astrocytes were monitored for purity by immunofluorescence, and by non-specific esterase staining for contaminating microglia as previously described (benveniste and merrill, ) . the primary astrocytes were plated ( . x ) on mm glass coverslips, incubated in culture medium for days, washed twice with phosphate-buffered saline (pbs), and fixed for s in cold acetone. the cells were then stained for gfap, an intracellular antigen unique to astrocytes (bignami et al., ) , using a monoclonal antibody to gfap ( : ) for min at room temperature, followed by a min incubation with goat anti-mouse ig/fitc ( : ). the coverslips were then mounted in % glycerol, and visualized by fluorescent microscopy. astrocyte cultures were routinely > % positive for gfap, and less than % of the cells were microglia based on their positive staining for non-specific esterase. total cellular rna was isolated from confluent monolayers of astrocytes that were incubated for various intervals ( - h) without or with ifn-y and/or tnf-a. in some experiments, the protein synthesis inhibitor, chx ( #g/ml) or the rna synthesis inhibitor, actinomycin d ( #g/ml), were added to the cytokine-treated astrocytes for - h. rna isolation followed the procedure of chomczynski ( ) . the cells were collected, washed times with cold pbs, and pelleted. rna was extracted with guanidinium isothiocyanate and phenol, and precipitated with ethanol. samples ( ~g) of total cellular rna were denatured with formaldehyde for rain at °c, and rna was size fractionated by electrophoresis through a . % agarose gel" containing ethidium bromide for visualization of s and s ribosomal rna bands. the visualization of rna bands was useful for assessing the integrity of the rna and for varifying the amount of rna loaded. the rna was then transferred to nitrocellulose paper in x standard saline citrate (ssc) ( m naci and . m sodium citrate) at °c. after the transfer, the nitrocellulose paper was air-dried and the rna cross-linked in a uv stratalinker oven. prehybridization was performed at °( in a solution containing % (v/v) formamide, x ssc, × denhardt's solution, p,g/ml of denatured salmon sperm dna, and . % sodium dodecyl sulfate (sds) for - h. hybridization was carried out at ( ` for h in prehybridization solution containing % dextran sulfate, . mm na phosphate buffer and denatured ? p-labeled murine class i e-e~ cdna probe ( x w' cpm/ml). the blots were then washed in x ssc (twice for min) at room temperature, followed by x ssc containing . % sds (twice for min) at °c and finally in . x ssc for rain at °c. the blots were dried between whatman filter paper and exposed to kodak x-omat ar film plus intensifying screens at - °c. the autoradiographs were quantitated by scanning densitometry with a bio-rad model video densitometer. filters were stripped to remove bound class mhc probe, and rehybridized with a second control probe, cyclophilin. a edna probe (peacll) specific for mouse class ii e-a (mathis et al., ) was the generous gift of dr. jerold woodward, university of kentucky. the . kb ecori insert was isolated, and labeled with [et-s p]deoxyctp using an amersham nick translation kit according to the manufacturer's instructions. a specific activity of . - x () ~ cpm/~g dna was routinely attained. a edna probe for rat cyclophilin (plb ) (danielson et al., ) was the generous gift of dr. jim douglass, the oregon health sciences university. primary rat astrocytes were resuspended in dmem containing % fetal bovine serum (fbs), and plated at - x ~ cells/well into -well ( mm) plates (costar, cambridge, ma, u.s.a.). the plates were incubated overnight to allow recovery of the cells from trypsinization and to assure adherence of the astrocytes. after h the original medium was aspirated off and fresh serum-free medium ( ml) was added to the wells. triplicate wells of primary rat astrocytes were treated with u/ml of recombinant rat ifn-y and/or ng/ml of recombinant human tnf-a for various incubation periods ( days). at each time point, the cells were trypsinized and stained for class it antigens, as previously described (benveniste et al., ) . briefly. astrocytes were incubated with ~ of ox- monoclonal antibody for rain in the cold. washed times with pbs containing . % fbs and . % azide (pbs-fbs-azide), and then incubated with /tl of goat anti-mouse ig-fit(" ( : ) for another rain in the cold. after washing times with pbs-fbs-azide, the cells were fixed in a final volume of ~ of % paraformaldehydc and analyzed on the facstar (becton-dickinson, mountain view, ca, u.s.a.) for class ii antigen expression. negative controls were incubated with /tl of pbs-fbs-azide in place of first antibody, or with an irrelevant monoclonal antibody of the same isotype. the gate window of forward-angle light scatter lay between channels and : the gate window for log of green fifc fluorescence lay between channels and . ten thousand cells were analyzed for each sample. the level of class i mhc mrna was examined in astrocytes following treatment for various times with ifn-y, tnf-a or a combination of the two cytokines. to determine the steady-state level of mrna for class ii, northern blot analysis was performed using a edna probe for murine class ii genes (e-a), with total rna isolated from cultured astrocytes. as seen in fig. , a . kb class ii mhc mrna transcript was present in ifn-~, treated astrocytes (lanes and ) and absent in untreated cells (lanes and ) . class it m}tc mrna expression was more pronounced when the cells were cultured with ifn-y in serum-free medium (sfm) (fig. , lane ) as opposed to serum-containing medium (fig. , lane ) , thus, all the subsequent experiments were con- in primary rat astrocytes. northern blot of rna from astrocytes that were incubated in serum containing media (lanes and ) or serum-free medium (sfm) (lanes and ) without (lanes and ) or with if'n-), ( u/ml) (lanes and ) for h. total rna was extracted and size fractionated by gel electrophoresis. hybridization was performed with a cdna probe (e-a) specific for a murine class i mhc gene. the blot was then exposed at - °c for h to kodak x-omat ar film plus two intensifying screens, kb, kilobases. ducted in sfm. optimal expression of class ii mrna was detected when cells were stimulated with - u/rnl of ifn-'r (data not shown). some variability in the concentration of ifn-t required for induction of class ii mrna was noted, and this variability was dependent on the lot of ifn- used. therefore, it was necessary to do a dose-response study for each lot of ifn-t used. for this study, u/ml of ifn-t was sufficient for maximal expression of class ii mrna. the optimal time required for class ii mrna expression following treatment of astrocytes with ifn-t is illustrated in fig. . astrocytes were incubated in sfm without or with ifn-~, for , or h prior to harvesting. a low level of class ii mhc mrna was detected at h following treatment with ifn-~,, with maximal expression detected after a h incubation with ifn-t. there was a . -fold increase in class ii mhc mrna expression from to h, and a slight reduction at h. we have previously shown that the level of class ii protein expression, based on fluorescenceactivated cell sorting (facs) analysis, was enhanced when the cells were treated with both ifn-t and tnf-a (benveniste et al., ) . similarly, in this present study, the incubation of as- kb fig. . kinetic analysis of ifn-y treatment on astrocyte class ii mhc mrna expression. astrocytes were cultured in sfm without (lanes , , and ) or with ifn-'r (lanes , , and ) for h (lanes and ) , h (lanes and ) or h (lanes and ). total rna was extracted and analyzed for class mrna by northern blot hybridization method. the blot was exposed to kodak x-omat ar film plus two intensifying ~reens at - °c for h. trocytes with both ifn-y and tnf-a resulted in an enhanced expression of class ii mrna compared to ifn- alone (fig. ) . optimal enhancement of class ii mrna was demonstrated using tnf-a at ng/ml (fig. , lane ) , which correlates with the concentration of tnf-a used for synergistic induction of class ii mhc protein (benveniste et al., ) . a . -fold increase in class ii mrna expression in the presence of ng/ml of tnf-a was detected, compared to ifn-y alone. as expected, tnf-a alone did not induce mrna for class ii antigens (data not shown). class ii mhc mrna expression induced by ifn-y/tnf-a was also enhanced when experi- kb , for h. rna was isolated for analysis by northern blot hybridization method. the blot was probed with labeled e-a cdna, and exposed at - °c for h to kodak x-omat ar film plus two intensifying screens. lg ments were performed in sfm (data not shown), indicating that a serum component(s) has a slight inhibitory effect on class i mrna expression. in other cell types, a lag phase of approximately - h precedes the appearance of class ii mrna induced by ifn- (basta et al,, ; blanar et al., , rosa and fellous, ; amaldi et al., ) . we performed a more indepth analysis of the kinetics of induction of class ii mrna by ifn- and ifn- /tnf-a in astrocytes. analysis of mrna was performed at different times after induction with ifn-y (fig. , lanes , , , and ) and ifn-y/tnf-a (fig. , lanes , , , and ). no class ii mrna was detected until h following treatment with ifn- , with maximal exvression detected h after exposure to ifn-y. similarly, class mrna was not detected until h in astrocytes that were stimulated with ifn- /tnf-a; however, the intensity of the rna signal was increased in the presence of both cytokines, as expected. thus, there was an h time lag before class ii mrna was detected in astrocytes. at early time points ( and h), mrna doublets are seen which ultimately merge into a diffuse, and ) . and h (lanes and ). astrocytes in sfm alone (lane ). the blot was exposed to kodak x-omat ar film plus two intensifying screens at - o c for days. more intense . kb band at h. this may be due to multiple transcription initiation sites described for the e-a gene (mathis et al., ) . in addition, a larger mrna species of . kb is seen at h. the significance of this band is unknown at this time. results for the induction of class ii mhc antigen expression and mrna accumulation are summarized in fig. . tnf-a increases ifn-v-induced class ii expression by increasing levels of mrna for the class ii molecule. however, it is not known whether tnf-a acts by increasing transcription or by stabilizing the mrna. experiments were conducted to assess class ii mrna stability in the presence of ifn- or ifn-y/tnf-a. class ii mrna was induced in astrocytes with either ifn-"/or ifn--//tnf-a for h, then actinomycin d (a transcription inhibitor) was added for various times ( , , , , , and h). total cellular rna was isolated and analyzed by northern blotting. preliminary results indicated that a decrease in class ii mrna was not detected until h of actinomycin d treatment (data not shown). subsequent experiments were performed utilizing rna extracted after , and h of actinomycin d treatment. as shown in fig. actinomycin d treatment, tnf-a did not appreciably affect the stability of e-a mrna compared to the stability of ifn-y-induced e-a mrna. in fact, it appears that tnf-a contributes to an accelerated destabilization of class ii mrna. the approximate half-life of e-a mrna in the presence of ifn-v/tnf-a was h, compared to greater than h in the presence of ifn-v alone. these same blots were reprobed for cyclophilin mrna to demonstrate that the integrity and quantity of rna loaded in each lane was similar (data not shown). these data indicate that tnf-a does not act by mrna stabilization to enhance if/q-v-induced class ii expression. the h delay in class ii mrna expression after ifn-v or ifn-v/tnf-a stimulation of as- trocytes suggests that signal transmission initiated by these cytokines involves a number of intermediary steps, possibly the expression of newly synthesized gene products. to test this, we examined whether protein synthesis was required for induction of class i mrna by ifn-v and ifny/tnf-a. chx, an inhibitor of protein synthesis, was added to astrocytes at a concentration ( /.tg/rnl) that inhibited protein synthesis by more than %, while still maintaining cell viability (data not shown). astrocytes were cultured for h in the presence of ifn-y, ifn-y/tnf-a, chx alone, ifn-y plus chx, ifn-y/tnf-a plus chx, rna extracted, and then analyzed. fig. demonstrates the effect of chx on the induction of class ii mrna by ifn-v and tnf-a. no mrna for class ii was detected in cells treated with chx alone, ifn-y plus chx, or ifny/tnf-a plus chx (fig. , lanes , , and ). inhibition of protein synthesis completely abolished the induction of class ii mrna by ifn-y and ifn-y/tnf-ct. however, there was no inhibition of cyclophilin mrna expression (fig. b) , and no alteration in the pattern of ethidium bromide staining of rna in all the samples treated with chx alone or chx plus the cytokines (fig. c) , indicating that chx did not cause a generalized inhibition of mrna expression in astrocytes. cyclophilin was used as a control for these experiments as rna levels do not change upon treatment with ifn-v or ifn-v/tnf-a. that newly synthesized protein(s) is required for the induction of the class ii mhc gene in astrocytes treated with ifn-y or ifn-y/tnf-a was suggested by results in fig. . the duration of protein synthesis required to allow expression of the class ii mhc gene in astrocytes was examined in cells that were pretreated with ifn-y or ifn- /tnf-a for different lengths of time prior to the addition of chx. class ii mhc mrna was measured h after the treatments were started. as shown in fig. a , when chx was added simultaneously with ifn-y/tnf-a or - h after ifn-y/tnf-a treatment, there was no detectable expression of class ii mhc mrna. however, when astrocytes were incubated with ifn- however, in samples that were treated for h with ifn-y/tnf-c~ before ctlx was added, there was still a % reduction in the expression of class ii mhc signal compared to the positive control of fn-y/tnf-a alone (fig. a, lane ) , suggesting that continuous synthesis of protein is required for optimal expression of the class mhc gene. chx treatment had no effect on the expression of cyclophilin rna (fig. b) . similar results were seen when astrocytes were incubated with ifn-t and chx, except that the expression of class ii mhc mrna was detected only after cells were incubated with ifn- for h prior to the addition for h. total rna was extracted, northern blot hybridization performed and the blot was exposed to kodak x-omat ar film plus two intensifying screens at - °c for days. autoradiograph of class ii mrna (a). autoradiograph for cyclophilin mrna was obtained by stripping class i probe and rehybridizing with a second probe to detect cyclophilin mrna expression (b). photograph of the original gel stained with ethidium bronude to show that there was no alteration in the quantity or the quality of rna in all the samples treated with chx (c). ~q /tnf-a for h prior to addition of chx, and class ii rna measured h later, a low level of class ii rna was detected. the increase in the level of class i mhc mrna detected parallels the increase in the amount of time the cells were treated with ifn-t/tnf-a before the addition of chx, i.e., the longer the treatment with ifn- /tnf-a before the addition of chx, the stronger the mrna signal. these results, therefore, suggest that protein synthesis, initiated within h of the cells encountering ifn-t/tnf-a, is critical for subsequent class ii mhc mrna expression. the blot was exposed at - ° c for days to kodak x-omat ar film plus two intensifying screens (a). autoradiograph for cyclophilin mrna obtained by stripping class ii probe and rehybridizing with a second probe to detect cyclophilin mrna (b). photograph of the original gel stained with ethidium bromide (c). of chx (data not shown), indicating that h of protein synthesis was critical for ifn-~-induced class ii mrna expression. in this study we have shown that primary neonatal rat astrocytes, upon stimulation with ifn-~,, express mrna transcripts for class ii mhc genes, and that tnf-a enhances the expression of ifn-~,-induced class ii mrna. these results support previous findings that ifn-~, and tnf-a synergize in the induction of class ii mhc protein expression in rat astrocytes (benveniste et al., ) . kinetic analysis demonstrated that class ii mrna was first detected after h of treatment with ifn-y, followed by an increase in mrna expression over the next h. when astrocytes were treated with ifn-~, and tnf-a simultaneously, the kinetics of class ii mrna expression did not change; however, the overall amount of steady-state class ii mrna was increased. optimal expression of class ii mrna was detected h after incubation with ifn- , alone or ifn-~,/tnf-a. although the predominant forms of gene regulation occur at the transcriptional level, a number of control mechanisms can act on rna once its transcription has been initiated. post-transcriptional regulatory mechanisms include ( ) changes in mrna stability, ( ) alternative rna splicing, ( ) poly a addition, and ( ) control of translational initiation. in our experiments, tnf-a did not increase the stability of ifn- ,-induced class ii mrna, indicating that tnf-a did not act at that level of post-transcriptional control. preliminary results from our laboratory suggest that the increase in class ii mrna occurs primarily by an increase in transcription of the e-a gene since nuclear run-on assays detected no transcription of the class ii genes without induction by ifn-y, and enhanced transcription in the presence of ifn-~, plus tnf-a. further experimentation is necessary to determine conclusively if tnf-a acts solely at the transcriptional level, or whether both transcriptional and post-transcriptional events result in increased class ii mhc mrna and protein. the time required for the appearance of class ii mhc mrna following treatment with ifn-~, or ifn-~,/tnf-a ( h) suggests that cytokine signal transmission is complex and may involve a number of intermediary steps. we examined whether protein synthesis was required for ifn-), or ifn-"t/tnf-a-induced expression of astrocyte class ii genes. the expression of class ii mrna was completely inhibited when chx was included with ifn-~, and ifn-'t/tnf-~ treatment, indicating that newly synthesized protein is required for astrocyte class ii mhc gene expression. a minimum of h of active protein synthesis was required for subsequent ifn-t/tnf-a-induced class ii mrna expression, while h was required for subsequent ifn-), expression. however, in experiments where chx was added h after treatment with ifn-), or ifn-),/tnf-~, there was still a % and % reduction, respectively, in the expression of class ii mrna compared to astrocytes incubated with the cytokines alone. this indicates that the synthesis of novel proteins is required continuously for optimal class ii gene expression in astrocytes. other studies have shown that protein synthesis was required for up to h after ifn-~, was added to murine p d cells to detect an increase in the level of i-aa (boettger et al., ) , while in peritoneal mouse macrophages, a % decrease in i-at~ mrna levels was observed even when chx was added after h of ifn-'rtreatment (fertsch et al., ) . in contrast, celada et al. ( ) demonstrated that protein synthesis was only required for rain after murine macrophages were treated with ifn-), for an increase in i-aft mrna to be detected. thus, different cell types have varying requirements for active protein synthesis to express class ii mrna in response to ifn-),. other reports on ifn-t-induced expression of class i genes have indicated that protein synthesis is not required. induction of dra mrna in the human glioblastoma cell line u -mg (basta et al., ) , dermal fibroblasts (collins et al., ) and i-aa in murine wehi- cells (woodward et al., ) , occurs in the absence of protein synthesis. this suggests that the expression of class ii mrna in these cells is mediated by pre-existing trans-acting factors that are triggered by ifn-'t (woodward et ai., ) . it is also important to note that primary astrocytes (this study) and glioblastoma cells (basta et al., ) differ in their requirements for protein synthesis for class expression, illustrating fundamental differences between normal astrocytes and transformed glial cells. tnf-a may be an important enhancer of class i expression in the cns as it can function in an autocrine fashion on the astrocyte. in addition to responding to tnf-a and expressing specific high affinity receptors for this factor (benveniste et al., ) , astrocytes can also secrete tnf-a (robbins et al., ; sawada et al., ; chung and benveniste, ) . more importantly, ifn-t primes the astrocyte to produce tnf-a (chung and benveniste, ) , thus ifn-t can influence both tnf-a and class ii gene expression in the astrocyte. although class ii expression on astrocytes has been conclusively demonstrated in vitro, in vivo studies have generated conflicting results. direct injection of ifn-t into the brains of mice induced class ii antigens on astrocytes, indicating that astrocytes have the potential to express these antigens in vivo (wong et al., ) . many laboratories have examined whether astrocytes express class i antigens in a variety of immune-mediated disease states to better understand the possible role of the astrocyte as a local apc. traugott et al. ( ) demonstrated class ii expression on astrocytes in active chronic multiple sclerosis (ms) lesions, and then confirmed these studies by performing double-staining for both class ii and gfap (traugott and lebon, ) . a study by hofman et al. ( ) also identified class ll-posirive astrocytes in ms brain by double-staining. rodriguez et al. ( ) have studied class i expression on glial cells in an animal model of cns demyelination induced by theiler's virus. in susceptible strains of mice (bio.s and bio.asr ), the majority of class ii-positive glial cells had morphological characteristics of astrocytes, while uninfected mice or resistant strains (bio.s, ( r)) were class ii negative. in sjl mice with acute or chronic relapsing experimental allergic encephalomyelitis (eae), an animal model for ms, some class ii-positive ceils were identified as astrocytes (sakai et al., ) . however, other studies investigating the eae model in lewis rats failed to detect class ii-positive astrocytes in the brain (hickey et al., : matsumoto et al., vass et al., ) . thesc conflicting results may bc due solely to technical problems involved with antigen fixation and staining methodologies, or may indicate that the ability of astrocytes to function as apc in vivo may only bc relevant in certain diseases or specific stages of disease. another possibility may be the loss of class ii-positive astrocytes by class ii mhc-restricted t cell-mediated cytotoxicity as shown by sun and wekerle ( ) . the disease eae appears to be strain-specific as brown-norway rats and balb/c or c bl/ mice are resistant, whereas lewis rats and sjl mice are susceptible (linthicum and frelinger, ) . recent studies have demonstrated that astrocytes derived from susceptible strains express much higher levels of class ii antigen upon treatment with either ifn-~, or virus compared to astrocytes prepared from eae-resistant strains (massa et al., a, b) . this hyperinduction of class ii in eae-susceptible animals was astrocyte specific as both peritoneal macrophages and microglial cells of susceptible and resistant strains showed identical patterns for class ii induction. this differential expression of class ii on astrocytes in response to ifn-t compared to microglia suggests that regulation of class i expression on astrocytes may correlate with antigen-presenting capacity and ultimately, disease development in the cns. we have begun, at the molecular level, to dissect the regulatory mechanisms utilized by primary rat astrocytes for class i mhc gene expression. future studies will focus on the regulation of gene expression at the transcriptional level, and ifn-t/tnf-a-induced trans-acting regulatory factors required for class ii gene expression. reactivation by a trans-acting factor of human mhc-ia gene expression in interspecies hybrids between an ia-negative human b cell variant and an la-positive mouse b cell lymphoma induction of hla class ii genes by ifn-y is transcriptional and requires a trans-acting protein identification of an interferon-y response region ' of the human histocompatibility leukocyte antigen dret chain gene which is active in human glioblastoma multiform lines detailed delineation of an interferon-y-responsive element important in human hla-dra gene expression in a glioblastoma multiform line role of mhc gene products in immune regulation stimulation of oligodendroglial proliferation and maturation by interleukin- tumor necrosis factor-a enhances interferon-y mediated class i! antigen expression on astrocytes induction and regulation of interleukin- gene expression in rat astrocytes localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence a ( ) transcriptional activation of hla-dra by interferon y requires a trans-acting protein cycloheximide, an inhibitor of protein synthesis, prevents y-interferon-induced expression of class ii mrna in a macrophage cell line lnterferon-y activates multiple pathways to regulate the expression of the genes for major histocompatibility class ii i-a#, tumor necrosis factor and complement component c in mouse macrophages single step method of rna isolation by acid guanidinium thiocyanate-phenolchloroform extraction tumor necrosis fac- tor-alpha production by astrocytes: induction by lipopolysaccharide, interferon-gamma and interleukin- recombinant human tumor necrosis factor increases mrna levels and surface expression of hla-a,b antigens in vascular endothelial cells and dermal fibroblasts in vitro plbl : a cdna clone of the rat mrna encoding cyclophilin induction of macrophage la antigen expression by rlfn-y and down-regulation by ifn-a/fl and dexamethasone are mediated by changes in steady-state levels of la mrna induction of macrophage la antigen expression by rlfngamma and down regulation by ifn-alpha/beta and dexamethasone are regulated transcriptionally astrocytes as antigen presenting cells, t. induction of la antigen expression on astrocytes by t cells via immune interferon and its effect on antigen presentation production of prostaglandin e and an interleukin-l-like factor by cultured astrocytes and c glioma cells astrocytes present myelin basic protein to encephalitogenic t-cell lines astrocytes of the brain synthesize interleukin- - ike factors antigen presentation and tumor cytotoxicity by interferon-y-treated microglial cells on the cellular source and function of interleukin- produced in the central nervous system in viral diseases class ii mhc-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific th clones interleukin- of the central nervous system is produced by ameboid microglia tissue distribution of la antigens: la on spermatozoa, macrophages and epidermal cells primary rat astroglial cultures can generate leukotriene b functional interactions between astrocytes and neurons expression of la molecules by astrocytes during acute experimental allergic encephalomyelitis in the lewis rat immunoregulatory molecules and il- receptors identified in multiple sclerosis brain astrocytes induce bloodbrain barrier properties in endothelial cells production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus acute autoimmune encephalomyelitis in mice. i . susceptibility is controlled by the combination of h- and histamine sensitization genes antigen presenting function of class !i mhc expressing pancreatic beta cells viral particles induce la antigen expression on astrocytes inducibility of la antigen on astrocyte by murine coronavirus jhm is rat strain dependent hypersensitivity of la antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis the murine e-a immune response gene lmmunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to la-positive cells with dendritic morphology presentation of myelin basic protein by murine cerebral vascular endothelial cells preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissues neuron-glial relationship during granule cell migration in developing cerebellar cortex. a golgi and electromicroscopic study in maccacus rhesus production of cytotoxic factor for oligodendroeytcs by stimulated astrocytes immune response gene products (la antigens) on glial and endothelial cells in virus-induced demvelination regulation of hla-dr gene by ifn-~,. transcriptional and post-transcriptional control ) la expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured t cell lines in mice evidence for two trans-acting genes regulating hla class ii antigen expression pr(xluction of tumor necrosis factor-alpha by microgila and astrocytes in culture upstream dna sequences required for tissue-specific expression of the hla-dra gene class ii box consensus sequences in the hla-dra gene: transcriptional function and interaction with nuclear proteins axonal guidance during development of the optic nerve: the role of pigmented epithelia and other intrinsic factors ) la-restricted encephalitogenic t lymphocytes mediating eae lyse autoantigen-presenting astrocytes astrocytes produce interferon that enhances the expression of h- antigens on a subpopulation of brain cells interferon-'), and la antigen are present on astrocytes in active chronic multiple sclerosis lesions on the presence of la-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation the distribution of la antigen in the lesions of rat acute experimental allergic encephalomyelitis inducible expression of h- and la antigens on brain cells mhc class ii transcription in different mouse cell types: differential requirement for protein synthesis between b cells and macrophages this work was funded in part by grants rg -a- and rg -a- from the national multiple sclerosis society (e.n.b) and grant bns- from the national science foundation (e.n.b). we acknowledge the support of the university of alabama at birmingham flow cytometry core facility (am ).we thank mr. keith berry for facs analysis, and ii yup chung, j. gavin norris and john r. bethea for helpful discussions. key: cord- -w x i im authors: volk, t.; kox, w.j. title: endothelium function in sepsis date: journal: inflamm res doi: . /s sha: doc_id: cord_uid: w x i im endothelial cells can be the prime target for an infection and infected endothelial cells may serve as an initiating system for a systemic response as these cells are able to secrete many mediators known to be of paramount importance. endothelial cell functions in turn are regulated by these circulating mediators. cellular interactions with leukocytes revealed protective and destructive functions. single cell and animal studies indicate that endothelial permeability is increased and apart from clinical obvious edema formation in septic patients, the endothelial component remains unknown. endothelial coagulation activation has been shown in vitro, however human data supporting an endothelial procoagulatory state are lacking. defects in endothelium dependent vasoregulation in animal models are well known and again human studies are largely missing.¶an imbalanced production of reactive oxygen species including nitric oxide has been found to be involved in all endothelial functions and may provide a common link which at present can be supported only in animal studies. sepsis is considered the leading cause of death in noncoronary intensive care units. it has been defined as a systemic inflammatory reaction to an infection. among many cellular disturbances endothelial cells play a major role in the pathogenesis of this disease as these cells are critically involved in maintaining a delicate balance between vasoconstriction and vasodilation, blood cell adherence and nonadherence, anticoagulation and procoagulation, permeability and thightness. all these functions are believed to be imbalanced and impairment is believed to precede clinically recognizable alterations (e.g. bleeding, edema, organ dysfunction and shock) but it is by no means clear whether these changes are the cause or consequence of endothelial dysfunction in sepsis. endothelial functions have largely been studied in vitro from the first successful attempts of culturing isolated human endothelial cells dating back to the early ties. endothelial cells from and within different organs or different species behave differently and tend to change properties the longer they are kept in culture. to overcome isolation variabilities several endothelial cell lines are currently available which have retained at least some features. however, experiments from single cell cultures are flawed in many ways and results from these may never be of any relevance to medical practice. it is inherent to any cell culturing that data obtained from these experiments often are restricted to cell type, time of culture and general working conditions. in vitro stressed endothelial cells almost uniquely tend to activate a functional program leading to a proinflammatory, procoagulatory and hyperpermeable phenotype. in this review we want to summarize investigations of disturbed endothelial functions including infection, mediator and cellular interactions, permeability, coagulation and vasoactivc properties from molecular findings to patient care. staphylococcus aureus is the most prevalent bacterial pathogen isolated from patients with blood stream infection in north america [ ] . s. aureus has been reported to directly infect human umbilical vein endothelial cells (huvec) thereby inducing secretion of cytokines and functional upregulation of adhesion molecules [ ] . internalized s. aureus may lead to apoptosis in huvec [ ] or persistence as small colony variants [ ] . group a streptococci can enter huvec [ ] , a process which may render these cells particularly sen-sitive to otherwise subtoxic concentrations of hydrogen peroxide [ ] . group b streptococci (gbs) are the most common cause of neonatal sepsis and pneumonia. gbs-induced endothelial cell injury can be confirmed by histological findings at autopsy, in animal studies and in vitro [ ] . gbs invasion and subsequent damage of endothelial cells may be inhibited by cytochalasin d in huvec implicating that cytoskeletal interactions are important for toxicity. however, invasion of brain microvascular endothelial cells by gbs may be dose dependently cytotoxic due to beta-hemolysin production [ ] . streptococcus pneumoniae may enter activated endothelial cells using paf-receptors [ ] . this receptor engagement may also serve as a sorting signal for endothelial transcytosis [ ] . infection and activation of endothelial cells by listeria monocytogenes is believed to be a critical component of the pathogenesis of this disease and includes ceramide generation, transcription factor activation and increases in adhesion molecule expression on huvec [ ] . listeria have been described to enter huvec either directly via internalin b or by a cell-to-cell spread from infected monocytes [ ] . gram negative bacteria have lipopolysaccarides (lps) within their cell wall. cellular binding of lps usually is accomplished by cd . endothelial cells lack cd receptors and lps effects on endothelial cells generally require the presence of cd in the serum. lps effects from gram negative live bacteria (b. fragilis, e. cloacae, h. influenzae, k pneumoniae) on endothelial cells have been demonstrated by transcription factor activation and subsequent surface expression of e-selectin and tissue factor which was not seen from viable or heat-killed gram-positive bacteria (s. aureus, e. faecalis, s. pneumoniae) [ ] . neisseria meningitidis adherence on endothelial cells has been reported to be influenced by pilus protein c expression and cd on endothelial surfaces [ , ] and may cause tissue factor expression due to the presence of lps within the cell wall. haemophilus influenzae generally is not toxic to endothelial cells except three clones of biogroup aegyptius causing brazilian purpuric fever [ ] . toxicity has been reported to be independent of endotoxin, phagocytosis and replication since irradiation, cycloheximide, cytochalasin d and methylamine have no effect on the ability of the bacterium to invade and cause a cytotoxic response. piliated pseudomonas aeruginosa adheres to and enters human endothelial cells leading to progressive damage [ ] or may persist by lysis of endosomal membranes [ ] . escherichia coli may invade human brain microvascular endothelial cells involving specialized proteins [ , ] . endothelial infection by chlamydia pneumoniae also activates endothelial cells to produce cytokines and adhesion molecules and become procoagulant [ ] [ ] [ ] . bartonella quintana, the cause of trench fever transmitted by the body louse, has recently been implicated in culture-negative endocarditis and bacteraemia amongst homeless people [ ] . infection and damage of endothelial cells by b. quintana has been demonstrated in vitro and in vivo [ ] . interaction of bartonella henselae with endothelial cells may result in bacterial aggregation on the cell surface and the subsequent internalisation of the bacterial aggregate by a unique struc-ture, the invasome [ ] . rickettsia rickettsii, an obligate intracellular gram-negative bacterium which causes rocky mountain spotted fever, inhibits endothelial apoptosis allowing to remain inside the host endothelium [ ] but is also known to cause a proinflammatory endothelial phenotype. rickettsia conorii causes mediterranean spotted fever which causes endothelial infection with secretion of cytokines, increases in adhesion molecules and induction of surface tissue factor [ , ] . attachment of borrelia burgdorferi, the agent inducing lyme disease, to endothelial cells may be accomplished by cd , alpha(v)beta and alpha beta integrins or different classes of proteoglycans [ ] [ ] [ ] . b. burgdorferi activates the transcription of chemokine and adhesion in molecule gene expression in endothelial cells [ ] . plosmodium infected erythrocytes may bind to endothelial cells via p-selectin, cd , intercellular adhesion molecule (icam- ) or platelet endothelial cell adhesion molecule (pecam- ) on the endothelial surface [ ] [ ] [ ] . phagocytosed live candida albicans stimulates cytokine secretion and inducible cyclooxygenase expression in endothelial cells [ , ] . some viral diseases are known to primarily infect endothelial cells and alter their function. dengue virus infection of huvec leads to production of chemoattractant proteins rantes and il- [ ] , herpes and measles virus infection of brain microvascular endothelial cells increases lymphocyte adhesion by increasing icam- [ ] and measles virus and cytomegalovirus increases tissue factor expression on huvec [ , ] . hemorrhagic fever caused by hantaviruses may be accomplished by integrin mediated endothelial infection [ ] . on the other hand, ebola virus infects endothelial cells with a transmembrane glycoprotein and inhibits inflammatory responses [ ] . exotoxins are known to directly activate endothelial cells. platelet activating factor (paf), no˙and pgi secretion from huvec has been demonstrated by e. coli hemolysin via inositolphosphate/diacylglycerol formation and by s. aureus alpha-toxin via transmembrane ca + entry [ ] . there is increasing evidence that hemolytic uremic syndrome results from the systemic action of verocytotoxin producing e. coli on vascular endothelial cells [ ] . alpha toxin from clostridium perfringens is a phospholipase c and has been reported to induce adhesion molecule expression and secretion of chemokines from endothelial cells [ ] . brain capillary endothelial cells have been reported to express mbec , a protein that may serve as the c. perfringens enterotoxin receptor [ , ] . the activity of small gtpase rho has been shown to be altered by c. difficile toxin b [ ] and pasteurella mulrocida toxin [ ] , which leads to alterations of endothelial permeability. p. aeruginosa exotoxin a may directly injure endothelial cells by a motif shared by many toxins [ ] . listeriolysin and phosphatidylinositol-specific phospholipase c secreted from l. monocytogenes has been shown to induce phosphatidyinositol metabolism and diacylglycerol formation in the absence of bacterial uptake by the endothelial cells [ ] . some bacterial exotoxins have been used for years as pharmacological tools like pertussis toxin for studying g-protein dependent endothelial cell functions. lipoteichoic acid and peptidoglycan from cell wall components of gram positive bacteria have been shown to induce sepsis in animal models. while lipoteichoic acid has been reported to directly activate endothelial cells [ ] , peptidoglycan seems monocyte dependent [ ] . most in vitro experiments, however, were performed with different sources of lps as a surrogate activator modelling gram negative bacterial infection. endothelial stimulation using lps in relevant concentrations are usually performed in the presence of serum containing soluble cd -receptor because endothelial cells generally lack cd . alternatively, proinflammatory cytokines including tumor necrosis factor alpha (tnf-a), interleukins (il- , il- ) and interferon gamma (ifng) acting on endothelial cells have extensively been investigated and shown to alter endothelial in vitro functions [ , ] . the inflammatory response in endothelial cells has been linked to an alteration in reactive oxygen production including superoxide (o -˙) , hydrogen peroxide (h o ), nitric oxide (no˙), hydroxyl radicals (oh˙) and secondary reaction products thereof. o -˙i s believed to be present in unstressed conditions in less than nanomolar quantities within cells. mitochondrial and cytoplasmatic superoxide dismutase readily reacts with o -˙f orming h o which has been measured in micromolar concentrations in human blood. sources of endothelial o -˙p roduction apart from mitochondrial leakage may include metabolism of cytp or other metabolic byproducts and production by a nadh oxidase system or by nitric oxide synthase in the absence of l-arginine. some bacterial pathogens are known to be able to produce h o by themselves, however interaction with the endothelium may greatly enhance cellular alterations. streptococcal hemolysin, streptolysin s, is capable of interacting with h o to injure vascular endothelial cells [ ] . iron bound to the p. aeruginosa siderophore, pyochelin, augments oxidantmediated endothelial cell injury by modification of transferrin to form iron complexes capable of catalyzing the formation of oh˙from o -˙a nd h o [ ] . r. rickettsii infection of the endothelial cell line ea.hy and huvec has been demonstrated to cause glutathione depletion, a major intracellular antioxidant, and reduced glutathione peroxidase activity leading to increased amounts of intracellular peroxide [ ] . an increase in reactive oxygen species production has been shown in endothelial cells after incubation with lps, il- , tnf-a and ifn-g [ ] [ ] [ ] [ ] [ ] [ ] . tnf-a has many times been reported to increase, e.g., adhesion molecule expression inhibitable by various antioxidants [ , [ ] [ ] [ ] . nitric oxide, like o -˙, is chemically not very reactive at all. endothelial production has been established by either constitutive no-synthase (nos) iii in a ca + and phosphorylation dependent manner or by inducible nos ii. direct biochemical actions of no˙include metalcomplex containing proteins, other radical species, oxygen and oxygen derivatives leading to oxidation, nitrosation and nitration. relevant concentrations in vivo have been reported to range from nm to mm. no˙directly reacts with oxyhemoglobin (fe -o ) leading to methemoglobin (fe + ) and nitrate (no -). no˙reacts with o forming nitrite (no -) via intermediate no and n o . mainly n o is participating in n-or s-nitrosylations leading to nitrosamines or nitrosothioles, the latter may serve as a circulating source or as a transporter across cell membranes. reduced glutathione has a high affinity to n o and may also be important in toxicity related to no˙autoxidation. toxicity related cellular targets of no˙may include inhibition of cytochrome c oxidase, inhibition of catalase or dna damage. on the other hand, no˙has been reported to inhibit iron catalysed fenton reaction and to inhibit lipid peroxidation. iron nitrosyl formation in heme containing proteins are the best characterized reactions for no˙in biology. this type of interaction includes very sensitive stimulation of guanylate cyclase and inhibition of cytochrome c oxidase. e. coli hemolysin and s. aureus alpha toxin induce no˙formation in cultured porcine pulmonary endothelial cells [ ] . transformed mouse endothelial cells stimulated by the combination of ifn-g and tnf-a killed intracellular r.conorii by a mechanism that required the synthesis of no˙ [ ] . ifn-g, tnf-a and il- stimulated murine endothelial cells have been shown to kill schistosoma mansoni through the production of nitric oxide [ ] . both no˙and o -˙p roduction may have a limited influence on endothelial viability under resting conditions. cultured bovine and porcine aortic endothelial cells showed decreased no˙production after h of lps incubation which was related to decreases in capacitative ca + signals [ ] . posttranscriptional destabilization of nos iii mrna may have accounted for this early decrease in no˙production [ ] . nos ii, which is believed to produce larger amounts of no˙is also known to be regulated by many proinflammatory stimuli with significant cell type variablilities. at sites of endothelial involvement in an inflammatory process both vascular non-endothelial and non-resident cells are known to produce no˙. as the amount and physiological consequences of no˙produced from noss at the microcirculatory level is not known, it may well serve also to reduce inflammatory processes as recently implicated from a coculture experiment [ ] . that an increase in reactive oxygen species is present in human sepsis has been documented by almost any study trying to quantify secondary reaction products by several methods, however the cellular sources remain speculative ( table ). in beckman et al. showed that the presence of both no˙and o -˙p roduced peroxynitrite (onoo -) which may decompose to produce ho˙like molecules and thereby kill endothelial cells [ ] . at ph its lifetime is in the order of a second. half of the onoo formed is rapidly equilibrated to peroxynitrous acid (onooh) and breaks down to no - sepsis immunohistochemical endothelial nitrotyrosine≠ [ ] septic shock no -/no -, plasmatic nitrotyrosine≠ [ ] septic lung injury immunohistochemical endothelial nitrotyrosine≠ antioxidant capacity was defined as the ability of plasma to inhibit * ferryl myoglobin production by hydrogen peroxide addition to metmyoglobin or ** oxo-iron induced damage to deoxyribose, phospholipids and dna. tbars, thiobarbituric acid reactive substances; xod, xanthine oxidase. models and therefore question the view that this molecule solely is detrimental. toxicity induced by an interaction between hydrogen peroxide and nitric oxide has led to conflicting results. rat lung microvascular endothelial cells and porcine pulmonary artery endothelial cells exposed to h o have been reported to be protected by no˙donors [ , ] , whereas toxicity in bovine aortic endothelial cells [ ] and in rat liver microvascular endothelial cells [ ] was increased in the presence of no˙donors. no˙in the presence of h o may also produce oh˙like molecules independent of the presence of iron [ ] . neutrophils may add to the complexity of toxic reactions. myeloperoxidase from activated neutrophils, which produces hocl and oh˙molecules in the presence of o -˙, has recently been demonstrated to convert no into no , thereby damaging endothelial cells [ ] . high doses of reactive oxygen species (including no˙) have been shown to cause apoptosis of endothelial cells, whereas low doses were protective [ ] . in mice disseminated endothelial apoptosis has been suggested to be responsible for organ failure and shock induced by endotoxin or tnf-a [ ] . both lps or tnf-a usually do not cause endothelial cell death unless protein synthesis is blocked probably due to simultaneous increases in antiapoptotic protein synthesis [ ] . however, postmortal investigation in humans deceased from or with sepsis did not confirm these results [ ] . most of the genes activated in vitro during the endothelial stress response are controlled by at least two transcription factor families: activator protein (ap- ) and nuclear factor kappa b (nfkb). nfkb has gained wide interest as a target in inflammatory diseases as it seems to be invariably upregulated [ ] . a variety of agents including cytokines and reactive oxygen stress cause ikb to dissociate from the complex after phosphorylation by ikb-kinase complex. h o has been reported to activate transcription factor nfkb in porcine aortic endothelial cells [ ] whereas huvec were unresponsive [ ] . no˙has in most cases been shown to inhibit transcription factor nfkb and its influence on transcription factor ap- is unclear. inhibition of nfk-b as a therapeutic means has been suggested. however, as this transcription factor is also involved in protective gene regulation, its inhibition can make cells sensitive to e.g. tnf-a [ ] . data on activated intracellular signalling pathways in sepsis patients are scarce but include nfkb within mononuclear cells [ ] . usually any blood cell is kept off endothelial surfaces. this is believed to be accomplished by net electrical charge, biomechanical characteristics of flowing blood and the secretion of no˙. if blood cells touch the endothelium a ca + -signal is induced [ ] , but it is unclear at present whether this has any functional consequence. it is tempting to speculate that ca +signals may then in a context sensitive manner augment proadhesive processes or antiadhesive endothelial properties. activated endothelial cells are potent producers of cytokines like il- , a major proinflammatory cytokine, and chemotactic peptides including il- for neutrophils, macrophage inflammatory protein- alpha (mip- a), monocyte chemoattractant proteins - and rantes (regulated on activa-tion, normal t cell expressed and secreted) for monocytes, t-lymphocytes and dendritic cells, growth related protein (gro) and gamma-interferon-inducible protein (ip- ) for activated t-lymphocytes, epithelial neutrophil activating peptide (ena- ), vascular monocyte adhesion-associated protein (vmap- ) and endothelial monocyteactivating polypeptide ii (emap-ii) for monocytes [ ] . many adhesion molecules are expressed on the surface of endothelial cells in a highly complex yet regulated manner. p-selectin, e-selectin, icam- , vascular cell adhesion molecule (vcam- ), pecam- are well known for their stimulus-, cell-, time-and organ specific dependence of expression and their importance in regulation of leukocyteendothelial interactions. moreover, apart from being passive adhesion molecules, all of the above mentioned molecules have been shown to signal inside endothelial cells upon receptor engagement. shed receptors from endothelial surfaces may also serve as endogeneous antiadhesive molecules demonstrating even more the dynamic and complex nature of these processes. soluble forms of adhesion molecules have been shown to be present in high amounts in human sepsis (table ) , however whether this is beneficial or detrimental is not known and the assumption that these parameters may serve as practical indexes remains to be established. particularly ifn-g has been repeatedly shown to increase endothelial hla-dr expression rendering them capable of mhc class ii restricted interactions with cd + t-cells. costimulatory cd (b - ) and cd (b - ) are usually not present on endothelial surfaces leading to the conventional view that endothelial cells are semiprofessional antigen presenting cells. however, under certain conditions both costimulatory molecules and cd can be upregulated on endothelial surfaces indicating excessive antigen presentation [ ] . migration of lymphocytes into inflamed mouse tis-vol. , endothelial function in sepsis sues has been reported to depend on psgl- and esl- binding endothelial p-selectin and e-selectin, respectively [ ] . this phenotype was found to be restricted to th lymphocytes, but human sepsis seems to be predominated by a th type [ ] . both tnf-a and ifn-g are able to promote transmigration of leukocytes, whereas coapplication of both cytokines inhibit this process [ ] . t-cells migrating through the endothelial barrier in a pecam- -dependent manner are subject to inhibitory signals which may limit their activation in tissues [ ] . tnf bound to monocytes has been shown to inhibit endothelial apoptosis, whereas this process is promoted in the presence of lymphocytes [ ] . unperturbed endothelial cells express fas-ligand which has been implicated as a means of signalling apoptosis to constitutively fas receptor (cd ) bearing cells, whereas tnf-a treated endothelial cells decrease fas ligand expression thereby allowing leukocyte survival during extravasation [ ] . how the endothelium might interact specifically with lymphocytes or monocytes in septic patients can only be speculated on. neutrophils interacting with endothelial cells have repeatedly been shown to cause toxicity due to the release of enzymes and reactive oxygen species. if uncontrolled, these cells are believed to mediate significant tissue damage. however whether uncontrolled activation or rather deactivation is present in human sepsis is a matter of debate. endothelial cells have been reported to inhibit some neutrophil functions [ ] . transmigrated neutrophils may actively participate in the endothelial resealing process by the secretion of adenosin precursors [ ] . however, massive leukocyte extravasation as one would expect from most animal studies has never been shown in septic patients [ ] . endothelium is known to regulate transvascular fluid flux, flux of nutrients, mediators and cells by either paracellular or transcellular vacuolar channel related pathways. lateral junction proteins including the vascular endothelial cadherin-complex, platelet-endothelial cell adhesion molecule- , occludin, zona occludens- , recently described junctional adhesion protein, cd /platelet endothelial tetraspan antigen and cd /target of antiproliferative antigen are known to participate in this process. paracellular permeability is achieved by either an active contraction or the controlled release of an intrinsic tone mediated in most cases by the action of myosin light chain kinase (mlck) acting on non muscle myosin. generally an increase in the concentration of camp keeps cultured endothelial monolayers tight and cgmp has been reported to assist this function in human aortic and foreskin vessels [ ] . endothelial retraction may be initiated by increases in intracellular ca + concentration, but elevation of ca + in the presence of maintained camp-kinase dependent phosphorylation is not edemagenic. these antagonistic effects of ca + and camp in endothelial permeability regulation have recently been reviewed by moore et al. [ ] . many reports documented increases in endothelial permeability involving exotoxins like s. aureus alpha-toxin and p. aeruginosa cytotoxin [ , ] or endotoxins [ ] . for example, p. multocida toxin has been shown to activate rho/rho kinase, which inactivates mlc phosphatase. the resulting increase in mlc phosphorylation caused endothelial cell retraction and a rise in endothelial permeability [ ] . lps induced increases in paracellular permeability by caspase activated cleavage of adherens junction proteins [ ] . counteracting lipid peroxidation during lps activation may inhibit increases in permeability [ ] . tnf-a stimulated endothelial cadherin complex is disrupted in a proteasome dependent manner [ ] . the resulting increase in permeability has been reported to lower camp and activate phosphediesterase ii and iv [ ] . h o induced hyperpermeability of porcine pulmonary endothelial cells has been reported to be effectively reduced by cgmp elevating drugs including phosphodiesterase ii inhibition or no˙donators [ ] . the electroneutral na-k-cl cotransport system is thought to function in the maintenance of a selective permeability. il- , tnf-a and lps upregulate the expression of a bumetanide-sensitive na-k-cl cotransporter subtype in huvec and in murine lung and kidney endothelial cells [ ] . septic rats show different increases in albumin flux accross several endothelial beds [ ] . increases in venular permeability have been shown to be preventable by the antioxidants n-acetyl-cystein or tirilazad mesylate in e. coli infused rats [ , ] . il- , an antiinflammatory cytokine not produced by endothelial cells, was shown to participate as an inhibitor of endothelial permeability induced by lps in mice [ ] . clinically, increases in endothelial permeability may be obvious in many septic patients, but only recently venous congestion plethysmography showed a selectively elevated filtration capacity as a measure of endothelial dysfunction in septic patients [ ] . which of the many pathways of increased permeability might be turned on and whether it persists remains unknown. in principle endothelial cells are believed to be anticoagulatory by virtue of their surface expression of glycosaminoglycan-antithrombin iii complex, thrombomodulin, heparin releasable tissue factor pathway inhibitor and production of adenosine by ecto-adpases, their secretion of protein s, prostacyclin and no˙. no˙production was shown to participate in heparan sulfate preservation in porcine aortic endothelial cells [ ] and may be responsible for prostacyclin secretion by activating cyclooxygenase- under resting conditions [ ] . endothelial release of plasminogen activator (t-pa) and plasminogen activator inhibitor (pai- ) may determine the fibrinolytic potential of plasma. endothelial cells specifically bind coagulation factors xii, iia, ix, viia and xa. xa was shown to bind to endothelial effector cell protease receptor- and thereby cause release of no˙, il- , il- , mcp- and functional upregulation of icam- , e-selectin and vcam- [ ] . when endothelium is perturbed by physical or chemical factors transformation to a prothrombotic surface is invariably seen in in vitro models. thrombomodulin surface expression on huvec can easily be downregulated by lps, il- and tnf-a and upregulated by increasing camp [ ] . a tnf-a induced decrease in surface thrombomodulin has been suggested via activation of phosphodiesterase ii and iv thereby decreasing camp in baec [ ] . vascular endothelial growth factor may counteract il- , tgf-b and lps induced suppression of both thrombomodulin surface antigen and mrna [ ] . adenosin nucleotides are released from damaged as well as lps stimulated and shear stressed huvec [ ] . endothelial cells have atp diphosphohydrolase (cd ) on their surface to degrade atp via adp and amp to adenosine. adenosine is known to have antiaggregatory properties due to stimulation of prostacyelin and no˙production. however, activating endothelial cells with tnf-a has been reported to cause loss of atp diphosphohydrolase activity, which was preventable in the presence of antioxidants [ ] . tissue factor (tf) expression on endothelial cells by bacteria, lps, il- and tnf-a is well known. tissue factor pathway inhibitor (tfpi), a serine protease inhibitor of xa and xa/viia/tf complex on endothelial surfaces, which immediately blocks tissue factor activation, has been shown to be decreased under proinflammatory conditions. another counterbalancing mechanism includes shear stress in tnf-a stimulated huvec [ ] . however, an anticipated increase in endothelial tissue factor expression has not convincingly been demonstrated in animal or human sepsis [ , ] . fibrinolytic systems on endothelial surfaces are also believed to be altered in sepsis. increases in pai- has been reported after stimulation with il- or lps [ , ] . however soluble pai- in septic patients was not found to be different from nonseptic patients [ ] . once thrombin formation has occured, its cleavage of endothelial proteinase activated receptor (par) in turn may lead to secretion of il- and il- [ ] , upregulation of icam- and vcam- [ ] , relaxation via no˙production or to vasoconstriction by an as yet unidentified factor [ ] . these data may demonstrate an interconnection between coagulation activation, inflammation and vasoregulation mediated by the endothelium. coagulation activation is clearly present in septic patients, however endothelial participation in this process is unclear. potent procoagulatorv sources may well include bacterial surfaces per se [ ] or monocytes [ ] . up to the late ies the endothelium was viewed as a passive organ, which at best was able to remove vasoactive hormones in the lung. in - sir john vane's group (noble laureate ) reported that endothelial cells can synthesize i series prostaglandins (like prostacyclin) and thereby relax arteries and inhibit platelet aggregation. however, whether pgi regulates basal vascular tone is unclear. after a new technician used an unintended vessel preparation robert furchgott realized after a series of contradicting results that acetylcholine (ach) was no longer able to relax precontracted arteries when endothelium was removed and termed the nonprostanoid mediator an endothelium derived relaxing factor (edrf). in superoxide was shown to participate in vasoregulation. the presence of superoxide dismutase prolonged the action of edrf whereas addition of o -˙i nactivated edrf. even direct effects of several reactive oxygen species have been suggested to be relevant in cerebral or coronary circulation. collectively robert furchgott, louis ignarro and ferrid murad received the noble laureate in for demonstrating that no˙is a major edrf. endothelial cells produce more relaxing factors which pharmacologically can be separated from nitric oxide action and these were termed endothelium derived hyperpolarizing factors (edhfs). these factors may particularly be important in coronary and gastrointestinal vessels. epoxyeicosatrienoic acids, anandamide, the endogenous ligand of cannabinoid receptors or simply the release of k + may constitute edhfs. conceptually shear may in larger vessels primarily determine production of no˙, whereas cyclic strain determines physiological edhf release. soon after the discovery of edrf endothelin- (et- ), a vasoconstricting peptide produced from endothelial cells was isolated. low doses of et- can induce no˙release and subsequent relaxation via et breceptors on endothelial cells. endothelin secretion is thought to occur abluminally leading to et a -receptor activation on smooth muscle cells and subsequent vasoconstriction. many other factors clearly contribute to endothelial control of vasoregulation by e.g. transcellular production of vasoconstricting prostanoids like thromboxane a or prostaglandin h or the enzymatic conversion of angiotensin i to angiotensin ii by angiotensin converting enzyme. a hallmark of sepsis is the heterogeneous pattern of vasoconstriction and vasodilatation in different organs, culminating in a fall in total peripheral vascular resistance concomitant with regional maldistribution of blood flow. vasoactive substances produced by the endothelium under experimental septic conditions are known to be altered by factors such as no˙, pgi , angiotensin converting enzyme (ace) activity, endothelin and adrenomedullin. endothelium dependent vasoregulation has largely been studied in animal models (table ). in endothelium dependent vasoregulatory failure was seen as a defect in reactive hyperemia related vasodilator release [ ] and decreased dilatation of arterioles induced by ach [ ] . in a rat model of cecal ligation and puncture decreased vasoconstriction was found after administration of norepinephrine in septic animals which was largely reversible by removal of the endothelium [ ] . parker et al. [ ] showed in explanted coronary arteries and aortas of guinea pigs treated with lps intraperitoneally for h that endothelium dependent relaxation induced by acetylcholine and adp was depressed, whereas relaxation induced by substance p or receptor independent relaxations by ca + -ionophore a was unaffected. edrf release and bioactivity from explanted aortas of these animals was decreased after adp or ach stimulation, whereas a induced edrf release was unaltered [ ] . this group also demonstrated reduced adp and ach responses after h of lps endotoxemia in guinea pigs and that adp may produce constricting thromboxane in septic animals [ ] . in contrast, coronary arteries of rabbits treated for weeks with low doses of lps stimulation with ach but not adp showed increased relaxation of explanted vessels [ ] . wang et al. [ ] isolated subepicardial arterioles from rats treated h intraperitoneally with feces containing life e. coli and showed in a pressurized no-flow chamber that relaxation by alpha agonist clonidine and adp was reduced in an endothelium dependent manner, which could be inhibited by the nos inhibitor lnma. also, in this model mesenteric arter-vol. , endothelial function in sepsis iolar relaxation after adp and clonidine was decreased, whereas in skeletal muscle these agonists caused vasoconstriction [ ] . pulmonary arteries of rats treated with lps showed depressed endothelin- induced contractions which were even augmented in endothelium denuded vessels. the authors [ ] concluded that a vasoconstrictor eicosanoid is produced in lps treated animals by pulmonary endothelium upon et- stimulation. swine infused with live p. aeruginosa showed no alteration in endothelium dependent bradykinin and endothelium independent nitroprusside relaxation, whereas ach induced relaxation was found to be reduced in explanted peripheral arteries [ ] . chaudry's group investigated endothelium dependent relaxation in rats treated with cecal ligation and puncture. a time dependent alteration was demonstrated with increased ach induced vasorelaxation early after challenge whereas depressed vasodilatation after - h was found in explanted aortas with no alteration in nitroglycerine induced relaxation [ ] . the decreased endothelium dependent response to ach was also found in superior mesenteric arteries and small intestinal arteries [ ] . in the same model this group demonstrated a reduction of immunodetectable nos iii in explanted aortas [ ] . porcine coronary arterioles incubated for h with e. coli lps ( mg/ml) decreased bradykinin induced edhf secretion [ ] . carotid and coronary arteries from rabbits also showed decreases in edhf-release in an ex-vivo assay after treatment with lps, tnf-a and il- [ ] . collectively these data indicate that the majority of sepsis models consistently show a disruption of receptor coupled relaxation mechanism leading to an intraendothelial signalling deficit. to quantify endothelial function in humans several methods are available. endothelium dependent relaxation after pharmacological stimulation or flow dependent relaxation after vessel obstruction are frequently quantified by high resolution ultrasound techniques [ ] , alternatively flow and size can be determined angiographically. however, definite functional measurements in human sepsis are scarce. endothelium dependent relaxation has been investigated in isolated superficial hand veins of healthy volunteers after lps exposure. reduced vasorelaxation by bradykinin and arachidonic acid in noradrenalin precontracted vessels were noted which persisted for more than days [ ] . reactive hyperemia is believed to mainly test endothelial no˙production upon shear stress if vessel diameters and flow is monitored. implications from indirect measurements support an endothelial dysfunction in septic patients [ ] [ ] [ ] . however, data on pharmacological stimulation of endothelium dependent relaxation in humans are currently not available. t. volk +/-ec: presence or absence of endothelium; ne: norepinephrine; ach: acetylcholine; adp, adenosine diphosphate; sp, substance p; a , ca + -ionophore; cox, cycloogygenase; snp, sodium nitroprusside; ntg, nitroglycerine; et, endothelin; bk, bradykinin; edhf, endothelium derived hyperpolarizing factor; pres., preserved. table . endothelium dependent relaxation is impaired in animal sepsis models. a normal response to infection or other insults is a self limiting process that through temporal expression of regulators and effector molecules causes resolution. the failure to resolve the causative infection may lead to sepsis. cellular and animal models of sepsis using bacteria, endotoxins, exotoxins, cytokines or some peptides all consistently produce endothelial impairment which is usually regarded as dysfunctional. blocking the majority of pathways used by these inducing agents has often lead to the inhibition of such endothelial alterations. many aspects of these induced alterations can be expected to reveal exciting new pathways and complex interactions at various molecular and cellular level. the past has taught us that inhibitors of presumably activated pathways consistently failed to improve survival in septic patients. this has stimulated many researchers to reconcile the results of experimental and clinical models in sepsis. compared to activating pathways, considerably less is known about how an inflammatory response is endogenously counterregulated. cytokines induce a whole host of signal inhibiting proteins and endogenous counterregulating systems are just beginning to be elucidated. activation of endogenous counterregulatory systems may become the predominant feature of the so-called compensatory antiinflammatory response syndrome. endothelial responses to endogenously present antiinflammatory mediators have hardly been investigated in sepsis models. almost all endothelial cell studies in sepsis indicated that an imbalance in reactive oxygen species production is associated with the above described dysfunctions. animal studies in which endothelial function could be improved pharmacologically also consistently indicate that reversal of imbalanced reactive oxygen production may be a common link (table ). it seems that at times an adequate production of nitric oxide is lacking whereas superoxide and/or derivatives are overproduced. however, as endothelial functional measurements in septic humans become available, we will hopefully get a clearer picture of what might happen in our patients. [ ] clp, cecal ligation and puncture; lpo, lipid peroxidation; ros, reactive oxygen species. table . treatment of endothelial vasoregulatory dysfunction in animal sepsis models. bacterial pathogens isolated from patients wit bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the sentry antimicrobial surveillance program (united states and canada, ) staphylococcus aureus infections internalization of staphylococcus aureus by endothelial cells induces apoptosis staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu genetic inactivation of the extracellular cysteine protease enhances in vitro internalization of group a streptococci by human epithelial and endothelial cells interaction of viable group a streptococci and hydrogen peroxide in killing of vascular endothelial cells group b streptococci invade endothelial cells: type iii capsular polysaccharide attenuates invasion invasion of brain microvascular endothelial cells by group b streptococci streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor pneumococcal trafficking across the blood-brain barrier. molecular analysis of a novel bidirectional pathway two distinct phospholipases c of listeria monocytogenes induce ceramide generation, nuclear factor-kappa acivation, and e-selectin expression in human endothelial cells internalin b is essential for adhesion and mediates the invasion of listeria monocytogenes into human endothelial cells activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble cd interaction of neisseria maningitidis with the components of the blood-brain barrier correlates with an increased expression of pilc the ndomain of the human cd a adhesion molecule is a target for opa proteins of neisseria meningitidis and neisseria gonorrhoeae human microvascular endothelial tissue culture cell model for studying pathogenesis of brazilian purpuric fever pseudomonas aeruginosa selective adherence to and entry into human endothelial cells endothelial function in sepsis cincomitant endosome-phagosome fusion and lysis of endosomal membranes account for pseudomonas aeruginosa survival in human endothelial cells endothelial cell glcnac beta - glcnac epitopes for outer membrane protein a enhance traversal of escherichia coli across the blood-brain barrier escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe characterization of a strain of chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp gene and biological activity in human endothelial cells chlamydia species infect human vascular endothelial cells and induce procoagulant activity signal transduction pathways activated in endothelial cells following infection with chlamydia pneumoniae bartonella (rochalimaea) quintana endocarditis in three homeless men bartonella quintana invades and multiplies within endothelial cells in vitro and in vivo and forms intracellular blebs interaction of bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome nf-kappa b-dependent inhibition of apoptosis is essential for host cellsurvival during rickettsia rickettsii infection rickettsia conorii infection enhances vascular cell adhesion molecule- -and intercellular adhesion molecule- -dependent mononuclear cell adherence to endothelial cells il- and il- production from cultured human endothelial cells stimulated by infect on with rickettsia conorii via a cell-associated il- alpha-dependent pathway the role of cd in signaling mediated by outer membrane lipoproteins of borrelia burgdorferi integrins alpha(v)beta and alpha beta mediate attachment of lyme disease spirochetes to human cells different classes of proteoglycans contribute to the attachment of borrelia burgdorferi to cultured endothelial and brain cells borrelia burgdorferi upregulates the adhesion molecules e-selectin, p-selectin, icam- and vcam- on mouse endothelioma cells in vitro characterization of plasmodium falciparum-infected erythrocyte and p-selectin interaction under flow conditions intercellular adhesion molecule- and cd synergize to mediate adherence of plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells pecam- /cd , an endothelial receptor for binding plasmodium falciparum-infected erythrocytes candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells secreted aspartyl proteinases and interactions of candida albicans with human endothelial cells dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis adhesion molecule expression and lymphocyte adhesion to cerebral endothelium: effects of measles virus and herpes simplex virus measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro effects of viral activation of the vessel wall on inflammation and thrombosis cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta integrins ebola virus inhibits induction of genes by double-stranded rna in endothelial cells human endothelial cell activation and mediator release in response to the bacterial exotoxins escherichia coli hemolysin and staphylococcal alpha-toxin infection by verocytotoxin-producing escherichia coli alpha toxin from clostridium perfringens induces proinflammatory changes in endothelial cells brain capillary endothelial cells express mbec , a protein that is related to the clostridium perfringens enterotoxin receptors phospholipase c and perfringolysin o from clostridium perfringens upregulate endothelial cellleukocyte adherence molecule and intercellular leukocyte adherence molecule expression and induce interleukin- synthesis in cultured human umbilical vein endothelial cells glucosylation of small gtp-binding rho proteins disrupts endothelial barrier function pasteurella multocida toxin increases endothelial permeability via rho kinase and myosin light chain phosphatase evidence for a structural motif in toxins and interleukin- that may be responsible for binding to endothelial cells and initiating vascular leak syndrome the listerial exotoxins listeriolysin and phosphatidylinositol-specific phospholipase c synergize to elicit endothelial cell phosphoinositide metabolism lipoteichoic acid-induced neutrophil adhesion via e-selectin to human umbilical vein endothelial cells (huvecs) endothelial and epithelial cells do not respond to complexes of peptidoglycan with soluble cd but are activated indirectly by peptidoglycan-induced tumor necrosis factor-alpha and interleukin- from monocytes cytokines and endothelial cell biology cytokine regulation of endothelial cell function: from molecular level to he bedside pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury superoxide dismutase-dependent, catalase-sensitive peroxides in human endothelial cells infected by rickettsia rickettsii superoxide release from interleukin- b-stimulated human vascular cells: in situ electrochemical measuremeut lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells e-selectin expression in human endothelial cells by tnf-alpha-induced oxidant generation and nf-kappab activation superoxide responses of endothelial cells to c a and tnf-alpha: divergent signal transduction pathways lactosylceramide mediates tumor necrosis factor-alpha induced intercellular adhesion molecule- (icam- ) expression and the adhesion of neutrophil in human umbilical vein endothelial cells effect of antioxidants on lipopolysaccharide-stimulated induction of mangano superoxide dismutase mrna in bovine pulmonary artery endothelial cells ambient but not incremental oxidant generation effects intercellular adhesion molecule induction by tumour necrosis factor alpha in endothelium icam- and vcam- expression induced by tnf-alpha are inhibited by a glutathione peroxidase mimic glutathione peroxidase mimics prevent tnfalpha-and neutrophilinduced endothelial alterations pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells endothelial cells are activated by cytokine treatment to kill an intravascular parasite, schistosoma mansoni, through the production of nitric oxide escherichia coli endotoxin inhibits agonistmediated cytosolic ca + mobilization and nitric oxide biosynthesis in cultured endothelial cells expressional control of the "constitutive" isoforms of nitric oxide synthase (nos i and nos iii) inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury nitric oxide attenuates hydrogen peroxide-mediated injury to porcine pulmonary artery endothelial cells protective effects of tetrahydrobiopterin against nitric oxide-induced endothelial cell death endothelial damage induced by nitric oxide: synergism with reactive oxygen species hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide halliwell b van d v. formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation lipopolysaccharide induces the antiapoptotic molecules, a and a , in microvascular endothelial cells apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction nuclear factor-kappab: a pivotal transcription factor in chronic inflammatory diseases oxidant-sensitive and phosphorylation-dependent activation of nf-kappa b and ap- in endothelial cells endothelial activation by hydrogen peroxide. selective increases of intercellular adhesion molecule- and major histocompatibility complex class i adenovirus-mediated expression of a dominant negative mutant of p /rela inhibits proinflammatory gene expression in endothelial cells without sensitzing to apoptosis role of nfkappab in the mortality of sepsis endothelial function in sepsis initial contact and subsequent adhesion of human neutrophils or monocytes to human aortic endothelial cells releases an endothelial intracellular calcium store chemokines and leukocyte traffic cd ligation induced phenotypic and functional expression of cd by human cardiac microvascular endothelial cells cd + t cells migrate into inflamed skin only if they express ligands for e-and p-selectin t helper cell subset ratios in patients with severe sepsis cutting edge: combined treatment of tnf-alpha and ifngamma causes redistribution of junctional adhesion molecule in human endothelial cells a new role for platelet-endothelial cell adhesion molecule- (cd ): inhibition of tcrmediated signal transduction monocytes stimulate expression of the bcl- family member, a , in endothelial cells and confer protection against apoptosis negative regulation of inflammation by fas ligand expression on the vascular endothelium regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury neutrophil-derived ¢-adenosine monophosphat promotes endothelial barrier function via cd -mediated conversion to adenosine and endothelial a b receptor activation neutrophil migration during endotoxemia expression of cgmp-dependent protein kinase i and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin signal transduction and regulation of lung endothelial cell permeability interaction between calcium and camp bacterial exotoxins and endothelial permeability for water and albumin in vitro effects of escherichia coli hemolysin on endothelial cell function endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a -aminosteroid endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-tocell junctions tnf modulates endothelial properties by decreasing camp role of nitric oxide and phosphodiesterase isoenzyme ii for reduction of endothelial hyperpermeability expression of the bumetanide-sensitive na-k-cl cotransporter bsc is differentially regulated by fluid mechanical and inflammatory cytokine stimuli in vascular endothelium endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat n-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo effect of the -aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotoxemia endogenous interleukin- regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (vcp) endothelial-derived nitric oxide preserves anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? hypotension and inflammatory cytokine gene expression triggered by factor xa-nitric oxide signaling up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor increased release of atp from endothelial cells during acute inflammation loss of atp diphosphohydrolase activity with endothelial cell activation fluid shear stress attenuates tumor necrosis factoralpha-induced tissue factor expression in cultured human endothelial cells cell biology of tissue factor, the principal initiator of blood coagulation on behalf of the subcommittee on tissue factor pathway inhibitor (tfpi) of the scientific and standardization committee of the isth effects of lipopolysaccharide on the expression of fibrinolytic factors in an established cell line from human endothelial cells induction of plasminogen activator inhibitor type and type collagen expression in rat cardiac microvascular endothelial cells by interleukin- and its dependence on oxygencentered free radicals plasminogen: an important hemostatic parameter in septic patients potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression intercellular adhesion molecule- cd ) and vascular cell adhesion molecule- (vcam- ; cd ) dual endothelium-dependent vascular activities of proteinase-activated receptor- -activating peptides: evidence for receptor heterogeneity activation of the contact-phase system on bacterial surfaces -a clue to serious complications in infectious diseases reactive hyperemic responses of single arterioles are attenuated markedly after intestinal ischemia, endotoxemia and traumatic shock: possible role of endothelial cells failure of microscopic metarterioles to elicit vasodilator responses to acetylcholine, bradykinin, histamine and substance p after ischemic shock, endotoxemia and trauma: possible role of endothelial cells vascular endothelium contributes to decreased aortic contractility in experimental sepsis selective inhibition of endotheliumdependent vasodilator capacity by escherichia coli endotoxemia release of edrf and no in ex vivo perfused aorta: inhibition by in vivo e. coli endotoxemia inhibition of endothelium-dependent vasodilation by escherichia coli endotoxemia chronic endotoxemia and endothelium-dependent vasodilation in coronary arteries chronic septicemia alters alpha-adrenergic mechanisms in the coronary circulation mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis contraction to endothelin- in pulmonary arteries from endotoxin-treated rats is modulated by endothelium pulmonary artery endothelial cell function in swine pseudomonas sepsis nitric oxide. to block or enhance its production during sepsis? endothelium-dependent relaxation is depressed at the macro-and microcirculatory levels during sepsis endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis attenuation of endothelium-dependent hyperpolarizing factor by bacterial lipopolysaccharides proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic gmp-dependent mechanism technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound local venous responses to endotoxin in humans reactive hyperemia in patients with septic conditions microvascular function and rheologic changes in hyperdynamic sepsis peripheral vascular tone in sepsis decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis correlation with severity of disease xanthine oxidase activity and free radical generation in patients with sepsis syndrome ascorbyl radical formation in patients with sepsis: effect of ascorbate loading the effects of intravenous antioxidants in patients with septic shock nitrogen oxide levels in patients after trauma and during sepsis evidence of increased nitric oxide production in patients with the sepsis syndrome nitrite/nitrate oxide (nox) and cytokine levels in patients with septic shock l-arginine: nitric oxide pathway in endotoxemia and human septic shock relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock assessment of inflammatory cytokines, nitrate/nitrite, type ii phospholipase a , and soluble adhesion molecules in systemic inflammatory response syndrome plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis endothelial function in sepsis measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome activation of the l-arginine nitric oxide pathway in severe sepsis increased serum nitrite and nitrate concentrations in children with the sepsis syndrome circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock effect of l-name, an inhibitor of nitric oxide synthesis, on plasma levels of il- , il- , tnf alpha and nitrite/nitrate in human septic shock extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock evidence for in vivo peroxynitrite production in human acute lung injury elevated von willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome soluble e-selectin levels in sepsis and critical illness. correlation with infection and hemodynamic dysfunction die zirkulierenden adhäsionsmoleküle sicam- und sb-selectin bei patienten mit sepsis elevated circulating e-selectin, intercellular adhesion moleculc , and von willebrand factor in patients with severe infection increased circulating thrombomodulin in children with septic shock systemic endothelial activation occurs in both mild and severe malaria. correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity increased plasma von willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation blood levels of endothelin- and thrombomodulin in patients with disseminated intravascular coagulation and sepsis plasma levels of endothelial cell protein c receptor are elevated in patients with sepsis and systemic lupus or erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes demonstration of rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von willebrand factor in patients with mediterranean spotted fever influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis influence of group b streptococci on piglet pulmonary artery response to bradykinin effects of antisense oligonucleotide to inos on hemodynamic and vascular changes induced by lps pentoxifylline maintains vascular endothelial cell function during hyperdynamic and hypodynamic sepsis a novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis effect of endotoxin-enhanced hepatic reperfusion injury on endonthelium-dependent relaxation in rat aorta splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals endothelial dysfunction in a rat model of endotoxic shock. importance of the activation of poly (adp-ribose) synthetase by peroxynitrite endothelial cell dysfunction in septic shock key: cord- -sbdtpsz authors: ramírez-pérez, sergio; hernández-palma, luis alexis; oregon-romero, edith; anaya-macías, brian uriel; garcía-arellano, samuel; gonzález-estevez, guillermo; muñoz-valle, josé francisco title: downregulation of inflammatory cytokine release from il- β and lps-stimulated pbmc orchestrated by st , a myd dimerisation inhibitor date: - - journal: molecules doi: . /molecules sha: doc_id: cord_uid: sbdtpsz the inflammatory process implicates homeostasis disruption and increased production of inflammatory mediators. myeloid differentiation primary response (myd ) is an essential protein recruited after lipopolysaccharide (lps) and interleukin (il)- β stimulation, a process that converges in nuclear factor kappa b (nf-κb) activation, as well as a transcription of several genes of both pro- and anti-inflammatory cytokines. the inhibition of myd has shown efficacy by decrease inflammatory response, and has demonstrated potential application as a therapeutic target in chronic diseases. in this study, we investigate the effect of myd dimerisation inhibitor st on cytokine production from rhil- β and lps-stimulated peripheral blood mononuclear cells (pbmc) from healthy blood donors (hbd). st significantly downregulates the production of ifn-γ, il- , il- , il- , il- , il- , vegf, il- ra, il- , il- , il- and il- (p < . ) in lps-stimulated pbmc. moreover, st had a relatively low impact on il- β signalling pathway inhibition, showing that only a few specific cytokines, such as ifn-γ and il- ra, are inhibited in rhil- β-stimulated pbmc (p < . ). in conclusion, myd dimerisation inhibitor st showed high efficacy by inhibiting pro- and anti-inflammatory cytokine production in lps-stimulated pbmc. moreover, although rhil- β induced a sustained cytokine production (p < . ), st did not show a significant effect in the secretion of neither pro- nor anti-inflammatory cytokines in rhil- β-stimulated pbmc. myeloid differentiation primary response (myd ) represents an important molecule associated with activation of several signalling pathways, which are implicated in the inflammatory immune response [ ] . interleukin (il)- β and toll-like receptors (tlr) signalling pathways are one of the most strongly studied mechanisms in which myd plays a primary role [ ] [ ] [ ] [ ] . the il- β activity implicates binding between this cytokine and the il- r type i (il- ri), this binding triggers the interaction of toll-il- -receptor (tir) domains followed by myd recruitment and downstream signalling cascades, which converge in the activation of several transcription factors and pro-inflammatory cytokine production [ , ] . regarding inflammation-associated tlr activation, molecules , , of tlr has been the best-studied molecule in both innate and adaptive immunity [ , ] . tlr signalling pathway can be activated myd -dependent or independent manner [ ] ; nevertheless, tlr -dependent lps-regulated signalling involves the recruitment and homodimerisation of myd and leads to pathways of intracellular signal transduction which converge in the production of inflammatory mediators implicated in the regulation of the inflammatory process [ , ] . overactivated myd -dependent lps and il- β inflammatory signalling pathways have displayed high expression of pro-inflammatory mediators not only in healthy blood donors (hbd), but also in patients with chronic, systemic and autoimmune diseases [ ] [ ] [ ] [ ] [ ] [ ] . due to this fact, the identification of new molecules that regulate these signalling pathways has taken high relevance [ , , [ ] [ ] [ ] . the chemical molecule st acts as an inhibitor of myd dimerisation and its activity has been demonstrated through the inhibition of tlr -dependent cpg-regulated signalling, and inhibition of il- , il- β, il- and tumor necrosis factor alpha (tnf-α) expression in lps-stimulated raw . cells [ ] [ ] [ ] [ ] . however, the effect of the st molecule on cytokine production mediated by il- β and lps-stimulated peripheral blood mononuclear cells (pbmc) has yet been clarified. in the present study, pbmc obtained from hbd were stimulated with both rhil- β and lps to identify pro-and anti-inflammatory cytokine profiles, as well as, the inhibitory activity of st molecule on the cytokine secretion. our results indicate that inhibition of myd dimerisation mediated by st molecule causes a decrease secretion of both pro-and anti-inflammatory cytokines in supernatants of lps-stimulated pbmc; however, st showed high impact neither pro-nor anti-inflammatory cytokine secretion in rhil- β-stimulated pbmc. to determine the specific concentration of st in which the secretion of cytokines was inhibited, curves of different concentrations of st were performed ( figure ). tnf-α quantification was taken as a positive control, and the concentration of this cytokine was determined in supernatants of lps-stimulated pbmc after h ( figure a ). the concentration of tnf-α in supernatants of pbmc without stimuli was . pg/ml; whereas, a high concentration of tnf-α in lps-stimulated pbmc was identified ( . pg/ml). regarding st stimuli three different concentrations were taken , and µm and tnf-α levels were determined, the medium values were . pg/ml (p = not significant [n.s.]), . pg/ml (p < . ), and . pg/ml (p < . ), respectively. similarly, the concentration of tnf-α was determined in supernatants of rhil- β-stimulated pbmc ( figure b ). tnf-α levels from rhil- β-stimulated pbmc were . pg/ml, for rhil- β plus µm of st were . pg/ml (p = n.s.), and after add and µm of st to rhil- β-stimulated pbmc, the tnf-α levels were pg/ml for both (p < . ) ( figure b ). lps has been implicated in the production of pro-inflammatory cytokines through tlr activation. our results indicate that lps is a potent inductor of several pro-inflammatory cytokines in pbmc. statistically significant differences were found between pbmc treated with rpmi alone and lps (p < . ). in addition, st molecule was used as a negative regulator of tlr -dependent lps-regulated signalling pathway. st in lps-stimulated pbmc decreased secretion of interferon gamma (ifn-γ) (p < . ), il- (p < . ), il- (p < . ), il- (p < . ), vascular endothelial growth factor (vegf) (p < . ), il- (p < . ) and il- (p < . ) ( figure ; table s ). since our study included males and females; in order to identify differential effects on cytokine production release a statistical analysis by gender was performed. however, our results showed non-statistically significant differences between males and females (data not shown). as a control for the effect of st alone, a statistical analysis was performed by comparing the production of inflammatory cytokines studied in the presence or absence of st . for ifnγ, tnfα, il- ra and il- , statistically significant differences were found (p < . ). the levels of these cytokines in the presence of st were significantly lower than in pbmc treated with rpmi alone; furthermore, a higher cytokine secretion as an effect of st than in the basal response of untreated pbmc was not observed (table s ) . molecules , , x of as a control for the effect of st alone, a statistical analysis was performed by comparing the production of inflammatory cytokines studied in the presence or absence of st . for ifnγ, tnfα, il- ra and il- , statistically significant differences were found (p < . ). the levels of these cytokines in the presence of st were significantly lower than in pbmc treated with rpmi alone; furthermore, a higher cytokine secretion as an effect of st than in the basal response of untreated pbmc was not observed (table s ) . the concentration of anti-inflammatory cytokines was determined in supernatants of lpsstimulated pbmc. interestingly and contrary to expectations, after h of stimulation with lps in pbmc, we observed anti-inflammatory cytokine production of il- ra, il- , il- , il- , il- and il- (p < . ). additionally, st inhibited the secretion of il- ra (p < . ), il- (p < . ), il- (p < . ), il- (p < . ) and il- (p < . ), but not il- ( . pg/ml, p = n.s.) ( figure ; table s ). moreover, it was observed that anti-inflammatory cytokine secretion from pbmc stimulated with st alone, have a similar response to unstimulated cells (table s ). based on these results, pbmc stimulated with lps can secrete pro-and anti-inflammatory cytokines and st can inhibit the observed response; this is a relevant finding that has not been reported till date. (b) the soluble levels of tnf-α in the supernatant of rhil- β-stimulated pbmc at ng/ml and rhil- β ( ng/ml) plus different concentrations of st ( , and µm) were determined. significant inhibition was identified at µm (p < . ) and µm (p < . ) of st for lps; while for rhil- β significant inhibition was identified at µm (p < . ) and µm (p < . ) of st . data provided in medians and interquartile ranges (n = ), Φ kruskal-wallis test was performed, and dunn's test obtained statistically significant differences. the concentration of anti-inflammatory cytokines was determined in supernatants of lps-stimulated pbmc. interestingly and contrary to expectations, after h of stimulation with lps in pbmc, we observed anti-inflammatory cytokine production of il- ra, il- , il- , il- , il- and il- (p < . ). additionally, st inhibited the secretion of il- ra (p < . ), il- (p < . ), il- (p < . ), il- (p < . ) and il- (p < . ), but not il- ( . pg/ml, p = n.s.) ( figure ; table s ). moreover, it was observed that anti-inflammatory cytokine secretion from pbmc stimulated with st alone, have a similar response to unstimulated cells (table s ). based on these results, pbmc stimulated with lps can secrete pro-and anti-inflammatory cytokines and st can inhibit the observed response; this is a relevant finding that has not been reported till date. the role of il- β has been widely described in several chronic conditions, as well as in several cell types. our results showed high secretion of pro-inflammatory cytokines in rhil- β-stimulated pbmc (table ). in an exciting way and as previously reported, il- β represents an important cytokine capable of inducing th -related cytokine profile. in this study, we observed high production of these cytokines: however, only il- a, granulocyte-monocyte colony-stimulating factor (gm-csf) and granulocyte colony-stimulating factor (g-csf) increased significantly after h of rhil- β stimulation (p < . ). furthermore, the concentration of cytokines, such as il- (p < . ), vegf (p < . ) and il- (p < . ), were found higher after rhil- β stimulation. on the other hand, only il- and il- significantly increased after rhil- β stimulation (p < . ). regarding the st effect on rhil- β-stimulated pbmc and contrary to our expectations; our results showed that this molecule had a relatively low impact on the il- β signalling pathway inhibition (table ) . st molecule only inhibited the secretion of ifn-γ (p < . ) and il- ra molecules , , of (p < . ). the present study shows that the specific inhibition of critical components in the il- signalling pathway is not enough to avoid the secretion of inflammatory mediators, the above suggests that various myd -independent mechanisms could regulate the production of cytokines in pbmc. the role of il- β has been widely described in several chronic conditions, as well as in several cell types. our results showed high secretion of pro-inflammatory cytokines in rhil- β-stimulated pbmc (table ). in an exciting way and as previously reported, il- β represents an important cytokine capable of inducing th -related cytokine profile. in this study, we observed high production of these cytokines: however, only il- a, granulocyte-monocyte colony-stimulating factor (gm-csf) and granulocyte colony-stimulating factor (g-csf) increased significantly after h of rhil- β stimulation (p < . ). furthermore, the concentration of cytokines, such as il- (p < . ), vegf (p < . ) and il- (p < . ), were found higher after rhil- β stimulation. on the other hand, only il- and il- significantly increased after rhil- β stimulation (p < . ). regarding the st effect on rhil- β-stimulated pbmc and contrary to our expectations; our results showed that this molecule had a relatively low impact on the il- β signalling pathway inhibition (table ) . st molecule only inhibited the secretion of ifn-γ (p < . ) and il- ra (p < . ). the present study shows that the specific inhibition of critical components in the il- signalling pathway is not enough to avoid the secretion of inflammatory mediators, the above suggests that various myd -independent mechanisms could regulate the production of cytokines in pbmc. the role of inflammatory key mediators, such as il- β and lps, in activating the innate immune response and subsequently leading to inflammation has been widely described in several studies [ , ] . il- β and lps-signalling pathways trigger cascades of intracellular activation mediated by myd recruitment, which converges in the activation of transcription factors, such as nf-κb and its translocation to the nucleus [ , , , ] . the expression of receptors associated with these pro-inflammatory mediators can be given in a variety of cells of the immune system, within the main ones are professional antigen-presenting cells, treg cells and effector t cells [ ] [ ] [ ] [ ] . our results show that after h, pro-inflammatory cytokine levels of il- β, tnf-α, ifn-γ, il- , il- , il- a, g-csf, gm-csf, il- , vegf, il- and il- significantly increased in lps-stimulated pbmc. recent studies performed in vitro have described that in both pbmc and thp- cells can be possible to carry out a differentiation towards m macrophages by stimulation with lps, ifn-γ or gm-csf; m macrophages have been characterised by the expression of pro-inflammatory cytokines, such as il- , il- , tnf-α and il- β [ , , ] . regarding cytokines, such as il- and tnf-α, previous studies performed in lps-stimulated pbmc from hbd reported increased levels of these cytokines in comparison with those levels found in unstimulated pbmc [ , ] . an important cytokine involved in the innate immune response mediated by nk and nkt cells is il- , which increased after lps stimulation; concerning this result, one study reported that lps-stimulated monocytes could produce il- [ ] . concerning the expression of gm-csf and vegf, previous studies conducted in lps-stimulated pbmc after h showed high levels of both cytokines, as we observed in this study [ ] . an earlier report indicated that gm-csf expression increased in lps-stimulated pbmc; nonetheless, its expression remains low compared with other pro-inflammatory cytokines, such as tnf-α or il- , which could suggest that this cytokine is produced only for a specific population of monocytes [ ] . the activation of several transcription factors after lps stimulation has been demonstrated in a large number of studies. rothfuchs et al. reported that ifn-γ mrna expression was strongly diminished in tlr -/macrophages compared with the wild type phenotype; moreover, tlr activation causes myd -dependent ifn-α production, which results in an autocrine effect that regulates ifn-γ mrna expression by stat activation [ ] . on the other hand, increased expression of ror-γt and the phosphorylated form of nf-κb were found after lps stimulation, and this effect was associated with the differentiation of th cells and high expression of il- a [ ] . peyssonnaux et al. reported that hif- α was highly expressed in lps-stimulated macrophages; interestingly, hif- α/rorγt/p complex can be linked to the promoter region of il a and can also promote its transcription [ , , ] . vegf is a cytokine produced in response to the hypoxia process and subsequently to hif- α activation which, as mentioned above, hif- α is a transcription factor induced in response to lps [ , ] . transcription factor activation followed by high production of pro-inflammatory cytokines in a tlr -lps-dependent pathway has been widely described. however, posttranscriptional mechanisms implicated in tlr activation have also recently been described. for example, arid a protein is a crucial factor for the production of il- ; this protein binds to the '-utr region of the il- mrna and leads to its stabilisation and subsequently, to its efficient expression in vivo [ ] . moreover, nyati et al. described an alternative lps signalling pathway that is independent on p activation, but dependent on the mitogen-activated protein kinase (mapk) phosphatase (mkp- ) [ ] . this phosphatase mkp- can induce the translocation from the nucleus to the cytoplasm of au-rich element rna-binding protein (auf- ), and auf- acts by stabilising the mrna of il- , tnf-α and il- [ ] . according to the present study, we observed that the production of anti-inflammatory cytokines significantly increases in lps-stimulated pbmc. several studies have reported that tlr -dependent lps-regulated signalling pathway causes a predominantly pro-inflammatory response in pbmc. however, some interesting studies have reported that the expression of irf could also be expressed after lps/ifn-γ or il- stimulation; irf is a key transcription factor involved in the differentiation of m macrophages [ , , ] . however, a significant limitation in our study is that the expression of cytokines was determined after h of stimulation. in this regard, several reports indicate that pro-inflammatory cytokines have an early maximum expression peak within the first eight hours of lps stimulation (il- , il- β, il- , tnf-α and il- ) and expression of cytokines, such as il- and il- ra, exhibit a maximum expression peak at and h, respectively [ ] . this behaviour on the cytokine profile could also be explained by a process known as "tlr tolerance", which is characterised by reducing expression of pro-inflammatory cytokines and high expression of m activation markers after sustained exposure to tlr ligands [ ] . additionally, a specific type of m polarisation in human mononuclear cells after induction of lps tolerance has been reported [ ] , and after lps tolerance recovering, macrophages can express both m and m polarisation states [ ] . stimulation with rhil- β triggered the production of several pro-inflammatory cytokines. interestingly, as previously described in other studies, this cytokine induces the release of th -related cytokine profile; il- a, gm-csf and g-csf were significantly expressed in our research [ ] [ ] [ ] . nevertheless, a new t helper cell subset characterised by high production of gm-csf has been currently described [ ] . this cell subset was identified as gm-csf producing cd + t cell (th-gm-csf), and its differentiation depends on il- β signalling pathway, and subsequent irak and nf-κb activation [ ] . furthermore, th-gm-csf cells are able to produce high concentrations of pro-inflammatory cytokines, such as il- , il- and tnf-α [ ] . our results also showed increased expression of il- and vegf; regarding il- production, langlet et al. reported that this cytokine could be expressed in an il- β-dependent activation [ ] . moreover, previous reports have shown that vegf expression requires activation of hif- α, and activation of hif- α occurs after il- β stimulation [ ] [ ] [ ] . concerning the results of the inhibition of myd dimerisation and according to expectations, st molecule significantly inhibits the pro-inflammatory and anti-inflammatory cytokine production mediated by the activation of lps-tlr pathway. about these results, long et al. reported a significant decrease in cytokine expression of il- , il- β, il- and tnf-α from raw . cells treated with lps plus st [ ] . several studies have reported that st causes decreased recruitment and activation of specific molecules and transcription factors involved in the activation of tlr and the lps-dependent immune response activation. the main inhibited molecules, due to the activity of st , are irak , irak , traf , p-ikk, p-ikbα, p-nf-κb and hif- α [ , ] . st has also been proposed as a novel drug targeting in diseases like lymphoma, leukaemia, human hepatocellular carcinoma, and traumatic brain injury [ ] [ ] [ ] . however, its role as a possible inhibitor in the production of cytokines produced after stimulation with lps remains undetermined. the decrease recruitment of molecules implicated in the myddosome formation may explain the inhibition of pro-and anti-inflammatory cytokines as a consequence of tlr -dependent lps-regulated signalling. at the same time, signalling pathway activation after il- -il- ri-il- racp complex formation has been widely described [ , , , , ] . this process implicates recruitment and homodimerisation of myd , as well as intracellular signalling cascades that converge in the transcription of genes of pro-inflammatory mediators [ , , , , ] . specific myd dimerisation inhibition has been tested in many studies where the role of this molecule in an il- β-dependent activation pathway was evident [ , , ] . another study performed in healthy human articular chondrocytes reported decreased map kinase (mapk) activation after myd dimerisation inhibition and il- β stimulation [ ] . an interesting study conducted by wang et al. ( ) previously reported that st decreases the expression of several molecules involved in the myddosome formation, such as phosphorylated btk and iκb, along with the decreased secretion of il- and ifn-β from b-cell lymphoma cell lines [ ] . in our study, il- release decreases on both il- β and lps-stimulated pbmc treated with st ; nonetheless, the effect was not statistically significant. in relation to the ifn response, a decreased secretion of ifn-γ on both il- β and lps-stimulated pbmc was observed our study as an effect of st . however, our results did not show a substantial inhibitory effect on cytokine production from pbmc treated with il- β plus st . in regard to this result, loiarro et al. ( ) previously described an inhibitory effect observed on nf-κb activity after stimulation with il- β stimulation ( ng/ml) plus st ( µm) on hek t cells [ ] . nevertheless, although nf-κb activity decreases, st did not deplete nf-κb activation, which could provide signalling activation enough to produce some of the inflammatory cytokines observed in our study [ ] . indeed, since this st chemical compound affects only the association of tir domains of myd and the disruption of this tir domain interaction inhibits the recruitment of irak . by extension, irak and the subsequent signalling cascade, dimerisation inhibition of myd might affect only one specific signalling pathway [ ] . these results might suggest that alternative il- β signalling pathways independent of myd homodimerisation and recruitment in pbmc could be active as well. this approach arises from previous studies in which new receptors associated with the recognition of il- β have been observed. il- racpb is a unique receptor expressed on neurons, and its expression implicates activation of certain signalling pathways, such as p mapk, but not nf-κb; it has even been observed that this alternative signalling pathway is independent on myd , irak and traf [ , ] . moreover, heinz et al. reported a new molecule known as unc cl; this protein contains death domains (dd) similarly to those found in myd [ ] . unc cl is considered as a pro-inflammatory signalling inducer and involves recruitment of irak , irak , traf and converges in nf-κb and jnk activation in a myd -independent manner [ ] . currently, there are not reports in which these new molecules have been reported in pbmc; however, the possibility to perform future studies that elucidate this observation remains open. moreover, in spite of the fact that st did not show a substantial inhibitory effect on downregulation of inflammatory cytokine from il- β-stimulated pbmc, it might be necessary to consider the use of other il- inhibitors, such as il- and il- [ , ] , which could be useful to compare a differential response orchestrated by st on il- β-stimulated pbmc and the inhibitory effect of both il- and il- . in this regard, conti et al. mentioned that il- suppresses the innate and acquired immune response and inhibits the inflammation through its binding with il- receptor-α chain (il- rα) [ ] . additionally, il- can activate the mtor signalling pathway and increase the adenosine monophosphate (amp) kinase [ ] ; therefore, il- and il- might represent cytokines of great interest in experimental models where the suppressive effect of several inflammatory mediators is required. furthermore, a weakness of this study was not to measure cell viability after stimulation with st . differences (that were not statistically significant) have been previously reported for st in other studies at , or µm on cell viability [ , , ] . our study used pbmc, reduction on specific pbmc subpopulations might contribute to the behaviour observed on these inflammatory cytokines. therefore, considering this limitation will be important in future studies to analyse the observed response of this molecule on cell viability and the percentage of apoptosis by the effect of st . the understanding of inflammatory mechanisms regarding activation and effector function on physiological processes in the first instance can provide us with an overview of the behaviour of specific factors involved in the regulation and maintenance of the inflammatory process and how it can lead to the development of chronic inflammation. this study provides information about the inhibitory activity of st on cytokine production (figure ) , possibly through the tlr signalling pathway regulation in lps-stimulated pbmc. moreover, a relatively low impact on il- β signalling pathway inhibition orchestrated by st in pbmc was observed ( figure ) ; possibly due to the various mechanisms of activation that remain unexplored on this signalling pathway, which could be cell subset-dependent. nevertheless, future studies focused on the identification of specific down-stream factors implicated in both il- β and lps signalling pathway activation to elucidate how the regulation of cytokine production takes place in distinct pbmc subpopulations will be required. therefore, our results not only provide valuable evidence about the potential use of the st chemical molecule to inhibit the inflammatory cytokine release in pbmc from hbd, but also leave open the possibility to study the effect of this molecule in chronic diseases, such as rheumatic and autoimmune diseases, in which the inflammatory process plays a critical role. regulation of cytokine production takes place in distinct pbmc subpopulations will be required. therefore, our results not only provide valuable evidence about the potential use of the st chemical molecule to inhibit the inflammatory cytokine release in pbmc from hbd, but also leave open the possibility to study the effect of this molecule in chronic diseases, such as rheumatic and autoimmune diseases, in which the inflammatory process plays a critical role. ten hdb over years of age were included in the study, five females and five males. a blood sample ( ml) was collected from each participant to obtain pbmc and perform cell culture experiments. the presence of infections and body mass index ≥ kg/m were taken as exclusion criteria. all subjects included in the present study signed the informed consent letter before their inclusion, and the present study was performed following the declaration of helsinki amendments. the pbmc were isolated from a blood sample following the density gradient separation method using histopaque ® - (sigma aldrich, st. louis, mo, usa; ρ . - . g/ml). the obtained pbmc were washed and resuspended in rpmi- medium supplemented with penicillin ( u/ml, sigma aldrich, st. louis, mo, usa) and streptomycin ( µg/ml, sigma aldrich, st. louis, mo, usa) at a concentration of % for both. the trypan blue test analysed the cell viability, and the total of separated cells per ml was quantified directly in a neubauer chamber. the pbmc were placed in -well plates after the density adjustment at × cells/ml (final volume of µl). cells were cultured in rpmi- medium without serum and supplemented with antibiotic and antifungal. untreated cells were taken as the control group for each experiment. the effect of lps ( ng/ml) in the secretion of tnf-α was studied in samples from four hbd to demonstrate the positive stimulation of the cells. the concentration of st necessary to inhibit the rhil- β and lps response in pbmc was determined at , , and µm. subsequently, pbmc culture was performed with lps ( ng/ml), lps ( ng/ml) plus st ( µm) or without stimulation (control group). similarly, pbmc were stimulated with rhil- β ( ng/ml), rhil- β ( ng/ml) plus st ( µm), st ( µm) alone or without stimulation (control group). st molecule was added to the corresponding well min before the stimuli with rhil- β or lps. each experiment was done with two biological replicates and was incubated for h at • c in a humidified % co atmosphere. once the incubation time had elapsed, supernatants were collected and stored at − • c for the subsequent quantification of pro-inflammatory and anti-inflammatory cytokine secretion. the concentration of il- β, tnf-α, ifn-γ, il- , il- , il- a, m-csf, gm-csf, il- , vegf, il- , il- , il- ra, il- , il- , il- , il- and il- and were quantified from culture supernatants by multiplex immunoassay method using the bio-plex pro tm human cytokine -plex assay (bio-rad laboratories, inc., hercules, ca, usa) according to the manufacturer's instructions. luminex magpix ® (luminex corporation, austin, tx, usa) instrument was used for xmap assays. all data were shown as medians and interquartile ranges. the differences between the non-parametric quantitative variables were analysed by u of mann-whitney test to compare two groups and both the kruskal-wallis test and the dunn's post hoc test for multiple comparisons. data analysis was performed using graphpad prism v . software, and a p-value < . was considered statistically significant. myd : a central player in innate immune signaling understanding early tlr signaling through the myddosome the il- family of cytokines and receptors in rheumatic diseases signaling in innate immunity and inflammation future potential therapeutic targets for ra the interleukin- receptor family toll-like receptors: critical proteins linking innate and acquired immunity toll-like receptors in immunity and inflammatory diseases: past, present, and future lps-induced cytokine production in human monocytes and macrophages lipopolysaccharide and il- β coordinate a synergy on cytokine production by upregulating myd expression in human gingival fibroblasts the il- β signalling pathway and its role in regulating pro-inflammatory and pro-labour mediators in human primary myometrial cells effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus elispot analysis of lps-stimulated leukocytes: human granulocytes selectively secrete il- , mip- beta and tnf-alpha increased production of il- and il- in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis analysis of cytokines and chemokines produced by whole blood, peripheral mononuclear and polymorphonuclear cells discovery of small molecule inhibitors of myd -dependent signaling pathways using a computational screen the role of intermediary domain of myd in cell activation and therapeutic inhibition of tlrs toll-like receptors as therapeutic targets for autoimmune connective tissue diseases advance: inhibition of myd dimerisation and recruitment of irak and irak by a novel peptidomimetic compound pharmacological inhibition of tlr activation blocks autoantibody production in human b cells from sle patients targeting the toll-like receptor/interleukin receptor pathway in human diseases: rational design of myd inhibitors polygonatum sibiricum polysaccharides play anti-cancer effect through tlr -mapk/nf-κb signaling pathways interleukin- (il- ) pathway the regulatory roles of toll-like receptor in secretions of type /type relative cytokines by splenocytes and dendritic cells exposed to clonorchis sinensis excretory/secretory products expression of interleukin receptors on human peripheral t cells the interleukin- family: back to the future optimised flow cytometry protocol for analysis of surface expression of interleukin- receptor types i and ii thp- and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarise in vitro m macrophages and their role in rheumatic diseases peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines ccl (mcp- ) and cxcl (il- ) intracellular bacterial infection-induced ifn-gamma is critically but not solely dependent on toll-like receptor -myeloid differentiation factor -ifn-alpha beta-stat signaling lipopolysaccharide directly stimulates th differentiation in vitro modulating phosphorylation of relb and nf-κb cutting edge: essential role of hypoxia inducible factor- alpha in development of lipopolysaccharide-induced sepsis e ubiquitin ligases siah / regulate hypoxia-inducible factor- (hif- )-mediated th cell differentiation tlr -induced nf-κb and mapk signaling regulate the il- mrna stabilising protein arid a interleukin- induced interferon regulatory factor (irf) participates in the regulation of alternative macrophage priming negative regulation of toll-like-receptor signaling by irf- endotoxin tolerance represents a distinctive state of alternative polarisation (m ) in human mononuclear cells identification of a unique hybrid macrophage-polarisation state following recovery from lipopolysaccharide tolerance interleukin- and il- induce innate il- production from gammadelta t cells, amplifying th responses and autoimmunity pivotal role of dermal il- -producing γδ t cells in skin inflammation critical regulation of early th cell differentiation by interleukin- signaling interleukin- β-induced irak ubiquitination is required for th-gm-csf cell differentiation in t cell-mediated inflammation pkc-alpha controls myd -dependent tlr/il- r signaling and cytokine production in mouse and human dendritic cells interleukin induces hypoxia-inducible factor in human gingival and synovial fibroblasts il- beta-mediated up-regulation of hif- alpha via an nfkappab/cox- pathway identifies hif- as a critical link between inflammation and oncogenesis regulation of hypoxia-inducible factor- α (hif- α) expression by interleukin- β (il- β), insulin-like growth factors i (igf-i) and ii (igf-ii) in human osteoarthritic chondrocytes dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating tlr /myd signal pathway tlr promotes the expression of hif- α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention effect of st on the proliferation and apoptosis of human hepatocellular carcinoma cells inhibition of myeloid differentiation factor (myd ) by st provides neuroprotection after experimental traumatic brain injury in mice myd inhibitor st suppresses the growth of lymphoma and leukaemia cells overview of the interleukin- family of ligands and receptors the interleukin (il)- cytokine family-balance between agonists and antagonists in inflammatory diseases interactive sites in the myd toll/interleukin (il) receptor domain responsible for coupling to the il beta signaling pathway peptide-mediated interference of tir domain dimerisation in myd inhibits interleukin- -dependent activation of nf-{kappa}b irak and traf knockdown in human chondrocytes inhibits interleukin- -induced matrix metalloproteinase- gene expression and promoter activity by impairing map kinase activation disrupting myddosome assembly in diffuse large b-cell lymphoma cells using the myd dimerisation inhibitor st neuron-specific effects of interleukin- β are mediated by a novel isoform of the il- receptor accessory protein a central nervous system-restricted isoform of the interleukin- receptor accessory protein modulates neuronal responses to interleukin- the death domain-containing protein unc cl is a novel myd -independent activator of the pro-inflammatory irak signaling cascade interleukin- family cytokines and mast cells: activation and inhibition car-t cell therapy causes inflammation by il- which activates inflammatory cytokine mast cells: anti-inflammatory role of il- induction of pro-inflammatory cytokines (il- and il- ) and lung inflammation by coronavirus- (covi- or sars-cov- ): anti-inflammatory strategies this article is an open access article distributed under the terms and conditions of the creative commons attribution the authors declare no conflict of interest.molecules , , key: cord- -dvhkk authors: lee, jae min; choi, sun sil; park, mi hyeon; jang, hyunduk; lee, yo han; khim, keon woo; oh, sei ryang; park, jiyoung; ryu, hyung won; choi, jang hyun title: broussonetia papyrifera root bark extract exhibits anti-inflammatory effects on adipose tissue and improves insulin sensitivity potentially via ampk activation date: - - journal: nutrients doi: . /nu sha: doc_id: cord_uid: dvhkk the chronic low-grade inflammation in adipose tissue plays a causal role in obesity-induced insulin resistance and its associated pathophysiological consequences. in this study, we investigated the effects of extracts of broussonetia papyrifera root bark (pre) and its bioactive components on inflammation and insulin sensitivity. pre inhibited tnf-α-induced nf-κb transcriptional activity in the nf-κb luciferase assay and pro-inflammatory genes’ expression by blocking phosphorylation of iκb and nf-κb in t -l adipocytes, which were mediated by activating ampk. ten-week-high fat diet (hfd)-fed c bl male mice treated with pre had improved glucose intolerance and decreased inflammation in adipose tissue, as indicated by reductions in nf-κb phosphorylation and pro-inflammatory genes’ expression. furthermore, pre activated amp-activated protein kinase (ampk) and reduced lipogenic genes’ expression in both adipose tissue and liver. finally, we identified broussoflavonol b (bf) and kazinol j (kj) as bioactive constituents to suppress pro-inflammatory responses via activating ampk in t -l adipocytes. taken together, these results indicate the therapeutic potential of pre, especially bf or kj, in metabolic diseases such as obesity and type diabetes. inflammation is a protective response against infection, tissue stress, and injury in any tissue and defends and restores physiological functions. however, dysregulated inflammatory processes result in chronic inflammation, which is increasingly seen as a major driver of numerous diseases such as obesity and type diabetes [ ] . obese adipose tissue produces inflammatory cytokines, including tumor necrosis factor (tnf)-α, monocyte chemokine protein (mcp)- , and interleukin (il)- [ ] . subsequently, the elevated inflammatory stimuli induce the activation of the inhibitor of κb (iκb) kinase (ikk)/nf-κb and c-jun n-terminal kinase (jnk) pathways, which negatively regulate insulin action in not only adipose tissue, but also other peripheral tissues, such as liver [ ] . thus, the accumulation of pro-inflammatory responses in adipose tissue may be one of the causal factors for insulin resistance. a previous study has demonstrated that pro-inflammatory gene expression is elevated in adipose tissue in the early onset of obesity, but in other tissues, such as liver and skeletal muscle, there is no differences in the expression of inflammatory gene expressions [ ] . thus, adipose tissues appear to act as priming tissues that respond to a high-fat diet (hfd) and initiate inflammation in obesity. therefore, understanding the inflammatory responses in adipose tissues of obese individuals is of clinical importance. it has been well demonstrated that amp-activated protein kinase (ampk) is a master regulator for energy sensing, which responds to control energy homeostasis. ampk can be activated by various conditions. starvation, hypoxia, exercise, and oxidative damages are the main cellular stresses for activating ampk [ ] . there are two well-known upstream kinases: liver kinase b (lkb ) and ca + /calmodulin-dependent protein kinase kinase (camkk) can activate ampk via phosphorylation. several reports clearly demonstrated that one of the major roles of ampk is regulating metabolic requirement. for example, ampk stimulates energy production pathways through fatty acid oxidation, mitochondrial biogenesis, and glucose catabolism. on the other hand, it inhibits energy-consuming pathways, including fatty acids' synthesis and amino acids' biogenesis [ ] . thus, dysfunctions of ampk or downstream signaling pathways could result in metabolic diseases, such as obesity and type diabetes [ ] . interestingly, it has been reported that ampk could suppress the nf-κb transcriptional activity [ ] . the activation of ampk by aicar ( -aminoimidazole- -carboxamide- -β-d-ribofuranoside) can inhibit colitis [ ] , autoimmune encephalomyelitis [ ] , and inflammation after lung injury [ ] . in contrast, disrupting ampk-mediated signaling in hematopoietic-derived cells induced the infiltration of adipose tissue macrophages (atms) and hepatic steatosis [ ] . in addition, pro-inflammatory responses inhibited the activation of ampk in adipose tissue and induced the expression of pro-inflammatory genes in vivo [ ] . it has been reported that the infiltration of atms is significantly increased in ampkα −/− mice, and these mice showed increased expression of pro-inflammatory genes, such as il- or tnf-α, in adipose tissue [ ] . together, these observations that ampk can suppress inflammation have a significant impact on obese-mediated inflammation in adipose tissue. paper mulberry (broussonetia papyrifera) is a deciduous tree that is distributed throughout asia, and its barks, roots, and fruits are used in traditional chinese medicine. it has been shown that broussonetia papyrifera has anti-tyrosinase and antioxidant activity [ , ] and anti-inflammatory activities in cells [ ] . constituents of the roots of this plant, broussochalcone a, kazinol a, and kazinol i, have been reported as inhibitors of lipopolysaccharide-induced nitric oxide (no) production by suppressing nf-κb activation in macrophages [ , ] . moreover, kazinol b, a b. papyrifera-derived prenylated flavan, has been shown to inhibit no production [ ] . interestingly, kazinol b enhances glucose uptake via akt (a serine/threonine kinase) and ampk activation in adipocytes [ ] . collectively, these reports suggest that b. papyrifera might ameliorate inflammation, but to what degree it elicits systemic insulin sensitivity, and by what mechanism, remains unclear. in the present study, we aimed to demonstrate that roots of b. papyrifera improve pre-established insulin resistance and identify major bioactive compounds that modulate obese-associated inflammation in adipose tissue. the root bark of b. papyrifera was sampled at mugo-ri, gonyang-myeon, sacheon-si, gyeongsangnam-do, south korea, in june , (by dr. jin-hyub paik). the collected raw materials were deposited in the korea research institute of bioscience and biotechnology (kribb) and the international biological material center (ibmrc) (kribb ) [ ] . of the collected roots, only barks were used for obtaining a better yield. the target compounds were isolated from dried root bark of b. papyrifera as previously described [ ] . briefly, the total b. papyrifera root bark extracts (tpre, yield . %) were separated by spot-ii mplc (medium-pressure liquid chromatography) (gilson, middleton, wi, usa) using reversed-phase silica gel (ymc-pack ods-aq hg, × mm, µm, kyoto, japan) eluted with meoh-h o to give tpre nos. - ( figure s a and figure b) . broussoflavonol b and kazinol j were found to be components of tpre no. (pre) based on the uplc-pda-qtof-ms chromatograms ( figure s c ). among these fractions, tpre no. (pre) was subjected to a gx- (automated liquid handler) semipreparative hplc system (gilson, middleton, wi) using a reversed-phase column (ymc-pack ods-aq-hg, µm) and eluted with the meoh-h o gradient system ( % → % meoh, min) by repeated injections of the samples ( g/ml methanol dilutions) to yield four fractions (pre nos. - ~ - ). a further preparation.-hplc procedure was repeated several times using each condition (see below). the fraction - - ( . mg) enriched with broussoflavonol b was further isolated by prep.-hplc (gilson, middleton, ma, usa). broussoflavonol b ( . mg) and broussonol d ( . mg) were isolated using a ymc-pack pro c column. the fraction - - enriched with kazinol j was further isolated by prep.-hplc (plc ) with a gradient system of meoh-h o, and (-)-( s)-kazinol i ( . mg), kazinol j ( . mg), broussoflavonol c ( . mg), and broussonol g ( . mg) were obtained. the isolated compounds were purified as described previously, and purity the was more than . %, as determined by ultra-performance liquid chromatography [ ] . two compounds were characterized using spectroscopic data, including h, c nmr, and hrms, in comparison with previously published data [ , ] . an acquity uplc™ system (waters corporation, milford, ma, usa) equipped with a binary solvent delivery manager and a photodiode array (pda) was used for uplc (ultra-performance liquid chromatography) analysis. hrms analysis was performed using an ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (uplc-qtof-ms) equipped with an electrospray ionization (esi) interface (waters q-tof premiertm, waters corporation, milford, ma, usa). the nmr analysis was carried out using a fourier transform (ft)-nmr spectrometer (jeol ecz r, jeol ltd., akishima, tokyo, japan) for d spectra ( h nmr and c nmr). the overall processes are described in figure s d . all extracts and single compounds for the experiments were prepared by dissolving in dimethyl sulfoxide (dmso, sigma, st. louis, mo, usa). t -l , raw . , and hek cells were obtained from the american tissue culture collection (atcc, manassas, va, usa) and cultured in dulbecco's modified eagle's medium (dmem, life technologies, ny, usa) with % bovine calf serum (invitrogen, gaithersburg, ca, usa) and % fetal bovine serum (atlas, co, usa), respectively. adipocyte differentiation was induced by treating cells with dmem containing % fbs, . mm isobutylmethylxanthine (ibmx), µm dexamethasone, and nm insulin. after h, the medium was replaced every other day with dmem containing % fbs and nm insulin. all chemicals for cell culture were obtained from sigma-aldrich (st. louis, mo, usa) unless otherwise indicated. after - days from initiation of differentiation ( figure s a ), we treated compounds as indicated concentrations and time. after treating fully differentiated adipocytes with pre, bf, or kj for h, cell morphology was monitored by an inverted microscope (zeiss, oberkochen, germany) ( figure s b ). for oil red o staining, t l preadipocytes or differentiated t l adipocytes treated with/without pre, bf, or kj as indicated concentrations were stained with the oil red o staining kit according to the manufacturer´s recommendations (biovision, inc., milpitas, ca, usa). hek- cells were transfected with nf-κb-responsive luciferase reporter (promega, san luis obispo, wi, usa) and prl-renilla using lipofectamine (invitrogen, gaithersburg, ca, usa). following an overnight transfection, the cells were treated with pre, bf, or kj for h, followed by treatment with tnf-α ( ng/ml) for h. dmso was used as the vehicle. the cells were harvested, and reporter gene assays were carried out using the dual-luciferase kit (promega, san luis obispo, wi, usa). luciferase activity was normalized to renilla activity. raw macrophages were seeded in well plates ( . × cells/ml) and treated with pre, br or kj as the indicated concentration with/without lipopolysaccharide (lps, sigma, st. louis, mo, usa) for h. for no production, the amount of no was calculated by measured nitrate in media using griess reagent according to the manufacturer´s recommendations (sigma, st. louis, mo, usa). for cell viability, cells were determined using the mtt solution ( -( , -dimethylthiazol- -yl)- , -diphenyltetrazolium bromide), sigma, st. louis, mo, usa) at . mg/ml. the purple formazan crystals were dissolved in dmso, and the absorbance was recorded on a microplate reader at a wavelength of nm. all animal experiments were performed according to the procedures approved by ulsan national institute of science and technology's institutional animal care and use committee (unistiacuc- - ). seven-week-old male c bl/ j mice (dbl, samsung, korea) were fed a high fat diet ( % kcal fat, d , research diets inc., new brunswick, nj, usa) for weeks the mice were housed (n = /cage) and granted free access to food and water. food and water were changed once a week. for glucose tolerance tests (gtt), mice were intraperitoneally (i.p.) injected daily with mg/kg of pre or vehicle (saline containing % dmso and % tween (sigma, st. louis, mo, usa) for days and fasted for h ( p.m. to a.m.) prior to i.p. injection of d-glucose ( g/kg body weight). pre solution prepared at mg/ml in saline containing % dmso and % tween was injected in an amount of µl/g of body weight. fasting insulin was determined using the ultrasensitive mouse insulin elisa kit (crystal chem., eik grove village, il, usa). once mice were sacrificed, isolated adipose tissue and liver were weighed and immediately frozen in liquid nitrogen and then used for western blot analysis and gene expression analysis. liver sections were embedded in paraffin and stained with hematoxylin and eosin (h&e) to visualize hepatocytes and lipid droplets in the tissues. sections were analyzed by an inverted microscope (zeiss, oberkochen, germany). each sample (cells or tissues) was lysed with ripa lysis buffer containing protease and phosphatase inhibitor (sigma-aldrich, st. louis, mo, usa). an equal amount of protein was separated on sds-page and transferred onto nitrocellulose membranes (ge healthcare, chigago, il, usa). the membranes were blocked in a % bovine serum albumin (bsa) blocking buffer and incubated with specific primary antibodies for phospho-nf-κb, nf-κb, phospho-iκb, iκb, phospho-ampk, ampk, phospho-acc, and acc (cell signal technology, danver, ma, usa) at • c overnight. the signals were detected using an ecl detection kit (ge healthcare, chigago, il, usa), followed by incubation with horseradish peroxidase-conjugated secondary antibodies (thermofisher, gaithersburg, ca, usa). we quantified the band intensity by using the imagej program (nih, bethesda, md, usa). total rna was isolated from cells or tissues using trizol reagents (invitrogen, city, ca, usa). the rna was reverse-transcribed using the abi reverse transcription kit. quantitative pcr reactions were performed with sybr green fluorescent dye using an abi pcr machine. relative mrna expression was determined by the ∆∆-ct method normalized to tata-binding protein (tbp) levels. data were presented as the means +s.e.m. statistical significance was estimated by an unpaired t-test for comparisons between two conditions. a one-way anova was used for comparisons between more than two conditions. dunnett's post hoc test was used for multiple comparisons. all statistics were performed with graphpad prism . software (graphpad, san diego, ca, usa). to investigate the effects of pre on inflammation, we first tested nf-κb transcriptional activity of tpre because nf-κb is an essential regulator of pro-inflammatory response ( figure s ). as shown in figure a , tpre suppressed nf-κb transcriptional activity induced by tnf-α, and it was dose-dependent. to further evaluate the effect of tpre for inhibiting nf-κb activity, we partitioned tpre using medium-pressure liquid chromatography into eight sub-fractions ( figure s ), which were then used to assay nf-κb transcriptional activity. of the eight sub-fractions, four fractions significantly inhibited nf-κb transcriptional activity induced by tnf-α. sub-fraction (pre) had the most potent activity for inhibiting nf-κb activation and dose-dependently repressed nf-κb transcriptional activity ( figure b ,c). -aminoimidazole- -carboxamide ribonucleotide (aicar), an amp analog, was used as the positive control for ampk activation. nutrients , , of data were presented as the means +s.e.m. statistical significance was estimated by an unpaired t-test for comparisons between two conditions. a one-way anova was used for comparisons between more than two conditions. dunnett's post hoc test was used for multiple comparisons. all statistics were performed with graphpad prism . software (graphpad, san diego, ca, usa). to investigate the effects of pre on inflammation, we first tested nf-κb transcriptional activity of tpre because nf-κb is an essential regulator of pro-inflammatory response ( figure s ). as shown in figure a , tpre suppressed nf-κb transcriptional activity induced by tnf-α, and it was dosedependent. to further evaluate the effect of tpre for inhibiting nf-κb activity, we partitioned tpre using medium-pressure liquid chromatography into eight sub-fractions ( figure s ), which were then used to assay nf-κb transcriptional activity. of the eight sub-fractions, four fractions significantly inhibited nf-κb transcriptional activity induced by tnf-α. sub-fraction (pre) had the most potent activity for inhibiting nf-κb activation and dose-dependently repressed nf-κb transcriptional activity ( figure b and figure c ). -aminoimidazole- -carboxamide ribonucleotide (aicar), an amp analog, was used as the positive control for ampk activation. next, we further tested the effect of pre on inflammatory responses. differentiated adipocytes were treated with tnf-α, and we examined the effects of pre on the expression of pro-inflammatory genes. as shown in figure a , pre repressed the tnf-α-mediated pro-inflammatory gene, and this effect was dose-dependent. furthermore, pre blocked lipopolysaccharide (lps)-induced proinflammatory response in raw . cells, as previously reported ( figure s ) [ ] . ampk is a wellknown, important inflammatory suppressor, and ampk signaling critically regulates inflammation in many cell types [ ] . therefore, to further investigate the molecular mechanism involved in preassociated repression of the nf-κb signaling pathway, we first tested whether pre activated ampk. in t -l adipocytes, pre enhanced the phosphorylation of ampk, while pre did not affect ampk protein level. this phosphorylation was blocked by compound c, a specific inhibitor of ampk ( figure b) . similarly, the phosphorylation of acetyl-coa carboxylase (acc), a substrate of ampk, was enhanced by pre treatment, and its phosphorylation was blocked by compound c treatment. next, we further tested the effect of pre on inflammatory responses. differentiated adipocytes were treated with tnf-α, and we examined the effects of pre on the expression of pro-inflammatory genes. as shown in figure a , pre repressed the tnf-α-mediated pro-inflammatory gene, and this effect was dose-dependent. furthermore, pre blocked lipopolysaccharide (lps)-induced pro-inflammatory response in raw . cells, as previously reported ( figure s ) [ ] . ampk is a well-known, important inflammatory suppressor, and ampk signaling critically regulates inflammation in many cell types [ ] . therefore, to further investigate the molecular mechanism involved in pre-associated repression of the nf-κb signaling pathway, we first tested whether pre activated ampk. in t -l adipocytes, pre enhanced the phosphorylation of ampk, while pre did not affect ampk protein level. this phosphorylation was blocked by compound c, a specific inhibitor of ampk ( figure b) . similarly, the phosphorylation of acetyl-coa carboxylase (acc), a substrate of ampk, was enhanced by pre treatment, and its phosphorylation was blocked by compound c treatment. pre treatment decreased tnf-α-induced phosphorylation of iκb and nf-κb in adipocytes ( figure c ). in addition, pretreatment with aicar specifically inhibited tnf-α-mediated pro-inflammatory signaling. pretreatment with compound c blocked pre-induced suppression of phosphorylation of iκb and nf-κb in t -l adipocytes ( figure c ). together, these results strongly suggest that pre suppresses tnf-α-mediated pro-inflammatory gene expression by activating ampk. nutrients , , of pre treatment decreased tnf-α-induced phosphorylation of iκb and nf-κb in adipocytes ( figure c ). in addition, pretreatment with aicar specifically inhibited tnf-α-mediated pro-inflammatory signaling. pretreatment with compound c blocked pre-induced suppression of phosphorylation of iκb and nf-κb in t -l adipocytes ( figure c ). together, these results strongly suggest that pre suppresses tnf-α-mediated pro-inflammatory gene expression by activating ampk. next, we determined whether pre exhibited anti-diabetic activities in vivo. ten-week-hfd-fed c bl/ mice were used for a glucose tolerance test (gtt). pre and glucose were administrated intraperitoneally, because the components of pre have been reported to inhibit alpha-glucosidase to exclude the possibility that oral glucose and pre administration suppress glucose absorption from the gut [ ] . the pre-treated group showed increased glucose tolerance compared to that in control mice ( figure a ). plasma glucose levels in pre-treated mice, as determined by the area under the curve (auc), were significantly suppressed compared to those of control mice. furthermore, the fasting insulin level showed a tendency to decrease ( figure c ), suggesting that pre ameliorates obesity-induced glucose intolerance. body weight ( figure b ), adipose tissue weight ( figure s a ), and liver weight ( figure s b) were not changed by treatment with pre. after t -l adipocytes were pre-incubation with/without compound c for h, cells were treated with pre or aicar for an additional h. the expression of phospho-ampk, ampk, phospho-acc, and acc was analyzed by western blotting. (c) t -l adipocytes were pretreated with the indicated concentration of pre for h and aicar for h before ng/ml tnf-α treatment for min. compound c (comp. c) was pretreated for h before pre treatment. the expression of phospho-iκb, iκb, phospho-nf-κb, nf-κb, and tubulin was analyzed by western blotting. next, we determined whether pre exhibited anti-diabetic activities in vivo. ten-week-hfd-fed c bl/ mice were used for a glucose tolerance test (gtt). pre and glucose were administrated intraperitoneally, because the components of pre have been reported to inhibit alpha-glucosidase to exclude the possibility that oral glucose and pre administration suppress glucose absorption from the gut [ ] . the pre-treated group showed increased glucose tolerance compared to that in control mice ( figure a ). plasma glucose levels in pre-treated mice, as determined by the area under the curve (auc), were significantly suppressed compared to those of control mice. furthermore, the fasting insulin level showed a tendency to decrease ( figure c ), suggesting that pre ameliorates obesity-induced glucose intolerance. body weight ( figure b ), adipose tissue weight ( figure s a ), and liver weight ( figure s b our initial results showed that pre activated ampk and suppressed pro-inflammatory mediators in vitro. therefore, we tested whether pre activated ampk and nf-κb in obese adipose tissue in vivo. upon treatment with pre, nf-κb phosphorylation was significantly decreased, whereas ampk phosphorylation was increased in epididymal white adipose tissue (ewat) ( figure a ). next, we assessed the effects of pre on inflammation in adipose tissue. as shown in figure b , the expression of pro-inflammatory genes (il- β and inducible nitric oxide synthase (inos)) was significantly reduced in ewat after treatment with pre. however, marker genes of macrophages (f / , cd b, and cd ) or marker genes of the m macrophage, including arginase- (arg- ), mannose receptor c-type (mrc- ), macrophage galactose binding lectin (mgl), and ym- (chitinaselike ) were not changed ( figure s ). interestingly, pre-treated hfd-fed mice showed significantly decreased expression of lipogenic genes (fatty acid synthase (fasn), sterol regulatory element-binding protein (srebp- c), and acc- ) in adipose tissue ( figure c ). these results indicated that pre had anti-inflammatory and anti-lipogenic activities in adipose tissue. our initial results showed that pre activated ampk and suppressed pro-inflammatory mediators in vitro. therefore, we tested whether pre activated ampk and nf-κb in obese adipose tissue in vivo. upon treatment with pre, nf-κb phosphorylation was significantly decreased, whereas ampk phosphorylation was increased in epididymal white adipose tissue (ewat) ( figure a ). next, we assessed the effects of pre on inflammation in adipose tissue. as shown in figure b , the expression of pro-inflammatory genes (il- β and inducible nitric oxide synthase (inos)) was significantly reduced in ewat after treatment with pre. however, marker genes of macrophages (f / , cd b, and cd ) or marker genes of the m macrophage, including arginase- (arg- ), mannose receptor c-type (mrc- ), macrophage galactose binding lectin (mgl), and ym- (chitinase-like ) were not changed ( figure s ). interestingly, pre-treated hfd-fed mice showed significantly decreased expression of lipogenic genes (fatty acid synthase (fasn), sterol regulatory element-binding protein (srebp- c), and acc- ) in adipose tissue ( figure c ). these results indicated that pre had anti-inflammatory and anti-lipogenic activities in adipose tissue. our initial results showed that pre activated ampk and suppressed pro-inflammatory mediators in vitro. therefore, we tested whether pre activated ampk and nf-κb in obese adipose tissue in vivo. upon treatment with pre, nf-κb phosphorylation was significantly decreased, whereas ampk phosphorylation was increased in epididymal white adipose tissue (ewat) ( figure a ). next, we assessed the effects of pre on inflammation in adipose tissue. as shown in figure b , the expression of pro-inflammatory genes (il- β and inducible nitric oxide synthase (inos)) was significantly reduced in ewat after treatment with pre. however, marker genes of macrophages (f / , cd b, and cd ) or marker genes of the m macrophage, including arginase- (arg- ), mannose receptor c-type (mrc- ), macrophage galactose binding lectin (mgl), and ym- (chitinaselike ) were not changed ( figure s ). interestingly, pre-treated hfd-fed mice showed significantly decreased expression of lipogenic genes (fatty acid synthase (fasn), sterol regulatory element-binding protein (srebp- c) , and acc- ) in adipose tissue ( figure c ). these results indicated that pre had anti-inflammatory and anti-lipogenic activities in adipose tissue. next, we examined whether pre prevented hepatic steatosis, which is increased by obesity. histological observations revealed that pre significantly suppressed hepatic steatosis in obese mice induced by hfd ( figure a and figure s ). because ampk plays crucial roles in suppressing hepatic steatosis [ ] and pre activated ampk in adipose tissue, we examined ampk signaling in liver. as shown in figure b , treatment with pre increased ampk phosphorylation in liver. furthermore, pre significantly decreased lipogenic gene expression (srebp- c and stearoyl-coa desaturase- (scd- )) ( figure c ). in addition, pre increased the expression of acyl-coa synthetase long-chain (acsl), very-long-chain acyl-coa dehydrogenase (vlcad), and short-chain acyl-coa dehydrogenase (scad), which are involved in fatty acid oxidation ( figure d ). taken together, these results suggested that pre activated ampk, which improved fatty liver. genes (b) and lipogenic genes (c) were analyzed by quantitative real-time pcr. data are shown as the mean±s.e.m. (n = ) *p < . ; **p < . ; ***p < . vs. hfd-fed vehicle group. next, we examined whether pre prevented hepatic steatosis, which is increased by obesity. histological observations revealed that pre significantly suppressed hepatic steatosis in obese mice induced by hfd ( figure a and figure s ). because ampk plays crucial roles in suppressing hepatic steatosis [ ] and pre activated ampk in adipose tissue, we examined ampk signaling in liver. as shown in figure. b, treatment with pre increased ampk phosphorylation in liver. furthermore, pre significantly decreased lipogenic gene expression (srebp- c and stearoyl-coa desaturase- (scd- )) ( figure. c ). in addition, pre increased the expression of acyl-coa synthetase long-chain (acsl), very-long-chain acyl-coa dehydrogenase (vlcad), and short-chain acyl-coa dehydrogenase (scad), which are involved in fatty acid oxidation (figure. d ). taken together, these results suggested that pre activated ampk, which improved fatty liver. to identify the bioactive compounds in pre that activate ampk, we isolated compounds via methanolic extraction ( figure s ). among them, we found that broussoflavonol b (bf) and kazinol j (kj) dramatically increased ampk phosphorylation in t -l adipocytes ( figure a ). both bf and kj increased ampk and acc phosphorylation, and compound c significantly blocked them ( figure b ). furthermore, bf and kj significantly suppressed tnf-α-induced nf-κb transcriptional activity ( figure c ). consistent with nf-κb activity, treatment with bf and kj downregulated tnf-αstimulated pro-inflammatory gene expression (il- , mcp- , and inos-only in the bf-treated group) in adipocytes ( figure d ). in addition, both bf and kj decreased iκb degradation and nf-κb phosphorylation, and compound c significantly blocked them ( figure e ). they also suppressed lps-mediated no production in raw . ( figure s ). together, these results strongly indicated that bf and kj were bioactive compounds of pre and could block an inflammatory response through blocking the nf-κb signaling pathway via ampk activation. to identify the bioactive compounds in pre that activate ampk, we isolated compounds via methanolic extraction ( figure s ). among them, we found that broussoflavonol b (bf) and kazinol j (kj) dramatically increased ampk phosphorylation in t -l adipocytes ( figure a ). both bf and kj increased ampk and acc phosphorylation, and compound c significantly blocked them ( figure b ). furthermore, bf and kj significantly suppressed tnf-α-induced nf-κb transcriptional activity ( figure c ). consistent with nf-κb activity, treatment with bf and kj downregulated tnf-α-stimulated pro-inflammatory gene expression (il- , mcp- , and inos-only in the bf-treated group) in adipocytes ( figure d ). in addition, both bf and kj decreased iκb degradation and nf-κb phosphorylation, and compound c significantly blocked them ( figure e ). they also suppressed lps-mediated no production in raw . ( figure s ). together, these results strongly indicated that bf and kj were bioactive compounds of pre and could block an inflammatory response through blocking the nf-κb signaling pathway via ampk activation. (b) t -l adipocytes were pre-incubated with/without compound c ( μm) for h, and then, cells were treated with bf or kj for an additional h. the expression of phospho-ampk, ampk, phospho-acc, and acc was analyzed by western blotting. (c) hek- cells were transfected with the nf-κb-responsive luciferase reporter and prl-renilla. the cells were treated with bf and kj as the indicated concentration for h, followed by treatment with tnf-α ( ng/ml) for an additional h. the cells were harvested, and luciferase activity was measured. data are shown as the mean ± s.e.m (n = ) *p < . ; **p < . ; ***p < . vs. the tnf-α-only-treated group. (d) after t -l adipocytes were pretreated with/without compound c, cells were incubated with/without bf or kj for h and stimulated with tnf-α ( ng/ml) for min. the expressions of phospho-iκb, iκb, phospho-nf-κb, nf-κb, and tubulin were analyzed by western blotting. (e) t -l adipocytes were pre-incubated with the indicated concentration of bf or kj for h, followed by treatment with ng/ml tnf-α for h. total rna was isolated, and the mrna expression level of each gene was analyzed by quantitative real-time pcr. data are shown as the mean ± s.e.m (n = ) *p < . ; **p < . ; ***p < . vs. the tnf-αonly-treated group. obesity is very closely related to chronic and low-grade inflammation. many reports have suggested that insulin resistance accompanies chronic inflammation and abnormal mediator secretion in obese adipose tissue [ ] , indicating that reduction of tissue inflammation could be an indispensable target for improving obesity-related metabolic syndromes. it has been reported that the cells were treated with bf and kj as the indicated concentration for h, followed by treatment with tnf-α ( ng/ml) for an additional h. the cells were harvested, and luciferase activity was measured. data are shown as the mean ± s.e.m. (n = ) * p < . ; ** p < . ; *** p < . vs. the tnf-α-only-treated group. (d) after t -l adipocytes were pretreated with/without compound c, cells were incubated with/without bf or kj for h and stimulated with tnf-α ( ng/ml) for min. the expressions of phospho-iκb, iκb, phospho-nf-κb, nf-κb, and tubulin were analyzed by western blotting. (e) t -l adipocytes were pre-incubated with the indicated concentration of bf or kj for h, followed by treatment with ng/ml tnf-α for h. total rna was isolated, and the mrna expression level of each gene was analyzed by quantitative real-time pcr. data are shown as the mean ± s.e.m. (n = ) * p < . ; ** p < . ; *** p < . vs. the tnf-α-only-treated group. obesity is very closely related to chronic and low-grade inflammation. many reports have suggested that insulin resistance accompanies chronic inflammation and abnormal mediator secretion in obese adipose tissue [ ] , indicating that reduction of tissue inflammation could be an indispensable target for improving obesity-related metabolic syndromes. it has been reported that roots of b. papyrifera have been used as a suppressant for edema in traditional chinese medicine [ ] . the core phytochemicals in the roots of b. papyrifera are flavonols, flavans, and chalcones [ ] . there is emerging evidence that these core phytochemicals have anti-inflammatory activities. [ , , ] . in the present study, we focused on the anti-inflammatory effects of pre in adipose tissue and investigated whether it could ameliorate systemic insulin resistance in obese mice. pre potently inhibited tnf-α-induced inflammatory responses by suppressing nf-κb activation in adipocytes. this effect improved not only glucose tolerance, but also hepatic steatosis in hfd-induced obese mice. using the fda guideline to calculate human equivalent doses (hed), the hed of this effective dose of pre ( mg/kg) was mg/day in humans. this dose was lower than that of metformin ( mg~ mg/day) even though pre was a crude extract. furthermore, bf and kj, the isolated phytochemicals from pre, were the bioactive compounds that suppressed inflammatory responses in t -l adipocytes through blocking nf-κb signaling. of significance, these effects were partially dependent on ampk activation in adipocytes ( figure s ) . ampk has been shown to have strong anti-inflammatory activity via inhibiting inflammatory responses in various in vivo models [ ] . various studies have shown that ampk inhibits pro-inflammatory signaling in many tissues and cells, especially adipocytes and macrophages, which are the main cell types of adipose tissue [ , ] . in addition, ampk ameliorates insulin resistance in obesity [ , , , ] . it has been reported that ampk activators specifically suppressed the expression of pro-inflammatory genes and the activation of nf-κb-mediated signaling [ , ] . the molecular mechanism for nf-κb activation is: ( ) the degradation of iκb in a ubiquitin-dependent manner is triggered through its phosphorylation by ikk; ( ) iκb degradation results in nuclear translocation of nf-κb [ ] . based on these results, we proposed the roles of pre and its constituents to inhibit nf-κb transcriptional activity through the blockade of phosphorylation-mediated iκb degradation and nf-κb phosphorylation; this effect was reversed by inhibition of ampk. thus, pre-mediated nf-κb inactivation would likely be accompanied by inhibition of the tnf-α-stimulated ikk/iκb/nf-κb signaling pathway. in addition to the identified signaling pathways, it remains to be elucidated whether other molecular mechanisms for the ampk-mediated anti-inflammatory effect of pre exist. ampk has several phosphorylation targets [ ] , but there are some reports suggesting that ampk could inhibit nf-κb activity and its signaling indirectly via sirtuin (sirt ) [ ] , the forkhead box o (foxo) family [ ] , and peroxisome proliferator-activated receptor γ co-activator (pgc- α) [ ] , which are known as downstream mediators of ampk. these mediators could inactivate the p subunit of nf-κb, and the expression of pro-inflammatory genes is subsequently repressed. thus, further studies related to the underlying mechanism of how pre and its active components regulate ampk activation and its resultant anti-inflammatory effect are needed. obesity-associated adipocyte dysfunction by chronic inflammation in adipose tissue contributes to developing hepatic steatosis: ( ) excessive free fatty acids from adipose tissue, which stimulate inflammation, could be delivered to liver; thus, triglycerides could be accumulated in liver; ( ) adipose tissue secretes pro-inflammatory cytokines including tnf-α, which exacerbate inflammation in liver and induce hepatic steatosis [ ] . here, we demonstrated that pre did not alter ewat mass and adiposity, by it ameliorated adipose tissue inflammation indicated by significant decreases in the pro-inflammatory signaling and pro-inflammatory genes' expression. furthermore, pre enhanced ampk activation, which regulates gene expression related to fatty acid oxidation and lipogenesis. thus, improved adipose tissue inflammation and ampk activation by pre could ameliorate hepatic steatosis. we demonstrated that pre and its active components had potential therapeutic effects on ameliorating inflammation in both adipose tissue and liver. furthermore, pre could reduce hepatic steatosis and improve glucose homeostasis. in addition, we proposed that the activation of ampk by pre and its active components could be the underlying molecular mechanism by which they have anti-inflammatory effects. taken together, these finding demonstrated the beneficial effects of b. papyrifera root and its phytochemicals and indicated their potential as candidates for targeting ampk for the treatment of obesity and/or type diabetes. the following are available online at http://www.mdpi.com/ - / / / /s : figure s : scheme of extract and isolation, figure s : adipogenic induction of t l preadipocytes into adipocytes, figure s : the effect of pre on adipose tissue and liver weight, figure s : the effects of pre on lps-induced pro-inflammatory gene expression in raw . cells, figure s : the effect of pre on adipose tissue and liver weight, figure s : the effect of pre on macrophage infiltration and polarization in hfd-fed obese mice, figure s : the effect of pre in liver steatosis, figure s : the effect of bf and kj on lps-induced no production and cell viability in raw . cells, figure s : pre improves insulin sensitivity via suppressing inflammation by activation of ampk in adipose tissue. chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance inflammation and insulin resistance inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance ampk as a therapeutic target for treating metabolic diseases. trends endocrino ampk: mechanisms of cellular energy sensing and restoration of metabolic balance exploiting the anti-inflammatory effects of amp-activated protein kinase activation ampk agonist downregulates innate and adaptive immune responses in tnbs-induced murine acute and relapsing colitis singh, i. -aminoimidazole- -carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis ampk agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells hematopoietic ampk β reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity macrophage alpha amp-activated protein kinase (alpha ampk) antagonizes fatty acid-induced inflammation through sirt amp-activated protein kinase α protects against diet-induced insulin resistance and obesity antityrosinase and antioxidant effects of ent-kaurane diterpenes from leaves of broussonetia papyrifera antioxidant lignans from the fruits of broussonetia papyrifera comparison with various parts of broussonetia papyrifera as to the antinociceptive and anti-inflammatory activities in rodents inhibition of nitric oxide production on lps-activated macrophages by kazinol b from broussonetia kazinoki kazinol b from broussonetia kazinoki improves insulin sensitivity via akt and ampk activation in t -l adipocytes anti-inflammatory flavonoids from root bark of broussonetia papyrifera in lps-stimulated raw . cells evaluation of polyphenols from broussonetia papyrifera as coronavirus protease inhibitors polyphenols from broussonetia papyrifera displaying potent alpha-glucosidase inhibition inflammation, stress, and diabetes five new diprenylated flavonols from the leaves of broussonetia kazinoki the genus broussonetia: a review of its phytochemistry and pharmacology prenylated polyphenols from broussonetia kazinoki as inhibitors of nitric oxide production role of amp-activated protein kinase in adipose tissue metabolism and inflammation adenosine -monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype luteolin reduces obesity-associated insulin resistance in mice by activating ampkα signalling in adipose tissue macrophages berberine suppresses proinflammatory responses through ampk activation in macrophages nf -κb, inflammation, immunity and cancer: coming of age amp-activated protein kinase and its downstream transcriptional pathways tnf-α reduces pgc- α expression through nf-κb and p mapk leading to increased glucose oxidation in a human cardiac cell model the authors declare no conflict of interest. key: cord- -eq zhtd authors: nan title: abstracts of oral presentations and posters date: journal: ann hematol doi: . /bf sha: doc_id: cord_uid: eq zhtd nan since the blood cells are primarily concerned with host defense, the introduction of the csfs as therapeutic agents offers the opportunity to develop unique therapeutic strategies designed to enhance overall host defense, particularly with relevance to cancer and aids. administration of csfs is associated with profound changes in cellular function, and treatment strategies will need to consider the potential deleterious effects of heightened host cell activity and potential effects on nonhematopoietic cells. memorial sloan-kettering cancer center, new york, ny , usa a cytokine the majority of hemopoietic stem cells in the steady state marrow are dormant in the cell cycle. using serial observation (mapping) of blast cell colony formation from bone marrow cells of mice that have been treated with a high dose -fluorouracil ( -fu), we have identified a number of cytokines that appear to control the cell cycling of the primitive hemopoietic progenitors. the early-acting cytokines may be divided into three groups. the first group would consist of il- , gm-csf, and il- . the second group consists of il- , g-csf, il- , il- , and lif/dia. the third group consists of steel factor (sf). according to our studies in culture, cytokines in each group can interact with those in other groups to initiate cell division in the cell cycle dormant primitive progenitors. while studies using retrovirally-labeled murine stem cells demonstrated unequivocally the presence of lymphohemopoietic progenitors that are capable of producing both lymphoid and myeloid progenies, it has not been possible to identify and quantitate these progenitors in culture. recently, we have developed a two-step methylcellulose culture method to quantitate murine lymphohemopoietic progenitors that are capable of producing myeloid cells and and pre-b-cells. after establishing the primary culture system initially with medium conditioned by pokeweed mitogen stimulated spleen cells, we characterized combinations of cytokines that are able to maintain the b-lymphoid potentials of the primary colonies. we observed that two-factor combinations including sf such as sf plus il- , sf plus g-csf, sf plus il- , sf plus il- were effective in maintaining the proliferation of b-cell progenitors. somewhat less effectively il- -based combinations such as il- plus il- and il- plus il- also supported the b-cell potentials of the the primary colonies. interestingly, il- -based combinations were unable to maintain the b-cell potentials of the primary colonies even though the cells in myeloid lineages proliferated strongly. we also found that addition of il- to an effective two-factor combination such as sf plus il- inhibit the b-cell potentials of the primary colonies. our cell culture for the murine lymphohemopoietic progenitors may provide an important tool for studying the mechanisms regulating the early process of lymphopoiesis. the survival and proliferation of haemopoietic stem cells, induced by growth factors, occurs concomitantly with differentiation and developmeat of the stem cells and their progeny, into mature blood cells. are the growth factors simply permissive for these processes? or do they have an inductive role to play in lineage commitment of stem cells and subsequent maturation into phenotypically mature cells? from various experiments, it is clear that the outcome of the response (that is the types of mature cells produced) is a reflection of the range of growth factors to which the cells are exposed-suggesting that combinations of growth factors may well influence the choice of lineage options taken by multipotent cells. the problem, of course, is that in all systems studied to date, no detailed examination has been made of cell death, and that even in growth factor combinations where, for example, no erythropoiesis is found, it is possible that erythroid progenitors are being produced as a consequence of differentiation of the multipoteni cells but that these cells are then dying due to lack of availability of the appropriate survival (growth factor) stimulus. we have recently been able to circumvent some of these problems and have shown that, orovided the cells receive a survival stimulus, differentiation can occur hi the absence of added growth factors and also that proliferation it not a prerequisite for acquisition of a mature cell phenotype. in other words, the growth factors may act primarily as survival and mitogenic stimuli and not as "inducers" of differentiation. expression of p bcr/abl by transfection converts interleukin- (il- )-dependent cell lines to factor independence and transforms immature hematopoietic cells in vitro. we tested the hypothesis that p bcr/abl may induce factor-independence by constitutively activating signal transduction pathways which are normally regulated by il- /gm-csf. in both the il- -dependent murine myeloid cell line, dcl , and the il- /gm-csf-dependent human line, mo e, p bcr/abl induces rapid factor-independence despite continuous growth in il- -containing medium. one-and two-dimensional antiphosphotyrosine immunoblotting showed that most proteins tyrosine phosphorylated by p bcr/abl are different that those phosphorylated in response to il- . several signaling molecules have been found to be activated or phosphorylated by both il- /gm-csf and p bcr/abl, including raf- , map kinase, shc, vav, and probably pi k. other signal transducing proteins were found to be phosphorylated only by pz bcr/abl (p rasgap, two rasgap associated proteins, and c-fes), or only by . in order to better define the biochemical activities of p bcr/abl which lead to mitogenesis, a series of cell lines were constructed in which the functional expression of pz bcr/abl was inducible. the uninduced cell lines had a wild-type phenotype while the induced cell lines displayed markedly reduced apoptosis in the absence of growth factor, and some were hyper responsive to growth factors. the phenotypes of these cell lines have been stable in culture, and the lines should be useful to define biochemical activities of p obcr/abl which are important for mitogenesis. r.e. donahue, m.r. kirby, p.d. lawman, s.e. sellers, s.w. kessler, and m.j.p. lawman a novel factor has been purified to homogeneity from a cell line derived from a human mixed germ cell tumor. by western blot analysis, using a polyclonal rabbit antibody raised to the purified native protein, scpf was found to be expressed both as a kd secreted and as a kd membrane-bound protein. to further evaluate scpfs' ability to support cd + cell growth in culture, scpf was used in short-and long-term cultures using immunoselected cd + cells. for short-term culture studies, cd + cel~s were evaluated prior to and subsequent to a six day exposure to either media alone or media supplemented with il- , scpf, or il- +scpf. the greatest expansion of cd + cells was in those expressing od . compared to pre-culture, cultures maintained in scpf, il- , or il- +scpf had, respectively, a . , . , or . -fold increase in cd +cd + numbers. there was also a consistent increase in the ratio of large cd + + cells to small cd +cd + cells. presumptively, this change represents an increase in the number of cells in either the g /m or s phase of the cell cycle. of the cytokine combinations evaluated, only the combination of il- + scpf led to a t . -fold expansion of cd + cd -cells above baseline values. by themselves, scpf and il- led to a . and . -fold reduction in cd +cd -numbers. when compared, however, to the number of cd + cd -cells present in media alone after the days in culture, scpf, il- , and il- + scpf hat respectively a . , . , and . -fold greater number of cd +cd -cells. in long-term culture assays in the absence of scpf, the cultures deteriorated rapidly and were test by day . in the presence of scpf, cell numbers were maintained over the initial - days in culture, with proliferation becoming evident days post-culture. at day , some of the cells were removed from culture media containing scpf and replatad in culture media alone. after an additional days in culture the cells that were no longer exposed to the scpf had differentiated. interestingly, the cells that were cultured in scpf continued to proliferate. after days in culture, these cells were predominantly cd +, cd +, cd +, cd +, cd +, and hi.a-dr +, and failed to express thy t, cd , cd , cd , od , or cd . karyotypic analysis demonstrated that these cells hat multiple chromosomal aberrations, civin, a. gewirtz, p. rockwell, l. witte we have cloned the cdna for stk- (stem cell tyrosine kinase ), a human growth factor receptor tyrosine kinase, and investigated its expression in bone marrow, leukemias, and leukemic derived cell lines. stk- expression is restricted to the cd + fraction of normal human bone marrow, the fraction containing all of the hematopoietic stem cell activity of marrow. experiments in which cd + cells grown on irradiated bone marrow stromal feeder layers were exposed to stk- antisense oligonucleotides resulted in inhibition of colony formation. stk- is also expressed in most cases of aml, b lineage all, and t cell all. a number of hematopoietic tissue culture cell lines which express stk- have been identified, including kmt , kgla, kg , ml- , hl- , nalm- , and reh. ml- cells stop growing and differentiate after exposure to phorbol esters and other agents. stk- expression is completely shut off by this treatment. antipeptide antibody generated against several regions of stk- identifies a doublet of proteins of kd and kd, probably corresponding to different degrees of glycosylation, in several of the cell lines. these data imply a possible role for the stk- receptor in the normal proliferation of hematopoietic stem cells and the abnormal proliferation of leukemic cells. further antisense experiments and the isolation of the growth factor for this receptor will be necessary to fully understand its role in hematopoiesis and leukemia. murine long term repopulation and double transplantation assays have clearly demonstrated irreversible damage to early stem cells by repeated doses of alkylating agents or anti-metabolites. the ability to protect from the short term effects of chemotherapy-induced myelosuppression by administration of hematopoietic growth factors has obscured the potential problem of long term stem cell insufficiency. indeed in murine models involving repeated cyclophosphamide administration, csf administration has been reported to protentiate stem cell damage. the development of techniques for isolation of human hematopoietic stem cells in a cd + lin -re fraction of marrow and blood, together with long term culture-initiating assays on marrow stroma or long term ex vivo expansion with cytokine combinations, permits quantitative analysis of human stem cell proliferation potential. it is becoming apparent that extensive chemotherapy treatment gravely compromises the population of primitive hematopoietic stem cells as reflected in their impaired capacity to peripheralize and to be represented in the blood cd + population following csf treatment with or without cytoxan. five strategies are currently under evaluation: ) upfront harvesting of marrow and/or elicited peripheral blood prior to onset of chemotherapy with subsequent "rescue" following chemotherapy; )fine tuning of cytokine and chemotherapy administration to take advantage of "rebound quiescence" of stem cells; )administration of negative regulators to suppress stem cell proliferation. transforming growth factor , macrophage inflammatory protein e and tumor necrosis factor have all proved protective in preclinical models. ) utilize cytokines, eg il- , that protect stem cells by increasing drug enzymatic inactivation, decreasing drug influx and/or increasing drug efflux, and inducing dna repair or decreasing dna damage. ) ut ze gene therapy to introduce into hematopoietic stem cells drug resistance genes such as mutated dihidrofolate reductase that confers methotrexate resistance or enhance the expression of the multi-drug resisting gene (mdr) expression. interleukin- : a novel hematopoietic cytokine possessing multiple biological activities in vitro and in vivo. j.p. leonard and s.j. goldman, genetics institute, cambridge, ma. interleukin- is a multifunctional hematopoietic cytokine which was originally identified in the conditioned medium from an il- stimulated primate stromal cell line. the human cdna was subsequently cloned from a fetal fibroblast cell line enabling the expression and purification of the human protein. the in vitro biological activities of rhll- result predominantly from synergistic interactions with other growth factors. in combination with other cytokines, rht[,- has been shown to support the formation of primitive human blast ceil coionies from bone marrow, promote erythroid burst formation and stimulate both early and late stages of megakaryocyte proliferation and differentiation. in addition, rhll- alone directly increased the size and ploidy of enriched megakaryocytes. although rhll- has no inherent cell growth factor activity, rhll- has been shown to stimulate immunoglobulin producing b cells both in vitro and in vivo. rhll-i is biologically active in mice, rats, dogs and primates when administered as a single agent in vivo. the predominant effect of rhll- in naive animals was on cells of the megakaryocyte lineage, increasing the number of bone marrow megakaryocyte progenitors, stimulating megakaryocyte endoreplication and increasing peripheral platelet counts in a dose dependent fashion. in a variety of murine rtiodels of myelosuppression, the effects of rhtl- were multitineage, stimulating the recovery of megakaryocyte, erythroid, and granulocyte and macrophage progenitors in the bone marrow, rhll-i administration reduced the platelet and hematocrit nadirs and the overall duration and severity of thrombocytopenia and anemia in these models. in a murine bone marrow transplant model, rhll- also accelerated neutrophil recovery. the results from ongoing preclinical studies continue to confirm the broad spectrum of biological activities possessed by rhil- in vitro and suggest this cytokine may be an effective agent in the treatment of myelosuppression associated with cancer chemotherapy and bone marrow transplantation. preclinical biology of human il- t.l. nagabhushan, s.k. narula and m.i. siegel human il- (hull- ) is a amino acid polypeptide synthesized by a number of different cell types. it is a pleiotropic factor with both immunosuppressive and immunostimulatory activity. recombinant hull- expressed in cho cells is not glycosylated, and when expressed in e. coil the protein retains the biological activity of the cho-derived product. in the presence of antigen presenting cells, hull- inhibits cytokine synthesis in t cells. hull- downregulates ,f-ifn and il- induced mhc class ii antigen expression on monocytesmacrophages. in contrast, it has no effect on class ii expression on purified tonsillar and peripheral b cells. hull- also inhibits the synthesis of il- % il- /l il- , il- , tnf-m gm-csf and g-csf at the protein and rna levels in monocytes activated by lps or lps and .r the y-ifn or gm-csf induced phagocytosis of opsonized yeast particles by human peripheral blood-derived macrophages and granulocytes is downregulated by hull- . il- induced ige synthesis by pbmnc is inhibited by hull- . the protein also potentiates a strong lak activity in human pbmnc. these results will be discussed along with some early in vivo biology in rodents. a monomeric pentapeptide (peedck) inhibits murine hematopoiesis in vitro and in vivo while its dimer counterpart (peedck): formed through a disulphide bridge has a stimulatory effect in the same systems. stable peptides of the rimer have been made by substitution of the disulphide bridge with a dimethylene bridge. in vitro the dimer seems to have no direct effect on gm-cfc or on purified lin-scal + cells in the hpp-cfc assay ( cells per culture, - % pe). the monomer does not affect gm-cfcs, but inhibits approximately % of the purified hpp-cfcs. the dimer stimulates human or mouse stromal cells to produce m-csf and possibly other cytokines which augment colony formation in vitro and also activate human pbl as measured by an increased expression of cd lb. in ex vivo experiments it was found that the dimer increases and the monomer decreases cell cycle rate of cfu-gm and cfu-s in the bone marrow. intraperitoneal injection of the dimer ( to ng/kg) into mice, led to increased progenitor cell number in the bone marrow and also increased survival of mice given a lethal dose of cyclophosphamide ( mg/kg). at present receptors of the peptides have not been identified. these studies have shown that the dimer has an indirect effect on hematopoiesis as a stimulator of cytokine production, while the monomer seems to act both as an antagonist of dimer action and is also able to directly inhibit early myeloid progenitor cells. the possibility that these two compounds have therapeutic efficacy in diseases involving a myelosuppressed bone marrow is indicated. there is evidence that basic fibroblast growth factor (bfgf) plays a role in the regulation of normal blood cell proliferation and differentiation. basic fgf is produced by and is a potent mitogen for human slromal cells. it is found in megakaryocytes and cells of the granulocyte lineage, in vivo, and it enhances megakaryopoiesis and myelopoiesis in human long term bone marrow cultures. it stimulates progenitor cell growth and augments the proliferation of progenitor cells when added in conjunction with other hematopoietic growth factors. in addition, it counteracts the suppressive effects of transforming growth factor beta. basic fgf also synergizes with stem cell growth factor to augment granulocyte macrophage colony stimulating factor stimulated progenitor cell growth. based on the observations in normal hematopoiesis, the role of bfgf in malignant bematopoiesis is presently an area of active investigation. scf is one of the earliest-acting hematopoietic growth factors. pre-clinical studies have demonstrated its multi-lineage hematopoietic effects. we have conducted a phase i trial of scf and report now on the first patients (pts) with stage iiib (n= ) or iv (n= ) breast cancer. the study was designed to evaluate the toierabllity and biologic effects of scf. pts received scf prechemo (cycle o) and following cycles - of c/a chemotherapy. cohorts of lots were randomized in a : ratio to receive either scf (n= ) by subcutaneous injection at dosages of i , , and so/~g/kg/day for days or no scf as a parallel c/a control group (n= ). various physiologic, biochemical, pharmacokinetic, and hematologic parameters were studied. bone marrow (bm) and peripheral blood (pb) progenitors were assayed. scf administration was associated with pb progenitor mobilization in cycle at all dose levels. absolute neutrophil counts demonstrated modest doserelated increases over baseline ranging from median values of % ( pg/kg/d) to % (so/jg/kg/d). no reproducible effects were seen on red blood cells or platelets. the principal adverse events were derrnatologic in nature. they included mild to moderate reactions at the injection site in all pts, and moderate to severe reactions distant to the site in i pts (primarily at higher doses). at pg/kg/d, / pts experienced dose-limiting respiratory symptoms including cough, hoarseness, and laryngospasrn. because of scfs known mast cell effects, prophylaxis with h /h blockers and bronchodilators is being evaluated. no pts developed antibodies to scf. evaluation of effects following chemotherapy is ongoing. we conclude that scf is an active hematopoietin capable of stimulating production of bm and pb progenitor cells as well as peripheral neutrophils. g. trinchieri nksf/il- is a heterodimeric cytokine produced by monocytemacrophages, b cells and other accessory cells in response to various stimuli including bacteria and bacterial products. nksf/il- acts on t cells and nk cells inducing cytokine production, proliferation, and enhancement of cytotoxic activity. nksf/il- is a particularly efficient inducer of ifn- production, acting alone or in synergy with other ifn- inducers such as il- , antigens, anti-cd or anti-cd antibodies, mitogens, and phorbol diesters. nksf/il- appears to play a major role in regulation of natural resistance: when produced by monocyte-macrophages, it directly activates the cytotoxic activity of nk cells and induces both nk and t cells to produce ifn- and other cytokines with important effects on activation of phagocytic cells. the important role of nksf/il- in response to bacterial products is clearly demonstrated by the ability of anti-nksf/il- antibodies to inhibit in vivo in mice the ifn-y production induced by lps ii~ a toxic shock model. nksf/il- is also an important factor in the regulation of adaptive immune response, by inducing the differentiation and growth of t helper cells type (th- ) and by preventing the differentiation of il- producing th- cells. a possibly obligatory role of nksf/il- for th- cell differentiation can be demonstrated in vitro in the human lymphocyte response to allergens or bacteria-derived antigens and both in vitro and in vivo in the murine system, e.g. in the immune response to leishmania infection. production of nksf/il- by accessory ceils is stimulated by ifn- , a product of th- cells and suppressed by il- or il- , products of th- cells. these results suggest that nksf/il- represents an important link between natural resistance and adaptive immunity and is at the center of a cytokine network that regulates the equilibrium between cellular and humoral immunity. work with alpha-interferon in cml started at mdacc in and has evolved over the years to allow us interpretation of response rate in a large number of patients with relatively long follow up. newly diagnosed patients ( pts per dose step. before ct rhll- is given dl iv and d - sc. ct (mitoxantrone mg/m and thiotepa mg/m , iv dl) starts d , q wks. after ct rhll- is given d - se in all cycles (c). before ct pts were treated. rml~ related side effects were: fever who gri-ii ( %), headache ( %), myalgia ( %), local erythema ( %) and starting at . #g nausea ( %), increase of liver enzymes who gri-ii ( %) and anemia ( %). symptoms were controllable with acetaminophen (n= ) and antiemetics (n= ). upto #g them was a dose response related platelet increase compared to dl (r= . , p< . ), with highest count after rml- cessation. at . /~g max. increase was . + . (se), at ~g . + . %. on d a leukocyte increase compared to dl was observed starting at . #g upto /~g (dl . + . , d . + . , p< . ) mainly due to neutrophil increase (p< . ). at d increase of lymphocytes occurred compared to dl (dl . + . , d . + . , p< . ). there was a reversible hemoglobin reduction especially at and i ,gg, starting d with a max. decrease at dg ( /zg . + . g/l, #g . + . g/l), at d initial values were almost reached without intervention. a dose related acute phase response was observed, with max. value of crp (mg/l) • at . /zg and • at /tg (r= . , p< . ), and max. value of serum amyloid a (rag/l) at . /zg of • and at #g + (r= . , p< . ). after ct c (no c= ) were evaluable upto dose #g, in these e rhll- related side effects were: fever ( %), headache ( %), myalgia ( %), local erythema ( %), nausea ( %) and increase in liver enzymes ( %). uptu c there was no difference in platelet nadir, moment and duration of platelets < x /l between . - /~g and . - #g doses. the same was observed for leukocytes. in conclusion, rml- upto #g/kg/d has a acceptable toxicity profile and results, before ct, in dose dependent platelet and acute phase proteins increase. after ct, evaluable now for the first cycle, there is a faster platelet recovery at higher dose steps. university hospital groningen, division of medical oncology, department of internal medicine, oostersingel , ez gronlngen, the netherlands. g-csf in acute lymphoblastic leukemia. d.hoelzer, o.ottmann rhg-csf given in acute lymphoblastic leukemia (all) after induction/consolidation therapy or allogeneic/autologous bmt can shorten the recovery time of neutrophils by - days, with reductions of the infection rate in some studies. granulocytopenia is the major dose limiting toxicity not only after but also during chemotherapy. for example, severe neutropenia occurs in ~ of patients during the intensive wk induction regimen of the german all trials. therefore, the effect of parallel administration of g-csf (filgrastim) and chemotherapy was explored, rhg-csf ( ~g/kg) was given concurrently with cyclophosphamide, arac, -mercaptopurine, prednisone and prophylactic cranial irradiation, rhg-csf was continued until neutrophil counts exceeded /~i, but for at least seven days following the last dose of chemotherapy. in a pilot study of pts, the median duration of granulocytopenia < /~i was days compared to days in a historical control group. when rhg-csf was applied throughout the entire wk induction treatment (scherrer et al) in pts, the cr rate was %, the tim~ of nm,trophil reeoverv to > ~o~l~l after the end of chemotherapy was reduced from , days to , days, and the infection rate was lower in the g-csf treated patients. from these studies it was concluded that the concomitant administration of rhg-csf and intensive chemotherapy in adult all is leasable, well tolerated and without major side effects; in particular, there was no evidence of prolonged neutropenia due to stimulation of hemopoietic stem cells by g-csf and their subsequent elimination by chemotherapy. the clinical effects of rhg-csf given concomitantly to chemotherapy require confirmation in a randomized trial. in an ongoing randomized multicenter trial~ an interim analysis of pts revealed a highly significant reduction of the total duration of severe neutropenia (< /~l) in the patients receiving g-csf. further analysis of the potential clinical benefits of this treatment modality is in progress. we performed a phase h trial to assess the ability of g-csf -mobilized pbpc to rapidly and completely restore hemopeiesis after high dose chemotherapy in the absence of bone marrow infusions, with selection for pbpc-only infusions based on yield of granulocyte -macrophage colony -forming cells (gm-cfc) after g-csf treatment. twenty-nine adults with acute lymphoblastic leukemia, non-hodgkin's lymphoma, or hodgkin's disease who were eligible for autologons bone marrow transplantation were treated. g-csf was given at or ixg/kg/d for - d and mononuclear cells collected by apheresis on days , , or , , . yield of pbpc was assessed by assay for granulocyte-macrophage colony forming cells (gm-cfc). high yield was defined as total gm-cfc collected > x /kg. high dose bnsulfan ( mg/kg/d x d) an& cyclophosphamide ( mg/kgtd x (: ) were administered and hemopoiedc cells infused• and recovery of hemopoiesis mouitored. progenitor cell yield was high in of patients. patients given infusions of g-csf-mobilized pbpc, but without bone marrow infusion, experienced recovery of hemopoiesis in all cases. no patient given pbpc alone required bone marrow infusion in up to months of follow up. kinetics of recovery of both the platelet and neutrophil counts were more rapid in the high yield (pbpc-alone) group than in the low yield group (pbpc pins bone marrow). pintelels recovered to > x / at a median of days and neutrophils to > . x / at days in the high yield group, compared with days and days in the low yield group (p= . and . respectively). fewer platelet transfusions were required in the high yield group (median packs per patient vs. , p--- . ). we conclude that in patients with a high yield of pbpc after g-csf therapy, infusion of g-csf-mobilized pbpc results in rapid and sustained restoration of hemopoiesis. use of g-csf mobilised pbpc to support multiple cycles of hdc for treatment of high-risk stage ii and iii breast carcinoma is now being examined in a phase i study pursued by our group. our data on pbpc moblisation without chemotherapy allows consideration of g-csf-mobilised pbpc for haemopoietie ceil allotmnsplantation and for gene therapy trials. our approach for high-dose (hd) chemotherapy is to first treat patients eligible for dose intensification with a standard dose chemotherapy (vip: vp = etoposide: mg/m , ifosfamide: g/m , cis-platinum: mg/m ) followed by the application of colony stimulating factors (g-csf, gm-csf or il- + gm-csf) in order to combine a regimen with broad anti-tumor activity with the recruitment of peripheral blood progenitor cells (pbpcs). pbpcs are reinfused into the patients after high dose intensification chemotherapy (according to underlying disorder: hd-vip, vic-e or beam). highest numbers of pbpc were recruited by the sequential administration of _- + gm-csf (median of cd + cells/iji and . total progenitors/ml, including multilineage as well as megakaryocytic progenitors). csf-mobilized pbpcs include lineage negative cd + cells, -hc resistant precursors as well as long term culture initiating cells (ltc-ic). so far, a total of patients were supported with pbpos and csfs following hd-chemotherapy. the period of severe neutropenia (< //ji) as well as thrombocytopenia (< . o//ji) was reduced to a median of or days respectively. in order to decrease the number of potentially contaminating tumor cells in the leukapheresis preparations, we have started to positively select cd + cells by an avidin-biotin immunoadsorption column (provided by r. berenson, cellpro, usa). in all these patients, recovery data were comparable to the patients who received unseparated cells. to provide sufficient numbers of pbpcs for repetitive use or in patients with low progenitor cell yield as well as to possibly avoid leukapheresis, we investigated the ability of hematopoietic growth factor combinations to expand pbpcs ex vivo. chemotherapy + g-csf recruited cd + cells from patients were enriched by immunoadsorption (purity: . -+ . ) and cultured in suspension. a combination of stem cell factor, erythropoietin, interleukin- , il- , and il- was identified as the optimal combination for the expansion of clonogenic progenitors. proliferation peaked at day with a mean -fold increase (range - ) of clonogenic cells. interferon-gamma synergized with the -factor combination, whereas the addition of gm-csf or g-csf decreased the number of clonogenic cells. large-scale expansion of cd + cells in auto-iogous plasma supplemented with the -factor combination resulted in an equivalent expansion. our data indicate the feasibility of large-scale pro+genitor cell expapsion in cancer patients, starting from small numbers of cd ceils. given the pressures on health care resources new health technologies need to be assessed to establish whether their benefits justify their costs. g-csf is an important new technology that has profound impacts on cancer chemotherapy and patients outcome. as clinical studies show, the main economic benefits of g-csf come from * a significant reduction of hospitalisation during chemotherapy, * reduced expenditure on inpatient and outpatient i.v. and oral antibiotic treatment, * and reduced platelet and rbc transfusions. in addition, it is expected that a therapy with g-csf during cancer chemotherapy shows intangible and non-monetary benefits: * increase in the rate of treatment as intended (time, number of cycles) * increase of quality of life of patients * reduction of drop-outs * ability to intensify dosage recently coducted economic cost-cost studies show that the cost of managing neutropenia and infection and the cost of chemotherapy are lower for patients receiving g-csf than those who do not. future studies have to focus mainly on the quality-of-life cost-effectiveness of g-csf. the aim of this study is to evaluate the effects of recombinant human erythropoietin (rhu epo) on hematopoietic regeneration after allogeneic or autologous bone marrow transplantation. patients were randomized to receive either u rhu epo/kg body weight or placebo as continuous intravenous infusion from day after bmt until independence from erythrocyte transfusions for days or until day . the randomization was performed per each center and stratified according allogeneic or autologous bmt and major abo-blood group incompatibility. at the time of the planned interim analysis with patients treated, the time to erythrocyte transfusion independence after allogeneic bmt was shorter in group a (n = ) than in group b (n = ). after autologous bmt no difference between group a (n = ) and b (n = ) could be detected so far concerning time to transfusion independence or the number of transfusions applied, considering either erythrocyte or thrombocyte transfusions. there were no major differences in side effects between groups a and b. as of october , the study was finished with a total of patients. since rcc patients have been screened for entry into clinical trials and entered onto surveillance as first management policy until symptoms or serial radiology indicated tumour progression. + ( %) have demonstrated unexplained "spontaneous" cr+pr(median duration mths), and ( %) "stable" disease(median mths). none of not nephrectomised regressed, while cr+pr was % of nephrectomised at diagnosis of metastasis, % of developing metastases - mths after nephrectomy and % of developing metastases more than mths after nephrectomy. it was % of with lung only verses % of with other sites. possible evidence for relief of potentially immunosupressive influences have been demonstrated in of patients demonstrating unexplained "spontanous regression. study of hla class i and ii antigen abnormally on these tumours and their influence on tumour infiltrating lymphocytes will be reviewed. patients seen to progress on surveillance were entered into treatment trials, the remainder being too old, sick or having bone or brain metastases needing radiotherapy. + ( %) achieved cr+pr. + of ( %) of patients with lung only verses + of ( . %) of those with other sites of metastasis. although these results suggest that no harm has come from a period of preliminary surveillance, the fact that the therapeutic benefits including durable complete remission from therapy are confined almost entirely to the good risk small volume asymptomatic patients makes it difficult to justify a policy of surveillance for such patients. auto bmt, as alternative of allo bmt, lack{ immunotherapical effect delivered by allo graft. however immune reconstiturion after auto bmt shows features recalling the post allo setting. futhermore in vitro and in vivo in rll is able to stimulate the proliferation and the lyric functions of nk and t cells, major effectors of this gvl effect. for these reasons from , we have so far treated patients with acute leukemia (aml- ;all: ) in cr with auto bmt followed with rll . all conditioning regimen included tbi. median rime between diagnosis and bmt was r~. mths ( - mths).arll was started as soon as platelets reach x ~/ and anl . x ~/ . rll was given in cycles of days (c ) and days (c to c ), starting on d ,d ,d ,d ,d ~. rll was given as a continuous infusion at a median of m iu/m~/d ( m- m). no patient died of rll related toxicity. platelet toxicity was obvious during the starting cycle but did not impair the long term hematological recovery. immune stimulation was major and intense for both nk and t cells and both lak and nk activity (all p < . ). long term infusion conducts to privilegiate nk stimulation. with a median follow-up of mths, relapse and survival probabilities are respectively % and % fo all and % and % for aml comparying favorably with historical control ; these data invited us to set up a randomised study in cr aml and all after auto bmt. started in in france, italy and england, pts have been so far included. we have shown that local, inhalative il- application in combination with low dose systemic il- and ifna is highly effective and has low toxicity (j urol , , ) . here we report about longterm follow-up from to month of an outpatient schedule in patients with pulmonary metastasis of renal cell carcinoma. treatment protocol based on time daily inhalation of il- ( x . i j) combined with low dose i.v. il- ( x u/ days every weeks) in patients or low dose il- s.c. injection of . u per day in patients. all patients received x s.c. ifna three times weekly. median treatment duration was month (range - month). toxicity of il- inhalation was low, no fever, no vasculary leakage. even after up to month of continuous inhalative treatment no evidence for irreversible pulmonary damage due to il- induced immunomodulation occured in patients. in pulmonary metastases complete response ( month), partial response ( , , , , + , , , , ) and stable disease ( , , , + , , , +) were achieved. of patients responded with nonpulmonary metastasis. overall tumor response considering both, pulmonary and nonpulmonary metastases was complete response, partial responses stable diseases, mixed responses and progressive disease. while il- per inhalation had to be stopped because of grade ii toxicity in patient only, ifna systemically had to be stopped in of and il- i.v. cycles in of patients. patients are alive with median actual survival of all patients of . month which seems to be prolonged compared to risk factors. inhalafive treatment with il- combined with low dose systemic cytokines represents a highly valuable model for the low toxicity of lccal il- application, resulting in an effective long term treatment schedule with long term responses. recent clinical trials for the biological therapy of solid tumors have used recombinant human cytokines in combination with conventional chemotherapy. in patients with metastatic renal cell carcinoma, we established a -drug combination of subcutaneous recombinant human interferon-u (ifn-u), interleukin- (il- ) and -fluorouracil ( -fu) as outpatient regimen. treatment consisted of eight weeks each of ifn-~ ( million u/m' x per week sq) combined sequentially with il- ( - million iu/m' x per week sq for four weeks) and -fu ( mg/m iv weekly for four weeks). among consecutive patients treated, there were complete ( . %) and ( . %) partial responders, with an overall objective response rate of . % ( % confidence interval, - %). median response duration was calculated at + months, and no relapse has occurred among complete responders. systemic toxicity was mild to moderate, with no severe -fu related mucositis or diarrhea. there were no dose limiting adverse effects of sq il- and no toxic deaths. in summary, this outpatient biochemotherapy was as effective as the most aggressive inpatient iv il- regimen; it appeared to significantly improve the therapeutic index in patients with metastatic renal cell carcinoma. medizinische hochschule, d- hannover, germany metastatic melanoma: immunotherapy with ifna and il- , dtic/ifna as second line treatment, ifne(/il- + dtic or cddp. u keilholz, c scheibenbogen, w tilgen, d maclachlan, p brossart, th m hler, w hunstein. this abstract summarises our -year experience in the treatment of metastatic melanoma with sequential or combined chemo-immunotherapy. patients with progressing metastatic melanoma have been treated with ifna and il- . mill u/sqm ifn(~ were given s.c. on days - , and a new decrescendo regimen of il- was used: lmg/sqm/ hours, followed by mg/sqm/ hours, and mg/sqm/ hours, and . mg/sqrrv hours x . the current response rate is % ( cr, pr, mr/sd, pd). patients not responding to ifnedll- (sd and pd) were eligible for subsequent chemotherapy with dtic, mg/sqm day , followed by ifna, mill u/day - . the response rate for this second line regimen is % ( cr, pr, sd, pd, n= ). using this sequential approach, the overall response rate in this cohort is %, and the median survival is months. in preparation of a randomized trial comparing chemo-immunotherapy and immunotherapy a pilot study was performed. patients not responding to the standard ifnedll- regimen received a single dose of dtic, mg/sqm (n= ) or cddp, mg/sqm (n= ) on day one, followed by ifn~il- according to the identical protocol as previously without chemotherapy. in the case of cddp, grade nephrotoxicity was observed in / patients. pharmacokinetics of il- were not influenced by previous chemotherapy, except in the patients with cddp-associated nephrotoxicity. induction of secondary mediators (tnfa, ifn'~, neopterin, scd ) by il- was not diminished by previous chemotherapy. patients unresponsive to immunotherapy alone showed tumor shrinkage upon chemo-immunotherapy. conclusion~: with initial immunotherapy followed in nonresponders by chemotherapy a response rate above % is achieved. combined chemoimmunotherapy is feasible, and the immunologic response to il- is not diminished by previous chemotherapy. a randomised trial is necessary to determine, whether combined chemo-immunotherapy is superior to immunotherapy alone. inflammation is characterized by an accumulation of leucocytes at the site of injury. it hab been well established that the disease associated lesions are caused by a plethora of soluble mediators released by both the infiltrated leukocytes as well by tissue cells, including many degrading enzymes, lipid mediators, reactive oxygen species, or cytokines. among those, cytokines play a crucial role in the inflammatory process as their release appears to represent the initial response which mediates the secretion of subsequent effector molecules responsible for the pathophysiological effects (e.g. changes of vascular resistance) in an autocrine or paracrine fashion. this holds true for the acute inflammation during which circulating granulocytes or monocytes are activated directly by a noxious agent; an example being the pivotal function of tumor necrosis factor (tnf) in septic shock. chronic inflammatory diseases are initiated and perpetuated by immune reactions. cytokines represent an important link between immune reactions and the recruitment and activation of blood borne infiltrating inflammatory ceils. thus interferon r and tumor necrosis factor , secreted by activated t lymphocytes, are potent stimulators of mononuclear phagocytes. the activated macrophages themselves secrete cytokines such as interleukin-t (il-t), tnf a or interleukin- (il- ) which have been termed collectively as inflammatory cytokines, il- and tnf again in an autocrine or paracrine way upreguiate the synthesis of the ultimate pathogenic mediators in macrophages-e.g. the secretion of degrading enzymes as in rheumatoid arthritis-. equally important they induce functional changes in vascular and autochthonous tissue cells which are thus recruited to contribute to the inflammatory lesions. il- , and similarly the lymphocyte derived rantes, chemotactically attracts to the site of lesion and activates granulocytes, which then participate in the inflammatory reaction. while this rapidly recruits circulating phagocytic cells, the secretion of colony stimulating factors by activated t lymphocytes and macrophages also increases the pool of granulocytes and monocytes by stimulating their synthesis in the bone marrow. in turn il- an tnf a synthesized by monocytes (and also some tissue cells) are coactivators of t lymphocytes, and thus contribute to al local immune reaction. besides this general role of cytokines in inflammation their involvement in specific situations becomes increasingly apparent, an important example being the allergic inflammation. cytokines synthesized by t lymphocytes such as interleukin- or interleukin- not only regulate immunogtobulin synthesis of b lymphocytes, including ige, but equally important modulate the functions of mast cells or eosinophilic leukocytes to become effective effector cells of allergic reactions. the detailed functions of cytokines in different acute or chronic inflammatory diseases will be discussed in the subsequent contributions. clinical results e holier, r hintermeier-knabe, b ertl, hj kolb, m kaul, u behrends, s thierfelder, w wilmanns experimental as well as clinical studies suggest dual involvement of proinflammatory cytokines as tnfalpha and ill in complications and gvhd following allogeneic bmt: nonspecific activation of recpient tissues during pretransp~ant conditioning results in early release of tnfa which strongly enhances donor t cell activation; in the effector phase, t cell stimulation is amplified by ifngamma and lps mediated release of tnf and ill. the role of these mediators as critical effectors of gvhd related tissue damage could be confirmed by application of cytokine antagonists early after murine bmt: both, anti-tnfa and ill-receptor-antagonist (illra, as shown by j ferrara, boston) resulted in a > % reduction of gvhd related mortality in mice, while pentoxifylline proved to be ineffective. in human bmt, phase l/ll studies analyzing anti-tnfa and illra in refractory gvhd report substantial improvement in - % of patients, though reoccurrence of symptoms after cessation of treatment in most patients indicates a late effector function of cytokines at least in advanced gvhd. contribution of tnfa to recipient related induction of gvhd is further suggested by a recent phase / study performed in our institution as prophylactic application of anti-tnfa during pretransplant conditioning suppressed occurrence of early gvhd in high risk patients as compared to historical controls. though these data indicate a future role of a variety of cytokine antagonists in management of clinical complications of bmt their impact on long term survival has to be evaluated and compared to classical strategies (e.g.the use of corticosteroids and t-cell-manipulation) in randomized studies. the cytokines il- and tnf play central roles in inflammatory responses which can lead to tissue injury, naturally occurring antagonists such as soluble cytokine receptors or receptor antagonists are also produced during inflammatory responses. these soluble receptors and antagonists may act as a buffer system to reduce and limit tissue injury induced by cytokines. however, in some disease states this naturally occurring buffer system may not be sufficient to inhibit the detrimental actions of an inflammatory response. responses to il- are mediated via the type receptor (il- r, type i). the type ii receptor (il- r, type ii) has never been shown to signal, but instead appears to be shed as an il- antagonist. both recombinant soluble il- r, type i an il- r, type ii are capable of binding il- and inhibiting responses in vitro. in a phase i clinical study evaluating soluble l- r (type ) in modifying cutaneous allergic responses, il- r was a potent inhibitor of allergen induced latephase inflammation in the skin, with a high safety profile. responses to tnf are mediated via the ps or pt tnf receptor. soluble forms of both the p and tnfr occur naturally and are increased in many inflammatory states. dimeric constructs of the p tnf have been engineered to form a soluble fc fusion protein with two monomeric tnfr extraceuular portions contained on a truncated ig heavy chain (tnfr:fc). the tnfr:fc possesses higher affinity than a monomeric soluble receptor and the ig-like fc structure imparts a longer half life. animal studies have shown that soluble il- r, type i and tnfr:fc are effective antagonists of inflammation. in animal models for arthritis and pulmonary inflammation, il-ir and tnfr:fc reduced inflammatory celt infiltration and tissue damage. both molecules are currently in clinical trials and hold promise for treatment of autoimmune and allergic diseases such as rheumatoid arthritis and asthma. recently, evidence was raised that pentoxifylline (pof} is able to suppress the synthesis of tumor necrosis factor-alpha [tnf} in cell cultures, in vivo, and to protect experimental animals against endotoxin shock: it was found that pof selectively inhibits the formation of tnf but not interleukin- (il- ]. we could confirm these pharmacological effects of pof in humans under controlled conditions of endotoxlnemia. ten healthy volunteers recieved a bolus injection of endotoxin [ ng of lps of s.a.e.], which caused a transient increase of circulating tnf and il- . weeks later the voluntecrs were again injected with endotoxin and pof was also infused. due to pof administration, there was no rise in circulating tnf, whereas il- levels rose in parauel with body temperature, comparable to those seen in the first part of the study. treatment of allograft transplant recipients with the murine anti-cd monoclonal antibody okt leads to an acute cytokine release syndrome. especially tnf seems to play a pivotal role in the pathophysiology of the okt first-dose reaction. pretreatment of patients with pof prior to okt administration was able to reduce the endogetlous tnf formation significantly as compared to controls and, thus, prevents severe clinical side effects, whereas il- formation and febrile response were not affected. severe pulmonary tuberculosis is associated with a chronic cytokine release syndrome [elevated levels of circulating tnf and il- ]. in patients pof treatment inhibited chronic tnf release selectively, and, thus, reduced tnf-dependent caehexia without affecting chronic il- formation and related symptoms, such as fever and night sweat. in conclusion, we suggest that pof may improve therapeutic strategies in cases of acute and chronic cytoklne release syndromes. tumor necrosis factor (tnf) plays a central role in the maintenance of the inflammatory events in rheumatoid arthritis. we evaluated the expression of p and p tnf receptors (tnfr) and of tnf-a and tnf-i~ on the surface of synovial fluid mononuclear cells in patients with rheumatoid arthritis (ra) (n = ), spondylarthropathy (spa) (n = ), and traumatic effusions (n= ). synovial t-lymphocytes from ra patients express in all cases the p tnfr on the cell-membrane, in / cases also a weak expression of the p tnfr is detectable, both mrnas can be detected by polymerase chain reaction (pcr). synovial macrophages also express the p tnfr and low amounts of the p tnfr. patients with active ra also have circulating p tnfr positive t-lymphocytes in their blood. high concentrations of soluble tnfr (stnfr) are found in the joint effusions of ra patients: up to ng/ml of p stnfr and ~jp to ng/ml p stnfr. significantly lower stnfr levels are found in spa effusions. both receptors are also more elevated in the serum of ra patients ( . _+ . ng/ml p stnfr and . + . ng/ml p stnfr) as compared to spa patients ( . _+ . ng/ml p stnfr and . + . ng/ml p stnfr, p < . ). tnf-a could be detected in the synovial fluid of ra patients (up to pg/ml), but not in the serum. the soluble tnfr are biologically active and neutralize the effects of tnf-a in a cytotoxicity assay. the high levels of soluble tnfr in the inflammatory effusions may reflect tnf neutralizing activity in an environment where enhanced tnf synthesis has occured. we have generated several anti-sense-tnf-a oligonucleotides (as-tnf), in order to down-regulate tnf biosynthesis at the mrna level. with as-tnf- we could achieve more than % inhibition of tnf secretion in pha-stimulated peripheral blood or synovial fluid lymphocytes. the effects of as-tnf- on the expression of tnfr and on the synthesis of other cytokines are currently being investigated. to investigate the effects of g-csf (r-methug-csf, aragon, thousand oaks, ca) on neutrophil production, blood distribution, survival and function, daily subcutaneous injections of g-csf were administered to healthy, young (y) ( - years) and healthy elderly (o) ( - years) subjects for days at three dose levels, mcg (n= ), mcg (n= ), and mcg (n = ). daily cbcs and serial measurements of neutrophil oxidative activity by chemiluminescence were made. in addition, blood neutrophil kinetics were determined (day ), transit time of the marrow neutrophil post mitotic pool (ntt) (days to ), neutrophil migration to skin chambers (days and ), and blood colony forming cells (cfu-gm) (day and ), as well as routine marrow morphology studies (days , and ) were performed. baseline neutrophil counts were similar in the y and o subjects and counts increased similarly for the two age groups, with peak counts of . --+- . for the mcg dose. g-csf significantly shortened the ntt from . - . days (control) to . - . days ( mcg) and . - . days ( mcg) (p< . ). a concomitant of the shortened ntt was a dose dependent increase in the chemiluminescence responses, reflecting higher myeloperoxidase activity. the shortened ntt was also reflected by a decreased proportion of marrow cells in the post mitotic pool (metas, bands and pmns) and apparently lengthened blood half life of the circulating pmns. neutrophil migration to cutaneous inflammatory sites was also decreased in a dose dependent fashion. comparison of the age groups showed the only significant difference to be in the mobilization of blood colony forming cells with blood cfu-gm increasing fold in the young versus fold in the elderly over days ( mcg). no significant toxicities were observed in these normal subjects. these studies demonstrate the dose dependent stimulation of neutrophil production with g-csf administration, which is not affected by the age of the subjects. the neutrophils released into the peripheral blood have enhanced oxidative responses but somewhat reduced migratory capacities, probably reflecting the accelerated production and early release of the developing neutrophils. these changes are remarkably similar to changes in neutrophil production and function observed with bacterial infections in hematological normal individuals. the systemic regulation of the host response during acute inflammatory states remains poorly understood. among the regulatory systems that are likely to play a role in controlling host responses to bacterial infection is the neuroendocrine axis. the pituitary for example, is ideally situated to integrate central and peripheral stimuli and among other effects initiates the systemic increase in glucocorticoid production that accompanies host stress responses. we studied the secretory response of the murine pituitary cell line att- in vitro and whole pituitaries in vivo after endotoxin (lps) stimulation. we identified macrophage migration inhibitory factor (mif), a previously described t-cell cytokine, as a major secreted protein of att- cells that were stimulated by sub-nanogram amounts of lps. to study the expression of pituitary-derived mif in vivo, balb/c mice were injected ip with sub-lethal amounts of lps. pituitaries and serum were collected at intervals and pituitary mif mrna and pituitary and serum mif protein were measured. pituitary mif mrna specifically increased with time and reached a plateau - hr after lps challenge. mif protein, which is present constitutively in the pituitary, decreased within hr. determination of serum mif in normal, athymic and hypophysectomized balb/c mice indicated that the pituitary is an important source of serum mif that appears in the post-acute phase ( - hr), whereas t cell mif contributes primarily to the hyper-acute rise in serum mif ( hr). these data suggest that mif plays a central role in the systemic response to endotoxin and that pituitary mif is likely to reflect the interplay of diverse neurohumoral stimuli that regulate acute and chronic inflammation. pretreatment of mice or rats with granulocyte colony-stimulating factor (g-csf) protected against endotoxin-induced lethal shock or against endotoxin-induced liver injury in galactosamine-sensitized animals. in the animals protected by such pretreatment, the systemic tumor necrosis factor r (tnf) bioactivity was significantly suppressed. various macrophage populations taken ex vivo from g-csf-pretreated animals showed an attenuated tnf release following lps stimulation. however, g-csf had no such effects on macrophages when directly added in vitro to the cells. these findings show that g-csf protects against septic shock via tnf suppression in a way requiring the participation of additional circulating cells or factors. pretreatment of rodents with granulocyte macrophage colony stimulating factor (gm-csf) greatly enhanced the susceptibility of the animals to endotoxin and led to a tremendous increase of the systemic tnf found following an lps challenge. an anti-gm-csf antibody significantly protected animals against septic organ failure. considerable amounts of endogenous gm-csf are released following endotoxin chaitenge with a maximum at h. the enhancement of lps-inducible tnf release from rnacrophages takes also place in vitro. it is concluded that gm-csf is a pivotal mediator of sepsis as well as a directly acting enhancer of lpsinducible tnf release. we have previously demonstrated that protein production and mrna expression of gm-csf, g-csf, and il- were decreased in activated mnc from umbilical cord (c) compared with adult (a) peripheral blood (cairo, et al, pediatr res : , , and : , ) . rhg-csf + recombinant rat stem cell factor (rrscf) administration in newborn rats has, however, resulted in a significant induction of neutrophilia, an increase in bone marrow post-mitotic pool, and is synergistic with antibiotics during experimental group b streptococcal sepsis (cairo, et al, blood : , , and : , . to assess the toxicity and efficacy of rhg-csf in newborns with presumed sepsis, nb < days ( - wks) with a diagnosis of presumed sepsis were randomized to either placebo (p), . , . , or . pg/kg q hrs, . or . /lg/kg q hrs of iv rhg-csf x days. cbc, differential, and platelet counts were obtained at time , , , , , and hrs. tibial bone marrow aspirates were performed at hrs and bone marrow nsp, npp, cfu-gm, and cfu-gemm were determined. serum for g-csf levels was obtained before and , , , , , , and hrs after rhg-csf dosing and measured by a sandwich elisa assay. rhg-csf induced significant neutrophilia at hrs vs. placebo ( + %) following both . ( + %, p< . ) and . ijg/kg/d ( -+ %, p< . ). significant neutrophilia continued at and hrs at both . (p< . and < . ) and h'g/kg/d (p< . s and < . ) respectively. rhg-csf also significantly induced a dosedependent increase in the bm post-mitotic pool (p vs. ijg/kg/d) ( +- . vs. + . %) (p< . ). t /z of g-csf in the nb was . _+ . hrs (r= - . ) with peak g-csf levels occurring within hrs. to date there has been no evidence of acute or chronic toxicity secondary to rhg-csf. future studies are required to determine the clinical implications of the biological efficacy of rhg-csf in newborns with presumed sepsis. children's hospital of orange county, orange, california usa depenbrock, t. block, h. vogelsang, ch. fellbaum, j. rastetter, a.-r. hanauske tgf-po is known to function both as inhibitory and stimulatory factor depending on the type of cell line investigated. the purpose of our study was to determine the effects of tgf-~ and tgf- (concentrations: . - - ng/ml) on soft agar colony formation of freshly explanted i~uman tumors in vitro. of specimens, had to be excluded from further analyses ( confirmed benign, bacterial/fungal contamination). of the remaining tumors showed evaluable growth in control capillaries ( %). at ng/ml, tgf-po inhibited colony formation (_< . x control) in specimens ( %): / renal, / non hodgkin's lymphoma, / breast, / ovarian, / melanoma (median: . x control, range: . - . ). at ng/ml, tgf-e,= showed inhibition of colony formation in specimens ( %) with a similar spectrum of activity (median: . x control, range . - . ). stimulation (colony formation _> . x control) was observed in only / specimens. combination of tgf-po with epidermal growth factor (egf) reversed the inhibitory activity in / specimens ( %). combination of tgf-p~ with platelet derived growth factor (pdgf) reversed the inhibitory activity in / specimens ( %). similar results were observed for tgf z. we conclude that tgf-i~ and tgf-i~ inhibit a subgroup of freshly explanted clonogenic tumor cells. their activity, however, appears to be modulated by other growth factors. a korfel. z yon marschall. d ol~erbera. e thiel. and we berdel mip-i~ is a member of a family of proinflammatory cytokines produced by activated macrophages which has been shown to be a negative regulator of early hematopoietic stem cell progenitors. our group investigates the interactions between hematopoietic cytokines and non-hematopoietic malignant cells. here, we describe results testing rhmip-lc~ (rh stem cell inhibitor, sci; kindly provided by dr. wolpe, genetics institute, cambridge, ma, usa) on the clonal growth of different human non-hematopoietic tumor cell lines in vitro. cell lines tested included the following histologies: gtioblastoma x, neuroblastoma lx, head and neck carcinoma x, lung carcinoma lx, colorectal carcinoma x, gastric carcinoma lx, pancreatic carcinoma l x, breast carcinoma l x, bladder carcinoma lx, prostate carcinoma lx, choriocarcinoma lx, ovary carcinoma lx, osteosarcoma lx, melanoma x. mip- ( , , , ng/ml) was tested in human tumor cloning assays (htca) in mixtures of methylcellulose and agar. htca has previously been shown to detect positive and negative growth control by cytokines. plating efficacy of the cells in the controls was > % (median %, range . - . %) in this series of experiments: tumor cells were continuously exposed to the cytokine for the complete assay period. clonal growth of none of the celt tines was significantly and reproducibly stimulated or inhibited by mip-lm since mip-lc~ may enter clinical trials for indications such as protecting hematopoietic stem cells from damage caused by cytotoxic chemotherapy in tumor patients, further experiments should be performed in vitro and in vivo. dfg be / - klinikum steglitz, freie universitaet berlin, berlin, germany clinical studies have demonstrated the activity of single hematopoietic growth factors (hgf) in restoring bone marrow function after chemotherapy. these studies have prompted clinical trials using multiple growth factors to promote the maturation of precursor cells at various stages of differentiation. however, hgf also have the capability to stimulate growth of non-hematopoietic tumor ceils at least in long-term cell cultures. we have assessed the growth-modulating activity of combinations of various hgfs on freshly explanted human tumor colony forming units in vitro. a total of tumor specimens were exposed for - days to il- , gm-csf, g-csf, scf (a~l at final concentrations of ng/ml) and il- (final concentration: ng/ml) or combinations of these hgfs using a capillary soft agar cloning system. specimens ( %) showed evaluable growth in control capillaries. stimulation of colony growth was observed in / tests ( . %) with / ( %) specimens expressing sensitivity to individual hgfs, / ( %) to combinations of two hgf, and / ( %) to combinations of more than two hgfs. inhibition of colony growth was observed in a total of / tests ( . %) with / ( %) specimens expressing marginal sensitivity to individual hgfs, / ( %) to combinations of two hgf, and / ( %) to combinations of more than two hgfs. for inhibitory effects, median colony survival for combinations > hgfs was . x control (range . - . ). for stimulatory effects, median colony survival for combinations > hgfs was . x control (range: . - . ). our data indicate that combinations of hgf will not substantially alter the pattern of clonal proliferation of the majority of freshly explanted tumor cells in vitro. however, growth modulation may occur in a minority of tumors. klinikum rechts der isar der technischen universit&t m nchen, ismaninger str. , m nchen supported by grants w / /ha- - from the deutsche krebshilfe and . . from the withe~m-sander stiftung is granulocyte colony-stimulating factor an angiogenic factor in human glioblastoma? s. corbacioglu, k. welte and t. pietsch granulocyte-colony stimulating factor (g-csf) belongs to a family of glycoproteins winch regulate growth, differentiation and function of hematopoietic ceils of the myelomonocytic lineage. in addition, g-csf induces migration and proliferation of endothelial cells in vitro. to investigate the effects of g-csf on vascularization of glioblastoma in vivo we transplanted the human glioblastoma cell line u- mg which is capable of producing g-csf in high amounts. after s.c. inocculation of these cells into the backs of athymic mice, they developped highly vascularized solid tumors. in order to block the effect of g-csf directly or to inhibit the production of g-csf by tumor cells neutrolizing monoclonal antibody (mab) a against g-csf or dexamethasone were injected intravenously. at -day intervals the tumor volumes were measured. after seven days the mice were sacrificed and the tumors were explanted. blood was collected for differential blood counts and serum was tested for g-csf. fresh frozen sections of the tumors were specifically stained for capillaries using bandeiraea (griffoina) simplicifolia lectin i isolectin b (bsl b ). morphometric studies of the stained sections were performed in order to quantitate the vascularization of the tumors. the differential blood counts showed significantly increased neutropinls due to the effect of human g-csf produced by the glioblastoma cells. tins effect was inhibited by anti-g-csf mabs or dexamethasone. however neither g-csf mabs nor dexamethasone could inhibit tumm growth compared untreated tumor bearing mice. dexamethasone significantly decreased the tumor vascularization whereas anfi-g-csf mabs did not have any effects on tumor vascularization. these findings suggest that g-csf is not an essential angiogenic factor in vivo. pediatric hematology/oncology, medical school hannover, konstanty-gutschow-str. , harmover , germany michael martin, torsten spencker, karen welch*, and andreas strasser* the spgm cell line was established from a transplantable mouse progranulocytic/promacrophage tumor (d hrsen u et al. , leukemia : - ) . extensive phenotyping of this mouse progenitor line revealed the properties of a typical cd positive pre-b cell, spgm being positive for pb , b (cd r), and the pre-b cell immunoglobulin receptor complex, comprising p-heavy chains, xs-and vpree-surrogate light chains and the igma and igl~ co-receptor molecules. southern blot analysis revealed clonal rearrangement of the p-heavy chain locus and germline light chain loci. interestingly, spgm readily formed blast cell, macrophage and occasional granulocytic colonies in soft agar in the presence of interleukin (il- ). in suspension cultures il- also induced macrophage differentiation, the cells becoming larger, adherent and independent of -mercaptoethanol in the culture medium. il- induced an initial burst of proliferation during differentiation, accompanied by loss of self renewal capacity, subsequently followed by a decrease and cessation of proliferation. the earliest changes were detectable at hours by northern blot analysis. il- treatment increased mac mrna, induced cfms mrna (m-csf receptor) and down regulated mrna for p, x , vpree, and mbl. after to days the cells morphologically, phenotypically and functionally resembled macrophages, expressing strongly mac and f / , and phagocytosing latex beads (martin met al. j.immunol. in press). thus, il- induced the cd positive pre- cell line spgm to switch its differentiation program in a coordinate fashion from a pre-b cell to a macrophage. igf is known to be mitogenic for a variety of cell lines in vitro. we have studied the effects of insulin-like-growth-factor i [igf-i] and insulin-like-growth-factor ii [igf-ii] on freshly explanted human tumors using a capillary soft agar cloning system. specimens had to be excluded from further analyses ( confirmed benign, bacterial/fungal contamination). / specimens ( %) showed adequate growth in controls ( renal, breast, lymphoma, colorectal, miscellaneous) with a median colony formation of . colonies/capillary (range: . - . ). at final concentrations between lr m and . m, igf-i significantly stimulated colony formation (_> . x control) in / evaluable specimens ( %) with a median of . x control (range: . - . ) and inhibited colony formation ( _< . x control) in / specimens ( %, median: . x control, range: . - . ). igf-ii stimulated / specimens ( %, median: . x control, range: . - . ) and inhibited / specimens ( %, median: . x control, range: . - . ). the optimal concentration for stimulation was found to be -~ m for igf-i and igf-ii. of specimens not significantly stimulated by either igf-i ( g m) or epidermal growth factor (egf, ~ m), ( %) were significantly stimulated by the combination of the two factors. ( %) specimen was stimulated by a combination of igf-ii ( -~ m) and egf. we conclude that igf modulates the clonogenic growth of a subgroup of freshly explanted human cancer cells in vitro. the myeloid growth factors g-csf and gm-csf are increasingly introduced in therapy trials in neutropenic disorders and in mds. in a series of therapy trials . % up to . % of patients treated with gm-csf displayed a stimulation of blast cells (antin , estey , ganser , vadhan-raj . recently, we could demonstrate a growth advantage for monosomy -cells in gm-csf containing bone marrow cultures (haase, ) which is supported by results from others (andreeff ). now, further data are available corroborating an association of monosomy and leukemic blast stimulation by myeloid growth factors. in a cytogenetic follow-up study of patients with mds under gm-csf (in preparation) we could observe a cytogenetic, clinical, and cytologic progression in a patient with monosomy within days. in a patient with kostman's syndrome, receiving g-csf, we performed sequential cytogenetic analyses. the patient's disease progressed to mds and finally to aml. he initially had a mosaic karyotypeof normal and monosomy cells but displayed a rapid karyotype evolution with supersession of normal cells and gain of additional abnormalities. a recent publication from a japanese group adds further information to a possible association of monosomy with stimulation of leukemia in % of neutropenic children treated with g-csf (kojima, ) . besides the need for further cytogenetic follow-up studies in growth factor therapy trials, data are accumulating that monosomy is a risk factor in gm-csf and g-csf therapy. ii- is a cytokine with multilineage activity and stimulates proliferation of immature hemopoietic progenitors (yang, ) . recently, il- has been introduced in clinical trials in mds (dunbar, ; ganser, ) . as in gm-csf therapy one major concern attributes to an il- mediated stimulation of leukemic cells, since a rise in blast counts has been observed in two of patients reported (ganser, ) . however, as yet it is not known whether the blasts stimulated belong to the normal or leukemic population. we performed cytogenetic analyses of bone marrow cultures with and without addition of i ng/ml il- (behringwerke, marburg). the influence of this cytokine on the clonal compostion in patients ( anll, mds) with mosaic karyotypes was examined. in all patients independent from diagnosis and chromosome abnormality the normal cell population was promoted by il- with different intensity. individual data are outlined on the the effect of stem cell factor (scf) on peripheral blood b-cll-celis were studied in vitro by bromodeoxyuridine/propidiumiodide (brdu/pi) cell-cycle-analysis. peripheral blood cells from patients with b-cll were examined with cd-markcrs and prepared as follows: after ficoll centrifugation and lysis of monocytes by leucine-methyl-ester (lme) t-lymphocytes were depleted with a cd monoclonal antibody and magnetic cell sorting. the cells were grown in serum free culture medium (cg-medium) containing #mol/l brdu, and . ng/ml up to ng/ml scf. controls were grown without cytokines. samples were drawn repeatedly at , , , , and hours. cell-cycle-analysis was performed after double dna staining with propidiumiodide and anti-brdu-antibodies and determinated by flow cytometry. minimal alterations were observed with t-cell depletion, the b-cll cells from patients were stimulated by scf during the first hours reaching a maximum of - . % compared with the controls after hours in cultures containing ng/ml scf. on the other hand, cultures without t-cell depletion showed no effect for scf. we conclude that scf has only a minimal stimulatory, early effect in inducing the proliferation of b-cll cells. stem cell factor (scf) is known to promote proliferation of hematopoieticprogenitors and mast cells.however, the spectrum ot its biological effects is not completely understood. since scf may be able to accelerate hemopoietic recovery after chemotherapy or in other situations where severe immunosuppression is present, we were interested in its effects on t cells. thus, we have studied the influence of human recombinant scf on t cell proliferation invitro. when cultured for days in serum-f~ee medium, h-thymidine incorporation of unstimulated peripheral blood mononuclear ee ells s (pmnc) resulted in -+ epm without growth factors, +_ clam with .- ( ng/ml), +_ cpm with scf (lon~/ml), and _+ c.m with both . and scf (n=fi~ addition of scf to one way" mixed lymphocyte cultures (mlc) increased thymidine incorporation by % ( - %); addition of scf plus id increased thymidine incorporation by % ( - %; id alone %, n= ). after depletion of monocytes and the majority of b cells from pmnc, the proliferation of the remaining eeu fraction, which consisted mainly of t cells, was not enhanced by id , scf or il- + scf. we conclude that scf can promote proliferation of unstimtdated or allostimulated t cells in the presence of id . since this effect requires monoeytes or other accessory ceils, a direct influence of scf on t cells does not become evident from our data. it is, however, still unclear whether ltb acts in this regard directly or indirectly by stimulating the release of chemotactic and inflammatory cytokines. here we report that ltb induces synthesis of interleukin (il)- by human blood monocytee through transcriptional activation of the il- gene. we furthermore demonstrate that this process involves activation of the transcription factor nf-rb and, to a lesser extent, of nf-il , white the activity of the transcriptior~ factor ap- , shown to otherwise confer il- inducibility, appeared to be unaffected by ltb . involvement of nf-~:b and nf-il in induction of il- transcripts by monocytes was demonstrated using deleted forms of the il- promoter. activation of the il- promoter by ltb was not only associated with accumulation of the respective transcripts but resulted in synthesis of functional il- protein as well. in addition, ltb mediated transcactivation of a heterologous promoter construct containing the nf-~:b or the nf-il enhancer, but not the ap- enhancer. the signalling events mediating this effect appeared to involve the release of h , since ltb failed to induce nf-rb or nf-il in the presence of the scavenger of h , n-acetyi-l-cysteine. both interleukin- (il- ) and granulocyte-macrophage colony-stimulating factor (gm-csf) have been previously identified to induce rapid phosphorylation of the map-kinase (blood : (blood : , . however, little is known about signalling events initiated by il- /gm-csf which occur downstream of the map-kinase. map-kinase has been shown to phosphorylate the ap- transcription factor and to activate two kinases designated insulin-stimulated protein kinase- (ispk- ) and mapkapkinase . we here report that il- and gm-csf induce mapkap-kinase activity in the human megakaryoblastic leukemia cell line mo e and phos-phorylate the human small heat shock protein hsp on serine residues. in contrast, neutrophils failed to phosphorylate hsp upon il- , while gm-csf induced hsp phosphorylation in a similar range as observed in mo e cells suggesting that mapkap-kinase mediated hsp activation occurs independently of proliferation. hsp phosphorylation is dose-dependent and occurs as early as minutes following exposure to il- or gm-csf. moreover, hsp phosphorylation is inhibited by tyrosine kinase inhibitors such as genistein or herbimycin a. in addition, we show that protein tyrosine phosphatase and protein phosphatase a (ppa ) interfere with the ability of il- or gm-csf to induce serine phosphorylation of hsp . taken together, our findings indicate that tyrosine phosphorylation of map-kinase is a prerequisite for serine phosphorylation of hsp mediated by mapkap-kinase . hsp is localized in the nucleus and has been linked to the cellular stress response. its precise function, however, is largely unknown. our data identify hsp as a target of il- /gm-csf stimulation via map-kinase and mapkap-kinase . further-more, our results indicate that hsp may also exert phosphorylation-activation functions involved in growth signalling pathways in unstressed cells. in recent years it has been shown that the mechanism of betalactam antibiotic-induced agranulocytosis involves a direct inhibition of the replicative dna polymerases alpha, delta, and epsilon. in this report we examine, as a representative of these antibiotics, the effect of freshly prepared ceftazidime (cef) and degradation products of cef on myelopoiesis. we investigated freshly dissolved cef and cef incubated for hours at + (cefd) on the production of myeloid cells in the supernatant (sn cells) and colony stimulating activity (csa) by the stroma. one week after drug treatment of the mltbmc a significan~ dosedependent inhibition of the myeloid cell production (xl ~ and csa (assessed by cfu-gm assay) occured, as summarized in the following we here report that human lung fibroblasts respond to x-ray treatment (xrt) with release of interleukin (il)- . synthesis of il- upon ionizing radiation is preceded by an increase of il- transcript levels resulting from transcriptional activation of the il- gene. analysis of deleted fragments of the il- promoter indicated that transcriptional activation of the il- promoter was due to enhanced binding activity of the transcription factor nuclear factor (nf)-~b. although activation protein (ap)-i did not participate in the rapid induction of the il- promoter, its binding activity was also enhanced by xrt. in contrast to binding kinetics observed with nf-~:b, ap- binding following xrt was biphasic with the second peak being dependent on de novo protein synthesis. in contrast, however, nf-il- activity was not enhanced by xrt in fibroblasts. the introduction of both the nf-~b-and the ap- recognition sequence, conferad inducibility by xrt to a heterolgous promoter, with reporter gene activity being maximal hours or hours following xrt, respectively. sequential acitvation of two distinct transcription factors might thus contribute to synchronize transcriptional activation of different genes participating in the x-ray (xr) response. on the basis of study of functional and morphological characteristic of bone marrow stromal tissue of human fetuses, - week gestation, and of adults aged - years, and in experiments on animals, the role of the sinusoidal endothelium, reticular, fat and endosteal cells in hemopoiesis regulation has been concretely defined. the endothelium of sinuses forms the histo-hematic barrier "bone marrow-blood', ensures the wanscellular migration of stem cells and mature blood cells, releases hemopoiesis-regulating factors and is involved in the erythroid cell maturation. bone marrow reticular cells participate in the formation of intramedallar supporting frame-work, regulate the transvasal and intramedullar cell migration, form the extracellular matrix, produce humoral regulators of hemopoiesis, effect the cell differentiation by way ot their intercellular contacts with hemopoietic precursors and give origin to adipocytes, lntramedullar adipocytes present an energetic depot of hemopoietic and stromal tissues and in the stage of preadipocytes they effect, by means of contacts, the granuloeyte development. the endosteal cells of bone marrow are the source of intramedullar stromal tissue, they participate in the anchorage of the hemopoietic stem cells and form the microenvironment of the latter, regulate the endosteal ca ion levels and might be a possible source of hemopoietic tissue (population of cells of the residual embryonal mesenchyma). the thesis on the mechanism causative of the impaired regulation of precursor proliferation and differentiation in hematologic diseases is proposed. the self-renewal capacity of cfu-s (spleen colony-forming unit) following the treatment of (cbaxc b )f female mice with recombinant human granutocyte colony-sffmulating factor (rhg-csf) was investigated. the possibility of synergism between erythropoietin (epo) and rhg-csf in blood cfu-s mobilization was also studied. during the investigation the following observations were made: and mkg/kg/day injection of rhg-csf expended the number of cfu-s- in circulation -and -fold, accordingly. the self-maintenance potential of peripheral blood cfu-s-i did not change significantly. the treatment of mice with mkg/kg/day of rhg=csf resulted in two fold increase of spleen cellularity and fold augmentation of cfu-s- number, without noticeable changes in their self-renewal capacity. moderate changes in cfu-s- number were observed after epo administration in spleen and peripheral blood, however no significant synergistic effect of epo with both doses of rhg-csf was detected. the multifold increase of cfu-s- number in peripheral blood following rhg-csf administration with no reduction in their self-maintenance potential suggests that mobilized with rhg-csf blood stem cells provide an appropriate source for reconstitution of the hematopoietic system. we used the brdu-incorporation method to show the effects of l- ( , , u/ml),il- ( . , , ng/ml) and il- ( u/nil) plus il- ( ng/ml) on b-cll-ceiis. after ficollseparation, lysis of the erythrocytes (nh ci) and lysis of monocytes ( - eucin-methyl-ester), cells were divided into two groups. group was cultured in a serum free medium (+brdu +cytokine) without any t-cell depletion. group was cultured in a serum free medium (+brdu +cytokine) after t-cell (cd +) elimination by the macs (magnetic activated cell sorting). samples were taken after h, h, h, l h and h. after staining with anti-brdu fitc and propidiumiodide (pi) proliferation was measured by flow cytomemy (facs scan). . p=proliferation n=no effect i=inhibition conclusions: i[,- shows a proliferative effect on b-cll-cells independent of t-cells. il- shows heterogeneous effects. by itself it has most often no effect on proliferation, but sometimes it inhibits or increases the prolifoation. this effect does not seem to depend on t-cells. it could depend on the dosage or some unknown patients' characteristics. further on il- inhibits ,- induced proliferation in nearly all cases independent of t-cells. ii-i and tnf are inflammatory cytokines with overlapping biological activities. human vascular endothelial cells express ii-i and tnf receptors and respond to ii-i and tnf stimulation by elaboration of colony stimulating factors such as g-csf and gm-csf.however quantitative data are required in order to evaluate the contribution of ii-i and tnf to the activation of inflammatory hemopoietic cells such as granulocytes and macrophages by csfs. therefore we quantified the production of g-csf and gm-csf in endothelial cell cultures subsequent to treatment with il-l~ ( .l- u/ml) and tnf( - u/ml)or ll- in combination with tnf.a dosedependent stimulation of g-csf and gm-csf secretion was found following ll-i and tnf treatment of endothelial cells.ll-i was a more potent inducer of g-csf secretion than was tnf using approximately equipotent doses of il-i ( u/ml) and tnf ( u/ml) regarding the induction of gm-csf.in addition significant snperadditive stimulation of g-csf and gm-csf production was found with a low dose of il- ( iu/ml) and a saturating dose of tnf( oou/ml) in combination.however the costimulatory effect of ii-l(iu/ml) was significantly more pronounced with g-csf than with respect to gm-csf.in summary the differential modulation of g-csf and gm-csf production ~n endothelial cells by ii- and tnf may indicate 'a disparate role of ii-i and tnf in vascular inflammatory processes and atherosclerosis regarding recruitment and activation of inflammatory leukocytes. cytokines are known to be involved in the pathophysiology of graft versus host disease (ghvd) and to effect lymphohematopoetic progenitor cell growth after bone marrow transplantation. the use of t-cell depleted marrow in human transplantation is associated with suppression of gvhd but decreased rates of engraftment. we have shown in rodent models that uvb irradiation (uvb) of donor inoculum inhibits gvhd while preserving engraftment. to determine the effects of uvb on eytokine production by cells associated with gvhd, human marrow mononuclear cells isolated by ficoll density gradient were uvb-irradiated at doses of - j/m and then stimulated with pha/lps or allogeneic cells. elisa assays were used to measure the production of gm-csf, il- , lif, il-lbeta, il- , il- , tnf-alpha, and lfn-gamma by stimulated cells . two week methylcellulose cultures were used to determine viability of cfu-gm, bfu-e and cfu-gemm progenitor cells after uvb. all results were compared to non-uvb-irradiated marrow and to marrow depleted by soybean agglutination and sheep erythrocyte rosetting. progressively increasing doses of uvb produced progressively decreasing levels of all cytokines except il- , which remained unchanged. t-cell depleted marrow produced decreased levels of all cytokines except il- . uvb at j/m resulted in higher levels of gm-csf and il- as compared to t-cell depleted marrow. this same dose of uvb essentially preserved cfu-gm, bfu-e, and cfu-gemm colonies. we conclude that uvb may inhibit the cytokine cascade active in gvhd while preserving progenitor cell growth at uvb jim . uvb may serve as gvhd prophylaxis in clinical marrow transplantation and in vivo studies on non-human primates are in preparation. the ability to migrate is fundamental for the acquisition of invasive properties by tumor cells. a tumor derived cytokine was identified by its ability to induce direct and random migration via a receptor mediating signal pathway, i.e. autocrine motility factor (amf). we identified the receptor for amf (hamf-r) and found ~at hamf-r plays a role in invasiveness and metastasis in human bladder carcinomas. we investigated the expression pattern of hamf-r in fresh frozen bladder cancer specimens by immunofluorescence technique on the translation level and found a strong correlation (p< . ) to tumor stage and grade. furthermore we have shown that patients who were found to be hamf-r positive have an increased risk for early tumor progression (p< . ). a large number of substances from the working place and in the general environment such as quartz and coal mine dusts are causing silicosis and leading to lung fibrosis. alveolar macrophages are the primary target for the noxious effect of quartz dust. quartz dust incubated human macrophages release in vitro a cytokine, which stimulates cell proliferation of human lung fibroblasts (wistar ). in recent studies we found that beside fibroblasts also epithelial cells of the alveolar unit, such as pneumoeyte type ii cells (a- ) respond to the cytokine with strong proliferation. supernatants of quartz dust exposed macrophages were concentrated by ultrafiltration and thereafter fractionated by gelfiltration (sephadex g , pharmacia). biological activity of the factor eluted within a molecular range of - kd. furthermore, the factor was purified by anion exchange chromatography (q-sepharose). fractions revealing biological activity were further analysed by sds-gel eleetrophoresis (page) and showed two protein bands with apparently molecular masses of and kd,respectively. after addition of the supernatant initially spindle shaped pneumocytes were detected, followed by epithelial-like cells when cell proliferation progressed. induction of spindle-shaped pneumocyte type ii cells could also be seen after addition of pure tumor necrosis factora. however, in this case no cell proliferation was observed. we assume that beside the cytokine, which is responsible for the induction of cell proliferation tnf~ is present in supernatant. differences in a variety of immunologic parameters. in peripheral blood however differences to healthy persons have hardly been described. in this investigation we compared serum levels and concentrations of interferon- (fin-y) and il-l--ct in stimulated samples of whole blood. ixl whole blood of healthy controls (ref) and patients with sareoidosis, without treatment (pot) and under corticoid medication (put), was incubated in medium at ~ and % co . con a was used for stimulation of ifn-y and lps for il- --m concentrations were determined with an elisa. results: without stimulation no measatalg, e amounts of ifn--y could be found. after stimulation ref showed median coneentrations of ng/ml, pob ng/ml and put ng/ml. the difference between ref and put respectively pot was statistically significant. il-l-m without lps the differences were not significant. under stimulation pot had si~ificantly higher values ( pg/ml) compared to ref ( pg/ml) and also to put ( pg/ml). in conclusion we were able to demonstrate that in conlrast to serum levels stimulation of peripheral whole blood reveals significant differences in concentrations of ifn--y and il- --ct between patients with sarcoidosis and healthy references. we established a modified polymerase chain reaction protocol for the detection and semiquantitative assessment of mrna-transcdpt levels for il- , il- , il- , il- , ifn- , tnf-cl, gm-csf, tgf- and il- -receptor-c{ (il- r). the method was shown to distinguish -fold differences in template concentration after rounds each of amplification in the range from to cycles; the lower threshold of sensitivity was at copies per pcr-reaction. reproducibility was > % for a positive result after rounds of amplification; it decreased to % after rounds. this corresponded to the detection of , and template copies, respectively, per pcr-reaction. human peripheral blood mononuclear cells (pbmc) and tumor cell lines were evaluated for mrna-expression with or without stimulation and these results were compared to secretion of the corresponding cytokine. for pbmc, constitutive mrna-expression was found positive for tnf-o~, ifn- , il- , il- , tgf- and il- r, whereas detectable expression of il- , il- and gm-csf was induced only after stimulation. using ~-actin as an intemal standard, the pcr could demonstrate relative differences in cytokine transcripts after stimulation with (a) ]u/ml il- , (b) % lymphocyte-culture conditioned media (ccm) and (c) pma ( ng/ml) plus a ( ng/ml). for il- transcripts no detectable expression was found without stimulus or after addition of il- , whereas ccm resulted in a , -and pmna in a , -fold increase. other mrnatranscripts increased t -fold (tnf-(~) up to , -fold (gm-csf) with or without differences between the stimulating agents. the cell lines caki- (renal cell carcinoma) and daudi (burkitt lymphoma) also expressed comparable levels for cytokine transcripts, with a strong induction after stimulation with pmna . the relative ifn~ mrnacontent in caki- increased from to , , for gm-csf from to , . the influence of different cytostatics on il- production by peripheral blood mononuclear cells (pbmc) was studied. pbmc were pre-incubated with or without phytohemagglutinin p (pha-p), then pulse exposed during hr to different cytostatics in their therapeutical concentrations, washed three times and incubated additionally during - hrs. then the supernatants were collected and il- biological activity was measured in mttmodified b -cells biological assay. though significant individual variations of the il- production were found, all the studied drugs can be separated on severa) groups: ) adriamycine and methotrexate induced late increase of il- production ( - hrs ); ) cytarabine strongly increased the early as well as the late il- production ; ) the pretreatment with etoposide and rubomycine suppressed subsequent production of il- by pbmc during - hrs, the late production was increased; ) in contrast, the cyclophosphamide pretreatment stimulated the early production and strongly suppressed the late one. the changes of il- production by pbmc was not due to the cellular death. the pha-p stimulated pbmc produced usually more il- that unstimulated cells did. these data suggest that the cytostatics possess the different effects on il- production by pbmc that could be important in the therapy of malignancies. recent studies implicating a deficiency of interleukins in several diseases have underlined the importance of measuring in vitro the dna synthesis and the cytokine production (il- , il- , il- , tnfalpha) in the same cell system. previously had found that normal peripheral blood mononuclear cells (mnc) of patients suffering from high-malignant non-hodgkin lymphomas showed a decreased capability to proliferate after mitogenic stimulation (pha, con a, pwm). here we have studied the dna synthesis and the production of different cytokines (il- , il- , il- , tgf-i~ and tnf-alpha) by pokeweed mitogen (pwm) stimulated mnc from healthy control subjects and from patients with nhl. the il- production of pwm-stimulated mnc of patients with nhl was found to be significantly decreased, wheras the il- , il- and tnf-alpha release were not changed significantly. these data showed a good correlation with the reduced capability of mnc from patients with nhl to proliferate after mitogenic stimulation. the multifunctional cytokine transforming growth factor-ii (tgf-i ) is known to inhibit the dna synthesis, as well as the il- production of mitogenstimulated mnc. however, tgf-i~ release was not significantly changed in call culture supernatants from patients with nhl in comparison to healthy controls. we conclude that the suppressed dna synthesis and _- production of mnc from patients with nhl is not the consequence of a deceased tgf- level secreted by these cells. is a co~on problem after chemotherapy and requires supportive care until normal hemopoiesis has recovered. to study the importance of endogenously produced cytokines for regeneration of bone marrow progenitors we measured serum levels of g-csf and ii- . blood samples were obtained before and hours after chemotherapy, during the stage of leukopenia (< /ul) and recovery (> /ul)of leucocyte counts. in / patients we found a more than -fold increase in serum g-csf levels at the stage of leukopenia. highest amounts were observed in two patients with lethal outcome. there was no correlation between thrombocytopenia and levels of g-csf or il- . serum g-csf (pg/ml, mean, range) before (leuko> ) after (< /ul) chemotherapy aml dav ( -i ,n= ) ( - ,n= ) all 'h~izer" ( - ,n= ) ( we measured different hematopoietic cytokines as g-csf, gm-csf and il- in amniotic fluid and cord blood to ctearify their physiological and palhophysiological role in fetal and neonatal development amniotic fluid was available from the th to the st week of gestation (n= ), cord blood from the th to the nd week of gestation (n- ). activity levels of cytokines were determined by stimulation of the ceii lines nfs- , d , and tf-i. which are responding specifically to g-csf, il- , and gm-csf. specificity has been proved by neutralizing antibodies. calculation of cytokine levels was done by standards of recombinant growth factors. sensivity for g-csf and il- : pg/ml for gm-csf: oo pg/ml. in amniotic fluid g-csf tanged from to i .ooo pg/m[ and il- from to . pg/ml, whereas gm-csf was not detectable. in cord blood g-csf was between and . pg/ml and [l- between and pg/mh in most of the samples (qo%~ gm-csf was beyond the sensivity limit. in % ( of cases) g-csf levels were elevated over pg/ml and associated with amnion infection syndrome, while green amnioflc fluid alone during delivery did not stimulate the production of g-csf, the levels of the hematopoietic cytokines showed no influence by the gastational age. identical twins without maternal infection showed the same g-csf levels. inflammation of the amniotic membrane and maternal sepsis is associated with elevated g-csf levels in cord blood. gm-csf can normally not be detected in cord btcod and amniotic fluid. detectable levels of gm-csf in cord blood and amniotio fluid maybe give a hint for a pathological situation during pregnancy. total number of children with all, boys and girls, aged from to years were included to the study. tnf production was studied acc. the method based on growth inhibition of sensitive to tnf l mice fibroblasts, ill- production ace. method based on inhibition of autologous rosette formation by thymoeyteg of cba mouse and l- production ace. to conventional el sa genzyme-test. twenty five healthy children served as the control group. it was found that in children with all during the whole period of therapy the il- and il- production, was significantly lower than that observed in the control group of healthy children (p . ). the tnf production in all children before therapy was lower in comparison with the control group values. during cytostafic therapy was higher and grew up above the normal limits after cessation of the therapy. il- production grew up after the end of the therapy but never reached the value of the control group. efs at ruth in all children with il- production < /~ before therapy was higher than that in children with il- < /~ (efs % v %). the il- production seems to be a good prognostic marker. (pts) with active autoimmune disorders as well as with malignant lymphomas. in addition, cd and its soluble form (scd ) is thought to be involved in the regulation of b-cell proliferation. therefore, we examined scd , scd , and scd in pts with b-cell chronic lymphocytic leukemia (b-cll) in order to assess their role as indicators of disease activity. fifty-five pts with b-cll were studied so far. staging was performed according to the classification systems of rat and binet, respectively. serum samples were freshly stored in liquid nitrogen until further processing. levels of scd , scd , and scd were measured by a sandwich elisa technique using commercially available assays (biermann, germany). advancing rat stages were associated with a progressive increase of all the three serum factors (scds: rat + u/mt vs rat iv + u/ml, scd : rat - - u/ml vs rat iv __. u/ml; scd : rat + u/ml vs rat iv +_ u/ml). this progression was also evident when binet's classification was applied. occurrence of b-symptoms was associated with high levels of scd (p< . ), whereas scd and scd were found also to be increased but without statistical significance. high levels of all the three factors strongly correlated with a lymphocyte doubling time < months, a lymphocyte count > . /tzl, and with the presence of hepato-and splenomegaly. interestingly, occurrence of bulky lymph nodes (i.e. at least one nodule of > cm in diameter) was linked with high levels of scd only (p< . ). in summary, ( ) progressive serum levels of scd , scd , and scd correlate with advancing stages of disease in b-cll. ( ) b-symptoms were associated with high levels of scd . ( ) we found scd to be the more sensitive marker of the total tumor load than scd and scd . thus, scd may be useful in monitoring pts with b-cll. cytosine arabinoside (ara-c) is one of the most active single agenls in the treatment of acute myeloid leukemia (aml). its cytotoxic activity mainly depends on its phosphorylation to ara-ctp and on its incorporation into the dna. based on recent in vitro studies showing that hematopoietic growth factors like gm-csf and il- enhance the cytotoxicity of ara-c on clonogenic leukemic cells, the gm-csf priming concept is currently explored in clinical phase ii and iii studies. in an ongoing study at the universities of muenster and goettingen gm-csf ( /~g/m /d) is started hrs before induction chemotherapy (tad /ham) until recovery of blood ceil counts. this study provided a means to assess the effect of gm-csf on the intraceunlar ara-c metabolism in vivo in pts with aml. enzyme activities of deoxycytidine kinase (dck), thymidine kinase (tk), dcoxycytidine deaminase (dcd), dna polymerase (pol) and dna polymerase alpha (pola) were determined before therapy, hrs after the administration of gm-csf and hrs after the administration of ara-c. in addition, ara-c incorporation into the dna was measured after hrs ara-c administration. enhancement of enzyme activity was observed in / , / , / , / and / cases for pola, pol, tk, dck and dcd, respectively. increases ranged from - % for pola (median %), - % for pol (median %), - % for tk (median %), - % for dck (median %) and - % ( %) for dcd. inadequate blast cell reduction after tad (> % blast cells on day or ) was associated with significantly higher dcd blast cell activities compared to the dcd activity values obtained for pts with adequate blast cell clearance (median values: . vs . nmol/min x mg, p< . ). cases with dcd activities < nmol/min x mg showed significantly higher ara-c incorporation into the dna compared to pts with dcd activities > nmol/min x mg ( . vs . ng/ cells). furthermore, inadequate blast cell clearance was associated with lower ara-c incorporation into the dna (median . vs . ng/ cells) and lower pola activities (median . vs . pmol/min x mg). in pts we investigated simultaneously the effect of gm-csf pretreatment on ara-c metabolism in vitro. enzyme activities of pola, tk and pol correlated significantly in vivo and in vitro (rp~ rtk=o. , rp~ p< . ). these data demonstrate that gm-csf enl/ances dna synthesizing enzyme activities in vivo and in vitro. furthermore, these data suggest that gm-csf might improve the therapeutic response to induction chemotherapy by increasing dna polymerase alpha activity and thereby increasing the ara-c incorporation into the dna. the effects of interferon-alpha (ifn-alpha), interferon-beta / lnterleukin- (il- ) and interferon-gamma (ifn-gamma) in inducing megakaryocytic differentiation of blast cells from acute megakaryoblastic leukaemia (amegl) patient determined by the increase in cd and cim b expressions using monoelonal antibodies in apaap technique were investigated in liquid suspension culture. after six days of culture, the percentage of cd and cd b positive cells increased in control cultures from , % and , % on day to , i , % and , • , %, respectively. the addition of ifn-alpha significantly increased the number of cimi and cim b positive cells by about two to three fold compared to control cultures, p < , and by about four to six fold compared to day , p < , . similarly, ifn-beta /il- induced a significant increase in cd and dc b positive cells. on the other hand, ifn-gamma failed to increase the number of cim and cd b positive cells in comparison to control cultures on day and instead induced a significant increase in the number of monocytes/macrophages from only , _+ , % in control cultures to , + , %, , + , %, , • , % and , • , % in , , and units/nil ifn-gamma-treated cultures, respectively, p < , . the present results suggest that megakaryocytic differentiation of blast cells in amegl could be induced by ifn-alpha and il- and support a clinical role for il- in the treatment of amegl patients. also, the present results showed that monocytic differentiation of blast cells in amegl could be induced by ifn-gamma~ supporting the multipotent stem or progenitor cell origin of the amegl subtype of acute myeloid leukaemia. a monoclonal antibody-based elisa and bioassay were used to measure leukemia inhibitory factor (lif) protein levels, activity and the functional role of lif in superuatants of cultured stromal cells derived from patients with acute and chronic myelogenous leukemia, myelodysplastic syndrome, and hairy cell leukemia and from normal controls. we demonstrate that biologically active lif protein is constitutively produced and secreted by coltured bone marrow stromal cells from all subjects studied. in addition, adherent-layer conditioned-media lif protein levels were significantly elevated in samples from patients with all hematologic malignancies studied as compared to samples from normal controls. confluent adherent layers exposed for hours to interleukin (il) or tumor necrosis factor- (tnf-a) showed a significant increase in lif protein levels, whereas exposure to il- (sterling drug inc., great valley, pa) resulted in a dose-dependent decrease in lif levels. . (i. - . ) . ( . - . ) . interestingly, neutralizing antibody against lif caused a % reduction in normal progenitor proliferation derived from the superuatant but not from the adherent layers, and this effect was reversible by the addition of recombinant lif protein. we conclude that (i) biologically active lif protein is constitutively produced by adherent layers from normal donors, (ii) tnf-ct and il- increase and il- decreases adherent layers lif protein levels, (iii) the steady state levels of lif protein produced by adherent layers from leukemic patients is significantly elevated, and (iv) lif may participate in the interaction between adherent layers and hematopoietic progenitors to maintain normal hematopoietic colony growth. it is well known that bone marrow stromal cells have crucial impact on haemopoietic cell proliferation. little is known about stromal humoral factors leukemic cell proliferation. the aim of this study is to evaluate the effect of stromal cell conditioned media (sccm) on the h-thymidine uptake by normal and leukemic target cells. patients with aml were studied treated with " + " based regimens. long term bone marrow cultures were established in non-leukemic and leukemic patients (before and during treatment). target cells for sccm were normal haemopoietic cells and leukemic blasts. the results are the comparison of the effects of leukemic and non-leukemic stromal cells. a part of the patients revealed high stimulative activity upon non-leukemic cells (+ + %, p< . ) and inhibited proliferation of leukemic cells (- • %, p< . ) this group entered complete remission. sccm of another group of patients inhibited proliferation of nonleukemic cells (- _+ %, p< . ) and stimulated blast cell proliferation (+ + %, p< . ). the magnitude of the figures was even more profound later: during treatment, bone marrow aplasia, recovery. this group of patients failed to achieve remission. it seems that stromal cells has significant on impact on restoration of normal or leukemic hemopoiesis after chemotherapy. peripheral b-cll-cells from patients were investigated upon the proliferating effect of ifn~, tnf~ or combination of both in serum free culture medium (cg-medium). blood cells were drawn from patients and lymphocytes separated by ficoll hypaque and monocyte-lysis (leucinemethyl-ester incubation). t-cells were depleted using a, cd mab and macs (magnetic activated cell separat r, miitenyi biotec). at each step heterogeniety of the population was controlled by facs analysis with different mab (cd , , , o, , , , ) . the homogeneous population (contamination less than %) was co-incubated with both cytokines ( . - ng/ml) and bromodeoxyuridine (brdu) in cgmedium. after , , , and t hours cells were harvested an analysed for brdu-incorporation into the genome. ifnu and tnfc~ measurings ( in total) were almost similar: patients were non-responder and showed no stimulatory effect on cells; patients showed an inhibitory effect; cells from patients were responding upon cytokine cultivation. the combination of both ifn~ and tnf~ produced in these cells an additive effect ( out of ). best results could be observed when the control population (without cytokine) was minimal proliferating compared to no proliferation. a high correlation was observed between cytokine response and pre-treatment: without glucocorticoid treatment of patients prior to measurements the influence of cytokines on resting b-cll-cells was significantly higher (with methyl-prednisolone %, without we-treatment % were responders). functional defects of the monocyte/macrophage system probably contribute to the increased rate of severe infections in patients with myelodysplastic syndromes (mds). therapeutic trials with hematopoietic growth factors (hpgf) have resulted in substantial improvement of cytopenia, especially neutropenia. however, little is known about the alterations of the monocyte/macrophage system during these therapeutic interventions. it therefore was the aim of the present study to analyze the capacity of monocytes/macrophages from mds patients prior to and after hpgf therapy to secrete il- ~, tnfe, il- , and il- upon in vitro stimulation with lipopolysacharide (lps). sixteen patients were studied: t had a refractory anemia, had a refractory anemia with excess of blast cells. prior to therapy, the capacity of adherent monocytes/macrophages to secrete il- ~, tnfc~, il- , and il was significantly reduced by - percent as compared to normal controls. on the other hand, oxygen radical release was normal in mds patients tested. treatment with gm-csf ( - /~g/m /d sq x - ; n= ), il- ( - /~g/m /d sq x - ; n= ), and g-csf ( - fg/kg/d sq x in combination with all-trans retinoic acid; n= ) normalized the potenital of monocytes/macrophages to secrete il-ti~, tnf~, and il- . il- secretion was only improved by il- or gm-csf dosages _> /~g/mz. oxygen radical release was significantly stimulated by both gm-csf and il- . these results indicate that treatment of mds patients with gm-csf, il- , and g-csf (the latter in combination with all-trans retinoic acid) can restore deficient monocyte/macrophage secretory function to normal. depletion of cd positive t ceils has been used in human patients for prevention of gvhd. we studied depletion of cd + cells from canine marrow for induction of gvh-tolerance across a complete dla-haplotype difference. prompt engraftment and fatal gvhd occurs in a littermate combination of dla-homozygous donors and dla-heterozygous recipients when undepleted marrow is given. aiiogeneic marrow depleted with a crossreactive antibody to human cd and immunomagnetic beads was given to dogs. one dog died with haemorrhage on day due to thrombocytopenia, dogs showed complete hematopoietic recovery. dogs became tolerant chimeras and one dog died with gvhd due incomplete depletion. chimerism was mixed early after transplantation, became complete later and is still complete in / dogs after - years. dogs received cd depleted marrow grafts and loijg/kg/d s.c. r-canine g-csf starting on day after transplantation. although all dogs had fast recovery of granulocytes, dogs receiving . x mnc/kg died of marrow aplasia on days and without recovery of thrombopoiesis. two dogs receiving x mnc/kg had sustained engraftment with delayed recovery of thrombocytes compared to dogs without g-csf. facs analysis of depleted marrow showed complete depletion of cd + cells but about % of cd + cells; cfu-c growth and nk-activity was retained after depletion. cd depleted marrow inhibited the generation of cytotoxic cells. these experiments indicate that qualitative t-cell depletion is effective, since cd recognizes only subpopulations of t-cells. the application of r-canine g-csf enhanced the recovery of granulocytes but led to graft failure in dogs receiving a low number of marrow cells. gsf-inst. fdr immunologic, marchioninistr. , mqnchen supported by the wilhelm-sander foundation we wished to analyse the factors which may affect the yield of pbpc (cfu-gm) to be collected by leukapheresis following high-dose cyclophosphamide (hd-cyc: g/m ). we retropectively studied the following criteria in patients with high-risk mm of which received gm-csf (sandoz sa/ schering-plough) after hd-cyc: time from diagnosis to hd-cyc, number of chemotherapy cycles (ctc) (fermand, ) , b microglobulin, bone marrow plasma cell count before hd-cyc, administration of gm-csf after hd-cyc, "slow" or "fast" rate of platelet and wbc recovery (jagarmath, schwartzenberg, ), "poor" or "good" mobilization ofpbpc (jagannath, ), differential wbc count between "day x ~ and "day x-l" during haematopoietic recovery. each variable was studied as continuous (regression analysis) and discontinuous (t-or chisquare tests). when the differential wbc count was < wbc/ial, % of the leukapheresis procedures performed on day x yielded more than x cfu-gm vs % when it was _> /tjl (p< . ). the infusion of gm-csf was asaocaated with a higher yield of cfu-gm (bidt, ). the patients with "good ~ pbpc mobilization (> x cfu-gm in >_ leukapheresis) could all be transplanted with pbpc alone (vs % of those with ~poor" mobilization). they had a shorter duration of aplasia after transplantation than the other patients (p< . ). the "fast" wbc recoverers had a higher yield of cfu-gm than the other patients (p< . ). when only the patients who did not receive gm-csf after hd-cyc were considered, a higher yield of cfu-gm was achieved in patients who underwent < crc as compared to those who underwent > ctc before hd-cyc (p lxlog/l. a positive correlation of the rising and decreasing subpopulation counts within the mnc's were noticed (r=. -. ), however the cd * were in inversed ratio to the cd § cells (r =-. ). the percentages of cd * and especially of the cd + cells showed an increment immediately after ctx, where the proportions of cd " and cd § cells tended to fall. there was also a correlation between cd " and cd § cells (r=. , p<. ) and between cd § ceils and cfu-gm growth (r= . , p<. ). an increased clonogenity was associated with low numbers of cd * cells: cd ~: cfu-gm : before ctx; : immediately after ctx; : during the regeneration phase. the same phenomenon could be seen by intensively pretreated compared to less intensively pretreated patients. the hematopoietic reconstitution parameters (median) were as follows in the pbsc-rescued vs non-rescued pts: platelet transfusions - vs (p<. ), rbc transfusions - vs , days with platelets < // - vs (p<. ), duration of neutropenia with wbc< //ji - vs , days with fever - vs . . the augmentation of cd § cells correlated with rising numbers of mnc's and especially of cd § but not with cd *. the correlation between cd " cells and cfu-gm in peripheral blood was convincing. dose-escalated cytotoxic therapy with stem cell support may be considered for patients with stage ii multiple myeloma, because of the poor median survival of only . years with conventional treatment. a threshold quantity of x cd + eells/kg bw is necessary for a rapid and sustained engr~ent following myeloablative conditioning therapy. since june six patients (median age: years, range - ) with mm received pg g-csf/kg bw (neupogan r, amgen) so. daily at the time of best response with conventional treatment. the content of cd + cells in the peripheral blood was monitored by facs each day. leukapheresis were started when a detectable population of cd + cells appeared. in of steady-state leukaphereses, more than , xl ~ cd +cells were harvested. after the therapy with high dose eyclophosphamide ( pts g/m , pt g/m ) plus g-csf more than , xl cd + cells were collected in of leukapheresis. to date two pts have undergone myeloablative conditoning therapy with hyperfractioned total body irradiation ( , gy) and melphalan ( mg/mz). one patient received mg/sqm melphalan as eonditoning therapy. after the reinfusion of the g-csf-mobilized pbsc, a rapid engraftment was achieved with median time of days ( range - ) to reach , x / neutrophils and days (range - ) for . x / platelets. no hematopoietic growth factors were given post-transplantation. in this pilot study, high dose eyclophosphamide and g-csf is an effective method for harvesting pbsc. evaluation of the mobilization of hematopoietic stem cells during steady-state hematopoiesis using higher doses of g-csf is planned. were treated with mtx, ifo, ara-c, prednisolone and escalating doses of vp . pts. (n = ) with relapsed or advanced non-seminomatous germ cell tumors were treated with cisplatinum, escalating doses of vp and ifo. the protocol design was similar: g-csf before ctx ( x pg/kg/die s.c.) with pbsc-aphereses at days to (nhl) or days , (nsgct} followed by to ctx-courses. cytaphereses were also performed after ctx when the total wbc's recovered above lxl ~ the ctx-cycles were followed by reinfusion of the previously collected pbsc (n = ) and application of g-csf ( pg/kg/d.; n = ) up to the last day of the subsequent stem cell collection. the cd § cells, the clonogenic peripheral blood progenitor cells (cfu-gm & bfu-e) and light density cell (ldc) counts were determined in cytapheresis samples. the ctx/g-csf courses contributed to substantially higher progenitor cell amounts than g-csf alone (n= / ; p< , ), without a difference in the collected ldc ( . • vs . • ldc; . • vs . • ~ cd § cells; . + . vs . • . x cfu-gm; . • . vs . • . x bfu-e/kg/apheresis; n = / ; mean + sem), but with approximately two times lower clonogenity. two or three leukaphereses were enough to rescue ctx-courses with a minimal dose of x cd + cells/kg/patient. the optimal time to initiate pbsc-collection after ctx in the studied patient group was proved to be at the l't to ~h day after reaching leukocyte > pl. the original total leukocyte, light density cell (ldc) and platelet counts in the peripheral blood at start of leukapheresis played an essential role for the efficiency of the procedure (eff), as shown by regression analysis: eff to total leukocyte count correlation was r =- . (p< .ot); eff to ldc-count r =- . (p pl and days -platelets> ooo pl; duration of neutropenia was days; and days to become platelet transfusion-independent (median). total number of children, girls and boys, with neoplasia aged from - years were treated with gm-csf-leucomax sandoz and g-csf filgrastim hoffmann-la roche, during severe myelosupression occuring after intensive polychemotherapy. in children gm-csf was applied twice after consequent courses of chemotherapy. one child received gm-csf four times after chemotherapy courses. twenty children with malignancies served as historical control group. gm-csf was given at dose #g/kg, g-csf - #g/kg daily s.c. duration of therapy ranged from - days with median days. after cytokines therapy increase of mean and median numbers of total wbs, neutrophils, monocytes and eosinophils was observed. the median time to hematopoietic recovery was shorter in the group of children treated with cytokines when compared with the control group. ( v days). in of children signs of infection disappeared even before granulocyte count increase. also shorter median time of febrile days, v days, in comparison with the control group was observed. no serious side effects during cytokines therapy were noticed. only in one patient local erythema in injection place was observed. in two children transient retrosternal pain was seen. our results showed that gm-csf and g-csf administered in children with neoplasia after chemotherapy shortens the period of neutropenia and infection duration. for both hodgkin's disease and non-hodgkin's lymphoma the outcome of chemotherapy has been shown to correlate closely with the dose intensity of treatment. however, dose intensification is limited most often by severe myelosuppression with the subsequent risk of fever and infections. we performed a clinical trial in patients with hodgkin's disease or non-hodgkin's lymphoma to evaluate whether r-methug-csf could facilitate the safe and timely administration of an intensive chemotherapy regimen. patients who developed neutropenia _< . x /l for more than two days and / or fever _> . ~ and / or signs of infection after a cycle of chemotherapy (ceboppnim protocol administered at intervals of days), as well as patients in which chemotherapy had to be delayed due to an anc _< . x /l on day , were eligible for treatment with r-methug-csf. in the subsequent cycles r-methug-csf was given subcutaneously at a dose of #g/kg/d from day to . of patients were evaluable, one patient had received only day of r-methug-csf treatment. of the evaluable patients experienced neutropenia with an anc of less than . x /l during the chemotherapy course preceeding r-methug-csf treatment, whereas only patients had ancs _< . x , l after the subsequent therapy with r-methug-csf (p< . ).overall analysis showed that the duration of anc nadirs < . x /l was on average . days in cycles without r-methug-csf compared to . days in cycles with r-methug-csf treatment. the administration of chemotherapy had to be delayed only for . days (mean value) during cycles with r-methug-csf. side effects probably related to r-methug-csf, were moderate muscle and joint pain in patients and chills in one patient. in general, r-methug-csf was well tolerated. under this treatment regimen patients reached complete remission, patients reached partial remission and one patient had stable disease. one patient was treated adjuvantly after gastrectomy. in conclusion, r-methug-csf allowed the safe and timely administration of this intensive chemotherapy regimen and reduced myelosuppression for patients with hodgkin's disease and non-hodgkin's lymphoma. based on previous studies (cancer res. : , , blood, : , we know that many patients (pts) cannot receive ct consisting of carboplatin (cbdca) mg/m and cyclophosphamide (cyclo) mg/m for oc every wks without hematopoietic growth factor support. the desirable dose of rhil- based on a phase i/ii study in this setting was or gg/kg/day. a study was designed to determine whether rhil- would allow ct administration every wks with pts treated to date. cyclo was administered mg/m and cbdca was dose adjusted to creatinine clearance: - ml/min: mg/m , - : mg/m , - : mg/m , > : mg/m . a total of cycles (c) was administered. rhil- ( or /zg/kg/d) was given sc d - in each c. at and #g doses are ( c) and ( c) pts evaluable for toxicity and i ( c) and ( c) pts for efficacy. side effects were fever and headache controllable with acetaminophen. at #g rhll- in three c ( pts) and at #g in six c ( pts) urticaria occurred. in episodes dyspnea and/or oedema was observed. this reaction only occurred during c ~ and was controlled with antihistamine and prednisolone. ct could be administered every wks in / c ( / c at /~g, and in / c at /zg (ns)), every wks in / c and > wks in / c. no platelet transfusions were required. thus, in % of c it was possible to give a ct dose intensification of %. if full dose ct were to be given every wks it would have been possible to administer in % of c in time. conclusion: with rhil- ct dose intensification of % is possible by reducing ct intervals, while no platelet transfusions were required with rhil- . dept. of medical oncology. university hospital groningeu. oostersingel , ez groningen. the netherlands. k. mempel, a. reiter, e. yakisan, e. odenwald, m. pfetsch, g. schwab, h. riehm, k. welte. in the multicenter trial all-bfm , we have initiated a phase iii study of rhg-csf in children with high risk all. high risk (hr) patients are characterized by at least one of three criteria: . prednisone poor response ( /mm absolute blasts number in the blood at day after days' exposure to prednisone), . failure to achieve complete remission at day of induction therapy, and . t( ; ). the primary objective was to test whether rhg-csf reduces the incidence of febrile neutropenic episodes. the second objective was to examine whether rhg-csf administration allows closer adherence to planned dosing schedule and to determine the overall response to chemotherapy. hr-all pts are randomized to receive either cycles of chemotherapy (hrg i) or cycles of chemotherapy (day - ) followed by rhg-csf (day - ; hrg li). up to date, pts have been treated according to this protocol (hrg i: pts, hrg i : pts). in hrg ii, rhg-csf is well tolerated without g-csf related adverse events. in each arm, one pt relapsed. the incidence of neutropenia was % in hrg i and % in hrg i . more importantly the incidence of febrile neutropenia was % in hrg i and % in hrg ii. these data demonstrate that rhg-csf allows for reduction of the incidence of febrile neutropenia in hr-all-patients. the patient has experienced complete resolution of stomatitis, fever and malaise. the administration of g-csf in patient with idiopathic neutropenia significantly increased the absolute ueutrophil counts (p < . ). g-csf was effective in reducing the severity of neutropenia and infectious complications in our patient. hansen f., stenbygaard l. and skovsgaard t. twenty patients with recurrent metastatic breast cancer treated with high-dose myelosuppressive antjr eoplastic drugs (cyclophosphamide , g/m or epirubicin mg/m both q . weeks) as first or second line chemotherapy were randomized in a prostective study to gm-csf (n= ) microg/ kg/dag for ten days after cessation of chemotherapy or control (n= ). compared to the control-group highly significant reduction in granulocyte nadir duration (two days ( - ) with gm-csf vs. seven ( - ) days) and severity (wbc . x /i with gm-csf vs. . x i /i) was found. no difference in frequency of neutropen fever or antibiotic use could be observed. even though the patients treated with gm-csf at random were more heavily pretreated with chemotherapy, there was a surprisingly higher responserate in these patients as compared to the control-group, namely % vs. %, resp. no severe side effects were seen, but presumably due to gm-csf one patient developed an allergic type i reaction and one patient developed a possible pericardia[ exudation. both were fully reversible after cessation of gm-csf treatment. keywords: gm-scf, chemotherapy, breast cancer. twelve adult patients with chronic neutropenia, including patients with idiopathic sporadic neutropenia, with idiopathic familial neutropenia and with cyclic neatropenia have been treated with rhu-met-g-csf (amgen, thousand oaks, usa). treatment has been started in all patients with #g/kg/d sc once daily. doses have been modified according to wbc. all patients had a rapid increase of absolute neutrophil counts. data are shown for idiopathic neutropenia (base line, after , and weeks). doses required ranged from . to #g/kg/d. treatment has been continuously given up to three years in patients with severe preceeding infections. the clinical efficacy of the treatment was excellent with abrogation of significant infections. one patient with idiopathic i sporadic neutropenia recovered after days of treatment with an anc of "~ ~o o > /# after stop of g-csf. in a patient with familial cyclic neutropenia cycle length shortened from to days. in another patient with acquired idiopathic cyclic neutropenia the cycle length of days remained constant but re t w w w the nadir of anc rose from to /# . this patient was taken off therapy because of urticaria related to g-csf on day . there were no further significant adverse events. no loss of effectivity was observed during long-term treatment. we conclude that g-csf is safe for long-term treatment of idiopathic neutropenie with severe preceeding infections. as response to treatment is quic, it may also be an effective interventional treatment in acute infections in these patients. cytokines and growth factors are widely used to promote growth and proliferation ofbematologic cell populations. improvement or wonnu healing by stimulation with g-csf has been relxn'ted in patients suffering from kostmann syndrome, felty syndrome or from neutro-~ nia due to chemotherapy. e report on two patients with mds/ra (ha, female, age ; sh, male age ); duration of disease was months and years, respectively. ha was admitted for neutropenia (neuu'ophils: . - . g/l), epistaxis and a growing ulcerous wound in the pubic area (diameter mm) already pretreated with antibiotics for days. surgery was not possible due to poor heart condition and thrombocytopenia refractory to donor platelets. mu g-csf were administered subcutaneously daily for days resulting in neutrophil counts of . g/ and effective wound granulation and epithelialisation. the patient died of cardiac failure on day . sh was adnutted for infected hematoma of the left thigh. subcutaneous infection progressed due to severe neutropenia (neula-ophils < . g/l). incision and resection (ulcus diameter ram with deep invasion into the fascia) was performed. days later the defect measured x mm, reaching the knee joint, and the patient underwent a second surgical interventaon. enterococcus, staphylococcus epidermidis and bacterium xerosis could be cultured from direct swabs. therapy with g-csf at a dose of mu s.c. was started on day . neutrophils reached . g/i and g-csf was reduced to every other day. complete wound healing without any further surgical intervention was achieved by day and sh was dismissed. after discontinuation of g-csf the patient is well and has normal differential blood counts. we conclude that g-csf is successful in promotion of wound healing in mds patients due to enhancement of neutrophil production. leukemic conversion of mds during g-csf was not observed. we report on a year old male patient presenting in / with moderate thrombocytopenia~ transfusion dependent macrocytic anemia and normal., wbc. trephine biopsy showed hyperceuular marrow without fibrosis wzm trilineage dysplasia (mds/ra). cytogenetic analysis was ,xy. in / vasculilas ~as diagnosed. from / to / three cycles of gm-csf ( #g/m s.c. - days) were administered, resulting in both transient leukocytosis and increased platelet counts_ bone marrow aspirations showed dysplasia but no blast proliferation. in / vasculitis progressed, splenomegaly and hemolytic anemia developed requiring prednisolon. in / high dose erythropoietin was started ( iu/kg i.v. twice weekly) and continued till / . there was no change clinically, bone marrow smears and cytogenetics. in / the patient complained of pain in the lumbosacral region and neuralgia in both legs developed; a ct scan was negative. both pain and neurological symptoms (paraplegia and sensibility disorders) progressed. act scan and an mrt showed an intraspinal tumor (d -d ). "although severe thrombocytopenia refractory to high dose i.v. immnnoglobulin and platelet support (hla class i & lymphocytotoxic antibodies) developed, therapeutic laminectomy was performed in / , but only a part of the tumor could be resected. histologically the tumor consisted only of erythropoiesis with dysplasia without excess of blasts. wound healing was without complicatmns. after surgery gamma irradiation and therapy with ifnc~ ( #g s.c. times/week) were performed. the patient recovered totally from neurological disorders and is still alive but iransfusion dependent because of severe cytopenia. we conclude: intraspinal extramedullary hematopeiesis is a rare symptom in mds. althoughthis infiltration was diagnosed months after gm-csf a_ad hd-epo therapy, it could be induced by cytokine therapy. ( monoclonal antlbodles elther' with or without gam crosslinking. in addition, we added the cytokines. the phenotypic change of expression of fcy receptors was measured. ~o production and calcium flux using the dihydrorhodamine (dhr) and fluo- am methods, resepectively. there were no changes in expression of fcy receptors, but a significant enhancement of pmn activation via fc receptors by all three cytokines. we observed an increase of h production . fold by g-csf, fold by gm-csf and . fold by il- . a fcyriii-b specific monoclonal antibody fgr pmn (id ), which was alone unable to mobilize ca i+, together with all three cytokines was a potent stimulator. the effects of gm-csf and g-csf were calcium independent, in contrast, il- also enhanced calcium mobilization significantly. in summary, all three cytokines potentiate the fcy receptor activation of pmns and therefore play a significant role in inflammatory granulocyte activation as in leukocytoclastic vasculitis. g-csf is a hematopoetic growth factor required for proliferation and differentiation of hematopoeitic progenitor cells. it is now being successfully used to overcome neutropenias of various etiologies. recently, we demonstrated that rhg-csf induced neutrophils from patients with severe congenital neutropenia showed altered surface marker expression (upregulation of fcyri (cd } and cd and downregulation of fcvriilicd )) as well as decreased chemotaxis towards a variety of chemoattractants including fmlp. to separate the effects of the underlying disease from those of the rhg-csf therapy, we investigated neutrophils from patients receiving cytotoxic chemotherapy (n = ) and healthy adults (n = ) after application of rhg-csf. results: neutrophils from patients receiving daily application of rhg-csf (neupogen ~ #g sc.) were studied ex vivo one day before, three times during and - days after cessation of rhg-csf treatment. expression of fcvri, cd and cd (measured by flow cytometry) increased during therapy reaching a maximum at - days after initiation of rhg-csf therapy, whereas expression of fcvrll! decreased to a minimum after - days. chemotaxis of neutrophils under agarose towards fmlp was also reduced during therapy. investigation of surface marker expression and chemotaxis - days after cessation of rhg-csf revealed return to levels before therapy. to exclude the possibility that the observed alterations were caused by the underlying disease or chemotherapy, five healthy adults were treated with a single dose of rhg-csf (neupogen', pg, sc.). a continuous upregulation of fcvri and cd starting h after application with a maximum after hours (fc~l) and hours (cd ) and a downmodulation of fcrriii reaching a minimum at hours was observed. chemotaxis towards fmlp decreased to h after application and returned to normal after h, whereas expression of fcrri, cd and f%riii showed baseline values after hours. conclusions: the results obtained from the healthy test subjects clearly demonstrate that neither the malignant disease nor chemotherapy, but rhg-csf induced the profound alterations of fcr receptor and cd expression and chemotaxis in neutrophils in vivo. the continuous character of the surface marker alterations without appearance of subpopulations and the increase in cd expression suggests that preactivation rather than immaturity of rhg-csf induced neutrophils alone might be responsible for the observed phenomena. fraunhofer institute ita, nikolai-fuchs-sral e , w- hannover severe congenital neutropenia (scn) is a disorder of myelopoiesis characterized by a maturation arrest on the level of promyelocytes with absolute neutrophil counts below /pt in the peril~heral blood. in this study we investigated the expression of receptors for the granulocyte colony-stimulating factor (g-csf) on neutrophils from patients with scn during g-csf therapy. the normal g-csf receptor expression on neutrophils is in the range of - receptors per cell. neutrophils from scn patients express increased numbers of receptors in the range of - receptors per cell. the dissociation constant of the binding of g-csf to the g-csf receptor is not altered as compared to healthy donors. in contrast neutrophils from patients suffering from cyclic neutropenia express normal g-csf receptor numbers ( - receptors per ceil). in addition, we have compared the g-csf receptor cdna of neutrophils from healthy donors and scn patients using the polymerase-chain-reaction technique. we could not detect any major alterations in the g-csf receptor cdna in scn patients. preliminary cdna sequencing data also did not reveal any point mutation. from this data we conclude that there is no defect in g-csf receptor expression and no alteration in the sequence of the g-csf receptor mrna in scn. pediatric hematology and konstanty-gutschow-str. , d- hannover oncology, medical school hannover, severe congenital neutropenia is a disorder of myelopoiesis characterized by severe neutropenia secondary to either a maturational arrest of myelopoiesis at the level of promyelocytes (kostmenn's-syndrome; scn) or regular cyclic fluctuations in the number of blood neutrophils with a median anc below / ~ (cyclic neutropenia). we have treated patients with scn and patients with cyclic neutropenia. thirty of patients with scn and all patients with cyclic neutropenia responded to rhg-csf treatment with an increase of the median anc to above /ixl. the doses needed to achieve and maintain the response varied between . and i~g/kg/d. long-term treatment did not exhaust the myelopoiesis: the mean anc remained stable up to years of treatment. the increase in anc was associated with dramatic clinical responses: significant reduction of severe bacterial infections, reduction of intravenous antibiotic treatment episodes, and reduction of hospitalizations. no severe bacterial infections occured in any of the rhg-csf responders during long-term treatment. severe adverse events, most likely associated with the underlying disease, included the development of mds/leukemia in two patients, and osteopenia/osteoporosis in patients. these results demonstrate the benefical effects of rhg-csf treatment in severe congenital neutropenia patients. fifty-two patients (pts) (median age - years) with philadelphia chromosome positive (ph +) chronic myeloid leukemia (cml) have been treated with ifn ( x units/m ) within six months of diagnosis (median . months (mths), range - mths). we divided the pts into three groups according to sokars classification: low risk group (n = ), intermediate risk group (n = ) and high risk group (n = ). forty-three pts acheived a complete hematological response (chr) as defined by the houston criteria. the cytological response was evaluable in pts: pts ( . %) demonstrated a partial or major eytogenetical response (more than % ph i negative metaphases). the hematological and cytogenetical responses were influenced bsr the risk factors, os the percentage of chr and cytogenetical responses was higher for the pts from the low or intermediate risk groups ( % and % respectively) than for the high risk group ( % and %). transformation occurred in four pts who did not demonstrate a cytogenetical response. the estimated chance of surviving at three years was % for the overall population. toxicity was mild but ifn had to be internpted in four pts for cardiac (n = ), liver (n = t) or neurological (n = ) tocxic effects. these results confirm that ifn is a very effective treatment for cml. the effect of rhg-csf on platelets was studied in healthy volunteers with the thrombometer, a specially developed device which is described in detail. additionally, conventional aggregation tests were performed low doses of rhg-csf enhance functional platelet activity, as shown by significant acceleration of the occlusion of the thrombometer channel. similar results were found in conventional aggregation tests using collagen for induction. with g-csf concentrations of , and , ng/ml the time of response was significantly accelerated and the maximum response was observed in a higher proportion ofplatelets. however, the second phase of aggregation induced by epinephrine was significantly inhibited by , ng/ml g-csf. the expression of cd , cd and cd on platelets' surface was determined in ten patients before and niter administration of g-csf (facscan flow cytometer).quality controls were done by calculating the events positive for cd and cd , which were expressed in nearly t % of the platelets without being changed by the cytokine. the expression of cd in the platelets' surface however was significantly enhanced indicating a depletion of the c~-granules. no platelet aggregation was observed. cd expressed on thrombocytes' or damaged endothel cells' membrane is a receptor for macrophages. this property facilitates rapid adhesion of leucocytes to endothelium at regions of tissue injury as well as platetetleucocyte interactions at areas of inflammation and hemorrhage.-in contrast cd can also have an antiinflammatory function because exposure of tnfa-activated neutrophils to plasmatic cd inhibits their cdl -dependent adhesion to resting endothelium and superoxide production. ifn a has a unique activity in cml leading to complete and partial remissions in - % of the patients. to improve these results, we are currently treating patients with ph'+ cml with a combination of cytosine-arabiuoside at a maximum dose of mg/m z sc on days per week and ifn c~- b. ifn u- b is started at a dose of muim sc dally and escalated to the maximum tolerated dose. patients ( male, female, median age years) have been entered into the trial. patients have been pretreated with other regimen for a median time of months. patients are without pretreatment. the treatment has been well tolerated. besides the ifn a related side-effects some patients experienced gastrointestinal toxicity with nausea and vomiting after prolonged ara-c application. the median observation time in the study is now months and patients are still entered. up to now complete hematologic remissions have been achieved in patients, and partial ones in patients. the rate of complete hematologic remissions was higher in patients without pretreatment ( %) compared to patients who have been pretreated ( %). five partial eytogenetic remissions have been observed and minor reductions in the ph'+ cell done. all cytogenetic responses have been found in patients without pretreatment. we conclude that a combination of cytosine-arabinoside and ifn u- b is well tolerated in patients with cml. early results are encouraging. longer follow up times are necessary to evaluate whether combination therpy will give superior results compared to a txeatment with ifn a alone. during rlfn-~ therapy a minority of patients develops high-titered antibodies neutralizing the injected rlfn-a . the rlfn-c~-andbodies from six of such patients, who lost their clinical response to rlfn-c~ and showed a relapse of their leukemia ( cml, hcl) despite continuous rlfn-c~ a-therapy, as well as ifn-c~-specific antibodies from two patients with systemic lupus erythematusus (sle) were characterized. the anti-ifn activity was purified by sequential protein g -and rifn-c~ affinity chromatography and was found to consist only of igg-antibodies. these antibodies were further tested for their capacity to neutralize the antiviral and antiproliferative activity of various rifns-c~-subtypes. all six sera tested showed a common pattern of neutralization (mdbk-vsv bioassay) distinct from the sleantibodies. all six neutralized rifn-c~a and rifn-ak consistently with a higher titer against aa. three of the six sera neutralized aa, ak, ~c, ~c/j and m, but not m, m and some other subtypes. therefore, from the structure of the c/jl-hybrid, it seems that one epitope recognized by these three sera is at the nh -terminal half of the molecule. in contrast, the sle associated antibed]es neutralized the antiproliferative and antiviral activity of every subtype tested. these data indicate that the therapy-induced antibodies against rifn-c~ recognize very selected epitopes on the rifn-cd-molecule suggesting that only a part of the rifn-~ molecule is immunogenic. in vitro experiments indicate higly synergistic effects of combining ifn with cytostatic drugs such as anthracylines (a). in a phase i/ii-study patients (pts) with pro$ressive inoperable hcc were treated with e mg/m z weekly x and ifn mio iu/m s.c. x weekly for weeks, followed by one week off treatment. in case of at least no change (nc) and tolerable toxicity the therapy was continued. escalation of e in steps of mg/m z per cycle was attempted. pts characteristics: median age years ( - ); male , female pts. pretreated with a pts. toxicity and treatment: total number of cycles ; median ( - ) per pt. worst toxicity per pt (who): wbc ~ %, ~ %; platelets ~ %, ~ %; diarrhoea ~ %, ~ ~%; n~isea/vumitinq ~ %; ~ %; ifn related fever (maximal ~ in %. ifn-related wasting syndrome pts, no severe organ toxicity. divisione di ematologia -ospedale san camillo -roma from november to october six patients with acute leukaemia, who achieved their first complete remission with standard chemotherapy followed by autologous bone marrow transplantation (abmt), were consecutively treated with r.interferon alfa- a (ra-ifn). patients ( all and anll) were from ii to years old, of them ( anll and all) were reinfused with autologous bone marrow purged with asta-z i mcg/ml/ x cells and in the remaining all patients immunomagnetic purging was employed. conditioning regimens were bucy in patients and cy-tbi in the others, ra-ifn started at median time of months ( - ) after abmt when complete consolitated hemopoietic recovery occurred. the ra-ifn dose was . iu/sqm times a week for years. none of the patients presented significant toxicity and only short suspensions occurred for fever or alt level increase. the incidence of infectious complications were particularly low compared with other autotransplanted groups of patients who received similar antinfectious prophilaxis. one case six months after abmt and days after acyclovir prophilaxis interruption presented a mild herpes-zoster complication which required new acyclovir therapy and resolved i days later. the amount of these patients is extremely low because the study was early interrupted to start a new protocol including il- ; but the long duration of the good continous complete remission ( / years after abmt) in all these unselected and consecutively treated patients is very interesting. surgical procedures may be associated with an inceased risk of tumor spreading due to surgical mobilisation of the tumor and transient postoperative immunosuppression. recurrences may result either from early growth of micrometastases already present at the time of surgery or from the seeding of malignant cells shed during operative manipulation of the tumor. imrnunomodulators have been proposed to correct the immunological impairement induced by surgical procedures. from / to / , patients with advanced stage cancer underwent surgical resection with peri-operative interferon-alpha administration. patients received interferon alpha- a (roferon-a), by daily subcutaneous injection for fourteen days, starting on three days before surgery. incremental doses were , , , , and x iu for , , , , and patients respectively. peripheral blood lymphocyte (pbl) subset numbers were assessed using flow cytometric analysis the day before injection (d- ), before surgery (d-i), at the day and . absolute numbers of total t cell (cd +) and nk cell (cd +, cd -) were determined, as well as auxiliary t cell (cd +), activated t cell (cd +, dr+), and b cell (cd +) counts. short-term cytotoxicity of pbmc against k and daudi target celts in a -hour standard chromium release assay were determined. no w.h.o. grade iv toxicity were observed. a significant post-operative fall of the total pbl count, of cd +; cd +; cd +; cd - + occured from d- to d . the decrease were not significant for cd +dr+. values were not significantly different, between d- and d , only for cd dr+ and cd - +. cytotoxicity against k and daudi target ceils increased significantly from d- to d-l, and from d-i to d , with a significant fall of cytotoxicity against daudi from d- to d . peri-operative interferon alpha administration is well tolerated even at the . iu doses. in spite of treatment and increasing cytotoxicity activity, we observed a post-operative fail for the majority of the imunological parameters. further studies are necessary to compared with a control group, with more patients treated with . tiiu daily. patients: six patients have been treated (med. age yrs.; - yrs.) four patients had acute myeloid leukemia (aml m : , m : , m eo: ). two patients had acute lymphocytic leukemia (both t-all). all patients had manifest disease with more than % blasts in the bone marrow. patients were selected not to have rapidly progressive diesease allowing the application of the cytokine. treatment and toxicities: ifn a was given for a median of ( - ) days at a dose of - mu sc daily. the following toxicities _>grade who were observed: fever , gpt , pulmonal , infection ( pneumonia), pains . the patients with aml ware transsusion dependent for platelets and erythrocytes. no significant additional bleeding was observed. results: one aml patients had stable disease and three had disease progression. of the all patients one had disease stabilization and one progression. conclusions: ifn a is well tolerated in patients with refractory aml and all if they ere in a relatively stable condition. the effectivity of ifn a- b as a single agent is poor in patients with refractory aml or all. freund et al. eds, springer-verlag, ) have confn'med the wide range of clinical usefulness of ifn alphabased therapy in cancer patients (pts). we present in this paper a retrospective analyses of cases with advanced neoplasias treated between - by a sequential administration of ifn alpha and standard chemotherapy. there were w, m, aged - y, with solid cancers pats and lymphomas pts. the treatment consisted of a sequential association of ifn alpha (also with ra all-trans) and cht plus tamoxifen (for appropriate cancers). the ifn schedule was of monthly series, one series consisting of million iu/d for consecutive days. cht, appropriate for each primary cancer also administered in monthly series. the results are grouped according to the status of the disease (subsets of pts) at the onset of ifn-based therapy, and refer especially to long term survival ( - y +). for minimal residual disease (mrd) from cases there were cr ( / breast ca, / cr melanomas, each sts and rcc / rc, / gastric and head and neck cancers together, /t lymphoma. for progressive disease, pre-lfn-based therapy there were pts, and post ifn-cht treatment there were sd and pd. in of failure pts association of ifn alpha and bropirimine (ifn-inducer) appeared an unusual good response. conclusions: ) ifn alpha-based therapy is a very useful one especially in mrd. ) the therapy must be individualized for selected subsets of pts and for each patient day to day. authors have used inf alpha b in cases of haematological malignancies for three years. the number of cases not too high, and non fo cml cases was so called "early" cml. our cases are: cml, non-hodgkin malignant lymphoma, myeloma multiplex, essential thrombocythemia. the tnf alpha b was used as monotherapy in the cases of low grade non-hodgkin malignant lymphoma, and essential thrombocythemia, and was combined with chemotherapy in the other cases. on the basis of our initial results, we recommend the inf alpha b in the treatment of haematological malignancies in suitably selected cases. department of haematology and oncology, hospital of ministry of interior, vftrosligeti fasor - the influence of low oral doses of human leukocyte derived interferon alpha on the immune system of chronically hbv infected patients with depressed immunological response. low oral doses &the interferon were given to a group &seven children with limphoblastic acute leucaemia in the state of remission, chronically hbv infected. interferon alpha was produced by hayashibara biochemical laboratories inc. okayama, japan, in tablets of iu and iu respectively. immunological response was checked by measuring population and subpopulations of limphocytes, level ofimmunoglobulin and complement c fraction. a distinct stimulation of cellular immune response was observed: the fraction of activated limphocytes t increased significantly, index cd /cd became normal and population of limphocytes b increased gradually. there was no influence of interferon treatment on immunoglobulin and complement c fraction serum level. the interferon treatment improved the patients' general condition and shortened the period of intoxication after cytostatic treatment. no side effects were observed. none of the children eliminated the hb virus during the six months treatment. cytokines play an important role in activating the immune system against malignant cells. one of these cytokines, il- has entered clinical phase i trials because of its immunoregulatory potency. in the present study we report that rhll- has direct antiproliferative effects on some human lung cancer cell lines in vitro as measured by a human tumor cloning assay (htca). this activity could be abolished by neutralizing antibody against rhll- . the biological response of the tumor cells to the cytokine is correlated with expression of receptors for bll- on both the mrna level and the protein level. the most responsive cell line ccl secretes il- after being incubated with rhll- . on the other hand, neutralizing antibodies against il- showed no influence on the growth modulatory efficacy of rhil- in this cell line. furthermore, ccl does not show detectable production ot il- , tnf-~ or ifn-y alter incubation with rhll- . thus, the response to rhll- is not mediated through autoeriee production of these cytokines triggered by rhll- . in a next series of experiments the ceillines were xenotransplanted to balb/c nu/nu mice. subsequently, the mice were treated for > days with twice , mg/m rhll- (rhll- was a kind gift from dr. urdal, immunex, seattle, usa) or control vehicle subcutaneously per day. treatment with rhll- yielded a significant inhibition of tumor growth versus control in the responsive cell lines ccl and htb , but no therapeutic effect in the non-responsive cell lines. plasma levels of rhtl- were sufficient for in vitro growth-inhibition in the responsive lines. histology of the tumors in both groups showed no marked infiltration of the tumors with murine hematopoietic and lymphocytic cells consistent with the species specificity of il- . we conclude that rhll- has direct antiproliferative effects on the growth of some human lung tumor cell lines in vitro and in vivo which together with its regulatory effects on various effector cell populations makes this cytokine an interesting candidate for further investigation in experimental cancer treatment. the combination of systemic chemotherapy and immunotherapy comprising interleukin- and alpha-interferon leads to significant tumor regressions in patients with advanced malignant melanoma. in contrast to chemotherapy by itself, the combination produces a significantly extended remission duration in the majority of treatment responders. we conducted phase ii studies.to assess the potentially additive or synergistic effects of chemotherapy and immunotherapy in metastatic malignant melanoma patients: the first study comprised two cycles of carboplatin ( mg/m ) and dacarbazine ( mg/m~); the sesond study included up to four cycles of cisplatin ( mg/m x days), dacarbazine ( mg/m x days), bcnu ( mg/m , cycle i+ ) and tamoxifen ( mg daily). chemotherapy was followed by up to cycles of a -week immunotherapy comprising interleukin- ( - million iu/m ~ sc x weekly) and alpha-interferon ( - million u/m sc x weekly). among evaluable patients in study i, there were ( %cr, %pr) objective responders; median remission duration was + months for complete, and + months for partial responders. chemotherapy intensification in study ii lead to an increased response rate of % ( out of patients). in both studies, the progression free interval was significantly extended when compared to patients who received chemotherapy, only (historic controls). the role of immunotherapy as maintenance in patients with advanced metastatic malignant melanoma is currently being evaluated in a prospective randomized trial. integrin receptors play a crucial role in cell-cell and cell-matrix adhesive function, and thus are supposed to influence invasion and metastasis. very little is known about the impact of interleukins on integrin regulation in tumor cell lines. therefore, we investigated the expression of of and i integrin subunits on well (ht ) and poorly differentiated (sw ) human colon cancer cell lines using a panel of specific monoclonal antibodies and cdna probes. ht and sw expressed similarly high levels of ~ , a , ~ gt, and f~ subunits on the cell surface. no a , ~ , and ~ was detected on either cell line. while a was not expressed on ht , sw showed higher levels of the laminin receptor ~ . the poorly differentiated cell line sw was resistant to il- , whereas ht was sensitive. treatment with il- induced a decrease in ~ , a , '~ , ~v, l~l, and integrin expression. however, ~ subunit was markedly upregulated. in contrast to il- , there was no evidence that il-lfi could modulate integrin expression on these celt lines. the function of integrin receptors was assessed by measuring adhesion to collagen, laminin, vitronectin, and fibronectin. il- significantly increased the adhesion of ht to fibronectin, while attachment to collagen, laminin, and vitronectin remained unchanged. these results suggest differential integrin expression pattern on well and poorly differentiated tumor cell lines. we provide evidence that integrin expression may be selectively regulated by il- , but not by il-ib. furthermore, il- can alter adhesive behavior of tumor cells. since il- is currently studied in clinical trials, the metastatic potential of malignant tumors should be monitored thoroughly. immunotherapy with ifncz and il- is an active regimen in malignant melanoma and has shown response rates of - %. in previous studies no prognostic parameters for response could be identified. patients with progressive metastatic melanoma have been enrolled in various immunotherapy trials including ifno~ and high dose il- since with an overall response rate of %. patients with mm treated in our phase ii trials could be analysed to identify possible prognostic parameters for response. patients were divided into three groups: responder ( cr/ pr), stable disease ( sd/ mr), and nonresponder ( pd). all patients had measurable tumor, a karnofsky index of > %, no cns metastasis, and no severe cardiorespiratory or renal disease. we examined the following pretreatment parameters for prognostic relevance of response: age, sex, performance status, time from diagnosis to onset of first metastases/ to begin of immunotherapy, tumor toad, number of metastatic sites, organ sites of metastases, ldh, ap, esr, and hla-type. of these several variables were found to significantly correlate with response: tumor load (p= . ), number of metastatic sites (p= . ), serum ldh (p= . ) and ap (p= . ). tumor load, ldh and ap are no independent parameters. while time from diagnosis to onset of first metastasis is of no prognostic significance for response, the time between first diagnosis and begin of immunotherapy, usually reflecting metastatic disease necessetating systemic treatment, significantly correlates with probability of response (p= . ). since several hla class i alleles have been shown to function as restriction elements for recognition of melanoma cells by specififc t cells in vitro, namely a , a , b , and cw , we compared the frequency of these hla antigens between responder and non-responder. we found a , b and cw to be increased in responder vs. non-responder. our results indicate that in patients with mm tumor load, number of metastatic sites, ldh, and time from diagnosis to begin of immunotherapy are prognostic parameters for response to immunotherapy. these parameters may be useful to determine patients with good and poor risk for response to immunotherapy and are of relevance for stratification in randomized clinical trials. dept of medicine, university of heidelberg, hospitalstr. , heidelberg, germany surgery of metastatic melanoma following successful il- based immunotherapy. u keilholz , e stoelben , c scheibenbogen , hd saeger , k neumann , w hunstein surgery of advanced metastatic melanoma is of limited value and usually not recommended. immunotherapy using high dose il- is effective in a substantial proportion of patients, however, the duration of responses is limited, and benefits in survival are not yet proven. this evaluation was done to determine the value ot resection of residual tumor lesions following successful immunotherapy. patients with progressive metastatic melanoma have been enrolled in various immunotherapy trials including ifna and high dose il- since . patients showed evidence of antitumor response ( cr, pr, mr/sd). in patients responding to immunotherapy, residual lesions were resected, whenever technically possible and patients agreed to surgery ( patients). of the responding patients without surgery relapsed, the median time to progression was months (range - ), almost all initial relapses occured locally, patients died so far. of patients who underwent surgery ( pr, mr/sd) were converted into cr by surgery. of the patients disease-free after surgery relapsed, locally ( , , and months after surgery), and one cns months after surgery. patients are still free of recurrence ( +, +, +, +, +, +, + months after surgery) and of are still alive. in the patient with cns relapse complete resection of this lesion was again possible, and there was no evidence of recurrence for months after this second surgery. histology revealed vital tumor cells in almost all resected specimens, however in of patients profound necrosis of the tumor tissue was observed. of special importance is the observation that patients with minor response or sd according to imaging procedures were found to have an almost complete response histologically. interestingly, almost all metastases resected after immunotherapy had developed a fibrous capsule. surgical reevaluation and resection of residual lesions should be considered in patients with partial response after immunotherapy, and in selected cases also with stable disease. this approach offers the chance for extended disease free survival, and may be curative in certain patients. t-cell-receptor (tcr) vcz~ usage of tumorinfiitrating t-cells in primary, regressing and progressing melanoma metastases following [mmunotherapy with ifn~ and il- : evidence for a specific t-cell response. mshler, t., willhauck, m., scheibenbogen, c., pawlita, m.#, bludau, h.#, brossart. p.. keilholz. u. the identification and characterization of immunological effector cells mediating tumor regression in immunotherapy with il is of great interest for understanding and further development of this therapeutic approach. tumor infiltrating lymphocytes specific for autologous tumor cells can be expanded from certain melanoma tissues. t cells recognizing the same antigen use a limited tcr repertoire with a certain vc~ and [ variable region, determining the specifity of their receptor. we therefore analyzed t-cell receptor v-regio,q distribution in tumor tissue from melanoma patients prior to and following immunotherapy with il- . we used a highly sensitive rna-pcr method. after rna-extraction from tissue and subsequent cdna-synthesis semiquantitative pcr with different primers for all known vc~-and vii-t-cell receptor gene families ( vc~ and v~) was pedormed. tumor tissue samples were analysed including samples of primary malignant melanoma and tumor samples of three patients after immunotherapy. the results were compared to control tissues (peripheral blood, unatfected skin, and liver tissue). the analysis of primary malignant melanoma tissue showed a weak overexpression of different v[ -families. preferential usage of different tcr-v~,genes was more obvious in tumor tissue of patients alter immunotherapy. of special interest is a patient with a mixed response to immunotherapy with progressing and regressing skin metastases, in the regressing lesion we could demonstrate a predominant usage of tcr-v[~ -gene almost lacking in the progressing lesion. this suggests a role of v[ -expressing t-cells in mediating tumor regression in this patient. cloning and sequenzing analysis are currently performed to assess wether this represents a true clonal t-cell proliferation. recently a highly sensitive assay combining reverse transcription and polymerase chain reaction (rt/pcr) to assess for melanoma cells in peripheral blood has been developed. the detection of tyrosinase mrna, a tissue spezific enzyme in melanocytes and melanoma cells in peripheral blood indicates the presence of melanoma cells, we used rt/pcr assay to determine malignant melanoma ceils in peripheral blood of patients with malignant melanoma in different stages of disease. in none of patients with stage i (localised tumor) but in of patients in stage ii (regional lymph node metastases) tyrosinase transcripts were detected. tyrosinase mrna was found in all patients with distant metastases (stage iii). this method may be helpful to define a group of patients at high risk for development of hematogenous metastases, that would be a possible target group to explore adjuvant treatment strategies. we then examined blood samples and bone marrow aspirates of patients with metastatic malignant melanoma for presence of melanoma ceils prior to and after therapy with ifn-a and il- . patients showed antitumor response to immunotherapy: complete remissions (cr) and ? partial remissions (pr r. hilse, m.meffert, j.grosse, h.kirchner, h.poliwoda, and j.atzpodien we investigated the use of pcr for a semiquantitative estimation of cytokine expression patterns in pbmc before and after administration of il- to patients with advanced renal cell carcinoma or malignant melanoma, mrna of cytokines was measured using a modified polymerase chain reaction protocol, which could detect -fold differences in mrna-contents of stimulated pbmc in vitro. weekly rna-samples of patients receiving a total of treatment cycles were examined for long term changes, in patients frequent samples were taken immediately after tl- -administration for transcript-kinetics, mrnaexpression for il- , il- , il- , ifn-)', tnf-c~, gm-csf, tgf-~ and il- receptor-c~ was clearly detectable in most of the samples, including four healthy donors. however, our method could not detect significant changes in transcript-levels of pbmc during days following injection of (a) mio.lu or (b) x mioju dl- daily. this was in marked contrast to cytokine secretion assayed by elisa. thus, serum il- peaked - hours after administration followed by secondary cytokines with a peak - hours later. increases for tnf-m ifn- , il- and il- r serum levels were significant (p< , ) with the highest response found for il- , increasing -(a) and -fold (b) at day , or -/ -fold at day . comparing normal individuals to patients, only small differences in constitutive cytokine expression were seen (< -fold) with no distinct pattern. during therapy, changes could be seen for all cytokines except for il- and tgf-i . in one patient, a -fold increase for il- , tnf-c~ and ifn- transcripts was observed during week of the second treatmentcycle, other changes were approximately -fold. abt. h&matologie und onkologie, medizinische hochschule hannover, d- hannover , germany regional immunotherapy: perfusion of liver metastases with lak cells u. keilholz, c. scheibenbogen, m. brado, w. tilgen, and w. hunstein a regional approach of adoptive immunotberapy with interleukin- and lymphokine activated killer cells for the treatment of liver metastases is reported. the treatment consists of continuous infusion of interleukin- i.v. or into the splenic artery, and transfer of ex vivo generated lymplaokine activated killer cells into the portal vein or the hepatic artery. patients with malign ant melanoma, with renal cell carcinoma, and with thyroid carcinoma have been treated. all had progressive liver metastases. trafficking studies using indium-oxine labelled cells revealed that > % of the lak cells remained in the liver after regional adoptive transfer. in patients with liver metastases of cutaneous melanoma, cr ( and + months), pr ( + months, converted to cr by surgery), sd ( and months), ad pd were observed. the lesion in the patient with pr was resectable after two cycles of treatment, and histology revealed almost completely necrotic tumor tissue surrounded by a dense fibrous capsule. no responses were observed in patients with liver metastases of ocular melanoma, suggesting an immunologic difference between these two melanoma subtypes. pr ( months) and sd ( months) were achieved in patients with renal cell carcinoma, and sd ( months) in the patient with thyroid carcinoma. evidence for the crucial role regional cell transfer is provided by the observation in a patient with an anatomic variation of hepatic blood supply in whom we achieved complete and durable tumor regression. in this case anti-tumor responses were only observed in anatomic areas of the liver which were perfused with lak cells. depts. of internal medicine, diagnostic radiology, and dermatology, hospitalstrage , heidelberg, germany in a randomized phase ii study we evaluated the response and side effects of a combined administration of interleukin- (il- ) and interferon-alpha b (ifn-alpha b) versus interferon-gamma (ifn-gamma) in patients with metastatic renal cell cancer. patients in group a received subcutaneous (sc.) meg ifn-gamma once a week. in group b patients were treated with a (sc.) combination therapy of ill- ( x iu/m in week and , x' iu/m in week , , and , twice a day for days) and ifn-alpha b ( x u/m ) over weeks once a day times a week. up to now patients were treated, patients in each group. toxicity of ifn-gamma treatment was absent. the therapy with il- and ifn-alpha b led to sideeffects grade (who): fever, chivering, fatigue and weight-loss. treatment were withheld in %, follow up after months ( - months) showed stable disease in patients and progression inl patients in group a in group b there were complete remissions, partial remission and patients with progressive disease. although the combination therapy showed % objective response (p< . , fisher-test) no significant improvement on survival was seen (p = . logrank test). patients with locally advanced renal carcinoma are at high risk of relapse after initial radical surgery. we initiated a clinical phase ii trial using autologous tumor vaccines for the surgical adjuvant therapy of renal cancer patients. seventy-two patients (pts) ( female, male; median age, yrs; range, - yrs) with locally advanced renal carcinoma (pt b- pn or ptxni- m ) received autologous newcastle disease virus modified and lethally irradiated tumor vaccines in combination with . million iu of il- and . million u of ifn-~ , once weekly over consecutive weeks. toxicity was very mild with transient flu-like symptoms. among evaluable patients, there were relapses ( pts, pt ani- ; pts, pt bn ); the median relapse-free survival was + months with a range from to + months; survival probability in this vaccine treated cohort was significantly better than in all historic controls. using western blot analyses, we could demonstrate a vaccine specific in-vivo b-cell response in all patients receiving ndv tumor vaccine. a subset of peripheral blood natural killer (nk) cells has been found to exhibit high density surface expression of the nk associated cd antigen; it has been suggested that these nk cells respond to lower concentrations of il- when compared to the majority of nk cells expressing cell surface cd at low density. we evaluated density of the cd antigen on circulating nk cells of patients with advanced renal cell carcinoma by flow cytometry. patients received a combination of low-dose subcutaneous recombinant interleukin- (ril- ) at million iu/m /day on days and , followed by . million iu/m /day, days per week, over consecutive weeks, in combination with recombinant ~-interferon (rifn-~) at million iu/m , three times weekly. antigen density of cd before therapy was found . -fold higher (p< . ) in patients who subsequently achieved a complete or partial tumor remission (n= ) when compared with patients who presented with progressive disease on therapy (n=ll). after a -week treatment cycle, nk cells of treatment responders expressed significantly ( .l-fold; p< . ) more cd antigens than nk cells in nonresponding patients. these results suggested a potential role of both pre-and posttreatment nk antigen density levels as a biologic correlate to treatment response in tumor patients receiving low-dose ril- and rifn-a. intravesical immunotherapy against superficial bladder tumor recurrences and carcinoma in situ is a recognized and highly effective regimen in urology. to further clarify the mode of action of this approach, the local immune response of patients was investigated: the cytokines il- , il- , and tnf were determined in the urine before and after intravesical instillation by elisas and biological assays. furthermore, bladder biopsies taken before and after the treatment course were analysed by means of immunohistology for the presence of mononuclear cell subsets. the results show a significant increase of urinary cytokines with a maximum - hours after the instillation of bcg which returned to baseline values within hours. this intense locai immune activation was further reflected by the accumulation of activated mononuclear cells, predominated by t cells as demonstrated with bladder biopsies. the local t-helper/t-suppressor cell ratio shifted towards the t-helper subset. these changes persisted for more than year after the initial treatment course. in conclusion, this local immune response may be associated with the therapeutic success of bcg. further analyses will dissect the role of each factor with regard to antitumor cytotoxicity against bladder carcinoma. enhancement of therapeutic effect of intarleukin- (il- ) by association with cyclephcsphamide (cy) was studied on el-/+ lymphoma maintained in ascitic form in syngeneic c bl/ (h- b) mice and lymphoreticulosarcoma (spontaneous origin) maintained in solid form in syngeneic cba (h- k) mice. immunotherapy with il- (obtained by in vitro stimulation of el- lymphoma cells with phorbol myristate-acetate) was applied hours after transplantation of el- lymphcma and i days after transplantation of lym phoreticulosarcoma be administration i.p. (intratumorel) in el- bearing mice and s.c.(peritumoral) in lymphoreticulosarcoma bearing mice for three consecutive days. cyclophosphamide was administered at a dose of mg/kg i.p. six hours before the immune treatment with il- . the results obtained demonstrated that the prolongation of the survival rate expressed by the median survival time (mst) and the percentage of increasing llfe span (ils) of the groups treated with il- associated with cy was significantly higher than that of the groups which receveid a single treatment with il- or cy. enhancement of therapeutic effects of il- in association with cy on lymphoreticulosarcema was revealed by inhibition of tumor growth with a marked regression in the vol~tme of the established tumors and even resorption in some cases. we conclude that the antitumoral effect of il- treatment was enhancemented by association with c a well known cytoreductive drug which selectively removed t-suppressor l~mphocytes from the tumor bearers. this could be conside red as an alternative to immune-or chemotherapy in cancer. to investigate the toxicity and clinical efficacy of aerosolized nil- (biotest) patients presenting with advanced malignancy were entered into a phase i trial. patients suffered from metastasizing renal cell carcinoma, patients from advanced bronchial carcinoma. at start the patients received either , or u nil applied as a single dose. if no adverse events were observed, treatment was continued with the same dose times daily for six weeks. in addition to standard invetigations detailed evaluation of the respiratory function was performed once weekly. soluble interleukin receptor serum levels and the effect on numbers and/or phenotype of lymphocytes in the bronchoalveolar lavage fluid were measured for assessment of biological response to inhalative nil- treatment. treatment with aerosolized nil- was well tolerated. most prominent toxicity appeared to be resistant cough in all patients treated with x u/d. no febrile reactions or other constitutional side effects were observed. a dose-dependent increase of the numbers of memory t lymphocytes, macrophages and eosinophil granulocytes could be demonstrated in bal fluid. in addition, the treatment resulted an increased expression of adhesion molecules on lymphocytes. patient suffering from renal cell carcinoma achieved a partial remission after weeks of treatment with x u/d. we conclude that treatment with aerosolized nil- is biologically active and well tolerated and should be further tested in clinical phase ii trials. divisions of hematology and pulmology of the iiird department of internal medicine, medical center of the johannes gutenberg university, w- mainz, department of urology, univ. hospital eppendorf, hamburg. soluble interleukin- receptors (sil- r) exert a potential role in immunoregulation. we investigated the ex vivo effects of sil- r on several interleukin- (il- )-dependent activation events. proliferation of the il- -dependent mouse cell line ctll- and isolated human pbmc stimulated with recombinant il- (ril- ) was suppressed by sil- r added to the culture medium in a dose-dependent way. preincubation of sil- r with ril- did not enhance this suppression. cytotoxicity of ril- -stimulated human pbmc against the human cell lines k and daudi was correlated inversely to the concentration of sil- r in the culture medium during ril- stimulation. sil- r concentrations higher than . pm produced a significant decrease in cytotoxicity (p< . ). light microscopy of il- -stimulated pbmc revealed no signs of cellular activation when high dosages of sil- r had been added. the effect of different sil- r concentrations added to cultured human pbmc on secondary il- and sil- r production was tested by elisa. initial supply with high sil- r dosages yielded weak increase and subsequent slow reduction of il- levels. in contrast, strong secondary il- production followed by rapid clearance was observed when low sil- r concentrations had been added. endogenous shedding of sil- r in response to ril- was abrogated by the initial exogenous addition of high amounts of sil- r whereas low exogenous addition of sil- r was followed by a continuing endogenous production of sil- r after five days of culture. our studies may lead to a better understanding of il- -related immunoregulation in the preclinical and clinical settings. we investigated the effect of interferons (ifn) on expression of il- and other cytokines regulating inflammatory responses in various cellular models in vitro and in vivo. in peripheral blood mononuclear cells (pbmnc) of healthy individuals il- gene expression which was upregulated in vitro was significantly reduced in presence of ifn-o~. in dose titration experiments a reduction of the il- protein was detected at ifn concentrations as low as u/ml. in cml patients with constitutive expression of il- a reduction of il- mrna expression was seen after therapeutic administration of ifn-a. by contrast, in lps stimulated granulocytes ifn failed to inhibit il- expression in vitro. we investigated the mechanism of il- inhibition in the thp- cell line more in detail. nuclear run on assays and rna decay analysis in presence of acinomycin d suggested that the effect was regulated predominant/y at a posttranscriptional level. de novo protein synthesis was not required since the inhibitory effect was also detected in presence of cycioheximide. in addition to il- expression we studied the effect of ifn-o~ on the synthesis of il- , tnf, il- and il- ra in pbmnc and bone marrow stromal cell cultures. these experiments revealed an antagonistic effect of il- action by ifn x at two levels which was most striking in bone marrow stromal cells. expression of il- mrna was downregulated whereas the production of il- ra was enhanced by ifn-c~. in contrast expression of il- and tnf was enhanced by ifn. we conclude that ifn-o~ differentially regulates proinflammatory cytokines. the inhibition of il- and il- action suggest an antiinflammatory role of type i ifns. in a phase i clinical trial of recombinant human interleukin- (il- ), patients were entered to receive daily subcutaneous injections of il- over days followed by a two week observation period and another weeks of daily il- injections. doses varied between . and pg/kg body weight. patients were evaluable for studying immune functions. at all dose levels il- administration led to a marked increase in serum levels of c reactive protein and complement factor c . natural killer (nk) cell activity was reduced at doses exceeding pg/kg. similarly lymphokine activated killer (lak) cell activity induced by in vitro culture over days in the presence of u/ml interleukin- (il- ) was suppressed at and p.g/kg, as was the proliferative response to il- in vitro. however no changes were observed in the proliferation induced by phytohaemagglutinin, pokeweed mitogen or fixed staphylococcus aureus. there were no changes in peripheral blood lymphocyte subpopulations as measured by cd and cd , nor in the expression of hla dr. serum levels of immunoglobulins iga, igm and igg remained unaffected by il- treatment. in contrast we found consistent elevations in levels of ige all over the dose range. we conclude that il- inhibits nk and lak activity in vivo which may be of interest in future studies with cytokine combinations and that the role of il- in ige related diseases might be more important than previously thought. one of the most potent stimulatory agents for the induction of cytokines in myeloid cells is the bacterial ceuwallproduct lps (liopopolysaccharide or endotoxin). in the bloodstream it forms a complex with lbp (lps binding protein) and is recognized by effector cells via the cdi receptor. here we report on studies performed with human peritoneal macrophages that were stimulated in vitro with lps and a synthetic lps homologue in the presence and absence of serum. as revealed by elisa-based analysis of the cellsupernatants, strong, serum-dependent resonses were seen for tnf-, il- , il- and g-csf production, while unstimulated cells produced basically only il- . repeated stimulation of the cells with lps resulted in adaptation that was different for certain groups of cytokines. the "adapted" ceils produced much less tnf and il- while il-i and g-csf was superinduced. stimulation of the cells with the lipid a anolog mrl showed a similar picture, given that mrl had to be used in higher concentration. "adapatation" of the cells with mrl also resulted in an "adapted" response to a challenge with a high dose of lps so that it might be useful as a therapeutic agent for preventing the septic shock syndrome, e.g. northern blot analysis showed that the differentiated response of the cells towards a low dose lps stimulation regarding cytokine production after an lps challenge occured on transcriptional level, as mrna levels were regulated accordingly. these results give evidence that two different pathways for lps dependent stimulation of myeloid cells for cytokineproduction exist and experiments to further elucidate this phenomenon and possibly discover cdi independent and dependent pathways are underway. the neutrophil-activating peptide (nap- ), a member of the "intercrine"-family of chemotactic and reparative host defense cytokines, represents one of several n-terminally truncated cleavage products that originate from platelet-derived -thromboglobulin through proteolytic processing. here we present evidence that there exists also a naturally occurring c-terminally truncated form of nap- that is about four times more potent in eliciting neutrophil degranulation than the original cytokine. the novel molecule was detected in concentrates of culture supernatants from peripheral blood mononuclear ceils and could be separated from authentic nap- by several steps of column chromatography. according to amino acid sequence analysis it had a n-terminus identical to nap- , whereas electrophoretic analyses indicated a lower molecular weight as well as a higher isoelectric point. immunochemical analyses performed with epitope-characterized antibodies raised against nap- c-terminal synthetic peptides identified limited truncation at the c-terminus of the variant molecule. comparison of reactivity patterns of these antibodies in western blots as well as in a nap- biologic assay (pmn degranulation assay) confirmed that the variant nap- was truncated by at least one and by maximally three residues. thus, there is for the first time evidence that proteolytic processing at the n-terminus is not necessarily the only mechanism regulating the formation of neutrophilactivating peptides, but that modification at the c-terminus may assist in the fine-adjustment of biological activity. cytokines like interleukin- -beta (ill), interleukin- (il ), interleukin- (il ) and tumor-necrosis-factor-alpha (tnf) are involved in the pathogenesis of fever and infection. however, intra-and inter-individual values differ considerably and there is only limited data on early.cytokine serum levels and their evolution in febrile neutropenic patients. therefore. we measured cytokine levels in adults with chemotherapy-induced aplasia and fever. concentrations of ill. il and tnf were determined by irma. il by elisa in specimens per patient. ill and tnf were elevated in of patients with peak values of pg/ml and pg/ml, respectively. il and il were elevated in all patients with a maximum of . pg/ml (median pg/ml, range - pg/ml) for il and . oo pg/ml (median pg/ml, range - . ) for il . both cytokines showed a high correlation (r= . ). the individual il concentration-time curve closely paralleled the temperature curve. in of patients il was elevated before onset of fever and peaked at or one hour before the temperature maximum in seven cases. so also in the cytopenie patient lacking a main source of cytokine producing cells and cytokine target cells consistently high il and il serum levels can be detected very early in the course of fever and infection. the biological and clinical significance of this cytokine response and its regulation mechanisms remain to be determined. interleukin (il- ) and the neutrophil-activating peptide (nap- ) are two closely related members of the "intercrine" family of host defense cytokines. the expression of at least two different receptor classes for il- on human neutrophils (pmn) exhibiting similar affinities has been demonstrated recently. using iodinated ligands we could directly demonstrate that si-nap- specifically bound to pmn with two different affinities, characterized by kd-values of about . nm and . nm, respectively. cold -residue il- competed with iodinated nap- for binding to the high affinity site(s) with practically equivalent efficacy, while it was significantly more effective in displacing %nap- from its low affinity site(s) than was cold nap- itself. as new findings, unlabeled il- could completely displace ~ -nap- and vice versa, indicating that there are no distinct binding sites for either cytokine on pmn. in contrast to il- , nap- did not induce pmn degranulation at concentrations ( nm), engaging solely its high affinity site. however, short-term priming of pmn with the same amount of nap- dramatically down-regulated degranulation inducible by higher concentrations of nap- as a secondary stimulus. the il- -induced secondary response was also diminished, but to lower extents. these phenomena correlated with the rapid downregulation and internalization of nap- high affinity binding sites from the cell surface. thus, our data provide direct evidence for a regulatory function of nap- at very low concentrations, obviously occurring through the modulation of nap- and il- receptor expression on pmn. determination of cytokine plasma levels possesses many promising features concerning monitoring and studying of an array of different diseases including febrile reactions. detailed analysis of the role of these factors is of crucial importance for the understanding of the complex cytokine network. investigation of cytokine blood levels however is complicated by their short half-fife in circulation, the presence of soluble inhibitors and the ill-defined beginning of fever. looking for a suitable in-vivo-model allowing a sequential and well-defined analysis of cytokine plasma levels we chose the acute toxicity after intravenous amphotericin b (am b) application consisting of fever, chills and hypotension. these side-effects were reported to be mediated by release of pro-inflammatory cytokines such as tnf a and interleuldn (il- ). in order to compare mutual interations and different temporal patterns of liberation we determined a panel of cytokines including tnf a, s-tnfreceptor (s-tnf-r), interleukin- , interleukin- -receptor-antagonist (il- -ra), intefleukin- and interleukin- from patients suffering from acute leukemia and fungai infections. serial edta-plasma samples were obtained before and up to hours after start of am b infusion. samples were immediately centrifuged and stored at - ~ c until analysis by elisa (medgenix and r&d systems). patients experiencing adverse reactions showed tnf c~ peak plasma levels - minutes after starting am b infusion reaching maximum concentrations of pg/ml. concentrations declined m base levels within the following - hours. il- as welt as il- concentrations showed similar, but delayed changes of plasma concentration. compared to tnf a s-tnf-rlevels peaked about minutes later with a prolonged decrease to basal concentrations. in contrast to tnf c~ no circulating il-i- could be detected, while il- -ra demonstrated up to -fold increases in concentration. we conclude that this model of a drug induced acute-phase-reaction offers wide possibilities for studying the behaviour of inflammatory cytokines and their inhibitors by means of plasma level determination. inflammatory processes following severe trauma were found to be associated with an abnormal high secretion of inflammatory cytokines. these cytokines are discussed to be involved in neutrophil activation associated with the release of high amounts of destructive lysosomal proteases into the extracellular space. the task of our investigations was to evaluate the possible regulation of the degranulation of neutrophils by the immunostimulatory cytokine il- and the immunosuppressive factor tgf-i.~. we analysed the concentration of the cqantltrypsin-complex of the lysosomal protease elastase as markers for the degranulation of neutrophils as well as the levels of il- and tgf-i~ in the plasma of patients with multiple trauma or after severe surgeries. the time courses of the plasma levels of il- and the elastase-inhibitor-complex were found to be highly correlated, suggesting a possible regulatory role of this cytokine on the neutrophil degranulation. however the plasma concentrations of tgf-~, were not significantly altered in comparsion to the control group. in additional experiments, the effect of both cytokines on the degranulation of healthy donors was investigated in vitro. pathological high concentrations of rh~l- up to ulml (as detected in several probes from the surgical area) were found to be capable to induce a significant degranulation of the azurophilic granules ( , _+ , % of the total cellular enzyme content) under serum free conditions as detected by measurement of elastase release by elisa technique and enzymatic methods. in contrast to this, the degranulation of neutrophils was found to be uneffected by tgf-i~. in conclusion, these data suggest that the inflammatory cytokine il- may contribute to the activation of neutrophil granulocytes in acute inflammatory processes following severe irauma, whereas the immunosupresive factor tgf-fil seems to have no direct regulatory effects beside the described chemotactic effects on neutrophils. we determined serum concentrations of soluble tumor necrosis factor receptor (stnf-rs) in hiv infected individuals. eighty-five percent of these had increased serum concentrations of stnf-r type i (p ) (stnf-r ) and % had increased stnf-r type ii (p ) (stnf-r ). the extent of the increase of stnf-r was greater in more advanced hiv infection (p= . ) as it was measured by dividing the individuals into two groups according to the median of the cd + t cell count, stnf-r- did not differ between these two groups. a strong correlation was found between stnf-r and the soluble immune activation markers b -microglobulin (rs= . , p< . ) and urinary neopterin rs= . , p< . ), and a less strong correlation with interferon gamma (rs= . , p= . ). the correlations observed for stnf-r were also significant but were always weaker than that for stnf-r . a weak inverse correlation was found between the number of cd + t cells and stnf-r (rs=- . , p= . ), no such correlation was observed with stnf-r . our findings suggest that increased concentrations of serum stnf-rs in hiv infection are linked to immune activation where synergistic action of interferongamma and the tnf-alpha system are likely to play an important role. to answer the question whether il- is of hematogenous origin, immunohistochemistry and in situ hybridization with il- specific s labeled rna probes was established to study the frequencies of il- expressing peripheral blood mononuclear cells. a two color immunofluorescence assay with antibodies to cd and il- was utilized to correlate il- mrna expression and il- protein production in monocytes of patients and control individuals. - % of circulating monocytes spontaneously expressed il- mrna compared to % in normal individuals. a strong correlation of il- protein production and il- mrna was found in monocytes of patients and controls. semiquantification of il- mrna and il- i mrna by pcr demonstrated that about to fold higher amounts of mrna were found in untreated patients compared to normal individuals. in contrast, we did not find evidence for excessive synthesis of tnfa mrna. the overproduction of il- and il- in the absence of detectable tnfn mrna establishes a specific cytokine pattern in circulating monocytes of pmr and gca patients. we analyzed the il- mrna expression in biopsy specimens from gca patients applying in situ hybridization. autoradiographs were analyzed by visual examination and by using an image-analysis system. tissue infiltrating macrophages expressed il- mrna, however, the proportion of il- mrna + cd t was lower than in the peripheral blood. also, immunohistochemistry with an il- specific antibody demonstrated that only a small fraction of macrophages produced this cytokine. these data suggest that in pmr and gca, circulating monocytes are activated and produce il- and il- . tissue infiltration of macrophages is not accompanied by a local activation, in contrast, cytokine production is downregulated. our objective was to evaluate the prognostic value of p protein levels in patients with advanced hivinfection during cytokine therapy (ifn or ifn/combination). methods: p serum levels were measured every two months by elisa in hiv-infected patients during a period of to months (median , ) and compared with clinical stage (wr), disease progression and response to therapy. patients suffered from an infection or an inflammation disease during therapy and from kaposi sarcoma (ks). results: in patients with stable disease constant p levels (• ng/ml) were observed. changes of disease correlated with distinct increasing levels of p (in patients with acute infection and/or inflammation disease, in patients with progress of ks). after start of azt-therapy, chemotherapy and antibiotic/ antimycotic therapy p level decreased. the highest amount of p (up to ng/ml) was found in phases with opportunistic infections. the lowest amount of p ( ng/ml) was observed in a clinically stable patient without an evident progress of disease. conclusions: here, we detected increased levels of p in hiv-i infected patients under ifn-therapy during acute opportunistic infection. protein p may be a useful marker for the activation of the immunesystem and a prognostic marker during the course of ifn-therapy. previous studies have shown that the diacetylated synthetic pentapeptide splenopentin (dac-sp- ) accelerates hemopoietic recovery following sublethal irradiation and nutologons bone marrow transplantation in mice, but the effects of the peptide on human bone marrow cells were still unknown. in this study, human granulocyte-macrophage (rhgm-csf), macrophage (rhm-csf), and granulocyte colonystimulating factor (rhg-csf) as well as interleukin-l~ (rhil-l~) and interleukin- (rhll- ) were compared for their stimulatory activity on human granulocytemacrophnge colony-forming cells (cfc-gm) alone and in combination with dac-sp- . after depletion of accessory cells from bone marrow mononuclear cells (bmmnc) in semi-liquid cultures the combination of rhgm-csf plus splenopentin stimulated the growth of cfc-gm/-m in dose-depended manner. furthermore, similar effects were seen in combination of dac-sp- plus rhil-la and and rhil- , but not in rhg-csf and rhm-csf plus splenopentin. in unseparated as well as in bmmnc enriched for cd + cells comparable stimulatory effects of sp- alone were missed. additionally, in bmmnc enriched for cd +/cd + population, the preculture with dac-sp- for l days enhanced the ability of rhgm-csf, rhil-lct and rhll- to induce colony formation from this cell source. however, in all these combinations, mainly differentiation to macrophage lineage has been observed. pheuotypie analysis of precultured bmmnc with splenopentin leads to the suggestion that this compound may recruit a cell population being more sensitive to gm-csf, il-la and il- , because the percentage of cd + cells decreased rapidly, whereas the expression of hla-dr + was enhanced. therefore, this potentially interresting molecule might be a candidate as a therapeutic adjuvant with hemopoietic growth factors. although, the examination of gm-csf, il-lcc and . the role of t-lymphocyte subsets in the development of aplastie anaemia (aa) remains poorly understood. therefore we analysed by cytophomotry the contribution and proportion of lymphocyte subpopulationa in the peripheral blood (pb) and bone maxrow (ibm of patients with aa before, after weeks of treatment and additionally after weeks of therapy with anti-lymphocyte globulin (alg), methylprednisolon, and eyelosporine a (csa). for double labeling immtmofluorescence studies mouoelonal antibodies directed against the following specifities were used: tcrct~-, tcr~ , tcs , cd , cd , cd , cds, cd , cd , cd , and hla-dr. hi patients with aa a sigmficant decrease of cd positive t-cells was observed after weeks of therapy (pb , . , ; bm , • as compared with normal controls (pb , • bm , + , ). before therapy, the cd /cd ratio in pi and lqm did not differ ~om the ratio in the control population; however a reversed ratio (< ) was present in pb and bm after and weeks of therapy. the number of activated t-cells defined by the antigens cd , hla-dr and cd were low or in the normal range,and did not fu~er decrease during therapy in contrast to the non-activated t-cells. ? -t-cells were significantly decreased betbre and after weeks of therapy as compared with healthy controls. however, the proportion of the ~/~-subpopulation ~tcsi was markedly increased betbre (pb +_ , ; bm +_ , i) after weeks (pb , + , ; bm , +_ , ) and esspeciauy after weeks of therapy (pb ,.t~l . ) as compared with that in normal subjects (pb _+ , ; bm , _+_ , ). these data indicate that tcs -t-celis are a t-cell population not affected by treatment with alg, methylpredrtisolone and csa . ftwther studies have to show whether tiffs subpopulafion has an effect on the hematopoiesis of patients with aa. il- j , il- , tnf-i , g-csf and other cytokines are characterised to have proline in the second position of the n-terminal peptide sequence. from this they could be potential substrates of the dipeptidyl peptidase iv (dp iv). using the method of capillary electrophoresis, here we show that purified soluble dp iv is capable of hydrolysing oligopeptides with sequences analogous to the n-terminal part of human il-lb, il- , tnf-b and mouse il- up to a length of amino acids. furthermore, it could be demonstrated that hydrolysis rates are negatively correlated the with chain length of the oligopeptides. glycosylation of threonine in the third position of the il- hexapeptide sequence has no effect on the hydrolysis rate of this peptide by the dp iv. in contrast to these results, no degradation was found in the case of rll-lp, rll- , natural il- , and rg-csf, using up to -fold higher dpiv concentrations than in the experiments with oligopeptides. after incubation with both, dp iv and aminopeptidase n, also no cytokine degradation was found. possible explanations for this results will be discussed. hemopd~'etic growth factors are now being tested in several institutions, in an effort to reduce the duration of neutropenia after bone marrow trasnplantation (bmt). in the past years, we have conducted or participated to several double blind multicentric studies using gm-csf and g-csf (schering-plough/sandoz, behring/hoechst and roche lab.) in patients (pts) with nhl. we wish to summarize these studies and also report on our own observations. -gm-csf post-abmt: double blind international studies and the french national trial that we conducted (blood (blood , , (blood - have clearly demonstrated the gm-csf infusion post-abmt significantly accelerates neutrophil recovery by to days, both in pts receiving unpurged marrow or marrow purged by mafosfamide. the duration of hospitalization is reduced by days with a possible cost benefit. -in pts with documented cmv infection requiring dhpg treatment, myelosuppression was not seen in those who received gm-csf and dhpg concomitantly while in contrast a severe neutropenia developped in those who received dhpg after administration and discontinuation of gm-csf (lancet, , . - pts. in our institution received gm-csf in a compassionate use for delayed enraftment or engraftment failure after autologous (abmt : ) or allogeneic bone marrow transplantation (bmt : ). the pretransplant regiment included total body irradiation (tbi) in and consisted of high dose polychemotherapy only in . interestingly pts were transplanted for acute myelocytic leukemia (aml), a disease in which the presence of receptors to gm-csf has been detected in vitro in about % of cases, pts hat nhl, and all. of the abmt, pts received marrow heavily treated in vitro by mafosfamide and marrow purged by long term marrow culture (ltc). in (aml , all , nhl ), granulopoietic recovery occured within days ( - ). this included a pt with refractory all who received ltc marrow, developped cytomegalovirus (cmv) infection and had not engraftment by day : in this pt the absolute nucleated count (anc) peaked to . /i, days later. an additional pt with aml had not engrafted by day when gm-csf was administered for days with no efficacy. infusion of back up marrow (which has never been effective in our past experience) combined with gm-csf and cyclosporine a was follwoed by sustained engraftment occuring days later. dt (aml) had a minor and transient response and failed. additional pts in the context of entgraftment failure have since received in various sequences gm-csf and cyclosporine a + back up marrow after no response to gm-csf. have recovered sufficient hemopdfesis strongly suggesting a role of cycloporine a in engraftment failure (manuscript in prepration). we conclude that gm-csf is now the first line treatment for poor engraftment and/or engraftment failure. we do not freeze any longer back up marrow in pts autografted after pretransplant regimens not containing tbi. in pts with engraftment failure post tbi, who do not respond to first line gm-csf, we suggest that the combination of back up marrow and cyclosporine a on top of gm-csf should be further evaluated. -we administered gm-csf at a dose of #g/m /day to pts with resistant nhl and bone marrow involvement after the beam myeloablative regimen; reconstitution occurred within the same delays than observed after abmt in . we propose that gm-csf may replace abmt in highly selected cases of non-hodgkin's lymphoma with progressive disease and bone marrow involvement (lancet , , ) . -we have transplanted since september nhl pts with cd purified stem cells followed by infusion of gm-csf. successful engraftment was obtained in all with recovery to . x pmn/i by day ( - ) and to x plts/l by day ( - ). the expansion of cd + cells in short term liquid culture with cytokines (including gm and g-csf) is another approach toward transplantation with total abrogation of neutropenia. overall the introduction of hemopoietic growth factors in transplant units has considerably changed the situation in several aspects. further studies will combine gm-csf and g-csf to other cytokines. dept. of hematology, bone marrow transplant unit -h pital st-antoine, paris, france alter a pre-phase of vcr . rag/@ (maximum rag) i.v. days , and pradnisolone rng/n~ p.o. days - the high-dose chemotherapy consisted of prednisolone rag/n? p.o. days - , ifosfamide days - , methotrexate , mg/m day as a hour infusion, cytosine-arabinoside , mg/m i.v. days + , and etopeside i.v. days + . etoposide has been escalated from mg/rn to rng/ nf at the present time. the dose of itostamide is currently escalated from , rag/ rlf to , mg/rtf and finally , mg/rn as a continuous hour infusion. the high-dose chemotherapy is repeated for a maximum of four times. during the prephase pg/kg fiigrastim (recombinant g-csf) are given twice daily. apheresis of apbsc is done on days - . apbsc are reinfused after the high-dose chemotherapy and fiigrastim is given at a dose of p.g/kg. with wbc rising to > , /p.i aphereses are performed repeatedly. the pre-phase for induction of pbsc was excellently tolerated and a median of we report here the effects of long-term g-csf subcutaneous administration in patients (congenital n= , cyclic n= , idiopathic n= ) treated for - years. a sustained anc response was seen in / congenital patients, in / cyclic patients, and in / idiopathic patients. the g-csf doses needed to maintain these responses ranged between and #g/kg/d. the anc responses were associated with a significant decrease in the incidence of severe infections and the need for intravenous antibiotics. g-csf has been well tolerated in the majority of patients and resulted in a dramatic improvement in the quality of life. the adverse events noted included: osteopenia (n= ), vasculitis (n= ), mesangioproliferative glomerulonephritis (n= ), and the development of mds/leukemia (n= ). these adverse events are most likely associated with the underlying disease and not caused by g-csf treatment we have evaluated recombinant human granulocyte-macrophage colonystimulating factor (rhgm-csf) (sandoz-schering/plough) as an adjunct for cop-blam in the primary treatment of high grade malignant non-hodgkin's lymphomas (nhl). patients (n = , stage ii-lv, age - years), were randomized to rhgm-csf ( #g) or placebo for days s.c. following chemotherapy. efficacy was analyzed for patients receiving at least % of study medication (n = ). the frequency of clinical relevant infection was reduced by rhgm-csf ( vs infections, vs patients, p = . ) with a cumulative probability of remaining infection free in % vs % (p = . , log rank test at days). periods of neutropenia (p _< . in / courses), days with fever ( . vs . , p = . ) and days of hospitalization for infection ( . vs . days, p = . ) were significantly reduced. complete response (cr) rates, assessed by prognostic risk patients (pts) entered an outpatient protocol designed to test the tolerance, and the clinical and biological effects of extended administration of sc low-dose il- following high dose chemotherapy with autologous bone marrow rescue (bmt). two il- regimens were used. protocol a consisted of a once daily dose administered in -day cycles of millions iu/m z sc ril- (ru kindly provided by roussel-uclaf) every other week. the pts were treated at home and the treatment was scheduled for months (i.e. cycles for months) in the absence of major disease progression or sideeffects. protocol b consisted of a once daily dose of millions iu/m sc il in days/cycles for consecutive weeks (i.e. cycles for weeks). il- was started to days following bmt. blood lymphocyte subsets and nk/lak cytotoxic activity were determined monthly. pts received regimen a and pts were given regimen b. in both regimens, inflammatory skin reactions were the main side effect, leading to interruption of treatment in case. no capillary leak was observed. flue like syndrom was occasionny observed in protocol b. hematological parameters were not adversely affected by il- . at the lowest dose levels (regimen a), long term administration of il- did not produce any changes of blood lymphocyte subsets. on the other hand, the administration of millions iu/m il- resulted in a significant increase of cd +, cd + cells and cd -cd + ceils, and nk/lak cytotoxic activity of fresh pbls. this study confirms the feasability of long-term administration of sc lowdose il following autologous abmt. a dose of millions iu/m /d resulted in detectable activation of circulating lymphocytes. further studies are needed to assess the clinical impact of prolonged low-dose il- in this clinical setting. aim: to study the incidence of infectious episodes (ie) in a single centre series of autologous bmt patients who received il- in an attempt to prevent relapse. patients. methods: il- was given as a oontinuous i.v. infusion through a hickman catheter with a portable pump: . iu/m /d for the first week and . iu/m /day thereafter during weeks. il- was started when full neutrophil engraftment was achieved and platelet counts remained stable over . platelets/mm (median: day + . range: - ).median age was years ( - ). were mate. bmt was performed for acute lymphoblastic leukemia ( ), lymphoma ( ), and myeloma ( ). results: il- planned therapy was completed in patients ( early relapse, refusal) in a median of days ( - ). median intensity dose of il- was . x iu/m /day ( . x - . x ). infectious episodes who precised admission to the hospital were observed in patients. ol these infections were microbiologically documented: % of isolations corresponded to gram negative and % to gram positive. first ie was detected at a median of days ( - ) after the starting of il- . median cumulative tl- dose until first infectious episode was x iu/m ( . x ~' - x loe). catheter were removed in of them. in our experience, low dose continuous i.v. administration ol il- is associated with a high incidence of infectious episodes. sr (sanofi recherche) is a cho-derived r-il , glycosylated on the threonine in position . its specific activity is identical to native il . dose escalation studies were performed using sr either as iv bolus or iv continuous infusion in advanced-stage cancer patients. treatment schedule consisted in three -day cycles with -day rest in between. pts received iv bolus q - hrs at dose levels ( ; ; ; millions iu/m-'/bolus) and pts received iv continuous infusion at dose levels ( . ; . ; ; ; millions iu/m /day). mtd were found to be millions iu/m q hrs/day and millions iu/m /day for bolus and continuous iv infusion respectively. toxieities were similar in nature to those described under treatment with non-glycosylated rll- . dlt were mainly related to capillary leak. pr (nhl) was obtained. a significant rise of t-cell and nk cell subsets as well as nk/lak cytotoxicity in blood was observed at day . stimulation was already maximum for the lowest dose levels. at . millions iu/mz/day, the mean number of cd + cd + cells increased from to /mm -~ on day . similarly, cd + cells increased from to /mm , and cytotoxicity of fresh pbl against k increased from % to % (e/t ratio = : ). in vivo, sr appears to exhibit effects similar to those observed with higher doses (x - fold) of non glycosylated rll . although intravesical therapy with bacillus calmette-gutrin (bcg) against superficial bladder cancer recurrences and carcinoma in situ is highly effective, its mode of action is still unclear. the bladder tumor cell lines bt-a, bt-b (grade transitional cell carcinoma), sbc , and sbc (grade transitional cell carcinoma) are nearly resistant to natural killer cell activity in vitro. we could demonstrate that these cell lines are susceptible to lymphokine-activated killer cells generated by interleukin (il)- or interferon (ifn)-% we have now investigated whether bcg itself is able to activate a lak cell-like reaction against bladder tumor cells. our results show that activation of pbmc with viable bcg is a potent way of generating cytotoxic effector cells against bladder tumor cells. in contrast, killing of the nk and lak cell-sensitive k cell line was not enhanced by bcg-induced pbmc. because of their different target cell pattern and their, compared to lak ceils, distinct way of activation these cytotoxic effector cells were termed "bcg-activated killer (bak) cells". antibodies neutralizing ifn-t activity blocked the induction of bak cell cytotoxicity, indicating that this cytokine is playing a crucial role during this process. with respect to the phenotype of bak cells, our data show that the effector cells belong to the cd +/cd § lymphocyte subset. depletion of either cd + or cd + cells from bcg-induced pbmc led to a decrease of cytotoxicity against bladder tumor cells. furthermore, positively selected cd + cells could maintain the level of cytotoxicity exerted by bcg-induced pbmc whereas the depletion of cd § cells from this population also eliminated the cytotoxic effect. a direct involvement of cd + cells or macrophages in the killing of bladder tumor cells was not observed. in patients with superficial bladder cancer lak and bak cells might play an important role in the maintenance of the relapse free state. in this report we summarize our experience with high-dose therapy and peripheral blood stem cell (pbsc) autografting in advanced malignant lymphoma. since may , patients ( male / female) were included into this study. the median age was years (range - ). patients had hodgkin's disease and non-hodgkjn's lymphoma ( low-grade / highgrade nhl). four patients received recombinant g-csf (filgrastim) ( i~g/m / day s.c.) during steady-state hematopoiesis, while in the remaining patients recombinant g-csf (filgrastim) was started hours after conventional chemotherapy. for all patients, a target quantity of . x /kg total nucleated cells (tnc) was reached. a wide interindividual range with respect to the level of circulating hematopoietic progenitor cells ( -fold for cfu-gm/ml and fold for cd + cells/id) was observed. with a median number of leukaphereses (range - ), a median of . x cfu-gm/kg bw and . x cd + celts/kg bw could be harvested, respectively. high-dose therapy consisted of either tbi ( . gy, hyper-fractionated)/cyclophosphamide ( mg/kg) or the beam-protocol. with the exception of patient who died of a respiratory distress syndrome days following autografting, transplant-related toxicity was moderate. the low toxicity is reflected by the kinetics of hematological reconstitution: (median) days for . x / pmn and days for x ~/i platelets. platelet reconstitution was closely related to the number of cd + cells reinfused. twenty-six patients are evaluable for response: patients ( %) relapsed after a median of months (range - ) posttransplant. the remaining patients are alive in remission with a median follow-up of months (range - ). in summary, recombinant g-csf (filgrastim) is highly efficient in mobilizing pbsc capable of restoring hematopoiesis after myeloablative conditioning therapy. the quantity of cd + cells harvested was inversely related to the amount of previous cytotoxic chemotherapy. therefore, high-dose therapy with stem cell support should be considered as an upfront treatment modality in poor prognosis nhl patients.department of internal medicine, university of heidelberg, heidelberg, germany. many of the in vivo effects of the haemopoietic cell growth factors may well have been anticipated based on their known ability to stimulate proliferation and development of multipotent and lineage-restricted progenitor ceils in vitro. what was not predicted from these in vitro studies, however, was the observed ability of at least some of these growth factors to mobillse large numbers of haemopoietic progenitor cells from the bone marrow into the peripheral blood. this was an added "oonus" effect of growth factors and one that is now being widely exploited in a variety of clinical situations.initially these mobilised pbpc were used, in combination with bone marrow cells, to facilitate the more rapid recovery of myeloid cells following transfer into patients receiving high dose cytotoxic therapy. but when experimental studies showed that the mobilised pbpc also contained primitive (repopulating) stem cells -this encouraged the use of pbpc alone as a source of cells for transplantation. in most of these studies however, collection of the pbpc was performed over several cycles of apheresis -and this was somewhat limiting to their widespread use.because of this, our approach has been to define the optimal growth factor regimen for mobillsation of pbpc such that apheresis is not required, i.e. to use whole blood and then to identify groups of patients who may benefit from receiving these cells either for autologous or for allogeneic marrow recenstitution. using a sensitive immunohistochemical technique, . -> . logs of breast cancer cell depletion was documented in the positively-selected fractions of marrow ( patients) and -> logs from the pbpc fractions ( patients), in whom tumor was initially detected. to date no tumor has been detected in the cd + pbpc fractions. the engraftment rates for cohorts and were significantly faster than those of the other cohorts. the preliminary data suggest that since cd + pbpcs alone are capable of restoring hematopoiesis following high-dose therapy, a marrow fraction may no longer be needed for this purpose. longer follow-up will be required to assess the ultimate therapeutic effect of the entire treatment program. the principal morbidity and mortality of high dose chemotherapy with autologous bone marrow support (abmt) relates to the infectious complications which occurs during - week aplasia until the marrow autografi recovers. progenitor cells can be mobilized into the peripheral blood compartment by hematopoietic growth factors, alone or used after chemotherapy. we describe four trials using cytokine-mobilized peripheral blood progenitor cells (pbpc). in the first trial, pbpc collected after gm-csf administration are used to augment marrow. reconstitution of tririneage marrow function occurred quickly, resulting in short hospital stays and fewer platelet transfusions. in a second study, gm-csf/chemotherapy-mobilized pbpc were used as the sole hematopoietic support during high dose chemotherapy. granulocyte and platelet reconstitution was rapid. time to hematopoietie recovery, transfusion requirements and duration of hospital stay were all significantly improved for the patients receiving pbpc compared with similar patients receiving marrow alone. however, some patients had poor platelet engraftment. two recent trials were designed to explore multiple high-dose therapy. in the third trial, pbpc with and without marrow made it feasible to deliver two sequential cycles of high dose therapy. the fourth trial utilizes pbpc in addition to cytokines to deriver four cycles of dose-intensive therapy utilizing doses of chemotherapy that could not be given with cytokine support alone. pbpc appears to make multiple course combination high dose therapy feasible, is particularly useful to support platelets, and may enhance the safety, tolerance and cost of high dose therapy. severe neutropenia and functjonal defects of neutrophils are an increasing problem in treating advanced hiv infected p. neutropenia may result from bone marrow failure due to hiv by itself, or maybe.secondary to drug toxicity (mainly zidovudine, ganciclovir, chemotherapy) or bone marrow infiltration (mycobacterial infection, neoplasms). p. with severe neutropenia are at a higher risk of developing bacterial infections. since both gm-csf and g-csf have been-successfully used in cancer to optimalize dose intensity and to prevent neutropenia and secondary infections in p. receiving myelotoxic agents, clinical trials have recently been conducted in arc and aids p. with neutropenia to determine their potential benefits and toxicity profile. our previous experience in treating p. with non hodgkin's lymphoma (nhl) with a -cycle third generation regimen (promnce-cytabom), with gm-csf given at alternate cycles, clearly demonstrated that doses of chemotherapy following the adjunction of gm-csf were significantly higher than doses given without prior gm-csf administration. gm-csf was largely well tolerated in those p., with no sign of active viral replication as measured by hiv- p antigenemia. we have also performed an open clinical trial in p. with severe neuttopenia to assess the efficacy and tolerance of gm-csf with a three weekly subcutaneous administration in p. who initially responded to a daily dose. out the enrolled p. (median duration : days) showed a rise of the absolute neutrophil count (anc) above the target value of /mm after a median period of day at mcg/kg/d. only / p. were given antiretrovirals while other concomitant drugs included mainly ganciclovir ( ) and pyrimethamine ( ). of the p. who entered the maintenance phase at weekly doses, ( %) showed a sustained increase of the anc > , while in the remaining p, a new episode of neutropenia was observed.in contrast to p. with nhl, adverse reactions were commonly observed, mostly fever ( %) and flu-like symptoms ( %). furthermore among the p. without antiretroviral therapy who were p ag negative at baseline, a detectable p antigenemia was found in p. these preliminary data on this original schedule of gm-csl = administration was effective in preserving anc levels at > in % of the responders. such an approach could enhance p.'s compliance and have a direct impact on the cost/benefit evaluation of such therapy. in addition, antiretrovirals should always be associated with gm-csf to reduce the increased risk of viral replication. attempts to further improving the curative treatment for aml have to overcome the problem of residual disease represented by leukemic cells surviving in a therapy resistant state. a novel approach aims at recruiting those cells into a sensitive state by the use of gm-csf before and together (priming) with chemotherapy. in vitro, the recruitment of leukemic blasts to colony forming cells in presence of gm-csf (blood : , ) is documented by numerous reports. given to patients with newly diagnosed aml gm-csf priming decreased the proportion of leukemic cells in go and increased cells in sensitive cycle phases within - h (blood : , ) . a similar priming with preinfusion of gm-csf for a variable period of - days before chemotherapy started resulted in significantly inferior outcome and more persistent leukemias than in historical controls suggesting protective effects of gm-csf (blood : , . in a first study we showed that gm-csf following chemotherapy in high risk aml effectively reduced both neutrophii recovery and early mortality and had no adverse impact on leukemic regrowth and remission duration (blood : (blood : , . in current randomized study in patients with newly diagnosed aml we give gm-csf from h before chemotherapy and then on to neutrophil recovery which is repeated in each of the initial treatment courses and is compared to chemotherapy alone. / years from study start and after entering patients (median age , range - years) this update in the gm-csf group and controls shows % and % cr, and persistent leukemias and a clearance of day b.m. blasts to < % in % and in %, and remission duration shows a trend in favour of the gm-csf group. in addition to recruitment, other effects of gm-csf like enhancement of ara-c cytotoxicity (leukemia : , ; ch. router et al. leukemia in press) may contribute to this strategy. thus, gm-csf appears not to antagonize antileukemic chemotherapy. whether gm-csf priming and longterm administration ultimately improves the cure rate in aml should be shown some later from the multiple course strategy used in this study.medizinische universit~itsldinika (h~imatologie/onkologie), albert-schweitzer-str. , d- mfinster in this multicenter trial was evaluated, whether rhu gm-csf given concomitant and after chemotherapy (ct) can improve the outcome of aml patients by increasing the cytotoxic effect of ct and by reducing the rate of infectious complications. induction and early consolidation therapy included cytarabine (ara-c, mg/m , day - civi), daunorubicin ( mg/m , iv, day - ,) and etoposide ( mg/m , day - , h iv infusion) with reduced dosages in the second induction and early consolidation course. late consolidation included one cycle with high-dose ara-c ( g/m , doses) and daunorubicin ( mg/m , day - ) for patients aged years and younger, whereas patients over years received a reduced dose of ara-c ( . g/m , doses). patients were randomized after the first induction course to receive either rhu gm-csf (e. coil, pg/m /day, s.c.) or placebo starting hours prior to the second induction and the subsequent courses and given throughout chemotherapy until absolute neutrophil count had recovered > /pl. eighty out of patients (median age = years) included into the study could be randomized to receive either gm-csf (n = , median age = years) or placebo (n = , median age = years). out of patients ( %) achieved a complete remission (cr). patients ( . %) were treatment failures. two patients died and in one patient the response to therapy was not evaluable. there was no statistically significant difference in cr rate between patients of the gm-csf ( %) and placebo group ( %) nor between patients aged years or less and those over years old. the proportion of relapse free survival at a median follow up of months is % in the gm-csf versus % in the placebo group (p = . ). the proportion of survival of the gm-csf group at months is % versus % in the placebo group (p = . ). gm-csf did not significantly shorten the period of critical neutropenia and prolonged the period of critical thrombocytopenia especially in patients aged over years. the overall incidence of infectious complications as well as the non-hematological toxicity was similiar in boths groups. thus gm-csf therapy is feasible in aml therapy while its influence on remission quality and survival remains still open.dept. int. med. iii, university of uim, uim/d, frg.al key: cord- - qfmo rq authors: reinholdt, j.; baxendale, h.; ekström, n.; kayhty, h.; poulsen, k.; kilian, m. title: pneumococcal iga protease activity interferes with opsonophagocytosis of streptococcus pneumoniae mediated by serotype‐specific human monoclonal iga antibodies date: - - journal: scand j immunol doi: . /j. - . . t.x sha: doc_id: cord_uid: qfmo rq bacteria‐specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody‐treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as fabα (monovalent) deprived of fcα which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody‐coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero‐steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type‐ polysaccharide‐induced phagocytosis of iga protease‐deficient type‐ pneumococci equally well in the absence as in the presence of complement. iga antibody to type‐ polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type‐ polysaccharide served as opsonin. iga antibody extracted from iga protease‐producing target bacteria was almost exclusively in the form of fabα. conversely, iga from protease‐deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody‐mediated opsonophagocytosis. besides, in these experiments, iga‐mediated opsonophagocytosis was independent of complement. the nuclear receptor heterodimers of liver x receptors (lxrs) are recently identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. lxrs and their ligands are negative regulators of macrophage inflammatory gene expression. multiple sclerosis (ms), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. sweden belongs to the countries with a high ms incidence. in italy, incidence is lower, with an exception for sardinia where the incidence is even higher than that in sweden. subjects from sardinia are ethnically more homogeneous and differ from swedes, also regarding genetic background and environment. we studied lxrs and their related molecules of blood mononuclear cells (mncs) from female patients with untreated relapsing-remitting ms from sassari, sardinia and stockholm, sweden. sex-and age-matched healthy controls (hcs) were from both areas. mrna expression was evaluated by real-time pcr. lxr-a was lower (p < . ) in ms (mean ae sem: . ae . ; n ¼ ) compared to hc ( . ae . ; n ¼ ). lxr-a was lower in ms from stockholm ( . ae . ; n ¼ ) compared to corresponding hc ( . ae . ; n ¼ ; p < . ) and compared to ms ( . ae . ; n ¼ ; p < . ) and hc ( ae . ; n ¼ ; p < . ) from sardinia. ms patients from stockholm, but not from sassari, also expressed lower (p < . ) lxr-b (À . ae . ) compared to corresponding hc (À . ae . ). ms from stockholm was associated with higher abca- ( . ae . versus . ae . ; p < . ) and higher estrogen receptor-b-cx ( . ae . versus . ae . ; p < . ) compared to corresponding hc. the hc from sassari had higher androgen receptor ( . ae . ) compared to ms from sassari ( . ae . ; p < . ), ms ( . ae . ; p < . ) and hc from stockholm ( . ae . ; p < . ). ms from sassari had lower cyclooxygenase- compared to corresponding hc ( . ae . versus . ae . ; p < . ) and lower prostaglandin-e (À . ae . ) compared to the hc ( . ae . ; p < . ) and ms ( . ae . ; p < . ) and hc from stockholm ( . ae . , p < . ). our findings identify lxrs and their related molecules as being involved in ms from stockholm but not from sassari, while sex hormone receptors seem to be involved in ms in sassari. multiple sclerosis: ifn-b induces cd + bdca -dendritic cells that produce il- and il- and have no enhanced type i interferon production y. m. huang, s. adikari, u. båve, a. sanna , & g. alm dc antigens (bdca) and investigate their ability to produce type i ifn in response to virus stimulation. we show that ifn-b induces development of cd þ dc from human blood monocytes, which coexpress bdca þ but are negative for bdca -, a specific marker for plasmacytoid dc. such ifn-b-modulated dc produce large amounts of il- and il- , but no il- p and have no enhanced ifn-b and ifn-b production. the findings indicate that ifn-bmodulated dc represent a myeloid dc subset with diminished cd c, bdca- and cd a expression, having potent th -promoting function but lacking antiviral capacity. the association of psoriasis with throat infections by streptococcus pyogenes suggests a potential antigenic target for the t cells that are known to infiltrate dermis and epidermis of psoriatic skin. streptococcal m protein shares an extensive sequence homology with human epidermal keratins. keratins (k ) and (k ) are mostly absent from uninvolved skin but are upregulated in psoriatic lesions. there is increasing evidence that cd þ t cells play an important effector role in psoriasis and m proteinprimed t cells may recognize these shared epitopes in skin via molecular mimicry. to identify candidate epitopes, peptides with sequences from k were selected on the basis of predicted binding to hla-cw and sequence similarities with m protein. matched peptides from the sequence of m protein and a set of peptides with poor predicted binding were also selected. cw þ individuals with psoriasis and cw þ healthy controls, having a family history of psoriasis, were recruited. pbmcs were incubated with the peptide antigens. t-cell activation in the cd þ , cd þ and later the skin-homing cutaneous lymphocyteassociated antigen (cla)-expressing subset of cd þ t cells was evaluated by cd expression and intracellular ifn-g accumulation using flow cytometry. we demonstrate that cw þ psoriasis patients had significant cd þ t-cell ifn-g responses to peptides from k and m protein selected on the basis of sequence homology and predicted hla-cw* binding. these responses were about times more frequent in the skin-homing cutaneous lymphocyte-associated antigen-expressing (cla þ ) subset of cd þ t cells. cd þ t cells showed only borderline responses. cd þ t cells from cw þ nonpsoriatic individuals responded to some m peptides but very rarely to k peptides, and this also applied to the cla þ cd þ subset. these findings indicate that psoriatic individuals have cd þ t cells that recognize keratin self-antigens and that epitopes shared by streptococcal m protein and human keratin may be targets for the cd þ t cells that infiltrate psoriatic skin lesions. autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly % in ra patients and a suggestive involvement in the pathogenesis. the targeted epitopes are generated by a post-translational modification catalysed by the calcium-dependent enzyme peptidyl arginine deaminase that converts the positively charged arginine to polar but uncharged citrullin. the aim of this study was to analyse the presence of citrulline in the joints at different time points of collagen-induced arthritis in da rats by immunohistochemistry and to investigate how immunogenicity and arthritogenicity was affected by citrullination of rat serum albumin (rsa) and collagen type ii (cii). our results indicate that citrulline could be detected in joints of arthritic animals, first appearance at the onset of disease and increasing as disease progressed into a chronic state. unimmunized animals or time points before clinical signs of arthritis were negative. by morphology, we state that some infiltrating macrophages as well as the cartilage surface stain positive for citrulline, while the major source of citrullinated proteins appears to be fibrin depositions. a specific cit-rsa t-cell response was observed in animals challenged by citrullinated rsa, no response was recorded when rsa was used as a stimulus. the igg analysis reveals not only a response towards the modified protein but also cross-reactivity to native rsa. no t-cell or b-cell response was noted in animals injected with unmodified rsa. cit-cii induced a disease with higher incidence and earlier onset than did the native counterpart. we conclude that, in contrast to the human disease, citrulline does not seem to appear before clinical signs. as inflammation proceeds, citrulline is detected specifically in the joints. all other organs investigated were negative. we also conclude that citrullination of a protein can break tolerance and increase its arthritogenic properties. ectopic germinal centers (gcs) can be detected in the salivary glands of approximately / of patients with sjögren's syndrome (ss) and appear in both primary and secondary ss. previously, ectopic gc have been associated with increased local autoantibody production. the aim of this study was to determine whether gc in primary sjögren's syndrome (pss) defines a distinct seroimmunological phenotype. retrospectively, a material of haematoxylin and eosin-stained paraffin-embedded tissue sections of minor salivary gland tissue from patients with pss was morphologically screened for the presence of ectopic gc. gc-like lesions were detected in / ( %) of the pss patients. seventy-two pss patients lacking these structures (gc-) were randomly selected for comparison. focus score was significantly increased in the gc þ patients compared to the gcpatients (p ¼ . ). in the gc þ group, . % of the patients presented with anti-ro/ssa compared to . % in the gcgroup. anti-la/ssb was detected in . % of the gc þ patients compared to . % of the gcpatients. sixty-one percentage of gc þ patients presented with increased levels of igg, a nonsignificant difference when compared to . % in the gcpatients (p ¼ . ). levels of rf, ana, ena, igm and iga were similar in both patient groups, as were esr and crp. in conclusion, patients with ectopic gc have a higher focus score and more often present with autoantibodies and increased levels of igg compared to pss patients with regular focal infiltration (gc -). our findings may indicate a certain seroimmunological phenotype and warrant for further prospective studies. association between mannose-binding lectin and vascular complications in type diabetes complement activation and inflammation have been suggested in the pathogenesis of diabetic vascular lesions. we investigated serum mannose-binding lectin (mbl) levels and polymorphisms in the mbl gene in type diabetic (t dm) patients with and without diabetic nephropathy and associated macrovascular complications. polymorphisms in the mbl gene and serum mbl levels were determined in t dm patients with overt nephropathy and t dm patients with persistent normoalbuminuria matched for age, sex and duration of diabetes as well as in healthy control subjects. the frequencies of high and low expression mbl genotypes were similar in patients with t dm and healthy controls. high mbl genotypes were significantly more frequent in diabetic patients with nephropathy than in the normoalbuminuric group, and the risk of having nephropathy, given a high mbl genotype, assessed by odds ratio was . ( . - . ), p ¼ . . median serum mbl concentrations were significantly higher in patients with nephropathy than in patients with normoalbuminuria [ mg/l (iqr - mg/l) versus mg/l (iqr - ), p ¼ . ], and even when comparing patients with identical genotypes, serum mbl levels were higher in the nephropathy group than in the normoalbuminuric group. patients with a history of cardiovascular disease had significantly elevated mbl levels independently of nephropathy status [ mg/l (iqr - mg/l) versus mg/l (iqr - mg/l), p ¼ . ]. the differences in mbl levels between patients with and without vascular complications were driven primarily by pronounced differences among carriers of high mbl genotypes (p < . ). our findings suggest that mbl may be involved in the pathogenesis of microvascular and macrovascular complications in type diabetes and that determination of mbl status might be used to identify patients at increased risk of developing these complications. neuroimmunology unit, center for molecular medicine, karolinska institutet, stockholm, sweden. e-mail: judit.wefer@cmm.ki.se dna vaccine coding for the encephalitogenic peptide mog - protects lew. av from subsequent development of experimental autoimmune encephalomyelitis (eae). protection is associated with a type immune response and is dependent on the presence of cpg dna motifs. the mechanisms underlying the observed reduction of eae development in protected rats have not been fully clarified. we investigated immunological characteristics of lymphocytes after dna vaccinaton and subsequent eae induction. we confirm that protection was not associated with suppression of t cells, as transcription of the novel molecule rat t-cell immunoglobulin-and mucindomain-containing molecule (tim- ), reported to be exclusively expressed on differentiated t cells, was not altered by dna vaccination. we did not note any clonal deletion upon tolerization, but detected an antigen-specific lymphocyte population upregulating ifng upon recall stimulation weeks after protective dna vaccination. in protected rats, we observed ( ) no alterations in antigenspecific th or th responses, ( ) reduced mhc ii expression on splenocytes early after eae induction, ( ) antigen-specific upregulation of ifnb upon recall stimulation and ( ) reduced il- rb on lymphocytes. we thus demonstrate an association of the protective effect of dna vaccination with expression of ifnb. we are currently investigating the cellular mechanisms behind this ifnb-mediated protection. multiple sclerosis (ms) is an autoimmune condition characterized by degeneration of nerve fibre myelin sheets. a candidate autoantigen, myelin basic protein (mbp), has especially attracted attention. the presence of anti-mbp antibodies is a predictor of definite ms, but their role in the pathogenesis remains obscure. t cells have long been known to play a pivotal role in the pathogenesis of ms. recently, an important role for b cells as autoantigen-presenting cells has been demonstrated in other autoimmune diseases, including rheumatoid arthritis and diabetes. the uptake of mbp by b cells and the presentation of mbp-derive peptides to t helper (th) cells by b cells may be promoted by the formation of complement (c) activating immune complexes (ics) between mbp and natural autoantibodies in healthy individuals and disease-associated anti-mbp antibodies in ms patients, respectively. we have investigated the formation of mbp-containing ic, the binding of mbp to b cells, the mbp-elicited induction of th-cell and b-cell proliferation and the cytokine production in peripheral blood mononuclear cells (pbmcs) from healthy donors grown in the presence of intact or c-inactivated serum from healthy donors or patients with ms. while mbp did not induce measurable proliferation of b cells nor cd þ t cells, we observed the production of tnf-a, ifn-g and il- by pbmc in response to incubation with mbp in the presence of sera from healthy controls as well as sera from ms patients. by contrast, no production of il- , il- and il- was detected. we are currently investigating the capability of ms sera to promote the formation of mbp-containing ic and thereby enhance the cytokine responses, by virtue of elevated anti-mbp contents. the phagolysosomally localized acid sphingomyelinase (asmase) activated by proinflammatory cytokines such as tnf and ifn-g generates the signalling molecule ceramide which in turn results in the activation of proteases like cathepsin d. these characteristics of asmase suggest a possible role of this molecule in the phagocytotic uptake and phagosomal degradation processes of antigens or in antigen presentation. we show here that asmase -/mice fail to eliminate the noncytopathic lymphocytic choriomeningitis (lcm) virus as rapidly as littermate wildtype mice. investigation of the immune response revealed a reduced expansion of cd þ t cells. the secretion of ifn-g in response to contact with target cells as well as the cytolytic activity of virus-specific cd þ t cells was severely impaired. additionally, both phases of the lcm virus-specific dth response, mediated by cd þ and cd þ t cells consecutively, were diminished in asmase -/mice. however, the secondary memory response of virus-specific ctl was not altered, and the abstracts ................................................................................................................................................................................................. virus was effectively controlled for at least months by asmase -/mice. in conclusion, the results of this study suggest an involvement of the asmase in the activation, expansion or maturation of virus-specific cd þ t cells during the acute infection of mice with the lcm virus. novel markers for alternative activation of macrophages: macrophage galactose-type c-type lectins and in parallel with the th /th dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in, for example cytokine environment and pathological conditions. while the best-studied, classically activated macrophage is induced by type i stimuli such as ifn-g, a type ii cytokine environment antagonizes the classical activation of macrophages and is capable of alternatively activating macrophages. however, molecular markers associated with these type ii cytokine-dependent, alternatively activated macrophages remain scarce. besides the earlier documented markers macrophage mannose receptor and arginase , we recently demonstrated that murine alternatively activated macrophages are characterized by increased expression of fizz and ym. we now report that expression of the two members of the mouse macrophage galactose-type c-type lectin gene family, termed mmgl and mmgl , is induced in diverse populations of alternatively activated macrophages, including peritoneal macrophages elicited during infection with the protozoan trypanosoma brucei or the helminth taenia crassiceps, and alveolar macrophages elicited in a mouse model of allergic asthma. we also demonstrate that, in vitro, interleukin- and interleukin- upregulate mmgl and mmgl expression and that, in vivo, induction of mmgl and mmgl is dependent on interleukin- receptor signalling. moreover, we show that regulation of mgl expression is similar in human monocytes and monocyte-derived macrophages. hence, macrophage galactose-type c-type lectins represent novel markers for both murine and human alternatively activated macrophages; thus, paving the way for further characterization of the phenotype of macrophages occurring in th conditions. background: human parvovirus b (b ) is a ubiquitous pathogen, normally causing a mild self-limiting disease, but also capable of causing both significant pathology and long-term persistence. the small size and stability of the virus makes it suitable for mapping of the full breath and the kinetics of the cellular immune responses following acute viral infection. methods: five patients with acute primary b infection were included in the study and followed consecutively for up to weeks. cellular immune responses were mapped by ifng enzyme-linked immunospot to overlapping peptides spanning the whole b genome. results: in all five acutely infected patients, we were able to monitor the kinetics of a strong specific cellular immune reaction. responses peaked at levels of - sfc/ million pbmcs, roughly corresponding to . - . % b specific cd þ cells circulating in peripheral blood at - weeks post-infection. the responses in individual patients were directed to three or four different peptide pools, and the specificity was confined to the same cd epitopes present in the pools throughout the follow-up period. the majority of responses were directed to the virus nonstructural protein, only two patients showed any response to the capsid proteins, elicited by the same epitope in both cases. conclusion: the cellular immune responses to acute b infection are surprisingly narrow in distribution and remain at high levels for up to weeks post-infection. the initial epitope specificity is maintained, and the majority of responses target the virus nonstructural protein, which is not included in vaccine preparations, evaluated against the infection. the relationship between malnutrition and malaria is controversial. on one hand, malaria may cause malnutrition, while on the other, malnutrition itself may modulate susceptibility to the disease. we investigated the association between plasmodium falciparum malaria and malnutrition in a cohort of children living on the coast of kenya. the study involved longitudinal follow-up for clinical malaria episodes and anthropometric measurements at four cross-sectional surveys. we used poisson regression analysis to investigate the association between malaria and nutritional status. compared to baseline (children with a waz or haz score of !À ), the crude incidence rate ratios (irrs) for malaria in children with low haz or waz scores (<À ) during the period prior to assessment were . ( % ci . - . ; ¼ . ) and . ( . - . ; . ), respectively, suggesting no association between malaria and the subsequent development of pem. however, we found that age was acting as an effect modifier in the association between malaria and malnutrition. the irr for malaria in children - years old who were subsequently characterized as wasted was . ( . - . ; p ¼ . ), and a significant overall relationship between malaria and low-haz was found on regression analysis when adjusting for the interaction with age (irr . ; . - . ; p < . ). although children living on the coast of kenya continue to suffer clinical episodes of uncomplicated malaria throughout their first decade, the association between malaria and malnutrition appears to be limited to the first years of life. a. astrinidou-vakaloudi, s. xytsas, i. diamanti, h. ioannidis & p. pangidis microbiology department of general hospital of thessaloniki 'agios pavlos', thessaloniki, greece, and nefrology, nd ika hospital of thessaloniki, thessaloniki, greece. e-mail: stasa@hol.gr aim: renal dysfunction may influence the colonization of gastric mucosa by urea-splitting bacteria such as helicobacter pylori, by increasing urea concentrations in the gastric juice. our aim was to investigate the prevalence of h. pylori in patients with end-stage renal disease (esrd), receiving long-term haemodialysis treatment. methods: this study included sera from patients with esrd ( male and female) undergoing periodic haemodialysis; mean time of treatment was . months. using elisa technique, we investigated the presence of igg and iga antibodies against h. pylori as well as igg caga (antibodies specific for caga(þ) strains of h. pylori). sera from healthy blood donors were used as a control group. results: h. pylori igg antibodies were detected in out of ( %) patients in the dialysis group, while / ( . %) tested positive for iga. igg caga antibodies were present in out of ( . %). prevalence of h. pylori igg, iga and caga igg antibodies in the control group was , and %, respectively. conclusions: although international data suggest that prevalence of h. pylori infection is the same in esrd patients as in healthy individuals, in our study that seems not to be the case. the higher blood and gastric juice urea levels may be a risk factor (among many others), but more studies are required in order to understand the relation of h. pylori infection in this group of patients. flanders interuniversity institute for biotechnology, department of molecular and cellular interactions, free university of brussels, brussels, and pasteur institute of brussels, mycobacterial immunology, brussels, belgium. e-mail: tgartner@vub.ac.be immunity against tuberculosis (tb), caused by mycobacterium tuberculosis, depends largely on activation and maintenance of strong cell-mediated immune responses involving both cd þ and cd þ t cells and the ability to respond with th -type cytokines, particularly ifn-g. recent studies suggested that bcg, the only licensed vaccine against m. tuberculosis, may fail to induce t-cell responses in the lung mucosa and may therefore not protect against pulmonary tb. a decrease in tb mortality may be achieved by enhancing immunity in the lung. the present study evaluated the induction of antigen-specific immunity in the lung by intranasal (i.n.) delivery of the lipoprotein i (opri) from pseudomonas aeruginosa. opri has shown to be a toll-like receptor / agonist that, when given subcutaneously, induces type- immune responses against heterologous antigens. here, a fusion of opri to ag a of mtb (opri-ag a) was used as a subunit vaccine in homologous prime-boost immunizations. in addition, opri-ag a was combined with an ag a-encoding dna vaccine (ag a dna) or with bcg in heterologous prime-boost vaccinations. intranasal and parenteral delivery with opri-ag a elicited comparable t-cell responses in the spleen; in addition, i.n. delivery elicited specific t-cell responses in the lung lymph nodes (llns). intramuscular delivery of ag a dna induced significant systemic th immune responses. intranasal boosting with opri-ag a enhanced this response and in addition induced an antigen-specific ifn-g response in lln. opri may therefore be an efficient adjuvant for mucosal boosting. we continue to evaluate the protection induced by opri-based prime-boost vaccinations against pulmonary tb. results on the immunogenicity and protection against intravenous mtb h rv infection will be presented. toll-like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress-associated molecules. tlr-ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus-induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus-encoded inhibitor of tlr-signalling a r or dominant-negative myd totally inhibited hsv-induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv-induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr-dependent and -independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. - -oligoadenylate synthetases are interferon-induced, double-stranded rna-activated antiviral enzymes which are the only proteins known to catalyse -specific nucleotidyl transfer. this first crystal structure of a - oligoadenylate synthetase reveals a structural conservation with the -specific poly(a) polymerase that, coupled with structure-guided mutagenesis, supports a conserved catalytic mechanism for the -and -specific nucleotidyl transferases. comparison with structures of other superfamily members indicates that the donor substrates are bound by conserved active site features while the acceptor substrates are oriented by nonconserved regions. the - oligoadenylate synthetases are activated by viral doublestranded rna in infected cells and initiate a cellular response by synthesizing - -oligoadenylates, that in turn activate rnase l. this crystal structure suggests that activation involves a domain-domain shift and identifies a putative dsrna activation site that is probed by mutagenesis. we demonstrated that this site is required both for the binding of dsrna and for the subsequent activation of oas. this rna-binding site is different from known rna-binding site; rather than forming a defined three-dimensional domain, it is located at the interface of the two major domains in oas. this novel architecture ensures that the dsrna helix can make simultaneously contact with both domains of oas and ensure the subsequent structural rearrangement leading to the activation of oas. our work provides structural insight into cellular recognition of double-stranded rna of viral origin and identifies a novel rna-binding motif. bacteria-specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody-treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as faba (monovalent) deprived of fca which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody-coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero-steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type- polysaccharide-induced phagocytosis of iga protease-deficient type- pneumococci equally well in the absence as in the presence of complement. iga antibody to type- polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type- polysaccharide served as opsonin. iga antibody extracted from iga protease-producing target bacteria was almost exclusively in the form of faba. conversely, iga from protease-deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody-mediated opsonophagocytosis. besides, in these experiments, iga-mediated opsonophagocytosis was independent of complement. vitamins e and c have been found to increase the cellular and humeral immunity of pigs. vitamin e deficiency has also been found to predispose pigs to different diseases, e. coli infection is one among them. after weaning, the vitamin e status of pigs often decreases to a critical low level. in this experiment, we studied whether vitamin c supplementation would be a possible feeding strategy to optimize the immune status of weaners. the interaction between vitamin e and c is interesting due to the reported sparing action on vitamin e or synergism between these to vitamins. piglets were weaned at day of age from sows fed increasing dietary vitamin e during lactation, and piglets were during the following weeks fed either a control diet or this diet supplemented with mg stay-c per kg. blood sampling was obtained weekly from day and until day of age. on the same days, one piglet per dietary treatment was killed and alveolar macrophages (am) were harvested. vitamin c supplementation increased the concentration of igm in serum of piglets throughout the weaning period. although the vitamin e concentration in am decreased with increasing age of the piglets, the concentration was numerically higher in piglets of sows fed the high dietary level of vitamin e. however, vitamin c supplementation tended to increase the total am concentration of vitamin e after weaning and increased the proportion of the biologically most active isomer of vitamin e [rrr-(a-tocopherol)] in the am. the eicosanoid synthesis by am was not influenced by the vitamin c supplementation, but the synthesis of leukotriene b was decreased weeks after weaning compared to other days of am harvesting. in conclusion, dietary vitamin c supplementation improved the immune responses of piglets after weaning. a whole blood stimulation assay with escherichia coli (o :b ) endotoxin was established to measure the capacity of dairy cows to produce the proinflammatory cytokine tumour necrosis factor-a (tnf-a) ex vivo. initially, a time-and dose-dependent study was carried out to find the optimal stimulation conditions for the tnf-a response. the tnf-a response peaked between and h at . c. a dose in the range of - g of e. coli lipopolysaccharide (lps)/ml whole blood was found to give the maximum tnf-a response. thirty-eight danish-holstein dairy cows were investigated for their tnf-a responsiveness ex vivo in the periparturient period. heparin-stabilized blood samples were collected seven times over a period of months (weeks À , À , , , , and around calving) and stimulated with g/ml of e. coli lps. indeed, fluctuations in the tnf-a responsiveness occurred over time. moreover, the mean tnf-a responsiveness of cows was found to be significantly increased (p < . ) in the weeks close to calving. however, in the more stabile physiological periods, some cows had a consistently low tnf-a response, whereas others had high a tnf-a response. we are currently investigating whether high and low tnf-a responders to e. coli lps also exist in dairy cows in vivo. moreover, the importance of tnf-a responsiveness ex vivo to dairy cows' susceptibility and clinical response to experimental e. coli infections in the udder is being investigated. coelomic cytolytic factor (ccf) is a kda invertebrate pattern recognition molecule isolated from the coelomic fluid of the earthworm eisenia foetida (oligochaeta, annelida). ccf displays a number of similarities with the mammalian cytokine tumour necrosis factor-a (tnfa) as a result of a shared n,n -diacetylchitobiose lectin-like domain. however, these similarities are solely functional and are not based on any (dna or amino acid) sequence homology, thus suggesting a form of convergent evolution. in particular, the lectin-like domain of tnf-a has been shown to induce membrane depolarization in various mammalian cell types, through interactions with endogenous amiloride-sensitive ion channels. this nonreceptor-mediated activity of tnf-a has been reported to be involved in the resorption of oedema. likewise, the lectin-like domain of ccf also induces membrane depolarization in mammalian cells. here, we show that ccf appears to be able to induce oedema resorption in an alveolar epithelial cell line through its lectin-like domain. this lectin-like domain of ccf interacts (directly or indirectly) with endogenous sodium and/or chloride channels, and not potassium channels, on mammalian cells. additionally, we suggest that the jnk/sapk and erk / pathways are involved in ccf-induced macrophage activation. these results further establish the functional analogy between an invertebrate pattern recognition molecule and a mammalian cytokine and, from a more applied point of view, suggest the possibility of utilizing ccf in the treatment of oedema. release of svegf and svegfr from white blood cells and platelets during surgery and stimulation with bacterial antigens introduction: the influence of surgery on release of soluble vascular endothelial growth factor (svegf) and the soluble vascular endothelial growth factor inhibitory receptor (svegfr ) is unknown. we studied the effect of major and minor surgery on potential variations in svegf and svegfr concentrations in vivo and on bacterial antigen-induced release of svegf and svegfr from whole blood in vitro. methods: sixty-one patients with abdominal diseases undergoing five different surgical procedures were included. blood samples were drawn from anaesthetized patients before and after the operation. white blood cells and platelets were counted, and plasma svegf and svegfr was determined by an elisa method. whole blood from each blood sample was stimulated in vitro with bacteria-derived antigens (lps or protein-a) and svegf and svegfr levels were subsequently determined in the supernatants. stimulation with isotonic saline served as control assay. neither svegf or svegfr in plasma changed during surgery. in vitro stimulation of blood samples with bacteria-derived antigens resulted in a significant increase in svegf (p < . ) and a less pronounced but still significant increase in svegfr . release of svegf due to stimulation was significantly higher after the operation (nonsignificant), whereas svegfr release remained largely unchanged after surgery. correlation between bacterial antigen-induced release of svegf and neutrophile cell count was highly significant (p < . ). there was no correlation between svegf and platelet cell count, and bacterial antigen-induced svegfr release did not correlate with counts of neutrophils and platelets. conclusions: plasma svegf and svegfr concentrations did not change during surgery. in vitro bacterial stimulation led to increased release of svegf and svegfr , which was not significantly amplified during surgery and which may be related to number of circulating neutrophils. natural killer cell functions and subsets after in vitro stimulation with il- and il- , with special emphasis on intracellular ifn-g and nk-cell cytotoxicity r. nyboe, , t. rix, , j. krog, , e. tønnesen & m. hokland department of anaesthesiology and intensive care, aarhus university hospital, and institute of medical microbiology, and immunology, university of aarhus, aarhus, denmark. e-mail: rnsr@studmed.au.dk materials and methods: isolated cryopreserved human peripheral blood mononuclear cells (pbmcs) were stimulated with il- and il- . this stimulation has previously been shown to activate nk cells. cell cytotoxicity was measured by flow cytometry after incubation with k cells. this method was compared to the current standard cr release assay. cells were treated with bfa to accumulate ifn-g, stained for surface markers, permeabilized and stained for intracellular ifn-g. flow cytometry was then performed to measure intracellular ifn-g production in pbmc, especially in nk cells. results: we have demonstrated that stimulation with il- and il- is effective in increasing the number of ifn-gpositive cells. there is a distinct difference between the cd -cd dim and the cd -cd bright subsets, with a much greater proportion of ifn-g-positive cells in the cd -cd bright subset. the effects of stimulation with il- and il- on cytotoxicity will be presented, as will the relation between ifn-g production and cytotoxicity. in addition, we will present results of these assays applied to porcine cells. discussion: in combination, these tests will address nk cell function by combining cytotoxicity with ifn-g production in nk cell subsets. the results will demonstrate whether this could serve as a useful tool in describing nkcell function, which could be of value in clinical and experimental settings. culture of regulatory t-cell lines from bronchial mucosa t lymphocytes play a major role in many immune responses. in the last decade, special focus has been on the function of th and th effector cells. now the importance of regulatory cd þ cd þ t cells in maintenance of the immunological homeostasis emerges. sarcoidosis is a multisystem granulomatous disorder often affecting the lungs. the typical sarcoid granulomas consists of epitheloid cells, macrophages and lymphocytes, mainly cd þ t cells of th phenotype. we have cultured t cells from bronchial biopsies of patients with sarcoidosis as well as from controls in high levels of interleukin (il- ) and il- and demonstrate spontaneously arising cd þ cd þ populations and high concentrations of il- in these cultures. the main difference between cultures of sarcoid origin compared to controls is a very much higher concentration of the inflammatory cytokines il- and tnf-a in cultures of sarcoid origin. the effects of hyperbaric exposure on human peripheral blood mononuclear cells, with special emphasis on natural killer cell cytotoxicity and subsets materials and methods: as an experimental physiological stress model, we examined the effects of hyperbaric exposure on peripheral blood mononuclear cells (pbmcs) obtained from venous blood drawn from eight divers during a simulated heliox saturation dive. eight persons working in normobar atmosphere outside the pressurized chamber served as control donors. the spontaneous cytotoxicity of the pbmcs was estimated in a h cr-release assay using k as nk-sensitive target cells. the pbmcs were characterized, using -colour flow cytometry, with special emphasis on the nk-cell subsets. the data were statistically analysed using a multivariate regression model (stata . ). p values < . was considered statistically significant. results: the estimated cytotoxicity increased significantly in both the group of divers and control donors during the dive (pdivers < . and pcontrols < . ). although the cytotoxicity increased relatively more (p < . ) in the group of divers compared to the group of control donors between day and . discussion: the increased cytotoxicity of pbmc estimated in the group of divers indicate that parts of the cellular immune system are affected during the extreme physiological conditions induced during the initial phase of the presented experimental hyperbaric setup. the increase in cytotoxicity observed in the group of control donors could hypothetically reflect the stress level in persons working outside the pressurized chamber during the dive. the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin- (il- ), il- and transforming growth factor (tgf)-b are important regulators of chronic inflammatory disease, where cutaneous lymphocyteassociated antigen (cla) and ae integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue-specific homing but may help to retain t cells within epithelial layers. we have previously shown that il- alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd þ but not cd þ t cells. while il- increased superantigen-stimulated expression of cla, this cytokine strongly inhibited the cd expres-sion, and a combination of il- and tgf-b completely abrogated the induced cd expression. conversely, il- suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th -mediated inflammatory responses, il- may also inhibit the migration of cd þ t cells into the skin while il- promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il- and il- , and the balance between these cytokines could influence the t-cell migration of inflammatory cells into epithelial tissues. during contact sensitivity reaction, immune cells proliferate. in order to study the histological picture of these proliferation phases, we used a mouse model of contact sensitivity in the oral mucosa and on skin. we also used bromodeoxyuridin (brdu, an analogue to thymidin) that is incorporated into the nucleus during cell replication. the hapten oxazolone (oxa) was used to sensitize and elicit the oral mucosa and/or the ear skin. mice were killed at various times after elicitation, and unsensitized animals were also exposed to the hapten as controls. brdu ( mg/ kg animal) was injected i.p. h before the kill. specimens from the oral mucosa, ear skin and submandibular and auricular lymph nodes were cut and fixed in % paraformaldehyde. they were then treated with acid and biotinylated anti-brdu antibody and developed using abc-kit and dab. the analyses were performed using a leica light microscope and the computer program analysis. in the oral mucosa, the frequency of proliferating cells were increasing during the observation period, - h after elicitation, regardless of site of sensitization. the proliferating cells were found mainly in the basal cell layer of the epithelium. similar patterns were found in ear skin. the regional lymph nodes demonstrated a few scattered proliferating cells h after elicitation. after h, these cells were found frequently in the whole lymph node. control animals exhibited considerable less proliferating cells at all times. we conclude that most proliferating cells were found h after elicitation locally at the hapten-exposed sites (the oral mucosa or the ear skin) as well as in the regional lymph nodes. the endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective anti-inflammatory effects. adenosine acts via four adenosine receptors of which the a a receptor is the predominant form in t cells. adenosine levels are elevated in asthmatic lung, and adenosine can directly induce mast cell degranulation and bronchoconstriction in these patients. instead, the role of anti-inflammatory mechanisms of adenosine on t cells in asthma is unclear. aim: to study the a a receptor expression in peripheral blood cd þ t cells in asthmatic and healthy individuals using flow cytometric and quantitative real-time pcr methods. results: unstimulated cd þ cells of asthmatic patients expressed significantly lower levels (p < . ) of a a receptor in protein level (mean percentage of cells positive ae sem: . ae . , n ¼ ) compared to healthy individuals ( . % ae . , n ¼ ). double staining for cd expression showed that stimulation of cd þ cells decreased a a expression in both groups but indicated that the detected lower levels of a a in unstimulated cells of asthmatics was not due to preactivation in these patients. surprisingly, a a mrna expression in unstimulated cd þ cells was significantly higher (p < . ) in asthmatics (n ¼ ) compared to healthy controls (n ¼ ). the expression did not correlate with serum total ige levels. conclusions: asthmatic individuals express less a a adenosine receptor on their peripheral cd þ t cells. the higher mrna levels instead may point to a negative feedback regulation in the receptor expression. the role of possibly decreased adenosine-mediated anti-inflammatory effects in asthma pathogenesis require further studies on this t-cell mediated disease. the chronic inflammatory skin disease atopic eczema (ae) affects almost % of the population in many countries today. the pathogenesis of ae is not fully understood. a combination of genetic predisposition and environmental factors like microorganisms seems to contribute to the symptoms. the yeast malassezia sympodialis is part of our normal skin micro flora but can act as an allergen and elicit specific ige and t-cell reactivity in patients with ae. recently, we identified a novel major m. sympodialis allergen, designated mala s ( . kda), with sequence similarity to the mitochondrial enzyme manganese superoxide dismutase (mnsod). interestingly, mala s has a high degree of homology to human mnsod. the aim of this study was to examine the effects of recombinant mala s on antigen-presenting dendritic cells. monocytederived dendritic cells (mddcs) from healthy blood donors were cultured with or without mala s for different time periods. it was found that the maturation marker cd and the costimulatory molecules cd and cd were upregulated on the mddcs exposed to mala s for h, as demonstrated by flow cytometry. furthermore, coculture of mddcs with mala s for h induced an increased production of the inflammatory cytokines il- ( -fold), tnf-a ( -fold) and il- (sixfold), as detected by the cytometric bead array (cba) analysis. our results suggest that mala s affects the immune response through dc maturation and production of inflammatory cytokines. the potential cross-reactivity with human mnsod needs to be explored and the exact role of mala s in the pathogenesis of ae assessed in clinical studies involving skin prick and atopy patch tests. allergen-specific immunotherapy (sit) is commonly conducted with allergen extracts adsorbed to aluminium hydroxide (alum). drawbacks linked to the use of alum, such as the formation of granuloma at the site of injection, have led to suggestions of novel allergen carriers. an alternative carrier is mm carbohydrate-based particles (cbps). in mouse, allergen-coupled cbps have been demonstrated to skew the allergen-specific immune response towards a th -like activity (grönlund et al. immunology, ) . we here coupled the recombinant major cat allergen fel d to cbps (cbp-fel d ) by cyanogen-bromide activation, resulting in covalent binding. the effect of cbp-fel d on monocyte-derived dendritic cells (mddcs) from healthy human blood donors was studied. we found that the majority of the cd a þ mddcs were capable of taking up fitc-labelled cbp-fel d , as demonstrated by flow cytometry and confocal laser scanning microscopy. furthermore, incubation with cbp-fel d resulted in an upregulation of the costimulatory molecule cd on the mddcs, which was not observed with fel d or cbps alone. finally, cbp-fel d induced a fivefold increase in the release of the pro-inflammatory cytokine tumour necrosis factor (tnf)-a and a fourfold increase in the release of the chemokine interleukin- from mddcs. taken together, the effects cbps possess make them interesting as novel allergen carriers for sit. the cysteine protease der p from dust mite of the genus dermatophagoides pteronyssinus is a major type i allergen. about % of house dust mite (hdm) allergic individuals are reactive to this protease in standard assays for detection of ige. a curative treatment for atopic allergy is immunotherapy (it) with hdm extracts which are complex mixtures occasionally resulting in anaphylactic reactions. novozymes focuses on developing a recombinant variant of der p which exhibit lowered risk of ige-mediated allergic reactions, while maintaining its ability to trigger proper th-cell responses. this may provide a safer alternative for specific it of hdm allergy. a secreted recombinant form of pro-der p expressed by saccharamyces cerevisiae was obtained by fusion of the pro-enzyme to a fungal signal peptide. the n-glycosylation site of der p was mutated resulting in a deglycosylated pro-enzyme with a molecular mass of kda. protein purification procedure was developed to obtain nearly pure der p protein followed by determination of concentration by active-site-titration with the cysteine protease inhibitor e . the deglycosylated recombinant pro-der p revealed immunologic similarity to the native der p molecule when compared in basophile histamine release, ige-binding assays and t-cell proliferation assays. by in silico epitope mapping of a modelled -dimensional structure of der p , five putative igg and ige epitopes were predicted. by protein engineering, the predicted epitopes were removed one by one in der p and screening for hypoallergenic variants was performed. combining inhaled long-acting b- agonist (laba) and inhaled corticosteroid (ics) seems to offer asthma control at a lower dose of ics than achieved by ics alone. fine mapping of t-cell surface markers by flow cytometry offers a detailed status of the individual's inflammatory response. the frequency of mt (cd þ cd ra -cd l þ cd adim) and mt (cd þ cd ra -cd l -cd abright) cells in peripheral blood, and their ratio, has been shown to differ predictably in atopics and patients with leprosy, where mt correlates with a th phenotype and mt with a th phenotype. stable asthmatics, requiring fluticasone propionate (fp) - mg daily or equivalent, were randomized to receive, double-blinded, either seretide [salmeterol and fluticasone propionate (sfc, n ¼ )] mg/ mg bd or fp mg bd (n ¼ ). if asthma was controlled based on lung function and symptoms at clinic visits every weeks, ics dose was tapered until asthma exacerbated or mg was reached. the frequency and ratio of mt and mt t cells of the patients was monitored at week intervals. as treatment tapered, the frequency of mt cells decreased (p ¼ from first to final visit), whereas that of mt cells increased. the ratio of mt /mt decreased (p ¼ from first to final visit). in patients receiving laba þ ics, the fall in mt /mt ratio appeared to be more pronounced than in patients receiving ics alone. thus, the mt phenotype may be associated with stable asthma, whereas an imminent exacerbation may associate with an increase in the mt phenotype. laba may allow for a greater effect of fp on the mt ratio. activation of complement pathways, leading to production of c a and c a anaphylatoxins, has been postulated in the pathogenesis of asthma and allergic airway inflammation. the present study was undertaken to investigate the role of mannan-binding lectin (mbl), an initiator of the lectin pathway of complement, in asthma and allergic rhinitis. mbl levels and mbl-induced complement activity were determined in patients of bronchial asthma with allergic rhinitis and unrelated, age-matched controls of indian origin. mbl levels and activity were correlated with percent eosinophilia and percent predicted fev values of the patients. association of single nucleotide polymorphisms (snps) in exon and intron of the mbl with the disease, clinical markers, mbl levels and mbl-induced complement activity was analysed using standard statistical tools. significantly higher mbl levels and activity were observed in patients of bronchial asthma with allergic rhinitis as compared to the controls. we identified five snps, of which two, a g in exon and g a in intron of the mbl, were novel. snp g a was significantly associated with the disease (p ¼ . , or ¼ . , % ci: . < or < . ). individuals with 'a' allele at position showed increased mbl levels, activity and disease severity. our results suggest that 'a' allele at position leading to high mbl levels and complement activity may be contributing to the severity of bronchial asthma and allergic airway inflammation. serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid-encoded, surface-exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h-binding proteins of approximately - kda has been described. the ospe-related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe-related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h-binding regions of ospe-related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c-terminal regions of both human and mouse factor h (scrs - ) specifically bind to ospe-related lipoproteins. we also found fhr- , whose c-terminal scrs - are homologous to scrs - of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i-v) in ospe that could directly interact with factor h. deleting the c-terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c-termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c-terminal-binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h-binding regions were mutated to alanines, we observed that lysines in the factor h-binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe-related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c-termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h-binding proteins may account for their susceptibility to serum lysis. role of yada, ail and lipopolysaccharide in serum resistance of yersinia enterocolitica serotype o: mannan-binding lectin (mbl), l-ficolin and h-ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l-ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type- , - , - , - and - ). h-ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h-ficolin initiated activation of complement factor c , whereas l-ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . mg of mbl/ml, . mg of l-ficolin/ml and . mg of h-ficolin/ ml, respectively. the absence of early complement components (c , c and c but not c ) is a predisposing factor for systemic lupus erythematosus (sle). recently, we demonstrated that, in c -deficient (c def.) mice, igm-containing immune complexes (igm-ic) are filtered by the splenic barrier of marginal zone macrophages (mzm), resulting in an increased immune response against antigens within these igm-ic, but this could not be observed in wildtype or c def. mice. we hypothesized that splenic cd b þ mzm play an important role in the induction of autoimmunity, and we therefore analysed their cytokine profile after isolation with the help of magnetic antibody cell sorting. mrna was isolated, and real-time pcr was performed with specific primers for murine ifn-g (ifn-g), interleukin- (il- ) and ifn-a (ifn-a). we observe a moderate increase of il- and ifn-g mrna in cd b þ cells of c def. mice compared to wildtype cells. surprisingly, the concentration of ifn-a mrna is six times higher in c def. mice. preliminary results suggest that mrna in cd b þ cells of c def. mice is even lower than that in wt. six hours following i.v. application of mg of a abstracts .................................................................................................................................................................................................. murine monoclonal igm anti-dsdna antibody, production of il- , ifn-g and ifn-a mrna is increased in cd b þ cells of both c def. and wt mice. several references described increased levels of inf-a in patients with sle. dendritic cells are discussed as a major source of ifn-a. our observation that c -deficient, sle-susceptible mice demonstrate an increased spontaneous ifn-a production by splenic cd b þ marginal zone macrophages could be an early sign and a trigger for the development of sle. this is supported by the fact that the absence of c is not a predisposing factor for sle and our observation that c def. animals display low levels of ifn-a mrna. - million people worldwide and represents one of the leading causes for liver cirrhosis and hepatocellular carcinoma. control over the hbv infection is achieved mainly by vaccination with hepatitis b surface antigen (hbsag). hbsag contains n-linked glycosylation side and is recognized by both mbl-a and mbl-c in a cadependent manner. hbsag-mbl complexes activate complement and may thus affect humoural immunity. to investigate the role of mbl in humoural responses to hbsag, we immununized mice that lack both mbl-a and mbl-c proteins with soluble hbsag. it has been shown that deficiencies in other complement components like c q, c and c result in decreased antibody responses. however, mbl double ko animals mounted dramatically increased humoural responses. after priming, mbl double kos mounted hbsag-specific igm responses, which were threefold higher than wt controls. after boosting the hbsag, total igg was -fold higher in mbl ko than in wt control animals. similar to the response to hbsag, other glycosylated soluble antigens (e.g. invertase) induced better humoural responses in mbl double ko animals, suggesting that mbl plays an important role in a negative feedback regulation of adaptive immunity. reconstitution experiments with rmbl partially rescued the ko phenotype. we propose that the clearance of glycoprotein antigens in mbl ko is handled differently from the wt, resulting in better stimulation of humoural responses. alternatively, glycoprotein-ag-mbl-rich complexes inhibit b-cell responsiveness via putative mbl receptors. the complement system is an important part of the innate immune system. the activation of complement proceeds through three different pathways that converge in the generation of c -activating enzyme complexes. complement activation via the lectin pathway is initiated when recognition molecules, mannan-binding lectin (mbl) or ficolin, bind to carbohydrate structures characteristic for microbial surfaces. in the circulation, mbl and ficolins are found in association with three structurally related mblassociated serine proteases (masp)- , - and - and a small, nonenzymatic component, map . masp- has been shown to elicit complement activation through the sequential proteolytic cleavage of c and c upon binding of mbl/masp- complexes to microbial surfaces. we have recently uncovered a polymorphism in the masp- /map gene in a patient shown to be deficient in the lectin pathway of complement activation. the polymorphism results in a single amino acid substitution in the n-terminal part of the masp- protein. recombinant wildtype masp- and masp- containing the amino acid substitution in question was produced, and the ability to activate complement was studied. the mutation had a profound impact on masp- function, resulting in the lack of complement activation through the lectin pathway. elisa-based experiments showed that the mutation leads to the impairment of complement activation through influencing the binding of masp- to mbl or ficolins. deficiencies in the lectin pathway of complement activation have so far been accounted for only by lack of functional mbl. the mutation described above is the first defect described affecting both activation through mbl and the ficolins. .................................................................................................................................................................................................. th , th and treg cell balance. dcs are present in the gut mucosa and may thus be target for modulation by gut microbes, including ingested probiotics. here, we tested the hypothesis that species of lactic acid bacteria, important members of the gut flora, differentially activate dc. a large panel of human gut-derived lactobacillus and bifidobacterium spp. was screened for dc-polarizing capacity by exposing bone marrow-derived murine dc to lethally irradiated bacteria. cytokines in culture supernatants and dc-surface maturation markers were analysed. substantial differences were found among strains in the capacity to induce interleukin- (il- ) and tumour necrosis factor (tnf)-a, while the differences for il- and il- were less pronounced. bifidobacteria tended to be weak il- and tnf-a inducers, while both strong and weak il- inducers were found among the strains of lactobacillus. remarkably, strains weak in il- induction inhibited il- and tnf-a production induced by an otherwise strong cytokine-inducing strain of lactobacillus casei, while il- production remained unaltered. selected strains were tested for induction of dc maturation markers. those lactobacilli with greatest capacity to induce il- were most effective in upregulating surface mhc class ii and cd . moreover, l. casei-induced upregulation of cd was reduced in the presence of a weak il- inducing l. reuteri. in conclusion, human lactobacillus and bifidobacterium spp. polarize differentially dc maturation. thus, the potential exists for th /th /treg-driving capacities of the gut dc to be modulated according to composition of gut flora including ingested probiotics. the intestinal micro flora is indispensable in developing and maintaining homeostasis of the gut-associated immune system. evidence indicates that lactic acid bacteria (lab), e.g. lactobacilli and bifidobacteria, have beneficial effects on the host. established health effects include increased gut maturation, antagonisms towards pathogens and immune modulation. the objective of this study is to evaluate the immunomodulating properties of a range of lab of human origin. as dendritic cells (dcs) play a pivotal role in the balance between tolerance and immunity to commensal microorganisms, in vitro-generated immature dcs serve as a suitable model for studying the immunomodulating effects of lab. human immature dcs were generated in vitro from monocytes and exposed to lethally uv-irradiated lab. the effect of various species of lab on dcs in direct contact was evaluated. furthermore, the maturation pattern of dcs separated from the bacteria by an epithelial cell layer (caco- cells), which should mimic the intestinal environment, was studied. cytokine secretion (il- , il- and tnf-a) and upregulation of maturation surface markers on dcs (cd and cd ) was measured. different lab induced diverse cytokine responses. some strains were strong il- and tnf-a inducers and others weak. all strains induced il- . different lab also differentially modulated expression of cd and cd on dcs. although some variation in the response to lab of dcs generated from different blood donors was observed, general differences in the effect of the various lab was revealed. experiments with the dc caco- coculture system are ongoing. different species of lab differentially affect dc maturation; this suggets that the gut flora plays a pivotal role in polarization of the immune response. natural killer (nk) cells are cells of the nonspecific immune system lysing altered self-cells. a noncytolytic subset of nk cells may serve a regulatory role by secreting cytokines. bacteria translocating across the gastrointestinal mucosa are presumed to gain access to nk cells, as consumption of certain lactic acid bacteria has been shown to increase in vivo nk cytotoxicity. here, we investigated how human gut flora-derived lactobacilli affect nk cells in vitro, by measuring proliferation and ifn-g production of human nk cells upon bacterial stimulation. cd -cd þ nk cells were isolated from buffy coats by negative isolation using non-nk lineage-specific antibodies and magnetic beads. nk cells were incubated with mg/ml uv-inactivated bacteria or mg/ml phytohemagglutinin (pha) for days. proliferation was assessed by incorporation of radioactive thymidine into nk-cell dna. the ifn-g concentration was measured by elisa. incubation of nk cells with a lactobacillus acidophilus strain increased the proliferation of the nk cells and induced ifn-g production, both to levels comparable to pha stimulation. the proliferative response was further enhanced with autologous monocytes present, probably because cytokines, secreted by monocytes having engulfed bacteria, stimulated the nk cells. in contrast, a lactobacillus paracasei strain caused the nk cells to proliferate only in the presence of monocytes. these results demonstrate that various strains of lactobacilli have the capacity to activate nk cells in vitro, in a monocyte-dependent or -independent way. hence, the encounter of nk cells with lactic acid bacteria will affect nk-cell activation. such activation of nk cells may potentially skew an on-going or subsequent immune response towards a th response. lactobacilli are nonpathogenic gram-positive inhabitants of the normal human intestine known for their healthpromoting effects. in our earlier work, it is shown that human monoclonal antibody isolated from sera of a patient with waldenstrom macroglobulinaemia possess innate antibody characteristics and binds to lactic acid bacteria. according to the immune network model, immunization with this bacteria could induce the perturbations in immune system that might result in production of anti-lactobacillus antibodies, human monoclonal antibody like (ab ) and anti-idiotypic antibody (ab ). in this study, balb/c mice were immunized with two doses of bacteria lactobacillus acidophilus in complete and incomplete freund's adjuvant and phosphate-buffered saline (pbs), respectively. seven days after the last immunization, sera from immunized mice were collected and the presence of lactobacillus-specific ab and ab were determined by elisas. in the sera of immunized mice, antibodies specific to bacteria lactobacillus acidophilus were shown. the concentration of lactobacillus-specific antibodies was higher in the sera of hyperimmunized mice (mice immunized with mg of igm dj) than in sera of mice immunized with times lower doses of immunogen ( . mg per doses). moreover, ab and ab antibodies were detected in the sera of lactobacillus-hyperimmunized mice. in this study, we have shown the idiotypic network interactions in mice immunized with bacteria lactobacillus acidophilus. the normal gastrointestinal flora is crucial for the maturation of the acquired immunity via effects on antigenpresenting cells (apcs). here, we have investigated how two types of apcs, monocytes and dendritic cells (dcs), react to different bacterial strains typical of the commensal intestinal flora. purified monocytes and monocyte-derived dcs were stimulated with uv-inactivated gram-positive (lactobacillus plantarum and bifidobacterium adolescentis) and gram-negative (escherichia coli and veillonella parvula) bacterial strains. monocytes produced higher levels of il- p and tnf, as detected by elisa, in response to l. plantarum than to e. coli and v. parvula. in contrast, dcs secreted high amounts of il- p , tnf, il- and il- in response to e. coli and v. parvula but were practically unresponsive to l. plantarum and b. adolescentis. the lack of response to the gram-positive strains correlated with a lower surface expression of toll-like reseptor (tlr ) on dcs compared to monocytes. the surface expression of tlr on dcs was undetectable when analysed by flow cytometry, but blocking this receptor decreased the tnf production in response to v. parvula, indicating that low tlr expression on dcs is sufficient to mount an inflammatory response to gram-negative bacteria. ifn-g increased the expression of tlr on dcs and also potentiated the cytokine response to gram-negative bacteria. our results indicate that, when monocytes differentiate into dcs, their ability to respond to different commensal bacteria dramatically changes, thereby becoming unresponsive to probiotic gram-positive bacteria. these results may have important implications for the capacity of different groups of commensal bacteria to regulate mucosal and systemic immunity. probiotic bacteria, e.g. lactobacillus spp., may improve diseases such as chronic inflammatory bowel disease. we examined cytokine production and phenotypic change after in vitro stimulation of t cells from healthy volunteers using different probiotic strains. methods: t cells were cultured from colonic biopsies from eight healthy volunteers (agnholt and kaltoft, exp clin immunogenet ; : - ) , and dendritic cells were matured from their peripheral blood mononuclear cells. t-cell cultures were stimulated with autologous bacterial sonicate or strains of lactobacillus spp., with and without the addition of dendritic cells. cytokine levels (tnf-a, ifn-g, il- and gm-csf) and phenotype (cd , cd , cd and cd ) were measured on day . results: lactobacillus spp. induced higher productions of tnf-a and il- than did autologous bacteria. in presence of dendritic cells, the production of all cytokines increased. however, the increases of ifn-g and tnf-a were more pronounced in wells with autologous bacteria than in wells with lactobacillus spp. the addition of dendritic cells upregulated cd expression without simultaneous upregulation of cd . the upregulation was pronounced after stimulation with lactobacillus rhamnosus gg compared with autologous bacteria and other lactobacilli. discussion: in presence of dendritic cells, autologous bacteria induced inflammatory cytokines, while probiotics mainly induced regulatory cytokines. lactobacillus rhamnosus gg induced a regulatory phenotype (cd þ ), in part mediated by dendritic cells. future studies will address whether this shift to a cd þ phenotype represents a differentiation into competent regulatory t cells. in a clinical context, such cells might be used for treatment of inflammatory diseases. protein microarrays will play a key role in the postgenomic era and offer a unique possibility to perform highthroughput global proteome analysis. a chip can be printed with thousands of protein probes (e.g. antibodies), the biological sample added (e.g. a proteome) and any binding detected. we aim to develop protein microarrays based on human recombinant scfv antibody fragments for global proteome analysis. the concept of comparing proteomic maps of healthy versus diseased samples will allow diseasespecific proteins to be detected. in fact, antibody microarrays will allow us to perform comparative proteome analysis on any sample format in a species-independent manner, as long as a proteome can be isolated. however, the complexity of proteomes, containing several thousands of different proteins, is a problem. here, we have designed antibody microarrays targeting the water-soluble fraction of a proteome. to this end, an anticytokine antibody array was developed and human dendritic cells (aeactivation) was used as model system. the results showed that our antibody microarrays could be used to examine the cytokine profile in complex samples. furthermore, we have taken the first steps towards comparing our results with those of other technologies on both the protein and gene level. due to the complexity of the model proteome, we also examined the possibility to prefractionate the proteome in a simple one-step procedure (based on size) prior to the labelling step. in more detail, the sample proteome was fractionated into two fractions using membrane devices with different molecular weight cut-offs. the results showed that the fractionation considerably enhanced the assay sensitivity allowing cytokines in the pg/ml range to be readily detectable. the immunomodulatory effect of heat shock protein : immunization with a dna construct based on the malarial antigen fused with a fragment of hsp primes for a th- type of response finding an appropriate adjuvant for human vaccination is crucial. heat shock proteins (hsps) act as adjuvants when coadministered with peptide antigens or given as fusion proteins. however, there is a potential risk of autoimmunity when using the complete molecules, because hsps are evolutionary conserved. to overcome this, we first evaluated the adjuvant effect against two different antigens of a less-conserved fraction of plasmodium falciparum hsp (pf c) and compared it to the whole hsp molecule from trypanosoma cruzi (tchsp ). we found that pf c exhibited similar adjuvant properties as the whole molecule. we later evaluated the adjuvant potential of pf c against the malarial antigen eb in a chimeric dna construct. no appreciable levels of eb -specific abstracts .................................................................................................................................................................................................. antibodies were detected in mice immunized only with the dna constructs. however, dna primed the immune system, because subsequent challenge with the corresponding recombinant fusion proteins elicited a strong th- antibody response. in contrast, no priming effect was observed for ex vivo ifn-g production but stimulation with the hsp-chimeric fusion protein induced a stronger secretion of ifn-g in vitro than other proteins used. these results indicate that the use of hsps is promising in the design of new vaccines. high-throughput proteomics on antibody-based microarrays: the importance of probe and surface design in analogy to dna microarrays, protein microarrays offer a new distinct possibility to perform sensitive highthroughput global proteome analysis. however, the development of the protein microarray technology will place high demands upon the design of both probes and solid supports. the analysis of thousands of heterogeneous proteins on a single microarray requires the use of uniform probes, such as antibodies, directly designed for protein microarray applications. we have recently generated a human recombinant single-chain fv antibody library, genetically constructed around one framework, the ncoder-library, containing  clones. single framework antibody fragments (sinfabs) selected from this library were successfully applied as probes for microarrays providing sensitive detection in the attomol (mass spectrometry) and the zeptomole range (fluorescence). however, the choice of framework is critical. we have shown that the selected ncoder framework displayed excellent functional on-chip stability and arrayed dehydrated probes retained their activity for several months. furthermore, we have addressed the issues of biocompatibility of the solid support and immobilization strategies for our microarray setup. an in-house-designed substrate, macroporous silicon coated with nitrocellulose (map -nc ), displayed properties equal to, or better than, those of five commercially available supports used as reference surfaces. we have also evaluated different coupling strategies, such as adsorption, covalent coupling, diffusion and affinity coupling. using a novel affinity tag, the double-(his) -tag, we increased the binding efficiency of sinfab-molecules to ni þ -coated solid supports, thereby allowing nonpurified probes to be directly applied. the mannan-binding lectin (mbl) pathway is part of the innate immune system providing a first line of defence against infections. mbl and ficolins circulate in complexes with mbl-associated serine proteases (masp- , - and - ). after recognition of a microorganism by mbl, activation of the complement system occurs. masp- and masp- share five domains (making up the so-called a-chain), whereas they have unique protease domains (b-chains). before the identification of masp- , an assay for masp was presented, based on antibodies against the a-chain of masp- . with the new knowledge of the three masps, and the sharing of domains by masp- and masp- , assays specific for the protease domains have to be constructed, if one wishes to measure the proteins individually. we present an assay for quantifying total masp- in plasma and serum samples. the assay is a sandwich-type assay using as catching antibody a monoclonal antibody against the common a-chain of masp- / and a developing secondary antibody against the c-terminal part of the protease domain of masp- . we have used this assay for estimating the normal concentration of the protein as well as the concentration in patients and also for characterizing by gel permeation chromatography the masp- protein in serum. inducible costimulator ligand (icosl) is a costimulatory molecule related to b . (cd ) and b . (cd ). b cells, monocytes, dendritic cells and endothelial cells express icosl. inducible costimulator (icos) interacts with icosl, and this interaction leads to signals involved in isotype switching and the development of immunological memory. hitherto, no polymorphisms of this gene have been described. the aim of this study was to reveal variation of the icosl gene in normal individuals. all eight exons, except exon , were sequenced with flanking introns in healthy blood donors. eight single nucleotide polymorphisms (snps) and two length polymorphisms were found. one of the snps was found in the coding regions of the gene. the base involved was located in exon and caused a conservative amino acid change from valine (gtt) to isoleucine (att). three individuals were heterozygous g/a for the exon polymorphism, while the remaining seven individuals were homozygous for the wildtype g/g. exon encodes the immunoglobulin variable (igv)-like domain of the molecule which is situated outside the cell. this means that the amino acid could be critical for the stability of the molecule or could constitute part of the binding site for icos. the results form the basis for further experiments to find possible associations of the alleles to diseases caused by immune dysregulation. especially, the exon variant is interesting and could play a role for the development of immunological diseases. besides, it would be interesting to see whether both exon alleles are expressed or only the wildtype allele is functional. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. myxovirus a (mxa) is a resistance gtpbinding protein that is specifically induced by treatment with type ifns. for example, ifn-b-induced mxa in blood leucocytes has been used as a biomarker in ifn-btreated patients with multiple sclerosis. however, the degree of specificity of mxa in this regard is unclear, and measurements of mxa protein and/or mrna are not yet suitable for routine clinical use. in an attempt to find new and better reporter genes (and, hopefully, genes and gene products with proven specificity for ifn-a and -b), microarray screenings with u a genechips (affymetrix) were carried using human blood leucocytes and the human lung carcinoma cell line a . we studied the simultaneous expression of , transcripts before and after exposure to human recombinant ifn-a and ifn-b and other antiviral and immunomodulatory cytokines. the results will be presented at the conference. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large-scale screening in specialized laboratories. the read-out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn-a or -b, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. in our laboratory, we have developed a database system, which we believe is of immediate interest to the general scientific community. the database represents a computerbased replacement for the laboratory notebooks used in the majority of research laboratories worldwide. in addition, the database provides an effective tool for organizing and managing laboratory information at all levels, spanning from managing and revising standard operating procedures and producing documentation of research activities to keeping track of data and conclusions. using the commercially available database toolkit software filemaker pro, we have developed a relational database solution for management of laboratory information. the system consists of a hierarchy of five interrelated databases, each pertaining to a separate type of information, namely, overall project information, information relating to individual experiment setups, documentation of daily research activity, generated data and descriptions of standard operating procedures. like other databases, each individual database consists of a number of records, each comprised of a set of fields in which information is entered. in each record, a certain field is reserved to specify the relation of the record to a record in another database at a higher level. thus, the database is essentially five databases linked by a hierarchy of one-to-many relations, organizing information in a folder-like structure. importantly, the database system allows multiple users to access and edit records simultaneously, and the data entered in one database immediately becomes accessible through the other databases. the limitations of laboratory notebooks are apparent when looking for information, which is dispersed throughout one or more notebooks, or possibly on loose sheets of paper or printouts 'somewhere'. the often complicated process of gathering laboratory data or results when writing grant applications or research papers is made considerably easier with the database system. thus, the database solution presented should be broadly attractive to researchers, irrespective of their scientific discipline. an effective sars vaccine is likely to include components that can induce specific cytotoxic t-cell (ctl) responses. the specificities of such responses are governed by hlarestricted presentation of sars-derived peptide epitopes. exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear sequences directly from genomic/proteomic sequence information. the latter was recently established when a causative coronavirus (sars cov) was isolated and full-length sequenced. here, we have combined advanced bioinformatics and high-throughput immunology to perform an hla supertype, genome-wide scan for sars-specific cytotoxic t cell epitopes. the scan includes all nine human hla supertypes in total covering > % of all major human populations. for each hla supertype, we have selected the top candidates for test in biochemical-binding assays. at this time (approximately months after the genome was established), we have tested the majority of the hla supertypes and identified almost potential vaccine candidates. these should be further validated in sars survivors and used for vaccine formulation. we suggest that immunobioinformatics may become a fast and valuable tool in rational vaccine design. rationale: major histocompatibility complex class i (mhc i) molecules monitor the protein content of the cell by binding small derived peptides and presenting them to cytotoxic cd þ t cells. the goal of the human mhc project is to predict the binding strength of any given peptide/mhc complex. this prediction allows the design of peptide-based vaccines. the prediction requires representative binding data from mhc alleles from all the nine hla supertypes. here, we describe the genetic construction, protein production and purification as well as the establishment-binding assays for two recombinant mhc supertype alleles, hla-b* and hla-b* . methods: using the quikchange multisite directed mutagenesis kit (stratagene), codon-optimized genes encoding hla-b* and hla-b* are created. the two mhc i molecules are fermented and purified by ion exchange chromatography, hydrophobic interaction chromatography and size exclusion chromatography. the binding (kd) of natural t-cell epitopes, as well as predicted peptide ligands, is described by radioactive immunoassays (rias) and enzyme-linked immunosorbent assays (elisas). the mhc molecules are biotinylated during expression. results: the expression of mhc i resulted in multiple disulfide bond isomers, which are separated by hydrophobic interaction chromatography and used in subsequent binding studies resulting in the determination of kd for various peptide ligands ranging from strong binders we have previously demonstrated that bioinformatics tools such as artificial neural networks (anns) are capable of performing pathogen-, genome-and hlawide predictions of peptide-hla interactions. these tools may therefore enable a fast and rational approach to epitope identification and thereby assist in the development of vaccines and immunotherapy. a crucial step in the generation of such bioinformatics tools is the selection of data representing the event in question (in casu peptide-hla interaction). this is particularly important when it is difficult and expensive to obtain data. herein, we demonstrate the importance in selecting information-rich data and we develop a computational method, query-bycommittee, which can perform a global identification of such information-rich data in an unbiased and automated manner. furthermore, we demonstrate how this method can be applied to an efficient iterative development strategy for these bioinformatics tools. methods: a large panel of binding affinities of peptides binding to hla a* was measured by a radioimmunoassay (ria). this data was used to develop multiple first generation anns, which formed a virtual committee. this committee was used to screen (or 'queried') for peptides, where the anns agreed ('low-qbc'), or disagreed ('high-qbc'), on their hla-binding potential. seventeen low-qbc peptides and high-qbc peptides were synthesized and tested. the high-or low-qbc data were added to the original data, and new high-or low-qbc second generation anns were developed, respectively. this procedure was repeated times. the high-qbc-enriched ann performed significantly better than the low-qbc-enriched ann in of the tests. conclusion: these results demonstrate that high-qbcenriched networks perform better than low-qbc-enriched networks in selecting informative data for developing peptide-mhc-binding predictors. this improvement in selecting data is not due to differences in network training performance but due to the difference in information content in the high-qbc experiment and in the low-qbc experiment. finally, it should be noted that this strategy could be used in many contexts where generation of data is difficult and costly. interleukin- (il- ), a pro-inflammatory cytokine that is produced by both lymphoid and nonlymphoid cells, has a critical role in modulation of innate and adaptive immunity. its primary function in stimulation of ifn-g production and stimulation of nk-cell-cytotoxic activities makes this cytokine a candidate for cancer immunotherapy. in oral cavity, this cytokine is produced by oral epithelia and carcinoma cells and is related to tumour regression in nude mice bearing salivary adenocarcinoma. however, direct effects of this cytokine on oral cancer cells have not been elucidated. in this project, we investigated il- effect on an oral carcinoma (kb) cell line. with rt-pcr technique, kb-cell line was found to express il- receptors (il- ra and il- rb), indicating that this oral carcinoma line is a target for il- study. we showed that recombinant human il- inhibited kb-cell proliferation by % at concentration of ng/ml (p < . ), whereas ldh release by these cells in treatment group and control groups was comparable, indicating that il- suppression of cell proliferation was not mediated by the induction of cell death. to further address this hypothesis, we found that il- treatment did not induce apoptotic cell death, as studied by dna laddering and tunel assays. in addition, expression pattern of cell death-controlling genes (bcl- and bax) was not altered by this cytokine. findings in these studies indicated that suppression of kb-cell proliferation may be attributed to control of cell cycle, growth arrest or induction of cell differentiation. the data presented in this project could provide an insight of how cancer cell directly responds to il- , as this cytokine is an important regulator of anticancer mechanisms. aloe emodin (ae) is a naturally occurring compound with wide spectrum of biological properties, including antimicrobial, vasorelaxant, immunosuppressive and anticancer actions. this anthraquinone induces apoptosis in several tumour cell lines with special affinity to tumours of neuroectodermal origin. high amounts of nitric oxide (no) released by activated macrophages induce tumour cell death. therefore, we explored the capacity of ae to modulate no-mediated antitumour response in vitro. interestingly, while ae markedly suppressed no release from macrophages alone, it significantly potentiated no production in cocultures of macrophages and c cells, after h of cultivation. accordingly, the viability of c cells cocultivated with macrophages was reduced in the presence of ae. moreover, the observed ae-imposed potentiation of no production in macrophages was closely related to macrophage culture cell density. according to these data, we proposed that no modulator capacity of ae strongly depended on intercellular contact, indicating that macrophage antitumour response was not compromised but even potentiated by ae. immunotherapy represents an attractive fourth-modality therapeutic approach, especially in the light of the shortcomings of conventional surgery, radiation and chemotherapies in the management of metastatic cancer. to this end, a large number of peptide antigens derived from taa have been applied in immunotherapeutic trials for the treatment of various malignancies, e.g. cancers of the breast, prostate and kidney, in addition to haematological cancers. in some cases the response rates have been impressive and no adverse autoimmunity have been observed. a major strategic difficulty associated with these trials relates to the choice of best-suited peptide antigens. the vast majority of the antigens described thus far is not vital for survival and growth of the tumour cells, and immunoselection of antigen-loss variants may therefore prove to be an additional obstacle for the clinical applicability of most of the known peptide epitopes. in this respect, the development of acquired antigen loss during immunotherapy has been demonstrated in several cases. obviously, the development of loss-variant tumour cells implies that these cells acquire a pronounced growth advantage and are left unaffected by further treatment. ideally, target antigens should be derived from proteins required for survival and growth of tumour cells, as antigens with these characteristics would not be inflicted by the development of loss-variant tumour cells. in this respect, several inhibitors of apoptosis proteins (iaps) are universally expressed among tumours and play an important role in tumour cell escape from apoptosis. we have characterized spontaneous t-cell reactivity against iapderived peptides in cancer patients. from the iap survivin, we have characterized peptides restricted to the class i molecules hla-a , a , a , a , b and b . furthermore, we have demonstrated that survivin-specific t cells infiltrate metastatic lesions and that isolated survivinspecific ctls are capable of killing hla-matched tumour cells. survivin-derived peptides are now in clinical trial, and continued work in our lab has demonstrated that other iaps are targets for spontaneous t-cell reactivity in cancer patients. we previously reported that in mice with large progressing t-cell lymphoma tumours, dysfunctions in the antitumour ctl activity occur, associated with an accumulation of splenic arginase-producing myeloid suppressor cells (mscs). in this study, we first demonstrate that both the presence and the activation state of these msc depends on tumour evolution. while in tumour regressors hardly any arginase-producing msc can be found, both the amount and the arginase activity of this population expands from early over late progressors. this gradual induction of mscs is paralleled by an increasing suppression of ctl activity and th , but not th , cytokine production. upon analysing the molecular repertoire of msc in vitro, we found, besides arginase , a well-established marker for alternatively activated myeloid cells or m , a strong upregulation of fizz and ym, two additional recently identified markers for m . further evaluation of molecular markers by microarray analysis in msc yielded genes involved in wound healing (e.g. coagulation factor xiiia), anti-inflammation (e.g. selenoprotein p), immunomodulation (e.g. pd-l ) and fat and sugar metabolism (e.g. leptin receptor). of note, many of these genes are regulated by type cytokines (il- , il- and il- ) and are therefore rather m associated. overall, our data provide new markers for msc in cancer and further establish their m activation state. study. only sp-a showed a significant expression in normal mucosa which was downregulated in crc. as the absolute signal level was below the noise threshold, these results have to be interpreted with caution and require confirmation by direct measurenment of the proteins. our results suggest that there is no major role for the human collectins in colorectal cancer. tetramerization is visualized by sds-page. conclusion: an effective method for the production of highly pure mhc i molecules has been applied to hla-b* and hla-b* , and ria and elisa binding assays for those alleles have been established background: proliferation, differentiation and apoptosis are essential processes in the normal functions of the mammary epithelium. the hypothesis examined in this study is that the transcription factor bcl- is critically important not only for regulating b-cell growth and development but also for mammary epithelial apoptosis. methodology: twenty breast cancer cases and healthy controls were used to investigate whether bcl- protein in involved in breast cancer (grade iii). full length bcl- cdna was retrovirally transduced into eph- cell line. we then used flow cytometry of brdurd-stained cells to investigate the cell-cycle duration of the control and transduced cell lines. tunel was used as a marker of apoptosis to find out differences in the frequencies of apoptotic cells in the control and transduced cell lines. finally, immunohistochemistry staining was performed to detect bcl- in breast cancer (iii). results: restoration of bcl- into eph- cells not only inhibits apoptosis but also prolongs the cell cycle and results in increased cell size and protein content. the results also indicated that the cell-cycle time of bcl- -transduced eph- cells is prolonged by about h, presumably as a result of the action of bcl- at the bcl- at the g /s transition. we found differences in the frequencies of viable and apoptotic cells in cultures of the parent eph- cells, control-transduced eph- cells and bcl- -transduced eph- cells. consistently, we demonstrated that bcl- is expressed in % of high grade of breast carcinoma, which is considered as the most aggressive of tumours. conclusion: together, these results suggest that bcl- is likely to be involved in mammary gland development and carcinogenesis. inflammatory cytokines have a critical role in modulation of both innate and adaptive immunity in response to foreign antigen. they also play an important role in anticancer immunity. for example, they can promote cell-mediated immunity against cancer cells. with their immunostimulatory effects, these cytokines are being tested for cancer treatment in the form of dna vaccine or adjuvant or therapeutic cytokines. direct effect of these cytokines on cancer cell, however, is still unclear. in this project, we investigated whether il- ( and il- can modulate cancer cell proliferation. we employed a simple nonradioactive proliferation (mtt) assay and detection of lactate dehydrogenase (ldh) to test the effect of these recombinant human cytokines on various cancer cell lines, including breast cancer cell line (mcf- ), oral carcinoma cell line (kb), colon cancer cell line (caco- ) and choriocarcinoma cell line (jar). cytokines used in this study had both inhibitory and stimulatory effect on cell proliferation. findings in this project could provide an insight of cancer cell response to these cytokines and this could lead to a consideration on using cytokine as immunotherapy for cancer treatment.capacity of ae to modulate nitric oxide production depended on intercellular contact donor t cells are involved in the antitumour effects observed after bmt. thus, patients receiving t-celldepleted bmt have a higher risk of leukaemia relapse compared to patients receiving nonmanipulated bmt, and patients experiencing graft-versus-host disease (gvhd) have a lower risk of disease relapse than patients who do not experience gvhd. although the importance of donor t cells for the curative action of bmt has been established, the exact mechanisms and molecules involved in this graft-versus-tumour effect remain largely unknown. in a recently initiated project, we have conducted a longitudinal study of t-cell clonotypes in patients who received peripheral blood stem cell grafts after nonmyeloablative conditioning. peripheral blood samples were obtained sequentially after transplant, and the mononuclear cells (mncs) were isolated and cryopreserved. cd þ t cells were isolated from the mncs by use of immunomagnetic beads or facs and analysed for the presence of clonally expanded cells by t-cell receptor clonotype mapping based on rt-pcr and denaturing gradient gel electrophoresis (dgge). using this gel-based methodology, clonally expanded t cells were monitored after transplant and compared to the clinical data of the patients. the preliminary results demonstrates the presence of clonally expanded cd þ t cells at all time points analysed. furthermore, a number of clonotypes persisted for more than months, and other clonotypes emerged during this period. the appearance of newly emerged clonotypes which coincided with clinical gvhd could indicate a role for these t cells in the pathogenesis of gvhd. background: deficiency of the mannan-binding lectin (mbl) pathway of innate immunity leads to increased susceptibility to infections. in patients with colorectal cancer, postoperative infection is associated with poor prognosis. the aim of the present study was to evaluate ( ) the relation between the mbl pathway and postoperative infectious complications and survival of patients resected for colorectal cancer and ( ) the role of mbl as acute phase reactant compared to crp. methods: preoperative mbl concentration, mbl/mblassociated serine protease (masp) activity and crp were determined in serum from patients and healthy controls. the patients were observed for years. postoperative infections, recurrence and survival were recorded. results: the mbl pathway components were increased in the patients (p < . ) compared to healthy controls. low mbl levels were predictive of pneumonia (p ¼ . ), and pneumonia (n ¼ ) was associated with poor survival (p ¼ . , hr ¼ . , % ci . - . ). mbl and mbl/ masp activity could not predict postoperative overall infections. mbl showed no correlation (spearman's r ¼ . , % ci À . - . ) with crp. conclusions: low preoperative mbl levels are predictive of pneumonia, which is associated with poorer survival. mbl concentration and mbl/masp activity was not predictive of other postoperative infections or long-term prognosis. mbl apparently is not a surrogate measure of crp. department of surgery, university hospital of erlangen, erlangen, germany. e-mail: michael.siassi@rzmail.uni-erlangen.de introduction: the human collectins, mannan-binding lectin (mbl), surfactant protein-a (sp-a) and surfactantprotein-d (sp-d) play a central role in the innate immune system. immunological responses to malignant transformation of epithelial cells gained increasing interest recently. a former study could demonstrate binding of mbl to certain colorectal carcinoma (crc) cell lines in vitro. we therefore examined the expression of human collectins in normal colon mucosa and in colorectal carcinomas. materials and methods: colon samples from crc patients and normal mucosa samples were collected immediately after surgery. the tissue was microdissected and rna isolated (qiagen, rneasy-kit). gene expression profiles were analysed using gene-chips (affymetrix, hg-u ). we analysed the data for the expression of mbl, its associated serine proteases mannan-binding lectinassociated serine protease / (masp / ), sp-a and sp-d. the signal intensity of the genes of interest was compared using the mann-whitney u-test. results: the expression of human collectins in normal human colon mucosa was generally low. only the expression of sp-a and masp- reached the noise threshold of signals. these genes were significantly downregulated in crc specimens. the expression of the other proteins showed no difference in normal mucosa and crc. conclusion: as demonstrated before, the expression of human collectins in normal colon was low in this being the first lymph node to receive drainage from the tumour area, the sentinel node offers a unique possibility to obtain tumour-reactive lymphocytes. we investigated antitumour immune responses in sentinel nodes from patients with bladder cancer, by assaying tumour-specific proliferation and tcr vb repertoires. during tumour surgery, sentinel lymph nodes were identified by peritumoural injection of blue dye. fresh specimens of tumour, sentinel and nonsentinel lymph nodes were obtained, and single-cell suspensions were prepared. cells were assayed for reactivity against autologous tumour extract in [ h]-thymidine incorporation assays and characterized by flow cytometry. parallel analyses of the expression of vb gene families were performed with padlock probes, linear oligonucleotides which upon target recognition can be converted to circular molecules by a ligase. probes were reacted with cdna prepared from magnetically separated cd þ cells, and the tcr repertoire was determined by hybridizing the products to oligonucleotide microarrays. dose-dependent proliferation in response to tumour extract could be detected in sentinel lymph nodes. common clonal expansions were detected among tumourinfiltrating lymphocytes and in sentinel lymph nodes. nonsentinel lymph nodes displayed a divergent tcr vb repertoire. these results indicate an ongoing immune response against tumour antigens in sentinel nodes, draining urinary bladder cancer. identification of sentinel lymph nodes makes it possible to obtain tumour-reactive lymphocytes for use in adoptive immunotherapy. key: cord- - nye nc authors: krarup, a.; sørensen, u.; matsushita, m.; jensenius, j. c.; thiel, s. title: mannan‐binding lectin, l‐ficolin and h‐ficolin selectively binds to different bacteria date: - - journal: scand j immunol doi: . /j. - . . al.x sha: doc_id: cord_uid: nye nc mannan‐binding lectin (mbl), l‐ficolin and h‐ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l‐ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type‐ , ‐ , ‐ , ‐ and ‐ ). h‐ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h‐ficolin initiated activation of complement factor c , whereas l‐ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . μg of mbl/ml, . μg of l‐ficolin/ml and . μg of h‐ficolin/ml, respectively. the nuclear receptor heterodimers of liver x receptors (lxrs) are recently identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. lxrs and their ligands are negative regulators of macrophage inflammatory gene expression. multiple sclerosis (ms), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. sweden belongs to the countries with a high ms incidence. in italy, incidence is lower, with an exception for sardinia where the incidence is even higher than that in sweden. subjects from sardinia are ethnically more homogeneous and differ from swedes, also regarding genetic background and environment. we studied lxrs and their related molecules of blood mononuclear cells (mncs) from female patients with untreated relapsing-remitting ms from sassari, sardinia and stockholm, sweden. sex-and age-matched healthy controls (hcs) were from both areas. mrna expression was evaluated by real-time pcr. lxr-a was lower (p < . ) in ms (mean ae sem: . ae . ; n ¼ ) compared to hc ( . ae . ; n ¼ ). lxr-a was lower in ms from stockholm ( . ae . ; n ¼ ) compared to corresponding hc ( . ae . ; n ¼ ; p < . ) and compared to ms ( . ae . ; n ¼ ; p < . ) and hc ( ae . ; n ¼ ; p < . ) from sardinia. ms patients from stockholm, but not from sassari, also expressed lower (p < . ) lxr-b (À . ae . ) compared to corresponding hc (À . ae . ). ms from stockholm was associated with higher abca- ( . ae . versus . ae . ; p < . ) and higher estrogen receptor-b-cx ( . ae . versus . ae . ; p < . ) compared to corresponding hc. the hc from sassari had higher androgen receptor ( . ae . ) compared to ms from sassari ( . ae . ; p < . ), ms ( . ae . ; p < . ) and hc from stockholm ( . ae . ; p < . ). ms from sassari had lower cyclooxygenase- compared to corresponding hc ( . ae . versus . ae . ; p < . ) and lower prostaglandin-e (À . ae . ) compared to the hc ( . ae . ; p < . ) and ms ( . ae . ; p < . ) and hc from stockholm ( . ae . , p < . ). our findings identify lxrs and their related molecules as being involved in ms from stockholm but not from sassari, while sex hormone receptors seem to be involved in ms in sassari. multiple sclerosis: ifn-b induces cd + bdca -dendritic cells that produce il- and il- and have no enhanced type i interferon production y. m. huang, s. adikari, u. båve, a. sanna , & g. alm dc antigens (bdca) and investigate their ability to produce type i ifn in response to virus stimulation. we show that ifn-b induces development of cd þ dc from human blood monocytes, which coexpress bdca þ but are negative for bdca -, a specific marker for plasmacytoid dc. such ifn-b-modulated dc produce large amounts of il- and il- , but no il- p and have no enhanced ifn-b and ifn-b production. the findings indicate that ifn-bmodulated dc represent a myeloid dc subset with diminished cd c, bdca- and cd a expression, having potent th -promoting function but lacking antiviral capacity. the association of psoriasis with throat infections by streptococcus pyogenes suggests a potential antigenic target for the t cells that are known to infiltrate dermis and epidermis of psoriatic skin. streptococcal m protein shares an extensive sequence homology with human epidermal keratins. keratins (k ) and (k ) are mostly absent from uninvolved skin but are upregulated in psoriatic lesions. there is increasing evidence that cd þ t cells play an important effector role in psoriasis and m proteinprimed t cells may recognize these shared epitopes in skin via molecular mimicry. to identify candidate epitopes, peptides with sequences from k were selected on the basis of predicted binding to hla-cw and sequence similarities with m protein. matched peptides from the sequence of m protein and a set of peptides with poor predicted binding were also selected. cw þ individuals with psoriasis and cw þ healthy controls, having a family history of psoriasis, were recruited. pbmcs were incubated with the peptide antigens. t-cell activation in the cd þ , cd þ and later the skin-homing cutaneous lymphocyteassociated antigen (cla)-expressing subset of cd þ t cells was evaluated by cd expression and intracellular ifn-g accumulation using flow cytometry. we demonstrate that cw þ psoriasis patients had significant cd þ t-cell ifn-g responses to peptides from k and m protein selected on the basis of sequence homology and predicted hla-cw* binding. these responses were about times more frequent in the skin-homing cutaneous lymphocyte-associated antigen-expressing (cla þ ) subset of cd þ t cells. cd þ t cells showed only borderline responses. cd þ t cells from cw þ nonpsoriatic individuals responded to some m peptides but very rarely to k peptides, and this also applied to the cla þ cd þ subset. these findings indicate that psoriatic individuals have cd þ t cells that recognize keratin self-antigens and that epitopes shared by streptococcal m protein and human keratin may be targets for the cd þ t cells that infiltrate psoriatic skin lesions. autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly % in ra patients and a suggestive involvement in the pathogenesis. the targeted epitopes are generated by a post-translational modification catalysed by the calcium-dependent enzyme peptidyl arginine deaminase that converts the positively charged arginine to polar but uncharged citrullin. the aim of this study was to analyse the presence of citrulline in the joints at different time points of collagen-induced arthritis in da rats by immunohistochemistry and to investigate how immunogenicity and arthritogenicity was affected by citrullination of rat serum albumin (rsa) and collagen type ii (cii). our results indicate that citrulline could be detected in joints of arthritic animals, first appearance at the onset of disease and increasing as disease progressed into a chronic state. unimmunized animals or time points before clinical signs of arthritis were negative. by morphology, we state that some infiltrating macrophages as well as the cartilage surface stain positive for citrulline, while the major source of citrullinated proteins appears to be fibrin depositions. a specific cit-rsa t-cell response was observed in animals challenged by citrullinated rsa, no response was recorded when rsa was used as a stimulus. the igg analysis reveals not only a response towards the modified protein but also cross-reactivity to native rsa. no t-cell or b-cell response was noted in animals injected with unmodified rsa. cit-cii induced a disease with higher incidence and earlier onset than did the native counterpart. we conclude that, in contrast to the human disease, citrulline does not seem to appear before clinical signs. as inflammation proceeds, citrulline is detected specifically in the joints. all other organs investigated were negative. we also conclude that citrullination of a protein can break tolerance and increase its arthritogenic properties. ectopic germinal centers (gcs) can be detected in the salivary glands of approximately / of patients with sjögren's syndrome (ss) and appear in both primary and secondary ss. previously, ectopic gc have been associated with increased local autoantibody production. the aim of this study was to determine whether gc in primary sjögren's syndrome (pss) defines a distinct seroimmunological phenotype. retrospectively, a material of haematoxylin and eosin-stained paraffin-embedded tissue sections of minor salivary gland tissue from patients with pss was morphologically screened for the presence of ectopic gc. gc-like lesions were detected in / ( %) of the pss patients. seventy-two pss patients lacking these structures (gc-) were randomly selected for comparison. focus score was significantly increased in the gc þ patients compared to the gcpatients (p ¼ . ). in the gc þ group, . % of the patients presented with anti-ro/ssa compared to . % in the gcgroup. anti-la/ssb was detected in . % of the gc þ patients compared to . % of the gcpatients. sixty-one percentage of gc þ patients presented with increased levels of igg, a nonsignificant difference when compared to . % in the gcpatients (p ¼ . ). levels of rf, ana, ena, igm and iga were similar in both patient groups, as were esr and crp. in conclusion, patients with ectopic gc have a higher focus score and more often present with autoantibodies and increased levels of igg compared to pss patients with regular focal infiltration (gc -). our findings may indicate a certain seroimmunological phenotype and warrant for further prospective studies. association between mannose-binding lectin and vascular complications in type diabetes complement activation and inflammation have been suggested in the pathogenesis of diabetic vascular lesions. we investigated serum mannose-binding lectin (mbl) levels and polymorphisms in the mbl gene in type diabetic (t dm) patients with and without diabetic nephropathy and associated macrovascular complications. polymorphisms in the mbl gene and serum mbl levels were determined in t dm patients with overt nephropathy and t dm patients with persistent normoalbuminuria matched for age, sex and duration of diabetes as well as in healthy control subjects. the frequencies of high and low expression mbl genotypes were similar in patients with t dm and healthy controls. high mbl genotypes were significantly more frequent in diabetic patients with nephropathy than in the normoalbuminuric group, and the risk of having nephropathy, given a high mbl genotype, assessed by odds ratio was . ( . - . ), p ¼ . . median serum mbl concentrations were significantly higher in patients with nephropathy than in patients with normoalbuminuria [ mg/l (iqr - mg/l) versus mg/l (iqr - ), p ¼ . ], and even when comparing patients with identical genotypes, serum mbl levels were higher in the nephropathy group than in the normoalbuminuric group. patients with a history of cardiovascular disease had significantly elevated mbl levels independently of nephropathy status [ mg/l (iqr - mg/l) versus mg/l (iqr - mg/l), p ¼ . ]. the differences in mbl levels between patients with and without vascular complications were driven primarily by pronounced differences among carriers of high mbl genotypes (p < . ). our findings suggest that mbl may be involved in the pathogenesis of microvascular and macrovascular complications in type diabetes and that determination of mbl status might be used to identify patients at increased risk of developing these complications. neuroimmunology unit, center for molecular medicine, karolinska institutet, stockholm, sweden. e-mail: judit.wefer@cmm.ki.se dna vaccine coding for the encephalitogenic peptide mog - protects lew. av from subsequent development of experimental autoimmune encephalomyelitis (eae). protection is associated with a type immune response and is dependent on the presence of cpg dna motifs. the mechanisms underlying the observed reduction of eae development in protected rats have not been fully clarified. we investigated immunological characteristics of lymphocytes after dna vaccinaton and subsequent eae induction. we confirm that protection was not associated with suppression of t cells, as transcription of the novel molecule rat t-cell immunoglobulin-and mucindomain-containing molecule (tim- ), reported to be exclusively expressed on differentiated t cells, was not altered by dna vaccination. we did not note any clonal deletion upon tolerization, but detected an antigen-specific lymphocyte population upregulating ifng upon recall stimulation weeks after protective dna vaccination. in protected rats, we observed ( ) no alterations in antigenspecific th or th responses, ( ) reduced mhc ii expression on splenocytes early after eae induction, ( ) antigen-specific upregulation of ifnb upon recall stimulation and ( ) reduced il- rb on lymphocytes. we thus demonstrate an association of the protective effect of dna vaccination with expression of ifnb. we are currently investigating the cellular mechanisms behind this ifnb-mediated protection. multiple sclerosis (ms) is an autoimmune condition characterized by degeneration of nerve fibre myelin sheets. a candidate autoantigen, myelin basic protein (mbp), has especially attracted attention. the presence of anti-mbp antibodies is a predictor of definite ms, but their role in the pathogenesis remains obscure. t cells have long been known to play a pivotal role in the pathogenesis of ms. recently, an important role for b cells as autoantigen-presenting cells has been demonstrated in other autoimmune diseases, including rheumatoid arthritis and diabetes. the uptake of mbp by b cells and the presentation of mbp-derive peptides to t helper (th) cells by b cells may be promoted by the formation of complement (c) activating immune complexes (ics) between mbp and natural autoantibodies in healthy individuals and disease-associated anti-mbp antibodies in ms patients, respectively. we have investigated the formation of mbp-containing ic, the binding of mbp to b cells, the mbp-elicited induction of th-cell and b-cell proliferation and the cytokine production in peripheral blood mononuclear cells (pbmcs) from healthy donors grown in the presence of intact or c-inactivated serum from healthy donors or patients with ms. while mbp did not induce measurable proliferation of b cells nor cd þ t cells, we observed the production of tnf-a, ifn-g and il- by pbmc in response to incubation with mbp in the presence of sera from healthy controls as well as sera from ms patients. by contrast, no production of il- , il- and il- was detected. we are currently investigating the capability of ms sera to promote the formation of mbp-containing ic and thereby enhance the cytokine responses, by virtue of elevated anti-mbp contents. the phagolysosomally localized acid sphingomyelinase (asmase) activated by proinflammatory cytokines such as tnf and ifn-g generates the signalling molecule ceramide which in turn results in the activation of proteases like cathepsin d. these characteristics of asmase suggest a possible role of this molecule in the phagocytotic uptake and phagosomal degradation processes of antigens or in antigen presentation. we show here that asmase -/mice fail to eliminate the noncytopathic lymphocytic choriomeningitis (lcm) virus as rapidly as littermate wildtype mice. investigation of the immune response revealed a reduced expansion of cd þ t cells. the secretion of ifn-g in response to contact with target cells as well as the cytolytic activity of virus-specific cd þ t cells was severely impaired. additionally, both phases of the lcm virus-specific dth response, mediated by cd þ and cd þ t cells consecutively, were diminished in asmase -/mice. however, the secondary memory response of virus-specific ctl was not altered, and the abstracts ................................................................................................................................................................................................. virus was effectively controlled for at least months by asmase -/mice. in conclusion, the results of this study suggest an involvement of the asmase in the activation, expansion or maturation of virus-specific cd þ t cells during the acute infection of mice with the lcm virus. novel markers for alternative activation of macrophages: macrophage galactose-type c-type lectins and in parallel with the th /th dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in, for example cytokine environment and pathological conditions. while the best-studied, classically activated macrophage is induced by type i stimuli such as ifn-g, a type ii cytokine environment antagonizes the classical activation of macrophages and is capable of alternatively activating macrophages. however, molecular markers associated with these type ii cytokine-dependent, alternatively activated macrophages remain scarce. besides the earlier documented markers macrophage mannose receptor and arginase , we recently demonstrated that murine alternatively activated macrophages are characterized by increased expression of fizz and ym. we now report that expression of the two members of the mouse macrophage galactose-type c-type lectin gene family, termed mmgl and mmgl , is induced in diverse populations of alternatively activated macrophages, including peritoneal macrophages elicited during infection with the protozoan trypanosoma brucei or the helminth taenia crassiceps, and alveolar macrophages elicited in a mouse model of allergic asthma. we also demonstrate that, in vitro, interleukin- and interleukin- upregulate mmgl and mmgl expression and that, in vivo, induction of mmgl and mmgl is dependent on interleukin- receptor signalling. moreover, we show that regulation of mgl expression is similar in human monocytes and monocyte-derived macrophages. hence, macrophage galactose-type c-type lectins represent novel markers for both murine and human alternatively activated macrophages; thus, paving the way for further characterization of the phenotype of macrophages occurring in th conditions. background: human parvovirus b (b ) is a ubiquitous pathogen, normally causing a mild self-limiting disease, but also capable of causing both significant pathology and long-term persistence. the small size and stability of the virus makes it suitable for mapping of the full breath and the kinetics of the cellular immune responses following acute viral infection. methods: five patients with acute primary b infection were included in the study and followed consecutively for up to weeks. cellular immune responses were mapped by ifng enzyme-linked immunospot to overlapping peptides spanning the whole b genome. results: in all five acutely infected patients, we were able to monitor the kinetics of a strong specific cellular immune reaction. responses peaked at levels of - sfc/ million pbmcs, roughly corresponding to . - . % b specific cd þ cells circulating in peripheral blood at - weeks post-infection. the responses in individual patients were directed to three or four different peptide pools, and the specificity was confined to the same cd epitopes present in the pools throughout the follow-up period. the majority of responses were directed to the virus nonstructural protein, only two patients showed any response to the capsid proteins, elicited by the same epitope in both cases. conclusion: the cellular immune responses to acute b infection are surprisingly narrow in distribution and remain at high levels for up to weeks post-infection. the initial epitope specificity is maintained, and the majority of responses target the virus nonstructural protein, which is not included in vaccine preparations, evaluated against the infection. the relationship between malnutrition and malaria is controversial. on one hand, malaria may cause malnutrition, while on the other, malnutrition itself may modulate susceptibility to the disease. we investigated the association between plasmodium falciparum malaria and malnutrition in a cohort of children living on the coast of kenya. the study involved longitudinal follow-up for clinical malaria episodes and anthropometric measurements at four cross-sectional surveys. we used poisson regression analysis to investigate the association between malaria and nutritional status. compared to baseline (children with a waz or haz score of !À ), the crude incidence rate ratios (irrs) for malaria in children with low haz or waz scores (<À ) during the period prior to assessment were . ( % ci . - . ; ¼ . ) and . ( . - . ; . ), respectively, suggesting no association between malaria and the subsequent development of pem. however, we found that age was acting as an effect modifier in the association between malaria and malnutrition. the irr for malaria in children - years old who were subsequently characterized as wasted was . ( . - . ; p ¼ . ), and a significant overall relationship between malaria and low-haz was found on regression analysis when adjusting for the interaction with age (irr . ; . - . ; p < . ). although children living on the coast of kenya continue to suffer clinical episodes of uncomplicated malaria throughout their first decade, the association between malaria and malnutrition appears to be limited to the first years of life. a. astrinidou-vakaloudi, s. xytsas, i. diamanti, h. ioannidis & p. pangidis microbiology department of general hospital of thessaloniki 'agios pavlos', thessaloniki, greece, and nefrology, nd ika hospital of thessaloniki, thessaloniki, greece. e-mail: stasa@hol.gr aim: renal dysfunction may influence the colonization of gastric mucosa by urea-splitting bacteria such as helicobacter pylori, by increasing urea concentrations in the gastric juice. our aim was to investigate the prevalence of h. pylori in patients with end-stage renal disease (esrd), receiving long-term haemodialysis treatment. methods: this study included sera from patients with esrd ( male and female) undergoing periodic haemodialysis; mean time of treatment was . months. using elisa technique, we investigated the presence of igg and iga antibodies against h. pylori as well as igg caga (antibodies specific for caga(þ) strains of h. pylori). sera from healthy blood donors were used as a control group. results: h. pylori igg antibodies were detected in out of ( %) patients in the dialysis group, while / ( . %) tested positive for iga. igg caga antibodies were present in out of ( . %). prevalence of h. pylori igg, iga and caga igg antibodies in the control group was , and %, respectively. conclusions: although international data suggest that prevalence of h. pylori infection is the same in esrd patients as in healthy individuals, in our study that seems not to be the case. the higher blood and gastric juice urea levels may be a risk factor (among many others), but more studies are required in order to understand the relation of h. pylori infection in this group of patients. flanders interuniversity institute for biotechnology, department of molecular and cellular interactions, free university of brussels, brussels, and pasteur institute of brussels, mycobacterial immunology, brussels, belgium. e-mail: tgartner@vub.ac.be immunity against tuberculosis (tb), caused by mycobacterium tuberculosis, depends largely on activation and maintenance of strong cell-mediated immune responses involving both cd þ and cd þ t cells and the ability to respond with th -type cytokines, particularly ifn-g. recent studies suggested that bcg, the only licensed vaccine against m. tuberculosis, may fail to induce t-cell responses in the lung mucosa and may therefore not protect against pulmonary tb. a decrease in tb mortality may be achieved by enhancing immunity in the lung. the present study evaluated the induction of antigen-specific immunity in the lung by intranasal (i.n.) delivery of the lipoprotein i (opri) from pseudomonas aeruginosa. opri has shown to be a toll-like receptor / agonist that, when given subcutaneously, induces type- immune responses against heterologous antigens. here, a fusion of opri to ag a of mtb (opri-ag a) was used as a subunit vaccine in homologous prime-boost immunizations. in addition, opri-ag a was combined with an ag a-encoding dna vaccine (ag a dna) or with bcg in heterologous prime-boost vaccinations. intranasal and parenteral delivery with opri-ag a elicited comparable t-cell responses in the spleen; in addition, i.n. delivery elicited specific t-cell responses in the lung lymph nodes (llns). intramuscular delivery of ag a dna induced significant systemic th immune responses. intranasal boosting with opri-ag a enhanced this response and in addition induced an antigen-specific ifn-g response in lln. opri may therefore be an efficient adjuvant for mucosal boosting. we continue to evaluate the protection induced by opri-based prime-boost vaccinations against pulmonary tb. results on the immunogenicity and protection against intravenous mtb h rv infection will be presented. toll-like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress-associated molecules. tlr-ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus-induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus-encoded inhibitor of tlr-signalling a r or dominant-negative myd totally inhibited hsv-induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv-induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr-dependent and -independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. - -oligoadenylate synthetases are interferon-induced, double-stranded rna-activated antiviral enzymes which are the only proteins known to catalyse -specific nucleotidyl transfer. this first crystal structure of a - oligoadenylate synthetase reveals a structural conservation with the -specific poly(a) polymerase that, coupled with structure-guided mutagenesis, supports a conserved catalytic mechanism for the -and -specific nucleotidyl transferases. comparison with structures of other superfamily members indicates that the donor substrates are bound by conserved active site features while the acceptor substrates are oriented by nonconserved regions. the - oligoadenylate synthetases are activated by viral doublestranded rna in infected cells and initiate a cellular response by synthesizing - -oligoadenylates, that in turn activate rnase l. this crystal structure suggests that activation involves a domain-domain shift and identifies a putative dsrna activation site that is probed by mutagenesis. we demonstrated that this site is required both for the binding of dsrna and for the subsequent activation of oas. this rna-binding site is different from known rna-binding site; rather than forming a defined three-dimensional domain, it is located at the interface of the two major domains in oas. this novel architecture ensures that the dsrna helix can make simultaneously contact with both domains of oas and ensure the subsequent structural rearrangement leading to the activation of oas. our work provides structural insight into cellular recognition of double-stranded rna of viral origin and identifies a novel rna-binding motif. bacteria-specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody-treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as faba (monovalent) deprived of fca which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody-coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero-steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type- polysaccharide-induced phagocytosis of iga protease-deficient type- pneumococci equally well in the absence as in the presence of complement. iga antibody to type- polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type- polysaccharide served as opsonin. iga antibody extracted from iga protease-producing target bacteria was almost exclusively in the form of faba. conversely, iga from protease-deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody-mediated opsonophagocytosis. besides, in these experiments, iga-mediated opsonophagocytosis was independent of complement. vitamins e and c have been found to increase the cellular and humeral immunity of pigs. vitamin e deficiency has also been found to predispose pigs to different diseases, e. coli infection is one among them. after weaning, the vitamin e status of pigs often decreases to a critical low level. in this experiment, we studied whether vitamin c supplementation would be a possible feeding strategy to optimize the immune status of weaners. the interaction between vitamin e and c is interesting due to the reported sparing action on vitamin e or synergism between these to vitamins. piglets were weaned at day of age from sows fed increasing dietary vitamin e during lactation, and piglets were during the following weeks fed either a control diet or this diet supplemented with mg stay-c per kg. blood sampling was obtained weekly from day and until day of age. on the same days, one piglet per dietary treatment was killed and alveolar macrophages (am) were harvested. vitamin c supplementation increased the concentration of igm in serum of piglets throughout the weaning period. although the vitamin e concentration in am decreased with increasing age of the piglets, the concentration was numerically higher in piglets of sows fed the high dietary level of vitamin e. however, vitamin c supplementation tended to increase the total am concentration of vitamin e after weaning and increased the proportion of the biologically most active isomer of vitamin e [rrr-(a-tocopherol)] in the am. the eicosanoid synthesis by am was not influenced by the vitamin c supplementation, but the synthesis of leukotriene b was decreased weeks after weaning compared to other days of am harvesting. in conclusion, dietary vitamin c supplementation improved the immune responses of piglets after weaning. a whole blood stimulation assay with escherichia coli (o :b ) endotoxin was established to measure the capacity of dairy cows to produce the proinflammatory cytokine tumour necrosis factor-a (tnf-a) ex vivo. initially, a time-and dose-dependent study was carried out to find the optimal stimulation conditions for the tnf-a response. the tnf-a response peaked between and h at . c. a dose in the range of - g of e. coli lipopolysaccharide (lps)/ml whole blood was found to give the maximum tnf-a response. thirty-eight danish-holstein dairy cows were investigated for their tnf-a responsiveness ex vivo in the periparturient period. heparin-stabilized blood samples were collected seven times over a period of months (weeks À , À , , , , and around calving) and stimulated with g/ml of e. coli lps. indeed, fluctuations in the tnf-a responsiveness occurred over time. moreover, the mean tnf-a responsiveness of cows was found to be significantly increased (p < . ) in the weeks close to calving. however, in the more stabile physiological periods, some cows had a consistently low tnf-a response, whereas others had high a tnf-a response. we are currently investigating whether high and low tnf-a responders to e. coli lps also exist in dairy cows in vivo. moreover, the importance of tnf-a responsiveness ex vivo to dairy cows' susceptibility and clinical response to experimental e. coli infections in the udder is being investigated. coelomic cytolytic factor (ccf) is a kda invertebrate pattern recognition molecule isolated from the coelomic fluid of the earthworm eisenia foetida (oligochaeta, annelida). ccf displays a number of similarities with the mammalian cytokine tumour necrosis factor-a (tnfa) as a result of a shared n,n -diacetylchitobiose lectin-like domain. however, these similarities are solely functional and are not based on any (dna or amino acid) sequence homology, thus suggesting a form of convergent evolution. in particular, the lectin-like domain of tnf-a has been shown to induce membrane depolarization in various mammalian cell types, through interactions with endogenous amiloride-sensitive ion channels. this nonreceptor-mediated activity of tnf-a has been reported to be involved in the resorption of oedema. likewise, the lectin-like domain of ccf also induces membrane depolarization in mammalian cells. here, we show that ccf appears to be able to induce oedema resorption in an alveolar epithelial cell line through its lectin-like domain. this lectin-like domain of ccf interacts (directly or indirectly) with endogenous sodium and/or chloride channels, and not potassium channels, on mammalian cells. additionally, we suggest that the jnk/sapk and erk / pathways are involved in ccf-induced macrophage activation. these results further establish the functional analogy between an invertebrate pattern recognition molecule and a mammalian cytokine and, from a more applied point of view, suggest the possibility of utilizing ccf in the treatment of oedema. release of svegf and svegfr from white blood cells and platelets during surgery and stimulation with bacterial antigens introduction: the influence of surgery on release of soluble vascular endothelial growth factor (svegf) and the soluble vascular endothelial growth factor inhibitory receptor (svegfr ) is unknown. we studied the effect of major and minor surgery on potential variations in svegf and svegfr concentrations in vivo and on bacterial antigen-induced release of svegf and svegfr from whole blood in vitro. methods: sixty-one patients with abdominal diseases undergoing five different surgical procedures were included. blood samples were drawn from anaesthetized patients before and after the operation. white blood cells and platelets were counted, and plasma svegf and svegfr was determined by an elisa method. whole blood from each blood sample was stimulated in vitro with bacteria-derived antigens (lps or protein-a) and svegf and svegfr levels were subsequently determined in the supernatants. stimulation with isotonic saline served as control assay. neither svegf or svegfr in plasma changed during surgery. in vitro stimulation of blood samples with bacteria-derived antigens resulted in a significant increase in svegf (p < . ) and a less pronounced but still significant increase in svegfr . release of svegf due to stimulation was significantly higher after the operation (nonsignificant), whereas svegfr release remained largely unchanged after surgery. correlation between bacterial antigen-induced release of svegf and neutrophile cell count was highly significant (p < . ). there was no correlation between svegf and platelet cell count, and bacterial antigen-induced svegfr release did not correlate with counts of neutrophils and platelets. conclusions: plasma svegf and svegfr concentrations did not change during surgery. in vitro bacterial stimulation led to increased release of svegf and svegfr , which was not significantly amplified during surgery and which may be related to number of circulating neutrophils. natural killer cell functions and subsets after in vitro stimulation with il- and il- , with special emphasis on intracellular ifn-g and nk-cell cytotoxicity r. nyboe, , t. rix, , j. krog, , e. tønnesen & m. hokland department of anaesthesiology and intensive care, aarhus university hospital, and institute of medical microbiology, and immunology, university of aarhus, aarhus, denmark. e-mail: rnsr@studmed.au.dk materials and methods: isolated cryopreserved human peripheral blood mononuclear cells (pbmcs) were stimulated with il- and il- . this stimulation has previously been shown to activate nk cells. cell cytotoxicity was measured by flow cytometry after incubation with k cells. this method was compared to the current standard cr release assay. cells were treated with bfa to accumulate ifn-g, stained for surface markers, permeabilized and stained for intracellular ifn-g. flow cytometry was then performed to measure intracellular ifn-g production in pbmc, especially in nk cells. results: we have demonstrated that stimulation with il- and il- is effective in increasing the number of ifn-gpositive cells. there is a distinct difference between the cd -cd dim and the cd -cd bright subsets, with a much greater proportion of ifn-g-positive cells in the cd -cd bright subset. the effects of stimulation with il- and il- on cytotoxicity will be presented, as will the relation between ifn-g production and cytotoxicity. in addition, we will present results of these assays applied to porcine cells. discussion: in combination, these tests will address nk cell function by combining cytotoxicity with ifn-g production in nk cell subsets. the results will demonstrate whether this could serve as a useful tool in describing nkcell function, which could be of value in clinical and experimental settings. culture of regulatory t-cell lines from bronchial mucosa t lymphocytes play a major role in many immune responses. in the last decade, special focus has been on the function of th and th effector cells. now the importance of regulatory cd þ cd þ t cells in maintenance of the immunological homeostasis emerges. sarcoidosis is a multisystem granulomatous disorder often affecting the lungs. the typical sarcoid granulomas consists of epitheloid cells, macrophages and lymphocytes, mainly cd þ t cells of th phenotype. we have cultured t cells from bronchial biopsies of patients with sarcoidosis as well as from controls in high levels of interleukin (il- ) and il- and demonstrate spontaneously arising cd þ cd þ populations and high concentrations of il- in these cultures. the main difference between cultures of sarcoid origin compared to controls is a very much higher concentration of the inflammatory cytokines il- and tnf-a in cultures of sarcoid origin. the effects of hyperbaric exposure on human peripheral blood mononuclear cells, with special emphasis on natural killer cell cytotoxicity and subsets materials and methods: as an experimental physiological stress model, we examined the effects of hyperbaric exposure on peripheral blood mononuclear cells (pbmcs) obtained from venous blood drawn from eight divers during a simulated heliox saturation dive. eight persons working in normobar atmosphere outside the pressurized chamber served as control donors. the spontaneous cytotoxicity of the pbmcs was estimated in a h cr-release assay using k as nk-sensitive target cells. the pbmcs were characterized, using -colour flow cytometry, with special emphasis on the nk-cell subsets. the data were statistically analysed using a multivariate regression model (stata . ). p values < . was considered statistically significant. results: the estimated cytotoxicity increased significantly in both the group of divers and control donors during the dive (pdivers < . and pcontrols < . ). although the cytotoxicity increased relatively more (p < . ) in the group of divers compared to the group of control donors between day and . discussion: the increased cytotoxicity of pbmc estimated in the group of divers indicate that parts of the cellular immune system are affected during the extreme physiological conditions induced during the initial phase of the presented experimental hyperbaric setup. the increase in cytotoxicity observed in the group of control donors could hypothetically reflect the stress level in persons working outside the pressurized chamber during the dive. the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin- (il- ), il- and transforming growth factor (tgf)-b are important regulators of chronic inflammatory disease, where cutaneous lymphocyteassociated antigen (cla) and ae integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue-specific homing but may help to retain t cells within epithelial layers. we have previously shown that il- alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd þ but not cd þ t cells. while il- increased superantigen-stimulated expression of cla, this cytokine strongly inhibited the cd expres-sion, and a combination of il- and tgf-b completely abrogated the induced cd expression. conversely, il- suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th -mediated inflammatory responses, il- may also inhibit the migration of cd þ t cells into the skin while il- promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il- and il- , and the balance between these cytokines could influence the t-cell migration of inflammatory cells into epithelial tissues. during contact sensitivity reaction, immune cells proliferate. in order to study the histological picture of these proliferation phases, we used a mouse model of contact sensitivity in the oral mucosa and on skin. we also used bromodeoxyuridin (brdu, an analogue to thymidin) that is incorporated into the nucleus during cell replication. the hapten oxazolone (oxa) was used to sensitize and elicit the oral mucosa and/or the ear skin. mice were killed at various times after elicitation, and unsensitized animals were also exposed to the hapten as controls. brdu ( mg/ kg animal) was injected i.p. h before the kill. specimens from the oral mucosa, ear skin and submandibular and auricular lymph nodes were cut and fixed in % paraformaldehyde. they were then treated with acid and biotinylated anti-brdu antibody and developed using abc-kit and dab. the analyses were performed using a leica light microscope and the computer program analysis. in the oral mucosa, the frequency of proliferating cells were increasing during the observation period, - h after elicitation, regardless of site of sensitization. the proliferating cells were found mainly in the basal cell layer of the epithelium. similar patterns were found in ear skin. the regional lymph nodes demonstrated a few scattered proliferating cells h after elicitation. after h, these cells were found frequently in the whole lymph node. control animals exhibited considerable less proliferating cells at all times. we conclude that most proliferating cells were found h after elicitation locally at the hapten-exposed sites (the oral mucosa or the ear skin) as well as in the regional lymph nodes. the endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective anti-inflammatory effects. adenosine acts via four adenosine receptors of which the a a receptor is the predominant form in t cells. adenosine levels are elevated in asthmatic lung, and adenosine can directly induce mast cell degranulation and bronchoconstriction in these patients. instead, the role of anti-inflammatory mechanisms of adenosine on t cells in asthma is unclear. aim: to study the a a receptor expression in peripheral blood cd þ t cells in asthmatic and healthy individuals using flow cytometric and quantitative real-time pcr methods. results: unstimulated cd þ cells of asthmatic patients expressed significantly lower levels (p < . ) of a a receptor in protein level (mean percentage of cells positive ae sem: . ae . , n ¼ ) compared to healthy individuals ( . % ae . , n ¼ ). double staining for cd expression showed that stimulation of cd þ cells decreased a a expression in both groups but indicated that the detected lower levels of a a in unstimulated cells of asthmatics was not due to preactivation in these patients. surprisingly, a a mrna expression in unstimulated cd þ cells was significantly higher (p < . ) in asthmatics (n ¼ ) compared to healthy controls (n ¼ ). the expression did not correlate with serum total ige levels. conclusions: asthmatic individuals express less a a adenosine receptor on their peripheral cd þ t cells. the higher mrna levels instead may point to a negative feedback regulation in the receptor expression. the role of possibly decreased adenosine-mediated anti-inflammatory effects in asthma pathogenesis require further studies on this t-cell mediated disease. the chronic inflammatory skin disease atopic eczema (ae) affects almost % of the population in many countries today. the pathogenesis of ae is not fully understood. a combination of genetic predisposition and environmental factors like microorganisms seems to contribute to the symptoms. the yeast malassezia sympodialis is part of our normal skin micro flora but can act as an allergen and elicit specific ige and t-cell reactivity in patients with ae. recently, we identified a novel major m. sympodialis allergen, designated mala s ( . kda), with sequence similarity to the mitochondrial enzyme manganese superoxide dismutase (mnsod). interestingly, mala s has a high degree of homology to human mnsod. the aim of this study was to examine the effects of recombinant mala s on antigen-presenting dendritic cells. monocytederived dendritic cells (mddcs) from healthy blood donors were cultured with or without mala s for different time periods. it was found that the maturation marker cd and the costimulatory molecules cd and cd were upregulated on the mddcs exposed to mala s for h, as demonstrated by flow cytometry. furthermore, coculture of mddcs with mala s for h induced an increased production of the inflammatory cytokines il- ( -fold), tnf-a ( -fold) and il- (sixfold), as detected by the cytometric bead array (cba) analysis. our results suggest that mala s affects the immune response through dc maturation and production of inflammatory cytokines. the potential cross-reactivity with human mnsod needs to be explored and the exact role of mala s in the pathogenesis of ae assessed in clinical studies involving skin prick and atopy patch tests. allergen-specific immunotherapy (sit) is commonly conducted with allergen extracts adsorbed to aluminium hydroxide (alum). drawbacks linked to the use of alum, such as the formation of granuloma at the site of injection, have led to suggestions of novel allergen carriers. an alternative carrier is mm carbohydrate-based particles (cbps). in mouse, allergen-coupled cbps have been demonstrated to skew the allergen-specific immune response towards a th -like activity (grönlund et al. immunology, ) . we here coupled the recombinant major cat allergen fel d to cbps (cbp-fel d ) by cyanogen-bromide activation, resulting in covalent binding. the effect of cbp-fel d on monocyte-derived dendritic cells (mddcs) from healthy human blood donors was studied. we found that the majority of the cd a þ mddcs were capable of taking up fitc-labelled cbp-fel d , as demonstrated by flow cytometry and confocal laser scanning microscopy. furthermore, incubation with cbp-fel d resulted in an upregulation of the costimulatory molecule cd on the mddcs, which was not observed with fel d or cbps alone. finally, cbp-fel d induced a fivefold increase in the release of the pro-inflammatory cytokine tumour necrosis factor (tnf)-a and a fourfold increase in the release of the chemokine interleukin- from mddcs. taken together, the effects cbps possess make them interesting as novel allergen carriers for sit. the cysteine protease der p from dust mite of the genus dermatophagoides pteronyssinus is a major type i allergen. about % of house dust mite (hdm) allergic individuals are reactive to this protease in standard assays for detection of ige. a curative treatment for atopic allergy is immunotherapy (it) with hdm extracts which are complex mixtures occasionally resulting in anaphylactic reactions. novozymes focuses on developing a recombinant variant of der p which exhibit lowered risk of ige-mediated allergic reactions, while maintaining its ability to trigger proper th-cell responses. this may provide a safer alternative for specific it of hdm allergy. a secreted recombinant form of pro-der p expressed by saccharamyces cerevisiae was obtained by fusion of the pro-enzyme to a fungal signal peptide. the n-glycosylation site of der p was mutated resulting in a deglycosylated pro-enzyme with a molecular mass of kda. protein purification procedure was developed to obtain nearly pure der p protein followed by determination of concentration by active-site-titration with the cysteine protease inhibitor e . the deglycosylated recombinant pro-der p revealed immunologic similarity to the native der p molecule when compared in basophile histamine release, ige-binding assays and t-cell proliferation assays. by in silico epitope mapping of a modelled -dimensional structure of der p , five putative igg and ige epitopes were predicted. by protein engineering, the predicted epitopes were removed one by one in der p and screening for hypoallergenic variants was performed. combining inhaled long-acting b- agonist (laba) and inhaled corticosteroid (ics) seems to offer asthma control at a lower dose of ics than achieved by ics alone. fine mapping of t-cell surface markers by flow cytometry offers a detailed status of the individual's inflammatory response. the frequency of mt (cd þ cd ra -cd l þ cd adim) and mt (cd þ cd ra -cd l -cd abright) cells in peripheral blood, and their ratio, has been shown to differ predictably in atopics and patients with leprosy, where mt correlates with a th phenotype and mt with a th phenotype. stable asthmatics, requiring fluticasone propionate (fp) - mg daily or equivalent, were randomized to receive, double-blinded, either seretide [salmeterol and fluticasone propionate (sfc, n ¼ )] mg/ mg bd or fp mg bd (n ¼ ). if asthma was controlled based on lung function and symptoms at clinic visits every weeks, ics dose was tapered until asthma exacerbated or mg was reached. the frequency and ratio of mt and mt t cells of the patients was monitored at week intervals. as treatment tapered, the frequency of mt cells decreased (p ¼ from first to final visit), whereas that of mt cells increased. the ratio of mt /mt decreased (p ¼ from first to final visit). in patients receiving laba þ ics, the fall in mt /mt ratio appeared to be more pronounced than in patients receiving ics alone. thus, the mt phenotype may be associated with stable asthma, whereas an imminent exacerbation may associate with an increase in the mt phenotype. laba may allow for a greater effect of fp on the mt ratio. activation of complement pathways, leading to production of c a and c a anaphylatoxins, has been postulated in the pathogenesis of asthma and allergic airway inflammation. the present study was undertaken to investigate the role of mannan-binding lectin (mbl), an initiator of the lectin pathway of complement, in asthma and allergic rhinitis. mbl levels and mbl-induced complement activity were determined in patients of bronchial asthma with allergic rhinitis and unrelated, age-matched controls of indian origin. mbl levels and activity were correlated with percent eosinophilia and percent predicted fev values of the patients. association of single nucleotide polymorphisms (snps) in exon and intron of the mbl with the disease, clinical markers, mbl levels and mbl-induced complement activity was analysed using standard statistical tools. significantly higher mbl levels and activity were observed in patients of bronchial asthma with allergic rhinitis as compared to the controls. we identified five snps, of which two, a g in exon and g a in intron of the mbl, were novel. snp g a was significantly associated with the disease (p ¼ . , or ¼ . , % ci: . < or < . ). individuals with 'a' allele at position showed increased mbl levels, activity and disease severity. our results suggest that 'a' allele at position leading to high mbl levels and complement activity may be contributing to the severity of bronchial asthma and allergic airway inflammation. serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid-encoded, surface-exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h-binding proteins of approximately - kda has been described. the ospe-related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe-related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h-binding regions of ospe-related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c-terminal regions of both human and mouse factor h (scrs - ) specifically bind to ospe-related lipoproteins. we also found fhr- , whose c-terminal scrs - are homologous to scrs - of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i-v) in ospe that could directly interact with factor h. deleting the c-terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c-termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c-terminal-binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h-binding regions were mutated to alanines, we observed that lysines in the factor h-binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe-related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c-termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h-binding proteins may account for their susceptibility to serum lysis. role of yada, ail and lipopolysaccharide in serum resistance of yersinia enterocolitica serotype o: mannan-binding lectin (mbl), l-ficolin and h-ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l-ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type- , - , - , - and - ). h-ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h-ficolin initiated activation of complement factor c , whereas l-ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . mg of mbl/ml, . mg of l-ficolin/ml and . mg of h-ficolin/ ml, respectively. the absence of early complement components (c , c and c but not c ) is a predisposing factor for systemic lupus erythematosus (sle). recently, we demonstrated that, in c -deficient (c def.) mice, igm-containing immune complexes (igm-ic) are filtered by the splenic barrier of marginal zone macrophages (mzm), resulting in an increased immune response against antigens within these igm-ic, but this could not be observed in wildtype or c def. mice. we hypothesized that splenic cd b þ mzm play an important role in the induction of autoimmunity, and we therefore analysed their cytokine profile after isolation with the help of magnetic antibody cell sorting. mrna was isolated, and real-time pcr was performed with specific primers for murine ifn-g (ifn-g), interleukin- (il- ) and ifn-a (ifn-a). we observe a moderate increase of il- and ifn-g mrna in cd b þ cells of c def. mice compared to wildtype cells. surprisingly, the concentration of ifn-a mrna is six times higher in c def. mice. preliminary results suggest that mrna in cd b þ cells of c def. mice is even lower than that in wt. six hours following i.v. application of mg of a abstracts .................................................................................................................................................................................................. murine monoclonal igm anti-dsdna antibody, production of il- , ifn-g and ifn-a mrna is increased in cd b þ cells of both c def. and wt mice. several references described increased levels of inf-a in patients with sle. dendritic cells are discussed as a major source of ifn-a. our observation that c -deficient, sle-susceptible mice demonstrate an increased spontaneous ifn-a production by splenic cd b þ marginal zone macrophages could be an early sign and a trigger for the development of sle. this is supported by the fact that the absence of c is not a predisposing factor for sle and our observation that c def. animals display low levels of ifn-a mrna. - million people worldwide and represents one of the leading causes for liver cirrhosis and hepatocellular carcinoma. control over the hbv infection is achieved mainly by vaccination with hepatitis b surface antigen (hbsag). hbsag contains n-linked glycosylation side and is recognized by both mbl-a and mbl-c in a cadependent manner. hbsag-mbl complexes activate complement and may thus affect humoural immunity. to investigate the role of mbl in humoural responses to hbsag, we immununized mice that lack both mbl-a and mbl-c proteins with soluble hbsag. it has been shown that deficiencies in other complement components like c q, c and c result in decreased antibody responses. however, mbl double ko animals mounted dramatically increased humoural responses. after priming, mbl double kos mounted hbsag-specific igm responses, which were threefold higher than wt controls. after boosting the hbsag, total igg was -fold higher in mbl ko than in wt control animals. similar to the response to hbsag, other glycosylated soluble antigens (e.g. invertase) induced better humoural responses in mbl double ko animals, suggesting that mbl plays an important role in a negative feedback regulation of adaptive immunity. reconstitution experiments with rmbl partially rescued the ko phenotype. we propose that the clearance of glycoprotein antigens in mbl ko is handled differently from the wt, resulting in better stimulation of humoural responses. alternatively, glycoprotein-ag-mbl-rich complexes inhibit b-cell responsiveness via putative mbl receptors. the complement system is an important part of the innate immune system. the activation of complement proceeds through three different pathways that converge in the generation of c -activating enzyme complexes. complement activation via the lectin pathway is initiated when recognition molecules, mannan-binding lectin (mbl) or ficolin, bind to carbohydrate structures characteristic for microbial surfaces. in the circulation, mbl and ficolins are found in association with three structurally related mblassociated serine proteases (masp)- , - and - and a small, nonenzymatic component, map . masp- has been shown to elicit complement activation through the sequential proteolytic cleavage of c and c upon binding of mbl/masp- complexes to microbial surfaces. we have recently uncovered a polymorphism in the masp- /map gene in a patient shown to be deficient in the lectin pathway of complement activation. the polymorphism results in a single amino acid substitution in the n-terminal part of the masp- protein. recombinant wildtype masp- and masp- containing the amino acid substitution in question was produced, and the ability to activate complement was studied. the mutation had a profound impact on masp- function, resulting in the lack of complement activation through the lectin pathway. elisa-based experiments showed that the mutation leads to the impairment of complement activation through influencing the binding of masp- to mbl or ficolins. deficiencies in the lectin pathway of complement activation have so far been accounted for only by lack of functional mbl. the mutation described above is the first defect described affecting both activation through mbl and the ficolins. .................................................................................................................................................................................................. th , th and treg cell balance. dcs are present in the gut mucosa and may thus be target for modulation by gut microbes, including ingested probiotics. here, we tested the hypothesis that species of lactic acid bacteria, important members of the gut flora, differentially activate dc. a large panel of human gut-derived lactobacillus and bifidobacterium spp. was screened for dc-polarizing capacity by exposing bone marrow-derived murine dc to lethally irradiated bacteria. cytokines in culture supernatants and dc-surface maturation markers were analysed. substantial differences were found among strains in the capacity to induce interleukin- (il- ) and tumour necrosis factor (tnf)-a, while the differences for il- and il- were less pronounced. bifidobacteria tended to be weak il- and tnf-a inducers, while both strong and weak il- inducers were found among the strains of lactobacillus. remarkably, strains weak in il- induction inhibited il- and tnf-a production induced by an otherwise strong cytokine-inducing strain of lactobacillus casei, while il- production remained unaltered. selected strains were tested for induction of dc maturation markers. those lactobacilli with greatest capacity to induce il- were most effective in upregulating surface mhc class ii and cd . moreover, l. casei-induced upregulation of cd was reduced in the presence of a weak il- inducing l. reuteri. in conclusion, human lactobacillus and bifidobacterium spp. polarize differentially dc maturation. thus, the potential exists for th /th /treg-driving capacities of the gut dc to be modulated according to composition of gut flora including ingested probiotics. the intestinal micro flora is indispensable in developing and maintaining homeostasis of the gut-associated immune system. evidence indicates that lactic acid bacteria (lab), e.g. lactobacilli and bifidobacteria, have beneficial effects on the host. established health effects include increased gut maturation, antagonisms towards pathogens and immune modulation. the objective of this study is to evaluate the immunomodulating properties of a range of lab of human origin. as dendritic cells (dcs) play a pivotal role in the balance between tolerance and immunity to commensal microorganisms, in vitro-generated immature dcs serve as a suitable model for studying the immunomodulating effects of lab. human immature dcs were generated in vitro from monocytes and exposed to lethally uv-irradiated lab. the effect of various species of lab on dcs in direct contact was evaluated. furthermore, the maturation pattern of dcs separated from the bacteria by an epithelial cell layer (caco- cells), which should mimic the intestinal environment, was studied. cytokine secretion (il- , il- and tnf-a) and upregulation of maturation surface markers on dcs (cd and cd ) was measured. different lab induced diverse cytokine responses. some strains were strong il- and tnf-a inducers and others weak. all strains induced il- . different lab also differentially modulated expression of cd and cd on dcs. although some variation in the response to lab of dcs generated from different blood donors was observed, general differences in the effect of the various lab was revealed. experiments with the dc caco- coculture system are ongoing. different species of lab differentially affect dc maturation; this suggets that the gut flora plays a pivotal role in polarization of the immune response. natural killer (nk) cells are cells of the nonspecific immune system lysing altered self-cells. a noncytolytic subset of nk cells may serve a regulatory role by secreting cytokines. bacteria translocating across the gastrointestinal mucosa are presumed to gain access to nk cells, as consumption of certain lactic acid bacteria has been shown to increase in vivo nk cytotoxicity. here, we investigated how human gut flora-derived lactobacilli affect nk cells in vitro, by measuring proliferation and ifn-g production of human nk cells upon bacterial stimulation. cd -cd þ nk cells were isolated from buffy coats by negative isolation using non-nk lineage-specific antibodies and magnetic beads. nk cells were incubated with mg/ml uv-inactivated bacteria or mg/ml phytohemagglutinin (pha) for days. proliferation was assessed by incorporation of radioactive thymidine into nk-cell dna. the ifn-g concentration was measured by elisa. incubation of nk cells with a lactobacillus acidophilus strain increased the proliferation of the nk cells and induced ifn-g production, both to levels comparable to pha stimulation. the proliferative response was further enhanced with autologous monocytes present, probably because cytokines, secreted by monocytes having engulfed bacteria, stimulated the nk cells. in contrast, a lactobacillus paracasei strain caused the nk cells to proliferate only in the presence of monocytes. these results demonstrate that various strains of lactobacilli have the capacity to activate nk cells in vitro, in a monocyte-dependent or -independent way. hence, the encounter of nk cells with lactic acid bacteria will affect nk-cell activation. such activation of nk cells may potentially skew an on-going or subsequent immune response towards a th response. lactobacilli are nonpathogenic gram-positive inhabitants of the normal human intestine known for their healthpromoting effects. in our earlier work, it is shown that human monoclonal antibody isolated from sera of a patient with waldenstrom macroglobulinaemia possess innate antibody characteristics and binds to lactic acid bacteria. according to the immune network model, immunization with this bacteria could induce the perturbations in immune system that might result in production of anti-lactobacillus antibodies, human monoclonal antibody like (ab ) and anti-idiotypic antibody (ab ). in this study, balb/c mice were immunized with two doses of bacteria lactobacillus acidophilus in complete and incomplete freund's adjuvant and phosphate-buffered saline (pbs), respectively. seven days after the last immunization, sera from immunized mice were collected and the presence of lactobacillus-specific ab and ab were determined by elisas. in the sera of immunized mice, antibodies specific to bacteria lactobacillus acidophilus were shown. the concentration of lactobacillus-specific antibodies was higher in the sera of hyperimmunized mice (mice immunized with mg of igm dj) than in sera of mice immunized with times lower doses of immunogen ( . mg per doses). moreover, ab and ab antibodies were detected in the sera of lactobacillus-hyperimmunized mice. in this study, we have shown the idiotypic network interactions in mice immunized with bacteria lactobacillus acidophilus. the normal gastrointestinal flora is crucial for the maturation of the acquired immunity via effects on antigenpresenting cells (apcs). here, we have investigated how two types of apcs, monocytes and dendritic cells (dcs), react to different bacterial strains typical of the commensal intestinal flora. purified monocytes and monocyte-derived dcs were stimulated with uv-inactivated gram-positive (lactobacillus plantarum and bifidobacterium adolescentis) and gram-negative (escherichia coli and veillonella parvula) bacterial strains. monocytes produced higher levels of il- p and tnf, as detected by elisa, in response to l. plantarum than to e. coli and v. parvula. in contrast, dcs secreted high amounts of il- p , tnf, il- and il- in response to e. coli and v. parvula but were practically unresponsive to l. plantarum and b. adolescentis. the lack of response to the gram-positive strains correlated with a lower surface expression of toll-like reseptor (tlr ) on dcs compared to monocytes. the surface expression of tlr on dcs was undetectable when analysed by flow cytometry, but blocking this receptor decreased the tnf production in response to v. parvula, indicating that low tlr expression on dcs is sufficient to mount an inflammatory response to gram-negative bacteria. ifn-g increased the expression of tlr on dcs and also potentiated the cytokine response to gram-negative bacteria. our results indicate that, when monocytes differentiate into dcs, their ability to respond to different commensal bacteria dramatically changes, thereby becoming unresponsive to probiotic gram-positive bacteria. these results may have important implications for the capacity of different groups of commensal bacteria to regulate mucosal and systemic immunity. probiotic bacteria, e.g. lactobacillus spp., may improve diseases such as chronic inflammatory bowel disease. we examined cytokine production and phenotypic change after in vitro stimulation of t cells from healthy volunteers using different probiotic strains. methods: t cells were cultured from colonic biopsies from eight healthy volunteers (agnholt and kaltoft, exp clin immunogenet ; : - ) , and dendritic cells were matured from their peripheral blood mononuclear cells. t-cell cultures were stimulated with autologous bacterial sonicate or strains of lactobacillus spp., with and without the addition of dendritic cells. cytokine levels (tnf-a, ifn-g, il- and gm-csf) and phenotype (cd , cd , cd and cd ) were measured on day . results: lactobacillus spp. induced higher productions of tnf-a and il- than did autologous bacteria. in presence of dendritic cells, the production of all cytokines increased. however, the increases of ifn-g and tnf-a were more pronounced in wells with autologous bacteria than in wells with lactobacillus spp. the addition of dendritic cells upregulated cd expression without simultaneous upregulation of cd . the upregulation was pronounced after stimulation with lactobacillus rhamnosus gg compared with autologous bacteria and other lactobacilli. discussion: in presence of dendritic cells, autologous bacteria induced inflammatory cytokines, while probiotics mainly induced regulatory cytokines. lactobacillus rhamnosus gg induced a regulatory phenotype (cd þ ), in part mediated by dendritic cells. future studies will address whether this shift to a cd þ phenotype represents a differentiation into competent regulatory t cells. in a clinical context, such cells might be used for treatment of inflammatory diseases. protein microarrays will play a key role in the postgenomic era and offer a unique possibility to perform highthroughput global proteome analysis. a chip can be printed with thousands of protein probes (e.g. antibodies), the biological sample added (e.g. a proteome) and any binding detected. we aim to develop protein microarrays based on human recombinant scfv antibody fragments for global proteome analysis. the concept of comparing proteomic maps of healthy versus diseased samples will allow diseasespecific proteins to be detected. in fact, antibody microarrays will allow us to perform comparative proteome analysis on any sample format in a species-independent manner, as long as a proteome can be isolated. however, the complexity of proteomes, containing several thousands of different proteins, is a problem. here, we have designed antibody microarrays targeting the water-soluble fraction of a proteome. to this end, an anticytokine antibody array was developed and human dendritic cells (aeactivation) was used as model system. the results showed that our antibody microarrays could be used to examine the cytokine profile in complex samples. furthermore, we have taken the first steps towards comparing our results with those of other technologies on both the protein and gene level. due to the complexity of the model proteome, we also examined the possibility to prefractionate the proteome in a simple one-step procedure (based on size) prior to the labelling step. in more detail, the sample proteome was fractionated into two fractions using membrane devices with different molecular weight cut-offs. the results showed that the fractionation considerably enhanced the assay sensitivity allowing cytokines in the pg/ml range to be readily detectable. the immunomodulatory effect of heat shock protein : immunization with a dna construct based on the malarial antigen fused with a fragment of hsp primes for a th- type of response finding an appropriate adjuvant for human vaccination is crucial. heat shock proteins (hsps) act as adjuvants when coadministered with peptide antigens or given as fusion proteins. however, there is a potential risk of autoimmunity when using the complete molecules, because hsps are evolutionary conserved. to overcome this, we first evaluated the adjuvant effect against two different antigens of a less-conserved fraction of plasmodium falciparum hsp (pf c) and compared it to the whole hsp molecule from trypanosoma cruzi (tchsp ). we found that pf c exhibited similar adjuvant properties as the whole molecule. we later evaluated the adjuvant potential of pf c against the malarial antigen eb in a chimeric dna construct. no appreciable levels of eb -specific abstracts .................................................................................................................................................................................................. antibodies were detected in mice immunized only with the dna constructs. however, dna primed the immune system, because subsequent challenge with the corresponding recombinant fusion proteins elicited a strong th- antibody response. in contrast, no priming effect was observed for ex vivo ifn-g production but stimulation with the hsp-chimeric fusion protein induced a stronger secretion of ifn-g in vitro than other proteins used. these results indicate that the use of hsps is promising in the design of new vaccines. high-throughput proteomics on antibody-based microarrays: the importance of probe and surface design in analogy to dna microarrays, protein microarrays offer a new distinct possibility to perform sensitive highthroughput global proteome analysis. however, the development of the protein microarray technology will place high demands upon the design of both probes and solid supports. the analysis of thousands of heterogeneous proteins on a single microarray requires the use of uniform probes, such as antibodies, directly designed for protein microarray applications. we have recently generated a human recombinant single-chain fv antibody library, genetically constructed around one framework, the ncoder-library, containing  clones. single framework antibody fragments (sinfabs) selected from this library were successfully applied as probes for microarrays providing sensitive detection in the attomol (mass spectrometry) and the zeptomole range (fluorescence). however, the choice of framework is critical. we have shown that the selected ncoder framework displayed excellent functional on-chip stability and arrayed dehydrated probes retained their activity for several months. furthermore, we have addressed the issues of biocompatibility of the solid support and immobilization strategies for our microarray setup. an in-house-designed substrate, macroporous silicon coated with nitrocellulose (map -nc ), displayed properties equal to, or better than, those of five commercially available supports used as reference surfaces. we have also evaluated different coupling strategies, such as adsorption, covalent coupling, diffusion and affinity coupling. using a novel affinity tag, the double-(his) -tag, we increased the binding efficiency of sinfab-molecules to ni þ -coated solid supports, thereby allowing nonpurified probes to be directly applied. the mannan-binding lectin (mbl) pathway is part of the innate immune system providing a first line of defence against infections. mbl and ficolins circulate in complexes with mbl-associated serine proteases (masp- , - and - ). after recognition of a microorganism by mbl, activation of the complement system occurs. masp- and masp- share five domains (making up the so-called a-chain), whereas they have unique protease domains (b-chains). before the identification of masp- , an assay for masp was presented, based on antibodies against the a-chain of masp- . with the new knowledge of the three masps, and the sharing of domains by masp- and masp- , assays specific for the protease domains have to be constructed, if one wishes to measure the proteins individually. we present an assay for quantifying total masp- in plasma and serum samples. the assay is a sandwich-type assay using as catching antibody a monoclonal antibody against the common a-chain of masp- / and a developing secondary antibody against the c-terminal part of the protease domain of masp- . we have used this assay for estimating the normal concentration of the protein as well as the concentration in patients and also for characterizing by gel permeation chromatography the masp- protein in serum. inducible costimulator ligand (icosl) is a costimulatory molecule related to b . (cd ) and b . (cd ). b cells, monocytes, dendritic cells and endothelial cells express icosl. inducible costimulator (icos) interacts with icosl, and this interaction leads to signals involved in isotype switching and the development of immunological memory. hitherto, no polymorphisms of this gene have been described. the aim of this study was to reveal variation of the icosl gene in normal individuals. all eight exons, except exon , were sequenced with flanking introns in healthy blood donors. eight single nucleotide polymorphisms (snps) and two length polymorphisms were found. one of the snps was found in the coding regions of the gene. the base involved was located in exon and caused a conservative amino acid change from valine (gtt) to isoleucine (att). three individuals were heterozygous g/a for the exon polymorphism, while the remaining seven individuals were homozygous for the wildtype g/g. exon encodes the immunoglobulin variable (igv)-like domain of the molecule which is situated outside the cell. this means that the amino acid could be critical for the stability of the molecule or could constitute part of the binding site for icos. the results form the basis for further experiments to find possible associations of the alleles to diseases caused by immune dysregulation. especially, the exon variant is interesting and could play a role for the development of immunological diseases. besides, it would be interesting to see whether both exon alleles are expressed or only the wildtype allele is functional. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. myxovirus a (mxa) is a resistance gtpbinding protein that is specifically induced by treatment with type ifns. for example, ifn-b-induced mxa in blood leucocytes has been used as a biomarker in ifn-btreated patients with multiple sclerosis. however, the degree of specificity of mxa in this regard is unclear, and measurements of mxa protein and/or mrna are not yet suitable for routine clinical use. in an attempt to find new and better reporter genes (and, hopefully, genes and gene products with proven specificity for ifn-a and -b), microarray screenings with u a genechips (affymetrix) were carried using human blood leucocytes and the human lung carcinoma cell line a . we studied the simultaneous expression of , transcripts before and after exposure to human recombinant ifn-a and ifn-b and other antiviral and immunomodulatory cytokines. the results will be presented at the conference. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large-scale screening in specialized laboratories. the read-out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn-a or -b, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. in our laboratory, we have developed a database system, which we believe is of immediate interest to the general scientific community. the database represents a computerbased replacement for the laboratory notebooks used in the majority of research laboratories worldwide. in addition, the database provides an effective tool for organizing and managing laboratory information at all levels, spanning from managing and revising standard operating procedures and producing documentation of research activities to keeping track of data and conclusions. using the commercially available database toolkit software filemaker pro, we have developed a relational database solution for management of laboratory information. the system consists of a hierarchy of five interrelated databases, each pertaining to a separate type of information, namely, overall project information, information relating to individual experiment setups, documentation of daily research activity, generated data and descriptions of standard operating procedures. like other databases, each individual database consists of a number of records, each comprised of a set of fields in which information is entered. in each record, a certain field is reserved to specify the relation of the record to a record in another database at a higher level. thus, the database is essentially five databases linked by a hierarchy of one-to-many relations, organizing information in a folder-like structure. importantly, the database system allows multiple users to access and edit records simultaneously, and the data entered in one database immediately becomes accessible through the other databases. the limitations of laboratory notebooks are apparent when looking for information, which is dispersed throughout one or more notebooks, or possibly on loose sheets of paper or printouts 'somewhere'. the often complicated process of gathering laboratory data or results when writing grant applications or research papers is made considerably easier with the database system. thus, the database solution presented should be broadly attractive to researchers, irrespective of their scientific discipline. an effective sars vaccine is likely to include components that can induce specific cytotoxic t-cell (ctl) responses. the specificities of such responses are governed by hlarestricted presentation of sars-derived peptide epitopes. exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear sequences directly from genomic/proteomic sequence information. the latter was recently established when a causative coronavirus (sars cov) was isolated and full-length sequenced. here, we have combined advanced bioinformatics and high-throughput immunology to perform an hla supertype, genome-wide scan for sars-specific cytotoxic t cell epitopes. the scan includes all nine human hla supertypes in total covering > % of all major human populations. for each hla supertype, we have selected the top candidates for test in biochemical-binding assays. at this time (approximately months after the genome was established), we have tested the majority of the hla supertypes and identified almost potential vaccine candidates. these should be further validated in sars survivors and used for vaccine formulation. we suggest that immunobioinformatics may become a fast and valuable tool in rational vaccine design. rationale: major histocompatibility complex class i (mhc i) molecules monitor the protein content of the cell by binding small derived peptides and presenting them to cytotoxic cd þ t cells. the goal of the human mhc project is to predict the binding strength of any given peptide/mhc complex. this prediction allows the design of peptide-based vaccines. the prediction requires representative binding data from mhc alleles from all the nine hla supertypes. here, we describe the genetic construction, protein production and purification as well as the establishment-binding assays for two recombinant mhc supertype alleles, hla-b* and hla-b* . methods: using the quikchange multisite directed mutagenesis kit (stratagene), codon-optimized genes encoding hla-b* and hla-b* are created. the two mhc i molecules are fermented and purified by ion exchange chromatography, hydrophobic interaction chromatography and size exclusion chromatography. the binding (kd) of natural t-cell epitopes, as well as predicted peptide ligands, is described by radioactive immunoassays (rias) and enzyme-linked immunosorbent assays (elisas). the mhc molecules are biotinylated during expression. results: the expression of mhc i resulted in multiple disulfide bond isomers, which are separated by hydrophobic interaction chromatography and used in subsequent binding studies resulting in the determination of kd for various peptide ligands ranging from strong binders we have previously demonstrated that bioinformatics tools such as artificial neural networks (anns) are capable of performing pathogen-, genome-and hlawide predictions of peptide-hla interactions. these tools may therefore enable a fast and rational approach to epitope identification and thereby assist in the development of vaccines and immunotherapy. a crucial step in the generation of such bioinformatics tools is the selection of data representing the event in question (in casu peptide-hla interaction). this is particularly important when it is difficult and expensive to obtain data. herein, we demonstrate the importance in selecting information-rich data and we develop a computational method, query-bycommittee, which can perform a global identification of such information-rich data in an unbiased and automated manner. furthermore, we demonstrate how this method can be applied to an efficient iterative development strategy for these bioinformatics tools. methods: a large panel of binding affinities of peptides binding to hla a* was measured by a radioimmunoassay (ria). this data was used to develop multiple first generation anns, which formed a virtual committee. this committee was used to screen (or 'queried') for peptides, where the anns agreed ('low-qbc'), or disagreed ('high-qbc'), on their hla-binding potential. seventeen low-qbc peptides and high-qbc peptides were synthesized and tested. the high-or low-qbc data were added to the original data, and new high-or low-qbc second generation anns were developed, respectively. this procedure was repeated times. the high-qbc-enriched ann performed significantly better than the low-qbc-enriched ann in of the tests. conclusion: these results demonstrate that high-qbcenriched networks perform better than low-qbc-enriched networks in selecting informative data for developing peptide-mhc-binding predictors. this improvement in selecting data is not due to differences in network training performance but due to the difference in information content in the high-qbc experiment and in the low-qbc experiment. finally, it should be noted that this strategy could be used in many contexts where generation of data is difficult and costly. interleukin- (il- ), a pro-inflammatory cytokine that is produced by both lymphoid and nonlymphoid cells, has a critical role in modulation of innate and adaptive immunity. its primary function in stimulation of ifn-g production and stimulation of nk-cell-cytotoxic activities makes this cytokine a candidate for cancer immunotherapy. in oral cavity, this cytokine is produced by oral epithelia and carcinoma cells and is related to tumour regression in nude mice bearing salivary adenocarcinoma. however, direct effects of this cytokine on oral cancer cells have not been elucidated. in this project, we investigated il- effect on an oral carcinoma (kb) cell line. with rt-pcr technique, kb-cell line was found to express il- receptors (il- ra and il- rb), indicating that this oral carcinoma line is a target for il- study. we showed that recombinant human il- inhibited kb-cell proliferation by % at concentration of ng/ml (p < . ), whereas ldh release by these cells in treatment group and control groups was comparable, indicating that il- suppression of cell proliferation was not mediated by the induction of cell death. to further address this hypothesis, we found that il- treatment did not induce apoptotic cell death, as studied by dna laddering and tunel assays. in addition, expression pattern of cell death-controlling genes (bcl- and bax) was not altered by this cytokine. findings in these studies indicated that suppression of kb-cell proliferation may be attributed to control of cell cycle, growth arrest or induction of cell differentiation. the data presented in this project could provide an insight of how cancer cell directly responds to il- , as this cytokine is an important regulator of anticancer mechanisms. aloe emodin (ae) is a naturally occurring compound with wide spectrum of biological properties, including antimicrobial, vasorelaxant, immunosuppressive and anticancer actions. this anthraquinone induces apoptosis in several tumour cell lines with special affinity to tumours of neuroectodermal origin. high amounts of nitric oxide (no) released by activated macrophages induce tumour cell death. therefore, we explored the capacity of ae to modulate no-mediated antitumour response in vitro. interestingly, while ae markedly suppressed no release from macrophages alone, it significantly potentiated no production in cocultures of macrophages and c cells, after h of cultivation. accordingly, the viability of c cells cocultivated with macrophages was reduced in the presence of ae. moreover, the observed ae-imposed potentiation of no production in macrophages was closely related to macrophage culture cell density. according to these data, we proposed that no modulator capacity of ae strongly depended on intercellular contact, indicating that macrophage antitumour response was not compromised but even potentiated by ae. immunotherapy represents an attractive fourth-modality therapeutic approach, especially in the light of the shortcomings of conventional surgery, radiation and chemotherapies in the management of metastatic cancer. to this end, a large number of peptide antigens derived from taa have been applied in immunotherapeutic trials for the treatment of various malignancies, e.g. cancers of the breast, prostate and kidney, in addition to haematological cancers. in some cases the response rates have been impressive and no adverse autoimmunity have been observed. a major strategic difficulty associated with these trials relates to the choice of best-suited peptide antigens. the vast majority of the antigens described thus far is not vital for survival and growth of the tumour cells, and immunoselection of antigen-loss variants may therefore prove to be an additional obstacle for the clinical applicability of most of the known peptide epitopes. in this respect, the development of acquired antigen loss during immunotherapy has been demonstrated in several cases. obviously, the development of loss-variant tumour cells implies that these cells acquire a pronounced growth advantage and are left unaffected by further treatment. ideally, target antigens should be derived from proteins required for survival and growth of tumour cells, as antigens with these characteristics would not be inflicted by the development of loss-variant tumour cells. in this respect, several inhibitors of apoptosis proteins (iaps) are universally expressed among tumours and play an important role in tumour cell escape from apoptosis. we have characterized spontaneous t-cell reactivity against iapderived peptides in cancer patients. from the iap survivin, we have characterized peptides restricted to the class i molecules hla-a , a , a , a , b and b . furthermore, we have demonstrated that survivin-specific t cells infiltrate metastatic lesions and that isolated survivinspecific ctls are capable of killing hla-matched tumour cells. survivin-derived peptides are now in clinical trial, and continued work in our lab has demonstrated that other iaps are targets for spontaneous t-cell reactivity in cancer patients. we previously reported that in mice with large progressing t-cell lymphoma tumours, dysfunctions in the antitumour ctl activity occur, associated with an accumulation of splenic arginase-producing myeloid suppressor cells (mscs). in this study, we first demonstrate that both the presence and the activation state of these msc depends on tumour evolution. while in tumour regressors hardly any arginase-producing msc can be found, both the amount and the arginase activity of this population expands from early over late progressors. this gradual induction of mscs is paralleled by an increasing suppression of ctl activity and th , but not th , cytokine production. upon analysing the molecular repertoire of msc in vitro, we found, besides arginase , a well-established marker for alternatively activated myeloid cells or m , a strong upregulation of fizz and ym, two additional recently identified markers for m . further evaluation of molecular markers by microarray analysis in msc yielded genes involved in wound healing (e.g. coagulation factor xiiia), anti-inflammation (e.g. selenoprotein p), immunomodulation (e.g. pd-l ) and fat and sugar metabolism (e.g. leptin receptor). of note, many of these genes are regulated by type cytokines (il- , il- and il- ) and are therefore rather m associated. overall, our data provide new markers for msc in cancer and further establish their m activation state. study. only sp-a showed a significant expression in normal mucosa which was downregulated in crc. as the absolute signal level was below the noise threshold, these results have to be interpreted with caution and require confirmation by direct measurenment of the proteins. our results suggest that there is no major role for the human collectins in colorectal cancer. tetramerization is visualized by sds-page. conclusion: an effective method for the production of highly pure mhc i molecules has been applied to hla-b* and hla-b* , and ria and elisa binding assays for those alleles have been established background: proliferation, differentiation and apoptosis are essential processes in the normal functions of the mammary epithelium. the hypothesis examined in this study is that the transcription factor bcl- is critically important not only for regulating b-cell growth and development but also for mammary epithelial apoptosis. methodology: twenty breast cancer cases and healthy controls were used to investigate whether bcl- protein in involved in breast cancer (grade iii). full length bcl- cdna was retrovirally transduced into eph- cell line. we then used flow cytometry of brdurd-stained cells to investigate the cell-cycle duration of the control and transduced cell lines. tunel was used as a marker of apoptosis to find out differences in the frequencies of apoptotic cells in the control and transduced cell lines. finally, immunohistochemistry staining was performed to detect bcl- in breast cancer (iii). results: restoration of bcl- into eph- cells not only inhibits apoptosis but also prolongs the cell cycle and results in increased cell size and protein content. the results also indicated that the cell-cycle time of bcl- -transduced eph- cells is prolonged by about h, presumably as a result of the action of bcl- at the bcl- at the g /s transition. we found differences in the frequencies of viable and apoptotic cells in cultures of the parent eph- cells, control-transduced eph- cells and bcl- -transduced eph- cells. consistently, we demonstrated that bcl- is expressed in % of high grade of breast carcinoma, which is considered as the most aggressive of tumours. conclusion: together, these results suggest that bcl- is likely to be involved in mammary gland development and carcinogenesis. inflammatory cytokines have a critical role in modulation of both innate and adaptive immunity in response to foreign antigen. they also play an important role in anticancer immunity. for example, they can promote cell-mediated immunity against cancer cells. with their immunostimulatory effects, these cytokines are being tested for cancer treatment in the form of dna vaccine or adjuvant or therapeutic cytokines. direct effect of these cytokines on cancer cell, however, is still unclear. in this project, we investigated whether il- ( and il- can modulate cancer cell proliferation. we employed a simple nonradioactive proliferation (mtt) assay and detection of lactate dehydrogenase (ldh) to test the effect of these recombinant human cytokines on various cancer cell lines, including breast cancer cell line (mcf- ), oral carcinoma cell line (kb), colon cancer cell line (caco- ) and choriocarcinoma cell line (jar). cytokines used in this study had both inhibitory and stimulatory effect on cell proliferation. findings in this project could provide an insight of cancer cell response to these cytokines and this could lead to a consideration on using cytokine as immunotherapy for cancer treatment.capacity of ae to modulate nitric oxide production depended on intercellular contact donor t cells are involved in the antitumour effects observed after bmt. thus, patients receiving t-celldepleted bmt have a higher risk of leukaemia relapse compared to patients receiving nonmanipulated bmt, and patients experiencing graft-versus-host disease (gvhd) have a lower risk of disease relapse than patients who do not experience gvhd. although the importance of donor t cells for the curative action of bmt has been established, the exact mechanisms and molecules involved in this graft-versus-tumour effect remain largely unknown. in a recently initiated project, we have conducted a longitudinal study of t-cell clonotypes in patients who received peripheral blood stem cell grafts after nonmyeloablative conditioning. peripheral blood samples were obtained sequentially after transplant, and the mononuclear cells (mncs) were isolated and cryopreserved. cd þ t cells were isolated from the mncs by use of immunomagnetic beads or facs and analysed for the presence of clonally expanded cells by t-cell receptor clonotype mapping based on rt-pcr and denaturing gradient gel electrophoresis (dgge). using this gel-based methodology, clonally expanded t cells were monitored after transplant and compared to the clinical data of the patients. the preliminary results demonstrates the presence of clonally expanded cd þ t cells at all time points analysed. furthermore, a number of clonotypes persisted for more than months, and other clonotypes emerged during this period. the appearance of newly emerged clonotypes which coincided with clinical gvhd could indicate a role for these t cells in the pathogenesis of gvhd. background: deficiency of the mannan-binding lectin (mbl) pathway of innate immunity leads to increased susceptibility to infections. in patients with colorectal cancer, postoperative infection is associated with poor prognosis. the aim of the present study was to evaluate ( ) the relation between the mbl pathway and postoperative infectious complications and survival of patients resected for colorectal cancer and ( ) the role of mbl as acute phase reactant compared to crp. methods: preoperative mbl concentration, mbl/mblassociated serine protease (masp) activity and crp were determined in serum from patients and healthy controls. the patients were observed for years. postoperative infections, recurrence and survival were recorded. results: the mbl pathway components were increased in the patients (p < . ) compared to healthy controls. low mbl levels were predictive of pneumonia (p ¼ . ), and pneumonia (n ¼ ) was associated with poor survival (p ¼ . , hr ¼ . , % ci . - . ). mbl and mbl/ masp activity could not predict postoperative overall infections. mbl showed no correlation (spearman's r ¼ . , % ci À . - . ) with crp. conclusions: low preoperative mbl levels are predictive of pneumonia, which is associated with poorer survival. mbl concentration and mbl/masp activity was not predictive of other postoperative infections or long-term prognosis. mbl apparently is not a surrogate measure of crp. department of surgery, university hospital of erlangen, erlangen, germany. e-mail: michael.siassi@rzmail.uni-erlangen.de introduction: the human collectins, mannan-binding lectin (mbl), surfactant protein-a (sp-a) and surfactantprotein-d (sp-d) play a central role in the innate immune system. immunological responses to malignant transformation of epithelial cells gained increasing interest recently. a former study could demonstrate binding of mbl to certain colorectal carcinoma (crc) cell lines in vitro. we therefore examined the expression of human collectins in normal colon mucosa and in colorectal carcinomas. materials and methods: colon samples from crc patients and normal mucosa samples were collected immediately after surgery. the tissue was microdissected and rna isolated (qiagen, rneasy-kit). gene expression profiles were analysed using gene-chips (affymetrix, hg-u ). we analysed the data for the expression of mbl, its associated serine proteases mannan-binding lectinassociated serine protease / (masp / ), sp-a and sp-d. the signal intensity of the genes of interest was compared using the mann-whitney u-test. results: the expression of human collectins in normal human colon mucosa was generally low. only the expression of sp-a and masp- reached the noise threshold of signals. these genes were significantly downregulated in crc specimens. the expression of the other proteins showed no difference in normal mucosa and crc. conclusion: as demonstrated before, the expression of human collectins in normal colon was low in this being the first lymph node to receive drainage from the tumour area, the sentinel node offers a unique possibility to obtain tumour-reactive lymphocytes. we investigated antitumour immune responses in sentinel nodes from patients with bladder cancer, by assaying tumour-specific proliferation and tcr vb repertoires. during tumour surgery, sentinel lymph nodes were identified by peritumoural injection of blue dye. fresh specimens of tumour, sentinel and nonsentinel lymph nodes were obtained, and single-cell suspensions were prepared. cells were assayed for reactivity against autologous tumour extract in [ h]-thymidine incorporation assays and characterized by flow cytometry. parallel analyses of the expression of vb gene families were performed with padlock probes, linear oligonucleotides which upon target recognition can be converted to circular molecules by a ligase. probes were reacted with cdna prepared from magnetically separated cd þ cells, and the tcr repertoire was determined by hybridizing the products to oligonucleotide microarrays. dose-dependent proliferation in response to tumour extract could be detected in sentinel lymph nodes. common clonal expansions were detected among tumourinfiltrating lymphocytes and in sentinel lymph nodes. nonsentinel lymph nodes displayed a divergent tcr vb repertoire. these results indicate an ongoing immune response against tumour antigens in sentinel nodes, draining urinary bladder cancer. identification of sentinel lymph nodes makes it possible to obtain tumour-reactive lymphocytes for use in adoptive immunotherapy. key: cord- - wh kb p authors: melchjorsen, j.; bowie, a. g.; matikainen, s.; paludan, s. r. title: differential requirements for toll‐like receptor signalling for induction of chemokine expression by herpes simplex virus and sendai virus date: - - journal: scand j immunol doi: . /j. - . . r.x sha: doc_id: cord_uid: wh kb p toll‐like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress‐associated molecules. tlr–ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus‐induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus‐encoded inhibitor of tlr‐signalling a r or dominant‐negative myd totally inhibited hsv‐induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv‐induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr‐dependent and ‐independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. the nuclear receptor heterodimers of liver x receptors (lxrs) are recently identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. lxrs and their ligands are negative regulators of macrophage inflammatory gene expression. multiple sclerosis (ms), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. sweden belongs to the countries with a high ms incidence. in italy, incidence is lower, with an exception for sardinia where the incidence is even higher than that in sweden. subjects from sardinia are ethnically more homogeneous and differ from swedes, also regarding genetic background and environment. we studied lxrs and their related molecules of blood mononuclear cells (mncs) from female patients with untreated relapsing-remitting ms from sassari, sardinia and stockholm, sweden. sex-and age-matched healthy controls (hcs) were from both areas. mrna expression was evaluated by real-time pcr. lxr-a was lower (p < . ) in ms (mean ae sem: . ae . ; n ¼ ) compared to hc ( . ae . ; n ¼ ). lxr-a was lower in ms from stockholm ( . ae . ; n ¼ ) compared to corresponding hc ( . ae . ; n ¼ ; p < . ) and compared to ms ( . ae . ; n ¼ ; p < . ) and hc ( ae . ; n ¼ ; p < . ) from sardinia. ms patients from stockholm, but not from sassari, also expressed lower (p < . ) lxr-b (À . ae . ) compared to corresponding hc (À . ae . ). ms from stockholm was associated with higher abca- ( . ae . versus . ae . ; p < . ) and higher estrogen receptor-b-cx ( . ae . versus . ae . ; p < . ) compared to corresponding hc. the hc from sassari had higher androgen receptor ( . ae . ) compared to ms from sassari ( . ae . ; p < . ), ms ( . ae . ; p < . ) and hc from stockholm ( . ae . ; p < . ). ms from sassari had lower cyclooxygenase- compared to corresponding hc ( . ae . versus . ae . ; p < . ) and lower prostaglandin-e (À . ae . ) compared to the hc ( . ae . ; p < . ) and ms ( . ae . ; p < . ) and hc from stockholm ( . ae . , p < . ). our findings identify lxrs and their related molecules as being involved in ms from stockholm but not from sassari, while sex hormone receptors seem to be involved in ms in sassari. multiple sclerosis: ifn-b induces cd + bdca -dendritic cells that produce il- and il- and have no enhanced type i interferon production y. m. huang, s. adikari, u. båve, a. sanna , & g. alm dc antigens (bdca) and investigate their ability to produce type i ifn in response to virus stimulation. we show that ifn-b induces development of cd þ dc from human blood monocytes, which coexpress bdca þ but are negative for bdca -, a specific marker for plasmacytoid dc. such ifn-b-modulated dc produce large amounts of il- and il- , but no il- p and have no enhanced ifn-b and ifn-b production. the findings indicate that ifn-bmodulated dc represent a myeloid dc subset with diminished cd c, bdca- and cd a expression, having potent th -promoting function but lacking antiviral capacity. the association of psoriasis with throat infections by streptococcus pyogenes suggests a potential antigenic target for the t cells that are known to infiltrate dermis and epidermis of psoriatic skin. streptococcal m protein shares an extensive sequence homology with human epidermal keratins. keratins (k ) and (k ) are mostly absent from uninvolved skin but are upregulated in psoriatic lesions. there is increasing evidence that cd þ t cells play an important effector role in psoriasis and m proteinprimed t cells may recognize these shared epitopes in skin via molecular mimicry. to identify candidate epitopes, peptides with sequences from k were selected on the basis of predicted binding to hla-cw and sequence similarities with m protein. matched peptides from the sequence of m protein and a set of peptides with poor predicted binding were also selected. cw þ individuals with psoriasis and cw þ healthy controls, having a family history of psoriasis, were recruited. pbmcs were incubated with the peptide antigens. t-cell activation in the cd þ , cd þ and later the skin-homing cutaneous lymphocyteassociated antigen (cla)-expressing subset of cd þ t cells was evaluated by cd expression and intracellular ifn-g accumulation using flow cytometry. we demonstrate that cw þ psoriasis patients had significant cd þ t-cell ifn-g responses to peptides from k and m protein selected on the basis of sequence homology and predicted hla-cw* binding. these responses were about times more frequent in the skin-homing cutaneous lymphocyte-associated antigen-expressing (cla þ ) subset of cd þ t cells. cd þ t cells showed only borderline responses. cd þ t cells from cw þ nonpsoriatic individuals responded to some m peptides but very rarely to k peptides, and this also applied to the cla þ cd þ subset. these findings indicate that psoriatic individuals have cd þ t cells that recognize keratin self-antigens and that epitopes shared by streptococcal m protein and human keratin may be targets for the cd þ t cells that infiltrate psoriatic skin lesions. autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly % in ra patients and a suggestive involvement in the pathogenesis. the targeted epitopes are generated by a post-translational modification catalysed by the calcium-dependent enzyme peptidyl arginine deaminase that converts the positively charged arginine to polar but uncharged citrullin. the aim of this study was to analyse the presence of citrulline in the joints at different time points of collagen-induced arthritis in da rats by immunohistochemistry and to investigate how immunogenicity and arthritogenicity was affected by citrullination of rat serum albumin (rsa) and collagen type ii (cii). our results indicate that citrulline could be detected in joints of arthritic animals, first appearance at the onset of disease and increasing as disease progressed into a chronic state. unimmunized animals or time points before clinical signs of arthritis were negative. by morphology, we state that some infiltrating macrophages as well as the cartilage surface stain positive for citrulline, while the major source of citrullinated proteins appears to be fibrin depositions. a specific cit-rsa t-cell response was observed in animals challenged by citrullinated rsa, no response was recorded when rsa was used as a stimulus. the igg analysis reveals not only a response towards the modified protein but also cross-reactivity to native rsa. no t-cell or b-cell response was noted in animals injected with unmodified rsa. cit-cii induced a disease with higher incidence and earlier onset than did the native counterpart. we conclude that, in contrast to the human disease, citrulline does not seem to appear before clinical signs. as inflammation proceeds, citrulline is detected specifically in the joints. all other organs investigated were negative. we also conclude that citrullination of a protein can break tolerance and increase its arthritogenic properties. ectopic germinal centers (gcs) can be detected in the salivary glands of approximately / of patients with sjögren's syndrome (ss) and appear in both primary and secondary ss. previously, ectopic gc have been associated with increased local autoantibody production. the aim of this study was to determine whether gc in primary sjögren's syndrome (pss) defines a distinct seroimmunological phenotype. retrospectively, a material of haematoxylin and eosin-stained paraffin-embedded tissue sections of minor salivary gland tissue from patients with pss was morphologically screened for the presence of ectopic gc. gc-like lesions were detected in / ( %) of the pss patients. seventy-two pss patients lacking these structures (gc-) were randomly selected for comparison. focus score was significantly increased in the gc þ patients compared to the gcpatients (p ¼ . ). in the gc þ group, . % of the patients presented with anti-ro/ssa compared to . % in the gcgroup. anti-la/ssb was detected in . % of the gc þ patients compared to . % of the gcpatients. sixty-one percentage of gc þ patients presented with increased levels of igg, a nonsignificant difference when compared to . % in the gcpatients (p ¼ . ). levels of rf, ana, ena, igm and iga were similar in both patient groups, as were esr and crp. in conclusion, patients with ectopic gc have a higher focus score and more often present with autoantibodies and increased levels of igg compared to pss patients with regular focal infiltration (gc -). our findings may indicate a certain seroimmunological phenotype and warrant for further prospective studies. association between mannose-binding lectin and vascular complications in type diabetes complement activation and inflammation have been suggested in the pathogenesis of diabetic vascular lesions. we investigated serum mannose-binding lectin (mbl) levels and polymorphisms in the mbl gene in type diabetic (t dm) patients with and without diabetic nephropathy and associated macrovascular complications. polymorphisms in the mbl gene and serum mbl levels were determined in t dm patients with overt nephropathy and t dm patients with persistent normoalbuminuria matched for age, sex and duration of diabetes as well as in healthy control subjects. the frequencies of high and low expression mbl genotypes were similar in patients with t dm and healthy controls. high mbl genotypes were significantly more frequent in diabetic patients with nephropathy than in the normoalbuminuric group, and the risk of having nephropathy, given a high mbl genotype, assessed by odds ratio was . ( . - . ), p ¼ . . median serum mbl concentrations were significantly higher in patients with nephropathy than in patients with normoalbuminuria [ mg/l (iqr - mg/l) versus mg/l (iqr - ), p ¼ . ], and even when comparing patients with identical genotypes, serum mbl levels were higher in the nephropathy group than in the normoalbuminuric group. patients with a history of cardiovascular disease had significantly elevated mbl levels independently of nephropathy status [ mg/l (iqr - mg/l) versus mg/l (iqr - mg/l), p ¼ . ]. the differences in mbl levels between patients with and without vascular complications were driven primarily by pronounced differences among carriers of high mbl genotypes (p < . ). our findings suggest that mbl may be involved in the pathogenesis of microvascular and macrovascular complications in type diabetes and that determination of mbl status might be used to identify patients at increased risk of developing these complications. neuroimmunology unit, center for molecular medicine, karolinska institutet, stockholm, sweden. e-mail: judit.wefer@cmm.ki.se dna vaccine coding for the encephalitogenic peptide mog - protects lew. av from subsequent development of experimental autoimmune encephalomyelitis (eae). protection is associated with a type immune response and is dependent on the presence of cpg dna motifs. the mechanisms underlying the observed reduction of eae development in protected rats have not been fully clarified. we investigated immunological characteristics of lymphocytes after dna vaccinaton and subsequent eae induction. we confirm that protection was not associated with suppression of t cells, as transcription of the novel molecule rat t-cell immunoglobulin-and mucindomain-containing molecule (tim- ), reported to be exclusively expressed on differentiated t cells, was not altered by dna vaccination. we did not note any clonal deletion upon tolerization, but detected an antigen-specific lymphocyte population upregulating ifng upon recall stimulation weeks after protective dna vaccination. in protected rats, we observed ( ) no alterations in antigenspecific th or th responses, ( ) reduced mhc ii expression on splenocytes early after eae induction, ( ) antigen-specific upregulation of ifnb upon recall stimulation and ( ) reduced il- rb on lymphocytes. we thus demonstrate an association of the protective effect of dna vaccination with expression of ifnb. we are currently investigating the cellular mechanisms behind this ifnb-mediated protection. multiple sclerosis (ms) is an autoimmune condition characterized by degeneration of nerve fibre myelin sheets. a candidate autoantigen, myelin basic protein (mbp), has especially attracted attention. the presence of anti-mbp antibodies is a predictor of definite ms, but their role in the pathogenesis remains obscure. t cells have long been known to play a pivotal role in the pathogenesis of ms. recently, an important role for b cells as autoantigen-presenting cells has been demonstrated in other autoimmune diseases, including rheumatoid arthritis and diabetes. the uptake of mbp by b cells and the presentation of mbp-derive peptides to t helper (th) cells by b cells may be promoted by the formation of complement (c) activating immune complexes (ics) between mbp and natural autoantibodies in healthy individuals and disease-associated anti-mbp antibodies in ms patients, respectively. we have investigated the formation of mbp-containing ic, the binding of mbp to b cells, the mbp-elicited induction of th-cell and b-cell proliferation and the cytokine production in peripheral blood mononuclear cells (pbmcs) from healthy donors grown in the presence of intact or c-inactivated serum from healthy donors or patients with ms. while mbp did not induce measurable proliferation of b cells nor cd þ t cells, we observed the production of tnf-a, ifn-g and il- by pbmc in response to incubation with mbp in the presence of sera from healthy controls as well as sera from ms patients. by contrast, no production of il- , il- and il- was detected. we are currently investigating the capability of ms sera to promote the formation of mbp-containing ic and thereby enhance the cytokine responses, by virtue of elevated anti-mbp contents. the phagolysosomally localized acid sphingomyelinase (asmase) activated by proinflammatory cytokines such as tnf and ifn-g generates the signalling molecule ceramide which in turn results in the activation of proteases like cathepsin d. these characteristics of asmase suggest a possible role of this molecule in the phagocytotic uptake and phagosomal degradation processes of antigens or in antigen presentation. we show here that asmase -/mice fail to eliminate the noncytopathic lymphocytic choriomeningitis (lcm) virus as rapidly as littermate wildtype mice. investigation of the immune response revealed a reduced expansion of cd þ t cells. the secretion of ifn-g in response to contact with target cells as well as the cytolytic activity of virus-specific cd þ t cells was severely impaired. additionally, both phases of the lcm virus-specific dth response, mediated by cd þ and cd þ t cells consecutively, were diminished in asmase -/mice. however, the secondary memory response of virus-specific ctl was not altered, and the abstracts ................................................................................................................................................................................................. virus was effectively controlled for at least months by asmase -/mice. in conclusion, the results of this study suggest an involvement of the asmase in the activation, expansion or maturation of virus-specific cd þ t cells during the acute infection of mice with the lcm virus. novel markers for alternative activation of macrophages: macrophage galactose-type c-type lectins and in parallel with the th /th dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in, for example cytokine environment and pathological conditions. while the best-studied, classically activated macrophage is induced by type i stimuli such as ifn-g, a type ii cytokine environment antagonizes the classical activation of macrophages and is capable of alternatively activating macrophages. however, molecular markers associated with these type ii cytokine-dependent, alternatively activated macrophages remain scarce. besides the earlier documented markers macrophage mannose receptor and arginase , we recently demonstrated that murine alternatively activated macrophages are characterized by increased expression of fizz and ym. we now report that expression of the two members of the mouse macrophage galactose-type c-type lectin gene family, termed mmgl and mmgl , is induced in diverse populations of alternatively activated macrophages, including peritoneal macrophages elicited during infection with the protozoan trypanosoma brucei or the helminth taenia crassiceps, and alveolar macrophages elicited in a mouse model of allergic asthma. we also demonstrate that, in vitro, interleukin- and interleukin- upregulate mmgl and mmgl expression and that, in vivo, induction of mmgl and mmgl is dependent on interleukin- receptor signalling. moreover, we show that regulation of mgl expression is similar in human monocytes and monocyte-derived macrophages. hence, macrophage galactose-type c-type lectins represent novel markers for both murine and human alternatively activated macrophages; thus, paving the way for further characterization of the phenotype of macrophages occurring in th conditions. background: human parvovirus b (b ) is a ubiquitous pathogen, normally causing a mild self-limiting disease, but also capable of causing both significant pathology and long-term persistence. the small size and stability of the virus makes it suitable for mapping of the full breath and the kinetics of the cellular immune responses following acute viral infection. methods: five patients with acute primary b infection were included in the study and followed consecutively for up to weeks. cellular immune responses were mapped by ifng enzyme-linked immunospot to overlapping peptides spanning the whole b genome. results: in all five acutely infected patients, we were able to monitor the kinetics of a strong specific cellular immune reaction. responses peaked at levels of - sfc/ million pbmcs, roughly corresponding to . - . % b specific cd þ cells circulating in peripheral blood at - weeks post-infection. the responses in individual patients were directed to three or four different peptide pools, and the specificity was confined to the same cd epitopes present in the pools throughout the follow-up period. the majority of responses were directed to the virus nonstructural protein, only two patients showed any response to the capsid proteins, elicited by the same epitope in both cases. conclusion: the cellular immune responses to acute b infection are surprisingly narrow in distribution and remain at high levels for up to weeks post-infection. the initial epitope specificity is maintained, and the majority of responses target the virus nonstructural protein, which is not included in vaccine preparations, evaluated against the infection. the relationship between malnutrition and malaria is controversial. on one hand, malaria may cause malnutrition, while on the other, malnutrition itself may modulate susceptibility to the disease. we investigated the association between plasmodium falciparum malaria and malnutrition in a cohort of children living on the coast of kenya. the study involved longitudinal follow-up for clinical malaria episodes and anthropometric measurements at four cross-sectional surveys. we used poisson regression analysis to investigate the association between malaria and nutritional status. compared to baseline (children with a waz or haz score of !À ), the crude incidence rate ratios (irrs) for malaria in children with low haz or waz scores (<À ) during the period prior to assessment were . ( % ci . - . ; ¼ . ) and . ( . - . ; . ), respectively, suggesting no association between malaria and the subsequent development of pem. however, we found that age was acting as an effect modifier in the association between malaria and malnutrition. the irr for malaria in children - years old who were subsequently characterized as wasted was . ( . - . ; p ¼ . ), and a significant overall relationship between malaria and low-haz was found on regression analysis when adjusting for the interaction with age (irr . ; . - . ; p < . ). although children living on the coast of kenya continue to suffer clinical episodes of uncomplicated malaria throughout their first decade, the association between malaria and malnutrition appears to be limited to the first years of life. a. astrinidou-vakaloudi, s. xytsas, i. diamanti, h. ioannidis & p. pangidis microbiology department of general hospital of thessaloniki 'agios pavlos', thessaloniki, greece, and nefrology, nd ika hospital of thessaloniki, thessaloniki, greece. e-mail: stasa@hol.gr aim: renal dysfunction may influence the colonization of gastric mucosa by urea-splitting bacteria such as helicobacter pylori, by increasing urea concentrations in the gastric juice. our aim was to investigate the prevalence of h. pylori in patients with end-stage renal disease (esrd), receiving long-term haemodialysis treatment. methods: this study included sera from patients with esrd ( male and female) undergoing periodic haemodialysis; mean time of treatment was . months. using elisa technique, we investigated the presence of igg and iga antibodies against h. pylori as well as igg caga (antibodies specific for caga(þ) strains of h. pylori). sera from healthy blood donors were used as a control group. results: h. pylori igg antibodies were detected in out of ( %) patients in the dialysis group, while / ( . %) tested positive for iga. igg caga antibodies were present in out of ( . %). prevalence of h. pylori igg, iga and caga igg antibodies in the control group was , and %, respectively. conclusions: although international data suggest that prevalence of h. pylori infection is the same in esrd patients as in healthy individuals, in our study that seems not to be the case. the higher blood and gastric juice urea levels may be a risk factor (among many others), but more studies are required in order to understand the relation of h. pylori infection in this group of patients. flanders interuniversity institute for biotechnology, department of molecular and cellular interactions, free university of brussels, brussels, and pasteur institute of brussels, mycobacterial immunology, brussels, belgium. e-mail: tgartner@vub.ac.be immunity against tuberculosis (tb), caused by mycobacterium tuberculosis, depends largely on activation and maintenance of strong cell-mediated immune responses involving both cd þ and cd þ t cells and the ability to respond with th -type cytokines, particularly ifn-g. recent studies suggested that bcg, the only licensed vaccine against m. tuberculosis, may fail to induce t-cell responses in the lung mucosa and may therefore not protect against pulmonary tb. a decrease in tb mortality may be achieved by enhancing immunity in the lung. the present study evaluated the induction of antigen-specific immunity in the lung by intranasal (i.n.) delivery of the lipoprotein i (opri) from pseudomonas aeruginosa. opri has shown to be a toll-like receptor / agonist that, when given subcutaneously, induces type- immune responses against heterologous antigens. here, a fusion of opri to ag a of mtb (opri-ag a) was used as a subunit vaccine in homologous prime-boost immunizations. in addition, opri-ag a was combined with an ag a-encoding dna vaccine (ag a dna) or with bcg in heterologous prime-boost vaccinations. intranasal and parenteral delivery with opri-ag a elicited comparable t-cell responses in the spleen; in addition, i.n. delivery elicited specific t-cell responses in the lung lymph nodes (llns). intramuscular delivery of ag a dna induced significant systemic th immune responses. intranasal boosting with opri-ag a enhanced this response and in addition induced an antigen-specific ifn-g response in lln. opri may therefore be an efficient adjuvant for mucosal boosting. we continue to evaluate the protection induced by opri-based prime-boost vaccinations against pulmonary tb. results on the immunogenicity and protection against intravenous mtb h rv infection will be presented. toll-like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress-associated molecules. tlr-ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus-induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus-encoded inhibitor of tlr-signalling a r or dominant-negative myd totally inhibited hsv-induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv-induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr-dependent and -independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. - -oligoadenylate synthetases are interferon-induced, double-stranded rna-activated antiviral enzymes which are the only proteins known to catalyse -specific nucleotidyl transfer. this first crystal structure of a - oligoadenylate synthetase reveals a structural conservation with the -specific poly(a) polymerase that, coupled with structure-guided mutagenesis, supports a conserved catalytic mechanism for the -and -specific nucleotidyl transferases. comparison with structures of other superfamily members indicates that the donor substrates are bound by conserved active site features while the acceptor substrates are oriented by nonconserved regions. the - oligoadenylate synthetases are activated by viral doublestranded rna in infected cells and initiate a cellular response by synthesizing - -oligoadenylates, that in turn activate rnase l. this crystal structure suggests that activation involves a domain-domain shift and identifies a putative dsrna activation site that is probed by mutagenesis. we demonstrated that this site is required both for the binding of dsrna and for the subsequent activation of oas. this rna-binding site is different from known rna-binding site; rather than forming a defined three-dimensional domain, it is located at the interface of the two major domains in oas. this novel architecture ensures that the dsrna helix can make simultaneously contact with both domains of oas and ensure the subsequent structural rearrangement leading to the activation of oas. our work provides structural insight into cellular recognition of double-stranded rna of viral origin and identifies a novel rna-binding motif. bacteria-specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody-treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as faba (monovalent) deprived of fca which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody-coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero-steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type- polysaccharide-induced phagocytosis of iga protease-deficient type- pneumococci equally well in the absence as in the presence of complement. iga antibody to type- polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type- polysaccharide served as opsonin. iga antibody extracted from iga protease-producing target bacteria was almost exclusively in the form of faba. conversely, iga from protease-deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody-mediated opsonophagocytosis. besides, in these experiments, iga-mediated opsonophagocytosis was independent of complement. vitamins e and c have been found to increase the cellular and humeral immunity of pigs. vitamin e deficiency has also been found to predispose pigs to different diseases, e. coli infection is one among them. after weaning, the vitamin e status of pigs often decreases to a critical low level. in this experiment, we studied whether vitamin c supplementation would be a possible feeding strategy to optimize the immune status of weaners. the interaction between vitamin e and c is interesting due to the reported sparing action on vitamin e or synergism between these to vitamins. piglets were weaned at day of age from sows fed increasing dietary vitamin e during lactation, and piglets were during the following weeks fed either a control diet or this diet supplemented with mg stay-c per kg. blood sampling was obtained weekly from day and until day of age. on the same days, one piglet per dietary treatment was killed and alveolar macrophages (am) were harvested. vitamin c supplementation increased the concentration of igm in serum of piglets throughout the weaning period. although the vitamin e concentration in am decreased with increasing age of the piglets, the concentration was numerically higher in piglets of sows fed the high dietary level of vitamin e. however, vitamin c supplementation tended to increase the total am concentration of vitamin e after weaning and increased the proportion of the biologically most active isomer of vitamin e [rrr-(a-tocopherol)] in the am. the eicosanoid synthesis by am was not influenced by the vitamin c supplementation, but the synthesis of leukotriene b was decreased weeks after weaning compared to other days of am harvesting. in conclusion, dietary vitamin c supplementation improved the immune responses of piglets after weaning. a whole blood stimulation assay with escherichia coli (o :b ) endotoxin was established to measure the capacity of dairy cows to produce the proinflammatory cytokine tumour necrosis factor-a (tnf-a) ex vivo. initially, a time-and dose-dependent study was carried out to find the optimal stimulation conditions for the tnf-a response. the tnf-a response peaked between and h at . c. a dose in the range of - g of e. coli lipopolysaccharide (lps)/ml whole blood was found to give the maximum tnf-a response. thirty-eight danish-holstein dairy cows were investigated for their tnf-a responsiveness ex vivo in the periparturient period. heparin-stabilized blood samples were collected seven times over a period of months (weeks À , À , , , , and around calving) and stimulated with g/ml of e. coli lps. indeed, fluctuations in the tnf-a responsiveness occurred over time. moreover, the mean tnf-a responsiveness of cows was found to be significantly increased (p < . ) in the weeks close to calving. however, in the more stabile physiological periods, some cows had a consistently low tnf-a response, whereas others had high a tnf-a response. we are currently investigating whether high and low tnf-a responders to e. coli lps also exist in dairy cows in vivo. moreover, the importance of tnf-a responsiveness ex vivo to dairy cows' susceptibility and clinical response to experimental e. coli infections in the udder is being investigated. coelomic cytolytic factor (ccf) is a kda invertebrate pattern recognition molecule isolated from the coelomic fluid of the earthworm eisenia foetida (oligochaeta, annelida). ccf displays a number of similarities with the mammalian cytokine tumour necrosis factor-a (tnfa) as a result of a shared n,n -diacetylchitobiose lectin-like domain. however, these similarities are solely functional and are not based on any (dna or amino acid) sequence homology, thus suggesting a form of convergent evolution. in particular, the lectin-like domain of tnf-a has been shown to induce membrane depolarization in various mammalian cell types, through interactions with endogenous amiloride-sensitive ion channels. this nonreceptor-mediated activity of tnf-a has been reported to be involved in the resorption of oedema. likewise, the lectin-like domain of ccf also induces membrane depolarization in mammalian cells. here, we show that ccf appears to be able to induce oedema resorption in an alveolar epithelial cell line through its lectin-like domain. this lectin-like domain of ccf interacts (directly or indirectly) with endogenous sodium and/or chloride channels, and not potassium channels, on mammalian cells. additionally, we suggest that the jnk/sapk and erk / pathways are involved in ccf-induced macrophage activation. these results further establish the functional analogy between an invertebrate pattern recognition molecule and a mammalian cytokine and, from a more applied point of view, suggest the possibility of utilizing ccf in the treatment of oedema. release of svegf and svegfr from white blood cells and platelets during surgery and stimulation with bacterial antigens introduction: the influence of surgery on release of soluble vascular endothelial growth factor (svegf) and the soluble vascular endothelial growth factor inhibitory receptor (svegfr ) is unknown. we studied the effect of major and minor surgery on potential variations in svegf and svegfr concentrations in vivo and on bacterial antigen-induced release of svegf and svegfr from whole blood in vitro. methods: sixty-one patients with abdominal diseases undergoing five different surgical procedures were included. blood samples were drawn from anaesthetized patients before and after the operation. white blood cells and platelets were counted, and plasma svegf and svegfr was determined by an elisa method. whole blood from each blood sample was stimulated in vitro with bacteria-derived antigens (lps or protein-a) and svegf and svegfr levels were subsequently determined in the supernatants. stimulation with isotonic saline served as control assay. neither svegf or svegfr in plasma changed during surgery. in vitro stimulation of blood samples with bacteria-derived antigens resulted in a significant increase in svegf (p < . ) and a less pronounced but still significant increase in svegfr . release of svegf due to stimulation was significantly higher after the operation (nonsignificant), whereas svegfr release remained largely unchanged after surgery. correlation between bacterial antigen-induced release of svegf and neutrophile cell count was highly significant (p < . ). there was no correlation between svegf and platelet cell count, and bacterial antigen-induced svegfr release did not correlate with counts of neutrophils and platelets. conclusions: plasma svegf and svegfr concentrations did not change during surgery. in vitro bacterial stimulation led to increased release of svegf and svegfr , which was not significantly amplified during surgery and which may be related to number of circulating neutrophils. natural killer cell functions and subsets after in vitro stimulation with il- and il- , with special emphasis on intracellular ifn-g and nk-cell cytotoxicity r. nyboe, , t. rix, , j. krog, , e. tønnesen & m. hokland department of anaesthesiology and intensive care, aarhus university hospital, and institute of medical microbiology, and immunology, university of aarhus, aarhus, denmark. e-mail: rnsr@studmed.au.dk materials and methods: isolated cryopreserved human peripheral blood mononuclear cells (pbmcs) were stimulated with il- and il- . this stimulation has previously been shown to activate nk cells. cell cytotoxicity was measured by flow cytometry after incubation with k cells. this method was compared to the current standard cr release assay. cells were treated with bfa to accumulate ifn-g, stained for surface markers, permeabilized and stained for intracellular ifn-g. flow cytometry was then performed to measure intracellular ifn-g production in pbmc, especially in nk cells. results: we have demonstrated that stimulation with il- and il- is effective in increasing the number of ifn-gpositive cells. there is a distinct difference between the cd -cd dim and the cd -cd bright subsets, with a much greater proportion of ifn-g-positive cells in the cd -cd bright subset. the effects of stimulation with il- and il- on cytotoxicity will be presented, as will the relation between ifn-g production and cytotoxicity. in addition, we will present results of these assays applied to porcine cells. discussion: in combination, these tests will address nk cell function by combining cytotoxicity with ifn-g production in nk cell subsets. the results will demonstrate whether this could serve as a useful tool in describing nkcell function, which could be of value in clinical and experimental settings. culture of regulatory t-cell lines from bronchial mucosa t lymphocytes play a major role in many immune responses. in the last decade, special focus has been on the function of th and th effector cells. now the importance of regulatory cd þ cd þ t cells in maintenance of the immunological homeostasis emerges. sarcoidosis is a multisystem granulomatous disorder often affecting the lungs. the typical sarcoid granulomas consists of epitheloid cells, macrophages and lymphocytes, mainly cd þ t cells of th phenotype. we have cultured t cells from bronchial biopsies of patients with sarcoidosis as well as from controls in high levels of interleukin (il- ) and il- and demonstrate spontaneously arising cd þ cd þ populations and high concentrations of il- in these cultures. the main difference between cultures of sarcoid origin compared to controls is a very much higher concentration of the inflammatory cytokines il- and tnf-a in cultures of sarcoid origin. the effects of hyperbaric exposure on human peripheral blood mononuclear cells, with special emphasis on natural killer cell cytotoxicity and subsets materials and methods: as an experimental physiological stress model, we examined the effects of hyperbaric exposure on peripheral blood mononuclear cells (pbmcs) obtained from venous blood drawn from eight divers during a simulated heliox saturation dive. eight persons working in normobar atmosphere outside the pressurized chamber served as control donors. the spontaneous cytotoxicity of the pbmcs was estimated in a h cr-release assay using k as nk-sensitive target cells. the pbmcs were characterized, using -colour flow cytometry, with special emphasis on the nk-cell subsets. the data were statistically analysed using a multivariate regression model (stata . ). p values < . was considered statistically significant. results: the estimated cytotoxicity increased significantly in both the group of divers and control donors during the dive (pdivers < . and pcontrols < . ). although the cytotoxicity increased relatively more (p < . ) in the group of divers compared to the group of control donors between day and . discussion: the increased cytotoxicity of pbmc estimated in the group of divers indicate that parts of the cellular immune system are affected during the extreme physiological conditions induced during the initial phase of the presented experimental hyperbaric setup. the increase in cytotoxicity observed in the group of control donors could hypothetically reflect the stress level in persons working outside the pressurized chamber during the dive. the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin- (il- ), il- and transforming growth factor (tgf)-b are important regulators of chronic inflammatory disease, where cutaneous lymphocyteassociated antigen (cla) and ae integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue-specific homing but may help to retain t cells within epithelial layers. we have previously shown that il- alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd þ but not cd þ t cells. while il- increased superantigen-stimulated expression of cla, this cytokine strongly inhibited the cd expres-sion, and a combination of il- and tgf-b completely abrogated the induced cd expression. conversely, il- suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th -mediated inflammatory responses, il- may also inhibit the migration of cd þ t cells into the skin while il- promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il- and il- , and the balance between these cytokines could influence the t-cell migration of inflammatory cells into epithelial tissues. during contact sensitivity reaction, immune cells proliferate. in order to study the histological picture of these proliferation phases, we used a mouse model of contact sensitivity in the oral mucosa and on skin. we also used bromodeoxyuridin (brdu, an analogue to thymidin) that is incorporated into the nucleus during cell replication. the hapten oxazolone (oxa) was used to sensitize and elicit the oral mucosa and/or the ear skin. mice were killed at various times after elicitation, and unsensitized animals were also exposed to the hapten as controls. brdu ( mg/ kg animal) was injected i.p. h before the kill. specimens from the oral mucosa, ear skin and submandibular and auricular lymph nodes were cut and fixed in % paraformaldehyde. they were then treated with acid and biotinylated anti-brdu antibody and developed using abc-kit and dab. the analyses were performed using a leica light microscope and the computer program analysis. in the oral mucosa, the frequency of proliferating cells were increasing during the observation period, - h after elicitation, regardless of site of sensitization. the proliferating cells were found mainly in the basal cell layer of the epithelium. similar patterns were found in ear skin. the regional lymph nodes demonstrated a few scattered proliferating cells h after elicitation. after h, these cells were found frequently in the whole lymph node. control animals exhibited considerable less proliferating cells at all times. we conclude that most proliferating cells were found h after elicitation locally at the hapten-exposed sites (the oral mucosa or the ear skin) as well as in the regional lymph nodes. the endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective anti-inflammatory effects. adenosine acts via four adenosine receptors of which the a a receptor is the predominant form in t cells. adenosine levels are elevated in asthmatic lung, and adenosine can directly induce mast cell degranulation and bronchoconstriction in these patients. instead, the role of anti-inflammatory mechanisms of adenosine on t cells in asthma is unclear. aim: to study the a a receptor expression in peripheral blood cd þ t cells in asthmatic and healthy individuals using flow cytometric and quantitative real-time pcr methods. results: unstimulated cd þ cells of asthmatic patients expressed significantly lower levels (p < . ) of a a receptor in protein level (mean percentage of cells positive ae sem: . ae . , n ¼ ) compared to healthy individuals ( . % ae . , n ¼ ). double staining for cd expression showed that stimulation of cd þ cells decreased a a expression in both groups but indicated that the detected lower levels of a a in unstimulated cells of asthmatics was not due to preactivation in these patients. surprisingly, a a mrna expression in unstimulated cd þ cells was significantly higher (p < . ) in asthmatics (n ¼ ) compared to healthy controls (n ¼ ). the expression did not correlate with serum total ige levels. conclusions: asthmatic individuals express less a a adenosine receptor on their peripheral cd þ t cells. the higher mrna levels instead may point to a negative feedback regulation in the receptor expression. the role of possibly decreased adenosine-mediated anti-inflammatory effects in asthma pathogenesis require further studies on this t-cell mediated disease. the chronic inflammatory skin disease atopic eczema (ae) affects almost % of the population in many countries today. the pathogenesis of ae is not fully understood. a combination of genetic predisposition and environmental factors like microorganisms seems to contribute to the symptoms. the yeast malassezia sympodialis is part of our normal skin micro flora but can act as an allergen and elicit specific ige and t-cell reactivity in patients with ae. recently, we identified a novel major m. sympodialis allergen, designated mala s ( . kda), with sequence similarity to the mitochondrial enzyme manganese superoxide dismutase (mnsod). interestingly, mala s has a high degree of homology to human mnsod. the aim of this study was to examine the effects of recombinant mala s on antigen-presenting dendritic cells. monocytederived dendritic cells (mddcs) from healthy blood donors were cultured with or without mala s for different time periods. it was found that the maturation marker cd and the costimulatory molecules cd and cd were upregulated on the mddcs exposed to mala s for h, as demonstrated by flow cytometry. furthermore, coculture of mddcs with mala s for h induced an increased production of the inflammatory cytokines il- ( -fold), tnf-a ( -fold) and il- (sixfold), as detected by the cytometric bead array (cba) analysis. our results suggest that mala s affects the immune response through dc maturation and production of inflammatory cytokines. the potential cross-reactivity with human mnsod needs to be explored and the exact role of mala s in the pathogenesis of ae assessed in clinical studies involving skin prick and atopy patch tests. allergen-specific immunotherapy (sit) is commonly conducted with allergen extracts adsorbed to aluminium hydroxide (alum). drawbacks linked to the use of alum, such as the formation of granuloma at the site of injection, have led to suggestions of novel allergen carriers. an alternative carrier is mm carbohydrate-based particles (cbps). in mouse, allergen-coupled cbps have been demonstrated to skew the allergen-specific immune response towards a th -like activity (grönlund et al. immunology, ) . we here coupled the recombinant major cat allergen fel d to cbps (cbp-fel d ) by cyanogen-bromide activation, resulting in covalent binding. the effect of cbp-fel d on monocyte-derived dendritic cells (mddcs) from healthy human blood donors was studied. we found that the majority of the cd a þ mddcs were capable of taking up fitc-labelled cbp-fel d , as demonstrated by flow cytometry and confocal laser scanning microscopy. furthermore, incubation with cbp-fel d resulted in an upregulation of the costimulatory molecule cd on the mddcs, which was not observed with fel d or cbps alone. finally, cbp-fel d induced a fivefold increase in the release of the pro-inflammatory cytokine tumour necrosis factor (tnf)-a and a fourfold increase in the release of the chemokine interleukin- from mddcs. taken together, the effects cbps possess make them interesting as novel allergen carriers for sit. the cysteine protease der p from dust mite of the genus dermatophagoides pteronyssinus is a major type i allergen. about % of house dust mite (hdm) allergic individuals are reactive to this protease in standard assays for detection of ige. a curative treatment for atopic allergy is immunotherapy (it) with hdm extracts which are complex mixtures occasionally resulting in anaphylactic reactions. novozymes focuses on developing a recombinant variant of der p which exhibit lowered risk of ige-mediated allergic reactions, while maintaining its ability to trigger proper th-cell responses. this may provide a safer alternative for specific it of hdm allergy. a secreted recombinant form of pro-der p expressed by saccharamyces cerevisiae was obtained by fusion of the pro-enzyme to a fungal signal peptide. the n-glycosylation site of der p was mutated resulting in a deglycosylated pro-enzyme with a molecular mass of kda. protein purification procedure was developed to obtain nearly pure der p protein followed by determination of concentration by active-site-titration with the cysteine protease inhibitor e . the deglycosylated recombinant pro-der p revealed immunologic similarity to the native der p molecule when compared in basophile histamine release, ige-binding assays and t-cell proliferation assays. by in silico epitope mapping of a modelled -dimensional structure of der p , five putative igg and ige epitopes were predicted. by protein engineering, the predicted epitopes were removed one by one in der p and screening for hypoallergenic variants was performed. combining inhaled long-acting b- agonist (laba) and inhaled corticosteroid (ics) seems to offer asthma control at a lower dose of ics than achieved by ics alone. fine mapping of t-cell surface markers by flow cytometry offers a detailed status of the individual's inflammatory response. the frequency of mt (cd þ cd ra -cd l þ cd adim) and mt (cd þ cd ra -cd l -cd abright) cells in peripheral blood, and their ratio, has been shown to differ predictably in atopics and patients with leprosy, where mt correlates with a th phenotype and mt with a th phenotype. stable asthmatics, requiring fluticasone propionate (fp) - mg daily or equivalent, were randomized to receive, double-blinded, either seretide [salmeterol and fluticasone propionate (sfc, n ¼ )] mg/ mg bd or fp mg bd (n ¼ ). if asthma was controlled based on lung function and symptoms at clinic visits every weeks, ics dose was tapered until asthma exacerbated or mg was reached. the frequency and ratio of mt and mt t cells of the patients was monitored at week intervals. as treatment tapered, the frequency of mt cells decreased (p ¼ from first to final visit), whereas that of mt cells increased. the ratio of mt /mt decreased (p ¼ from first to final visit). in patients receiving laba þ ics, the fall in mt /mt ratio appeared to be more pronounced than in patients receiving ics alone. thus, the mt phenotype may be associated with stable asthma, whereas an imminent exacerbation may associate with an increase in the mt phenotype. laba may allow for a greater effect of fp on the mt ratio. activation of complement pathways, leading to production of c a and c a anaphylatoxins, has been postulated in the pathogenesis of asthma and allergic airway inflammation. the present study was undertaken to investigate the role of mannan-binding lectin (mbl), an initiator of the lectin pathway of complement, in asthma and allergic rhinitis. mbl levels and mbl-induced complement activity were determined in patients of bronchial asthma with allergic rhinitis and unrelated, age-matched controls of indian origin. mbl levels and activity were correlated with percent eosinophilia and percent predicted fev values of the patients. association of single nucleotide polymorphisms (snps) in exon and intron of the mbl with the disease, clinical markers, mbl levels and mbl-induced complement activity was analysed using standard statistical tools. significantly higher mbl levels and activity were observed in patients of bronchial asthma with allergic rhinitis as compared to the controls. we identified five snps, of which two, a g in exon and g a in intron of the mbl, were novel. snp g a was significantly associated with the disease (p ¼ . , or ¼ . , % ci: . < or < . ). individuals with 'a' allele at position showed increased mbl levels, activity and disease severity. our results suggest that 'a' allele at position leading to high mbl levels and complement activity may be contributing to the severity of bronchial asthma and allergic airway inflammation. serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid-encoded, surface-exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h-binding proteins of approximately - kda has been described. the ospe-related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe-related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h-binding regions of ospe-related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c-terminal regions of both human and mouse factor h (scrs - ) specifically bind to ospe-related lipoproteins. we also found fhr- , whose c-terminal scrs - are homologous to scrs - of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i-v) in ospe that could directly interact with factor h. deleting the c-terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c-termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c-terminal-binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h-binding regions were mutated to alanines, we observed that lysines in the factor h-binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe-related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c-termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h-binding proteins may account for their susceptibility to serum lysis. role of yada, ail and lipopolysaccharide in serum resistance of yersinia enterocolitica serotype o: mannan-binding lectin (mbl), l-ficolin and h-ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l-ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type- , - , - , - and - ). h-ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h-ficolin initiated activation of complement factor c , whereas l-ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . mg of mbl/ml, . mg of l-ficolin/ml and . mg of h-ficolin/ ml, respectively. the absence of early complement components (c , c and c but not c ) is a predisposing factor for systemic lupus erythematosus (sle). recently, we demonstrated that, in c -deficient (c def.) mice, igm-containing immune complexes (igm-ic) are filtered by the splenic barrier of marginal zone macrophages (mzm), resulting in an increased immune response against antigens within these igm-ic, but this could not be observed in wildtype or c def. mice. we hypothesized that splenic cd b þ mzm play an important role in the induction of autoimmunity, and we therefore analysed their cytokine profile after isolation with the help of magnetic antibody cell sorting. mrna was isolated, and real-time pcr was performed with specific primers for murine ifn-g (ifn-g), interleukin- (il- ) and ifn-a (ifn-a). we observe a moderate increase of il- and ifn-g mrna in cd b þ cells of c def. mice compared to wildtype cells. surprisingly, the concentration of ifn-a mrna is six times higher in c def. mice. preliminary results suggest that mrna in cd b þ cells of c def. mice is even lower than that in wt. six hours following i.v. application of mg of a abstracts .................................................................................................................................................................................................. murine monoclonal igm anti-dsdna antibody, production of il- , ifn-g and ifn-a mrna is increased in cd b þ cells of both c def. and wt mice. several references described increased levels of inf-a in patients with sle. dendritic cells are discussed as a major source of ifn-a. our observation that c -deficient, sle-susceptible mice demonstrate an increased spontaneous ifn-a production by splenic cd b þ marginal zone macrophages could be an early sign and a trigger for the development of sle. this is supported by the fact that the absence of c is not a predisposing factor for sle and our observation that c def. animals display low levels of ifn-a mrna. - million people worldwide and represents one of the leading causes for liver cirrhosis and hepatocellular carcinoma. control over the hbv infection is achieved mainly by vaccination with hepatitis b surface antigen (hbsag). hbsag contains n-linked glycosylation side and is recognized by both mbl-a and mbl-c in a cadependent manner. hbsag-mbl complexes activate complement and may thus affect humoural immunity. to investigate the role of mbl in humoural responses to hbsag, we immununized mice that lack both mbl-a and mbl-c proteins with soluble hbsag. it has been shown that deficiencies in other complement components like c q, c and c result in decreased antibody responses. however, mbl double ko animals mounted dramatically increased humoural responses. after priming, mbl double kos mounted hbsag-specific igm responses, which were threefold higher than wt controls. after boosting the hbsag, total igg was -fold higher in mbl ko than in wt control animals. similar to the response to hbsag, other glycosylated soluble antigens (e.g. invertase) induced better humoural responses in mbl double ko animals, suggesting that mbl plays an important role in a negative feedback regulation of adaptive immunity. reconstitution experiments with rmbl partially rescued the ko phenotype. we propose that the clearance of glycoprotein antigens in mbl ko is handled differently from the wt, resulting in better stimulation of humoural responses. alternatively, glycoprotein-ag-mbl-rich complexes inhibit b-cell responsiveness via putative mbl receptors. the complement system is an important part of the innate immune system. the activation of complement proceeds through three different pathways that converge in the generation of c -activating enzyme complexes. complement activation via the lectin pathway is initiated when recognition molecules, mannan-binding lectin (mbl) or ficolin, bind to carbohydrate structures characteristic for microbial surfaces. in the circulation, mbl and ficolins are found in association with three structurally related mblassociated serine proteases (masp)- , - and - and a small, nonenzymatic component, map . masp- has been shown to elicit complement activation through the sequential proteolytic cleavage of c and c upon binding of mbl/masp- complexes to microbial surfaces. we have recently uncovered a polymorphism in the masp- /map gene in a patient shown to be deficient in the lectin pathway of complement activation. the polymorphism results in a single amino acid substitution in the n-terminal part of the masp- protein. recombinant wildtype masp- and masp- containing the amino acid substitution in question was produced, and the ability to activate complement was studied. the mutation had a profound impact on masp- function, resulting in the lack of complement activation through the lectin pathway. elisa-based experiments showed that the mutation leads to the impairment of complement activation through influencing the binding of masp- to mbl or ficolins. deficiencies in the lectin pathway of complement activation have so far been accounted for only by lack of functional mbl. the mutation described above is the first defect described affecting both activation through mbl and the ficolins. .................................................................................................................................................................................................. th , th and treg cell balance. dcs are present in the gut mucosa and may thus be target for modulation by gut microbes, including ingested probiotics. here, we tested the hypothesis that species of lactic acid bacteria, important members of the gut flora, differentially activate dc. a large panel of human gut-derived lactobacillus and bifidobacterium spp. was screened for dc-polarizing capacity by exposing bone marrow-derived murine dc to lethally irradiated bacteria. cytokines in culture supernatants and dc-surface maturation markers were analysed. substantial differences were found among strains in the capacity to induce interleukin- (il- ) and tumour necrosis factor (tnf)-a, while the differences for il- and il- were less pronounced. bifidobacteria tended to be weak il- and tnf-a inducers, while both strong and weak il- inducers were found among the strains of lactobacillus. remarkably, strains weak in il- induction inhibited il- and tnf-a production induced by an otherwise strong cytokine-inducing strain of lactobacillus casei, while il- production remained unaltered. selected strains were tested for induction of dc maturation markers. those lactobacilli with greatest capacity to induce il- were most effective in upregulating surface mhc class ii and cd . moreover, l. casei-induced upregulation of cd was reduced in the presence of a weak il- inducing l. reuteri. in conclusion, human lactobacillus and bifidobacterium spp. polarize differentially dc maturation. thus, the potential exists for th /th /treg-driving capacities of the gut dc to be modulated according to composition of gut flora including ingested probiotics. the intestinal micro flora is indispensable in developing and maintaining homeostasis of the gut-associated immune system. evidence indicates that lactic acid bacteria (lab), e.g. lactobacilli and bifidobacteria, have beneficial effects on the host. established health effects include increased gut maturation, antagonisms towards pathogens and immune modulation. the objective of this study is to evaluate the immunomodulating properties of a range of lab of human origin. as dendritic cells (dcs) play a pivotal role in the balance between tolerance and immunity to commensal microorganisms, in vitro-generated immature dcs serve as a suitable model for studying the immunomodulating effects of lab. human immature dcs were generated in vitro from monocytes and exposed to lethally uv-irradiated lab. the effect of various species of lab on dcs in direct contact was evaluated. furthermore, the maturation pattern of dcs separated from the bacteria by an epithelial cell layer (caco- cells), which should mimic the intestinal environment, was studied. cytokine secretion (il- , il- and tnf-a) and upregulation of maturation surface markers on dcs (cd and cd ) was measured. different lab induced diverse cytokine responses. some strains were strong il- and tnf-a inducers and others weak. all strains induced il- . different lab also differentially modulated expression of cd and cd on dcs. although some variation in the response to lab of dcs generated from different blood donors was observed, general differences in the effect of the various lab was revealed. experiments with the dc caco- coculture system are ongoing. different species of lab differentially affect dc maturation; this suggets that the gut flora plays a pivotal role in polarization of the immune response. natural killer (nk) cells are cells of the nonspecific immune system lysing altered self-cells. a noncytolytic subset of nk cells may serve a regulatory role by secreting cytokines. bacteria translocating across the gastrointestinal mucosa are presumed to gain access to nk cells, as consumption of certain lactic acid bacteria has been shown to increase in vivo nk cytotoxicity. here, we investigated how human gut flora-derived lactobacilli affect nk cells in vitro, by measuring proliferation and ifn-g production of human nk cells upon bacterial stimulation. cd -cd þ nk cells were isolated from buffy coats by negative isolation using non-nk lineage-specific antibodies and magnetic beads. nk cells were incubated with mg/ml uv-inactivated bacteria or mg/ml phytohemagglutinin (pha) for days. proliferation was assessed by incorporation of radioactive thymidine into nk-cell dna. the ifn-g concentration was measured by elisa. incubation of nk cells with a lactobacillus acidophilus strain increased the proliferation of the nk cells and induced ifn-g production, both to levels comparable to pha stimulation. the proliferative response was further enhanced with autologous monocytes present, probably because cytokines, secreted by monocytes having engulfed bacteria, stimulated the nk cells. in contrast, a lactobacillus paracasei strain caused the nk cells to proliferate only in the presence of monocytes. these results demonstrate that various strains of lactobacilli have the capacity to activate nk cells in vitro, in a monocyte-dependent or -independent way. hence, the encounter of nk cells with lactic acid bacteria will affect nk-cell activation. such activation of nk cells may potentially skew an on-going or subsequent immune response towards a th response. lactobacilli are nonpathogenic gram-positive inhabitants of the normal human intestine known for their healthpromoting effects. in our earlier work, it is shown that human monoclonal antibody isolated from sera of a patient with waldenstrom macroglobulinaemia possess innate antibody characteristics and binds to lactic acid bacteria. according to the immune network model, immunization with this bacteria could induce the perturbations in immune system that might result in production of anti-lactobacillus antibodies, human monoclonal antibody like (ab ) and anti-idiotypic antibody (ab ). in this study, balb/c mice were immunized with two doses of bacteria lactobacillus acidophilus in complete and incomplete freund's adjuvant and phosphate-buffered saline (pbs), respectively. seven days after the last immunization, sera from immunized mice were collected and the presence of lactobacillus-specific ab and ab were determined by elisas. in the sera of immunized mice, antibodies specific to bacteria lactobacillus acidophilus were shown. the concentration of lactobacillus-specific antibodies was higher in the sera of hyperimmunized mice (mice immunized with mg of igm dj) than in sera of mice immunized with times lower doses of immunogen ( . mg per doses). moreover, ab and ab antibodies were detected in the sera of lactobacillus-hyperimmunized mice. in this study, we have shown the idiotypic network interactions in mice immunized with bacteria lactobacillus acidophilus. the normal gastrointestinal flora is crucial for the maturation of the acquired immunity via effects on antigenpresenting cells (apcs). here, we have investigated how two types of apcs, monocytes and dendritic cells (dcs), react to different bacterial strains typical of the commensal intestinal flora. purified monocytes and monocyte-derived dcs were stimulated with uv-inactivated gram-positive (lactobacillus plantarum and bifidobacterium adolescentis) and gram-negative (escherichia coli and veillonella parvula) bacterial strains. monocytes produced higher levels of il- p and tnf, as detected by elisa, in response to l. plantarum than to e. coli and v. parvula. in contrast, dcs secreted high amounts of il- p , tnf, il- and il- in response to e. coli and v. parvula but were practically unresponsive to l. plantarum and b. adolescentis. the lack of response to the gram-positive strains correlated with a lower surface expression of toll-like reseptor (tlr ) on dcs compared to monocytes. the surface expression of tlr on dcs was undetectable when analysed by flow cytometry, but blocking this receptor decreased the tnf production in response to v. parvula, indicating that low tlr expression on dcs is sufficient to mount an inflammatory response to gram-negative bacteria. ifn-g increased the expression of tlr on dcs and also potentiated the cytokine response to gram-negative bacteria. our results indicate that, when monocytes differentiate into dcs, their ability to respond to different commensal bacteria dramatically changes, thereby becoming unresponsive to probiotic gram-positive bacteria. these results may have important implications for the capacity of different groups of commensal bacteria to regulate mucosal and systemic immunity. probiotic bacteria, e.g. lactobacillus spp., may improve diseases such as chronic inflammatory bowel disease. we examined cytokine production and phenotypic change after in vitro stimulation of t cells from healthy volunteers using different probiotic strains. methods: t cells were cultured from colonic biopsies from eight healthy volunteers (agnholt and kaltoft, exp clin immunogenet ; : - ) , and dendritic cells were matured from their peripheral blood mononuclear cells. t-cell cultures were stimulated with autologous bacterial sonicate or strains of lactobacillus spp., with and without the addition of dendritic cells. cytokine levels (tnf-a, ifn-g, il- and gm-csf) and phenotype (cd , cd , cd and cd ) were measured on day . results: lactobacillus spp. induced higher productions of tnf-a and il- than did autologous bacteria. in presence of dendritic cells, the production of all cytokines increased. however, the increases of ifn-g and tnf-a were more pronounced in wells with autologous bacteria than in wells with lactobacillus spp. the addition of dendritic cells upregulated cd expression without simultaneous upregulation of cd . the upregulation was pronounced after stimulation with lactobacillus rhamnosus gg compared with autologous bacteria and other lactobacilli. discussion: in presence of dendritic cells, autologous bacteria induced inflammatory cytokines, while probiotics mainly induced regulatory cytokines. lactobacillus rhamnosus gg induced a regulatory phenotype (cd þ ), in part mediated by dendritic cells. future studies will address whether this shift to a cd þ phenotype represents a differentiation into competent regulatory t cells. in a clinical context, such cells might be used for treatment of inflammatory diseases. protein microarrays will play a key role in the postgenomic era and offer a unique possibility to perform highthroughput global proteome analysis. a chip can be printed with thousands of protein probes (e.g. antibodies), the biological sample added (e.g. a proteome) and any binding detected. we aim to develop protein microarrays based on human recombinant scfv antibody fragments for global proteome analysis. the concept of comparing proteomic maps of healthy versus diseased samples will allow diseasespecific proteins to be detected. in fact, antibody microarrays will allow us to perform comparative proteome analysis on any sample format in a species-independent manner, as long as a proteome can be isolated. however, the complexity of proteomes, containing several thousands of different proteins, is a problem. here, we have designed antibody microarrays targeting the water-soluble fraction of a proteome. to this end, an anticytokine antibody array was developed and human dendritic cells (aeactivation) was used as model system. the results showed that our antibody microarrays could be used to examine the cytokine profile in complex samples. furthermore, we have taken the first steps towards comparing our results with those of other technologies on both the protein and gene level. due to the complexity of the model proteome, we also examined the possibility to prefractionate the proteome in a simple one-step procedure (based on size) prior to the labelling step. in more detail, the sample proteome was fractionated into two fractions using membrane devices with different molecular weight cut-offs. the results showed that the fractionation considerably enhanced the assay sensitivity allowing cytokines in the pg/ml range to be readily detectable. the immunomodulatory effect of heat shock protein : immunization with a dna construct based on the malarial antigen fused with a fragment of hsp primes for a th- type of response finding an appropriate adjuvant for human vaccination is crucial. heat shock proteins (hsps) act as adjuvants when coadministered with peptide antigens or given as fusion proteins. however, there is a potential risk of autoimmunity when using the complete molecules, because hsps are evolutionary conserved. to overcome this, we first evaluated the adjuvant effect against two different antigens of a less-conserved fraction of plasmodium falciparum hsp (pf c) and compared it to the whole hsp molecule from trypanosoma cruzi (tchsp ). we found that pf c exhibited similar adjuvant properties as the whole molecule. we later evaluated the adjuvant potential of pf c against the malarial antigen eb in a chimeric dna construct. no appreciable levels of eb -specific abstracts .................................................................................................................................................................................................. antibodies were detected in mice immunized only with the dna constructs. however, dna primed the immune system, because subsequent challenge with the corresponding recombinant fusion proteins elicited a strong th- antibody response. in contrast, no priming effect was observed for ex vivo ifn-g production but stimulation with the hsp-chimeric fusion protein induced a stronger secretion of ifn-g in vitro than other proteins used. these results indicate that the use of hsps is promising in the design of new vaccines. high-throughput proteomics on antibody-based microarrays: the importance of probe and surface design in analogy to dna microarrays, protein microarrays offer a new distinct possibility to perform sensitive highthroughput global proteome analysis. however, the development of the protein microarray technology will place high demands upon the design of both probes and solid supports. the analysis of thousands of heterogeneous proteins on a single microarray requires the use of uniform probes, such as antibodies, directly designed for protein microarray applications. we have recently generated a human recombinant single-chain fv antibody library, genetically constructed around one framework, the ncoder-library, containing  clones. single framework antibody fragments (sinfabs) selected from this library were successfully applied as probes for microarrays providing sensitive detection in the attomol (mass spectrometry) and the zeptomole range (fluorescence). however, the choice of framework is critical. we have shown that the selected ncoder framework displayed excellent functional on-chip stability and arrayed dehydrated probes retained their activity for several months. furthermore, we have addressed the issues of biocompatibility of the solid support and immobilization strategies for our microarray setup. an in-house-designed substrate, macroporous silicon coated with nitrocellulose (map -nc ), displayed properties equal to, or better than, those of five commercially available supports used as reference surfaces. we have also evaluated different coupling strategies, such as adsorption, covalent coupling, diffusion and affinity coupling. using a novel affinity tag, the double-(his) -tag, we increased the binding efficiency of sinfab-molecules to ni þ -coated solid supports, thereby allowing nonpurified probes to be directly applied. the mannan-binding lectin (mbl) pathway is part of the innate immune system providing a first line of defence against infections. mbl and ficolins circulate in complexes with mbl-associated serine proteases (masp- , - and - ). after recognition of a microorganism by mbl, activation of the complement system occurs. masp- and masp- share five domains (making up the so-called a-chain), whereas they have unique protease domains (b-chains). before the identification of masp- , an assay for masp was presented, based on antibodies against the a-chain of masp- . with the new knowledge of the three masps, and the sharing of domains by masp- and masp- , assays specific for the protease domains have to be constructed, if one wishes to measure the proteins individually. we present an assay for quantifying total masp- in plasma and serum samples. the assay is a sandwich-type assay using as catching antibody a monoclonal antibody against the common a-chain of masp- / and a developing secondary antibody against the c-terminal part of the protease domain of masp- . we have used this assay for estimating the normal concentration of the protein as well as the concentration in patients and also for characterizing by gel permeation chromatography the masp- protein in serum. inducible costimulator ligand (icosl) is a costimulatory molecule related to b . (cd ) and b . (cd ). b cells, monocytes, dendritic cells and endothelial cells express icosl. inducible costimulator (icos) interacts with icosl, and this interaction leads to signals involved in isotype switching and the development of immunological memory. hitherto, no polymorphisms of this gene have been described. the aim of this study was to reveal variation of the icosl gene in normal individuals. all eight exons, except exon , were sequenced with flanking introns in healthy blood donors. eight single nucleotide polymorphisms (snps) and two length polymorphisms were found. one of the snps was found in the coding regions of the gene. the base involved was located in exon and caused a conservative amino acid change from valine (gtt) to isoleucine (att). three individuals were heterozygous g/a for the exon polymorphism, while the remaining seven individuals were homozygous for the wildtype g/g. exon encodes the immunoglobulin variable (igv)-like domain of the molecule which is situated outside the cell. this means that the amino acid could be critical for the stability of the molecule or could constitute part of the binding site for icos. the results form the basis for further experiments to find possible associations of the alleles to diseases caused by immune dysregulation. especially, the exon variant is interesting and could play a role for the development of immunological diseases. besides, it would be interesting to see whether both exon alleles are expressed or only the wildtype allele is functional. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. myxovirus a (mxa) is a resistance gtpbinding protein that is specifically induced by treatment with type ifns. for example, ifn-b-induced mxa in blood leucocytes has been used as a biomarker in ifn-btreated patients with multiple sclerosis. however, the degree of specificity of mxa in this regard is unclear, and measurements of mxa protein and/or mrna are not yet suitable for routine clinical use. in an attempt to find new and better reporter genes (and, hopefully, genes and gene products with proven specificity for ifn-a and -b), microarray screenings with u a genechips (affymetrix) were carried using human blood leucocytes and the human lung carcinoma cell line a . we studied the simultaneous expression of , transcripts before and after exposure to human recombinant ifn-a and ifn-b and other antiviral and immunomodulatory cytokines. the results will be presented at the conference. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large-scale screening in specialized laboratories. the read-out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn-a or -b, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. in our laboratory, we have developed a database system, which we believe is of immediate interest to the general scientific community. the database represents a computerbased replacement for the laboratory notebooks used in the majority of research laboratories worldwide. in addition, the database provides an effective tool for organizing and managing laboratory information at all levels, spanning from managing and revising standard operating procedures and producing documentation of research activities to keeping track of data and conclusions. using the commercially available database toolkit software filemaker pro, we have developed a relational database solution for management of laboratory information. the system consists of a hierarchy of five interrelated databases, each pertaining to a separate type of information, namely, overall project information, information relating to individual experiment setups, documentation of daily research activity, generated data and descriptions of standard operating procedures. like other databases, each individual database consists of a number of records, each comprised of a set of fields in which information is entered. in each record, a certain field is reserved to specify the relation of the record to a record in another database at a higher level. thus, the database is essentially five databases linked by a hierarchy of one-to-many relations, organizing information in a folder-like structure. importantly, the database system allows multiple users to access and edit records simultaneously, and the data entered in one database immediately becomes accessible through the other databases. the limitations of laboratory notebooks are apparent when looking for information, which is dispersed throughout one or more notebooks, or possibly on loose sheets of paper or printouts 'somewhere'. the often complicated process of gathering laboratory data or results when writing grant applications or research papers is made considerably easier with the database system. thus, the database solution presented should be broadly attractive to researchers, irrespective of their scientific discipline. an effective sars vaccine is likely to include components that can induce specific cytotoxic t-cell (ctl) responses. the specificities of such responses are governed by hlarestricted presentation of sars-derived peptide epitopes. exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear sequences directly from genomic/proteomic sequence information. the latter was recently established when a causative coronavirus (sars cov) was isolated and full-length sequenced. here, we have combined advanced bioinformatics and high-throughput immunology to perform an hla supertype, genome-wide scan for sars-specific cytotoxic t cell epitopes. the scan includes all nine human hla supertypes in total covering > % of all major human populations. for each hla supertype, we have selected the top candidates for test in biochemical-binding assays. at this time (approximately months after the genome was established), we have tested the majority of the hla supertypes and identified almost potential vaccine candidates. these should be further validated in sars survivors and used for vaccine formulation. we suggest that immunobioinformatics may become a fast and valuable tool in rational vaccine design. rationale: major histocompatibility complex class i (mhc i) molecules monitor the protein content of the cell by binding small derived peptides and presenting them to cytotoxic cd þ t cells. the goal of the human mhc project is to predict the binding strength of any given peptide/mhc complex. this prediction allows the design of peptide-based vaccines. the prediction requires representative binding data from mhc alleles from all the nine hla supertypes. here, we describe the genetic construction, protein production and purification as well as the establishment-binding assays for two recombinant mhc supertype alleles, hla-b* and hla-b* . methods: using the quikchange multisite directed mutagenesis kit (stratagene), codon-optimized genes encoding hla-b* and hla-b* are created. the two mhc i molecules are fermented and purified by ion exchange chromatography, hydrophobic interaction chromatography and size exclusion chromatography. the binding (kd) of natural t-cell epitopes, as well as predicted peptide ligands, is described by radioactive immunoassays (rias) and enzyme-linked immunosorbent assays (elisas). the mhc molecules are biotinylated during expression. results: the expression of mhc i resulted in multiple disulfide bond isomers, which are separated by hydrophobic interaction chromatography and used in subsequent binding studies resulting in the determination of kd for various peptide ligands ranging from strong binders we have previously demonstrated that bioinformatics tools such as artificial neural networks (anns) are capable of performing pathogen-, genome-and hlawide predictions of peptide-hla interactions. these tools may therefore enable a fast and rational approach to epitope identification and thereby assist in the development of vaccines and immunotherapy. a crucial step in the generation of such bioinformatics tools is the selection of data representing the event in question (in casu peptide-hla interaction). this is particularly important when it is difficult and expensive to obtain data. herein, we demonstrate the importance in selecting information-rich data and we develop a computational method, query-bycommittee, which can perform a global identification of such information-rich data in an unbiased and automated manner. furthermore, we demonstrate how this method can be applied to an efficient iterative development strategy for these bioinformatics tools. methods: a large panel of binding affinities of peptides binding to hla a* was measured by a radioimmunoassay (ria). this data was used to develop multiple first generation anns, which formed a virtual committee. this committee was used to screen (or 'queried') for peptides, where the anns agreed ('low-qbc'), or disagreed ('high-qbc'), on their hla-binding potential. seventeen low-qbc peptides and high-qbc peptides were synthesized and tested. the high-or low-qbc data were added to the original data, and new high-or low-qbc second generation anns were developed, respectively. this procedure was repeated times. the high-qbc-enriched ann performed significantly better than the low-qbc-enriched ann in of the tests. conclusion: these results demonstrate that high-qbcenriched networks perform better than low-qbc-enriched networks in selecting informative data for developing peptide-mhc-binding predictors. this improvement in selecting data is not due to differences in network training performance but due to the difference in information content in the high-qbc experiment and in the low-qbc experiment. finally, it should be noted that this strategy could be used in many contexts where generation of data is difficult and costly. interleukin- (il- ), a pro-inflammatory cytokine that is produced by both lymphoid and nonlymphoid cells, has a critical role in modulation of innate and adaptive immunity. its primary function in stimulation of ifn-g production and stimulation of nk-cell-cytotoxic activities makes this cytokine a candidate for cancer immunotherapy. in oral cavity, this cytokine is produced by oral epithelia and carcinoma cells and is related to tumour regression in nude mice bearing salivary adenocarcinoma. however, direct effects of this cytokine on oral cancer cells have not been elucidated. in this project, we investigated il- effect on an oral carcinoma (kb) cell line. with rt-pcr technique, kb-cell line was found to express il- receptors (il- ra and il- rb), indicating that this oral carcinoma line is a target for il- study. we showed that recombinant human il- inhibited kb-cell proliferation by % at concentration of ng/ml (p < . ), whereas ldh release by these cells in treatment group and control groups was comparable, indicating that il- suppression of cell proliferation was not mediated by the induction of cell death. to further address this hypothesis, we found that il- treatment did not induce apoptotic cell death, as studied by dna laddering and tunel assays. in addition, expression pattern of cell death-controlling genes (bcl- and bax) was not altered by this cytokine. findings in these studies indicated that suppression of kb-cell proliferation may be attributed to control of cell cycle, growth arrest or induction of cell differentiation. the data presented in this project could provide an insight of how cancer cell directly responds to il- , as this cytokine is an important regulator of anticancer mechanisms. aloe emodin (ae) is a naturally occurring compound with wide spectrum of biological properties, including antimicrobial, vasorelaxant, immunosuppressive and anticancer actions. this anthraquinone induces apoptosis in several tumour cell lines with special affinity to tumours of neuroectodermal origin. high amounts of nitric oxide (no) released by activated macrophages induce tumour cell death. therefore, we explored the capacity of ae to modulate no-mediated antitumour response in vitro. interestingly, while ae markedly suppressed no release from macrophages alone, it significantly potentiated no production in cocultures of macrophages and c cells, after h of cultivation. accordingly, the viability of c cells cocultivated with macrophages was reduced in the presence of ae. moreover, the observed ae-imposed potentiation of no production in macrophages was closely related to macrophage culture cell density. according to these data, we proposed that no modulator capacity of ae strongly depended on intercellular contact, indicating that macrophage antitumour response was not compromised but even potentiated by ae. immunotherapy represents an attractive fourth-modality therapeutic approach, especially in the light of the shortcomings of conventional surgery, radiation and chemotherapies in the management of metastatic cancer. to this end, a large number of peptide antigens derived from taa have been applied in immunotherapeutic trials for the treatment of various malignancies, e.g. cancers of the breast, prostate and kidney, in addition to haematological cancers. in some cases the response rates have been impressive and no adverse autoimmunity have been observed. a major strategic difficulty associated with these trials relates to the choice of best-suited peptide antigens. the vast majority of the antigens described thus far is not vital for survival and growth of the tumour cells, and immunoselection of antigen-loss variants may therefore prove to be an additional obstacle for the clinical applicability of most of the known peptide epitopes. in this respect, the development of acquired antigen loss during immunotherapy has been demonstrated in several cases. obviously, the development of loss-variant tumour cells implies that these cells acquire a pronounced growth advantage and are left unaffected by further treatment. ideally, target antigens should be derived from proteins required for survival and growth of tumour cells, as antigens with these characteristics would not be inflicted by the development of loss-variant tumour cells. in this respect, several inhibitors of apoptosis proteins (iaps) are universally expressed among tumours and play an important role in tumour cell escape from apoptosis. we have characterized spontaneous t-cell reactivity against iapderived peptides in cancer patients. from the iap survivin, we have characterized peptides restricted to the class i molecules hla-a , a , a , a , b and b . furthermore, we have demonstrated that survivin-specific t cells infiltrate metastatic lesions and that isolated survivinspecific ctls are capable of killing hla-matched tumour cells. survivin-derived peptides are now in clinical trial, and continued work in our lab has demonstrated that other iaps are targets for spontaneous t-cell reactivity in cancer patients. we previously reported that in mice with large progressing t-cell lymphoma tumours, dysfunctions in the antitumour ctl activity occur, associated with an accumulation of splenic arginase-producing myeloid suppressor cells (mscs). in this study, we first demonstrate that both the presence and the activation state of these msc depends on tumour evolution. while in tumour regressors hardly any arginase-producing msc can be found, both the amount and the arginase activity of this population expands from early over late progressors. this gradual induction of mscs is paralleled by an increasing suppression of ctl activity and th , but not th , cytokine production. upon analysing the molecular repertoire of msc in vitro, we found, besides arginase , a well-established marker for alternatively activated myeloid cells or m , a strong upregulation of fizz and ym, two additional recently identified markers for m . further evaluation of molecular markers by microarray analysis in msc yielded genes involved in wound healing (e.g. coagulation factor xiiia), anti-inflammation (e.g. selenoprotein p), immunomodulation (e.g. pd-l ) and fat and sugar metabolism (e.g. leptin receptor). of note, many of these genes are regulated by type cytokines (il- , il- and il- ) and are therefore rather m associated. overall, our data provide new markers for msc in cancer and further establish their m activation state. study. only sp-a showed a significant expression in normal mucosa which was downregulated in crc. as the absolute signal level was below the noise threshold, these results have to be interpreted with caution and require confirmation by direct measurenment of the proteins. our results suggest that there is no major role for the human collectins in colorectal cancer. tetramerization is visualized by sds-page. conclusion: an effective method for the production of highly pure mhc i molecules has been applied to hla-b* and hla-b* , and ria and elisa binding assays for those alleles have been established background: proliferation, differentiation and apoptosis are essential processes in the normal functions of the mammary epithelium. the hypothesis examined in this study is that the transcription factor bcl- is critically important not only for regulating b-cell growth and development but also for mammary epithelial apoptosis. methodology: twenty breast cancer cases and healthy controls were used to investigate whether bcl- protein in involved in breast cancer (grade iii). full length bcl- cdna was retrovirally transduced into eph- cell line. we then used flow cytometry of brdurd-stained cells to investigate the cell-cycle duration of the control and transduced cell lines. tunel was used as a marker of apoptosis to find out differences in the frequencies of apoptotic cells in the control and transduced cell lines. finally, immunohistochemistry staining was performed to detect bcl- in breast cancer (iii). results: restoration of bcl- into eph- cells not only inhibits apoptosis but also prolongs the cell cycle and results in increased cell size and protein content. the results also indicated that the cell-cycle time of bcl- -transduced eph- cells is prolonged by about h, presumably as a result of the action of bcl- at the bcl- at the g /s transition. we found differences in the frequencies of viable and apoptotic cells in cultures of the parent eph- cells, control-transduced eph- cells and bcl- -transduced eph- cells. consistently, we demonstrated that bcl- is expressed in % of high grade of breast carcinoma, which is considered as the most aggressive of tumours. conclusion: together, these results suggest that bcl- is likely to be involved in mammary gland development and carcinogenesis. inflammatory cytokines have a critical role in modulation of both innate and adaptive immunity in response to foreign antigen. they also play an important role in anticancer immunity. for example, they can promote cell-mediated immunity against cancer cells. with their immunostimulatory effects, these cytokines are being tested for cancer treatment in the form of dna vaccine or adjuvant or therapeutic cytokines. direct effect of these cytokines on cancer cell, however, is still unclear. in this project, we investigated whether il- ( and il- can modulate cancer cell proliferation. we employed a simple nonradioactive proliferation (mtt) assay and detection of lactate dehydrogenase (ldh) to test the effect of these recombinant human cytokines on various cancer cell lines, including breast cancer cell line (mcf- ), oral carcinoma cell line (kb), colon cancer cell line (caco- ) and choriocarcinoma cell line (jar). cytokines used in this study had both inhibitory and stimulatory effect on cell proliferation. findings in this project could provide an insight of cancer cell response to these cytokines and this could lead to a consideration on using cytokine as immunotherapy for cancer treatment.capacity of ae to modulate nitric oxide production depended on intercellular contact donor t cells are involved in the antitumour effects observed after bmt. thus, patients receiving t-celldepleted bmt have a higher risk of leukaemia relapse compared to patients receiving nonmanipulated bmt, and patients experiencing graft-versus-host disease (gvhd) have a lower risk of disease relapse than patients who do not experience gvhd. although the importance of donor t cells for the curative action of bmt has been established, the exact mechanisms and molecules involved in this graft-versus-tumour effect remain largely unknown. in a recently initiated project, we have conducted a longitudinal study of t-cell clonotypes in patients who received peripheral blood stem cell grafts after nonmyeloablative conditioning. peripheral blood samples were obtained sequentially after transplant, and the mononuclear cells (mncs) were isolated and cryopreserved. cd þ t cells were isolated from the mncs by use of immunomagnetic beads or facs and analysed for the presence of clonally expanded cells by t-cell receptor clonotype mapping based on rt-pcr and denaturing gradient gel electrophoresis (dgge). using this gel-based methodology, clonally expanded t cells were monitored after transplant and compared to the clinical data of the patients. the preliminary results demonstrates the presence of clonally expanded cd þ t cells at all time points analysed. furthermore, a number of clonotypes persisted for more than months, and other clonotypes emerged during this period. the appearance of newly emerged clonotypes which coincided with clinical gvhd could indicate a role for these t cells in the pathogenesis of gvhd. background: deficiency of the mannan-binding lectin (mbl) pathway of innate immunity leads to increased susceptibility to infections. in patients with colorectal cancer, postoperative infection is associated with poor prognosis. the aim of the present study was to evaluate ( ) the relation between the mbl pathway and postoperative infectious complications and survival of patients resected for colorectal cancer and ( ) the role of mbl as acute phase reactant compared to crp. methods: preoperative mbl concentration, mbl/mblassociated serine protease (masp) activity and crp were determined in serum from patients and healthy controls. the patients were observed for years. postoperative infections, recurrence and survival were recorded. results: the mbl pathway components were increased in the patients (p < . ) compared to healthy controls. low mbl levels were predictive of pneumonia (p ¼ . ), and pneumonia (n ¼ ) was associated with poor survival (p ¼ . , hr ¼ . , % ci . - . ). mbl and mbl/ masp activity could not predict postoperative overall infections. mbl showed no correlation (spearman's r ¼ . , % ci À . - . ) with crp. conclusions: low preoperative mbl levels are predictive of pneumonia, which is associated with poorer survival. mbl concentration and mbl/masp activity was not predictive of other postoperative infections or long-term prognosis. mbl apparently is not a surrogate measure of crp. department of surgery, university hospital of erlangen, erlangen, germany. e-mail: michael.siassi@rzmail.uni-erlangen.de introduction: the human collectins, mannan-binding lectin (mbl), surfactant protein-a (sp-a) and surfactantprotein-d (sp-d) play a central role in the innate immune system. immunological responses to malignant transformation of epithelial cells gained increasing interest recently. a former study could demonstrate binding of mbl to certain colorectal carcinoma (crc) cell lines in vitro. we therefore examined the expression of human collectins in normal colon mucosa and in colorectal carcinomas. materials and methods: colon samples from crc patients and normal mucosa samples were collected immediately after surgery. the tissue was microdissected and rna isolated (qiagen, rneasy-kit). gene expression profiles were analysed using gene-chips (affymetrix, hg-u ). we analysed the data for the expression of mbl, its associated serine proteases mannan-binding lectinassociated serine protease / (masp / ), sp-a and sp-d. the signal intensity of the genes of interest was compared using the mann-whitney u-test. results: the expression of human collectins in normal human colon mucosa was generally low. only the expression of sp-a and masp- reached the noise threshold of signals. these genes were significantly downregulated in crc specimens. the expression of the other proteins showed no difference in normal mucosa and crc. conclusion: as demonstrated before, the expression of human collectins in normal colon was low in this being the first lymph node to receive drainage from the tumour area, the sentinel node offers a unique possibility to obtain tumour-reactive lymphocytes. we investigated antitumour immune responses in sentinel nodes from patients with bladder cancer, by assaying tumour-specific proliferation and tcr vb repertoires. during tumour surgery, sentinel lymph nodes were identified by peritumoural injection of blue dye. fresh specimens of tumour, sentinel and nonsentinel lymph nodes were obtained, and single-cell suspensions were prepared. cells were assayed for reactivity against autologous tumour extract in [ h]-thymidine incorporation assays and characterized by flow cytometry. parallel analyses of the expression of vb gene families were performed with padlock probes, linear oligonucleotides which upon target recognition can be converted to circular molecules by a ligase. probes were reacted with cdna prepared from magnetically separated cd þ cells, and the tcr repertoire was determined by hybridizing the products to oligonucleotide microarrays. dose-dependent proliferation in response to tumour extract could be detected in sentinel lymph nodes. common clonal expansions were detected among tumourinfiltrating lymphocytes and in sentinel lymph nodes. nonsentinel lymph nodes displayed a divergent tcr vb repertoire. these results indicate an ongoing immune response against tumour antigens in sentinel nodes, draining urinary bladder cancer. identification of sentinel lymph nodes makes it possible to obtain tumour-reactive lymphocytes for use in adoptive immunotherapy. key: cord- -r yd i authors: huber-lang, markus; gebhard, florian title: inflammatory changes and coagulopathy in multiply injured patients date: - - journal: the poly-traumatized patient with fractures doi: . / - - - - _ sha: doc_id: cord_uid: r yd i severe tissue trauma leads to an early activation of several danger recognition systems, including the complement and the coagulation system, often resulting in an overwhelming almost synchronic pro- and anti-inflammatory response of the host. although the immune response is associated with beneficial effects at the site of injury including the elimination of exogenous and endogenous danger molecules as well as the initiation of regenerative processes, an exaggerated systemic inflammatory response significantly contributes to posttraumatic complications such as multiple organ failure (mof) and early death. besides pre-existing physical conditions, age, gender, and underlying comorbidities, surgical and anesthesiological management after injury is decisive for outcome. improvements in surgical intensive care have increased number of patients who survive the initial phase after trauma. however, instead of progressing to normal recovery, patients often pass into persistent inflammation, immunosuppression, and catabolism syndrome (pics). the characterization and management of pics will require new strategies for direct monitoring and therapeutic intervention into the patient’s immune function. in this chapter, we describe various factors involved in the inflammatory changes after trauma and aim to understand how these factors interact to progress to systemic inflammation, mof, and pics. multiple trauma results in a significant blood loss and accumulation of necrotic and/or devitalized tissue in an ischemic-hypoxic environment, both of which will become the origin of coagulatory and inflammatory changes. the inflammatory response after polytrauma is a major part of the host's molecular danger response. the acute posttraumatic phase of inflammation consists of two rather synchronically mounted columns: the pro-inflammatory response (systemic inflammatory response syndrome, sirs) and the anti-inflammatory response (compensatory anti-inflammatory response syndrome, cars) [ ] . sirs includes changes in the heart rate, respiratory rate, temperature regulation, and immune cell activation (table . ) [ ] . in the natural course of the inflammatory response after trauma, the balance of the pro-and antiinflammatory response is in equilibrium, which maintains the biological homeostasis and induces controlled regeneration processes, enabling the patient to recover normally without significant complications. however, the excessive inflammatory response after trauma seems to simultaneously and rapidly involve the induction of innate (both pro-and anti-inflammatory mediators) and suppression of adaptive immunity [ , , ] all of which decisively contribute to the development of the early multi-organ dysfunction syndrome (mods). furthermore, a prolonged and dysregulated immune-inflammatory state is associated with delayed recovery and complications, especially the development of late mods. based on improved intensive care and organ support, there is often a progress to the clinically evident persistent inflammation, immune suppression, and catabolism syndrome (pics) which might have replaced the late mods, but still is associated with a poor outcome, appearing as "silent death" [ ] . the steps of an inflammatory reaction to trauma involve fluid phase mediators (cytokines, chemokines, coagulation-and complement activation products, oxygen radicals, eicosanoids, and nitric oxide (no)) and cellular effectors (neutrophils, monocytes/macrophages, and endothelial cells) that translate the trauma-induced signals into cellular responses. these factors are closely interrelated and interconnected by upregulatory and down-regulatory mechanisms. the combination of these factors may cause severe sirs, acute respiratory distress syndrome (ards) and sepsis, acute kidney injury (aki), progressing to mods, depending on the type of injured tissue, the surgical and anesthesiological management after injury, age, gender, genetics, and most importantly, underlying comorbidities and physical conditions (exogenous and endogenous factors) ( fig. . ). patient survival after severe trauma requires an adequate molecular and cellular danger response. the injured tissues release cytosolic molecules (e.g., atp), organelles (e.g., mitochondria), histones, nucleosomes, dna, rna, matrix, and membrane fragments, all functioning as damage-associated molecular patterns (damps). furthermore, damage of external and internal barriers (e.g., skin, gut-blood barrier, air-blood barrier, brain-blood barrier) facilitates invasion of microorganisms, resulting in additional exposure to microorganisms-derived pathogenassociated molecular patterns (pamps). after multiple injury, the immune system of the injured patient is exposed to both damps (also termed alarmins) and pamps, which are summarized as danger-associated molecular patterns [ ] . the " -r-challenge" for the innate and adaptive immune system is to recognize, respond to, and resolve the "molecular danger". for recognition of the damage, there are effective fluid-phase "master alarm systems", such as the coagulation and complement cascade, and effective cellular "danger sensors", such as the pattern recognition receptors (prr). these systems transfer the damage/danger signals to the cells which in turn mount an acute phase reaction and inflammatory response to resolve the damaged tissue load [ ] . within an hour after trauma, inflammation resulting from tissue injury induces an increase in plasma concentration of a number of liverderived proteins (the acute phase proteins, app). pro-inflammatory cytokines (il- β, tnf, il- ) released locally by kupffer cells can systemically influence other cell types such as hepatocytes to synthesize more apps. proactive apps, sirs can be diagnosed when two or more of these criteria are present such as c-reactive protein (crp), procalcitonin (pct), serum amyloid a (saa), complement activation products (c a, c a), activated coagulation proteins (fviia, fxa, fiia), proteinase inhibitors, and metal-binding proteins, are increased during this phase [ ] , whereas the production of inhibitory apps, such as albumin, high-density lipoprotein (hdl), protein c, protein s, and atiii are decreased [ , ] . plasma concentrations of crp are normally below mg/l [ ] . hepatic synthesis of crp is regulated mainly by il- . serum levels of crp can be detected about h after systemic detection of il- . clinically, the plasma levels of crp are relatively non-specific and may not correlate with injury severity and are not predictive of posttraumatic complications such as infections [ ] . in the context of trauma, it is also still unclear whether the native pentameric or the denatured monomeric form of crp is responsible for the crp-induced cellular effects [ ] . pct is physiologically produced in the thyroid gland as the precursor molecule of calcitonin [ ] . during sepsis, stimulation by endotoxins or pro-inflammatory cytokines such as il- β or tnf dramatically increases the serum levels of pct up to -fold [ ] . in trauma patients, pct has been proposed as a practical biomarker for predicting posttraumatic complications such as severe sirs, sepsis, and mods [ ] [ ] [ ] [ ] . the biological immune response after trauma was considered in the past to be divided into an early innate phase and a late adaptive response. however, since multiple intensive interactions between both systems are known (e.g., via the complement cascade), a spatial-or timedependent discrimination of both systems in regard to pathomechanistic changes after multiple injury is irrational. both immune mechanisms contribute to effective recognition, activation, discrimination, regulation, and eradication of invading damage-and pathogen-associated signals [ ] . nevertheless, the innate immune response represents the "first line of defense", consisting of a barrier against exogenous nonself antigens and microorganisms. this includes the integrity of epithelial and mucosal cells: skin, respiratory tract, alimentary tract, urogenital tract, brain, and conjunctiva. exogenous pathogens that escape the first barrier are rapidly recognized and removed by the multiple components of innate immune cells such as neutrophils, monocytes/macrophages, natural killer cells, and dendritic cells [ ] . the innate immune response is closely accompanied by the specifically acquired immune response after the trauma impact. the adaptive immune response is conducted by the interaction of antigen-presenting cells (apcs), dendritic cells, monocytes/macrophages, t-lymphocytes, and b-lymphocytes. the apcs capture invading pathogens and create peptide-mhc (major histocompatibility complex) protein complexes. t-lymphocytes recognize the peptide-mhc protein complex via t-cells expressing antigen-binding receptors (tcrs) and are thereby activated. in turn, activated t-lymphocytes release cytokines to activate and amplify further cells of the immune system. t-helper lymphocytes (cd + t cells) differentiate into two phenotypes according to the cytokine release, the th and th lymphocytes. th cells promote the pro-inflammatory response through the release of il- , tnf, and interferon-γ (ifn-γ), while th cells produce anti-inflammatory cytokines (il- , il- , and il- ), which suppress macrophage activity [ ] . attention has been focused on the th /th -ratio. il- secreted from monocytes/macrophages promotes the differentiation of th cells by increasing the production of ifn-γ [ , ] . several studies have shown that a suppressed il- , il- , and ifn-γ, and elevated il- are observed after major trauma, which correlated with a shift of the th / th ratio towards the th -type pattern [ , ] . this imbalance in th /th -type cytokine response (from pro-to anti-inflammation) is not only a compensatory response but also increases the risk of infection by immune suppression [ ] . however, other reports do not support this view and question the clinical relevance of the th / th -shift after major tissue injury [ , ] . bleeding is a leading cause of death following polytrauma, and acute trauma-induced coagulopathy (atic) increases both the risk and severity of bleeding. clinically, there are several routine laboratory parameters which are indicative of coagulopathy development (table . ). around one third of severe polytrauma patients are already coagulopathic upon arrival in the emergency room [ ] and coagulopathy belongs together with acidosis and hypothermia to the "lethal triad" of polytrauma. thus, an important diagnostic and therapeutic strategy has been developed proposed as the "stop bleeding campaign" [ ] that addresses three major aspects of coagulopathy: fast detection and stopping of relevant bleeding sources; estimation and resuscitation of the lost blood volume; and rapid monitoring for coagulopathic conditions. the major mechanism of activation of the coagulation cascade following trauma is via the extrinsic coagulation system [ ] . the extrinsic cascade mediates inflammation by tissue factor (tf). exposure of the fvii to tf (e.g., from injured cells) results in the conversion of fvii to fviia. the fviia-tf-complexes activate fx to fxa, and fxa converts prothrombin to thrombin (fiia). thrombin activates fv, fviii, and fxi, which results in enhanced thrombin formation. thrombin also cleaves fibrinogen, and the fibrin clot is formed following polymerization and stabilization. in normal conditions, small amounts of tf are exposed to the circulating blood. however, under pathophysiological conditions, tf is upregulated on the surface of neutrophils, macrophages, and endothelial cells. endotoxin, activated complement (c a), and cytokines (il- β, tnf) induce tf expression [ ] . tf is highly thrombogenic, and its upregulation often results in hypercoagulability, leading to an increased tendency of thrombosis [ , ] . another phylogenetically ancient activation pathway is the rather unknown fsap (fvii activating protease) pathway that is activated by an autocatalytic mechanism promoted by factors released by necrotic or post-apoptotic cells such as nucleic acids, nucleosomes, and polyamines. fsap can regulate coagulation and fibrinolysis by activating factor vii and pro-urokinase, respectively. in polytrauma patients, an early and robust activation of fsap is seen which in turn contributes to the activation of both, the coagulation and complement system [ ] . in addition, coagulation mediators (fviia, fxa, and fiia) elicit inflammation with expression of tnf, cytokines, adhesion molecules (mcp- , icam- , vcam- , selectins, etc.), and growth factors (e.g., vegf) [ ] . inhibitors to prevent a hypercoagulable state include antithrombin iii (atiii), protein c, protein s and tf pathway inhibitor (tfpi). atiii inhibits fixa, fxa, and thrombin. tfpi suppresses the activity of tf/fviia/fxa complexes [ ] . protein c is activated by the thrombin-thrombomodulin complex on endothelial cells, and activated protein c, in combination with free protein s, cleaves and inactivates fv and fviii [ ] . therapeutically intervening with the production and/or activity of inhibitors could help to improve outcome by mitigating complications such as ards. for example, the crash trial has recently revealed that early application of tranexamic acid (a synthetic derivative of the amino acid lysine) that inhibits fibrinolysis by blocking the lysine binding sites on plasminogen significantly reduces the risk of death in bleeding trauma patients [ ] . almost synchronically to the coagulation response, there is an activation of the complement cascade immediately after multiple trauma [ , ] . the complement system consists of more than proteins. in the resting state, complement proteins circulate as inactive forms in plasma. the activation of the complement system can occur through four pathways (alternative, classical, lectin, and coagulation paths). the classical pathway of complement is activated by antigenantibody complexes (immune-globulin m or g) or crp. the alternative pathway is activated by modified from maegele et al. [ ] , brohi et al. [ ] , greuters et al. [ ] bacterial products such as lipopolysaccharides (lps). the lectin pathway is initiated by lectin binding to mannose, glucose, or other sugars of microorganisms. upon activation of the complement system, there is a generation of biologically active peptides. the cleavage of the central complement components c and c to the anaphylatoxins c a and c a, respectively, also induces the formation of opsonins and the membrane attack complexes (mac, c b- ) [ , ] . early after polytrauma, serum levels of the complement activation products c a and c a are significantly elevated and correlate with the severity of the injury (e.g., traumatic brain injury), septic complications, and mortality [ , ] . the circulating soluble mac is also enhanced within the first hours after polytrauma but almost not detectable between and h after polytrauma [ , ] . regulation of complement activation and protection against complement-mediated tissue destruction is provided by a selection of soluble-and membranebound complement regulatory proteins (cregs). the expression profile of cregs on leukocytes is specifically altered post polytrauma: cd (membrane co-factor protein) is significantly reduced in neutrophils, monocytes, and lymphocytes. in contrast, cd (decay accelerating factor) seems to be increased on neutrophils early after trauma. a delayed up-regulation of cd has been observed in monocytes from trauma patients. an initial enhancement of cd (mac inhibitor) expression was measured in neutrophils and monocytes at the time of admission. remarkably, c a receptor (c ar), cd and cd expression on neutrophils reversely correlated with injury severity [ ] . the anaphylatoxins c a and c a mainly play pro-inflammatory roles, which include the recruitment and activation of phagocytic cells (polymorphonuclear cells, pmns), monocytes/ macrophages, the enhancement of the hepatic acute-phase reaction, stimulation of the release of vasoactive mediators (such as histamine), and promoting the adhesion of leukocytes to endothelial cells and their permeation through injured tissues. c b forms a complex by the consecutive binding of proteins c -c , culminating in the formation of the mac (c b- ), which leads to the formation of pores in the cellular membrane causing lysis and death of the target cells [ ] . furthermore, the inflammatory response of complement activation leads to the production of free oxygen radicals and arachidonic acid metabolites and cytokines. the complement cascade bridges innate and adaptive immunity for defense against microbial pathogens. however, excessive consumption of complement proteins may also cause tissue damage of the host after trauma. within the first h after multiple injuries, there is a massive reduction in complement hemolytic activity (ch ), which recovers only around days after trauma, and can be used to discriminate between lethal and non-lethal outcome. this trauma-induced reduction of global complement function is referred to as trauma-induced "complementopathy" in analogy with "coagulopathy", both of which significantly participate to the impairment of the innate immune response after polytrauma (fig. . ). the kallikrein-kinin system involves a cascade of plasma proteases and is related to the complement and clotting cascade (intrinsic activation) [ ] . this contact system consists of plasma proteins factor xii (hageman factor; fxii), prekallikrein, high molecular weight kininogen (hmwk), and fxi. contact with negatively charged surfaces such as foreign bodies or the membrane fragments of stimulated platelets activates fxii [ ] . the active protein fxiia converts prekallikrein into the proteolytic enzyme kallikrein, which in turn cleaves the plasma glycoprotein precursor hmwk to form bradykinin [ ] . bradykinin increases vascular permeability and causes dilation of blood vessels by its action on smooth muscle cells. in turn, as a positive feedback loop, kallikrein itself accelerates the conversion of fxii to fxiia. kallikrein can also activate fibrinolysis to counterbalance the clotting cascade activated by fxiia. furthermore, kallikrein also exhibits chemotactic activity, converting c and c into the chemoattractant products c a and c a, respectively [ ] . pro-inflammatory cytokines play key local and systemic roles as intercellular messengers to initiate, amplify, and perpetuate the inflammatory response after trauma (table . ). cytokines are produced by many cell types in all organs. they have multiple targets and act in a pleiotropic manner. early after trauma, production and release of pro-inflammatory cytokines such as il- β, tnf, il- , and il- is initiated by monocytes and macrophages. il- β and tnf as well as il- and il- are released early after polytrauma [ , ] and predominantly function as pro-inflammatory mediators to repair damaged tissue. the release of il- β and tnf is mainly stimulated by bacterial endotoxins or other microbial products, immune complexes, and a variety of inflammatory stimuli. upon release, il- β and tnf usually return to baseline levels within h. tnf increases the activity of neutrophils and monocytes by activating the underlying endothelium. tnf promotes the expression and release of adhesion molecules such as icam or e-selectin, and increases the permeability of endothelial cells, which facilitates neutrophil migration into the damaged tissue [ ] . some studies have proposed tnf as a valid serum marker for complications after trauma. however, the results are inconsistent and to date, no data is available indicating whether tnf correlates to the severity of trauma or trauma outcome [ ] [ ] [ ] [ ] [ ] [ ] . many different cell types produce il- : in addition to immune cells such as monocytes, macrophages, neutrophils, t cells, and b cells, it is also produced by endothelial cells, smooth muscle cells, and fibroblasts. il- upregulates the hepatic acute-phase response, stimulating generation of c-reactive protein (crp), procalcitonin, serum amyloid a, fibrinogen, α -antitrypsin, and complement activation products (e.g., c a), which then promote neutrophil activation. there is strong evidence that serum il- level correlates with the severity of trauma, trauma pattern (especially in combination with chest trauma), and the risk of subsequent ards, mof, and lethal outcome [ , ] . therefore, il- may be considered as a clinically relevant and feasible parameter to estimate the severity of injury and prognosis after trauma [ , ] . in addition, for patients requiring second or subsequent surgeries following trauma, il- may prove to be an important biological marker in deciding the correct timing of surgery. in trauma patients with high initial levels of il- (> pg/dl), it is recommended to delay secondary procedures for more than days [ ] . the chemokine il- is secreted by monocytes/ macrophages, neutrophils, and endothelial cells. il- is mainly synthesized by t lymphocytes and monocytes/macrophages. it is the pivotal role of il- to inhibit the production of monocyte/macrophage-derived tnf, il- , il- , and free oxygen radicals [ ] . il- plasma levels are proportional to the severity of trauma and to posttraumatic complications [ ] [ ] [ ] [ ] [ ] ( table . ). in addition to its pro-inflammatory role, il- also has anti-inflammatory properties. as an immunoregulatory cytokine, il- stimulates macrophages to release anti-inflammatory cytokines such as il- receptor antagonists and soluble tnf receptors [ ] . moreover, il- induces macrophages to release prostaglandin e (pge ), the most powerful endogenous immune suppressant. pge regulates the synthesis of tnf and il- β by macrophages and induces the release of il- [ ] [ ] [ ] . overall, it has to be emphasized that almost all cytokines may not act strictly in either a pro-or anti-inflammatory manner, but rather may exhibit a "janus-faced behavior" depending on the underlying tissue, local environment, and trauma conditions. furthermore, the categorized pro-and anti-inflammatory cytokines follow not a specific temporal pattern but are rather synchronically and rapidly generated and released [ , ] , mounting the overall inflammatory response. when the simultaneous cytokine response is excessive, prolonged, and dysregulated, this may lead to severe complications, such as organ dysfunctions [ ] or persistent inflammation, immunosuppression, and catabolism syndrome (pics) [ ] (fig. . ). reactive oxygen species are released by leukocytes after exposure to pro-and antiinflammatory cytokines, chemokines, complement factors, and bacterial products. (fig. . ) . ros cause lipid peroxidation, cell membrane disintegration, and dna damage to endothelial and parenchymal cells [ , ] . furthermore, ros secreted by polymorphonuclear leukocytes (pmn) induce cytokines, chemokines [ ] , heat shock protein (hsp) [ ] , and adhesion molecules (p-selectin, icam- ) [ ] leading to cell and tissue damage. early after severe tissue trauma, neutrophils migrate along the chemoattractant gradient of complement activation products, interleukins, and ros to the site of tissue damage and to remote organ tissue. neutrophil mobilization is important for wound healing and protection against invading microorganisms, but their immigration to remote organ tissue contributes to sirs [ ] . neutrophil migration is composed of four steps: the first step, generation of leukocyte selectins (e.g., l-selectins) and e-and p-selectins on the endothelium is induced by anaphylatoxins (e.g., c a), cytokines (e.g., il- ), and toxins [ ] . these adhesion molecules are responsible for the rolling of neutrophils. the second step involves expression of integrins on neutrophils such as cd and cd , and intercellular adhesion molecules (icam- ) and vascular cell adhesion molecules (vcam- ) on the surface of endothelial cells, all of which are strongly induced by c a [ ] [ ] [ ] . the interaction of these upregulated molecules activate neutrophils to reinforce the contact between neutrophils and endothelial cells (sticking). in the next step, migration and accumulation into tissues occur, mediated by chemokines and complement anaphylatoxins. to migrate through cellular barriers, neutrophils undergo significant deformational changes to permeate through small cellular gaps with the help of locally released matrix metalloproteinases. in the final step, activation of neutrophils occurs to protect against dangerous molecules, microorganisms, and cells. neutrophils utilize a large arsenal for forming the "first line of defense" after trauma: chemotaxis, phagocytosis, oxidative burst reaction with release of ros and myeloperoxidase (mpo), generation of no, leukotriens, plateletactivating factor (paf), tissue factor (tf), proteases, and multiple pro-inflammatory cytokines. however, the active substances released from neutrophils may not only harm the invading microorganisms or injured cells but also healthy host cells, especially since neutrophils become "long-lived" after trauma by significant inhibition of neutrophil apoptosis. thus, neutrophils after trauma function as "friend and foe". monocytes/macrophages and neutrophils play a central role for the innate host defense, tissue repair, and remodelling, and for the intermediaries to the antigen-specific adaptive immune response. monocytes are circulating precursors of macrophages. monocytes migrate into the different tissues (liver, spleen, lungs, etc.) even in absence of local inflammation and become tissue macrophages. when monocytes/macrophages are activated by various phagocytotic events in response to trauma, they regulate the activation of t and b lymphocytes, which induce antigen presentation by the major histocompatibility complex ii (mhc ii). monocytes/macrophages also release chemokines, cytokines (il- , tnf, il- , il- , tgf-β), and various growth factors (fibroblast growth factor [fgf], epidermal growth factor [egf], and platelet-derived growth factors [pdgf] ) that initiate the formation of new extracellular matrix and promote angiogenesis and generation of new tissue at the site of injury. the functional phenotype shifts from a pronounced pro-inflammatory m type to a more anti-inflammatory and regenerative m -type macrophage. the monocyte/macrophage cellular response after minor trauma embodies several beneficial effects for the host. however, major trauma induces massive monocyte/macrophage activation. in this state, the effects of the monocyte/macrophage response become systemic and may also induce detrimental effects. systemically, the macrophagemodulated immune response influences microcirculation, metabolism, and triggering and progression of remote organ injury. deactivation of monocytes and decreased expression of mhc ii on their surface are observed after major trauma correlating with the severity of injury [ ] . natural killer (nk) cells are antigen-non-specific lymphocytes that recognize pathogen-associated molecular patterns (pamps) of invading microorganisms [ ] as well as damaged, transformed, or virus-infected host cells [ ] . since they are not dependent on pre-sensitization [ ] to mediate their cytotoxic effects and to release excessive amounts of pro-and anti-inflammatory cytokines within minutes of stimulation, nk cells are regarded as part of the "first line of defense" [ ] . their ability to release immune-modulatory cytokines may provide important regulatory functions during immune response, especially following severe injury. however, studies addressing the role of human nk cells after severe tissue trauma are rare and contradictory. some studies revealed an increase of nk cells in the early stage after severe trauma [ ] , whereas nk cell function is greatly depressed by traumatic injury. however, there was no correlation between the nk cell count or activity and injury severity [ , ] . concerning the effect of plasma samples from trauma patients on the cytotoxic activity of healthy nk cells in vitro, it has been shown that incubation times of more than h lead to suppressed nk cell function, suggesting that posttraumatic immune suppression is associated with suppression of nk cell activity [ ] . vice versa, murine experiments have collectively shown that nk cells as a key source of interferon γ exert harmful pro-inflammatory effects in the posttraumatic immune response and during the pathogenesis of sepsis [ , ] . in support, early depletion of nk cells results in reduction of liver il- expression and a % improved survival rate in a murine polytrauma model. lymphocyte apoptosis in spleen as well as neutrophil infiltration into lungs and liver is also attenuated [ ] . furthermore, in various mouse models of sepsis, depletion of nk cells leads to improved survival [ , ] suggesting that early posttraumatic activation of nk cells promotes amplification of the inflammatory response, and the subsequent loss of cellular functions might contribute to immune suppression manifested in later stages after trauma [ ] . mechanisms of the development of organ dysfunction the initial trauma insult activates an inflammatory cascade that stimulates the host immune system. massive initial trauma impact (first hit) causes severe sirs. in this situation, the overwhelming production and release of pro-and anti-inflammatory mediators result in rapid mods and early death. an initial trauma insult of lower severity induces a moderate state of sirs/cars. in this instance, inflammatory and immune cells undergo some "priming". however, some patients develop posttraumatic complications, such as sepsis, aki, ards, and mods. the development of these complications is regulated by various exogenous and endogenous factors. among these factors, it is important to understand the relationship between the biological changes and the anatomical region of initial injury. the central nervous system is a rich source of inflammatory mediators. traumatic brain injuries (tbi) with the disruption of the blood-brain barrier (bbb) allow immune cells to migrate into the subarachnoid space, leading to an accumulation of leukocytes from the periphery [ , [ ] [ ] [ ] . trauma to the chest area, particularly lung contusions, leads to an early increase in plasma mediators, which is associated with systemic inflammatory and anti-inflammatory reactions, such as pneumonia, ards, and mods [ ] [ ] [ ] . patients with severe soft tissue injuries to the extremities with resulting hemorrhagic shock or severe muscle crush syndrome are at risk of developing more serious remote organ injury (e.g., aki). ischemia/reperfusion injury (i/r) leads to the production of large quantities of ros. femoral fractures with soft tissue injuries usually result in alteration of hemodynamic parameters such as increased cardiac output, tachycardia, decreased systemic vascular resistance, and decreased hepatic blood flow [ ] . long bone fractures and unstable pelvic fractures are characterized by high blood loss and are associated with severe soft tissue injury, which initiate both a local and systemic inflammatory response [ , [ ] [ ] [ ] [ ] [ ] . these bodies of evidence suggest that the initial trauma itself predisposes trauma patients to posttraumatic complications. traumatized patients who survive the initial injury ("first hit") may still be at risk of death from sepsis and multiple organ failure. secondary insults following the initial injury amplify the systemic inflammatory response and upset the balance of pro-and anti-inflammatory mediators, pro-and anti-coagulatory factors, pro-and anti-apoptotic events, and pro-and anti-regenerative processes. secondary insults ("second hits") are compounded by endogenous and exogenous factors. endogenous secondary insults include respiratory distress, cardiovascular instability, ischemia and reperfusion injury, and infection. exogenous secondary insults include surgical and anesthesiological interventions [ ] [ ] [ ] , blood transfusions, and -not to forget -missed injuries. clinical studies have revealed that orthopedic surgical intervention can also cause major changes in the inflammatory response, and these changes are in proportion to the magnitude of surgery. for instance, femoral nailing induces an increase in systemic plasma levels of il- and il- . in these patients, human leukocyte antigen-dr expression on monocytes is reduced as well [ , ] . furthermore, reamed femoral nailing appears to be associated with greater impairment of immune reactivity than un-reamed nailing [ ] . blood transfusions are a paramount therapy in the management of trauma/hemorrhagic shock patients. however, various studies have demonstrated that blood transfusions are associated with infection, sirs, ards, and mods after trauma [ ] [ ] [ ] [ ] [ ] [ ] , also representing a "second hit" for the multiply injured patient. ischemia/reperfusion (i/r) injury is a common and important event in clinical situations such as trauma, hemorrhagic shock, cardiac arrest (hypoxemia, hypotension of systemic tissue), contusions, lacerations, vascular injuries, and compartment syndrome (increased pressure in a preformed anatomical compartment with resulting hypoperfusion and hypoxemia of local tissue). inadequate microvascular flow results in the activation of leukocytes and converts local endothelial cells into a pro-inflammatory and pro-thrombotic phenotype. i/r injury consists of two specific stages. during the first stage of ischemia and hypoxemia, oxygen and nutrients are deprived from tissues temporarily by the disruption of blood supply. during the ischemic phase, the lack of oxygen leads to decreased production as well as consumption of adenosine triphosphate (atp). as consumption of atp continues, it is degraded into adenosine diphosphate (adp) and adenosine monophosphate (amp), which is further degraded to inosine and hypoxanthine [ ] . atp depletion leads to an alteration in intercellular calcium and sodium concentration. it also results in the activation of cytotoxic enzymes such as proteases or phospholipases, all cumulating to reversible or irreversible cellular damage. the second stage of reperfusion is the revascularization or reestablished supply of oxygen to the ischemic tissue. the hallmark of the reperfusion phase is the generation of byproducts of neutrophil activation, which induces secondary tissue damage and organ dysfunction. on reperfusion with the reintroduction of molecular oxygen into the ischemic tissue, oxygen reacts with leukocytes and endothelial cells promoting the generation of reactive oxygen species and platelet-activation factor. the interactions of neutrophils and endothelial cells have been shown to contribute to massive interstitial edema caused by microvascular capillary leakage after reperfusion injury. the ischemia and reperfusion injury with atp depletion is a major cause for breakdown of physiological organ-blood barriers, such as bloodbrain, blood-gut, and blood-alveolus barrier. broken barriers characterized by diffuse microvascular leakage and tissue edema are thought to be main drivers of bacterial translocation (bt) and sepsis [ ] . bacterial translocation is defined as the phenomenon of both viable and nonviable bacteria as well as their products (bacterial cell wall components, lps, and peptidoglycan) crossing the intestinal barrier to external sites such as the mesenteric lymph nodes, liver, and spleen. bt occurs as a result of a loss of integrity of the gut barrier function after trauma, hemorrhagic shock, and burns [ ] , and may be associated with posttraumatic complications [ , ] . although most data on bt and its complications have shown consistent results in animal models of hemorrhagic shock, trauma, and severe burns, its importance in humans is questionable, with variable results in clinical studies. in addition, it is still debatable whether bt is an important pathophysiologic event or simply an epiphenomenon of severe disease [ ] . following trauma, acute inflammatory reactions may be triggered by infections (bacterial, viral, fungal, parasitic) and microbial toxins, or by any of several molecules released from necrotic tissue (hmgb , hyaluronic acid, etc.). pattern recognition receptors (prrs), including tolllike receptors, can detect these stimuli and trigger a signaling pathway that leads to the production of various mediators. in the acute phase of trauma, vasodilatation is induced by vasodilatatory mediators (no, prostaglandins), quickly followed by increased permeability of the microvasculature. vasodilatation and extravasation of plasma result in hemoconcentration, facilitating the peripheral migration of neutrophils. neutrophil migration from the blood stream into interstitial tissue is divided into several steps, which are mediated by endothelial cell adhesion molecules, cytokines produced by monocytes/macrophages and various other cells, chemokines, the complement system, and arachidonic acid. migrated neutrophils produce several mediators such as neutral protease, reactive oxygen species (ros), lipids (leukotriene, paf), and tissue factor (tf). these mediators act as secondary tissue damage mediators and pro-coagulatory factors depending on the degree of initial injury as well as additional insults. during inflammation, the plasmaic cascade, consisting of the complement cascade, the kallikrein-kinin system, and the coagulation cascade, is activated by toxins and inflammatory mediators. activation of the complement system induces generation and depletion of complement activation products, causing an increase in vascular permeability, chemotaxis, opsonization, activation of the coagulation cascade, and trauma-induced complementopathy. excessive activation of the coagulation system results in a hypercoagulable state, leading to an acute trauma-induced coagulopathy (atic). activation of the kallikrein-kinin system results in kinins with vasoactive properties. in addition to its role in stimulating inflammation, the immune system (innate and adaptive) is a main driver for the barrier breakdown, clinically evident as diffuse microvascular leakage syndrome and organ failure. the exact knowledge of the pathophysiological changes after polytrauma is a prerequisite for effective, targeted, and patienttailored future therapies to support the immune and organ functions after severe tissue trauma. a genomic storm in critically injured humans definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis untersuchungen zur systemischen posttraumatischen inflammation in der frühphase nach trauma compensatory antiinflammatory response syndrome persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care the danger model: a renewed sense of self polytrauma-pathophysiology and management principles inflammatory cytokines and cell response in surgery acute phase reaction and acute phase proteins acute phase protein levels as an index of severity of physical injury serum c-reactive protein in patients with serious trauma structural and functional comparison of native pentameric, denatured monomeric and biotinylated c-reactive protein procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma procalcitonin and c-reactive protein during the early posttraumatic systemic inflammatory response syndrome procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients systemic inflammation after trauma the systemic inflammatory response induced by trauma is reflected by multiple phenotypes of blood neutrophils interleukin- and the regulation of innate resistance and adaptive immunity the biology of il- : coordinating innate and adaptive immune responses surgical stress induces a shift in the type- /type- t-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibodymediated immunity commensurate to the trauma depressed interleukin- -producing activity by monocytes correlates with adverse clinical course and a shift toward th -type lymphocyte pattern in severely injured male trauma patients th -and th -type cytokines in plasma after major trauma the potential pattern of circulating lymphocytes th /th is not altered after multiple injuries acute traumatic coagulopathy early coagulopathy in multiple injury: an analysis from the german trauma registry on patients acute and delayed mild coagulopathy are related to outcome in patients with isolated traumatic brain injury the stop the bleeding campaign blood coagulation as an intrinsic pathway for proinflammation: a mini review a novel c a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways coagulation abnormalities in acute lung injury and sepsis tissue factor mediates inflammation factor vii-activating protease is activated in multiple trauma patients and generates anaphylatoxin c a theories of blood coagulation protein s: a conduit between anticoagulation and inflammation effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (crash- ): a randomised, placebo-controlled trial early complementopathy after multiple injuries in humans circulating complement proteins in multiple trauma patients-correlation with injury severity, development of sepsis, and outcome complement activation in injured patients occurs immediately and is dependent on the severity of the trauma the complement system in trauma-related and ischemic tissue damage: a brief review early expression changes of complement regulatory proteins and c a receptor (cd ) on leukocytes after multiple injury in humans complement: more than a 'guard' against invading pathogens? evidence for a role of kallikrein-p nin system in patients with shock after blunt trauma formation of bradykinin: a major contributor to the innate inflammatory response molecular intercommunication between the complement and coagulation systems is interleukin an early marker of injury severity following major trauma in humans? hemorrhage induces an increase in serum tnf which is not associated with elevated levels of endotoxin serum tumor necrosis factor-alpha profile in trauma patients tumor necrosis factor and monocytes are released during hemorrhagic shock cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. relation with subsequent adult respiratory distress syndrome and multiple organ failure experimental hemorrhage and blunt trauma do not increase circulating tumor necrosis factor role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats interleukin- in the injured patient. marker of injury or mediator of inflammation? assessment of the clinical course with inflammatory parameters barney resident research award winner. the inflammatory profile of interleukin- , interleukin- , and soluble intercellular adhesion molecule- in postinjury multiple organ failure major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers cytokines in patients with polytrauma interleukin- and development of adult respiratory distress syndrome in at-risk patient groups increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? interleukin inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation relative production of tumour necrosis factor alpha and interleukin in adult respiratory distress syndrome the association between mortality rates and decreased concentrations of interleukin- and interleukin- receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome immediate il- expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis relationship of interleukin- plasma levels to severity of injury and clinical outcome in injured patients attenuation of proinflammatory response by recombinant human il- in human endotoxemia: effect of timing of recombinant human il- administration anti-inflammatory cytokines a new view of prostaglandin e regulation of the immune response interleukin- (il- ) as an anti-inflammatory cytokine: induction of circulating il- receptor antagonist and soluble tumor necrosis factor receptor p oxidative stress and ischemiareperfusion injury in gastrointestinal tract and antioxidant, protective agents early onset of lipid peroxidation after human traumatic brain injury: a fatal limitation for the free radical scavenger pharmacological therapy? ischaemia-reperfusion injury to the intestine regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates reactive oxygen intermediates as apparently widely used messengers in the activation of the nf-kappa b transcription factor and hiv- hydrogen peroxide pretreatment of perfused canine vessels induces icam- and cd -dependent neutrophil adherence association of traumatic severity with change in lymphocyte subsets in the early stage after trauma circulating postinjury neutrophils are primed for the release of proinflammatory cytokines elevated levels of soluble icam- correlate with the development of multiple organ failure in severely injured trauma patients cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion molecular mechanics and dynamics of leukocyte recruitment during inflammation trauma-induced suppression of antigen presentation and expression of major histocompatibility class ii antigen complex in leukocytes direct bacterial protein pamp recognition by human nk cells involves tlrs and triggers alpha-defensin production nk cell recognition augmentation of nk cell activity by a circulating peptide isolated from the plasma of trauma patients natural killer cells as an initial defense against pathogens mechanism of suppression of natural killer cell activity in trauma patients depletion of nk cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response the role of natural killer cells in sepsis natural killer cells contribute to the lethality of a murine model of escherichia coli infection inflammation in traumatic brain injury: role of cytokines and chemokines modulation of immune response by head injury closed head injury-an inflammatory disease? blunt chest trauma induces delayed splenic immunosuppression pulmonary contusion causes impairment of macrophage and lymphocyte immune functions and increases mortality associated with a subsequent septic challenge biochemical characterization of individual injury pattern and injury severity femur fracture with associated soft-tissue injury produces hepatic ischemia. possible cause of hepatic dysfunction review: systemic effects of femoral nailing: from kuntscher to the immune reactivity era production of interleukin- in human fracture soft-tissue hematomas the immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden the pattern of preformed cytokines in tissues frequently affected by blunt trauma surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches immune response of severely injured patients-influence of surgical intervention and therapeutic impact cell response to surgery stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. an analysis of the second hit interleukin- release and monocyte human leukocyte antigen-dr expression during femoral nailing blood transfusion, independent of shock severity, is associated with worse outcome in trauma insights from studies of blood substitutes in trauma blood transfusion. an independent risk factor for postinjury multiple organ failure early predictors of postinjury multiple organ failure emerging risks and outcomes of blood transfusion in surgery transfusion of the injured patient: proceed with caution application of heme oxygenase- , carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury broken barriers: a new take on sepsis pathogenesis bacterial translocation: clinical implications and prevention bacterial translocation-related mortality may be associated with neutrophil-mediated organ damage the gut: the 'motor' of multiple organ dysfunction syndrome? curr opin clin nutr metab care bacterial [correction of baterial] translocation in humans key: cord- - d gf az authors: sønder, s. u. s.; hedegaard, c. j.; bendtzen, k. title: monitoring patients treated with type interferons: antiviral versus mxa induction assays date: - - journal: scand j immunol doi: . /j. - . . bb.x sha: doc_id: cord_uid: d gf az interferon‐α/β (ifn‐α/β) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large‐scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large‐scale screening in specialized laboratories. the read‐out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn‐α or ‐β, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. the nuclear receptor heterodimers of liver x receptors (lxrs) are recently identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. lxrs and their ligands are negative regulators of macrophage inflammatory gene expression. multiple sclerosis (ms), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. sweden belongs to the countries with a high ms incidence. in italy, incidence is lower, with an exception for sardinia where the incidence is even higher than that in sweden. subjects from sardinia are ethnically more homogeneous and differ from swedes, also regarding genetic background and environment. we studied lxrs and their related molecules of blood mononuclear cells (mncs) from female patients with untreated relapsing-remitting ms from sassari, sardinia and stockholm, sweden. sex-and age-matched healthy controls (hcs) were from both areas. mrna expression was evaluated by real-time pcr. lxr-a was lower (p < . ) in ms (mean ae sem: . ae . ; n ¼ ) compared to hc ( . ae . ; n ¼ ). lxr-a was lower in ms from stockholm ( . ae . ; n ¼ ) compared to corresponding hc ( . ae . ; n ¼ ; p < . ) and compared to ms ( . ae . ; n ¼ ; p < . ) and hc ( ae . ; n ¼ ; p < . ) from sardinia. ms patients from stockholm, but not from sassari, also expressed lower (p < . ) lxr-b (À . ae . ) compared to corresponding hc (À . ae . ). ms from stockholm was associated with higher abca- ( . ae . versus . ae . ; p < . ) and higher estrogen receptor-b-cx ( . ae . versus . ae . ; p < . ) compared to corresponding hc. the hc from sassari had higher androgen receptor ( . ae . ) compared to ms from sassari ( . ae . ; p < . ), ms ( . ae . ; p < . ) and hc from stockholm ( . ae . ; p < . ). ms from sassari had lower cyclooxygenase- compared to corresponding hc ( . ae . versus . ae . ; p < . ) and lower prostaglandin-e (À . ae . ) compared to the hc ( . ae . ; p < . ) and ms ( . ae . ; p < . ) and hc from stockholm ( . ae . , p < . ). our findings identify lxrs and their related molecules as being involved in ms from stockholm but not from sassari, while sex hormone receptors seem to be involved in ms in sassari. multiple sclerosis: ifn-b induces cd + bdca -dendritic cells that produce il- and il- and have no enhanced type i interferon production y. m. huang, s. adikari, u. båve, a. sanna , & g. alm dc antigens (bdca) and investigate their ability to produce type i ifn in response to virus stimulation. we show that ifn-b induces development of cd þ dc from human blood monocytes, which coexpress bdca þ but are negative for bdca -, a specific marker for plasmacytoid dc. such ifn-b-modulated dc produce large amounts of il- and il- , but no il- p and have no enhanced ifn-b and ifn-b production. the findings indicate that ifn-bmodulated dc represent a myeloid dc subset with diminished cd c, bdca- and cd a expression, having potent th -promoting function but lacking antiviral capacity. the association of psoriasis with throat infections by streptococcus pyogenes suggests a potential antigenic target for the t cells that are known to infiltrate dermis and epidermis of psoriatic skin. streptococcal m protein shares an extensive sequence homology with human epidermal keratins. keratins (k ) and (k ) are mostly absent from uninvolved skin but are upregulated in psoriatic lesions. there is increasing evidence that cd þ t cells play an important effector role in psoriasis and m proteinprimed t cells may recognize these shared epitopes in skin via molecular mimicry. to identify candidate epitopes, peptides with sequences from k were selected on the basis of predicted binding to hla-cw and sequence similarities with m protein. matched peptides from the sequence of m protein and a set of peptides with poor predicted binding were also selected. cw þ individuals with psoriasis and cw þ healthy controls, having a family history of psoriasis, were recruited. pbmcs were incubated with the peptide antigens. t-cell activation in the cd þ , cd þ and later the skin-homing cutaneous lymphocyteassociated antigen (cla)-expressing subset of cd þ t cells was evaluated by cd expression and intracellular ifn-g accumulation using flow cytometry. we demonstrate that cw þ psoriasis patients had significant cd þ t-cell ifn-g responses to peptides from k and m protein selected on the basis of sequence homology and predicted hla-cw* binding. these responses were about times more frequent in the skin-homing cutaneous lymphocyte-associated antigen-expressing (cla þ ) subset of cd þ t cells. cd þ t cells showed only borderline responses. cd þ t cells from cw þ nonpsoriatic individuals responded to some m peptides but very rarely to k peptides, and this also applied to the cla þ cd þ subset. these findings indicate that psoriatic individuals have cd þ t cells that recognize keratin self-antigens and that epitopes shared by streptococcal m protein and human keratin may be targets for the cd þ t cells that infiltrate psoriatic skin lesions. autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly % in ra patients and a suggestive involvement in the pathogenesis. the targeted epitopes are generated by a post-translational modification catalysed by the calcium-dependent enzyme peptidyl arginine deaminase that converts the positively charged arginine to polar but uncharged citrullin. the aim of this study was to analyse the presence of citrulline in the joints at different time points of collagen-induced arthritis in da rats by immunohistochemistry and to investigate how immunogenicity and arthritogenicity was affected by citrullination of rat serum albumin (rsa) and collagen type ii (cii). our results indicate that citrulline could be detected in joints of arthritic animals, first appearance at the onset of disease and increasing as disease progressed into a chronic state. unimmunized animals or time points before clinical signs of arthritis were negative. by morphology, we state that some infiltrating macrophages as well as the cartilage surface stain positive for citrulline, while the major source of citrullinated proteins appears to be fibrin depositions. a specific cit-rsa t-cell response was observed in animals challenged by citrullinated rsa, no response was recorded when rsa was used as a stimulus. the igg analysis reveals not only a response towards the modified protein but also cross-reactivity to native rsa. no t-cell or b-cell response was noted in animals injected with unmodified rsa. cit-cii induced a disease with higher incidence and earlier onset than did the native counterpart. we conclude that, in contrast to the human disease, citrulline does not seem to appear before clinical signs. as inflammation proceeds, citrulline is detected specifically in the joints. all other organs investigated were negative. we also conclude that citrullination of a protein can break tolerance and increase its arthritogenic properties. ectopic germinal centers (gcs) can be detected in the salivary glands of approximately / of patients with sjögren's syndrome (ss) and appear in both primary and secondary ss. previously, ectopic gc have been associated with increased local autoantibody production. the aim of this study was to determine whether gc in primary sjögren's syndrome (pss) defines a distinct seroimmunological phenotype. retrospectively, a material of haematoxylin and eosin-stained paraffin-embedded tissue sections of minor salivary gland tissue from patients with pss was morphologically screened for the presence of ectopic gc. gc-like lesions were detected in / ( %) of the pss patients. seventy-two pss patients lacking these structures (gc-) were randomly selected for comparison. focus score was significantly increased in the gc þ patients compared to the gcpatients (p ¼ . ). in the gc þ group, . % of the patients presented with anti-ro/ssa compared to . % in the gcgroup. anti-la/ssb was detected in . % of the gc þ patients compared to . % of the gcpatients. sixty-one percentage of gc þ patients presented with increased levels of igg, a nonsignificant difference when compared to . % in the gcpatients (p ¼ . ). levels of rf, ana, ena, igm and iga were similar in both patient groups, as were esr and crp. in conclusion, patients with ectopic gc have a higher focus score and more often present with autoantibodies and increased levels of igg compared to pss patients with regular focal infiltration (gc -). our findings may indicate a certain seroimmunological phenotype and warrant for further prospective studies. association between mannose-binding lectin and vascular complications in type diabetes complement activation and inflammation have been suggested in the pathogenesis of diabetic vascular lesions. we investigated serum mannose-binding lectin (mbl) levels and polymorphisms in the mbl gene in type diabetic (t dm) patients with and without diabetic nephropathy and associated macrovascular complications. polymorphisms in the mbl gene and serum mbl levels were determined in t dm patients with overt nephropathy and t dm patients with persistent normoalbuminuria matched for age, sex and duration of diabetes as well as in healthy control subjects. the frequencies of high and low expression mbl genotypes were similar in patients with t dm and healthy controls. high mbl genotypes were significantly more frequent in diabetic patients with nephropathy than in the normoalbuminuric group, and the risk of having nephropathy, given a high mbl genotype, assessed by odds ratio was . ( . - . ), p ¼ . . median serum mbl concentrations were significantly higher in patients with nephropathy than in patients with normoalbuminuria [ mg/l (iqr - mg/l) versus mg/l (iqr - ), p ¼ . ], and even when comparing patients with identical genotypes, serum mbl levels were higher in the nephropathy group than in the normoalbuminuric group. patients with a history of cardiovascular disease had significantly elevated mbl levels independently of nephropathy status [ mg/l (iqr - mg/l) versus mg/l (iqr - mg/l), p ¼ . ]. the differences in mbl levels between patients with and without vascular complications were driven primarily by pronounced differences among carriers of high mbl genotypes (p < . ). our findings suggest that mbl may be involved in the pathogenesis of microvascular and macrovascular complications in type diabetes and that determination of mbl status might be used to identify patients at increased risk of developing these complications. neuroimmunology unit, center for molecular medicine, karolinska institutet, stockholm, sweden. e-mail: judit.wefer@cmm.ki.se dna vaccine coding for the encephalitogenic peptide mog - protects lew. av from subsequent development of experimental autoimmune encephalomyelitis (eae). protection is associated with a type immune response and is dependent on the presence of cpg dna motifs. the mechanisms underlying the observed reduction of eae development in protected rats have not been fully clarified. we investigated immunological characteristics of lymphocytes after dna vaccinaton and subsequent eae induction. we confirm that protection was not associated with suppression of t cells, as transcription of the novel molecule rat t-cell immunoglobulin-and mucindomain-containing molecule (tim- ), reported to be exclusively expressed on differentiated t cells, was not altered by dna vaccination. we did not note any clonal deletion upon tolerization, but detected an antigen-specific lymphocyte population upregulating ifng upon recall stimulation weeks after protective dna vaccination. in protected rats, we observed ( ) no alterations in antigenspecific th or th responses, ( ) reduced mhc ii expression on splenocytes early after eae induction, ( ) antigen-specific upregulation of ifnb upon recall stimulation and ( ) reduced il- rb on lymphocytes. we thus demonstrate an association of the protective effect of dna vaccination with expression of ifnb. we are currently investigating the cellular mechanisms behind this ifnb-mediated protection. multiple sclerosis (ms) is an autoimmune condition characterized by degeneration of nerve fibre myelin sheets. a candidate autoantigen, myelin basic protein (mbp), has especially attracted attention. the presence of anti-mbp antibodies is a predictor of definite ms, but their role in the pathogenesis remains obscure. t cells have long been known to play a pivotal role in the pathogenesis of ms. recently, an important role for b cells as autoantigen-presenting cells has been demonstrated in other autoimmune diseases, including rheumatoid arthritis and diabetes. the uptake of mbp by b cells and the presentation of mbp-derive peptides to t helper (th) cells by b cells may be promoted by the formation of complement (c) activating immune complexes (ics) between mbp and natural autoantibodies in healthy individuals and disease-associated anti-mbp antibodies in ms patients, respectively. we have investigated the formation of mbp-containing ic, the binding of mbp to b cells, the mbp-elicited induction of th-cell and b-cell proliferation and the cytokine production in peripheral blood mononuclear cells (pbmcs) from healthy donors grown in the presence of intact or c-inactivated serum from healthy donors or patients with ms. while mbp did not induce measurable proliferation of b cells nor cd þ t cells, we observed the production of tnf-a, ifn-g and il- by pbmc in response to incubation with mbp in the presence of sera from healthy controls as well as sera from ms patients. by contrast, no production of il- , il- and il- was detected. we are currently investigating the capability of ms sera to promote the formation of mbp-containing ic and thereby enhance the cytokine responses, by virtue of elevated anti-mbp contents. the phagolysosomally localized acid sphingomyelinase (asmase) activated by proinflammatory cytokines such as tnf and ifn-g generates the signalling molecule ceramide which in turn results in the activation of proteases like cathepsin d. these characteristics of asmase suggest a possible role of this molecule in the phagocytotic uptake and phagosomal degradation processes of antigens or in antigen presentation. we show here that asmase -/mice fail to eliminate the noncytopathic lymphocytic choriomeningitis (lcm) virus as rapidly as littermate wildtype mice. investigation of the immune response revealed a reduced expansion of cd þ t cells. the secretion of ifn-g in response to contact with target cells as well as the cytolytic activity of virus-specific cd þ t cells was severely impaired. additionally, both phases of the lcm virus-specific dth response, mediated by cd þ and cd þ t cells consecutively, were diminished in asmase -/mice. however, the secondary memory response of virus-specific ctl was not altered, and the abstracts ................................................................................................................................................................................................. virus was effectively controlled for at least months by asmase -/mice. in conclusion, the results of this study suggest an involvement of the asmase in the activation, expansion or maturation of virus-specific cd þ t cells during the acute infection of mice with the lcm virus. novel markers for alternative activation of macrophages: macrophage galactose-type c-type lectins and in parallel with the th /th dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in, for example cytokine environment and pathological conditions. while the best-studied, classically activated macrophage is induced by type i stimuli such as ifn-g, a type ii cytokine environment antagonizes the classical activation of macrophages and is capable of alternatively activating macrophages. however, molecular markers associated with these type ii cytokine-dependent, alternatively activated macrophages remain scarce. besides the earlier documented markers macrophage mannose receptor and arginase , we recently demonstrated that murine alternatively activated macrophages are characterized by increased expression of fizz and ym. we now report that expression of the two members of the mouse macrophage galactose-type c-type lectin gene family, termed mmgl and mmgl , is induced in diverse populations of alternatively activated macrophages, including peritoneal macrophages elicited during infection with the protozoan trypanosoma brucei or the helminth taenia crassiceps, and alveolar macrophages elicited in a mouse model of allergic asthma. we also demonstrate that, in vitro, interleukin- and interleukin- upregulate mmgl and mmgl expression and that, in vivo, induction of mmgl and mmgl is dependent on interleukin- receptor signalling. moreover, we show that regulation of mgl expression is similar in human monocytes and monocyte-derived macrophages. hence, macrophage galactose-type c-type lectins represent novel markers for both murine and human alternatively activated macrophages; thus, paving the way for further characterization of the phenotype of macrophages occurring in th conditions. background: human parvovirus b (b ) is a ubiquitous pathogen, normally causing a mild self-limiting disease, but also capable of causing both significant pathology and long-term persistence. the small size and stability of the virus makes it suitable for mapping of the full breath and the kinetics of the cellular immune responses following acute viral infection. methods: five patients with acute primary b infection were included in the study and followed consecutively for up to weeks. cellular immune responses were mapped by ifng enzyme-linked immunospot to overlapping peptides spanning the whole b genome. results: in all five acutely infected patients, we were able to monitor the kinetics of a strong specific cellular immune reaction. responses peaked at levels of - sfc/ million pbmcs, roughly corresponding to . - . % b specific cd þ cells circulating in peripheral blood at - weeks post-infection. the responses in individual patients were directed to three or four different peptide pools, and the specificity was confined to the same cd epitopes present in the pools throughout the follow-up period. the majority of responses were directed to the virus nonstructural protein, only two patients showed any response to the capsid proteins, elicited by the same epitope in both cases. conclusion: the cellular immune responses to acute b infection are surprisingly narrow in distribution and remain at high levels for up to weeks post-infection. the initial epitope specificity is maintained, and the majority of responses target the virus nonstructural protein, which is not included in vaccine preparations, evaluated against the infection. the relationship between malnutrition and malaria is controversial. on one hand, malaria may cause malnutrition, while on the other, malnutrition itself may modulate susceptibility to the disease. we investigated the association between plasmodium falciparum malaria and malnutrition in a cohort of children living on the coast of kenya. the study involved longitudinal follow-up for clinical malaria episodes and anthropometric measurements at four cross-sectional surveys. we used poisson regression analysis to investigate the association between malaria and nutritional status. compared to baseline (children with a waz or haz score of !À ), the crude incidence rate ratios (irrs) for malaria in children with low haz or waz scores (<À ) during the period prior to assessment were . ( % ci . - . ; ¼ . ) and . ( . - . ; . ), respectively, suggesting no association between malaria and the subsequent development of pem. however, we found that age was acting as an effect modifier in the association between malaria and malnutrition. the irr for malaria in children - years old who were subsequently characterized as wasted was . ( . - . ; p ¼ . ), and a significant overall relationship between malaria and low-haz was found on regression analysis when adjusting for the interaction with age (irr . ; . - . ; p < . ). although children living on the coast of kenya continue to suffer clinical episodes of uncomplicated malaria throughout their first decade, the association between malaria and malnutrition appears to be limited to the first years of life. a. astrinidou-vakaloudi, s. xytsas, i. diamanti, h. ioannidis & p. pangidis microbiology department of general hospital of thessaloniki 'agios pavlos', thessaloniki, greece, and nefrology, nd ika hospital of thessaloniki, thessaloniki, greece. e-mail: stasa@hol.gr aim: renal dysfunction may influence the colonization of gastric mucosa by urea-splitting bacteria such as helicobacter pylori, by increasing urea concentrations in the gastric juice. our aim was to investigate the prevalence of h. pylori in patients with end-stage renal disease (esrd), receiving long-term haemodialysis treatment. methods: this study included sera from patients with esrd ( male and female) undergoing periodic haemodialysis; mean time of treatment was . months. using elisa technique, we investigated the presence of igg and iga antibodies against h. pylori as well as igg caga (antibodies specific for caga(þ) strains of h. pylori). sera from healthy blood donors were used as a control group. results: h. pylori igg antibodies were detected in out of ( %) patients in the dialysis group, while / ( . %) tested positive for iga. igg caga antibodies were present in out of ( . %). prevalence of h. pylori igg, iga and caga igg antibodies in the control group was , and %, respectively. conclusions: although international data suggest that prevalence of h. pylori infection is the same in esrd patients as in healthy individuals, in our study that seems not to be the case. the higher blood and gastric juice urea levels may be a risk factor (among many others), but more studies are required in order to understand the relation of h. pylori infection in this group of patients. flanders interuniversity institute for biotechnology, department of molecular and cellular interactions, free university of brussels, brussels, and pasteur institute of brussels, mycobacterial immunology, brussels, belgium. e-mail: tgartner@vub.ac.be immunity against tuberculosis (tb), caused by mycobacterium tuberculosis, depends largely on activation and maintenance of strong cell-mediated immune responses involving both cd þ and cd þ t cells and the ability to respond with th -type cytokines, particularly ifn-g. recent studies suggested that bcg, the only licensed vaccine against m. tuberculosis, may fail to induce t-cell responses in the lung mucosa and may therefore not protect against pulmonary tb. a decrease in tb mortality may be achieved by enhancing immunity in the lung. the present study evaluated the induction of antigen-specific immunity in the lung by intranasal (i.n.) delivery of the lipoprotein i (opri) from pseudomonas aeruginosa. opri has shown to be a toll-like receptor / agonist that, when given subcutaneously, induces type- immune responses against heterologous antigens. here, a fusion of opri to ag a of mtb (opri-ag a) was used as a subunit vaccine in homologous prime-boost immunizations. in addition, opri-ag a was combined with an ag a-encoding dna vaccine (ag a dna) or with bcg in heterologous prime-boost vaccinations. intranasal and parenteral delivery with opri-ag a elicited comparable t-cell responses in the spleen; in addition, i.n. delivery elicited specific t-cell responses in the lung lymph nodes (llns). intramuscular delivery of ag a dna induced significant systemic th immune responses. intranasal boosting with opri-ag a enhanced this response and in addition induced an antigen-specific ifn-g response in lln. opri may therefore be an efficient adjuvant for mucosal boosting. we continue to evaluate the protection induced by opri-based prime-boost vaccinations against pulmonary tb. results on the immunogenicity and protection against intravenous mtb h rv infection will be presented. toll-like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress-associated molecules. tlr-ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus-induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus-encoded inhibitor of tlr-signalling a r or dominant-negative myd totally inhibited hsv-induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv-induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr-dependent and -independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. - -oligoadenylate synthetases are interferon-induced, double-stranded rna-activated antiviral enzymes which are the only proteins known to catalyse -specific nucleotidyl transfer. this first crystal structure of a - oligoadenylate synthetase reveals a structural conservation with the -specific poly(a) polymerase that, coupled with structure-guided mutagenesis, supports a conserved catalytic mechanism for the -and -specific nucleotidyl transferases. comparison with structures of other superfamily members indicates that the donor substrates are bound by conserved active site features while the acceptor substrates are oriented by nonconserved regions. the - oligoadenylate synthetases are activated by viral doublestranded rna in infected cells and initiate a cellular response by synthesizing - -oligoadenylates, that in turn activate rnase l. this crystal structure suggests that activation involves a domain-domain shift and identifies a putative dsrna activation site that is probed by mutagenesis. we demonstrated that this site is required both for the binding of dsrna and for the subsequent activation of oas. this rna-binding site is different from known rna-binding site; rather than forming a defined three-dimensional domain, it is located at the interface of the two major domains in oas. this novel architecture ensures that the dsrna helix can make simultaneously contact with both domains of oas and ensure the subsequent structural rearrangement leading to the activation of oas. our work provides structural insight into cellular recognition of double-stranded rna of viral origin and identifies a novel rna-binding motif. bacteria-specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody-treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as faba (monovalent) deprived of fca which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody-coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero-steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type- polysaccharide-induced phagocytosis of iga protease-deficient type- pneumococci equally well in the absence as in the presence of complement. iga antibody to type- polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type- polysaccharide served as opsonin. iga antibody extracted from iga protease-producing target bacteria was almost exclusively in the form of faba. conversely, iga from protease-deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody-mediated opsonophagocytosis. besides, in these experiments, iga-mediated opsonophagocytosis was independent of complement. vitamins e and c have been found to increase the cellular and humeral immunity of pigs. vitamin e deficiency has also been found to predispose pigs to different diseases, e. coli infection is one among them. after weaning, the vitamin e status of pigs often decreases to a critical low level. in this experiment, we studied whether vitamin c supplementation would be a possible feeding strategy to optimize the immune status of weaners. the interaction between vitamin e and c is interesting due to the reported sparing action on vitamin e or synergism between these to vitamins. piglets were weaned at day of age from sows fed increasing dietary vitamin e during lactation, and piglets were during the following weeks fed either a control diet or this diet supplemented with mg stay-c per kg. blood sampling was obtained weekly from day and until day of age. on the same days, one piglet per dietary treatment was killed and alveolar macrophages (am) were harvested. vitamin c supplementation increased the concentration of igm in serum of piglets throughout the weaning period. although the vitamin e concentration in am decreased with increasing age of the piglets, the concentration was numerically higher in piglets of sows fed the high dietary level of vitamin e. however, vitamin c supplementation tended to increase the total am concentration of vitamin e after weaning and increased the proportion of the biologically most active isomer of vitamin e [rrr-(a-tocopherol)] in the am. the eicosanoid synthesis by am was not influenced by the vitamin c supplementation, but the synthesis of leukotriene b was decreased weeks after weaning compared to other days of am harvesting. in conclusion, dietary vitamin c supplementation improved the immune responses of piglets after weaning. a whole blood stimulation assay with escherichia coli (o :b ) endotoxin was established to measure the capacity of dairy cows to produce the proinflammatory cytokine tumour necrosis factor-a (tnf-a) ex vivo. initially, a time-and dose-dependent study was carried out to find the optimal stimulation conditions for the tnf-a response. the tnf-a response peaked between and h at . c. a dose in the range of - g of e. coli lipopolysaccharide (lps)/ml whole blood was found to give the maximum tnf-a response. thirty-eight danish-holstein dairy cows were investigated for their tnf-a responsiveness ex vivo in the periparturient period. heparin-stabilized blood samples were collected seven times over a period of months (weeks À , À , , , , and around calving) and stimulated with g/ml of e. coli lps. indeed, fluctuations in the tnf-a responsiveness occurred over time. moreover, the mean tnf-a responsiveness of cows was found to be significantly increased (p < . ) in the weeks close to calving. however, in the more stabile physiological periods, some cows had a consistently low tnf-a response, whereas others had high a tnf-a response. we are currently investigating whether high and low tnf-a responders to e. coli lps also exist in dairy cows in vivo. moreover, the importance of tnf-a responsiveness ex vivo to dairy cows' susceptibility and clinical response to experimental e. coli infections in the udder is being investigated. coelomic cytolytic factor (ccf) is a kda invertebrate pattern recognition molecule isolated from the coelomic fluid of the earthworm eisenia foetida (oligochaeta, annelida). ccf displays a number of similarities with the mammalian cytokine tumour necrosis factor-a (tnfa) as a result of a shared n,n -diacetylchitobiose lectin-like domain. however, these similarities are solely functional and are not based on any (dna or amino acid) sequence homology, thus suggesting a form of convergent evolution. in particular, the lectin-like domain of tnf-a has been shown to induce membrane depolarization in various mammalian cell types, through interactions with endogenous amiloride-sensitive ion channels. this nonreceptor-mediated activity of tnf-a has been reported to be involved in the resorption of oedema. likewise, the lectin-like domain of ccf also induces membrane depolarization in mammalian cells. here, we show that ccf appears to be able to induce oedema resorption in an alveolar epithelial cell line through its lectin-like domain. this lectin-like domain of ccf interacts (directly or indirectly) with endogenous sodium and/or chloride channels, and not potassium channels, on mammalian cells. additionally, we suggest that the jnk/sapk and erk / pathways are involved in ccf-induced macrophage activation. these results further establish the functional analogy between an invertebrate pattern recognition molecule and a mammalian cytokine and, from a more applied point of view, suggest the possibility of utilizing ccf in the treatment of oedema. release of svegf and svegfr from white blood cells and platelets during surgery and stimulation with bacterial antigens introduction: the influence of surgery on release of soluble vascular endothelial growth factor (svegf) and the soluble vascular endothelial growth factor inhibitory receptor (svegfr ) is unknown. we studied the effect of major and minor surgery on potential variations in svegf and svegfr concentrations in vivo and on bacterial antigen-induced release of svegf and svegfr from whole blood in vitro. methods: sixty-one patients with abdominal diseases undergoing five different surgical procedures were included. blood samples were drawn from anaesthetized patients before and after the operation. white blood cells and platelets were counted, and plasma svegf and svegfr was determined by an elisa method. whole blood from each blood sample was stimulated in vitro with bacteria-derived antigens (lps or protein-a) and svegf and svegfr levels were subsequently determined in the supernatants. stimulation with isotonic saline served as control assay. neither svegf or svegfr in plasma changed during surgery. in vitro stimulation of blood samples with bacteria-derived antigens resulted in a significant increase in svegf (p < . ) and a less pronounced but still significant increase in svegfr . release of svegf due to stimulation was significantly higher after the operation (nonsignificant), whereas svegfr release remained largely unchanged after surgery. correlation between bacterial antigen-induced release of svegf and neutrophile cell count was highly significant (p < . ). there was no correlation between svegf and platelet cell count, and bacterial antigen-induced svegfr release did not correlate with counts of neutrophils and platelets. conclusions: plasma svegf and svegfr concentrations did not change during surgery. in vitro bacterial stimulation led to increased release of svegf and svegfr , which was not significantly amplified during surgery and which may be related to number of circulating neutrophils. natural killer cell functions and subsets after in vitro stimulation with il- and il- , with special emphasis on intracellular ifn-g and nk-cell cytotoxicity r. nyboe, , t. rix, , j. krog, , e. tønnesen & m. hokland department of anaesthesiology and intensive care, aarhus university hospital, and institute of medical microbiology, and immunology, university of aarhus, aarhus, denmark. e-mail: rnsr@studmed.au.dk materials and methods: isolated cryopreserved human peripheral blood mononuclear cells (pbmcs) were stimulated with il- and il- . this stimulation has previously been shown to activate nk cells. cell cytotoxicity was measured by flow cytometry after incubation with k cells. this method was compared to the current standard cr release assay. cells were treated with bfa to accumulate ifn-g, stained for surface markers, permeabilized and stained for intracellular ifn-g. flow cytometry was then performed to measure intracellular ifn-g production in pbmc, especially in nk cells. results: we have demonstrated that stimulation with il- and il- is effective in increasing the number of ifn-gpositive cells. there is a distinct difference between the cd -cd dim and the cd -cd bright subsets, with a much greater proportion of ifn-g-positive cells in the cd -cd bright subset. the effects of stimulation with il- and il- on cytotoxicity will be presented, as will the relation between ifn-g production and cytotoxicity. in addition, we will present results of these assays applied to porcine cells. discussion: in combination, these tests will address nk cell function by combining cytotoxicity with ifn-g production in nk cell subsets. the results will demonstrate whether this could serve as a useful tool in describing nkcell function, which could be of value in clinical and experimental settings. culture of regulatory t-cell lines from bronchial mucosa t lymphocytes play a major role in many immune responses. in the last decade, special focus has been on the function of th and th effector cells. now the importance of regulatory cd þ cd þ t cells in maintenance of the immunological homeostasis emerges. sarcoidosis is a multisystem granulomatous disorder often affecting the lungs. the typical sarcoid granulomas consists of epitheloid cells, macrophages and lymphocytes, mainly cd þ t cells of th phenotype. we have cultured t cells from bronchial biopsies of patients with sarcoidosis as well as from controls in high levels of interleukin (il- ) and il- and demonstrate spontaneously arising cd þ cd þ populations and high concentrations of il- in these cultures. the main difference between cultures of sarcoid origin compared to controls is a very much higher concentration of the inflammatory cytokines il- and tnf-a in cultures of sarcoid origin. the effects of hyperbaric exposure on human peripheral blood mononuclear cells, with special emphasis on natural killer cell cytotoxicity and subsets materials and methods: as an experimental physiological stress model, we examined the effects of hyperbaric exposure on peripheral blood mononuclear cells (pbmcs) obtained from venous blood drawn from eight divers during a simulated heliox saturation dive. eight persons working in normobar atmosphere outside the pressurized chamber served as control donors. the spontaneous cytotoxicity of the pbmcs was estimated in a h cr-release assay using k as nk-sensitive target cells. the pbmcs were characterized, using -colour flow cytometry, with special emphasis on the nk-cell subsets. the data were statistically analysed using a multivariate regression model (stata . ). p values < . was considered statistically significant. results: the estimated cytotoxicity increased significantly in both the group of divers and control donors during the dive (pdivers < . and pcontrols < . ). although the cytotoxicity increased relatively more (p < . ) in the group of divers compared to the group of control donors between day and . discussion: the increased cytotoxicity of pbmc estimated in the group of divers indicate that parts of the cellular immune system are affected during the extreme physiological conditions induced during the initial phase of the presented experimental hyperbaric setup. the increase in cytotoxicity observed in the group of control donors could hypothetically reflect the stress level in persons working outside the pressurized chamber during the dive. the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin- (il- ), il- and transforming growth factor (tgf)-b are important regulators of chronic inflammatory disease, where cutaneous lymphocyteassociated antigen (cla) and ae integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue-specific homing but may help to retain t cells within epithelial layers. we have previously shown that il- alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd þ but not cd þ t cells. while il- increased superantigen-stimulated expression of cla, this cytokine strongly inhibited the cd expres-sion, and a combination of il- and tgf-b completely abrogated the induced cd expression. conversely, il- suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th -mediated inflammatory responses, il- may also inhibit the migration of cd þ t cells into the skin while il- promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il- and il- , and the balance between these cytokines could influence the t-cell migration of inflammatory cells into epithelial tissues. during contact sensitivity reaction, immune cells proliferate. in order to study the histological picture of these proliferation phases, we used a mouse model of contact sensitivity in the oral mucosa and on skin. we also used bromodeoxyuridin (brdu, an analogue to thymidin) that is incorporated into the nucleus during cell replication. the hapten oxazolone (oxa) was used to sensitize and elicit the oral mucosa and/or the ear skin. mice were killed at various times after elicitation, and unsensitized animals were also exposed to the hapten as controls. brdu ( mg/ kg animal) was injected i.p. h before the kill. specimens from the oral mucosa, ear skin and submandibular and auricular lymph nodes were cut and fixed in % paraformaldehyde. they were then treated with acid and biotinylated anti-brdu antibody and developed using abc-kit and dab. the analyses were performed using a leica light microscope and the computer program analysis. in the oral mucosa, the frequency of proliferating cells were increasing during the observation period, - h after elicitation, regardless of site of sensitization. the proliferating cells were found mainly in the basal cell layer of the epithelium. similar patterns were found in ear skin. the regional lymph nodes demonstrated a few scattered proliferating cells h after elicitation. after h, these cells were found frequently in the whole lymph node. control animals exhibited considerable less proliferating cells at all times. we conclude that most proliferating cells were found h after elicitation locally at the hapten-exposed sites (the oral mucosa or the ear skin) as well as in the regional lymph nodes. the endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective anti-inflammatory effects. adenosine acts via four adenosine receptors of which the a a receptor is the predominant form in t cells. adenosine levels are elevated in asthmatic lung, and adenosine can directly induce mast cell degranulation and bronchoconstriction in these patients. instead, the role of anti-inflammatory mechanisms of adenosine on t cells in asthma is unclear. aim: to study the a a receptor expression in peripheral blood cd þ t cells in asthmatic and healthy individuals using flow cytometric and quantitative real-time pcr methods. results: unstimulated cd þ cells of asthmatic patients expressed significantly lower levels (p < . ) of a a receptor in protein level (mean percentage of cells positive ae sem: . ae . , n ¼ ) compared to healthy individuals ( . % ae . , n ¼ ). double staining for cd expression showed that stimulation of cd þ cells decreased a a expression in both groups but indicated that the detected lower levels of a a in unstimulated cells of asthmatics was not due to preactivation in these patients. surprisingly, a a mrna expression in unstimulated cd þ cells was significantly higher (p < . ) in asthmatics (n ¼ ) compared to healthy controls (n ¼ ). the expression did not correlate with serum total ige levels. conclusions: asthmatic individuals express less a a adenosine receptor on their peripheral cd þ t cells. the higher mrna levels instead may point to a negative feedback regulation in the receptor expression. the role of possibly decreased adenosine-mediated anti-inflammatory effects in asthma pathogenesis require further studies on this t-cell mediated disease. the chronic inflammatory skin disease atopic eczema (ae) affects almost % of the population in many countries today. the pathogenesis of ae is not fully understood. a combination of genetic predisposition and environmental factors like microorganisms seems to contribute to the symptoms. the yeast malassezia sympodialis is part of our normal skin micro flora but can act as an allergen and elicit specific ige and t-cell reactivity in patients with ae. recently, we identified a novel major m. sympodialis allergen, designated mala s ( . kda), with sequence similarity to the mitochondrial enzyme manganese superoxide dismutase (mnsod). interestingly, mala s has a high degree of homology to human mnsod. the aim of this study was to examine the effects of recombinant mala s on antigen-presenting dendritic cells. monocytederived dendritic cells (mddcs) from healthy blood donors were cultured with or without mala s for different time periods. it was found that the maturation marker cd and the costimulatory molecules cd and cd were upregulated on the mddcs exposed to mala s for h, as demonstrated by flow cytometry. furthermore, coculture of mddcs with mala s for h induced an increased production of the inflammatory cytokines il- ( -fold), tnf-a ( -fold) and il- (sixfold), as detected by the cytometric bead array (cba) analysis. our results suggest that mala s affects the immune response through dc maturation and production of inflammatory cytokines. the potential cross-reactivity with human mnsod needs to be explored and the exact role of mala s in the pathogenesis of ae assessed in clinical studies involving skin prick and atopy patch tests. allergen-specific immunotherapy (sit) is commonly conducted with allergen extracts adsorbed to aluminium hydroxide (alum). drawbacks linked to the use of alum, such as the formation of granuloma at the site of injection, have led to suggestions of novel allergen carriers. an alternative carrier is mm carbohydrate-based particles (cbps). in mouse, allergen-coupled cbps have been demonstrated to skew the allergen-specific immune response towards a th -like activity (grönlund et al. immunology, ) . we here coupled the recombinant major cat allergen fel d to cbps (cbp-fel d ) by cyanogen-bromide activation, resulting in covalent binding. the effect of cbp-fel d on monocyte-derived dendritic cells (mddcs) from healthy human blood donors was studied. we found that the majority of the cd a þ mddcs were capable of taking up fitc-labelled cbp-fel d , as demonstrated by flow cytometry and confocal laser scanning microscopy. furthermore, incubation with cbp-fel d resulted in an upregulation of the costimulatory molecule cd on the mddcs, which was not observed with fel d or cbps alone. finally, cbp-fel d induced a fivefold increase in the release of the pro-inflammatory cytokine tumour necrosis factor (tnf)-a and a fourfold increase in the release of the chemokine interleukin- from mddcs. taken together, the effects cbps possess make them interesting as novel allergen carriers for sit. the cysteine protease der p from dust mite of the genus dermatophagoides pteronyssinus is a major type i allergen. about % of house dust mite (hdm) allergic individuals are reactive to this protease in standard assays for detection of ige. a curative treatment for atopic allergy is immunotherapy (it) with hdm extracts which are complex mixtures occasionally resulting in anaphylactic reactions. novozymes focuses on developing a recombinant variant of der p which exhibit lowered risk of ige-mediated allergic reactions, while maintaining its ability to trigger proper th-cell responses. this may provide a safer alternative for specific it of hdm allergy. a secreted recombinant form of pro-der p expressed by saccharamyces cerevisiae was obtained by fusion of the pro-enzyme to a fungal signal peptide. the n-glycosylation site of der p was mutated resulting in a deglycosylated pro-enzyme with a molecular mass of kda. protein purification procedure was developed to obtain nearly pure der p protein followed by determination of concentration by active-site-titration with the cysteine protease inhibitor e . the deglycosylated recombinant pro-der p revealed immunologic similarity to the native der p molecule when compared in basophile histamine release, ige-binding assays and t-cell proliferation assays. by in silico epitope mapping of a modelled -dimensional structure of der p , five putative igg and ige epitopes were predicted. by protein engineering, the predicted epitopes were removed one by one in der p and screening for hypoallergenic variants was performed. combining inhaled long-acting b- agonist (laba) and inhaled corticosteroid (ics) seems to offer asthma control at a lower dose of ics than achieved by ics alone. fine mapping of t-cell surface markers by flow cytometry offers a detailed status of the individual's inflammatory response. the frequency of mt (cd þ cd ra -cd l þ cd adim) and mt (cd þ cd ra -cd l -cd abright) cells in peripheral blood, and their ratio, has been shown to differ predictably in atopics and patients with leprosy, where mt correlates with a th phenotype and mt with a th phenotype. stable asthmatics, requiring fluticasone propionate (fp) - mg daily or equivalent, were randomized to receive, double-blinded, either seretide [salmeterol and fluticasone propionate (sfc, n ¼ )] mg/ mg bd or fp mg bd (n ¼ ). if asthma was controlled based on lung function and symptoms at clinic visits every weeks, ics dose was tapered until asthma exacerbated or mg was reached. the frequency and ratio of mt and mt t cells of the patients was monitored at week intervals. as treatment tapered, the frequency of mt cells decreased (p ¼ from first to final visit), whereas that of mt cells increased. the ratio of mt /mt decreased (p ¼ from first to final visit). in patients receiving laba þ ics, the fall in mt /mt ratio appeared to be more pronounced than in patients receiving ics alone. thus, the mt phenotype may be associated with stable asthma, whereas an imminent exacerbation may associate with an increase in the mt phenotype. laba may allow for a greater effect of fp on the mt ratio. activation of complement pathways, leading to production of c a and c a anaphylatoxins, has been postulated in the pathogenesis of asthma and allergic airway inflammation. the present study was undertaken to investigate the role of mannan-binding lectin (mbl), an initiator of the lectin pathway of complement, in asthma and allergic rhinitis. mbl levels and mbl-induced complement activity were determined in patients of bronchial asthma with allergic rhinitis and unrelated, age-matched controls of indian origin. mbl levels and activity were correlated with percent eosinophilia and percent predicted fev values of the patients. association of single nucleotide polymorphisms (snps) in exon and intron of the mbl with the disease, clinical markers, mbl levels and mbl-induced complement activity was analysed using standard statistical tools. significantly higher mbl levels and activity were observed in patients of bronchial asthma with allergic rhinitis as compared to the controls. we identified five snps, of which two, a g in exon and g a in intron of the mbl, were novel. snp g a was significantly associated with the disease (p ¼ . , or ¼ . , % ci: . < or < . ). individuals with 'a' allele at position showed increased mbl levels, activity and disease severity. our results suggest that 'a' allele at position leading to high mbl levels and complement activity may be contributing to the severity of bronchial asthma and allergic airway inflammation. serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid-encoded, surface-exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h-binding proteins of approximately - kda has been described. the ospe-related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe-related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h-binding regions of ospe-related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c-terminal regions of both human and mouse factor h (scrs - ) specifically bind to ospe-related lipoproteins. we also found fhr- , whose c-terminal scrs - are homologous to scrs - of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i-v) in ospe that could directly interact with factor h. deleting the c-terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c-termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c-terminal-binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h-binding regions were mutated to alanines, we observed that lysines in the factor h-binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe-related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c-termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h-binding proteins may account for their susceptibility to serum lysis. role of yada, ail and lipopolysaccharide in serum resistance of yersinia enterocolitica serotype o: mannan-binding lectin (mbl), l-ficolin and h-ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l-ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type- , - , - , - and - ). h-ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h-ficolin initiated activation of complement factor c , whereas l-ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . mg of mbl/ml, . mg of l-ficolin/ml and . mg of h-ficolin/ ml, respectively. the absence of early complement components (c , c and c but not c ) is a predisposing factor for systemic lupus erythematosus (sle). recently, we demonstrated that, in c -deficient (c def.) mice, igm-containing immune complexes (igm-ic) are filtered by the splenic barrier of marginal zone macrophages (mzm), resulting in an increased immune response against antigens within these igm-ic, but this could not be observed in wildtype or c def. mice. we hypothesized that splenic cd b þ mzm play an important role in the induction of autoimmunity, and we therefore analysed their cytokine profile after isolation with the help of magnetic antibody cell sorting. mrna was isolated, and real-time pcr was performed with specific primers for murine ifn-g (ifn-g), interleukin- (il- ) and ifn-a (ifn-a). we observe a moderate increase of il- and ifn-g mrna in cd b þ cells of c def. mice compared to wildtype cells. surprisingly, the concentration of ifn-a mrna is six times higher in c def. mice. preliminary results suggest that mrna in cd b þ cells of c def. mice is even lower than that in wt. six hours following i.v. application of mg of a abstracts .................................................................................................................................................................................................. murine monoclonal igm anti-dsdna antibody, production of il- , ifn-g and ifn-a mrna is increased in cd b þ cells of both c def. and wt mice. several references described increased levels of inf-a in patients with sle. dendritic cells are discussed as a major source of ifn-a. our observation that c -deficient, sle-susceptible mice demonstrate an increased spontaneous ifn-a production by splenic cd b þ marginal zone macrophages could be an early sign and a trigger for the development of sle. this is supported by the fact that the absence of c is not a predisposing factor for sle and our observation that c def. animals display low levels of ifn-a mrna. - million people worldwide and represents one of the leading causes for liver cirrhosis and hepatocellular carcinoma. control over the hbv infection is achieved mainly by vaccination with hepatitis b surface antigen (hbsag). hbsag contains n-linked glycosylation side and is recognized by both mbl-a and mbl-c in a cadependent manner. hbsag-mbl complexes activate complement and may thus affect humoural immunity. to investigate the role of mbl in humoural responses to hbsag, we immununized mice that lack both mbl-a and mbl-c proteins with soluble hbsag. it has been shown that deficiencies in other complement components like c q, c and c result in decreased antibody responses. however, mbl double ko animals mounted dramatically increased humoural responses. after priming, mbl double kos mounted hbsag-specific igm responses, which were threefold higher than wt controls. after boosting the hbsag, total igg was -fold higher in mbl ko than in wt control animals. similar to the response to hbsag, other glycosylated soluble antigens (e.g. invertase) induced better humoural responses in mbl double ko animals, suggesting that mbl plays an important role in a negative feedback regulation of adaptive immunity. reconstitution experiments with rmbl partially rescued the ko phenotype. we propose that the clearance of glycoprotein antigens in mbl ko is handled differently from the wt, resulting in better stimulation of humoural responses. alternatively, glycoprotein-ag-mbl-rich complexes inhibit b-cell responsiveness via putative mbl receptors. the complement system is an important part of the innate immune system. the activation of complement proceeds through three different pathways that converge in the generation of c -activating enzyme complexes. complement activation via the lectin pathway is initiated when recognition molecules, mannan-binding lectin (mbl) or ficolin, bind to carbohydrate structures characteristic for microbial surfaces. in the circulation, mbl and ficolins are found in association with three structurally related mblassociated serine proteases (masp)- , - and - and a small, nonenzymatic component, map . masp- has been shown to elicit complement activation through the sequential proteolytic cleavage of c and c upon binding of mbl/masp- complexes to microbial surfaces. we have recently uncovered a polymorphism in the masp- /map gene in a patient shown to be deficient in the lectin pathway of complement activation. the polymorphism results in a single amino acid substitution in the n-terminal part of the masp- protein. recombinant wildtype masp- and masp- containing the amino acid substitution in question was produced, and the ability to activate complement was studied. the mutation had a profound impact on masp- function, resulting in the lack of complement activation through the lectin pathway. elisa-based experiments showed that the mutation leads to the impairment of complement activation through influencing the binding of masp- to mbl or ficolins. deficiencies in the lectin pathway of complement activation have so far been accounted for only by lack of functional mbl. the mutation described above is the first defect described affecting both activation through mbl and the ficolins. .................................................................................................................................................................................................. th , th and treg cell balance. dcs are present in the gut mucosa and may thus be target for modulation by gut microbes, including ingested probiotics. here, we tested the hypothesis that species of lactic acid bacteria, important members of the gut flora, differentially activate dc. a large panel of human gut-derived lactobacillus and bifidobacterium spp. was screened for dc-polarizing capacity by exposing bone marrow-derived murine dc to lethally irradiated bacteria. cytokines in culture supernatants and dc-surface maturation markers were analysed. substantial differences were found among strains in the capacity to induce interleukin- (il- ) and tumour necrosis factor (tnf)-a, while the differences for il- and il- were less pronounced. bifidobacteria tended to be weak il- and tnf-a inducers, while both strong and weak il- inducers were found among the strains of lactobacillus. remarkably, strains weak in il- induction inhibited il- and tnf-a production induced by an otherwise strong cytokine-inducing strain of lactobacillus casei, while il- production remained unaltered. selected strains were tested for induction of dc maturation markers. those lactobacilli with greatest capacity to induce il- were most effective in upregulating surface mhc class ii and cd . moreover, l. casei-induced upregulation of cd was reduced in the presence of a weak il- inducing l. reuteri. in conclusion, human lactobacillus and bifidobacterium spp. polarize differentially dc maturation. thus, the potential exists for th /th /treg-driving capacities of the gut dc to be modulated according to composition of gut flora including ingested probiotics. the intestinal micro flora is indispensable in developing and maintaining homeostasis of the gut-associated immune system. evidence indicates that lactic acid bacteria (lab), e.g. lactobacilli and bifidobacteria, have beneficial effects on the host. established health effects include increased gut maturation, antagonisms towards pathogens and immune modulation. the objective of this study is to evaluate the immunomodulating properties of a range of lab of human origin. as dendritic cells (dcs) play a pivotal role in the balance between tolerance and immunity to commensal microorganisms, in vitro-generated immature dcs serve as a suitable model for studying the immunomodulating effects of lab. human immature dcs were generated in vitro from monocytes and exposed to lethally uv-irradiated lab. the effect of various species of lab on dcs in direct contact was evaluated. furthermore, the maturation pattern of dcs separated from the bacteria by an epithelial cell layer (caco- cells), which should mimic the intestinal environment, was studied. cytokine secretion (il- , il- and tnf-a) and upregulation of maturation surface markers on dcs (cd and cd ) was measured. different lab induced diverse cytokine responses. some strains were strong il- and tnf-a inducers and others weak. all strains induced il- . different lab also differentially modulated expression of cd and cd on dcs. although some variation in the response to lab of dcs generated from different blood donors was observed, general differences in the effect of the various lab was revealed. experiments with the dc caco- coculture system are ongoing. different species of lab differentially affect dc maturation; this suggets that the gut flora plays a pivotal role in polarization of the immune response. natural killer (nk) cells are cells of the nonspecific immune system lysing altered self-cells. a noncytolytic subset of nk cells may serve a regulatory role by secreting cytokines. bacteria translocating across the gastrointestinal mucosa are presumed to gain access to nk cells, as consumption of certain lactic acid bacteria has been shown to increase in vivo nk cytotoxicity. here, we investigated how human gut flora-derived lactobacilli affect nk cells in vitro, by measuring proliferation and ifn-g production of human nk cells upon bacterial stimulation. cd -cd þ nk cells were isolated from buffy coats by negative isolation using non-nk lineage-specific antibodies and magnetic beads. nk cells were incubated with mg/ml uv-inactivated bacteria or mg/ml phytohemagglutinin (pha) for days. proliferation was assessed by incorporation of radioactive thymidine into nk-cell dna. the ifn-g concentration was measured by elisa. incubation of nk cells with a lactobacillus acidophilus strain increased the proliferation of the nk cells and induced ifn-g production, both to levels comparable to pha stimulation. the proliferative response was further enhanced with autologous monocytes present, probably because cytokines, secreted by monocytes having engulfed bacteria, stimulated the nk cells. in contrast, a lactobacillus paracasei strain caused the nk cells to proliferate only in the presence of monocytes. these results demonstrate that various strains of lactobacilli have the capacity to activate nk cells in vitro, in a monocyte-dependent or -independent way. hence, the encounter of nk cells with lactic acid bacteria will affect nk-cell activation. such activation of nk cells may potentially skew an on-going or subsequent immune response towards a th response. lactobacilli are nonpathogenic gram-positive inhabitants of the normal human intestine known for their healthpromoting effects. in our earlier work, it is shown that human monoclonal antibody isolated from sera of a patient with waldenstrom macroglobulinaemia possess innate antibody characteristics and binds to lactic acid bacteria. according to the immune network model, immunization with this bacteria could induce the perturbations in immune system that might result in production of anti-lactobacillus antibodies, human monoclonal antibody like (ab ) and anti-idiotypic antibody (ab ). in this study, balb/c mice were immunized with two doses of bacteria lactobacillus acidophilus in complete and incomplete freund's adjuvant and phosphate-buffered saline (pbs), respectively. seven days after the last immunization, sera from immunized mice were collected and the presence of lactobacillus-specific ab and ab were determined by elisas. in the sera of immunized mice, antibodies specific to bacteria lactobacillus acidophilus were shown. the concentration of lactobacillus-specific antibodies was higher in the sera of hyperimmunized mice (mice immunized with mg of igm dj) than in sera of mice immunized with times lower doses of immunogen ( . mg per doses). moreover, ab and ab antibodies were detected in the sera of lactobacillus-hyperimmunized mice. in this study, we have shown the idiotypic network interactions in mice immunized with bacteria lactobacillus acidophilus. the normal gastrointestinal flora is crucial for the maturation of the acquired immunity via effects on antigenpresenting cells (apcs). here, we have investigated how two types of apcs, monocytes and dendritic cells (dcs), react to different bacterial strains typical of the commensal intestinal flora. purified monocytes and monocyte-derived dcs were stimulated with uv-inactivated gram-positive (lactobacillus plantarum and bifidobacterium adolescentis) and gram-negative (escherichia coli and veillonella parvula) bacterial strains. monocytes produced higher levels of il- p and tnf, as detected by elisa, in response to l. plantarum than to e. coli and v. parvula. in contrast, dcs secreted high amounts of il- p , tnf, il- and il- in response to e. coli and v. parvula but were practically unresponsive to l. plantarum and b. adolescentis. the lack of response to the gram-positive strains correlated with a lower surface expression of toll-like reseptor (tlr ) on dcs compared to monocytes. the surface expression of tlr on dcs was undetectable when analysed by flow cytometry, but blocking this receptor decreased the tnf production in response to v. parvula, indicating that low tlr expression on dcs is sufficient to mount an inflammatory response to gram-negative bacteria. ifn-g increased the expression of tlr on dcs and also potentiated the cytokine response to gram-negative bacteria. our results indicate that, when monocytes differentiate into dcs, their ability to respond to different commensal bacteria dramatically changes, thereby becoming unresponsive to probiotic gram-positive bacteria. these results may have important implications for the capacity of different groups of commensal bacteria to regulate mucosal and systemic immunity. probiotic bacteria, e.g. lactobacillus spp., may improve diseases such as chronic inflammatory bowel disease. we examined cytokine production and phenotypic change after in vitro stimulation of t cells from healthy volunteers using different probiotic strains. methods: t cells were cultured from colonic biopsies from eight healthy volunteers (agnholt and kaltoft, exp clin immunogenet ; : - ) , and dendritic cells were matured from their peripheral blood mononuclear cells. t-cell cultures were stimulated with autologous bacterial sonicate or strains of lactobacillus spp., with and without the addition of dendritic cells. cytokine levels (tnf-a, ifn-g, il- and gm-csf) and phenotype (cd , cd , cd and cd ) were measured on day . results: lactobacillus spp. induced higher productions of tnf-a and il- than did autologous bacteria. in presence of dendritic cells, the production of all cytokines increased. however, the increases of ifn-g and tnf-a were more pronounced in wells with autologous bacteria than in wells with lactobacillus spp. the addition of dendritic cells upregulated cd expression without simultaneous upregulation of cd . the upregulation was pronounced after stimulation with lactobacillus rhamnosus gg compared with autologous bacteria and other lactobacilli. discussion: in presence of dendritic cells, autologous bacteria induced inflammatory cytokines, while probiotics mainly induced regulatory cytokines. lactobacillus rhamnosus gg induced a regulatory phenotype (cd þ ), in part mediated by dendritic cells. future studies will address whether this shift to a cd þ phenotype represents a differentiation into competent regulatory t cells. in a clinical context, such cells might be used for treatment of inflammatory diseases. protein microarrays will play a key role in the postgenomic era and offer a unique possibility to perform highthroughput global proteome analysis. a chip can be printed with thousands of protein probes (e.g. antibodies), the biological sample added (e.g. a proteome) and any binding detected. we aim to develop protein microarrays based on human recombinant scfv antibody fragments for global proteome analysis. the concept of comparing proteomic maps of healthy versus diseased samples will allow diseasespecific proteins to be detected. in fact, antibody microarrays will allow us to perform comparative proteome analysis on any sample format in a species-independent manner, as long as a proteome can be isolated. however, the complexity of proteomes, containing several thousands of different proteins, is a problem. here, we have designed antibody microarrays targeting the water-soluble fraction of a proteome. to this end, an anticytokine antibody array was developed and human dendritic cells (aeactivation) was used as model system. the results showed that our antibody microarrays could be used to examine the cytokine profile in complex samples. furthermore, we have taken the first steps towards comparing our results with those of other technologies on both the protein and gene level. due to the complexity of the model proteome, we also examined the possibility to prefractionate the proteome in a simple one-step procedure (based on size) prior to the labelling step. in more detail, the sample proteome was fractionated into two fractions using membrane devices with different molecular weight cut-offs. the results showed that the fractionation considerably enhanced the assay sensitivity allowing cytokines in the pg/ml range to be readily detectable. the immunomodulatory effect of heat shock protein : immunization with a dna construct based on the malarial antigen fused with a fragment of hsp primes for a th- type of response finding an appropriate adjuvant for human vaccination is crucial. heat shock proteins (hsps) act as adjuvants when coadministered with peptide antigens or given as fusion proteins. however, there is a potential risk of autoimmunity when using the complete molecules, because hsps are evolutionary conserved. to overcome this, we first evaluated the adjuvant effect against two different antigens of a less-conserved fraction of plasmodium falciparum hsp (pf c) and compared it to the whole hsp molecule from trypanosoma cruzi (tchsp ). we found that pf c exhibited similar adjuvant properties as the whole molecule. we later evaluated the adjuvant potential of pf c against the malarial antigen eb in a chimeric dna construct. no appreciable levels of eb -specific abstracts .................................................................................................................................................................................................. antibodies were detected in mice immunized only with the dna constructs. however, dna primed the immune system, because subsequent challenge with the corresponding recombinant fusion proteins elicited a strong th- antibody response. in contrast, no priming effect was observed for ex vivo ifn-g production but stimulation with the hsp-chimeric fusion protein induced a stronger secretion of ifn-g in vitro than other proteins used. these results indicate that the use of hsps is promising in the design of new vaccines. high-throughput proteomics on antibody-based microarrays: the importance of probe and surface design in analogy to dna microarrays, protein microarrays offer a new distinct possibility to perform sensitive highthroughput global proteome analysis. however, the development of the protein microarray technology will place high demands upon the design of both probes and solid supports. the analysis of thousands of heterogeneous proteins on a single microarray requires the use of uniform probes, such as antibodies, directly designed for protein microarray applications. we have recently generated a human recombinant single-chain fv antibody library, genetically constructed around one framework, the ncoder-library, containing  clones. single framework antibody fragments (sinfabs) selected from this library were successfully applied as probes for microarrays providing sensitive detection in the attomol (mass spectrometry) and the zeptomole range (fluorescence). however, the choice of framework is critical. we have shown that the selected ncoder framework displayed excellent functional on-chip stability and arrayed dehydrated probes retained their activity for several months. furthermore, we have addressed the issues of biocompatibility of the solid support and immobilization strategies for our microarray setup. an in-house-designed substrate, macroporous silicon coated with nitrocellulose (map -nc ), displayed properties equal to, or better than, those of five commercially available supports used as reference surfaces. we have also evaluated different coupling strategies, such as adsorption, covalent coupling, diffusion and affinity coupling. using a novel affinity tag, the double-(his) -tag, we increased the binding efficiency of sinfab-molecules to ni þ -coated solid supports, thereby allowing nonpurified probes to be directly applied. the mannan-binding lectin (mbl) pathway is part of the innate immune system providing a first line of defence against infections. mbl and ficolins circulate in complexes with mbl-associated serine proteases (masp- , - and - ). after recognition of a microorganism by mbl, activation of the complement system occurs. masp- and masp- share five domains (making up the so-called a-chain), whereas they have unique protease domains (b-chains). before the identification of masp- , an assay for masp was presented, based on antibodies against the a-chain of masp- . with the new knowledge of the three masps, and the sharing of domains by masp- and masp- , assays specific for the protease domains have to be constructed, if one wishes to measure the proteins individually. we present an assay for quantifying total masp- in plasma and serum samples. the assay is a sandwich-type assay using as catching antibody a monoclonal antibody against the common a-chain of masp- / and a developing secondary antibody against the c-terminal part of the protease domain of masp- . we have used this assay for estimating the normal concentration of the protein as well as the concentration in patients and also for characterizing by gel permeation chromatography the masp- protein in serum. inducible costimulator ligand (icosl) is a costimulatory molecule related to b . (cd ) and b . (cd ). b cells, monocytes, dendritic cells and endothelial cells express icosl. inducible costimulator (icos) interacts with icosl, and this interaction leads to signals involved in isotype switching and the development of immunological memory. hitherto, no polymorphisms of this gene have been described. the aim of this study was to reveal variation of the icosl gene in normal individuals. all eight exons, except exon , were sequenced with flanking introns in healthy blood donors. eight single nucleotide polymorphisms (snps) and two length polymorphisms were found. one of the snps was found in the coding regions of the gene. the base involved was located in exon and caused a conservative amino acid change from valine (gtt) to isoleucine (att). three individuals were heterozygous g/a for the exon polymorphism, while the remaining seven individuals were homozygous for the wildtype g/g. exon encodes the immunoglobulin variable (igv)-like domain of the molecule which is situated outside the cell. this means that the amino acid could be critical for the stability of the molecule or could constitute part of the binding site for icos. the results form the basis for further experiments to find possible associations of the alleles to diseases caused by immune dysregulation. especially, the exon variant is interesting and could play a role for the development of immunological diseases. besides, it would be interesting to see whether both exon alleles are expressed or only the wildtype allele is functional. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. myxovirus a (mxa) is a resistance gtpbinding protein that is specifically induced by treatment with type ifns. for example, ifn-b-induced mxa in blood leucocytes has been used as a biomarker in ifn-btreated patients with multiple sclerosis. however, the degree of specificity of mxa in this regard is unclear, and measurements of mxa protein and/or mrna are not yet suitable for routine clinical use. in an attempt to find new and better reporter genes (and, hopefully, genes and gene products with proven specificity for ifn-a and -b), microarray screenings with u a genechips (affymetrix) were carried using human blood leucocytes and the human lung carcinoma cell line a . we studied the simultaneous expression of , transcripts before and after exposure to human recombinant ifn-a and ifn-b and other antiviral and immunomodulatory cytokines. the results will be presented at the conference. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large-scale screening in specialized laboratories. the read-out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn-a or -b, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. in our laboratory, we have developed a database system, which we believe is of immediate interest to the general scientific community. the database represents a computerbased replacement for the laboratory notebooks used in the majority of research laboratories worldwide. in addition, the database provides an effective tool for organizing and managing laboratory information at all levels, spanning from managing and revising standard operating procedures and producing documentation of research activities to keeping track of data and conclusions. using the commercially available database toolkit software filemaker pro, we have developed a relational database solution for management of laboratory information. the system consists of a hierarchy of five interrelated databases, each pertaining to a separate type of information, namely, overall project information, information relating to individual experiment setups, documentation of daily research activity, generated data and descriptions of standard operating procedures. like other databases, each individual database consists of a number of records, each comprised of a set of fields in which information is entered. in each record, a certain field is reserved to specify the relation of the record to a record in another database at a higher level. thus, the database is essentially five databases linked by a hierarchy of one-to-many relations, organizing information in a folder-like structure. importantly, the database system allows multiple users to access and edit records simultaneously, and the data entered in one database immediately becomes accessible through the other databases. the limitations of laboratory notebooks are apparent when looking for information, which is dispersed throughout one or more notebooks, or possibly on loose sheets of paper or printouts 'somewhere'. the often complicated process of gathering laboratory data or results when writing grant applications or research papers is made considerably easier with the database system. thus, the database solution presented should be broadly attractive to researchers, irrespective of their scientific discipline. an effective sars vaccine is likely to include components that can induce specific cytotoxic t-cell (ctl) responses. the specificities of such responses are governed by hlarestricted presentation of sars-derived peptide epitopes. exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear sequences directly from genomic/proteomic sequence information. the latter was recently established when a causative coronavirus (sars cov) was isolated and full-length sequenced. here, we have combined advanced bioinformatics and high-throughput immunology to perform an hla supertype, genome-wide scan for sars-specific cytotoxic t cell epitopes. the scan includes all nine human hla supertypes in total covering > % of all major human populations. for each hla supertype, we have selected the top candidates for test in biochemical-binding assays. at this time (approximately months after the genome was established), we have tested the majority of the hla supertypes and identified almost potential vaccine candidates. these should be further validated in sars survivors and used for vaccine formulation. we suggest that immunobioinformatics may become a fast and valuable tool in rational vaccine design. rationale: major histocompatibility complex class i (mhc i) molecules monitor the protein content of the cell by binding small derived peptides and presenting them to cytotoxic cd þ t cells. the goal of the human mhc project is to predict the binding strength of any given peptide/mhc complex. this prediction allows the design of peptide-based vaccines. the prediction requires representative binding data from mhc alleles from all the nine hla supertypes. here, we describe the genetic construction, protein production and purification as well as the establishment-binding assays for two recombinant mhc supertype alleles, hla-b* and hla-b* . methods: using the quikchange multisite directed mutagenesis kit (stratagene), codon-optimized genes encoding hla-b* and hla-b* are created. the two mhc i molecules are fermented and purified by ion exchange chromatography, hydrophobic interaction chromatography and size exclusion chromatography. the binding (kd) of natural t-cell epitopes, as well as predicted peptide ligands, is described by radioactive immunoassays (rias) and enzyme-linked immunosorbent assays (elisas). the mhc molecules are biotinylated during expression. results: the expression of mhc i resulted in multiple disulfide bond isomers, which are separated by hydrophobic interaction chromatography and used in subsequent binding studies resulting in the determination of kd for various peptide ligands ranging from strong binders we have previously demonstrated that bioinformatics tools such as artificial neural networks (anns) are capable of performing pathogen-, genome-and hlawide predictions of peptide-hla interactions. these tools may therefore enable a fast and rational approach to epitope identification and thereby assist in the development of vaccines and immunotherapy. a crucial step in the generation of such bioinformatics tools is the selection of data representing the event in question (in casu peptide-hla interaction). this is particularly important when it is difficult and expensive to obtain data. herein, we demonstrate the importance in selecting information-rich data and we develop a computational method, query-bycommittee, which can perform a global identification of such information-rich data in an unbiased and automated manner. furthermore, we demonstrate how this method can be applied to an efficient iterative development strategy for these bioinformatics tools. methods: a large panel of binding affinities of peptides binding to hla a* was measured by a radioimmunoassay (ria). this data was used to develop multiple first generation anns, which formed a virtual committee. this committee was used to screen (or 'queried') for peptides, where the anns agreed ('low-qbc'), or disagreed ('high-qbc'), on their hla-binding potential. seventeen low-qbc peptides and high-qbc peptides were synthesized and tested. the high-or low-qbc data were added to the original data, and new high-or low-qbc second generation anns were developed, respectively. this procedure was repeated times. the high-qbc-enriched ann performed significantly better than the low-qbc-enriched ann in of the tests. conclusion: these results demonstrate that high-qbcenriched networks perform better than low-qbc-enriched networks in selecting informative data for developing peptide-mhc-binding predictors. this improvement in selecting data is not due to differences in network training performance but due to the difference in information content in the high-qbc experiment and in the low-qbc experiment. finally, it should be noted that this strategy could be used in many contexts where generation of data is difficult and costly. interleukin- (il- ), a pro-inflammatory cytokine that is produced by both lymphoid and nonlymphoid cells, has a critical role in modulation of innate and adaptive immunity. its primary function in stimulation of ifn-g production and stimulation of nk-cell-cytotoxic activities makes this cytokine a candidate for cancer immunotherapy. in oral cavity, this cytokine is produced by oral epithelia and carcinoma cells and is related to tumour regression in nude mice bearing salivary adenocarcinoma. however, direct effects of this cytokine on oral cancer cells have not been elucidated. in this project, we investigated il- effect on an oral carcinoma (kb) cell line. with rt-pcr technique, kb-cell line was found to express il- receptors (il- ra and il- rb), indicating that this oral carcinoma line is a target for il- study. we showed that recombinant human il- inhibited kb-cell proliferation by % at concentration of ng/ml (p < . ), whereas ldh release by these cells in treatment group and control groups was comparable, indicating that il- suppression of cell proliferation was not mediated by the induction of cell death. to further address this hypothesis, we found that il- treatment did not induce apoptotic cell death, as studied by dna laddering and tunel assays. in addition, expression pattern of cell death-controlling genes (bcl- and bax) was not altered by this cytokine. findings in these studies indicated that suppression of kb-cell proliferation may be attributed to control of cell cycle, growth arrest or induction of cell differentiation. the data presented in this project could provide an insight of how cancer cell directly responds to il- , as this cytokine is an important regulator of anticancer mechanisms. aloe emodin (ae) is a naturally occurring compound with wide spectrum of biological properties, including antimicrobial, vasorelaxant, immunosuppressive and anticancer actions. this anthraquinone induces apoptosis in several tumour cell lines with special affinity to tumours of neuroectodermal origin. high amounts of nitric oxide (no) released by activated macrophages induce tumour cell death. therefore, we explored the capacity of ae to modulate no-mediated antitumour response in vitro. interestingly, while ae markedly suppressed no release from macrophages alone, it significantly potentiated no production in cocultures of macrophages and c cells, after h of cultivation. accordingly, the viability of c cells cocultivated with macrophages was reduced in the presence of ae. moreover, the observed ae-imposed potentiation of no production in macrophages was closely related to macrophage culture cell density. according to these data, we proposed that no modulator capacity of ae strongly depended on intercellular contact, indicating that macrophage antitumour response was not compromised but even potentiated by ae. immunotherapy represents an attractive fourth-modality therapeutic approach, especially in the light of the shortcomings of conventional surgery, radiation and chemotherapies in the management of metastatic cancer. to this end, a large number of peptide antigens derived from taa have been applied in immunotherapeutic trials for the treatment of various malignancies, e.g. cancers of the breast, prostate and kidney, in addition to haematological cancers. in some cases the response rates have been impressive and no adverse autoimmunity have been observed. a major strategic difficulty associated with these trials relates to the choice of best-suited peptide antigens. the vast majority of the antigens described thus far is not vital for survival and growth of the tumour cells, and immunoselection of antigen-loss variants may therefore prove to be an additional obstacle for the clinical applicability of most of the known peptide epitopes. in this respect, the development of acquired antigen loss during immunotherapy has been demonstrated in several cases. obviously, the development of loss-variant tumour cells implies that these cells acquire a pronounced growth advantage and are left unaffected by further treatment. ideally, target antigens should be derived from proteins required for survival and growth of tumour cells, as antigens with these characteristics would not be inflicted by the development of loss-variant tumour cells. in this respect, several inhibitors of apoptosis proteins (iaps) are universally expressed among tumours and play an important role in tumour cell escape from apoptosis. we have characterized spontaneous t-cell reactivity against iapderived peptides in cancer patients. from the iap survivin, we have characterized peptides restricted to the class i molecules hla-a , a , a , a , b and b . furthermore, we have demonstrated that survivin-specific t cells infiltrate metastatic lesions and that isolated survivinspecific ctls are capable of killing hla-matched tumour cells. survivin-derived peptides are now in clinical trial, and continued work in our lab has demonstrated that other iaps are targets for spontaneous t-cell reactivity in cancer patients. we previously reported that in mice with large progressing t-cell lymphoma tumours, dysfunctions in the antitumour ctl activity occur, associated with an accumulation of splenic arginase-producing myeloid suppressor cells (mscs). in this study, we first demonstrate that both the presence and the activation state of these msc depends on tumour evolution. while in tumour regressors hardly any arginase-producing msc can be found, both the amount and the arginase activity of this population expands from early over late progressors. this gradual induction of mscs is paralleled by an increasing suppression of ctl activity and th , but not th , cytokine production. upon analysing the molecular repertoire of msc in vitro, we found, besides arginase , a well-established marker for alternatively activated myeloid cells or m , a strong upregulation of fizz and ym, two additional recently identified markers for m . further evaluation of molecular markers by microarray analysis in msc yielded genes involved in wound healing (e.g. coagulation factor xiiia), anti-inflammation (e.g. selenoprotein p), immunomodulation (e.g. pd-l ) and fat and sugar metabolism (e.g. leptin receptor). of note, many of these genes are regulated by type cytokines (il- , il- and il- ) and are therefore rather m associated. overall, our data provide new markers for msc in cancer and further establish their m activation state. study. only sp-a showed a significant expression in normal mucosa which was downregulated in crc. as the absolute signal level was below the noise threshold, these results have to be interpreted with caution and require confirmation by direct measurenment of the proteins. our results suggest that there is no major role for the human collectins in colorectal cancer. tetramerization is visualized by sds-page. conclusion: an effective method for the production of highly pure mhc i molecules has been applied to hla-b* and hla-b* , and ria and elisa binding assays for those alleles have been established background: proliferation, differentiation and apoptosis are essential processes in the normal functions of the mammary epithelium. the hypothesis examined in this study is that the transcription factor bcl- is critically important not only for regulating b-cell growth and development but also for mammary epithelial apoptosis. methodology: twenty breast cancer cases and healthy controls were used to investigate whether bcl- protein in involved in breast cancer (grade iii). full length bcl- cdna was retrovirally transduced into eph- cell line. we then used flow cytometry of brdurd-stained cells to investigate the cell-cycle duration of the control and transduced cell lines. tunel was used as a marker of apoptosis to find out differences in the frequencies of apoptotic cells in the control and transduced cell lines. finally, immunohistochemistry staining was performed to detect bcl- in breast cancer (iii). results: restoration of bcl- into eph- cells not only inhibits apoptosis but also prolongs the cell cycle and results in increased cell size and protein content. the results also indicated that the cell-cycle time of bcl- -transduced eph- cells is prolonged by about h, presumably as a result of the action of bcl- at the bcl- at the g /s transition. we found differences in the frequencies of viable and apoptotic cells in cultures of the parent eph- cells, control-transduced eph- cells and bcl- -transduced eph- cells. consistently, we demonstrated that bcl- is expressed in % of high grade of breast carcinoma, which is considered as the most aggressive of tumours. conclusion: together, these results suggest that bcl- is likely to be involved in mammary gland development and carcinogenesis. inflammatory cytokines have a critical role in modulation of both innate and adaptive immunity in response to foreign antigen. they also play an important role in anticancer immunity. for example, they can promote cell-mediated immunity against cancer cells. with their immunostimulatory effects, these cytokines are being tested for cancer treatment in the form of dna vaccine or adjuvant or therapeutic cytokines. direct effect of these cytokines on cancer cell, however, is still unclear. in this project, we investigated whether il- ( and il- can modulate cancer cell proliferation. we employed a simple nonradioactive proliferation (mtt) assay and detection of lactate dehydrogenase (ldh) to test the effect of these recombinant human cytokines on various cancer cell lines, including breast cancer cell line (mcf- ), oral carcinoma cell line (kb), colon cancer cell line (caco- ) and choriocarcinoma cell line (jar). cytokines used in this study had both inhibitory and stimulatory effect on cell proliferation. findings in this project could provide an insight of cancer cell response to these cytokines and this could lead to a consideration on using cytokine as immunotherapy for cancer treatment.capacity of ae to modulate nitric oxide production depended on intercellular contact donor t cells are involved in the antitumour effects observed after bmt. thus, patients receiving t-celldepleted bmt have a higher risk of leukaemia relapse compared to patients receiving nonmanipulated bmt, and patients experiencing graft-versus-host disease (gvhd) have a lower risk of disease relapse than patients who do not experience gvhd. although the importance of donor t cells for the curative action of bmt has been established, the exact mechanisms and molecules involved in this graft-versus-tumour effect remain largely unknown. in a recently initiated project, we have conducted a longitudinal study of t-cell clonotypes in patients who received peripheral blood stem cell grafts after nonmyeloablative conditioning. peripheral blood samples were obtained sequentially after transplant, and the mononuclear cells (mncs) were isolated and cryopreserved. cd þ t cells were isolated from the mncs by use of immunomagnetic beads or facs and analysed for the presence of clonally expanded cells by t-cell receptor clonotype mapping based on rt-pcr and denaturing gradient gel electrophoresis (dgge). using this gel-based methodology, clonally expanded t cells were monitored after transplant and compared to the clinical data of the patients. the preliminary results demonstrates the presence of clonally expanded cd þ t cells at all time points analysed. furthermore, a number of clonotypes persisted for more than months, and other clonotypes emerged during this period. the appearance of newly emerged clonotypes which coincided with clinical gvhd could indicate a role for these t cells in the pathogenesis of gvhd. background: deficiency of the mannan-binding lectin (mbl) pathway of innate immunity leads to increased susceptibility to infections. in patients with colorectal cancer, postoperative infection is associated with poor prognosis. the aim of the present study was to evaluate ( ) the relation between the mbl pathway and postoperative infectious complications and survival of patients resected for colorectal cancer and ( ) the role of mbl as acute phase reactant compared to crp. methods: preoperative mbl concentration, mbl/mblassociated serine protease (masp) activity and crp were determined in serum from patients and healthy controls. the patients were observed for years. postoperative infections, recurrence and survival were recorded. results: the mbl pathway components were increased in the patients (p < . ) compared to healthy controls. low mbl levels were predictive of pneumonia (p ¼ . ), and pneumonia (n ¼ ) was associated with poor survival (p ¼ . , hr ¼ . , % ci . - . ). mbl and mbl/ masp activity could not predict postoperative overall infections. mbl showed no correlation (spearman's r ¼ . , % ci À . - . ) with crp. conclusions: low preoperative mbl levels are predictive of pneumonia, which is associated with poorer survival. mbl concentration and mbl/masp activity was not predictive of other postoperative infections or long-term prognosis. mbl apparently is not a surrogate measure of crp. department of surgery, university hospital of erlangen, erlangen, germany. e-mail: michael.siassi@rzmail.uni-erlangen.de introduction: the human collectins, mannan-binding lectin (mbl), surfactant protein-a (sp-a) and surfactantprotein-d (sp-d) play a central role in the innate immune system. immunological responses to malignant transformation of epithelial cells gained increasing interest recently. a former study could demonstrate binding of mbl to certain colorectal carcinoma (crc) cell lines in vitro. we therefore examined the expression of human collectins in normal colon mucosa and in colorectal carcinomas. materials and methods: colon samples from crc patients and normal mucosa samples were collected immediately after surgery. the tissue was microdissected and rna isolated (qiagen, rneasy-kit). gene expression profiles were analysed using gene-chips (affymetrix, hg-u ). we analysed the data for the expression of mbl, its associated serine proteases mannan-binding lectinassociated serine protease / (masp / ), sp-a and sp-d. the signal intensity of the genes of interest was compared using the mann-whitney u-test. results: the expression of human collectins in normal human colon mucosa was generally low. only the expression of sp-a and masp- reached the noise threshold of signals. these genes were significantly downregulated in crc specimens. the expression of the other proteins showed no difference in normal mucosa and crc. conclusion: as demonstrated before, the expression of human collectins in normal colon was low in this being the first lymph node to receive drainage from the tumour area, the sentinel node offers a unique possibility to obtain tumour-reactive lymphocytes. we investigated antitumour immune responses in sentinel nodes from patients with bladder cancer, by assaying tumour-specific proliferation and tcr vb repertoires. during tumour surgery, sentinel lymph nodes were identified by peritumoural injection of blue dye. fresh specimens of tumour, sentinel and nonsentinel lymph nodes were obtained, and single-cell suspensions were prepared. cells were assayed for reactivity against autologous tumour extract in [ h]-thymidine incorporation assays and characterized by flow cytometry. parallel analyses of the expression of vb gene families were performed with padlock probes, linear oligonucleotides which upon target recognition can be converted to circular molecules by a ligase. probes were reacted with cdna prepared from magnetically separated cd þ cells, and the tcr repertoire was determined by hybridizing the products to oligonucleotide microarrays. dose-dependent proliferation in response to tumour extract could be detected in sentinel lymph nodes. common clonal expansions were detected among tumourinfiltrating lymphocytes and in sentinel lymph nodes. nonsentinel lymph nodes displayed a divergent tcr vb repertoire. these results indicate an ongoing immune response against tumour antigens in sentinel nodes, draining urinary bladder cancer. identification of sentinel lymph nodes makes it possible to obtain tumour-reactive lymphocytes for use in adoptive immunotherapy. key: cord- -d gxew authors: grimble, robert f. title: the interaction between nutrition and inflammatory stress throughout the life cycle date: journal: nutrients, stress, and medical disorders doi: . / - - - : sha: doc_id: cord_uid: d gxew the human race inhabits a world in which it is surrounded by a myriad of different microorganisms—yeasts, bacteria, protozoa, and viruses. most of these are benign, and some, such as the normal gut flora, play an important part in promoting health via the synthesis of vitamins and stimulation of normal function of gut epithelia. approximately . % of microbes in our environment have catastrophic effects if they penetrate the epithelial surfaces of the body (bryson, ). history reveals many instances in which armies have been defeated and civilizations have collapsed because of encounters between humans and such microorganisms (diamond, ). the human race inhabits a world in which it is surrounded by a myriad of different microorganisms--yeasts, bacteria, protozoa, and viruses. most of these are benign, and some, such as the normal gut flora, play an important part in promoting health via the synthesis of vitamins and stimulation of normal function of gut epithelia. approximately . % of microbes in our environment have catastrophic effects if they penetrate the epithelial surfaces of the body (bryson, ) . history reveals many instances in which armies have been defeated and civilizations have collapsed because of encounters between humans and such microorganisms (diamond, ) . humans, like all mammals, have evolved with a complex immune system, which is present as specialized organs (spleen, thymus) or cell types (lymphocytes, macrophages, and mast cells) throughout the body. the system can detect and destroy any cell or particle that is not"self," i.e., a normal component of the body. a complex series of events follows from contact between components of the immune system and microbes invading the body ( fig. ) . the response can be divided into two main categories. the first is the acquired immune response, in which the immune system recognizes specific chemical motifs on the invader and "remembers" the encounter so that a more rapid, specific, and intense response can be produced at any future meeting. the second category is the nonspeciflc response in which the response to each encounter is similar for all invaders of the body. the process of inflammation is a central part of the second category of response. the immune response is also activated by a wide range of adverse events, such as surgery, bums, and trauma. the primary purposes of the response are to kill pathogens and initiate the curative processes that will restore body function to normal. the first purpose is achieved by creating a hostile tissue environment through production of oxidant molecules and activation of t and b lymphocytes. part of the response ensures a supply of substrate, from endogenous sources, for supporting the activity of t and b lymphocytes and enhancement of antioxidant defenses. the latter event is important for protecting healthy tissue from the oxidants produced as part of the inflammatory response (grimble, a) . the response exerts considerable biological demands and stress on the body. a central part of substrate provision is the release of amino acids into the blood from the breakdown of proteins in skeletal muscle, skin, and bone matrix, and fatty acids released from triglycerides stored in adipose tissue. enhanced gluconeogenesis, catabolic hormone production, and decreased insulin sensitivity occurs to facilitate this redistribution of tissue infective or cellular fig. . diseases and conditions in which inappropriate or excessive amounts of pro-inflammatory cytokines exert adverse or lethal effects on the host. components (fig. ) . the animal loses the desire to carry out many day-to-day activities. physical weakness ensues, exploratory activity declines, appetite is decreased, and apathy and sleep may occur. the response thus exerts physiological and mental stress upon the body. inflammation comes under the control of signaling proteins (cytokines) that possess hormone-like actions. the pro-inflammatory cytokines interleukin (il)- , il- , and tumor necrosis factor (tnf)-t~, are major activators and modulators of the events described above. to modulate the degree of stress imposed on the body, in achieving the essential functions of inflammation, the response comes under the control of powerful anti-inflammatory mechanisms. these will impose their biological effects with increasing vigor as the original stimulus for the inflammatory response (infection, injury) declines in intensity. heat-shock proteins, endorphins, glucocorticoid hormones, and cytokine receptor antagonists are important components of this anti-inflammatory system.this system is essential for closing down the inflammatory response once it has achieved its primary purposes because of the high biological cost it imposes on the body (grimble, a) . although cytokines play an important role in the response to infection and injury, they can exert damaging and lethal effects on the host. many studies have shown that excessive or prolonged production of cytokines is associated with increased morbidity and mortality in a wide range of acute and chronic inflammatory conditions (fig. ) . these include sepsis, adult respiratory distress syndrome, malaria, meningitis, cancer, cystic fibrosis, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis, and asthma. events similar to those seen in the inflammatory response to injury and infection can be observed during the course of overt inflammatory diseases such as rheumatoid arthritis and crohn's disease and in diseases that have a covert inflammatory basis, for example, atherosclerosis and diabetes mellitus (fig. ) . clearly the inflammatory response in these situations does not have a purposeful nature and contribute to the disease process. recent studies indicate that low-intensity inflammation occurs in elderly and obese individuals (grimble (grimble , . thus, the inflammatory response, which has evolved to allow humankind to survive infection and injury, is indiscriminate in both its triggers and targets. as a result, the process is a two-edged sword capable of both defending and damaging its bearer. during the remainder of this chapter we will be exploring the biological and nutritional factors that determine the intensity of, and outcome from, the inflammatory process. various components of the inflammatory response interact to modulate its intensity. predominant among these interactions are the relative amounts of pro-and anti-inflammatory cytokines produced during the response to microbes and injury and the effect of oxidant molecules on cytokine production. early work on cytokines and the response to infection linked excessive pro-inflammatory cytokine production with increased morbidity and mortality in a wide range of conditions, such as malaria, meningitis, and sepsis. however, research in the last yr has shown that the balance in production between pro-and anti-inflammatory cytokines has a more direct bearing on the outcome of infection and injury. for example, in sepsis, plasma il- concentrations were higher and il- concentrations were lower in patients who died than in those who survived (arnalich et al., ; taniguchi et al., ) . a survey of over patients admitted to hospital in the netherlands with fever showed that, independently of how the patients were clinically classified (positive blood cultures, presence of endotoxin), those who subsequently died had a higher plasma il- :tnf-o~ ratio than patients who survived (van dissell, van langervelde, westendorp, kwappenberg, & frolich, ) . powerful oxidant molecules (e.g., superoxide, hydrogen peroxide, hypochlorous acid) are produced as part of the inflammatory response. their biological purpose is to destroy invading microbes. however, these molecules also have the capacity to damage host tissues and to increase the intensity of the inflammatory response. clearly both of these biological events can have adverse effects upon the host. the oxidant molecules activate at least two important families of proteins in the host that are sensitive to changes in cellular redox state. the families are nuclear transcription factor k b (nf-rd ) and activator protein (ap ). these transcription factors act as "control switches" for biological processes, not all of which are of advantage to the individual. nf-rd is present in the cytosol in an inactive form, by virtue of being bound to an inhibitory unit i-r,b. phosphorylation and dissociation of i-r,b renders the remaining nf-~cb dimer active. the dissociated i-rd is degraded, and the active nf-r,b is translocated to the nucleus, where it binds to response elements in the promoter regions of genes. a similar translocation of ap , a transcription factor composed of the protooncogenes c-fos and c-jun, from cytosol to nucleus, also occurs in the presence of oxidant stress. binding of the transcription factors is implicated in activation of a wide range of genes associated with inflammation and the immune response, including those encoding cytokines, cytokine receptors, cell adhesion molecules, acute-phase proteins, and growth factors (schreck, rieber, & baeurerle, ) (fig. ) . activation of nf-rd can be brought about by a wide range of stimuli including pro-inflammatory cytokines, hydrogen peroxide, mitogens, bacteria and viruses and their related products, and ultraviolet (uv) and ionizing radiations. the extent of activation of nf-rd will depend in part upon the strength and efficiency of the antioxidant defenses of the body. these comprise endogenous components such as glutathione (gsh) and enzymatic components of antioxidant defenses, such as catalase, superoxide dismutase (sod), and gsh peroxidase, and dietary components that have antioxidant properties (e.g., vitamins c and e and polyphenolic compounds). the influence of modulation of inflammation by these dietary factors are dealt with later. an unfortunate side effect of activation of nf-r,b arises from the ability of the transcription factor to activate transcription of the genes of some viruses, such as human immunodeficiency virus (hiv) (fig. ) . this sequence of events, in the case of hiv, accounts for the ability of minor infections to speed the progression of individuals who are infected with hiv towards acquired immunodeficiency syndrome (aids). thus, if antioxidant defenses are poor, each encounter with general infections results in cytokine and oxidant production, nf-~zb activation, and an increase in hiv replication. it is thus unfortunate that reduced cellular concentrations of gsh are a common feature of infections, including that from the hiv (staal, ela, & roederer, ) . oxidant damage to cells will indirectly create a pro-inflammatory effect by the production of lipid peroxides. this situation may also lead to upregulation of nf-tcb activity. as will be seen in later sections, genetic and dietary factors change the intensity of the inflammatory response. thus, although the inflammatory response has evolved to ensure the survival of the human species, individuals may die as a result primarily of the response to invasion rather than from the invasive agent itself. it has recently become apparent that single base changes (single-nucleotide polymorphisms [snps]), usually in the promoter region of genes responsible for producing the molecules involved in the inflammatory process, exert a modulatory effect on the intensity of inflammation. in vitro production of tnf-o~ by peripheral blood mononuclear cells (pbmcs) from healthy and diseased subjects stimulated with inflammatory agents shows remarkable individual constancy in males and postmenopausal females (jacob et al., ) . this constancy suggests that genetic factors exert a strong influence. a number of studies have shown that snps in the promoter regions for the tnf-o~ and lymphotoxin table single nucleotide polymorphisms (snps) in cytokine genes associated with altered levels of cytokine production # gene and location of polymorphism in promoter region genotype associated with raised cytokine production and~or altered clinical outcome to inflammation b pro-inflammatory cytokines tnf-t~ - lt-t~ + il-l~- il- - anti-inflammatory cytokines il- - c tgf- [~ + (arg- -pro) c tnf-ct - a allele (tnf ) lt-t~ + aa (tnfb : ) ct or tt g allelle gg gg tnf, tumor necrosis factor; lt, lymphotoxin; il, interleukin; tgf, transforming growth factor; c, cytosine; g, guanosine; t, thymidine, a, adenine. athe location of the polymorphism is indicated by the nucleotide position in the promotor region. bpoor clinical outcome for pro-inflammatory cytokines. clmproved clinical outcome for anti-inflammatory cytokines. (lt)-o~ genes are associated with differential tnf-t~ production (allen, ; messer et al., ; wilson et al., ) . the tnf (a) and tnfb (a) alleles (at - and + for the tnf-o~ and lt-t~ genes, respectively) are linked to high tnf production, particularly in homozygous individuals. the snp in the lt-ot gene (+ ) is found in linkage disequilibrium with major histocompatibility molecules hla-a , b , dr (messer et al., ; wilson et al., ) . this genotype has also been reported to define a tnf "high expresser" haplotype (warzocha et al., ) , in addition to modifying expression of lt-o~ itself (messer et al., ) . a large body of research has indicated that snps occur in the upstream regulatory (promoter) regions of many cytokine genes (bidwell et al., ) . many of these genetic variations influence the level of expression of genes and the outcome from the inflammatory response. both pro-and anti-inflammatory cytokines are influenced by the differences in genotype (allen ; turner, williams, & sankeran, ) . a number of snps that have been implicated in the outcome of inflammatory stress are shown in table . nf-lcb is activated by oxidants and switches on many of the genes involved in the inflammatory response (cytokines, adhesion molecules, and acute-phase proteins). enhancement of antioxidant defenses is important in protecting healthy tissues and in preventing excessive activation of nf-~zb by the oxidative cellular environment during inflammation (schreck et al., ) . nf-rd upregulates cytokine and adhesion molecule expression, increasing the risk of host damage (jersmann, hii, ferrante, & ferrante, ) . genetic factors also influence the propensity of individuals to produce oxidant molecules and thereby influence nf-rd activation. natural resistance-associated macrophage protein (nramp ) has effects on macrophage functions, including tnf-ct production and activation of inducible nitric oxide synthase (inos), which occurs by cooperation between the nramp , tnf-o~, and lt-o~ genes (ables et al., ) . there are four variations in the nramp gene, resulting in different basal levels of activity and differential sensitivity to stimulation by inflammatory agents. alleles , , and are poor promoters, whereas allele causes high gene expression. hyperactivity of macrophages, associated with allele , is linked to autoimmune disease susceptibility and high resistance to infection, whereas allele increases susceptibility to infection and protects against autoimmune disease (searle & blackwell, ) . as indicated earlier, a number of molecules suppress production of pro-inflammatory cytokines and exert an anti-inflammatory influence. these include antioxidant defenses and il- (chernoff et al., ; espevik et al., ) . production is modulated by genetic factors. there are at least three polymorphic sites (- , - , - ) in the il-l promoter that influence production (perrey, pravice, sinnott, & hutchinson, ) . snps also occur in genes encoding enzymatic components of antioxidant defenses, such as catalase, sod, and gsh peroxidase, which influence levels of activity (chorazy, schumacher, & edlind, ; forsberg, lyrenas, de faire, & morgenstern, ; mitrunen et al., ) . there is circumstantial evidence, that at an individual level, an inflammatory genotype exists that can adversely effect the host. in a study of inflammatory lung disease caused by exposure to coal dust, the tnf (lt-a+ a) allele was almost twice as common in miners with the disease than in those who were healthy (zhai, jetten, schins, franssen, & borm, ) . development of farmer's lung from exposure to hay dust was % greater in individuals with the tnf allele than in those without the allele (schaaf, seitzer, pravica, aries, & zabel, ) . the tnf allele was also twice as common in smokers who developed chronic obstructive pulmonary disease than in those who remained disease-free (sakao et al., ) . in addition to disease progression, genetic factors have important effects on mortality and morbidity in infectious and inflammatory disease. during malaria, children who were homozygous for tnf had a sevenfold greater risk of death or serious pathology than children who were homozygous for the tnf allele (mcguire, hill, allsopp, greenwood, & kwiatkowski, ) . in intensive-care patients the occurrence of "g high-producing allele for il- was present in those who developed multiorgan failure with a frequency of one-fifth of that of the normal population (reid, hutchinson, campbell, & little, ) . in sepsis, patients possessing the tnf allele had a . -fold greater risk of death than those without the allele, and patients who were homozygous for the lt-~ + a allele had twice the mortality rate and higher peak plasma tnf-ot concentrations than heterozygotic individuals (mira et al., ; stuber, peterson, bokelmann, & schade, ) . the tnf allele also been found in increased frequencies in systemic lupus erythromatosus, dermatitis hepetiformis, and insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus (niddm) (jacob et al., , wilson, clay, & crane, wilson, gordon, & di giovine, ) . thus, it now appears that each individual possesses combinations of snps in their genes associated with inflammation corresponding to inflammatory drives of differing intensities when microbes or tissue injury are encountered. at an individual level this may express itself as differing degrees of morbidity and mortality (fig. ) . the strength of the genomic influence on the inflammatory process may affect the chances of an individual developing inflammatory disease, particularly if their antioxidant defenses are poor. in addition to disease progression, genetic factors have important effects on mortality and morbidity in infectious and inflammatory disease and following injury (paolini-giacobino, grimble, & pichard, ) . there are sex-linked differences in the influence of genotype on the inflammatory processes. in general, males are more sensitive to the genomic influences on the strength of the inflammatory process than females. in a study on lt-a genotype and mortality from sepsis, it was found that men possessing a tnfb (lt-o~+ aa) genotype had a mortality of % compared with men who were tnfb (lt-o~+ gg), who had a % mortality rate. in female patients the mortalities for the two genotypes were % and %, respectively (schroder, kahlke, book, & stuber, ) . in a study on patients undergoing surgery for gastrointestinal cancer, it was found that postoperative c-reactive protein (crp) and il- concentrations were higher in men than in women. multivariate analysis showed that males possessing the tnf (tnf-o~- a) allele had greater responses than men without it. the genomic influence was not seen in females (table ) (grimble, thorell, et al., ) . furthermore, possession of the il- - t allele was associated with a % greater length of stay in hospital in old men admitted for geriatric care (table ) (grimble, anderson, et al., ) . women were unaffected by these genetic influences. paradoxically, with improvements in hygiene and vaccination programs against infectious diseases, two major changes in public health and population characteristics have led to a general increase in inflammatory stress in populations of industrialized countries in the last half century. these are, respectively, an increase in the number of overweight and obese subjects and an increase in longevity. we will now examine the mechanisms underlying this phenomenon. it has been recognized for many years that there is a strong link between the "diseases of affluence"--obesity, insulin sensitivity, and atherosclerosis. however, it is only quite recently that the realization came that inflammation provided a link between the three ( ) tnf, tumor necrosis factor; il, interleukin; crp, c-reactive protein. a d postoperatively. bl d postoperatively. *significantly different from females with same genotype by multivariate analysis allowing for longer operation time and greater blood loss; p = . andp = . for crp and il- , respectively. means + sd, values in parentheses are the number of patients. ( ) + ( ) + ( ) + ( )* + ( ) tnf, tumor necrosis factor; il, interleukin; c, cytosine; t, thymidine; a, adenine; g, guanine. athe location of the polymorphism is indicated by the nucleotide position in the il- ~ and lt-t~ genes, tnfb (gg), tnfb (ag), tnfb (aa). *significantly different from value for same sex possessing the other genotype; p < . using mann-whitney test. means + sd, values in parentheses are the number of patients. biological phenomena (fig. ) . many studies have shown a clear link between obesity, oxidant stress, and inflammation (grimble ) . the link may lie in the ability of adipose tissue to produce pro-inflammatory cytokines, particularly tnf-t~. there is a positive relationship between adiposity and tnf production. a positive correlation ,i, plasma triglyceride concentrations fig. . interaction between leptin and tumor necrosis factor (tnf) with adipose tissue mass, lipid metabolism, and inflammation. tnf and leptin stimulate the immune system and adipose tissue, respectively. both also act on lipid metabolism and plasma triglyceride concentrations. between serum tnf-~ production and body mass index (bmi) has been noted in niddm patients and healthy women (nilsson, jovinge, niemann, reneland, & lithell, ; yaqoob, newsholme, & calder, ) . leptin has been shown to influence proinflammatory cytokine production ( fig. ). thus, plasma triglycerides, body fat mass, and inflammation may be loosely associated because of these endocrine relationships. a number of population studies have been conducted to explore the extent and nature of the relationship of inflammation to these diseases of affluence. the studies have examined populations in which there is a high incidence of insulin insensitivity, such as pima indians and individuals with a south asian background. tnf-o~ is overexpressed in adipose and muscle tissues of obese subjects compared with tissues from lean individuals (hotamisligl & spiegelman. ) . in a study of a group of nondiabetic pima indians, employing the hyperinsulinemic euglycemic clamp to assess insulin action, strong evidence of the links between inflammation, insulin insensitivity, and obesity emerged. plasma il- was found to be related positively to adiposity and negatively to insulin sensitivity. the investigators concluded that the relationship between il- and insulin action appeared to be mediated through adiposity (vozarova, weyer, & hanson, ) . a number of studies have looked at the extent of the interaction between insulin insensitivity and inflammation by studying the extreme form of diabetes, type diabetes mellitus. a study assessed endothelial cell perturbation by measurement of von willebrand factor and tissue-plasminogen activator (t-pa), in type diabetics who had had the disease for < or > yr. compared with normal subjects, children with diabetes for yr of age (elderly group) and -< years of age (young group). serum il- concentrations, tnf-ct production and cd b/cd expression by monocytes, and the postoperative clinical course were compared between the two groups to assess the inflammatory response to surgery. tnf-~ production by lps-stimulated monocytes and cd l b/cd expression on monocytes were significantly higher in the elderly than in the young group. moreover, serum il- concentrations on the first postoperative day in the elderly group were significantly higher than those in the young group. paradoxically, both loss of body weight and lean tissue and obesity are found in elderly populations. is there, therefore, a link between this phenomenon and increased levels of inflammation? the loss of muscle mass and strength that occurs with aging is described clinically as sarcopenia (rosenberg, ; roubenoff, ) . it is an important contributor to the development of frailty and functional impairment during aging. it is well established that aging is associated with a significant decline in muscle strength that becomes functionally important by the seventh decade of life. the relationship between chronic inflammation owing to disease during aging and the prevalence of low body mass are well illustrated in rheumatoid arthritis. in a study on patients with rheumatoid arthritis, the loss of body mass was greater for lean tissue than fat, with over % of the rheumatoid group falling into the lowest th percentile of a reference population for skeletal muscle mass assessed from the upper arm muscle area. in female patients there was a significant correlation between reduced fat-free mass and two indicators of inflammatory stress---erythrocyte sedimentation rate and plasma crp concentration (munro & capell, ) . clinical and animal studies show a relationship between raised plasma cytokine concentrations and low muscle mass. visser et al. ( ) investigated whether markers of inflammation are associated with muscle mass and strength over a time course of several years in over healthy well-functioning black and white elderly persons ( - yr). mid-thigh muscle cross-sectional area, appendicular muscle mass, and muscle strength were assessed. plasma concentrations of il- and tnf-~ were also measured. higher cytokine concentrations were associated with lower muscle mass and lower muscle strength. the most consistent relationship across the gender and race groups was observed for il- and grip strength. when an overall indicator of elevated cytokine production was created by combining the concentrations of il- and tnf-o~, with the exception of white men, elderly persons having high concentrations of il- (> . pg/ml) as well as high levels of tnf-~ (> . pg/ml) had a smaller muscle area, less appendicular muscle mass, and lower muscle strength compared to those with low levels of both cytokines. thus, raised plasma concentrations of il- and tnf-~ are associated with lower muscle mass and lower muscle strength in well-functioning older men and women as well as those suffering frank inflammatory disease. nutrient intake is clearly another important determinant of lean body weight and fat mass and may play a part in the decline in lean tissue with age as well as an increase in inflammatory stress. a recent survey of , subjects in communities in nhanes iii in the united states also included a survey of about elderly people ranging in age from to yr, to yr, and + yr (marwick, ) . the report indicated that the median intake of total energy was in general lower than the recommended kcal for men and kcal for women (marwick, ) . chronic inflammation is either a causative agent or a closely associated process in the pathology of obesity, insulin insensitivity, and atherosclerosis.the incidence of these conditions increases with aging. a fundamental question is which precedes the other-the general increase in inflammation or the development of diseases with overt and covert inflammatory bases? this "chicken-and-egg" question is difficult to answer. however, examination of data from studies conducted in elderly populations may throw some light on the answer to this conumdrum. there are at least two potential mechanisms for the higher level of chronic inflammation observed in elderly than in younger subjects. the first of these is that the elderly are experiencing a higher level of asymptomatic urinary infection. this possibility was studied in consecutive patients ( - yr) admitted to the hospital for functional disability. patients were examined for the presence or absence of bacteria in the urine. twenty subjects had a positive urine culture, and sex-and age-matched subjects had a negative urine culture. inclusion criteria were temperature < . °c, no clinical signs of infection, and no current antibiotic treatment. patients with asymptomatic bacteriuria had significantly increased levels of tnf receptors and a higher number of neutrophils in the blood compared to the group without bacteriuria. thus, the study provides some support for the hypothesis that asymptomatic urinary infections are associated with low-grade inflammatory activity in frail, elderly subjects (prio, bruunsgaard, roge, & pedersen, ) . a second potential mechanism resides in endocrine changes during aging. in aging, dysregulation of secretion of hormones that come under the regulation of the hypothalamic-pituitary-adrenal axis may occur. this may have an effect on the regulation of cortisol secretion, as mentioned earlier. cortisol is important as an anti-inflammatory agent. the effect of aging on glucocorticoid sensitivity of pro-inflammatory cytokine production was examined in elderly men, testosterone-treated elderly men, and young controls. stress-induced increases in cortisol did not differ significantly between experimental groups, but glucocorticoid sensitivity increased significantly in young controls and testosterone-treated elderly men, whereas a decrease was found in untreated elderly men. as the increase in glucocorticoid sensitivity after stress serves to protect the individual from detrimental increases of pro-inflammatory cytokines, the disturbed mechanism in elderly men may result in an increase in inflammatory stress (rohleder, kudielka, hellhammer, wolf, & kirschbaum, ) . there is now a large body of evidence suggesting that the decline in ovarian function with menopause is associated with spontaneous increases in pro-inflammatory cytokine production. as mentioned earlier, studies in men and postmenopausal women indicate a remarkable individual constancy in the ability of pbmcs to produce tnf-cz ex vivo, and genetic determinants underlie this constancy. however in premenopausal women production is highly variable at an individual level, indicating how ovarian hormones are able to override the influence of genotype (jacob et al., ) . the exact mechanisms by which estrogen interferes with cytokine activity are still incompletely known but may include interactions of the estrogen receptor with other transcription factors, modulation of nitric oxide activity, antioxidative effects, plasma membrane actions, and changes in immune cell function. experimental and clinical studies also strongly support a link between the increased state of pro-inflammatory cytokine activity and postmenopausal bone loss (pfeilschifter et al., ) . recent evidence indicates the presence of snps, associated with the strength of the inflammatory response, affects longevity. human longevity may be directly correlated with optimal functioning of the immune system. therefore, it is likely that one of the genetic determinants of longevity resides in polymorphisms for genes influencing the activity of the immune system. it has been estimated that up to variations in the genome contribute to life span (martin, ) . those contributing to loss of muscle and bone mass during aging are related to the inflammatory process and include pro-and anti-inflammatory cytokines and their receptors. studies in mice have shown that the genes controlling the major histocompatibility complex (mhc), known to control a variety of immune functions, are associated with differences in the life span of different strains of mice, but a major difference between observations in mice and humans is that the latter have a lifetime experience of exposure to pathogens, whereas for laboratory animals this exposure is kept to a minimum. thus, although hla studies in mice of different genotypes may be interpreted to support studies of mhc effects on longevity in humans, in mice the association may be by way of altered susceptibility to lymphomas, whereas in human beings the effect on longevity is likely to be via an altered response to pathogens and susceptibility to infectious disease. a number of cross-sectional studies have examined the role of hla genes on human longevity by comparing hla antigen frequencies between groups of young and elderly persons. conflicting findings have been obtained. when this topic was reviewed (caruso et al., ) , it was concluded that in humans there may be an association between longevity and some hla-dr alleles or the hla-bs,dr haplotype. these genotypes are involved in the antigen nonspecific control of immune response, in other words, the component of immune function associated with inflammation and cytokine biology. recent evidence indicates that presence of snps in certain pro-and anti-inflammatory cytokine genes influences life span. when individuals between and yr of age were studied, it was noted that not only was plasma il- concentration positively related to age but individuals with a snp in the promoter region of the il- gene, which predisposes to high levels of production of the cytokine (- gg), decreased in frequency with age. the effect was seen in men but not in women (bonafe, olivieri, & cavallone, ) . although men with snps made up % of the -to -yr-old age group, the percentage fell to % in subjects < years of age. conversely, one of three snps in the il- gene (- gg), which is closely linked to higher production of the anti-inflammatory cytokine il- (hutchinson, pravica, hajeer, & sinnott, ; turner et al., ) , was found in higher proportions in male centenarians than in younger controls ( vs %). in females this genotype exerted no effect upon longevity (lio et al., ) . thus, it would appear that genetic characteristics that might influence the balance between proand anti-inflammatory cytokines influence mortality in men but not in women (franceschi et al., ) . a study on snps that influence interferon (ifn)-~t production further reinforces the concept that possession of a genotype that predisposes to a raised pro-inflammatory status is not compatible with a long life span (lio et al., ) . in women, possession of the a allele, which is associated with low production of ifn-'~, significantly increased the possibility of reaching old age. it might be concluded that possession of high-producing alleles of the il- is universally protective against morbidity as well as mortality. possession of a genotype that results in low levels of il- production (- aa) increases the risk of developing inflammatory diseases (hajeer, lazanes, & turner, ; huizinga, keijsers, & yanni, ; tagore, gonsalkorale, & pravica, ) . however, as already mentioned, in a large survey of hospitai admission in the netherlands, patients with raised il- :il- ratios had higher mortality rates (van dissel et al., ) . not all studies implicate cytokine gene snp in longevity. cytokine gene polymorphisms at il- o~, il- ~, il- ra, il- , il- , and tnf-o~ were measured in finnish nonagenarians ( men and women) and in healthy blood donors ( - yr) used as controls. no statistically significant differences were found in the distribution of genotype, allelic frequencies, and a + carrier status between nonagenarians and younger controls (wang, hurme, jylha, & hervonen, ) . in a review on the different impact of genetic factors on the probability of reaching old age, franceschi et al. ( ) concluded from studies conducted in italy that emerging evidence (regarding mtdna haplogroups, thyrosine hydroxylase, and il- genes) suggests that female longevity is less dependent on genetics than male longevity and that female centenarians are more likely to have had a healthier lifestyle and more favorable environmental conditions than males. however, a recent study conducted by our group suggests that although a pro-inflammatory genotype may be disadvantageous to elderly males, it may confer a survival benefit in females. subsequent survival was studied in elderly geriatric patients ( + yr) after a period of hospitalization for a range of conditions necessitating geriatric care. although women possessing a pro-inflammatory genotype (tnf-o~- a allele or il- - gg) had improved yr survival rates, men possessing pro-inflammatory genotypes (il-l~- t allele or lt-ct + aa) had shortened survival rates (grimble, thorell, et al., ) (table ) . as outlined in the preceding sections, the inflammatory response, although essential for survival in the presence of pathogens, can exert deleterious effects on the host.the clear need to find ways of modulating cytokine production and other aspects of inflammation has fostered the research area of immunonutrition. in a clinical context the purpose of immunonutrition is to find nutritional means of altering the patient' s inflammatory response to infection and injury, from the detrimental to the beneficial side of the pivot on which an individual undergoing a response is positioned. while inflammation may be exerting deleterious effects most obviously in patients, people on the borderline of health and disease living in the general population table nutrients commonly used in immunonutrient supplements and their potential mode of action • n- polyunsaturated fatty acids: act as anti-inflammatory agents and reverse immunosuppression • sulfur amino acids and their precursors: enhance antioxidant status via gsh synthesis • glutamine: nutrient for immune cells, improves gut barrier function, precursor for gsh • arginine: stimulates nitric oxide and growth hormone production, improves helper t-cell numbers • nucleotides: rna and dna precursors, improve t-cell function may also require nutritional modulation of ongoing inflammatory processes. during the last years the pace of evolution ofimmunomodulatory feeds and intravenous solutions has accelerated. these products contain combinations of a number of components to which various functional attributes are ascribed them (table ) (grimble, a) . many studies have indicated that n- polyunsaturated fatty acids (pufas), glutamine, arginine, sulfur amino acids, and nucleotides are all potentially capable of shifting the balance from a disadvantageous to an advantageous response to infection and injury. the examples used here are illustrative rather than comprehensive. a number of studies indicate that improvement of antioxidant status is associated with an increase in cellular aspects of immune function. meta-analyses have been conducted on the efficacy of immunonutrients that influence antioxidant status. in clinical trials, indices such as infection rates, mortality rates, and length of stay are often measured in the absence of functional and biochemical aspects of the response, such as t-cell function, cytokine production, and antioxidant status, and vice versa, giving a rather incomplete picture of the mechanisms of any observed effects of immunonutrition. however, beale, bryg, & bihari ( ) , in a meta-analysis of studies containing more than patients receiving enteral immunonutrition, observed that although there was no effect upon mortality, there were significant reductions in infection rates, time spent on a ventilator, and length of hospital stay. while this finding indicates that immunonutrition may be useful in modulating the inflammatory process in patients experiencing severe inflammation, the consistency of the effects observed was disappointing. there are at least three major reasons why it is difficult to demonstrate a consistent effect. first, patients used as the subjects of clinical trials of immunonutrients will constitute a diverse population--different ages, at different stages of a disease process, and undergoing complex clinical treatment in addition to nutrient therapy. second, patients will have differing genetic backgrounds that will influence the intensity of the inflammatory and immune responses they are undergoing. this issue is dealt with below. third, nutrients may exert paradoxical effects, as illustrated by the findings of the first observations of the effects of fish oil on cytokine production in healthy subjects. the findings of endres et al. ( ) that a daily supplement of g/d of fish oil given to nine young men for wk was able to reduce ex vivo production ofll- and tnf-~ by lps-stimulated pbmcs aroused great interest in fish oil as an anti-inflammatory nutrient. this perception was supported by a large amount of animal data. however, endres' data showed a wide variability in the effect of the fish oil supplements. the standard deviations of the mean for il- and tnf-cx production were and %, respectively. this indicates that cytokine production could have risen or fallen as a consequence of taking the supplement. the effects of supplementing healthy young men with g/d offish oil for wk, on tnf-ct production by pbmcs stimulated with endotoxin have been studied in the author' s laboratory. it was found that % of subjects experienced a fall in production and % a rise. although the ability of fish oil to increase tnf-t~ production is at first sight paradoxical, earlier work of dinarello, bishai, rosenwasser, and coceani ( ) and kunkel, remick, spengler, and chensue ( ) indicated that fish oil could potentially change cytokine production in either direction. what mechanisms could result in this divergent effect? inflammation will result in activation of phospholipase a , which releases arachidonic acid (aa) (c : n- ) from the cell membrane for prostaglandin e (pge ) or leukotriene b (lt b ) synthesis. the in vitro studies (kunkel et al., ) showed that pge suppressed tnf-t~ production, whereas ltb had the opposite effect (dinarello et al., ) .. fish oil is rich in eicosapentaenoic acid (c : n- ), which will replace aa in the cell membrane and results in the production of pge and lt b . pge and lt b are considerably less potent than the corresponding compounds produced from aa, and thus dietary fish oil may lessen the inhibitory influence of pge or the stimulatory influence of ltb on tnf-o~ production, resulting in a potential increase or decrease, respectively, in production of the cytokine. fish oil could thus result in an inflammatory cytokine response, which could fall on either side of the pivot. the response to bacterial invasion of the body, or injury, contains a paradox. although the inflammatory response and the t-cell response both play a part in defeating the invader, the inflammatory response may in some clinical circumstances exert an inhibitory influence on t-cell function. in severely infected or traumatized patients, an enhanced inflammatory state occurs, which is associated with immunosuppression. in vitro studies support this inverse relationship. pbmcs taken from healthy young subjects and incubated with gsh show decreased pge and ltb production (reduced inflammation) and an increase in mitogenic index and il- production (enhanced immune function) (wu, meydani, sastre, hayek, & meydani, ) . thus, enhancement of antioxidant defenses reduces the likelihood of the inflammatory response suppressing t-cell function (grimble, (grimble, , b . although all antioxidants are important owing to the linked nature of antioxidant defense (fig. ) , gsh plays a pivotal role as it acts directly as an antioxidant and maintains other components of defense in a reduced state through enzymic conversion between the oxidized and reduced states. various compounds can be used to increase gsh synthesis (fig. ). n-acetyl cysteine (nac) and the gsh prodrug oxothiazalidine- -carboxylate (procysteine) have been used in a number of clinical studies. tissue gsh content is also influenced by protein and sulfur amino acid intake. unfortunately, surgery, a wide range of diseases that have an inflammatory component, and aging and protein energy malnutrition decrease gsh concentration in blood and other tissues (boya et al., ; loguercio et al., ; luo, hammarqvist, anderson, & wernerman, ; micke, beeh, schlaak, & buhl, ; nuttal et al., ; reid et al., ) (table ). within h of elective abdominal surgery, muscle gsh content falls by > %. values return to normal h postoperatively. a smaller perturbation in blood gsh occurs over a shorter time course. modification of the gsh content of liver, lung, spleen, and thymus in young rats by feeding diets containing a range of casein (a protein with a low sulfur amino acid content) concentrations changed immune cell numbers in lung (hunter & grimble, found that in unstressed animals the number of lung neutrophils decreased as dietary protein intake and tissue gsh content fell. however, in animals given an inflammatory challenge (endotoxin), liver and lung gsh concentrations increased directly in relation to dietary protein intake. lung neutrophils, however, became related inversely with tissue gsh content. addition of methionine to the protein-deficient diets normalized tissue gsh content and restored lung neutrophil numbers to those seen in unstressed animals fed a diet with adequate protein content (fig. ) . why does tissue gsh content have differing effects on immune cell populations depending on whether or not an inflammatory response is occurring? a partial explanation may come from an in vitro study using hela cells and cells from human embryonic kidney. in the study, both tnf-o~ and hydrogen peroxide resulted in activation of nf-~cb and ap (wesselborg, bauer, vogt, schmitz, & schulze-osthoff, ) . addition of the antioxidant sorbitol to the medium suppressed nf-~fl activation as expected, but unexpectedly activated ap . thus, the antioxidant environment of the cell might exert opposite effects upon transcription factors closely associated with inflammation (e.g., nf-~fl ) and cellular proliferation (e.g., ap ). evidence for this biphasic effect was seen when gsh was incubated with immune cells from young adults (wu et al., ) . a rise in cellular gsh content was accompanied by an increase in il- production and lymphocyte proliferation (enhancement of t-cell function) and a decrease in production of the inflammatory mediators pge and ltb (anti-inflammatory influence). without doubt, a decline in antioxidant status in the presence of oxidant stress will increase inflammatory stress. the interaction between oxidant stress and an impaired ability to synthesize gsh, a situation that stimulates inflammation, is clearly seen in cirrhosis, a disease that results in high levels of oxidative stress and an impaired ability to synthesize gsh . in pena an inverse relationship between gsh concentration and the ability of monocytes to produce il- , il- , and tnf-t~ was observed. treatment of cirrhotic patients with the procysteine increased monocyte gsh content and reduced il- , il- , and tnf-t~ production. septic patients given an infusion of nac ( mg/kg bolus followed by infusion of mg/kg over -h) showed a decrease in plasma il- and soluble tnf receptor p , had a reduced requirement for ventilator support, and spent fewer days in intensive care than patients not receiving nac (spapen et al., ). de rosa et al. ( showed that nac was able to restore tissue gsh concentrations in individuals with hiv infection. in a study on hiv-positive patients, brietkreutz et al. ( ) showed that a dose of mg/d of nac for mo resulted in a decrease in plasma il- (decreased inflammation), an increase in natural killer cell activity, and increased responsiveness of t lymphocytes to tetanus toxin stimulation (improved lymphocyte function). antioxidants might act to prevent nf-r,b activation by quenching oxidants. however, nf-rd and ap may not respond to changes in cell redox state in the same way. when rats were subjected to depletion of effective tissue gsh pools by administration of diethyl maleate, there was a significant reduction in lymphocyte proliferation in spleen and mesenteric lymph nodes (robinson et al., ) . an increase in inflammatory stress would be expected in this study. thus, it can be hypothesized that antioxidants exert an immunoenhancing effect by activating transcription factors that are strongly associated with cell proliferation (e.g., ap ) and an anti-inflammatory effect by preventing activation of nf-r,b by oxidants produced during the inflammatory response (drö ge et al., ) .thus, inclusion of antioxidants or substances that increase gsh synthesis in immunonutrient mixes would seem to be beneficial. improvement of antioxidant defenses is also possible by feeding other components of antioxidant defenses. supplementation of the diet of healthy subjects and smokers with iu/d t~-tocopherol for wk suppressed the ability of pbmcs to produce tnf-t~ (mol, de rijke, demacher, & stalenhoef, ) . the same dose given to healthy elderly subjects for d increased delayed-type hypersensitivity and raised antibody titers to hepatitis b (meydani et al., ). an enteral feed enriched with vitamin e, vitamin c, and taurine given to intensive-care patients decreased total lymphocyte and neutrophil content in bronchioalveolar lavage fluid (decreased inflammation) and resulted in a reduction in organ failure rate, a reduced requirement for artificial ventilation, and a reduction of d in intensive-care stay (gadek et al., ) . a number of roles have been ascribed to glutamine as an immunonutrient: (a) as an essential nutrient for immune cells, (b) as an important modulator of gut barrier function, and (c) as a substrate for gsh synthesis. a number of reviews have been written about the first two of these roles (newsholme, crabtree, salleh, & ardawi, ; elia, ) ; we will consider the last one here. could glutamine be exerting an anti-inflammatory influence via an effect on gsh that enhances immune function? in a study in rats, glutamine supplementation resulted in an increased production of gsh by the gut (cao, feng, hoos, & klimberg, ) , and total parenteral nutrition (tpn) with glutamine raised plasma gsh concentrations in these animals (denno, rounds, faris, halejko, & wilmore, ) . in randomized controlled trials the administration of glutamine, either as a dipeptide during tpn to surgical patients or as a glutamine-enriched enteral feed to trauma patients, resulted, respectively, in improved nitrogen retention (less tissue protein depletion) and a . -d reduction in hospital stay, a concomitant suppression of the rise in plasma-soluble tnf receptors (reduced inflammation), and a lower incidence ofbacteremia, pneumonia, and sepsis (improved immune function) (houdijk et al., ; morlion et al., ) in the previous section the influence of antioxidants on severe inflammation was considered. do the general findings from this type of study also apply to modulation of low-grade chronic inflammation, such as has been observed in the elderly and obese? because aging is so closely associated with increased oxidative stress, which might both result from and contribute to a stimulation in the level of inflammation in the elderly, antioxidant therapy could produce beneficial effects. the effects would be seen in a decrease in oxidant damage, downregulation of inflammation, and, because of the inverse link between inflammation and immune function, an improvement in t-lymphocyte function. meydani, meydani, & verdon ( ) reported that supplementation of aged mice ( mo old) with dietary vitamin e ( ppm) improved several indices of the immune system to levels comparable to those seen in young animals. supplementation of aged mice with this vitamin also increased clearance of influenza virus from the lung to that observed in animals supplemented with other antioxidants such as melathonine, gsh, or strawberry extract, which contains a high level of flavonoids with antioxidant activity . in a double-blind, placebo-controlled study, meydani and colleagues (meydani, barklund, & lui, ; meydani et al., ) also reported that supplementation of elderly subjects with vitamin e for a short ( mo) or long ( . too) period of time also improved several in vitro and in vivo indices of immune response. the optimal immune response was observed with iu of vitamin e per day in the long-term study. it is worth noting that this level of vitamin e has also been reported to be the optimal level for reducing plasma f -isoprostane, a reliable index of lipid peroxidation (dillon, vita, & leeuwenburgh, ) . improving the immune response in the elderly may result in a lower incidence of infections, which are prevalent among the elderly, and thus may contribute to a longer and healthier life. many observational and clinical trials have also indicated that a high intake or high plasma level of this vitamin is associated with a low risk of cardiovascular disease. the vitamin may be operating at two levels; first, by protecting ldl from peroxidation, thereby reducing its atherogenicity, and second, by lowering the level of chronic inflammation by downregulation of nf-r,b. a reduction in platelet aggregability may also arise out of this action (huang et al., ; tanus-santos et al., ) . indeed, several lines of evidence indicated that supplements of vitamin e may prevent cardiovascular disease by reducing the susceptibility of ldls to oxidation (jailal, fuller, & huet, ) , reducing the expression of chemokines, adhesion molecule expression, and monocyte adhesion (wu, koga, martin, & meydani, ) , decreasing smooth muscle proliferation (azzi, boscoboinik, & marilley, ) , and decreasing platelet aggregation (steiner ) . another anti-inflammatory approach using nutrients would be to supplement diets of the elderly with n- pufas. supplementation with n- pufas from fish oil, however, has been reported to suppress the immune response (meydani, endres, & woods, ; meydani, ) , which hampers enthusiasm for the use of n- pufas for their benefits in cvd. however, the latter concern could be addressed by including a vitamin e supplement along with fish oil supplements. in a recent study it was found that supplementing elderly persons with (n- ) fatty acids of fish oil in combination with vitamin e while maintaining the anti-inflammatory properties of (n- ) pufas did not reduce immune indices in the elderly . fish oil supplementation is not universally efficacious in the treatment of inflammatory disease (grimble, ) . rheumatoid arthritis and inflammatory bowel disease have been the most successfully treated of all inflammatory diseases (calder, ) . the antiinflammatory mechanism may be through suppression of tnf-tx production. endres et al. ( ) reported that large doses ( g/d for wk) of oil in nine healthy volunteers resulted in a small but statistically significant reduction in tnf-o~ and il- [ production from pbmcs. subsequently, fewer than half of similar small intervention studies were able to demonstrate a statistically significant reduction in cytokine production. to understand the differences in response more closely, the author's laboratory conducted a study on young men fed g fish oil daily for wk and measured tnf-tx production by pbmcs before and after supplementation in relation to the snp at - in the tnf-o~ and at + in the lt-tx genes. no significant effect of fish oil on cytokine production was noted in the group as a whole. however, when data were examined according to tertile of tnf-ct production prior to supplementation, homozygosity for tnfb (lt-o~+ a) was . times more frequent in the highest than in the lowest tertile of production. the percentage of individuals in whom fish oil suppressed production was lowest ( %) in the lowest tertile and doubled with each ascending tertile. in the highest tertile, mean values were decreased by % (p < . ). in the lowest tertile, mean values were increased by % (p < . ). tnfb (lt-cz+ aa) homozygotes were strongly represented among unresponsive individuals in the lowest tertile of tnf-cz production prior to supplementation. in this lowest tertile, only tnfb l/b (lt-o~+ ga) heterozygous subjects were responsive to the suppressive effects of fish oil. in the medium tertile, this genotype was six times more frequent than other lt-t~ genotypes among responsive individuals. no relationship between possession of tnf or (tnf-ot- g or a) alleles and responsiveness to fish oil was found. clearly, although the level of inflammation determines whether fish oil will exert an anti-inflammatory influence or not and is influenced by the tnfb (lt-ct+ a) allele, the precise genomic mechanism for an anti-inflammatory effect is unclear at present . antioxidant intake also modifies cytokine production. in a study on healthy men and women and smokers, dietary supplementation with iu/d ct-tocopherol for mo suppressed the ability of pbmcs to produce tnf-t~. production was reduced by and % in nonsmokers and smokers, respectively (mol et al., ) . in a similar dietary intervention study on normolipaemic and hypertriglyceridaemic subjects given iu/ d of o~-tocopherol for wk, reduced tnf-o~, il- , and il- production by lps-stimulated blood mononuclear cells occurred (mol et al., ; van tits, demacker, de graaf, hak-lemmers, & stalenhoef, ) . a similar effect of cx-tocopherol was noted in a study on normal subjects and type diabetics (devaraj & jialal, ) . however, there were large standard deviations in the data from these studies, indicating major intraindividual variability in the ability of vitamin e to suppress production of the cytokine. although a number of studies have shown that o~-tocopherol suppresses superoxide production, the situation with regard to nitric oxide is less clear (mol et al., ; van tits et al., ) n the a-tocopherol derivative pentamethyl-hydroxychromane inhibited lps-stimulated nf-gb and inos activation in cultured j macrophages (hattori, ) . at present it is not known whether antioxidants interact differently with snps in the genes associated with oxidant stress and inflammation than they do with the other anti-inflammatory nutrient, n- pufa. this topic is currently an area of active research at the author's laboratory. proteomic studies have shown that inos and sod are both influenced by the nramp gene (kovorova, necasova, porkertova, radzoich, & macela, ) . the production of oxidant molecules enhancing pro-inflammatory cytokine production via high levels of nf-kb activation may thus be under a genomic influence owing to the aforementioned variations in the nramp gene (formica, roach, & blackwell, ) . a better understanding of this interaction and of the interaction of n- pufas and antioxidants with genotype may allow the better design of nutrient products for the treatment of inflammatory disease. it is clear from the current understanding about the purpose and functioning of the immune system throughout the life cycle that it is a powerful biological entity that profoundly alters body function while it is carrying out its prime purpose of defending the body against invasion by pathogens. however, within the response lie the seeds of disaster at an individual level, for the inflammatory component of the response can turn against the body, particularly as the body ages or becomes obese. the response, which can be devastating when directed against microbes entering the body, also sows the seeds of atherosclerosis, degradation of brain function, and insulin insensitivity and hastens the passage of hiv-infected individuals towards full-blown aids. along with the insights arising from the unraveling of the human genome has come evidence that the inflammatory response is able to protect the human species from invasion by pathogens but not all individuals within the species from ill health. the differing ability of humans, particularly the male of the species, at an individual level to mount an inflammatory response of different levels of intensity owing to genotype can result in widely contrasting outcomes of invasion of the body by pathogens. on the one hand, individuals may effectively fight off invasion provided the immune response follows a normal pathway, whereas other individuals within the same community encoutering the same pathogens will die from the strength and nature of the response rather than from the direct effects of the invader. insights gained from the genomic influences on cytokine production and the response to malaria suggest that the retention of alleles in pro-inflammatory cytokine genes that resulted in enhanced cytokine production within the human gene pool over generations could be a result of the heterozygotes' better capacity for fighting pathogens, whereas homozygotes of the high-producing genotype run an increased risk of a strong adverse inflammatory response. in the case of sickle cell anemia, where heterozygotic individuals reap an advantage in resistance to malaria by possession of only one copy of the anemia allele, homozygous individuals for the sickle cell trait pay the price for possession of two copies of the allele and die young. because of the overall advantage of this situation to the species, the potentially disadvantageous allele will be retained within the human gene pool over generations. with the twin discoveries that nutrients can modulate the inflammatory response and that cytokine genotype can modulate the effectiveness of nutrients in controlling inflammation, nutritional science sits at an exciting moment in its development. the mapping of how pro-and anti-inflammatory cytokine genotypes interact with responsiveness to immunonutrients at an indivividual level will allow tailor-made nutritional treatments of all diseases that have an underlying inflammatory basis. furthermore, a better understanding of how nutritonal therapies and genetics interact will allow the twin adverse biological factors increasing the level of inflammatory stress in populations---obesity and aging--to be tackled by targeted nutritional therapy. the roles of nramp and tnfo~ genes in nitric oxide production and their effect on the growth of salmonella typhimurium in macrophages from nrampl congenic and tumor necrosis factor-alpha-/-mice polymorphism of the human tnf-cz promoter--random variation or functional diversity? molecular immunolology periodontal infections and cardiovascular disease--how strong is the association? oral disease predictive value of nuclear factor kappab activity and plasma cytokine levels in patients with sepsis vitamin e: a sensor and an information transducer of the cell oxidation state lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors immunonutrition in the critically ill: a systematic review of clinical outcome inflammation, insulin resistance, infection, diabetes, and atherosclerosis. endocrinological practice interleukin- is an essential, corticotropin-releasing hormone-independent stimula-torof the adrenal axis during immune system activation cytokine gene polymorphism in human disease: online databases, supplement a gender-dependent genetic predisposition to produce high levels of il- is detrimental to longevity impaired glucose tolerance, type diabetes mellitus and carotid atherosclerosis: prospective results of the bruneck study antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis c improvement of immune functions in hiv infection by sulfur supplementation: two randomized trials a short history of nearly everything n- polyunsaturated fatty acids and cytokine production in health and disease glutamine enhances gut glutathione production immunogenetics of longevity. is major histocompatibility complex polymorphism relevant to the control of human longevity? a review of literature data c-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in indian asians from the united kingdom compared with european whites a randomized, controlled trial of il- in humans. inhibition of inflammatory cytokine production and immune responses glutathione peroxidase in rheumatoid arthritis: analysis of enzyme activity and dna polymorphism prostaglandin-e regulation of tumor necrosis factor receptor release in human monocytic thp- cells plasma insulin, leptin, and soluble tnf receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men the concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments selective aspects of the insulin resistance syndrome the pleiotropic functions of peroxisome proliferator-activated receptor gamma glutamine enriched tpn enhances plasma glutathione in resting state n-acetylcysteine replenishes glutathione in hiv infection low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation guns, germs and steel: the fate of human societies ~-tocopherol supplementation reduces systemic markers of oxidative damage in healthy adults the influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin- ) functions of glutathione and glutathione disulphide in immunology and immunopathology chronic activation of the innate immune system may underlie the metabolic syndrome glutamine in parenteral nutrition socs- inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice the effect of dietary supplementation with n- polyunsaturated fatty acids on the synthesis ofinterleukin- and tumor necrosis factor by mononuclear cells age-associated increased interleukin- gene expression, late diseases, and frailty inhibition of cytokine production by cyclosporin a and transforming growth factor beta leptin regulation of the immune response and the immunodeficiency of malnutrition serum il- level and the development of disability in older persons the relation of body fat mass and distribution to markers of chronic inflammation the investigators of the nhbli family heart study. association of c-reactive protein with markers of prevalent atherosclerotic disease interaction with extracellular matrix proteins influences lsh/ity/bcg (candidate nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release a common functional c-t substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. free radicalbiology andmedicine do men and women follow different trajectories to reach extreme longevity? ppars, metabolic disease and atherosclerosis effect of enteral feeding with eicosapentaenoic acid, - inolenic acid, and antioxidants in patients with acute respiratory distress syndrome increased cytokine release by leucocytes in survivors of stroke at young age serum albumin and mortality theory and efficacy of antioxidant therapy effect of antioxidative vitamins on immune function with clinical applications dietary lipids and the inflammatory response nutritional modulation of immune function stress proteins in disease inflammatory status and insulin resistance. current opinion in clinicainutrition and metabolic care inflammatory response in the elderly. current opinion in clinical nutrition and metabolic care gene:gene interactions influence the outcome in elderly patients the ability of fish oil to suppress tumor necrosis factor-alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes which influence tnf-alpha production cytokine genotype and gender influence the inflammatory response to surgery il- gene promoter polymorphisms in rheumatoid arthritis markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the rotterdam study effect of long-term dietary antioxidant supplementation on influenza virous infection associations between elevated interleukin- and c-reactive protein levels with mortality in the elderly pentamethyl-hydroxychromane, vitamin e derivative, inhibits induction of nitric oxide synthase by bacterial lipopolysaccharide nfkappab polymorphisms and susceptibility to type diabetes reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes irs- -mediated inhibition of insulin receptor tyrosine kinase activity in tnf-alpha-and obesity-induced insulin resistance tumor necrosis factor a: a key component of the obesitydiabetes link randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma inhibition of the expression of inducible nitric oxide synthase and cyclooxygenase- in macrophages in macrophages by & hq derivatives: involvement of ikappab-alpha stabilisation are differences in interleukin production associated with joint damage? cysteine and methionine supplementation modulate the effect of tumor necrosis factor c~ on protein synthesis, glutathione and zinc content of tissues in rats fed a lowprotein diet identification of high and low responders to allographs the effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type diabetes heritable major histocompatibility complex class ii-associated differences in production of tumor necrosis factor-co relevance to genetic predisposition to systemic lupus erythematosus immunocompetence and oxidant defense during ascorbate depletion of healthy men bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of nf-kappab and p mitogen-activated protein kinase signaling pathways. infection and immunology the effect of alpha-tocopherol supplementation on ldl oxidation severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial chlamydial heat shock protein localizes in human atheroma and regulates macrophage tumor necrosis factor-a andmatrix metalloproteinase expression a natural resistance to intracellular pathogens: modulation of macrophage signal transduction related to the expression of the bcg locus plasma proinflammatory cytokine response to surgical stress in elderly patients modulation of macrophage-derived interleukin- and tumour necrosis factor by prostaglandin e allele frequencies of + tga single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of italian centenarians ethanol consumption, amino acid and glutathione blood levels in patients with and without chronic liver disease skeletal muscle glutathione after surgical trauma genetics and the pathobiology of ageing nhanes iii health data relevant for aging nation variation in the tnfalpha promoter region associated with susceptibility to cerebral malaria polymorphic structure of the tumour necrosis factor (tnf) locus: an nco i polymorphism in the first intron of the human tnf-~ gene correlates with a variant amino acid in position and a reduced level of tnfc~ production vitamin e supplementation enhances cell-mediated immunity in healthy elderly subjects oral (n- ) fatty acid supplementation supresses cytokine production and lymphocyte proliferation: comparison between young and older women immunological effects of national cholesterol education panel (ncep) step- diets with and without fish-derived (n- ) fatty acid enrichment vitamin e supplementation and in vivo immune response in healthy subjects. a randomized controlled trial vitamin e supplementation suppresses prostaglandin e synthesis and enhances the immune response of aged mice oral supplementation with whey proteins increases plasma glutathione levels in hiv-infected patients association of tnf , a tnf-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study association between manganese superoxide dismutase (mnsod) gene polymorphism and breast cancer risk plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and smokers: effect of vitamin e treatment potential role of tnf-alpha in the pathogenesis of insulin resistance and type diabetes inhibition of monocyte chemoattractant protein- expression in cytokine-treated human lung epithelial cells by thiazolidinedione total parenteral nutrition with glutamine dipeptide after major surgery. a double blind controlled study prevalence of low body mass in rheumatoid arthritis: association with the acute phase response increase in il- and decrease of interleukin production during the ageing process are influenced by health status glutamine metabolism in lymphocytes. its biochemistry, physiology and clinical importance relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus periodontal inflammation and insulin resistance--lessons from obesity age-dependent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus c-reactive protein and coronary heart disease in western turkey increased monocyte activation in elderly patients after surgical stress c-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women genomic interactions with disease and nutrition treatment with glutathione precursor decreases cytokine activity genotyping for polymorphisms in interferon-gamma, interleukin- , transforming growth factor-beta and tumour necrosis factor-alpha genes: a technical report changes in proinflammatory cytokine activity after menopause c-reactive protein, interleukin , and risk of developing type diabetes mellitus asymptomatic bacteriuria in elderly humans is associated with increased levels of circulating tnf receptors and elevated numbers of neutrophils genetic variation in cytokine production may be protective of icu admission and may influence mortality in vivo rates of erythrocyte glutathione synthesis in children with severe protein-energy malnutrition altered cytokine production in the elderly glutathione depletion in rats impairs t-cell and macrophage immune function age and sex steroid-related changes in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress endothelial perturbation in children and adolescents with type diabetes: association with markers of the inflammatory reaction epidemiologic and methodologic problems in determining nutritional status of older persons the pathogenesis of atherosclerosis: a perspective for the s origins and clinical relevance of sarcopenia association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease reactive oxygen intermediates as apparently widely used messengers in the activation of nuclear transcription factor-~j and hiv- tumor necrosis factor-alpha - promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients gender differences in sepsis: genetically determined? shock evidence for a functional repeat polymorphism in the promoter of the human nramp gene that correlates with autoimmune versus infectious disease susceptibility involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type diabetic patients does n-acetyl cysteine inflkuence cytokine response during early human septic shock? alterations in lipid and carbohydrate metabolism in sepsis altered control of carbohydrate metabolism in endotoxemia glutathione deficiency in human immunodeficiency virus infection vitamin e, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease a genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis interleukin (il- ) genotypes in inflammatory bowel disease change in the ratio of interleukin- to interleukin- predicts a poor outcome in patients with systemic inflammatory response syndrome effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol an investigation ofpolymorphisms in the interleukin- gene promoter antiinflammatory cytokine profile and mortality in febrile patients alphatocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals relationship of interleukin- and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health abc study circulating interleukin- in relation to adiposity, insulin action, and insulin secretion high white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type diabetes ppar-gamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and crohn's disease lack of association between human longevity and polymorphisms of il- cluster, il- , il- and tnf-alpha genes in finnish nonagenarians genetic polymorphisms in the tumor necrosis factor locus influence non-hodgkin's lymphoma outcome activation of transcription factor nf-kappa b and p mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in pima indians biology of arterial atheroma comparative genetic association of human leukocyte antigen class ii and tumor necrosis factor-alpha with dermatitis herpetiformis an allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with hla-a , b , and dr alleles a genetic association between systemic lupus erythematosus and tumor necrosis factor alpha effect of vitamin e on human aortic endothelial cell production of chemokines and adhesion to monocytes effect of dietary supplementation with fish oil in combination with different levels of vitamin e on immune response in healthy elderly human subjects in vitro glutathione supplementation enhances interleukin- production and mitogenic responses in peripheral blood mononuclear cells from young and old subjects associations of serum c-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the third national health and nutrition examination survey production of tumour necrosis factor--alpha increases with age and bmi in healthy women the influence of age and gender on serum dehydroepiaandrosterone sulphate (dhea-s), il- , il- soluble receptor (il- sr) and transforming growth factor beta (tgf-beta ) levels in normal healthy blood donors polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year the author is grateful to the bbsrc for funding much of the work reported in this chapter. the author is also grateful to collegues in the united kingdom, sweden, and switzerland for scientific collaboration and advice. key: cord- -zjyrhlxn authors: sigmundsdóttir, h.; johnston, a.; gudjónsson, j. e.; valdimarsson, h. title: differential effects of interleukin‐ and interleukin‐ on superantigen‐induced expression of cutaneous lymphocyte‐associated antigen and αeβ integrin (cd ) by cd (+) t cells date: - - journal: scand j immunol doi: . /j. - . . ab.x sha: doc_id: cord_uid: zjyrhlxn the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin‐ (il‐ ), il‐ and transforming growth factor (tgf)‐β are important regulators of chronic inflammatory disease, where cutaneous lymphocyte‐associated antigen (cla) and αe integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue‐specific homing but may help to retain t cells within epithelial layers. we have previously shown that il‐ alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd (+) but not cd (+) t cells. while il‐ increased superantigen‐stimulated expression of cla, this cytokine strongly inhibited the cd expression, and a combination of il‐ and tgf‐β completely abrogated the induced cd expression. conversely, il‐ suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th ‐mediated inflammatory responses, il‐ may also inhibit the migration of cd (+) t cells into the skin while il‐ promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il‐ and il‐ , and the balance between these cytokines could influence the t‐cell migration of inflammatory cells into epithelial tissues. the nuclear receptor heterodimers of liver x receptors (lxrs) are recently identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. lxrs and their ligands are negative regulators of macrophage inflammatory gene expression. multiple sclerosis (ms), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. sweden belongs to the countries with a high ms incidence. in italy, incidence is lower, with an exception for sardinia where the incidence is even higher than that in sweden. subjects from sardinia are ethnically more homogeneous and differ from swedes, also regarding genetic background and environment. we studied lxrs and their related molecules of blood mononuclear cells (mncs) from female patients with untreated relapsing-remitting ms from sassari, sardinia and stockholm, sweden. sex-and age-matched healthy controls (hcs) were from both areas. mrna expression was evaluated by real-time pcr. lxr-a was lower (p < . ) in ms (mean ae sem: . ae . ; n ¼ ) compared to hc ( . ae . ; n ¼ ). lxr-a was lower in ms from stockholm ( . ae . ; n ¼ ) compared to corresponding hc ( . ae . ; n ¼ ; p < . ) and compared to ms ( . ae . ; n ¼ ; p < . ) and hc ( ae . ; n ¼ ; p < . ) from sardinia. ms patients from stockholm, but not from sassari, also expressed lower (p < . ) lxr-b (À . ae . ) compared to corresponding hc (À . ae . ). ms from stockholm was associated with higher abca- ( . ae . versus . ae . ; p < . ) and higher estrogen receptor-b-cx ( . ae . versus . ae . ; p < . ) compared to corresponding hc. the hc from sassari had higher androgen receptor ( . ae . ) compared to ms from sassari ( . ae . ; p < . ), ms ( . ae . ; p < . ) and hc from stockholm ( . ae . ; p < . ). ms from sassari had lower cyclooxygenase- compared to corresponding hc ( . ae . versus . ae . ; p < . ) and lower prostaglandin-e (À . ae . ) compared to the hc ( . ae . ; p < . ) and ms ( . ae . ; p < . ) and hc from stockholm ( . ae . , p < . ). our findings identify lxrs and their related molecules as being involved in ms from stockholm but not from sassari, while sex hormone receptors seem to be involved in ms in sassari. multiple sclerosis: ifn-b induces cd + bdca -dendritic cells that produce il- and il- and have no enhanced type i interferon production y. m. huang, s. adikari, u. båve, a. sanna , & g. alm dc antigens (bdca) and investigate their ability to produce type i ifn in response to virus stimulation. we show that ifn-b induces development of cd þ dc from human blood monocytes, which coexpress bdca þ but are negative for bdca -, a specific marker for plasmacytoid dc. such ifn-b-modulated dc produce large amounts of il- and il- , but no il- p and have no enhanced ifn-b and ifn-b production. the findings indicate that ifn-bmodulated dc represent a myeloid dc subset with diminished cd c, bdca- and cd a expression, having potent th -promoting function but lacking antiviral capacity. the association of psoriasis with throat infections by streptococcus pyogenes suggests a potential antigenic target for the t cells that are known to infiltrate dermis and epidermis of psoriatic skin. streptococcal m protein shares an extensive sequence homology with human epidermal keratins. keratins (k ) and (k ) are mostly absent from uninvolved skin but are upregulated in psoriatic lesions. there is increasing evidence that cd þ t cells play an important effector role in psoriasis and m proteinprimed t cells may recognize these shared epitopes in skin via molecular mimicry. to identify candidate epitopes, peptides with sequences from k were selected on the basis of predicted binding to hla-cw and sequence similarities with m protein. matched peptides from the sequence of m protein and a set of peptides with poor predicted binding were also selected. cw þ individuals with psoriasis and cw þ healthy controls, having a family history of psoriasis, were recruited. pbmcs were incubated with the peptide antigens. t-cell activation in the cd þ , cd þ and later the skin-homing cutaneous lymphocyteassociated antigen (cla)-expressing subset of cd þ t cells was evaluated by cd expression and intracellular ifn-g accumulation using flow cytometry. we demonstrate that cw þ psoriasis patients had significant cd þ t-cell ifn-g responses to peptides from k and m protein selected on the basis of sequence homology and predicted hla-cw* binding. these responses were about times more frequent in the skin-homing cutaneous lymphocyte-associated antigen-expressing (cla þ ) subset of cd þ t cells. cd þ t cells showed only borderline responses. cd þ t cells from cw þ nonpsoriatic individuals responded to some m peptides but very rarely to k peptides, and this also applied to the cla þ cd þ subset. these findings indicate that psoriatic individuals have cd þ t cells that recognize keratin self-antigens and that epitopes shared by streptococcal m protein and human keratin may be targets for the cd þ t cells that infiltrate psoriatic skin lesions. autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly % in ra patients and a suggestive involvement in the pathogenesis. the targeted epitopes are generated by a post-translational modification catalysed by the calcium-dependent enzyme peptidyl arginine deaminase that converts the positively charged arginine to polar but uncharged citrullin. the aim of this study was to analyse the presence of citrulline in the joints at different time points of collagen-induced arthritis in da rats by immunohistochemistry and to investigate how immunogenicity and arthritogenicity was affected by citrullination of rat serum albumin (rsa) and collagen type ii (cii). our results indicate that citrulline could be detected in joints of arthritic animals, first appearance at the onset of disease and increasing as disease progressed into a chronic state. unimmunized animals or time points before clinical signs of arthritis were negative. by morphology, we state that some infiltrating macrophages as well as the cartilage surface stain positive for citrulline, while the major source of citrullinated proteins appears to be fibrin depositions. a specific cit-rsa t-cell response was observed in animals challenged by citrullinated rsa, no response was recorded when rsa was used as a stimulus. the igg analysis reveals not only a response towards the modified protein but also cross-reactivity to native rsa. no t-cell or b-cell response was noted in animals injected with unmodified rsa. cit-cii induced a disease with higher incidence and earlier onset than did the native counterpart. we conclude that, in contrast to the human disease, citrulline does not seem to appear before clinical signs. as inflammation proceeds, citrulline is detected specifically in the joints. all other organs investigated were negative. we also conclude that citrullination of a protein can break tolerance and increase its arthritogenic properties. ectopic germinal centers (gcs) can be detected in the salivary glands of approximately / of patients with sjögren's syndrome (ss) and appear in both primary and secondary ss. previously, ectopic gc have been associated with increased local autoantibody production. the aim of this study was to determine whether gc in primary sjögren's syndrome (pss) defines a distinct seroimmunological phenotype. retrospectively, a material of haematoxylin and eosin-stained paraffin-embedded tissue sections of minor salivary gland tissue from patients with pss was morphologically screened for the presence of ectopic gc. gc-like lesions were detected in / ( %) of the pss patients. seventy-two pss patients lacking these structures (gc-) were randomly selected for comparison. focus score was significantly increased in the gc þ patients compared to the gcpatients (p ¼ . ). in the gc þ group, . % of the patients presented with anti-ro/ssa compared to . % in the gcgroup. anti-la/ssb was detected in . % of the gc þ patients compared to . % of the gcpatients. sixty-one percentage of gc þ patients presented with increased levels of igg, a nonsignificant difference when compared to . % in the gcpatients (p ¼ . ). levels of rf, ana, ena, igm and iga were similar in both patient groups, as were esr and crp. in conclusion, patients with ectopic gc have a higher focus score and more often present with autoantibodies and increased levels of igg compared to pss patients with regular focal infiltration (gc -). our findings may indicate a certain seroimmunological phenotype and warrant for further prospective studies. association between mannose-binding lectin and vascular complications in type diabetes complement activation and inflammation have been suggested in the pathogenesis of diabetic vascular lesions. we investigated serum mannose-binding lectin (mbl) levels and polymorphisms in the mbl gene in type diabetic (t dm) patients with and without diabetic nephropathy and associated macrovascular complications. polymorphisms in the mbl gene and serum mbl levels were determined in t dm patients with overt nephropathy and t dm patients with persistent normoalbuminuria matched for age, sex and duration of diabetes as well as in healthy control subjects. the frequencies of high and low expression mbl genotypes were similar in patients with t dm and healthy controls. high mbl genotypes were significantly more frequent in diabetic patients with nephropathy than in the normoalbuminuric group, and the risk of having nephropathy, given a high mbl genotype, assessed by odds ratio was . ( . - . ), p ¼ . . median serum mbl concentrations were significantly higher in patients with nephropathy than in patients with normoalbuminuria [ mg/l (iqr - mg/l) versus mg/l (iqr - ), p ¼ . ], and even when comparing patients with identical genotypes, serum mbl levels were higher in the nephropathy group than in the normoalbuminuric group. patients with a history of cardiovascular disease had significantly elevated mbl levels independently of nephropathy status [ mg/l (iqr - mg/l) versus mg/l (iqr - mg/l), p ¼ . ]. the differences in mbl levels between patients with and without vascular complications were driven primarily by pronounced differences among carriers of high mbl genotypes (p < . ). our findings suggest that mbl may be involved in the pathogenesis of microvascular and macrovascular complications in type diabetes and that determination of mbl status might be used to identify patients at increased risk of developing these complications. neuroimmunology unit, center for molecular medicine, karolinska institutet, stockholm, sweden. e-mail: judit.wefer@cmm.ki.se dna vaccine coding for the encephalitogenic peptide mog - protects lew. av from subsequent development of experimental autoimmune encephalomyelitis (eae). protection is associated with a type immune response and is dependent on the presence of cpg dna motifs. the mechanisms underlying the observed reduction of eae development in protected rats have not been fully clarified. we investigated immunological characteristics of lymphocytes after dna vaccinaton and subsequent eae induction. we confirm that protection was not associated with suppression of t cells, as transcription of the novel molecule rat t-cell immunoglobulin-and mucindomain-containing molecule (tim- ), reported to be exclusively expressed on differentiated t cells, was not altered by dna vaccination. we did not note any clonal deletion upon tolerization, but detected an antigen-specific lymphocyte population upregulating ifng upon recall stimulation weeks after protective dna vaccination. in protected rats, we observed ( ) no alterations in antigenspecific th or th responses, ( ) reduced mhc ii expression on splenocytes early after eae induction, ( ) antigen-specific upregulation of ifnb upon recall stimulation and ( ) reduced il- rb on lymphocytes. we thus demonstrate an association of the protective effect of dna vaccination with expression of ifnb. we are currently investigating the cellular mechanisms behind this ifnb-mediated protection. multiple sclerosis (ms) is an autoimmune condition characterized by degeneration of nerve fibre myelin sheets. a candidate autoantigen, myelin basic protein (mbp), has especially attracted attention. the presence of anti-mbp antibodies is a predictor of definite ms, but their role in the pathogenesis remains obscure. t cells have long been known to play a pivotal role in the pathogenesis of ms. recently, an important role for b cells as autoantigen-presenting cells has been demonstrated in other autoimmune diseases, including rheumatoid arthritis and diabetes. the uptake of mbp by b cells and the presentation of mbp-derive peptides to t helper (th) cells by b cells may be promoted by the formation of complement (c) activating immune complexes (ics) between mbp and natural autoantibodies in healthy individuals and disease-associated anti-mbp antibodies in ms patients, respectively. we have investigated the formation of mbp-containing ic, the binding of mbp to b cells, the mbp-elicited induction of th-cell and b-cell proliferation and the cytokine production in peripheral blood mononuclear cells (pbmcs) from healthy donors grown in the presence of intact or c-inactivated serum from healthy donors or patients with ms. while mbp did not induce measurable proliferation of b cells nor cd þ t cells, we observed the production of tnf-a, ifn-g and il- by pbmc in response to incubation with mbp in the presence of sera from healthy controls as well as sera from ms patients. by contrast, no production of il- , il- and il- was detected. we are currently investigating the capability of ms sera to promote the formation of mbp-containing ic and thereby enhance the cytokine responses, by virtue of elevated anti-mbp contents. the phagolysosomally localized acid sphingomyelinase (asmase) activated by proinflammatory cytokines such as tnf and ifn-g generates the signalling molecule ceramide which in turn results in the activation of proteases like cathepsin d. these characteristics of asmase suggest a possible role of this molecule in the phagocytotic uptake and phagosomal degradation processes of antigens or in antigen presentation. we show here that asmase -/mice fail to eliminate the noncytopathic lymphocytic choriomeningitis (lcm) virus as rapidly as littermate wildtype mice. investigation of the immune response revealed a reduced expansion of cd þ t cells. the secretion of ifn-g in response to contact with target cells as well as the cytolytic activity of virus-specific cd þ t cells was severely impaired. additionally, both phases of the lcm virus-specific dth response, mediated by cd þ and cd þ t cells consecutively, were diminished in asmase -/mice. however, the secondary memory response of virus-specific ctl was not altered, and the abstracts ................................................................................................................................................................................................. virus was effectively controlled for at least months by asmase -/mice. in conclusion, the results of this study suggest an involvement of the asmase in the activation, expansion or maturation of virus-specific cd þ t cells during the acute infection of mice with the lcm virus. novel markers for alternative activation of macrophages: macrophage galactose-type c-type lectins and in parallel with the th /th dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in, for example cytokine environment and pathological conditions. while the best-studied, classically activated macrophage is induced by type i stimuli such as ifn-g, a type ii cytokine environment antagonizes the classical activation of macrophages and is capable of alternatively activating macrophages. however, molecular markers associated with these type ii cytokine-dependent, alternatively activated macrophages remain scarce. besides the earlier documented markers macrophage mannose receptor and arginase , we recently demonstrated that murine alternatively activated macrophages are characterized by increased expression of fizz and ym. we now report that expression of the two members of the mouse macrophage galactose-type c-type lectin gene family, termed mmgl and mmgl , is induced in diverse populations of alternatively activated macrophages, including peritoneal macrophages elicited during infection with the protozoan trypanosoma brucei or the helminth taenia crassiceps, and alveolar macrophages elicited in a mouse model of allergic asthma. we also demonstrate that, in vitro, interleukin- and interleukin- upregulate mmgl and mmgl expression and that, in vivo, induction of mmgl and mmgl is dependent on interleukin- receptor signalling. moreover, we show that regulation of mgl expression is similar in human monocytes and monocyte-derived macrophages. hence, macrophage galactose-type c-type lectins represent novel markers for both murine and human alternatively activated macrophages; thus, paving the way for further characterization of the phenotype of macrophages occurring in th conditions. background: human parvovirus b (b ) is a ubiquitous pathogen, normally causing a mild self-limiting disease, but also capable of causing both significant pathology and long-term persistence. the small size and stability of the virus makes it suitable for mapping of the full breath and the kinetics of the cellular immune responses following acute viral infection. methods: five patients with acute primary b infection were included in the study and followed consecutively for up to weeks. cellular immune responses were mapped by ifng enzyme-linked immunospot to overlapping peptides spanning the whole b genome. results: in all five acutely infected patients, we were able to monitor the kinetics of a strong specific cellular immune reaction. responses peaked at levels of - sfc/ million pbmcs, roughly corresponding to . - . % b specific cd þ cells circulating in peripheral blood at - weeks post-infection. the responses in individual patients were directed to three or four different peptide pools, and the specificity was confined to the same cd epitopes present in the pools throughout the follow-up period. the majority of responses were directed to the virus nonstructural protein, only two patients showed any response to the capsid proteins, elicited by the same epitope in both cases. conclusion: the cellular immune responses to acute b infection are surprisingly narrow in distribution and remain at high levels for up to weeks post-infection. the initial epitope specificity is maintained, and the majority of responses target the virus nonstructural protein, which is not included in vaccine preparations, evaluated against the infection. the relationship between malnutrition and malaria is controversial. on one hand, malaria may cause malnutrition, while on the other, malnutrition itself may modulate susceptibility to the disease. we investigated the association between plasmodium falciparum malaria and malnutrition in a cohort of children living on the coast of kenya. the study involved longitudinal follow-up for clinical malaria episodes and anthropometric measurements at four cross-sectional surveys. we used poisson regression analysis to investigate the association between malaria and nutritional status. compared to baseline (children with a waz or haz score of !À ), the crude incidence rate ratios (irrs) for malaria in children with low haz or waz scores (<À ) during the period prior to assessment were . ( % ci . - . ; ¼ . ) and . ( . - . ; . ), respectively, suggesting no association between malaria and the subsequent development of pem. however, we found that age was acting as an effect modifier in the association between malaria and malnutrition. the irr for malaria in children - years old who were subsequently characterized as wasted was . ( . - . ; p ¼ . ), and a significant overall relationship between malaria and low-haz was found on regression analysis when adjusting for the interaction with age (irr . ; . - . ; p < . ). although children living on the coast of kenya continue to suffer clinical episodes of uncomplicated malaria throughout their first decade, the association between malaria and malnutrition appears to be limited to the first years of life. a. astrinidou-vakaloudi, s. xytsas, i. diamanti, h. ioannidis & p. pangidis microbiology department of general hospital of thessaloniki 'agios pavlos', thessaloniki, greece, and nefrology, nd ika hospital of thessaloniki, thessaloniki, greece. e-mail: stasa@hol.gr aim: renal dysfunction may influence the colonization of gastric mucosa by urea-splitting bacteria such as helicobacter pylori, by increasing urea concentrations in the gastric juice. our aim was to investigate the prevalence of h. pylori in patients with end-stage renal disease (esrd), receiving long-term haemodialysis treatment. methods: this study included sera from patients with esrd ( male and female) undergoing periodic haemodialysis; mean time of treatment was . months. using elisa technique, we investigated the presence of igg and iga antibodies against h. pylori as well as igg caga (antibodies specific for caga(þ) strains of h. pylori). sera from healthy blood donors were used as a control group. results: h. pylori igg antibodies were detected in out of ( %) patients in the dialysis group, while / ( . %) tested positive for iga. igg caga antibodies were present in out of ( . %). prevalence of h. pylori igg, iga and caga igg antibodies in the control group was , and %, respectively. conclusions: although international data suggest that prevalence of h. pylori infection is the same in esrd patients as in healthy individuals, in our study that seems not to be the case. the higher blood and gastric juice urea levels may be a risk factor (among many others), but more studies are required in order to understand the relation of h. pylori infection in this group of patients. flanders interuniversity institute for biotechnology, department of molecular and cellular interactions, free university of brussels, brussels, and pasteur institute of brussels, mycobacterial immunology, brussels, belgium. e-mail: tgartner@vub.ac.be immunity against tuberculosis (tb), caused by mycobacterium tuberculosis, depends largely on activation and maintenance of strong cell-mediated immune responses involving both cd þ and cd þ t cells and the ability to respond with th -type cytokines, particularly ifn-g. recent studies suggested that bcg, the only licensed vaccine against m. tuberculosis, may fail to induce t-cell responses in the lung mucosa and may therefore not protect against pulmonary tb. a decrease in tb mortality may be achieved by enhancing immunity in the lung. the present study evaluated the induction of antigen-specific immunity in the lung by intranasal (i.n.) delivery of the lipoprotein i (opri) from pseudomonas aeruginosa. opri has shown to be a toll-like receptor / agonist that, when given subcutaneously, induces type- immune responses against heterologous antigens. here, a fusion of opri to ag a of mtb (opri-ag a) was used as a subunit vaccine in homologous prime-boost immunizations. in addition, opri-ag a was combined with an ag a-encoding dna vaccine (ag a dna) or with bcg in heterologous prime-boost vaccinations. intranasal and parenteral delivery with opri-ag a elicited comparable t-cell responses in the spleen; in addition, i.n. delivery elicited specific t-cell responses in the lung lymph nodes (llns). intramuscular delivery of ag a dna induced significant systemic th immune responses. intranasal boosting with opri-ag a enhanced this response and in addition induced an antigen-specific ifn-g response in lln. opri may therefore be an efficient adjuvant for mucosal boosting. we continue to evaluate the protection induced by opri-based prime-boost vaccinations against pulmonary tb. results on the immunogenicity and protection against intravenous mtb h rv infection will be presented. toll-like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress-associated molecules. tlr-ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus-induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus-encoded inhibitor of tlr-signalling a r or dominant-negative myd totally inhibited hsv-induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv-induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr-dependent and -independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. - -oligoadenylate synthetases are interferon-induced, double-stranded rna-activated antiviral enzymes which are the only proteins known to catalyse -specific nucleotidyl transfer. this first crystal structure of a - oligoadenylate synthetase reveals a structural conservation with the -specific poly(a) polymerase that, coupled with structure-guided mutagenesis, supports a conserved catalytic mechanism for the -and -specific nucleotidyl transferases. comparison with structures of other superfamily members indicates that the donor substrates are bound by conserved active site features while the acceptor substrates are oriented by nonconserved regions. the - oligoadenylate synthetases are activated by viral doublestranded rna in infected cells and initiate a cellular response by synthesizing - -oligoadenylates, that in turn activate rnase l. this crystal structure suggests that activation involves a domain-domain shift and identifies a putative dsrna activation site that is probed by mutagenesis. we demonstrated that this site is required both for the binding of dsrna and for the subsequent activation of oas. this rna-binding site is different from known rna-binding site; rather than forming a defined three-dimensional domain, it is located at the interface of the two major domains in oas. this novel architecture ensures that the dsrna helix can make simultaneously contact with both domains of oas and ensure the subsequent structural rearrangement leading to the activation of oas. our work provides structural insight into cellular recognition of double-stranded rna of viral origin and identifies a novel rna-binding motif. bacteria-specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody-treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as faba (monovalent) deprived of fca which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody-coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero-steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type- polysaccharide-induced phagocytosis of iga protease-deficient type- pneumococci equally well in the absence as in the presence of complement. iga antibody to type- polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type- polysaccharide served as opsonin. iga antibody extracted from iga protease-producing target bacteria was almost exclusively in the form of faba. conversely, iga from protease-deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody-mediated opsonophagocytosis. besides, in these experiments, iga-mediated opsonophagocytosis was independent of complement. vitamins e and c have been found to increase the cellular and humeral immunity of pigs. vitamin e deficiency has also been found to predispose pigs to different diseases, e. coli infection is one among them. after weaning, the vitamin e status of pigs often decreases to a critical low level. in this experiment, we studied whether vitamin c supplementation would be a possible feeding strategy to optimize the immune status of weaners. the interaction between vitamin e and c is interesting due to the reported sparing action on vitamin e or synergism between these to vitamins. piglets were weaned at day of age from sows fed increasing dietary vitamin e during lactation, and piglets were during the following weeks fed either a control diet or this diet supplemented with mg stay-c per kg. blood sampling was obtained weekly from day and until day of age. on the same days, one piglet per dietary treatment was killed and alveolar macrophages (am) were harvested. vitamin c supplementation increased the concentration of igm in serum of piglets throughout the weaning period. although the vitamin e concentration in am decreased with increasing age of the piglets, the concentration was numerically higher in piglets of sows fed the high dietary level of vitamin e. however, vitamin c supplementation tended to increase the total am concentration of vitamin e after weaning and increased the proportion of the biologically most active isomer of vitamin e [rrr-(a-tocopherol)] in the am. the eicosanoid synthesis by am was not influenced by the vitamin c supplementation, but the synthesis of leukotriene b was decreased weeks after weaning compared to other days of am harvesting. in conclusion, dietary vitamin c supplementation improved the immune responses of piglets after weaning. a whole blood stimulation assay with escherichia coli (o :b ) endotoxin was established to measure the capacity of dairy cows to produce the proinflammatory cytokine tumour necrosis factor-a (tnf-a) ex vivo. initially, a time-and dose-dependent study was carried out to find the optimal stimulation conditions for the tnf-a response. the tnf-a response peaked between and h at . c. a dose in the range of - g of e. coli lipopolysaccharide (lps)/ml whole blood was found to give the maximum tnf-a response. thirty-eight danish-holstein dairy cows were investigated for their tnf-a responsiveness ex vivo in the periparturient period. heparin-stabilized blood samples were collected seven times over a period of months (weeks À , À , , , , and around calving) and stimulated with g/ml of e. coli lps. indeed, fluctuations in the tnf-a responsiveness occurred over time. moreover, the mean tnf-a responsiveness of cows was found to be significantly increased (p < . ) in the weeks close to calving. however, in the more stabile physiological periods, some cows had a consistently low tnf-a response, whereas others had high a tnf-a response. we are currently investigating whether high and low tnf-a responders to e. coli lps also exist in dairy cows in vivo. moreover, the importance of tnf-a responsiveness ex vivo to dairy cows' susceptibility and clinical response to experimental e. coli infections in the udder is being investigated. coelomic cytolytic factor (ccf) is a kda invertebrate pattern recognition molecule isolated from the coelomic fluid of the earthworm eisenia foetida (oligochaeta, annelida). ccf displays a number of similarities with the mammalian cytokine tumour necrosis factor-a (tnfa) as a result of a shared n,n -diacetylchitobiose lectin-like domain. however, these similarities are solely functional and are not based on any (dna or amino acid) sequence homology, thus suggesting a form of convergent evolution. in particular, the lectin-like domain of tnf-a has been shown to induce membrane depolarization in various mammalian cell types, through interactions with endogenous amiloride-sensitive ion channels. this nonreceptor-mediated activity of tnf-a has been reported to be involved in the resorption of oedema. likewise, the lectin-like domain of ccf also induces membrane depolarization in mammalian cells. here, we show that ccf appears to be able to induce oedema resorption in an alveolar epithelial cell line through its lectin-like domain. this lectin-like domain of ccf interacts (directly or indirectly) with endogenous sodium and/or chloride channels, and not potassium channels, on mammalian cells. additionally, we suggest that the jnk/sapk and erk / pathways are involved in ccf-induced macrophage activation. these results further establish the functional analogy between an invertebrate pattern recognition molecule and a mammalian cytokine and, from a more applied point of view, suggest the possibility of utilizing ccf in the treatment of oedema. release of svegf and svegfr from white blood cells and platelets during surgery and stimulation with bacterial antigens introduction: the influence of surgery on release of soluble vascular endothelial growth factor (svegf) and the soluble vascular endothelial growth factor inhibitory receptor (svegfr ) is unknown. we studied the effect of major and minor surgery on potential variations in svegf and svegfr concentrations in vivo and on bacterial antigen-induced release of svegf and svegfr from whole blood in vitro. methods: sixty-one patients with abdominal diseases undergoing five different surgical procedures were included. blood samples were drawn from anaesthetized patients before and after the operation. white blood cells and platelets were counted, and plasma svegf and svegfr was determined by an elisa method. whole blood from each blood sample was stimulated in vitro with bacteria-derived antigens (lps or protein-a) and svegf and svegfr levels were subsequently determined in the supernatants. stimulation with isotonic saline served as control assay. neither svegf or svegfr in plasma changed during surgery. in vitro stimulation of blood samples with bacteria-derived antigens resulted in a significant increase in svegf (p < . ) and a less pronounced but still significant increase in svegfr . release of svegf due to stimulation was significantly higher after the operation (nonsignificant), whereas svegfr release remained largely unchanged after surgery. correlation between bacterial antigen-induced release of svegf and neutrophile cell count was highly significant (p < . ). there was no correlation between svegf and platelet cell count, and bacterial antigen-induced svegfr release did not correlate with counts of neutrophils and platelets. conclusions: plasma svegf and svegfr concentrations did not change during surgery. in vitro bacterial stimulation led to increased release of svegf and svegfr , which was not significantly amplified during surgery and which may be related to number of circulating neutrophils. natural killer cell functions and subsets after in vitro stimulation with il- and il- , with special emphasis on intracellular ifn-g and nk-cell cytotoxicity r. nyboe, , t. rix, , j. krog, , e. tønnesen & m. hokland department of anaesthesiology and intensive care, aarhus university hospital, and institute of medical microbiology, and immunology, university of aarhus, aarhus, denmark. e-mail: rnsr@studmed.au.dk materials and methods: isolated cryopreserved human peripheral blood mononuclear cells (pbmcs) were stimulated with il- and il- . this stimulation has previously been shown to activate nk cells. cell cytotoxicity was measured by flow cytometry after incubation with k cells. this method was compared to the current standard cr release assay. cells were treated with bfa to accumulate ifn-g, stained for surface markers, permeabilized and stained for intracellular ifn-g. flow cytometry was then performed to measure intracellular ifn-g production in pbmc, especially in nk cells. results: we have demonstrated that stimulation with il- and il- is effective in increasing the number of ifn-gpositive cells. there is a distinct difference between the cd -cd dim and the cd -cd bright subsets, with a much greater proportion of ifn-g-positive cells in the cd -cd bright subset. the effects of stimulation with il- and il- on cytotoxicity will be presented, as will the relation between ifn-g production and cytotoxicity. in addition, we will present results of these assays applied to porcine cells. discussion: in combination, these tests will address nk cell function by combining cytotoxicity with ifn-g production in nk cell subsets. the results will demonstrate whether this could serve as a useful tool in describing nkcell function, which could be of value in clinical and experimental settings. culture of regulatory t-cell lines from bronchial mucosa t lymphocytes play a major role in many immune responses. in the last decade, special focus has been on the function of th and th effector cells. now the importance of regulatory cd þ cd þ t cells in maintenance of the immunological homeostasis emerges. sarcoidosis is a multisystem granulomatous disorder often affecting the lungs. the typical sarcoid granulomas consists of epitheloid cells, macrophages and lymphocytes, mainly cd þ t cells of th phenotype. we have cultured t cells from bronchial biopsies of patients with sarcoidosis as well as from controls in high levels of interleukin (il- ) and il- and demonstrate spontaneously arising cd þ cd þ populations and high concentrations of il- in these cultures. the main difference between cultures of sarcoid origin compared to controls is a very much higher concentration of the inflammatory cytokines il- and tnf-a in cultures of sarcoid origin. the effects of hyperbaric exposure on human peripheral blood mononuclear cells, with special emphasis on natural killer cell cytotoxicity and subsets materials and methods: as an experimental physiological stress model, we examined the effects of hyperbaric exposure on peripheral blood mononuclear cells (pbmcs) obtained from venous blood drawn from eight divers during a simulated heliox saturation dive. eight persons working in normobar atmosphere outside the pressurized chamber served as control donors. the spontaneous cytotoxicity of the pbmcs was estimated in a h cr-release assay using k as nk-sensitive target cells. the pbmcs were characterized, using -colour flow cytometry, with special emphasis on the nk-cell subsets. the data were statistically analysed using a multivariate regression model (stata . ). p values < . was considered statistically significant. results: the estimated cytotoxicity increased significantly in both the group of divers and control donors during the dive (pdivers < . and pcontrols < . ). although the cytotoxicity increased relatively more (p < . ) in the group of divers compared to the group of control donors between day and . discussion: the increased cytotoxicity of pbmc estimated in the group of divers indicate that parts of the cellular immune system are affected during the extreme physiological conditions induced during the initial phase of the presented experimental hyperbaric setup. the increase in cytotoxicity observed in the group of control donors could hypothetically reflect the stress level in persons working outside the pressurized chamber during the dive. the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin- (il- ), il- and transforming growth factor (tgf)-b are important regulators of chronic inflammatory disease, where cutaneous lymphocyteassociated antigen (cla) and ae integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue-specific homing but may help to retain t cells within epithelial layers. we have previously shown that il- alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd þ but not cd þ t cells. while il- increased superantigen-stimulated expression of cla, this cytokine strongly inhibited the cd expres-sion, and a combination of il- and tgf-b completely abrogated the induced cd expression. conversely, il- suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th -mediated inflammatory responses, il- may also inhibit the migration of cd þ t cells into the skin while il- promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il- and il- , and the balance between these cytokines could influence the t-cell migration of inflammatory cells into epithelial tissues. during contact sensitivity reaction, immune cells proliferate. in order to study the histological picture of these proliferation phases, we used a mouse model of contact sensitivity in the oral mucosa and on skin. we also used bromodeoxyuridin (brdu, an analogue to thymidin) that is incorporated into the nucleus during cell replication. the hapten oxazolone (oxa) was used to sensitize and elicit the oral mucosa and/or the ear skin. mice were killed at various times after elicitation, and unsensitized animals were also exposed to the hapten as controls. brdu ( mg/ kg animal) was injected i.p. h before the kill. specimens from the oral mucosa, ear skin and submandibular and auricular lymph nodes were cut and fixed in % paraformaldehyde. they were then treated with acid and biotinylated anti-brdu antibody and developed using abc-kit and dab. the analyses were performed using a leica light microscope and the computer program analysis. in the oral mucosa, the frequency of proliferating cells were increasing during the observation period, - h after elicitation, regardless of site of sensitization. the proliferating cells were found mainly in the basal cell layer of the epithelium. similar patterns were found in ear skin. the regional lymph nodes demonstrated a few scattered proliferating cells h after elicitation. after h, these cells were found frequently in the whole lymph node. control animals exhibited considerable less proliferating cells at all times. we conclude that most proliferating cells were found h after elicitation locally at the hapten-exposed sites (the oral mucosa or the ear skin) as well as in the regional lymph nodes. the endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective anti-inflammatory effects. adenosine acts via four adenosine receptors of which the a a receptor is the predominant form in t cells. adenosine levels are elevated in asthmatic lung, and adenosine can directly induce mast cell degranulation and bronchoconstriction in these patients. instead, the role of anti-inflammatory mechanisms of adenosine on t cells in asthma is unclear. aim: to study the a a receptor expression in peripheral blood cd þ t cells in asthmatic and healthy individuals using flow cytometric and quantitative real-time pcr methods. results: unstimulated cd þ cells of asthmatic patients expressed significantly lower levels (p < . ) of a a receptor in protein level (mean percentage of cells positive ae sem: . ae . , n ¼ ) compared to healthy individuals ( . % ae . , n ¼ ). double staining for cd expression showed that stimulation of cd þ cells decreased a a expression in both groups but indicated that the detected lower levels of a a in unstimulated cells of asthmatics was not due to preactivation in these patients. surprisingly, a a mrna expression in unstimulated cd þ cells was significantly higher (p < . ) in asthmatics (n ¼ ) compared to healthy controls (n ¼ ). the expression did not correlate with serum total ige levels. conclusions: asthmatic individuals express less a a adenosine receptor on their peripheral cd þ t cells. the higher mrna levels instead may point to a negative feedback regulation in the receptor expression. the role of possibly decreased adenosine-mediated anti-inflammatory effects in asthma pathogenesis require further studies on this t-cell mediated disease. the chronic inflammatory skin disease atopic eczema (ae) affects almost % of the population in many countries today. the pathogenesis of ae is not fully understood. a combination of genetic predisposition and environmental factors like microorganisms seems to contribute to the symptoms. the yeast malassezia sympodialis is part of our normal skin micro flora but can act as an allergen and elicit specific ige and t-cell reactivity in patients with ae. recently, we identified a novel major m. sympodialis allergen, designated mala s ( . kda), with sequence similarity to the mitochondrial enzyme manganese superoxide dismutase (mnsod). interestingly, mala s has a high degree of homology to human mnsod. the aim of this study was to examine the effects of recombinant mala s on antigen-presenting dendritic cells. monocytederived dendritic cells (mddcs) from healthy blood donors were cultured with or without mala s for different time periods. it was found that the maturation marker cd and the costimulatory molecules cd and cd were upregulated on the mddcs exposed to mala s for h, as demonstrated by flow cytometry. furthermore, coculture of mddcs with mala s for h induced an increased production of the inflammatory cytokines il- ( -fold), tnf-a ( -fold) and il- (sixfold), as detected by the cytometric bead array (cba) analysis. our results suggest that mala s affects the immune response through dc maturation and production of inflammatory cytokines. the potential cross-reactivity with human mnsod needs to be explored and the exact role of mala s in the pathogenesis of ae assessed in clinical studies involving skin prick and atopy patch tests. allergen-specific immunotherapy (sit) is commonly conducted with allergen extracts adsorbed to aluminium hydroxide (alum). drawbacks linked to the use of alum, such as the formation of granuloma at the site of injection, have led to suggestions of novel allergen carriers. an alternative carrier is mm carbohydrate-based particles (cbps). in mouse, allergen-coupled cbps have been demonstrated to skew the allergen-specific immune response towards a th -like activity (grönlund et al. immunology, ) . we here coupled the recombinant major cat allergen fel d to cbps (cbp-fel d ) by cyanogen-bromide activation, resulting in covalent binding. the effect of cbp-fel d on monocyte-derived dendritic cells (mddcs) from healthy human blood donors was studied. we found that the majority of the cd a þ mddcs were capable of taking up fitc-labelled cbp-fel d , as demonstrated by flow cytometry and confocal laser scanning microscopy. furthermore, incubation with cbp-fel d resulted in an upregulation of the costimulatory molecule cd on the mddcs, which was not observed with fel d or cbps alone. finally, cbp-fel d induced a fivefold increase in the release of the pro-inflammatory cytokine tumour necrosis factor (tnf)-a and a fourfold increase in the release of the chemokine interleukin- from mddcs. taken together, the effects cbps possess make them interesting as novel allergen carriers for sit. the cysteine protease der p from dust mite of the genus dermatophagoides pteronyssinus is a major type i allergen. about % of house dust mite (hdm) allergic individuals are reactive to this protease in standard assays for detection of ige. a curative treatment for atopic allergy is immunotherapy (it) with hdm extracts which are complex mixtures occasionally resulting in anaphylactic reactions. novozymes focuses on developing a recombinant variant of der p which exhibit lowered risk of ige-mediated allergic reactions, while maintaining its ability to trigger proper th-cell responses. this may provide a safer alternative for specific it of hdm allergy. a secreted recombinant form of pro-der p expressed by saccharamyces cerevisiae was obtained by fusion of the pro-enzyme to a fungal signal peptide. the n-glycosylation site of der p was mutated resulting in a deglycosylated pro-enzyme with a molecular mass of kda. protein purification procedure was developed to obtain nearly pure der p protein followed by determination of concentration by active-site-titration with the cysteine protease inhibitor e . the deglycosylated recombinant pro-der p revealed immunologic similarity to the native der p molecule when compared in basophile histamine release, ige-binding assays and t-cell proliferation assays. by in silico epitope mapping of a modelled -dimensional structure of der p , five putative igg and ige epitopes were predicted. by protein engineering, the predicted epitopes were removed one by one in der p and screening for hypoallergenic variants was performed. combining inhaled long-acting b- agonist (laba) and inhaled corticosteroid (ics) seems to offer asthma control at a lower dose of ics than achieved by ics alone. fine mapping of t-cell surface markers by flow cytometry offers a detailed status of the individual's inflammatory response. the frequency of mt (cd þ cd ra -cd l þ cd adim) and mt (cd þ cd ra -cd l -cd abright) cells in peripheral blood, and their ratio, has been shown to differ predictably in atopics and patients with leprosy, where mt correlates with a th phenotype and mt with a th phenotype. stable asthmatics, requiring fluticasone propionate (fp) - mg daily or equivalent, were randomized to receive, double-blinded, either seretide [salmeterol and fluticasone propionate (sfc, n ¼ )] mg/ mg bd or fp mg bd (n ¼ ). if asthma was controlled based on lung function and symptoms at clinic visits every weeks, ics dose was tapered until asthma exacerbated or mg was reached. the frequency and ratio of mt and mt t cells of the patients was monitored at week intervals. as treatment tapered, the frequency of mt cells decreased (p ¼ from first to final visit), whereas that of mt cells increased. the ratio of mt /mt decreased (p ¼ from first to final visit). in patients receiving laba þ ics, the fall in mt /mt ratio appeared to be more pronounced than in patients receiving ics alone. thus, the mt phenotype may be associated with stable asthma, whereas an imminent exacerbation may associate with an increase in the mt phenotype. laba may allow for a greater effect of fp on the mt ratio. activation of complement pathways, leading to production of c a and c a anaphylatoxins, has been postulated in the pathogenesis of asthma and allergic airway inflammation. the present study was undertaken to investigate the role of mannan-binding lectin (mbl), an initiator of the lectin pathway of complement, in asthma and allergic rhinitis. mbl levels and mbl-induced complement activity were determined in patients of bronchial asthma with allergic rhinitis and unrelated, age-matched controls of indian origin. mbl levels and activity were correlated with percent eosinophilia and percent predicted fev values of the patients. association of single nucleotide polymorphisms (snps) in exon and intron of the mbl with the disease, clinical markers, mbl levels and mbl-induced complement activity was analysed using standard statistical tools. significantly higher mbl levels and activity were observed in patients of bronchial asthma with allergic rhinitis as compared to the controls. we identified five snps, of which two, a g in exon and g a in intron of the mbl, were novel. snp g a was significantly associated with the disease (p ¼ . , or ¼ . , % ci: . < or < . ). individuals with 'a' allele at position showed increased mbl levels, activity and disease severity. our results suggest that 'a' allele at position leading to high mbl levels and complement activity may be contributing to the severity of bronchial asthma and allergic airway inflammation. serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid-encoded, surface-exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h-binding proteins of approximately - kda has been described. the ospe-related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe-related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h-binding regions of ospe-related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c-terminal regions of both human and mouse factor h (scrs - ) specifically bind to ospe-related lipoproteins. we also found fhr- , whose c-terminal scrs - are homologous to scrs - of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i-v) in ospe that could directly interact with factor h. deleting the c-terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c-termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c-terminal-binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h-binding regions were mutated to alanines, we observed that lysines in the factor h-binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe-related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c-termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h-binding proteins may account for their susceptibility to serum lysis. role of yada, ail and lipopolysaccharide in serum resistance of yersinia enterocolitica serotype o: mannan-binding lectin (mbl), l-ficolin and h-ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l-ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type- , - , - , - and - ). h-ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h-ficolin initiated activation of complement factor c , whereas l-ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . mg of mbl/ml, . mg of l-ficolin/ml and . mg of h-ficolin/ ml, respectively. the absence of early complement components (c , c and c but not c ) is a predisposing factor for systemic lupus erythematosus (sle). recently, we demonstrated that, in c -deficient (c def.) mice, igm-containing immune complexes (igm-ic) are filtered by the splenic barrier of marginal zone macrophages (mzm), resulting in an increased immune response against antigens within these igm-ic, but this could not be observed in wildtype or c def. mice. we hypothesized that splenic cd b þ mzm play an important role in the induction of autoimmunity, and we therefore analysed their cytokine profile after isolation with the help of magnetic antibody cell sorting. mrna was isolated, and real-time pcr was performed with specific primers for murine ifn-g (ifn-g), interleukin- (il- ) and ifn-a (ifn-a). we observe a moderate increase of il- and ifn-g mrna in cd b þ cells of c def. mice compared to wildtype cells. surprisingly, the concentration of ifn-a mrna is six times higher in c def. mice. preliminary results suggest that mrna in cd b þ cells of c def. mice is even lower than that in wt. six hours following i.v. application of mg of a abstracts .................................................................................................................................................................................................. murine monoclonal igm anti-dsdna antibody, production of il- , ifn-g and ifn-a mrna is increased in cd b þ cells of both c def. and wt mice. several references described increased levels of inf-a in patients with sle. dendritic cells are discussed as a major source of ifn-a. our observation that c -deficient, sle-susceptible mice demonstrate an increased spontaneous ifn-a production by splenic cd b þ marginal zone macrophages could be an early sign and a trigger for the development of sle. this is supported by the fact that the absence of c is not a predisposing factor for sle and our observation that c def. animals display low levels of ifn-a mrna. - million people worldwide and represents one of the leading causes for liver cirrhosis and hepatocellular carcinoma. control over the hbv infection is achieved mainly by vaccination with hepatitis b surface antigen (hbsag). hbsag contains n-linked glycosylation side and is recognized by both mbl-a and mbl-c in a cadependent manner. hbsag-mbl complexes activate complement and may thus affect humoural immunity. to investigate the role of mbl in humoural responses to hbsag, we immununized mice that lack both mbl-a and mbl-c proteins with soluble hbsag. it has been shown that deficiencies in other complement components like c q, c and c result in decreased antibody responses. however, mbl double ko animals mounted dramatically increased humoural responses. after priming, mbl double kos mounted hbsag-specific igm responses, which were threefold higher than wt controls. after boosting the hbsag, total igg was -fold higher in mbl ko than in wt control animals. similar to the response to hbsag, other glycosylated soluble antigens (e.g. invertase) induced better humoural responses in mbl double ko animals, suggesting that mbl plays an important role in a negative feedback regulation of adaptive immunity. reconstitution experiments with rmbl partially rescued the ko phenotype. we propose that the clearance of glycoprotein antigens in mbl ko is handled differently from the wt, resulting in better stimulation of humoural responses. alternatively, glycoprotein-ag-mbl-rich complexes inhibit b-cell responsiveness via putative mbl receptors. the complement system is an important part of the innate immune system. the activation of complement proceeds through three different pathways that converge in the generation of c -activating enzyme complexes. complement activation via the lectin pathway is initiated when recognition molecules, mannan-binding lectin (mbl) or ficolin, bind to carbohydrate structures characteristic for microbial surfaces. in the circulation, mbl and ficolins are found in association with three structurally related mblassociated serine proteases (masp)- , - and - and a small, nonenzymatic component, map . masp- has been shown to elicit complement activation through the sequential proteolytic cleavage of c and c upon binding of mbl/masp- complexes to microbial surfaces. we have recently uncovered a polymorphism in the masp- /map gene in a patient shown to be deficient in the lectin pathway of complement activation. the polymorphism results in a single amino acid substitution in the n-terminal part of the masp- protein. recombinant wildtype masp- and masp- containing the amino acid substitution in question was produced, and the ability to activate complement was studied. the mutation had a profound impact on masp- function, resulting in the lack of complement activation through the lectin pathway. elisa-based experiments showed that the mutation leads to the impairment of complement activation through influencing the binding of masp- to mbl or ficolins. deficiencies in the lectin pathway of complement activation have so far been accounted for only by lack of functional mbl. the mutation described above is the first defect described affecting both activation through mbl and the ficolins. .................................................................................................................................................................................................. th , th and treg cell balance. dcs are present in the gut mucosa and may thus be target for modulation by gut microbes, including ingested probiotics. here, we tested the hypothesis that species of lactic acid bacteria, important members of the gut flora, differentially activate dc. a large panel of human gut-derived lactobacillus and bifidobacterium spp. was screened for dc-polarizing capacity by exposing bone marrow-derived murine dc to lethally irradiated bacteria. cytokines in culture supernatants and dc-surface maturation markers were analysed. substantial differences were found among strains in the capacity to induce interleukin- (il- ) and tumour necrosis factor (tnf)-a, while the differences for il- and il- were less pronounced. bifidobacteria tended to be weak il- and tnf-a inducers, while both strong and weak il- inducers were found among the strains of lactobacillus. remarkably, strains weak in il- induction inhibited il- and tnf-a production induced by an otherwise strong cytokine-inducing strain of lactobacillus casei, while il- production remained unaltered. selected strains were tested for induction of dc maturation markers. those lactobacilli with greatest capacity to induce il- were most effective in upregulating surface mhc class ii and cd . moreover, l. casei-induced upregulation of cd was reduced in the presence of a weak il- inducing l. reuteri. in conclusion, human lactobacillus and bifidobacterium spp. polarize differentially dc maturation. thus, the potential exists for th /th /treg-driving capacities of the gut dc to be modulated according to composition of gut flora including ingested probiotics. the intestinal micro flora is indispensable in developing and maintaining homeostasis of the gut-associated immune system. evidence indicates that lactic acid bacteria (lab), e.g. lactobacilli and bifidobacteria, have beneficial effects on the host. established health effects include increased gut maturation, antagonisms towards pathogens and immune modulation. the objective of this study is to evaluate the immunomodulating properties of a range of lab of human origin. as dendritic cells (dcs) play a pivotal role in the balance between tolerance and immunity to commensal microorganisms, in vitro-generated immature dcs serve as a suitable model for studying the immunomodulating effects of lab. human immature dcs were generated in vitro from monocytes and exposed to lethally uv-irradiated lab. the effect of various species of lab on dcs in direct contact was evaluated. furthermore, the maturation pattern of dcs separated from the bacteria by an epithelial cell layer (caco- cells), which should mimic the intestinal environment, was studied. cytokine secretion (il- , il- and tnf-a) and upregulation of maturation surface markers on dcs (cd and cd ) was measured. different lab induced diverse cytokine responses. some strains were strong il- and tnf-a inducers and others weak. all strains induced il- . different lab also differentially modulated expression of cd and cd on dcs. although some variation in the response to lab of dcs generated from different blood donors was observed, general differences in the effect of the various lab was revealed. experiments with the dc caco- coculture system are ongoing. different species of lab differentially affect dc maturation; this suggets that the gut flora plays a pivotal role in polarization of the immune response. natural killer (nk) cells are cells of the nonspecific immune system lysing altered self-cells. a noncytolytic subset of nk cells may serve a regulatory role by secreting cytokines. bacteria translocating across the gastrointestinal mucosa are presumed to gain access to nk cells, as consumption of certain lactic acid bacteria has been shown to increase in vivo nk cytotoxicity. here, we investigated how human gut flora-derived lactobacilli affect nk cells in vitro, by measuring proliferation and ifn-g production of human nk cells upon bacterial stimulation. cd -cd þ nk cells were isolated from buffy coats by negative isolation using non-nk lineage-specific antibodies and magnetic beads. nk cells were incubated with mg/ml uv-inactivated bacteria or mg/ml phytohemagglutinin (pha) for days. proliferation was assessed by incorporation of radioactive thymidine into nk-cell dna. the ifn-g concentration was measured by elisa. incubation of nk cells with a lactobacillus acidophilus strain increased the proliferation of the nk cells and induced ifn-g production, both to levels comparable to pha stimulation. the proliferative response was further enhanced with autologous monocytes present, probably because cytokines, secreted by monocytes having engulfed bacteria, stimulated the nk cells. in contrast, a lactobacillus paracasei strain caused the nk cells to proliferate only in the presence of monocytes. these results demonstrate that various strains of lactobacilli have the capacity to activate nk cells in vitro, in a monocyte-dependent or -independent way. hence, the encounter of nk cells with lactic acid bacteria will affect nk-cell activation. such activation of nk cells may potentially skew an on-going or subsequent immune response towards a th response. lactobacilli are nonpathogenic gram-positive inhabitants of the normal human intestine known for their healthpromoting effects. in our earlier work, it is shown that human monoclonal antibody isolated from sera of a patient with waldenstrom macroglobulinaemia possess innate antibody characteristics and binds to lactic acid bacteria. according to the immune network model, immunization with this bacteria could induce the perturbations in immune system that might result in production of anti-lactobacillus antibodies, human monoclonal antibody like (ab ) and anti-idiotypic antibody (ab ). in this study, balb/c mice were immunized with two doses of bacteria lactobacillus acidophilus in complete and incomplete freund's adjuvant and phosphate-buffered saline (pbs), respectively. seven days after the last immunization, sera from immunized mice were collected and the presence of lactobacillus-specific ab and ab were determined by elisas. in the sera of immunized mice, antibodies specific to bacteria lactobacillus acidophilus were shown. the concentration of lactobacillus-specific antibodies was higher in the sera of hyperimmunized mice (mice immunized with mg of igm dj) than in sera of mice immunized with times lower doses of immunogen ( . mg per doses). moreover, ab and ab antibodies were detected in the sera of lactobacillus-hyperimmunized mice. in this study, we have shown the idiotypic network interactions in mice immunized with bacteria lactobacillus acidophilus. the normal gastrointestinal flora is crucial for the maturation of the acquired immunity via effects on antigenpresenting cells (apcs). here, we have investigated how two types of apcs, monocytes and dendritic cells (dcs), react to different bacterial strains typical of the commensal intestinal flora. purified monocytes and monocyte-derived dcs were stimulated with uv-inactivated gram-positive (lactobacillus plantarum and bifidobacterium adolescentis) and gram-negative (escherichia coli and veillonella parvula) bacterial strains. monocytes produced higher levels of il- p and tnf, as detected by elisa, in response to l. plantarum than to e. coli and v. parvula. in contrast, dcs secreted high amounts of il- p , tnf, il- and il- in response to e. coli and v. parvula but were practically unresponsive to l. plantarum and b. adolescentis. the lack of response to the gram-positive strains correlated with a lower surface expression of toll-like reseptor (tlr ) on dcs compared to monocytes. the surface expression of tlr on dcs was undetectable when analysed by flow cytometry, but blocking this receptor decreased the tnf production in response to v. parvula, indicating that low tlr expression on dcs is sufficient to mount an inflammatory response to gram-negative bacteria. ifn-g increased the expression of tlr on dcs and also potentiated the cytokine response to gram-negative bacteria. our results indicate that, when monocytes differentiate into dcs, their ability to respond to different commensal bacteria dramatically changes, thereby becoming unresponsive to probiotic gram-positive bacteria. these results may have important implications for the capacity of different groups of commensal bacteria to regulate mucosal and systemic immunity. probiotic bacteria, e.g. lactobacillus spp., may improve diseases such as chronic inflammatory bowel disease. we examined cytokine production and phenotypic change after in vitro stimulation of t cells from healthy volunteers using different probiotic strains. methods: t cells were cultured from colonic biopsies from eight healthy volunteers (agnholt and kaltoft, exp clin immunogenet ; : - ) , and dendritic cells were matured from their peripheral blood mononuclear cells. t-cell cultures were stimulated with autologous bacterial sonicate or strains of lactobacillus spp., with and without the addition of dendritic cells. cytokine levels (tnf-a, ifn-g, il- and gm-csf) and phenotype (cd , cd , cd and cd ) were measured on day . results: lactobacillus spp. induced higher productions of tnf-a and il- than did autologous bacteria. in presence of dendritic cells, the production of all cytokines increased. however, the increases of ifn-g and tnf-a were more pronounced in wells with autologous bacteria than in wells with lactobacillus spp. the addition of dendritic cells upregulated cd expression without simultaneous upregulation of cd . the upregulation was pronounced after stimulation with lactobacillus rhamnosus gg compared with autologous bacteria and other lactobacilli. discussion: in presence of dendritic cells, autologous bacteria induced inflammatory cytokines, while probiotics mainly induced regulatory cytokines. lactobacillus rhamnosus gg induced a regulatory phenotype (cd þ ), in part mediated by dendritic cells. future studies will address whether this shift to a cd þ phenotype represents a differentiation into competent regulatory t cells. in a clinical context, such cells might be used for treatment of inflammatory diseases. protein microarrays will play a key role in the postgenomic era and offer a unique possibility to perform highthroughput global proteome analysis. a chip can be printed with thousands of protein probes (e.g. antibodies), the biological sample added (e.g. a proteome) and any binding detected. we aim to develop protein microarrays based on human recombinant scfv antibody fragments for global proteome analysis. the concept of comparing proteomic maps of healthy versus diseased samples will allow diseasespecific proteins to be detected. in fact, antibody microarrays will allow us to perform comparative proteome analysis on any sample format in a species-independent manner, as long as a proteome can be isolated. however, the complexity of proteomes, containing several thousands of different proteins, is a problem. here, we have designed antibody microarrays targeting the water-soluble fraction of a proteome. to this end, an anticytokine antibody array was developed and human dendritic cells (aeactivation) was used as model system. the results showed that our antibody microarrays could be used to examine the cytokine profile in complex samples. furthermore, we have taken the first steps towards comparing our results with those of other technologies on both the protein and gene level. due to the complexity of the model proteome, we also examined the possibility to prefractionate the proteome in a simple one-step procedure (based on size) prior to the labelling step. in more detail, the sample proteome was fractionated into two fractions using membrane devices with different molecular weight cut-offs. the results showed that the fractionation considerably enhanced the assay sensitivity allowing cytokines in the pg/ml range to be readily detectable. the immunomodulatory effect of heat shock protein : immunization with a dna construct based on the malarial antigen fused with a fragment of hsp primes for a th- type of response finding an appropriate adjuvant for human vaccination is crucial. heat shock proteins (hsps) act as adjuvants when coadministered with peptide antigens or given as fusion proteins. however, there is a potential risk of autoimmunity when using the complete molecules, because hsps are evolutionary conserved. to overcome this, we first evaluated the adjuvant effect against two different antigens of a less-conserved fraction of plasmodium falciparum hsp (pf c) and compared it to the whole hsp molecule from trypanosoma cruzi (tchsp ). we found that pf c exhibited similar adjuvant properties as the whole molecule. we later evaluated the adjuvant potential of pf c against the malarial antigen eb in a chimeric dna construct. no appreciable levels of eb -specific abstracts .................................................................................................................................................................................................. antibodies were detected in mice immunized only with the dna constructs. however, dna primed the immune system, because subsequent challenge with the corresponding recombinant fusion proteins elicited a strong th- antibody response. in contrast, no priming effect was observed for ex vivo ifn-g production but stimulation with the hsp-chimeric fusion protein induced a stronger secretion of ifn-g in vitro than other proteins used. these results indicate that the use of hsps is promising in the design of new vaccines. high-throughput proteomics on antibody-based microarrays: the importance of probe and surface design in analogy to dna microarrays, protein microarrays offer a new distinct possibility to perform sensitive highthroughput global proteome analysis. however, the development of the protein microarray technology will place high demands upon the design of both probes and solid supports. the analysis of thousands of heterogeneous proteins on a single microarray requires the use of uniform probes, such as antibodies, directly designed for protein microarray applications. we have recently generated a human recombinant single-chain fv antibody library, genetically constructed around one framework, the ncoder-library, containing  clones. single framework antibody fragments (sinfabs) selected from this library were successfully applied as probes for microarrays providing sensitive detection in the attomol (mass spectrometry) and the zeptomole range (fluorescence). however, the choice of framework is critical. we have shown that the selected ncoder framework displayed excellent functional on-chip stability and arrayed dehydrated probes retained their activity for several months. furthermore, we have addressed the issues of biocompatibility of the solid support and immobilization strategies for our microarray setup. an in-house-designed substrate, macroporous silicon coated with nitrocellulose (map -nc ), displayed properties equal to, or better than, those of five commercially available supports used as reference surfaces. we have also evaluated different coupling strategies, such as adsorption, covalent coupling, diffusion and affinity coupling. using a novel affinity tag, the double-(his) -tag, we increased the binding efficiency of sinfab-molecules to ni þ -coated solid supports, thereby allowing nonpurified probes to be directly applied. the mannan-binding lectin (mbl) pathway is part of the innate immune system providing a first line of defence against infections. mbl and ficolins circulate in complexes with mbl-associated serine proteases (masp- , - and - ). after recognition of a microorganism by mbl, activation of the complement system occurs. masp- and masp- share five domains (making up the so-called a-chain), whereas they have unique protease domains (b-chains). before the identification of masp- , an assay for masp was presented, based on antibodies against the a-chain of masp- . with the new knowledge of the three masps, and the sharing of domains by masp- and masp- , assays specific for the protease domains have to be constructed, if one wishes to measure the proteins individually. we present an assay for quantifying total masp- in plasma and serum samples. the assay is a sandwich-type assay using as catching antibody a monoclonal antibody against the common a-chain of masp- / and a developing secondary antibody against the c-terminal part of the protease domain of masp- . we have used this assay for estimating the normal concentration of the protein as well as the concentration in patients and also for characterizing by gel permeation chromatography the masp- protein in serum. inducible costimulator ligand (icosl) is a costimulatory molecule related to b . (cd ) and b . (cd ). b cells, monocytes, dendritic cells and endothelial cells express icosl. inducible costimulator (icos) interacts with icosl, and this interaction leads to signals involved in isotype switching and the development of immunological memory. hitherto, no polymorphisms of this gene have been described. the aim of this study was to reveal variation of the icosl gene in normal individuals. all eight exons, except exon , were sequenced with flanking introns in healthy blood donors. eight single nucleotide polymorphisms (snps) and two length polymorphisms were found. one of the snps was found in the coding regions of the gene. the base involved was located in exon and caused a conservative amino acid change from valine (gtt) to isoleucine (att). three individuals were heterozygous g/a for the exon polymorphism, while the remaining seven individuals were homozygous for the wildtype g/g. exon encodes the immunoglobulin variable (igv)-like domain of the molecule which is situated outside the cell. this means that the amino acid could be critical for the stability of the molecule or could constitute part of the binding site for icos. the results form the basis for further experiments to find possible associations of the alleles to diseases caused by immune dysregulation. especially, the exon variant is interesting and could play a role for the development of immunological diseases. besides, it would be interesting to see whether both exon alleles are expressed or only the wildtype allele is functional. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. myxovirus a (mxa) is a resistance gtpbinding protein that is specifically induced by treatment with type ifns. for example, ifn-b-induced mxa in blood leucocytes has been used as a biomarker in ifn-btreated patients with multiple sclerosis. however, the degree of specificity of mxa in this regard is unclear, and measurements of mxa protein and/or mrna are not yet suitable for routine clinical use. in an attempt to find new and better reporter genes (and, hopefully, genes and gene products with proven specificity for ifn-a and -b), microarray screenings with u a genechips (affymetrix) were carried using human blood leucocytes and the human lung carcinoma cell line a . we studied the simultaneous expression of , transcripts before and after exposure to human recombinant ifn-a and ifn-b and other antiviral and immunomodulatory cytokines. the results will be presented at the conference. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large-scale screening in specialized laboratories. the read-out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn-a or -b, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. in our laboratory, we have developed a database system, which we believe is of immediate interest to the general scientific community. the database represents a computerbased replacement for the laboratory notebooks used in the majority of research laboratories worldwide. in addition, the database provides an effective tool for organizing and managing laboratory information at all levels, spanning from managing and revising standard operating procedures and producing documentation of research activities to keeping track of data and conclusions. using the commercially available database toolkit software filemaker pro, we have developed a relational database solution for management of laboratory information. the system consists of a hierarchy of five interrelated databases, each pertaining to a separate type of information, namely, overall project information, information relating to individual experiment setups, documentation of daily research activity, generated data and descriptions of standard operating procedures. like other databases, each individual database consists of a number of records, each comprised of a set of fields in which information is entered. in each record, a certain field is reserved to specify the relation of the record to a record in another database at a higher level. thus, the database is essentially five databases linked by a hierarchy of one-to-many relations, organizing information in a folder-like structure. importantly, the database system allows multiple users to access and edit records simultaneously, and the data entered in one database immediately becomes accessible through the other databases. the limitations of laboratory notebooks are apparent when looking for information, which is dispersed throughout one or more notebooks, or possibly on loose sheets of paper or printouts 'somewhere'. the often complicated process of gathering laboratory data or results when writing grant applications or research papers is made considerably easier with the database system. thus, the database solution presented should be broadly attractive to researchers, irrespective of their scientific discipline. an effective sars vaccine is likely to include components that can induce specific cytotoxic t-cell (ctl) responses. the specificities of such responses are governed by hlarestricted presentation of sars-derived peptide epitopes. exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear sequences directly from genomic/proteomic sequence information. the latter was recently established when a causative coronavirus (sars cov) was isolated and full-length sequenced. here, we have combined advanced bioinformatics and high-throughput immunology to perform an hla supertype, genome-wide scan for sars-specific cytotoxic t cell epitopes. the scan includes all nine human hla supertypes in total covering > % of all major human populations. for each hla supertype, we have selected the top candidates for test in biochemical-binding assays. at this time (approximately months after the genome was established), we have tested the majority of the hla supertypes and identified almost potential vaccine candidates. these should be further validated in sars survivors and used for vaccine formulation. we suggest that immunobioinformatics may become a fast and valuable tool in rational vaccine design. rationale: major histocompatibility complex class i (mhc i) molecules monitor the protein content of the cell by binding small derived peptides and presenting them to cytotoxic cd þ t cells. the goal of the human mhc project is to predict the binding strength of any given peptide/mhc complex. this prediction allows the design of peptide-based vaccines. the prediction requires representative binding data from mhc alleles from all the nine hla supertypes. here, we describe the genetic construction, protein production and purification as well as the establishment-binding assays for two recombinant mhc supertype alleles, hla-b* and hla-b* . methods: using the quikchange multisite directed mutagenesis kit (stratagene), codon-optimized genes encoding hla-b* and hla-b* are created. the two mhc i molecules are fermented and purified by ion exchange chromatography, hydrophobic interaction chromatography and size exclusion chromatography. the binding (kd) of natural t-cell epitopes, as well as predicted peptide ligands, is described by radioactive immunoassays (rias) and enzyme-linked immunosorbent assays (elisas). the mhc molecules are biotinylated during expression. results: the expression of mhc i resulted in multiple disulfide bond isomers, which are separated by hydrophobic interaction chromatography and used in subsequent binding studies resulting in the determination of kd for various peptide ligands ranging from strong binders we have previously demonstrated that bioinformatics tools such as artificial neural networks (anns) are capable of performing pathogen-, genome-and hlawide predictions of peptide-hla interactions. these tools may therefore enable a fast and rational approach to epitope identification and thereby assist in the development of vaccines and immunotherapy. a crucial step in the generation of such bioinformatics tools is the selection of data representing the event in question (in casu peptide-hla interaction). this is particularly important when it is difficult and expensive to obtain data. herein, we demonstrate the importance in selecting information-rich data and we develop a computational method, query-bycommittee, which can perform a global identification of such information-rich data in an unbiased and automated manner. furthermore, we demonstrate how this method can be applied to an efficient iterative development strategy for these bioinformatics tools. methods: a large panel of binding affinities of peptides binding to hla a* was measured by a radioimmunoassay (ria). this data was used to develop multiple first generation anns, which formed a virtual committee. this committee was used to screen (or 'queried') for peptides, where the anns agreed ('low-qbc'), or disagreed ('high-qbc'), on their hla-binding potential. seventeen low-qbc peptides and high-qbc peptides were synthesized and tested. the high-or low-qbc data were added to the original data, and new high-or low-qbc second generation anns were developed, respectively. this procedure was repeated times. the high-qbc-enriched ann performed significantly better than the low-qbc-enriched ann in of the tests. conclusion: these results demonstrate that high-qbcenriched networks perform better than low-qbc-enriched networks in selecting informative data for developing peptide-mhc-binding predictors. this improvement in selecting data is not due to differences in network training performance but due to the difference in information content in the high-qbc experiment and in the low-qbc experiment. finally, it should be noted that this strategy could be used in many contexts where generation of data is difficult and costly. interleukin- (il- ), a pro-inflammatory cytokine that is produced by both lymphoid and nonlymphoid cells, has a critical role in modulation of innate and adaptive immunity. its primary function in stimulation of ifn-g production and stimulation of nk-cell-cytotoxic activities makes this cytokine a candidate for cancer immunotherapy. in oral cavity, this cytokine is produced by oral epithelia and carcinoma cells and is related to tumour regression in nude mice bearing salivary adenocarcinoma. however, direct effects of this cytokine on oral cancer cells have not been elucidated. in this project, we investigated il- effect on an oral carcinoma (kb) cell line. with rt-pcr technique, kb-cell line was found to express il- receptors (il- ra and il- rb), indicating that this oral carcinoma line is a target for il- study. we showed that recombinant human il- inhibited kb-cell proliferation by % at concentration of ng/ml (p < . ), whereas ldh release by these cells in treatment group and control groups was comparable, indicating that il- suppression of cell proliferation was not mediated by the induction of cell death. to further address this hypothesis, we found that il- treatment did not induce apoptotic cell death, as studied by dna laddering and tunel assays. in addition, expression pattern of cell death-controlling genes (bcl- and bax) was not altered by this cytokine. findings in these studies indicated that suppression of kb-cell proliferation may be attributed to control of cell cycle, growth arrest or induction of cell differentiation. the data presented in this project could provide an insight of how cancer cell directly responds to il- , as this cytokine is an important regulator of anticancer mechanisms. aloe emodin (ae) is a naturally occurring compound with wide spectrum of biological properties, including antimicrobial, vasorelaxant, immunosuppressive and anticancer actions. this anthraquinone induces apoptosis in several tumour cell lines with special affinity to tumours of neuroectodermal origin. high amounts of nitric oxide (no) released by activated macrophages induce tumour cell death. therefore, we explored the capacity of ae to modulate no-mediated antitumour response in vitro. interestingly, while ae markedly suppressed no release from macrophages alone, it significantly potentiated no production in cocultures of macrophages and c cells, after h of cultivation. accordingly, the viability of c cells cocultivated with macrophages was reduced in the presence of ae. moreover, the observed ae-imposed potentiation of no production in macrophages was closely related to macrophage culture cell density. according to these data, we proposed that no modulator capacity of ae strongly depended on intercellular contact, indicating that macrophage antitumour response was not compromised but even potentiated by ae. immunotherapy represents an attractive fourth-modality therapeutic approach, especially in the light of the shortcomings of conventional surgery, radiation and chemotherapies in the management of metastatic cancer. to this end, a large number of peptide antigens derived from taa have been applied in immunotherapeutic trials for the treatment of various malignancies, e.g. cancers of the breast, prostate and kidney, in addition to haematological cancers. in some cases the response rates have been impressive and no adverse autoimmunity have been observed. a major strategic difficulty associated with these trials relates to the choice of best-suited peptide antigens. the vast majority of the antigens described thus far is not vital for survival and growth of the tumour cells, and immunoselection of antigen-loss variants may therefore prove to be an additional obstacle for the clinical applicability of most of the known peptide epitopes. in this respect, the development of acquired antigen loss during immunotherapy has been demonstrated in several cases. obviously, the development of loss-variant tumour cells implies that these cells acquire a pronounced growth advantage and are left unaffected by further treatment. ideally, target antigens should be derived from proteins required for survival and growth of tumour cells, as antigens with these characteristics would not be inflicted by the development of loss-variant tumour cells. in this respect, several inhibitors of apoptosis proteins (iaps) are universally expressed among tumours and play an important role in tumour cell escape from apoptosis. we have characterized spontaneous t-cell reactivity against iapderived peptides in cancer patients. from the iap survivin, we have characterized peptides restricted to the class i molecules hla-a , a , a , a , b and b . furthermore, we have demonstrated that survivin-specific t cells infiltrate metastatic lesions and that isolated survivinspecific ctls are capable of killing hla-matched tumour cells. survivin-derived peptides are now in clinical trial, and continued work in our lab has demonstrated that other iaps are targets for spontaneous t-cell reactivity in cancer patients. we previously reported that in mice with large progressing t-cell lymphoma tumours, dysfunctions in the antitumour ctl activity occur, associated with an accumulation of splenic arginase-producing myeloid suppressor cells (mscs). in this study, we first demonstrate that both the presence and the activation state of these msc depends on tumour evolution. while in tumour regressors hardly any arginase-producing msc can be found, both the amount and the arginase activity of this population expands from early over late progressors. this gradual induction of mscs is paralleled by an increasing suppression of ctl activity and th , but not th , cytokine production. upon analysing the molecular repertoire of msc in vitro, we found, besides arginase , a well-established marker for alternatively activated myeloid cells or m , a strong upregulation of fizz and ym, two additional recently identified markers for m . further evaluation of molecular markers by microarray analysis in msc yielded genes involved in wound healing (e.g. coagulation factor xiiia), anti-inflammation (e.g. selenoprotein p), immunomodulation (e.g. pd-l ) and fat and sugar metabolism (e.g. leptin receptor). of note, many of these genes are regulated by type cytokines (il- , il- and il- ) and are therefore rather m associated. overall, our data provide new markers for msc in cancer and further establish their m activation state. study. only sp-a showed a significant expression in normal mucosa which was downregulated in crc. as the absolute signal level was below the noise threshold, these results have to be interpreted with caution and require confirmation by direct measurenment of the proteins. our results suggest that there is no major role for the human collectins in colorectal cancer. tetramerization is visualized by sds-page. conclusion: an effective method for the production of highly pure mhc i molecules has been applied to hla-b* and hla-b* , and ria and elisa binding assays for those alleles have been established background: proliferation, differentiation and apoptosis are essential processes in the normal functions of the mammary epithelium. the hypothesis examined in this study is that the transcription factor bcl- is critically important not only for regulating b-cell growth and development but also for mammary epithelial apoptosis. methodology: twenty breast cancer cases and healthy controls were used to investigate whether bcl- protein in involved in breast cancer (grade iii). full length bcl- cdna was retrovirally transduced into eph- cell line. we then used flow cytometry of brdurd-stained cells to investigate the cell-cycle duration of the control and transduced cell lines. tunel was used as a marker of apoptosis to find out differences in the frequencies of apoptotic cells in the control and transduced cell lines. finally, immunohistochemistry staining was performed to detect bcl- in breast cancer (iii). results: restoration of bcl- into eph- cells not only inhibits apoptosis but also prolongs the cell cycle and results in increased cell size and protein content. the results also indicated that the cell-cycle time of bcl- -transduced eph- cells is prolonged by about h, presumably as a result of the action of bcl- at the bcl- at the g /s transition. we found differences in the frequencies of viable and apoptotic cells in cultures of the parent eph- cells, control-transduced eph- cells and bcl- -transduced eph- cells. consistently, we demonstrated that bcl- is expressed in % of high grade of breast carcinoma, which is considered as the most aggressive of tumours. conclusion: together, these results suggest that bcl- is likely to be involved in mammary gland development and carcinogenesis. inflammatory cytokines have a critical role in modulation of both innate and adaptive immunity in response to foreign antigen. they also play an important role in anticancer immunity. for example, they can promote cell-mediated immunity against cancer cells. with their immunostimulatory effects, these cytokines are being tested for cancer treatment in the form of dna vaccine or adjuvant or therapeutic cytokines. direct effect of these cytokines on cancer cell, however, is still unclear. in this project, we investigated whether il- ( and il- can modulate cancer cell proliferation. we employed a simple nonradioactive proliferation (mtt) assay and detection of lactate dehydrogenase (ldh) to test the effect of these recombinant human cytokines on various cancer cell lines, including breast cancer cell line (mcf- ), oral carcinoma cell line (kb), colon cancer cell line (caco- ) and choriocarcinoma cell line (jar). cytokines used in this study had both inhibitory and stimulatory effect on cell proliferation. findings in this project could provide an insight of cancer cell response to these cytokines and this could lead to a consideration on using cytokine as immunotherapy for cancer treatment.capacity of ae to modulate nitric oxide production depended on intercellular contact donor t cells are involved in the antitumour effects observed after bmt. thus, patients receiving t-celldepleted bmt have a higher risk of leukaemia relapse compared to patients receiving nonmanipulated bmt, and patients experiencing graft-versus-host disease (gvhd) have a lower risk of disease relapse than patients who do not experience gvhd. although the importance of donor t cells for the curative action of bmt has been established, the exact mechanisms and molecules involved in this graft-versus-tumour effect remain largely unknown. in a recently initiated project, we have conducted a longitudinal study of t-cell clonotypes in patients who received peripheral blood stem cell grafts after nonmyeloablative conditioning. peripheral blood samples were obtained sequentially after transplant, and the mononuclear cells (mncs) were isolated and cryopreserved. cd þ t cells were isolated from the mncs by use of immunomagnetic beads or facs and analysed for the presence of clonally expanded cells by t-cell receptor clonotype mapping based on rt-pcr and denaturing gradient gel electrophoresis (dgge). using this gel-based methodology, clonally expanded t cells were monitored after transplant and compared to the clinical data of the patients. the preliminary results demonstrates the presence of clonally expanded cd þ t cells at all time points analysed. furthermore, a number of clonotypes persisted for more than months, and other clonotypes emerged during this period. the appearance of newly emerged clonotypes which coincided with clinical gvhd could indicate a role for these t cells in the pathogenesis of gvhd. background: deficiency of the mannan-binding lectin (mbl) pathway of innate immunity leads to increased susceptibility to infections. in patients with colorectal cancer, postoperative infection is associated with poor prognosis. the aim of the present study was to evaluate ( ) the relation between the mbl pathway and postoperative infectious complications and survival of patients resected for colorectal cancer and ( ) the role of mbl as acute phase reactant compared to crp. methods: preoperative mbl concentration, mbl/mblassociated serine protease (masp) activity and crp were determined in serum from patients and healthy controls. the patients were observed for years. postoperative infections, recurrence and survival were recorded. results: the mbl pathway components were increased in the patients (p < . ) compared to healthy controls. low mbl levels were predictive of pneumonia (p ¼ . ), and pneumonia (n ¼ ) was associated with poor survival (p ¼ . , hr ¼ . , % ci . - . ). mbl and mbl/ masp activity could not predict postoperative overall infections. mbl showed no correlation (spearman's r ¼ . , % ci À . - . ) with crp. conclusions: low preoperative mbl levels are predictive of pneumonia, which is associated with poorer survival. mbl concentration and mbl/masp activity was not predictive of other postoperative infections or long-term prognosis. mbl apparently is not a surrogate measure of crp. department of surgery, university hospital of erlangen, erlangen, germany. e-mail: michael.siassi@rzmail.uni-erlangen.de introduction: the human collectins, mannan-binding lectin (mbl), surfactant protein-a (sp-a) and surfactantprotein-d (sp-d) play a central role in the innate immune system. immunological responses to malignant transformation of epithelial cells gained increasing interest recently. a former study could demonstrate binding of mbl to certain colorectal carcinoma (crc) cell lines in vitro. we therefore examined the expression of human collectins in normal colon mucosa and in colorectal carcinomas. materials and methods: colon samples from crc patients and normal mucosa samples were collected immediately after surgery. the tissue was microdissected and rna isolated (qiagen, rneasy-kit). gene expression profiles were analysed using gene-chips (affymetrix, hg-u ). we analysed the data for the expression of mbl, its associated serine proteases mannan-binding lectinassociated serine protease / (masp / ), sp-a and sp-d. the signal intensity of the genes of interest was compared using the mann-whitney u-test. results: the expression of human collectins in normal human colon mucosa was generally low. only the expression of sp-a and masp- reached the noise threshold of signals. these genes were significantly downregulated in crc specimens. the expression of the other proteins showed no difference in normal mucosa and crc. conclusion: as demonstrated before, the expression of human collectins in normal colon was low in this being the first lymph node to receive drainage from the tumour area, the sentinel node offers a unique possibility to obtain tumour-reactive lymphocytes. we investigated antitumour immune responses in sentinel nodes from patients with bladder cancer, by assaying tumour-specific proliferation and tcr vb repertoires. during tumour surgery, sentinel lymph nodes were identified by peritumoural injection of blue dye. fresh specimens of tumour, sentinel and nonsentinel lymph nodes were obtained, and single-cell suspensions were prepared. cells were assayed for reactivity against autologous tumour extract in [ h]-thymidine incorporation assays and characterized by flow cytometry. parallel analyses of the expression of vb gene families were performed with padlock probes, linear oligonucleotides which upon target recognition can be converted to circular molecules by a ligase. probes were reacted with cdna prepared from magnetically separated cd þ cells, and the tcr repertoire was determined by hybridizing the products to oligonucleotide microarrays. dose-dependent proliferation in response to tumour extract could be detected in sentinel lymph nodes. common clonal expansions were detected among tumourinfiltrating lymphocytes and in sentinel lymph nodes. nonsentinel lymph nodes displayed a divergent tcr vb repertoire. these results indicate an ongoing immune response against tumour antigens in sentinel nodes, draining urinary bladder cancer. identification of sentinel lymph nodes makes it possible to obtain tumour-reactive lymphocytes for use in adoptive immunotherapy. key: cord- - yzkqykg authors: müller-werdan, u.; buerke, m.; christoph, a.; flieger, r.r.; loppnow, h.; prondzinsky, r.; reith, s.; schmidt, h.; werdan, k. title: schock date: journal: klinische kardiologie doi: . / - - - _ sha: doc_id: cord_uid: yzkqykg nan pathophysiologie des schocks - therapie der metabolischen azidose - . . volumentherapie - . . inotrope und vasoaktive substanzen - . . optimierung des intravasalvolumens - . . neue therapieansätze zur schockbehandlung - . . gerinnungsaktive substanzen - . . hypothermie/cooling - . . pharmakotherapie des kritisch kranken - . multiorgandysfunktionssyndrom (mods) - . . hypothesen zur entstehung - . . schweregradeinteilung durch score-systeme - . . organdysfunktion der lunge - . . organdysfunktion der niere (akutes nierenversagen) - . . organdysfunktion des gehirns - . . organdysfunktion des peripheren und autonomen nervensystems sowie der skelettmuskulatur - . . organdysfunktion des herzens und des kreislaufs - . . organdysfunktion des gastrointestinaltrakts - . . dysfunktion des gerinnungssystems - . . dysfunktion des stoffwechsels und künstliche ernährung - . . dysfunktion des endokrinium - . . dysfunktion des immunsystems - . spezifi sche schockformen - . . kardiogener schock - . . septischer schock - . . hypovolämischer schock - . . traumatischer schock - . . anaphylaktischer schock - die reduktion der effektiven gewebeperfusion kann dabei hervorgerufen werden durch eine abnahme der herzleistung, durch störungen der makro-und mikrozirkulation mit verminderter perfusion, durch eine kritische abnahme des blutvolumens, eine beeinträchtigung der o -aufnahme in der lunge und der o -abgabe im gewebe. zur beeinträchtigung essenzieller zellfunktionen kommt es im gefolge einer exogenen intoxikation, einer endogenen Überschwemmung mit mediatoren ( abschn. . . ) oder endokrin/metabolischer krisen. klar zu trennen vom schockbegriff sind die synkope und der kollaps. eine passagere kritische herabsetzung der gehirndurchblutung mit gleichzeitiger bewusstlosigkeit wird als synkope bezeichnet (task force on syncope, european society of cardiology ). nicht immer ist damit eine allgemeine kreislaufi nsuffi zienz vergesellschaftet. bei einem kollaps über-wiegen vagale reaktionen, das ereignis ist von kurzer dauer, organschäden infolge o -mangels treten nicht auf. von den zahlreichen schockklassifi kationsversuchen (adams et al. ; kumar u. parrillo ) erscheint die schockeinteilung nach hämodynamischen gesichtspunkten für den kliniker am hilfreichsten (. tabellen . , . und . abb. . ): hypovolämischer schock infolge eines im verhältnis zur gefäßkapazität verminderten zirkulierenden blutvolumens, charakterisiert durch erniedrigte diastolische füllungsdrücke und -volumina des herzens; kardiogener schock infolge eines pumpversagens, hervorgerufen durch eine eingeschränkte myokardkontraktilität, einen verlust an funktionsfähiger myokardmasse oder eine intrinsischstrukturelle bzw. -mechanische behinderung der herzfunktion, charakterisiert durch erhöhte diastolische füllungsdrücke und -volumina des herzens; extrakardial-obstruktiver schock infolge einer flussobstruktion im herz-kreislauf-system, charakterisiert entweder durch eine behinderung der diastolischen füllung oder eine exzessive nachlasterhöhung; verteilungsschock infolge eines verlustes der vasomotorenkontrolle mit dilatation von arteriolen und venolen, charakterisiertnach adäquater volumensubstitution -durch einen erhöhten herzindex und einen erniedrigten systemischen gefäßwiderstand. f f f f abb. . . zusammenspiel von schockursachen bei verschiedenen schockformen. im falle des kardiogenen, hypovolämischen und obstruktiven schocks resultiert die hypotonie im wesentlichen aus der abnahme des herzindex, mit konsekutivem anstieg des systemischen gefäßwiderstands. im falle des distributiven -insbesondere des septischen -schocks ist die hypotonie v. a. auf die erniedrigung des systemischen gefäßwiderstands zurückzuführen mit sekundärem anstieg des . herzindex. bei zahlreichen schockformen wird das hämodynamische profi l durch komponenten der hypovolämie, der myokarddepression (ischämisch und infolge anderer ursachen) und der gefäßdysfunktion (mit einfl uss auf die nachlast) mitbeeinfl usst. bei einem volumenverlust von - % (stadium ii) beginnen die kompensationsmechanismen zu versagen, es treten eine milde bis mäßige hypotonie, eine abnahme des herzindex und eine orthostase auf. der systemische gefäßwiderstand nimmt beträchtlich zu, und das serumlaktat kann ansteigen. traumapatienten, die - % ihres blutvolumens verloren haben (stadium iii), weisen eine ausgeprägte tachykardie, hypotension und bewusstseinsstörungen auf. ein hypovolämischer schock manifestiert sich bei einem verlust von über % (stadium iv) des zirkulierenden volumens, es resultiert ein abfall des herzindex und der gewebeperfusion auf weniger als die hälfte; die auftretende laktatazidose kündigt eine ungünstige prognose mit in der regel irreversiblem hämorrhagischem schock an. besteht ein blutverlust von % oder mehr über einen zeitraum von h oder sogar länger, so muss bereits mit der erfolglosigkeit der dann eingeleiteten maßnahmen gerechnet werden. prognostisch ungünstige faktoren beim hypovolämischen schock sind die geschwindigkeit des auftretens des volumenverlustes (je rascher, desto ungünstiger) und eine vorbestehende einschränkung der herzfunktionsreserve (z. b. bei zustand nach herzinfarkt). povolämischen schock die eingeleitete therapie trotz adäquater volumensubstitution nicht mehr erfolgreich ist. blutverluste, plasmaverluste und exogene flüssigkeits-/wasserverluste zählen zu den häufi gsten ursachen dessen, was sich in komplizierter verkettung der sekundären reaktionen und regulationen klinisch-symptomatologisch als »hypovolämischer schock« manifestiert. der kardiogene schock ist die häufi gste todesursache von infarktpatienten in der krankenhausphase (hollenberg ; prondzinsky et al. ) . klinisch fi ndet sich ein zentralisierter kreislaufschock mit low-output-syndrom (hypotonie, oligurie, blasse, kühle haut) und den symptomen der akuten links-und rechtsherzinsuffi zienz mit . herzton, halsvenenund lungenstauung bis hin zum lungenödem. hämodynamisch (. tabelle . ) imponieren die zunahme der vorlast (zunahme von ventrikelvolumina, linksventrikulärem füllungsdruck, pulmonalkapillardruck und zentralem venendruck) und eine abnahme von herzindex, schlagvolumenindex und schlagarbeitsindex, verbunden mit einem anstieg des systemischen gefäßwiderstandes. als kriterien des infarktbedingten kardiogenen schocks (hochman et al. ; prondzinsky et al. ) myokardfunktionsverlust. die häufi gste ursache eines kardiogenen schocks (. tabelle . ) ist ein mindestens %iger myokardfunktionsverlust im rahmen einer khk: beim akuten, großen myokardinfarkt -häufi g bei proximalem verschluss des r. interventricularis anterior (riva) der linken koronararterie oder der lad (»left anterior descendens«)aber auch bei rezidivinfarkten und in der stunned-myocardium-phase. akute mitralinsuffi zienz. eine weitere ursache eines kardiogenen schocks ist die akute mitralinsuffi zienz infolge einer sehnenfadenruptur oder einer papillarmuskeldysfunktion/ruptur bei myokardischämie, akutem herzinfarkt (häufi g infolge eines lad-verschlusses), endokarditis, stumpfem thoraxtrauma, mitralklappenprolaps oder klappenprothesendysfunktion. die ischämische papillarmuskelruptur tritt häufi g - tage nach akutem herzinfarkt auf; ein neu aufgetretenes apikales holosystolikum kann der ruptur vorausgehen. akute aorteninsuffi zienz. als schockursache ist die akute aorteninsuffi zienz meistens auf eine fl oride endokarditis zurückzuführen, weiterhin auf eine prothesendysfunktion oder eine aortendissektion. > tabelle . . ursachen des infarktbedingten kardiogenen schocks; daten von patienten des shock trial und shock registry a (hochman et al. ; mod. nach prondzinsky et al. ) . häufi gkeit (%) ventrikelruptur. die infarktbedingte ventrikelseptumruptur tritt ebenfalls wenige tage nach dem infarkt, häufi g bei lad-verschluss, auf. bei einem therapiefraktären hinterwandinfarkt ist auch an das vorliegen eines begleitenden (selten eines isolierten) rechtsherzinfarkts zu denken, der in - % der fälle zum kardiogenen schock führt (zehender et al. ). weitere ursachen. weitere auslöser des auftretens eines kardiogenen schocks sind akute myokarditis, terminalstadien von kardiomyopathien, dekompensiertes hochdruckherz und vitien, maligne brady-und tachykarde rhythmusstörungen sowie traumatisch bedingte myokardkontusionen und intoxikationen mit negativ-inotropen pharmaka. die klinische symptomatik und die hämodynamischen befunde sind geprägt durch die kombination krankheitsspezifischer befunde mit einem low-output-syndrom. auch bei dieser schockform ist der zeitverlauf prognosebestimmend. bei einer akuten perikardtamponade durch ischämische ruptur der freien ventrikelwand (in der regel - tage nach herzinfarkt) oder infolge einer blutung bei thoraxtrauma bzw. nach thrombolysetherapie reichen bereits ml blut im perikardbeutel zur schockentwicklung aus; bei einem chronischen malignen oder entzündlichen perikarderguss können dagegen - l ergussfl üssigkeit ohne schockentwicklung toleriert werden. bei einer akuten lungenembolie ohne vorbestehende kardiopulmonale erkrankung führt der verschluss von oder mehr lappenarterien und damit von - % des lungengefäßbettes zum schock; im falle chronischer, rezidivierender lungenembolien mit adaptativer rechtsherzhypertrophie werden teilweise wesentlich höhere anteile an lungenstrombettverschlüssen ohne schocksymptomatik toleriert. der gemeinsame nenner des verteilungsschocks (. tabelle . ) ist der verlust an peripherem gefäßwiderstand. neben den allgemeinen schockzeichen mit arterieller hypotonie, tachykardie, tachypnoe, oligurie und bewusstseinsstörung imponieren warme, relativ gut durchblutete extremitäten und ein erniedrigter diastolischer blutdruck. anamnese und charakteristische befunde können häufi g eine rasche ätiologische einordnung ermöglichen: eine urtikaria spricht für einen anaphylaktischen, eine rückenmarksverletzung für einen neurogenen und zeichen der infektion für einen septischen schock, der weitaus häufi gsten form des verteilungsschocks. hämodynamisch imponiert beim verteilungsschock eine ausgeprägte erniedrigung des systemischen gefäßwiderstandes, wobei jedoch in den einzelnen organgefäßbetten der widerstand erniedrigt, unverändert und auch erhöht sein kann. initial (vor volumentherapie) können herzindex und ventrikuläre füllungsdrücke erniedrigt sein, danach sind sie in der regel erhöht (. tabelle . ). der septische schock, die häufi gste todesursache auf der intensivstation, ist folge einer toxin-/mediatorkaskade, die sowohl durch gramnegative als auch durch grampositive bakterien ausgelöst werden kann, ebenso polymikrobiell und in seltenen fällen auch durch pilze oder viren ( abschn. . . ). % der patienten mit einer sepsis entwickeln innerhalb von h (median) eine schwere sepsis, und % der patienten mit schwerer sepsis innerhalb der nächsten tage (median) einen septischen schock (moerer et al. ) . die letalität der sepsis (ca. - %) steigt bei der schweren sepsis auf ca. % und beim septischen schock auf - % an. circa % aller sepsistodesfälle sind auf ein intraktables mods zurückzuführen, % auf ein therapierefraktäres kreislaufversagen, und bei % ist eine nicht beherrschbare septische kardiomyopathie ( abschn. . . ) die ursache. an der verbesserung der sepsisdefi nitionen und -klassifizierung (. tabelle . ) wird permanent gearbeitet: die piro-klassifi zierung ist ausdruck des bemühens um eine bessere charakterisierung der sepsis ähnlich der tumorklassifi zierung (levy et al. ) . wesentlich aussagekräftiger als die qualitative sepsisdiagnose (. tabelle . ) sind quantitative parameter zur beschreibung des schweregrads der sepsis (z. b. der sepsis-score nach elebute u. stoner, . abb. . ), des septischen multiorganversagens (z. b. der apache-ii-schweregrad-score, . abb. . ), des ausmaßes der septischen gefäßschädigung (abfall des systemischen gefäßwiderstands) und der septischen myokarddepression (abnahme des linksventrikulären schlagarbeitsindex). sie erlauben nicht nur eine abschätzung der prognose der sepsispatienten, sondern auch des ansprechens auf die therapie (müller- . . tabelle . zeigt das charakteristische profi l von sepsispatienten im vergleich zu patienten mit fieber, aber lediglich lokaler infektion und im vergleich zu patienten mit kardialem pumpversagen. die sepsispatienten sind durch einen hohen sepsis-score, eine hyperdyname kreislaufsituation mit hohem herzindex bei erniedrigtem systemischem gefäßwiderstand und schlagarbeitsindex und durch störungen der o -verwertung gekennzeichnet. die inzidenz der schweren sepsis liegt bei / krankenhaus-und - / intensivstationaufnahmen, die inzidenz des septischen schocks bei , / krankenhausaufnahmen und - / intensivaufnahmen (moerer et al. ) . im verständnis der sepsis und des septischen schocks ist allerdings in den letzten jahren ein erheblicher wandel eingetreten (. abb. . ). stand früher die bakterielle oder pilzinfektion mit einschwemmung von keimen in die blutbahn ganz im vordergrund der betrachtungsweise, so sind es heute vielmehr die durch die mikrobiellen toxine via aktivierung von mediatorzellen induzierten zytokin-und mediatorkaskaden, die für das mods und den septischen schock verantwortlich gemacht werden ( abschn. . . ). diese einschätzung wird unterstützt durch die tatsache, dass nur bei jedem . oder . patienten mit sepsis eine positive kultur gefunden wird und diese auch nicht prognosebestimmend ist. auch dass nichtinfektiöse noxen (trauma, pankreatitis, herzchirurgische operationen mit der herz-lungen-maschine) zu einem ganz ähnlichen klinischen bild wie bei bakteri-ell ausgelöster sepsis und septischem schock führen können, spricht für eine mehr oder weniger gemeinsame zytokin-/mediatorendstrecke als verantwortliche schädigungskaskade sowohl bei infektiösen als auch bei nichtinfektiösen (sirs, . tabelle . ) systemisch-entzündlichen schockformen. der anaphylaktische schock ist ein akut eintretender, »warmer« schockzustand, der durch anaphylaktische und anaphylaktoide reaktionen ausgelöst wird: der blutdruckabfall infolge vasodilatation mit relativer hypovolämie kann einhergehen mit larynxödem, bronchospasmus, angioödem, urtikaria, erythemen und myokarddepression. tabelle . . herz-kreislauf-veränderungen und o -metabolismus bei patienten mit sepsis, fieber und kardialem pumpversagen. (nach werdan et al. ; boekstegers et al. ) . sepsis fieber kardiales pumpversagen (n= ) (n= ) (n= ) sepsis-score (elebute) ( ) ( ) ( ) multiorganversagen-score (apache ii) ( ) ( ) ( ) hämodynamik herzindex (l/min/m ) , ( , ) , ( , ) , ( , ) linksventrikulärer schlagarbeitsindex (g · m/m ) , ( , ) , ( , ) , ( , ) systemischer gefäßwiderstand (dyn · s · cm - ) ( ) klassische anaphylaktische reaktionen sind ige-vermittelte allergische ereignisse in reaktion auf ein antigen, entsprechend einer typ-i-reaktion nach gell u. coombs, die perakut und generalisiert systemisch ablaufen. antibiotika, insekten-und schlangengifte, impfstoffe, seren, jodhaltige kontrastmittel und nahrungsmittel gehören zu den typischen auslösenden allergenen. ige-spezifi sche effektorzellen der immunantwort sind im wesentlichen mastzellen und basophile, die nach stimulation eine vielzahl proinfl ammatorischer mediatoren freisetzen und damit das klinische erscheinungsbild der anaphylaxie hervorrufen. davon abzugrenzen sind ige-unabhängige unverträglichkeitsreaktionen ohne vorausgehende sensibilisierung mit einem sehr ähnlichen oder identischen klinischen erscheinungsbild: bei anaphylaktoiden reaktionen (typischerweise ausgelöst z. b. durch röntgenkontrastmittel, salizylate und opiate) kommt es durch chemische, physikalische oder osmotische stimuli zur mediatorfreisetzung aus mastzellen und basophilen. eine idiopathische anaphylaxie kann typischerweise bei jungen erwachsenen auftreten, häufi g nachts oder postprandial; auslösefaktoren und effektorzellen sind unbekannt. die anaphylaxis factitia wird dem münchhausen-syndrom zugerechnet. daneben wurden auch immunreaktionen vom typ iii nach gell u. coombs bei anaphylaktischen reaktionen beschrieben, bei denen komplexe aus igg und spezifi schem antigenkomplement komplement aktivieren und über die anaphylatoxine c a und c a die mediatorfreisetzung aus mastzellen und basophilen stimulieren. charakteristischerweise tritt diese reaktion bei patienten mit hereditärem iga-mangel, dem häufi gsten angeborenen defekt des immunsystems ( : - ), im rahmen von bluttransfusionen auf: präformierte antikörper gegen iga im serum dieser patienten können die mediatorkaskaden auslösen. der begriff »anaphylaktoide reaktion« kann auch als Überbegriff verwandt werden für akute unverträglichkeitsreaktionen mit den symptomen einer anaphylaxie, ohne damit eine aussage zum pathomechanismus zu implizieren walther u. böttiger ) . genaue zahlen zur inzidenz anaphylaktischer und anaphylaktoider reaktionen sind aufgrund deren unvorhersehbarkeit und unberechenbarkeit nicht bekannt walther u. böttiger ) . entsprechend einer retrospektiven epidemiologischen studie muss mit etwa anaphylaxiefällen pro . einwohner gerechnet werden, wobei zu % nahrungsmittel, zu % medikamente, diagnostika oder immuntherapeutika, zu % insektenstiche und zu % unklare ursachen zur anaphylaxie führten (yocum et al. ). antibiotika, jodhaltige kontrastmittel. etwa bei von hospitalisierten patienten kommt es nach einer älteren studie zur medikamenteninduzierten anaphylaxie. nach schätzungen ist bei verabreichung von penicillin bei einem von . patienten mit einer anaphylaxie zu rechnen, die in % der fälle tödlich verläuft, so dass jährlich in den usa mit mehreren hundert todesfällen zu rechnen ist. auch die einnahme von cephalosporinen, neueren β-laktamantibiotika und fluoro-chinolonen kann zur anaphylaxie führen. es wird geschätzt, dass etwa - % der patienten mit penicillinallergie kreuzreaktionen gegen ein cephalosporin aufweisen. etwa - todesfälle gehen in den usa jährlich zu lasten jodhaltiger kontrastmittel. tierische gifte. typische verursacher der anaphylaxie sind insektengifte, übertragen durch stiche der tiere der ordnung hymenoptera (u. a. bienen, wespen, hornissen), und schlangengifte (z. b. klapperschlangen, mokkassinschlangen), die neben toxischen auch schwere allergische reaktionen hervorrufen können. etwa , - % der bevölkerung haben schon eine schwere allergische reaktion auf einen insektenstich durchgemacht, und % dieser reaktionen kann in eine lebensbedrohliche anaphylaxie münden. nahrungsmittel. in der praxis ist bei akuten reaktionen nach mahlzeiten die abgrenzung allergischer reaktionen zu nahrungsmittelintoleranzen und bakterientoxinerkrankungen schwierig. nahrungsmittelallergien bestehen bei etwa - % der kinder und sind im erwachsenenalter seltener anzutreffen. schwere anaphylaktische reaktionen auf nahrungsmittel sind eher selten, sind jedoch gehäuft für erdnüsse, sojabohnen, eiweiß und schalentiere beschrieben worden. latex, exotische früchte. zunehmend ist die inzidenz latexallergischer anaphylaxien. diese können durch die benutzung von latexhandschuhen ausgelöst werden, es sind aber auch bei einführen von kathetern aus latex und bei kondomen anaphylaxien beschrieben worden. auch wenn keine exakten epidemiologischen daten vorliegen, so ist davon auszugehen, dass etwa - % der Ärzte und des pfl egepersonals auf latex allergisch reagieren. gefährdet sind neben arbeitern aus der latex-verarbeitenden industrie v. a. patienten, die sich mehreren operativen eingriffen unterzogen haben, ganz besonders spina-bifi da-patienten, die zu > % sensibilisiert sind. ein hohes allergiesierungspotenzial haben auch schleimhautkontakte, z. b. bei urogenitalen katheterisierungen oder bariumkontrasteinläufen. inzwischen stehen kommerzielle tests zur verfügung, die präoperativ innerhalb weniger stunden eine aussage darüber zulassen, ob bei einem patienten latex-spezifi sche ige-antikörper im serum vorhanden sind. Überzufällig häufi g ist die latexallergie vergesellschaftet mit nahrungsmittelallergien, häufi g gegen exotische früchte wie avocado, banane, kiwi, passionsfrucht oder auch kastanien. das risiko unerwünschter und multipler arzneimittelwirkungen erhöht. allergien. häufi g erlebt man anaphylaktische reaktionen bei allergikern und häufi ger nach intravenöser als nach oraler allergenzufuhr, weshalb der anaphylaktische schock nicht selten iatrogen verursacht wird. narkosemittel, muskelrelaxanzien. anaphylaktoide narkosezwischenfälle bis hin zum herzstillstand treten nach einer umfangreichen französischen studie mit einer inzidenz von : - : allgemeinanästhesien auf. in ca. % der fälle kam es trotz adäquater therapie zum tod des patienten. auslösende agenzien waren in - % der fälle muskelrelaxanzien, in ca. % latexprodukte und in ca. % kolloidale volumenersatzmittel. aufgrund struktureller besonderheiten (quartäre ammoniumgruppe) können alle muskelrelaxanzien unverträglichkeitsreaktionen hervorrufen. aber auch opioide, lokalanästhetika und narkotika wurden als potenziell anaphylaktoid wirkende agenzien herausgestellt. kumulativer mediatoreneffekt. der kumulative effekt der freigesetzten mediatoren besteht im wesentlichen in einer erhöhten gefäßpermeabilität, einer ausgeprägten vasodilatation und einem bronchospasmus. autoptisch wurde bei tödlich verlaufenden anaphylaxien ein Ödem der lungen mit oftmals fl üssigkeitsgefüllten alveolen, ein Ödem der oberen atemwege, einschließlich des larynx und der epiglottis, der haut und der viszeralen organe gefunden. im zusammenhang mit Ödemen der oberen atemwege kommt es oft zu einer pulmonalen Überblähung oder auch zu einer ausgeprägten bronchokonstriktion. der neurogene schock wird durch einen verlust der peripheren vasomotorenkontrolle infolge einer dysfunktion oder einer verletzung des nervensystems hervorgerufen. das klassische beispiel dafür ist der meist mit einer rückenmarkverletzung assoziierte spinale schock (hund u. abel ) . dem verlust des venentonus mit erhöhter venöser kapazität scheint hier die entscheidende bedeutung zuzukommen, wobei auch der arteriolentonus reduziert sein kann. in letzterem falle kommt es nach flüssigkeitssubstitution zu einer steigerung des herzindex. eine -allerdings selbstlimitierende und vorübergehende -neurale fehlregulation fi ndet sich auch als ursache der vasovagalen synkope und bei der spinalanästhesie. die addison-krise kündigt sich mit unspezifi schen symptomen an wie anorexie, Übelkeit, erbrechen, diarrhöen, abdominellen schmerzen, myalgien, gelenkschmerzen, kopfschmerzen, schwäche, verwirrtheit und agitation oder delir. bei exsikkose kann es zu hohem fieber kommen. das initiale hämodynamische profi l ähnelt dem des hypovolämischen schocks; nach adäquater volumensubstitution demaskiert sich ein hyperdynamer, vasopressorrefraktärer schock (claussen et al. ; parkar u. taylor ) , der einem septischen schock ähneln kann. Überlagern sich beide schockformen, so sind das erkennen der nebenniereninsuffi zienz (kortisolbestimmung, acth-test) und die eingeleitete kortikoidbehandlung oft lebensrettend. zur addison-krise (parkar u. taylor ) kann es einerseits bei patienten mit chronischer, substituierter nebennierenrindeninsuffi zienz bei besonderen krankheits-oder operationsbelastungen ohne ausreichende steigerung der kortikoidmedikation kommen; andererseits kann auch eine beidseitige nebennierenblutung im gefolge einer sepsis (meningokokken, gramnegative bakterien), einer hiv-infektion, einer pilzinfektion, einer malignen infi ltration, eines anaphylaktischen schocks (lefevre et al. ) oder auch eine einblutung unter antikoagulation zur akuten nebenniereninsuffi zienz führen (rao et al. ). seltene schock-und synkopenformen sind in der . Übersicht . aufgeführt. mit dem begriff »vasalperipherer schock« werden jene akuten zustände von kreislaufi nsuffi zienz bezeichnet, de-. der verlust von myokardmasse beim akuten herzinfarkt mit minderung der kontraktilität führt zur abfl achung der frank-starling-kurve und zur zunahme des vorhofdrucks (. abb. . a, a-b). durch das positiv-inotrop wirkende dobutamin (ohne wesentlichen einfl uss auf den venösen rückfl uss) kann die kontraktionskraft des herzens gesteigert und damit der herzauswurf erhöht werden (. abb. . a, b-c). im gegensatz zum dobutamin würden die katecholamine noradrenalin und dopamin nicht nur positiv-inotrop wirken, sondern auch die venöse kapazität reduzieren und damit den mittleren zirkulationsdruck erhöhen. hypovolämie vermindert das zirkulierende blutvolumen und damit auch den mittleren zirkulationsdruck pcm (. abb. . b, a-b). die resultierende abnahme des venösen rückstroms und damit des herzauswurfs kann durch volumensubstitution ausgeglichen werden (. abb. . b, b-c). das hämodynamische bild des hämorrhagischen hypovolämischen schocks ist nicht nur durch den blutvolumenverlust geprägt, sondern auch durch eine initiale kompensatorische vasokonstriktion, die im weiteren verlauf von einer therapeutisch schwer beeinfl ussbaren vasodilatation gefolgt wird. für letztere wird zum einen eine hochregulation der spinalen stickoxidsynthase verantwortlich gemacht (lu et al. ; abschn. . . ), zum anderen eine aktivierung der poly- (adp-ribose)-synthetase (pars), einem schlüsselenzym der apoptose ( abschn. . . ). der septische schock (thiemermann a) vor adäquater volumensubstitution reicht die abnahme des rv allerdings nicht aus, um die reduktion des pcm auszugleichen: der herzauswurf bleibt vermindert (. abb. . c, a-b). durch eine adäquate volumensubstitution lässt sich der pcm normalisieren; aufgrund des weiterhin erniedrigten venösen widerstands (rv) führt dies, bei fehlen einer myokarddepression, dann sogar zu einem supranormalen venösen rückstrom und einem supranormalen herzzeitvolumen (. abb. . c, b-c). die graphik verdeutlicht, dass die rv-abnahme bis zu einem gewissen grad eine meist vorhandene mäßige myokarddepression maskieren kann. erst bei einer ausgeprägten kontraktilitätsminderung wird diese als einschränkung des herzauswurfs manifest (. abb. . c, c-d), was bei ca. % aller sepsispatienten zutrifft (kumar u. parrillo ) . die mikrozirkulation und deren erkrankungsbedingte störungen können heutzutage beim patienten mit der orthogonalen polarisations-spektral-bildgebung (»orthogonal polarization spectral imaging«, ops; groner et al. ) sichtbar gemacht werden (. abb. . ). eine regelrechte durchblutung auf mikrozirkulationsebene (gefäße bis - µm durchmesser) ist voraussetzung für eine adäquate gewebeperfusion; ein normales herzzeitvolumen und ein normaler blutdruck sind dafür noch nicht ausreichend. die regionale durchblutung auf mikrozirkulationsebene wird durch lokale intrinsische (autoregulation) und durch extrinsische faktoren (autonomes nervensystem und humorale faktoren) geregelt (holtz ) . der blutfl uss zu den einzelnen organen wird durch den tonus der präkapillären arteriolen und prä-und postkapillären sphinktergefäße sowie durch lokale veränderungen der metabolischen aktivität gesteuert. mit der ops-methode (groner et al. ) lässt sich bei schwerer sepsis zeigen, dass die sublinguale mikrozirkulation in ihrer gefäßdichte reduziert - , ( , - , )/mm bei sepsis vs. , ( , - , )/mm bei gesunden -und der anteil der perfundierten kleinen gefäße (< µm) vermindert ist - ( - )% vs. ( - )%. diese veränderungen sind bei versterbenden ausgeprägter als bei Überlebenden. die topische applikation von azetylcholin kann diese veränderungen wieder rückgängig machen (de backer et al. ; ince ) . die durchblutung der einzelnen organe kann über einen weiten blutdruckbereich organspezifi sch konstant gehalten werden (. tabelle . ), für den menschen wird diese autoregulation für einen bereich von - mmhg angegeben (bond bei hypovolämie und anderen hypodynamen schockformen wird der blutfl uss in gehirn und herz autoregulatorisch aufrechterhalten, in allen anderen organgefäßbetten ist er jedoch teilweise erheblich eingeschränkt, damit der systemische blutdruck möglichst stabil gehalten werden kann (. tabelle . ). für diese vasokonstriktion sind v. a. ein erhöhter sympathikotonus und die freisetzung von katecholaminen aus der nebenniere verantwortlich. diese adaptativen mechanismen reichen aus, um bei gering bis mäßig eingeschränktem herzzeitvolumen lebenswichtige organe adäquat zu perfundieren; bei ausgeprägter hypotonie kommt es jedoch zur organischämie und zum organversagen. selbst nach wiederherstellung stabiler herz-kreislauf-verhältnisse können die störungen auf mikrozirkulationsebene über tage persistieren, v. a. im gehirn, in den nieren, in der leber und in anderen splanchnikusorganen (wang et al. ). die irreversible phase eines schweren hämorrhagischen schocks ist aufgrund experimenteller befunde durch die vasodilatation präkapillärer sphinkter charakterisiert. die splanchnikusperfusion beim kritisch kranken variiert sehr stark in abhängigkeit von der grunderkrankung, kompensatorischen mechanismen und therapeutischen interventionen (jakob u. takala ) : im falle einer systemischen hypoperfusion oder hypoxämie wird die splanchnikusperfusion reduziert, wobei der leberblutfl uss auch unter diesen bedingungen aufgrund intrinsischer kontrollmechanismen relativ hoch gehalten wird (jakob et al. ) . bei sepsis und septischem schock fi nden sich bereits bei noch relativ adäquaten blutdruckwerten störungen der organdurchblutung, die eine primäre schädigung auf mikrozirkulationsebene nahe legen (thiemermann a sie beruht auf einer sepsisinduzierten aktiven vasodilatation und dem verlust der extrinsischen vasomotorenkontrolle (bond ) , wodurch die durchblutung ausschließlich vom herzzeitvolumen abhängig wird. eine ausnahme von dieser regel stellt die hirndurchblutung dar, die in der sepsis weiterhin die fähigkeit zur autoregulation beibehält: bei patienten mit sepsis ist die hirndurchblutung bereits vor der ausbildung des schockzustandes um ein drittel reduziert, wobei diese durchblutungseinschränkung jedoch nicht als ursache der septischen enzephalopathie angesehen wird. im koronargefäßsystem fällt dagegen der widerstand noch stärker ab als in den anderen organen und demzufolge ist die koronarperfusion bei patienten mit septischem schock sogar häufi g erhöht (dhainaut et al. schock. die systemische und regionale minderperfusion spielt als verursacher der ischämisch bedingten zellschädigung bei den meisten schockformen eine prägende rolle. sind die neurohumoralen adaptationsmechanismen (. abb. . ) nicht mehr in der lage, die schockinduzierte organischämie und hypoxie zu kompensieren, so sind die hemmung des aeroben zellstoffwechsels, die abhängigkeit der energieproduktion von der allein nicht ausreichenden anaeroben glykolyse, die daraus resultierende zelluläre energieverarmung mit laktatanstieg und azidose die folge. diese schwerwiegende ischämisch bedingte zellschädigung ist jedoch keine simple hypoxiefolge auf die mitochon-driale atp-produktion allein: die mitochondrien zeigen auch noch bei sehr niedrigem o -partialdruck (michaelis-konstante < µm) eine adäquate atp-produktion. demzufolge garantiert diese hohe o -affi nität auch eine regelrechte funktion der atmungskette, selbst in der hypoxie, sieht man von extrembedingungen einmal ab. der so gestörte substrat-und energiestoffwechsel verursacht zahlreiche zellschäden, die sich als destruktion von mitochondrien, als beeinträchtigung der strukturellen und funktionellen zellmembranintegrität, in form zytotoxischer effekte und schließlich als zelltod manifestieren. leber und niere scheinen auf einen abfall des zell-atp besonders empfi ndlich zu reagieren. sepsis und septischer schock. die bedeutung eines energiemangels in der sepsis ist noch nicht eindeutig geklärt. zumindest lässt sich nachweisen, dass der atp-gehalt im skelettmuskel bei nichtüberlebenden stärker vermindert ist als bei Überlebenden (brealey et al. ) . zytokine (zell et al. ) , exzessive produktion von stickoxid und reduzierte zelluläre glutathionreserven (brealey et al. ) scheinen ursächlich für die der verminderten energieproduktion in der sepsis zugrunde liegenden hemmung der atmungskette zu sein, wie für den skelettmuskel (brealey et al. ) und den herzmuskel (gellerich et al. ) gezeigt. bei der diskussion dieser ergebnisse darf allerdings nicht vergessen werden, dass nicht nur ischämie und hypoxie zur beeinträchtigung der mitochondrialen funktion und atp-produktion führen können, sondern auch mediatoren, insbesondere zytokine (. Übersicht . ; . tabelle . ; zell et al. endotoxin ist zweifellos ganz entscheidend für die schlechte prognose bei gramnegativem schock mitverantwortlich. darüber sollte jedoch nicht vergessen werden, dass es in niedrigen konzentrationen über eine nur moderate mediatorfreisetzung bei der infektabwehr durchaus günstig wirken kann (mäßiges fieber, steigerung der immunabwehr, abtötung der keime). die durch endotoxin induzierte hypotension scheint mit der zeit eine abschwächung zu erfahren (mailman et al. ) . auch bei der entstehung und perpetuierung der herzinsuffi zienz scheint endotoxin eine rolle zu spielen (rauchhaus u. müller-werden ) . aus kardiologischer sicht bietet das endotoxin aber auch Überraschungen: neben der deletären direkten und indirekten kardiodepressiven wirkung ( abschn. . . ) lassen sich auch protektive effekte auf das herz nachweisen (mcdonough et al. ; song et al. ; yao et al. ). grampositive erreger verursachen mindestens ebenso viele sepsiserkrankungen wie gramnegative keime. da grampositive bakterien keine lipopolysaccharide synthetisieren und in ihre zellwand integrieren, scheidet endotoxin als induktor einer grampositiven sepsis aus. hierfür kommen einerseits peptidoglykane (. abb. . ), die wie endotoxin an cd binden können, und die lipoteichonsäuren der zellmembran in frage und andererseits toxine, die entweder als superantigene, als porenbildner oder als adp-ribosylierende toxine ihre zytotoxische wirkung entfalten. peptidoglykane und lipoteichonsäuren wirken pyrogen, aktivieren komplement und b-lymphozyten. dabei werden die makrophagen aktiviert und sezernieren zytokine, teils in größeren mengen als nach endotoxinstimulation. toxine mit superantigeneigenschaften, wie z. b. das toxinschocksyndromtoxin bestimmter staphylokokken, besitzen wie konventionelle antigene die fähigkeit, t-lymphozyten zu aktivieren. unter umgehung bestimmter kontrollmechanismen stimulieren sie jedoch nicht nur , % der zellen, wie konventionelle antigene, sondern - - % aller t-lymphozyten gleichzeitig. die folge ist eine Überaktivierung der t-zellen mit massiver zytokinfreisetzung, insbesondere tnf-α, und evtl. letalem schockverlauf. die bedeutung der superantigene bei der pathogenese der sepsis kann gegenwärtig noch nicht ausreichend abgeschätzt werden (visvanathan u. zabriskie ) . endotoxin und toxine grampositiver keime können sich in ihrer wirkung verstärken und über die toll-like-rezeptoren miteinander kommunizieren (li et al. das pseudomonas aeruginosa exotoxin a ist ein adp-ribosylierendes toxin, das hochselektiv den ribosomalen elongationsfaktor der proteinsynthese adp-ribosyliert und damit inaktiviert. das toxin stellt einen wesentlichen virulenzfaktor der pseudomonassepsis dar. an kardiomyoyzten führt exotoxin a über eine partielle proteinsynthesehemmung zu einer störung der neusynthese von β-adrenozeptoren und damit zur kontraktilitätsabschwächung auf katecholamine (müller- werdan et al. ) . das peptidoglykan ist hauptbestandteil der zellwand grampositiver bakterien. es wird ebenso wie endotoxin von cd -und toll-like rezeptoren gebunden; die bindung an letztere bewirkt eine zellaktivierung. weitere bakerielle toxine wie die lipoteichonsäure, lipoarabinomannan von mykobakterien oder nannuronan führen ebenfalls über einen cd -und toll-like rezeptor-abhängigen weg zur aktivierung von leukozyten. bestimmte bakterielle dns-sequenzen sind in der lage, antigenpräsentierende zellen (monozyten) zu aktivieren. diese dns-abschnitte sind reich an nichtmethylierten cpg-motiven. oligodeoxynukleotide mit cpg-motiven werden von toll-like-rezeptoren erkannt; diese dns-abschnitte werden in die zellen aufgenommen und führen nach einer azidifi zierung in den endosomen zu einer aktivierung sowohl von mitogen aktivierten proteinkinasen als auch dem transkriptionsfaktor nf-κb. das verständnis um die bedeutung von toxinen und mediatoren im schockgeschehen fußte zunächst auf erkenntnissen, die bei der aufklärung der pathogenese des septischen schocks gewonnen wurden (. abb. . ). heutzutage kann jedoch davon ausgegangen werden, dass die mediatorkaskade die gemeinsame endstrecke nicht nur des septischen schocks darstellt (. abb. . ), sondern dass auch ein hypovolämischer, traumatischer, anaphylaktischer und sogar der kardiogene schock komponenten dieser kaskade als auslösende oder unterhaltende ursachen beinhalten. dieses konzept spiegelt sich auch in der aktuellen terminologie von sepsis und sirs (»systemic infl ammatory response syndrome«, . tabelle . ) wider: ausgehend von infektiösen oder nichtinfektiösen stimuli (. abb. . ) kommt es zur aktivierung von mediatorzellen, die primäre mediatoren wie den tumornekrosefaktor α freisetzen. diese primären mediatoren beeinfl ussen weitere zielzellen, die einerseits geschädigt werden können, andererseits (wie z. b. die neutrophilen granulozyten) fi nale mediatoren auf diesen stimulus (wie z. b. reaktive o -verbindungen oder stickoxid) freisetzen. die mediatorfreisetzung soll zwar eigentlich zur bekämpfung der bakterien, zur neutralisierung von bakterientoxinen und zur schadensbegrenzung nichtinfektiöser insulte dienen, die aggressiven verbindungen schädigen dabei jedoch auch das herz-kreislauf-system und weitere vitale or- zytokine, insbesondere tnf-α und il- , stehen am anfang des mediatornetzwerks von schock und sepsis. bakterielle toxine, aber auch sirs-stimuli, können monozyten und makrophagen zur bildung und freisetzung insbesondere von tnf-α aktivieren (. abb. . ; loppnow ). als resultat der direkten und indirekten zytokinwirkungen stehen beim septischen schock die häufi g irreversible herz-kreislauf-schädigung und das mods. die bedeutung der zytokine beschränkt sich jedoch nicht nur auf den septischen schock: auch beim hämorrhagischen schock fi nden sich erhöhte tnf-serumspiegel; beim kardiogenen schock sind die interleukin- -spiegel vergleichbar hoch wie beim septischen schock , und das akute lungenversagen bei hypovolämischem und traumatischem schock lässt sich durch den einsatz von anti-tnf-α-antikörpern bessern. erhöhte zytokinserum-und -plasmaspiegel fi nden sich darüber hinaus auch bei zahlreichen infektiösen und nichtinfektiösen herz-kreislauf-erkrankungen (. tabelle . ). derzeit muss allerdings noch häufi g die frage offenbleiben, ob zytokine dabei kausale bedeutung haben, ein sekundäres phänomen von krankheitswert oder nur ein unwichtiges epiphänomen darstellen (ausführliche diskussion in müller- werdan et al. ; rauchhaus u. müller-werdan ) . das verstehen der zytokinwirkmechanismen (loppnow ; rauchhaus u. müller-werdan ) -gezeigt am beispiel des tnf-α -bietet die möglichkeit einer -bisher leider weder beim septischen schock noch bei herzinsuffi zienz erfolgreichen -kausalen therapie, z. b. mit anti-tnf-α-antikörpern. an der zielzelle bindet tnf-α (als trimer) an einen der beiden tnf-rezeptoren (tnfr mit einem mg von . ; tnfr mit einem mg von . ) und löst damit verschiedene zelluläre signale aus ( abschn. . . ). unterschiedliche stimuli (fieber, endotoxin, tnf-α selbst und andere zytokine) können zur proteolytischen spaltung der tnf-rezeptoren und ihrer freisetzung als lösliche tnf-rezeptoren ins plasma führen. deren bedeutung ist jedoch bisher noch unklar: in niedrigen konzentrationen scheinen sie ein reservoir für das gebundene tnf-α darzustellen, in höheren konzentrationen das tnf-α und damit seine zytotoxische wirkung zu neutralisieren. zytokine sind nicht nur schädlich; es ist vielmehr die massiv gesteigerte produktion und damit die dysbalance von proinfl ammatorischen mediatoren wie tnf, il- , il- , il- , ifn und dem plättchenaktivierenden faktor (paf) mit den antiinfl ammatorischen substanzen und mechanismen (il- , interleukin- -rezeptorantagonist, lösliche tnf-rezeptoren, glukokortikoide und auch fieber), die letztlich bei schock und sepsis die ungünstige prognose determiniert. so zeigt eine hohe interleukin- /interleukin- -relation bei kritisch kranken eine ungünstige prognose an (taniguchi et al. ) . die tatsache, dass niedrige zytokinkonzentrationen (z. b. tnfα) bei sepsis durchaus zur abwehrreaktion in protektiver weise beitragen können, belastet das kausale therapiekonzept der unterbrechung dieser zytokin-/mediatorkaskade. > > zytokine und gerinnung. bei schwerer sepsis und bei septischem schock kommt es regelhaft auf endothelzellebene zu störungen der gerinnung und fibrinolyse im sinne einer disseminierten intravasalen gerinnung (dic, verbrauchskoagulopathie), allerdings individuell in jeweils sehr unterschiedlichem ausmaß: gerinnungsvorgänge sind gesteigert, fibrinolyseaktivitäten vermindert, und das verarmen an gerinnungsfaktoren wie des aktivierten protein c trägt zur proinfl ammation bei (dempfl e ). zytokin-genpolymorphismen. die prognose eines schockpatienten hängt wahrscheinlich nicht nur von seinem phänotyp, sondern auch von seinem genotyp ab, wie bisher v. a. für patienten mit sepsis und septischem schock gezeigt worden ist. männliche sepsispatienten, die homozygot sind für das allel tnfb des tnf-polymorphismus (ncoi-restriktionsfragmentlängenpolymorphismus), produzieren höhere tnf-plasmaspiegel und haben eine ungünstigere prognose als die sepsispatienten mit dem genotyp tnfb /b bzw. tnfb /b . verknüpft mit dem tnf-polymorphismus und ohne eigenständige prognostische aussagekraft sind polymorphismen der hitzeschockproteine hsp -hom c/t und hsp - g/a bei patienten mit schwerer sepsis. während sich für die genotypverteilung des interleukin β keine unterschiede zwischen sepsispatienten und gesunden zeigen, fi ndet sich das allel a des interleukin- -rezeptorantagonisten (il- ra) bei patienten mit schwerer sepsis häufi ger als bei gesunden. dies könnte auf eine erhöhte sepsisempfi ndlichkeit bei dieser allelkonstellation hinweisen. nicht nur genpolymorphismen proinfl ammatorischer zytokine, sondern auch die antiinfl ammatorischer scheinen relevanz zu besitzen: sepsispatienten mit spezifi schen interleukin- -genpolymorphismen sezernieren geringere mengen dieses antiinfl ammatorischen zytokins und haben eine erhöhte sterblichkeit (lowe et al. ). reaktive o -verbindungen stellen im schockgeschehen eine wichtige gruppe terminaler mediatoren dar (de vega et al. ; motoyama et al. ) . dabei handelt es sich um moleküle mit einem ungepaarten elektron in der äußeren hülle. ursprungsort von freien radikalen sind zum einen aktivierten mediatorzellen, wie neutrophile granulozyten, makrophagen und endothelzellen, sowie andererseits (in der reperfusionsphase der schockbehandlung) das hypoxanthin als abbauprodukt des atp. das superoxidanion (o -), das hydroxylradikal (oh · ), das wasserstoffperoxidmolekül (h o ), die hypochlorige säure (hocl) neutrophiler granulozyten und das peroxinitritradikal (onoo -) sind dabei die wichtigsten verbindungen (. abb. . ). peroxinitrit -gebildet aus dem stickoxid-und dem superoxidradikal -ist ein potentes und hochreaktives oxidans mit ausgeprägter zytotoxischer wirkung, das besonders zur endothelschädigung führen kann, die thrombozytenaggregation steigert und die ansprechbarkeit der koronargefäße auf vasodilatatoren vermindert (lamy et al. ) . treten die so entstandenen sauerstoffradikale bzw. reaktiven verbindungen in kontakt mit einer zielzelle, so können sie auf verschiedene zelluläre strukturen wirken: auf die zellmembran, das zytosol, den zellkern und die mitochondri-> . · pathophysiologie des schocks en. schließlich wird durch diesen oxidativen stress eine reihe von genen aktiviert (»stress-response genes«), die zur bildung von antioxidanzien, o -radikalabbauenden enzymen, zytokinen und transkriptionsfaktoren führen. sie dienen einerseits der reparatur von zellschäden durch die sauerstoffradikale und führen, falls dies nicht möglich ist, zum gerichteten zelltod, der apoptose. ein beispiel des schädigungsmusters reaktiver sauerstoffverbindungen bei ischämie und reperfusion im herzen gibt . abb. . . das zunächst als »endothelial-derived relaxing factor« klassifi zierte stickoxid (no) wird enzymatisch aus arginin gebildet. die cnos-isoformen sind ständig vorhanden. sie können sofort aktiviert werden und produzieren geringe mengen an no, das dann zahlreiche physiologische funktionen erfüllt. die cnos-isoenzyme können weiterhin in die neuronale form (nnos oder nos i, lokalisiert im zytosol von zentralen und peripheren neuronen) und in die endotheliale form (enos oder nos iii, überwiegend membrangebunden) eingeteilt werden. die enos-isoform besitzt sowohl parakrine als auch autokrine aktivität; sie wird überwiegend durch den scherstress der gefäße aktiviert, das gebildete no diffundiert in die glatten gefäßmuskelzellen und führt zur erschlaffung. die enos ist nötig, um die gefäße in einem partiell relaxierten zustand zu halten, der durch noradrenalin und endothelin antagonisiert wird. sie reguliert damit den gefäßtonus, die organperfusion und den blutdruck. weiterhin hemmt das von der enos produzierte no die adhäsion von thrombozyten und neutrophilen an endothelzellen und möglicherweise auch die proliferation von gefäßmuskelzellen. die induzierbare form der stickoxidsynthase (inos oder nos ii) wurde zuerst in makrophagen gefunden, sie kommt jedoch in vielen zelltypen vor. ihre induktion durch zahlreiche triggersubstanzen (. tabelle . ) dauert einige stunden, das enzymmolekül ist relativ langlebig (halbwertszeit mehrere stunden), und es kann durch die inos-aktivität in kurzer zeit lokal sehr viel stickoxid gebildet werden. demzufolge besteht die möglichkeit, dass das zur verfügung stehende enzymsubstrat arginin die produktion von stickoxid durch inos limitiert, was im falle der wesentlich geringeren no-produktionsraten durch die cnos-aktivität nicht der fall ist. reaktive stickstoff-sauerstoff-verbindungen (rnos) -insbesondere das aus dem stickoxid-und dem superoxidradikal entstehende peroxinitritradikal -wirken, überschießend produziert, im zellstoffwechsel hochtoxisch ( abschn. . . ; lamy et al. ) . ein dritter, für das schockgeschehen möglicherweise sehr bedeutungsvoller bildungsweg ist die nichtenzymatische reduktion von nitrit zu no in minderdurchblutetem gewebe. im ischämischen, azidotischen myokard fi ndet sich nitrit in mikromolaren konzentrationen. mittels elektronenspinresonanzspektren ließ sich nachweisen, dass in diesem hochreduktiven stoffwechselmilieu nitrit in großen mengen nichtenzymatisch zu stickoxid reduziert wird (zweier et al. ) . das entstandene stickoxid kann entweder am ort der bildung reagieren (autokrine wirkung) oder in benachbarte zellen diffundieren (parakrine wirkung). ein großteil der stickoxidwirkungen (vasodilatation, kardiodepression) beruht auf der aktivierung der löslichen guanylatzyklase durch stickoxid, mit bildung des zyklischen guanosinmonophosphats (cgmp), des gegenspielers des zyklischen adenosinmonophosphats (camp). bildung und wirkung des stickoxids können auf verschiedenen stufen blockiert werden: die induktion der inos kann durch glukokortikoide unterdrückt werden; die stickoxidsynthasen lassen sich durch argininanaloga wie l-nmma (ng-monomethyl-l-arginin; thiemermann b) hemmen, und die aktivität der guanylatzyklase kann durch methylenblau blockiert werden. in der schockauslösung und der schocktherapie ist stickoxid ein entscheidender mediator (. tabelle . ; thiemermann a). die hemmung der zellulären o -verwertungs-> störung in den organen durch no-inhibition einer reihe mitochondrialer enzyme (aconitase, nadh-ubichinon-reduktase, succinat-ubichinon-oxidoreduktase; brealey et al. ; thiemermann a ) könnte dabei eine ursache für die erhöht gefundenen o -partialdrücke im skelettmuskel von sepsispatienten sein (. tabelle . ). natriuretische peptide wie das atriale natriuretische peptid (anp) und das b-typ-natriuretische peptid (»brain natriuretic peptide«, bnp) sind indikatoren einer mit einer ungünstigen prognose gekoppelten herzfunktionseinschränkung. darüber hinaus können zytokine der interleukin(il)- -familie die sekretion von anp und bnp induzieren. im septischen schock steigen plasma-anp ( , ± , vs. , ± , pg/ml) und plasma-bnp ( , ± , vs. , ± , pg/ml) an. der anp-anstieg korreliert dabei mehr mit dem il- -anstieg und weniger mit der kardiovaskuären dysfunktion, während der bnp-anstieg die pumpfunktionseinschränkung des herzens (abnahme des herzindex) widerspiegelt (witthaut et al. ) . in die schockpathogenese sind noch zahlreiche weitere hormone und mediatoren -endothelin, vasopressin ( abschn. . . ), adrenomedullin, adhäsionsmoleküle, hitzeschockproteine, arachidonsäurederivate u. a. -involviert (thiemermann a; müller-werdan et al. burchardi et al. ) . schockart (dhainaut et al. ). apoptose -der gerichtete zelltod -fi ndet sich bei patienten mit sepsis v. a. in lymphozyten und intestinalen epithelzellen, nicht dagegen in nennenswertem maße im herzen und anderen parenchymatösen organen. bei nichtseptischen schockzuständen ist die apoptose ein noch selteneres phänomen wie bei der sepsis (hotchkiss et al. ; moldawer ). zahlreiche der im schock und in der sepsis gebildeten mediatoren (Übersicht und literaturangaben in werdan ; krishnagopalan et al. ; müller-werdan et al. ; können eine myokarddepression hervorrufen und damit zum bild der akuten septischen kardiomyopathie beitragen. welche von den zahlreichen beschriebenen wirkungen auf die herzmuskelzelle jedoch tatsächlich klinische relevanz besitzen, ist bisher nur mit einschränkung zu beantworten. die z. z. am meisten favorisierte »negativ-inotrope kaskade« ist die endotoxin-tnf-α/il- -no-cgmp-kaskade (. abb. . ). zirkulierendes endotoxin stimuliert mediatorzellen zur systemischen und myokardialen freisetzung von tumornekrosefaktor α (tnf-α) und interleukin (il- ). tnfα und (wohl von geringerer bedeutung) il- induzieren dann die bildung der induzierbaren stickoxidsynthase (inos) im herzen. das von ihr gebildete stickoxid (no) stimuliert die lösliche guanylatzyklase des kardiomyozyten, und der daraus resultierende anstieg des cgmp führt schließlich über eine hemmung des ca + -einstroms in die zelle oder über eine desensibilisierung der myofi lamente gegenüber ca + zur kardiodepression (kumar u. parrillo ; . alle einzelschritte sind weitgehend belegt. die gabe von endotoxin führt bei probanden zur hyperdynamischen > herz-kreislauf-situation mit blutdrucksenkung, vasodilatation und steigerung des herzindex bei gleichzeitiger abnahme des schlagarbeitsindex als klinischem inotropieparameter (suffredini et al. ) . auch der anstieg des zirkulierenden tnf-α nach endotoxinapplikation ist bei probanden gezeigt worden (michie et al. ) , und erhöhte tnfα-plasmaspiegel fi nden sich auch im septischen schock. bei therapeutisch mit tnf behandelten tumorpatienten kann es zur ausgeprägten myokarddepression kommen. im tierexperiment führt die gabe von tnf-α zu einer bis mehrere tage anhaltenden myokarddepression (müller- werdan et al. ) . der nachweis der direkten depressorischen wirkung des tnf-α auf die funktion des kardiomyozyten lässt sich im zellkulturexperiment führen: tnf-α hemmt in klinisch relevanten konzentrationen nach mehrstündiger einwirkungsdauer die »positiv-inotrope« wirkung des β-adrenozeptoragonisten isoproterenol und auch die hoher ca + -konzentrationen. die depressorische tnf-α-wirkung kann durch anti-tnf-α-antikörper neutralisiert werden. auch die induktion einer induzierbaren stickoxidsynthase in kardiomyozyten durch tnf-α und il- ist experimentell gut belegt, ebenso wie bei patienten mit septischem schock eine erhöhte aktivität der inos und ein cgmp-anstieg im herzen. es spricht also vieles dafür, dass die diskutierte »negativinotrope« kaskade für die myokarddepression in der sepsis und im septischen schock wesentlich mitverantwortlich ist. dennoch scheint dies nicht der einzige kardiodepressive mechanismus zu sein: einerseits kann tnf-α im experiment auch stickoxidunabhängig negativ-inotrop wirken, andererseits wird durch tnf-α nicht nur die positiv-inotrope wirkung von β-adrenozeptoragonisten, sondern auch die von α-adrenozeptoragonisten gehemmt. letzteres ist über eine alleinige induktion der stickoxidsynthase nicht zu erklären; so hemmt endotoxin, das in kardiomyozyten die stickoxidsynthase stimuliert, zwar auch die positiv-inotrope wirkung von β-adrenozeptoragonisten, nicht aber die von α-adrenozeptoragonisten (müller- werdan et al. ) . aufbauend auf experimentellen befunden dieser art kann davon ausgegangen werden, dass neben der stickoxid-cgmp-kaskade auch noch andere mechanismen für die negativ-inotrope wirkung von tnf-α verantwortlich sein müssen (. abb. . ). die belegte hemmung des phosphoinositolstoffwechsels durch dieses zytokin erklärt die hemmung der positiv-inotropen wirkung von α-adrenozeptoragonisten, und die ebenfalls dokumentierte abschwächung des ca + -transients durch tnf schwächt alle inotropen effekte ab. ebenfalls belegt ist die hemmung des ca + -einwärtsstroms durch einen kardiodepressiven peptidfaktor, der sich in hämofi ltraten von patienten mit kardiogenem und septischem schock in konzentrationen nachweisen lässt, die diese hemmwirkung in humanen herzmuskelzellen hervorrufen ). die gewebeschäden sind nicht allein durch den mangel an sauerstoff während der ischämiephase, sondern auch durch die reperfusion und reoxygenation der ischämischen organe bedingt (abella u. becker ) . bei der enzymatischen reaktion der in der ischämiephase akkumulierten atp-abbauprodukte hypoxanthin und xanthin mit sauerstoff kommt es zur bildung freier sauerstoffradikale (wasserstoffperoxid, superoxidradikal, hydroxylradikal), die durch lipidperoxidation die aktivierung des prostaglandinsystems und eine denaturierung von zellmembranproteinen bewirken. katalysiert wird diese radikalproduktion durch das enzym xanthinoxidase, das in der ischämie durch umwandlung aus der xanthindehydrogenase (nicht zur radikalbildung befähigt) entsteht. dieser umwandlungsprozess läuft in den geweben bei ischämie unterschiedlich schnell ab (darm: s; herzmuskel: min; leber, milz, niere, lunge: min), was die unterschiedliche empfi ndlichkeit der einzelnen gewebe auf reperfusionsschäden mit erklären soll freie sauerstoffradikale rufen darüber hinaus eine verstärkte akkumulation polymorphkerniger leukozyten hervor, begünstigen das leukozytensticking sowie über den »respiratory burst« die bildung weiterer sauerstoffradikale aus polymorphkernigen leukozyten (. abb. . ). demzufolge kommt der leukozyten-endothel-interaktion -leukozyteneinwanderung, -rollen, feste adhäsion, gefäßtransmigration -via adhäsionsmoleküle -selektine, integrine, immunglobulinsuperfamilie, cadherine -bei dem ischämiereperfusionsschaden eine große bedeutung zu (finney et al. ) . exzessive stickoxid-und damit peroxinitritbildung, komplementaktivierung (ciurana u. hack ) und apoptoseinduktion (abella u. becker ) tragen wahrscheinlich ebenfalls entscheidend zum komplexen ischämiereperfusionsschädigungsmuster bei. ein weiterer kandidat ist das kernenzym poly(adp-ribose)-polymerase (parp; synonym: par-synthetase, pars; liaudet et al. ; szabo u. liaudet ; . abb. . ): proinfl ammatorische zytokine im kreislaufschock produzieren reaktive sauerstoffverbindungen via stimulation der xanthinoxidase, de-novo-expression der induzierbaren stickoxidsynthase, induktion einer mitochondrialen dysfunktion und rekrutierung von neutrophilen granuloyzten mit expression der nadph-oxidase. als folge davon werden die sauerstoffradikale peroxinitrit, wasserstoffperoxid und hydroxylradi-kale gebildet, durch interaktion von superoxidanionen, stickoxid und der eisenkatalysierten oxidation von superoxidanionen. der so entstehende oxidative zellstress induziert die bildung des transkriptionsfaktors ap- und löst dns-einzelstrangbrüche aus. die dns-schäden aktivieren die parp. die parp-aktivierung verbraucht atp sowie redoxäquivalente (nadph), induziert damit eine endothelzellschädigung sowie den zelltod und potenziert die aktivierung der transkriptionsfaktoren ap- und »nuclear factor kappa b (nfκb)«. letzteres hat die verstärkte transkription und translation der ap- -und nfκb-abhängigen gene für inos, icam, mip- α, tnf-α und komplement-c zur folge. das aus c gebildete c und die gesteigerte endotheliale expression des adhäsionsmoleküls icam- führt zu einer verstärkten einwanderung von aktivierten leukoyzten in den infl ammatorischen fokus und bewirkt damit eine intensivierung der bildung reaktiver sauerstoffverbindungen. der teufelskreis wird mit der triggerung weiterer dns-strangbrüche durch den oxidativen stress geschlossen. da natürliche schutzstoffe gegen die effekte der sauerstoffradikale (scavenger-substanzen, superoxiddismutase (elsakka et al. ) , glutathion, glutathionperoxidase, katalase) im intrazellulärraum nur in geringer konzentration vorliegen, können sie den als folge der reperfusion und reoxygenation eintretenden reperfusionsschaden, der durch endothelläsion, intrazelluläres Ödem und letztlich deletären einstrom von kalziumionen in die zellen charakterisiert ist, nicht verhindern. der reperfusionsschaden wird als wichtiger pathogenetischer faktor bei der entwicklung des mods im schock gesehen. noch ausstehend ist der nachweis der klinischen wirksamkeit einer antioxidanzientherapie (mullan u. mccloskey ) , der in zahlreichen studien für folgende substanzen nicht erbracht werden konnte: superoxiddismutase, katalase, glutathionperoxidase, ascorbinsäure, glutathion, harnsäure, α-tocopherol, karotinoide, der xanthinoxidasehemmer allopurinol, lazaroide, pyruvat (fink ) , der hemmung der komplementaktivierung (ciurana u. hack ) , von parp-inhibitoren (szabó u. liaudet ; liaudet et al. ) oder der inhibition der map-kinasen (tulleken et al. ). hrv-td zeitdomäne der herzfrequenzvariabilität; hrv-fd frequenzdomäne der herzfrequenzvariabilität zusätzlich zu den intrinischen anpassungsmechanismen der neurohumoralen und auto-/parakrinen regelkreise im schock können bakterientoxine (endotoxin) und möglicherweise auch mediatoren eine fehlstellung der stellglieder induzieren (schmidt et al. ; schmidt u. müller-werdan ) : sowohl die baro-als auch die chemorefl exsensitiät und ebenso die herzfrequenzvariabilität zeigen bei kritisch kranken im schockbedingten mods ausgeprägte, prognosebestimmende einschränkungen (. tabelle . ; abschn. . . ). auf welcher ebene toxine und mediatoren diese autonome dysfunktion bewirken -zentralnervensystem, autonomes nervensystem, zielzelle (. abb. . ) -bleibt noch zu klären; experimentell ist bei spontan schlagenden neonatalen kardiomyozyten (»schrittmacherzellen«) durch züchtung der zellen in endotoxin eine einschränkung der schlagfrequenzvariabilität zu erzielen, ohne dass dabei das autonome nervensystem involviert ist (schmidt et al. ). ) schock bedeutet für den patienten immer eine lebensbedrohliche notfallsituation. er erfordert ein sofortiges handeln, beginnend in der prähospitalphase (christ u. lackner ) , fortgesetzt in der notaufnahme (laggner ) und schließlich auf der intensivstation. bei der erstversorgung müssen basisdiagnostik und basistherapie zum frühestmöglichen zeitpunkt begonnen werden. diese basisversorgung dient primär der kreislaufstabilisierung und gilt für alle schockformen. sie mündet nach feststellung der schockform in eine schockformspezifi sche behandlung. je kürzer die schockdauer ist, je schneller die stabilisierung des kreislaufs erreicht wird und je früher die schockformspezifi sche behandlung begonnen werden kann, um so günstiger die prognose. patienten, bei denen ein kreislaufschock vermutet wird, sollten auf der intensivstation weiter betreut und behandelt werden. die in der . Übersicht . aufgeführten technischen untersuchungen schließen sich an. patienten mit unklarer schockätiologie oder mit einer sich nach volumensubstitution nicht rasch stabilisierenden kreislaufl abilität sollten baldmöglichst einem invasiven hämodynamischen monitoring unterzogen werden ( abschn. . . ). extremitäten. blutungen und thromboembolische komplikationen können bei diesen patienten auf eine verbrauchskoagulopathie hinweisen. kranke mit einem septischen fieber und neutropenie weisen häufi g keinen fokus auf; der septische schock kann sowohl mit hohem fieber als auch mit hypothermie einhergehen. das klinische bild des schockpatienten ändert sich mit der behandlung (laggner ) : der unbehandelte patient mit septischem schock in der notaufnahme ist ein patient mit zentralisiertem, »kühlem« schock, der behandelte patient mit septischem schock auf der intensivstation zeigt das »klassische« bild des »warmen«, hyperzirkulatorischen schocks (. tabelle . ). das vorgehen bei klinischem schockverdacht im rahmen der erstversorgung zeigt die . Übersicht . . empfehlungen zur klinisch-hämodynamischen basisdiagnostik bei kardiogenem schock sind der . Übersicht . zu entnehmen. die höhe der troponin-und ck-mb-anstiege und das flächenintegral korrelieren zwar mit der infarktausdehnung und der ungünstigen prognose, ein cut-off-wert für den infarktbedingten kardiogenen schock kann allerdings nicht angegeben werden. ein nicht unerheblicher anteil (> %) der patienten mit schwerer sepsis und septischem schock zeigt erhöhte troponinserumspiegel und weist damit auf eine myokardschädigung in der sepsis hin. patienten mit erhöhten troponinwerten haben eine ungünstigere prognose (spies et al. bei schwerer sepsis und septischem schock scheint das serielle pro-nt-bnp-monitorig innerhalb der ersten tage nach diagnosestellung prognostische bedeutung zu haben: während bei den später versterbenden die pro-nt-bnp-spiegel stark erhöht bleiben oder sogar weiter ansteigen, sinken sie bei den Überlebenden signifi kant ab. gerinnungsparameter. da patienten mit akuten kardialen erkrankungen in der regel antithrombotische, antithrombozytäre und fi brinolytische substanzen singulär oder in kombination erhalten, ist die standardmäßige bestimmung von parametern der blutgerinnung obligat: thrombozyten, aptt, prothrombinzeit, fibrinogenkonzentration, d-dimere (bei verdacht auf beinvenenthrombose, lungenembolie). sobald die umstände dies gestatten, sollten vorrangig ein ekg und eine thoraxröntgenaufnahme angefertigt werden. bildgebende (janssens ; und invasive verfahren (s. unten), evtl. kombiniert mit interventionellen maßnahmen, ergänzen die diagnostik und bieten erste therapeutische ansätze. das monitoring und entsprechende therapeutische konsequenzen sind in den . Übersichten . und . wiedergegeben (müller- arterielle druckmessung. bei allen patienten mit kreislaufschock sollte eine kontinuierliche, blutige arterielle druckmessung erfolgen, da die manuelle messung mit der manschette oder mit nichtinvasiven oszillometrischen techniken aufgrund der zentralisierung und vasokonstriktion unzuverlässig. ist. in der regel wird dafür die a. radialis kanüliert; bei schwerster zentralisation sollte allerdings die a. femoralis bevorzugt werden. zentraler venendruck. die messung des zentralen venendrucks ist bei kritisch kranken, insbesondere schockpatienten, für das hämodynamische monitoring normalerweise nicht genügend, eine abschätzung der linksventrikulären vorlast kann damit nicht ausreichend sicher durchgeführt werden, ebenso wenig wie mit der klinischen einschätzung allein. für die therapieoptimierung des patienten im kardiogenen shock ist die kenntnis des herzzeitvolumen (hzv) zwingend erforderlich. das hzv ist die regelgröße des herz-kreislauf-systems und wird im wesentlichen durch vorlast, nachlast und kontraktilität sowie die herzfrequenz bestimmt. klassische klinische zeichen wie blutdruck, urinausscheidung, halsvenenfüllung, hautperfusion und hautturgor erlauben keine zuverlässige einschätzung der hämodynamik beim schwerkranken intensivpatienten (eisenberg et al. ) . pulmonalarterienkatheter. der pulmonalarterienkatheter (pak) ist weiterhin ein grundpfeiler der erweiterten hämodynamischen Überwachung bei patienten mit kardiogenem schock (flieger et al. ; janssens bruch et al. ( ) f für das prognoserelevante monitoring weniger geeignet (müller-werdan u. werdan ) als anfangs gedacht. der grad der regionalen gewebeoxygenierung im schock ist spektroskopisch durch messung der hämoglobin-o -sättigung und des cytochrom-aa -redoxstatus möglich (beilman et al. ) . während die kontinuierliche messung der co -atemgaskonzentration (kapnographie) v. a. in der notfallmedizin und in der kardiopulmonalen reanimation zur beurteilung von kreislauf-und respiratorischer funktion zum einsatz kommt, ist die sublinguale kapnometrie (messung des sublingualen co -partialdrucks) ein neues, nichtinvasives verfahren zur beurteilung des schweregrades und der prognose von schockzuständen (weil et al. ). bei patienten mit akutem koronarsyndrom wurden klinische modelle entwickelt, die zuverlässig das auftreten eines kardiogenen schocks im weiteren verlauf vorhersagen können. für den patienten mit st-strecken-elevations-myokardinfarkt (stemi) erfolgte dies auf der grundlage der gusto-i-und -iii-studiendaten (. tabelle . ). dieser risiko-score, der innerhalb weniger minuten in der notaufnahme erhoben werden kann, erlaubt auf schnelle und unkomplizierte weise, eine frühzeitige abschätzung des risikos einer schockentstehung im weiteren klinischen verlauf (hasdai et al. b das grundsätzliche ziel der symptomatischen schocktherapie ist die wiederherstellung einer suffi zienten durchblutung der vitalorgane und gewebe, ehe sich ein zellschaden ausbilden kann. dies erfordert einen ausreichenden herzindex und blutdruck. kurze perioden einer ausgeprägten minderperfusion werden besser toleriert als gravierende blutdruckabfälle. die aufrechterhaltung eines mittleren blutdrucks von mehr als - mmhg hat initial priorität vor dem anheben des herzindex auf werte von > , l/min/m im falle des kardiogenen und obstruktiven bzw. > , - , l/min/m beim septischen und beim volumensubstituierten hämorrhagischen schock. die durchblutung sollte zumindest so gesteigert werden, dass der arterielle laktatspiegel unter , meq/l verbleibt, eine weitgehende garantie dafür, dass der stoffwechsel weiter ae- nicht länger als s sollte die intubation als sicherste beatmungsmethode in anspruch nehmen. die intubation (klasse-i-empfehlung) sollte nur durch sehr gut trainierte personen praktiziert werden. im zweifelsfall ist (auch aus juristischen gründen) die leichter zu beherrschende maskenatmung (beatmung immer mit % sauerstoff) anzuwenden. larynxmaske oder kombi-tubus gelten als klasse-ii-option. der (peripher-)venöse zugang ist ebenfalls eine klasse-i-intervention. die anfl utzeit der medikamente beträgt - min. aufgrund vielfältiger komplikationsmöglichkeiten wird die anlage eines zentralvenösen zugangs nur in ausnahmefällen als indiziert angesehen. alternativ besteht insbesondere bei kindern, aber auch bei erwachsenen die möglichkeit, medikamente über eine intraossäre kanüle zu applizieren; dies wird unterhalb der tuberositas tibialis in der markhöhle platziert und ermöglicht neben der gabe von medikamenten auch die infusion von flüssigkeit. f f f f > adrenalin, atropin und lidocain können in notfällen auch endobronchial über den tubus gegeben werden ( abschn. . . ). hierbei muss dann die dosis mindestens verdoppelt ( -bis , fach) in ml , %igem nacl appliziert werden. adrenalin ist das einzige routinemäßig empfohlene medikament, alle anderen, z. b. antiarrhythmika, natriumbikarbonat, kalzium-und magnesiumzubereitungen, sind speziellen reanimationssituationen vorbehalten. adrenalin. die standarddosis ist mg i.v. alle - min bis zur kreislaufstabilisierung, gefolgt von jeweils ml i.v.-spülvolumen. dosen über mg haben bestenfalls den primären, nicht jedoch den langfristigen reanimationserfolg verbessern können (gueugniaud et al. ). höhere adrenalindosen korrelieren sogar mit einem ungünstigen neurologischen defi zit (behringer et al. ) . dennoch sehen die empfehlungen im verlauf der reanimation eine eskalation der adrenalindosis auf bis zu , mg/kgkg alle - min im sinne einer klasse-ii-empfehlung vor. vasopressin. ermutigend, aber noch nicht standardempfehlung, ist die wirkung von vasopressin ( ie i.v.), das in vergleichsstudien mit adrenalin zumindest gleichwertig, bei nachweis einer asystolie sogar vorteilhaft war (wenzel et al. ) . im falle eines adrenalinrefraktären schocks infolge kammerfl immerns bei erwachsenen gilt vasopressin als klasse-iia-empfehlung. atropin. in einer dosierung von mg als bolus i.v. alle - min bis zu einer gesamtdosis von , mg/kgkg ist atropin indiziert bei asystolie und pulsloser elektrischer aktivität. die dosis von mg atropin sollte nicht unterschritten werden, da es bei niedrigeren dosen zu paradoxen effekten (bradykardien) kommen kann. bei symptomatischen bradykardien tritt die atropingabe hinter die transvenöse oder behelfsweise transkutane stimulation zurück. amiodaron. amiodaron wird empfohlen bei persistenz von kammertachykardie oder kammerfl immern nach defi brillation und adrenalingabe (dorian et al. ) . initial wird eine rasche -mg-infusion in - ml kochsalz-oder glukoselösung gegeben, ggf. gefolgt von einer infusion mit mg/ min für h und anschließend , mg/min bis zu einem täglichen maximum von g. die gabe von lidocain ist generell nicht als routinemaßnahme zu sehen, auch nicht bei patienten mit akutem myokardinfarkt! in einer dosis von , - , mg/kgkg i.v. kann lidocain bei kammerfl immern/pulsloser kammertachykardie nach erfolgloser defi brillation und adrenalingabe verabreicht werden (wirksamkeit als unsicher eingestuft), ggf. gefolgt von weiteren , - , mg/kgkg innerhalb von - min (maximaldosis mg/kgkg oder - mg/h). lidocain stellt z. z. allerdings bei dieser indikation im vergleich zu amiodaron nur ein antiarrhythmikum der zweiten wahl dar. > ! > . · therapieprinzipien bei schock zur rezidivprophylaxe nach erfolgreicher defi brillation oder kardioversion kann lidocain in einer dosierung von , - , mg/kgkg gegeben werden, gefolgt von ml nacl , %, mit einer anschließenden dauerinfusion von - mg/ kgkg/h. vor einer defi brillation angewandt, erhöht lidocain eher die defi brillationsschwelle. monomorphe kammertachykardien nicht primär ischämischer genese können mit lidocain nur zu etwa % unterbrochen werden. dagegen ist ajmalin ( , mg/kgkg i.v.) mit einer %igen erfolgsrate wesentlich effektiver. natriumbikarbonat. da eine bedeutsame arterielle azidose während der kardiopulmonalen reanimationssituation in der regel durch eine unzureichende ventilation begründet ist und nahco selbst zu einem paradoxen intrazellulären co -anstieg führen kann, ist die gabe von natriumbikarbonat üblicherweise nicht indiziert. in speziellen situationen kann die gabe von bikarbonat allerdings hilfreich sein: bei vorbestehender metabolischer azidose, bei hyperkaliämie und bei intoxikationen mit trizyklischen antidepressiva oder phenobarbital. nach protrahiertem herz-kreislauf-stillstand oder langdauernden wiederbelebungsbemühungen -nach ineffektiver defi brillation, herzmassage, intubation, beatmung und vasopressorentherapiekann bikarbonat ( meq/kgkg als initiale dosis) von nutzen sein. andere puffersubstanzen haben bisher keinen eingang in die offi zielle empfehlung gefunden. elektrolyte: kalzium, magnesium. eine kalziumgabe als routinemaßnahme kann nicht empfohlen werden. nur im falle einer hypokalzämie, einer hyperkaliämie oder einer intoxikation mit kalziumantagonisten ist die gabe von kalzium bedingt indiziert (klasse-iib-empfehlung): %ige kalziumchloridlösung in einer dosis von - mg/kgkg, wiederholung in -minütigen intervallen möglich. die applikation von magnesium (intravenöse gabe von - g magnesiumsulfat in - min) ist indiziert bei bestätigter hypomagnesiämie und refraktärem oder rezidivierendem kammerfl immern. ebenfalls indiziert ist die intravenöse gabe von - g magnesiumsulfat bei torsade-de-pointes-tachykardien. enttäuschend war bisher der einsatz der transkutanen antibradykarden stimulation in einer studie mit patienten mit herz-kreislauf-stillstand. weder bei asystolie noch überbrückend nach defi brillation mit nachfolgender asystolie konnte dadurch der ausgang der prähospitalen kardiopulmonalen reanimation entscheidend effi zienter gestaltet werden (literatur in . in mehreren studien konnte gezeigt werden, dass nach kardiopulmonaler reanimation durch die induktion einer milden therapeutischen hypothermie mit temperaturen zwischen und °c eine verbesserung des Überlebens und der neurologischen funktion erreicht werden kann (bernard et al. ; group thacas ) ; aufgrund der guten ergebnisse ist das > »cooling« nach cpr bei herzstillstand infolge kammerfl immerns als klasse-i-maßnahme in die ilcor-empfehlungen eingegangen (nolan et al. ) . nach eventueller durchführung von reanimationsmaßnahmen erfolgt die stabilisierung des herz-kreislauf-systems und der lungenfunktion. zur herz-kreislauf-stabilisierung dienen kristalloide und kolloide plasmaersatzlösungen sowie der einsatz von katecholaminen ( abschn. . . und . . ). dazu dienen auch anxiolyse und analgesie, relaxierung zur einsparung von sedativa und die beseitigung von fieber (hyperthermie steigert den o -verbrauch um %/°c). ebenfalls beachtet werden müssen die negativen auswirkungen der peep-beatmung auf die herzfunktion (zunahme der rechtsventrikulären nachlast, zunahme des rechtsventrikulären durchmessers und abnahme der linksventrikulären diastolischen dehnbarkeit, direkte myokarddepressive wirkung), ebenso bei kontrollierter mechanischer (»controlled mechanical ventilation«, cmv) oder intermittierender ventilation (»intermittent mandatory ventilation«, imv). die langwierige und schwierige weaning-off-phase gerade bei herzkranken und schockpatienten kann durch einhalten standardisierter protokolle erleichtert werden (lehmann et al. ; seige et al. ) . die myokarddepression kann weiterhin verstärkt werden durch anästhetika und barbiturate. während benzodiazepine und opioide für sich keine relevante myokarddepression hervorrufen (mit ausnahme von meperiden), können sie in kombination einen additiven negativ-inotropen effekt induzieren. > > evidenzbasierte empfehlungen zur beatmung des schockpatienten, speziell des patienten mit kardiogenem schock, gibt es z. z. noch nicht (kontoyannis et al. ; lesage et al. ). bei Überwiegen der vorteile der maschinellen beatmung bei patienten mit kardiogenem schock (reduktion der kardialen vor-und nachlast, abnahme der pulmonalen stauung, reduktion der atemarbeit) erscheint eine eher großzügige indikationsstellung bei diesen patienten gerechtfertigt. ein engmaschiges kardiopulmonales monitoring und ein rasches anpassen der beatmung an Änderungen der herzfunktion ist angebracht (lehmann et al. ; seige et al. ). antiarrhythmische therapie. ein spezifi sches muster an rhythmusstörungen ist für den schockpatienten nicht dokumentiert. dennoch muss häufi g mit potenziell malignen rhythmusstörungen gerechnet und entsprechend behandelt werden. die im kardiogenen schock meist vorhandene hochgradige pumpfunktionseinschränkung reduziert die frequenztoleranz des patienten beträchtlich und birgt so die gefahr einer weiteren verschlechterung der schockzustandes, falls die hämodynamisch relevante rhythmusstörung nicht rasch beseitigt wird. abhängig von der klinischen situation (z. b. kardiogener schock bei herzinfarkt) kann eine schmerzbehandlung und eine analgosedierung erforderlich werden (ruß et al. ) . intravenöse morphinbolusgaben ( - mg i.v. alle - min bis zu einer gesamtdosis von - mg/kgkg) sind, z. b. in den ersten stunden eines herzinfarktes, das mittel der wahl. auf eine mögliche blutdrucksenkung infolge einer direkten und indirekten hemmung des sympathikus muss geachtet werden, v. a. bei relativer hypovolämie. im kreislaufschock kann die morphinclearance durch die minderperfusion der leber eingeschränkt sein. morphin hemmt nicht nur den schmerz, sondern trägt auch zur senkung des o -verbrauchs bei. der wichtigste parameter der metabolischen azidose ist der laktatanstieg. die anhebung des extrazellulären ph-werts mit bikarbonat führt nicht immer zum gewünschten erfolg des intrazellulären ph-anstiegs, der zudem eine linksverschiebung der hämoglobindissoziationskurve und damit eine erschwerte o -abgabe an das gewebe bewirkt. die therapie der laktatazidose kann aber zu einer besserung der systemischen und hepatischen zirkulation führen, die ihrerseits zum abbau verbleibenden laktats beiträgt. der therapeutische einsatz von bikarbonat sollte auf ph-werte von , - , beschränkt bleiben. klinisch wurde die hämodynamik von schockpatienten durch bikarbonat auch bei ausgeprägter azidose nicht verbessert (cooper et al. ); eine isolierte stimulation der pyruvatdehydrogenase mit dichloracetat senkte bei laktatazidose die hohe letalität von % nicht (stacpoole et al. ). ob kollodiale oder kristalloide lösungen zur volumensubstitution besser geeignet sind, wird seit langem kontrovers diskutiert; die art der lösung scheint allerdings für den therapieerfolg nur eine untergeordnete rolle zu spielen. unterschiede bezüglich morbidität und letalität konnten für verschiedene flüssigkeitsregimes bisher nicht eindeutig gezeigt werden (kreimeier u. prückner ; ; task force of the american college of critical care medicine, society of critical care medicine ). kristalloide lösungen sind kostengünstig, leicht zu lagern, steigern ausreichend die diurese und können zusätzlich extravasale flüssigkeitsverluste bei dehydratationszuständen ersetzen. nachteilig sind das auftreten ausgeprägter peripherer Ödeme und die relativ kurze hämodynamische wirksamkeit (. tabelle . ). am häufi gsten kommen physiologische ( , %ige) kochsalzlösung und vollelektrolyte (z. b. ringer-laktatlösung) zum einsatz, die sich beide gleichermaßen im intravasalraum und im interstitium verteilen; nach h fi nden sich aber nur noch weniger als % des infundierten volumens in der zirkulation. beide lösungen senken den kolloidosmotischen druck. im vergleich zu kolloidalen lösungen muss etwa das -bis fache des intravasalen flüssigkeitsdefi zits an kristalloider flüssigkeit zur erzielung einer vorübergehenden normovolämie infundiert werden. %ige glukoselösung fi ndet sich h nach infusion nur noch zu % im intravasalraum; sie erhöht neben dem volumen des extrazellulärraums unerwünschterweise auch das des intrazellulärraums (infolge des wassereinstroms in die zellen zum ausgleich des infusionsbedingten osmotischen gradienten). sie sollte deshalb zur volumentherapie nicht verwendet werden. zu den kollodialen lösungen zählen albumin, hydroxyäthylstärke, dextran und gelatine (. tabelle . ). diese verbleiben zunächst vorwiegend im intravasalraum und stellen dort den plasmaonkotischen druck wieder her. sie führen demzufolge in geringerem ausmaß zu peripheren Ödemen, und es genügen kleinere volumina zur substitution als beim einsatz von kristalloiden lösungen. nachteile sind neben den hohen kosten die bekannten, substanzeigenen nebenwirkungen (s. unten). dass kolloidale lösungen v. a. bei der sepsis mit ihrer erhöhten kapillarpermeabilität das auftreten eines lungenödems fördern, ist viel diskutiert, aber bisher nicht gesichert worden. von den kolloidalen substanzen wird in deutschland am häufi gsten hydroxyäthylstärke eingesetzt. für die initiale volumentherapie mit kolloidalen lösungen erscheinen %ige lösungen von mittelmolekularer hydroxyäthylstärke (hes . / , oder . / , ) sowie die %ige dextran- -lösung (macrodex) am besten geeignet. nicht nur wegen der limitierten tagesdosen können die kolloidalen lösungen mit kristalloiden (z. b. im verhältnis : ) kombiniert werden. die derzeitige datenlage spricht dafür, dass das kolloid der zukunft eine stärkepräparation der dritten genera-> . · therapieprinzipien bei schock tion (hes / ; . tabelle . ) sein wird (boldt ; dieterich ) . albumin. albumin fi ndet als %ige (kolloidosmotischer druck ca. mmhg) und als -bis %ige lösung (kolloidosmotischer druck ca. - mmhg) verwendung und verbleibt relativ lange im intravasalraum (> % nach h). bei hypovolämie ist initial eher die %ige lösung angebracht; bei ödematösen patienten kann die verwendung der hyperonkotischen albuminlösung eine erwünschte flüssigkeitsverschiebung aus dem interstitium in den intravasalraum bewirken. beim direkten studienvergleich der volumensubstitution kritisch kranker erbrachten die gabe von albumin im vergleich zu kochsalzlösung keine unterschiede hinsichtlich letalität und morbidität (safe study investigators ). kristalloide und synthetische kolloidale lösungen haben das humanalbumin bei der volumentherapie weitgehend ersetzt; geblieben ist beim erwachsenen als indikation eine hypalbuminämie < , g/dl bzw. ein gesamteiweiß < , - , g/dl. es ist jedoch nicht sinnvoll, eine hypalbuminämie als folge eines kapillären lecks (wie bei der sepsis) mit albumin vollständig auszugleichen, da dieses mit einer halbwertszeit von - h aus dem intravasal-in den extravasalraum abwandert. der absolutwert des kolloidosmotischen drucks hat sich als parameter zur albuminsubstitution nicht durchgesetzt. unerwünschte, in der regel milde nebenwirkungen (fieber, schüttelfrost, urtikaria) treten mit einer häufi gkeit von ca. , % auf; die blutgerinnung wird nicht beeinträchtigt. bei der infusion großer albuminmengen kann es zu einer senkung des ionisierten plasmakalziums kommen. > dextrane. dextrane sind hochmolekulare lineare polysaccharide mit vereinzelten seitenketten, gelöst in physiologischer kochsalzlösung. sie werden entsprechend ihrer molekularmasse entweder direkt (mg < . ) oder nach enzymdegradation, bevorzugt renal, eliminiert. durch den hohen kolloidosmotischen druck füllt die %ige dextran- -lösung den intravasalraum durch einen ausgeprägten einstrom aus dem interstitium auf, was im schock mit gestörter mikrozirkulation erwünscht, bei einem depletierten extrazellulärraum jedoch eher unerwünscht ist. dextran reduziert die geldrollenbildung der erythrozyten, und es soll auch die gewebeoxygenierung verbessern. hydroxyäthylstärkepräparationen. im deutschsprachigen raum ist hydroxyäthylstärke (hes) sicherlich die am häufi gsten eingesetzte substanz zur therapie der hypovolämie. hes-lösungen werden aus kartoffel-oder maisstärke produziert innerhalb der letzten jahre ist es zur entwicklung deutlich verbesserter hes-präparationen ( . generation: / ; . generation: / , / , / , ; . generation: / ; . tabelle . ) hinsichtlich intravasalem hes-abbau und nebenwirkungsprofi l -res-speicherung oder nephrotoxität (s. unten) -gekommen (boldt in einem cross-over-vergleich bei kritisch kranken erzielte die gabe von ml albumin % eine zunahme des plasmavolumens min nach infusionsende um ml, nach l ringer-laktatlösung waren es dagegen kurzfristig maximal ml. wesentliche verbesserungen der hämodynamik und des o -transports korrelieren eindeutig mit der plasmaexpansion. sie sind nach gabe kristalloider lösungen entweder gar nicht oder wesentlich schwächer als nach infusion kolloidaler lösungen nachweisbar. die wirksamkeit der einzelnen kolloidalen lösungen untereinander scheint vergleichbar (. tabelle . ), die wirkdauer der hes-lösungen dagegen länger als die der %igen albuminlösung. lungenfunktion. bei der diskussion um die ideale volumenersatzlösung spielt die potenzielle gefahr der auslösung eines lungenödems eine entscheidende rolle. verfechter des einsatzes kolloidaler lösungen führen an, dass kristalloide flüssigkeiten den kolloidosmotischen druck (kod) nachhaltig erniedrigen und damit diese gefahr hervorrufen. befürworter des einsatzes kristalloider lösungen fürchten dagegen bei der anwendung kolloidaler lösungen einen verstärkten abstrom kolloidosmotisch wirksamer moleküle durch die geschädigte alveolokapilläre membran ins interstitium, verbunden mit einem anstieg des extravaskulären kod und damit der gefahr der ausbildung oder verstärkung eines lungenödems. eindeutige vorteile hinsichtlich der organperfusion sind weder für kristalloide noch für kolloidale lösungen bei der volumensubstitution kritisch kranker überzeugend belegt (müller-werdan u. . als zielkriterien einer adäquaten flüssigkeitssubstitution des schocks dienen zunächst klinische parameter wie herzfrequenz, diurese und blutdruck, die sich in den physiologischen bereichen bewegen sollten. bei ausbleiben einer raschen hämodynamischen stabilisierung und bei patienten mit bereits vorbestehender eingeschränkter herzfunktion empfi ehlt sich das invasive monitoring mittels pulmonalarterienkatheter ( abschn. . . ). während der volumensubstitution muss mit dilutionsbedingtem abfallen von hämatokrit und hb ( - g/dl) gerechnet werden, die in der regel auch akzeptiert werden können: bei einem hämatokritwert von % liegt eine maximale o -transportkapazität ohne gefahr einer gewebehypoxie vor. während der primären volumentherapie -in der initialen phase der hypovolämie -ist aus diesem grund ein hb-wert von - , g/dl bzw. ein hämatokrit von - % als ausreichend anzusehen. nachfolgend -bei normovolämie, erzielt durch volumengabe -ist eine substitution von erythrozytenkonzentraten erst ab hb-werten < - , g/dl indiziert > kritisch kranke. bei kritisch kranken ist eine mäßige anämie infolge eines okkulten blutverlustes und einer supprimierten erythropoese nicht selten. Übereinstimmung besteht darüber, dass patienten mit akuter anämie und einem hämoglobinwert von ≤ g/dl und darunter entsprechend den allgemeinen empfehlungen (simon et al. ) mit erythrozytentransfusionen substituiert werden sollten. dagegen konnte bei kritisch kranken mit hb-werten von - g/dl durch erythrozytentransfusionen die prognose nicht verbessert werden (hebert et al. ) . mögliche günstige effekte der transfusion könnten durch ungünstige reaktionen -wie rheologische störungen gealterter transfundierter erythrozyten, störungen der immunfunktion infolge der transfusion nicht leukozytengefi lterter erythrozyten (blumberg u. heal ) -wieder zunichte gemacht werden. sepsispatienten. die gabe eines erythrozytenkonzentrates erbrachte bei anämischen (hb < g/dl) sepsispatienten keine verbesserung der o -utilisation, weder global (vo ) noch regional (magentonometrie). beobachtet wurde eine %ige zunahme des linskventrikulären schlagarbeitsindex, aber auch eine ungünstige, %ige zunahme des pumonalvaskulären widerstands (fernandes et al. ) . bei patienten mit schwerer sepsis und septischem schock mit einem hämatokrit < % und gleichzeitig einer auf < % erniedrigten zentralvenösen sauerstoffsättigung (s cv o ) wird die gabe von erythrozytenkonzentraten zur anhebung des hämatokrits auf ≥ % empfohlen, zumindest in der frühphase der sepsis innerhalb der ersten h auf der notaufnahme (rivers et al. ) . ansonsten gilt die empfehlung, erythrozytenkonzentrate bei einem hämoglobinwert < , g/dl (< g/l) zu geben und das hb auf einen wert von , - , g/dl anzuheben (dellinger et al. ). kritisch kranke. die verminderte erythropoetinbildung beim anämischen kritisch kranken und der hohe anteil von knapp % transfundierten intensivpatienten bilden die rationale für die erprobung einer erythropetingabe (epo) bei intensivpatienten: im rahmen einer studie mit intensivpatienten wurden wöchentlich -bis zu -mal - . einheiten rhuepo bzw. placebo gegeben. die epo-gabe reduzierte den prozentsatz transfusionspfl ichtiger patienten von , auf , % und die zahl der transfusionen um %, wobei der hb-anstieg mit , g/dl stärker ausfi el als in der placebogruppe ( , g/dl). die letalität der epo-gruppe war mit % nicht unterschiedlich im vergleich zu der der placebogruppe (corwin et al. ) . der nutzen dieser epo-gabe bei intensivpatienten wird z. z. kritisch gesehen (eckardt ) . sepsispatienten. bei patienten mit schwerer sepsis wird erythropoetin zur behandlung einer anämie nicht empfohlen (dellinger et al. ). mit ausnahme des hypovolämisch-traumatischen schocks mit versorgungsengpässen gibt es bei allen anderen schock-formen z. z. für den einsatz hyperton-onkotischer lösungen keine indikation (meier-hellman u. burgard ). im wesentlichen sind es die katecholamine dobutamin, dopamin, noradrenalin und adrenalin (. tabelle . ) und die phosphodiesterasehemmstoffe amrinon, milrinon und enoximon, (. tabelle . ), deren positiv-inotrope wirkung ausgenutzt werden kann . sie werden eingesetzt, um die herz-kreislauf-schädigung zu kompensieren und damit die durchblutung und die o -versorgung der vitalorgane sicherzustellen. bei den klinischen symptomen eines kardiogenen schocks ist dobutamin (positiv-inotrope wirkung, mittel der . wahl bei > akutem myokardinfarkt; - µg/kgkg/min) und ggf. zusätzlich noradrenalin (positiv-inotrope und vasokonstriktorische wirkung; , - , µg/kgkg/min) indiziert; burchardi et al. ; . es handelt sich dabei um eine symptomatische, nicht um eine kausale therapie. bei vergleichbarer positiv-inotroper wirkung beeinfl ussen katecholamine herzfrequenz, blutdruck und gefäßwiderstand sowie den linksventrikulär-enddiastolischen füllungsdruck am gesunden herzen in unterschiedlicher weise (. tabelle . ; burchardi et al. ; : adrenalin wirkt am stärksten, noradrenalin am wenigsten positiv-chronotrop. vor allem noradrenalin erhöht den gefäßwiderstand und damit den blutdruck; in höheren konzentrationen tun dies allerdings auch dopamin und adrenalin. bei sepsis und schock können desensibilisierungsprozesse und toxin-und mediatorschädigungen das ansprechen auf katecholamine ganz erheblich beeinträchtigen ( abschn. . . ). . dosisbereich ( (hochman et al. ) . fragt man sich dann aber, wie denn die wirksamkeit der katecholamintherapie gesichert sei, so wird man enttäuscht: weder für den kardiogenen noch für den septischen schock gibt es hinsichtlich einer möglichen letalitätssenkung evidenzbasierte daten! lediglich für die behandlung der akuten herzinsuffi zienz fi ndet sich in der literatur eine metaanalyse, die sich mit der wirksamkeit von intravenös applizierbaren, über den adrenergen signalweg wirksamen inotropen substanzen -vorwiegend dobutamin, dopamin, dopexamin und phosphodiesterasehemmer -beschäftigt (thackray et al. ) . das ergebnis der kleinen studien mit geringer statistischer aussagekraft ( studien mit insgesamt patienten) ist enttäuschend: nicht eine letalitätssenkung, sondern eine im trend höhere sterblichkeit wurde bei dem einsatz der inotropen substanzen gefunden (odds-ratio , ; %iges konfidenzintervall , - , ). wegen der potenziell unerwünschten und gefährlichen nebenwirkungen der katecholamintherapie -wie die infl ammationsinduktion sowohl systemisch als auch im herzen selbst schwertz et al. ) -sollte man beim einsatz von katecholaminen im schock eher zurückhaltend sein. während dobutamin den linksventrikulär-enddiastolischen druck entweder unbeeinfl usst lässt oder ihn sogar geringfügig senkt, wird er durch dopamin meistens etwas gesteigert. die ursache dafür dürfte ein erhöhter venöser rückstrom durch eine α-adrenozeptorvermittelte venokonstriktion sein. bei der volumensubstitution des septischen schocks mit dobutamin können deshalb größere flüssigkeitsmengen erforderlich werden als im falle des dopamins müller-werdan u. werdan ; task force of the american college of critical care medicine, society of critical care medicine ). dobutamin ist das katecholamin der wahl zur therapie der eingeschränkten pumpfunktion der septischen kardiomyopathie! dagegen ist nach der empfehlung einer deutschen expertenkommission dopamin kein katecholamin der ersten wahl bei der therapie des septischen schocks in kontrollierten studien konnte durch dopamin in »nierendosis« ( , - - µg/kgkg/min) keinerlei nephroprotektiver effekt und auch keine prognoseverbesserung dokumentiert werden. der routinemäßige einsatz von niedrigdosiertem dopamin zur nephroprotektion bei schock-, mods-und sepsispatienten kann demzufolge nicht empfohlen werden dellinger et al. ; . bei patienten mit septischem schock zeigen katecholamine (dobutamin) eine geringere positiv-inotrope wirkung als bei patienten mit sepsis ohne schock (silverman et al. ) . diese katecholamintoleranz ist zumindest partiell auf eine dysregulation des β-adrenozeptor-adenylatzyklase-systems zurückzuführen (down-regulation der β -adrenozeptoren; hochregulation der inhibitorischen g-proteine), hervorgerufen durch endogene und pharmakologisch applizierte katecholamine, sowie durch zytokine u. a. sepsismediatoren (. abb. . a,b; müller- werdan et al. ; reithmann et al. ; silverman et al. ) . sie lässt sich zumindest partiell durch eine steigerung der katecholamindosis ausgleichen. da diese β -adrenozeptor-adenylatzyklase-desensibilisierung jedoch alle am myokardialen β -adrenozeptor angreifenden katecholamine in gleichem maße betrifft, resultieren daraus keine differenzialtherapeutischen konsequenzen. Über den erfolgreichen einsatz von β-rezeptorenblockern zur verbesserung der katecholaminansprechbarkeit wurde bisher beim patienten mit schock noch nicht berichtet. auch die gefäße zeigen im septischen schock eine katecholamintoleranz mit einer abgeschwächten bis fehlenden vasokonstriktion auf α-adrenozeptoragonisten. in diesem falle scheint jedoch nicht die im tierexperiment bei sepsis und endotoxinämie gefundene abnahme der zahl der gefäß-α-adrenozeptoren die entscheidende rolle zu spielen, sondern vielmehr das vermehrt gebildete stickoxid. durch hemmstoffe der stickoxidsynthase lässt sich im sepsisund endotoxin-tiermodell die stark abgeschwächte vasokonstriktorische katecholaminwirkung wieder restaurieren (. abb. . a,b). die zahl der gefäß-β -adrenozeptoren ist im tierexperiment bei sepsis und endotoxinämie als nicht verändert beschrieben. insbesondere bei kardiogenem schock nach herzoperationen scheinen sich phosphodiesterasehemmstoffe (pde-hemmstoffe; . tabelle . ) als katecholaminbegleittherapie zu bewähren . bei akuter herzinsuffi zienz konnte der pde-hemmer milrinon in einer randomisierten studie lediglich bei patienten mit nichtischämischer herzinsuffi zienz, nicht jedoch im gesamtkollektiv eine letalitätssenkung erzielen, wohingegen bei patienten mit akuter ischämischer herzinsuffi zienz sogar eine letalitätserhöhung erwartet werden muss (cuffe et al. ) . digitalis spielt bei sinusrhythmus in der therapie des kardiogenen schocks als inotropikum keine wesentliche rolle; da-> gegen ist es bei tachykardem vorhoffl immern und vorhoffl attern zur frequenznormalisierung bei schockpatienten das antiarrhythmikum der wahl. als neues therapieprinzip bei akuter herzinsuffi zienz scheint der kalziumsensitzer levosimendan erfolgreich (follath et al. ; kivikko et al. ; moiseyev et al. ) . levosimendan (in deutschland nicht zugelassen) sensibilisiert kalziumabhängig troponin c für kalzium und verbessert damit die kontraktilität des herzmuskels, wobei die diastolische relaxation entweder unbeeinfl usst bleibt oder sogar verbessert wird. durch Öffnung atp-sensitiver kaliumkanäle wirkt levosimendan darüber hinaus vasodilatierend. bei akuter herzinsuffi zienz (herzindex , l/min/m ) war levosimendan (bolus von µg/kgkg über min, danach , µg/ kgkg/min für h) hämodynamisch effektiver als dobutamin ( -tage-letalität in der levosimendangruppe: %, in der dobutamingruppe %; follath et al. ) . Ähnlich günstige effekte von levosimendan wurden für patienten mit akutem herzinfarkt und linksherzinsuffi zienz beschrieben (moiseyev et al. ) . zur senkung der vor-und nachlast dient bei akutem herzinfarkt in . linie nitroglyzerin und in . linie nitroprussidnatrium. nitroglyzerin wird in einer infusionsdosierung von , - , - µg/kgkg/min gegeben; die nitroprussidnatriuminfusi-on wird mit , µg/kgkg/min begonnen und bis zum maximal erwünschten effekt alle min bis zu einer dosis von - µg/ kgkg/min gesteigert; sie kann mit positiv-inotropen pharmaka kombiniert werden (alpert u. becker ) . nesiritide, das endogene b-typ-natriuretische peptid (in deutschland nicht zugelassen), senkt bei dekompensierter herzinsuffi zienz den pulmonarkapillardruck rascher und effektiver als nitroglyzerin. im vergleich zur behandlung mit dobutamin scheint nesiritide (i.v.-bolus , µg/kgkg, anschließend infusion mit , µg/kgkg/min bzw. i.v.-bolus , µg/kgkg, anschließend infusion mit , µg/kgkg/min) rascher eine rekompensation zu bewirken und möglicherweise sogar die prognose zu verbessern (silver et al. klinzing et al. ( ) infundierten vasopressin in einer dosis von , - , u/min, um die gabe von noradrenalin vollständig beenden zu können. ihre ergebnisse zeigen eine deutliche umverteilung des intestinalen blutfl usses zu lasten der magenschleimhaut. im vergleich zu anderen arbeiten wurde allerdings in dieser studie vasopressin nicht im sinne einer substitution bei vasopressinmangel, sondern in einer sehr hohen dosierung eingesetzt. dieselbe arbeitsgruppe hat auch die effekte einer niedrig dosierten ( , u/kgkg/h) vasopressininfusion auf die globale und intestinale hämodynamik untersucht. in dieser untersuchung wurden patienten im septischen schock (noradrenalinbedarf: , - , µg/kgkg/min) mit arginin-vasopressin behandelt. ein adäquate splanchnikusperfusion blieb trotz eines signifi kantem abfalles des herzindexes erhalten. allerdings kam es auch bei dieser niedrigen dosierung zu einer redistribution des blutfl usses zu lasten der gastralen mukosa. auch eine niedrigdosierte vasopressintherapie kann mit einer bedeutsamen gastrointestinalen minderperfusion einhergehen. es gibt hinweise darauf, dass eine restriktive flüssigkeitstherapie kombiniert mit der infusion von vasopressin bei der behandlung einer unkontrollierbaren intraabdominellen blutung zu einer verbesserung der Überlebensrate führt. wer dieses -im tierexperiment überaus erfolgreiche -konzept in die praxis einführen will, muss jedoch wissen, dass es zur zeit noch keine klinischen beweise seiner wirksamkeit gibt. beim septischen schock besteht ein vasopressinmangel. in mehreren untersuchungen konnte gezeigt werden, dass vasopressin sowohl in niedriger als auch in hoher dosierung bei septischen patienten zu einer deutlichen stabilisierung der hämodynamik führt. signifi kante nebenwirkungen traten dabei nicht auf. allerdings gibt es andere untersuchungen, in denen störungen der intestinalen und der hepatischen perfusion und generell der mikrozirkulation nach vaso-> pressininfusion nachgewiesen wurden. solange es so deutlich widersprüchliche erkenntnisse gibt, kann unseres erachtens die gabe von vasopressin im septischen schock nicht generell empfohlen werden, auch wenn die surviving sepsis campaign (. tabelle . ; dellinger et al. ) bei therapierefraktärem septischem schock die zusätzliche gabe von vasopressin ( , - , u/ml) für vertretbar ansieht. der kardiogene schock führt häufi g zu lungenstauung/lungenödem und zum prärenalen nierenversagen und damit zur oligurie. neben der kreislaufstabilisierung können diuretika und hämofi ltration erforderlich werden ( abschn. . . ). das im schock via induktion der inos überschießend produzierte stickoxid (no) zeigt neben seinen erwünschten wirkungen im rahmen der infektabwehr unerwünschte deletäre effekte ( abschn. . . ). insofern erscheint die blockade der überschießenden no-produktion mittels inos-hemmer (argininanaloga wie l-name) sinnvoll. klinische ergebnisse zu diesem therapieprinzip liegen für den septischen und den kardiogenen schock vor. gesicherte relevanz besitzen diese substanzen bei kardiogenem und bei septischem schock. kardiogener schock. der einsatz von thrombolytika und weiteren gerinnungsaktiven substanzen im kardiogenen schock wird in abschn. . . besprochen. gp iib/iiia-rezeptor-antagonisten scheinen neben ihrer thrombozytenaggregationshemmenden auch antiinfl ammatorische eigenschaften zu besitzen (bonz et al. ; köster et al. ; lincoff et al. ) , deren therapeutischer stellenwert aber noch nicht ausreichend abgeschätzt werden kann. nach größeren notfalloperationen muss in ca. % der fälle mit dem auftreten eines einorganversagens, in % mit einem zweiorganversagen, in % mit einem dreiorganversagen und in % mit einem vierorganversagen gerechnet werden; lungen-, nieren-und leberversagen sind dabei mit - % etwa gleich häufi g. die prognose der patienten mit mods ist um so ungünstiger, je mehr organe geschädigt sind und je länger das organversagen anhält. die sterblichkeit nach -, -und -tägiger dauer eines einorganversagens liegt bei , bzw. %, im falle eines zweiorganversagens bei , bzw. %, und bei einem dreiorganversagen bei , bzw. fast %. die aufgeführten zahlen gehen auf untersuchungen zurück, die vor jahren durchgeführt worden sind. bei der ungünstigen prognose des mods hat sich seit mit einer berichteten letalität von % bis mit % zwar eine verbesserung gezeigt, die sterblichkeit ist jedoch weiterhin sehr hoch und weitgehend unabhängig von der art des geschädigten vitalorgans. ein lebensalter > jahre erhöht die letalität auf das doppelte. die mediatoren-/zytokin-hypothese (. abb. . , . und . ) postuliert eine exzessive oder prolongierte produktion von zytokinen durch entzündungszellen, z. b. granulozyten und makrophagen, sowie durch dazu fähige körperzellen, z. b. kardiomyozyten. zu diesen zytokinen gehören interleukin , tumornekrosefaktor α, interleukin- , das auch antiinfl ammatorische teilwirkungen hat, interleukin- u. a. diese zytokine induzieren die produktion fi naler mediatoren wie stickoxid, arachidonsäuremetaboliten, bradykinin und histamin, die neutrophile granulozyten und endothelzellen aktivieren und damit die gewebeschädigung induzieren. die induktion dieser überschießenden infl ammation kann sowohl durch infektiöse stimuli (infektion, sepsis) als auch durch nichtinfektiöse stimuli (sirs; abschn. . ) induziert werden. die mikrozirkulations-und ischämie-/reperfusionshypothese propagiert die ischämie und/oder die gefäßendothelschädigung als ursache des mods, mit inadäquater o -versorgung von geweben und zellen (alleinige ischämie), mit einer ischämie-/reperfusionsschädigung und der generie-! rung von toxischen o -radikalen und/oder gewebeschädigung infolge der endothel-leukozyten-interaktion. diese hypothese favorisiert auch die annahme mehrerer toxischer stimuli in sequenz als auslöser des mods (»two-hit model of mods«). diese hypothese geht von der darmwandtranslokation von bakterien und endotoxinen als mods-ursache aus. bei patienten mit septischem und nichtseptischem mods fi ndet sich eine erhebliche autonome dysfunktion (»uncoupling of biological oscillators«; godin u. buchman ), die sich z. b. als einschränkung der herzfrequenzvariabilität messen lässt (. abb. . a-d). im gegensatz zur autonomen dysfunktion herzkranker mit gesteigerter sympathikusaktivierung scheint diejenige des mods-patienten von einer abschwächung sowohl der sympathikus-als auch der parasympathikusaktivität geprägt zu sein (heinroth et al. ob es allerdings tatsächlich nur eine einheitliche ursache eines einheitlichen mods gibt, muss z. z. noch offen bleiben! viel wahrscheinlicher ist eine multifaktorielle mods-genese unter beteiligung der aufgeführten mechanismen. die komplexität des mods macht es verständlicherweise schwierig, den prognosebestimmenden schweregrad dieses krankheitssyndroms zu beschreiben. score-systeme stel-> len eine möglichkeit dazu dar (graf et al. ) . zwei versuche dieser art sollen hier vorgestellt werden: der schweregrad-der-erkrankung-score apache ii (»acute physiology and chronic health evaluation«) und der sepsisbezogene organversagen-score (sofa-score). in verschiedenen bereichen der medizin werden score-systeme seit längerem zur quantitativen erfassung von befunden eingesetzt. so dient z. b. die glasgow-coma-scale (. tabelle . ) zur abschätzung des schweregrades einer bewusstseinstrübung. bei patienten einer intensivstation können score-systeme eingesetzt werden, um objektive, quantifi zierbare parameter zu gewinnen zur (graf et al. ; scores (wie der schweregrad-der-erkrankung-score apa-che ii oder der sepsis-score nach elebute u. stoner) kön-f f f f nen am patientenbett innerhalb von - min mit einem auf einem mikrocomputer installierten programm einfach bestimmt und dokumentiert werden (müller- . fortentwicklungen mit noch besserer prognostischer aussagekraft wie der mpm-score, der apache-iii-score und das supportsystem bedürfen noch der praktikabilitätsumsetzung und haben noch keine sehr weite verbreitung (graf et al. ; janssens et al. ) . bei einem schweregrad-der-erkrankung-score wie dem apa-che-ii-score (knaus et al. ; . abb. . ) korreliert die score-höhe mit der letalität, und zwar sowohl des gesamtkollektivs kritisch kranker als auch bestimmter subkollektive (z. b. patienten mit sepsis). ein mögliches problem bei der anwendung von score-systemen stellt jedoch die abhängigkeit der score-werte von der grundkrankheit dar. zusätzlich zu den bereits bestehenden organversagen-scores wurde von der europäischen intensivmedizinischen gesellschaft der sofa-score (»sepsis-related organ failure assessment score«) entwickelt (. tabelle . ). er erfasst die wichtigsten organdysfunktionen mit jeweils einem einzelnen pa-tabelle . . schweregradklassifi zierung des mods-sofa-score. (nach vincent et al. ) . sepsisbezogener organversagen-score (sofa-score) punktzahl augen öffnen: (spontan), (bei aufforderung), (bei schmerz), (nicht); beste motorische antwort: (gezielt nach aufforderung), (gezielt nach schmerz), (ungezielt nach schmerz), (beugemechanismen), (streckmechanismen), (keine); verbale antwort: (orientiert), (verwirrt), (inadäquat), (unverständlich), (keine) rameter und teilt den schweregrad der organdysfunktion entsprechend der abweichung dieses parameters von der norm ein. der sofa-score wird zunehmend auf bei nichtsepsispatienten zur abschätzung des schweregrades des mutiorganversagens eingesetzt, auch bei kardiologischen patienten. auch die prognose von patienten mit herzerkrankungen auf einer coronary care unit (ccu) kann mit score-systemen prognostiziert werden ( abschn. . . ): die aussagekraft des initial erhobenen saps-ii-score (»simplifi ed acute and physiology score«) ist bei ccu-patienten mindestens so prägnant wie bei patienten auf einer intensivstation (. abb. . a,b; schuster et al. ) . dies unterstreicht eindrücklich, dass nicht nur die schwere der herzerkrankung, sondern v. a. das daraus resultierende multiorgandysfunktionssyndrom über das Überleben des herzpatienten entscheidet. bei patienten nach herzoperationen erlaubt der apache-ii-score die identifi zierung der patienten mit eskalierendem systemischen infl ammationsreaktionssyndrom nach kardiopulmonalem bypass (eskalierendes cpb-sirs; . tabelle . ). es ist charakterisiert durch eine -im vergleich zum unkomplizierten postoperativen verlauf -überschießende systemische entzündungsreaktion infolge des operationstraumas und des einsatzes des kardiopulmonalen bypass, mit hohen tumornekrosefaktor-α(tnf-α)-und tnf-rezeptor-, leukozytenelastase-und neopterinplasmaspiegeln als ausdruck einer leukozyten/makrophagen-aktivierung, einem sepsisähnlichen multiorgandysfunktionssyndrom mit myokarddepression und hoher letalität (müller- . dieses nur bei wenigen patienten (< %) auftretende eskalierende cpb-sirs kann bereits am ersten postoperativen tag anhand eines apache-ii-score≥ identifi ziert werden (. abb. . ). aufgrund der ergebnisse von beobachtungsstudien in den zeiträumen zeiträumen - zeiträumen und pathophysiologie nach kreislaufschock kann es in abhängigkeit von der schockform und der zugrunde liegenden erkrankung zu formen der lungenschädigung mit daraus resultierender insuffi zienz kommen: ein kardiogen bedingter kreislaufschock induziert primär eine erhöhung des lungenkapillardrucks, während die übrigen schockformen eine gesteigerte permeabilität der lungenkapillaren bedingen (engelmann a ). das lungenödem bei erhöhtem kapillardruck hat als häufi gste ursache einen gesteigerten hydrostatischen druck in den lungenkapillaren, der wiederum in erster linie folge eines linksherzversagens ist. die filtration von flüssigkeit und protein wird als folge der erhöhten kapillarpermeabilität so gesteigert, dass der abtransport über die lymphwege bei weitem nicht ausreicht, um dies zu kompensieren. aufgrund der gestörten barrierefunktion kann auch kein nennenswerter osmotischer druckgradient aufgebaut werden, so dass sich diese Ödemform mit rascher progredienz entwickelt. die störung der barrierefunktion des endothels wird nach gegenwärtiger auffassung durch mediatoren ausgelöst. die uniformität der pulmonalen reaktion bei sehr unterschiedlichen klinischen ausgangskonstellationen wird dabei > auf das limitierte repertoire des organismus an effektorsystemen zurückgeführt. es wird postuliert, dass alle formen des kreislaufschocks, die zu einem ards führen, letztlich ein ischämie/reperfusionssyndrom darstellen, wobei endotoxineinschwemmung, gewebehypoxie, makrophagen-und leukozyteneinwanderung, -adhäsion (mittels adhäsionsmolekülen) und -aktivierung mit freisetzung von zahlreichen entzündungsmediatoren als dominierende faktoren angesehen werden. bei % aller schockpatienten fi ndet sich eine akute respiratorische insuffi zienz. die frühesten veränderungen der lungenfunktion im rahmen eines kreislaufschocks basieren auf reaktionen des zentralen atemantriebs oder der atemmuskulatur. sowohl der gesteigerte atemantrieb infolge der stimulation der pulmonalen j-rezeptoren und der chemorezeptoren des karotissinus als auch die minderperfusion des medullären atemzentrums führen zur steigerung des atemminutenvolumens (tachypnoe, hyperpnoe), zur hypokapnie und zur initialen respiratorischen alkalose. ventilations-perfusions-störungen infolge des gesteigerten atemminutenvolumens bei gleichzeitiger reduktion des herzzeitvolumens können die folge sein. der lungenwiderstand ist initial unverändert oder nur minimal erhöht, falls nicht bereits schockbedingt eine arterielle hypoxämie besteht. die erhöhte atemarbeit bei gleichzeitiger minderperfusion der atemmuskulatur und des zwerchfells kann zur frühzeitigen respiratorischen insuffi zienz führen. falls der schockzustand nicht rasch behoben werden kann, sind kardiales lungenödem bzw. ein ards zu befürchten. zur klinik des lungenödems mit erhöhtem kapillardruck (kardiales lungenödem) kap. . . das lungenödem bei erhöhter kapillarpermeabilität bedingt ein klinisches syndrom, für das der begriff des »adult/acute respiratory distress syndrome« geprägt worden ist. die letalität des ards beträgt nach wie vor ca. - %, wobei fortschritte auf dem gebiet der beatmungstechniken (engelmann a, b) ten patienten mit ards nach unterschiedlichen auslösern zu einer vermehrten mikrobiellen belastung der lunge, für die im wesentlichen eine retrograde keimaszension aus dem gesamtintestinaltrakt mit mikroaspirationen in verbindung mit gestörten host-defense-mechanismen der lunge verantwortlich gemacht wird. in abhängigkeit von der dauer des ards kommt es zunehmend zu nosokomialen pneumonien, die bei über tägiger beatmung mehr als % der ards-patienten betreffen können. die Übergänge zwischen pneumonie und ards sind fl ießend und entziehen sich häufi g einer exakten klinischen defi nition (american thoracic society et al. bei zentraler atemdepression und bei pulmonal bedingter respiratorischer insuffi zienz mit erniedrigtem po und erhöhtem pco ist eine endotracheale intubation und eine assistier-> > te oder kontrollierte beatmung angezeigt (artigas et al. ; lehmann et al. ; seige et al. ) . für den beatmungspfl ichtigen patienten mit kardiogenem schock wurde in einer studie eine letalität von % angegeben und als wesentliche prognostische risikofaktoren ein apache-ii-sore > , ein serumkreatinin > µmol/l und eine linksventrikuläre auswurffraktion < % gefunden (lesage et al. vorbedingung für prophylaxe und therapie (kierdorf der routinemäßige einsatz von niedrigdosiertem dopamin zur nephroprotektion bei schock-, mods-und sepsispatienten kann nicht empfohlen werden ( abschn. . . ). diese substanz ist für die verbesserung der nierendurchblutung besonders attraktiv. ein signifi kanter Überlebensvorteil durch die gabe von diuretika bei intensivpatienten mit akutem nierenversagen konnte bisher nicht gezeigt werden. eine retrospektive untersuchung erbrachte sogar im zusammenhang mit einer diuretikagabe eine letalitätssteigerung und eine erhöhung der inzidenz einer terminalen niereninsuffi zienz (mehta et al. bei freisetzung von chromoproteinen (hämolyse, myolyse), bei paraproteinämie und aminoglykosidinduziertem anv wirkt eine alkalisierung mit bikarbonat protektiv. sie wurden bislang unter der vorstellung, eine zelluläre schädigung zu verhindern oder abzuschwächen, bei folgenden formen des anv zur nephroprotektion eingesetzt: bei ischämieinduziertem anv nach nierentransplantation und bei nephrotoxininduziertem anv (kontrastmittel, aminoglykoside). zur differenzialtherapie stehen verschiedene verfahren zur verfügung: hämofi ltration, hämodiafi ltration, high-fl ux-dialyse, ultrafi ltration, plasmapherese, hämoperfusion (kierdorf ). bei der hämofi ltration liegt die standardhämofi ltrationsrate im anv bei - l/h. nicht bestätigt hat sich die hoffnung, damit relevante mengen deletärer mediatoren eliminieren zu können: zwar können immunmodulatorische substanzen wie zytokine und kardiotoxische faktoren hämofi ltrationsmembranen passieren, ein wesentlicher abfall der plasmakonzentrationen dieser substanzen scheint jedoch dadurch nicht zustande zu kommen, obwohl eine vorübergehende kreislaufstabilisierung -messbar als anstieg des systemischen gefäßwiderstandes -beschrieben ist (hoffmann et al. (hoffmann et al. , . auch die »high-volume-hämofi ltration« mit durchsatzraten von l/h kann diesbezüglich trotz einsparung von vasopressoren kaum überzeugendere ergebnisse liefern (cole et al. ) . eine effi ziente endotoxinelimination bei patienten mit gramnegativer sepsis und mods sowie mit peritonitis ist mit dem matisse-adsorber möglich (reinhart et al. ). an makroporöse trägerkügelchen gebundenes immobilisiertes humanes serumalbumin bindet während eines hämoadsorptionzyklus endotoxin und bewirkt auf diese weise einen deutlichen abfall der serumendotoxinkonzentration. in einer phase-ii-studie mit patienten mit vermuteter gramnegativer sepsis, davon mit peritonitis, führte die tägliche endotoxinadsorption in den ersten tagen nach diagnosestellung im trend zu einer vorübergehenden besserung des mods (stärkerer abfall des apache-ii-und des sofa-score während der ersten tage) und zu deutlicheren senkung des serumendotoxins; die letalität -nicht primäres zielkriterium (!) -war mit und ohne endotoxinabsorptionstherapie nicht unterschiedlich (reinhart et al. ) . für aphereseverfahren (formica et al. ; kellum ; samtleben et al. ; shehata et al. ; stegmayr ; stegmayr et al. ) und die gekoppelte plasmafi ltrationadsorption sind bei patienten mit septischem mods günstige effekte bisher nur in fallberichten und in relativ kleinen kontrollierten studien beschrieben. die schwere leberinsuffi zienz ist charakterisiert durch eine, möglicherweise stickoxidbedingte, hyperdyname systemische kreislaufsituation mit erhöhtem herzzeitvolumen und erniedrigtem systemischem gefäßwiderstand. reaktiv dazu kommt es zur konstriktion der nierenarterien und damit zur na + -retention und aszitesbildung. diese hochgradige renale vasokonstriktion bei leberschädigung wird durch eine aktivierung des renin-angiotensin-aldosteron-systems und eine noradrenalinfreisetzung bewirkt und als hepatorenales syndrom bezeichnet. es ist charakterisiert durch eine oligurie (< ml/ h), einen anstieg des serumkreatinins trotz adäquatem blutdruck und eine erniedrigte urin-na + -konzentration von < mmol/ l. im initialstadium ist es reversibel, im weiteren verlauf treten jedoch tubulusschäden auf. eine gesicherte therapie ist nicht bekannt, ggf. muss hämodialysiert werden. obwohl neurone sehr ischämieempfi ndlich sind, kommt es durch die protektive autoregulation der hirndurchblutung erst in relativ späten schockstadien zu ausgeprägteren zerebralen durchblutungsstörungen. ohne vorbestehende zerebrovaskuläre insuffi zienz fi nden sich erst bei einem abfall des arteriellen mitteldrucks auf - mmhg irreversible störungen der ischämieempfi ndlichsten kortex-und rückenmarksareale. bereits vorher können jedoch reversible bewusstseinsstörungen in form von konfusionen bis zur bewusstlosigkeit auftreten, je nach grad der durchblutungsstörung, ggf. verstärkt durch begleitende störungen des säure-basen-und des elektrolythaushalts. das elektroenzephalogramm zeigt dabei unspezifi sche veränderungen (zauner et al. ) . septische enzephalopathie. die septische enzephalopathie ist charakterisiert als eine reversible dysfunktion des zentralnervensystems ohne erkennbare strukturelle schäden, als deren ursachen toxinwirkungen oder ein geändertes neurotransmittermuster diskutiert werden (papadopoulos et al. ) . sie kann sich bereits bei blutdruckwerten > mmhg manifestieren und geht mit einer erhöhten letalität einher (briegel ; eggers et al. ; green et al. ) . sie äußert sich als irritabilität, agitation, desorientiertheit, konfusion, stupor und koma. eine spezifi sche therapie der septischen enzephalopathie ist z. z. noch nicht etabliert. bei erfolgreicher behandlung der sepsis kann in der regel mit einer raschen besserung der septischen enzephalopathie gerechnet werden. Über % aller patienten mit länger bestehender sepsis und multiorganversagen scheinen eine axonale sensorische und motorische neuropathie zu entwickeln, die charakterisiert ist durch abgeschwächte oder fehlende sehnenrefl exe und schlaffheit der extremitätenmuskulatur (hund ) . die hirnnerven sind intakt; im liquor fi ndet sich bei manchen patienten eine erhöhung des proteingehalts, die zellzahl ist normal. eine spezifi sche therapie ist nicht bekannt. eine retrospektive analyse ( patienten mit multiorganversagen) erbrachte erste hinweise auf eine mögliche günstige wirkung einer frühzeitigen immunglobulin-gma-gabe bei der polyneuropathie kritisch kranker mit gramnegativer sepsis (mohr et al. ) ; als gesicherte therapie kann dieses konzept z. z. noch nicht empfohlen werden. septisches und nichtseptisches mods sind durch eine autonome dysfunktion geprägt, die sich als einschränkung der herzfrequenzvariabilität sowie der baro-und chemorefl exsensitivität bemerkbar macht, im ausmaß mit dem schweregrad des mods korreliert und auch bei intensivpatienten verlässlich und praktikabel messbar ist (schmidt et al. ; schmidt u. müller-werdan ) . eine gezielte therapie der autonomen dysfunktion des mods-patienten existiert bisher nicht. generalisierte muskelschwäche und abgeschwächte oder fehlende muskeleigenrefl exe kennzeichnen auch das klinische bild der myopathie des kritisch kranken (hund ) . diese ist durch eine typ-i-und v. a. durch eine typ-ii-faseratrophie gekennzeichnet und geht nur selten mit einer erhöhung der serumkreatinkinasewerte einher. differenzialdiagnostische schwierigkeiten kann die abgrenzung zur polyneuropathie des kritisch kranken (muskelbiopsie), zur myopathie durch glukokortikoide und muskelrelaxanzien sowie zur -sehr seltenen -septisch-metastatischen pyomyositis bereiten. das klinische bild von polyneuropathie und myopathie ist durch eine schwäche der extremitäten, hyporefl exie, verzögerte respiratorentwöhnung und durch eine komplikationsreiche, verlängerte motorische rehabilitiation mit erhöhter letalität gekennzeichnet. muskelrelaxanzien und kortikosteroide können zusätzliche schädigende effekte am neuromuskulären system hervorrufen, die sich als transiente neuromuskuläre blockade, axonale motorische neuropathie oder myopathie der dicken filamente zeigen. wegen der eingeschränkten klinisch-neurologischen beurteilung eines intensivpatienten kommt den elektrophysiologischen untersuchungen (elektromyo-und elektroneurographie), der messung der kreatinkinase im serum, der muskel-und nervenbiopsie, der liquorpunktion und gelegentlich der kernspintomographie eine große diagnostische und differenzialdiagnostische bedeutung zu. nach schwerem krankheitsverlauf fi nden sich bei mehr als % der patienten noch nach jahren muskelschwäche und neurologische defi zite (fletcher et al. ) . die schockverursachte sympathikusaktivierung manifestiert sich am herzen als tachykardie, selten bei hämorrhagischem schock als eine vagusvermittelte bradykardie, und in form von tachykarden supraventrikulären und ventrikulären rhythmusstörungen. bei koronarkranken patienten kann sie über die steigerung des myokardialen o -verbrauchs (bei gleichzeitiger hypotonie) ein defi zit der koronarperfusion hervorrufen und damit eine myokardischämie provozieren. eine sympathikusvermittelte gefäßkonstriktion wird an den koronararterien durch die gefäßautoregulation ( abschn. . . und . tabelle . ) weitgehend verhindert. die sympathikusaktivierung ist auch für die bei manchen schockformen (septisch, hypovolämisch, traumatisch) beschriebene steigerung der myokardkontraktilität verantwortlich, die jedoch durch zirkulierende kardiodepressive schockfaktoren auch vermindert werden kann. die akute septische kardiomyopathie wird in den abschn. . . und . . dargestellt. zur komplexen organdysfunktion des kreislaufs bei den verschiedenen schockformen abschn. . . im schock reagieren die splanchnikusgefäße auf die sympathikusaktivierung mit einer raschen und intensiven vasokonstriktion. demzufolge ist der darmtrakt sehr ischämiegefährdet; typische schädigungsmuster sind in . tabelle . aufgeführt. aufgepfropft auf die darmischämie können die in der reperfusionsphase gebildeten o -radikale eine schädigung der darmbarriere bewirken (bahrami et al. ; stallmach u. zeitz ) . alle symptome treten nur inkonstant auf. Übelkeit, erbrechen und schmerzen im rechten oberbauch gehen dem fieber häufi g voraus; die allerdings nur selten palpable raumforderung im rechten oberbauch sichert weitgehend die diagnose. laborparameter helfen diagnostisch häufi g nicht weiter; wegweisend ist die sonographie. die therapie besteht in der gallenblasenentfernung (letalität ca. %) oder in der perkutanen, transhepatische gallenblasenpunktion mit und ohne drainageeinlage (cholezystotomie). wenige stunden nach einem akuten stressereignis können erosionen und ulzera der schleimhaut vorwiegend im magenkorpus, weniger im antrum oder duodenum, auftreten. die pathophysiologie dieser läsionen ist komplex und unterscheidet sich von der der durch säure und helicobacter pylori hervorgerufenen ulzera. durch eine mukosale minderversorgung mit oxygeniertem blut als folge von minderperfusion oder hypoxie wird ein schleimhautschädigender circulus vitiosus, bestehend aus venöser stase, sludge, vasospasmus, gewebehypoxie, mediatorenfreisetzung, radikalbildung und autokongestion der gefäße in gang gesetzt. die magensäuresekretion ist bei den meisten kritisch kranken reduziert und nur bei patienten mit sepsis, verbrennungen, erhöhtem intrakraniellem druck oder schädel-hirn-trauma erhöht (ruß et al. ). eine gastrointestinale blutung des kritisch kranken kann schweregraden zugeordnet werden (ruß et al. ) : zum einen die offenkundige blutung, nachgewiesen durch hämatemesis oder aspiration aus einer gastralen sonde, und zum anderen die klinisch relevante blutung, bestehend aus einer offenkundigen blutung mit arterieller hypotension und transfusionsbedarf von erythrozytenkonzentraten. die rate der offenkundigen blutung liegt bei beatmeten intensivpatienten bei % und im gesamtkollektiv der intensivpatienten bei , %. die häufi gkeit klinisch relevanter gastrointestinaler blutungen bei kritisch kranken auf der intensivstation ist in den letzten jahren von bis zu % ohne prophylaxe auf z. z. ungefähr , % gesunken. dafür sind neben der ulkusprophylaxe überwiegend die verbesserten intensivmedizinischen therapiemöglichkeiten verantwortlich. für das auftreten klinisch relevanter stressulkusblutungen im gesamtkollektiv der intensivpatienten konnten in einer großen prospektiven studie nur der vermuteten risikofaktoren statistisch signifi kant bestätigt werden: in der vorbeugung einer stressulkusblutung des kritisch kranken sind h -rezeptorantagonisten, sucralfat und antazida hocheffektiv gegenüber placebo (ruß et al. ) . bei einem ph-wert < ist der magensaft von % der intensivpatienten steril. dies gilt nur noch für % bei einem intragastralen ph-wert > unter säurehemmender medikation, bedingt durch eine ph-wert-abhängige kolonisation des magensaftes mit gramnegativen keimen. diese erreger können u. a. durch regurgitation und/oder weitere kolonisation des oropharyngealen raumes und anschließender mikroaspiration in das bronchialsystem gelangen und nosokomiale, besonders beatmungsassoziierte pneumonien hervorrufen. der vergleich von ranitidin ( -mal mg i.v./tag) mit sucralfat ( -mal g intragastral/tag) zeigte in der prophylaxe einer klinisch relevanten blutung bei für mehr als h beatmeten intensivpatienten eine signifi kant niedrigere blutungsrate für ranitidin ( , vs. , %). im gegensatz zu früheren untersuchungen und metaanalysen konnte kein signifi kanter unterschied der sterblichkeit ( , vs. , %) und nur ein trend in der reduzierung der gesamtrate beatmungsassozierter pneumonien ( , vs. , %) unter sucralfat nachgewiesen werden. die für h -rezeptorantagonisten, antazida und sucralfat beschriebene wirksamkeit bei der stressulkusprophylaxe kritisch kranker gilt auch für die protonenpumpeninhibitoren, wobei für diese substanzgruppe ähnlich umfangreiche untersuchungen und analysen bisher nicht vorliegen (weitere dosierungsempfehlungen s. ruß et al. ). die leber reagiert empfi ndlich auf hypotonie und minderperfusion. dennoch ist die »schockleber« -massive ischämische nekrosen mit sehr hohem transaminasenanstieg -ohne vorbestehende lebererkrankung ein seltenes ereignis (böker u. manns ). viel häufi ger dagegen ist eine zentrilobuläre schädigung mit einem milden anstieg der transaminasen, der ldh, des bilirubins und der alkalischen phosphatase. der transaminasenanstieg erreicht am .- . tag sein maximum, er normalisiert sich über die folgenden - tage. trotz der hepatischen synthese von akute-phase-proteinen ist die proteinsynthese der leber im kreislaufschock eingeschränkt; dies trifft v. a. für präalbumin, albumin und gerinnungsfaktoren zu. auch nach erfolgreicher schockbehandlung kann die biliäre stase mit erhöhten werten für bilirubin und alkalische phosphatase lange persistieren. die septische hepatopathie imponiert klinisch durch den ikterus, funktionell ist die eingeschränkte syntheseleistung das entscheidende. eine spezifi sche therapie ist nicht bekannt. therapierefraktärer aszites, hepatorenales syndrom, hyponatriämie und hepatopulmonales syndrom können bei patienten mit chronischen lebererkrankungen und mods/ sepsis den sepsisverlauf komplizieren (ruß et al. ) . pathophysiologie mods, sirs und sepsis verursachen eine aktivierung des gerinnungssystems sowie eine initiale aktivierung und anschließende hemmung der fibrinolyse (huhle ; dempfl e ; riess )! diese veränderungen führen schließlich zur disseminierten intravasalen gerinnung (dic) -ausdruck einer mikroangiopathischen hämolyse, verbrauchsthrombozytopenie, verbrauch an gerinnungsfaktoren und mikrothromben. an der pathophysiologischen bedeutung der thrombozyten bei verschiedenen klinischen und experimentellen schockzuständen ist nicht mehr zu zweifeln. bei einer reihe von noxen, die direkt (z. b. biogene amine, thrombin usw.) oder indirekt (z. b. kollagen) nach freisetzung aus subendothelialen gefäßstrukturen auf die thrombozyten einwirken, kommt es zu deren aggregation. diese aggregation ist zunächst reversibel. ihr kann unter geeigneten bedingungen die spontane desaggregation folgen. untersuchungen an patienten mit quantifi ziertem schweregrad einer sepsis (elebute-score) und eines multiorganversagens (apache-ii-score) sprechen dafür, dass die sepsis einen hyperaggregiblen, aber noch reversiblen zustand des thrombozyten induziert (erhöhte fibrinogenrezeptoraktivität, gemessen als libs -expression), während der zunehmende schweregrad des multiorganversagens zur irreversiblen thrombozytendegranulierung führt, erkenntlich an der verstärkten oberfl ächenexpression der thrombozytenadhäsionsmoleküle gmp- und thrombospondin mit zunehmendem schweregrad des multiorganversagens (gawaz et al. ) . diese normalerweise in den plättchengranula gespeicherten adhäsionsmoleküle verstärken durch ihre oberfl ächenaggregation die plättchenmikroaggregation und führen somit zur irreversiblen thrombozytendegranulation im sinne der dic. die dic ist klinisch durch die kombination von blutungen (petechien, purpura, ekchymosen, verstärkte blutungen nach gefäßpunktionen) und thrombosen (gangrän, akrale zyanose, hautnekrosen, tiefe venenthrombosen) charakterisiert (dempfl e ). sie fi ndet sich bei unterschiedlichen erkrankungen, wobei sepsis und septischer schock im rahmen des mods im vordergrund stehen. die dic bei gramnegativem schock (wo sie am häufi gsten gesehen wird) wird mit dem endotoxin als auslöser in verbindung gebracht ( abschn. . . ); die fulminant verlaufende dic bei meningokokkensepsis (waterhouse-friderichsen-syndrom), die mit sehr hohen endotoxinspiegeln einhergeht, liefert dafür ein gewichtiges argument. allerdings fi ndet sich die dic auch bei grampositiver sepsis, wie z. b. der pneumokokkensepsis. beim hämorrhagischen schock ist das auftreten einer dic ein seltenes ereignis; hier steht die verdünnungsthrombozytopenie nach adäquater volumensubstitution im vordergrund. abfall von thrombozytenzahl, fibrinogen und antithrombin, anstieg von ptt, prothrombinzeit, thrombinzeit, d-dimeren, fibrinmonomeren, thrombin-antithrombin-komplex, fibrinopeptid a und prothrombinfragmenten (f + f ). im sofa-score (. tabelle . ) dient die thrombozytopenie als maß für den schweregrad der gerinnungsstörung in der sepsis. kontrollierte studien zur prophylaxe der dic bei mods, schock und sepsis gibt es bisher nicht. die gesicherten therapieempfehlungen zur therapie der klinisch manifesten dic bei mods, schock und sepsis sind in der . Übersicht . zusammengefasst (riess ; . gerinnungshemmende medikamente werden bei sepsis nicht nur bei klinisch manifester dic, sondern häufi g auch unabhängig davon eingesetzt (kujath et al. ; werdan et al. ) . dieses vorgehen beruht zum einen auf der vorstellung einer »prophylaxe« der ingangsetzung der pathogenetisch gefährlichen gerinnungskaskade. zum anderen wird zunehmend evident, wie eng gerinnungsaktivierung und proinfl ammation in der sepsis verknüpft sind; darauf beruht das konzept, mit der bremsung der gerinnungskaskade -v. a. der thrombinaktivierung -auch das überschießende proinfl ammatorische potenzial des körpers zu dämpfen. lange zeit war heparin ein nachdrücklich propagierter ansatz bei sepsis, wahrscheinlich aber ein wenig oder sogar nicht wirksamer und dazu noch ein potenziell gefährlicher. in den letzten jahren konzentriert sich das interesse v. a. auf den ersatz endogener inhibitoren einer unerwünschten generalisierung der gerinnungsabläufe, die in der sepsis erniedrigte serumspiegel zeigen und meist mit einer ungünstigen prognose verknüpft sind: antithrombin, protein c, protein s und gewebsthromboplastininhibitor (tissue-factor-pathway-inhibitor, tfpi). und schließlich darf nicht vergessen werden, dass in der sepsis thrombozytopenie und thrombozytendysfunktion ebenfalls gerinnungsprobleme machen können. wenig bekannt ist, dass thrombozyten auch mikrobiozide peptide sezernieren und über kontaktabhängige mechanismen zur bakterienabtötung beitragen können (. Übersicht . ). in der prowess-studie (»effi cacy and safety of recombinant human activated protein c for severe sepsis) wurden patienten in der frühphase einer schweren sepsis (sepsis mit organversagen, . tabelle . ) eingeschlossen und entweder mit aktiviertem protein c (drotrecogin alfa aktiviert, xigris) oder mit placebo behandelt (bernard et al. ) . nach einschluss von patienten wurde die studie wegen der Überlegenheit des verumpräparates vorzeitig abgebrochen: die -tage-letalität der patienten mit standardtherapie lag bei , %, die der patienten mit aktiviertem protein c bei , % (p = , ). dies entspricht einer letalitätssenkung absolut von , % und relativ von , % (nnt ). der günstige effekt war dabei unabhängig von der höhe des initialen plasma-protein-c-spiegels. nicht alle sepsispatienten scheinen in gleicher weise zu profi tieren: pneumonie, patientenalter > jahre, apache-ii-score ≥ , mehrorganversagen und schock sind faktoren, bei denen eine besonders erfolgreiche behandlung erwartet werden kann; die prognostisch günstige urosepsis und die nichtabominelle chirurgische sepsis scheinen dagegen eher weniger anzusprechen. demzufolge ist die indikation in den usa auf den erwachsenen patienten mit schwerer sepsis und einem hohem letalitätsrisiko (wie einem apache-ii-score ≥ ) und in europa auf den erwachsenen sepsispatienten mit mindestens organversagen ausgerichtet. der gestörte stoffwechsel bei patienten mit mods, schock und sepsis und die erforderlichen ernährungsmaßnahmen besitzen für die prognose des kritisch kranken eine wesentlichere bedeutung als lange angenommen . bei patienten mit mods ist -wie bei allen kritisch kranken -eine möglichst frühzeitige enterale ernährung anzustreben (ruß et al. ) . trotz des ausgeprägten katabolen zustands kritisch kranker und insbesondere der schock-, mods-und sepsispatienten kann der gesteigerte abbau nicht einfach durch ein mehr an zugeführten kalorien ausgeglichen werden, da diese patienten, insbesondere mit septischem schock, gar nicht in der lage sind, ein Übermaß an kalorienangebot zu verwerten. in der an die akute katabole krankheitsphase anschließenden anabolen erholungsperiode muss dann durch eine überdurchschnittliche kalorienzufuhr dem gesteigerten bedarf rechnung getragen werden (ruß et al. ) . immunonutrition. der einsatz der immunonutrition -die enterale zufuhr von mehrfach ungesättigten fettsäuren, nukleotiden und arginin sowie die parenterale/enterale gabe von glutamin -zur verbesserung des immunstatus kritisch kranker scheint bei intensivmedizinischen risikopatienten -ards (pacht et al. ) , mods-und sepsisgefährdete patienten in der perioperativen phase -günstige effekte zu haben; bei manifester sepsis sprechen studiendaten eher für eine ungünstige wirkung (bertolini et al. , heyland u. samis suchner ) . welche »drüsen« sind mods-anfällig? derzeit richtet sich das »endokrinologische augenmerk« bei mods, schock und sepsis auf den insulin-glukose-stoffwechsel einerseits ( abschn. . . ) und die hypothalamus-hypophysen-nebennieren-achse (»hypothalamo-pituitary-adrenal axis«, hpa-achse) andererseits (beishuizen u. thijs ; werdan et al. ) . endotoxin kann die hpa-achse auf unterschiedlichen ebenen beeinfl ussen (beishuizen u. tijs Über verschiedenene mechanismen kann es im septischen schock zu einer relativen nebennierenrindeninsuffi zienz kommen . bei diesen patienten wird in unerwünschter weise die antiinfl ammatorische wirkung des endogenes cortisols abgeschwächt. die folge ist ein vermindertes ansprechens des kreislaufs auf vasopressorische katecholamine und wahrscheinlich auch eine erhöhte sterblichkeit (annane u. cavaillon ) . im prolongiert verlaufenden septischen schock geht die negative feedbackkontrolle der hypothalamus-hypophysen-nebennierenrinden-achse (hpa-achse) verloren, mit einem verlust des pulsatilen sekretionsverhaltens des cortisols. ursache dafür sind eine tnf-bedingte sekretionshemmung von corticotropin-releasing-hormon und acth sowie eine abschwächung der acth-stimulierbarkeit der cortisolproduktion der nebenniererenrinde. infolge der down-regulation zellulärer glukokortikoidrezeptoren mit abnahme von rezeptorzahl und affi nität bildet sich im septischen schock eine glukokortikoidresistenz aus. wahrscheinliche ursache dafür ist eine hohe lokale konzentration proinfl ammatorischer zytokine, die über die bildung von transkriptionsfaktoren wie activator-protein (ap ) und »nuclear factor kappa b« (nfκb) zu einer komplexbildung mit aktiviertem glukokortikoid-rezeptorelementen führt. da die glukokortikoid-rezeptorzahl in den gefäßen mit dem mittleren arteriellen blutdruck korreliert, trägt die glukokortikoid-down-regulation entscheidend zur hämodynamischen instabilität im septischen schock bei (zonghai et al. ) . bei zwei dritteln aller patienten mit septischem schock lässt sich anhand des acth-tests die diagnose einer relativen nebennierenrindeninsuffi zienz stellen. bei diesen patienten können stress-hydrocortison-dosen von - mg/tag die erworbene glukokortikoidresistenz überwinden und die proinfl ammation im septischen schock dämpfen. für den behandelnden intensivmediziner ist es beeindruckend, wie unter dieser hydrocortisongabe die katecholaminansprechbarkeit der gefäße wiederhergestellt und damit innerhalb weniger tage eine drastische einsparung von katecholaminen möglich wird (annane et al. ) . die in einer relativ kleinen studie mit patienten gefundene letalitätssenkung durch hydrocortison bei patienten mit septischem schock und relativer nebennierenrindeninsuffi zienz (annane et al. ) wird z. z. in der europäischen corticus-studie mit geplanten patienten überprüft. nicht nur bei septischem schock, sondern auch bei eskalierendem sirs nach herzchirurgie scheinen stressdosen von hydrocortison die überschießende infl ammationsreaktion zu dämpfen und die prognose zu verbessern (kilger et al. ). die hohe infektanfälligkeit kritisch kranker und insbesondere der patienten im schock ist folge einer komplexen schädigung des humoralen und zellulären immunsystems bei schock und sirs (. tabelle . , . abb. . a-c und . ). von den möglichkeiten einer infektions-/sepsisprophylaxe bei intensivmedizinischen risikopatienten sind neben allge-> meinen hygienemaßnahmen und der erzielung einer normoglykämie mittels hochdosierter insulingabe ( abschn. . . ) v. a. die möglichkeiten einer prophylaxe mit immunglobulinen zu nennen (werdan b; werdan et al. ) . durch prophylaktische gabe von immunglobulinen (ig) kann das auftreten von infektionen bei verschiedenen intensivpatientenkollektiven gesenkt werden, v. a. bei »infektions-hochrisiko-patienten« und bei »infektions-hochrisiko-operationen« (werdan b) : anerge patienten (ca. %) nach herzchirurgischen operationen mit der herz-lungen-maschine: die prophylaktische gabe von iviggma senkt die im vergleich zu normergen patienten höhere inzidenz postoperativer infektionen auf werte unter diejenige normerger patienten (kress et al. einheiten, schweres abdominelles oder retroperitoneales trauma mit transfusionsbedarf von mehr als einheiten und intubationspfl ichtigkeit länger als h. bei patienten mit schwerem trauma (injury severity score - ) senkt die prophylaktische gabe von ivigg ( , g/kgkg an den tagen , , , ) zwar die häufi gkeit von infektionen, insbesondere pneumonien (um mehr als %), die infektionsverursachte morbidität und letalität wird allerdings nicht vermindert (douzinas et al. ) . spezifi sche schockformen k. werdan, r. prondzinsky, m. buerke, u. müller-werdan unabhängig von der art des kardiogenen schocks (. tabellen . und . ) besteht die initialbetreuung des patienten mit kardiogenem schock (. Übersicht . ) zunächst in der hämodynamischen stabilisierung und ausreichenden oxygenie- rung, dem adäquaten hämodynamischen monitoring und der möglichst raschen klärung der schockursache. anschließend lassen sich, soweit möglich, kausale behandlungsmaßnahmen einleiten, die im infarktbedingten myogenen pumpversagen ischämischer genese in der möglichst raschen wiedereröffnung des verschlossenen infarktgefäßes besteht (. abb. . ). die schockbehandlung ist ein wettlauf mit der zeit! jede »schockminute« erhöht das risiko des auftretens des prognosebestimmenden multiorgandysfunktionssyndroms ( abschn. . )! die behandlung des kardiogenen schocks kann in symptomatische (medikamentöse therapie, mechanische unterstützungssysteme) und in kausale (interventionelle oder chirurgische koronarreperfusion, verschluss von shunts oder rupturstellen) maßnahmen eingeteilt werden. ziel der medikamentösen, symptomatischen (!) behandlung (bengur u. meliones ; goldberg et al. ; hollenberg ; hollenberg et al. ) ist die steigerung der myokardkontraktilität und die situationsbezogene optimierung von vor-und nachlast (volumenentzug, vasodilatatoren, blutdruckstabilisierung), um so -gesteuert mittels invasivem monitoring -einen adäquaten herzindex und blutdruck und damit eine ausreichende perfusion der vitalorgane aufrechtzuerhalten ( abschn. . . , cotter et al. a ). im wesentlichen sind es die katecholamine dobutamin, dopamin, noradrenalin und adrenalin und die phosphodies-! terasehemmstoffe amrinon, milrinon und enoximon, deren positiv-inotrope wirkung ausgenutzt werden kann ( abschn. . . ; . tabellen . und . ). digitalis. digitalis spielt bei sinusrhythmus in der therapie des kardiogenen schocks als inotropikum keine wesentliche rolle; dagegen ist es bei tachykardem vorhoffl immern und vorhoffl attern zur frequenznormalisierung das antiarrhythmikum der wahl. levosimendan. als neues therapieprinzip bei akuter herzinsuffi zienz scheint der kalziumsensitzer levosimendan erfolgreich ( abschn. . . ). der kardiogene schock führt häufi g zu lungenstauung/lungenödem und zum prärenalen nierenversagen und damit zur oligurie. neben der kreislaufstabilisierung können diuretika und hämofi ltration erforderlich werden ( abschn. . . ). zur senkung der vor-und nachlast dient bei akutem herzinfarkt in erster linie nitroglyzerin und in zweiter linie nitroprussidnatrium ( abschn. . . ). bei dekompensierter herzinsuffi zienz ist nesiritide, das endogene b-typ-natriuretische peptid (in deutschland nicht zugelassen) ein neuer therapieansatz ( abschn. . . ). zum experimentellen einsatz von stickoxidsynthetaseinhibitoren (l-name/l-nmma), inhibitoren der komplementkaskade und von pyruvat abschn. . . . antiarrhythmische therapie ( kap. ) die konservativ nicht beherrschbare schocksymptomatik kann ein chirurgisches eingreifen erforderlich machen. die akutherztransplantation dieser patienten wird zwar weiterhin die ausnahme bleiben, mit den ventrikulären assist-systemen (wie z. b. dem novacor) stehen dem chirurgen jedoch über wochen einsetzbare bridging-maßnahmen zur verfügung (martin et al. ) , die auch dem patienten mit kardiogenem schock zugute kommen könnten. bei kardiogenem schock infolge eines myokardinfarkts ist aufgrund der guten erfolge der akut-pci eine aortokoronare bypass-notfalloperation nur noch selten nötig. als mögliche indikationen gelten hierfür: fortbestehende ischämie bei koronarographisch nachgewiesener mehrgefäßerkrankung und/ oder lca(linke koronararterie)-hauptstammstenose; nach pci-komplikationen bzw. nicht erfolgreicher pci. die operation sollte dann aber notfallmäßig erfolgen, da die präoperative ischämiedauer der entscheidende prädiktor der perioperativen letalität ist. auch bei der perkutanen koronarintervention (pci) muss mit einem akuten koronarverschluss und mit einer letalität von , - , % rechnen, vorwiegend als folge eines sich entwickelnden kardiogenen schocks. vor allem bei der hochrisiko-pci (hochgradig eingeschränkte linksventrikuläre pumpfunktion, dreigefäßkrankheit, das zu dehnende gefäß als das . Übersicht . . basisbehandlungskonzept des kardiogenen schocks katecholamine, (phosphodiesterasehemmer) ggf. ca ++ -sensitizer vom typ des levosimendan vor-und nachlastsenkung (cave: hypovolämie): vorlast: nitrate ( , - , - µg/kgkg/min bzw. , - , mg/h) vorlast + nachlast: nitroprussidnatrium ( , - einzige noch perfundierte koronargefäß) kann das risiko der koronardehnung durch prophylaktisch oder im stand-by genutzte mechanische unterstützungssysteme (. Übersicht . ) reduziert werden (ferrari u. figulla ) . in der wartephase auf die herztransplantation können auch hier ventrikuläre assist-systeme als bridging-verfahren eingesetzt werden. bezüglich der pci bei myokardinfarkt s. unten. die mechanischen unterstützungssysteme im kardiogenen schock reichen von der kardiopulmonalen reanimation ( abschn. . . ) über die wiederherstellung einer suffi zienten koronarperfusion bis hin zu mehr oder weniger komplexen kreislaufunterstützungssystemen. die jährlich . patienten mit einem akuten herzinfarkt in deutschland, von denen ca. - % einen kardiogenen schock entwickeln, unterstreichen das quantitative ausmaß, das solche verfahren bereits haben oder haben könnten. mechanische kreislaufunterstützungssysteme fi nden beim akuten herzstillstand (ferrari et al. ) , im kardiogenen schock und bei der hochrisiko-ptca anwendung (martin et al. ) . beim herzstillstand wird ein komplettes kreislaufunterstützungssystem benötigt, das in min unter fortlaufender kardiopulmonaler reanimation möglichst unter röntgenkontrolle installiert werden kann (ferrari et al. ) . im kardiogenen schock ist eine partielle kreislaufunterstützung mittels der intraaortalen ballonpulsation (iabp) für einen zeitraum bis zu etwa tagen möglich. bei der hochrisiko-pci kommt die mechanische kreislaufunterstützung mittels iabp oder kardiopulmonalem bypass je nach befundkonstellation auf der stand-by-basis im bedarfsfall oder elektiv vor beginn der pci zum einsatz. da % der akuten reokklusionen innerhalb der ersten h nach pci auftreten, sollten diese verfahren zumindest für diese zeit sofort verfügbar sein (ferrari u. figulla ) . methodik, komplikationen, kontraindikationen. ein ballonkatheter ( f) von ca. cm länge (z. b. ballonlänge cm, insuffl ationsvolumen ml) wird perkutan transfemoral über eine schleuse (z. b. f) eingeführt und so platziert, dass der ballon in der thorakalen aorta distal des abgangs der linken a. subclavia zum liegen kommt. mit einem ekg-gesteuerten augmentierungsmodus von : - : wird der ballon in der diastole aufgeblasen (füllung mit heliumgas) und am beginn der systole abrupt desuffl iert (. abb. . a-c) . die komplika-tionsrate (zumeist ischämie der unteren extremität, arterielle thrombose, infektion, persistierende blutung inguinal; bei längerer anwendung gelegentlich beeinträchtigte leber-und nierenfunktion) liegt aktuell bei , %, bei einer mittleren liegezeit von tagen; eine vorzeitige beendigung der iabp-therapie ist bei etwa % der patienten erforderlich (gregg et al. ) . kontraindikationen sind schwere iliofemorale gefäßveränderungen, aortendissektion, höhergradige aortenklappeninsuffi zienz und eine blutungsdiathese. wirkprinzip und erzielbare wirkungen. durch das streng auf die diastole beschränkte aufblasen des ballons nimmt der aortendruck phasisch zu (diastolische augmentierung; »kamelhöckerform« der blutdruckkurve; . abb. . a) und bewirkt damit eine zunahme der koronarperfusion. die abrupte desuffl ierung des ballons am beginn der systole führt über eine sogwirkung zur absenkung des bei pumpversagen erhöhten diastolischen ventrikeldrucks (vorlastsenkung) sowie des systolischen aortendrucks (nachlastsenkung) und damit zu einer, allerdings nicht sehr ausgeprägten, senkung des myokardialen o -verbrauchs. im transösophagealen echokardiogramm zeigte sich eine verbesserung der linksventrikulären pumpfunktion, und bei der dopplersonographischen koronarfl ussmessung steigerte sich die maximale sowie die integrale flussgeschwindigkeit um etwa % bzw. um ca. %. hypotensive patienten mit einem systolischen blutdruck ≤ mmhg zeigen dabei den größten anstieg der koronaren flussgeschwindigkeit. der fluss im poststenotischen anteil (cohen et al. ) . der vorteilhafte effekt der intraaortalen gegenpulsation im zusammenhang mit perkutaner revaskularisation (brodie et al. ; lindholm et al. ) wie auch unter thrombolytischer therapie (barron et al. ; kovack et al. stomel et al. ) ist bei patienten mit infarktbedingtem kardiogenem schock gut belegt. amerikanische kliniken mit hoher iabp-implantations-frequenz (> /jahr) erzielen bei schockpatienten eine um % niedrigere letalität (barron et al. ) . bei akutem koronarverschluss nach pci und bei pci-hochrisikopatienten mit mehrgefäßerkrankung und erheblich eingeschränkter pumpfunktion (im mittel % aller patienten) lässt sich die iabp mit gutem primärergebnis und ausreichend sicher einsetzen. bei patienten mit kardiogenem schock kann der iabp-einsatz bereits in der notaufnahme sicher durchgeführt werden (bur et al. ) . ein früher einsatz der iabp bei nichtherzchirurgischen krankheitsbildern scheint nach den daten der benchmark-registry mit weltweit über . patienten die prognose zu senken (cohen et al. ) . limitationen der iabp-anwendung sind die notwendigkeit eines mindestherzindex von , l/min/m und eines weitgehend stabilen rhythmus sowie der eher bescheidene erfolg mit einer einsparung des myokardialen o -verbrauchs um nur - %. bei herzchirurgischen patienten mit »low-output-syndrom« kommt die iabp häufi g zum einsatz. ein prädiktiver score erlaubt die identifi zierung derjenigen patienten, bei denen die iabp-behandlung des low-output-syndroms nicht ausreicht und ein wechsel auf ein herzunterstützungssystem notwendig wird (hausmann et al. ) . die katheter können entweder perkutan oder nach chirurgischer gefäßeröffnung in die femoralgefäße eingeführt werden. im falle der »supported angioplasty« bevorzugen wir als anästhesieverfahren die elektive intubationsnarkose. das system kann von einem erfahrenen team innerhalb von min installiert werden. indikationen. indikationen sind die Überbrückung akut vital bedrohlicher mechanischer infarktkomplikationen wie der ventrikelruptur, der herzstillstand und die hochrisiko-pci. in den usa erleiden jährlich . - . patienten einen herzstillstand im krankenhaus; diese patienten könnten somit möglicherweise ohne zeitlichen verzug wiederbelebt werden. bei erfolgloser konventioneller reanimation wären diese patienten kandidaten für eine notfall-pcps (ferrari et al. ) . die zu erwartenden ergebnisse wären günstig, wenn man die resultate einer multizentrischen studie mit pcps-reanimierten patienten zugrunde legt ( % der mit pcps reanimierten patienten konnten aus dem krankenhaus entlassen werden, im vergleich zu % der konventionell reanimierten eines historischen kontrollkollektivs). von patienten mit fulminanter myokarditis und kardiogenem schock überlebten bei vorübergehendem einsatz des perkutanen kardiopulmonalen bypass-systems für - tage ohne nachfolgende transplantation (kato et al. ) . natürlich müssen indikationsrichtlinien für die anwendung des perkutanen kardiopulmonalen bypass-systems vorliegen, soll dieses verfahren mit einer gewissen aussicht auf erfolg eingesetzt werden und nicht nur den irreversiblen schockzustand und damit das leiden des patienten verlängern. als richtlinien können gelten (ferrari u. figulla ): keine spontanzirkulation trotz optimaler reanimation über min bei patienten unter jahren mit dokumentiertem plötzlichem herzstillstand, sofort eingeleiteter reanimation und ohne neurologische defi zite; der einsatz der perkutanen kreislaufunterstützungssysteme als Überbrückung bis zur diagnostik, bis zur koronarrevaskularisation (ptca), bis zur implantation eines biventrikulären unterstützungssystems (»bridging to bridging«). die bisher beschriebenen mechanischen unterstützungssysteme sind für den einsatz von stunden bis tage gedacht; sie sind geeignet, eine akute schockphase zu überwinden. jüngst konnte auch mittels eines perkutan einsetzbaren mechanischen unterstützungssystems (tandem-heart) ein günstiger verlauf für patienten im protrahierten kardiogenen schock aufgezeigt werden (thiele et al. ) , ebenso wie für das impella-system (ferrari u. figulla ) . komplexere ventrikuläre unterstützungssysteme, wie z. b. das linksventrikuläre system novacor oder biventrikuläre künstliche herzen, dienen für terminal herzinsuffi ziente patienten zur Überbrückung der wartephase auf ein spenderherz (martin et al. ) . bei der konventionellen herzdruckmassage (hdm) wird ein herzzeitvolumen von nur - % des normalwertes erreicht. diastolische drücke von mmhg und systolische drücke von - mmhg werden selten überschritten. unter den bedingungen der manuellen herzdruckmassage reichen zerebraler und myokardialer blutfl uss nicht aus, um auf dauer einen hypoxischen schaden abzuwenden. um höhere blutfl üsse zu erreichen, werden alternative bzw. zusätzliche methoden zur hdm erprobt, wie die sequenzielle thorakoabdominelle kompression, die cpr mittels pneumatischer weste, die aktive kompressions-dekompressions-reanimation und die sog. »inspiratory threshold valve«. während die pneumatische weste v. a. den kompressionsvorgang automatisiert, haben die anderen genannten verfahren eine steigerung des venösen rückfl usses zum ziel. nach den aktuellen empfehlungen können mechanische hilfsmittel zur cpr verwendet werden. die herzdruckmassage mit interponierter abdomineller kompression (iac, »interposed abdominal compression cardiopulmonary resuscitation«) stellt ein vielversprechendes verfahren dar. bei der herzdruckmassage wird von einem zusätzlichen helfer mit der handfl äche eine kompression von ± mmhg auf die nabelgegend ausgeübt, und zwar alternierend mit der kardiopulmonalen kompression im verhältnis : . dadurch kommt es zu deutlich höheren blutfl üssen als mit konventioneller hdm. die aktive kompressions-dekompressions-pumpe (acd-cpr, »active compression-decompression cardiopulmonary resuscitation«) ist ein vielversprechendes und leicht anwendbares konzept (. abb. . a,b). ein griff wird mittels eines saugnapfes (z. b. cardiopump) auf der brust des patienten fixiert. so kann sowohl druck auf den thorax ausgeübt als auch durch zug an dem griff ein unterdruck erzeugt werden (mit förderung des venösen rückfl usses und einem höheren aortalen blutfl uss bei der nächsten kompression). in mehreren randomisierten prähospitalstudien zeigte der einsatz der cardiopump leider keinen Überlebensvorteil. bei patienten, die außerhalb des krankenhauses mit acd-cpr reanimiert worden waren, ließ sich jedoch eine verbesserte langzeitüberlebensrate nachweisen (plaisance et al. ). > . · spezifi sche schockformen während in den vergangenen jahren die dokumentierte infarktsterblichkeit seit der einführung der intensivüberwachung, der thrombolyse, effektiver antithrombotischer therapien sowie der perkutanen koronarintervention (pci) von ca. % um auf zwischenzeitlich %- % deutlich gesenkt werden konnte, ist die historisch zwischen und % angesiedelte sterblichkeit bei kardiogenem schock infolge eines akuten myokardinfarktes trotz moderner therapiemaßnahmen nicht in diesem ausmaß verbessert worden. unverändert stellt der kardiogene schock die hauptursache der infarktsterblichkeit im krankenhaus dar. ein kardiogener schock entwickelt sich bei - % aller patienten mit akutem herzinfarkt (hochman et al. , jacobs et al. menon et al. c) , und zwar am häufi gsten dann, wenn mindestens % der linksventrikulären muskelmasse akut oder sukzessive infarziert (menon et al. a; prondzinsky et al. ) abb. . a,b. aktive kompressions-dekompressions-pumpe (acd-cpr). a das system besteht aus einem saugnapf (radius , cm), einem gleitkolben und einem horizontalen griff (gesamthöhe , cm). b in die oberfl äche des griffes ist eine messskala (kg oder pounds) eingearbeitet. die aktive kompression/dekompression wird mit der mitten auf dem sternum platzierten pumpe mit - kompressionen (unabhängig vom atemzyklus) durchgeführt. der kompressionsdruck beträgt dabei (abhängig von der steifheit des brustkorbs) , - , kg, entsprechend einer kompressionstiefe von , - , cm. die gleichlange dekompressionsphase mit einem sog von im mittel , kg dient dazu, den brustkorb ohne kontaktverlust maximal zu expandieren. (nach cohen et al. ) . primäre pumpstörung mit schock bei ausgedehntem infarkt die daten der prähospitalen thrombolysestudie (captim; bonnefoy et al. ) legen nahe, dass der frühzeitige prähospitale einsatz von thrombolytika tendenziell zur verringerung nachfolgend auftretender schocksituationen führt. diese prospektiv erhobenen daten, die einen günstigen trend zu gunsten der thrombolyse mit einer annähernden halbierung der schockrate im weiteren hospitalverlauf aufwiesen, werden durch eine reihe retrospektiver daten positiv gestützt. verschiedene kleinere studien wie die daten des shock-trial-registry weisen auf einen deutlichen behandlungsvorteil für patienten mit kardiogenem schock in folge linksventrikulären pumpversagens mittels thrombolyse und begleitender intraaortaler gegenpulsation hin, insbesondere bei nachfolgender revaskularisation mittels pci oder aortokoronarer bypass-op. die autoren schlussfolgern, dass für krankenhäuser ohne möglichkeiten zur unmittelbaren koronarintervention eine strategie mit früher systemischer thrombolyse und gleichzeitiger intraaortaler gegenpulsation eine frühestmögliche vorbehandlung darstellt, bei nachfolgendem transfer des patienten in ein entsprechendes herzzentrum mit möglichkeiten zur pci oder aortokoronaren bypass-op. diese daten stehen interessanterweise in einem deutlichen kontrast zu den daten der danami-studie (andersen et al. ) , in der bei herzinfarktpatienten auch bis zu h zeitverzögert interventioneller koronartherapie ein eindeutiger behandlungsvorteil zu gunsten der mechanischen koronarrevaskularisiation gegenüber der thrombolyse aufgezeigt werden konnte. hierbei ist jedoch einschränkend zu bemerken, dass die gesamtsterblichkeit in beiden gruppen überdurchschnittlich niedrig war und sich diese daten primär nicht auf schockpatienten übertragen lassen dürften. darüber zeigte sich in der isolierten betrachtung des kombinierten endpunktes nach tagen (tod, reinfarkt, schlaganfall) nur für den einzelnen endpunkt »reinfarkt« ein signifi kanter vorteil für die patienten mit primärer pci. erst die wiederherstellung eines effektiven blutfl usses durch die sofortige wiedereröffnung des verschlossenen koronargefäßes mittels akut-pci (meyer et al. ) erbrachte nahezu eine halbierung der sterblichkeit. die shock-studie (hochman et al. ; ryan ) überprüfte die wirksamkeit der akutrevaskularisation (überwiegend akut-pci) bei patienten mit kardiogenem schock nach herzinfarkt im sinne der evidenzbasierten medizin (. tabelle . ). primäres zielkriterium war dabei die senkung der -tage-letalität, sekundäres zielkriterium u. a. die senkung der -monate-letalität. die %ige senkung der -tage-letalität im gesamtkollektiv war nicht signifi kant unterschiedlich, wohl aber die der -monate-letalität, und -in einer nachuntersuchung -die -monate-sterblichkeit. besonders die patienten < jahren profi tierten von der akutrevaskularisation, ebenso die patienten mit einem zeitintervall < h von schmerzbeginn bis randomisierung und die mit einem zweitinfarkt, weiterhin männer mehr als frauen. zu ähnlichen aussagen kommt das alkk-schockregister in deutschland (zeymer et al. während im shock-trial (hochman et al. ) der eindeutige behandlungsvorteil auf die altersgruppe der unter- -jährigen begrenzt war, konnten weitere arbeiten den behandlungsvorteil der pci auch für patienten im höheren alter aufzeigen (antoniucci et al. ; dzavik et al. ) . das alter stellt zwar bei kardiogenem schock einen eigenständigen risikoprädiktor dar; bei frühzeitiger und technisch erfolgreicher intervention ist allerdings der relative nutzen vergleichbar. die möglichkeit zur stent-implantation und der einsatz von gp iib/iiia-hemmern hat den effi zienzgrad und die sicherheit der akut-ptca bei kardiogenem schock noch weiter gesteigert. die effektivität des glykoproteinrezeptorantagonisten abciximab konnte sowohl bei perkutanen koronarhochri- . · spezifi sche schockformen sikointerventionen als auch insbesondere bei infarktbedingtem kardiogenen schocks aufgezeigt werden (zahn et al. ; zeymer et al. ) . so wird in einer pci-serie (antoniucci et al. ) mit schockpatienten über die implantation eines stents bei % berichtet; die primäre erfolgsrate lag dabei bei %, ein optimales angiographisches ergebnis wurde zu % erzielt, die -monate-Überlebensrate lag bei %; und % der patienten hatten nach monaten einen nyha-herzinsuffi zienzschweregrad von nur i-ii. von besonderem interesse war, dass gestentete koronarien eine geringere -monate-restenose-/reokklusionsrate ( %) hatten als dilatierte, aber nichtgestentete herzkranzgefäße ( %). ebenso ließ sich auch ein langfristiger Überlebensvorteil bei erfolgter stent-implantation und verabreichung von abciximab gegenüber einer strategie mit alleiniger ballonangioplastie, alleiniger stent-implantation oder ptca sowie abciximabgabe ohne stent-implantation belegen. der initial signifi kant verbesserte timi-iii-fluss ließ sich auch nach , jahren als signifi kanter Überlebensvorteil für die patienten, die mit stent und abciximab behandelt wurden, nachweisen (antoniucci et al. ; chan et al. ; giri et al. ) . die akut-pci kann bei kardiogenem schock infolge herzinfarkt als das verfahren der wahl angesehen werden (hamm et al. ) der überzeugende erfolg der pci im vergleich zur medikamentösen therapie mit i.v.-thrombolyse dürfte darauf zurückzuführen sein, dass mittels pci in einem sehr viel höheren prozentsatz ein timi-grad- -koronarfl uss (komplette reperfusion) wiederhergestellt werden kann, als dies mit der thrombolyse möglich ist. wegen der günstigen ergebnisse der akut-pci bei infarktbedingtem schock scheint die empfehlung gerechtfertigt, infarktpatienten mit manifestem oder beginnendem schock (katecholaminpfl ichtigkeit) möglichst rasch in ein zentrum mit der möglichkeit zur akut-pci durch ein erfahrenes herzkatheterteam zu verlegen (hamm et al. ) . dabei kann durchaus vorab eine i.v.-thrombolyse durchgeführt werden, sie stellt für die akut-pci keine kontraindi-> kation dar. falls verfügbar, sollte der transport mit liegender intraaortaler gegenpulsation (iabp) erfolgen, ein beträchtlicher nutzen der iabp bei den so behandelten patienten (n = ) ist in einer retrospektiven analyse aufgezeigt: -jahres-letalität mit iabp-behandlung %, -jahres-letalität ohne iabp-behandlung % (p = , ; kovack et al. ). die akute mitralinsuffi zienz (bei % aller infarktpatienten; , - % aller infarkttodesfälle; - tage, im mittel tage nach hinterwandinfarkt) kann entweder als folge einer papillarmuskeldysfunktion oder einer papillarmuskelruptur entstehen; meistens ist die papillarmuskeldysfunktion von transienter natur und führt nur zu einer milden mitralinsuffi zienz, während der papillarmuskelabriss in der regel ein refraktäres lungenödem und eine schwere beeinträchtigung des kreislaufs hervorruft. die mitralinsuffi zienz infolge papillarmuskelabriss fi ndet sich typischerweise bei älteren patienten mit erstmaligem, oftmals eher kleinem infarkt und nur leicht eingeschränkter auswurffraktion; eine insuffi zienz infolge dysfunktion des halteapparates -ohne papillarmuskelabriss -tritt eher bei jüngeren patienten mit koronarer mehrgefäßerkrankung und eingeschränkter auswurffraktion auf (calvo et al. ) . frauen und ältere infarktpatienten sind von der akuten mitralinsuffi zienz, die gemeinsam mit der ruptur des ventrikelseptums etwa % aller schockinfarktpatienten ausmacht, häufi ger betroffen; möglicherweise führt die i.v.-thrombolyse zu einem früheren auftreten dieser komplikation (hochman et al. ) . bei der mehrzahl der patienten ist die rechte kranzarterie oder der r. circumfl exus das infarktgefäß. bei bis zu % aller patienten mit akutem myokardinfarkt lässt sich auskultatorisch oder echokardiographisch eine mitralinsuffi zienz nachweisen. eine höhergradige mitralinsuffi zienz fi ndet sich hingegen nur bei % aller infarktpatienten, wobei die hälfte dieser patienten ein lungenödem oder einen manifesten kardiogenen schock entwickelt (tcheng et al. ) . das systolikum -in typischer weise holosystolisch über dem apex zu auskultieren und in die axilla ausstrahlend -ist tabelle . . shock-studie: akutrevaskularisation bei patienten mit kardiogenem schock nach herzinfarkt. (nach hochman et al. (zotz et al. ) . das hämodynamische monitoring zeigt eine abnahme des herzzeitvolumens und das auftreten einer v-welle in der pulmonalkapillare (. tabelle . ). die letalität innerhalb der ersten h kann bis zu % betragen. nach initialer stabilisierung mit vasopressoren, nachlastsenkung (typischerweise mit dem gut steuerbaren nitroprussidnatrium) und implantation der intraaortalen ballongegenpulsation muss bei der papillarmuskelruptur zum frühestmöglichen zeitpunkt ein klappenersatz (ggf. mit anlegen eines aortokoronaren bypasses) durchgeführt werden. die ergebnisse der frühoperation sind mit einer letalität von % deutlich besser als die der spätoperation (letalität %; thompson et al. ) . falls eine papillarmuskelruptur sicher auszuschließen ist und »nur« eine papillarmuskelischämie vorliegt, kann eine pci des den betroffenen papillarmuskel versorgenden koronargefäßes in betracht gezogen werden. eine ventrikelseptumruptur (birnbaum et al. ; menon et al. b ) tritt bei - % aller infarkte innerhalb der . woche auf und ist etwa gleich auf alle infarktlokalisationen verteilt. die ruptur kann mit neuerlichen herzschmerzen einhergehen. typisch dafür ist das laute holosystolikum mit punctum maximum am linken sternalrand, gelegentlich vergesellschaftet mit einem schwirren. die diagnose lässt sich echokardiographisch stellen (ballal et al. ) , der o -sättigungssprung zwischen rechtem vorhof und rechtem ventrikel lässt eine quantitative shunt-abschätzung zu. neben der shunt-größe ist prognostisch auch die lokalisation wichtig: die hämodynamische beeinträchtigung durch den shunt wird v. a. durch die gestörte compliance des rechten ventrikels geprägt, wenn dieser, wie bei einem hinterwandinfarkt, ebenfalls infarziert ist (held et al. ) . die hälfte der patienten entwickelt einen kardiogenen schock. die prognose wird in erster linie vom ausmaß der links-und rechtsventrikulären infarzierung und weniger von der größe des defektes bestimmt (cummings et al. ) . bei hämodynamischer instabilität besteht nach ansicht der meisten autoren eine dringliche bzw. notfallmäßige operationsindikation, da sich unter konservativer therapie bei diesen patienten häufi g ein multiorgandysfunktionssyndrom entwickelt (lemery et al. ; cox et al. ; killen et al. ) . therapeutisch bietet nur die rasche operative deckung des defektes nach vorheriger implantation der intraaortalen ballongegenpulsation (thiele et al. ) und medikamentöeser stabilisierung (nachlastsenkung mittels nitroprussidnatrium zur shunt-reduktion, ggf. in kombination mit katecholaminen) aussicht auf erfolg. aber selbst bei frühzeitiger operation muss mit einer sterblichkeit von % im vergleich zur sterblichkeit von % bei abwartender haltung gerechnet werden (hochman et al. ) . der perkutane translu-minale verschluss einer septumruptur gilt vorerst als experimentelle methode. die ruptur der freien ventrikelwand (figueras et al. ; slater et al. ) geht mit einer letalität von % einher. sie tritt am häufi gsten zwischen dem . und . tag nach infarkt auf, aber jede . ruptur fi ndet bereits innerhalb der ersten h statt. sie betrifft häufi ger frauen, den erstinfarkt, den vorderwandinfarkt, den älteren patienten und diejenigen mit hochdruck. sie wird gehäuft gesehen bei vorausgegangener medikation mit kortikoiden und antiphlogistika. der frühzeitige einsatz von thrombolytika scheint die inzidenz zu senken, der späte einsatz sie zu erhöhen. die ruptur der freien wand führt zum hämoperikard und zur raschen perikardtamponade. oft kommt es zu neuerlichen starken herzschmerzen mit sofortiger elektromechanischer entkopplung. am häufi gsten führt der einseitige einriss zum tode; subakute einrisse können jedoch ebenfalls als akute tamponade, als großer perikarderguss oder als chronisches pseudoaneurysma imponieren. der akute schock nach infarkt muss immer an die diagnose einer ventrikelruptur denken lassen. eine sofortige perikardpunktion kann zur vorübergehenden stabilisierung führen, die zur zügigsten diagnostik (echokardiogramm: perikarderguss; swan-ganz-katheter: tamponadedruckprofi l) genutzt werden muss. sehr selten wird eine ventrikelruptur überlebt, nur dann, wenn der patient schnellstens (richtwert: h) an die herz-lungen-maschine angeschlossen wird und der einriss erfolgreich übernäht werden kann. das geronnene blut im perikardbeutel verstopft sehr schnell eine perikarddrainage, was für die reanimation am offenen thorax spricht. zahlreiche erkrankungen sehr unterschiedlicher Ätiologie können in einen kardiogenen oder extrakardial-obstruktiven schock münden (. tabelle . ). nach entsprechender diagnostik wird sich die therapie zunächst darauf konzentrieren, einerseits eine besserung der pumpfunktion des herzens zu erzielen, andererseits versuchen, kardiale und extrakardiale obstruktionen zu beseitigen (z. b. punktion eines tamponierenden perikardergusses, thrombolyse bei massiver lungenembolie) oder schockauslösende rhythmusstörungen zu beherrschen (z. b. kardiopulmonale reanimation). man wird dann bestrebt sein, die therapie in eine kausale münden zu lassen, soweit dies möglich ist. bei aktueller inoperabilität eines patienten mit dekompensierter aortenklappenstenose und schock kann auf der intensivstation bei sorgfältigem invasivem hämodynamischem monitoring eine nachlastsenkung mit nitroprussidnatrium zur entlastung des ventrikels versucht werden (khot et al. ) , und auch die aortenklappenvalvuloplastie kann im einzelfall zur rekompensation beitragen und damit die voraussetzungen für den späteren klappenersatz schaffen (melzer et al. ). > . · spezifi sche schockformen intoxikationen mit kardiodepressiven und vasotoxischen substanzen (schmidt et al. ) . trotz der potenziell akut lebensbedrohlichen situation ist die langzeitprognose dieser patienten nach erfolgreicher akutbehandlung in der regel sehr günstig. dies rechtfertigt auch den einsatz eines kardiopulmonalen bypasses für einige stunden, falls die konventionellen detoxikationsmaßnahmen und die symptomatische therapie zu keiner herz-kreislauf-stabilisierung führen. herzverletzungen (redling et al. ). offene, aber auch stumpfe thoraxtraumen mit schockentwicklung sollten immer an eine herzverletzung denken lassen; nach rascher diagnosestellung ist hier die sofortige herzoperation häufi g lebensrettend. perioperativer herzinfarkt mit schockentwicklung. wegen der häufi g nur kurz zurückliegenden operation muss bei auftreten eines herzinfarktes häufi g auf die i.v.-thrombolyse verzichtet werden, obwohl wegen des meist kurzen zeitintervalls zwischen infarktbeginn und infarktdiagnostik die erfolgschancen der thrombolyse günstig wären. in solchen fällen sollte -wann immer möglich -die akut-ptca auch des beatmeten patienten in erwägung gezogen werden. zwischen zwischen und f − − − f − − in deutschland werden z. z. jährlich . operationen mit der herz-lungen-maschine durchgeführt mit einer durchschnittlichen letalität von , %. wesentliche todesursachen sind dabei septischer schock und mods. gründe für das erhöhte sepsisrisiko sind die kardiale vorschädigung der patienten, die folgen der thorakotomie mit einer erhöhten inzidenz an pneumonien sowie bakteriämie, endotoxinämie und vorwiegend pulmonalen mikrozirkulationsstörungen als folge der extrakorporalen zirkulation. ein weiterer wesentlicher aspekt ist die kontaktaktivierung des blutes in der herz-lungen-maschine: sie löst eine ausgeprägte systemische entzündungsreaktion (»post pump infl ammatory response«) aus. als folge davon kommt es zur aktivierung von blutzellen mit freisetzung von aggressiven mediatoren und proinfl ammatorischen zytokinen, die z. t. in höheren serumkonzentrationen gefunden werden als in der sepsis. diese entzündungsreaktion wird für das auftreten des mods nach herzchirurgischen operationen mitverantwortlich gemacht (prondzinsky et al. ). die möglichkeiten einer positiv-inotropen intervention sind bei dem muskelschwachen rechten ventrikel relativ begrenzt (maisch u. christ ) . insbesondere digitalis sollte vorsichtig dosiert werden, um intoxikationen zu vermeiden. die senkung der zur dekompensation führenden pulmonalen hypertonie steht im vordergrund. rechtsherzdekompensation bei ards und sepsis: abschn. . . in der therapie des rechtsherzversagens und der pulmonalen hypertonie nach operativen, insbesondere herzchirurgischen eingriffen, bewirkt inhalativ appliziertes stickoxid (no, , - ppm) eine selektive pulmonale vasodilatation ohne systemvaskuläre nebenwirkungen rinne u. zwissler ) . die pulmonale vasodilatation geschieht ohne beeinträchtigung der hypoxischen pulmonalen vasokonstriktion, so dass es weder zu einer erhöhung des intrapulmonalen shunts noch zu einer reduktion der arteriellen oxygenierung kommt. die wirkung von inhalativ appliziertem no kann jedoch variieren. prinzipiell denkbare effekte auf koronarien und myokard scheinen nicht sehr ausgeprägt bis fehlend zu sein (cheifetz et al. ) . bedenken gegen den einsatz von inhalativem no bei akuten koronaren syndromen bestehen nicht (lindenfeld ) . zunehmend setzt sich zur intraoperativen anwendung neben inhalativem no das inhalativ applizierbare, stabile prostaglandin-i (pgi )-analogon iloprost (ilomedin) aufgrund seiner längeren hwz und seiner technisch einfacheren anwendbarkeit durch (rinne u. zwissler (bowers et al. ; jacobs et al. ; pfi sterer ; seyfarth u. schömig ) . hinweisend dafür sind st-strecken-hebungen in den rechtspräkordialen ableitungen v r und besonders v r . der rechtsherzinfarkt -charakterisiert durch einen schockzustand (hypotonie, niedriges herzzeitvolumen) ohne lungenstauung -lässt sich echokardiographisch als großer, hypokinetischer rechter ventrikel und kleiner linker ventrikel kenntlich machen. wegweisend für die diagnose sind neben klinik und echokardiographie auch der niedrige pulmonalkapillardruck trotz schockzustand. der rechtsherzinfarkt disponiert zu bradykarden rhythmusstörungen in form höhergradiger av-blockierungen. vorgehen der wahl bei rechtsherzinfarkt mit oder ohne begleitenden schockzustand ist die akut-ptca (bowers et al. ) : in einer untersuchung an patienten mit rechtsventrikulärem infarkt konnte durch die akut-ptca bei patienten ( %) eine wiedereröffnung der verschlossenen rechten koronararterie erzielt werden, mit einer prompten und beeindruckenden erholung der rechtsventrikulären pumpfunktion innerhalb einer stunde und einer niedrigen hypotonie-( %) und letalitätsrate ( %). bei den patienten, bei denen die wiedereröffnung nicht gelang, persistierte die rechtsventrikuläre funktionsstörung; die hypotonierate lag bei % und die letalität bei % (bowers et al. trotz des gewachsenen verständnisses des krankheitsablaufs und neuer therapieansätze konnte die hohe letalität des septischen schocks von - % bisher noch nicht wesentlich gesenkt werden. die sepsishäufi gkeit ist zunehmend, in den vereinigten staaten erkranken jährlich etwa . patienten an einer sepsis, und . versterben daran. wesentliches zur klassifi kation und Ätiologie (. abb. . , abschn. . . ), zur pathophysiologie ( abschn. . . ), zur basisdiagnostik ( abschn. . . ) und basistherapie ( abschn. . ) und zum mods ( abschn. . ). die typischen herz-kreislauf-veränderungen bei gramnegativem und grampositivem septischen schock sind: blutdruckabfall infolge der ausgeprägten vasodilatation, erniedrigung des systemischen gefäßwiderstandes bis auf % der norm, kompensatorische zunahme des herzzeitvolumens, des schlagvolumenindex und des schlagarbeitsindex. fehlt eine relative kardiale vorschädigung, so liegen die gemessenen herzfunktionsparameter dabei auch beträchtlich höher als die gesunder probanden mit einem normalen systemischen gefäßwiderstand um dyn · s · cm - (. abb. . ). die beiden toxinschocksyndrome werden durch das toxicshock-syndromtoxin (tsst- ) von staphylococcus aureus bzw. durch das streptococcus-pyogenes-exotoxin (spe) von streptokokken produziert. beide toxine haben superantigeneigenschaften ( abschn. . . ), was den dramatischen klinischen verlauf über eine massive zytokinfreisetzung erklären könnte. bei verdacht auf eine der genannten erkrankungen müssen die erkrankten auf die intensivstation gebracht werden, wo schnellstmöglich mit der antibiotika-und der symptomatischen schocktherapie und engmaschigen Überwachung begonnen werden muss, da sich sehr rasch ein schock entwickeln kann. die toxische vasodilatation mit massivem blutdruckabfall könnte ein gesundes herz durch einen drastischen anstieg des herzzeitvolumens kompensieren (. abb. . ). eine so weitgehende kompensation der erniedrigten nachlast, d. h. ein wesentlicher anstieg des herzzeitvolumens wie in . abb. . beschrieben, wird im septischen schock nur selten beobachtet, v. a. nicht bei protrahierten verläufen: die pumpfunktionsparameter des herzens sind dabei zwar im vergleich zu gesunden probanden mit normalem systemischem gefäßwi-> derstand meist nicht erniedrigt oder sogar leicht erhöht, berücksichtigt man jedoch die inverse korrelation mit dem systemischen gefäßwiderstand (. abb. . ), so wird die eingeschränkte pumpleistung des herzens bei vielen patienten bereits in der hyperdynamen phase des septischen schocks und sogar bereits bei septischen patienten mit noch normalem blutdruck (raper et al. ) rasch evident. die erklärung für die nur inadäquate steigerung der herzförderleistung ist eine potenziell reversible, multifaktorielle herzschädigung in der sepsis, die durch klinische befunde belegt werden kann. als charakteristika der akuten septischen kardiomyopathie (müller- werdan et al. ; (redl et al. ) . insgesamt ist jedoch die diskussion um das »ideale« katecholaminregime bei primär rechtsventrikulärer septischer herzschädigung noch in vollem gange; die möglichkeit zur detaillierten quantifizierung des therapieerfolgs wird im einzelfall sicherlich hilfreich sein. der septische schock stellt ein bereits weit fortgeschrittenes krankheitsstadium dar! er ist in der regel hyperdynam (herzindex > , l/min/m ; systemischer gefäßwiderstand dyn·s·cm - ) und nur in der spätphase oder bei nicht ausreichender volumensubstitution hypodynam (< , ; ). die z. z. noch weitgehend symptomatische behandlung beinhaltet zunächst die rasche und adäquate volumensubstitution, ggf. gefolgt und unterstützt durch den einsatz von katecholaminen. die mikrobielle diagnostik (blutkulturen und organbezogener keimnachweis), die fokuselimination und der beginn einer antibiotischen therapie leiten bereits zu den kausalen maßnahmen über. sepsis und septischer schock können ein facettenreiches mods induzieren, das die prognose des patienten entscheidend prägt. das konzept der therapie des septischen schocks besitzt mehrere eckpfeiler (czock u. keller ; dellinger ; dellinger et al. ; freeman et al. ; werdan et al. bei der wahl des richtigen präparates zur kalkulierten und gezielten antiinfektiösen therapie sind die empfehlungen der paul-ehrlich-gesellschaft sehr hilfreich (bodmann u. vogel ) , wobei die zunehmende resistenzentwicklung ein ernsthaftes problem darstellt. mit einer innerhalb der ersten h auf der notaufnahme begonnenen, an hämodynamischen zielkriterien orientierten volumen-und katecholamintherapie (. abb. . ) lässt sich bei patienten mit schwerer sepsis und septischem schock die -tage-sterblichkeit im vergleich zur »konventionellen intensivtherapie« von auf % senken (rivers et al. ) . neu an diesem im vergleich zu früheren »sauerstoff-zielorientierten«, bisher erfolglos gewesenen ansätzen ist der sehr frühe beginn der behandlung. dennoch darf dieses »erfolgsrezept« nicht kritiklos von der notaufnahme auf die intensivstation übertragen werden: der noch nicht anbehandelte »notfallsepsispatient« unterscheidet sich hämodynamisch beträchtlich von dem klassischen »intensivstationsepsispatienten« (dan-nino et al. ; . einen die früh-und die stabile sepsisphase integrierenden vorschlag zur herz-kreislauf-therapie gibt . abb. . . sepsispatienten sind durch ein absolutes und ein relatives intravasales volumendefi zit charakterisiert. die sofortige und adäquate flüssigkeitstherapie ist der entscheidende erste schritt zur behandlung des septischen schocks (. tabelle . ; müller-werdan u. . bei einem hämatokrit < % und gleichzeitig einer auf < % erniedrigten zentralvenösen sauerstoffsättigung (s cv o ) wird die gabe von erythrozytenkonzentraten zur anhebung des hämatokrits auf ≥ % empfohlen (. abb. . ), zumindest in der frühphase der sepsis innerhalb der ersten h auf der notaufnahme (rivers et al. ) . ansonsten gilt die empfehlung, erythrozytenkonzentrate bei einem hämoglobinwert < , g/ dl zu geben und das hb auf einen wert von , - , g/dl anzuheben. eythropoetin wird nicht zur behandlung der anämie im rahmen einer schweren sepsis empfohlen (. tabelle . ; dellinger et al. ). berücksichtigt man weiterhin die auswirkungen der katecholaminbehandlung auf die leber-splanchnikus-perfusion, den magenmukosa-ph und den laktatspiegel, so schneiden dobutamin und noradrenalin hinsichtlich unerwünschter wirkungen günstiger als dopamin und wesentlich günstiger als adrenalin ab , so dass auch aus diesen gründen der einsatz von noradrenalin und dobutamin empfohlen werden kann. phosphodiesterasehemmstoffe und dopexamin sind im septischen schock eher pharmaka der . wahl. digitalis ist bei tachykardem vorhoffl immern und bei vorhoffl attern indiziert, bei sinusrhythmus ist seine bedeutung als positiv-inotrope substanz eher gering einzustufen. selten kommen vasopressin sowie -noch wesentlich seltener -angiotensin, vasodilatatoren, n-acetylcystein, glukagon und kalzium als positiv-inotrope und direkt sowie indirekt vasoaktiv wirkende pharmaka bei patienten mit septischem schock zum einsatz dellinger ; dellinger et al. ; . eine prognosebesserung ist nicht belegt. zu ernährung und stoffwechsel . tabelle . und abschn. . . . die gabe von hydrocortison hat eingang in die offi ziellen therapieempfehlungen gefunden (. tabelle . ). hydrocortison bessert den vaskulär bedingten schock, mit einem anstieg des erniedrigten systemischen gefäßwiderstandes und einer verkürzung der behandlungsdauer mit vasopressorischen katecholaminen; die myokarddepression der septischen kardiomyopathie lässt sich durch hydrocortison allerdings nicht bessern: der erniedrigte linksventrikuläre schlagarbeitsindex steigt nicht an (briegel et al. ) . die hinweise auf eine letalitätssenkende wirkung (annane et al. ) werden z. z. in der corticus-studie überprüft ( abschn. . . ). auch die gabe von aktiviertem protein c (drotrecogin alfa aktiviert; xigris) ist bestandteil der offi ziellen therapieempfehlung bei schwerer sepsis in der frühphase (. tabelle . ; abschn. . . ). wie in einer cochrane-analyse beschrieben haben i.v.-immunglobuline -das iviggma-präparat pentaglobin -je , g/ kgkg an aufeinanderfolgenden tagen -mehr noch als ivigg-präparate eine letalitätssenkung in mehreren kleinen studien gezeigt (septischer schock mit endotoxinämie, abdominelle sepsis; zitiert in werdan b; werdan et al. ) ; die datenlage reichte der survival sepsis campaign jedoch nicht aus, um die gabe von iviggma in ihre therapieempfehlungen aufzunehmen (dellinger et al. ) . derzeit nicht zu empfehlen ist der einsatz von antiendotoxintherapien, von steroiden in hoher dosierung und prostaglandin e, von anti-tnf-α-antikörpern, interleukin- -rezeptorantagonisten, paf-antagonisten, n-acetylcystein und antioxidanzien. die peripheren venen sind kollabiert und der jugularvenendruck ist niedrig, es sei denn, der hypovolämische schock ist assoziiert mit einer einfl ussstauung, z. b. durch ein myokardiales pumpversagen, eine perikardtamponade oder einen pneumothorax. die akren sind kühl, und v. a. bei älteren patienten kann es zu einem absinken der körpertemperatur kommen. die kapilläre füllung ist vermindert. weitere klinische zeichen des hypovolämischen schocks sind periphere zyanose, verminderter hautturgor und trockene schleimhäute. die patienten klagen über durst, schwitzen und kurzatmigkeit, sie sind ängstlich. im schweren schock werden die patienten zunehmend apathisch oder verwirrt. der blutdruck kann nichtinvasiv nicht mehr messbar sein, oder es kann ein großer gradient zwischen blutig und unblutig gemessenem blutdruck nachweisbar sein. die hypotension kann im sitzen oder orthostatisch verstärkt sein. die atemabhängigen schwankungen des systolischen arteriellen blutdrucks sind intensiviert. die typischerweise zu beobachtende tachykardie kann durch die vorausgegangene einnahme von β-rezeptorenblockern ausbleiben. gelegentlich kommt es zu einer bradykardie. der zur abschätzung des volumen-/blutverlustes berechenbare schockindex -quotient aus puls und systolischem blutdruck; normal , (blutverlust < %); drohender schock (blutverlust < - %); manifester schock , (blutverlust > - %) -ist keine große hilfe und kann zu fehleinschätzungen führen (große variabilität; interferenz mit vormedikation (β-blocker) und begleiterkrankungen (arterielle hypertonie). sind trauma und äußerliche blutung die ursache des schocks, so haben die kontrolle des blutverlustes, die bereitstellung von gekreuzten blutkonserven und die infusion von flüssigkeit und blutprodukten eine höhere priorität als weitergehende diagnostische maßnahmen (groneveld ). nach stumpfem abdominellem trauma sollte eine diagnostische peritoneallavage durchgeführt werden. eine computertomographie des abdomens gehört zur weiterführenden diagnostik; diese ist zwar zeitaufwendiger und weniger sensitiv als die peritoneallavage und nur bei relativ stabilen patienten durchführbar, sie ist aber diagnostisch spezifi scher. ein rupturiertes bauchaortenaneurysma kann sonographisch oder, falls der zustand des patienten es erlaubt, angiographisch erfasst werden. ein stumpfes thoraxtrauma kann kompliziert sein durch eine aortenruptur, einen spannungspneumothorax, hämatothorax, hämoperikard oder eine tamponade. eine thoraxröntgenaufnahme kann hier diagnostisch weiterführen. bei gastrointestinalen blutungen sollten weiterführende endoskopisch-diagnostische maßnahmen auch erst nach der initialen flüssigkeitstherapie erfolgen. eine magensonde sollte gelegt werden, um die aspiration von mageninhalt bei erbrechen zu verhindern und um eine magenblutung erkennen zu können. > > laboruntersuchungen umfassen neben der blutgruppenanalyse und bereitstellung gekreuzter blutkonserven die bestimmung des blutbildes, der elektrolyte, der laktatkonzentration, des serumkreatinins, der blutgase einschließlich des ph-werts und der glukose. unmittelbar nach einer blutung können der hämoglobingehalt und hämatokrit des blutes noch normal sein. ein akuter hypovolämischer schock kann mit einer leichten leukopenie und anschließenden leukozytose einhergehen. die Überwachung der patienten erfordert neben einer kontrolle des arteriellen blutdrucks und der urinausscheidung ggf. die messung des zentralen venendrucks und ein hämodynamisches monitoring mittels pulmonalarterienkatheter zur Überwachung der flüssigkeitstherapie. die messung des pulmonalkapillären verschlussdrucks ist besonders wichtig bei funktions-und compliance-störungen des linken ventrikels, etwa bei einer vorbestehenden herzerkrankung. umgekehrt kann bei schwerer pulmonaler hypertonie und rechtsherzinsuffi zienz der druck im linken herzen anhand des zentralen venendrucks unterschätzt werden. durch kontrolle der kardialen füllungsdrücke kann die entstehung eines lungenödems bei der flüssigkeitssubstitution vermieden werden. therapieziel ist neben der substitution des verlorengegangenen volumens die optimierung der o -zufuhr an die peripheren gewebe (christ u. lackner ; groeneveld ) . der therapieplan beim hypovolämischen schock erfolgt nach den aufgeführten gesichtspunkten: lagerung und schmerzstillung, volumenersatz, kausaltherapie, zusätzliche (fakultative) maßnahmen, prophylaxe. aufgrund der mikrozirkulationsstörung und der sekundären volumenverluste sind oft weit höhere volumina erforderlich, um die makro-und mikroperfusion sicherzustellen, als aufgrund des initialen volumenverlustes bzw. schockereignisses zu erwarten wäre. seit jahrzehnten ist gegenstand der diskussion, ob die volumenersatztherapie mit kristalloiden oder kolloiden lösungen erfolgen soll ( abschn. . . ). in der regel werden bei der behandlung des hypovolämischen schocks kolloide und kristalloide in einem fi xen verhältnis (z. b. teil kolloid: , evtl. teile kristalloid) verabreicht. hyperton-onkotische lösungen zeigen beim hypovolämischen schock keine medizinischen vorteile (meier-hellman u. burgard ). vasoaktive pharmaka werden im hypovolämischen schock dann eingesetzt, wenn die therapieziele mit adäquater volumensubstitution nicht zu erreichen waren, oder als überbrückende maßnahme bis zur einleitung der volumentherapie. in abhängigkeit vom klinischen bild sind begleitende therapiemaßnahmen wie sedierung, analgesie und frühzeitige beatmung anzustreben. zur beherrschung schwerster hypovolämischer schockzustände kann der einsatz von antischockhosen (mast, »medical/military anti-shock trousers«) hilfreich sein. dabei werden durch getrennte pneumatische kammern unterschenkel, oberschenkel und abdomen mit zentripedal abfallenden drücken komprimiert. nach wie vor ist trauma die häufi gste todesursache bei personen im alter von - jahren. verkehrsunfälle sind die häufi gste ursache des stumpfen traumas. statistisch sind in der frühphase nach einem trauma verbluten oder schwere schädelverletzungen die häufi gsten todesursachen; einige tage nach dem ereignis kommt es zu einer häufung von todesfällen durch schwere schädel-hirn-traumen; im abstand von mehreren wochen zum trauma sind sepsis und multiorganversagen die häufi gsten todesursachen. die traumatische verletzung ist ein komplexes, multifaktorielles geschehen, das ein weites spektrum an verschiedenen autonomen endokrinen und zellulären reaktionen auslöst. schmerz, angst, blutverlust, gewebeverletzung, hypoxie und bakterielle kontamination wirken als neuroendokrine stimuli; zusätzliche einfl ussfaktoren sind der individuelle bewusstseinszustand und die gabe von medikamenten, v. a. anästhetika. meist handelt es sich beim traumatischen schock jedoch um die pathogenetische konstellation eines hypovolämischen schocks, der durch wiederholte blutverluste aggraviert verlaufen kann (shapiro ). beim hämorrhagischen schock fi nden sich die klinischen zeichen der hypovolämie ( abschn. . . ) und das bild der äußeren oder inneren blutung oder andere zeichen der gewalteinwirkung (shapiro ) . der traumatische schock ist nicht immer ein blutungsschock. viele weitere ursachen sind zu nennen und bestimmen das klinische bild, z. b. spinaler schock (hund u. abel ) , hirnödem, kardiale kontusion, herztamponade, spannungspneumothorax, hypothermie, flüssigkeitsverluste durch verbrennungen und crush-verletzungen mit einer massiven freisetzung von myoglobin. bei allen patienten, die ein trauma erlitten haben, ist nach zeichen des schocks zu fahnden. der genaue unfallhergang ist ebenso zu erfragen wie eventuelle internistische vorerkrankungen. gerade bei älteren patienten können auch scheinbar geringfügige gewalteinwirkungen zu schweren verletzungen führen, etwa aufgrund einer osteoporose. der vollständig entkleidete traumapatient sollte nach Überprüfung der vitalfunktionen mit größter sorgfalt körperlich untersucht werden. zur weiterführenden diagnostik abschn. . . . da das ausmaß der verletzungen oftmals nicht anatomisch genau feststellbar ist, kommen zur objektivierung des schweregrades des traumas score-systeme zur anwendung, häufi g wird der »revised trauma score« genutzt. parallel zur Überprüfung der vitalfunktionen (atemwege, atmung, herz-kreislauf-funktion) sollte sofort eine rasche volumensubstitution erfolgen. bleibt der patient trotz volumengabe hypotensiv, so können zusätzlich erythrozytenkonzent-> rate transfundiert werden. die zentrale frage bei der weiteren behandlung des traumapatienten ist, ob eine sofortige operative therapie erforderlich ist. ein fehlendes ansprechen der schocksymptomatik auf die flüssigkeitsverabreichung ist verdächtig auf eine andauernde blutung. aktive externe blutungen können oft schon durch direkten druck unterbrochen werden. sind äußere blutungen kontrolliert, so muss nach versteckten blutungsursachen gefahndet und diese ggf. operativ angegangen werden. gerade in notaufnahmen muss darauf geachtet werden, dass die patienten im traumatischen schock nicht außerdem noch in eine hypothermie geraten, die den patienten zusätzlich gefährdet und die gerinnung beeinträchtigen kann. eine massive transfusion von erythrozytenkonzentraten kann zu einer schweren koagulopathie führen durch den prozentual zu geringen anteil an gerinnungsfaktoren im vergleich zu den blutzellen, durch hypothermie und durch die sekundäre gerinnungsstörung im schock. die koagulopathie wird durch gabe von ffp (»fresh frozen plasma«) und thrombozytenkonzentraten behandelt. eine klinische unterscheidung zwischen anaphylaktischer und anaphylaktoider reaktion gelingt nicht. das klinische erscheinungsbild (haupt ; walther u. böttiger ) variiert interindividuell stark, auch in abhängigkeit vom antigeneintrittsort, der absorptionsrate und dem ausmaß der sensibilisierung. initial können daher gastrointestinale symptome, Übelkeit, erbrechen, durchfälle, kolikartige beschwerden, unwillkürlicher abgang von stuhl und harn, selten darmblutungen, hauterscheinungen oder beschwerden von seiten des respirationstraktes im vordergrund stehen. das zeitliche intervall bis zum auftreten von beschwerden kann minuten bis mehrere stunden betragen; ganz überwiegend treten die symptome innerhalb der ersten stunde nach antigenexposition auf. die sich meist rapide entwickelnde systemische reaktion geht sehr oft (mehr als %) einher mit hauterscheinungen wie pruritus, flush, erythem, urtikaria und in schweren fällen angioödem. häufi g sind juckreiz und schwellungen der nasen-, augen-und mundschleimhaut sowie Ödeme der lippen, der augenlider und der zunge. häufi g und bedrohlich sind atemwegsobstruktionen, extrathorakal durch Ödeme im larynx-und pharynxbereich, intrathorakal durch bronchialobstruktion. oft kommt es zum lungenödem. in schweren fällen einer anaphylaxie, etwa bei intravenöser antigenexposition, kann es ohne hauterscheinungen und atembeschwerden unmittelbar zum schock kommen. die hämodynamischen veränderungen des anaphylaktischen schocks sind aus kasuistischen beschreibungen bekannt (hanashiro u weil ) . im vordergrund stehen hypovolämie aufgrund von flüssigkeitsverschiebungen ins interstitium bei erhöhter gefäßpermeabilität und peripherer vasodilatation, tachykardie und erniedrigte kardiale füllungsdrücke (carlson et al. ; silverman et al. ) . initial im verlauf einer anaphylaxie wurden erhöhte herzzeitvolumi-! . · spezifi sche schockformen na beobachtet, die einerseits durch die erhöhten katecholamin-und histaminspiegel zustande kommen, andererseits die folge des erniedrigten systemischen gefäßwiderstands sein könnten (moss et al. ; hamberger et al. ) . im weiteren verlauf sinkt das herzzeitvolumen ab bei einem erniedrigten venösen rückstrom. niedrige pulmonalkapilläre verschlussdrücke, wie sie im anaphylaktischen schock gefunden werden, sprechen gegen eine kardiale verursachung des häufi g gefundenen lungenödems; vielmehr ist dies am ehesten die folge der erhöhten gefäßpermeabilität (carlson et al. ) . jedoch wurden im anaphylaktischen schock ekg-veränderungen gefunden im sinne von ischämiezeichen und arrhythmien (booth u. patterson ; sullivan ; austin et al. ) . auch über eine reversible myokarddepression wurde bereits berichtet (raper u. fisher ) , wenn auch ältere studien nur eine geringe beeinträchtigung der herzfunktion fanden. für die notfalltherapie (haupt ; waltheru. böttiger ) spielt die unterscheidung zwischen anaphylaktischer und anaphylaktoider reaktion keine rolle. im folgenden ist daher nur von der anaphylaxie als Überbegriff die rede. bei verdacht auf eine anaphylaxie ist sofortiges handeln erforderlich (. tabelle . ), so dass eine rasche evaluation der situation unter berücksichtigung möglicher differenzialdiagnosen erfolgen muss (haupt ) . schwere anaphylaktische reaktionen können auch unter adäquater therapie progredient verlaufen, oder es kann nach einer vorübergehenden besserung zu einem erneuten einbruch der symptomatik kommen. daher ist oftmals eine intensivmedizinische Überwachung dieser patienten angezeigt. grundpfeiler der sofortbehandlung bei hypotension und hypoxie sind: ausschalten des mutmaßlichen auslösers, offenhalten der atemwege, %ige o -zufuhr, intravaskuläre volumenexpansion und katecholamine. differenzierte empfehlungen zur schweregradabhängigen (stadium -iv) akuttherapie anaphylaktoider reaktionen unter berücksichtigung der führenden klinischen symptomatik (kutan, pulmonal oder kardiovaskulär) wurden in einer interdisziplinären konsensuskonferenz erarbeitet (ahnefeld et al. ) . hinsichtlich der differenzialtherapie mit volumenersatz, katecholaminen, histaminantagonisten, glukokortikoiden und theophyllin wird auf die detaillierte abhandlung der konsensuskonferenz verwiesen. allgemeine therapiemaßnahmen und -prinzipien entfernung des auslösenden agens. das auslösende agens muss an der eintrittspforte entfernt (z. b. insektenstachel) oder die weitere systemische absorption vermindert (z. b. anlegen eines tourniquets bei eintrittspforte an einer extremität) bzw. die antigenzufuhr gestoppt werden. in bestimmten situationen (z. b. insektenstich) kann die subkutane injektion von adrenalin ( , - , mg) -möglichst in nähe der einstichstelle -sinnvoll sein. freie atemwege. freie atemwege müssen sichergestellt sein -schon ab stadium i (leichte allgemeinreaktion) o -zufuhr über eine maske, bei bedrohlicher hypotension und/oder dyspnoe endotracheale intubation und %ige o -beat-mung. ein larynxödem kann die intubation erschweren oder sogar unmöglich machen: in solchen fällen kann die koniotomie lebensrettend sein. entwickelt sich eine obstruktion der oberen atemwege, so wird eine intubation des patienten erforderlich, die dann meist schwierig ist. eine kontrollierte mechanische beatmung mit positivem endexspiratorischem druck wird häufi g notwendig, wenn sich hypoxie und lungenödem entwickelt haben. lagerung. die flachlagerung des patienten, möglichst trendelenburg-lagerung (ausnahme: lungenödem) wird empfohlen. volumen. schon ab stadium i (leichte allgemeinreaktion) sollte über einen zuverlässigen, möglichst großlumigen venösen zugang, möglichst rasch volumen (elektrolyt-und kolloidale lösungen) substituiert werden. die kausale therapie der relativen hypovolämie ist die adäquate volumensubstitution. schwere anaphylaktoide reaktionen erfordern nicht selten die zufuhr größerer flüssigkeitsmengen innerhalb kurzer zeit ( - l in - min). dies ist nur über einen großlumigen zugang möglich. auch nach primärer kreislaufstabilisierung können im verlauf der nächsten stunden infusionen von mehreren litern erforderlich werden. gelingt die zufuhr ausreichender volumina in kürzester zeit, sind häufi g keine weiteren therapeutischen maßnahmen erforderlich. dies gilt offenbar v. a. für anaphylaktoide reaktionen in der perioperativen phase, die sich primär oder ausschließlich am kardiovaskulären system manifestieren. bei kardial grenzwertig kompensierten patienten sollte die zufuhr großer volumina unter erhöhter vorsicht erfolgen, um eine akute kardiale dekompensation zu vermeiden. im stadium iii (bedrohliche allgemeinreaktion: anaphylaktischer schock) ist die alleinige gabe von elektrolytlösungen unzureichend. höhermolekulare lösungen sind zu bevorzugen. albumin bietet dabei gegenüber den künstlichen plasmaersatzmitteln keine vorteile. hydroxyäthylstärke (hes) mit einem mittleren molekulargewicht (hes . ) kann als volumenmittel der wahl zur soforttherapie anaphylaktoider reaktionen angesehen werden. begrenzt wird der einsatz durch die maximal zu verabreichende menge von etwa - ml/kgkg/tag (ca. , l beim erwachsenen). eine darüber hinaus erforderliche volumenzufuhr sollte bevorzugt mit elektrolytlösungen erfolgen. adrenalin. die pharmakologische behandlung der anaphylaxie beruht in erster linie auf dem einsatz von adrenalin, womit sowohl die hypotension als auch die bronchokonstriktion wirksam bekämpft werden kann. adrenalin kann intravenös, intramuskulär (sofortige selbsttherapie von patienten mit bekannter allergie nach allergenexposition im stadium ii -ausgeprägte allgemeinreaktion -mit kommerziell erhältlichen fertigspritzen, fastjekt), sublingual, endotracheal oder als dosieraerosol verabreicht werden. eine eindeutige indikation zur parenteralen verabreichung von adrenalin besteht im stadium iii (bedrohliche allgemeinreaktion: schock), jedoch kann der einsatz bei zunehmender hypotension trotz adäquater volumengabe schon im späten stadium ii erwogen werden. die intravenöse verabrei-tabelle . . differenzialtherapie anaphylaktischer/anaphylaktoider reaktionen. (mod. nach ahnefeld et al. ; . kutane um eine ausreichend genaue dosierung zu erreichen, wird hierbei mg ( ml) adrenalin in einer -ml-spritze mit ml nacl , % aufgezogen. eine maximaldosis von mg adrenalin (med nach dab) sollte in der regel nicht überschritten werden. steht kein intravenöser zugang zur verfügung, kann adrenalin endobronchial appliziert werden. in diesem fall sollte adrenalin etwa -bis -mal höher als bei intravenöser gabe dosiert werden (ca. , mg) und mit nacl , % oder aqua bidest. auf ein volumen von etwa ml verdünnt werden; evtl. erforderliche wiederholungsgaben sollten möglichst intravenös erfolgen. die wirkung von adrenalin hält bei endobronchialer gabe länger an als bei intravenöser verabreichung. eine pulmonale symptomatik (bronchospasmus) im stadium ii oder iii kann durch inhalative applikation von adrenalin oder -bei nichtverfügbarkeit -mit den zur asthmatherapie verwandten β -sympathomimetika wirksam behandelt werden; die dosierung richtet sich nach den nebenwirkungen. die maximaldosis ist erreicht, wenn tachykardie und etwas später tremor auftreten. die therapie kardiovaskulärer reaktionen mittels adrenalininhalationen ist jedoch nicht gesichert. man sollte jedoch an diese möglichkeit denken, wenn keine parenteral applizierbaren katecholamine zur verfügung stehen. besondere aufmerksamkeit und vorsicht erfordert der einsatz von adrenalin bei patienten mit khk oder arrhythmien. in diesen fällen kann adrenalin zu einer akuten koronarinsuffi zienz bis hin zum myokardinfarkt bzw. kammerfl immern führen. andererseits muss gerade bei patienten mit khk der perfusionsdruck ausreichend hoch gehalten werden. dies gelingt im stadium iii häufi g nur durch gleichzeitige gabe von volumen und einem vasokonstriktor in ausreichender dosierung. stationäre aufnahme. alle patienten mit einer anaphylaktischen reaktion müssen stationär aufgenommen und kontinuierlich überwacht werden, auch dann, wenn die symptome rasch auf eine adäquate therapie ansprechen, da die symptomatik rekurrieren kann und sich spätreaktionen bis h nach dem initialen ereignis manifestieren können. das ekg und die vitalfunktionen müssen überwacht und ein pulsoxymeter angeschlossen werden, da es zum auftreten von arrhythmien, myokardialen ischämien, respiratorischer insuffi zienz und gewebehypoperfusion kommen kann. stellen sich zeichen eines kreislaufschocks und eines beeinträchtigten gasaustausches ein, ist ein hämodynamisches monitoring mit intraarterieller blutdruckmessung und pulmonalarterienkatheter angezeigt. stadium iv. die therapie des stadiums iv (vitales organversagen) richtet sich nach der jeweiligen organinsuffi zienz und dem ggf. eingetretenen herz-kreislauf-stillstand. ischemia-reperfusion and acute apoptotic cell death guidelines for cardiopulmonary resuscitation and emergency cardiovascular care -a consensus on science cardiogenic shock: elements of etiology, diagnosis, and therapy societé de reanimation langue francaise ( ) international consensus conferences in intensive care medicine. ventilator-associated lung injury in ards a comparison of coronary angioplasty with fi brinolytic therapy in acute myocardial infarction corticosteroids in sepsis: from bench to bedside effect of a treatment with low doses of hydrocortisone and fl udrocortisone on mortality in patients with septic shock systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation comparison of impact of emergency percutaneous revascularization on outcome of patients >or = to those < years of age with acute myocardial infarction complicated by cardiogenic shock and the consensus committee ( ) the american-european consensus conference of ards, part low-dose terlipressin improves systemic and splanchnic hemodynamics in fl uid-challenged endotoxic rats reversible acute cardiac injury during cefoxitin-induced anaphylaxis in a patient with normal coronary arteries der darm als ursache von sepsis und multiorganversagen usefulness of transesophageal echocardiography in the diagnosis of ventricular septal rupture secondary to acute myocardial infarction the use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the national registry of myocardial infarction cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome near-infrared spectroscopy measurement of regional tissue oxyhemoglobin saturation during hemorrhagic shock endotoxin and the hypothalamo-pituitaryadrenal (hpa) axis induced hypothermia in critical care medicine: a review effi cacy and safety of recombinant human activated protein c for severe sepsis cardiogenic shock treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia early enteral immunonutrition in patients with severe sepsis -results of an interim analysis of a randomized multicentre clinical trial ventricular septal rupture after acute myocardial infarction blood transfusion immunomodulation -the silent epidemic antimikrobielle therapie der sepsis -empfehlungen einer arbeitsgruppe der paul-ehrlich-gesellschaft für chemotherapie e skeletal muscle partial pressure of oxygen in patients with sepsis anwendung pharmakokinetischer prinzipien bei kritisch kranken themenheft: rationale arzneimitteltherapie bei kritisch kranken verursacht hydroxethylstärke (hes) ein nierenversagen? peripheral macro-and microcirculation primary angioplasty versus prehospital fi brinolysis in acute myocardial infarction: a randomised study effect of additional temporary glycoprotein iib/iiia receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (topstar trial) electrocardiographic changes in human anaphylaxis effect of reperfusion on biventricular function and survival after right ventricular infarction association between mitochondrial dysfunction and severity and outcome of septic shock septische enzephalopathie -häufi g verkannt und unterschätzt stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study intra-aortic ballon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction diagnostic usefulness and impact on management of transesophageal echocardiography in surgical intensive care units intra-aortic balloon counterpulsation in the emergency department: a -year review and analysis of predictors of survival expertenforum: hämodynamisch aktive substanzen in der intensivmedizin cardiogenic shock severe mitral regurgitation complicating acute myocardial infarction. clinical and angiographic differences between patients with and without papillary muscle rupture hypovolemia and permeability pulmonary edema associated with anaphylaxis long-term mortality benefi t with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia crystalloids vs. colloids in fl uid resuscitation: a systematic review molecular mechanisms of complement activation during ischemia and reperfusion yearbook of intensive care and emergency medicine acute adrenal insuffi ciency presenting as shock after trauma and surgery: three cases and review of the literature neue gerinnungsphysiologische erkenntnisse in der schweren sepsis: sind diese in der diagnostik nutzbar? in: huhle g (hrsg) themenheft: sepsis und gerinnung. intensiv notfallbehandl the detection and interpretation of endotoxaemia intra-aortic ballon counterpulsation in us and non-us-centers: results of benchmark-registry a comparison of active compression-decompression cardiopulmonary resuscitation with standard cardiopulmonary resuscitation for cardiac arrests occurring in the hospital high-volume haemofi ltration in human septic shock bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study effi cacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial the role of cardiac power and systemic vascular resistance in the pathopyhsiology and diagnosis of patients with acute congestive heart failure role of cardiac power in heart failure lincs: l-name (a no synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study early mortality after surgical repair of postinfarction ventricular septal rupture: importance of rupture location for the outcome of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (optime-chf) investigators. short-term intravenous milrinone for acute exacerbation of chronic heart failure -a randomized controlled trial correlates of survival in patients with postinfarction ventricular septal defect sirs und sepsis -akutes nierenversagen -nierenersatzverfahren und dosisanpassung von medikamenten lactic acidosis microvascular blood fl ow is altered in patients with sepsis cardiovascular management of septic shock for the surviving sepsis campaign management guidelines committee: surviving sepsis campaign guidelines for management of severe sepsis and septic shock veränderungen der hämostase in der sepsis: ursachen oder folgen? in: huhle g (hrsg) themenheft: sepsis und gerinnung oxidative stress in critically ill patients with systemic infl ammatory response syndrome cytokines, nitrite/nitrate, soluble tumor factor receptors, and procalcitonin concentations: comparison in patients with septic shock, cardiogenic shock, and bacterial pneumonia coronary hemodynamics and myocardial metabolism in sepsis and septic shock kristalloide versus kolloide -a never ending story? hemodynamic comparison of early and late phase severe sepsis and septic shock ventilation zur kardiopulmonalen reanimation amiodarone as compared with lidocaine for shock-resistant ventricular fi brillation prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins the effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis arginine vasopressin in advanced vasodilatory shock early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the shock trial registry septische enzephalopathie -differentialdiagnose und therapeutische einfl ußmöglichkeiten cardiac resuscitation clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients in: vincent jl (ed) yearbook of intensive care and emergency medicine hyperferritinemia as indicator of intravenous immunoglobulin treatment in reactive macrophage acitvation syndromes update-thema: akutes lungenversagen -ards red blood cell transfusion does not increase oxygen consumption in criticaly ill septic patients mechanische herz-kreislaufunterstützung in der kardiologie die perkutan implantierbare herz-lungen-maschine erweitert die therapeutischen und diagnostischen möglichkeiten bei therapierefraktärem kreislaufstillstand -fallpräsentation und Übersicht survival following self-limited left ventricular free wall rupture dring myocardial infarction. management differences between patients with or without pseudoaneurysm formation ethyl pyruvate: a novel anti-infl ammatory agent cell adhesion molecules and leucocyte traffi cking in sepsis hinds: persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness pulmonalarterienkatheter-monitoring bei kritisch kranken -eine momentaufnahme effi cacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the lido study): a randomised double-blind trial hemodynamic response to coupled plasmafi ltration-adsorption in human septic shock critical care medicineprinciples of diagnosis and management in the adult, nd edn severity of multiple organ failure (mof) but not of sepsis correlates with irreversible platelet degranulation impaired energy metabolism in hearts of septic baboons: diminished activities of complex i and complex ii of the mitochondrial respiratory chain exzessive gewebespeicherung von kolloiden im retikuloendothelialen system results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome temporal trends in cardiogenic shock complicating acute myocardial infarction nutzen intensivmedizinischer scoring systeme zur beurteilung der ergebnisqualität, prognoseabschätzung und kostenanalyse internistischer intensivpatienten pexelizumab an anti-c complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction sepsis associated encephalopathy (sae): a review contemporary utilization and outcomes of intra-aortic ballon counterpulsation in acute myocardial infarction critical care medicine -principles of diagnosis and management in the adult, nd edn orthogonal polarization spectral imaging: a new method for study of the microcirculation mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest for the european epinephrine study group ( ) a comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital endotoxin-induced cross-tolerance to gram-positive sepsis cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation cardiodepressant factors anaphylaxis and plasma catecholamines anaphylactic shock in man: report of two cases with detailed hemodynamic and metabolic studies herausgegeben vom vorstand der deutschen gesellschaft für kardiologie -herz-und kreislaufforschung teil : akutes koronarsyndrom mit st-hebung (myokardinfarkt) cardiogenic shock complicating acute coronary syndromes predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction platelet glycoprotein iib/iiia blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent st-segment elevation critical care medicine -principles of diagnosis and management in the adult, nd edn prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score elevation of systemic oxygen delivery in the treatment of critically ill patients a multicenter, randomized, controlled clinical trial of transfusion requirements in critical care eingeschränkte herzfrequenzvariabilität bei patienten mit septischem und nicht-septischem multiorgan-dysfunktions-syndrom rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical fi ndings and outcome hemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study for the canadian critical care trials group ( ) one-year outcomes in survivors of the acute respiratory distress syndrome does immunonutrition in patients with sepsis do more harm than good? for the shock investigators ( ) early revascularization in acute myocardial infarctions complicated by cardiogenic shock cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the shock trial registry. should we emergently revascularize occluded coronaries for cardiogenic shock? ventricular septal rupture causing cardiogenic shock: clinical profi le, timing and outcome der akute myokardinfarkt -ein unterschätzter und oft unerkannter mortalitätsfaktor bei septischen patienten? effect of hemofi ltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis hemofi ltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds cardiogenic shock cardiogenic shock hrsg) expertenforum: hämodynamisch aktive substanzen in der intensivmedizin apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction neuromuscular sequelae of critical illness themenheft: sepsis und gerinnung neurological complications of sepsis: critical illness polyneuropathy and myopathy spinaler schock the microcirculation unveiled prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection for the shock investigators ( ) cardiogenic shock with non-st-segment elevation myocardial infarction: a report from the shock trial registry cardiogenic shock caused by right ventricular infarction splanchnic hemodynamics in critical illness splanchnic vasoregulation during mesenteric ischemia and reperfusion in pigs mortality probability model (mpm ii - ) bei patienten einer kardiologischen intensivstation use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis hemoadsorption therapy for sepsis syndromes stress doses of hydrocortisone reduce severe systemic infl ammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery early repair of postinfarction ventricular septal rupture sustained hemodynamic effects of intravenous levosimendan nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis high-dose vasopressin is not superior to norepinephrine in septic shock apache ii: a severity of disease classifi cation system ) jähriger patient ohne vorerkrankung mit akuter schocksymptomatik und schwerer verbrauchskoagulopathie akutes cor pulmonale bei lungenembolie -entscheidender prognostischer faktor und kritischer parameter für die auswahl der therapeutischen strategie mechanical ventilation in conjunction with the intra-aortic ballon pump improves the outcome of patients in profound cardiogenic shock effects of tirofi ban on hemostatic activation and infl ammatory response during cardiopulmonary bypass thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock volumentherapie bei hypovolämie und schock reduced incidence of postoperative infections following intravenous application of an iga-and igm-enriched immunoglobulin preparation in anergic patients undergoing cardiac surgery myocardial dysfunction in the patient with sepsis improved outcome of apache ii score-defi ned escalating systemic infl ammatory response syndrome in patients post cardiac surgery in compared to - aktiviertes protein c, antithrombin shock: classifi cation, pathophysiology and approach to management der schockpatient auf der notaufnahme und der intensivstation reactive nitrogen and oxygen species: role and evidence of their production in humans bilateral massive adrenal haemorrhage complicating anaphylactic shock: a case report beatmung beim herzkranken prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention complicated acute myocardial infarction requiring mechanical ventilation in the intensive care unit: prognostic factors of clinical outcome in series of patients sccm/esicm/accp/ats/sis international sepsis defi nition conference distinct post-receptor alterations generate gene-and signal-selective adaptation and cross-adaptation of tlr and tlr in human leukocytes poly(adp-ribose) synthetase as a novel therapeutic target for circulatory shock abciximab suppresses the rise in levels of circulating infl ammatory markers after percutaneous coronary revascularization safety and effectiveness of inhaled nitric oxide and tirofi ban for acute coronary syndromes -a report from the cardiovascular and renal advisory panel of the food and drug administration effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. a single center experience multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor c : effect on survival in patients with septic shock zytokine: klassifi kation, rezeptoren, wirkungsmechanismen infl uence of interleukin- polymorphisms on interleukin- expression and survival in critically ill patients spinal nitric oxide participates in the control of the blood pressure during graded hemorrhage in the conscious rat time-and surgery-dependent effects of lipopolysaccharide on gut, cardiovascular and nitric oxide functions mechanische kreislaufunterstützung bei akuter und chronischer herzinsuffi zienz -eine standortbestimmung unter besonderer berücksichtigung der entwicklung in deutschland effects of endotoxin on the guinea pig heart response to ischemia reperfusion injury diuretics, mortality and nonrecovery of renal function in acute renal failure neue therapieansätze bei der prähospitalen und hospitalen schockbehandlung -hyperton-onkotische lösungen und vasopressin severe aortic stenosis and reduced ejection fraction: intensive care treatment the clinical profi le of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the shock trial registry outcome and profi le of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the shock trial registry acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the shock trial registry successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization and percutaneous coronary angioplasty detection of circulating tumor necrosis factor after endotoxin administration sepsis -epidemiologie und ökonomische aspekte effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis on behalf of russlan study investigators ( ) safety and effi cacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure de to an acute myocardial infarction organ apoptosis in the septic patient: a potential therapeutic target? cardiogenic shock hormonal and hemodynamic profi le of an anaphylactic reaction in man possible role of increased oxidant stress in multiple organ failure after systemic infl ammatory response syndrome yearbook of intensive care and emergency medicine acc expert consensus document. present use of bedside right heart catheterisation in patients with cardiac disease septischer schock und systemisches entzündungsreaktions-syndrom anaphylaxie und allergie -empfehlungen für die notfalltherapie septic cardiomyopathy cytokines and the heart -molecular mechanisms of septic cardiomyopathy fortschritte in der therapeutic hypothermia after cardiac arrest. an advisory statement by the advancement life support task force of the international liaison committee on resuscitation terlipressin for norepinephrine-resistant septic shock enteral nutrition with eicosapentaenoic acid, γ-linolenic acid, and antioxidants reduces alveolar infl ammatory mediators and protein infl ux in patients with acute respiratory distress syndrome pathophysiology of septic encephalopathy: a review critical care medicine -principles of diagnosis and management in the adult, nd edn benefi cial effects of short-term vasopressin infusion during severe septic shock right ventricular involvement in myocardial infarction and cardiogenic shock a comparison of standard cardiopulmonary resucitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest esc-erc recommendations for the use of automated external defi brillators (aeds) in europe kardiogener schock: pathomechanismen, klinischer verlauf, therapeutische ansätze und perspektiven surgical trauma affects the proinfl ammatory status post cardiac surgery to a higher degree than cardiopulmonary bypass pulmonary artery consensus conference: consensus statement bilateral massive adrenal hemorrhage: early recognition and treatment profound reversible myocardial depression after anaphylaxis relative myocardial depression in normotensive sepsis the effects of coronary artery disease on cardiac function in nonhypotensive sepsis toll receptors and sepsis right ventricular function in early septic shock states open randomized phase ii trial of an extracorporeal endotoxin absorber in suspected gram-negative sepsis desensitization of rat cardiomyocyte adenyl cyclase stimulation by plasma of noradrenalinetreated patients with septic shock hämostasestörungen im umfeld von sepsis und sirs intraoperatives anästhesiologisches management bei patienten mit pulmonaler hypertonie early goal-directed therapy in the treatment of severe sepsis and septic shock allgemeine intensivtherapie early revascularization in cardiogenic shock -a positive view of a negative trial a comparison of albumin and saline for fl uid resuscitation in the intensive care unit help apheresis in the treatment of sepsis impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the shock trial registry. should we emergently revascularize occluded coronaries for cardiogenic shock? warum sollte der intensivmediziner der autonomen dysfunktion seiner patienten beachtung schenken? lebensbedrohliche akute intoxikationen durch kardio-und vasotoxisch wirkende medikamente und drogen autonomic function in the icu patient pulmonary and left ventricular decompression by artifi cial pulmonary valve incompetence during percutaneous cardiopulmonary bypass support in cardiac arrest the ability of the simplifi ed acute physiology score (saps ii) to predict outcome in coronary care patients katecholamine im kardiogenen schock: hilfreich, nutzlos oder gefährlich critical care medicine -principles of diagnosis and management in the adult, nd edn mortality in emergency department sepsis (meds) score: a prospectively derived and validated clinical prediction rule a review of randomized controlled trials using therapeutic apheresis effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: association with myocardial hyporesponsiveness to catecholamines hemodynamic changes in human anaphylaxis practice parameter for the use of red blood cell transfusions -developed by the red blood cell administration practice guidelines development task force fo the college of american pathologists cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the shock trial registry attenuation by dexamethasone of endotoxin protection against ischaemia-induced ventricular arrhythmias serum cardiac troponin t as a prognostic marker in early sepsis a controlled trial of dichloroacetate for treatment of lactic acidosis in adults der darm als immunologisches organ apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome plasma exchange as rescue therapy in multiple organ failure ncluding acute renal failure treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital enterale immunonutrition: wann, für wen, welche zukunftsperspektiven gibt es? the cardiovascular response of normal humans to the administration of endotoxin cardiac disorders in penicillin-induced anaphylaxis low-dose vasopressin in the treatment of septic shock in sheep myocardial ischemia-reperfusion injury: role of the peroxynitrite-poly(adp-ribose) polymerase pathway change in the ratio of interleukin- to interleukin- predicts a poor outcome in patients with systemic infl ammatory response syndrome task force of the american college of critical care medicine, society of critical care medicine ( ) practice parameters for hemodynamic support of sepsis in adult patients in sepsis outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction the effectivenes and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure -a meta-regression analysis reversal of cardiogenic shock by percutaneuos left atrial to femoral artrial bypass-systems short-and long-term hemodynamic effects of intra-aortic balloon support in ventricular septal defect complicating acute myocardial infarction role of nitric oxide in sepsis and ards (update in intensive care and emergency medicine ) hrsg) expertenforum: hämodynamisch aktive substanzen in der intensivmedizin hrsg) expertenforum: hämodynamisch aktive substanzen in der intensivmedizin cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the shock trial registry nephritis epidemica auf einer interdisziplinären notaufnahme -fallsammlung im rahmen einer endemie-erfassung der ostalbregion und literaturübersicht hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock inhibition of mitogen activated protein kinase: a novel strategy in sepsis? yearbook of intensive care and emergency medicine hemodynamic and metabolic therapy in critically ill patients outcome benefi t of intensive insulin therapy in the critically ill: insulin dose versus glycemic control on behalf of the working group on sepsis-related problems of the european society of intensive care medicine ( ) the sofa (sepsis-related organ failure assessment) score to describe organ dysfunction the role of bacterial superantigens in sepsis and treatment implications anaphylaktoide reaktionen in der prähospitalphase hemorrhage produces depression in microvascular blood fl ow which persists despite fl uid resuscitation sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock a comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation hrsg) expertenforum: hämodynamisch aktive substanzen in der intensivmedizin mechanische und elektrische therapie kardialer arrhythmien assessment of ivig for prophylaxis and therapy of sepsis akute septische kardiomyopathie: bestandteil des multiorganversagens in der sepsis? plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin- and sepsis-associated left ventricular dysfunction cardioprotective effects of monophosphoryl lipid a, a novel endotoxin analogue in the dog epidemiology of anaphylaxis in olmsted county: a population -based study effectiveness of the glycoprotein iib/iiia antagonist abciximab during percutaneous coronary interventions (pci) in clinical practice at a single high-volume center metabolic encephalopathy in critically ill patients suffering from septic or nonseptic multiple organ failure right ventricuar infarction as an independent predictor of prognosis after acute inferior myocardial infarction tnf-a and il- a inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function prospective evaluation of early abciximab and primary percutaneous intervention for patients with st elevation myocardial infarction complicated by cardiogenic shock: results of the reo-shock trial predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (pci) -results of the primary pci registry of the arbeitsgemeinschaft leitende kardiologische krankenhausärzte (alkk) study on glucocorticoid receptors during intestinal ischemia shock and septic shock diagnosis of papillary muscle rupture after acute myocardial infarction by transthoracic and transesophageal echocardiography enzyme-independent formation of nitric oxide in biological tissues transfundieren sie thrombozytenkonzentrate bei einem thrombozytenabfall auf < /mm ( × /l), unabhängig vom vorliegen einer blutung, weiterhin bei thrombozytenzahlen von - . /mm ( - × /l) und vorhandenem signifi kanten blutungsrisiko. höhere thrombozytenzahlen wie ≥ . /mm ( × /l) sind für chirurgische und invasive prozeduren erforderlich (empfehlungsgrad e) key: cord- -h o yqv authors: nan title: oral communications and posters date: - - journal: inflamm res doi: . /bf sha: doc_id: cord_uid: h o yqv nan the drosophila host defense is a multifaceted process which involves reprogramming of gene expression, activation of proteolytic cascades in the blood and uptake of microrganismsby professionalphagocytes. most of the recent studies have focused on challenge-induced expression of antimicrobial peptides and have addressed the following questions : ( ) which genes are upregulated during various types of bacterial, fungal or viral infections and what are their functions? ( ),what is the nature of the intracellular signalling cascades which lead togene transcription during these infections; ( ) how does drosophila recognize infections and does it discriminate between various types of aggressors (e.g. fungal versus bacterial or viral) to mount an appropriate response. over the last ten years we have gained significant insights into these various aspects and the presentation will review our current understanding of the drosophila immune response and put it into a phylogenetic perspective, namely by drawing some stringent parallels with the mammalian innate immune response. there is strong evidence that autoimmunity to myelin antigens plays a major role in the development of multiple sclerosis. several myelin-derived autoantigenic targets have been described and include myelin basic protein (mbp), proteolipid protein and myelin oligodendrocyte glycoprotein. there has been a particular focus on mbp for at least two reasons: mbp-specific cd + tcell receptors (tcrs) have been found in multiple sclerosis brains, and cells presenting an immunodominant mbp( - ) peptide in complex with hla-dr b have been shown to be present in multiple sclerosis lesions. also, humanized mice expressing the hla-dr b gene and a human t-cell receptor (tcr) that recognises the mbp - peptide in the context of hla-dr b either spontaneously or after immunization with mbp - develop experimental autoimmune encephalomyelitis, which has several features in common with multiple sclerosis. this talk will focus on, how humanized mice recently has been used to study the interplay between genetic and environmental risk factors in multiple sclerosis. to resolve the pathogenic mechanisms of rheumatoid arthritis (ra) we need to identify the causative genetic and environmental factors. this has however proven to be complex, with many factors and genes interacting. inbred animals are useful for studies of the identification of genes associated with complex traits and diseases such as ra. animal models offer a possibility to better define the traits, and to segregate the genes in a controlled way enabling linkage analysis. there are several arthritis models, which each may reflect various variants of the heterogeneity of ra in humans. examples are collagen induced arthritis (cia) and pristane induced arthritis (pia), which both fulfills the clinical diagnostic criteria for ra. both diseases are genetically complex and the susceptibility is, as ra, dependent on many polymorphic genes operating in concert. so far genes in this concert have been identified; the mhc class ii ab gene in the mouse ( ) and the ncf gene in the rat ( ) and in the mouse ( ) . the ncf protein is a part of the nadph oxidase complex mediating oxidative burst. the discovery of the ncf polymorphism led to a new proposed pathway in which oxygen radicals modify antigen presentation and the resulting activation of autoreactive t cells. mice with the deficient ncf allele are more susceptible to cia, and also developed a chronic form of arthritis. interestingly, the immune response to cii was enhanced by the ncf deficiency linking the ncf pathway to the adaptive immune response. oxidation of t cell membranes seem to be a key event in the pathogenic mechanism as reduction of t cell membranes induces arthritis in rats ( ). on the basis of these findings a new type of therapy myasthenia gravis is a prototypic autoimmune disease, caused in most cases by autoantibodies to the muscle acetylcholine receptor (achr) at the neuromuscular junction. the antibodies reduce the number of achr leading to failure of neuromuscular transmission and muscle weakness. the achr antibodies as measured in conventional immunoprecipitation assays are igg, high affinity, polyclonal and specific for human achr. they reduce the numbers of achr by antigenic modulation and by complement-mediated damage to the neuromuscular junction. myasthenia gravis has a very intriguing relationship with the thymus gland. in many younger patients, the thymus is hyperplastic with immune cell infiltrates and germinal centre formation. around the germinal centres, within the medulla, there are rare muscle-like cells called myoid cells that express achrs. there are many b cells and plasma cells and thymic lymphocyte preparations synthesise achr antibodies. the possibility that the thymic achr induces the germinal centre formation and achr antibody synthesis is supported by much evidence. some patients, however, have thymic tumours and in these the role of the thymus is less clear. moreover, older patients with typical myasthenia usually have thymic tissue which is normal for their age. there are up to % of myasthenia patients that do not have the typical achr antibodies. some of these have instead antibodies to muscle specific kinase, a receptor tyrosine kinase that is restricted to the neuromuscular junction. the pathogenic mechanisms by which the antibodies cause disease are not yet clearly identified and the evidence will be discussed. finally, among the patients who have neither achr nor musk antibodies by conventional testing, we have evidence for lower affinity antibodies to achr which can now be detected using molecular approaches which will be described. arry- (azd ) is an inhibitor of mek / currently in development for cancer. phase determined the msd ( mg) and the safety of the compound given continuously. in decreasing frequency, common treatment-related side effects were rash, diarrhea, nausea, peripheral edema, and vomiting. paired pre-and postdose tumor biopsies showed a reduction in perk (- %) and proliferative index (- %). the trough plasma concentration ( ng/ml) corresponded to~ % inhibition of perk. about % of pts had stable disease after months. these results demonstrate that arry- (azd ) is well-tolerated, hits its target, and produces a high incidence of long-lasting stable disease. there are several on-going phase studies, in melanoma, colorectal, lung and pancreatic cancer. arry- is another potent, selective mek / inhibitor, currently in development for inflammatory diseases. when human whole blood was stimulated with tpa, arry- inhibited tnfa, il- b and il- (ic s of , and nm, respectively). % inhibition of perk required nm. arry- was highly efficacious in cia and aia rat models, with ed s of and~ mg/ kg, respectively. in normal volunteers arry- was well-tolerated and there was a dose-proportional increase in drug exposure. in ex vivo blood samples, there was a dramatic time-and concentration-dependent inhibition of tpa-induced tnfa and il b. an on-going multiple ascending dose clinical study is further exploring the pharmacokinetics, pharmacodynamics and tolerability of arry- monotherapy. in addition, we have initiated a clinical trial designed to evaluate arry- in combination with methotrexate in patients with rheumatoid arthritis. rho kinases (rock) are involved in many physiological and pathological processes including smooth muscle contraction, cytoskeletal arrangement, cell adhesion, migration and proliferation.rocks prominent role in cytoskeletal architecture suggests that rock inhibitors should have therapeutic impact in oncology and fibrotic diseases which require cytoskeletal rearrangement to progress.we have synthesized small molecule inhibitors of rock which are specific for the rock- isoform.these rock- inhibitors, typified by slx- and slx- , are potent (ic < nm), selective for rock- (> fold selectivity for rock- over rock- ) and exhibit good oral bioavailability.this talk will focus on several areas in oncology and fibrotic disease where the ability to demonstrate an in vitro effect on the cytoskeleton translates into activity in the disease model in vivo.slx- inhibits cell proliferation and migration in several tumor cell lines including ht- , panc- and mda-mb- . moreover in xenograft studies using nude mice, slx- significantly inhibited tumor growth with these same cell lines. in liver fibrosis, slx- prevents the differentiation of rat primary hepatic stellate cells into myofibroblasts and inhibits the proliferation of myofibroblasts as well as inhibiting hepatic steatosis in an atherosclerosis model.slx- is an effective antifibrotic agent in the kidney unilateral urethral obstruction model and inhibits renal fibroblast differentiation and proliferation.these data suggest that rock- selective inhibition of cytoskeletal modification in key cell types (e.g. tumor cells, stellate cells and fibroblasts) by compounds such as slx- and slx- will provide effective treatment for oncology and fibrotic disease. cyclooxygenases (cox) catalyze the first step in the synthesis of prostaglandins (pg) from arachidonic acid.cox- is constitutively expressed.the cox- gene is an immediate early-response gene that is induced by variety of mitogenic and inflammatory stimuli.levels of cox- are increased in both inflamed and malignant tissues.in inflamed tissues, there is both pharmacological and genetic evidence that targeting cox- can either improve (e.g., osteoarthritis) or exacerbate symptoms (e.g., inflammatory bowel disease).multiple lines of evidence suggest that cox- plays a significant role in carcinogenesis.the most specific data that support a cause-and effect relationship between cox- and tumorigenesis come from genetic studies.overexpression of cox- has been observed to drive tumor formation whereas cox- deficiency protects against several tumor types.selective cox- inhibitors protect against the formation and growth of experimental tumors.moreover, selective cox- inhibitors are active in preventing colorectal adenomas in humans.increased amounts of cox- -derived pge are found in both inflamed and neoplastic tissues.the fact that pge can stimulate cell proliferation, inhibit apoptosis and induce angiogenesis fits with evidence that induction of cox- contributes to both wound healing and tumor growth.taken together, it seems likely that cox- induction contributes to wound healing in response to injury but reduces the threshold for carcinogenesis. ( ), k hagihara( ), t nishikawa( ), j song( ), a matsumura ( ) ( ) health care center, osaka university, japan ( ) osaka university graduate school of medicine, japan it is still less known about the actual pathogenic role of il- in the inflammatory status. to know the pathogenic role of il- and the efficacy of il- blockade in inflammation, a humanized anti-il- receptor antibody, tocilizumab, was used for the treatment in chronic inflammatory diseases, such as castlemans disease, rheumatoid arthritis and crohns disease. since il- blocking therapy improved the clinical symptoms and the laboratory findings, the il- function in inflammation could be analyzed for the induction of inflammatory molecules, such as serum amyloid a (saa). saamrna induction, saa promoter activity and assembling of transcriptional factors on saa promoter were analyzed by the real time rt-pcr, gel shift assay and dna affinity chromatography in hepatocyte stimulated with the proinflammatory cytokines, il- , il- and tnf-alpha. in result, il- was an essential cytokine in induction of saamrna through the activation of stat which constructed the complex with nf-kappab p and a cofactor p . although there was no stat consensus region on saa promoter, stat bound at the site of nf-kappab re. the above research proved that il- signal is essential on the synergistic induction of saa via newly discovered stat transcriptional mechanism, suggesting the presence of this stat mechanism in inflammation, and confirming the normalization of serum saa level by il- blocking therapy in inflammatory diseases. this research method develops a subsequent therapy for serious aa amyloidosis by inhibition of saa production, and elucidates the cytokine mechanism on immunopathogenesis of chronic inflammatory diseases. takashi wada( ), k matsushima( ), s kaneko ( ) ( ) kanazawa university, japan ( ) university of tokyo, japan accumulating evidence indicates that chemokine/chemokine receptor system plays a key role in the pathogenesis of various renal diseases via leukocyte migration. pathophysiological impacts of chemokines have shed light on molecular mechanisms of leukocyte trafficking and their activation in the inflammatory aspects of progressive renal injury.locally expressed chemokines are proven to be capable of inciting leukocyte migration to the kidney, resulting in initiating and promoting chronic kidney diseases.the possible positive amplification loop from cxc chemokines to cc chemokines may contribute to progressive renal injury, resulting in sclerosis/fibrosis.it is of note that monocyte chemoattractant protein (mcp)- / monocyte chemotactic and activating factor (mcaf)/ ccl , a prototype of cc chemokines, promotes and escalates chronic kidney diseases with any etiologies via the infiltration and activation of monocytes/macrophages, proteinuria and collagen synthesis.interactions between infiltrated inflammatory cells and resident renal cells eventually lead to the progression of fibrosis. new insights into renal fibrosis have been uncovered by the regulation of fibrocytes dependent on chemokine system. in addition, recent studies demonstrate that chemokines have been expanding their universe beyond leukocyte migration to the kidney, including homeostasis, development and repair of the kidney.the selective intervention of chemokines might have the therapeutic potential to alter inflammatory responses, thereby halting the progression of renal injury. we focus on recent progresses on the role of chemokines and their cognate receptors in renal injury in this symposium. ( ), p lacamera ( ), b shea ( ), g campanella ( ), b karimi-shah ( ) , n kim ( ), z zhao( ), v polosukhin ( ), y xu( ), t blackwell ( ) aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathologic responses remain to be fully identified.here we demonstrate that lysophosphatidic acid (lpa) is induced by lung injury in the bleomycin model of pulmonary fibrosis, and that mice deficient for one of its receptors, lpa , are dramatically protected from pulmonary fibrosis and mortality following bleomycin challenge. the absence of lpa markedly reduced fibroblast responses to the chemotactic activity present in the airspaces following bleomycin, and attenuated the subsequent accumulation of fibroblasts in the lung.the increase in vascular permeability caused by lung injury was also markedly reduced in lpa -deficient mice, whereas bleomycin-induced leukocyte recruitment was preserved.these results demonstrate that lpa links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak, two of the wound-healing responses that are thought to be inappropriately excessive when injury leads to fibrosis rather than repair.lpa therefore represents a new target for lung diseases in which aberrant responses to injury contribute to the development of fibrosis, such as idiopathic pulmonary fibrosis and the acute respiratory distress syndrome. we have reported that inflammation is detrimental for survival of new hippocampal neurons early after they have been born. our data now show that microglia activation, as an indicator of inflammation, is not pro-or antineurogenic per se but the net outcome is probably dependent on the balance between secreted molecules with pro-and antiinflammatory action. we have found that a substantial fraction of the new hippocampal neurons formed after status epilepticus survive despite chronic inflammation. we have started to explore the role of tnf-alpha for adult neurogenesis. infusion of an antibody to tnf-alpha was shown to reduce survival of new striatal and hippocampal neurons generated after stroke, probably by interfering with action of the ligand on the tnf-r receptor. we have shown that tnf-r is a negative regulator of progenitor proliferation in basal and insult-induced hippocampal neurogenesis. we have also used patch-clamp technique to explore whether a pathological environment influences the synaptic properties of new granule cells. rats were exposed to either a physiological stimulus, i.e., running, or a brain insult, i.e., status epilepticus which is associated with inflammation. we found that new granule cells in runners and status epilepticus animals had similar intrinsic membrane properties. in contrast, the new neurons which had developed in the physiological and pathological tissue environments differed with respect to tonic drive and short-term plasticity of both excitatory and inhibitory afferent synapses. the role of inflammation for these differences is currently being explored. proteinase-activated receptor- (par- ) is cleaved within its aminoterminal extracellular domain by serine protei-nases such as trypsin, unmasking a new aminoterminus starting with sligkv that binds intramolecularly and activates the receptor. par- is implicated in innate defense responses associated with lung inflammation. we showed that par- is expressed by human alveolar (a ) and bronchial ( hbe) epithelial cell lines, and is activated by trypsin and by the activating synthetic peptide sligkv-nh . in cystic fibrosis patients, airspaces are invaded by polymorphonuclear neutrophils that release elastase and cathepsin g, two serine proteinases, and by pseudomonas aeruginosa that secretes an elastolytic metalloproteinase.we demonstrated that these three proteinases do not activate par- , but rather disarm this receptor, preventing its further activation by trypsin but not by sligkv-nh . preincubation of a par- transfected cell line with either proteinases leads to the disappearance of the cleavage/activation epitope. proteolysis by these three proteinases of synthetic peptides representing the aminoterminal extracellular domain encompassing the cleavage/activation sequence of par- , generate fragments that would not by themselves act as receptor-activating ligands and that would not yield receptor-activating peptides upon further proteolysis by trypsin. our data indicate that neutrophiland pathogen-derived proteinases can potentially silence the function of par- in the respiratory tract, thereby altering the host innate defense mechanisms. caspase- -dependent killing of host cells and to disrupt intestinal barrier function, which, at least in the case of giardiasis, ultimately causes lymphocyte-dependent intestinal malfunction, and the production of diarrheal symptoms. ongoing research is investigating whether par agonists and microbial pathogens may cause epithelial apoptosis, increased permeability, and overall epithelial malfunction in the gastrointestinal tract, via common or intersecting pathways. the intestinal epithelium is exposed to a variety of proteases in both health and disease, including digestive proteases such as trypsin.given that protease-activated receptor (par ) responds to trypsin and is expressed on intestinal epithelial cells, we investigated the effect of trypsin on intestinal epithelial barrier function.scbn, caco-ii and t epithelial cells were grown to confluence on filter supports and mounted in ussing chambers to study short circuit current (isc) and transepithelial resistance (rte).cell monolayers were incubated with inhibitors of transcellular ion transport in order to isolate the contribution of the paracellular pathway to rte.apical exposure to serine proteases including trypsin, elastase and chymotrypsin caused a rapid and sustained increase in rte and decreased the transepithelial flux of a mw dextran.interestingly, the effect of trypsin could not be replicated by activators of pars , and , suggesting that the effect on rte was not due to activation of pars.subsequent experiments showed that trypsin activated phosphatidylinositol-dependent phospholipase c.a trypsin-induced increase in intracellular calcium was not involved.inhibition of pkc-zeta, but not of typical pkcs, also blocked the response.our data point to a role for postprandial trypsin that extends beyond that of a digestive enzyme; it is also a participant in cellular pathways that control tight junction permeability. physiologically, the trypsin-induced increase in resistance could augment transcellular transport by reducing passive paracellular back-diffusion of ions. further studies will assess how these pathways might be disrupted in the barrier dysfunction characteristic of intestinal inflammation. clustering of inflammatory bowel disease in large families and the observation of an increased concordance between monozygotic twins suggests heritable components in these disorders. the high concordance in monozygotic twins (> %), which is not seen in dizygotic twins (< %) points to strong contribution of genetic susceptibility to the overall risk for disease. ibd represents a "complex disease" and may involve a large number of interacting disease genes. crohns disease has become an example for the successful molecular exploration of a polygenic etiology. crohns disease was not known before . incidence has increased since now leading to a lifetime prevalence of up to . % in western industrialized countries. the current hypotheses propose unknown trigger factors in the life style of western industrialized nations that interact with a polygenic susceptibility. it appears that increased expression and production of tnf and an enhanced state of activation of the nfkb system are main drivers of the mucosal inflammatory reaction. the exploration of inflammatory pathophysiology of crohns disease using full genome, cdna and oligonucleotide based arrays, respectively, has generated large sets of genes that are differentially expressed between inflamed mucosa and normal controls. while this may lead to new targets for a pathophysiology oriented therapy, it appears, however, that the dissection of the inflammatory pathophysiology does not allow to identify the multifactorial etiology of the disease. genome-wide linkage analysis has demonstrated eight confirmed susceptibility regions with the one on chromosome being most consistent between different populations. in three coding variations in the card gene were identified that are highly associated with development of the disease. all variants affect a part of the gene that codes for the leucin rich part of the protein, that appears to be involved in bacteria induced activation of nfkb in macrophages and epithelial cells. interestingly, the three disease associated snps are never found on the same haplotype. in compound heterozygotes or homozygotes they result in a rr of > to develop crohns disease as an adult. a particular subphenotype with localization of the disease in the ileocecal region is highly associated with the variants in the card gene. variations in the card gene do not fully explain the linkage finding in the pericentromeric region of chromosome . after stratification for card variants, the broad linkage peak is reduced to two more defined peaks on p and q, respectively. while the exploration of these regions has led to several association signals that are subject to further fine mapping a further disease gene progress has been greater in the other linkage regions (i.e. on chromosomes and , respectively). dlg- is the example of a low-risk susceptibility gene with a modest associated odds ratio ( . - . ) . interestingly, the associa-tion signal appears to be confined to young males. slc a / which encode the kation-transporters octn and have been suggested to represent the disease gene in the + kb haplotype block on chromosome q . mdr has also been implicated as a disease gene in ibd. although the human association studies have resulted in highly controversial findings a knockout mouse with a colitis phenotype makes mdr likely as a low risk susceptibility gene. with the advent of high-density, genome wide association studies enormous progress has been made to discover the remaining disease genes. recently a k illumina scan has been published identifying il- r as a further disease gene. we used a genome wide candidate gene approach (with appr. . csnps) to identify atg l as a further disease genes. both genes were confirmed and a further regulatory snp involving ptger was annotated by a belgian genome wide scan. by the time of presentation three further genome wide snp scans in crohn disease will most likely have entered the public domain. the further exploration of crohns disease (and other inflammatory conditions of barrier organs) will have to annotate the function and pathophysiologies based on genetic risk maps that are completed with amazing speed. the creation of a medical systems biology of disease will lead to new models and eventually new therapies. the chemokine receptor ccr plays a pivotal role in mediating the migration of t cells to the gastrointestinal mucosa. the ligand for ccr , teck, s highly expressed in the gi tract. the pathogenicity of intestinal ccr +/ cd + t cells has been demonstrated in animal models and this cell population is substantially increased in the peripheral circulation of crohns and celiac disease patients. ccx -b is a highly selective and potent, orally bioavailable, small molecule antagonist of ccr .the compound proved to be highly efficacious in the tnf-aare and mdr a-/-murine models of inflammatory bowel disease (ibd). in phase i trials, ccx -b was well-tolerated, and no drug-related saes were reported.a -day placebo-controlled phase ii study was recently completed in patients with moderate to severe crohns disease. ccx -b was shown to be both safe and to have encouraging clinical results: % of patients on ccx -b (cdai ! , crp > . mg/l) exhibited a -point drop in cdai compared to % on placebo. furthermore, a crp decrease of mg/l was seen in the ccx -b group compared to placebo. colonic biopsy samples were analyzed for expression of several pro-inflammatory cytokines. a mean decrease from baseline in the concentrations of tnf-alpha, il- p , ifn-gamma, and the chemokine rantes was shown in the ccx -b group while levels remained stable in the placebo group. ccx -b is the first chemokine-based inhibitor of leukocyte trafficking to be tested in ibd. the compound shows anti-inflammatory activity and encouraging evidence for clinical benefit in the treatment of crohns disease. the activating receptor nkg d seems to be implicated in the pathogenesis of several autoimmune diseases in humans and in animal models for type diabetes and multiple sclerosis. the aim of this study was to asses the role of nkg d in a model of inflammatory bowel disease, where cd +cd -t cells from balb/c mice are adoptively transferred to scid mice, and to evaluate the therapeutic effect of an anti-nkg d antibody therapy. the expression of nkg d was evaluated by flow cytometry, immunohistochemistry and by pcr. we found a marked up-regulation of nkg d on the cell surface as well as increased levels of nkg d mrna in cd + t cells from colitic scid mice as compared to normal balb/c mice. we next studied the effect of anti-nkg d antibody (cx ) treatment initiated either before onset of colitis, when the colitis was mild, or when severe colitis was established. cx treatment decreased the cellsurface expression of nkg d and prophylactic administration of cx attenuated the development of colitis significantly. a moderate reduction in the severity of disease was observed after cx administration to mildly colitic animals, whereas cx did not attenuate severe colitis. thus, nkg d may be involved in the pathogenesis of colitis in this model, particularly in the early phases, since the expression of nkg d in cd + t cells increased markedly during the development of disease and since administration of cx early but not late in the course attenuated the disease severity. proteins are used already for more than a century in the treatment of disease. the first generation were proteins derived from animals such as antisera used to treat infectious diseases as diphtheria and tetanus and later bovine and porcine insulin for the treatment ofdiabetes. the second generation were natural proteins from human source like the plasma derived clotting factors and human growth hormone. the development of the recombinant dna and cell fusion technology in the seventies of the th century opened up the possibilities to produce human proteins and monoclonal antibodies in unlimited amount in microbial and mammalian host cells. in human insulin was introduced as the first recombinant dna derived biopharmaceutical and since than more than have gained approval. the pipeline contains many more potential biopharmaceuticals and at present in new drug applications concerns a biotechnology derived product. a major problem of therapeutic proteins is the induction of antibodies. for foreign proteins such as the murine derived monoclonal antibodies thisimmunogenicity was to be expected. however the humanization of monoclonal antibodies has reduced but not solved the problem of immunogenicity. and also the proteins which are homologues of endogenousfactors such as gm-csf, interferons etc. induce antibodies, sometimes even in the majority of patients. by definition we are immune tolerant to products which are copies of endogenous proteins. the products not necessarily need to be exact copies of the natural proteins to share this immune tolerance. when human therapeutic proteins induce antibodies, they are breaking b cell tolerance, which starts with the activation of autoreactive b-cells. presenting the self-epitopes in an array form is very potent activator of these b-cells. this explains why aggregates of human proteins are the most important factor in induction of antibodies. these aggregates may not be immediately present in the product, but may appear during storage making stability and formulation an important issue in predicting the immunogenicity. there are only a few studies in experimental model systems on the properties of the aggregates which break b-cell tolerance, indicating that only multiple order aggregates (>trimers) are involved. we study the capacity of a protein product to break b-cell tolerance in mice made transgenic for the specific protein. these mice are immune tolerant and there is a good correlation of an immune response in these mice and in patients. although these models have helped to identify the factors important for breaking b-cell tolerance and also have been useful in improving the formulation of products, there is not yet enough experience to use them as absolute predictors of immunogenicity of human proteins. they also allow to study the involvement of tcells in breaking b cell tolerance. all data obtained untilnow indicate this process to be t-cell independent. contact information: dr huub schellekens, central laboratory animal institute, utrecht university, utrecht, the netherlands e-mail: h.schellekens@gdl.uu.nl biomonitor aps, and institute for inflammation research (iir), rigshospitalet, copenhagen, denmark using recombinant technology, one can now produce protein drugs which are almost identical with naturally occurring human proteins, including antibodies (abs). many have assumed that these drugs may be administered with little or no risk of triggering specific t-and/or b-lymphocyte reactivities, because patients according to immunological dogma are tolerant towards their own proteins. unfortunately, this is not the case, and even socalled % human biologicals are potentially immunogenic ( ) ( ) . i shall discuss two examples: ) recombinant human cytokines (ifn-beta- a and - b), and ) anticytokine ab constructs (anti-tumor necrosis factor (tnf)-alpha). ifn-beta has been used for treatment of patients with multiple sclerosis since the early nineties. though initially neglected as a clinical problem, ifn-beta like many other human proteins is indeed immunogenic, especially those produced by recombinant gene technologies. the reported frequencies and titers of anti-ifn-beta ab vary considerably depending upon ifn-beta preparations and administration, and the types of assays being used ( - ). it took more than years of clinical use before abmediated decrease in bioactivity of ifn-beta, a condition in which the clinical effect of continued injection of rec. ifn-beta is minimized or abrogated, was universally recognized ( , ). ) anti-tnf-alpha human ab constructs tnf-alpha is an inflammatory cytokine of central pathogenic importance in many immunoinflammatory conditions, and measures to diminish production and/or effects of tnf-alpha have long been a goal in the treatment of these conditions. currently, there are three approved and two other anti-tnf-alpha biopharmaceuticals in clinical use. unfortunately, response failure is frequently encountered. thus, - % of patients are primary non-or lowresponders to the anti-tnf constructs, and secondary response failure is commonplace, mostly due to induction of anti-abs. several different methods have been used to assess circulating levels of anti-tnf drugs as well as anti-abs. most of these have been based on elisa technology, with their inherent problems of false positivity, susceptibility to nonspecific interference, etc. interferon beta (ifnbeta) has been an important step forward in the treatment of multiple sclerosis(ms), an inflammatory disease of the human central nervous system. however, one of the problems of ifnbeta is its immunogenicity; a substantial percentage of ms patients treated this recombinant protein develop anti-ifnß antibodies, primarily of the igg class. the level of these antibodies tends to be low in the first month or two and peaks by six to eighteen months after initiation of therapy. most studies of these antibodies have measured their ability to neutralize ifnbetas effect in vitro, using assays in which sera from ms patients inhibit the protective effect of ifnbeta on viral killing of target cells. this antibody population is called neutralizing antibodies (nabs). tests measuring binding of antibodies to ifnß in vitro are called binding antibody (bab) assay. anti-ifnbeta antibodies detected by bab assays are present in a high percentage of ms patients, and can occur at low levels without any apparent adverse effect on ifnbeta bioactivity. the distinction between babs and nabs is artificial, and all binding antibodies are likely neutralizing, if the neutralizing assay system is adequately sensitive; i.e., the development of babs and nabs is a continuum with the assay systems simply measuring the strength of the antibody response. in many treated patients, the anti-ifnbeta antibody response is strong, despite the resemblance of the injected protein to the human homologue, and high levels of neutralizing antibodies develop. high levels of anti-ifnbeta antibodies with high affinity results in loss of ifnbeta bioactivity, a phenomenon which has been called antibody-mediated decreased bioactivity or adb. adb can be considered the in vivo correlate of the neutralizing effect of the anti-ifnß antibody population, while the nab assay measures the in vitro neutralization of this population of immunoglobulins in the serum. the three ifnbeta preparations have different incidences of nabs and different patterns of appearance and disappearance over time of nabs. because there is no direct correlation between nab levels and bioactivity at moderate levels of nab, in vivo bioactivity assays for ifnbeta have become increasingly utilized. in a large multicenter study in the us, called the insight study, bioactivity as measured by ifnbeta induced upregulation of the ifn-response genes mxa, viperin, and ifit , was shown to be highly correlated with nab levels, confirming a single center study (pachner, a.r., pak,e., narayan, k., multiplex analysis of expression of three ifnbeta-inducible genes in antibody-positive ms patients, neurology, : - , ) . multiple studies, including a large multicenter study in denmark and a recent study from our center using high resolution mri of the brain once a month, have demonstrated that nabs abolish the salutary effects of ifnbeta on clinical aspects of ms, especially inflammation. recent guidelines for european neurologists recommend stopping ifnbeta in nab-positive patients. in order to maintain bioactivity of this important medication for ms, some neurologists have attempted to use immunosuppressives either to prevent the development of nabs, or to treat them once they have developed. however, at this point in time, there is no clearly optimal way to treat nabs. major efforts have been underway to decrease the immunogenicity of ifnbeta and a new formulation of one of the higher immunogenicity products has been recently developed and tested. proteinase-activated receptors (pars). endogenous serine proteinases such as thrombin, mast cell tryptase, trypsins, kallikreins, cathepsin g, for example, as well as exogenous proteases released by mites or bacteria are involved in cutaneous inflammation, host defense or tumor cell regulation. thus, the expression of pars on keratinocytes, endothelial cells, nerves, and immune cells suggest important role of pars as a part of the communication system in the skin during inflammation and the immune response. for example, par activates nf-kb in keratinocytes and endothelial cells, stimulates the release of chemokines and cytokines, and is involved in proliferation and differentiation. on sensory nerves, this receptor controls neurogenic inflammation by modulating edema and extravasation via release of neuropeptides into the inflammatory site. par and par also modulate leukocyte-endothelial interactions in the skin, thereby regulating inflammatory responses such as leukocyte trafficking through the vessel wall. they also stimulate signal transduction pathways involved in cutaneous inflammation. in sum, this novel receptor family requires a paradigm shift in thinking about the role of proteases in cutaneous biology and disease. novel compounds regulating protease and par function may be beneficial for the treatment of several skin diseases such as atopic dermatitis, psoriasis or pruritus. serine proteinases are upregulated in arthritic joints where their enzymatic activity participates in the destruction of articular soft tissues. in addition to their degradative functions, serine proteinases can also act as signalling molecules by activating members of the gprotein coupled receptor family called the proteinase activated receptors (pars). these receptors are known to regulate tissue inflammation and pain, although their function in joints is unclear. our study examined the effect of par activation in joint inflammation and pain. male c bl/ mice received an intra-articular injection of either the par activating peptide aypgkf-nh or the inactive peptide yapgkf-nh ( mg) into the right knee. knee joint blood flow was then measured in these mice by laser doppler perfusion imaging while joint diameter measurements gave an indication of tissue oedema. mechanical allodynia was also assessed in these animals by application of von frey filaments onto the plantar surface of the ipsilateral hindpaw and a pain score was calculated. intra-articular injection of the par activating peptide caused knee joint blood flow to gradually increase by up to % over the succeeding hrs. knee joint swelling was also observed as well as the development of a mechanical allodynia. all responses could be blocked by pre-treatment with the selective par antagonist pepducin p pal ( mg i.p.). the control peptide yapgkf-nh had no discernible effect on joint inflammation or pain. these experiments show that peripheral activation of par receptors in mice knees causes joint inflammation and pain. vincent lagente ( ), e boichot ( ) ( ) air liquide, centre de recherche claude-delorme, jouy en josas, france ( ) inserm u , universitØ de rennes matrix metalloproteinases (mmps) are a major group of proteases known to regulate the turn-over of extracellular matrix and so they are suggested to be important in the process of lung disease associated with tissue remodelling. these led to the concept that modulation of airway remodeling including excessive proteolysis damage of the tissue may be of interest for future treatment. among metalloproteinases (mmps) family, macrophage elastase (mmp- ) is able to degrade extracellular matrix components such as elastin and is involved in tissue remodeling processes in chronic obstructive pulmonary disease (copd). pulmonary fibrosis has an aggressive course and is usually fatal for an average of three to six years after the onset of symptoms. pulmonary fibrosis is associated with deposition of extracellular matrix (ecm) components in the lung interstitium. the excessive airway remodeling as a result of an imbalance in the equilibrium of the normal processes of synthesis and degradation of extracellular matrix components could be in favor of anti-protease treatments. indeed, the correlation of the differences in hydroxyproline levels in the lungs of bleomycin-treated mice strongly suggests that a reduced molar pro-mmp- /timp- ratio in broncholaveolar lavage fluid is associated with collagen deposition, beginning as early as the inflammatory events at day after bleomycin administration. finally, these observations emphasize those effective therapies for these disorders must be given early in the natural history of the disease, prior to the development of extensive lung destruction and fibrosis. in addition to their degradative properties, proteases can act as signalling molecules that send specific messages to cells.recent work has demonstrated that proteases are able to signal to peripheral sensory neurons, thereby participating to neurogenic inflammation processes and to the transmission or inhibition of pain messages. serine proteases cleaving specifically at an arginin site are able to activate protease-activated receptors (pars), which then send specific messages to cells. we have demonstrated that members of the par family (par , par and par ) are present on peripheral sensory neurons, where they can be activated by different proteases.the activation of par and par in isolated sensory neurons provokes calcium mobilization and the release of substance p and cgrp, while the activation of par inhibited bradykinin-and capsaicin-induced calcium signal, and neuropeptide release.thrombin and pancreatic trypsin caused inflammation respectively through a par and par -dependent mechanism involving the release of neuropeptide.the extrapancreatic form of trypsin (mesotrypsin or trypsin iv) also caused neurogenic inflammation through a par and par dependent mechanism, and causes inflammatory hyperalgesia and allodynia, through a par -dependent mechanism.in contrast, activation of par on peripheral sensory neurons inhibited inflammatory hyperalgesia and allodynia. taken together, these results provide evidences that proteases can interfere with inflammatory and pain mechanisms through the activation of pars on peripheral sensory neurons.determining the role of each individual proteases and their receptors in sensory neuron signalling and above all inflammatory and pain mechanisms constitutes an important challenge to raise new anti-inflammatory and analgesic drugs. introduction: a scoring system for disseminated intravascular coagulation (dic) in humans has been proposed by the international society on thrombosis and haemostasis (isth). it was the objective of this study to develop and validate a similar scoring system for dic in dogs in order to establish the dog as a spontaneous animal model. methods: for the developmental study, consecutive dogs admitted to the intensive care unit (icu) were enrolled prospectively (group a). blood samples were collected daily and a broad panel of coagulation assays performed. diagnosis of dic was based on the expert opinion of one human physician and two veterinarians. a multiple logistic regression model was developed with the coagulation parameters as explaining variables for the diagnosis of dic. integrity and diagnostic accuracy was subsequently evaluated in a separate prospective study according to the stard criteria. the validation study prospectively enrolled consecutive dogs (group b). results: dogs were excluded from group a where / dogs ( %) had dic. final multiple logistic regression model was based on aptt, pt, d-dimer and fibrinogen and had a very high diagnostic sensitivity and specificity. diagnostic accuracy of the model was sustained by prospective evaluation in group b. conclusion: based on generally available assays, it was possible to design an objective diagnostic model for canine dic, which has both a high sensitivity and specificity. such a model will provide basis for treatment optimization and make it possible to conduct multicentered therapy studies with a minimum risk of systematic misclassification of patients. in , a coagulation independent change in light transmittance (biphasic waveform [bpw] ) was reported in automated activated partial thromboplastin time assays (aptt) in patients with disseminated intravascular coagulation (dic). a calcium-dependant precipitate of creactive protein and very-low-density-lipoprotein was causing the bpw. our group recently identified this phenomenon in dogs also. initially, bpw was introduced as a complementary tool to assist diagnosing dic. however, recent studies reported that bpw may have a stronger potential as a prognostic marker for survival. the aims of the study were to prospectively investigate (a) the diagnostic significance of bpw regarding dic and (b) the significance of bpw to outcome, in dogs with diseases known to predispose for dic. the study was performed as a prospective, observational study including consecutive dogs with a final diagnosis known to predispose for dic ( % were finally diagnosed with dic). outcome was -day survival. bpw was assessed by means of a hirudin-modified aptt assay (kjelgaard-hansen et al., jvim : ; - ) . relative risk according to bpw (rr [ % confidence interval]) for (a) a dic diagnosis and (b) -day mortality, were assessed. -day mortality in the study population was %. % were bpw positive. bpw was not a significant diagnostic factor for dic (rr= . [ . ; . ] ), but strongly so for outcome (rr= . [ . ; . ] ) with a % ( / ) mortality amongst bpw positive dogs. in conclusion, bpw was observed in dogs predisposed to dic, with a strong potential as a risk factor for outcome, a finding in line with recent findings in humans. ( ), b hideo ( ) ( ) department of molecular pathology, kumamoto university, japan ( ) department of gastroenterological surgery, kumamoto university, japan aeromonas species are facultative anaerobic gramnegative rods that are ubiquitous, waterborne bacilli, most commonly implicated as causative agents of gastroenteritis. aeromonas infections often develop sepsis and disseminated intravascular coagulation syndrome (dic) is a life-threatening complication of sepsis patients, causing multiple organ failure.however, a mechanism leading to coagulation induction in the bacterial infection has not been known. to study the dic induction by aeromonas species infection, we investigated coagulation activity of a serine protease (asp) from aeromonas sobria, predominantly isolated in patients blood. proteolytically active asp shortened both activated partial thromboplastin time and prothrombin time of human plasma in a dose-dependent manner starting at an enzyme concentration of nm. asp activated human prothrombin, releasing hydrolytic activity for thrombinspecific substrate boc-val-pro-arg-mca, but no enzymatic activity was produced from coagulation factors ix and x. analysis by sds-page revealed that asp released a prothrombin fragment with a molecular weight identical with that of f¿-thrombin in an incubation timedependent manner. western blotting using biotinylated phe-pro-arg-chloromethylketone, a thrombin inhibitor, showed that asp produced an enzymatically active fragment whose molecular weight was same as that of f¿-thrombin. prothrombin incubated with asp but not the protease itself caused platelet aggregation. these results indicate that asp activates prothrombin, producing f¿-thrombin that converts fibrinogen to fibrin clot, and suggest that asp coagulation-inducing activity contributes to dic development in sepsis caused by aeromonas sobria infection. the present study shows a link between inflammation and coagulation mediated by a bacterial protease. hemolytic episodes are often associated to high amounts of free heme in circulation (up to um) and the development of an inflammatory response that may develop to a chronic inflammation. our group has shown that free heme is a prototypical proinflammatory molecule, able to induce neutrophil migration, actin cytoskeleton reorganization and nadph oxidasederived reactive oxygen species (ros) generation, as well as pkc activation and interlukin- expression (graÅa-souza et al., ) . moreover, free heme inhibits human neutrophil spontaneous apoptosis, a feature that is closely related to the impairment of resolution of inflammation and consequent promotion of chronic inflammatory status. heme protective effect requires nadph oxidase-derived ros and involves the activation of mapk, pi k and nf-kb signaling cascades as well as heme oxygenase (ho) activity (arruda et al., ) . more recently, we have shown that heme antiapoptotic effect is closely related to the maintainance of mitochondrial stability, inhibition of bax insertion into mitochondria and a dramatic increase on bcl-xl/bad protein ratio in a ros-dependent manner, requiring the same signaling pathways that regulate heme anti-apoptotic effect. these findings attest to a prominent role of free heme in the onset of inflammation associated to hemolytic episodes as well as the statement of chronic inflammation related to these disorders. the recent advance on the study of free heme as a proinflammatory molecule brings up hope for the development of new strategies to ameliorate acute and chronic inflammation found during hemolytic episodes.financial support: faperj, cnpq, capes. ( ) ( ) university of melbourne, victoria, australia ( ) monash university, victoria, australia we have previously demonstrated that mice lacking the anti-oxidative enzyme, glutathione peroxidase (gpx ), show significantly larger infarcts after stroke. recent studies have demonstrated that adhesion molecule-mediated leukocyte recruitment is associated with increased tissue damage in stroke, while mice lacking key adhesion molecules conferred neuro-protection. nevertheless, the involvement of oxidative stress in leukocyte recruitment and subsequent regulated cell injury is yet to be elucidated. to explore this, gpx -/-mice were subjected to transient mid-cerebral artery occlusion (mcao) followed by cerebral intravital microscopy, for assessment of leukocyte-endothelium interactions in intact cerebral microvasculature. after hr mcao, leukocyte-endothelium interaction was significantly reduced in gpx -/-mice compared to wt counterparts during the second hour of reperfusion. laser doppler and direct measurement of blood flow in pial postcapillary venules revealed a reduction of reperfusion in gpx -/-mice following transient mcao. this suggests that the reduction in nutritive blood flow following stroke in gpx -/-mice may explain the enhanced injury in these mice as well as the reduced leukocyte-endothelium interaction. furthermore, matrix metalloproteinase- (mmp ) which has previously been shown to be implicated in endothelial dysfunction and the pathogenesis of stroke was found to be up-regulated in gpx -/-mice to a greater extent than in wt mice after mcao, suggesting a role for oxidative stress in cerebral microvascular injury. the data present here suggests oxidative stress may be one of the factors that contribute to reduced post-ischemic perfusion, via the disruption of the endothelial function as indicated by the increased level of mmp . chris bolton( ), c paul( ), s barker ( ), r mongru ( ) ( ) william harvey research institute, london, uk ( ) university west of england, bristol ( ) queen mary university of london adrenomedullin (am) acts as a vasodilator in many vascular beds including the cerebral circulation where the peptide is produced in larger amounts than in the periphery.in vitro work has shown that am beneficially regulates blood-brain barrier (bbb) characteristics including transendothelial electrical resistance, permeability and p-glycoprotein pump activation.our preliminary studies in acute experimental autoimmune encephalomyelitis (eae), a model of the human disease multiple sclerosis (ms), have demonstrated significant elevations in am peptide levels corresponding with am mrna changes during late, neurological disease where am production may be linked to the restoration of bbb function. however, am is not exclusively produced as result of am gene upregulation. furthermore, am peptide levels do not always match am mrna changes during other disease phases of eae.the current study has investigated, more closely, the relationship between am gene expression and subsequent levels of associated peptides. am mrna levels were determined, by rt-pcr, in the cerebellum, medulla-pons and spinal cord of normal and eae-inoculated lewis rats at the height of disease. am and proadrenomedullin peptide (pamp) levels were measured in the tissues by radioimmunoassay.all tissues examined showed an increase in am gene mrna compared to control levels.am and pamp changes were observed in the samples and differences between the peptide profiles were recorded.an understanding of alterations in the generation of am and related peptides during neuroinflammation may provide insight into mechanisms affecting bbb permeability and be of relevance to the changes in neurovascular function seen during ms. platelet-activating factor (paf) contributes to the robust inflammatory responses in acute phase and spread of secondary injury. although, paf is believed to be a potent edematous but non-painful mediator in peripheral tissues, we recently demonstrated that paf may be a mediator of noxious signaling in spinal cord in case of neuronal injury. paf-induced tactile allodynia may be mediated by atp, glutamate and the generation of nitric oxide (no). the present study elucidated down-stream signaling pathway for paf-induced tactile allodynia. paf-and glutamate-induced tactile allodynia was blocked by the pretreatment with no scavengers and inhibitors of no synthase, soluble guanylate cyclase or cgmp-dependent protein kinase (pkg). recent evidence attributes the generation of pain to specific disfunctions of inhibitory glycinergic neurotransmission. to explore the target molecule for induction of tactile allodynia, the effect of knockdown of glycine receptors containing the a subunit (glyr a ) by sirna spinally transfected with hvj-e vector was examined. in mice spinally transferred with sirna for glyr a , the reduction of glyr a was demonstrated in superficial layer of dorsal horn by immunohistochemical analysis. pcpt-cgmp, paf, glutamate failed to induce tactile allodynia in mice spinally transferred with sirna of glyr a , while these compounds produced tactile allodynia in mice transferred with mutant sirna of glyr a as a control. glycine tranporter inhibitors ameriolated paf-and pcpt-cgmp-induced allodynia. these results suggest that glutamate-no-cgmp-pkg pathway plays a key role for paf-induced tactile allodynia in spinal cord and glyr a may be a target molecule for pkg to induce allodynia. ( ), r leite( ), ys bakhle ( ) ( ) federal university of minas gerais, belo horizonte, brazil ( ) medical college of georgia, augusta, usa ( ) imperial college, london, uk selective cyclooxygenase inhibitors (coxibs) induce a characteristic increase in mechanical nociceptive threshold, referred to as "hypoalgesia", in inflammatory pain induced by carrageenan in rat paws.we have here assessed the role of the cytoskeleton in this hypoalgesia induced by celecoxib (cx). male holtzman rats ( - g; - animals/group) were injected in the right hind paw (ipl) with a range of cytoskeletal inhibitors (selective inhibitors of microtubules (taxol, nocodazole, colchicine), of actin microfilaments (latrunculin b, cytochalasin b) or of intermediary filaments (acrylamide) (pico to nanomoles per paw) and min later given cx ( mg/kg, s.c.). after a further min, rats were injected (ipl) with the inflammatory stimulus, carrageenan ( mg/paw). mechanical pain threshold was hourly measured over the next h, using the randall-sellitto method. the cxinduced hypoalgesia was reversed by low doses of latrunculin b or cytochalasin (latrunculin % reversal = . nanomoles), higher doses of microtubule inhibitors (taxol % reversal = . nanomoles) with no effect of acrylamide ( up to nanomoles).we conclude that ) local changes in (paw) cytoskeleton occurred during cxinduced hypoalgesia and ) actin microfilaments were the cytoskeletal components most critically involved in this hypoalgesia.financial support: cnpq, fapemig and capes there are reports regarding the up-regulation of cyclooxygenase isoenzyme particularly inducible isoform i.e. cox- in brain during neurodegenerative or neuropsychiatric disorders.in the present study, we examined the effect of nimesulide (a preferential cox- inhibitor) in subchronic immobilization stress. mice were subjected to immobilization stress for hrs daily for a period of seven days. nimesulide ( . mg/kg, i.p.) was administered daily for days before challenging them to immobilization stress. behavioral analysis revealed the hyperlocomotor activity and increased anxious response. subchronic stress decreased % retention of memory and also caused hyperalgesic response in mice. biochemical analysis revealed that chronic immobilization stress significantly increased lipid peroxidation and nitrite levels and decreased the reduced glutathione and adrenal ascorbic acid levels. chronic treatment with nimesulide significantly attenuated the immobilization stress-induced behavioral and biochemical alterations. these results suggested that the use of nimesulide could be a useful neuroprotective strategy in the treatment of stress. there is accumulated evidence for ngf role as a peripheral pain mediator. ngf is upregulated in diverse inflammatory conditions and evokes hyperalgesia when injected in humans and rats. ngf increase was also observed in temporomandibular join (tmj) after cfa injection, indicating its possible involvement in local hyperalgesic states. therefore, the objective here was to evaluate if ngf participate in the tmj nociception. to test this hypothesis, the ngf was injected into the tmj alone or after carrageenan (cg) and the spontaneous nociceptive behavior of head flinches was counted for up min. further evidence for the ngf nociceptive activity was obtained quantifying the local production of ngf after cg injection, by elisa, and the fos-like immunolabeling in the trigeminal sensory nucleus (including the caudalis, interpolaris and oralis) after ngf injection. injections were performed in . ul. ngf ( . , and ug) injected in the tmj challenged h prior by cg ( ug) induces a dose-dependent increase in the number of head flinches. this increase was reduced by k a ( and ug), indicating a trka receptor-mediated effect. we detected a significant increase in the ngf production and h after the tmj cg ( ug) injection. the tmj injection of ngf ( ug) alone did not induce detectable spontaneous nociceptive behavior. however, the ngf ( ug) injection induces a significant increase in the fos like immunolabeling (fli) in the sensory trigeminal nucleus compared to the saline injection. these results indicate that the ngf participates in the nociceptive activity in the tmj, specially in inflammatory conditions. mif was reported as a key cytokine in the pathogenesis of rheumatoid arthritis (ra) several years ago, but it now clear that mif is also involved in the pathogenesis of systemic lupus erythematosus (sle) and atherosclerosis. mif-deficient lupus-prone mrl/lpr mice exhibit prolonged survival and reduced renal and skin disease compared to mif-expressing mice. similarly, mif-deficient atheroma-pone ldlr-deficient or apoe-deficient mice are significantly protected from disease and antimif mab therapy is beneficial. ra and sle are each characterised both by an increased prevalence of atherosclerotic vascular disease and by overexpression of mif. given the effects of mif on atherosclerosis it can be hypothesised that mif overexpression participates in the risk of atherosclerotic vascular disease in ra and sle. recent data have provided insights into mechanisms of action for mif relevant to all these concepts. firstly, the newly described role of mif in the selective recruitment of monocyte-macrophage lineage cells is of particular relevance to ra, sle, and atherosclerosis, with evidence that mif mediates macrophage recruitment in sle and atherosclerosis. secondly, glucocorticoid (gc) therapy is possible risk factor for atherosclerosis in patients with ra and sle, and it is now clear that gc increase the expression and release of mif, potentially implicating mif in gc-related increases in atherosclerosis in ra and sle. specific therapeutic targeting of mif in ra and sle may address not only primary disease pathways but also the increased risk of atherosclerosis in these diseases. to enter inflamed tissues, leukocytes must undergo adhesion molecule-mediated interactions with the endothelial surface of vessels at the site of inflammation.cytokines such as tumour necrosis factor (tnf) are established as important mediators capable of promoting leukocyte-endothelial cell interactions.however, in inflammatory diseases such as atherosclerosis and rheumatoid arthritis, elevated expression of another cytokine, macrophage migration inhibitory factor (mif) occurs, yet the role of this cytokine in leukocyte recruitment is unknown.therefore we explored the ability of mif to regulate leukocyte recruitment.this was achieved using intravital microscopy to examine the intact microvasculature in mice following local mif treatment. these experiments showed that mif induced leukocyte adhesion and transmigration in vivo, resulting in accumulation of predominantly cd +/f / -ve/cd c-ve monocyte/ macrophage lineage cells.mif did not induce upregulation of adhesion molecules p-selectin and vcam- , although their constitutive expression contributed to recruitment.in contrast, mif-induced recruitment was blocked by antibodies to the monocyte-specific chemokine, ccl /mcp- , and its receptor ccr , and in response to anti-cxcr .this was supported by in vitro experiments showing that mif induced ccl /mcp- release from cultured murine endothelial cells.finally, mice lacking cd , the putative mif binding molecule, did not respond to mif.these data demonstrate a previously unrecognized function of this pleiotropic cytokine: induction of monocyte migration into tissues, and indicate the involvement of a pathway involving a complicated chemokine/chemokine receptor pathway with contribution from cd .this function may be critical to the ability of mif to promote diseases in which macrophages are key participants. gm-csf and m-csf (csf- ) can enhance macrophage lineage numbers as well as modulate their differentiation and function. of recent potential significance for the therapy of inflammatory/autoimmune diseases, their blockade in relevant animal models leads to a reduction in disease activity. what the critical actions are of these csfs on macrophages during inflammatory reactions are unknown. to address this issue, adherent macrophages (gm-bmm and bmm) were first derived from bone marrow precursors by gm-csf and m-csf, respectively, and stimulated in vitro with lps to measure secreted cytokine production, as well as nf-kb and ap- activities. gm-bmm preferentially produced tnfa, il- , il- and il- while, conversely, bmm generated more il- and ccl ; strikingly the latter population could not produce detectable il- and il- . following lps stimulation, gm-bmm displayed rapid ikba degradation, rela nuclear translocation and nf-kb dna binding relative to bmm, as well as a faster and enhanced ap- activation. each macrophage population was also pre-treated with the other csf prior to lps stimulation and found to adopt the phenotype of the other population to some extent as judged by cytokine production and nf-kb activity. thus gm-csf and m-csf demonstrate at the level of macrophage cytokine production different and even competing responses with implications for their respective roles in inflammation including a possible dampening role for m-csf. granulocyte macrophage-colony stimulating factor (gm-csf), initially discovered for its role in the differentiation of haematopoietic cells into granulocytes and macrophages, can also affect mature cell function and may be considered proinflammatory. gm-csf is able to prime macrophages for increased pro-inflammatory responses, including the increased release of tnfa and il- following stimulation with, for example, lps. in addition, gm-csf has been shown in vivo, using murine disease models, to play a key role in a number of inflammatory diseases. gm-csf-/-mice have been shown to be resistant to several diseases, including arthritis, and, most notably, blockade of gm-csf with a neutralizing monoclonal antibody was effective at ameliorating arthritis when given either prophylactically or therapeutically. t cells appear to be the major cell type responsible for gm-csf production required for arthritis, and gm-csf appears important in the effector phase of disease, subsequent to t cell activation. blockade of gm-csf results in fewer inflammatory cells, particularly macrophages, and cytokines such as tnfa, at the site of inflammation. these findings suggest that blockade of gm-csf may be an effective treatment in a range of inflammatory diseases. the autoimmune disease type diabetes mellitus (t dm) is thought to be mediated by autoreactive t cells recognizing islet autoantigens, including gad , ia- and proinsulin. this disease arises on a distinctive genetic background, mapping most notably to the mhc, and is also open to strong environmental influence. to investigate the pathogenesis of the disease, and in particular the prevailing paradigm that islet autoreactive t cells are important, we have developed an approach to epitope identification that is mhc allele and autoantigen specific, and operates for both cd and cd t cells. utilizing this, we have uncovered populations of islet antigen-specific t cells that have the immunological credentials to be both pathogenic (eg th , tc ) and protective (treg) in the disease. we have cloned some of these cell types, enabling us to analyse their function and provide an insight that will be important for an understanding of disease mechanisms, as well as guiding novel therapeutic interventions. tcr transgenic targeting b: - cause diabetes . knockouts of the insulin gene (expressed in thymus as well as islets) accelerates diabetes while knockout of insulin gene (islet expression) prevents % of diabetes . dual insulin knockout with transgenic insulin with altered peptide (b :a) prevents all diabetes . islets with native b: - sequence, but not altered sequence when transplanted into knockouts restore anti-insulin autoimmunity and diabetes transfer by t cells .anti-b - t cells have conserved valpha and jalpha chain usage but no conservation n region or beta chain . alpha chain as transgene sufficient to engender anti-insulin autoantibodies . kay and coworkers demonstrate insulin reactivity "upstream" of igrp and igrp reactivity nonessential.future studies in nod directed at deleting specific conserved alpha chains to test diabetes prevention and develop therapeutic.in man we can now identify at birth genetic risk as high as % of activating anti-islet autoimmunity with mhc analysis and restricted heterogeneity suggesting dominant target.insulin autoantibodies in prospective studies such as daisy usually appear initially and levels are related to progression to diabetes.analysis of cadaveric donors is underway to elucidate primary targets. (t d) is an autoimmune disease in which genes and environment contribute to cell-mediated immune destruction of insulin-producing beta cells in the islets of the pancreas. the holy grail of autoimmune disease prevention is negative vaccination against autoantigens to induce disease-specific immune tolerance. this has been achieved in rodents by administering autoantigen via a tolerogenic route (mucosal), cell type (stem cell or resting dendritic cell), mode (with blockade of t-cell co-stimulation molecules) or form (as an altered peptide ligand). compelling evidence demonstrates that proinsulin is the key autoantigen that drives beta-cell destruction in the non-obese diabetic (nod) mouse model of t d, and possibly in humans. proinsulin/ insulin dna, protein or t-cell epitope peptides administered in a tolerogenic manner to the nod mouse can delay or prevent the development of diabetes, via one or more mechanisms (deletion or anergy of effector t cells, induction of regulatory t cells). administration of autoantigen via the mucosal route, which induces anti-diabetic regulatory t cells in the rodent, is the most immediately translatable approach to humans. initial human trials of vaccination with oral autoantigens lacked evidence of bioeffect, probably due to inadequate dosage in end-stage disease. recently, however, the first evidence for a therapeutic effect of mucosal autoantigen has been seen in trials of oral and nasal insulin in islet autoantibodypositive individuals at risk for t d. combination autoantigen-specific vaccination also shows promise in combination with non-specific immunotherapy in established t d. leukocyte extravazation is an integral process both physiologically (immunosurveillance) and pathophysiologically (inflammation). the initial paradigm of a -step process comprising tethering/rolling, activation, firm adhesion, and diapedesis, each involving specific adhesion molecules, has repeatedly been modified in the light of more recent findings. additionally, organ-specific differences regarding the role of distinct molecules were established. finally, the skin became a good "model" to study due to its accessability and availability of powerful animal models. in-vitro adhesion assays, flow-chamber systems, intravital microscopy, animal models for delayed-type hypersensitivity, and transplantation approaches have successfully been employed to investigate leukocyte extravazation. numerous molecular interactions such as the cutaneous lymphocyte-associated antigen and sialyl-lewisx, or icam- and lfa- , have been proven sufficiently relevant to make them candidates for potential therapies. with the anti lfa- antibody efalizumab, approved for the treatment of psoriasis, the first therapeutic agent specifically targeting leukocyte extravazation is already on the market; other compounds are under development. moreover, novel data suggest that well-established anti-inflamamtory therapies such as fumarates also influence this process, thus contributing to their clinical efficacy. ongoing research aks for adopting a more "dynamic" view on leukocyte extravazation as several molecules obviously perform multiple tasks throughout this process rather than being limited to just one step of this multi-step cascade; this is particularly true for the so-called junctional adhesuíon molecules which obviously mediate more than just diapedesis. finally, similarities between leukocyte extravazation and hematogenic metastases are emerging. consequently, certain anti-inflammatory compounds may turn out to also exhibit striking anti-metastatic efficacy, and vice versa. department of dermatology, heinrich-heine-university, düsseldorf, germany atopic dermatitis, psoriasis vulagaris and cutaneous lupus erythematosus represent chronic inflammatory skin diseases showing distinct clinical phenotypes but sharing one aspect. the recruitment of pathogenic leukocyte subsets into the skin represents a prerequisite for their initiation and maintenance. during recent years, our knowledge of the immunopathogenesis of chronic inflammatory skin diseases increased significantly. with regard to the recruitment pathways of leukocytes, a superfamily of small cytokine-like proteins so called chemokines has attracted significant attention. here the complex interactions within the chemokine ligand-receptor network are introduced, the involvement of chemokines in memory t and dendritic cell trafficking is outlined and current concepts of their role in the immunopathogenesis of atopic dermatitis, psorasis vulgaris and cutaneous lupus erythematosus are summarized. the skin serves as a unique organ for studying general principles of inflammation because of its easy accessibility for clinical evaluation and tissue sampling. a network of pro-inflammatory cytokines including il- and tnf-a is known to play a key role in the pathogenesis of cutaneous inflammatory diseases through activation of specific signalling pathways. recently, progress in understanding the underlying mechanisms regulating inflammatory signalling pathways in the immunopathogenesis in skin carcinomas, psoriasis vulgaris and atopic dermatitis has been made. kinases have been identified to play a crucial role in regulating the expression and activation of inflammatory mediators in these inflammatory skin diseases. mitogen-activated protein kinases (mapks) are a family of serine/threonine protein kinases that mediate a wide variety of cellular behaviours in response to external stress signals. increased activity of mapks, in particular p mapk, and their involvement in the regulation of synthesis of inflammatory mediators at the transcriptional and translational level has recently been demonstrated. progress in our understanding of inflammatory signalling pathways has identified new targets for treating inflammatory diseases, but the challenge is to place a value on one target relative to another and to evolve strategies to target them. a careful examination of different signalling pathways in various inflammatory conditions is therefore needed. this presentation gathers recent advances in signal transduction in skin inflammation focusing interleukin- , tnf-µ, p mapk, msk / , mk , nf-kappab and ap- . histamine is an important inflammatory mediator in humans, and despite their relatively modest efficacy antihistamines are frequently used to treat allergic conditions, as well as other histamine-mediated reactions such as pruritus. in contrast, antihistamines are of very limited use for controlling other conditions where histamine production is abundant, including asthma. the discovery of the histamine h receptor (h r) prompted us to reinvestigate the role of histamine in pulmonary allergic responses, as well as in pruritus. h r deficient mice and mice treated with h r antagonists exhibited decreased allergic lung inflammation in several models, with decreases in infiltrating lung eosinophils and lymphocytes and decreases in th responses. ex vivo restimulation of primed t cells showed decreases in th cytokine production, and in vitro experiments suggest that decreased cytokine and chemokine production by dendritic cells after blockade of the h r was responsible for the the t cell effects. the influence of h r on allergic or histamine-induced pruritus was explored in mice using selective histamine receptor antagonists and h r deficient mice. the h r was found to mediate the majority of histamine-mediated and allergic itching, while the contibution by the h r was minor. surprisingly the h r effect was independent of mast cells or other hematopoetic cells. this work suggests that the h r can modulate both allergic responses via its influence on t cell activation, and pruritus through mechanisms that are independent of hematopoetic cells. the studies show that the h r mediates previously uncharacterized effects of histamine and highlight the therapeutic potential of h r antagonists. ( ), bsp reddy ( ) ( ) nizams institute of medical sciences, hyderabad; india ( ) genix pharma, india rupatidine, carries the majority of the histamine h receptor -blocking activity and has been introducedfor the treatment of allergic rhinitis and urticaria. objectives: the aim of this study was to compare the effect of two by measure of inhibition of histamine induced wheal and flare response. methodology: male volunteers were enrolled after written informed consent before to ethic committee approved protocol. in this randomised, double-blind, single oral dose, cross overstudy, they were randomized to receive either mg rupatidineformulation after overnight fast. washout was days. wheal and flare were induced on the forearm of the trial subjects, by histamine intradermally injection while the subject was lying comfortably with arm resting on the bed. ten minutes later, wheal and flare were visualized under a bright lamp. histamine induced wheal and flare skin test was performed before and regularly to hours after drug administration. results: administration of reference and test formulations of rupatidine, significantly inhibited the histamine induced cutaneous response in all the subjects. the least square mean ratio (%) t vs r for peak activity imax-% (maximum inhibition of histamine induced wheal and flare response); area under the activity time curve (auc - mmsq/hr and auc - %/hr) both for untransformed and log transformed data were found to be within - % of % ci limits both formulations well tolerated. conclusions: it can thus be concluded that be concluded that test formulation of rupatidine tablet is bioequivalent to reference rupatidine tablet ( ), h yoshimura( ), k ohara ( ), y mastui ( ), h hara ( ), h inoue ( ), h kitasato ( ), c yokoyama( ), s narumiya ( ), m majima ( ) ( ) kitasato university school of medicine, kanagawa, japan ( ) tokyo dental medical colledge, tokyo, japan ( ) kyoto university school of medicine, kyoto, japan thromboxane (tx) a is a potent stimulator of platelet activation and aggregation and vascular constriction. we have reported the magnitude of cytokine-mediated release of sdf- from platelets and the recruitment of nonendothelial cxcr + vegfr + hematopoietic progenitorsconstitute revascularization. we hypothesized that txa induces angiogenic response by stimulating sdf- and vegf which derived from platelet aggrega- inflamm. res., supplement ( ) tion.to evaluate this hypothesis, we dissected the role of the txa in angiogenesis response using mouse hind limb model. recovery from acute hind limb ischemia, as assessed by the ratio between the treated ischemic limb and the untreated control right limb was assessed in wild type mice (c bl/ wt) , prostaglandin i receptor (ip) knock out(ipko) and thromboxane (tx) a receptor (tp) knock out(tpko). blood recovery in tp-/-significantly delayed compared to wt and ipko. immunohistochemical studiesrevealed that tp-/-mice were less stained against pecam positive cells compared to wt and ipkoplasma sdf- and vegf concentration were significantly reduced in tp-/-mice. we observed during in vivo fluorescence microscopic study that compared to tpko, ipko and wt significantly increased platelet attachment to the microvessels around ligated area. tpko translpanted wt bone marrow cells increased blood recovery compared to tpko transplanted tpko bone marrow cells. in addition, mice injected with txa synthase c-dna expressing fibroblast increased blood flow recovery compared to control mice. these results suggested that tp signaling rescues ischemic condition by inducing angiogenesis by secreting sdf- and vegf from platelet aggregation. purpose: the s calcium-binding proteins, a , a and a are constitutively expressed in neutrophils and induced in activated macrophages. high levels are found in sera from patients with infection and several chronic inflammatory diseases. the calgranulin complex, a /a is anti-microbial; a has oxidant-scavenging functions. a is chemotactic for monocytes, and recruits leukocytes in vivo by activating mast cells (mc). effects of these mediators on mc and monocyte function were compared. methods: human pbmc or murine mc were activated in vitro with s and mediator release and cytokine induction (assessed by quantitative rt-pcr/elisa), determined. a cys to ala a mutant was used to determine whether effects on mc are mediated by redox. immunohistochemistry was used to demonstrate s s in asthmatic lung. the s s were expressed in asthmatic lung, particularly in eosinophils and alveolar macrophages. strong reactivity occurred with an antibody recognising predominantly the hypochlorite-oxidised from of a . a , a or the a /a complex had relatively low ability to induce il , tnf, il , and chemokines mrna from pbmc compared to a . only a induced significant levels of il ; none induced il or gm-csf mrna compared to lps. in contrast to a which is activating, a significantly inhibited mc degranulation provoked by ige cross-linking; suppression was dependent on cys . conclusions: the cytokine profile generated by a in mc and monocytes strongly supports a role the pathogenesis of asthma. in contrast, results strongly support a role from a in oxidant defence, particularly to hypobromite generated by activated eosinophils. ( ), d mankuta( ), g gleich ( ), f levi-schaffer ( ) ( ) hebrew university of jerusalem, israel ( ) hadassah university hospital, israel ( ) university of utah, usa the onset, amplitude and termination of allergic responses is regulated at the mast cell/eosinophil interface. eosinophil major basic protein (mbp), which activates mast cells in the late-chronic phase of allergic inflammation, is a central determinant in this interface. characterized more than two decades ago, the exact nature of this activation has not been clarified as yet. here we demonstrate that mbp exerts its activating effect on human mast cells and basophils through cd and hematopoietic cell kinase (hck). a genome-wide analysis showed that hck displays shifts in mrna levels specifically upon mbp-induced mast cell activation. hck also shows a unique priming pattern prior to this activation. cd is phosphorylated specifically upon activation with mbp and deploys a signaling complex that critically depends on hck. extracellular neutralization of cd interferes with mbp entry into the cell, and this as well as rna silencing of hck results in defective mbp-induced activation. finally, cd neutralization abrogates mbp-induced anaphylaxis in-vivo. these findings picture for the first time a chronic-phase specific pathway mediating eosinophil-induced mast cell activation with critical consequences for the therapy of chronic allergic inflammation. alexander robinson ( ), d kashanin ( ), f odowd( ), v williams( ), g walsh ( ) ( ) cellix ltd, institute of molecular medicine, dublin, ireland ( ) university of aberdeen, scotland, uk leukocyte adhesion to endothelial cell bound proteins, such as icam- and vcam- , is an initial step of the inflammatory response. we have developed an in vitro microfluidic system which mimics conditions found in blood vessels in vivo during an immune response. using this system, we can record leukocyte adhesion levels under physiologically relevant flow conditions (e.g. - dynes/cm ). the adhesion profiles of resting and pmastimulated peripheral blood lymphocytes (pbls) were recorded, with respect to vcam- , icam- , and bsa. images at each shear stress level were captured using a digital camera, and analysed using our in-house ducocell software package. distinct morphological changes in pma-stimulated pbls, compared to non-stimulated cells, can be observed. these include a less rounded appearance of the pma-stimulated pbls, and evidence of "uropod" formation, which anchor the t cell to the endothelium as part of the migration process. levels of adhesion to vcam- are high ( - %, compared to control), but there appears to be little difference between the adhesion profiles of non-stimulated and pma-stimulated pbls.however, there is a distinct difference between the adhesion levels of non-stimulated and pma-stimulated pbls to icam- , with pma-stimulated cells showing a higher affinity for icam- than nonstimulated cells (approx. % and %, respectively).pbl adhesion to bsa is negligible. we present a novel in vitro microfluidic pump system that can simulate leukocyte adhesion to the endothelium under flow conditions. this platform is a more efficient and economical system compared to those currently available, due to reduced material costs and style of construction. introduction: pulmonary aspiration of gastric contents is a common complication observed in icu patients and a potential trigger of ards. in this study we evaluated the course of lung inflammation induced by intranasal instillation of gastric juice (gj). methods: gj was obtained from donor rats (ph . ). male c bl/ were instilled with ml/kg of gj. after or h, the animals were sacrificed and lung and balf were collected. control group consisted of non-manipulated mice. . ae . , sg h: . ae . ; pg/ml). discussion: gj aspiration induced an initial adherence of pmn to lung tissue that is correlated with increased tnf-a/il- ratio in balf at the nd h. the reduction of mpo activity is correlated with the decrease in tnf-a/il- ratio. the late increase of pmn in balf might be a consequence of the early production of tnf-a. the results are suggestive that the treatment of patients exposed to acid aspiration should be focused in the initial period of the insult and in the blockage of tnf-a. objectives: intestinal i/r is implicated as a prime initiating event in the development of acute respiratory distress syndrome (ards) after trauma and hemorrhagic shock. we investigated the effects of lps challenge to mice previously submitted to i-i/r, a two-hit model of acute lung injury. methods: male c bl/ mice were subjected to min of intestinal ischemia and challenged with . mg/kg of intranasal lps at the th hour of reperfusion (two-hit). balf and culture of lung explants were performed h after lps challenge. mice subjected to i-i/r or lps alone were used as controls. results: two-hit mice showed marked increase in lung evans blue dye leakage compared to i-i/r ( . ae . vs . ae . , mg/mg). lung mpo was increased ( . ae . vs . ae . ; od nm) whereas the neutrophil recruitment to balf was inhibited in the two-hit group compared to lps group ( . ae . vs . ae . ; x e cells/mouse). the levels of nox-in the two-hit group were significantly increased when compared to i-i/ r controls in balf ( . ae . vs . ae . ; mm) and in lung explants ( . ae . vs . ae . ; mm/mg of tissue). conclusions: intestinal i/r predisposes the animal to an exacerbated response to a low dose lps insult. the exacerbated production of nitric oxide observed in the two-hit group may cause endothelial damage, thereby explaining the major increase in vascular permeability in the two-hit group. the results are suggestive that patients exposed to systemic inflammatory response might develop ards when in contact with secondary inflammatory stimuli. nitric oxide may play an important role in this process. ( ) ( ) novartis institutes for biomedical research, horsham, uk ( ) university of michigan, usa obligatory for using oxygen in energy transfer pathways was the simultaneous co-evolution of enzymes that detoxify the reactive species formed as by-products. thus, we hypothesized that individuals with low aerobic function will have reduced anti-oxidant capacity and, therefore, be more susceptible to smoking-related lung diseases like copd. to test this hypothesis, we exposed high capacity runner (hcr) and low capacity runner (lcr) rats to months of whole-body smoke exposures.the animals, bred over successive generations on the same background strain for high or low running capacity, differ by over % (p< x - ) for exercise capacity, measured by running on a treadmill.after months of exposures, inflammatory cells in bronchoalveolar lavage fluid were increased in both the hcr-and lcr-smokeexposed(se) animals compared to air-exposed controls (p< . ); however there was a - -fold increase in the number of neutrophils and lymphocytes in the lcr-over the hcr-se group (p< . ).histopathology revealed there was greater inflammation and lung damage present in the lcr-versus hcr-se group (p< . ). metabonomic (metabolite profiling) analysis revealed that while peroxidation of lung lipids occurred for both se groups, oxidative damage to the lung surfactant layer was significantly more extensive for the lcr-se. systemic oxidative damage was also more apparent in the lcr-se group, with metabolic profiling suggesting a reduced capacity to regenerate muscle glutathione. the metabolic data suggest that repair processes maybe more effective in the hcrs. in summary, these data support the concept that aerobic capacity may be central to ones susceptibility to developing smoking-related lung disease. ( ), ap ligeiro-oliveira( ), jm ferreira-jr( ), sr almeida( ), w tavares de lima( ), shp farsky ( ) ( ) university of s¼o paulo, brazil ( ) regional integrated university of alto uruguai and missðes, brazil methods: male wistar rats were exposed to vehicle or hq ( mg/kg; ip.;daily, days, two-day interval every five days). on day , animals were ip sensitized with ovalbumin (oa). assays were performed on day . results: hq-exposed rats presented reduced number of leukocytes in the bronchoalveolar fluid and by impaired in vitro oa-induced tracheal contraction. the latter effect suggests reduction on mast cell degranulation, and it was corroborated by in vivo decreased mesenteric mast cell degranulation after topical application of oa. the oa-specificity response was confirmed by normal ability of mast cells to degranulate in both groups of animals after topical application of compound / . in fact, lower levels of circulating oa-anaphylactic ige antibodies were found in hq-exposed rats. this latter effect was not dependent on number or proliferation of lymphocytes, nevertheless reduced expressions of costimulatory molecules cd and cd on oa-activated lymphocytes indicated the interference of hq exposure on signaling of the humoral response during an allergic inflammation. contact information: ms sandra manoela dias macedo, regional integrated university of alto uruguai and missðes / university of s¼o p, department of clinical and toxicological analyses, s¼o paulo, brazil e-mail: smdmacedo@yahoo.com.br ( ) ( ) radboud university nijmegen, medical centre, nijmegen, the netherlands ( ) university hospital, zürich, switzerland toll-like receptors (tlr) are essential in the recognition of invading microorganisms. however, increasing evidence shows involvement of tlr in autoimmunity, such as rheumatoid arthritis (ra), as well. here we investigated whether synovial expression of tlr and tlr was associated with the expression of ifna, tnfa, il- b, il- , il- , and il- and studied in what way these receptors and cytokines were associated in vitro. using immunohistochemistry, we found that tlr / tlr expression in synovial tissue was associated with the presence of ifna, il- b and il- , but not tnfa, il- and il- . to investigate whether ifna, il- b and il- could induce tlr / tlr upregulation in vitro, we incubated separate lymphocyte populations with these cytokines and subsequently determined tlr / mrna expression. ifna incubation resulted in significant tlr /tlr upregulation, whereas il- b and il- did not. pre-incubation with ifna and subsequent stimulation of tlr /tlr significantly enhanced il- , tnfa and ifna/b production, indicating that the ifn-induced tlr upregulation was functional. low amounts of biologically active il- b were produced upon stimulation with atp, but not upon tlr / tlr stimulation, although mrna levels were high. interestingly, ifna-priming significantly increased the atp-induced il- b production. here, we demonstrated a dual role for ifna in vitro, which could explain the association between tlr and il- b / il- in synovial tissue. first, involvement in tlr /tlr regulation and second, involvement in atp-induced production of biologically active il- b. these results suggest involvement of anti-viral immune responses in ra and ifna as a key player in chronic inflammation. the pathogenesis of chronic joint inflammation remains unclear although the involvement of pathogen recognition receptors (ppr) has been suggested recently. here, we described the role of two members of the nacht-lrr (nlr) family, nod (nucleotide/ binding oligomerization domain) and nod in model of acute joint inflammation induced by intraarticular injection of tlr (toll-like receptor) agonist streptococcus pyogenes cell wall fragments. we found that nod deficiency resulted in reduced joint inflammation and protection against early cartilage damage. in contrast, nod gene deficient mice developed enhanced joint inflammation with concomitant elevated levels of proinflammatory cytokines and cartilage damage. to explore whether the different function of nod and nod occurs also in humans, we exposed pbmcs carrying either nod frameshift or nod frameshift mutation with scw fragments in vitro. both tnfa and il- b production was clearly impaired in pbmcs carrying the nod fs compared to pbmcs isolated from healthy controls. in line with the nod gene deficient mice, human pbmcs bearing the nod mutation produced enhanced levels of proinflammatory cytokines after h stimulation with scw fragments. these data indicated that the nlr family members nod and nod have a different function in controlling tlr -mediated pathways. we hypothesize that intracellular nod -nod interactions determine the cellular response to tlr triggers. whether lack of controlling tlr -driven pathways by nod signalling is involved in the pathogenesis of autoinflammatory or autoimmune disease, such as rheumatoid arthritis (ra), remains to be elucidated. leukocyte immunoglobulin-like receptors (lilrs) are a family of receptors with potential immune-regulatory function. activating and inhibitory receptors play a role in maintaining immunological equilibrium and an imbalance may lead to the onset of autoimmune diseases such as rheumatoid arthritis (ra). ra is a chronic inflammatory disease of joints caused by mediators (i.e. tnf-a) produced by activated leukocytes. we recently demonstrated expression of activating lilra in synovial tissue macrophages from ra patients. the aim of this study was to determine expression and function of lilra in monocytes and macrophages. peripheral blood mononuclear cells (pbmc) were prepared by standard density gradient separation and in vitro-derived macrophages were generated by differentiating thp- cells with vitamin-d . lilra expression was measured by flow cytometry before and after modulation with cytokines. differentiation to macrophages significantly up-regulated lilra expression (p= . ). treatment of macrophages with lps, tnf-a, il- b and ifn-g but not il- caused significant down-regulation of lilra (p< . ). function of lilra was assessed by cross-linking with plate-immobilised lilra -specific mab. soluble tnf-a was measured by elisa. activation of cells elicited tnf-a production in a dose-dependent manner while time-course analysis shows maximal production at h. correlation between lilra expression and response to cross-linking indicates that level of expression may relate directly to the degree of activation. decrease expression in response to acute-phase cytokines suggests controlled regulation during inflammation. in ra, abnormal regulation of lilra could potentially exacerbate inflammation by inducing uncontrolled production of proinflammatory cytokines. pharmacological blocking of lilra could potentially provide therapeutic benefit. ( ) ( ) university of valencia, spain ( ) northwick park institute for medical research, uk co-releasing molecules (co-rms) mimic the biological actions of co derived from heme oxygenase activity. in the present work we studied the effects of a water-soluble co-releasing molecule (corm- ) on an animal model of human rheumatoid arthritis. dba- /j mice were treated with corm- ( , or mg/kg/day, i.p.) from day to after collagen-induced arthritis (cia) and sacrificed on day . administration of corm- resulted in a significant improvement of the clinical profile of this disease since it markedly reduced joint swelling and redness. histological analysis of the joints in control arthritic mice indicated the presence of granulocytes and mononuclear cells, cartilage erosion, chondrocyte death and proteoglycan depletion. all these parameters were significantly reduced by corm- treatment with the most pronounced protective effect observed at mg/kg. the levels of pro-inflammatory mediators (pge , il- beta, tnfalpha, il- and il- ) in the hind paw homogenates were significantly inhibited by corm- . in addition, comp levels in serum, a marker of cartilage degradation, was reduced by the co-releasing agent. our studies show that therapeutic administration of corm- alleviates the clinical features of murine cia at the late phase of this response. the beneficial action of co liberated from corm- appears to be associated with a decrease in inflammatory cytokines and reduction of cell infiltration into the synovial tissues ultimately leading to a protective effect on the cartilage. aim: to setup a bovine model for cytokine-induced articular cartilage collagen degradation, and characterize the model using a variety of compounds targeting different disease mechanisms relevant to arthritis. methods: full thickness bovine articular cartilage punches were cultured with or without ng/ml il- a, tnf-a and oncostatin m. after three weeks the cartilage and culture medium were analyzed for weight changes, water content, dna content, glycosaminoglycans (gag), hydroxyproline (hyp), damaged collagen molecules, mmp activity, ctx-ii and comp. diclofenac, dexamethasone, pioglitazone, remicade, risedronate, galardin and a - were tested for their effect on cartilage degradation. results: exposure of articular cartilage to cytokines resulted in a decreased cartilage weight, increased proteoglycans degradation, increased collagen degradation, increased percentage of denatured collagen, increased water content and increased levels of active mmps (all p < . ). comp release during the first week of culture showed a trend towards up regulation during the first week of culture for all three donors, this was however not significant due to the small number of donors. most of the described processes were modulated by one or more of the drugs tested, indicating that this model for articular cartilage destruction is sensitive to treatment. discussion: stimulation of bovine articular cartilage explants with a cocktail of il- a, tnf-a and osm results in clear and consistent changes in the cartilage, highly reminiscent of cartilage destruction during arthritis. further research needs to establish whether the model is also sensitive to anabolic factors that potentially could repair the damage. toll-like receptors (tlrs) may contribute to the progression of rheumatoid arthritis through recognition of hostderived damage-associated ligands that have repeatedly been found in arthritic joints. involvement of tlr and tlr activation in the expression of arthritis was studied using interleukin- receptor antagonist deficient (il- ra-/-) mice, which spontaneously develop an autoimmune t-cell mediated arthritis. spontaneous onset of arthritis was dependent on tlr activation by microbial flora, as germ-free mice did not develop arthritis. after crossing with tlr knockouts, il- ra-/-tlr -/-mice developed more severe arthritis compared to il-ra-/-tlr +/+ littermates; whereas, tlr -/-il- ra-/-mice were protected against arthritis. to clarify the mechanism by which tlr and tlr differentially regulated the disease expression, we studied the role of these tlrs in il- production and th development, both important in il- ra-/-arthritis. wild type bone-marrow-derived dendritic cells (bmdcs) produced similar levels of il- upon stimulation with tlr and tlr ligands; however, il- ra-/-bmdcs produced less il- than wild type dcs upon tlr stimulation and more il- than wild type dcs upon tlr stimulation. furthermore, il- ra-/-t cells produced lower amounts of il- when cultured with tlr -activated apcs and higher amounts of il- when cultured with tlr -stimulated apcs, both in combination with cd stimulation. facs analysis of th (cd +/il- +) cells from both spleen and draining lymph nodes revealed % reduction in il- ra-/-tlr -/-mice compared to il- ra-/-tlr +/+ littermates. specific cd /cd stimulation of non-adherent splenocytes confirmed lower il- production in il- ra-/-tlr -/-. these findings suggest important roles for tlr and tlr in regulation of th development and expression of arthritis. prostaglandine (pge ) stimulates the transactivational activity of p through p map kinase-dependent ser phosphorylation (jbc ) .p controls cell-cycle progression, in part, by differential regulation of ap- proto-oncogenes (jun/fos).currently we studied pge control of cyclin d promoter activity with particular attention to the role of ap- oncogenes.pge induced a . fold increase in junb mrna expression (northern blot), a . -fold increase in junb promoter activity (luciferase assay), and increased ser junb phosphorylation in human synovial fibroblasts (hsf) (western blot).c-jun was strongly inhibited while jund, c-fos, fra / , and fosb expression were upregulated by pge .in cell-cycle experiments, transformation with a constitutively active ha-ras construct (ras g v) resulted in a . fold increase in cyclin-d promoter activity, cyclin-d synthesis, thr /tyr phosphorylation of erk / ( . fold) and ap- (c-jun)-dependent transactivity ( . fold); cyclin d /cdk - inhibitor p ink a synthesis was suppressed. addition of excess rass n dominant negative mutant construct to the plasmid mix abrogated the aforementioned processes.ectopic expression of c-jun, c-fos and especially jund expression constructs stimulated cyclin d promoter activity/protein synthesis, blocked p ink a synthesis; the latter effects were reversed by the addition of excess junb.pge exerted temporal and bi-phasic dose-dependent control of the cyclin d promoter activity, largely through differential ap- activation and promoted cell cycle arrest and apoptosis in hsf at high physiological concentrations.the results provide further insight into the biology of the cpla / cox/pges biosynthetic axis and highlight the complexity of pge action in terms of cell-cycle progression. di-glucopyranosylamine (diga) is an antikeratitic (roberts et al., , acvo conference, scottsdale) immunomodulatory pyranosyl disaccharide with parenteral anti-rheumatic activity (bolton et al., , inflammation res. (s ) s ) and unknown mechanism of action.interestingly, anti-tnf therapy is anti-keratitic.-diga hydrolyses to monoglucosylamine (mga) and glucose, which is prevented by n-acetylation (nacdi-ga).lider ( , pnas. : - ) showed that sulphated disaccharides are orally active, inhibit tnf synthesis and the dth reaction.we have investigated the anti-tnf and anti-rheumatic activity of the sulphated and free digas.human whole blood (hwb) was stimulated with pha ( mg/ml) to synthesise tnf.antigen induced arthritis (aia) was induced in methylated bovine serum albumin (mbsa) sensitised c bl/ mice challenged i.a. into the stifle joint.collagen arthritis (cia) induced in dba mice by sensitisation to bovine collagen, were boosted i.p. with collagen at day . hwb tnf synthesis was inhibited by diga, mga and nacdiga(ic < . mm). diga ( ml, mm) i.a. prevented hour aia (- . +/- . mm).diga at mg/kg reduced aia when administered i.v. (- . +/- . mm, p< . ) and i.p. (- . +/- . mm, p< . ), but is hydrolysed p.o. ( . +/- . mm ns). polysulphated diga (diga s) was unstable, but stabilised by n-acetylation (nacdi-ga s).tnf synthesis was potently inhibited by both nacdiga and nacdiga s (ic < . mm).nacdiga s ( mg/kg p.o.) inhibited aia (- . +/- . mm), and nacdiga s with lower degrees of sulphation (mw and kda) inhibited the development of mouse collagen induced arthritis as assessed by clinical score. sulphated diglucosylamines represent a new class of heparinoid which are potent inhibitors of tnf synthesis and possess oral anti-rheumatic activity. excessive no appears to play a key role in the pathogenesis of chronic inflammatory diseases. in this study we aimed to evaluate no synthesis in rheumatoid arthritis (ra) before and after therapy. it was performed on persons, divided into groups: a negative control group of healthy volunteers, a positive control group with ra, a group with ra and physiotherapy (phys), a group with ra and low doses of cimetidine (cim) + doxycycline (dox), a group with ra and combined treatment phys + cim + dox, and a group treated with usual doses of ibuprofen (ibu). serum nitrite/nitrate (griess) was measured in order to evaluate no synthesis. results: compared to the positive control group, in all the treated groups no synthesis decreased significantly. there was no significant difference between phys and cim+dox effect alone. the combined treatment, phys + cim + dox had a much better inhibitory effect on no synthesis. between the phys, cim + dox and phys + cim + dox groups and that treated with ibuprofen, there was no significant difference in reducing no synthesis. conclusions: ) in ra phys + cim + dox treatment was as efficient as ibuprofen in reducing no synthesis. ) the low doses of cim and dox may allow a longer treatment due to the lower side effects risk enhanced socs expression following exposure of murine macrophages to lps implicated socs in the control of lps-mediated signaling. socs regulates nfkb signaling in murine macrophages, blocking at the level of mal or ikba phosphorylation. we investigated the role of socs in regulating the production tnf by lps and pam csk -activated primary human monocytes. blood monocytes were isolated by centrifugal elutriation and either infected with an adenoviral vector expressing socs (adv-socs ), control vector (adv-gfp) or left untreated. adv-socs monocytes were exposed to tlr and tlr ligands, lps ( ng/ml) or pam csk ( ng/ml). facs analysis demonstrated infection efficiencies of ae % and ae % (n= , mean ae sem) of monocytes expressing adv-gfp or adv-socs at moi . adv-socs blocked lps and pam csk induced tnf mrna and protein production in a dose-dependent manner. in contrast, il- and il- production by adv-socs -infected monocytes was not blocked. adv-socs also blocked lps and pam csk induced tnf production by macrophages isolated from synovial fluid. infection efficiencies of ae % or ae % were obtained. quantitative western blot analysis revealed that the classically defined nfkb pathway was not altered at the level of ikba or p activation. furthermore, the kinetics of lps and pam csk induced ikba phosphorylation and degradation in adv-socs monocytes remained unaffected (n= and donors, respectively). further, analysis of parallel mapk pathways demonstrated no block in p or erk mapk pathways. these data suggest that socs regulation of lps and pam csk -induced tnf production by human monocytes occurs downstream of tlrs, possibly at the level of transcription. recently, beta-nad+ has emerged as a novel extracellular player in the human urinary bladder. beta-nad+ is the natural substrate of cd which catalyzes the conversion of beta-nad+ to cadpr. under normal conditions in vivo, there is no or only very small quantities (submicromolar range) of extracellular beta-nad+ compared to intracellular levels ( - mm). during inflammation cell lysis may cause bursts of high local beta-nad+ levels. however, the effect of beta-nad+ on the human detrusor smooth muscle cells (hdsmc) was unknown. the effect of beta-nad+ on cultured (explant technique) hdsmc was determined by: ) measuring cytosolic free calcium ([ca +] i) in fura- loaded hdsmc using spectrofluorometry and ) force measurements in - mg detrusor strips. hdsmc responded to beta-nad+ ( - mm) with an immediate and transient increase in [ca +] i. the ca + transient was followed by one or two much slower and transient increases in [ca +] i, indicative of beta-nad+ enzymatic conversion into cadpr. the ca + responses persisted in the absence of extracellular calcium. the ca + responses to beta-nad+ were not affected by exposure of hdsmc to atp supporting the notion that the effects of beta-nad+ were not mediated via p x purinoceptors. furthermore, beta-nad+ caused a concentration-dependent detrusor muscle relaxation. this is the first study to report that extracellular beta-nad+ affect intracellular calcium homeostasis and force in hdsmc. these powerful actions of beta-nad+ suggest a role for beta-nad+/cadpr system as a novel extracellular player in the human detrusor during inflammation. aids remains a worldwide threat more than two decades after identification of hiv as the etiological agent. its wide dissemination can be partly attributed to its successful suppression of immunity resulting in disease progression and concomitant opportunistic infections including mycobacterial and cytomegalovirus infections. hiv trans-activator (tat) is one of the regulatory proteins that mediates hiv replication and dysregulates cellular functions such as apoptosis and cytokine expression. for example, tat induces tumor necrosis factor (tnf) and enhances gp -induced neurotoxicity. we recently showed that tat induces the overexpression of il- via cellular kinase pkr and activation of transcription factor ets- . in this study, we examined whether tat plays a role in perturbing interferon-& (ifn&) signal transduction. we showed that tat impaired ifn&-induced stat tyrosine phosphorylation, but had no effects on the serine residue of stat and jak kinases in primary human blood monocytes. furthermore, we found that the nuclear translocation of phospho-stat was abrogated by tat. the inhibition of phospho-stat led to the deformation of stat homodimers and subsequent stat-dna complex. to investigate the cellular consequences, we measured the expression of ifn&-stimulated genes including human leukocyte antigen (hla) and , oligoadenylate synthetase ( , oas), a key enzyme in the activation of latent ribonuclease l. the results showed that tat inhibited transcriptional activation of , oas and hla. taken together, we identified a new role for tat in which it impairs ifn& signal transduction and suppresses inflammation, thus crippling the immune system and contributing to hiv persistence, opportunistic infections and disease progression. caspase- belongs to the group of inflammatory caspases and is the activating enzyme for the pro-inflammatory cytokine interleukin- (il- ), a cytokine known to play an important role in the pathogenesis of psoriasis. the purpose of this study was to determine the expression of caspase- in psoriatic skin and the signaling mechanisms involved in stress induced activation of caspase- and il- . interestingly, increased caspase- activity in lesional compared with nonlesional psoriatic skin was seen as determined by western blotting. in vitro experiments in cultured human keratinocytes demonstrated anisomycin induced, p mapk dependent increased secretion of procaspase- and active caspase- . furthermore, anisomycin increased the mrna expression of il- through a p mapk dependent but caspase- independent mechanism, reaching a maximum level after hours of stimulation. finally, anisomycin caused a rapid ( hours) increase in the secretion of proil- and active il- . secretion of active il- was mediated through a p mapk/caspase- dependent mechanism, whereas secretion of proil- was mediated by a p mapk dependent but capsase- independent mechanism. these data demonstrate that the activity of caspase- is increased in psoriatic skin and that il- secretion is regulated by a p mapk/caspase- dependent mechanism, making caspase- a potential target in the treatment of psoriasis. prostaglandin e (pge ) regulates the stability of cyclooxygenase- (cox- ) mrna through adenylate/uridylate-rich elements (ares) in the untranslated region ( utr) by a positive autocrine/paracrine feed-forward loop. the principal objective of this study was to elucidate the molecular mechanisms involved in the pge dependent stabilization of cox- in human synovial fibroblasts (hsfs). transfection of well-known are binding proteins (aubps) demonstrated that tristetraprolin (ttp) potently destabilized a [luciferase-cox- utr] reporter fusion mrna ( ae . % decrease in luciferase activity vs. control). ttp protein levels in hsfs remained constant despite il- b-induced changes in ttp mrna levels, thus suggesting translational regulation of its expression. pge did not affect the transcription or translation of this gene in hsfs. western blot analysis of hsf ttp demonstrated the existence of a specific, covalent~ kda heterocomplex containing ttp (ttphcx). although ttphcxs exact composition and stoichiometry is yet to be defined, pge selectively regulated the amount of this heterocomplex in a time-dependent manner. furthermore, protein shuttling studies performed using real-time confocal microscopy revealed that pge can induce export of a small nuclear pool of ttp-gfp. finally, transfection of ttp into hsfs also influenced cox- gene transcription, thus enabling ttp to regulate cox- gene expression at both the transcriptional and post-transcriptional level. in conclusion, we have demonstrated that ttp is an rna binding protein capable of influencing cox- mrna stability and transcription and whose localization and interaction with other factors is regulated by pge . these data can provide important insight into deciphering the role of pge in fine-tuning physiological and pathophysiological gene regulation. ( ) ( ) chinese academy of sciences, shanghai, pr china ( ) ohio state university, usa mitogen-activated protein (map) kinases play a critical role in innate immune responses to microbial infection through eliciting the biosynthesis of proinflammatory cytokines. map phosphatases (mkp)- is an archetypical member of the dual-specificity phosphatase family that deactivates map kinases. induction of mkp- has been implicated in attenuating the lipopolysaccharide (lps) and peptidoglycan (pgn) responses, but how the expression of the mkp- is regulated is still not fully understood. here, we show that inhibition of p map kinase by specific inhibitor sb or rna interference (rnai) markedly reduced the expression of mkp- in lps or pgn-treated macrophages, which is correlated with prolonged activation of p and jnk. depletion of mapkap kinase (mk ), a downstream substrate of p , by rnai also inhibited the expression of mkp- . the mrna level of mkp- is not affected by inhibition of p , but the expression of mkp- is inhibited by treatment of cycloheximide. thus, p mapk plays a critical role in mediating expression of mkp- at a posttranscriptional level. furthermore, inhibition of p by sb prevented the expression of mkp- in lpstolerized macrophages, restored the activation of map kinases after lps restimulation. these results indicate a critical role of p -mk -dependent induction of mkp- in innate immune responses. the i-kb kinase (ikk) complex regulates the activation of nf-kb a key transcription factor in inflammation and immunity. whilst ikka activity is necessary for proinflammatory and anti-apoptotic gene expression, ikka has distinct roles in lymphorganogenesis and b cell maturation. here we describe a role for ikka in cell mediated immunity (cmi). paw inflammation in methylated bsa-induced cmi was significantly reduced in transgenic mice expressing a mutant ikka protein that cannot be activated (ikka aa/aa ) compared to wild-type (wt). antigen-induced il- and ifng production by ikka aa/aa splenocytes and ikka aa/aa t cell:dc cocultures were also significantly reduced ex vivo. this could be normalised by using wt t cell: ikka aa/aa dendritic cell (dc) but not ikka aa/aa t cell:wt dc combinations. this suggests that reduced cmi in ikka aa/ aa mice is due to a defect in ikka aa/aa t cells not dcs. this is not due to a requirement of ikka in tcrmediated activation of t cells, since anti-cd /cd mediated activation of ikka aa/aa t cells was unaltered. however, lps-induced production of the important th cytokine il- is impaired in ikka aa/aa dcs. we are currently addressing the hypothesis that ikka activity may be required for the generation and maintenance of antigen-specific t cells in vivo. recently we described a role for ikkµ in the negative regulation of innate immunity and acute inflammation, which is in contrast to its role shown here in promoting adaptive immunity and antigen-driven inflammation. ikka may represent an alternative target for the treatment of autoimmune disease which would not compromise host defence. as a latent transcription factor, nf-kb translocates from cytoplasm into nucleus upon stimulations and mediates expression of genes important in immunity, inflammation and development. although extensive studies have been done regarding how nf-kb is triggered into nucleus, little is known about how it is regulated inside nucleus. by twohybrid approach, we identify a prefolding-like protein snip that is expressed predominantly and interacts specifically with nf-kb inside nucleus. we show that rnai knockdown of snip leads to impaired nucleus activity of nf-kb and dramatically attenuates expression of nf-kb dependent genes. this interference also sensitizes cells to apoptosis by tnf-a. furthermore, snip forms a dynamic complex with nf-kb and is recruited to the nf-kb enhancesome upon stimulation. interestingly, snip protein level correlates with constitutive nf-kb activity in human prostate cancer cell lines. the presence of nf-kb within nucleus of stimulated or constitutive active cells is significantly diminished without endogenous snip. our results reveal that snip is an integral component of nf-kb enhancesome and essential for its stability in nucleus, which uncovers a new mechanism of nf-kb regulation. bone remodeling is a tightly regulated process that couples resorption of old bone by osteoclasts and the deposition of new bone by osteoblasts. an imbalance between bone formation and bone resorption can result in various metabolic bone diseases, such as rheumatoid arthritis and osteoporosis. osteoclasts are terminally differentiated cells that arise from a haematopoietic stem cell lineage, which also gives rise to monocytes and macrophages. osteoclast differentiation and regulation of this process to maintain bone homeostasis are central to the understanding of the pathogenesis and treatment of bone diseases, such as osteoporosis. in vitro, osteoclast formation from bone marrow macrophages is induced by rankl (receptor activator of nf-kappa b ligand) in the presence of m-csf (macrophage colony stimulating factor). osteoclastogenesis is markedly enhanced in bone marrow macrophages from ifnar -/-and ifnar -/-mice and results in increased number of multinucleated cells positive for osteoclast marker, trap (tartrate-resistant acid phosphatase). consequently, the mutant mice develop osteoporotic phenotype, characterised by reduced bone density. these findings suggest that the ifn alpha/beta system is critical for the negative feedback regulation of osteoclastogenesis and that rankl signaling is essential for the induction of osteoclast differentiation. atp acting on p x receptors in macrophage is one of the main physiological signals that lead to the processing and release of the pro-inflammatory cytokine, interleukin- beta (il- b), their activation also leads to rapid opening of a membrane pore permeable to dyes such as ethidium. here we identify pannexin- , a recently described mammalian protein that functions as an hemichannel when ectopically expressed, as this dye-uptake pathway and show that signalling through pannexin- is required for processing of caspase- and release of mature il- b induced by p x receptor activation. furthermore, maitotoxin and nigericin, two agents considered to evoke il- b release via the same mechanism were studied. maitotoxin evoked dye uptake whose kinetics were similar to a slow pannexin- -independent phase induced by p x receptor activation, and this was unaltered by pannexin- inhibition.nigericin did not induce dye uptake.inhibition of pannexin- blocked caspase- and il- b processing and release in response to this two stimuli.thus, while pannexin- is required for il- b release in response to maitotoxin, nigericin and atp, a mechanism distinct from pannexin- hemichannel activation must underlie the former two processes. introduction: saa is a classic acute-phase protein upregulated during inflammatory response. saa is active on leukocytes and modulates inflammation and immunity through the induction of cytokines, including the chemokine il- . here we verify the effect of saa on the mrna expression and release of mip- alpha, a chemokyne involved in the recruitment of dendritic cells. methods: peripheral blood mononuclear cells (pbmc) isolated from peripheral blood by density gradient were cultured in rpmi medium in the presence of saa. mip- alphaconcentration was determinated in the supernatant of cell cultures by elisa. mrnawas analyzed bythe ribonuclease protection assay (rpa). results: pbmc stimulated with saa ( ug/ml) induced the expression of mip- alpha mrna at , and hours. mip- alpha protein was found in the suppernatant of and hours cultures (p< , ) and the addition of sb (p inhibitor) and pd (erk / inhibitor) completely abolished the release of mip- alpha. conclusions: saa is an inducer of mip- alpha expression in pbmc and p and erk / are important pathway signaling to this effect. saa is one of the factors responsible by the recruitment of dendritic cells. the p pathway is activated in numerous inflammatory conditions, including ra, ibd asthma, acute coronary syndrome, and copd, and its activation helps drive the production of inflammatory mediators. inhibitors of p decrease mediator production and therefore can produce profound anti-inflammatory effects. arry- is a potent inhibitor of p enzyme (ic < nm) with a novel pharmacophore and physiochemical properties distinct from those of other p inhibitors, being very water soluble. it is extremely potent in human whole blood, blocking lps-stimulated tnf production with an ic < nm.in animal models of rheumatoid arthritis (cia and aia) the compound significantly normalized histologic endpoints, such as inflammation, bone resorption and cartilage damage (ed ~ mg/kg). a phase i single ascending dose clinical study was run in healthy volunteers. after an oral dose of , , , or mg), blood was drawn at various times, stimulated ex vivo with lps, and analyzed for cytokines and inflammatory mediatorsfj arry- was well-tolerated and drug exposure was proportional to dose. in ex vivo samples, there was both a time-and concentrationdependent inhibition of il , pge and tnffz with > % inhibition observed at the mg dose level. the plasma concentrations of drug peaked at~ ng/ml at the mg dose and cytokine inhibition was sustained for > hours, showing that low doses of arry- produced profound effects on clinical biomarkers. further evaluation of arry- in patients with inflammatory diseases is planned. introduction: we demonstrated that in vivo chronicle blockage of nos (l-name, mg/kg; oral route; days) impairs leukocyte-endothelial interactions and neutrophils migration into inflammatory focus. these effects may be depending, at least in part, on decreased expression of l-selectin on leukocytes and pecam- on endothelium. aimed to clarify the mechanisms involved on these inhibitory effects, we now investigated the role of l-name treatment on secretion of tnf and il- b; by circulating leukocytes and migrated peritoneal neutrophils. methods: male wistar rats were treated with l-name ( mg/kg; oral route; days) or sterile saline (control). circulating leukocytes were isolated from blood collected from abdominal aorta and migrated neutrophils were obtained hours after i.p. injection of oyster glycogen ( %; ml). no (griess reaction) and cytokines (elisa) were quantified in supernatants of x cultured cells before and hours after lps stimulation ( m;g/ml). results: levels of no, tnf and il- b; were reduced in circulating leukocytes from l-name-treated rats in both basal and lps stimulated conditions. on the other hand, only secretion of il- b; was impaired by migrated neutrophils. conclusions: results show that in vivo l-name treatment, which partially reduces no production, decreases the secretion of pro-inflammatory cytokines by circulating leukocytes. however, the same pattern of inhibition is not detected if neutrophils are in vivo primed. objectives: to investigate the ability and mechanism of ifn-g to suppress interleukin- (il- )-induced mmp- expression in articular chondrocytes. methods: human chondrocytes were treated with ifn-g or il- beta alone or in combination. mmp- mrna was analyzed by rt-pcr. mmp- protein, phospho-stat and p / mapk levels were measured by western blotting. mmp- promoter-luciferase, cmv-cbp/p plasmids and stat sirna were transfected by calcium phosphate method. ap- activity was monitored by elisa. stat -cbp/p interaction was studied by immunoprecipitation. results: ifn-gpotently suppressed il- -induced expression of mmp- and promoter activity. blockade with neutralizing ifn-gr antibody revealed that mmp- inhibition by ifn-¼ was mediated by the ifn-¼ receptor. ifn-beta-stimulated activation of stat was directly correlated with mmp- suppression. knockdown of stat gene by specific sirna or its inhibition with fludarabine partially restored the il- induction of mmp- expression and promoter activity. ifn-g did not alter activator protein (ap- ) binding ability but promoted physical interaction of stat and cbp/p co-activator. p overexpression reversed ifn-g inhibition of endogenous mmp- mrna expression and exogenous mmp- promoter activity. conclusions: ifn-g through its receptor activates stat , which binds with cbp/p co-activator, sequesters it from the cell system and thus inhibits transcriptional induction of mmp- gene in chondrocytes. ifn-g and its signaling pathways could be targeted therapeutically for ( ), p asmawidjaja ( ), r hendriks( ), erik lubberts ( ) ( ) erasmus medical center, department of rheumatology, rotterdam, the netherlands ( ) erasmus medical center, department of immunology, rotterdam, the netherlands the objective of this study was to identify the role of il- in th polarization in the prone autoimmune dba- mice with and without collagen-induced arthritis and to evaluate th specific cytokine and transcription factor expression. il- induced th cells in vitro from spleen cells of naïve and collagen-type ii (cii) immunized dba- mice. the percentage of th cells is markedly higher in cii-immunized versus naïve dba- mice. adding il- to tgf-beta/il- stimulated cd + t cells did not significantly increase the percentage of th cells. tgfbeta/il- in contrast to il- induced a relatively high percentage of il- +/ifn-gamma-cells and low il- -ifn-gamma+ cells. tgf-beta/il- did not increase il- receptor expression, which may explain why adding il- directly or two days after tgf-beta/il- did not result in an increase in the percentage of th cells. elevated expression of il- a and il- f as well as the th specific transcription factor rorgammat was found under il- as well as tgfbeta/il- conditions. interestingly, il- but not tgf-beta/il- is critical in the th cytokine il- expression in t cells from ciiimmunized dba- mice. these data show that il- was more pronounced in inducing il- +/ifn-gamma-(th ) cells under cii-immunized conditions. furthermore, il- did not markedly increase the percentage of th cells induced by tgf-beta/il- . however, il- is critical for the induction of il- expression, suggesting a unique role for il- in the induction of specific th cytokines ebi was initially discovered as a transcriptionally activated gene in epstein-barr virus-infected human b lymphocytes, and similar to p of il- . ebi protein has been shown to form heterodimers with p . p /ebi termed il- , can influence the function of multiple t cell subsets, including naive, effector, regulatory and memory t cells. however, previous studies showed that the overlapped expression of ebi and p is very limited. these data lead to the hypothesis that ebi may play a role independently from its association with p . thus, to define the function of ebi , we generated ebi transgenic (tg) mice expressing in multiple tissues. ebi tg mice exhibited no histologic abnormalities in various organs and normal numbers of naive and memory cd +, cd + t cells, b cells, nk cells and nkt cells. cd +t cells isolated from spleens of ebi tg mice, however, produced less ifn-g than cells from wt (wild type) control mice after in vitro stimulation with anti-cd and anti-cd antibodies. in vivo studies, delayed-type hypersensitivity (dth) and contact hypersensitivity (chs) responses were significantly reduced in ebi tg compared with wt mice. moreover, the chs responses in ebi tg mice were recovered with anti-ebi polyclonal antibody. notably, chs reaction in wt mice was increased by anti-ebi antibody. in contrast, anti-p antibody suppressed chs responses in wt mice. these data suggest that ebi acts in different from il- , and reduces th responses. ( ), o thaunat( ), x houard ( ), o meilhac ( ), g caligiuri( ), a nicoletti ( ) ( ) inserm u and university denis diderot-paris , chu xavier bichat, paris, france ( ) inserm umr s , universitØ pierre et marie curie-paris , centre de recherche des cordeliers, paris, france arteries are composed of three concentric tissue layers which exhibit different structures and properties. because arterial injury is generally initiated at the interface with circulating blood, most studies performed to unravel the mechanisms involved in injury-induced arterial responses have been focused on the innermost layer (intima). in contrast, the role of the outermost tunica, the adventitia, has attracted relatively little attention and remains elusive. in the present review, we focus on involvement of the adventitia in the response to various types of arterial injury leading to vascular remodeling. several lines of evidence show that the initial insult and the early intimal response lead to the genesis of (neo-) mediators that are centrifugally conveyed by mass transport towards the adventitia. these mediators trigger local adventitial responses including angiogenesis, immuno-inflammation, and fibrosis. we propose that these three processes sequentially interact and that their net balance participates in producing each specific pathological condition. hence, an adventitial adaptive immune response predominates in chronic rejection. inflammatory phagocytic cell recruitment and initiation of a shift from innate to adaptive immunity characterize the adventitial response to proteolysis products in abdominal aortic aneurysm. centripetal adventitial sprouting of neovessels, leading to intraplaque hemorrhages, predominates in atherothrombosis. adventitial fibrosis mediated by low inflammation characterizes the response to mechanical stress and is responsible for constrictive remodeling of arterial segments and initiating interstitial fibrosis in perivascular tissues. these adventitial events thus impact not only on the vessel wall biology but also on the surrounding tissue. atherosclerosis has many of the characteristics of an inflammatory disease, and thus would classically involve endothelial cox-derived prostaglandins such as pge and prostacyclin acting on ep and ip receptors, respectively.activation of vascular ip receptors is especially important in limiting the atherogenic properties of thromboxane a acting on tp receptors.more recently, expression of ghrelin receptors has been shown to be increased in atherosclerotic plaques, and ghrelin itself has anti-inflammatory properties in addition to its classical role as a hunger hormone.as well as the complex crosstalk between g-protein-coupled receptors (gpcrs), recent evidence indicates that many gpcrs exist constitutively as homodimeric complexes, and that the formation of heterodimers not only influences the classical cell signalling pathways used by these receptors, but also affects their subcellular distribution.we have found that ep -i, tp and ghrelin receptors readily form homodimers, but that co-transfection of hek cells with these receptors results in the formation of heterodimers with unpredictable effects on receptor distribution and cell signalling properties.since inflammatory conditions are thought to change the relative expression levels of gpcrs in the vasculature, and since varying the expression levels of gpcrs will affect their ability to form heterodimers, then one might predict that gpcr heterodimerization would indeed influence the reactivity of vascular tissue during inflammation. [this work was fully supported by grants from the research grants council of the hong kong special administrative region (cuhk / m and vascular inflammation leads to formation of leukotrienes through the -lipoxygenase pathway of arachidonic acid metabolism. leukotriene forming enzymes are expressed within atherosclerotic lesions and locally produced leukotrienes exert pro-inflammatory actions within the vascular wall by means of cell surface receptors of the blt and cyslt receptor subtypes. recent mechanistic studies have supported the notion of a major role of leukotriene signaling in atherosclerosis. leukotriene b (ltb ) is for example one of the most potent chemotactic mediators formed within the atherosclerotic lesion, inducing migration of a number different cell-types of both hematopoietic and non-hematopoietic origin. initially identified on neutrophils, blt receptor activation is involved in monocyte chemotaxis and adhesion as well as in vascular smooth muscle cell migration and proliferation, providing examples of potential mechanisms in ltb -induced atherogenesis. targeting ltb -induced activation of vascular smooth muscle cells has beneficial effects in models of intimal hyperplasia and restenosis after vascular injury. furthermore, blt receptor expression has been demonstrated on t-cells, suggesting ltb as a potential link between innate and adaptive immunological reactions. taken together, the local formation of leukotrienes within the atherosclerotic lesion and the potent pro-inflammatory effects of leukotriene receptor activation in target cells of atherosclerosis provide a rationale for a role leukotrienes in this disease. further experimental and clinical studies are however needed to develop therapeutic strategies of treatments targeting leukotriene signaling in atherosclerosis. in normal physiological conditions, the prostanoid (prostaglandin (pg) and thromboxane (tx)) synthesis is dependent on the constitutive isoform of cyclooxygenase (cox- ). this synthesis and release happen few minutes after cell or tissue stimulation. in vascular preparations submitted to pro-inflammatory conditions for some hours, the inducible isoform of cyclooxygenase (cox- ) and other prostanoid synthases can be observed. as an illustration of the previous experimental results, there is an increased presence of cox- and the inducible enzyme responsible for pge synthesis (mpges- ) detected by immunocytochemistry in the carotid atherosclerotic plaque with strong inflammation. in vascular cells in culture, pgi is the major biological active prostanoid produced in the normal physiological conditions. however, when cox- is induced, pgi and pge are equally produced. the role of cox- , cox- and mpges- activities is also dependent on the expression of the various prostanoid receptors in the considered vessel. there is increasing evidence for the presence and a role of the ep receptor subtypes (ep , ep , ep or ep ) preferentially stimulated by pge in the vascular wall. for these reasons, we have characterized the receptors activated by pge in human mammary arteries. in these vessels incubated with a pro-inflammatory cytokine (interleukin- â) and lipopolysaccharides a reduced contractility to norepinephrine has been observed. this effect is abolished by treatment of the vascular preparations with a selective cox- inhibitor, suggesting that prostanoid synthesis and/or prostanoid receptors could be involved. rheumatoid arthritis is a syndrome which probably consists of a number of diseases for which the risk factors differ. two major processes were identified: the generation of the anti-citrullinated antigens immune response (highly sepcific for ra).we show that the different hla class ii alleles contribute to the development of anti-ccp-positive and anti-ccp negative ra.the se alleles do not independently contribute to the progression to ra, but rather contributed to the development of anti-ccp antibodies. next we determined the effect of smoking and observed that smoking only conferred risk to contract ra in the ccp-positive group and not in the anti-ccp negative group. for the risk factor ptpn (a gene that regulates treshold of lumphocyte activation) the allele c t only contributed to ccp-positive ra. in contrast to hla two other risk factors were found to be associated with both ccp-positive and ccp-negative ra. the risk factor in the fcrl-gene as has been identified in the japanese population was also tested in dutch ra cases and unrelated dutch controls. carrier analysis of the snp (rs ) revealed association of cc genotype with higher risk of developing ra as compared to tt & tc carriers (p = . and or = . ). in a meta-analysis of all studies comparing individuals, the or for the cc genotype to develop ra was . and the p-value < . . in conclusion, different steps in pathogenesis of the syndrome ra can be delineated this talk will focus on recent advances in understanding primary genetic factors predisposing to inflammatory bowel disease (crohns disease and ulcerative colitis). proven genes containing genetic variants predisposing to crohns disease include ibd / q , card /nod and il r. data is suggestive but not yet as convincing for many other genes. a common theme is of genetic variants influencing early innate immune responses to intestinal bacterial components, and subsequent adaptive immune responses, leading to intestinal inflammation. only for card /nod is there (partial) understanding of how genetic variation influences biological function to cause chronic disease. some mouse models (gene targeted) of card appear to show opposite effects to other models and human systems. in humans, card mutations impair responses to bacterial components (muramyl dipeptide) mainly at low dose sensing. it is likely this receptor system normally maintains intestinal crypt sterility and protection from invasive infection. pathogen-recognition receptors (prrs) are key components of immune systems and are involved in innate effector mechanisms and activation of adaptive immunity. since their discovery in vertebrates, toll-like receptors (tlrs) have become the focus of extensive research that has revealed their significance in the regulation of many facets of our immune system. recently a new family of intracellular prrs, the nod-like receptors (nlrs), which include both nods and nalps have been described. mutations within the nalp /cryopyrin/ cias gene are responsible for three autoinflammatory disorders: muckle-wells syndrome, familial cold autoinflammatory syndrome, and cinca/nomid. the nalp protein associates with asc and caspase- (thereby forming a molecular machine termed inflammasome that displays high proil- beta-processing activity. macrophages from muckle-wells patients spontaneously secrete active il- beta. increased inflammasome activity is therefore likely to be the molecular basis of the symptoms associated with nalp -dependent autoinflammatory disorders. here we will emphasis on the ability of this protein complex to promote the development of autoinflammatory syndromes. allergic inflammation (ai) is a complex phenomenon initiated by allergen binding to ige sensitized mast cells and consequent mast cell activation. this causes the symptoms of the early phase of ai and the onset of the late phase characterized by the penetration in the inflamed tissue of inflammatory cells, notably the eosinophils. their subsequent activation is believed to cause tissue damage and to be the main responsible for the tissue remodeling, especially when the ai becomes a chronic process. we defined a novel functional unit that we termed the allergic synapse formed by mast celleosinophil couples. in the synapse these two old cellular players of ai have a cross talk via soluble mediators and receptor-ligand interactions. this results in mast celleosinophil functional synergism that consequently amplifies and prolongs the inflammatory response. in addition, mast cells and eosinophils are influenced and influence as in a sort of allergic niche the surrounding structural cells, i.e. fibroblasts and endothelial cells. we propose to view the allergic synapse/niche as a specialized effector unit worthy to be blocked for the treatment/prevention of allergic inflammation. ( ) ( ) erasmus mc, rotterdam, the netherlands ( ) department of immunology weizmann institute of science, rehovot, israel allergic asthma is one of the most common chronic diseases in western society, characterized by reversible airway obstruction, mucus hypersecretion and infiltration of the airway wall with th cells, eosinophils, and mast cells. if we are to devise new therapies for this disease, it is important to elucidate how th cells are activated and respond to intrinsically harmless allergens. dendritic cells (dcs) are the most important antigen presenting cells in the lung and are mainly recognized for their exceptional potential to generate a primary immune response and sensitization to aeroallergens. we have shown that intratracheal injection of ovalbumin (ova) pulsed dcs induces sensitization leading to eosinophilic airway inflammation upon ova aerosol challenge. we investigated the role of dcs in the secondary immune response in a murine asthma model. ova aerosol challenge in ova-dc sensitized mice, induced an almost fold increase in the number of airway dcs as well as an increase in eosinophils and t cells. to investigate the functional importance of dcs for the induction and maintenance of airway inflammation in response to allergen challenge, we conditionally knocked-out endogenous dcs in sensitised cd c-diphtheria toxin (dt) receptor (cd cdtr) transgenic mice by airway administration of dt h before ova aerosol ( x) challenge or during an ongoing inflammation (depletion after x ova aerosols continued with additional ova aerosols). numbers of balf eosinophils, th cytokine production by mediastinal lymph nodes and peribronchial and perivascular inflammatory infiltrates were dramatically decreased, illustrating an essential role for airway dcs during secondary challenge. karolinska institute, stockholm, sweden nk cells are innate lymphocytes with potent immunoregulatory functions. they are potent producers of several cytokines and chemokines, and also respond to similar molecules in the body and at inflammatory sites. even though traditionally best characterized for their role in anti-viral and anti-tumor immunity, they influence several other types of immune responses. for example, they are involved in, and affect, acute as well as chronic inflammatory responses. in the present talk, a general overview on our current knowledge of nk cell biology will be provided, with a special emphasis on the role of these cells in allergic inflammation. basophils are major effector cells in allergic reactions due to their ability to release substantial quantities of histamine and eicosanoids following activation of high affinity ige receptors (fcri) with allergens. although these attributes are shared with their tissuefixed mast cell compatriots, basophils are unique in their ability to also rapidly elaborate th -type cytokines (e.g. il- and il- ), subsequently supporting ige synthesis and underlying atopy. importantly, these mediators are additionally secreted following primary exposure to certain parasites (e.g. s. mansoni) and immunoglobulin superantigens, suggesting a role for basophils in innate immunity and in assisting developing th -type adaptive immune responses. while we are beginning to understand the potential physiological functions of these cells regarding host defence, blocking their activity with respect to treating symptoms of allergic disease has remained an enigma. recent advances, however, have shed light upon the major intracellular signal transduction processes involved in fcri activation and may lead to novel therapeutic strategies for inhibiting mediator secretions. an important discovery in this regard is the phosphatase ship, which downregulates pi -kinase signalling in both basophils and mast cells. recent data shows that ship expressions in basophils are reduced from donors with active allergic disease but that these levels may be increased, and the activity of basophils subsequently inhibited, by targeting receptors associated with ship recruitment (cd r, cd r). identifying the natural ligands for these inhibitory receptors may therefore pave the way for new therapies for the treatment of allergic inflammation. mitogenesis and proliferation of vsmc play an important role in atherogenesis. pro-inflammatory secretory phospholipases a (spla ) hydrolyse glycerophospholipids of hdl and ldl and release pro-inflammatory agents, lyso-lipids, oxidized and non-oxidized fatty acids and isoprostanes.spla s lipolysis products localize in vascular wall in vicinity of vsmc.we have tested the impact of spla , hdl and ldl and of their hydrolysis products on mitogenesis and pge and ltb release from vsmc.mitogenesis was significantly enhanced by native hdl, and ldl, and by group v spla . spla hydrolysis of hdl and ldl enhanced mitogenic activity in order v>x>iia.the release of pge from vsmc was enhanced by group x spla s but not iia or v.the greatest effect was seen for hdl hydrolysed by group v and x spla .native ldl and its spla hydrolysis products enhanced the release of pge in order x>v>iia.the release of ltb from vsmc was markedly increased by native ldl and hdl, and hydrolysis products of group v and x, but not iia spla .migration of vsmc was significantly enhanced by spla iia and inhibited by hdl.this study demonstrates a complex interaction of hdl and ldl with pro-inflammatory spla s, which affects mitogenesis, eicosanoid release and migration of vsmc.study of biocompatible spla blockers in the therapy of atherosclerosis is indicated. contact information: professor waldemar pruzanski, university of toronto, department of medicine, toronto, ontario, canada e-mail: drwpruzanski@bellnet.ca ( ) ( ) ipmc-cnrs umr , valbonne, france ( ) university of washington, seattle, usa ( ) inserm umrs , paris, france ( ) university of naples, italy the superfamily of phospholipase a comprises at least intracellular enzymes and up to secreted pla s (spla s). elucidating the biological roles of each pla member is currently the most challenging issue in the pla field. the different spla s are not isoforms and are likely to function either as enzymes producing key lipid mediators (eicosanoids and lysophospholipids) or as ligands that bind to specific soluble or membrane-bound proteins (like cytokines). increasing evidence suggests that spla s iia, iii, v, and x are involved in inflammatory diseases including atherosclerosis. among spla s, the human group x (hgx) enzyme has the highest enzymatic activity towards phosphatidylcholine, the major phospholipid of cellular membranes and low density lipoproteins (ldl). on human alveolar macrophages, hgx spla can trigger secretion of tnf alpha, il and il in a non-enzymatic manner. on colorectal cancer cells, hgx spla stimulates cell proliferation, produces potent eicosanoids including pge , and activates the transcription of key genes involved in inflammation and cancer. the enzyme can also hydrolyze pc and platelet-activating factor (paf) of ldl particles very efficiently. finally, hgx spla is present in human atherosclerotic lesions and converts ldl into a proinflammatory particle that induces macrophage foam cell formation, as well as map kinase activation, arachidonic acid release, and expression of adhesion molecules in huvec cells. some other key molecular features of spla s including hgx will be presented. we have reported preferential release of polyunsaturated fatty acids during hydrolysis of lipoprotein phosphatidylcholine (ptdcho) by spla s, but the mechanism of this selectivity is not known. since both sphingomyelin (sm) and lysoptdcho inhibit the activity while increasing fatty acid specificity of other pla s, we have examined fatty acid release by spla siia, v and x in relation to relative increases in proportion of endogenous sm and lysoptdcho during lipoprotein digestion. the analyses were performed by normal phase liquid chromatography with on-line electrospray mass spectrometry (lc/esi-ms) and lc/collision induced dissociation (cid)/esi-ms using conventional preparations ofldl and hdl. the highest preference for arachidonate release from ldl by group x spla was observed when the residual sm/ pdcho molar ratio had reached . compared to a starting ratio of . .group v spla showed preferential release of linoleate at residual sm/ptdcho molar ratio . , while at intermediate ratios, both arachidonate and linoleate were released at more comparable ratios. the relative increases in lysoptdcho and sm during the digestion with spla iia were much more limited, and a preferential hydrolysis of polyunsaturated fatty acids was not observed. these results suggest a lipid phase separation as a likely basis for a differential hydrolysis of molecular species of ptdcho. the residual sm/ptdcho ratios reached during group v and x spla digestion are similar to those observed for lesional ldl, which promote release of ceramides by smase leading to ldl aggregation. the above findings support a potential role of sphingomyelins in atherogenesis. although sphingomyelin (sm) is one of the most abundant phospholipids in lipoproteins and cell membranes, its physiological significance is unclear. because of its localization in the outer surface of the cells, and its structural similarity to phosphatidylcholine (pc),we proposed that it competitively inhibits phospholipolysis of cell membranes by external phospholipases (pla). we showed that sm inhibits several lipolytic enzymes including secretory pla iia, v, and x, and hepatic and endothelial lipases, all of which hydrolyze pc. treatment of sm in the substrate with smase c not only relieved the inhibition but also activated the pla reaction further, suggesting that ceramide, the product of smase c, independently stimulates pla , possibly by disrupting the bilayer structure. smase d treatment, which produces ceramide phosphate, did not stimulate the spla . the fatty acid specificity of pla is significantly affected by sm. thus spla x exhibited enhanced specificity for the release of arachidonic acid ( : ) in presence of sm, due to a preferential inhibition of hydrolysis of other pc species. in contrast, sm inhibited the release of : by spla v. ceramide selectively stimulated the release of : by both enzymes. only the long chain ceramides (> carbons) were effective, while ceramide phosphate did not stimulate spla activity. sm-deficient cells released more : in response to spla -treatment than normal cells, and pretreatment of normal cells with smase c increased their susceptibility to spla attack. these studies show that sm and ceramide regulate the activity and specificity of pla, and consequently the inflammatory response. secretory phospholipase a (spla ) types iia, v, or x, have been associated with inflammatory diseases and tissue injury including atherosclerosis in humans and mice.given the link between spla and atherogenesis, a mouse model of atherosclerosis (apoe-/-) was used to study the effects of a- , an inhibitor of spla enzymes, on atherosclerosis and cholesterol levels over weeks of treatment. mice were fed with a high-fat, high cholesterol diet alone during the study ( % fat; . % cholesterol, . % casein) and were treated with vehicle or a- bid at mg/kg or mg/kg by oral gavage. total cholesterol was significantly decreased after one month of treatment and remained lower throughout the study.treatment with a- significantly reduced aortic atherosclerotic plaque formation in apoe-/-mice fed a high fat diet when compared to the untreated control by approximately %. in a different model that used angiotensin ii in conjunction with a high fat diet in a background of apoe-/-deficient mice for weeks, oral dosing of a- ( mg/kg bid) significantly reduced aortic atherosclerosis and aneurysm rate when compared to vehicle. these data suggest that a- is a potential novel therapeutic agent for the treatment of atherosclerosis. ( ), s doty( ), c antonescu ( ), c staniloae ( ) ( ) saint vincents hospital manhattan, new york, usa ( ) hospital for special surgery, new york, usa ( ) sloan-kettering institute for cancer research, new york, usa tnf-stimulated gene (tsg- ) is induced by tnf-a during inflammation and its secreted product tsg- glycoprotein is involved in immune-mediated inflammatory diseases and fertility. it regulates cox- and prostaglandin synthesis, and participates in extracellular matrix remodeling. considering the chronic inflammatory nature of atherosclerosis we hypothesized that tsg- is expressed in atherosclerotic plaques and investigated tsg- protein expression and cellular distribution on superficial femoral artery endarterectomy specimens from diabetic and non-diabetic patients with peripheral vascular disease. six histologically normal radial artery specimens were analyzed as control. paraffin embedded samples were studied by immunohistochemistry using a goat polyclonal anti-human-tsg- antibody. tsg- expression was consistently present in all atherectomy specimens but not in control specimens. a distinct, strong cytoplasmic staining pattern was uniformly detected in the endothelial lining of the intima, as well as in the neo-vessel proliferation of the plaque. cytoplasmic staining was also identified in the smooth muscle cell proliferation of the neo-intima. patchy tsg- expression was noted in the extracellular matrix. within the inflammatory plaques from diabetic patients, tsg- stained the foamy macrophages. tsg- expression was also confirmed and quantified by qrt-pcr that showed a significant up-regulation of tsg- gene (more that fold induction compared to housekeeping genes). our study identifies for the first time the preferential expression of tsg- in atherosclerotic lesions and characterizes its distribution within the cellular and matrix components of the plaque. tsg- is a novel inflammatory mediator of atherosclerosis and a potentially new marker of endothelial / smooth muscle cell activation. ( ), r krohn ( ), h lue ( ), jl gregory( ), a zernecke ( ), rr koenen ( ), t kooistra ( ), p ghezzi( ), r kleemann ( ), r bucala( ), mj hickey ( ), c weber ( ) ( ) university hospital of the rwth aachen, germany ( ) centre for inflammatory diseases, monash university, melbourne, australia mediators, which cannot be classified into chemokine subfamilies but share functional patterns, e.g. signaling through chemokine receptors, constitute a group termed chemokine-like function (clf)-chemokines. the pleiotropic cytokine macrophage migration inhibitory factor (mif) plays a critical role in inflammatory diseases and atherogenesis. the underlying molecular mechanisms are poorly understood, but, interestingly, mif displays structural features resembling chemokines. we have identified the chemokine receptor cxcr as a functional receptor for mif. mif triggered galphai/integrin-dependent arrest and chemotaxis of monocytes specifically through cxcr , inducing rapid integrin activation. mif directly bound to cxcr with high affinity (kd of . nm). monocyte arrest mediated by mif in inflamed or atherosclerotic arteries involved cxcr as well as cd , a recently identified membrane receptor moiety for mif. accordingly, cxcr and cd were found to occur in a receptor complex. in vivo, mif deficiency impaired monocyte adhesion to the aortic/arterial wall in atherosclerosis-prone mice, as evidenced by intravital microscopy. thus, mif displays chemokine-like functions by acting as a non-cognate ligand of cxcr , serving as a regulator of inflammatory and atherogenic recruitment. these data harbor an intriguing novel therapeutic prospect by targeting mif in atherosclerosis and add a new dimension to mif and chemokine receptor biology. ( ), r toes ( ), h van bockel( ), paul quax ( , ) ( ) tno bioscienses, leiden, the netherlands ( ) department of vascular surgery, leiden university medical center, the netherlands ( ) department of rheumatoly, leiden university medical center, the netherlands the immune system is thought to play a crucial role in regulating collateral circulation (arteriogenesis), a vital compensatory mechanism in patients with arterial obstructive disease. here, we studied the role of lymphocytes in a murine model for artiogenenesis after acutehind limb ischemia. arteriogenesis was impaired in c bl/ mice depleted for natural killer (nk)-cells by anti-nk . antibodies and in nk-cell-deficient transgenic mice. arteriogenesis was, however, unaffected in jµ knockout mice that lack nk . + natural killer t (nkt)cells, indicating that nk-cells, rather than nkt-cells are involved in arteriogenesis. furthermore, arteriogenesis was impaired in c bl/ mice depleted for cd + tlymphocytes by anti-cd antibodies, and in major histocompatibility complex (mhc)-class-ii-deficient mice that lack mature peripheral cd + t-lymphocytes. this impairment was even more profound in anti-nk . treated mhc-class-ii-deficient mice that lack both nkand cd + t-lymphocytes. finally, collateral growth was severely reduced in balb/c as compared with c bl/ mice, two strains with different bias in immune responsiveness. correspondingly, fewer cd -positive lymphocytes accumulated around collaterals in balb/c mice. these data show that both nk-cells and cd + t-cells play an important role in arteriogenesis. moreover, our data hold promise for the development of novel clinical interventions as promoting lymphocyte activation might represent a powerful method to treat ischemic disease. post-interventional vascular remodeling in venous bypass grafts, seen as intimal hyperplasia (ih) and accelerated atherosclerosis, often causing graft failure. inflammation is an important trigger for these processe. complement is an important part of the immune system and participates in regulating inflammation. although involved in several other inflammatory diseases, the role of the complement cascade in vein graft remodeling is unknown. the involvement of the complement system in vein graft disease was studied here using a model in which caval veins are grafted in carotids arteries of hypercholesterolemic apoe leiden mice. in these veins ih and accelerated atherosclerotic lesions develop within days, consisting mainly of foamcells and smc. to study the functional role of complement in vein graft remodeling, cobra venom factor (cvf: u daily) was used to deplete complement starting one day prior to vein graft surgery. cvf-treatment reduced vein graft thickening by % (p= . ), when compared to saline treated controls (n= ).to confirm that the reduction by cvf was due to hampered complement function and not a direct effect of cvf, complement activation was blocked using crry-ig (inhibiting c convertases). crry-ig ( mg every other day) led to % decrease in vein graft thickening (p= . ) compared to controls receiving non-relevant control igg. these data prove that complement activation plays a major in intimal hyperplasia and accelerated atherosclerosis in vein grafts. ( ), m-c koutsing tine( ), p borgeat( ), h ong ( ), sylvie marleau ( ) ( ) universite de montreal, quebec, canada ( ) centre de recherche en rhumatologie et immunologie, canada we have previously shown that ep , a growth hormone-releasing peptide (ghrp) analogue binding selectively to the scavenger receptor cd , elicits a striking reduction in atherosclerosis development in apolipoprotein-deficient (apoe-/-), a condition associated with increased circulating numbers of primed/activated leukocytes. we investigated the effect of ghrp analogues on i/r-elicited remote lung injury in week-old apoe-/-mice fed a high fat high cholesterol (hfhc) diet from weeks of age. at weeks old, mice were treated daily with a s.c. injection of ep ( mg/kg) for days and were then subjected to unilateral hindlimb ischemia (by rubber band application) for minutes, followed by minutes reperfusion. our results show that ep significantly reduced leukocyte accumulation by % in the lungs, from . (ae . ) in vehicle-treated mice to . (ae . ) x leukocytes/g lung in ep -treated mice (n = - per group), as assessed by myeloperoxidase assay. this was associated with a % reduction of opsonized zymosan-elicited blood chemiluminescence. in contrast, neither blood chemiluminescence, nor leukocyte accumulation in the lungs were signicantly modulated in apoe-/-/cd -/-deficient mice, from . (ae . ) in vehicle-treated mice to . (ae . ) x leukocytes/g lung in ep -treated mice. we conclude that ep protects i/r-elicited circulating leukocyte priming/activation and remote lung injury, possibly through a cd -mediated pathway. glycogen synthase kinase beta (gsk- beta) is a serine/ threonine protein kinase that has recently emerged as a key regulatory switch in the modulation of the inflammatory response. dysregulation of gsk- beta has been implicated in the pathogenesis of several diseases including sepsis. here we investigate the effects of two chemically distinct inhibitors of gsk- beta, tdzd- and sb , on the circulatory failure and the organ injury and dysfunction associated with hemorrhagic shock. male wistar rats were subjected to hemorrhage (sufficient to lower mean arterial blood pressure to mmhg for min) and subsequently resuscitated with shed blood for h. hemorrhage and resuscitation resulted in an increase in serum levels of (a) creatinine and, hence, renal dysfunction, and (b) alanine aminotransferase and aspartate aminotransferase and, hence, hepatic injury. treatment of rats with either tdzd- ( mg/kg, i.v.) or sb ( . mg/kg, i.v.) min before resuscitation abolished the renal dysfunction and liver injury caused by hemorrhagic shock. the protection afforded by these compounds was confirmed by histological observations of lung, kidney and liver samples. in addition, tdzd- , but not sb , attenuated the increase caused by hemorrhage and resuscitation in plasma levels of the proinflammatory cytokine interleukin . neither of the gsk- beta inhibitors however affected the delayed fall in blood pressure caused by hemorrhagic shock. thus, we propose that inhibition of gsk- beta may represent a novel therapeutic approach in the therapy of hemorrhagic shock. ( ), y ito ( ), h yoshimura ( ), h inoue ( ), n kurouzu ( ), h hara ( ), y mastui ( ), h kitasato ( ), s narumiya( ), c yokoyama ( ), m majima ( ) ( ) kitasato university school of medicine, japan ( ) kyoto university school of medicine, japan ( ) tokyo medical and dental university, japan thromboxane (tx) a is a potent stimulator of platelet activation and aggregation and vascular constriction. we have reported cytokine-mediated release of sdf- from platelets and the recruitment of nonendothelial cxcr + vegfr + hematopoietic progenitors constitute the major determinant of revascularization. we hypothesized txa induces angiogenic response by stimulating sdf- and vegf which derived from platelet aggregation. to evaluate this hypothesis, we dissected the role of the txa in angiogenesis response using mouse hind limb ischemia. recovery from acute hind limb ischemia, as assessed in wild type mice (c bl/ wt) , prostaglandin i receptor (ip) knock out mice (ipko) and thromboxane (tx) a receptor (tp) knock out mice (tpko) by using lase doppler. blood recovery in tpko significantly delayed compared to wt and ipko. immunohistochemical studies revealed that the number of cd positive cells in the ischemic quadriceps were less stained in tpko compared to wt and ipko.plasma sdf- and vegf concentration were significantly reduced in tpko mice. we observed during in vivo fluorescence microscopic study that compared to tpko, ipko and wt significantly increased platelet attachment to the microvessels around ligated area. tpko translpanted wt bone marrow cells increased blood recovery compared to tpko transplanted tpko bone marrow cells. in addition, mice injected with txa synthase c-dna expressing fibroblast increased blood flow recovery compared to control mice. these results suggested that tp signaling rescues ischemic condition by inducing angiogenesis by secreting sdf- and vegf from platelet aggregation. administration of selective tp agonist may open new therapeutic strategy in regenerative cardiovascular medicine. during renal ischemia/reperfusion (i/r) injury, apoptosis has been reported as a very important contributor to the final kidney damage. the determinant role of cytoskeleton derangement in the development of apoptosis has been previously reported, but a clear description of the different mechanisms involved in this process has not been yet provided. the aim of the study is to know the role of peroxynitrite as inductor of cytoskeleton derangement and apoptosis during the inflammatory process associated to renal ischemia-reperfusion. based in a rat kidney i/r model, by experiments in which both the actin cytoskeleton and peroxynitrite generation were pharmacologically manipulated, results indicate that the peroxynitrite produced during the i/r derived oxidative stress state, is able to provoke cytoskeleton derangement and apoptosis development. thus, the control in the peroxynitrite generation during the i/r could be an effective tool for the improvement of cytoskeleton damage and reduction apoptosis incidence in the renal i/r injury. metabolomics, the global profiling of metabolites, may inform about the multiple interacting processes involved in inflammatory disease. using nmr spectroscopy we analysed metabolite fingerprints in serum from early arthritis, and at a site of inflammation, in the posterior segment of the eye. serum from patients with synovitis of "t months duration whose outcome was determined at clinical follow-up was used. vitreous samples were from patients undergoing vitrectomy for vitreoretinal disorders. one dimensional h nmr spectra were acquired. principal components analysis (pca) of the processed data was conducted along with a supervised classification. with the arthritis serum there was a clear relationship between each samples score in the pca analysis and the level of crp. supervised classification of the initial samples was able to predict outcome, whether rheumatoid arthritis, other chronic arthritis or self-limiting arthritis, with high specificity and sensitivity. a similar approach using the eye fluids was able to give a clear discrimination between two pathologically similar conditions lens-induced and chronic uveitis. in this case differences were not due to a straightforward relationship with inflammatory markers (il- , ccl ), which did not correlate with pca in these samples. similarly, certain molecules, such as lactate, were associated with ocular disease, but not rheumatoid arthritis. these results suggest that underlying inflammatory processes may differ in these conditions or may reflect predisposing metabolic patterns in individual patients. h-nmr-based metabolomics may provide a useful measure of outcome in inflammatory diseases and give novel insights into the pathological processes involved. ( ), am artoli( ), a sequeira( ), c saldanha ( ) ( ) instituto de medicina molecular,faculdade de medicina de lisboa, portugal ( ) cemat, instituto superior tØcnico, universidade de tØcnica de lisboa, portugal the recruitment of leukocytes from the blood stream and their subsequent adhesion to endothelial walls are essential stages to the immune response system during inflammation. the precise dynamic mechanisms by which molecular mediators facilitate leukocyte arrest are still unknown. in this study combined experimental results and computer simulations are used to investigate localized hydrodynamics of individual and collective behaviour of clusters of leukocytes. leukocyte-endothelial cell interactions in post-capillary venules of wistar rats cremaster muscle were monitorized by intravital microscopy. from these experiments the haemorheologic and haemodynamical measured parameters were used in time dependent three-dimensional computer simulations, using a mesoscopic lattice boltzmann solver for shear thinning fluids. the dynamics of leukocyte clusters under non-newtonian blood flow with shear thinning viscosity was computed and discussed. in this paper we present quantified distributions of velocity and shear stress on the surface of leukocytes and near vessel wall attachment points. we have also observed one region of maximum shear stress and two regions of minimum shear stress on the surface of leukocytes close to the endothelial wall. we verified that the collective hydrodynamic behaviour of the cluster of recruited leukocytes establishes a strong motive for additional leukocyte recruitment. it was found that the lattice boltzmann solver used here is fully adaptive to the measured experimental parameters. this study suggests that the influence of the leukocytes rolling on the increase of the endothelial wall shear stress may support the activation of more signalling mediators during inflammation. macrophages are essential for host defence, but when excessively and persistently activated, these cells contribute to the initiation and progression of inflammatory diseases such as rheumatoid arthritis. investigating the function of inflammatory genes in macrophages may identify novel therapeutic targets for inflammatory diseases. one family of transcripts that are highly expressed in activated macrophages are members of the schlafen (slfn) gene family; a recently identified family whose function is still unknown. this study examined the mrna expression of slfn in activated bone marrowderived macrophages in vitro, and in collagen-induced arthritis (cia) in vivo. real-time pcr expression analyses of bone marrow-derived macrophages stimulated with lipopolysaccharide (lps) over a time course, revealed differential expression of individual slfn family genes. in particular, slfn- , slfn- , and slfn- were maximally induced after hours. the maximal induction of slfn- and slfn- was observed after hours of lps treatment. individual members of the slfn family were also differentially expressed in cia, a model of rheumatoid arthritis. mrna levels of slfn- , slfn- , slfn- and slfn- were elevated in joints affected by cia. to investigate the role of slfn- , we have generated a transgenic mouse line, which over expresses slfn- specifically in cells of the mononuclear phagocyte system, by using a novel binary expression based on the c-fms promoter and gal . further characterisation of the slfn- over expressing mouse line will be used to assess the function of slfn- in macrophage biology and inflammation, and its potential as a therapeutic target. macrophages play an important role in resolving inflammation. it is known that the resolution of inflammation requires alternative activation of macrophages. but the precise events of phenotype switching in macrophages remain poorly understood. we show that lipocalin , lcn- , is able to provoke a switch in macrophage activation. in an in vitro co-culture model for renal epithelial cells and macrophages, we detected by sirna technique that the presence or absence of lcn- determines proliferation processes in damaged renal epithelial cells. the proliferative response was dependent on proinflammatory or anti-inflammatory environment. as lcn- is an acute phase protein synthesized during inflammation and unregulated in a number of pathological conditions, it may play an important role in survival and regeneration. we anticipate here that our results could be relevant for further research on the mechanisms of the phenotype switch induced by lcn- . ( ), y cao ( ), s adhikari ( ), m wallig ( ) ( ) national university of singapore, department of pharmacology, singapore ( ) university of illinois at urbana champaign, usa it has earlier been shown that the extent of apoptotic acinar cell death is inversely related to the severity of acute pancreatitis. our previous works have demonstrated that induction of pancreatic acinar cell apoptosis by crambene protects mice against acute pancreatitis. the current study aims to investigate the role of phagocytic receptors and the anti-inflammatory effect of phagocytosis in protecting mice against acute pancreatitis by crambene. acute pancreatitis was induced in the mouse by administering hourly injections of caerulein ( mg/kg) for , and hours respectively. neutralizing monoclonal anti-il- antibody ( . mg/kg) was administered either with or without crambene ( mg/kg) hours before the first caerulein injection. rt-pcr, western blotting and immunostaining were performed to detect cd expression. apoptosis in pancreatic sections was visualized by tunel. severity of acute pancreatitis was evaluated by estimation of serum amylase, pancreatic myeloperoxidase (mpo), water content, and morphological examination. pancreatic levels of inflammatory mediators were examined by elisa. the protective effect of crambene is mediated by reducing production of pro-inflammatory cytokines such as mcp- , tnf-a and il- â and up-regulating anti-inflammatory mediators like il- . phagocytotic clearance in mouse acute pancreatitis may be essentially through macrophage surface receptor cd .the anti-inflammatory mediator il- plays an important role in crambene-induced protective action against acute pancreatitis. the release of anti-inflammatory mediator il- is downstream of phagocytosis. these results show that induction of pancreatic acinar cell apoptosis by crambene treatment protects mice against acute pancreatitis via induction of anti-inflammatory pathways. ( , ) ( ) northern ontario school of medicine, thunder bay, ontario, canada ( ) lakehead university, canada integrin receptors and their ligands are involved in adhesion and internalization of several human pathogens, including pseudomonas aeruginosa. we have recently established that beta integrins in lung epithelial cells (lec) provide co-stimulatory signals regulating inflammatory responses (ulanova et al, am j physiol, , : l -l ). we hypothesized that lec integrins serve as receptors to recognize pathogen-associated molecules and mediate the innate immune response to p. aeruginosa. to determine molecular mechanisms of integrin involvement in innate immunity, we used an in vitro model of p. aeruginosa infection of a cells. to investigate interactions of bacteria with lec, p. aeruginosa strain pak was chromosomally labeled with a green fluorescent protein gene using a mini-tn delivery system.using several fluorescence-based detection systems, we established that the natural beta integrin ligand, fibronectin, mediates bacterial adhesion to lec.p. aeruginosa infection caused rapid transcriptional upregulation of alphav and beta integrin expression followed by the increased cell surface protein expression. the surface expression of integrin beta increased shortly following bacterial exposure without alterations of mrna expression, suggesting rapid protein redistribution within the cells. the data indicate that p. aeruginosa are capable to modulate integrin gene/protein expression in lec, potentially using fibronectin to alleviate bacterial binding to beta integrins. upon their engagement, integrin receptors can initiate intracellular signaling involved in innate immune and inflammatory responses to the pathogen. integrin receptors in lec may represent significant therapeutic targets in pulmonary infection caused by p. aeruginosa. the purine nucleoside adenosine has a major modulatory impact on the inflammatory and immune systems. neutrophils, which are generally the first cells to migrate toward lesions and initiate host defense functions, are particularly responsive to the action of adenosine. through activation of the a a receptor (a ar) present on neutrophils, adenosine inhibits phagocytosis, generation of cytotoxic oxygen species, and adhesion. also, recent work showed that adenosine can transform the profile of lipid mediators generated by neutrophils, inhibiting leukotriene b formation while potentiating that of prostaglandin e through the up-regulation of the cyclooxygenase (cox)- pathway. moreover, our laboratory determined that a ar engagement can dramatically modulate the generation and secretion of neutrophil-derived cytokines/chemokines, including tnf-and mips. in mice lacking the a ar, migrated neutrophils expressed less cox- than their wild type counterpart while displaying higher mrna levels of tnf-and mip- . mononuclear cells from a ar knock out mice, which eventually replace neutrophils into the air pouch, also displayed a more pro-inflammatory phenotype than those from wild-type animals. signal transduction experiments, aiming to delineate the intracellular events leading to the modulation of neutrophil functions following a ar engagement, implicate pivotal metabolic pathways such as intracellular cyclic amp, p and pi- k. together, these results indicate that adenosine may have a profound and multi-pronged influence on the phenotype of neutrophils and present this cell as being pivotal in mediating adenosines anti-inflammatory effects. the newest developments regarding adenosines effects on neutrophil functions will be presented.this work is supported by the canadian institutes of health research (cihr). human skin serves not only as a physical barrier against infection, but also as a "chemical barrier" by constitutively and inducibly producing antimicrobial proteins (amps). to identify human skin amps, we analysed extracts of healthy persons stratum corneum by reversed phase-hplc and purified a novel kda amp that showed sequence similarity to mouse hornerin. suggesting that it originates from the human ortholog, we cloned it. human hornerin encodes a amino acid protein that contains a s domain, an ef-hand calciumbinding domain, a spacer sequence and two types of tandem repeats, suggesting that it represents a novel member of the fused s protein family. strongest constitutive hornerin mrna expression was seen in differentiated keratinocyte cultures. to follow the hypothesis, that hornerin fragments represent amps, we recombinantly expressed three hornerin peptides, rhrnr (tandem repeat unit b), rhrnr (tandem repeat unit a) and rhrnr (c-terminus) and subsequently analysed their antimicrobial activity using the microdilution assay system. the rhrnr peptide, containing the sequence motif found in the purified natural hornerin fragment isolated from stratum corneum, exhibited antimicrobial activity at low micromolar concentrations against escherichia coli, pseudomonas aeruginosa and candida albicans. the other peptides were found to be not or nearly not antimicrobially active. our results suggest that hornerin may have a yet unknown protective function in healthy human skin as part of the "chemical barrier" with preformed amps, which are generated from parts of the tandem repeats of a hornerin precursor molecule by a yet unknown cleavage mechanism. ( ), n lu( ), r jonsson( ), d gullberg ( ) ( ) department of biomedicine, university of bergen, norway ( ) the gade institute, university of bergen, norway a ß is the latest addition to the integrin family of heterodimeric receptors for the extracellular matrix. previously, it has been shown that this collagen receptor takes part in processes such as cell migration and matrix contraction. in this study we investigated the factors that regulate mouse integrin a ß expression. specifically, we have analyzed the influence of cell passage, growth factors and the -d microenvironment. using sv immortalized as well as primary fibroblasts, we show that a ß integrin is up-regulated when these cells are cultured within stressed collagen type i lattices. however, a ß is downregulated when the collagen gels are made under relaxed conditions, allowing cells contract the lattice diameter. we also show here that a is upregulated by tgf-a on planar substrates. these findings suggest that mechanical tension and tgf-a are important factors in the regulation of a ß that need to be to taken into consideration when evaluating the role of a ß in wound healing and fibrotic disorders. ( ), n vergnolle ( ), p andrade-gordon ( ) ( ) inflammation research network, university of calgary, canada ( ) rw johnson pharmaceutical research institute, canada the objective of this study was to investigate the effects of par deficiency in various models of colonic inflammation in order to elucidate the role of endogenous par in the process of inflammation in the gut.colonic inflammation in c bl wildtype and par -/-mice was induced by treatment with . % dss (in drinking water) or tnbs ( mg or mg in ul of % ethanol, single intracolonic injection) or pre-sensitizing mice with % oxazolone (in olive oil) applied to the skin of the abdomen, and days later, a single intracolonic injection of % oxazolone (dissolved in % ethanol).intravital microscopy was performed, days (tnbs/dss) or days (oxazolone) after induction of colitis on the colonic venules to assess changes in leukocyte rolling, adhesion and vessel diameter.lastly, various parameters of inflammation were assessed following the intravital microscopy.par -/-mice showed significantly lower leukocyte adherence and vessel dilation compared to the wildtype mice in dss, and tnbs challenge. in all three challenges, mpo activity, macroscopic damage score and bowel thickness were significantly higher in wild-type mice, compared to par -/-.our evidences indicate that deficiency in par attenuates inflammatory responses in the experimental models of colitis associated with either th (tnbs/dss) or th (oxazolone) cytokine profile.therefore, par deficiency in the gut exerts antiinflammatory properties that are independent of th or th cytokine profile.the present study further highlights par as a potential target for inflammatory bowel diseases. ( ), n vergnolle ( ), p andrade-gordon ( ) ( ) inflammation research network, university of calgary, canada ( ) rw johnson pharmaceutical research institute, canada in a previous study, inflammatory responses induced by three different models of colitis (tnbs/dss/oxazolone) were significantly attenuated in mice deficient for par (par -/-). among the inflammatory parameters observed, infiltration of granulocytes to the colon was consistently reduced by par deficiency. aim of this study was to assess the effects of par deficiency (via par -/-mice) on the recruitment of leukocyte in colonic venules. in anaesthetized animals, leukocyte rolling/ adherence and vasodilation were induced, by topical administration of fmlp ( mm) or paf ( nm) or by intraperitoneal injection of tnf-a; ( . mg -given hours before the intravital microscopy). using intravital microscopy, we evaluated the ability of various leukocyte stimuli to induce leukocyte trafficking and vasodilation in colonic venules of par -/-versus par +/+ mice. fmlp and paf as well as tnf-a; induced significant vasodilation and an increase in rolling/adhesion of leukocytes in mouse colonic venules. par -/-mice showed significantly lower leukocyte rolling compared to the wildtype mice in response to fmlp topical administration. leukocyte adherence induced by fmlp and tnf-a; was significantly lower in par -/-mice compared to wild types as well. no difference was observed between par -/-and wildtype for leukocyte rolling/adherence-induced by paf. the lack of functional par attenuated leukocyte trafficking in response to fmlp and tnf-a; but not to paf. the involvement of par activation in mouse colon leukocyte trafficking highlights par as an important mediator of inflammatory cell recruitment and thereby a potential target for the treatment of inflammatory bowel diseases. ( ), kk hansen( ), k chapman( ), n vergnolle ( ), ep diamandis ( ), md hollenberg ( ) ( ) advanced center for detection of cancer, mount sinai hospital, university of toronto, toronto, on, canada ( ) proteinases and inflammation network, university of calgary, calgary, ab, canada kallikreins (klks) are secreted serine proteinases identified in many cancers and multiple sclerosis lesions. we have recently shown that klks can activate proteinaseactivated receptors (pars), a family of g-protein coupled receptors associated with inflammation. we hypothesized that like trypsin, kallikreins can trigger inflammation via the pars. we studied the ability of klks and to activate pars , and in vitro and to cause oedema in a mouse model of paw inflammation in vivo. we found that klk is able to activate both of pars and and to prevent thrombin from activating par . on the other hand, klk was a specific activator of par . kallikrein administration in vivo resulted in a paw oedema response comparable in magnitude and time to that generated by trypsin. the oedema was accompanied by a decreased threshold of mechanical and thermal nociception. our data demonstrate that by activating pars and and by inactivating par , kallikreins, like klks and , may play a role in regulating the inflammatory response and perception of pain. ( ), d park ( ), b short( ), n brouard( ), p simmons( ), s graves ( ), j hamilton ( ) ( ) melbourne university, melbourne, victoria, ( ) peter maccallum cancer institute. melbourne, australia mouse mesenchymal stem cell enriched populations can be isolated from bone tissue by employing lineage immuno-depletion followed by fluorescence-activated cell sorting based on the cell surface expression of the sca- antigen. such isolated cells can subsequently be cultured and differentiate towards the osteogenic, adipogenic or chondrogenic linage in vitro. using this model we investigated the influence of the proinflammatory cyto-kines, tnfa or il- b, on early osteogenesis in vitro. under osteogenic conditions, il- b was found to inhibit cell proliferation in a dose dependent manner, whereas tnfa exhibited no effect. histochemical examination revealed the presence of either tnfa or il- b to dramatically decreased mineralization in a dose dependent manner. q-pcr analysis indicated that in the presence of il- b, despite increased expression of bone-specific alkaline phosphatase (akp ) mrna, levels of other osteogenesis markers (runx , col a and sp ) were decreased. in the presence of tnfa, levels of akp , runx and sp were all decreased. our findings indicate that the influence of early mesenchymal progenitor cells on bone remodelling may be substantially altered in the presence of proinflammatory cytokines. using are-driven and nf-kb-targeted reporter genes, transfection of the nf-kb p subunit and nrf into hepg or other cells, as well as sirna technique to knockdown endogenous p in cells, we found that nf-kb p subunit repressed the anti-inflammatory and anticarcinogenetic nrf -are pathway at transcriptional level. in p -overexpressed cells, the are-dependent expression of heme oxygenase- was strongly repressed. in the cells where nf-kb and nrf were simultaneously activated, p unidirectionally antagonized nrf transcriptional activity. the p -mediated are inhibition was independent of the transcriptional and dna-binding activities of p . co-transfection and rna interference experiments revealed two mechanisms which coordinate the p -mediated repression of are: ( ) p selectively deprives creb binding protein (cbp) from nrf , but not mafk, by competitive interaction with the ch -kix domain of cbp, resulting in inactivation of nrf transactivation domain and concomitant abrogation of the nrf -stimulated coactivator activity of cbp; ( ) p promotes recruitment of histone deacetylases (hdac ) to are by enhancing the interaction of hdac with either cbp or mafk, leading to inactivation of cbp and deacetylation of mafk. this study may establish a novel pro-inflammatory and pro-carcinogenic model for the transrepression of the are-dependent gene expression by p subunit. since various inflammatory and tumor tissues constitutively overexpresses p in their nuclei, the finding in this study implies a strong repression of are-dependent gene expression must take place in those tissues. in this regard, the findings in this study may help to explain why oxidative stresses and toxic insults usually occur in those pathological loci. dendritic cells (dc) play a pivotal role in the induction of immune response and tolerance. it is less known that dc accumulate in atherosclerotic arteries, where they might activate t-cells and contribute to the progression of disease. the serine protease thrombin is the main effector protease of the coagulation cascade. thrombin is also generated at sites of vascular injury and during inflammation. hence, thrombin generation is observed within atherosclerotic and other inflammatory lesions including rheumatoid arthitis. thrombin activates various cells via protease-activated receptors (pars). immature dc do not express pars. upon maturation with lps, tnfalpha, or cd l, only lps-matured dc expressed par and par on their surface. stimulation of dc with thrombin, par -or par -activating peptides elicited actin polymerization and concentration-dependent chemotactic responses in lps-, but not in tnf-alphamatured dc. the thrombin-induced migration was a true chemotaxis as assessed by checkerboard analysis. stimulation of pars with thrombin or respective receptoractivating peptides led to activation of erk / and rho kinase i (rock-i) as well as subsequent phosphorylation of the regulatory myosin light chain (mlc ). the erk / -and rock-i-mediated phosphorylation of mlc was indispensable for the par-mediated chemotaxis as shown by use of pharmacological inhibitors of rock, erk and mlc kinases. in addition, thrombin significantly increased the ability of mature dc to activate proliferation of naive t-lymphocytes in mixed leukocyte reactions. in conclusion, our work demonstrates expression of functionally active thrombin receptors on lps-matured dc. we identified thrombin as a potent chemoattractant for mature dc, acting via rho/ erk-signaling pathways. data concerning the role of circulating modified low density lipoproteins (modldl) in atherogenesis and other pathologies are scarce. one reason for this is the lack of suitable radiolabeling methods for direct assessment of metabolic pathways of modldl in vivo. we report a novel approach for specific labeling of human native ldl (nldl) and modldl (iron-, hypochloriteand myeloperoxidase-oxidized, nitrated, glycated, and homocysteinylated ldl) with the positron emitter fluorine- ( f) by either nh -reactive n-succinimidyl- -[ f]fluorobenzoate or sh-reactive n-[ -( -[ f]fluorobenzylidene)-aminooxyhexyl]maleimide (radiochemical yields, - %; specific radioactivity, - gbq/ mmol). radiolabeling itself caused neither additional oxidative structural modifications of ldl lipids and proteins nor adverse alterations of their biological activity and functionality in vitro. the approach was evaluated with respect to binding and uptake of f-nldl and f-modldl in cells overexpressing various lipoproteinrecognizing receptors. the metabolic fate of f-nldl and f-modldl in vivo was delineated by dynamic small animal pet studies in rats and mice. the in vivo distribution and kinetics of nldl and modldl correlated well with the anatomical localization and functional expression of ldl receptors, scavenger receptors, and receptors for advanced glycation end products. the study shows that ldl modification, depending on type and extent of modification, in part or fully blocks binding to the ldl receptor, and reroutes the modldl to tissuespecific disease associated pathways. in this line, flabeling of modldl and the use of small animal pet provide a valuable tool for imaging and functional characterization of these pathways and specific sites of pathologic processes, including inflammatory processes, in animal models in vivo. the p mapk signaling pathway, which regulates the activity of different transcriptions factors including nuclear factor-Þb (nf-Þb), is activated in lesional psoriatic skin. the purpose of the present study was to investigate the effect of fumaric acid esters on the p mapk and the down stream kinases msk and in cultured human keratinocytes. cell cultures were incubated with dimethylfumarate (dmf), methylhydrogenfumarate (mhf) or fumaric acid (fa) and then stimulated with il- b before kinase activation was determined by western blotting. a significant inhibition of both msk and activations was seen after pre-incubation with dmf and stimulation with il- b whereas mhf and fa had no effect. also, dmf decreased phosphorylation of nf-kb / p (ser ), which is known to be transactivated by msk . furthermore, incubation with dmf before stimulation with il- b resulted in a significant decrease in nf-kb binding to the il- kb and the il- kb binding sites as well as a subsequent decrease in il- and il- mrna expression. our results suggest that dmf specifically inhibits msk and activations and subsequently inhibits nf-kb induced gene-transcriptions which are believed to be important in the pathogenesis of psoriasis. these effects of dmf explain the anti-psoriatic effect of fumaric acid esters. a humanized model of psoriasis was successfully established by transplanting non-lesional skin biopsies from psoriasis patients onto bg-nu-xid mice lacking b, t and nk cells. in this system, a psoriatic process is triggered by intradermal injection of activated autologous peripheral blood lymphocytes. inflammation is associated with the expression of activation markers and inflammatory medi-ators such as tnf-alpha, hla-dr and cd a and this results in increased proliferation and differentiation of keratinocytes, demonstrated by increased expression of ki- and ck- . epidermal hyperplasia is a typical readout in this model. in a series of studies, this model was found to be sensitive too a wide range of compounds, including inhibitors of tnf-alpha, antibodies directed against growth factors, mmp-inhibitors, calcipotriol, metothrexate, betamethasone and cyclosporine a.in addition, we showed that inhibition of fatty acid oxidation had an anti-psoriatic effect in this model (caspary et al. brit j dermatol ; , - ) . employing lesional skin it was demonstrated that inhibition can also be performed in a therapeutic setting.due to its humanized nature this model represents a powerful tool for the identification or validation of compounds with potential for the treatment of psoriasis. kristian otkjaer ( ), e hasselager( ), j clausen( ), l iversen ( ), k kragballe ( ) ( ) aarhus university hospital, denmark ( ) novo nordisk a/s, denmark interleukin- (il- ) is assumed to be a key cytokine in the pathogenesis of psoriasis. increased levels of il- are present in lesional psoriatic skin compared with nonlesional skin where it is barely detectable. whether il- is derived from antigen-presenting cells or keratinocytes remains unsolved. the aim of the present study was, therefore, to characterize il- expression in non-lesional psoriatic skin ex vivo. mm punch biopsies from nonlesional psoriatic skin were collected. biopsies were transferred to cacl enriched keratinocyte basal media and cultured with vehicle or il- beta ( ng/ml) for , , , , , and hours, respectively. the samples were analyzed by in situ hybridisation, qrt-pcr, immunofluorescent staining and elisa. incubation with il- beta rapidly induced il- mrna expression in the biopsies. the highest level of il- mrna was detected after hours and in situ hybridisation revealed that basal as well as suprabasal keratinocytes throughout the epidermis were the only cellular source of il- mrna. increased levels of il- protein were detected in the supernatant of the il- beta stimulated biopsies. immunofluorescent staining of the biopsies showed no il- protein in the keratinocytes, whereas the il- protein was present in epidermal cd a positive dendritic cells. our data emphasize the keratinocyte as the cellular source of il- expression in human skin. interestingly, immunofluorescent staining of our cultured biopsies showed il- protein in epidermal dendritic cells whereas no il- was detected in the keratinocytes. this indicates that epidermal dendritic cells are the target for keratinocytederived il- . one response of epidermal keratinocytes to inflammatory stress is the induction of matrix metalloproteinases (mmps) that participate in tissue remodeling. excessive proteolytic activity is associated with chronic wounds and tissue damage during persistent inflammation. calcitriol, the hormonally active form of vitamin d, is known to have beneficial effects during cutaneous inflammation. we hypothesized that one way in which calcitriol exerts its effect on inflamed skin is by attenuation of damages caused by excessive mmp proteolytic activity. our experimental model consists of hacat keratinocytes cultured with tnf to simulate an inflammatory state. pro-mmp- was quantified by gelatin zymography and mrna by real-time pcr. the levels and activation of signaling proteins were determined by immunoblotting. the increase in pro-mmp- activity and mrna levels induced by tnf was inhibited by~ % following h treatment with calcitriol. using specific inhibitors we established that the induction of mmp- was dependent upon the erk pathway, while p -mapk and pkc inhibited, and jun-kinase, pi- -kinase and src did not affect it. levels of c-fos, a component of ap- transcription complex known to mediate mmp- induction, were elevated by tnf and further increased by calcitriol. the induction of mmp- by tnf was abolished by inhibition of the egfr tyrosine kinase attesting to the requirement for egfr trans-activation. calcitriol also inhibited the induction of mmp- by egf. we conclude that calcitriol inhibits the induction of mmp- gene expression by tnf in keratinocytes by affecting an event downstream to the convergence of the egfr and the tnf signaling pathways. ( ), p verzaal ( ), t lagerweij ( ), c persoon-deen ( ), l havekes ( ), a oranje ( ) ( ) tno pharma, department of inflammatory and degenerative diseases, leiden, the netherlands ( ) erasmus medical center, department dermatology and venereology, rotterdam, the netherlands mice with transgenic overexpression of human apolipoprotein c in liver and skin display a strongly disturbed lipid metabolism. moreover, these mice show a loss of skin-barrier function evident from increased trans epidermal water loss. these mice develop symptoms of atopic dermatitis, i.e. scaling, lichenification, papules, excoriation and pruritus. both hyperplasia of epidermis and dermis are observed. histological analysis shows increased numbers of cd + t cells, eosinophils, mast cells and ige-positive cells in the dermis. serum levels of ige are increased as well. cytokine profiling of draining lymph nodes is in favor of a th -mediated disease. development of atopic dermatis in this model was found to be sensitive to topical treatment with triamcinoloneacetonide, fluticasone-proprionate and tacrolimus. moreover, oral treatment with dexamethasone successfully inhibits the development of disease in this model. impairment of the skin barrier is most likely the underlying cause of the development of atopic dermatitis in this model.this model is useful for identifying new therapeutic strategies and obtaining new insight into the pathogenesis of atopic dermatitis. topical immunosupppressants such as elidel and protopic are highly efficacious therapeutics for the treatment of atopic dermatitis and other dermatological conditions.-when delivered topically, these calcinuerin inhibitors offer several advantages over topical steroids; however, these marketed drugs have received a controversial "black box warning" because of a potential cancer risk. we speculated that systemic exposure of these drugs over long term use may contribute to the cancer risk.accordingly, we have designed and discovered a series of "soft" cyclosporin a (csa) derivatives as potentially safer alternatives.in general, soft drugs are engineered, via medicinal chemistry, to be effective upon local delivery but upon systemic exposure they are rapidly inactivated by metabolic pathways.in this way, exposure of active drug to distal organs is greatly minimized resulting in a significant enhancement in therapeutic index.the results or our drug discovery efforts around soft csa derivatives will be presented. ( ), y sawanobori ( ), u bang-olsen ( ), c vestergaard( ), c grønhøj-larsen ( ) background: a strain of japanese fancy-mice, nc/nga, serves as a model for atopic dermatitis. under specific pathogen-free conditions, the mice remain healthy, but when kept under non-sterile conditions, they exhibit pruritic lesions like atopic dermatitis. scratching behaviour of the mice precedes the development of dermatitis, and a correlation between registered scratching counts and expression of il- mrna has been shown. also, transgenic mice over-expressing il- exhibit increased scratching behaviour and develop severe dermatitis. consequently we decided to explore the therapeutic effect of an anti il- antibody on scratching behaviour and dermatitis in nc/nga mice. methods: prior to clinical manifestation of dermatitis, we commenced treatment of nc/nga mice with il- ratanti-mouse mg/kg intraperitoneally every fifth day for seven weeks. clinical dermatitis, scratching behaviour and weight gain, was assessed throughout the intervention period. serum analysis for ige and il- as well as histopathological and immunohistochemistry analysis on skin biopsies were also performed at end-point. results: taken over the entire intervention period, treatment with anti il- antibody in nc/nga mice from age seven weeks did not meet the primary end points, which were scratch, dermatitis and body weight. however, post hoc analysis revealed a significant reduc-tion of scratch by the anti il- antibody treatment in the time interval day - . our results suggest an anti pruritic role for il- antibody in an atopic dermatitis-like animal model. anti il- antibody is therefore a new therapeutic opportunity for the treatment of pruritus in atopic dermatitis and perhaps other pruritic diseases. ( ), p ferro ( ), hm asnagli ( ), v ardissone ( ), t ruckle ( ), f altruda ( ), ch ladel ( ) ( ) rbm merck serono/university of torino, italy ( ) merck serono pharmaceutical research institute, geneva, switzerland ( ) university of torino, dipartimento di genetica, biologia, biochimica, italy class-i phosphoinositide -kinases (pi ks) play a critical role in modulating innate and adaptive immune responses, as they are important transducers of external stimuli to cells, such as granulocytes and lymphocytes. since pi k-g plays a pivotal role in mediating leukocyte chemotaxis and activation, as well as mast cell degranulation, the pharmacological blockade of pi k-g might offer an innovative rationale-based therapeutic strategy for inflammatory skin disorders. in our study the inhibitory properties of a selective pi k-g inhibitor as on inflammation was applied to murine models modeling skin diseases like psoriasis and dermatitis. two mouse models were used: the first, irritant contact dermatitis (icd), is an innate inflammatory skin condition arising from the release of pro-inflammatory cytokines in response to haptens, usually chemicals. the second, contact hypersensitivity (chs) is a t-cell dependent model, modeling in part t-cell-mediated skin diseases such as psoriasis. we demonstrated the therapeutic effect of pi kg inhibition and subsequent inhibition of chemotaxis in models of skin diseases and showed that a selective pi k-g inhibitor can excert an important therapeutic efficacy (dose-dependent) in models of innate immunity (icd) -effective dose , mg/kg p.o. once -as well as in t-cell mediated skin pathology (chs)effective dose mg/kg p.o. bid. we conclude that the mechanism of action related to inhibition of pi k-g are demonstrable after oral administration of selective inhibitors like as in models of acute and chronic skin inflammation and are mediated by modulation of innate and acquired immunity. introduction: high mobility group box (hmgb ) has recently been identified as a late mediator of endotoxin lethality. we newly developed an extra corporeal hmgb absorber. the purpose of this study was to test the hypothesis that hmgb removal could prevent or reduce endotoxin induced lethality or tissue injury of rats. methods: all experiments were conducted in accordance with the institutional care and use committee.male wistar rats were randomly allocated into three groups; hmgb absorber group (group i),hmgb nonabsorber group (group ii), and vacant column group (group iii).we applied these columns for each groups at hours after lps injection. the rats were sacrificed hours after lps injection for pulmonary histology. we statistically analyzed survival rate with kaplan-meier and the levels of hmgb with anova. results: survival rate was % in the group i at hours after lps injection, as compared with % in the group ii and % in the group iii. the pulmonary histology in both group ii and group iii showed acute inflammatory injuries, whereas group i showed less inflammatory changes.the level of hmgb in the group i was significantly lower than those of group ii and iii. discussions:these results demonstratethat specific absorption of endogenous hmgb therapeutically reverses lethality of established sepsis indicating that hmgb inhibitors and absorber can be treated in a clinically relevant therapeutic window that is significantly wider than for other known cytokines. contact information: dr hideo iwasaka, oita university, anesthesiology and intensive care unit, yufu city, japan e-mail: hiwasaka@med.oita-u.ac.jp ( ) ( ) department of pharmacology, national university of singapore, singapore ( ) dso national laboratories, singapore hydrogen sulfide (h s) is increasingly recognized as a proinflammatory mediator in various inflammatory conditions. in this study, we have investigated the role of h s in regulating expression of some endothelial adhesion molecules and migration of leukocytes to inflamed sites in sepsis. male swiss mice were subjected to cecal ligation and puncture (clp) induced sepsis and treated with saline, dl-propargylglycine (pag, mg/kg i.p.), an inhibitor of h s formation or sodium hydrogen sulfide (nahs) ( mg/kg, i.p.), a h s donor. pag was administered either hour before or hour after induction of sepsis while nahs was given at the time of clp. using intravital microcopy, we found that in sepsis, prophylactic and therapeutic administration of pag significantly reduced the leukocyte rolling and adherence in mesenteric venules coupled with decreased mrna and protein levels of adhesion molecules (icam- , p-selectin and e-selectin) in lung and liver. in contrast, injection of nahs significantly upregulated leukocyte rolling and attachment as well as tissue levels of adhesion molecules in sepsis. on the other hand, normal mice were given nahs ( mg/kg i.p.) to induce lung inflammation with or without pretreatment of nf-x×b inhibitor, bay - . h s treatment enhanced the pulmonary level of adhesion molecules and neutrophil infiltration in lung. these alterations were reversed by pretreatment with bay - . moreover, expression of cxcr in neutrophils obtained from h s treated mice was significantly upregulated leading to an obvious elevation in mip- directed migration of neutrophils. therefore, h s act as an important endogenous regulator of leukocyte trafficking during inflammatory response. transient receptor potential vanilloid (trpv ) is primarily found on sensory nerves. we have demonstrated its pro-inflammatory potential in arthritis and now present evidence that it is protective in an endotoxininduced model of sepsis. selective trpv antagonists are not available for use in the mouse in vivo, thus established trpv knockout (-/-) mice were used. c bl wt and trpv -/-mice were matched for age and sex and injected intraperitoneally (i.p.) with lipopolysaccharide (lps). the response was monitored for h. blood pressure, measured before and at intervals after lps in conscious mice via a tail cuff was reduced in both wt and trpv -/-mice, with trpv -/-mice showing an enhanced drop at h. in a separate group temperature, a proposed pre-mortality marker was also reduced by h, again with a significantly increased drop in trpv ko. furthermore higher levels of two inflammatory markers tnfa and nitrite (as an indicator of no) were measured in peritoneal lavage and higher levels measured intrpv -/-as compared with wt samples. finally aspartate aminotransferase (ast) levels also enhanced in trpv -/-versus wt mice, although markers for kidney and pancreatic damage were similar in both genotypes. we conclude that trpv plays a protective role in sepsis. trpv is known to be present on nonneuronal (e.g. vascular components) and their relative involvement in sepsis is unknown. ( ), da souza-junior( ), l de paula ( ), mc jamur ( ), c oliver ( ), sg ramos ( ), cl silva ( ), lucia helena faccioli ( ) ( h rv) . infected balb/c mice developed an acute pulmonary inflammation and higher levels of tnf-a, il- , kc, mcp- and mip- were detected in the lungs by day . in vivo degranulation of mast cells by c / led to a reduction of the inflammatory reaction associated to a marked decline proinflammatory cytokine and chemokine levels in the lungs. the magnitude of cellular immune response was also partially impaired in infected mice and treated with c / . histologically, the exacerbated granulomatous inflammation shown in the lung parenchyma of infected mice was attenuated in infected mice and treated with c / . of interest, the number of mycobacterial bacilli recovered from the lungs was log higher after treatment of infected mice with c / . these findings suggest that mcs participate in host defense against m. tuberculosis infection through of the modulation of cytokines and chemokines, which are important for the recruitment and activation of inflammatory cells. ( ), ms chadfield ( ), db sørensen ( ), h offenberg ( ), m bisgaard ( ), he jensen ( ) ( ) department of veterinary pathobiology, faculty of life sciences, university of copenhagen, denmark ( ) novo nordisk a/s, cell biology, gentofte, denmark introduction: pasteurella multocida is an important cause of pneumonia in several animal species and may spread systemically. the aim of this study was to evaluate initial inflammatory reactions and the inocula effect due to strains of p. multocida of different origin in an aerogenous murine model. materials and methods: female balb/ c-j mice (app. g, taconic, denmark) were infected intranasally with two clinical isolates of p. multocida of avian (vp ) and porcine (p ) origin, at three different levels of inocula concentration. after euthanasia, specimens of lung and liver tissue were collected for bacteriological and histopathological evaluation. furthermore, lung tissue samples were taken for measurement of expression of metalloproteinase mmp- and metalloproteinase inhibitor timp- . results: all mice infected with the avian strain were euthanized after hours. viable counts recovered from lung and liver tissue were high, and histopathology revealed pronounced acute bronchopneumonia. in the liver, disseminated necrosis with formation of microabscess was also seen. on the contrary, a dose response was observed with the porcine strain with regard to recovery of viable counts and development of lesions was apparent after , and h. furthermore, differences were seen in the nature of the lesions caused by the two strains. there was a difference in expression of mmp- and timp- between infected and noninfected mice. the model proved suitable for the evaluation of pulmonary inflammatory reactions between the two different host-derived strains as demonstrated through viable counts, histopathology and expression of mmp- and timp- . ( ), r molinaro ( ), a franÅa ( ), m bozza ( ), f cunha( ), s kunkel ( ) ( ) universidade do rio de janeiro, brazil ( ) universidade de s¼o paulo, brazil ( ) university of michigan, usa introduction and objectives: studies reveal that regulatory t (treg) cells control immune responses; therefore these responses must be controlled to enable the effective protection against infections and cancer. ccr knockout mice (ccr -/-) are more resistant to lps shock. so, our aim is to study the mechanisms involved in the resistance of ccr -/-subjected to severe sepsis by cecal ligation and puncture (clp) and how tregs modulate this effect. results: c /bl mice were subjected to clp model, whereby the cecum was partially ligated and puncture nine times with a g needle. sham-operated mice were used as control. mice subjected to clp and sham surgery were treated with antibiotic since h after and until days. ccr -/-mice subjected to clp presented an increase in survival rate ( %) compared with wildtype mice ( %), and a marked improvement in the innate response concern to neutrophil migration to peritoneum and lung, bacteria load and cytokine levels compared to wild-type mice. besides, tregs from ccr -/-clp mice did not inhibit proliferation of t effector cells as observed for treg from wild clp mice, at a proportional ratio of teffector:treg. interesting, treg from ccr -/-clp mice did not inhibit neutrophil migration to bal when co-injected with fungal challenge as secondary infection, while the treg from wild clp mice did, as expected. conclusions: these results suggest that treg cells from ccr -/-mice did not present suppressive response and it could be an important factor in their survival. inflammation and oxidative stress are known to be one of the important causes that are responsible for many diseases. inflammation has been associated with diseases like cancer, diabetes and many other. proinflammatory cytokine (tnf -µ and il- â) and no are considered as pivotal mediators in inflammatory conditions like rheumatoid arthritis, sepsis and cancer etc. thus inhibition of pro-inflammatory cytokines and no production are important targets for treatment of inflammatory disorders. nowadays due to the emerging side effects of cox inhibitors, these targets have been paid more attention for the treatment of these conditions. some medicinal plants such as curcuma longa ( ), commiphora mukul ( ) in humoral memory, antibodies secreted into serum and other body fluids protect an individual against repeated challenges of previously encountered pathogens. antibody-secreting plasmacells are mostly considered to be shortlived, terminally differentiated b lymphocytes, eliminated after a few days or weeks by apoptosis. however, in secondary lymphoid organs and in the bone marrow, plasma cells can survive for months and years, without dna-synthesis and refractory to signals from antigen or antigen-antibody complexes. the lifetime of these longlived plasmacells depends on an intrinsic competence to survive in the distinct environment of those organs, which defines a specific survival niche. the niche provides survival signals like il- , cxcl and tnf. within a functional niche, the lifetime of a plasma cell is apparently not limited intrinsically. the number of niches in the body has to be limited, in order to maintain physiological concentrations of serum immunoglobulins. thus recruitment of new plasmacells to the pool of old memory plasma cells has to be competetive. this competition is probably controlled by a simple molecular mechanism, namely the dual functionality of chemokines like cxcl , which attract newly generated plasmablasts to a survival niche and at the same time are a survival signal for the plasma cell. plasmablasts and plasma cells express cxcr , the receptor for cxcl . while plasmablasts migrate in response to cxcl , plasma cells depend on it for survival in the niche, but are no longer migratory. thus once disloged from their niche, they will die. plasmablasts newly generated upon systemic secondary immunization, upon concommittant stimulation with interferon-gamma, can also express cxcr , the receptor for the interferon-gamma-induced chemokines cxcl , and , which may lure the plasmablasts into inflamed tissue. the switch in the potential to migrate provides also an efficient means to eliminate plasma cells of the peak of an immune response, which as plasmablasts had migrated to the tissue inflamed in that pathogenic challenge. inflamed tissue contains survival niches for plasma cells. in the inflamed tissue, plasma cells provide high local antibody concentrations while the tissue is inflamed. upon resolution of the inflammation the plasma cells will be dislodged and die. longlived plasma cells provide longlasting antibody titers (protective memory) and leave memory b cells a role in reactive memory, generating memoryplasmacells in secondary challenges, and if serum titers are not sufficient to protect. in chronic inflammation, this mechanism can contribute to pathogenesis. thus in the nzb/w model of lupus, longlived autoreactive plasma cells are generated early in pathogenesis, which survive in bone marrow and spleen. later, in established disease, autoreactive plasma cells are shortlived and continuously generated. they do not compete with the longlived plasma cells, and both populations coexist as prominent populations. interestingly, longlived plasmacells are resistant to therapeutic immunosuppression, while the generation of shortlived plasma cells is blocked. this may be the reason for the failure to cure antibodymediated immunopathology, e.g. in autoimmunity and allergy, by conventional immunosuppression, ( ), h lee ( ) c a is a potent inflammatory mediator produced during complement activation. unregulated c a signalling through its receptor (c ar) on neutrophils and other leukocytes is implicated in the pathogenesis of autoimmune diseases including rheumatoid arthritis and systemic lupus erythematosus. considerable effort has gone into development of c ar antagonists for human therapy. we took neutrophils from genetically modified human c ar knock-in mice in which the mouse c ar coding region was replaced with human c ar sequences and immunized wild-type mice to generate high affinity antagonist monoclonal antibodies (mabs) to human c ar. these mabs inhibit c a-induced neutrophil migration and calcium-flux, and bind to a region of the nd extracellular loop of c ar loop that seems to be critical for receptor activity. this study investigated the effectiveness of these mabs in the k/bxn serum-transfer model of inflammatory arthritis. human c ar knock-in mice were given - mg/kg mab intraperitoneally, before or after inflammatory arthritis developed. mice treated with anti-c ar mab one day before serum transfer did not develop swelling or clinical signs of arthritis in contrast to controls. histopathology of the joints in anti-c ar mab-treated mice revealed a complete block of the massive influx of leukocytes and cartilage erosion seen in controls. furthermore, and most significantly, a single mg/kg dose of anti-c ar mab given days after initiation of disease completely reversed inflammation. in the collagen-induced arthritis (cia) model, injection of anti-c ar mab after development of inflammation also reversed inflammation to baseline. these potent new antibodies to human c ar are in preclinical development. the cytokine macrophage migration inhibitory factor (mif) participates in fundamental events in innate and adaptive immunity. the profile of activities of mif in vivo and in vitro is strongly suggestive of a role for mif in the pathogenesis of many inflammatory diseases, including rheumatoid arthritis (ra), asthma, and sepsis. mif also has a unique relationship with glucocorticoids, in that despite antagonizing their effects, the expression of mif is in fact induced by glucocorticoids. thus, mif functions as a physiological counter-regulator of the anti-inflammatory effects of glucocorticoids. therapeutic mif antagonist may therefore provide a specific means of steroid sparing. since mif are highly conserved among different species, it is hard to develop high affinity antibodies due to immune tolerance.we developed a proprietary technique to break the immune tolerance and selected high affinity mouse monoclonal antibodies against mif.the antibody can neutralize mif activity in cell based assays, and is very effective in a lps induced mouse sepsis model. using this antibody as a tool, we are studying the function of mif in comparison with the function of lps.we found that lps induced inos expression and no secretion are dependent on the secretion of mif.we also found that although both lps and mif induce g arrest in macrophage cell line raw . , their functions are independent to each other. structure-based small molecule drug design. an effective agent would be the first orally active cytokine antagonist. methods: collagen-induced arthritis (cia) was induced in dba- mice by immunisation with bovine type ii collagen/adjuvant on day and . cor , synthesized on the basis of computer modeling of mif protein x-ray crystallographic data, was administered by daily oral gavage from day . etanercept ( mg/kg ip q d) was used as a positive control. the mek-erk pathway is activated in numerous inflammatory conditions, including ra, ibd and copd. arry- is a potent (ic = nm), selective, atp-uncompetitive mek / inhibitor.arry- is highly efficacious in cia and aia rat models, with ed s of and mg/kg, respectively, equal to or better than standard agents. addition of arry- to methotrexate, etanercept, ibuprofen or dexamethasone regimens in these models results in improved efficacy that is at least additive, if not synergistic. in tpa-stimulated human whole blood, this compound inhibited tnf, il- and il- production (ic s of , and nm, respectively). in contrast, inhibition of perk required nm to achieve a % reduction, demonstrating that inhibition of pro-inflammatory processes is very sensitive to perk inhibition.in clinical studies, healthy volunteers were administered a single oral dose of , , , or mg); blood was drawn at various times after dosing and stimulated ex vivo with tpa. arry- was well-tolerated and drug exposure was dose-proportional. in ex vivo blood samples, there was a dramatic time-and concentration-dependent inhibition of tpainduced il and tnffz with > % inhibition observed at plasma concentrations of and ng/ml, respectively. similar inhibition of perk required ng/ml. a multiple ascending dose clinical study has confirmed the pharmacokinetics and pharmacodynamics of arry- and helped define tolerability. clinical evaluation of arry- in combination with methotrexate in patients with rheumatoid arthritis is on-going. p (a mitogen-activated protein kinase) has been shown to play a key role in the release of cytokines such as tnfand il- a from monocytes in signaling cascades that are initiated due to extra cellular stress stimuli. inhibition of p activity is expected to regulate the levels of tnf-a and il- b thereby alleviating the effects of inflammation in ra. a new class of p inhibitors based on the naphthyridininone scaffold have been discovered. x-ray crystallography and site directed mutagenesis studies were critical tools that aided the evolution of the naphthyridinone lead class starting from a pyrido-pyrimidinone template. this presentation will discuss the derivation of key benchmark pre-clinical candidates in these novel scaffold classes (shown below) as influenced by structural biology studies, mutagenesis data and molecular modelling. efficacy studies in animal models for benchmark compounds will also be presented. ( ), h aaes ( ), w-h boehncke( ), j pfeffer( ), t skak-nielsen( ), i teige ( ), k abell ( ), ph kvist ( ), e ottosen ( ), tk petersen ( ), lars svensson ( ) ( ) discovery, leo pharma, industriparken, ballerup, denmark ( ) department of dermatology, johann wolfgang goethe-university, frankfurt am main, germany p map kinase plays an important role in mediating an inflammatory response in mammalian cells. as a consequence of activation, several inflammatory mediators are released including il- b] and tnfa. both cytokines have a central role in the pathogenesis of inflammatory conditions such as psoriasis. approximately % of psoriasis patients develop psoriatic arthritis. leo is a member of newly developed class of selective p map kinase inhibitors. the compound was tested orally in in vivo models relevant for psoriasis and psoriatic arthritis. the in vivo models selected include the cia arthritis model, the human psoriasis xenograft scid mouse model, the uvb-induced dermatitis model, the lps induced tnfa model and a local gvh model. treatment with leo led to an amelioration of the ongoing inflammation in all investigated in vivo models. in the cia model, a clear dose response effect was observed on the developing arthritis in both rats and mice ( % reduction in mice and % in rats at mg/kg p.o.). in the humanised psoriasis model, leo at a dose of mg/kg, had an effect on both the hyperplastic epidermis (epidermal thickness reduced by %) and on the infiltrating inflammatory cells. the anti-inflammatory effect of leo was even close to the effect of systemically delivered steroids in both models. we believe that the new highly selective class of p map kinase inhibitors has a strong potential as an orally delivered therapy for systemic inflammation diseases such as psoriasis and arthritis. slx- is a potent, selective, orally bioavailable inhibitor of the rho-kinase rock- . its ic for rock- and rock- inhibition is nm and > mm respectively. the ability of slx- to inhibit septic liver injury was investigated in c bl/ j mice challenged with lipopolysaccharide (lps) and d-galactosamine (d-gal). mice were given lps ( mg/mouse) and d-gal ( mg/ mouse) i.p and . hours later were sacrificed for analysis of liver injury. mice challenged with lps/d-gal had a > fold increase in serum alt and ast levels. this increase was reduced by > % in mice pretreated with slx- either orally ( mg/kg, and hrs prechallenge) or i.p. ( - mg/kg, min pre-challenge). slx- inhibited the increase in hepatic levels of tnffalpha produced by lps/d-gal by > %. to assess the kinetics of slx- s benefit, slx- ( mg/kg i.p.) was given min prior to, or or min after the lps/ d-gal. slx- was effective at inhibiting the rise in alt and ast levels at all time points suggesting that inhibiting rock- even after the initiation of the lps/d-gal driven cascade protects against septic liver injury. in a survival study, out of mice given lps/d-gal were dead by hrs whereas in mice given slx- ( mg/kg orally) animal died at hours and the remaining mice were alive hrs later. these results show that specific inhibitors of rock- may have therapeutic utility in the treatment of sepsis and subsequent liver injury. theta through three key hydrogen bond mediated interactions.they potently inhibit protein kinase c activity in vitro as demonstrated by inhibition of il- secretion in human purified t-cells stimulated with anti-cd and anti-cd or whole blood seb challenge.the pkc-theta inhibitors are orally bioavailable and demonstrate immunosuppressive activity in a mouse model of human delayed-type hypersensitivity responses. ( ), j zhang ( ), k henley ( ), m white ( ), d hilton ( ), b kile ( ) ( to investigate pathogenesis of rheumatoid arthritis, we used mice transgenic for the uniquely human fcgam-mariia in inducible and passively transferred models of arthritis. transgenic mice developed severe ra-like disease in both model systems, indicating that the transgene played a major role in arthritis pathogenesis. disease could be reduced by the administration of either specific monoclonal antibodies to fcgammariia or small chemical entities (sce) designed to bind to the fcgam-mariia dimer. to investigate the cause of this enhanced sensitivity to auto-immune stimuli, the phagocytic capacity of transgenic mice compared to c bl/ control mice was examined using phagocytosis of fluorescent beads coated with ova or ova/anti-ova immune complex or opsonised sheep red blood cells. in both assays macrophages from fcgammariia transgenic mice showed significantly increased phagocytosis comapred with cells from control mice at hours.this difference diminished over time andwas only seen where particles were opsonised. treatment of macrophages with specific fcgammariia blocking monoclonal antibody fragments . f(ab) or iv. f(ab) reduced phagocytosis to background levels . macrophages from transgenic mice also showed significantly greater production of inflammatory cytokines tnf-alpha and il- beta when stimulated in vitro with heat aggregated immunoglobulin (hagg). moreover, this response was also blocked by specific fcgammariia monoclonal antibody fragments or sce. thus, expression of the fcgammariia transgene in these mice leads to increased uptake of and reactivity to immune complexes, resulting in enhancement of inflammatory sequelae in the form of increased th cytokine secretion andamplification of the pro-inflammatory response leading to arthritic disease. harald burkhardt ( ), u hüffmeier ( ), i kçnig ( ), j lacorz ( ), a reis ( ), k reich ( ) ( ) johann wolfgang goethe university, frankfurt, germany ( ) friedrich-alexander-unisversity of erlangen-nuremberg, germany results: whereas the earlier described strong association of allele tnf*- a with psoriasis could be confirmed, our study revealed that this association was completely dependent on carrying the psors risk allele. for psa, but not psoriasis vulgaris without joint involvement strong association with the allele tnf*- t was detected (or= . , % ci . - . ; pcorr= . ) also in patients negative for the psors risk allele. our results indicate genetic differences between psoriasis vulgaris patients with and without joint manifestation. while the previously reported association between tnf*- a and psoriasis seems to primarily reflect ld with psors , tnf*- t may represent a risk factor for psa independent of psors . ( ), n modi ( ), m stanford ( ), e kondeatis ( ), r vaughan ( ), f fortune ( ), w madanat ( ), c kanawati( ), p murray ( ) methods: dna was obtained from patients with bd, from the uk and from the middle east (me), and controls individuals, from the uk and from me. dna was prepared by proteinase k digestion, and salt extraction and - and snp were detected by a pcr-ssp. results: there was no significant difference in expression of - c/t or a/g when all bd patients were compared to all control individuals, (p= . and . , respectively). as we have previously shown differences in snp expression in different patient groups we tested the uk and me patients separately. however, there was no significant difference in either snp in uk bd patients, (p= . , p= . ) or me bd patients (p= . , p= . ) when compared to the appropriate controls. ( ), da brown ( ), h johnen ( ), mr qiu ( ), t kuffner ( ), pgm curmi ( ), l brown ( ), m mazzanti ( ), sn breit ( ) ( introduction: cerebral palsy (cp) is a nonprogressive motor disorder caused by white matter damage in the developing brain. it is often accompanied with neurocognitive and sensory disabilities. the cause and pathogenesis of cp is multifactorial and continues to be poorly understood. chorioamnionitis, clinically silent or manifest, has been reported to be a risk factor for cp both in term and preterm infants. il- gene is single copy gene located on chromosome q . - in humans. interleukin- is synthesized by a variety of immune (t cells, eosinophils and dendritic cells) and non-immune (fibroblasts, epithelial and neuronal) cells. it is also detected in organ-specific secretions in a number of inflammatory processes. amniotic fluid interleukin- concentrations decreased with advancing gestational age. but, women with preterm labor and women with chorioamnionitis have higher interleukin amniotic fluid concentrations than those who delivered at term or those with sterile amniotic fluid. the aim of our study was to estimate allelic frequency for regulatory il - snp in the children with the cp. methods: dnas obtained from peripheral blood of cp patients and unrelated healthy volunteers were genotyped for the il - snp pcr-rflp method. results and conclusions: il - genotype fncc was more common in the population with cerebral palsy in the comparison to healthy volunteers. the significance of the association between il fngene polymorphisms and cerebral palsy has to be investigated in the future studies. ( ), d delbro ( ), e hansson ( ) ( ) kalmar university, sweden ( ) gçteborg university, sweden background: acetylcholine (ach) is a major signalling molecule, binding partly at nicotinic receptors (nachrs; a family of ions channels with nicotine as a selective ligand). one subtype, the alpha nachrs, has antiinflammatory effects by way of down-regulation of tnfalpha release from macrophages. the alpha nachrs have been demonstrated in neuronal as well nonneuronal tissues, e.g. astrocytes and microglia. aim. in rat astrocytes in primary culture, and in astrocytes cocultivated with primary microvessel cultures study: . the expression of alpha nachrs and alpha nachrs by immunofluorescence and western blot. . intracellular ca +-transients spread within the astroglial networks after stimulation with nicotine. . pro-inflammatory cytokines, il- b, il- , and tnfalpha, released from microglial cells after stimulation with nicotine. results: alpha nachrs expression was more evident in astrocytes co-cultivated with endothelial cells, suggesting that endothelial cells release factors, which increase the maturity of astrocytes. the ca + transient evoked by nicotine was also more pronounced in the co-cultured astrocytes. these ca + responses were blocked by the alpha nachr antagonist alpha-bungarotoxin. the release of pro-inflammatory cytokines was down-regulated after stimulation by nicotine. conclusion: alpha nachrs appear to be involved in some of the effects of nicotine administration to rat astrocytes. an anti-inflammatory action of cholinergic nerves on the astrocytes via nachrs seems probable, which may have therapeutic implications. university, department of natural sciences, kalmar, sweden e-mail: ann.pettersson@hik.se gedeon richter plc., budapest, hungary tramadol, an atypical opioid analgesic, is increasingly used for the treatment of osteoarthritis because it does not produce typical side effects of nsaids. review of clinical data show that it produces symptom relief and improves function, but these benefits are small and adverse events often cause participants to stop taking the medication (cohran database ). efficacy of tramadol in animal models of inflammatory pain is well established; however complex characterization of the drug regarding analgesic and side effects is missing in rats. our aim was to assess oral efficacy of tramadol at side effect free doses in rats. anti-hyperalgesic effect was determined in complete freunds adjuvant (cfa) induced thermal hyperalgesia test (th) and in model of cfa-induced knee joint arthritis. effect on inflammation was characterized in carrageenan induced paw edema test (et). for the characterization of side effect accelerating rotarod assay (arr) was used. significant impairment in arr was noted at mg/kg dose, and above. in the th test weak % effect was seen at side effect free dose ( mg/kg). in the arthritis model b.i.d. mg/kg dose of tramadol given on days - after cfa caused a maximum % effect on weight bearing incapacitance (day ). however, its effect seemed to diminish ( % on day ) upon repeated treatment. in et tramadol had significant anti-inflammatory effect at but not at mg/kg dose. these results show that efficacy of tramadol in rat inflammatory pain models is limited by its side effects, in accordance with clinical data. chronic relapsing experimental allergic encephalomyelitis (cr eae) is a disease that bears striking similarities to the human condition multiple sclerosis (ms). in particular, cr eae and ms have major inflammatory events in the central nervous system (cns) that culminate in demyelination and disruption of axonal function.one group of mediators involved in the progressive cns inflammation are the prostaglandins (pgs).pg generation is regulated in experimental non-immune conditions of the cns by n-methyl-d-aspartate (nmda) receptor activation.nmda receptor-mediated events are also evident in eae and may therefore have the potential to influence pg production.the study was designed to profile pge and pgd in cns tissues during the development of cr eae and to examine the role of the nmda receptor in pg production through the use of the specific antagonist mk- .biozzi mice were inoculated for cr eae and cns tissues were sampled during the course of disease.enzyme immunoassay of processed samples revealed pge and pgd levels within normal limits during the acute and subsequent remission phases of cr eae.in contrast, dramatic changes in pg concentrations were observed with a relapse of symptoms and a remission of disease.mk- was therapeutically administered to cr eae-diseased mice at the onset of relapse and changes in cns pg levels were recorded.the relapse phase of cr eae, but not the acute stage of disease, is characterised by an increase in cns pg production that may be influenced by nmda receptor activation. livia l camargo( ), lm yshii ( ) ( ), sk costa ( ) ( ) university of s¼o paulo, brazil ( ) king's college, london, uk ( ) butantan institute, s¼o paulo, brazil objectives: the neuropeptide substance p (sp) released by capsaicin-sensitive nerves (csn) plays a pivotal role in neurogenic inflammation. despite the prevalence of arthritis, the contribution of sp to the progression of arthritis has not been established. this study investigated the effect of csn ablation and sr , a sp antagonist, on knee joint inflammation and pain induced by intraarticular (i.a.) injection of kaolin ( %, h time course) in female wistar rats. the kaolin-injected knee (ipsilateral -ipsi) of vehicle-treated rats exhibited a significant, timedependent oedema as compared to the contralateral knee. in addition, increased pain score and high levels of myeloperoxidase (mpo, marker of neutrophil accumulation) and both pro-inflammatory (il- b and il- , but not tnfa) and anti-inflammatory (il- ) cytokines was detected in the ipsi synovial fluid of these animals. both destruction of knee joint csn fibres by neonatal capsaicin treatment and i.a. injection of rats with sr ( nmol/cavity) significantly attenuated the kaolin-induced pain score and knee oedema, suggesting that kaolin is acting, at least partially, via a neuronal mechanism. in contrast, the same treatment caused increased mpo activity and cytokine concentrations measured h post kaolin injection. conclusions: peripheral release of sp after kaolin injection acts to increase pain generation, oedema formation and inflammatory cell influx. however, chronic tachykininergic depletion by capsaicin treatment up-regulates the production of pro-inflammatory cytokines that are important in triggering cell influx in the synovial cavity. ( ) ( ) university of s¼o paulo, s¼o paulo, brazil ( ) butantan institute, s¼o paulo, brazil objectives: previously, intra-tracheal (i.tr.) injection of dep or , -naphthoquinone ( , -nq) evoked plasma extravasation and cell influx in rat airways. we now investigated whether simultaneous injection of these pollutants had a synergistic inflammatory action. we also determined the ability of dep and , -nq-induced airway inflammation to evoke changes in the rat isolated thoracic aorta (rta) and corpus cavernosum (rcc) reactivity using organ bath assays. results: capsaicin-or vehicle-treated male wistar rats received i.tr. injection of dep ( mg/kg) and , -nq ( nmol/kg). after min, dep and , -nq produced a potent (additive) plasma extravasation in the trachea and bronchi, but not lung, compared with each compound alone. in capsaicin-treated rats or treated with tachykinin antagonists, the response was inhibited, suggesting an important role for c-fibres, primarily tachykinins. increased mpo and cytokine levels were detected in bronchi of capsaicin-treated rats following h treatment with pollutants. this treatment contributes to augment the ach ( - - - m)-induced relaxation in the rta but not in the rcc. in capsaicin-treated rats, the rta response to the pollutants was not affected but it was capable of evoking a marked relaxation in rcc in animals challenged with pollutants. conclusions: , -nq exacerbates dep-induced plasma extravasation and mpo activity in the airways, indicating a neurogenic mechanism through tachykinins. the exposure to dep and , -nq affects the endotheliumdependent response in rta without interfering with rcc. neuropeptides are unlikely to affect the pollutantsinduced changes in the rta. acknowledgements: capes, cnpq, fapesp. we thank ma alves for technical assistance. trans-resveratrol (rv) is a naturally occurring polyphenolic compound present in certain foods that has anticancer and anti-inflammatory properties. the purpose of this study was to determine the effect of rv on the production of proinflammatory cytokines and reactive oxygen species stimulated by lipopolysaccharides (lps) in glial cells. rt-pcr showed that rv ( , , mm) dose-dependently inhibited ng/ml lps induced tnfa, il- b, il- , mcp- and inducible nitric oxide synthase mrna expression. rv also inhibited lps-induced production of these cytokines (elisa), nitric oxide and reactive oxygen species in a dose-dependent manner. western blot analyses showed that resveratrol could inhibit lps-stimulated phosphorylation of erk / and jnk but not p . nf-kb reporter assay showed rv could inhibit nf-kb activation by lps in microglia and astrocytes. these results suggest that rv may inhibit lps-induced microglial and astrocyte activation through erk / , jnk and nf-kb signaling pathways. therefore, rv is a natural product with therapeutical potential against disease conditions in cns that involve an overproduction of proinflammatory cytokines and reactive oxygen species. ( ), cs patil( ), sv padi ( ), vp singh ( ) ( ) university institute of pharmaceutical sciences, panjab university, chandigarh, india ( ) pharmacology r & d, panacea biotec ltd. lalru, punjab, india persistent stimulation of nociceptors and c-fibers by tissue injury causes hyperalgesia and allodynia by sensitization of nociceptors and facilitation of synaptic transmission in the spinal cord. the important participant in the inflammatory response of injured peripheral nerve may be nitric oxide (no). the aim of the present study was to test the sensitivity of pde inhibitor sildenafil in chronic constriction injury (cci) model, a rat model of neuropathic pain. sciatic nerve injury is associated with development of hyperalgesia days after the nerve ligation. sildenafil ( and fÝ g/rat, i.t.) produced a significant decrease in pain threshold, which in lower dose did not alter the nociceptive threshold. the hyperalgesic effect of sildenafil was blocked by l-name and methylene blue (mb), which on per se treatment showed antinociceptive effect in nerve ligated rats. the results from the present study indicated that the major activation of no cgmp pathway in the chronic constriction injury model of neuropathic pain. the aggravation of hyperalgesic response might be due to the increased cgmp levels resulting in pkg-i activation and its upregulation. glycine transporter (glyt) and glyt are expressed in glia and neurons, respectively. glyt make clearance of glycine released from glycinergic neuron in synapse and thus terminates the neurotransmission and also regulates over-stimulation by glycine spilled over to nmda receptors, while glyt supplies glycine into synaptic vesicles in glycinergic neurons. therefore, glyt inhibitors could modulate inhibitory glycinergic or excitatory glutamatergic neurotransmission. the present study examined the effects of glyt inhibitors on pain in animal models. inhibitors of glyt (sarcosine and org ) and glyt (alx and org ) by intrathecal (i.t.) injection reduced formalin-induced nociceptive behaviors. glyt inhibitors reduced allodynia score and reversed the reduction of paw withdrawal threshold in complete freund adjuvant (cfa)-induced inflammation mice but the antiallodynia effects appeared after latent period. on the other hand, glyt inhibitors produced antiallodynia effects immediately after the i.t. injection in cfa-treated mice. these inhibitors produced the similar antiallodynia effects in the partial sciatic nerve ligationinjury or streptozotocin-induced diabetic neuropathic pain models, either by i.t. injection or i.v. injection.pretreatment of specific antagonists of glycine site of the nmda receptors disappeared the latent periods of glyt inhibitors and potentiated the antiallodynia effect. glycine receptor antagonist, strychnine by i.t. injected reversed the antiallodynia effect of i.v. injected glyt inhibitors. these results suggest that both glyt and glyt inhibitors by enforcing glycinergic inhibitory neurotransmission in spinal cord produce potent antinociceptive effect and may be novel candidate for medicament of pain control. the tumour microenvironment in particular tumour associated macrophages (tams) play a role in determining tumour outcome. despite strong causative links between inflammation and human gastric cancer progression, little is known of the role of tams in this disease. we have utilized our mouse model of gastric tumourigenesis, the gp ff mouse to assess the effect of the gp ff mutation on macrophage function and ascertain the role of macrophages in tumor formation. this mouse has a knockin mutation in the il- family cytokine receptor gp preventing shp /ras/erk signaling and leading to constitutive stat transcriptional activation. tumour development is inflammation dependent, there is a requirement for il- , and development is inhibited by nsaid treatment or microbial eradication, however an adaptive immune response is s inflamm. res., supplement ( ) posters dispensable for tumorigenesis. in gastric antrum the gp ff mutation results, decreased erk / activation and constitutive phosphorylation of stat , abnormal signaling is replicated in macrophages. antral stat activation is unaffected by depletion of il- . however in macrophages an absence of il- results in higher stat activation demonstrating the anti-stimulatory role of il- on macrophages. the gp ff mutation results in macrophages with decreased il- and increased inos mrna expression reflecting a more basally activated phenotype. manipulations of the gp ff mouse that reduce tumor size (eg. antibiotic or nsaid treatment or stat hemizygosity) coincidently result in reduced macrophage infiltration of antral mucosa. macrophages of gp ff mice display aberrant gp signaling potentially resulting in exaggerated response to stimuli. the key difference between mutant gastric mucosa and macrophages are changes in transcription of target genes. ( ), y riffo-vasquez( ), s brain( ), s costa ( ) ( ) university of s¼o paulo, brazil ( ) king's college london, uk objectives: we have previously shown that simultaneous intra-tracheal injection of diesel exhaust particles (dep) and , -naphthoquinone ( , -nq) caused a potent inflammation in rat airways partially dependent on neurogenic-mediated mechanism. this study investigates the mechanism of action of thee pollutants using inflammatory assays and histopathological approach in the lung and trachea of wild type (wt) and trpv knockout (ko) mice exposed to dep and , -nq. dep ( mg/kg) and , -nq ( nmol/kg)-induced airway inflammation was assessed via i-labelled albumin h post pollutants injection. mpo assay and histopathology were performed h after treatment. staining of lung and trachea specimens with h&e provided a profile of cell infiltration in both wt and ko animals. results: injection of dep and , -nq evoked a potent plasma extravasation into the trachea and lung of wt, but not trpv ko, suggesting these pollutants act via a trpv -mediated mechanism. in contrast, mpo activity in the airways of trpv ko mice was exacerbated compared to wt mice data. likewise, the histopathology revealed high numbers of leukocytes and macrophages infiltrated into the lungs and trachea of trpv ko mice compared to wt. conclusions: inhibition of increased microvascular permeability in the airways of trpv ko mice treated with pollutants suggests that these receptors are the predominant mechanism involved in the inflammation. however, neutrophils/macrophages accumulate more in trpv ko, indicating that the lack of trpv receptors up-regulates production of inflammatory cells in response to pollutants, thus supporting a protective role for trpv receptors. acknowledgements: capes, cnpq, fapesp. ( ), n sato( , ), y endo ( ), s sugawara ( ) ( ) division of oral immunology, department of oral biology, tohoku university graduate school of dentistry, sendai, japan ( ) division of fixed prosthodontics, department of restorative dentistry, tohoku university graduate school of dentistry, sendai, japan biotin is a water-soluble vitamin of the b complex and functions as a cofactor of carboxylases.biotin deficiency causes alopecia and scaly erythematous dermatitis.moreover, serum biotin levels are significantly lower in atopic dermatitis patients than in healthy subjects, indicating that biotin deficiency is involved in inflammatory diseases.however, immunological effects of biotin on allergic inflammation remain unclear.in this study, we investigated the effects of biotin-deficiency on metal allergy using nickel (ni)-allergy model mouse and a murine macrophage cell line j . . female balb/c mice ( weeks old) received a basal diet or a biotin-deficient diet for weeks.ten days after sensitization with intraperitoneal injection of lps and nicl , the mice were challenged with intradermal injection of nicl into the pinnas.allergic inflammation was measured by ear swelling.the ethical board for nonhuman species of the tohoku university graduate school of medicine approved the experimental procedure followed in this study.j . cells were cultured in biotin-sufficient or deficient medium for weeks. ear swelling was significantly higher in biotin-deficient mice than biotin-sufficient mice.il- beta productions by splenocytes were significantly higher in biotin-deficient mice than in biotinsufficient mice.moreover, biotin-deficient j . cells produced il- beta significantly higher than biotinsufficient j . cells.to investigate the therapeutic effects of biotin-supplementation, biotin-deficient mice received biotin contained-water for weeks.ear swelling was significantly lower in biotin-supplement mice than biotin-deficient mice.these results indicated that biotindeficiency deteriorates allergic inflammation.the augmentation of il- beta production is probably involved in those deteriorations. one of the most important targets of cytokine action is the blood vessels, which undergo some structural and functional changes that result in activation of endothelium. applying the elisa technique, levels of il- , icam- and e-selectin were studied in patients with acute pancreatitis. mediators levels were studied in arterial, venous and pancreatic ascites samples. according the atlanta criterion the mild pancreatitis was established in patients and severe -in patients. the highest levels of il- were noted in ascites and lowest in arterial samples. the highest concentration of adhesion molecules was in venous samples and lowest in ascites. it was a clear correlation between levels of il- and adhesion molecules and severity of pancreatitis. during first week the levels of il- gradually increased in patients with severe pancreatitis, while in patients with the edematous pancreatitis its levels decreased starting from the third day. icam- levels gradually increased during first three day with the following decrease after this term. the highest levels of e-selectin were noted at the time of admission. the clear correlation between il- and adhesion molecules was noted in both groups of patients. besides that, the clear strong correlation was observed between il- and quantity of circulating granulocytes and between e-selectin and hematocrite in patients with necrotizing pancreatitis. our study confirms the importance of activation of endothelium as a part of the systemic inflammatory response in patients with acute pancreatitis. subsequently eos infiltrate the tissues, are activated, and release mediators inducing the late phase response. this is characterized by tissue damage and repair, and in chronic reactions, tissue remodeling and fibrosis. mc/eos cross-talk by physical and non-physical contact is an essential feature of late-phase and chronic allergic reactions. we have previously described an mc/eos interaction facilitated by soluble mediators and shown to enhance allergic inflammation. still, pathways that mediate mc/eos cross-talk in allergy are not fully characterized. methods: human cord-blood derived mc were cocultured with peripheral blood eos, and activated with anti-ige. mc/eos couples in co-culture and in human nasal polyp tissue sections were specifically stained and counted using microscopy. expression of surface molecules was analyzed by facs. mc activation was measured by chromogenic assays for â-hexosaminidase. relevant surface molecules were neutralized using antibodies, to assess interference with couple formation and activation. results: mc and eos physically interact, forming welldefined couples in-vitro and in-vivo. in the presence of eos, mc are more releasable under baseline or igeactivating conditions. this effect is partially mediated by cd and dnam- on mc, and b and nectin- on eos. we describe a novel physical interaction between mc and eos that we name "the allergic synapse". this synapse may upregulate allergic reactions, thus serving as a target for therapeutic intervention in allergic and inflammatory diseases. methods: mc were obtained from cord blood mononuclear cells ( - weeks with scf, interleukin- and prostaglandin e , cbmc). cbmc were activated, after their culture for days with myeloma ige ( mg/ml), by rabbit anti-human ige antibodies ( mg/ml), for , and h at c. activation was measured by b-hexosaminidase release, determined by enzymatic-colorimetric assay. the expression of flip, mcl- , bcl- , bcl-xl, bak and bax was assessed by immunoblot analysis. results: two anti-apoptotic proteins were found to be upregulated: flip, which is involved in the extrinsic apoptotic pathway and mcl- that is mainly implicated in the intrinsic apoptotic pathway. in contrast, the expression of two other anti-apoptotic proteins that we have examined (i.e. bcl- and bcl-xl) was not altered. likewise, the expression of pro-apoptotic proteins from the bcl- family (i.e. bak and bax) was either undetectable or unchanged. conclusions: our findings reveal that ige-dependent activation of human mc mainly induces the selective increase in the expression of two pro-survival molecules. this may be one of the mechanisms that underlay mc hyperplasia in the chronic allergic inflammation. ( ), c armishaw( ), z yang ( ), h cai ( ), p alewood( ), c geczy ( ) ( ) university of new south wales, faculty of medicne, sydney, australia ( ) university of queensland, institute for molecular biosciences, st lucia, australia purpose: human s a , s a and s a are closely related proteins associated with inflammation. s a is expressed in the human genome, but not in the mouse. s a is a potent monocyte chemoattractant and mast cell (mc) activator. mouse (m) s a and human (h) s a share % structural identity, but the hinge domains are more divergent. the ms a hinge (ms a - ) is a potent chemoattractant for leukocytes whereas this sequence in hs a (hs a - ) is inactive. methods: s a hinge domain and its alamine scan mutants were synthesized and their activities were tested by using thp cells or murine mc in vitro and mouse footpad injection. results: s a hinge domain (s a - ) was chemotactic for monocytes and mc and provoked mc degranulation in vitro and oedema, and leukocyte recruitment in vivo. in contrast to s a , the hinge domain only weakly induced cytokine production (il , il ) by macrophages. residues essential for oedema were hydrophobic in nature (leu , isoleu , isoleu and isoleu ). n and i were essential for responses provoked by - m s a - whereas mutation of k , l , n , i , d , k and i significantly reduced migration with - m s a - . conclusions: s a and ms a may be functional chemattractant equivalents; s a may have arisen by duplication of human s a . isoleucine residues in s a hinge domain are essential for its proinflammatory properties. ( ), g kiriakopoulou ( ), e tsimara( ), a voultsou( ), k zarkadis ( ) ( ) general hospital of zakynthos, greece ( ) medical centre of katastari, zakynthos, greece schistosome is a disease which pests in tropical countries. the endemic areas are south america, far and middle east, and africa. our aim is to present an incident which concerning a parasitic infection, not endemic in greece. patient: man years old who immigrated from pakistan (at the side of the aparkenar river) in greece, a year ago. he turned out with anlage, headache and weight loss. he is a swimmer. he mentioned also a fever before migrating to greece. clinically: largely-scaled paleness, stomach -mild and diffused sensitivity, with also lightly increased enteric sounds and a small degree of hepatomegaly, when palpated deeply. laboratory examination: leucocytes . eo . %, hb . g/dl, ht . %, mcv , fl, mch . pg, thrombocytes . , blood sedimentation mm, fe mg/ml, ferritin . ng/ml. normal biochemical examinations. u/s: livers size lightly increased . mm, hepatoportal vein with normal amplitude. parasitology of feces: in the immediate confection with lugol of the second sample, there were observed: big scattering oval ovules ( - mm) with a thin wall and quills on the side, as well as three imago worms (> mm): schistosoma mansoni. treatment: praziquantel was given. recheck in a months time: blood examinationleucosites . , eo . %, hb , g/dl, ht . %. parasitology of feces is negative. in the diagnosis of anemia combined with fever, to patients who are immigrants, schistosomiasis posters inflamm. res., supplement ( ) should be taken into account, especially when sideropenic anemia is accompanied with intense eosinophile, because the disease is mostly a reaction of retardate supersensitivity. bronchial asthma is a chronic airway inflammatory disease caused by immune cells such as t lymphocytes and eosinophils. recently, high-sensitivity crp (hs-crp) has become available for detecting small changes in crp levels within the normal range, allowing for assessment of subclinical inflammation. this study was undertaken to investigate the relationship between hs-crp and bronchial asthma. we collected blood samples from patients with bronchial asthma with or without attacks and measured serum eosinophil cationic protein (ecp) and pulmonary function as well as serum hs-crp. serum crp levels in patients without attacks (average . mg/ l; p < . ) and with attacks (average . mg/l; p < . ) were significantly higher than those of normal controls (average . mg/l). serum hs-crp levels were inversely correlated with fev . % in asthmatic patients (r = - . , p < . ). in conclusion, these results indicate that serum hs-crp as well as ecp may be related to the state of asthma exacerbation and allergic inflammation. objectives: the pshr assay can be used to test the biologic activity of allergens since it mimics the effector phase of a type i hypersensitivity reaction. in this study we tested methods for removing ige-antibodies (stripping) from donor basophils. moreover a method was developed for improving the antigen specificity profile in pshr. proof-of-concept was provided using absorption with complete allergen extracts. methods: buffy coats were screened to exclude reactivity against relevant allergens. subsequently pbmcs were purified and basophils were stripped with either lactate or a phosphate buffer. cells were passively sensitized with patient sera and challenged with allergen extracts in various concentrations. released histamine was measured spectrofluorometrically (hr-test, reflab). cutoff was % hr. for absorption experiments patient sera (from a peanut allergic and a codfish allergic patient) were incubated with streptavidin-coated sepharose beads coupled with biotinylated allergens (peanut, and bsa as control). after centrifugation the supernatant was used to passively sensitize stripped basophils. hr was measured as described above. results: stripping experiments using the two buffers only partially removed surface ige but passive sensitization of stripped basophils was equally effective enabling determinations of sub-nanogram quantities of peanut allergen. absorption experiments showed that it was possible to specifically remove peanut specific ige from patient serum. removal of specific ige reactivity to peanut extract was verified by western blotting. conclusions: using peanut extract as a model it was demonstrated that in pshr antigen specificity can be modified. ( ), sk bk( ), v sharma( ), rp bhandari ( ) ( ) nepal medical college teaching hospital, nepal ( ) all india institute of medical sciences, new delhi, background: nepal has one of the highest maternalmortality rates in the world. this study was to evaluate the incidence, disease pattern, and risk-factors for thromboembolism in pregnant nepalese women. methods: women with thromboembolic diseases were identified and their case records retrieved and reviewed s inflamm. res., supplement ( ) posters from january to december . demographiccharacteristics were compared between women with and without thromboembolism. the total number of deliveries over the study period was , , giving an incidence of . per deliveries. there were two cases of pulmonary-embolism and one resulted in a maternal-death. the others had deep-vein-thrombosis of which over % were limited to calf veins only. the ultrasound-examinations requested for suspected deep-venous-thrombosis before and after the event of maternal-death were . and . per deliveries (p <. );the corresponding cases of deepvenous-thrombosis diagnosed were . and . per deliveries, respectively (p <. ). the majority ( %) of cases were diagnosed in the postpartum period, mainly after cesarean-delivery. women with venous-thromboembolism were older, had higher bmi, and a higherincidence of preeclampsia. there were approximately twice as many postpartum as antepartum events. bloodgroup a, multiple-pregnancy, caesarean-section, cardiacdisease, delivery at gestational-age of < weeks, a bmi of , or more and maternal-age of or over were all found to increase incidence of venous-thromboembolism. the long-standing belief that thromboembolism is rare among nepalese is at least partly because of undiagnosis most of these events are deep-veinthromboses occurring in the postpartum period and it is very essential for primary prevention developing country like nepal. ( ), ch ladel ( ), t ruckle( ), c rommel( ), r cirillo ( ) ( ) rbm-merck serono, colleretto giacosa, italy ( ) serono pharmacological research institute, geneva, switzerland rheumatoid arthritis (ra) is a severe articular disease. massive leukocyte activation and infiltration into joints result in cartilage and bone destruction. blockade of pi k signalling pathway has been demonstrated to be curative in a murine model of ra, collagen-induced arthritis (cia). in this study we explored the molecular mechanisms by which pi k signalling inhibition resulted in clinical amelioration of disease symptoms. as , a novel isoform non-selective, yet specific class-i-pi k inhibitor, administered at mg/kg twice-a-day for days, to mice showing signs of arthritis, paw swelling and inflamed digits, induced a significant amelioration of disease course. at the end of treatment, post-arthritic paws were removed and phosphrylation levels of akt (p-akt), downstream target in pi k-mediated signal, were determined by semi-quantitative immunohistochemistry, also immunophenotyping of circulating cells by flowcytometry was conducted. akt phosporylation resulted to be significantly enhanced by disease induction and as was able to decrease its levels down to values comparable with naïve animals. controls and as treated mice were bled before treatment, after two days of treatment and at treatments end. no changes in cellular composition (morphology and hematology parameters) between experimental groups were observed. t cell number was not affected, however a significant decrease of natural-killer, memory and regulatory t cells was observed after as administration. finally, a non-significant, moderate reduction of bcell number was also observed. these data demonstrate that efficacy of as in arthritis models is mediated by direct modulation of the target resulting in a mixed anti-inflammatory (via pi kg) and immunosuppressive (via pi kd/a/b) activity. ( ) ( ) institute of biomedical science, university of sao paulo, brazil ( ) ibilce -sao paulo state university, brazil epidemiologic data suggest that female sex hormones are involved in the pathophysiology of allergic asthma. we investigated in rats the immunomodulatory potential of estradiol and progesterone on the expression of allergic asthma. seven days after being ovariectomized (ovx), groups of rats were sensitized with ovalbumin (oa). fourteen days after sensitization, the animals were oachallenged and used day thereafter. allergic,shamoperated animals were used as controls. some ovx animals were treated with estradiol ( ìg/kg) or progesterone ( ìg/kg) h before being challenged. mast cell degranulation was quantified in samples of isolated, oa-challenged bronchi. the airway reactivity of inner bronchi to methacholine and the functional activity of cells we analysed. ovx caused reduction of the allergic lung inflammation and bronchial hyperresponsiveness with regard to intact female rats. estradiol reverted the reduced cellular recruitment into lungs, whereas progesterone reduced the pulmonary inflammatory response and reverted the bronchial hyperresponsiveness. cultured bal and bone marrow cells from allergic rats increased posters inflamm. res., supplement ( ) s the release of il- and reduced that of il- and tnf. the release of il- by bone marrow cells was significantly reduced. these effects were reverted by estradiol, and progesterone reduced il- and increased il- production in bal and increased that of il- and tnf in bone marrow cells. bronchial mast cell degranulation upon direct contact with oa in ovx rats was less than in controls. it is suggested that female sex hormones can modulate the allergic lung inflammation in rats by acting on cellular migration/activity and airway responsiveness. objectives: to study the participation of fsh on modulation of e-and l-selectin, icam- and mac- expression in ovariectomized (ovx) rats made allergic. methods: female rats were sensitized (oa/alumen) after (ovx- ) or days (ovx- ) of ovx or sham-operated (sh). fourteen days thereafter animals were challenged (oa, %; aerosol) and sacrificed h after. bronchoalveolar lavage (bal) was collected and flow citometry analyses oficam- , mac- and l-selectin expression was studied. in parallel, lungs were frozen and sections were analysedfor e-selectin expression by immunohistochemistry. results: at day , e-selectin expression increased(ovx- = , ae , ) and at day , decreased (ovx- = , ae , ) as compared to respective controls (sh- = , ae , ; sh- = , ae , ). estrogen treatment reverted this profile in both groups (ovx- +e= , ae , ; ovx- +e= , ae , ). mean fluorescence intensity of bal cells showed increase of mac- expression (ovx- = ae , vs sh- = , ae , ), icam- (ovx- = , ae , vs sh- = , ae , ) and l-selectin (ovx- = , ae , vs sh- = , ae , ) at day i.e., ovx- group. on the other hand, we observed a decrease in icam- (ovx- = , ae , vs sh- = ae , ) and mac- expression (ovx- = , ae , vs sh- = , ae , ) was seen in ovx- group. conclusions: oscillation of hormone levels during immunization with oa increased (ovx- ) and decreased (ovx- ) expression of adhesion molecules. estradiol treatment reverted this effect. this results suggest that fsh modulates the ali in rats by acting on cell ( ), s lim ( ), y lin ( ), bp leung ( ), c thiemermann ( ), wsf wong ( ) ( ) national university of singapore ( ) the william harvey research institute, london, uk glycogen synthase kinase b (gsk- b) is known to regulate various cellular functions including inflammatory responses. we hypothesized that inhibition of gsk- b may have anti-inflammatory effects in a mouse asthma model. balb/c mice were sensitized with ovalbumin (ova) and challenged with aerosolized ova. tdzd- , a non-atp competitive gsk- b inhibitor, was administrated by i.v. injection one hour before ova challenge. tdzd- significantly reduced the ova-induced eosinophilia in a dose-dependent manner and inhibited the levels of il- , il- and eotaxin in bronchoalveolar lavage (bal) fluid. tdzd- also suppressed the mrna levels of icam- , vcam- and chitinase proteins in the lung. histological studies revealed that tdzd- substantially reduced the inflammatory cell infiltration and mucus secretion in the lung tissue. tdzd- also decreased ova-specific ige level in the serum. in addition, ova-induced increase in airway resistance and reduction in dynamic compliance were attenuated by tdzd- . our findings suggest that inhibition of gsk- b may have therapeutic potential for the treatment of allergic airway inflammation. ( ), a yildirim ( ), f ercan ( ), n gedik ( ), m yuksel( ), inci alican ( ) ( materials and methods: sprague-dawley rats ( - g) were exposed to oc (burn group) or oc water bath (control group) for s under ether anesthesia. adm ( ng/kg; s.c) was administered min before burn and all rats were decapitated h after the burn insult. trunk blood was collected for the measurement of tnf-alpha level and the lung, ileum and kidney samples were stored for microscopic scoring and for determination of lipid peroxidation (lp), myeloperoxidase (mpo) activity and formation of reactive oxygen metabolites (roms) using chemiluminescence assay. results: burn resulted in severe morphologic damage in tested tissues. lp increased in lung and kidney (p< . - . ) and mpo activity showed a marked increase in all tested tissues (p< . ) of the burn group. adm reversed these parameters effectively (p< . - . ). luminol chemiluminescence levels showed increases in both ileum and lung (p< . - . ) whereas lucigenin chemiluminescence levels increased in ileum and kidney (p< . ) of the burn group. adm treatment was also beneficial in reducing chemiluminescence levels near to controls (p< . ). adm reduced plasma tnf-alpha level (p< . ) which showed a significant increase in burned animals compared to controls (p< . ). conclusions: adm is beneficial in remote organ damage following burn insult via decreasing neutrophil infiltration, rom generation, lp, and the release of proinflammatory cytokine tnf-alpha. kalpana panday ( ), sd joshi ( ), kr reddy ( ) ( we determined the crystal structure of human hematopoietic prostaglandin (pg) d synthase (h-pgds) as the quaternary complex with glutathione (gsh), mg +, and an inhibitor, hql- , with anti-inflammatory activities in vivo, at . resolution. hql- was found to reside within the catalytic cleft between trp and gsh in the quaternary complex. hql- inhibited h-pgds competitively against the substrate pgh as well as noncompetitively with respect to gsh. surface plasmon resonance analysis revealed that hql- bound to h-pgds with an affinity that was -fold higher in the presence of gsh and mg + than in their absence. hql- inhibited selectively pgd production by human h-pgds-expressing megakaryocytes but only marginally affected the production of other prostanoids, suggesting the tight functional engagement between h-pgds and cyclooxygenase. orally administered hql- inhibited antigen-induced production of pgd , and airway inflammation in mice without affecting the production of pge and pgf f¿. knowledge about this quaternary structure should accelerate the structure-based development of novel anti-inflammatory drugs that inhibit pgd production specifically. introduction: it has been proved that high levels of mechanical ventilation produce lung injury as well as local inflammation. this study was designed to evaluate how the generation of inflammatory mediators by an over-stretched lung affects the non-hyperventilated lung. methods: male wistar rats ( - g) were anesthetized and paralyzed, and the two lungs were independently intubated. differential ventilation was applied for h ( breath/min). one lung was subjected to hyper-ventilation ( ml/kg/lung) and the other was ventilated with a normal volume ( ml/kg/lung). in a control group, both lungs were ventilated with a normal volume. after sacrifice, samples of lung, plasma and liver were collected. the expression of the pro-inflammatory chemokine mip- was evaluated by rt-pcr and the edema was assessed by the ratio between the wet and dry weight of the lung. systemic inflammation was estimated in liver by measuring the expression of tnfa by rt-pcr as well as its levels in plasma. the hiper-ventilated lung showed an increase in the ratio between the wet and dry weight and in mip- expression compared to the normal ventilated lung. no differences were found in edema, neither expression of mip- between the normally ventilated lung and control lungs. no significant changes were observed in liver expression and plasma levels of tnfa as a consequence of unilateral lung hyper-ventilation. the over-straining caused to the hyperventilated lung leaded to a local inflammatory response without systemic effects. the normal ventilated lung is not affected by the inflammatory process triggered on the over-strained lung. ( ), j-y gillon( ), v lagente ( ), e boichot ( ) ( ) university of rennes , rennes, france ( ) serono international s.a., geneva, switzerland macrophage elastase (mmp- ) is a metalloproteinase involved not only in emphysema but also in the inflammatory process associated with copd (chronic obstructive pulmonary disease). the mechanism of action of mmp- in the development of pulmonary inflammatory process is still unknown. in the present study, we investigated the effect of recombinant human mmp- (rhmmp ) on il- /cxcl release from alveolar epithelial cell line a and we explored the underlying mechanisms. a cells were stimulated with rhmmp- ( . - - . - u/ml) during hours and il- /cxcl level in supernatant was determined by elisa. involvement of map (mitogen activated protein)-kinases was studied by western-blotting and also using chemical inhibitors. nfkb activation was examined with the transam nfkb p kit. we observed that mmp- elicited il- /cxcl release in a dose-dependent manner. this production could be prevented by a pretreatment for hour with a selective mmp- inhibitor (as - mm) or with the nonselective inhibitor batimastat ( - mm) . the il- /cxcl production was also inhibited by actinomycin d ( mg/ml), erk / inhibitors (u mm and pd mm) and nfkb inhibitors including bay - ( mm) and nfkb activation inhibitor ( nm), whereas p kinase inhibitor (sb ) had no effect. stimulation with mmp- was rapidly followed by a phosphorylation of erk / ( min) and an nfkb nuclear translocation and activation ( h). the nfkb activation was not inhibited by a treatment with u . these data suggest that alveolar epithelium is a target of mmp- since it upregulates gene expres-s inflamm. res., supplement ( ) posters sion and release of il- /cxcl , via erk / and nfkb activation, but these two pathways appears to be distinct. agents which are associated with lung inflammation, such as cigarette smoke and lipopolysaccharide (lps), induce the production of pro-inflammatory chemokines in lung epithelial cells in vitro, and the induction of interleukin (il)- , in particular, is often used a measure of relative toxicity.in this study we have compared mrna expression and mediator release in nci-h human lung epithelial cells exposed to lung toxicants, namely: cigarette smoke total particulate matter (tpm), lps, bleomycin, diesel exhaust particles, residual oil fly ash (rofa), carbon black and vanadyl sulphate.polystyrene, poly(methyl-methacrylate) and the tpm vehicle, dimethyl-sulphoxide were used as negative controls.confluent monolayers of h cells were exposed to serial dilutions of test agents in serum-free medium for hours.the conditioned medium was then removed and assayed for a range of pro-inflammatory cytokines and other selected mediators by luminex technology.the levels of gene expression of il- , matrix-metalloprotease- (mmp- ), the gel-forming mucin muc ac, heparinbinding epidermal growth factor-like growth factor (hb-egf) and the cytochrome p s cyp a and cyp b were determined by quantitative-polymerase chain reaction.all of the toxicants induced similar responses whereas the negative controls were largely ineffective.-such a panel of biomarkers may enable an in vitro assessment of the potential to cause lung inflammation.-moreover the use of several biomarkers could give a more accurate picture of toxicity than the determination of il- alone, particularly in the case of agents such as tpm, where the conventional vehicle is found to have some biological activity. respiratory tract infections are a major public health issue. prevention in high risk populations relies mainly on vaccination. vaccination is highly recommended in decrease absenteeism. immunomodulating drugs are important tools in the treatment of infectious diseases. immunomodulatory agents are probably contributive in decreasing exacerbation rates. the authors present different classes of immunomodulators that are currently in use. the vaccine, created from a bacterial protein, reeducates the immune system to stop inflammation. by preventing infections, vaccines prevent the development of a strong t helper (th ) response. the challenge is now to inform about new possibilities of an optimal prevention respiratory tract infections. deoxypodophyllotoxin (dpt) is a medicinal herbal product that is isolated from anthriscus sylvestri. that inhibits cyclooxygenase- (cox- ) and cox- dependent phases of prostaglandin d (pgd ) generation in bone marrow-derived mast cells (bmmc) in a concentration-dependent manner with ic values of . mm and . mm, respectively. this compound inhibited cox- and -dependent conversion of the exogenous arachidonic acid to pgd in a dose-dependent manner with an ic values of . mm and . mm, respectively. however, dpt did not inhibit cox- protein expression up to a concentration of mm in the bmmc, indicating that dpt directly inhibits cox- activity. furthermore, this compound consistently inhibited the production of leukotriene c (ltc ) in a dose dependent manner, with an ic value of . mm. these posters inflamm. res., supplement ( ) s results clearly demonstrate that dpt has a dual cox- / -lox inhibitory activity in vitro. therefore, this compound might provide the basis for novel anti-inflammatory drugs. in order to determine anti-allergic and antiasthmatic activity of dpt in vivo, we used rat pca model which was activated by anti-dinirophenyl ige and ovalbumin/alum induced mouse asthmatic animal model, respectively. as a result, dpt strongly inhibited pca reaction as well as it reduced infiltrated eosinophil numbers in bronchoalveolar lavage fluid. furthermore, dpt decreased the mrna levels of the th cytokines in a murine asthmatic model. in addition, northern blot analysis showed that dpt also reduced both the eotaxin and arginase i mrna levels in a dose dependent manner. these results suggest that dpt may be beneficial in regulating various inflammatory diseases. an imbalance of proteases and anti-proteases in the lung has been implicated in the pathogenesis of chronic obstructive pulmonary disease (copd), a smokingrelated disorder associated with accelerated lung function decline.in particular, the activity of matrix metalloproteases (mmps) have been implicated in driving both the inflammation and parenchymal destruction observed in copd patients.here, we tested whether a broad spectrum mmp inhibitor, pkf- , could block the inflammation induced by an acute exposure to cigarette smoke in strains of mice, balb/c and c /bl .animals were administered the compound ( - mg/kg) either per os (p.o.) or intranasally (i.n.) hour before and hours after exposure to smoke on three consecutive days.bronchoalveolar lavage (bal) was performed and lungs were flash frozen for inflammatory marker analysis.pkf- dose-dependently reduced lung neutrophilia in balb/c mice when dosed either p.o. (~ % at mg/kg; p < . )or i.n. (~ % at mg/kg; p < . ).however, the compound had no clear effect on bal neutrophil infiltration in c /bl mice by either route of administration.interestingly, in both strains bal macrophages dose-dependently trended towards an increase when the compound was dosed p.o. and decreased when dosed locally (p < . ). examination of lung tissue cytokine levels revealed that while smoke-exposure increases il- beta, kc, and mip- , pkf- had little effect on these cytokines.these data suggests the ability of broad spectrum mmp inhibitors to inhibit smoke-induced acute neutrophil inflammation is strain-dependent, while its ability to limit macrophage infiltration may be route dependent. to investigate the role of seh in the regulation of the pulmonary inflammatory response, we have used seh deficient mice in a locally administered lps model. male seh deficient mice (ko) and their wildtype (wt) littermates were exposed to inhaled lps.four hours later they were sacrificed and bal was performed. differential counts and cytokine levels in bal were evaluated. results: lps induced a significant increase in total cell number and neutrophil number in bal in the seh deficient mice and in wt mice;no significant differences between the groups were seen (table ) cytokine analysis showed significant increases in tnfalpha, il- , kc, gm-csf, mcp- , il- beta and rantes in the lps-exposed wt mice. no significant differences were seen between lps exposed wt and ko mice except for a significant increase in tnfa in ko mice. our results show that seh has no pivotal role for the regulation of the acute inflammatory response to lung administered lps. fam.liliaceae. based on literature data which signaled the presence of steroidic saponins in the rhyzomes, isolation, identification and quantitative determination of these compounds were done. the antiinflammatory activity was tested in non-immune chronic inflammation model:the cotton-pellets granuloma test in rats, and in an immune chronic inflammation model:arthritis test induced by freunds adjuvant in rats. in the first test, the antiinflammatory effect of steroidic saponins mg/kg is weak, statistically insignificant. in the arthritis test, steroidic saponins mg/kg proved an antiinfalammatory activity, influencing especially the primary response, but also the secondary one, in the last part of the experiment (after days). in both tests, the suprarenal glands weight was modified. objectives: dendritic cells (dcs) are professional antigen presenting cells. many types of dc with subtle difference in phenotype have been reported in several organs. existence of dc was reported in synovial tissue of rheumatoid arthritis (ra), however, the details in ra dc still remains unclear. in this study, we generated a new lineage of dc with gmcsf (+tnfa) and investigated their functions. furthermore the ability of osteoclastgenesis was examined. methods: monocyte-derived dcs or macrophage were generated in ( ) tnfa + gm-csf ( ) gm-csf ( ) il- + gm-csf ( ) mcsf. the phenotypes of these cells were analyzed by morphological examination and flow cytometry (facs calibur). cell proliferation was examined by wst- assay. dc functions were assessed in antigen presenting ability (mlr assay), cytokine production (elisa), and endocytosis (fitc-dextran uptake). concerning osteoclastgenesis, monocyte-derived dcs were incubated with rankl and mcsf. trap stain was performed and the resorption ability was assessed on osteologic cell culture system and dentine slices. results: these cells were dendritic-like and their surface markers were cd a low cd b + cd c + cd + cd + cd low hla-dr + dc-sign low and different from conventional dc or macrophage. they had an antigen presenting ability to induce na*ve cd + t cell proliferation, il- production and endocytosis. in the presence of rankl and mcsf, they differentiated multinuclear trap-positive cells with bone resorption ability, which was strengthened by tnfa. we generated a new lineage of dc with gm-csf (+ tnfa). the dc seemed to play a pivotal role in inflammatory arthritis under tnf immunity. the clinical effectiveness of rituximab and other b cellattenuating rheumatoid arthritis (ra) therapies has increased interest in understanding the role of b cells in ra pathogenesis.the possible mechanisms underlying the effectiveness of rituximab were investigated by performing biosimulation research in the entelos ra physiolab platform, a mathematical model of the joint of an ra patient.the platform dynamically integrates the contributions of immune cells (t cells, b cells, and macrophages), resident cells (fibroblast-like synoviocytes and chondrocytes) and mediators to the joint inflammation and structural damage observed in ra.the b cell lifecycle is represented in the platform, as well as effector functions such as antigen presentation, mediator and autoantibody production, and immune complex formation.the dynamics of these b cell properties were calibrated to reproduce reported experimental behaviors and clinical outputs from ra patients (e.g., acr score and radiographic progression rates).an assessment of the contribution of individual b cell functions to clinical outcome suggests that plasma cell-derived immune complexes are key modulators of inflammation in ra patients. in contrast, proinflammatory cytokine production by b cells contributes minimally to synovial hyperplasia, but plays a role in the progression of structural damage.immune complex formation leads to monocyte activation, increased mediator production by macrophages and an increase in antigen availability to t cells.biosimulation research in the ra physiolab platform is advancing our understanding of the mechanisms underlying effective b cell-targeting ra therapies, and may guide the development of improved second-generation therapeutic approaches. methods: the hmscs were obtained at the operation.the mononuclear cells were extracted and the colony forming assay were performed after weeks. the hmscs were cultured and in passage ,the cell surface antigens of both groups were analyzed by flow cytometory.in passage , in control group, the cells were cultured with beta glycerophosphate(bgp) and in osteogenic group, the cells were cultured with bgp and ascorbic acid(aa) and dexamethasone(dex).after weeks, alp staining and activity were measured in each group.after weeks, alizarin red s assays were performed.rna was extracted from the cells cultured with bgp and aa and dex for weeks and weeks and the gene expressions of bone formation markers were examined by real time pcr. the mann-whitney test was used for the statistical analyses. the colony forming assays showed no significant differences in oa and ra. in flow cytometory, the cell surface antigens in oa and ra were almost same.in alp activity,there were no significant differences in oa and ra.in alizarin red s, there were significant differences.in real time pcr,the gene expressions showed no significant differences in oa and ra. conclusions: the hmscs of ra will be able to use for regenerative therapy. silje vermedal høgh ( ), hm lindegaard ( ), gl sorensen ( ), a høj ( ), c bendixen ( ), p junker ( ), u holmskov ( ) ( cytosolic phospholipase a (cpla ) plays a crucial role in eicosanoid production, by releasing an arachidonic acid from membrane phospholipids. in addition, cpla regulates the phagocyte nadph oxidase-releasing superoxides and that is the only isozyme responsible for the production of eicosanoid in phagocytic cells. collageninduced arthritis (cia) in mice is an experimental model of auto-immune diesease with several clinical and histological features resembling rheumatoid arthritis in humans. previous studies show that cpla -deficient mice are resistant to cia. thus we aimed to study whether cpla is up-regulated during the development of cia and to detect its exact location in the inflamed joints. immunoblot analysis revealed an increase in the level of joint cpla protein during the development of the disease which correlates with the severity of the inflammation, as examined by paw thickness. immunohistochemistry with specific anti-cpla antibodies revealed low positive cpla protein levels in skeletal muscles, sebaceous glands and skin (epidermis, dermis) tissues of healthy paws. in the joints of the cia mice, large amounts of inflammatory infiltrate containing cpla were detected. in addition, robust cpla protein expression in the skeletal muscles surrounding the joints and strong cpla positive staining in sebaceous glands were detected. the high correlation between the severity of inflammation and the elevated cpla protein, due to an inflammatory infiltrate and increased cpla expression, suggests an important role of cpla in the development of arthritis. rheumatoid arthritis (ra) is the complex disease depending on environmental as well as genetic factors. in spite of the large research efforts we know in fact only small number of genes involved in this disease. animal models are useful tools for better understanding of the pathogenic mechanisms and genes leading to the disease process. the aim of the current project is to identify the genes and their functional role importance for arthritis. two loci associated with arthritis were identified using a cross between the b .q (intermediate susceptible) and nod.q strains (resistant to arthritis). one on chromosome a disease protective locus (cia ) and another on chromosome a disease-promoting locus (cia ). nod.q allele at cia promotes arthritis whereas cia , has a protective effect in contrast to the b .q allele on chromosome . a promising candidate gene in cia locus is complement factor (c ) as the nod.q allele produced defective c protein. cia locus contains several genes of potential importance for disease such as fc riib, fc riii, fc riv ncf , fh. the results of cia (collagen induced arthritis) and caia (collagen antibody induced arthritis) experiments using the subcongenic mice generated that contains fc r region showed a significant difference in incidence and severity of arthritis. the disease is controlled in a recessive pattern. the fragment devoid of fc r region seems to be protective. the subcongenic for the cia locus has been generated recently which will be tested for cia and caia susceptibility. the results from these experiments will be discussed in detail. angela pizzolla, ka gelderman, r holmdahl ncf is a component of the nadph oxidase complex, which produces reactive oxygen species (ros) upon activation into phagosomes and extracellularly. polymorphisms in the ncf gene that impair the capacity to produce ros, enhance susceptibility of both mice and rats to arthritis. activation of autoreactive t cells drives arthritis development but neither ncf expression nor oxidative burst have been detected in t cells. we hypothesize that antigen presenting cells influence t cell activity by producing ros during antigen presentation. we aimed to clarify the role of ros produced by dendritic cells (dc) on t cell activation. dc were grown from bone marrow from ncf mutated and wildtype mice. we could show that ncf mutated dc proliferated and differentiated better, had higher expression levels of costimulatory molecules and mhc ii upon stimulation as compared to ncf wildtype dc. in addition, ncf mutated dc induced higher levels of il- production by hybridoma t cells. to analyze the role of ncf in dc on arthritis, mice were developed expressing functional ncf restricted to dc (b .qdcn). these mice are characterized for burst, ncf expression and ability to present antigen. we published that immunization with myelin oligodendrocyte glycoprotein (mog) protein resulted in higher disease severity than immunization with mog peptide in ncf deficient mice. this suggests that ncf plays a role in the uptake and processing of posters inflamm. res., supplement ( ) s antigens, probably by dc. this will be further investigated with the b .qdcn mice using in vitro assays as well as in vivo models for arthritis and multiple sclerosis. purpose: macrophage migration inhibitory factor (mif) is a pro-inflammatory cytokine involved in both innate and adaptive immune responses. it is expressed in human ra synovial tissue and its suppression inhibits t or b cell dependent animal models of ra. we investigated the role of mif in k/bxn serum transfer arthritis. methods: arthritis was induced by injection of k/bxn serum on days and in littermate wt and mif-/-mice. arthritis was scored clinically, ankle thickness was measured using microcallipers, and joints collected for histology. sections were scored for synovitis, synovial fluid exudate, cartilage degradation and bone damage. results: wt mice exhibited arthritis as early as day and % incidence was observed on day . mif -/-mice exhibited delayed arthritis, with onset on day and % incidence on day . mif -/-mice exhibited significantly reduced disease severity as measured by clinical disease score ( methods: osteoarthritis was induced by bilateral transection of the medial meniscus in dunkin-hartley guinea pigs using minimal invasive surgery to avoid cartilage damage due to inflammation and/or intra-articular bleeding. results: the first signs of osteoarthritis development were macroscopically observed four weeks after meniscal transection. twelve weeks after surgery the lesions were still restricted to the medial side of the joint and did not reach into the subchondral bone. cartilage destruction due to meniscal transection was also histologically detected. however, biomarkers for cartilage destruction (ctx-ii, hp/lp ratio, comp) were not increased. treatments aiming at different processes in osteoarthritis, such as bone destruction (risedronate), inflammation (pioglitazone and anakinra), and cartilage destruction (galardin) were not effective in this model. the early degenerative changes in this transection model are probably too mild to be measured in the systemic circulation using classic biomarkers. further research into new biomarkers is needed to detect and monitor the early stages of osteoarthritis. the ineffectiveness of the compounds tested in this model underscores the urgent need for new strategies to treat the disease. the meniscal transection model might prove to be useful tool for identifying new biomarkers and treatments. livia l camargo ( ), a denadai-souza ( ), lm yshii ( ), a schenka ( ), ma barreto ( ), d boletini-santos ( ), c lima ( ), v rioli ( ), mn muscar ( ), e ferro ( ), sk costa ( ) ( methods: aia was induced via intraarticular (i.a.) injection of methylated bovine serum albumin in immunized male rats. knee oedema and pain score were assessed daily in controls and animals treated with hemopressin ( or ìg/day; i.a.). histopathological changes, cell number and cytokines in the synovial fluid of aia rats were determined at day . results: aia rats developed a severe mono-arthritis characterized by a joint oedema and pain. at day , there was marked cellular infiltration, hyperplasia, pannus formation and destruction of bone and cartilage, but pro-inflammatory cytokines were undetectable by elisa. both doses of hemopressin significantly reduced the knee oedema, but only mg of hemopressin attenuated the pain score. acute joint inflammation was significantly reduced by hemopressin, but failed to significantly affect chronic histopathological signs (hyperplasia, pannus etc.). conclusions: hemopressin has potential for treating acute signs of aia by reducing synovial plasma protein extravasation, alleviating pain and reducing acute joint histopathological changes, thus providing an alternative strategy for treatment of oedema and pain in arthritis. calcitriol, the hormonal metabolite of vitamin d and it synthetic analogs exert an anti-inflammatory action on psoriatic skin lesions while eliciting mild inflammation on healthy skin. the map kinase erk plays an important role in the induction of chemokines, cytokines and adhesion molecules in keratinocytes that maintain the epidermal inflammatory response.we hypothesized that the dual effect of calcitriol may be partially attributed to differential effects on erk activation in the presence or absence of inflammatory mediators. our experimental model was immortalized non-tumorigenic human hacat keratinocytes cultured in the absence of exogenous growth factors or active mediators. inflammation was mimicked by exposure to tnf. level and activation of signaling molecules were determined by immunoblotting. by using the specific egf receptor (egfr) tyrosine kinase inhibitor, ag , we established that tnf activates erk in an egfr-dependent and egfrindependent modes. the egfr-dependent activation resulted in the induction of the transcription factor, c-fos, while the egfr-independent activation was of a shorter duration and did not affect c-fos expression. treatment with calcitriol alone increased erk activation and c-fos induction. pretreatment with calcitriol enhanced egfr-dependent erk activation and tyrosine phosphorylation of the egfr, but completely abolished egfr-independent tnf-induced erk activation. pretreatment with calcitriol increased the rate of de-phosphorylation of activated erk, accounting for the inhibition of egfr-independent erk activation by tnf. it is possible that effects on the erk cascade underlie the dual action of calcitriol and its synthetic analogs on cutaneous inflammation. christina barja-fidalgo ( ), r saldanha-gama ( ), ja moraes ( ), r zingali ( ), c marcienkewicz ( ) ( ) universidade do estado do rio de janeiro, rio de janeiro, brazil ( ) universidade federal do rio de janeiro, rio de janeiro, brazil ( ) temple university, philadelphia, usa neutrophils adhere on vascular endothelium and directly migrate toward inflamed tissue to exert their primary defense function. integrin are receptors that drive cell adhesion and motility and interfere with cell activation, functions and survival.acting as both anchoring molecules and signaling receptor, transducing signals outsidein and inside-out, integrins are potential targets for therapeutic and diagnostic opportunities. disintegrins are a family of cystein-rich low-molecular weight peptides that usually contain an rgd sequence, a cell attachment site of ecm and cell surface proteins recognized by integrins. they are considered selective and competitive antagonists of integrins, being potent inhibitors of platelet aggregation and cell-cell/cell-ecm interactions. we reported that rgd-disintegrins, selectively interact with integrin amb , a b and/or avb ) on human neutrophils, interfering with cell functions through the activation of integrin-coupled intracellular signaling pathways. recently showed that, a selective ligand of a /a b integrins, vlo , induces neutrophil chemotaxis, cytoskeleton mobilization and potently inhibiting neutrophil spontaneous apoptosis. these effects are mediated vlo interaction with a b integrin, activating the focal adhesion cascade. vlo effects on the delay of neutrophil is modulated by pi k, erk- mapk and nf-kb pathways that seems to interfere with the balance between anti-and pro-apoptotic bcl- family members and with mitochondrial membrane potential. data emphasize mechanistic details of the role of a b integrins interactions on human neutrophils and support the use of disintegrins as prototypes to develop logical combinations of drugs to optimize or minimize the susceptibility of a selected target cell population to apoptosis during therapeutic interventions. (faperj, cnpq, capes, ifs-sweeden) ( ), h serezani ( ), m peters-golden( ), sonia jancar ( ) '( ) university of s¼o paulo, brazil ( ) university of michigan, usa it is been shown that leukotriene (lt) b and cysteinyl lt (ltc , ltd and lte ) enhances fcr-mediated phagocytosis in alveolar macrophages (am), dependent on protein kinase c (pkc). in contrast, ltb but not cyslt effects are exclusive on syk activation. in the present study we investigated the role of specific pkc isoforms and its upstream and downstream targets involved in lt-enhanced fcr-mediated phagocytosis. to this purpose, ams were pretreated or not with inhibitors of pkc-d (rottlerin - um), pkc-a (ro- - - nm), pi k (ly - um and wortmannin- nm), erk / (pd - um), cpla (aacocf - um), p mapk (sb - um) and ca++ (bapta/am- um), before stimulation with ltb or ltd and addition of igg-opsonized red blood cells for min. activation (phosphorylation) of signaling molecules by lts were analyzed by western blot. our results demonstrate that ltb -enhanced phagocytosis is dependent on pkc-a, while ltd effects are mediated by pkc-d. cell proliferation and differentiation, adhesion, cell activation and apoptosis. while galectin- mainly acts as an anti-inflammatory and pro-apoptotic molecule, galectin- is known as a strong pro-inflammatory and anti-apoptotic signal. we have recently recognized galectin- as a new molecular target of immunomodulatory drugs in monocyte/macrophage-like cells. in this study we investigated the effects of immunomodulatory drugs (aspirin, indomethacin, hydrocortisone and dexamethasone), applied in therapeutic ranges on the expression of galectin- at gene and protein level in monocytic thp- cells. we have also tested the effects of these drugs on both galectins in the cells activated by lipopolysaccharide from e. coli (lps). the targeted mrna level was evaluated using quantitative rt-pcr technique and the expression of both galectins in cell homogenates was determined by western-immunoblot analysis. the results showed that immunomodulatory drugs affected the expression of galectin- on both, gene and protein level, and that the effects were dependent on drug type and applied concentration as well as time of the exposure. the modulatory effects of the applied drugs on galectin- and - expressions were also observed in the cells activated by lps. these findings represent important step in the understanding of the effects of immunomodulatory drugs on galectin- and- expressions, as well as the role of these lectins in the physiology of monocytes. introduction: pancreatitis-associated protein (pap) has been recently described as an endogenous mechanism involved in the regulation of inflammation. in the present study, we show some of the molecular mechanisms implicated in the intracellular signaling pathways modulated by pap. the pancreatic human cell line panc was incubated with pap ( ng/ml) and/or tnfa ( ng/ml). total rna was obtained and the expression of tnfa was examined by rt-pcr. in addition, the effect of pap on nfkb activation was measured by inmunofluorescence in cells. western blot analysis was used to determine the expression of nfkb mediators: phosphorylated ikk, ikba and p . results: we observed that pap administration to cells prevented nfkb translocation to the nucleus as well as the tnfa-induced tnfa gene expression. when tnfastimulated cells were treated with cycloheximide in order to block protein synthesis, the induction of tnfa gene expression was completely restored. on the other hand, pap had no effect on ikk phosphorylation or ikba degradation. conclusions:in this study we have provided evidence that pap modulates the inflammatory response by blocking nfkb translocation to the nucleus. this pap-induced nfkb inhibition requires a jak/stat-dependent de novo protein synthesis. objectives: this study investigated the inhibitory mechanism of hyaluronan (ha) on lipopolysaccharide (lps)stimulated production of proinflammatory cytokines in u macrophages. methods: ha was added to u macrophage cultures in the presence of lps, with or without pretreatment with anti-intercellular adhesion molecule- (icam- ) antibody. secreted levels of tumor necrosis factor a (tnfa), interleukin (il)- b, and il- were determined by enzyme-linked immunosorbent assay. the phosphorylation of nuclear factor (nf)-kb, ikba, and mitogenactivated protein kinases (mapks) was analyzed by immunoblotting. results: lps stimulated production of tnfa, il- b, and il- . in contrast to kda ha, kda ha at mg/ ml inhibited lps-induced cytokine production. anti-icam- antibody blocked the effects of ha on the lps actions on u cells. lps activated nf-kb and mapk pathways, whereas ha down-regulated p nf-kb and ikba phosphorylation by lps without affecting mapks. inhibition studies revealed the requirement of nf-kb for lps-stimulated cytokine production. anti-icam- antibody reversed the inhibitory effects of ha on phosphorylation of p nf-kb and ikba. conclusions: ha of intrinsic molecular weight suppresses lps-stimulated production of proinflammatory cytokines via icam- through down-regulation of nf-kb and ikb. exogenous ha into arthritic joints could act as an anti-nf-kb agent by the mechanism demonstrated in the present study. the principal eicosanoid product of endothelial cox- is prostacyclin (pgi ), which is a potent vascular patency factor. induction of endothelial cox- under hypoxic conditions is well documented. this response, along with associated pgi release, is likely an important protective homeostatic response. in order to explore the role of candidate signalling agents in cox- expression in response to hypoxia, studies were undertaken using luciferase reporter constructs of the cox- promoter region in huvec. cox- induction under hypoxic conditions was confirmed with the wild type construct. strategic mutations of transcription factor binding sites showed that sites for hypoxia inducible factors (hifs) were more important for cox- expression than those for nfkb. furthermore, expression of cox- was increased under normoxic conditions by transfection of huvec with normoxia-stable hif mutants. emsa showed hif binding in nuclear extracts from untransfected hypoxic huvec. under these hypoxic conditions, increased release of pgi but not vaso-occlusive thromboxane a was seen. thus the putative protective induction of cox- in endothelial cells in response to hypoxia involves signalling by hifs. crescentic glomerulonephritis is characterized by crescent formation and rapid progress to renal failure, where the predominance of th immune response plays a crucial role. however, the therapeutic efficacy of the regulation of th -predominant immune responses remains to be investigated. therefore, the effects of a th selective inhibitor tak- were investigated in a model of crescentic glomerulonephritis in wky rats. methods: tak- was administered orally, starting at the time of induction of glomerulonephritis. in group , the drug was administered daily for the initial days. tak- was administered on day only in group , and from day to in group . in each group, nephritic rats were killed on days and . results: in group , glomerular damage, including crescent formation, was improved on day , with reductions in the numbers of cd , cd and ed- positive cells, as well as in urinary protein excretion. protein and transcript levels of th cytokines in the diseased kidneys were markedly decreased by tak- treatment. renal pathology, including glomerulosclerosis and interstitial fibrosis, was ameliorated and proteinuria was markedly decreased. elevated levels of serum creatinine showed concomitant improvement. in group , in which treatment was initiated shortly after the appearance of glomerular abnormalities, glomerular damage was also diminished, resulting in a decrease in urinary protein excretion. treatment only on the first day in group , partially rescued renal dysfunction. conclusions: these results suggest that the initial inhibition of th immune response has an appealing therapeutic potential for crescentic glomerulonephritis. parasitic nematodes and their hosts are now known to produce a wide range of galectins. whilst host galectins have been shown to modulate the recruitment and effector function of inflammatory cells including mast cells, neutrophils and eosinophils, the role of secreted parasitic galectins is less well defined. studies at moredun have demonstrated that both the endoparasitic helminth, haemonchus contortus, and the ectoparasitic mite, psoroptes ovis, produce galectin-like factors which, in vitro, directly influence the migration and survival of eosinophils from their natural sheep host. excretory-secretory extracts from both parasites contained potent chemokinetic activity and were also able to promote eosinophil survival in the presence of dexamethasone. separation by affinity chromatography, as well as specific sugar inhibition and mass spectrometric profiling, revealed the active components to be galectins. in the case of h. contortus, there was homolgy with known est sequences, which allowed subsequent cloning and expression studies to be undertaken. a functional in vivo role for these parasitederived galectins awaits confirmation, but the possibility is raised that they could directly influence the host immune response following infection. this may have particular significance in mite infections in which exudates from the associated eosinophilc lesion appear s inflamm. res., supplement ( ) posters to provide the primary nutrient source for their survival. moreover, the observation that two very different parasites may have evolved similar mechanisms for manipulating the host inflammatory response to their benefit, raises the further possibility that parasite galectins may provide potentially novel therapeutic targets. the aim of the study was to investigate the time course of cytokine gene expression in liver and lungs of mice with lipopolysaccharide (lps)-induced septic shock and to assess the effect of three different immunomodulatory agents on cytokine mrna levels in these tissues. male cd- mice were injected intraperitoneally with mg/kg lps alone or concomitantly with an intravenous dose of pentoxifylline ( mg/kg), lisofylline ( mg/kg) or prednisolone ( mg/kg). the tissues were harvested , , , , and h following lps administration and stored at - c. relative quantification of tumor necrosis factoralpha (tnf-alpha), interleukin- beta (il- beta), interleukin- (il- ), and interferon-gamma (ifn-gamma) mrna levels was performed by real-time rt-pcr. the highest levels of cytokine mrna were observed at or h after lps administration, whereas the expression of tnf-alpha and il- beta in lungs and il- in liver reached the peak values at h and then decreased gradually. in addition, the lps effects on cytokine mrna were more pronounced in liver when compared to lungs. all administered compounds inhibited the lpsinduced tnf-alpha mrna expression (by up to approximately %), whereas lisofylline significantly increased ifn-gamma mrna levels in both tissues at most investigated time points. for other cytokines, the observed differences did not reached statistical significance. in conclusion, with the exception of ifn-gamma, the time course of cytokine mrnas differed considerably depending on the type of tissue. in the murine model of lps-induced septic shock, only tnf-alpha gene expression was suppressed by all compounds under investigation. maria sanz( ), m losada ( ), c company ( ), c lope-gines( ), l piqueras( ), j cortijo ( ) the migration of leukocytes into inflamed tissues involves a cascade of molecular events finely regulated by cell adhesion molecules and chemokines. fractalkine/ cx cl (fr) is a membrane-bound chemokine that functions as a mononuclear leukocyte chemoattractant and as an adhesion molecule. clinical studies and animal disease models have shown that fr is also involved in the pathogenesis atherosclerosis. we have demonstrated that angiotensin-ii (aii) has proinflammatory actions inducing the initial attachment of mononuclear cells to the arteriolar endothelium. in the present study we have investigated whether aii can cause the synthesis and expression of fr on human umbilical arterial endothelial cells (huaecs). huaecs were stimulated with ang-ii microm or with tnfalpha ( ng/ml) for , and h. fr was determined in the culture supernatants by conventional sandwich elisa. fr was only detected after h and h stimulation with tnfalphafnwhereas aii was unable to provoke the cleavage of the chemokine. semiquantitative rt-pcr analysis of huaecs showed increased fr mrna expression in aii-stimulated cells for and h. these effects were caused by the interaction of aii with its at receptor since they were abolished by losartan (at receptor antagonist). tnfalpha also increased fr mrna. immunohistochemical analysis of the cultured endothelial cells showed a clear expression of fr in huaecs stimulated with aii or tnfalpha for and h. these results suggest that fr could be a key chemokine in the selective adhesion of mononuclear leukocytes to the arterial endothelium elicited by aii. the lipophilic yeast malassezia is an exacerbating factor in atopic dermatitis (ad).among organisms of the malassezia species, m. globosa and m. restricta are particularly dominant on the skin of ad patients. our previous study has demonstrated that human keratinocytes responded to the two malassezia species with different th -type cytokine profiles, i.e. m. globosa induced il- , il- , and il- secretion from the keratinocytes, whereas m. restricta induced il- secretion.these findings suggest that m. globosa and m. restricta play a synergistic role in triggering or exacerbating ad by stimulating the th immune response. pattern recognition receptors (prrs) of human keratinocytes play an important role in the induction of inflammatory and innate immune responses. in this study, we assessed the role of prrs for cytokine production by human keratinocytes in response to malassezia species. human keratinocytes were pretreated with various anti-prr monoclonal antibodies (mabs) and stimulated with m. globosa or m. restricta. cytokine secretion from keratinocytes was measured by using fast quant elisa kit. exposure of human keratinocytes to m. globosa and m. restricta resulted in enhanced secretion of il- and il- , respectively. the m. globosainduced increase in il- secretion was inhibited by mabs against cd and cd . in case of m. restricta, mabs against toll-like receptor (tlr ) and cd suppressed significantly il- secretion from keratinocytes. these findings suggest that the distinct prrs interactions with fungal pathogen-associated molecular patterns (pamps) are key factors in differential cytokine secretion from keratinocytes stimulated with malassezia species. atopic dermatitis (ad) is a chronic, relapsing inflammatory skin disease associated with allergy. mdc (macrophage-derived chemokine/ccl ) and tarc (thymus and activation-regulated chemokine/ccl ) are th type cytokines, and it has been reported that serum mdc and tarc levels are associated with ad disease. in present study, we investigated the effect of prunus yedoensis matsum barks on the inflammatory chemokines (mdc and tarc) and jak-stat pathway in hacat keratinocytes. as a result, etoac fraction and e sub-fraction inhibited the mrna expression and protein level of mdc and tarc in a dose-dependent manner. also, e sub-fraction showed inhibitory activity on the stat protein level. these results suggest that p. yedoensis may have an anti-atopic activity by suppressing the inflammatory chemokines (mdc & tarc). the il- family now consists of members, most of which have assigned functions.there are members of the il- receptor family (including the decoy receptor type ii il- r).many of the il- family members possess neither a signal peptide nor an apparent prodomain, but nevertheless manage to exit the cell.the il- family members il- f , f and f signal through a complex of the il- r family member rp in association with il- r acp to activate common inflammatory pathways.the specific activity is is low, on the order of - ug/ml ec .we have found that removal of a few n-terminal amino acids from il- f , f , f and f can increase their bioactivity approximately -fold. the location of the n-terminus leading to increased specific activity is quite specific; removal of one more or one fewer amino acid eliminates the effect.in addition, n-terminally truncated il- f is capable of antagonizing signaling via il- rrp , but full-length f is inactive. ( ) university of ulsan, japan kyoto university, japan inflammation plays a pathogenic role in the development of obesity-related complications such as type ii diabetes and atherosclerosis. tumor necrosis factor alpha (tnfa) is closely associated with the enhanced inflammatory responses in obesity and the obesity-related pathologies. tr (hvem/tnfrsf ), which is a member of the tnf receptor superfamily and the receptor for lymphotoxins-related inducible ligand that competes for glycoprotein d binding to herpesvirus entry mediator on t cells (light/tnfsf ), is a potent mediator of inflammatory responses. the purpose of this study is to examine the hypothesis that obesity-induced inflammatory responses can be attenuated by inhibiting tr pathway. c bl/ tr knockout mice and their wild-type control were fed a high-fat diet for weeks and the obesity phenotypes were determined in the obese tr knockout mice and the control. the obese tr mice fed a high-fat diet elicited the attenuation of body weight gain and insulin resistance relative to wild-type control mice. expression levels of inflammatory genes significantly decreased in the adipose tissue of the obese tr knockout mice compared with those of the control. our results demonstrate that obesity-induced inflammatory responses and insulin resistance can be attenuated in obese tr knockout mice fed a high-fat diet. objectives: the present study was undertaken to investigate the role of insulin on allergic airway inflammation. methods: diabetic male wistar rats (alloxan, mg/kg, i.v.) and controls were sensitized with ova ( ìg) and al(oh) ( mg, s.c.) days after alloxan or saline injection. the animals were challenged days later by the intratracheal instillation of ova ( mg/ . ml). the following analyses were performed h thereafter: (a) total and differential cell counts in bronchoalveolar lavage (bal) fluid; (b) quantification of tnf-alpha and il- beta in the bal by elisa; and (c) immunohistochemistry for p-and e-selectins on lung vessels. results: compared to the control animals, diabetic rats exhibited reduced number of neutrophils ( %) and mononuclear cells ( %); reduced levels of tnf-alpha ( %) and il- beta ( %), and reduced p-selectin expression ( %) in response to ova challenge. these abnormalities were corrected after treatment of diabetic rats with a single dose of nph insulin ( iu, s.c.), h before ova challenge. although we did not find differences in e-selectin expression between diabetic rats and controls, expression of this molecule was amplified by insulin. conclusions: data presented show that insulin controls neutrophils migration during allergic airway inflammatory possibly by modulation of tnf-alpha and il- beta production and selectin expression. supported by fapesp and pronex. hormonally active vitamin d derivatives are beneficial in the treatment of cutaneous inflammatory disorders, particularly in psoriasis. their anti-inflammatory effect is usually attributed to inhibition of the activity of infiltrating immune cells.we examined whether vitamin d also interferes with the pro-inflammatory action of the keratinocytes themselves. human hacat keratinocytes cultured in the absence of exogenous growth factors or active mediators were exposed to tnf to simulate an inflammatory challenge and their response was monitored by assessing mrna levels of the cytokine tnf, the chemokine il- and the adhesion molecule icam- by real-time pcr. icam and il- were induced rapidly peaking after h, their mrna levels increased again from h to reach a plateau between h to h after exposure to tnf, whereas tnf mrna levels increased steadily between h and h. h pretreatment with calcitriol, the hormonal form of vitamin d, inhibited induction of il- but did not affect that of icam- or tnf h following exposure while calcitriol markedly inhibited the induction of all pro-inflammatory genes h after the tnf challenge.calcitriol inhibits the activation of jun kinase (jnk) and p by tnf. this action was mimicked by the posters inflamm. res., supplement ( ) s jnk inhibitor sp and the p inhibitor sb .the combination of the two inhibitors fully reproduced the time and gene dependent modulatory effect of calcitriol. we conclude that vitamin d attenuates the active contribution of keratinocytes to cutaneous inflammation and that this modulatory effect is explained by inhibition of the jnk and p cascades. ( ), cm lotufo ( ), p borelli ( ), zs ferreira ( ), rp markus ( ), shp farsky ( ) ( ) department of clinical and toxicological analyses, school of pharmaceutical sciences, university of s¼o paulo, brazil ( ) department of physiology, bioscience institute,university of s¼o paulo, braziil introduction: we showed that endogenous glucocorticoids (eg) control neutrophil mobilizations from the bone marrow and peripheral compartment by modulating the expression of l-selectin on segmented cells. aims: we evaluated the role of eg on endothelial cells (ec) and the molecular mechanisms responsible for hormonal actions in neutrophils and ec. methods: neutrophils were collected from blood, segmented leukocytes from femoral bone marrow and ec were cultured from testis vessels. cells were obtained from adrenalectomized (adx), ru -treated, shamoperated, vehicle-treated and non-manipulated (nm) wistar rats. results: circulating neutrophils and segmented cells from ru -treated rats presented elevated and decreased expressions of l-selectin vs cells from control animals, respectively. the effects were not dependent on alterations of l-selectin mrna levels. ec from adx animals presented more ability to adhere neutrophils from nm rats and enhanced mrna levels and membrane expressions of icam- , vcam- and pecam- . participation of the glucocorticoid cytosolic receptor(gcr) on these effects was shown by similar results in cells from ru treated rats. nfkappab translocation in neutrophils was equivalent in all groups of animals, but it was enhanced in ec from adx or ru -treated rats. conclusions: data show the participation of the gcr on events involved in neutrophil mobilizations, but nfkappab transcription is only involved on ec. ( ), y naito( ), t okuda ( ), k mizushima ( ), t okayama ( ), i hirata ( ), h tsuboi ( ), t suzuki ( ), o handa ( ) background: despite the inhalation of co at high concentrations had been considered as a toxic gas, the inhalation of co at low concentration has recently been shown the cytoprotective and anti-inflammatory effect against various animal models. however, it is unclear whether the direct exposure of co to the intestinal inflamed mucosa is effective or not. in this study, we investigated the therapeutic efficacy of the rectal co administration for rat colitis model. acute colitis was induced with trinitrobenzene sulfonic acid (tnbs) in male wistar rats. co( ppm- ml) was intrarectally administrated twice a day after the induction of colitis. rats were sacrificed at days after the administration of tnbs. the distal colon was removed, and the ulcer lesions were measured. thiobarbituric acid (tba)-reactive substances and tissueassociated myeloperoxidase (mpo) activity were measured in the colonic mucosa as indices of lipid peroxidation and neutrophil infiltration, respectively. moreover, we evaluated the expressions of cinc- mrna/protein and p-p mapk protein. the intracolonic administration of co ameliorated tnbs-induced colonic ulceration. the increases in tba-reactive substances and mpo activity after tnbs administration were both significantly inhibited by treatment with co. moreover, the rectal administration of co significantly inhibited the increased expression of cinc- mrna/protein and p-p mapk protein after the induction of tnbs-induced colitis. the rectal administration of co protected from the intestinal inflammation in rats. based on these data, the beneficial effects of co on the intestinal mucosal injury may be attributed to its anti-inflammatory properties. alessandra gambero ( ), m maróstica ( ), m saad( ), j pedrazzoli jr ( ) ( ) s¼o francisco university medical school, brazil ( ) state university of campinas, brazil recent studies have shown that adipocytes produce and secrete several bioactive molecules like adipocytokines. the adipose tissue can also present short and long-term changes during inflammation and infectious pathologies. in this study, the alterations of mesenteric and perinodal mesenteric adipose tissue during experimental colitis induced by repeated intracolonic tnbs instillations were evaluated. the adipocyte size was measured after collagenase digestion. the basal lipolysis (glycerol release) and adipocytokine production was monitored after short time culture of adipose tissue. the colitis animals showed higher mesenteric fat mass ( . +- . and . +- . % of body weight for colitis and control, respectively; p< . ) in despite of the lower body weight. the mesenteric adipocytes from colitis animals presented reduced diameter ( . +- . and . +- . um for colitis and control, respectively; p< . ), higher basal lipolysis ( . +- . and . +- . ug.mg- for colitis and control, respectively; p< . ) and tnf-alpha production ( . +- . and . +- . ng.mg- for colitis and control, respectively; p< . ). perinodal mesenteric adipocytes presented normal diameters, higher basal lipolysis ( . +- . and . . +- . ug.mg- for colitis and control, respectively; p< . ), increased tnfalpha ( . +- . and . +- . ng.ml- for colitis and control, respectively; p< . ), leptin ( . +- . and . +- . pg.ml- for colitis and control, respectively; p< . ) and adiponectin production ( +- and +- ng.ml- for colitis and control, respectively; p< . ). the mesenteric adipose tissue was modified during the experimental inflammation, but some alterations were site specific. perinodal adipose tissue retained the ability to produce anti-inflammatory and pro-inflammatory cytokines, while mesenteric adipose tissue only the pro-inflammatory one. this work was financially supported by fapesp. inflammatory bowel disease (ibd) is a group of chronic inflammatory disorders of the intestine. the role of the pro-inflammatory p mapk signalling cascade in the pathogenesis of ibd is highly controversial. we therefore aimed to investigate the role of p mapk in chronic dextran sodium sulfate (dss) induced colitis, an experimental model of ibd. chronic intestinal inflammation was induced by oral cyclic administration of % dss in sjl mice. clinically, the dss treatment produced episodes of colitis manifested by diarrhoea, gross intestinal bleeding, marked loss of body weight, and shortening of the colon. at the molecular level, this was accompanied by an up-regulation of tnfa, il- â, il- , il- , kc, cox- , igg heavy chain, and phospho-stat in the dss treated mice.the clinical and molecular features described above recapitulate findings reported in human ibd. in order to assess the role of p mapk, the activation of the p mapk signalling cascade was analysed by western blot analysis. the expression and phosphorylation levels of both p mapk and of mk and hsp , two down-stream targets, were not increased in dss treated animals compared to controls. leo , a potent inhibitor of p activity in vivo, was dosed as pretreatment and after completion of dss treatment. pretreatment had a deteriorating effect on all measured cytokines, whereas treatment after disease induction had no effect on any measured parameters. collectively, these results strongly suggest that the p kinase pathway only plays a minor role, if any, in the dss model. (sp) were gmcsf differentiated, dcs purified through gr + cell depletion, and spleen tcells isolated by pan tcell negative selection. spdcs or bmdcs were stimulated +/- ng/ml lps. for mlr, balb/c tcells were added for days. cells were incubated with sb ( -( -fluorophenyl)- -( -ethylsulfinylphenyl)- -( -pyridyl) h-imidazole, sb) or ml ((rs)-{ -[ -( -fluorophenyl)- -methylsulfanyl- h-imidazol- -yl]pyridine- -yl}-( -phenylethyl)amine, ml) and washed prior to lps stimulation (bmdcs) or cell mixing (t cells). hthymidine incorporation was measured, cell viability by mtt assay, tnfa and il- production by elisa. mlr tcell proliferation inspdcs or bmdcs was inhibited by sb (ic spdc . mm, bmdc . mm) and ml (ic spdc . mm, bmdc . mm). preincubation with dcs had no effect, despite reduced lps stimulated il- and tnfa synthesis by sb (ic il- . mm, tnf . mm) and ml (ic il- . mm, tnf . mm). preliminary data shows that preincubation of t cells with sb and ml modifies the mlr response. p plays a role in the interaction of dcs and t cells in antigen recognition. however, pre-incubation of drugs with dcs was ineffective. the role of t cell p mapk in the mlr is under investigation. p inhibitors may possess disease modifying properties because of reduced tcell antigen reactivity to dc antigen presentation. ( ), s luik( ), s laufer( ), m seed ( ), v holan( ), s fiorucci ( ) ( ) synovo gmbh, tübingen, germany ( ) university of tübingen, germany in vivo anti-inflammatory activity of certain p kinase inhibitors is limited by bioavailability. however, it is possible that they may be useful in the therapy of ibd should it be possible to mediate there uptake in and around bowel lesions. we reasoned that activity could be especially increased if drug physical properties were altered to allow preferential partition into macrophages and neutrophils (wbc) associated with lesions. we prepared prodrugs of p inhibitors and screened them using whole human blood, murine spleenocytes and peritoneal macrophage. pharmacologically inert macrocycle (azilide) conjugates were assessed for enhanced efficacy in murine collagen induced arthritis either therapeutically (after onset of signs) or prophylactically ( d post boost) or in a dss or tnbs model of ibd in the mouse. in both types of models, the prodrugs achieved improved suppression of arthritis and inflammatory score in colon sections at tolerated doses with optimal activity at mmolkg- d- . we propose that the prodrugs increase efficacy via improved pharmacokinetics partly related to biased disposition of the prodrug toward immune cells. despite the potent anti-inflammatory and immunosuppressive properties of glucocorticoids its applying in the management of severe necrotizing pancreatitis is still controversial. the plasma levels of interleukins (il- , il- ) and adhesion molecules (e-selectin and icam- ) were measured in patients with necrotizing pancreatitis. the measurement was performed immediately after admission, at the , , and day. all patients were divided on two groups: first group compiled patients, in which dexamethasone ( mg/day during - days) was applied in the complex management of acute pancreatitis, and control group - patients that did not receive corticosteroids. all patients received the initial therapy. the increased levels of il- , il- , il- , icam- , and eselectin were noted in both groups of patients at the time of admission. the gradually increase of all proinflammatory mediators plasma levels up to seventh day was noted in patients of the control group. its levels clear correlated with the severity of mods and spreading of necrotic processes confirmed by ct. starting from the third day the gradually decrease of mediators levels were noted in the patients of the first group. the incidence of contamination of necrotic foci had no difference in both groups of patients. the ability of glucocorticoids to inhibit expression of proinflammatory mediators due to the glucocorticoids-mediated repression of nf-kappa b pathway provide the pathogenetic substantiation for the applying of glucocorticoids in the complex management of necrotizing pancreatitis. the objective of this study was to examine whether t cell specific overexpression of the th transcription factor gata- can inhibit th /th cell mediated experimental mbsa arthritis. mbsa-immunized wild type mice developed joint inflammation which gradually increased in time with a maximum at day . at day , t cell specific gata- tg mice did not show any difference in arthritis score compared to wild type mice. however, at day , wild type mice had developed severe joint inflammation having the maximum arthritis score. in contrast, gata- tg mice showed only mild joint inflammation, suggesting that t cell specific overexpression of gata- protects against development of severe joint inflammation. facs analysis revealed low levels of il- +/ifn-gammacells in wild type as well as in gata- tg mice at day . as expected, il- positive cells were higher in gata- tg mice compared with wild type mice. interestingly, at day , the percentage of il- +/ ifn-gamma-cells were markedly increased in wild type mice but not in gata- tg mice, suggesting prevention of th expansion under gata- overexpression in vivo. these data revealed that t cell specific overexpression of the th transcription factor gata- protects against progression of severe joint inflammation during mbsainduced arthritis. furthermore, il- +/ifn-gammacells play a critical role in the progression of joint inflammation in this model and gata- overexpression in t cells prevents expansion of the il- +/ifn-gamma-t cell subset. pingping jiang ( ), pt sangild( ), t thymann ( ), hh-y ngai ( ), w-h sit ( ), k-l chan ( ), jm-f wan ( ) ( necrotizing enterocolitis (nec) is a severe intestinal inflammatory disease for which the disease etiology and progression remain unclear. preterm delivery and enteral milk formula feeding are factors predisposing to nec. to understand the pathophysiology of nec, two-dimensional gel electrophoresis ( d page) proteomic approach was applied in studying changes in intestinal protein pattern in preterm piglets with spontaneous nec occurring in response to days of parenteral feeding followed by day of enteral formula feeding. the intestinal proteomes of pigs with clinical symptoms of nec (n = ) were compared with corresponding pigs remained healthy (n = ). syproruby staining was used and differently expressed proteins were identified by maldi-tof ms or maldi-tof/tof ms. the proteins with significantly different expression between nec and healthy pigs involve in energy metabolism (sorbitol dehydrogenase, mitochondrial aldehyde dehydrogenase and chain a, medium-chain acyl-coa dehydrogenase with -thiaoctanoyl-coa etc.), inflammation (peptide-binding protein (pbp ) and snail homolog ), signal transduction proteins (thyroid hormone binding protein precursor, park protein and chain b, structure of the rho family gtp-binding protein cdc in complex with the multifunctional regulator rhogdi etc.) and anti-oxidation (manganese-containing superoxide dismutase(sod)). these data underscore the significant impact of intestinal proteomics in unraveling nec pathophysiology and biomarker discovery. blood are used to monitor the progression of inflammation. the aim of our study were to investigate systemic markers of disease in a rat model of lps induced pulmonary inflammation to provide a link between preclinical in vivo research and early clinical research. animals were exposed to bacterial lipopolysacharide (e.coli :b ) by inhalation. the lungs were lavaged hours post provocation and the level of cell influx was determined. relevant mediators of acute pulmonary inflammation were analysed with standard elisa technology in bronchoalveolar lavage fluid and in blood. in addition, measurement of changes in body temperature were performed at different time-points post provocation in order to monitor the systemic inflammatory responses to the local pulmonary inflammation manifested as alteration in body-temperature. results showing the effects of lps challenge on local and systemic parameters will be presented and the possible link to lps responses in man discussed. pulmonary inflammation models are widely used in pharmacological research. however, provocations and treatments aimed directly at the lung are often invasive which limits the possibility to perform repeated administrations of test agents and compounds. also, results derived from bronchioalvelar (bal) fluid are subject to variability if the retrieval techniques are non standardized. here we describe a non-invasive standardized method for retrieval of bal fluid to be used in mice. we present the characterisation of these techniques using the inflammatory response to lps and propose that this non invasive method can be used to refine lps and other challenge models. the objectives were to evaluate the dynamic response after a single intra-tracheal administration of of mg ( ml/animal) of lps (p.aeruginosa) to c bl/ j mice. control animals received a single dose of sterile ml . % saline/animal. the mice were terminated , , , and h after instillation using a non invasive and operator independent lavage technique. results showing the effects of single lps challenge on bal parameters, excised lung gas volume and lung weight will be presented showing reliable dynamic responses. these techniques open the possibility to run repeated treatments and chronic provocations and are not subject to variability from bal fluid retrieval. the human psoriasis xenograft scid mouse model is one of the most accepted and well characterized models for screening of novel anti-psoriatic compounds. the model has primarily been applied for testing novel treatment principles via systemic or intradermal administration routes. in order to evaluate the model for topical treatment, psoriatic keratome biopsies were grafted to immune-deficient scid mice. transplanted mice were treated with daivonex /dovobet (calcipotriol) and bms (betamethasone). the results show a strong antipsoriatic efficacy after treatment with bms (epidermal thickness reduced by %). treatment with daivonex / dovobet also showed an anti psoriatic effect with a % reduction in epidermal thickness. serum did not contain test compounds, indicating that the observed effect were not due to systemic exposure. the observed effects are in concordance with clinical results of treatment of psoriasis. it is concluded that the model is useful for testing topical treatments. we have demonstrated that adult rats offspring of dams submitted to protein restriction during early lactation, presented impaired acute immune responses probably related to an imbalance in glucocorticoids and insulin secretion (barja-fidalgo; inflamm res ( ): ) . here, we evaluated the innate immunity mediated by neutrophils and host defense against infection in adult rats offspring of dams fed with either a protein free diet (un-group) or % protein diet (c-group) during the first days of lactation. un rats showed lower number of blood pmn, though no difference in bone-marrow neutrophils number was observed. blood neutrophils from un-group presented a significantly reduced phagocytic activity against opsonized zymosan, constitutively expressed inos and spontaneously produced o -, no and tnf-alpha. in vivo treatment with lps, at non-lethal doses, significantly increases tnf-alpha and superoxide production by neutrophils, compared with controls. lps increased no production by neutrophils from both groups, inducing inos expression in control cells, but no further increase in inos expression in un rats. nucleare nf-kb is constitutively augmented in un rats. un animals presented a higher survival rate in a model of clp-induced severe sepsis. these results indicate that a metabolic programming induced during early lactation affects the innate immune responses in adult rats, which are unable to properly mount an inflammatory response, may predispose to chronic diseases in adult life. transgenic mice over-expressing vascular endothelial growth factor (vegf) in the epidermal basal layer under the human keratin (k ) promoter have previously been reported to develop a psoriasis-like inflammatory condition in the skin. important hallmarks of psoriasis are epidermal hyperplasia in association with infiltration of t-cells in the dermis and epidermis and also increased dermal angiogenesis. the aim of this study was to describe the epidermal hyperplasia and the infiltration of the skin with t-cells in transgenic k /vegf mice. we induced a cutaneous inflammation in the ear skin by repeated topical treatments with -o-tetradecanoylphorbol- -acetate (tpa), in order to investigate the inflammatory response. the in vivo pharmacological effect of topical treatment with a number of reference compounds, including betamethasone- -valerate, was also investigated. the ear thickness was significantly increased in transgenic animals compared to wild type animals following tpa-induction. the epidermal thickness measured in histological sections of biopsies from the ear skin was also significantly increased in transgenic animals. furthermore, increased dermal vascularisation was observed in the histological sections of the ear skin. a marked infiltration with cd -positive cells was observed in both dermis and epidermis, and this was highly correlated with the increase in epidermal thickness. finally, topical treatment with betamethasone- -valerate significantly reduced the ear swelling and epidermal thickness. we conclude that over-expression of vegf in the epidermal basal layer plays an important role in skin inflammation and for the development of important psoriatic hallmarks. the model may furthermore be used as an in vivo screening tool for novel anti-psoriatic compounds. background and aims: the diabetes-prone bb (bbdp) rat spontaneously develops insulin-dependent diabetes resembling type diabetes (t d) in man. the bbdp rat is t-cell lymphopenic with a profound lack of regulatory t cells. the recent thymic emigrants in bbdp rapidly undergo apoptosis unless rescued from apoptosis by tcr stimulation. the increase in apoptosis is due to a frameshift mutation in gimap which causes a severe truncation of the protein. the mutation is the strongest genetic factor for rat t d. we aim to detect how gimap affects the lifespan of t cells. results: overexpression in c cells of both wt gimap and gimap with the bbdp mutation causes an increase in apoptosis -the latter with a very rapid onset. reduction of human gimap by rna-interference in jurkat cells did not affect the number of apoptotic cells. overexpression of human gimap causes apoptosis in jurkat cells and primary naïve t cells but not in activated t cells. finally, gimap -mrna is upregulated in in vitro activated human primary t-cells (detected by rt-pcr). conclusions: based on the phenotype of the bbdp, rat gimap was expected to be anti-apoptotic. however, we report here that overexpression of both mutated and wt gimap causes rapid death of the cells. this suggests that gimap is pro-apoptotic. the results with human wt gimap support this conclusion: recently, much focus has been on the cellular cd / cadpr signaling system during inflammatory processes. the cd /cadpr system has been shown to be regulated by interferon, estrogen and the proinflammatory cytokine il- . to our knowledge, the expression and function of the cd /cadpr signaling system in the human detrusor muscle have not been described. cd protein expression in cultured (explant technique) human detrusor smooth muscle cells (hdsmc) was demonstrated by western blot (wb) and confocal microscopy (cm). cytosolic free ca + concentration ([ca +] i) in hdsmc and isometric force in human detrusor strips were measured by spectrofluorometry and myograph technique, respectively. wb and cm showed that hdsmc expressed cell surface cd which could be upregulated by il- ( ng/ml). in hdsmc briefly activated with il- ( ng/ml) cadpr induced a rapid, transient dose-dependent increase in [ca +]i. cyclic adpr-mediated ca + increase was greatly reduced in ca + free medium suggesting ca + entry as well as ca + release. cyclic adpr -elicited ca + increase was mimicked by -deaza-cadpr, and blocked by -bromo-cadpr, a cadpr antagonist, but not by nifedipine or verapamil. in the presence of il- , cadpr caused concentration-dependent relaxations of detrusor muscle. we report for the first time that ) hdsmc express cell surface cd , ) the expression and function of cd are augmented by il- , ) externally added cadpr elicited a rapid, il- -dependent, and -bromo-cadpr-inhibitable ca + mobilization, ) cadpr induces relaxation of human detrusor muscle. the study indicates a role of cd /cadpr in human urinary bladder inflammation. miao lin is a formulation of sen miao san and lingzhi that consists of cortex phellodendri, atractylodisa rhizoma, radix achyranthis bidentatae, and ganoderma lucidum. these ingredients are reported to have anti-inflammatory and analgesic effects. in this study, we have investigated the anti-arthritic property of miao lin in an animal model of arthritis induced by unilateral injection of freunds complete adjuvant (fca) into rat knees. contents of the miao lin capsules were dissolved in saline and administered to the rats daily by intraperitoneal or oral route for days before induction of arthritis and days after. extension angle, size and blood flow of the rat knee joints were measured to give indexes of algesia, oedema, and hyperaemia, respectively. assessments of the extent of cell infiltration, tissue proliferation, and erosions of cartilage and bone provided additional indexes of the arthritis condition. single unilateral injection of fca into rat knees produced significant oedema, algesia, hyperaemia, immune cell infiltration, synovial tissue proliferation, and erosions of cartilage and bone in the ipsilateral knees compared with the contralateral saline-injected knees. intra-peritoneal injection of miao lin ( mg/kg/day) suppressed oedema, pain and hyperaemia in the inflamed knees, and oral administration ( mg/kg/day) suppressed oedema and hyperaemia. histological examination showed that both routes of administrations of miao lin reduced immune cell infiltration and erosions of cartilage and bone, and intraperitoneally administered miao lin also attenuated synovial tissue proliferation. these findings suggest treatment with intra-peritoneal or oral miao lin could provide significant anti-arthritic effects. an extract of the anti-arthritic thermalife cream contains trace elements. diffusion studies were undertaken to assess the permeability of human epidermis to the trace elements. non-penetrating trace elements were discarded from the test formula (t ), and compared with the original formula (t ) for in vitro anti-inflammatory efficacy (tnf-a secretion in lps-challenged human monocytes). methods: human epidermis was mounted in vertical franz type diffusion cells (stratum corneum facing up). t cream (n= ) or no cream (n= ) was applied to the donor compartment of diffusion cells, with pbs in the receptor compartment ( . ml ; stirred continuously at c). min after administration the receptor fluid was analysed for presence of metal ions by icp-ms. a replication study used a different skin donor. subsequently, human monocyte cultures ( % fcs, % co ) were either stimulated with ng/ml lps (e.coli :b ,) or not in the presence of % t , % t , or no treatment. hours after incubation, culture media were collected, centrifuged, and assayed (cytokine elisa). statistical analyses used a treat by lps anova (p < . ). results: zinc was the only trace element to penetrate the human epidermis significantly. both formulations strongly suppressed lps-induced tnf-a secretion. t with zinc only was more effective than t (treat:f , = . , p < . ; lps:f , = . , p < . ; treat by lps:f , = . , p < . ). conclusions: anti-tnf efficacy from thermalife extracts was retained with zinc chloride as the only trace element. ( ) ( ) osprey pharmaceuticals limited, canada ( ) probetex, inc., texas, usa the ccl /ccr chemokine/receptor axis, infiltrating monocytes/macrophages (m/m), th cells and mast cells play a pathological role in tissue damage and fibrosis in kidney diseases. the eradication of the supernumerary activated leukocytes should curb the production of inflammatory mediators and modulate chemokine communications, thus ameliorating disease. a recombinant fusion protein comprised of the human ccl chemokine fused to a truncated form of the enzymatically active a domain of shiga toxin has been developed. the ccl portion binds specifically to ccr -bearing leukocytes and enters the cells, where the sa portion inhibits protein synthesis. the compound was tested in a model of anti-thymocyte serum (ats)-induced mesangioproliferative glomerulonephritis. male rats were injected with ats on day and treated intravenously with vehicle, or mg/kg of the recombinant protein q d from day until day . urine and blood collections were made prior to ats injection and on days and . animals were sacrificed on day . no treatment related effects on body weight or signs of clinical toxicity were observed. urine protein levels were decreased in treated animals. histopathological analyses of kidney sections revealed maximum reductions of , , , and % for glomerular lesions, m/m count, fibronectin and µ-smooth muscle actin, respectively. the latter two proteins are markers for extracellular matrix synthesis and mesangial cell activation, respectively. these results indicate a significant renal-protective effect in this model of nephritis. further observations suggest that different chemokine-ligand toxins may be used in the treatment of diseases modulated by other chemokine/receptor axes. inflamm. res., supplement ( ) posters immuno-depletion followed by fluorescence-activated cell sorting based on the cell surface expression of the sca- antigen. such isolated cells can subsequently be cultured and differentiate towards the osteogenic, adipogenic or chondrogenic linage in vitro. using this model we investigated the influence of the proinflammatory cytokines, tnfa or il- b, on early osteogenesis in vitro. under osteogenic conditions, il- b was found to inhibit cell proliferation in a dose dependent manner, whereas tnfa exhibited no effect. histochemical examination revealed the presence of either tnfa or il- b to dramatically decreased mineralization in a dose dependent manner. q-pcr analysis indicated that in the presence of il- b, despite increased expression of bone-specific alkaline phosphatase (akp ) mrna, levels of other osteogenesis markers (runx , col a and sp ) were decreased. in the presence of tnfa, levels of akp , runx and sp were all decreased. our findings indicate that the influence of early mesenchymal progenitor cells on bone remodelling may be substantially altered in the presence of proinflammatory cytokines. coronary artery disease (cad) is characterized by enrichment of inflammatory cells in the vessel wall. we hypothesized that an altered transmigration and activation of monocytes may contribute to plaque build up. in vivo transmigration was studied by use of a skin blister model. blisters are raised by suction and cells are analysed the following morning ( h blister) and after additional ten hours of incubation with pbs or autologous serum, corresponding to intermediate and intense blister. monocytes were analysed by flow cytometry for the expression of cd b, before and after in vitro fmlp stimulation. chemokines in serum and blister fluid was analysed in parallel. cd b expression on resting monocytes harvested from h blister was lower in patients as compared to controls (p= . ). lower expression of cd b in patients was also observed in the intermediate and intense blisters after stimulation with fmlp (p= . and p= . , respectively). the number of transmigrated cells was similar in both groups and increased with the intensity of inflammation. serum concentration of mip- µ was higher among patients (p= . ) and similar levels were seen in blister fluids. concentration of mcp- was similar in both serum and blister fluid. we demonstrate that monocytes from patients with cad have a reduced expression and ability to up-regulate the adhesion molecule cd b at sites of inflammation. these differences may modulate events related to the transmigration process and indicate a changed activation pattern. to which extent this feature might contribute to monocyte entrapment at the atherosclerotic site needs further studies to be delineated. in inflammation, nitric oxide (no) is produced by inducible nitric oxide synthase (inos) induced by bacterial products and cytokines, and no acts as a regulatory and proinflammatory mediator. one of the anti-inflammatory mechanisms of glucocorticoids is the inhibition of no production. the aim of the present study was to investigate the mechanisms how glucocorticoids inhibit inos expression and no production. dexamethasone and a dissociated glucocorticoid ru inhibited no production, and inos protein and mrna expression in murine j macrophages exposed to bacterial lipopolysaccharide (lps). in the presence of a glucocorticoid receptor (gr) antagonist mifepristone, the effects of dexamethasone and ru on no production were reduced. the role of histone deacetylation in the glucocorticoid effect was studied by using three inhibitors of histone deacetylases (hdacs); non-selective trichostatin a and apicidin, and hdac selective mc . hdac inhibitors reversed the effects of dexamethasone and ru on inos expression or no production. stably transfected a / cells containing human inos promoter were used in promoter-activity studies. cytokine-induced inos promoter activity was inhibited by dexamethasone and the inhibitory effect was reversed by trichostatin a. these results suggest that glucocorticoids inhibit inos expression and no production by a gr-mediated and gre-independent manner possibly through histone deacetylation and transcriptional silencing. we are investigating mechanisms involved in tnfainduced hyperalgesia in the mouse paw. previously, we have seen that tnfa causes a trpv -dependent bilateral hyperalgesia. here we investigate the role of cox in this process. female cd mice ( - g) were given intraplantar injections (i.pl.) of tnfa ( pmol/ microl) and tyrode (as vehicle, contralateral paw; microl). thermal hyperalgesic thresholds were measured using the hargreaves technique before and h after injection. indomethacin ( mg/kg) was co-injected with tnfa whilst contralateral paw was injected with tyrode and corresponding amounts of indomethacin vehicle ( % nahco ). another group of mice were injected with tnfa i.pl. plus % nahco with the contralateral paw injected with tyrode plus indomethacin ( mg/kg). results are expressed as mean ae s.e.m and statistical analysis performed using students t-test. tnfa ( pmol) leads to significantly reduced (p< . compared to baseline values) paw withdrawal latency in both paws h after injection i.e bilateral hyperalgesia. however, local injection of indomethacin ( mg/kg) with tnfa prevented this reduction in paw withdrawal latency in both paws suggesting that prostaglandins are important in the development of hyperalgesia. interestingly, indomethacin co-injected with tyrode in the contralateral paw did not prevent the reduction in paw withdrawal latency in both paws. the same results were seen using the selective cox- inhibitor, nimesulide. in conclusion, cox- derived prostaglandins are important in the development of hyperalgesia. local cox- inhibition at the site of tnfa-induced inflammation prevents the bilateral hyperalgesia suggesting that local prostaglandin production is sufficient to cause hyperalgesia in the contralateral paw. hydrogen sulfide (h s) is synthesized naturally in the body from cysteine by cystathionine g lyase (cse). h s has been variously reported to exhibit both pro-and antiinflammatory activity. in an attempt to obtain further information about the role of h s in inflammation we examined the effect of dexamethasone on lipopolysaccharide (lps)-mediated endotoxic shock. male sprague dawley rats ( - g) were administered dexamathasone ( mg/kg, i.p.) either h before or h after lps ( mg/kg, i.p.) injection. animals were killed h after lps administration and plasma and tissues harvested. as expected, lps injection significantly increased plasma tnfa and il- b as well as liver and lung myeloperoxidase (mpo) activity. lps also increased plasma nitrate/ nitrite (nox), h s concentration and liver and kidney h s synthesis from exogenous cysteine indicative of upregulation of cse in these tissues. either pre-or post treatment of animals with dexamethasone reduced signs of inflammation and also reduced the increase in plasma h s and tissue h s synthesizing activity. in separate in vitro experiments, exposure of rat peripheral leucocytes to lps ( ng/ml, h, oc) resulted in upregulation of both cse and inos (measured by western blot). dexamethasone ( nm) significantly (p< . ) reduced expression of both cse and inos. these data provide further evidence that h s is synthesised during endotoxic shock and suggest, for the first time, that at least part of the anti-inflammatory effect of dexamethsone may be related to inhibition of h s production. ( ), u jalonen ( ), h kankaanranta ( ), r tuominen( ), e moilanen ( ) ( ) the immunopharmacology research group, medical school, university of tampere and tampere university hospital, tampere, finland ( ) the division of pharmacology and toxicology, faculty of pharmacy, university of helsinki, helsinki, finland tristetraprolin (ttp), also known as nup , tis , g s and zfp , is a factor that binds to utr of mrna of some transiently expressed inflammatory genes and regulates mrna stability. ttp has been implicated in the posttranscriptional regulation of e.g. tumor necrosis factor a and inducible nitric oxide synthase. however, the regulation of the expression of ttp itself is largely unknown. in the present study, we investigated the role of classical protein kinase c (cpkc) isoenzymes in the regulation of ttp expression. in j macrophages ttp expression is induced by lipopolysaccharide (lps) and this can be further enhanced by addition of nm phorbol myristate acetate (pma). this additive effect of pma on ttp was abolished by a prolonged preincubation with a higher s inflamm. res., supplement ( ) posters concentration of pma for h, which also downregulated the expression of pkca, pkcbi and pkcbii isoenzymes. pkc inhibitors ro (inhibits pkcb, & and e), gÖ (inhibits pkca, b and &) and cgp (inhibits pkcbii) reduced lps + pma -induced ttp protein and ttp mrna expression. pkcbii inhibitor cgp did not affect ttp mrna half-life and therefore we measured the effects of cgp on the activation of transcription factors involved in ttp expression. cgp had no effect on the activation of nf-kb, egr or sp . in contrast, cgp reduced the activation of transcription factor ap- , which may explain its inhibitory action on ttp expression. the results suggest that pkcbii is involved in the regulation of ttp expression in activated macrophages, possibly through the activation of transcription factor ap- . the most widespread gracilaria verrucosa in the sea of korea is the attached form of red algae growing on a rockly substrate. in this study, we isolated fourteen compounds from g. verrucosa and investigated their inhibitory effect on the production of inflammatory markers (tnf-a il- , il- and no) in raw . cells. among them, -oxooctadec- -enoic acid and -oxooctadec- -enoic acid inhibited the production of tnf-a, il- , il- and no at the concentration of mg. also, these two compounds showed inhibitory activity on the mrna expression and protein level of inflammatory markers (tnf-a il- , il- and inos) in a dose-dependent manner. these results suggest that g. verrucosa may have anti-inflammatory activity through the inhibition of inflammatory cytokines and inos. lene jensen( ), p hjarnaa ( ), j fensholdt ( ), p-p elena( ), k abell ( ), tk petersen ( ) ( ) discovery, leo pharma, ballerup, denmark ( ) iris pharma, la gaude, france angiogenesis is known to play an important role in many inflammatory diseases including arthritis. additionally, inflammation is known to play a role in the angiogenesisdriven disease age-related macular degeneration (amd). we have synthesized a potent angiogenesis inhibitor, leo-a, targeting kinases related to angiogenesis, e.g. vegfr- . additionally, leo-a has potent effects on a broad panel of other kinases, whose normal functions are related to inflammation and immunity. the compound was tested systemically in inflammatory in vivo models in mice and rats. the in vivo models selected include the cia arthritis model (mice and rats), the local gvh rat model, the lps induced tnfa model (mice and rats), the anti-cd induced il- response mouse model and the rat argon laser-induced choroidal neovascularisation (chnv) model, a model for amd. the following results were obtained after systemic treatment with doses of up to mg/kg i.p. or mg/kg p.o. once daily: in the local gvh model, leo-a significantly inhibited the growth of the local lymph node by %. in the cia model, leo-a had a significant inhibitory effect on the progress of arthritis both in mice and in rats when dosed early (pretreatment). in the lps induced tnfa model in mice, high doses of leo-a were found to inhibit the tnfa release. in the chnv model, a significant effect was obtained following systemic treatment. in conclusion, leo-a has an interesting profile for the treatment of diseases in which inflammation and angiogenesis are involved. mice lacking pi kg and d isoforms display severe impairment of thymocyte development, but the outcome of this developmental defect has not been investigated. we show here that mice harbor pi kg gene depletion and pi kd kinase-inactive mutation, pik cgd koi, exhibited thymus atrophy, similar to previously reported pi kg and d double knockout (p g/d-/-) mice, and profound peripheral lymphoid depletion, markedly reduced lamda chain production and seemingly lymphopenia-provoked effector/memory t cell activity. in particular, serum igg / igg a ratio and ige level were elevated in pik cgd koi mice corresponding to a skewed th profile in vitro. histological analysis revealed eosionophil-and t celldominated inflammation in stomach and salivary gland as well as occasionally other organs of pik cgd koi mice, but organ-specific auto-antibody was not detected in circulation. on the contrary, when mature wt t cells were treated with pi k d or together with pi k g selective inhibitors, while th cytokines were suppressed th cytokines were not augmented in vitro. thus, t cell development, but not peripheral t cell proliferation or cytokine production, requires cooperativity of pi kg and d. genetic inactivation of these two isoforms leads to the development of severe lymphopenia, skewed type ig and t cell response, and increased susceptibility to eosinophilic multiple organ inflammation; whereas pharmacological inhibition at the adult stage would probably not promote th reaction but attenuate th medicated disorders. platelet activating factor (paf) is an important mediator in several pathophysiological processes. paf receptor activation can causes a series of cellular and tissue modifications and can lead to the production and/or release of diverse molecules, including cytokines, chemokines and receptors, amongst others, which are capable of amplifying the inflammation. paf can up-regulate kinin b receptor expression by various mechanisms. our aim was to investigate the role for kinases in paf-induced kinin b receptor up-regulation. wistar rats were treated with paf, or left untreated as controls, h before i.d. injection of . ml pbs containing des-arg -bradykinin (dapk, nmol right hind paw) and . ml pbs (for control, left paw). various kinase inhibitors were administered to the rats after paf treatment and oedema was measured by the use of a plethysmometer (ugo basile) - minutes after dapk-injection. oedema was expressed in ml as difference between right and left paws.additionally paw samples were taken for western blot analysis for total and phosphorylated forms of jnk and erk / . dabk-induced paw oedema after pafinjection is significantly inhibited by the selective jnk sp and erk / pd inhibitors. western blot analysis shows that phosphorylation of jnk and erk / is important in the up-regulation of b receptors. our results clearly show that the phosphorylation of both erk / and jnk mapkinases is an important step for the in vivo up-regulation of b receptors by paf. however, the exact mechanisms (transcriptional and post-transcriptional) by which paf can trigger kinase phosphorylation and then up-regulate the b receptor require further investigation. continued interest in development of small molecule inhibitors of p mitogen-activated protein (map) kinase is based on the central role this enzyme plays in inflammatory cell signaling. activation of p leads to increase production of pro-inflammatory cytokines such as tnf-a and il- b making it an prominent target for antiinflammatory drug discovery. a virtuell screening approach identified -( -chlorophenyl)- -(( -methoxyphenoxy)methyl)- [ , , ] triazolo [ , -b] [ , , ] thi adiazole as a potential hit. this was confirmed by synthesis and testing. to explore further sar, a first set of derivates was prepared by cyclization of the -substituted- -amino- -mercapto- h- , , -triazoles with carboxylic acids in presence of phosphorus oxychloride. the synthetic strategy used allows both variation at position and . synthesis and sar will be presented. cytokines like il- b and tnfa play central roles in inflammatory diseases like rheumatoid arthritis. production of cytokines in monocytes, macrophages and other cells is triggered by factors such as lps, uv-light, osmotic and cellular stress or physical and chemical attraction. in particular il- b and tnfa are key regulators as they amplify inflammatory stimuli in cells by induction and upregulation of further cytokines. involved in this signal pathway, p mapk as a pivotal enzyme is considered to be a validated drug target and therefore, p mapkinhibitors are of therapeutical interest. in this study, we developed and validated an economic in vivo whole blood assay for optimization and characterization of small molecule p mapk-inhibitors with promising in vitro activity. the assay procedure involves defined blood cell stimulation by lps and isolation of tnfa or il- b, which are subsequently quantified by tmb-elisa technique via photometric measurement. the validation of the assay conditions involved well characterized p mapk inhibitor sb and a highly active compound developed in our lab. a data set was generated by determining whole blood samples consisting of in each case three male and female individuals on three different days. statistical methods were used to analyze specificity, baseline-peak correlations, repeatability, robustness as well as gender specific intra-and interindividual differences. p mitogen-activated protein (map) kinase is required for the biosynthesis and release of pro-inflammatory cytokines il- and tnf a. inhibition of p map kinase could reduce the expression of these cytokines and is therefore a promising target for the treatment of many inflammatory disorders, like rheumatoid arthritis and inflammatory bowel disease. trisubstituted pyridinylimidazoles are potent inhibitors of the p map kinase. scope of this work was to investigate -thio-ether moiety as a position to link the inhibitors to macrocyclic drug carriers. we synthesised -alkylsulfanyl, -( -fluorophenyl), -( -aminopyridin- -yl) substituted imidazoles as p map kinase inhibitors. as substitution at this pyridinyl moiety allows both increase the anti-inflammatory activity as well as selectivity. the synthesis and biological testing of effective the -aminopyridin- -yl imidazoles with low inhibitory concentrations are described. biological data demonstrate both the imidazole derviates and the linked imidazoles lead to highly efficient inhibitors.variation at the -thio-ether moietywhich interacts in the phosphate binding region of the enzyme -with polar groups shows no loss of activity. studies underscored the importance of hydrogen bonding with the backbone nh group of met , for inhibitory activity. less clear is the importance of the hydrogen bond between n of the imidazole ring and lys of p map kinase.to investigate the role of lys in interacting with the scaffold we prepared two sets of , diaryl-substituted isoxazoles. these data suggest a dynamic interaction of the core heterocycle with lys , contrary to the observation on the compound vk- and p map kinase, that a nitrogen atom bearing a lone pair in position of the imidazole ring could be necessary to avoid a repulsive interaction with the positively charged side chain of lys rather than to form an attractive interaction with p map kinase. to complete our study, we focused on the interdependency of biological effects exerted by substitution at the pyridine ring for a series of -substituted and unsubstituted , -diarylisoxazoles investigating the interaction with the hydrophobic pocket ii of p . these data indicate that the isoxazole has better scaffold properties compared with imidazoles, suggesting that heterocycles that are stable as regioisomers, such as isoxazole (in contrast to tautomeric imidazoles), are worthy of further investigations. despite of the intensive research effort, sepsis is still the leading cause of death in critically ill patients. it is a consequence of acute inflammatory response to lipopolysaccharide (lps), a major component of the outer membrane of gram-negative bacteria. natural products are known sources of bioactive components exerting antioxidative and anti-inflammatory effects. in this study, we investigated the effect of ferulaldehyde (fa), a natural compound of red wine, on lps-induced endotoxic shock in mice and on lps-stimulated murine macrophage-like raw . cells. treatment of c bl/ mice with fa significantly attenuated the lps-induced inflammatory response in the gastrointestinal tract, and decreased the level of the two major pro-inflammatory cytokines tnf-a and il- b in the serum. the serum level of the anti-inflammatory cytokine il- was higher in mice treated with fa and lps compared to lps treatment alone. lps-induced phosphorylation and thereby activation of akt, and jnk was also strongly inhibited by fa treatment whereas the phosphorylation level of erk / and p mapks remained unaltered. activation of nuclear factor-kappab (nf-kb) in liver of fa-treated mice were significantly suppressed. although fa had no effect on the production of inflammatory cytokines, or on inhibition of signal transduction pathways in raw . cells either, it decreased the lps-induced ros and nitrite production in a dose-dependent manner. our results suggest that fa has antioxidative and anti-inflammatory activities by enhancing antioxidative defense systems, which in turn decrease inflammatory cytokine response and suppress nf-kb activity via the down-regulation of akt and jnk. myeloperoxidase (mpo), stored in the azurophilic granules of the neutrophil granulocyte, is a heme enzyme with the unique property of oxidising chloride ion to the powerful reactant hypochlorous acid in the presence of hydrogen peroxide. therefore, it plays an important role at inflammatory loci in killing invading micro-organisms. on the other hand, hypochlorous acid reacts with a variety of biomolecules as amino acids or membrane lipids and causes therefore host tissue damage resulting in widespread diseases like atherosclerosis or rheumatoid arthritis, e.g. the formation of chloramines from taurine or ammonium ions is one possibility to reduce tissue toxicity while maintaining bactericidal properties. membrane charge alterations during apoptosis provide docking sites for the kationic enzyme myeloperoxidase and this close contact to the membrane lipids opens the possibility for lipid alteration pathways even though these reactions will normally not take place because of their slowness. we investigated alterations in phospholipids after reaction with hypochlorous acid or the myeloperoxidase-hydrogen peroxide-chloride system by matrixassisted laser desorption and ionisation time-of-flight mass spectrometry (maldi tof ms). specific reaction products play an important role in the modulation of the immune response. comparative pathobiology of the disease is also discussed within the context of current human and animal reoviral disease models. objectives: to study the safety and efficacy of infliximab plus leflunomide combination therapy in adult rheumatoid arthritis (ra). methods: twenty patients with active ra received leflunomide mg for days followed by mg daily for weeks. at week all patients started infliximab mg/kg, and received a further four infusions at weeks , , and . results: the commonest adverse event was pruritis associated with an eczematous rash. there was no relationship between the serum concentration of a , the active metabolite of leflunomide, and adverse events. the mean disease activity score (das ) fell from . at week to . (p< . ) at week and remained between . and . up to week . in those patients remaining on treatment, more than % achieved an acr response from week to week , and up to % achieved an acr response. conclusions: infliximab plus leflunomide combination therapy appears to be highly efficacious in the treatment of adult ra. however, widespread use may be limited by adverse events, which were common and in some cases severe. objective: the transcription factor nuclear factor-kb (nfkb) regulates the expression of proinflammatory cytokines such as tnfa and il- those play pivotal roles in pathogenesis in rheumatoid arthritis. parthenolide, a sesquiterpene lactone, was reported to inhibit the dna-binding of nfkb. the objective of this study is to investigate the potential of parathenolid to inhibit the pathogenesis of collagen-induced arthritis. methods: mice were injected i.p. with a cocktail of anticollagentype ii mabs on day , followed by i.p. injection of lps on day to induce anti-collagen mab-induced arthritis. the mice were orally administrated with parathenolide ( mg/kg/day) starting on the day of first immunization (day ) in prophylactic treatment group and after the onset of arthritis (day ) in the therapeutic treatment group. clinical disease score, radiographic and histological scores were evaluated. mrna expression of il- b and tnfa in the affected joints were measured by real-time pcr. results: clinical disease scores were significantly reduced both in prophylactic treatment group ( . ae . ) and therapeutic treatment group ( . ae . ) compared to untreated group ( . ae . , p = . and p = . respectively). histological scores of joint destruction were significantly reduced in prophylactic treatment group compared to untreated mice (p< . ). steady state mrna levels of il- b and tnfa in isolated joints were significantly decreased in prophylactic treatment group compared to untreated mice (p< . ). the results in this study suggest that nfkb is an important therapeutic molecular target for treatment of inflammatory arthritis. fibrinogen is a soluble plasma glycoprotein, multifunctional, that participates in haemostasis and has adhesive and inflammatory functions through specific interactions with other cells. the concentration of this glycoprotein increase in inflammatory conditions. a fundamental paradigm involved in the acute inflammatory response is neutrophil migration to the affected tissues to mount an initial innate response to the aggression. the objective of this study is to characterize how fibrinogen modulates the pattern of neutrophil activation. neutrophils from healthy donors were isolated from peripheral venous blood and loaded with the fluorescent probe dihydrorhodamine ( ìm) to detect oxygen free radical production. the cells ( , x cell/ml) were then incubated with a range of concentrations of fibrinogen ( - mg/dl) for minutes. our results show that posters inflamm. res., supplement ( ) s fibrinogen leads to an increase in neutrophil activation as measured by free radical production. this effect becomes evident at borderline-high concentrations ( - mg/ dl), and in some of the individuals it was possible to differentiate two subpopulations of low-responsive and high responsive neutrophils to activation by fibrinogen. we hypothesize that, in this regard, the concentrations of fibrinogen identified as a risk factor might promote the setting of an inflammatory microenvironment in the circulation and facilitate cardiovascular disease progression. cyclooxygenases (cox- and cox- ) are isoenzymes involved in the first steps of the biosynthesis of prostanoids. the constitutively expressed isoform cox- is mainly involved in homeostatic processes, while the inducible isoform (cox- ) is associated with inflammatory reactions. various in vitro assays have been developed in order to define the selectivity against cox- and cox- of nonsteroidal anti-inflammatory drugs (nsaids). however, these in vitro assays can give discordant results related to several parameters. the aim of this study was to optimize and standardize two distinct in vitro methodologies to evaluate new nsaid candidates. first, in an enzymatic cox assay, the arachidonic acid concentration (aa; cox substrate), and the species of cox enzymes tested (ovine vs. human), two factors able to conceal the anti-cox activity of nsaids, have been evaluated and optimized. next, we developed an in vitro cell-based assay using human whole blood depleted from plasma and reconstituted in saline solution. this cell-based assay allows concomitant measurement of anti-cox- and anti-cox- effects by prostaglandin e (pge ) measurement after a (calcimycin) and bacterial lipopolysaccharide (lps) stimulations, respectively. both assays have been calibrated and compared by testing reference nsaids, selective or not for cox- or cox- . fifty % inhibitory concentration (ic ) values against cox- and cox- and cox- :cox- ratios obtained were in accordance with the previously described nsaid specificity and coherent between both assays (r= . ). in conclusion, both in vitro assays are optimized to determine the efficiency and the selectivity of new nsaid candidates against human cox- and cox- . for increasing the success of preclinical drug candidate molecules, there is a need for translatable animal models. the human serum skin chamber technique and the rodent carrageenan induced air pouch model are two wellestablished methods for measuring interstitial inflammation in respective species. we aimed to study the translational aspects of these models. material and methods: in humans, epidermal skin chambers were stimulated with autologous serum for hours. in rats, a dorsal subcutaneous air pouch was stimulated with autologous serum on day . the inflammatory response was measured after , and hours. the cellular distribution of in vivo transmigrated cells, the expression of cytokine receptors, adhesion molecules and inflammatory mediators was investigated. results: at / hours the cellular distribution was similar in air pouch and skin chambers. the major population constituted of granulocytes, followed by monocytes/macrophages and lymphocytes. both in human and rats the concentrations of mpo and mcp- were increased. furthermore, transmigrated cells displayed a different chemokine receptor pattern. in rats transmigrated cells expressed cd b, were cd lo, ssclo and rp- + (granulocyte marker). in humans, transmigrated granulocytes expressed cd and cd b. these cells had a significantly higher cd b expression compared to corresponding cells in peripheral circulation. our results indicate that the serum induced human skin chamber technique and rodent air pouch model translate well to each other. these models may be useful for bridgingpreclinical and clinical drug discovery. furthermore, they may work as translatable proof of mechanism (pom) models for drug candidates targeting different inflammatory components. objectives: to analyse if neopterin (a by-product of activated macrophage metabolism) is elevated in patients with systemic inflammatory insult at the time of ischemic stroke. material and methods: we investigated consecutive patients with mean age ae . years who were admitted within h after ischemic stroke. a control group of patients with mean age ae . years without ischemic stroke was also tested. measurement of serum neopterin levels were performed using enzyme linked immunosorbent assay. results: patients with acute ischemic stroke had significantly higher serum levels (mean value+sd) of neopterin than those without acute ischemic stroke: . ae . and ae . nmol/l. correlation analysis revealed p< . . discussion: immune mechanisms contribute to cerebral ischemic injury. the finding of higher serum levels of neopterin, which is regarded as a humoral component of the immune-mediated inflammatory response sustains the hypothesis that patients with ischemic stroke may show higher levels of inflammatory markers like neopterin. our results indicate increased macrophage activation after ischemic stroke. in patients with stroke it has been shown that neopterin was determinant of endothelium-dependent vascular dysfunction. however, these preliminary results need be confirmed by controlled studies. produced a marked (p< . ) reduction in the number and duration of ventricular tachycardia (vt) during both ischemic and reperfusion phases. the total number of ischemic ventricular ectopic beats (vebs) reduced from ffae in the control to ffae at the concentration of ffmg/ml (p< . ). in the ischemic phase, cynodon dactylon ( ffmg/ml) also decreased the incidence of vt from % (control) to %. in addition, incidences of reperfusion-induced vt, total vf and reversible vf duration were significantly lowered by the same concentration (p< . for all). the results show that cynodon dactylon has a protective effect against i/r-induced cardiac arrhythmias in isolated rat hearts. regarding the presence of flavonoid glycosides confirmed during phytochemical screening of the extract and their potential role in the scavenging of oxygen free radicals, it seems that the cardioprotective effects of cynodon dactylon probably is due to its anti-inflammatory properties.key words: cynodon dactylon; arrhythmias; anti-inflammatory; isolated heart; rat objectives: intestinal ischemia-reperfusion (iri) is well known to be associated with distant organ dysfunction; but no evidences to date have focused either the brain or skeletal muscle. we thus decided to investigate the effects of iri on nos and cox isoforms, neutrophil infiltration (mpo), lipoperoxidation (tbars) and protein tyrosine nitration (nt) in different brain areas and diaphragm muscle of wistar rats. methods: iri comprised the occlusion of superior mesenteric artery during min followed by h of reperfusion. sham animals were submitted to the surgical procedure with no interference on the blood flow. results: iri resulted in increased expression of mrna for nnos (cortex) and cox- (hypothalamus) associated to a marked reduction of ca +-dependent nos activity in cortex, hypothalamus and hippocampus (but not in cerebellum). tbars contents were also reduced in cortex and hypothalamus. neither mpo activity nor nt was altered by iri in the brain. diaphragms from animals with iri exhibited increased mpo and ca +-dependent nos activities, as well as tbars content and nt. in contrast, enos protein expression and both gene and protein nnos expression were reduced. no effects were observed on cox isoforms or enos gene expression. conclusions: these findings suggest that, within the first h of reperfusion following intestinal ischemia, an oxidative response is observed in diaphragm, involving both lipid and protein modifications. in the cns, distinctive susceptibility to the iri seems to occur in the different areas, probably as a defensive strategy aimed to counteract the iri-mediated systemic injury. anne-sofie johansson ( ), h qui ( ), m wang ( ), i vedin ( ), jz haeggstrçm ( ), j palmblad ( ) ( ( ), r carnuccio( ), p romagnoli ( ), f rossi ( ) ( ) second university of naples, italy ( ) university of naples, italy ( ) university of florence, italy we previously found that several inflammatory markers, e.g., nuclear factor-kb (nf-kb), were increased and a neointima was formed in a model of carotid surgical injury ( ) . the purpose of the present study was to determine if chronic treatment with rosiglitazone protects rat carotid artery from surgical injury induced by an incision of the vascular wall. to this aim we measured cox- , nf-kb, platelet aggregation and neointima formation in rats administered rosiglitazone ( mg/kg/ die, by gavage) for days before carotid injury and days after injury. control rats received physiological solution. days after injury cox- expression, evaluated by western blot, was significantly lower in the treated carotid versus controls (p< . ). rosiglitazone also caused a significant decrease of nf-kb/dna binding activity, evaluated by electrophoretic mobility shift assay, in nuclear extracts of treated carotids at all time points considered. platelet aggregation was reduced by % in treated versus control carotids (p< . ). the influx of inflammatory cells in response to injury, monitored by electron microscopy and immunohistochemistry, was lower in treated than in control carotids starting days after rosiglitazone treatment. the results indicate that rosiglitazone inhibits molecular and cellular inflammatory events induced by vascular injury. the aim of the present study was to investigate the relevance of peripheral macrophage activity for the susceptibility to the induction of experimental allergic encephalomyelitis (eae). rats of eae-susceptible dark agouti and eae-resistant albino oxford strain were immunized with guinea pig spinal cord homogenate (dagpsc and aogpsc), while non-immunized rats served as controls (danim, aonim). on day after immunization rat peritoneal macrophages were tested for adherence capacity, zymosan phagocytosis and respiratory burst. macrophages from aonim rats exhibited lower adherence capacity and higher phagocytosis and h o production then macrophages from danim rats. immunization decreased adherence and phagocytosis and increased h o production in macrophages from ao rats, but did not influence these activities in macrophages from da rats. our results suggest that inflammatory activities of macrophages from ao rats could be considered as regulatory mechanisms connected with the resistance to eae induction ( ( ), b sehnert ( ), h lanig( ), s päßler( ), r holmdahl ( ), h burkhardt ( ) ( ) johann wolfgang goethe university, frankfurt, germany ( ) friedrich-alexander university of erlangen-nuremberg, germany ( ) lund university, sweden objectives: the aim of the present study was to characterize the interaction sites between the prototypic arthritogenic murine igg mab ciic that is highly somatically mutated and its epitope on type ii collagen (cii, aa - ). methods: the establishment of a dynamic simulation modelling of a ciic single-chain fragment (scfv) in complex with the triple helical ciic epitope permitted structural insights into immune complex formation. the computer-based data were experimentally tested by mutations of predicted critical residues into alanine in the c scfvs and the respective ciic epitope that were produced as recombinant constructs. the binding affinities of the mutated scfvs were determined by elisa and surface plasmon resonance measurements. the mutation experiments confirmed the predicted interaction sites of cii in the cdr and cdr regions of both heavy andlight chain. surprinsingly also the model prediction, that the conversion of the c scfv sequence into the respective germline does not affect cii binding affinity (kd x - ) could be confirmed experimentally by the mutagenesis of (!) positions. our data indicate that potentially harmful cartilage specific humoral autoimmunity is germline encoded. the molecular modeling further demonstrate that the rigid collagen triple helix restricts the likelihood of molecular interactions with the corresponding cdrregions of the antibody considerably compared to globular antigens. these sterical constraints might provide an explanation why somatic mutations have no obvious impact on cii recognition by the arthritogenic autoantibody. moreover, the structural insights into cii-autoantibody interaction might be useful in future developments of collagenomimetic ligands for therapeutic and diagnosistic purposes. we observed a significant association between the mbp-elicited cd + t-cell proliferation and active brain lesions, on the one hand, and il- , il- and ifn-gamma, on the other. when grown in the presence of standard serum from a healthy donor, pbmc from healthy individuals responded to mbp with a higher il- production than pbmc from ms patients. thus, normal pbmc respond to mbp with production of tnf-alpha, ifn-gamma and il- , but ms is associated with enhanced tnf-alpha-, ifn-gammaand decreased il- responses, and disease activity is associated with mbp-induced proliferation of cd + t cells. ( ), k goula ( ), p georgakopoulos ( ) ( ) renal unit, st. anrdew hospital, patras, greece ( ) intensive care unit, st. anrdew hospital, patras, greece background: urethritis is an infection of the urethra. most cases are sexually transmitted. haemodialysedpeople seem more prone to all kinds of urinary tract infectionsthan others. patients with underlying diabetes are also a specific population at risk. urethritis may be caused by some sexually transmitted diseases (chlamydia, gonorrhea, and ureaplasma urealyticum infections) and by the same organisms that cause urinary tract infections (e. coli or klebsiella). viral causes of urethritis include herpes simplex virus and cytomegalovirus. neisseria gonorrhoeae and c trachomatis account for most cases of urethritis in men ( %). the aim of our study was to determine all cases of urethritis of haemodialysed patients at our unit during the last five years. we also determined diabetes as a coexisting factor in the infected patients. we retrospectively reviewed all cases of urethritis of maintenance haemodialysis patients at our center over the past years. the diagnosis was made according to patients symptoms and signs but also using urine specimens for culture. patients ( . %) from the study group were diabetic. results: cases of urethritis were determined. all infected patients were diabetic. isolated microorganisms were e. coli ( cases), enterobacter aerogenes ( case objectives: to explore the ability to use paquinimod as a steroid sparing drug in an animal model for sle. methods: mice were initially treated with a high dose of prednisolone ( mg/kg/day). thereafter the amount of steroid was reduced to . mg/kg/day and a low dose of paquinimod ( . mg/kg/day) was added. the development of glomerulonephritis was measured as hematuria during the experimental period. serum was collected for analysis of anti-dsdna antibodies. kidneys were collected and histopathological observations were performed. organ weight and lymphocyte sub-populations were assessed in the spleen. results: when treatment with high dose prednisolone was replaced by low dose prednisolone andpaquinimod a steroid sparing effect was seen in a number of variables. a significant reduction in the level of hematuria, in spleen enlargement and in the total number of cd +, cd + and on cd -cd -t cells was observed in mice treated with paquinimod and low dose of prednisolone compared to mice treated with high dose prednisolone alone. the development of glomerulonephritis was also significantly reduced in these mice. an almost complete inhibition of anti-dsdna in serum was seen in all treated groups. conclusions: when high dose prednisolone was replaced by low dose prednisolone and paquinimod a steroid sparing effect was seen when a number of variables e.g., hematuria, t-cell sub-populations and development of glomerulonephritis were examined. this setting could be of great importance in future treatment of human sle in order to reduce the steroid dose needed in the treatment of this disease. and la(ssb). the purpose of this study was to screen for novel antibodies against cell surface antigens in primary sjs. proteins (mp) were isolated from cell membranes (hela cells), and were tested with sera from sjs patients or healthy blood donors individually in western blot (wb) at : . mp were separated on -d gels and tested in wb ( : ) to locate the appropriate spots for mass spectrometry (ms) analysis. paraformaldehyde fixed hela cells were incubated with sera from patients or blood donors and examined by fluorescence microscopy. antigens were isolated at around , , , kda ( total positive/ tested patients). the dominant antigen was at kda. large quantities of endogenous proteins were obtained and the membrane fraction was enriched. one of the main obstacles to further study possible surface antigens as m muscarinic receptor was overcome. proteins were separated on d-gels and tested in wb to locate the relative spots for ms. the correct localization of the patients antibodies on the cell surface was confirmed by fluorescence microscopy. in conclusion, membrane or membrane-associated antigens were recognised by sera from sjs patients. one of them might correspond to m muscarinic receptor. this identification might help in developing a diagnostic assay for sjs. osamu handa, s kokura, k mizuahima, s akagiri, t takagi, y naito, n yoshida, t yoshikawa aim: various additives and preservatives are used in cosmetics, foods and medicines in order to prevent deterioration. however the precise mechanism of cytotoxicity of these additives are not known. in this study, we investigated the effects of ultraviolet-b (uvb) exposure on additives-treated human normal skin keratinocytes (hacat). most popularly used additives in cosmetics such as methylparaben (mp), octandiol (od) and phenoxyethanol (pe) were used. hacat keratinocyte was cultured in mp-containing medium for h, exposed to uvb and further cultured for another h. subsequent cellular viability was evaluated by fluorescent microscopy and flow cytometry using double staining method with hoechst and propidium iodide or annexin-v. same experiments were done using od and pe respectively instead of mp under same condition. in addition, gene chip analysis was performed in each group. results: uvb exposure enhances cytotoxicity of these additives even at low concentration. gene chip analysis showed that the expression of apoptosis-related genes, oxidative stress-related genes and transcription related genes were significantly upregulated in each group. these results indicate that some additives, which have been considered safe preservatives in cosmetics, may have harmful effects on human skin when exposed to sunlight. these kinases in the pathogenesis of psoriasis. recently, increased focal activation of the downstream target mitogen-and stress-activated protein kinase (msk ) was demonstrated in psoriatic epidermis. the purpose of this study was to investigate msk and the transcription factor camp-response-element-binding protein (creb) in psoriatic skin and in cultured normal human keratinocytes. keratome and punch biopsies were taken from patients with plaque-type psoriasis. normal human keratinocytes were cultured and stimulated by interleukin- â (il- ß) or anisomycin. some of anti-inflammatory plant flavonoids as a form of whole plant extracts have been used topically for skin inflammatory disorders. on human skin inflammation, matrix metalloproteinase- (mmp- ) plays a pivotal role on unbalanced turn-over or rapid breakdown of collagen molecules. in the present study, for establishing a therapeutic potential against skin inflammatory disorders, the effects of natural flavonoids on mmp- activity and mmp- expression were examined. from the results, the flavonols including quercetin and kaempferol were revealed to be strong inhibitors of human recombinant mmp- with the ic s of . - . ìm, while the flavones such as apigenin and wogonin showed weak inhibition. when the effects of flavonoids on mmp- induction were studied, it was found that quercetin, kaempferol, apigenin and wogonin ( . - . ìm) strongly inhibited mmp- induction from tpa-treated human dermal fibroblasts, but naringenin (flavanone) did not. by gel shift assay, these flavonoids were also found to inhibit the activation of the transcription factor, ap- , whereas naringenin did not. among mapks, quercetin inhibited the extracellular signal-regulated protein kinase (erk) and p mapk activation, and kaempferol inhibited the p mapk and c-jun n-terminal kinase (jnk) activation. on the contrary, the flavones and naringenin did not inhibit the activation of these three mapks. all these results indicate that the capacity of mmp- inhibition and mmp- down-regulation of flavonoids may block collagen breakdown in certain pathological conditions and certain flavonoids are useful to treat skin inflammation, especially by topical application. ( ) ( ) university of valencia, spain ( ) istituto di chimica biomolecolare cnr, napoli, italy avarol is a marine sesquiterpenoid hydroquinone with several pharmacological properties including antioxidant, anti-inflammatory, and antipsoriatic effects. recently, its derivative avarol- -thiosalicylate (ta) also demonstrated interesting perspectives as anti-inflammatory drug in vitro and in vivo.it is interesting to note that avarol and ta inhibited nf-Þb activation in hacat keratinocytes. now, the effect of avarol and ta was investigated in the tpa-induced hyperplasia murine skin model, which presents some similarities with psoriatic lesions. topical treatment with ta ( mg/ml) produced a % inhibition of oedema and a strong reduction of pge ( %), ltb ( %) and mpo activity ( %) in skin homogenates. the inhibitory effect of avarol at the same dose was % for oedema, % for pge , and % for ltb and mpo activity. histological study for both compounds showed a decrease in epidermal hyperplasia as well as leukocyte infiltration respect to tpa treatment. besides, the reduction of cutaneous tnf-a by avarol and ta was also detected by immunohistochemical analysis. these compounds were also capable of suppressing nf-Þb nuclear translocation in mouse skin. in summary, our results suggest that inhibition of proinflammatory metabolites by ta and avarol might be beneficial for the treatment of the inflammatory component of psoriasis. its mechanism of action is related to the inhibition of nf-Þb activation and can be mediated by the downregulation of intracellular signal-transduction ( ), ams silva( ), cmm santos( ), dcga pinto( ), jas cavaleiro( ), jlfc lima ( ) ( ) requimte, departamento de química-física, faculdade de farmµcia da universidade do porto, porto, portugal ( ) departamento de química, universidade de aveiro, aveiro, portugal -styrylchromones are a novel class of chromones, vinylogues of flavones ( -phenylchromones), which have recently been found in nature. several natural and synthetic chromones have demonstrated to possess biological effects of potential therapeutic applications. however, the anti-inflammatory potential of -styrylchromones has not been explored so far. thus, the aim of this work was to evaluate the putative anti-inflammatory properties of several synthetic -styrylchromones by studding their influence on different systems that are related to the inflammatory process. the putative inhibitory effects of several -styrylchromones on the proinflammatory enzymes cyclooxygenase (cox- ), cyclooxygenase (cox- ) and -lipoxygenase ( -lox) was evaluated in vitro and compared with structurally related flavonoids. the capacity of the studied -styrylchromones to scavenge reactive oxygen (ros) and nitrogen species (rns) was also assessed by different in vitro assays, which allowed to identify the influence of those compounds in each reactive species, separately. from the tested -styrylchromones, those having a catecholic bring where shown to be the most effective scavengers of ros and rns, being, in some cases, more active than flavonoids. no considerable correlation was found between the scavenging profile of these compounds and their interactions with pro-inflammatory enzymes. the results obtained from the present study indicate that some of the tested compounds are promising molecules with potential therapeutic value. the usefulness of -styrylchromones in the prevention or control of inflammation can only be clarified with additional studies concerning their influence on other relevant mechanisms of this pathology. the importance of tumor-associated inflammatory cells, able to affect different aspects of neoplastic tissue, is a current matter of debate. primarily monocytes are recruited from the circulation into solid tumors and metastases where they differentiate into macrophages with several phenotypes and, e.g., may significantly contribute to uptake of certain radiotracers. we therefore sought to characterize the uptake of various radiotracers used for positron emission tomography (pet) in a well characterized in vitro model of human monocytes/macrophages in comparison with that in various human tumor cells. uptake of radiotracers f-fluorodeoxyglucose (fdg), -o-methyl- - f-fluoro-l-dopa (omfd), and f-labeled native/oxidized low density lipoproteins (nldl, oxldl) in single-or cocultivated human myeloid (monocytic) leukemia cell line thp- was compared with that by squamous cell carcinoma (fadu), mamma (mcf- ) and colorectal adenocarcinoma (ht ) cell lines (without or in the presence of specific inhibitiors). several thp- phenotypes along the monocytic pathway (monocytes, differentiated macrophages, retrodifferentiated cells) were studied before, during and after incubation with phorbol myristate acetate. differentiated thp- cells show, when compared with tumor cells, a comparable fdg accumulation, a considerably lower omfd uptake, and a significantly higher oxldl uptake. on the other hand, during differentiation and retrodifferentiation thp- cells obviously establish a distinct sequence of biological processes also reflected by considerable alterations in radiotracer uptake. the observed differences in uptake of several radiotracers in vitro in-between thp- phenotypes and between thp- phenotypes and tumor cells, respectively, stimulate studies on the contribution of macrophage radiotracer uptake to the overall uptake in neoplastic or inflammatory lesions in vivo. genomic and full-length cdna sequences provide opportunities for understanding human gene expression. determination of the mrna start sites would be the first step in identifying the promoter region, which pivotally regulates transcription of the gene. although the mrna start sites of most genes show heterogeneity, this may reflect physiological, developmental, and pathological states of the particular cells or tissues. recently, we have developed a -end sage ( sage) that can be used to globally identify the transcriptional start sites and frequency of individual mrnas. a strong association exists between states of chronic inflammation and cancer, and it is believed that mediators of inflammation may be responsible for this phenomenon. another important factor in tumor development seems to be the epigenetic effects on tumor suppressor genes. because of its ability to suppress tumor cell proliferation, angiogenesis, and inflammation, the epigenetic drug such as histone deacetylase (hdac) inhibitor is currently in clinical trials. however, how epigenetic drugs mediate its effects is poorly understood. to assess the effects of epigenetic drugs, the gene expression by sage in colon cancer cell lines treated with epigenetically affecting agents, -aza- deoxycytidine, a potent inhibitor of genomic and promoter-specific dna methylation and trichostatin a, a hdac inhibitor was investigated. epigenetic modification induced not only the change of expression of several inflammation-associated genes and the cell cycle progression-associated genes in human colon cancer cells but also the gene expression with aberrant start sites. colon cancer is one of the most frequently diagnosed cancers in western societies. interleukin- (il- ) is a potent, pleiotropic, inflammatory cytokine that contributes to a multitude of physiological and pathophysiological processes. il- is produced by many different cell types. the main sources in vivo are stimulated monocytes, fibroblasts, and endothelial cells. a variety of studies have demonstrated that over expression of il- contributes to the pathogenesis of various inflammatory diseases as well as cancer. it has been reported that human colorectal cancer cells display a wide heterogeneity in their potential to express and produce il- . serum levels of il- are elevated in patients with colorectal cancer, however serum levels of il- were found to be independent of il- mrna expression in tumor tissue. in this study we analyzed il- mrna expression by real-time pcr in sporadic colon cancer tissue as well as corresponding normal mucous tissue. il- mrna expression in tumor tissue was lower than in the corresponding normal mucous tissue (p= , ). there was no correlation betweenil- mrna expression and tumor grade or stage. thus we can conclude that il- produced at the tumor site is not involved in sporadic colon cancer progression. ( ), t aiamsa-ard ( ), v chinswangwatanakul ( ), ki techatraisak ( ), s chotewuttakorn ( ), a thaworn ( ) ( material and methods: huvec were cultured as standard techniques and grown to confluence until use. serum was obtained from cholangiocarcinoma patients and normal healthy subjects. huvec were treated with % of serum and incubated for hours. cells were analyzed by using [ h] thymidine and immunoblotting assay for cell proliferation and cox- /nos- protein expression, respectively. results: serum of cca patients trend to have more effect on proliferation of endothelial cell than healthy control subjects. on the protein expression, cca serum significantly increased the expression of cox- but not nos- in hevec. however, the proliferate effect on endothelial cells by cca sera did not correlate with the expression of cox- . conclusions: this result suggested that some factors in serum of cancer patients could induce cox- protein expression in huvec. the increasing of cox- might be one of various factors involve in the proliferation process. aim: superoxide is responsible for the neutrophil-mediated tumoricidal activity. the aim of our work was to monitor the changes of superoxide production from neutrophil attributed to tumor development from the early phase to the advanced stage, and to investigate the effects of ok- @on neutrophil-derived superoxide production and tumor growth. methods: ah a rat hepatocellular carcinoma cells were implanted into the hind leg of male donryu rats. pmns were harvested from rat peritoneal cavity h after intraperitoneal injection of oyster glycogen. superoxide production were measured by the method of cladependent chemiluminescence, which has high sensitivity and specificity to superoxide. the counts of peripheral leukocytes were significantly increased during tumor progression, and there are significant difference between that of controls and tumor-bearing rats after days of tumor inoculation. both pma and oz-induced superoxide generation derived from neutrophils became significantly reduced in the advanced stage of cancer. the suppression of neutrophil-derived superoxide generation was accompanied with tumor progression and an increased number of neutrophils in the peripheral blood. the subcutaneous administration of ok- , a biological response modifier, prevented the suppression of neutrophil-derived superoxide generation during tumor progression, which might induce the tendency of tumor growth suppression. our results suggested that the decreased superoxide generation as well as the high leukocytes concentration in the peripheral blood could be considered as indicators of an advanced stage of cancer. furthermore, the effect of ok- on neutrophil-derived superoxide production in cancer-bearing rats may provide pharmacological evidence to the therapeutic effects of ok- . ( ), m jokic ( ), v zjacic-rotkvic( ), s kapitanovic ( ) ( ) university hospital sestre milosrdnice, bucharest, romania ( ) division of molecular medicine rudjer boskovic institute, bucharest, romania introduction: il- is a pleiotropic cytokine mapped to chromosome p - . its promoter snp - g/c is associated with high serum cytokine production, and according to current investigation can play a role in the development and progression of different gastrointestinal malignancies. we tested its genotypes in the gastrointestinal and pancreatic neuroendocrine tumors (gep-nets). patients and methods: dnas from patients diagnosed with gep-net and age and sex-matched volunteers were analyzed for - g/c snp of the il- gene. to analyze il - c/g polymorphism we used pcr -nlaiii rflp method. for statistical analysis Ä test and fishers exact test were used. the level of significance was . . results: there were no differences observed in the frequencies of the - high expression (gc and gg) genotypes between the patients and healthy volunteers (p= . ), as well as between patients with gastrointestinal or pancreatic endocrine tumors (p= . ). - g/c genotype was statistically more frequent among patients with non-functional pancreatic endocrine tumors (pets) than in those with functional pets (p= . ). conclusions: high expression genotypes of il- - snp are more frequent in non-functional pets and may be a marker for the mentioned malignancies. are important in inflammation, are found around and within a variety of human tumors. their number correlates with tumor vascularity and aggressiveness and is a negative indicator for patient survival. how mast cells influence tumor growth is not well understood. the neuroendocrine peptide, neurotensin (nt) is a potent secretagogue of mc that has tumor-promoting effects in animals and promotes the growth of a variety of human cancer cells, acting via its gpcr nt-type receptor (nts ). here we show that hmc- human mc express nt-precursor (pront) mrna and protein, and secrete immunoreactive nt when stimulated. rt-pcr on hmc- cell rna yielded a band with % sequence identity to pront and a band corresponding to the pront processing enzyme, pc a.immunocytochemistry on hmc- cells showed specific staining for pront. stimulation of hmc- cells with a + pma, pge , c / or mastoparan released immunoreactive nt.rt-pcr on hmc- cell rna yielded a band with % sequence identity to human nts . western blotting gave bands corresponding to unglycosylated ( kda) and glycosylated ( kda) nts .immunocytotochemistry on hmc- cells showed specific staining for nts . these finding have significance for the role of mast cells in tumor growth. ( ), j buddenkotte ( ), mp schçn( ), m steinhoff ( ) ( ) university hospital münster, germany ( ) university hospital würzburg, germany the proteinase-activated receptor par- has been demonstrated to modulate tumor growth, invasion and metastasis in various tissues. however, the role of par- in cutaneous cancerogenesis is still unknown. here we could show a protective role of par- in the development of epidermal skin tumors: we established a mouse skin tumor model using chemically induced carcinogenesis. to this end, par- -deficient and wild-type mice were painted once with dmba ( , -dimethylbenz[a]anthracene) for sensibilization, followed by topical application of the phorbol ester pma (phorbol myristate acetate ( -o-tetradecanoylphorbol- -acetate)) twice per week at the same sites. tumors started to appear after eight weeks. after weeks, par- -deficient mice showed a significantly increased number of skin tumors ( per animal on the average) in contrast to the wild-type (eight tumors per mouse). analysis of possible signal transduction pathways activated upon par- stimulation in hacat keratinocytes showed an involvement of extracellular signal regulated kinase / (erk / ) and profound epidermal growth factor receptor (egfr) transactivation, leading to secretion of the tumor-suppressing factor transforming growth factor-beta (tgf-â ). thus, our results provide the first experimental evidence for a tumor-protective role of par- . ( ), ma arbós ( ), a fraga ( ), i de torres( ), j reventós ( ), j morote ( ) ( pathogenesis of benign prostatic hyperplasia (bph) and prostate cancer (pca) is still unresolved, although chronic inflammation may play a significant role in disease progression. prostate stromal fibroblasts may be contributing to the inflammatory process through the expression and secretion of pro-inflammatory mediators, in particular proteoglycan-bound chemokines and other chemoatractants, and the interaction with inflammatory cells such as monocytes. to better understand molecular mechanisms underlying functional differences among prostate fibroblast populations, our primary objective was to characterize proteoglycan and chemokine gene expression in human fibroblasts of different histological/ pathological origin cultured in normal and monocyteconditioned media. we analysed primary human fibroblast cultures from normal transition zone (tz), normal peripheral zone (pz), benign prostatic hyperplasia (bph), and pathologically confirmed prostate cancer (ca). cells of different origin displayed distinct mrna expression profiles for the core proteins of proteoglycans and both sdf /cxcr and mcp /ccr chemokine axis. when incubated with monocyte-conditioned medium all four cell types significantly changed sdf /cxcr and mcp /ccr expression in a fibroblast population dependent manner. monocyte-fibroblast cell adhesion and the chemotactic response of fibroblasts to human peripheral blood monocytes were investigated in a coculture system. monocytes adhered rapidly to fibroblasts and preferentially to bph and pz cells. in addition, chemotaxis was significantly induced in both fibroblast cultures after incubation with monocytes. our results suggest that prostatic fibroblasts have a key inflammatory role associated to a distinctive proteoglycan gene expression and chemokine induction, which is dependent on their histological and pathological source. supported by the spanish urology society (madrid, spain). we have recently shown that paf-receptor is involved in phagocytosis of apoptotic and necrotic but not viable cells, possibly through its interaction with paf-like molecules present on the surface of these cells. removal of altered cells by macrophages could modify the microenvironment at an inflammatory site, and thus influence tumor growth. in the present study we investigated the impact of apoptotic cells or treatment with paf-r antagonist on ehrlich ascitic tumor (eat, ip) and melanoma b f (sc). paf-r antagonist, web ( mg/kg, ip) was given daily for days. we found that eat growth was significantly reduced by pretreatment with web , and that inoculation of apoptotic cells (thymocytes) before tumor implantation stimulated tumor growth, an effect reversed by web pretreatment. eat growth was accompanied by increased production of prostaglandin e , vegf and no which was reduced significantly by web treatment. in b f melanoma, web , alone or in association with an apoptosis inducer chemotherapeutic agent, dacarbazin (dcb, ug/kg,ip) significantly reduced tumor mass volume and the number of intratumoral small vessels. in association with dcb, web- reducedactive caspase- expression in the tumor andmarkedly increased the survival of tumor-bearing mice. the data obtained here show that during tumor growth, activation of paf-r by molecules present in the surface of apoptotic/necrotic cells, or by paf produced in the milieu, favors tumor growth and suggests that pafantagonists could be useful in tumor treatment, particularly when in association with chemotherapy. financial suport by fapesp and cnpq. ( ), mt quiles ( ), a figueras( ), r mangues( ), f vinals( ), jr germa( ), g capella ( ) ( ) institut de recerca vall de hebron, barcelona, spain ( ) translational research laboratory, idibell -institut cataladoncologia, spain the malignant potential of tumor cells may be influenced by the molecular nature of k-ras mutations. we have previously shown that codon mutations associate with an increased resistance to apoptosis. we hypothesized that their different malignant potential in vivo could be also related to the generation of a distinct angiogenic and inflammatory profile including vascular structure, macrophage infiltration and expression of angiogenic modulators, proteolytic mediators and the cxcl (sdf- )/ cxcr chemokine axis. to do so we have combined in vitro and in vivo studies using stable cys and asp nih t transfectants. cys tumors showed a higher microvessel density associated with shorter latency period. prominent vessels with µ-smooth muscle actin positives cells surrounded by f / macrophages were only observed in asp tumors associated with a shorter growth period. asp tumors displayed increased vegf expression both at the rna and protein levels, mainly produced by tumor cells. tsp- protein levels were similarly diminished in both transfectants. higher mmp and mmp activities and expression were observed in asp tumors probably produced by macrophages or stromal cells. total and active mmp levels were higher in cys tumors. the expression of sdf- and cxcr remained unchanged while sdf- g isoform was selectively induced in cys tumors, suggesting sdf- a or b are induced in asp tumors. these results show distinct k-ras mutations induce specific angiogenic phenotypes. the differential stimulation of vegf expression, metalloprotease activities and sdf- expression observed is the result of the joint action of tumor cells and the local microenvironment. contact information: dr maria a arbos via, institut de recerca vall de hebron, unitat de recerca biomedica, barcelona, spain e-mail: maarbos@ir.vhebron.net incisional hernias (ihs) represent a common complication of laparotomies, involving remarkable healthcare costs. representative ih animal models are lacking and characterization of human tissue resources is scant. this limited understanding of fundamental mechanisms regulating the destruction of the abdominal wall currently limits the prevention and treatment of ihs. here, we compared tissue specimens (carefully obtained > cm of the defect) and primary fibroblasts cultures from fascia and skeletal muscle of subjects with/without ih hernia. the most prominent morphologic characteristics of ih tissue were: alterations of the microstructure of the connective tissue and loss of extracellular matrix (ecm), and a paucity of fibroblasts. in ih muscles, inflammatory infiltrates were observed. other significant changes were: decreased collagen type i/iii ratio; differential proteoglycans mrna expression; enhanced metalloproteinases/ endogenous inhibitors ratio (mmps/timps); and upregulation of apoptosis effectors (caspase- and substrates; tnf-alpha; il- ). in vitro, hernia fibroblasts (ihfs) exhibited significantly higher ( -fold) cellular proliferation and migration rates and decreased strength of adhesion as compared to control fibroblasts, even after several passages. moreover, ihfs ultrastructure analysis revealed accumulation of autophagic vacuoles, autophagolysomes-like structures and multilayered lamellar and fingerprint profiles, as well as mitochondrial swelling. based on these descriptive results in human tissues, a novel hypothesis emerges regarding ih formation. specifically we propose that inflammation-related mechanisms triggering proteolytic and apoptotic effectors regulate cell turnover and eventually contribute to atrophy and progressive tissue insuffiency. overall, this may be causally involved in the mechanisms of ecm destruction yielding ih (supported by fis pi_ and gencat_agaur_ xt_ ). ( ), m spinola( ), c pignatiello( ), w cabrera ( ), og ribeiro ( ), n starobinas( ), t dragani ( ) ( ) butantan institute, sao paulo, brazil ( ) istituto nazionale tumori, milan, italy airmax and airmin mice are phenotypically selected for maximal or minimal subcutaneous acute inflammatory response, respectively, and display high inter-line differences in protein exudates and neutrophil infiltration, as well as in bone marrow granulopoiesis, inflammatory cytokines, and neutrophil apoptosis. in a combined experiment of urethane-induced lung inflammatory response and lung tumorigenesis, airmin mice developed a persistent subacute lung inflammation and a fold higher lung tumor multiplicity than airmax mice, which showed a transient lung inflammatory response. we have analyzed gene expression profiles of these outbred lines in comparison to the lung cancer resistant c bl/ and lung cancer susceptible a/j mouse strains. gene expression profile analysis of urethane-treated and untreated animals was performed using the applied biosystems mouse genome survey microarray containing , mouse transcripts. mrna expression of candidate differentially expressed genes was validated by quantitative real-time pcr and the over-represented biological themes were analyzed with the ease software. urethane treatment modulated the gene expression profile in all four lines. among the confirmed genes, vanin (vnn ) and major histocompatibility antigen e alpha (h -ea) resulted common to both mouse models. the most represented gene categories in air model were acute phase response, immunoresponse, electron and lipid transport, complement activation and tissue repair. mhc/antigen process and presentation and immunoresponse were the major themes in the inbred model. moreover, a gene cluster in chromosome ( . cm) was observed. the study suggests that the expression of a subset of genes may show a strain-and line-specific modulation pattern during inflammatory response and lung tumorigenesis. inhibition of tumour induced angiogenesis constitutes very attractive anti-cancer therapeutic approach.it is well established that the vegf signal transduction pathway is one of the key drivers of deregulated angiogenesis and selective inhibition can lead to inhibition of tumour growth. however, multiple angiogenic growth factors and pathways are involved, leading to a phenomenon of redundancy and overcoming of an inhibition of vegf signalling only. we have developed a nanomolar inhibitor (compound a) of the receptor tyrosine kinase vegfr-r (kdr), which was subsequently shown to be a potent inhibitor of closely related kinases (vegfr- and - , pdgfr, kit, csf- r) but also unrelated soluble tyrosine kinases (src-familily of kinases and raf). compound a potently inhibits vegf stimulated endothelial cell proliferation but has no effect on non-ec proliferation, which is suggestive of a selective antiangiogenic potential. the unique kinase inhibitory profile of compound a combined with excellent oral bioavailability ( %) has translated into superior in vivo anti- inflamm. res., supplement ( ) posters tumour efficacy when compared to the relatively selective kdr inhibitor ptk . thus, treatment of nude mice implanted with either commercial atcc derived tumour cells (a and du- ) or low passage patient derived tumors (cxf ; colon cancer, rxf ; renal cancer) with compound a resulted in inhibition of tumour growth which was significantly better than for ptk treated mice. compound a is fairly well tolerated by rodents and extended toxicological studies have been initiated to determine the therapeutic index, which also may allow for exploration of other non-cancer indications. ( ), p bobrowski( ), m shukla ( ), t haqqi ( ) ( ) albany medical college, usa ( ) rainforest nutritionals, inc, usa ( ) case western reserve university school of medicine, usa background: the amazonian medicinal plant sangre de grado (croton palanostigma) has traditional applications for wound healing and inflammation. we sought to characterize an extract (progrado) in terms of safety, proanthocyanidin profile, antioxidant activity and anabolic/catabolic actions in human cartilage explants. methods: acute oral safety and toxicity was tested in rats according under oecd protocol # . proanthocyanidin oligomers were quantified by hplc and progrados antioxidant activity assessed by the orac, norac and horac assays. human cartilage explants, obtained from surgical specimens, were treated with il- b ( ng/ ml) to induce matrix degradation and glycosaminoglycans (gag) release. progrado ( - mg/ml) was tested for its ability to maintain optimal igf- transcription and translation in cartilage explants and cultured chondrocytes. results: progrado displayed no evidence of toxicity ( mg/kg po) leading to gsh safety rating of /unclassifiable. oligomeric proanthocyanidin content was high ( mg/kg) with the majority of oligomers > mers.progrado was a remarkably potent antioxidant and in an ex vivo model of inflammation-induced cartilage breakdown, progrado was exceptionally effective in reducing both basal and il- b induced glycosaminoglycan release from human cartilage explants. progrado prevented il- b induced suppression of igf- production from human cartilage explants as well as stimulating basal igf- production (p< . ). comparable changes in igf- gene expression were noted in cultured human chondrocytes. conclusions: progrado has a promising safety profile, significant chondroprotective and antioxidant actions, and promotes the production of the cartilage repair factor, igf- . this suggests that progrado may offer therapeutic benefits in joint health, wound healing and inflammation. the solvent extracts from korean fermented soybean (chungkukjang) were evaluated for their protective effects against the generation of free radicals and lipid peroxidation. the activities of chungkukjang were compared with several antioxidants and soybean isoflavones including genistein and daidzein. in addition, the protective effects against h o -induced cytotoxicity and oxidative dna damage in the nih/ t fibroblasts line were examined. the extracts from chungkukjang and soy isoflavones inhibited the generation of , -diphenyl- picryl hydrazine (dpph) radicals, and had an inhibitory effect on ldl oxidation. the extracts from chungkukjang and soy isoflavones strongly inhibited h o -induced dna damage in the presence or absence of endonuclease iii and fpg. furthermore, they showed cytoprotective effects against h o , without cytotoxicity except for the hexane extract at high concentrations (> mg/ml). the ethanol and n-butanol extracts appeared to have most potent antioxidant activities. these in vitro results show that the extracts of chungkukjang may be a useful antigenotoxic antioxidant by scavenging free radicals, inhibiting lipid peroxidation and protecting against oxidative dna damage without having cytotoxic effect. moreover, the extracts of chungkukjang inhibited mda formation in the liver, dna damage assessed by comet assay and the microucleated reticulocyte formation of peripheral blood in kbro -treated mice. these in vivo results were similar to those of in vitro experiments. therefore, chungkukjang containing soy isoflavones is a promising functional food that can prevent oxidative stress. (supported by bk project from korea research foundation). sirt is a histone deacetylase, involved in oxidative stress and aging. because the role of aging and exercise on sirtuins activity in rats is unknown, we investigated the effects of exercise on age-related changes in the sirt activity, comparing heart (h) and adipose (a) tissue of sedentary young (n ), sedentary old (n ) and trained old (n ) rats. the trained old rats performed a -weeks moderate training on treadmill. on h and a tissue of all rats sirt activity was evaluated by assay kit, peroxidative damage measuring malondialdehyde (mda) and protein-aldehyde adducts -hydroxynonenal ( -hne), mnsod, catalase and foxo a by western blot, and gadd a, cyclin d and foxo a mrna by rt-pcr. aging reduced sirt activity in h (p< . ) without effects in a, producing an increase of mda (h, p< . ; a, p< . ) and -hne (h, p< . ; a, p< . ), and a decrease of mn-sod (p< . ) and catalase (p< . ) expression in both h and a. aging did not affect foxo a protein expression in h, and foxo a mrna in a. exercise produced an increase in h foxo a protein expression (p< . ) and in a foxo a mrna, associated to higher mn-sod (h, p< . ; a, p< . ) and catalase (h, p< . ; a, p= . ) levels in both h and a of aged rats. in heart exercise-induced higher sirt activity bring on decrease in cyclin d and increase in gadd a mrna expression. in a we found a similar decrease in cyclin d , without changes in gadd a mrna expression. these findings suggest that exercise is able to increase sirt activity in aged rats. ( ), t horiguchi( ), k abe( ), h inoue( ), t noma ( ) ( ) institute of health biosciences, the university of tokushima graduate school, tokushima, japan ( ) minophagen pharmaceutical co. ltd, japan objectives: glycyrrhizin (gl) is a major component of glycyrrhizae radix (licorice) that is generally used for treatment of hepatitis. gl has a regulatory activity on arachidonic metabolism, immunological function, and anti-viral effects. however, the molecular mechanisms of the effects remain unclear. to analyze the molecular basis of gl signaling, we performed the microarray analysis using ccl -induced mouse hepatitis models. methods: eight-week-old icr male mice were treated intraperitoneally with f×l/ kg bw of ccl w/wo mg/ kg bw of gl. after hours and hours, livers and serum were collected and analyzed. for microarray analysis, the expression patterns of genes between hour-treated-livers (ccl or ccl and gl) and no treated-livers were compared. results: gl-treatment dramatically decreased the gpt activity in plasma at hours compared to that in ccl treated plasma. however, the levels of mrna expression of inflammatory genes such as phospholipase a , hsp , and procollagen were still very high in gl-treated liver. after hours, the mrna levels of them were significantly reduced in gl-treated mice compared to those of ccl -treated liver. then, we screened , genes by microarray and found that genes were up-regulated and genes were down regulated in ccl +gl compared to ccl treatment. interestingly, ros scavenger-related genes were significantly up-regulated in ccl + gl. detail analysis is currently ongoing. we found the unique relationship between gl activity and ros regulation. this finding suggests a novel way to treat inflammatory diseases including hepatitis. objectives: experimental autoimmune encephalomyelitis (eae) is a demyelinating autoimmune disease that results from an immunological reaction against different myelin components at the cns. it is widely employed as an animal model of human multiple sclerosis. interestingly, the number of studies relating these diseases with peripheral organs is limited. we thus investigated the consequences of eae on the degree of lipoperoxidation (tbars) and mpo activity in different rat peripheral organs (eg. lung, spleen, liver, stomach, duodenum, colon, ileum, kidney and bladder). university of waikato, hamilton, new zealand mitochondria play a fundamental role in the life and death of all eukaryotic cells. cells with dysfunctional mitochondria are known to have higher levels of a molecular stress protein (cpn ). this protein is increasingly being implicated to play a role in modulating cellular inflammation. we have developed an in vitro model cell system using thp- monocyte cells with compromised mitochondrial bioenergetic functions to investigate the relationships between mitochondrial dysfunction, cpn expression and modulation of proinflammatory cytokine responses. we have found that the ability of cpn to modulate tnf-a expression was strongly correlated with the loss of mitochondrial bioenergetic functions in our thp- cells. we also demonstrate that such modulation involves both erk / and p mapk pathways. the significance of these results in relation to the role of mitochondria as modulators of inflammation will be discussed. ( ), b arnold( ), g opdenakker ( ) ( ) jagiellonian university, department of evolutionary immunobiology, krakow, poland ( ) german cancer research center, department of molecular immunology, heidelberg, germany ( ) rega institute for medical research, university of leuven, laboratory of immunobiology, leuven, belgium we showed that in mice genetically deprived of metalloproteinase (mmp- -/-) at least one compensatory mechanism operates as there are elevated levels of pge of cox- origin expressed by peritoneal macrophages during zymosan peritonitis; and this leads to increased early vascular permeability observed in those animals. also infiltration of peritoneal cavity by inflammatory neutrophils is changed in mmp- -/-mice as at hrs of inflammation, when otherwise highest numbers of neutrophils are detected in peritoneum, the cell numbers are significantly lower in the mice in comparison to their controls. in contrary, at hrs of peritonitis, when normally resolution of peritonitis takes place, no decrease in neutrophil counts is observed. thus the aim of the present study was to evaluate if impairment of neutrophil apoptosis could account for this latter phenomenon in mmp- -/-mice. for this numbers of apoptotic (annexin v) and necrotic ( -aad) peritoneal leukocytes were evaluated and levels of active caspases were tested by application of either caspase detecting antibodies or fluorochrome-labelled inhibitors; all analyses were performed by flow cytometry. the results revealed that both, numbers of apoptotic cells and levels of active caspase were significantly lowered in mmp- -/-mice while levels of caspase , and were significantly elevated in comparison to control animals. we conclude that an impairment of apoptosis is observed in mmp- -/mice during zymosan peritonitis and it is due to the decreased levels of active caspase . the increased activity of other examined caspases is most probably independent of apoptosis. ( ), h james ( ) the selective inhibition of nitric oxide generation by inhibiting the activity of nitric oxide synthase(nos) isoforms represents a novel therapeutic target for the development of anti-inflammatory agents. the aim of this study was to evaluate the activity of nos inhibitors in experimentally induced inflammation, pain and hyperalgesia. the effect on acute inflammation was studied in carrageenan-induced paw edema in rats. the effects on carrageenan-induced hyperalgesia, tail flick response to radiant heat and acetic acid-induced writhing were also studied. nos inhibitor ng-nitro-l-arginine methylester (l-name), and mg/kg produced a dose-dependent inhibition of paw edema ( % and % at h; % and % at h). a marked reduction in paw edema was observed with ng-monomethyl-l-arginine acetate (l-nmma), mg/kg( % at h; % at h). selective inducible nos(inos) inhibitor aminoguanidine hemisulfate inhibited the paw edema at a dose of mg/ kg( % at h; % at h) but not with a dose of mg/kg . the effects were comparable to nonselective cox inhibitor indomethacin mg and mg/kg ( % and % at h; % and % at h respectively) and selective cox- inhibitor rofecoxib, mg/kg ( % and % respectively). nos and inos inhibitors significantly increased the pain threshold latency in the tail-flick test. these inhibited the acetic acid-induced writhes, the effect being comparable to indomethacin. however, carrageenan-induced paw hyperalgesia was not inhibited. the results suggest that nitric oxide plays a role in carrageenan-induced acute inflammation and both nosand inos inhibitors have a potential anti-inflammatoryand anti-nociceptive activity. ( ), p hart( ), j edwards ( ), c quirk ( ) ( ) molecular pharmacology limited (usa), australian division, perth, western australia ( ) telethon institute for child health research, perth, western australia thermalife cream, an anti-arthritic biological product, has been successfully used off-label for sun burn recovery. a novel product, derived from thermalife, was assessed on its therapeutic potential in oxsoralen-uvb burns. as a possible mechanism for the sunburn efficacy, suppression of tnf-a and il- â production by human monocytes was assessed in vitro. methods: sunburn: four sites were marked on the arm of the subject. three sites were exposed to oxsoralen ( %) plus uva/uvb light, one site was exposed to oxsoralen only. cream was applied at min, or at hrs after injury. a third injury site was not treated. photographs were taken before, hrs, and weeks after injury. cytokines: human monocyte cultures ( % fcs, % co ) were either stimulated with ng/ml lps (e.coli :b ) or not in the presence of % or % active ingredient. hrs after incubation, culture media was collected, centrifuged, and assayed (cytokine elisa). results: at hrs after oxsoralen-uv, the min treatment site showed slight erythema, the hr treatment site had pronounced erythema and slight blister formation, whereas the untreated site had pronounced erythema and strong blister formation. weeks after injury, the min site was normal, the hr site was a dark colour, whereas the untreated site had a significant scar. oxsoralen alone had no effect on the skin. the novel product suppressed lps-induced tnf-a and il â secretion by . % and . %, respectively. conclusions: a novel thermalife-derived product reduced total injury after oxsoralen enhanced uva/ uvb burns, which is possibly related to cytokine suppression. ( ), p hart( ), j snowden ( ), maud eijkenboom ( ) ( ) molecular pharmacology limited (usa), australian division,perth, western australia ( ) telethon institute for child health research, perth, western australia a mixture of bovine plasma protein fractions and zinc chloride (bov-zn) was assessed for its ability to regulate cytokine production by lps-stimulated monocytes. dosereponse curves for tnf-a suppression were generated. further, competition with fcs in the culture medium and the metabolism of monocytes under influence of bov-zn were assessed. in all experiments the culture medium environment was similar. human monocyte cultures ( % fcs, % co ) were either stimulated with ng/ml lps (e.coli :b ) or not in the presence of %, . %, %, . %, %, % or % bov-zn (two pooled experiments). hours after incubation, culture media were collected, centrifuged, and assayed (cytokine elisa). a competitive inhibition design for the standard tnf-a assay was set up for %, %, %, % fcs against %, . %, %, % bov-zn. the culture media were treated as above. metabolism of non-proliferating monocytes was measured via accumulation of bioreduced formazan (promega celltiter ) in treated and untreated cell cultures over - hrs at intervals. the ic for tnf-a suppression was reached at . % bov-zn in each of two experiments. fcs did not compete with bov-zn in suppressing tnf-a in lpsstimulated monocytes. at low fcs concentrations bov-zn stimulated tnf-a production in the absence of lps. this tnf-a increase was countered with increasing concentrations of fcs. metabolism of cells was not affected by % bov-zn. conclusions: bov-zn could reliably and effectively reduce tnf-a secretion in vitro, without competing with the fcs in the culture medium, and without disturbing the metabolism of monocytes. inflammatory diseases such as rheumatoid arthritis (ra) result from overproduction of cytokines including tnf-£\ and il- fÒ. these cytokines are known to be regulated by the stress-activated p fnfnmap kinase pathway. because of this, inhibition of p map kinase has been one of the most compelling targets for the treatment of inflammatory disease. over the last years, numerous groups have reported on the development of p map kinase inhibitors. x-ray co-crystallization with the enzyme suggests a propensity to accommodate structurally diverse molecules. regions of the binding site are known to be unique to p vs other kinases, enabling the development of p selective molecules. inflamm. res., supplement ( ) posters anti-inflammatory activities. a series of labdane-type diterpenoids ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) with various patterns of substitution were tested for potential anti-inflammatory activity.of these compounds, and were selected to evaluate their influence in targets relevant to the regulation of the inflammatory response. these derivatives displayed good in vivo anti-inflammatory activity, and maximum inhibitions of and % were noted in the -o-tetradecanoyl-phorbol- -acetate (tpa)-induced ear oedema in mice. in addition, inhibition of myeloperoxidase activity, an index of cellular infiltration, was also observed. the diterpenoids also reduced the production of nitric oxide, prostaglandin e , and tumour necrosis factor-alpha in bacterial endotoxin-activated raw . macrophage cells with ic in the range - mm. inhibition of these inflammatory mediators was related to reductions in the expression of inducible nitric oxide synthase, and cyclooxygenase- , as determined by western-blot analysis and rt-pcr. since nuclear factor-kappab (nf-kb) plays a central role in the transcriptional regulation of these proteins, we investigated the effects of these diterpenoids on this signalling pathway. our results indicate that both compounds interfere with the phosphorilation of ikbalpha and ikbß, resulting in inhibition of their degradation. in summary, the anti-inflammatory effects of these labdane diterpenoids are related to the inhibition of inflammatory mediators by blocking nf-kb activation and provide potentially therapeutic perspectives in inflammatory conditions. the aim of the study was a research of mechanisms of inflammatory action of a new drug fepolen at a dosage of mg/kg prepared from bee products (bee pollen and phenolic hydrophobic extract of propolis) for prostatitis treatment. to fulfill above mentioned task a model of zimozan induced oedema whose dynamics gives a possibility to estimate influence of a drug on both routs of arachidonic acid metabolism -via cyclooxiginase and lipooxigenase was used. a comparison with diclofenacum at a dosage of mg/kg and substance ffw- Ñ (inhibitor of cyclooxygenase and lipooxygenase and has a high antiinflammatory effect ( %) at a dosage of mg/kg) was made. the results of influence of drugs dynamics of zimozan inflammation show that anti-inflammatory action of fepolen is based on decrease of release of biogenic amines and activity of lipooxigenase and is higher then effect of diclofenacum. fepolen revealed the highest effect during first min and hour of inflammation that was higher then action of diclofenacum. these data proves that fepolen decreases lipooxygenase activity that is in charge for the inflammation during this period. during next hours therapeutic effects of fepolen and diclofenacum were at the same level. fepolen showed the same dynamics of anti-inflammatory action as ffw- Ñ that demonstrates a property to influence both routs of arachidonic acid metabolism. in summary with previous results in conditions of carageninic inflammation we can conclude that anti-inflammatory action of fepolen is based mostly on influence on lipooxygenase then cyclooxygenase. the aim of this study was to establish a method by which probiotic bacteria can be selected for their immuno modulatory properties, especifically the ability of certain strains to suppress an inflammatory response. the gastrointestinal inflammatory condition crohns disease involves a th -response with increased levels of proinflammatory cytokines like tnfa and il , and mouse models of crohns disease show that the balance of il / is crucial for disease progression. we have used mouse bone marrow derived dendritic cells (bmdc) to model a proinflammatory crohns disease like condition in vitro with cocktail-induced bmdc secretion of il , il and tnfaf jthe model was validated using anti-inflammatory molecules like dexamethasone and prostaglandin d , which were able to suppress the cocktail induced il secretion. further validation of the model is confirmed by the fact, that probiotic strains which are able to suppress tnbs induced colitis in mice in preventive studies, also show potent anti-inflammatory activity in our model. among clinically relevant as well as novel probiotic strains, we have selected strains with potent anti-inflammatory properties, and are currently investigating the possible mechanism of action of these strains. in summary, our established model is suitable for identification of anti-inflammatory activity of probiotic strains and potentially other immune suppressing components, for rational selection of candidates for further preclinical and clinical evaluation and development. p - inflammation and human incisional hernia pathophysiology maria antonia arbos via( ) eae was induced by immunization of female lewis rats with guinea-pig myelin basic protein (mbp) in complete freunds adjuvant (cfa) and the animals were studied at the stage iii of the disease (characterized by complete paralysis of the hind-limbs) compared to cfa rats, eae resulted in increased mpo activity (u/mg tissue) in kidney ( ae vs. ae ae ; p< . ), and higher tbars contents (nmol mda/mg tissue) in liver acknowledgements: capes, cnpq, fapesp. contact information: ms simone teixeira, university of s¼o paulo, department of pharmacology, campinas, brazil e-mail: mone@usp.br tolerability, investigator and subject global assessments and rescue medication consumption supported by bk project from korea research foundation) contact information: mr young hoon kim here we report on the development of the pge mimetic combination therapy (dp- ) that inhibits basal and lps/tlr induced tnf-?, il- ß, and mmp- , , , in human and murine synovial membranes and peripheral macrophages.in a murine model of chronic synovitis (dorsal skin air pouch), dp dramatically inhibited il- ß, tnf-?, mip , mcp- and il- expression, delayed the profile of leukocyte/neutrophil extravasation and reduced exudate volume.in a model of inflammatory arthritis (collagen induced arthritis, cia), dp markedly reversed the inflammatory pathology by reducing synovial hyperplasia, cartilage erosion and articular inflammation.in addition, tnf-?, il- ß, mmp- and to a lesser extent mmp- expression/synthesis levels were strongly suppressed as judged by rt-pcr and elisa measurements we have developed two rias, one for functional blood levels of the above mentioned anti-tnf-alpha constructs, and one for anti-abs (all isotypes), and we have used these methods to monitor patients treated with infliximab/remicade and etanercept/enbrel ; i shall present some of these data ( , anatomy-physiology, faculty of medicine, laval university, quebec, canada neutrophils, which are often the first leukocytes to migrate at inflamed sites, can generate ltb from the -lipoxygenase pathway, pge through the inducible cyclooxygenase (cox- ) pathway and cytokines/chemokines as tnf-alpha, il- beta, il- , mip- alpha, mip- beta, mip- alpha and mip- alpha. engagement of the adenosine a a receptor (a ar) blocks the in vitro synthesis of ltb while it potentiates the cox- pathway in fmlp-treated neutrophils. in addition, it selectively prevents the expression and release of tnfalpha, mip- alpha, mip- beta, mip- alpha and mip- alpha in toll-like receptor- -stimulated human neutrophils. little effect was observed on il- beta and il- . using the murine air pouch model of inflammation with a ar-knockout mice, we observed that the activation of a ar positively impacts the expression of cox- in vivo, with particular magnitude in inflammatory leukocytes. in mice lacking the a a receptor, neutrophils that migrated into the air pouch h following lps injection expressed higher mrna levels of tnf-alpha, mip- alpha and mip- beta than neutrophils from wild type mice. together, these results indicate that neutrophils are important mediators of adenosines protective effects. given the uncontrolled inflammatory phenotype observed in a ar-knockout mice and in view of the potent inhibitory actions of pge on inflammatory cells, an increased cox- expression and a prevented release of tnf-alpha, mip- alpha and mip- beta caused by a ar activation, observed particularly in neutrophils, may take part in an early modulatory mechanism promoting anti-inflammatory activities of adenosine. sepsis induced by endotoxins including lipopolysaccharide (lps) is a big problem in clinical medicine. for a better insight into the molecular pathways and to assess markers of endotoxin-induced sepsis, we applied thetwo dimensional gel electrophoresis ( d-page) and maldi-tof to follow the changes of significant proteins in a murine macrophage cell line -raw . after challenged with lps (escherichia coli :b ) for , and hours. we identified proteins from approximately detected protein spots with either increased or decreased in relative abundance as a result of lps treatment. the proteins identified with increased expression are the retinoblastoma binding protein , capg protein, poly(rc) binding protein , isocitrate dehydrogenase (nad+) alpha, lactate dehydrogenase , a chain, guanine nucleotide binding protein (g protein), beta polypeptide like , triosephosphate isomerase and proteasome alpha subunit); and ones with decreased expression are the acidic ribosomal phosphoprotein p , malate dehydrogenase, soluble, proliferating cell nuclear antigen, proteasome (prosome, macropain) subunit, alpha type and rho, gdp dissociation inhibitor (gdi) beta). many of these altered proteins have interesting functions in inflammation. with the information obtained with the proteomic approach, it is possible to improve current methods of monitoring endotoxemia and to identify new therapeutic targets. the ubiquitous mitogen-activated protein (map) kinases are important enzymes in signal-tranduction cascades which regulates diverse cellular events such as cell transformation, proliferation, differentation, and apoptosis. they are therefore potential drug targets for therapeutic intervention in the treatment of inflammation, cancer, and other immune diseases. based on a virtual screening approach we identified -amino- -benzyl- -( -bromophenyl)- -methyl- , -dihydropyrano[ , c] pyrazole- -c arbonitrile as a potential novel lead structure as p map kinase inhibitors. a set of compounds were prepared starting from different substituted pyrazol- ( h)-ones via a base-catalyzed condensation with aldehydes and ch acids, such as malononitrile, to provide them for biological tests in a p enzyme assay. first structure-activity relationship confirm the value of this novel lead. this study was conducted to determine the physiological c-reactive protein (crp) and alpha -acid glycoprotein (aag) levels for two groups of beagle dogs: healthy dogs of various ages and pregnant dogs. serum crp levels were measured by elisa and aag levels were measured in healthy beagles of various ages by tia, and then separately -in pregnant beagles -by srid. serum crp levels ranged from . to . ìg/ml in male, and from . to . ìg/ml in female dogs. no significant sex-related differences were observed in the values. further, there were no significant age-related differences either. serum crp levels increased during pregnancy and peaked at . - . ìg/ml or days after ovulation, demonstrating two characteristic features of crp levels change in pregnant dogs. serum aag levels ranged from to ìg/ml in male, and from to ìg/ml in female dogs, without any significant sex-or age-related variation. serum aag levels increased in all pregnant beagles and peaked in the middle of gestation at - , ìg/ml. despite a high value of , - , ìg/ml being observed for serum aag levels in pregnant beagles inoculated with staphylococcus aureus, its levels in umbilical cord blood were below the detection limit of srid ( ìg/ml). no significant sex-/-age related differences were observed in serum both crp and aag levels and these levels increased during pregnancy. the results of aag levels in umbilical cords were below the detection levels suggest aag is not transported to the placenta. polymorphonuclear neutrophils (pmns) play a key role in the inflammatory response against infectious agents.however, they can elicit significant tissue damage and in this respect, anti-inflammatory drugs are of interest.in this study, we examined the effect of pbi- , a low molecular weight immunomodulatory molecule, on pmn activation by lps both in vitro and in vivo. we measured by elisa the production of tnf-a by human lps-activated pmn in the presence or absence of pbi- .the ability of pbi to modulate pmn activation and recruitment in vivo was assessed using a rat air pouch model of inflammation.exudates from different groups of animals (controls and pbi- treated animals, n= ) were used to assess leukocyte infiltration and to measure by elisa tnf-µ, mcp- and pge production.in vitro, pbi- is able to significantly decrease by . % ae . % (p< . ), tnf-a production by human lpsactivated pmn.in vivo, pbi- significantly decreased the production of tnf-a ( . % ae . %; p< . ), mcp- ( . % ae . %; p< . ) and pge ( . % ae . %; p< . ) induced by lps injection.however, pbi- did not significantly inhibit leukocyte infiltration.these results show that pbi- is able to modulate pmn activation and inflammatory response and suggest potential use as anti-inflammatory agent. ( ), lj lowenstine,( ), aj norris( ), t spangler( ), lm woods ( ) ( ) zoological society of san diego, usa ( ) department of pathology, microbiology, and immunology, university of california, davis, usa this study investigated the role of a novel reovirus in a outbreak of necrotizing typhlocolitis in american crows in california. included is a detailed characterization of the necrotizing and inflammatory characteristics of the disease, as well as a discussion of the implications of these findings upon proposed mechanisms of pathogenesis. complete histopathology including stains for lesion characterization and potential concurrent etiologic agents was performed on all outbreak crows. feces and ceca were submitted for culture, parasitology, and negative contrast electron microscopy. two control groups (n= each) were selected for parasitology and em (group ), and gross and histopathology (group ). all outbreak cases and group controls tested negative for west nile virus by pcr.all outbreak crows had marked, necrotizing heterophilic typhlocolitis, fibrinonecrotizing splenitis, and variable intestinal lamina proprial necrosis and hemorrhage.two cases had multifocal hepatic necrosis. negative contrast em revealed reovirus particles in % ( / ) of outbreak cases and in % ( / ) of controls. supplemental tests failed to suggest other concurrent or confounding etiologic agents.overall, the findings suggest association between the reovirus and the outbreak of typhlocolitis, and the absence of reovirus in controls suggests that it is not ubiquitous in the crow population.there was a noteable absence of similar typhlocolitis in archived crows submitted to the vmth from - , suggesting an emerging corvid disease in california, which bears further investigation. mitogen-activated protein kinase (mapks) pathways play an important role in the signalling system activated by proinflammatory cytokines. among the most important cascades the activation of erk / by mek / is reported to be responsible for inflammatory responses and degradation of osteoarthritic cartilage. as , a selective mek inhibitor, demonstrated anti-inflammatory properties in reducing tnf-alpha production induced by lps injection (ic mg/kg). therefore, primary aim of the present study was to assess the therapeutic strength of the as in a mouse model of collagen-induced rheumatoid arthritis (cia) assessing the effect of the compound on structural changes related to the cartilage. cia is characterized by severe polyarthritis affecting peripheral joints, synovial hyperplasia with persistent inflammation and cartilage erosion. as treatment was initiated when signs of arthritis were clinically visible (in terms of paw swelling and redness) and was continued for days (twice daily), by oral route at the doses of , and mg/kg. as at and mg/kg significantly reduced clinical arthritic read-outs such as clinical score and paw swelling. at histology, vehicle-treated animals showed severe inflammation and joint surface erosion. administration of as significantly decreased inflammatory infiltrates and treated cartilage surfaces that presented normal levels of proteoglycan content. in conclusion, the results obtained in this study clearly demonstrate that the selective blockade of mek could be considered as an innovative therapeutic approach to treat rheumatoid arthritis. experimental evidences have shown that the toxicity of ni salts may involve inflammatory processes, with a subsequent overproduction of reactive oxygen species (ros) and carcinogenicity. neutrophils are the most abundant leukocytes of blood, and participate actively in the inflammatory innate host defense response. however, relatively little is known about the potential of nickel salts in activating human neutrophils.thus, the aim of the present study was to evaluate the putative stimulation of oxidative burst in isolated human neutrophils by nickel nitrate. the measurement of neutrophil burst was undertaken in vitro, by chemiluminescence, by monitoring the oxidation of luminol by neutrophil-generated ros and reactive nitrogen species (rns). enzymatic inhibitors and specific reactive species scavengers were used to evaluate which species were involved in neutrophils activation by nickel nitrate. the obtained results showed that nickel nitrate stimulates human neutrophils burst in a concentration-dependent manner, within levels that may be attained in vivo. in the present experimental conditions, the reactive species involved in neutrophils activation by nickel nitrate were superoxide radical (o -.), hydrogen peroxide (h o ), hydroxyl radical (ho.) and perchloric acic (hocl). the observed activation of isolated human neutrophils burst by nickel nitrate and subsequent tissue damage due to a sustained formation of reactive species may contribute for the deleterious effects attributed to this transition metal, though this assumption needs to be confirmed in vivo. ( ), h spalteholz ( ), u reibetanz ( ), p salavei ( ), m fischlechner ( ), h-j glander( ), j arnhold ( ) ( ) university of leipzig, medical faculty, institute for medical physics and biophysics, germany ( ) university of leipzig, derpartment of dermatology, andrology training centre of the european academy of andrology, germany unintentional childlessness often caused by common reasons as inflammation affects - % of german couples. inflammations of the male genital tract lead to an infiltration of polymorphonuclear granulocytes (pmn), respectively induce a restricted spermatozoa quality associated with early triggered acrosome reaction (ar) and apoptosis as well as changes in the lipid structure and reduced mobility. stimulated pmn release the strongly cationic heme protein myeloperoxidase (mpo), which is able to bind to negatively charged membrane surfaces, e.g. apoptotic cell membranes with externalized phosphatidylserine (ps). a population of freshly prepared spermatozoa shows only a very small amount of cells with mpo binding ability as well as externalization of ps. the number of spermatozoa able to bind mpo raises considerably in samples containing predamaged cells or introducing the ar as could be observed with rhodamine b isothiocyanate (ritc)labelled mpo and antibody techniques by fluorescence microscopy as well as flowcytometry. the activation ofmpo with its substrate hydrogen peroxide (h o ) in the presence of chloride ions generates the powerful oxidizing and chlorinating species hypochlorous acid (hocl) and enhanced markedly the number of annexin v positive and non-vital cells. components of seminal plasma as well as serum albumin can protect spermatozoa for the deleterious effects of mpo. the coincidence of ps externalization and mpo binding to spermatozoa surfaces indicates an up to now unknown role of this enzyme in recognition and removal of apoptotic cells during inflammation. recent findings suggest a crucial role of proteinaseactivated receptor- (par ) in inflammation and innate immunity. par is the second member of a novel g protein-coupled receptor subfamily with seven putative trans-membrane domains. this subfamily is characterized by a unique mechanism of receptor activation. accessible serine proteases cleave the receptor to expose a new, previously cryptic, n-terminal sequence ("tethered ligand") which further interacts with the same receptor and activates it. tryptase, trypsin, and bacterial serine proteases are capable of directly activating par . par is expressed by human neutrophils, however its functions on these cells remained unclear. the data of our present study indicate that par agonists enhance interferon gamma (ifna)-induced up-regulation of cell surface fca;ri, one of the key receptors involved in neutrophil phagocytic activity. moreover, par agonists (serine proteases as well as synthetic activating peptide) and their receptor represent an additional system which controls neutrophil transendothelial migration and apoptosis in vitro. additionally, there is a significant increase of par expression on the neutrophil cell surface in the case of septic patients as compared to cells from healthy volunteers. together, our results indicate that par may be involved in the pathophysiology of acute bacteria-induced human diseases (sepsis or septic shock, for example) potentially by regulating neutrophil apoptosis, transendothelial migration and fca-receptor expression. aim: to ascertain the role of macrophages as direct inducers of regeneration after renal ischemia/reperfusion, and to establish whether inflammatory conditions contribute to the process. we determined whether adoptive transfer of macrophages at different stages of kidney inflammation after mouse renal i/r could restore reparation and assessed the influence of inflammation in the process.results: i/r provoked the increases in renal regeneration, as evaluated by inmunohistochemistry and pcr mrna of stathmin and pcna. the cytokine profile revealed the influence of the inflammatory environment on kidney repair. regeneration was macrophage-dependent, decreasing when depletion was provoked, and increasing with adoptive transfer of macrophages; however, administration of resting macrophages did not induce repair at the time points in which tissue was inflamed, and was only able to promote regeneration in the absence of inflammation ( hours). pro-inflammatory cytokines increased at the early stages of reperfusion, coinciding with low regeneration, and anti-inflammatory cytokines increased during the longer periods of reperfusion when regeneration was more evident.conclusions: macrophages directly induce renal regeneration after ischemia/reperfusion in an inflammationdependent manner. ( ), k bendtzen ( ), f sellebjerg ( ), ch nielsen ( ) ( antibodies against myelin basic protein (mbp) are present in sera from patients with multiple sclerosis (ms), but the role of these antibodies is controversial. we collected sera from ms patients and healthy individuals and found that both groups contained igm anti-mbp antibodies, while ms sera contained small amounts of igg anti-mbp. however, the two groups of sera did not differ significantly with respect to the content of either antibody subclass. addition of mbp to the various sera and subsequent addition of the mixtures to normal peripheral blood mononuclear cells (pbmc) resulted in a significant deposition of igm on cd + monocytes, indicating that formation of mbp/igm complexes had occurred. this deposition was strongly inhibited by addition of mm edta to the sera, indicating that it was complement dependent. the pbmc produced significant amounts of il- , tnf-alpha and ifn-gamma upon stimulation with mbp, and the extent of the cytokine production did not depend upon whether sera from ms patients or from healthy controls were present. however, disruption of the tertiary structure of mbp by boiling significantly reduced the production of all three cytokines, supporting a role for antibodies in the induction of cytokine responses to mbp. we propose that natural igm autoantibodies may form complexes with mbp, facilitating the uptake of mbp by antigenpresenting cells (apc). since sera from ms patients did not enhance this uptake and the subsequent cytokine production, the mechanism may be part of an appropriate peripheral regulation of self-reactivity. we currently investigate this possibility. loredana postiglione( ), g tarantino( ), a spanò( ), p ladogana ( ), fl perrone( ), s padula( ), a riccio ( ) ( ) federico ii university medical school of naples, department of molecular and cellular biology and pathology l.califano, naples, italy ( ) federico ii university medical school of naples, departmentof clinical and experimental medicine, naples, italybackground: hepatitis c virus (hcv) infection can induce immunological disorders with different clinical expression such asarthritis, sjogren sindrome and various form of vasculitis.aim: to study the prevalence of anti-cyclic citrullinated peptides antibodies (anti-ccp) in a group of patients affected by hcv-related arthritis and the eventual correlations with rheumatoid factor (rf) and/orantinuclear antibodies (ana), and articular involvement. study design: patients with arthritis were selected in a population of subjects affected by hcv infection. each patients was evaluated by clinical examination ( denoted poliarticular and mono-oligoarticualr involvement), by x-graphic aspects of joint involvement ( patients presented join erosions), by ana, rf and anti-ccp positiveness.results: , % of patients presented positivenessfor anti-ccp, without significant correlation between suchparameter and ana, rf and articular involvement. anti ccp resulted positive in out of the patients with joint erosions, and only in out of the patients without joint erosions. such frequency analyzed by chi square ended up in no significant differences. our patients presented an interesting prevalence of the positiveness for anti-ccp. these data suggest a consideration about the specificity, commonly attributed to this parameter in the diagnosis of rheumatoid arthritis. expression of nkg d on cd + t cells is generally rare in both mice and humans, but has been reported in a number of inflammatory diseases, including rheumatoid arthritis, crohns disease and an animal model of type diabetes. the monoclonal antibody cx recognizes murine nkg d and has been shown to block ligandbinding and mediate internalization of nkg d. furthermore, cx can inhibit and/or ameliorate disease in animal models of type diabetes and inflammatory bowel disease. thus, it is very likely that nkg d plays an important role in the development of inflammatory and autoimmune diseases. since little is known about the pharmacokinetics and pharmacodynamics of the cx antibody, we decided to study this in both regular balb/ c mice and immunodeficient cb .scid mice. different doses of cx antibody was injected intraperitoneally and pk and pd was measured by elisa (anti-cx elisa in serum) and flow cytometry (down-regulation of nkg d on cd b+ nk cells) for up to two weeks after administration. we found that cx very efficiently down-regulate nkg d on cd b+ nk cells and that the effects of the antibody can be seen for more than two weeks after one single injection. finally, we propose a model which may be helpful in predicting the effects of different doses of cx antibody in vivo. ( ), k mehta( ), n deo( ), j chaudhary( ), p bobrowski ( ) ( ) albany medical college, usa ( ) vedic lifesciences, usa ( ) rainforest nutritionals, inc, us background: the efficacy and safety of reparagen, in treating osteoarthritis was compared to glucosamine sulfate in a mumbai-based multi-center, randomized, double-blind study.methods: subjects (n= ) were screened and randomized to receive glucosamine sulfate (n= , mg/day) or reparagen (n= , mg/day), a polyherbal consisting of vincaria (uncaria guianensis) and rni (lepidium meyenii) administered orally, twice daily. primary efficacy variables were womac scores, visual analog score (vas) for pain, and response to treatment defined as a % improvement in womac pain, with assessments at , , , and weeks. secondary variables were results: subject randomization was effective and both treatments showed significant benefits in primary outcomes within one week (p< . ), with a similar, progressive improvement over the course of the week treatment protocol ( - % reduction in total womac or vas scores). the response rate was substantial for both glucosamine ( %) and reparagen ( %), which exceeded placebo responses ( %, p < . ) and supported by investigator and subject assessments. tolerability was excellent and safety parameters were unchanged. rescue medication use was significantly lower in the reparagen group (p < . ), and serum igf- levels were unaltered.conclusions: both reparagen and glucosamine sulfate produced substantial improvements osteoarthritis symptoms. response rates were high and the safety profile was excellent, with significantly less rescue medication use with reparagen. we speculate that the high response rate to glucosamine sulfate may reflect higher baseline pain levels or synergy with dietary curcumin. inflammation accompanies and aggravates progression of all modern human chronic pathological conditions. growing evidence indicates the beneficial role of proper nutrition in controlling inflammation. we investigated the effects of selected essential nutrients in experimental inflammation and the molecular mechanisms involved. tested nutrient mixture (nm) consisted of green tea catechins, citrus flavonoids hesperidin, naringenin and quercetin, ascorbate, lysine, proline, arginine and cysteine. systemic inflammation in mice challenged with bacterial lipopolysaccharide (lps) was monitored by blood plasma levels of fourteen key inflammatory cytokines. two week supplementation with mg nm/kg body weight prior to lps challenge provided significantly greater protection than did supplementation with ibuprofen. induction of interleukin- (il- ) and monocyte chemoattracting protein- , two cytokines especially responsive to lps challenge, was reduced in nmsupplemented animals by % and %, respectively. corresponding reduction in ibuprofen group was % and %. protective mechanisms involved were assessed in human cultured u macrophages stimulated with lps.the cytokines most responsive were tumor necrosis factor alpha ( % and % reduction by supplementation with nm and ibuprofen, respectively) and il- ( % and % in corresponding reduction). nm supplementation dramatically reduced prostaglandin e secretion by stimulated macrophages along with cyclooxigenase- (cox ) cellular protein expression. mrna levels forcox and inflammatory cytokines were also dramatically reduced. quercetin was the most effective nutrient when tested individually. however, nm appeared to surplus the combined effect of individual components. we conclude that the tested combination of essential nutrients demonstrates strong beneficial effects in experimental inflammation by targeting responsible gene expression. ( ), hp kim ( ), kh son ( ) ( ) college of pharmacy, kangwon national university, south korea ( ) department of food and nutrition, andong university, south korea chalcones belong to flavonoid family from plant origin and some of them possess anti-inflammatory activity. recently, several natural and synthetic chalcones were reported to inhibit inducible nitric oxide synthase (inos)-catalyzed no production in cell cultures. in the present study, to find the optimal chemical structures and to elucidate their action mechanisms, synthetic chalcones having the substituent(s) on a-and b-rings were prepared and their effects on inos-catalyzed no production were evaluated using lps-treated raw . cells. among the tested compounds, -methoxy- , -dichlorochalcone (ch ), -hydroxy- -methoxychalcone (ch ), -hydroxy- -bromo- -methoxychalcone (ch ) and -hydroxy- , -dimethoxychalcone (ch ) potently inhibited no production (ic s, . - . mm). the favorable chemical structures were found to be a methoxyl substitution in a-ring at adjacent position ( or ) to carbonyl moiety with/without -(or -)hydroxyl group and -halogen substitution in b-ring. when the cellular action mechanisms of ch , ch and ch were further examined, it was revealed that ch and ch clearly down-regulated inos expression while ch did not. moreover, ch and ch were proved to suppress the nuclear transcription factor-kb activation. from the results, it is suggested that certain chalcone derivatives potently inhibit inos-catalyzed no production by the different cellular mechanisms, inos down-regulation or inos inhibition, depending on their chemical structures. these chalcone derivatives may be possibly used as lead compounds for developing new anti-inflammatory agents. an oligomeric stilbene alpha-viniferin (avf) was isolated from root of carex humilis (cyperaceae) as an inhibitor of cyclooxygenase (cox)- activity by bioassayguided fractionation. the avf was later found to downregulate lipopolysaccharide (lps)-induced cox- expression as well as to inhibit nuclear factor (nf)-kb activation, in addition to its inhibitory effect on cox- activity. furthermore, the compound exhibited antiarthritic effect in vivo. avf is a trimer of resveratrol and contains benzofuran moieties in its central part. starting from benzofuran and its related chemicals, cyclohexylimino- -methyl- , -dihydro- h-benzo [ , ] oxathiol- -one (lyr- ) was discovered to inhibit lpsinduced nf-kb transcriptional activity in macrophages raw . . the lyr- reduced lps-induced dna binding activity and nuclear translocation of nf-kb as well as inhibited lps-induced degradation and phosphorylation of inhibitory kb (ikb) protein. these results suggest that lyr- could suppress lps signaling molecule, putatively ikb kinase (ikk) complex, upstream ikb degradation in nf-kb activating pathway. lyr- inhibited in vitro kinase activity, gst-ikb phosphorylation, of wild type ikkbeta or a constitutively active ikkbeta mutant (c/a, cys- to ala) but did not affect that of another constitutively active ikkbeta mutant (ss/ee, ser- and to glu). therefore, lyr- could inhibit lps-induced nf-kb activating pathway by targeting ser- and/or residues on the activation domain of ikkbeta. as pharmacological actions, lyr- prevented nf-kb-dependent expression of inducible nitric oxide synthase, cox- , or inflammatory cytokines at the transcription level in lps-stimulated macrophages raw . . furthermore, lyr- protected lpsinduced septic shock in vivo. faculty of medicine, institute of pharmacology, ljubljana, slovenia a part of anti-inflammatory action of antidepressants can arise from their effect on histamine elimination from the side of inflammation. in mammals histamine is mainly degraded by two enzymes: histamine-n-methyltransferase (hnmt) and diamine oxidase (dao). the aim of present investigation is to establish whether antidepressants amitriptyline and sertraline can affect histamine metabolism. their effects on enzyme activity and mrna expression were studied in guinea pig tissues. plasma and tissue homogenates were incubated with saline (control) and different antidepressant concentrations. specific enzymatic activities of dao and hnmt were determined by radiometric assay. in addition, guinea pigs were treated with saline or amitriptyline ( mg/kg, ip), afterwards dao and hnmt mrnas were detected by pcr in different tissues. results showed thatamitriptyline, nm, , and mm, increased guinea pig plasma dao activity by , , and %, respectively, while sertraline increased it at mm (by %). at higher concentrations ( and mm) sertraline decreased dao activity. in the guinea pig tissues hnmt activity changes were found only when incubated with amitriptyline; sertraline had no effect. at and nm amitriptyline the activity of hnmt increased by and %, respectively. in animals treated with amitriptyline an induction of dao and hnmt mrna expression was noticed in several tissues. our results suggest that in guinea pigs due to higher histamine metabolism antiinflammatory effects can be expected at lower concentrations of antidepressants. the effect might be the opposite with higher amitriptyline concentrations. steven hefeneider( , ), c macarthur ( ), d trune ( ), s mccoy ( ) ( ) oregon health and science university, portland, oregon, usa ( ) targeted gene delivery, inc., portland, oregon, usa engagement of toll-like receptors (tlrs) by bacterial components such as lps and dna initiates inflammation.the current study examines a novel anti-inflammatory peptide, termed p , for treatment of inflammation induced by either lps or bacteria.peptide p was derived from an immunoregulatory protein of vaccinia virus, and interferes with tlr signaling.in this study we examined the efficacy of p to limit inflammation in a mouse model of sepsis and a model of middle ear inflammation, termed acute otitis media (aom).we demonstrate in the sepsis model, that in vivo treatment of mice with p inhibited lps-induced production of serum inflammatory mediators.moreover, p treatment, administered after initiation of inflammation, significantly increased survival of mice injected with lps.in the aom model, peptide p significantly reduced in vivo middle ear inflammation and fluid accumulation initiated by h. influenza.assessment of route of administration and delayed treatment studies demonstrated the efficacy of peptide p .simultaneous injection of bacteria and peptide p resulted in a significant reduction in fluid accumulation, infiltrating cells, and tympanic membrane thickness.fluid accumulation within the eustachian tubes was also significantly reduced following p treatment.-subcutaneous and oral administrations of p , but not intravenous administration, were also efficacious in reducing inflammation. administration of p after initiation of an ongoing inflammatory response was effective at reducing inflammation and fluid development.taken together, these results demonstrate the therapeutic potential of peptide p to limit an inflammatory response and suggest a possible new treatment strategy for bacterial-induced inflammation. ( ), c zhou( ), y zhang( ), m sun( ), x wan ( ), h yu( ), x yang( ), rd ye ( ), j-k shen ( ) formyl peptide receptor-like (fprl ) is a structural homologue of fpr, which binds chemotactic peptides of as small as amino acids (e.g., fmet-leu-phe, fmlf) and activates potent bactericidal functions in neutrophils. in comparison, fprl ligands include peptides of - amino acids, such as trp-lys-tyr-met-val-[d]met (wkymvm) and other synthetic peptides. to determine the core peptide sequence required for fprl activation, we prepared various analogues based on wkymvm and evaluated their bioactivities in an fprl -transfected cell line. although substitution of d-met resulted in loss of activity, removal of val together with d-met produced a peptide that retained most of the bioactivities of the parent peptide. the resulting peptide, wkym, represents a core structure for an fprl ligand. further substitution of lys with nle slightly improved the potency of the tetrapeptide, which becomes a dual agonist for both fprl and fpr. based on these structure-activity studies, we propose a model in which the modified tetrapeptide trp-nle-tyr-met (wnleym) binds to fprl through aromatic interactions involving the side chains of trp and tyr , hydrophobic interaction of nle , and the thio-based hydrogen bonding of met , with the respective residues in fprl which have not been identified. the identification of the core sequence of a potent peptide agonist provides a structural basis for future design of peptidomimetics as potential therapeutic agents for fprl -related disorders.there is a growing awareness of the interaction of food constituents with the immune system. the present study aims to evaluate immunomodulatory effects of two of these nutritional components, i.e. glycine and lactoferrin. mice orally supplemented with glycine, lactoferrin or a combination were injected intradermal (in the ear) with zymosan. ear swelling, as a measure for inflammation, as well as il- , tnf-a and il- levels in the ear and the number of tnf-a producing spleen cells were analyzed.-glycine and lactoferrin were able to decrease the zymosan induced inflammatory response locally (decreased ear swelling and pro-inflammatory cytokine levels) as well as systemically (reduced number of tnf-a producing spleen cells).glycine effects ( , and mg/mouse/day) were concentration dependent whereas for lactoferrin only the lowest doses ( . and mg/mouse/ day) inhibited the inflammatory response significantly. surprisingly higher doses of lactoferrin ( and mg/ mouse/day) failed to influence the inflammatory reaction. a combination of both nutrients (lactoferrin . mg/ mouse/day in combination with glycine or mg/ mouse/day) inhibited the zymosan induced ear swelling synergistically. additionally an additive effect of both components was seen on the number of tnf-a producing spleen cells. the present data show anti-inflammatory activity of glycine and lactoferrin using the zymosan induced inflammation model.moreover a combination of both components demonstrated a synergistic effect on inflammation of the skin and an additive effect on the number of tnf-a producing spleen cells. ( ), p sambrook( ), k fukudome( ), m xue ( ) ( ) university of sydney, st leonards, nsw, australia ( ) saga medical school, saga, japan objectives: to investigate the i) expression of endothelial protein c receptor (epcr) in synovial membrane and peripheral blood monocytes from patients with rheumatoid arthritis (ra) and osteoarthritis (oa) and ii) role of epcr and its ligand, activated protein c (apc), on the function of monocytes from ra patients.methods: epcr, cd and pc/apc in synovial tissues were detected by immunostaining and in situ pcr. monocytes were isolated from peripheral blood of patients with ra and treated with apc, lipopolysaccharide (lps), and/or epcr blocking antibody, rcr . cells and supernatants were collected to analyze the expression/activation of epcr, nuclear factor nf-kb and tumour necrosis factor tnf-a.results: epcr was expressed by both oa and ra synovial tissues but was markedly increased in ra synovium. epcr was colocalized with pc/apc mostly on cd positive cells in synovium. in ra monocytes, apc upregulated epcr expression reduced monocyte chemoattractant protein- -induced chemotaxis of monocytes by approximately %. apc also completely suppressed lps-stimulated nf-kb activation and attenuated tnf-a protein by more than % in ra monocytes. the inhibitory effects of apc were reversed by rcr , indicating that epcr modulates the inhibitory effects of apc.conclusions: our results demonstrate for the first time that epcr is expressed by synovial tissues, particularly in ra, where it co-localizes with pc/apc on monocytes/ macrophages. in addition, apc inhibits the migration and activation of ra monocytes via epcr. these inhibitory effects on ra monocytes suggest that pc pathway may have a beneficial therapeutic effect in ra. key: cord- -wtc bml authors: el-radhi, a. sahib title: pathogenesis of fever date: - - journal: clinical manual of fever in children doi: . / - - - - _ sha: doc_id: cord_uid: wtc bml the generation of fever involves the following steps: numerous substances from outside the body, exogenous pyrogens, initiate the fever cycle. endotoxin of gram-negative bacteria, with their pyrogenic component lipopolysaccaride, is the most potent exogenous pyrogen. fever is also a common finding in children without obvious evidence of infection, for example hypersensitivity reaction, autoimmune diseases and malignancy. exogenous pyrogens initiate fever by inducing host cells (primarily macrophages) to produce and release endogenous pyrogens such as interleukin- , which has multiple biological functions essential for the immune response. endogenous pyrogens are transmitted to the hypothalamic thermoregulatory centre, specifically organum vasculosum of the lamina terminalis (ovlt), where they induce synthesis of prostaglandins, of which pge is the most important. these raise the thermostatic set point to initiate the febrile response. the hypothalamic thermoregulatory centre accomplishes heat production by inducing shivering and heat conservation through vasoconstriction. at an established degree, fever is regulated (even at a temperature of over . °c) and heat production approximates loss, as in health, though at a higher level of the set point. therefore fever does not climb up relentlessly. in addition to the function as an endogenous pyrogen, il- activates t-lymphocytes to produce various factors, such as inf and il- , which are vital for immune response. the production of fever simultaneously with lymphocyte activation constitutes the clearest and strongest evidence in favour of the protective role of fever. the induction of fever results in inhibition of bacterial growth, increased bactericidal effects of neutrophils, production of acute-phase protein synthesis and other physiological changes such as anorexia and somnolence. these changes suggest that fever has an adaptive role in the host’s survival during infection. • although infection is the most common cause of fever, fever is also a common finding in hypersensitivity reaction, autoimmune diseases and malignancy. • febrile response is mediated by endogenous pyrogens (cytokines) in response to exogenous pyrogens, primarily micro-organisms or their direct products (toxins). • these endogenous pyrogens act on thermo-sensitive neurons in the hypothalamus, which ultimately upgrade the set point via prostaglandins. • the body reacts by increasing the heat production and decreasing the heat loss until the body temperature reaches this elevated set point. • fever, in contrast to hyperthermia, will not climb up relentlessly because of an effective central control of the hypothalamic centre. • cytokines play a pivotal role in the immune response by activation of the b cells and t-lymphocytes. the production of fever simultaneously with lymphocyte activation constitutes the clearest and strongest evidence in favour of the protective role of fever. • the protective processes of the immune response are optimal at high temperature (around . °c). • not all effects resulting from fever generation benefit the host; some are harmful and even lethal. this occurs mainly by overproduction of the cytokines or imbalance between cytokines and their inhibitors, such as severe and fulminate infections and septic shock. research in fever has been centred on the hypothesis that fever results from physiological processes that are set in motion by an external stimulus. egyptian scholars recognized that local inflammation was responsible for fever. in , billroth ( - ) attempted to confirm this ancient observation by injecting pus into animals, thereby producing a febrile response. in , menkin carried out similar experiments and isolated a product termed "pyrexin" [ ] . beeson in isolated a fever-inducing substance from a leukocyte, leukocyte pyrogens, which later became known as endogenous pyrogen (ep). interleukin- (il- ) was first identified as a cytokine by gery and waksman and proved to be identical with ep [ ] . • fever (pyrexia) is a regulated body temperature above the normal range occurring as a result of il- -mediated elevation of the hypothalamic set point. once fever is established, body temperature is regulated, as in health, by a net balance between heat production and loss. • hyperthermia is an unregulated elevated body temperature above the normal range due to imbalance between heat production and loss. interleukins are not involved and therefore the hypothalamic set point is normal. • a pyrogen is a substance (infectious organisms or their product toxins or cytokines) that provokes fever. • exogenous pyrogens are substances, which originate outside the body and which are capable of inducing interleukins. • endogenous pyrogens are substances, which originate inside the body and which are capable of inducing fever by acting on the hypothalamic thermoregulatory centre. il- , tumour necrosis factor (tnf) and interferon (inf) are endogenous of albumin and transferrin decreases. characteristically there are a decreased concentration of iron and zinc and an increased copper concentration. the low iron is the result of reduced intestinal assimilation of iron and increased liver storage of iron. these changes contribute to host defence by depriving invading micro-organisms of essential nutrients, such as iron and zinc. the process is referred to as nutritional immunity. • cytokines are proteins produced throughout the body, mainly by activated macrophages, monocytes and t cells to regulate the immune responses within the body, control inflammatory and haematopoietic processes and may induce fever. as they enter the circulation and act on distant organs, they are considered as hormones. pro-inflammatory cytokines (e.g. il- , il- , tnf-α, inf-γ, granulocytes-macrophages colony stimulating factor, gm-csf) are responsible for initiating an effective defence against exogenous organisms (e.g. activating neutrophils). their overproduction may be harmful by causing shock, multiple organ failure and death. anti-inflammatory cytokines (e.g. il- receptor antagonist, il- , il- ) antagonize the pro-inflammatory cytokines and thus promoting healing and reducing inflammation. • monokines are cytokines that are produced by mononuclear phagocytic cells. • chemokines are cytokines that attract cells to the site of infection using chemical message (chemotaxis). typical chemokine is cxcl- that attracts neutrophils. • interleukins are cytokines, acting specifically as mediators between leukocytes, hence their name. their number known nowadays is enormous: at least interleukins have been identified. if their amino acid sequence is known, they are assigned an interleukin number. if their sequence is not known, then they are named according to the biological property. il- and il- play a major part in the pathogenesis of fever. • lymphokines are cytokines that are secreted by lymphocytes to regulate the immune response. important lymphokines are il- , il- , il- , il- , il- , il- , il- , il- , il- and tnf-gamma. • prostaglandins are lipids that are made at sites of infection and tissue damage to produce inflammation and fever as part of the healing process. • acute-phase response is the term used for haematological, endocrinological and metabolic changes that follow (within hours or days) the onset of fever in response to infections or local damage to a tissue. these changes are induced by several cytokines (il- being the primary inducer), which are beneficial to the host. during the response, various acute-phase proteins, notably c-reactive protein (crp) and serum amyloid a, are synthesized by hepatocytes and released into circulation in large amounts. crp plays a role in complement activation, opsonization and increasing platelet aggregation. although acutephase response is closely associated with fever, crp levels can be normal in viral infections and high in diseases without fever (e.g. tumours). syntheses of albumin and transferrin and the concentration of iron and zinc decrease, while copper concentration increases. the low iron is the result of reduced intestinal assimilation of iron and increased liver storage of iron. these changes contribute to host defence by depriving invading micro-organisms of essential nutrients, such as iron and zinc. the process is referred to as nutritional immunity. exogenous pyrogens (e.g. bacteria, viruses, toxins) initiate fever, usually within h of exposure, by interacting with macrophages or monocytes, leading to cytokine induction. other mechanisms to initiate fever include: • some endotoxins, produced by bacteria, act directly on the hypothalamus to alter the set point. il- is not involved. radiation of the hypothalamus, ddt (dichlorodiphenyltrichloroethane), poisoning and scorpion venom may also induce fever by a direct effect on hypothalamus. • exp may activate lymphocytes to secrete lymphokines, particularly inf-y, which in turn stimulate macrophages and monocytes to produce il- . • some bacteria produce exotoxins, which stimulate macrophages and monocytes to release il- . this mechanism operates in scarlet fever and toxic shock syndrome. in toxic shock syndrome, the shock is due to the toxin. diseases involving exotoxins produced by gram-positive bacilli are less fever-inducing than those produced by pyrogenic gram-positive cocci. • borrelia spirochetes (the cause of relapsing fever) do not contain endotoxin, and the attachment of these bacteria to the mononuclear cells induces il- . • other bacteria, such as pneumococci, have no endotoxin or other pyrogens, and the mechanisms responsible for fever are presumably immunological • gram-negative bacteria. the pyrogenicity of gram-negative bacteria (e.g. escherichia coli, salmonella) is due to a heat-stable factor, endotoxin. the active components of endotoxin are lipid and carbohydrate (lipopolysaccharide, lps), which are the major components of the outer membrane of these bacteria. endotoxin causes a dose-related progressive increase in temperature. in severe cases, it causes shock with vasodilatation, capillary leakage and hypotension. septicaemia caused by gram-negative endotoxin does not elicit fever in certain situations such as neonates, young infants or children with fulminating infection or with malnutrition. these children may present with normal temperature or even hypothermia in response to severe infection. mortality is significantly higher in septic children [ ] and adult [ ] patients due to reduced capacity to release tnf-α and il-β upon infection with lps. • gram-positive bacteria. the main pyrogen of most bacteria is peptidoglycan that forms the cell wall. penicillin works by inhibiting the biosynthesis of peptidoglycan, which results in cell lysis. this explains why penicillin is more effective against gram-positive bacteria. • viruses. it is well known in clinical practice that viruses cause fever. mechanisms by which viruses may produce fever include direct invasion of macrophages, immunological reaction to viral components involving antibody formation, induction by inf and necrosis of cells by viruses. • fungi. live or killed fungal products are exogenous pyrogens that induce fever. the induction of fever mainly occurs when the fungi are in the bloodstream. children with neoplastic diseases who develop fever associated with neutropenia are at high risk for developing invasive fungal infection. • phagocytosis is largely responsible for fever in blood transfusion reactions (once an infection is excluded) and immune haemolytic anaemia. • antigen-antibody complexes. an exogenous antigen may react with circulating, sensitized antibodies to form a complex, which induces il- production (immune fever). examples of immunologically mediated fever include systemic lupus erythematosis and adverse drug reactions. fever associated with penicillin hypersensitivity results from interaction of antigen-antibody complexes with leukocytes, which release il- . • most steroids are endogenous antipyretics, which suppress fever through their inhibitory effects on il- and tnf-α production as well as inhibition of prostaglandin synthesis. certain steroids, however, are pyrogenic in human such as etiocholanolone, a major metabolite of testosterone and -ketosteroid, which induce the release of interleukin- . etiocholanolone produces fever only when injected intramuscularly (not intravenously). etiocholanolone fever is characterized by recurrent fever for few days, in association with arthralgia, abdominal pain, leukocytosis, high esr and etiocholanolone level. fever does not respond to antipyretics but to steroids, e.g. prednisolone. etiocholanolone is responsible for fever in some patients with adrenogenital syndrome. • other nonmicrobial pyrogens include some hormones, drugs and intracranial lesions such as bleeding and thrombosis mononuclear cells are leukocytes ( - % of the leukocytes) and are largely responsible for the production of il- and fever induction. polymorphonuclear granulocytes are no longer thought to be responsible for il- production because fever may occur in their absence, e.g. agranulocytosis. the mononuclear cells are either circulating monocytes in the peripheral blood or tissue macrophages (histocytes) scattered in organs such as lung (alveolar macrophages), lymph nodes, placenta, peritoneal cavity and the subcutaneous tissue. the origin of both monocytes and macrophages is the granulocyte-monocyte colony-forming unit (gm-cfu) in the bone marrow. monocytes enter the circulation either to remain there for a few days as circulating monocytes or to migrate to the tissue where they undergo functional and morphological transformation into macrophages, when their life span is several months. these cells play an important role in: • host defence, including engulfing and destroying the microbe (phagocytosis) recognition of antigen and presenting it to attached lymphocytes. • activation of t-lymphocytes and tumour cell destruction. situations associated with reduced function of the mms include newborn infants, corticosteroid and other immunosuppressive therapy, systemic lupus erythematous, wiskott-aldrich syndrome (immune deficiency involving b and t cells, eczema and thrombocytopenia) and chronic granulomatous disease. the two major monocytemacrophage products (cytokines) are il- and tnf. endogenous pyrogens (ep) il- consists of three structurally related polypeptide, two agonists (il- α and il- β) and an antagonist (il- receptor antagonist = il- ra), which inhibit the activities of the two powerful agonists. anakinra is a naturally il- ra. il- α is produced in: • cells of healthy people including in all epithelial cells of mucosal membranes. • blood monocytes and tissue macrophages. • hepatic kupffer cells, keratinocytes and pancreatic langerhans cells. • astrocytes in the brain tissue, which may contribute to the immunological responses within the cns and the fever secondary to cns bleeding. • cells from certain malignant tumours (e.g. hodgkin's disease, acute leukaemia and renal carcinoma). this explains the frequent association of fever in these conditions in the absence of infection. il- β is not present in cells of healthy people and is mainly produced by monocytes, macrophages and dendritic cells. interleukin- has important roles in the following conditions ( fig. . ): • induction of fever by acting on the hypothalamus to raise its set point. • induction of hepatic acute-phase proteins (see above). • induction of inflammatory response and lymphocyte activation factor. • appetite suppression. il- is a potent anorexic cytokine (more potent than the hunger inhibitor leptin), which explains the reduction of food intake commonly seen in febrile illness. il- ra reverses the decrease in food intake. circulating il- ra, along with il- , are increased in obese and type diabetes [ ] . • il- β (along with tnf-α) regulates sleep by promoting non-rapid eye movement sleep. this cytokine is produced in astrocytes of the brain. the action of il- β may explain the observation of increased sleep in febrile illnesses. • joint diseases such as rheumatoid arthritis (ra) and ankylosing spondylitis. ra is an autoimmune mediated by il- . treatment with anakinra prevents the migration of inflammatory cells into the joint. • inflammation of the blood vessels (vasculitis). • stimulating the liver to produce acute-phase proteins (see above). • congenital deficiency of il- receptor antagonist is associated with overwhelming inflammation of the skin, joints and bones and large infiltration of neutrophils. infants with this condition die early in life unless anakinra is given that rapidly reverses the inflammation and prevents the death [ ] . • auto-inflammatory diseases are characterized by periodic fever due to recurrent episodes of systemic and local inflammation. anakinra has been successful in treating conditions such as familial mediterranean fever (see chap. ). • il- -mediated inflammation is contributing to the acute ischaemic conditions such as myocardial infarction, stroke, liver and renal failure. • hiv replication. il- ra has suppressive effects on the virus. • macrophage activation syndrome is a life-threatening disease in patients who suffer from eb-virus or cytomegalovirus. anakinra causes rapid recovery. • diabetes (type is an autoimmune disease mediated by t-lymphocytes; type is associated with obesity and physical inactivity causing insulin resistance). both types produce high glucose concentration that stimulates il- β causing destruction of the insulin-producing β-cells of the pancreas. tnf-α, discovered in , is a pro-inflammatory cytokine produced by immune cells, e.g. monocytes and macrophages (tnf-α), lymphocytes (tnf-β), natural killer cells, kupffer cells, astrocytes and microglia of the cns, in response to invasive or injurious insults. tnf-α is an endogenous pyrogen acting on the hypothalamus to induce fever. unlike il- , tnf has no direct effect on stem cell and lymphocyte activation. tnf-α has diverse beneficial biological effects, including: • sharing many biological properties with il- , e.g. early enhancing host defence against infection, promoting normal tissue remoulding, including wound healing, enhancing chemotaxis of macrophages and neutrophils as well as increasing their phagocytic and cytotoxic activity. • stimulant (along with il- ) for acute-phase response. • crucial physiological processes in the cns such as learning and memory, sleep and water and food intake. the initial enthusiasm to use tnf-α as a systemic antitumour treatment has waned because of its significant toxicity and lack of therapeutical benefit. however, tnf-α blockers (monoclonal antibodies, infliximab, adalimumab and etanercept) have altered the outcomes for children with inflammatory bowel disease, such as crohn's disease and ulcerative colitis and rheumatoid arthritis. according to a systematic review of literature [ ] , the treatment has resulted in a variety of infections in the treated children including bacterial, fungal, viral and tb. few children died. the antigen-specific cells of the immune system are lymphocytes, of which there are two main types: • b cells are responsible for antibody production. • t cells are the master regulators of the antigen-specific adaptive immune response. they regulate antibody synthesis and mediate cytotoxic function as well as inflammatory response of delayed-type hypersensitivity. t cells are either: -th cells which produce inf-γ, il- and tnf-β and promote cell-mediated immunity and phagocytic activity. -th cells which produce il- , il- , il- , il- and il- . these promote antibody production and play a crucial role in allergic responses (immediate-type hypersensitivity). il- has an essential role in the activation of lymphocytes. the t-lymphocyte recognizes antigen only after the antigens are processed and presented to them by macrophages; only then do t-lymphocytes become active. interferons are known for their ability to "interfere" (hence the name) with viral replication in infected cells. in addition, these cytokines have pyrogenic effect, antitumour and immuno-regulatory functions. there are three types, type (ifn-α, ifn-β), type ii (ifn-γ) and type iii (ifn-λ). only type i is used as therapy. type i and iii are produced by a variety of cells (such as leukocytes, dendritic cells, fibroblasts and macrophages), whereas synthesis of type ii is restricted to t-lymphocytes. the functions of the interferons include: • key mediators of both innate and adaptive immune responses, stimulating b cells to increase antibody production, and increasing the efficiency of natural killer cells. • inhibition of viral replication including hiv- replication. • interferon-γ release assays (igra) serve as a useful blood test in patients with tb. the result cannot distinguish between latent and active tb, and it is not affected by bcg vaccination status. type i inf is used as a treatment for a variety of diseases, including: • various viral infections, in particular hepatitis b and c. • upper respiratory tract infection. inf-α in a nasal spray is capable of significantly reducing symptoms due to rhinoviruses, but not those due to influenza viruses, parainfluenza viruses or coronaviruses. • thrombocytosis associated with myeloproliferative disorders. toxic effects of inf preparations are numerous and include fever, chills, arthralgia, myalgia, severe headaches, somnolence and vomiting. fever may occur in over % of the patients who receive inf and may reach . °c. these side-effects are responsive to paracetamol and prednisolone. severe side-effects include hepatic and cardiac failure, neuropathy and pancytopenia. inf therapy is contraindicated in pregnancy owing to its anti-proliferative effect. il- is probably the second most important lymphokine (after inf), which is released by activated t-lymphocytes (in particular cd + and cd + ) in response to exogenous pyrogen. it has a crucial effect on the growth and function of t cells, natural killer cells and b cells and for the development of cd + t cells. cases of severe congenital combined immunodeficiency due to a specific defect in the production of il- have been reported. effects of il- include: • stimulating the release of other cytokines, including il- , tnf and inf-γ. • as il- is also produced by mast cells, it controls the severity of chronic allergic dermatitis. • antitumour cytotoxicity (e.g. melanoma, including metastatic melanoma, renal cell carcinoma, acute myelogenous leukaemia) as a result of proliferation and activation of activated cytotoxic t lymphocytes. il- is the third most studied cytokines that has the following characteristics: • a pro-inflammatory, multifunction cytokine, which is secreted by macrophages and t-lymphocytes to stimulate both b and t cell function and immune response against infection. • acting on hepatocytes to induce acute-phase proteins such as crp, amyloid and haptoglobin. • an early marker of infection (preceding the increase of crp), responding within - h of bacterial infection, e.g. in early-onset neonatal bacterial infection. • increased in many diseases, e.g. sepsis, autoimmune diseases (e.g. systemic lupus erythematosus), kawasaki disease, tumours (e.g. multiple myeloma, renal cell carcinoma), brain disorders (e.g. astrocytoma, glioma, psychosis), and autoimmune and chronic inflammatory diseases. • is markedly elevated in many rheumatic diseases including systemic juvenile rheumatoid arthritis (jra) and ankylosing spondylitis. anti-il- receptor antibody, tocilizumab, has successfully been used to treat patients with jra. other cytokines with their main effects are shown in table . . of the four haematopoietic colony-stimulating factors (erythropoietin, granulocytecolony-stimulating factor (g-csf), macrophage colony-stimulating factor (m-csf), granulocyte-macrophage colony-stimulating factor (gm-csf)), gm-csf appears to have the most potential clinical benefits. it is a pro-inflammatory cytokine, which is produced mainly by lymphocytes, although monocytes, macrophages and mast cells are also capable of producing it. gm-csf's principal functions and potential therapeutic uses are: • to stimulate haematopoietic progenitor cells to proliferate and differentiate into granulocytes and macrophages, enhancing phagocytosis and promoting leukocyte chemotaxis and adhesion. • as a treatment in sepsis-associated immunosuppression. • it has a central role in the pathogenesis of autoimmune inflammatory diseases such as rheumatoid arthritis, multiple sclerosis and crohn's disease [ ] . • approved to treat chemotherapy-induced neutropenia, myelodysplasia and aplastic anaemia associated with stem cell transplantation. • gm-csf alone or with il- have been used in cancer treatment, including melanoma, renal cell carcinoma and glioma. the administration of gm-csf may be associated with the development of fever, which is blocked by non-steroidal anti-inflammatory drugs such as ibuprofen. thermoregulation requires intact peripheral mechanisms, which balance heat production and loss, and a functioning hypothalamic thermoregulatory centre regulating these mechanisms. this centre receives thermoreceptors from the temperature of the blood as it passes through the brain (the core temperature) and thermoreceptors from the skin via the dorsal horn of the spinal cord. both thermoreceptors have cold and warm receptors. the activation of warm receptors causes inhibition of cold receptors. the aim of the thermoregulation is to maintain a relatively constant body temperature at °c. heat production occurs by various mechanisms: • at rest as many organs such as the brain, muscles, viscera, liver, heart, thyroid, pancreas and adrenal glands contribute to heat production at the cellular level involving adenosine triphosphate (atp). • the newborn infants have no shivering due to skeletal muscle immaturity, and they rely on non-shivering thermogenesis to produce heat to protect newborns against cold exposure. brown adipose tissue (bat), localized mainly in the neck and scapular area, is highly vascularized and contains a large quantity of mitochondria. fatty acid oxidation in these mitochondria can increase heat production to twofold in response to cold. • in older children and adults, the first response to cold is behavioural (e.g. curling up, putting more clothes). if this response is insufficient, then the hypothalamic centre is stimulated to conserve heat by vasoconstriction and generate heat by shivering. the predominant stimulus for shivering is the skin rather than the core temperature. the energy produced is released as heat. • bat was, until recently, thought to be only functional in neonates and some animals. bat as a non-shivering thermogenesis has now emerged as a significant component of thermoregulation in elevating body temperature. this process induces and activates mitochondria, which uncouples protein to release chemical energy as heat. the bat-metabolic thermogenesis is regulated by norepinephrine which is secreted by bat-sympathetic nerve terminals. pathological uncontrollable increase of heat production occurs in malignant hyperthermia (see chap. ). in response to a rise in body temperature above °c (or ambient temperature above - °c), heat is lost from the body via the four physical modalities: evaporation, radiation, convection and conduction. when the body core temperature rises (e.g. fever), heat loss through evaporation (causing sweating) becomes the primary mechanism of heat loss. this is associated with cutaneous vasodilatation via acetylcholine-mediated relaxation of the vascular smooth muscles. the following are the mechanisms by which heat loss occurs at rest: • about one-quarter is lost by evaporation from the skin and lungs, which occurs as water is converted from liquid to gas ( kcal is lost for every ml of water). • in general, % of the total heat is lost by radiation (transfer of heat from the skin surface to the external surroundings not in contact), through electromagnetic waves. • convection ( % of the heat loss) is increasing blood flow to body surfaces to maximize heat loss. • conduction ( % of the heat loss) is the heat transfer between two objects in direct contact and at different temperatures. this is the primary mode of heat loss from the core to the surface. in a warm environment or when core temperature is elevated, the hypothalamic thermoregulatory centre activates efferent fibres of the automatic nervous system to produce vasodilatation. the increased blood flow to the skin causes heat loss from the core through the skin surface to the surroundings in the form of sweating. the hypothalamus stimulates vasodilatation to increase insensible loss (for every °c elevation of body temperature, there is a % insensible loss) and activates the sweat glands to increase perspiration production. physical factors obviously affect the ability to respond to temperature changes. the greater heat loss in the newborn infant is mainly due to a greater surface area compared to that of an older child. failure of heat loss occurs in anhidrotic ectodermal dysplasia and during anticholinergic drug overdose. in the classical model of pathogenesis, fever induction includes the following stages: • pyrogenic endogenous cytokines (e.g. il- , tnf, il- and interferons) are released into the bloodstream in response to exogenous pyrogens (e.g. viruses, bacteria, toxins). • these endogenous pyrogens act on a specific preoptic area of the anterior hypothalamus, which contains clusters of thermo-sensitive neurons localized within the rostral wall of the third ventricle. the site is called organum vasculosum of the lamina terminalis (ovlt), which has emerged as an interface between circulation and brain. the firing rate of these thermo-sensitive neurons changes according to the temperature of the area's blood supply and the input from the skin and muscular thermoreceptors. warm-sensitive neurons have firing rates that increase with warming and decrease with cooling, whereas the firing rates of cold-sensitive neurons increase with cooling or decrease with warming. • endogenous pyrogens enter the perivascular space of the ovlt through the fenestrated capillary wall to stimulate cells to produce prostaglandin e (pge ), which diffuses into the adjacent preoptic area to upturn the temperature set point and cause fever. • another structure termed circumventricular organs (cvos), which are situated in the anterior wall of the third ventricle. these organs are characterized by extensive vasculature and lack of blood-brain barrier allowing direct exchange between blood and nervous tissue. when circulating pyrogenic cytokines are detected by the cvos, pge is induced. • the ultimate result of these complex mechanisms is an upward shift of the thermostatic set point to a febrile level that signals efferent nerves, especially sympathetic fibres innervating peripheral blood vessels, to initiate heat conservation (vasoconstriction) and heat production (shivering). this is aided by behavioural means aimed also to increase body temperature, such as seeking a warmer environment or covering up with a blanket. the resulting temperature increase continues until body temperature approximates to the temperature of the elevated set point. • the raised set point is reset back to normal if the concentration of the cytokines falls or if antipyretics are administered that block prostaglandin synthesis. the normalization of temperature is initiated by vasodilatation and sweating through increased skin blood flow controlled by sympathetic fibres. prostaglandin e has been found to exert a negative feedback on the release of the cytokines, thus terminating the mechanisms that initially induced the fever the peptide angiotensin has been shown to lower body temperature at the final step of fever. it is involved in maintaining body temperature at the set point. in addition, arginine vasopressin (avp) acts within the cns to reduce pyrogensinduced fevers. a decrease in hypothalamic calcium concentration or an increase in sodium concentration elevates body temperature. the generation of fever involves the following steps: • numerous substances from outside the body, exogenous pyrogens, initiate the fever cycle. endotoxin of gram-negative bacteria, with their pyrogenic component lipopolysaccharide, is the most potent exogenous pyrogen. fever is also a common finding in children without obvious evidence of infection, for example hypersensitivity reaction, autoimmune diseases and malignancy. • exogenous pyrogens initiate fever by inducing host cells (primarily macrophages) to produce and release endogenous pyrogens such as interleukin- , which has multiple biological functions essential for the immune response. • endogenous pyrogens are transmitted to the hypothalamic thermoregulatory centre, specifically organum vasculosum of the lamina terminalis (ovlt), where they induce synthesis of prostaglandins, of which pge is the most important. these raise the thermostatic set point to initiate the febrile response. • the hypothalamic thermoregulatory centre accomplishes heat production by inducing shivering and heat conservation through vasoconstriction. at an established degree, fever is regulated (even at a temperature of over . °c), and heat production approximates loss, as in health, though at a higher level of the set point. therefore fever does not climb up relentlessly. • in addition to the function as an endogenous pyrogen, il- activates t-lymphocytes to produce various factors, such as inf and il- , which are vital for immune response. the production of fever simultaneously with lymphocyte activation constitutes the clearest and strongest evidence in favour of the protective role of fever. • the induction of fever results in inhibition of bacterial growth, increased bactericidal of neutrophils, production of acute-phase protein synthesis and other physiological changes such as anorexia and somnolence. these changes suggest that fever has an adaptive role in the host's survival during infection (see chap. for detail). chemical basis of fever potentiation of the lymphocyte response to mitogens: cellular source pf potentiating mediators infection in neonatal hypothermia risk factors, host response and outcome of hypothermic sepsis il- family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance treating inflammation by blocking interleukin- in a broad spectrum of diseases infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors: a systematic review of literature dual role of gm-csf as a pro-inflammatory and a regulatory cytokine: implications for immunotherapy key: cord- -x p u authors: alitalo, a.; meri, t.; lankinen, h.; cheng, z.‐z.; jokiranta, s.; seppälä, i.; lahdenne, p.; brooks, c.; hefty, p. s.; akins, d. r.; meri, s. title: lysine‐dependent binding of ospe to the c‐terminus of factor h mediates complement resistance in borrelia burgdorferi date: - - journal: scand j immunol doi: . /j. - . . aj.x sha: doc_id: cord_uid: x p u serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid‐encoded, surface‐exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h‐binding proteins of approximately – kda has been described. the ospe‐related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe‐related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h‐binding regions of ospe‐related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c‐terminal regions of both human and mouse factor h (scrs – ) specifically bind to ospe‐related lipoproteins. we also found fhr‐ , whose c‐terminal scrs – are homologous to scrs – of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i‐v) in ospe that could directly interact with factor h. deleting the c‐terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c‐termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c‐terminal‐binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h‐binding regions were mutated to alanines, we observed that lysines in the factor h‐binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe‐related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c‐termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h‐binding proteins may account for their susceptibility to serum lysis. the nuclear receptor heterodimers of liver x receptors (lxrs) are recently identified as key transcriptional regulators of genes involved in lipid homeostasis and inflammation. lxrs and their ligands are negative regulators of macrophage inflammatory gene expression. multiple sclerosis (ms), a demyelinating disease of the central nervous system of unknown cause, is characterized by recurrent inflammation involving macrophages and their inflammatory mediators. sweden belongs to the countries with a high ms incidence. in italy, incidence is lower, with an exception for sardinia where the incidence is even higher than that in sweden. subjects from sardinia are ethnically more homogeneous and differ from swedes, also regarding genetic background and environment. we studied lxrs and their related molecules of blood mononuclear cells (mncs) from female patients with untreated relapsing-remitting ms from sassari, sardinia and stockholm, sweden. sex-and age-matched healthy controls (hcs) were from both areas. mrna expression was evaluated by real-time pcr. lxr-a was lower (p < . ) in ms (mean ae sem: . ae . ; n ¼ ) compared to hc ( . ae . ; n ¼ ). lxr-a was lower in ms from stockholm ( . ae . ; n ¼ ) compared to corresponding hc ( . ae . ; n ¼ ; p < . ) and compared to ms ( . ae . ; n ¼ ; p < . ) and hc ( ae . ; n ¼ ; p < . ) from sardinia. ms patients from stockholm, but not from sassari, also expressed lower (p < . ) lxr-b (À . ae . ) compared to corresponding hc (À . ae . ). ms from stockholm was associated with higher abca- ( . ae . versus . ae . ; p < . ) and higher estrogen receptor-b-cx ( . ae . versus . ae . ; p < . ) compared to corresponding hc. the hc from sassari had higher androgen receptor ( . ae . ) compared to ms from sassari ( . ae . ; p < . ), ms ( . ae . ; p < . ) and hc from stockholm ( . ae . ; p < . ). ms from sassari had lower cyclooxygenase- compared to corresponding hc ( . ae . versus . ae . ; p < . ) and lower prostaglandin-e (À . ae . ) compared to the hc ( . ae . ; p < . ) and ms ( . ae . ; p < . ) and hc from stockholm ( . ae . , p < . ). our findings identify lxrs and their related molecules as being involved in ms from stockholm but not from sassari, while sex hormone receptors seem to be involved in ms in sassari. multiple sclerosis: ifn-b induces cd + bdca -dendritic cells that produce il- and il- and have no enhanced type i interferon production y. m. huang, s. adikari, u. båve, a. sanna , & g. alm dc antigens (bdca) and investigate their ability to produce type i ifn in response to virus stimulation. we show that ifn-b induces development of cd þ dc from human blood monocytes, which coexpress bdca þ but are negative for bdca -, a specific marker for plasmacytoid dc. such ifn-b-modulated dc produce large amounts of il- and il- , but no il- p and have no enhanced ifn-b and ifn-b production. the findings indicate that ifn-bmodulated dc represent a myeloid dc subset with diminished cd c, bdca- and cd a expression, having potent th -promoting function but lacking antiviral capacity. the association of psoriasis with throat infections by streptococcus pyogenes suggests a potential antigenic target for the t cells that are known to infiltrate dermis and epidermis of psoriatic skin. streptococcal m protein shares an extensive sequence homology with human epidermal keratins. keratins (k ) and (k ) are mostly absent from uninvolved skin but are upregulated in psoriatic lesions. there is increasing evidence that cd þ t cells play an important effector role in psoriasis and m proteinprimed t cells may recognize these shared epitopes in skin via molecular mimicry. to identify candidate epitopes, peptides with sequences from k were selected on the basis of predicted binding to hla-cw and sequence similarities with m protein. matched peptides from the sequence of m protein and a set of peptides with poor predicted binding were also selected. cw þ individuals with psoriasis and cw þ healthy controls, having a family history of psoriasis, were recruited. pbmcs were incubated with the peptide antigens. t-cell activation in the cd þ , cd þ and later the skin-homing cutaneous lymphocyteassociated antigen (cla)-expressing subset of cd þ t cells was evaluated by cd expression and intracellular ifn-g accumulation using flow cytometry. we demonstrate that cw þ psoriasis patients had significant cd þ t-cell ifn-g responses to peptides from k and m protein selected on the basis of sequence homology and predicted hla-cw* binding. these responses were about times more frequent in the skin-homing cutaneous lymphocyte-associated antigen-expressing (cla þ ) subset of cd þ t cells. cd þ t cells showed only borderline responses. cd þ t cells from cw þ nonpsoriatic individuals responded to some m peptides but very rarely to k peptides, and this also applied to the cla þ cd þ subset. these findings indicate that psoriatic individuals have cd þ t cells that recognize keratin self-antigens and that epitopes shared by streptococcal m protein and human keratin may be targets for the cd þ t cells that infiltrate psoriatic skin lesions. autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly % in ra patients and a suggestive involvement in the pathogenesis. the targeted epitopes are generated by a post-translational modification catalysed by the calcium-dependent enzyme peptidyl arginine deaminase that converts the positively charged arginine to polar but uncharged citrullin. the aim of this study was to analyse the presence of citrulline in the joints at different time points of collagen-induced arthritis in da rats by immunohistochemistry and to investigate how immunogenicity and arthritogenicity was affected by citrullination of rat serum albumin (rsa) and collagen type ii (cii). our results indicate that citrulline could be detected in joints of arthritic animals, first appearance at the onset of disease and increasing as disease progressed into a chronic state. unimmunized animals or time points before clinical signs of arthritis were negative. by morphology, we state that some infiltrating macrophages as well as the cartilage surface stain positive for citrulline, while the major source of citrullinated proteins appears to be fibrin depositions. a specific cit-rsa t-cell response was observed in animals challenged by citrullinated rsa, no response was recorded when rsa was used as a stimulus. the igg analysis reveals not only a response towards the modified protein but also cross-reactivity to native rsa. no t-cell or b-cell response was noted in animals injected with unmodified rsa. cit-cii induced a disease with higher incidence and earlier onset than did the native counterpart. we conclude that, in contrast to the human disease, citrulline does not seem to appear before clinical signs. as inflammation proceeds, citrulline is detected specifically in the joints. all other organs investigated were negative. we also conclude that citrullination of a protein can break tolerance and increase its arthritogenic properties. ectopic germinal centers (gcs) can be detected in the salivary glands of approximately / of patients with sjögren's syndrome (ss) and appear in both primary and secondary ss. previously, ectopic gc have been associated with increased local autoantibody production. the aim of this study was to determine whether gc in primary sjögren's syndrome (pss) defines a distinct seroimmunological phenotype. retrospectively, a material of haematoxylin and eosin-stained paraffin-embedded tissue sections of minor salivary gland tissue from patients with pss was morphologically screened for the presence of ectopic gc. gc-like lesions were detected in / ( %) of the pss patients. seventy-two pss patients lacking these structures (gc-) were randomly selected for comparison. focus score was significantly increased in the gc þ patients compared to the gcpatients (p ¼ . ). in the gc þ group, . % of the patients presented with anti-ro/ssa compared to . % in the gcgroup. anti-la/ssb was detected in . % of the gc þ patients compared to . % of the gcpatients. sixty-one percentage of gc þ patients presented with increased levels of igg, a nonsignificant difference when compared to . % in the gcpatients (p ¼ . ). levels of rf, ana, ena, igm and iga were similar in both patient groups, as were esr and crp. in conclusion, patients with ectopic gc have a higher focus score and more often present with autoantibodies and increased levels of igg compared to pss patients with regular focal infiltration (gc -). our findings may indicate a certain seroimmunological phenotype and warrant for further prospective studies. association between mannose-binding lectin and vascular complications in type diabetes complement activation and inflammation have been suggested in the pathogenesis of diabetic vascular lesions. we investigated serum mannose-binding lectin (mbl) levels and polymorphisms in the mbl gene in type diabetic (t dm) patients with and without diabetic nephropathy and associated macrovascular complications. polymorphisms in the mbl gene and serum mbl levels were determined in t dm patients with overt nephropathy and t dm patients with persistent normoalbuminuria matched for age, sex and duration of diabetes as well as in healthy control subjects. the frequencies of high and low expression mbl genotypes were similar in patients with t dm and healthy controls. high mbl genotypes were significantly more frequent in diabetic patients with nephropathy than in the normoalbuminuric group, and the risk of having nephropathy, given a high mbl genotype, assessed by odds ratio was . ( . - . ), p ¼ . . median serum mbl concentrations were significantly higher in patients with nephropathy than in patients with normoalbuminuria [ mg/l (iqr - mg/l) versus mg/l (iqr - ), p ¼ . ], and even when comparing patients with identical genotypes, serum mbl levels were higher in the nephropathy group than in the normoalbuminuric group. patients with a history of cardiovascular disease had significantly elevated mbl levels independently of nephropathy status [ mg/l (iqr - mg/l) versus mg/l (iqr - mg/l), p ¼ . ]. the differences in mbl levels between patients with and without vascular complications were driven primarily by pronounced differences among carriers of high mbl genotypes (p < . ). our findings suggest that mbl may be involved in the pathogenesis of microvascular and macrovascular complications in type diabetes and that determination of mbl status might be used to identify patients at increased risk of developing these complications. neuroimmunology unit, center for molecular medicine, karolinska institutet, stockholm, sweden. e-mail: judit.wefer@cmm.ki.se dna vaccine coding for the encephalitogenic peptide mog - protects lew. av from subsequent development of experimental autoimmune encephalomyelitis (eae). protection is associated with a type immune response and is dependent on the presence of cpg dna motifs. the mechanisms underlying the observed reduction of eae development in protected rats have not been fully clarified. we investigated immunological characteristics of lymphocytes after dna vaccinaton and subsequent eae induction. we confirm that protection was not associated with suppression of t cells, as transcription of the novel molecule rat t-cell immunoglobulin-and mucindomain-containing molecule (tim- ), reported to be exclusively expressed on differentiated t cells, was not altered by dna vaccination. we did not note any clonal deletion upon tolerization, but detected an antigen-specific lymphocyte population upregulating ifng upon recall stimulation weeks after protective dna vaccination. in protected rats, we observed ( ) no alterations in antigenspecific th or th responses, ( ) reduced mhc ii expression on splenocytes early after eae induction, ( ) antigen-specific upregulation of ifnb upon recall stimulation and ( ) reduced il- rb on lymphocytes. we thus demonstrate an association of the protective effect of dna vaccination with expression of ifnb. we are currently investigating the cellular mechanisms behind this ifnb-mediated protection. multiple sclerosis (ms) is an autoimmune condition characterized by degeneration of nerve fibre myelin sheets. a candidate autoantigen, myelin basic protein (mbp), has especially attracted attention. the presence of anti-mbp antibodies is a predictor of definite ms, but their role in the pathogenesis remains obscure. t cells have long been known to play a pivotal role in the pathogenesis of ms. recently, an important role for b cells as autoantigen-presenting cells has been demonstrated in other autoimmune diseases, including rheumatoid arthritis and diabetes. the uptake of mbp by b cells and the presentation of mbp-derive peptides to t helper (th) cells by b cells may be promoted by the formation of complement (c) activating immune complexes (ics) between mbp and natural autoantibodies in healthy individuals and disease-associated anti-mbp antibodies in ms patients, respectively. we have investigated the formation of mbp-containing ic, the binding of mbp to b cells, the mbp-elicited induction of th-cell and b-cell proliferation and the cytokine production in peripheral blood mononuclear cells (pbmcs) from healthy donors grown in the presence of intact or c-inactivated serum from healthy donors or patients with ms. while mbp did not induce measurable proliferation of b cells nor cd þ t cells, we observed the production of tnf-a, ifn-g and il- by pbmc in response to incubation with mbp in the presence of sera from healthy controls as well as sera from ms patients. by contrast, no production of il- , il- and il- was detected. we are currently investigating the capability of ms sera to promote the formation of mbp-containing ic and thereby enhance the cytokine responses, by virtue of elevated anti-mbp contents. the phagolysosomally localized acid sphingomyelinase (asmase) activated by proinflammatory cytokines such as tnf and ifn-g generates the signalling molecule ceramide which in turn results in the activation of proteases like cathepsin d. these characteristics of asmase suggest a possible role of this molecule in the phagocytotic uptake and phagosomal degradation processes of antigens or in antigen presentation. we show here that asmase -/mice fail to eliminate the noncytopathic lymphocytic choriomeningitis (lcm) virus as rapidly as littermate wildtype mice. investigation of the immune response revealed a reduced expansion of cd þ t cells. the secretion of ifn-g in response to contact with target cells as well as the cytolytic activity of virus-specific cd þ t cells was severely impaired. additionally, both phases of the lcm virus-specific dth response, mediated by cd þ and cd þ t cells consecutively, were diminished in asmase -/mice. however, the secondary memory response of virus-specific ctl was not altered, and the abstracts ................................................................................................................................................................................................. virus was effectively controlled for at least months by asmase -/mice. in conclusion, the results of this study suggest an involvement of the asmase in the activation, expansion or maturation of virus-specific cd þ t cells during the acute infection of mice with the lcm virus. novel markers for alternative activation of macrophages: macrophage galactose-type c-type lectins and in parallel with the th /th dichotomy, macrophages are capable of developing into functionally and molecularly distinct subpopulations, due to differences in, for example cytokine environment and pathological conditions. while the best-studied, classically activated macrophage is induced by type i stimuli such as ifn-g, a type ii cytokine environment antagonizes the classical activation of macrophages and is capable of alternatively activating macrophages. however, molecular markers associated with these type ii cytokine-dependent, alternatively activated macrophages remain scarce. besides the earlier documented markers macrophage mannose receptor and arginase , we recently demonstrated that murine alternatively activated macrophages are characterized by increased expression of fizz and ym. we now report that expression of the two members of the mouse macrophage galactose-type c-type lectin gene family, termed mmgl and mmgl , is induced in diverse populations of alternatively activated macrophages, including peritoneal macrophages elicited during infection with the protozoan trypanosoma brucei or the helminth taenia crassiceps, and alveolar macrophages elicited in a mouse model of allergic asthma. we also demonstrate that, in vitro, interleukin- and interleukin- upregulate mmgl and mmgl expression and that, in vivo, induction of mmgl and mmgl is dependent on interleukin- receptor signalling. moreover, we show that regulation of mgl expression is similar in human monocytes and monocyte-derived macrophages. hence, macrophage galactose-type c-type lectins represent novel markers for both murine and human alternatively activated macrophages; thus, paving the way for further characterization of the phenotype of macrophages occurring in th conditions. background: human parvovirus b (b ) is a ubiquitous pathogen, normally causing a mild self-limiting disease, but also capable of causing both significant pathology and long-term persistence. the small size and stability of the virus makes it suitable for mapping of the full breath and the kinetics of the cellular immune responses following acute viral infection. methods: five patients with acute primary b infection were included in the study and followed consecutively for up to weeks. cellular immune responses were mapped by ifng enzyme-linked immunospot to overlapping peptides spanning the whole b genome. results: in all five acutely infected patients, we were able to monitor the kinetics of a strong specific cellular immune reaction. responses peaked at levels of - sfc/ million pbmcs, roughly corresponding to . - . % b specific cd þ cells circulating in peripheral blood at - weeks post-infection. the responses in individual patients were directed to three or four different peptide pools, and the specificity was confined to the same cd epitopes present in the pools throughout the follow-up period. the majority of responses were directed to the virus nonstructural protein, only two patients showed any response to the capsid proteins, elicited by the same epitope in both cases. conclusion: the cellular immune responses to acute b infection are surprisingly narrow in distribution and remain at high levels for up to weeks post-infection. the initial epitope specificity is maintained, and the majority of responses target the virus nonstructural protein, which is not included in vaccine preparations, evaluated against the infection. the relationship between malnutrition and malaria is controversial. on one hand, malaria may cause malnutrition, while on the other, malnutrition itself may modulate susceptibility to the disease. we investigated the association between plasmodium falciparum malaria and malnutrition in a cohort of children living on the coast of kenya. the study involved longitudinal follow-up for clinical malaria episodes and anthropometric measurements at four cross-sectional surveys. we used poisson regression analysis to investigate the association between malaria and nutritional status. compared to baseline (children with a waz or haz score of !À ), the crude incidence rate ratios (irrs) for malaria in children with low haz or waz scores (<À ) during the period prior to assessment were . ( % ci . - . ; ¼ . ) and . ( . - . ; . ), respectively, suggesting no association between malaria and the subsequent development of pem. however, we found that age was acting as an effect modifier in the association between malaria and malnutrition. the irr for malaria in children - years old who were subsequently characterized as wasted was . ( . - . ; p ¼ . ), and a significant overall relationship between malaria and low-haz was found on regression analysis when adjusting for the interaction with age (irr . ; . - . ; p < . ). although children living on the coast of kenya continue to suffer clinical episodes of uncomplicated malaria throughout their first decade, the association between malaria and malnutrition appears to be limited to the first years of life. a. astrinidou-vakaloudi, s. xytsas, i. diamanti, h. ioannidis & p. pangidis microbiology department of general hospital of thessaloniki 'agios pavlos', thessaloniki, greece, and nefrology, nd ika hospital of thessaloniki, thessaloniki, greece. e-mail: stasa@hol.gr aim: renal dysfunction may influence the colonization of gastric mucosa by urea-splitting bacteria such as helicobacter pylori, by increasing urea concentrations in the gastric juice. our aim was to investigate the prevalence of h. pylori in patients with end-stage renal disease (esrd), receiving long-term haemodialysis treatment. methods: this study included sera from patients with esrd ( male and female) undergoing periodic haemodialysis; mean time of treatment was . months. using elisa technique, we investigated the presence of igg and iga antibodies against h. pylori as well as igg caga (antibodies specific for caga(þ) strains of h. pylori). sera from healthy blood donors were used as a control group. results: h. pylori igg antibodies were detected in out of ( %) patients in the dialysis group, while / ( . %) tested positive for iga. igg caga antibodies were present in out of ( . %). prevalence of h. pylori igg, iga and caga igg antibodies in the control group was , and %, respectively. conclusions: although international data suggest that prevalence of h. pylori infection is the same in esrd patients as in healthy individuals, in our study that seems not to be the case. the higher blood and gastric juice urea levels may be a risk factor (among many others), but more studies are required in order to understand the relation of h. pylori infection in this group of patients. flanders interuniversity institute for biotechnology, department of molecular and cellular interactions, free university of brussels, brussels, and pasteur institute of brussels, mycobacterial immunology, brussels, belgium. e-mail: tgartner@vub.ac.be immunity against tuberculosis (tb), caused by mycobacterium tuberculosis, depends largely on activation and maintenance of strong cell-mediated immune responses involving both cd þ and cd þ t cells and the ability to respond with th -type cytokines, particularly ifn-g. recent studies suggested that bcg, the only licensed vaccine against m. tuberculosis, may fail to induce t-cell responses in the lung mucosa and may therefore not protect against pulmonary tb. a decrease in tb mortality may be achieved by enhancing immunity in the lung. the present study evaluated the induction of antigen-specific immunity in the lung by intranasal (i.n.) delivery of the lipoprotein i (opri) from pseudomonas aeruginosa. opri has shown to be a toll-like receptor / agonist that, when given subcutaneously, induces type- immune responses against heterologous antigens. here, a fusion of opri to ag a of mtb (opri-ag a) was used as a subunit vaccine in homologous prime-boost immunizations. in addition, opri-ag a was combined with an ag a-encoding dna vaccine (ag a dna) or with bcg in heterologous prime-boost vaccinations. intranasal and parenteral delivery with opri-ag a elicited comparable t-cell responses in the spleen; in addition, i.n. delivery elicited specific t-cell responses in the lung lymph nodes (llns). intramuscular delivery of ag a dna induced significant systemic th immune responses. intranasal boosting with opri-ag a enhanced this response and in addition induced an antigen-specific ifn-g response in lln. opri may therefore be an efficient adjuvant for mucosal boosting. we continue to evaluate the protection induced by opri-based prime-boost vaccinations against pulmonary tb. results on the immunogenicity and protection against intravenous mtb h rv infection will be presented. toll-like receptors (tlrs) are pattern recognition receptors of the innate immune system, which recognize molecular structures on pathogens or cellular stress-associated molecules. tlr-ligand interactions trigger activation of inflammatory signal transduction and expression of genes involved in host defense. in this study, we have examined the requirement for different tlr adaptor molecules in virus-induced chemokine expression and are currently trying to identify the tlr involved. we have found that both a herpesvirus [herpes simplex virus (hsv)] and a paramyxovirus (sendai virus) require a functional genome to induce expression or proinflammatory chemokines in human and murine monocytic cell lines. for both viruses, this is independent of the tlr adaptor molecules trif and mal. however, overexpression of the vaccinia virus-encoded inhibitor of tlr-signalling a r or dominant-negative myd totally inhibited hsv-induced rantes expression but only partially prevented sendai virus from inducing this chemokine. this suggests that hsv-induced rantes expression occurs via a tlr pathways, whereas sendai virus utilizes both tlr-dependent and -independent pathways to stimulate expression of rantes. we are currently trying to identify the tlrs involved. data from these studies will also be presented at the meeting. - -oligoadenylate synthetases are interferon-induced, double-stranded rna-activated antiviral enzymes which are the only proteins known to catalyse -specific nucleotidyl transfer. this first crystal structure of a - oligoadenylate synthetase reveals a structural conservation with the -specific poly(a) polymerase that, coupled with structure-guided mutagenesis, supports a conserved catalytic mechanism for the -and -specific nucleotidyl transferases. comparison with structures of other superfamily members indicates that the donor substrates are bound by conserved active site features while the acceptor substrates are oriented by nonconserved regions. the - oligoadenylate synthetases are activated by viral doublestranded rna in infected cells and initiate a cellular response by synthesizing - -oligoadenylates, that in turn activate rnase l. this crystal structure suggests that activation involves a domain-domain shift and identifies a putative dsrna activation site that is probed by mutagenesis. we demonstrated that this site is required both for the binding of dsrna and for the subsequent activation of oas. this rna-binding site is different from known rna-binding site; rather than forming a defined three-dimensional domain, it is located at the interface of the two major domains in oas. this novel architecture ensures that the dsrna helix can make simultaneously contact with both domains of oas and ensure the subsequent structural rearrangement leading to the activation of oas. our work provides structural insight into cellular recognition of double-stranded rna of viral origin and identifies a novel rna-binding motif. bacteria-specific iga antibodies are efficient opsonins for neutrophils and mononuclear phagocytes, provided that the phagocytes express the fca receptor (cd ). expression of cd can be stimulated by inflammatory cytokines, activated complement factors and certain microbial components. in one study, unstimulated phagocytes were able to ingest iga antibody-treated pneumococci, but only in the presence of complement, which was found to be activated by the iga antibodies along the alternative pathway. pneumococci produce iga protease that cleaves human iga , but not iga , molecules in the hinge region. this leaves iga as faba (monovalent) deprived of fca which contains the docking site for cd . iga is the vastly predominant subclass of iga in the upper airways and circulation of humans. aims: to examine the effects of iga protease activity and complement on phagocytosis of iga antibody-coated pneumococci by an unstimulated human phagocytic cell line (hl ). materials and methods: iga and iga monoclonal antibodies to serotype pneumococcal capsular polysaccharide (ps) were generated by heterohybridoma technique involving b cells from human vaccinees. isogenic serotype pneumococci with and without iga protease activity, respectively, were obtained after inactivation of the iga gene of the tigr strain. opsonophagocytosis was quantitated using the assay described by romero-steiner et al. based on enumeration of surviving bacteria by culture. the integrity of iga molecules was examined by western blotting. results: both iga and iga antibody to type- polysaccharide-induced phagocytosis of iga protease-deficient type- pneumococci equally well in the absence as in the presence of complement. iga antibody to type- polysaccharide displayed a fourfold higher opsonophagocytosis titer against iga protease deficient compared to homologous wildtype target bacteria. a similar effect of iga protease activity of the target bacteria was not observed in a parallel experiment where iga antibody to type- polysaccharide served as opsonin. iga antibody extracted from iga protease-producing target bacteria was almost exclusively in the form of faba. conversely, iga from protease-deficient bacteria and iga from both types of bacteria were intact. conclusions: these results indicate that the iga protease activity of s. neumoniae may help the bacteria escape iga antibody-mediated opsonophagocytosis. besides, in these experiments, iga-mediated opsonophagocytosis was independent of complement. vitamins e and c have been found to increase the cellular and humeral immunity of pigs. vitamin e deficiency has also been found to predispose pigs to different diseases, e. coli infection is one among them. after weaning, the vitamin e status of pigs often decreases to a critical low level. in this experiment, we studied whether vitamin c supplementation would be a possible feeding strategy to optimize the immune status of weaners. the interaction between vitamin e and c is interesting due to the reported sparing action on vitamin e or synergism between these to vitamins. piglets were weaned at day of age from sows fed increasing dietary vitamin e during lactation, and piglets were during the following weeks fed either a control diet or this diet supplemented with mg stay-c per kg. blood sampling was obtained weekly from day and until day of age. on the same days, one piglet per dietary treatment was killed and alveolar macrophages (am) were harvested. vitamin c supplementation increased the concentration of igm in serum of piglets throughout the weaning period. although the vitamin e concentration in am decreased with increasing age of the piglets, the concentration was numerically higher in piglets of sows fed the high dietary level of vitamin e. however, vitamin c supplementation tended to increase the total am concentration of vitamin e after weaning and increased the proportion of the biologically most active isomer of vitamin e [rrr-(a-tocopherol)] in the am. the eicosanoid synthesis by am was not influenced by the vitamin c supplementation, but the synthesis of leukotriene b was decreased weeks after weaning compared to other days of am harvesting. in conclusion, dietary vitamin c supplementation improved the immune responses of piglets after weaning. a whole blood stimulation assay with escherichia coli (o :b ) endotoxin was established to measure the capacity of dairy cows to produce the proinflammatory cytokine tumour necrosis factor-a (tnf-a) ex vivo. initially, a time-and dose-dependent study was carried out to find the optimal stimulation conditions for the tnf-a response. the tnf-a response peaked between and h at . c. a dose in the range of - g of e. coli lipopolysaccharide (lps)/ml whole blood was found to give the maximum tnf-a response. thirty-eight danish-holstein dairy cows were investigated for their tnf-a responsiveness ex vivo in the periparturient period. heparin-stabilized blood samples were collected seven times over a period of months (weeks À , À , , , , and around calving) and stimulated with g/ml of e. coli lps. indeed, fluctuations in the tnf-a responsiveness occurred over time. moreover, the mean tnf-a responsiveness of cows was found to be significantly increased (p < . ) in the weeks close to calving. however, in the more stabile physiological periods, some cows had a consistently low tnf-a response, whereas others had high a tnf-a response. we are currently investigating whether high and low tnf-a responders to e. coli lps also exist in dairy cows in vivo. moreover, the importance of tnf-a responsiveness ex vivo to dairy cows' susceptibility and clinical response to experimental e. coli infections in the udder is being investigated. coelomic cytolytic factor (ccf) is a kda invertebrate pattern recognition molecule isolated from the coelomic fluid of the earthworm eisenia foetida (oligochaeta, annelida). ccf displays a number of similarities with the mammalian cytokine tumour necrosis factor-a (tnfa) as a result of a shared n,n -diacetylchitobiose lectin-like domain. however, these similarities are solely functional and are not based on any (dna or amino acid) sequence homology, thus suggesting a form of convergent evolution. in particular, the lectin-like domain of tnf-a has been shown to induce membrane depolarization in various mammalian cell types, through interactions with endogenous amiloride-sensitive ion channels. this nonreceptor-mediated activity of tnf-a has been reported to be involved in the resorption of oedema. likewise, the lectin-like domain of ccf also induces membrane depolarization in mammalian cells. here, we show that ccf appears to be able to induce oedema resorption in an alveolar epithelial cell line through its lectin-like domain. this lectin-like domain of ccf interacts (directly or indirectly) with endogenous sodium and/or chloride channels, and not potassium channels, on mammalian cells. additionally, we suggest that the jnk/sapk and erk / pathways are involved in ccf-induced macrophage activation. these results further establish the functional analogy between an invertebrate pattern recognition molecule and a mammalian cytokine and, from a more applied point of view, suggest the possibility of utilizing ccf in the treatment of oedema. release of svegf and svegfr from white blood cells and platelets during surgery and stimulation with bacterial antigens introduction: the influence of surgery on release of soluble vascular endothelial growth factor (svegf) and the soluble vascular endothelial growth factor inhibitory receptor (svegfr ) is unknown. we studied the effect of major and minor surgery on potential variations in svegf and svegfr concentrations in vivo and on bacterial antigen-induced release of svegf and svegfr from whole blood in vitro. methods: sixty-one patients with abdominal diseases undergoing five different surgical procedures were included. blood samples were drawn from anaesthetized patients before and after the operation. white blood cells and platelets were counted, and plasma svegf and svegfr was determined by an elisa method. whole blood from each blood sample was stimulated in vitro with bacteria-derived antigens (lps or protein-a) and svegf and svegfr levels were subsequently determined in the supernatants. stimulation with isotonic saline served as control assay. neither svegf or svegfr in plasma changed during surgery. in vitro stimulation of blood samples with bacteria-derived antigens resulted in a significant increase in svegf (p < . ) and a less pronounced but still significant increase in svegfr . release of svegf due to stimulation was significantly higher after the operation (nonsignificant), whereas svegfr release remained largely unchanged after surgery. correlation between bacterial antigen-induced release of svegf and neutrophile cell count was highly significant (p < . ). there was no correlation between svegf and platelet cell count, and bacterial antigen-induced svegfr release did not correlate with counts of neutrophils and platelets. conclusions: plasma svegf and svegfr concentrations did not change during surgery. in vitro bacterial stimulation led to increased release of svegf and svegfr , which was not significantly amplified during surgery and which may be related to number of circulating neutrophils. natural killer cell functions and subsets after in vitro stimulation with il- and il- , with special emphasis on intracellular ifn-g and nk-cell cytotoxicity r. nyboe, , t. rix, , j. krog, , e. tønnesen & m. hokland department of anaesthesiology and intensive care, aarhus university hospital, and institute of medical microbiology, and immunology, university of aarhus, aarhus, denmark. e-mail: rnsr@studmed.au.dk materials and methods: isolated cryopreserved human peripheral blood mononuclear cells (pbmcs) were stimulated with il- and il- . this stimulation has previously been shown to activate nk cells. cell cytotoxicity was measured by flow cytometry after incubation with k cells. this method was compared to the current standard cr release assay. cells were treated with bfa to accumulate ifn-g, stained for surface markers, permeabilized and stained for intracellular ifn-g. flow cytometry was then performed to measure intracellular ifn-g production in pbmc, especially in nk cells. results: we have demonstrated that stimulation with il- and il- is effective in increasing the number of ifn-gpositive cells. there is a distinct difference between the cd -cd dim and the cd -cd bright subsets, with a much greater proportion of ifn-g-positive cells in the cd -cd bright subset. the effects of stimulation with il- and il- on cytotoxicity will be presented, as will the relation between ifn-g production and cytotoxicity. in addition, we will present results of these assays applied to porcine cells. discussion: in combination, these tests will address nk cell function by combining cytotoxicity with ifn-g production in nk cell subsets. the results will demonstrate whether this could serve as a useful tool in describing nkcell function, which could be of value in clinical and experimental settings. culture of regulatory t-cell lines from bronchial mucosa t lymphocytes play a major role in many immune responses. in the last decade, special focus has been on the function of th and th effector cells. now the importance of regulatory cd þ cd þ t cells in maintenance of the immunological homeostasis emerges. sarcoidosis is a multisystem granulomatous disorder often affecting the lungs. the typical sarcoid granulomas consists of epitheloid cells, macrophages and lymphocytes, mainly cd þ t cells of th phenotype. we have cultured t cells from bronchial biopsies of patients with sarcoidosis as well as from controls in high levels of interleukin (il- ) and il- and demonstrate spontaneously arising cd þ cd þ populations and high concentrations of il- in these cultures. the main difference between cultures of sarcoid origin compared to controls is a very much higher concentration of the inflammatory cytokines il- and tnf-a in cultures of sarcoid origin. the effects of hyperbaric exposure on human peripheral blood mononuclear cells, with special emphasis on natural killer cell cytotoxicity and subsets materials and methods: as an experimental physiological stress model, we examined the effects of hyperbaric exposure on peripheral blood mononuclear cells (pbmcs) obtained from venous blood drawn from eight divers during a simulated heliox saturation dive. eight persons working in normobar atmosphere outside the pressurized chamber served as control donors. the spontaneous cytotoxicity of the pbmcs was estimated in a h cr-release assay using k as nk-sensitive target cells. the pbmcs were characterized, using -colour flow cytometry, with special emphasis on the nk-cell subsets. the data were statistically analysed using a multivariate regression model (stata . ). p values < . was considered statistically significant. results: the estimated cytotoxicity increased significantly in both the group of divers and control donors during the dive (pdivers < . and pcontrols < . ). although the cytotoxicity increased relatively more (p < . ) in the group of divers compared to the group of control donors between day and . discussion: the increased cytotoxicity of pbmc estimated in the group of divers indicate that parts of the cellular immune system are affected during the extreme physiological conditions induced during the initial phase of the presented experimental hyperbaric setup. the increase in cytotoxicity observed in the group of control donors could hypothetically reflect the stress level in persons working outside the pressurized chamber during the dive. the interaction with adhesion molecules expressed by vascular endothelium is the first step in lymphocyte infiltration into tissues. at both cutaneous and mucosal sites interleukin- (il- ), il- and transforming growth factor (tgf)-b are important regulators of chronic inflammatory disease, where cutaneous lymphocyteassociated antigen (cla) and ae integrin (cd ) may be expressed. unlike cla, cd is not believed to play a role in tissue-specific homing but may help to retain t cells within epithelial layers. we have previously shown that il- alone can together with an unknown cofactor increase the expression of cla. stimulation with streptococcal pyrogenic exotoxin c (spec) increased the expression of cd by cd þ but not cd þ t cells. while il- increased superantigen-stimulated expression of cla, this cytokine strongly inhibited the cd expres-sion, and a combination of il- and tgf-b completely abrogated the induced cd expression. conversely, il- suppressed cla but increased cd expression. these findings indicate that, in addition to suppressing the development of th -mediated inflammatory responses, il- may also inhibit the migration of cd þ t cells into the skin while il- promotes such migration. thus, the expression of cla and cd may be antagonistically regulated by il- and il- , and the balance between these cytokines could influence the t-cell migration of inflammatory cells into epithelial tissues. during contact sensitivity reaction, immune cells proliferate. in order to study the histological picture of these proliferation phases, we used a mouse model of contact sensitivity in the oral mucosa and on skin. we also used bromodeoxyuridin (brdu, an analogue to thymidin) that is incorporated into the nucleus during cell replication. the hapten oxazolone (oxa) was used to sensitize and elicit the oral mucosa and/or the ear skin. mice were killed at various times after elicitation, and unsensitized animals were also exposed to the hapten as controls. brdu ( mg/ kg animal) was injected i.p. h before the kill. specimens from the oral mucosa, ear skin and submandibular and auricular lymph nodes were cut and fixed in % paraformaldehyde. they were then treated with acid and biotinylated anti-brdu antibody and developed using abc-kit and dab. the analyses were performed using a leica light microscope and the computer program analysis. in the oral mucosa, the frequency of proliferating cells were increasing during the observation period, - h after elicitation, regardless of site of sensitization. the proliferating cells were found mainly in the basal cell layer of the epithelium. similar patterns were found in ear skin. the regional lymph nodes demonstrated a few scattered proliferating cells h after elicitation. after h, these cells were found frequently in the whole lymph node. control animals exhibited considerable less proliferating cells at all times. we conclude that most proliferating cells were found h after elicitation locally at the hapten-exposed sites (the oral mucosa or the ear skin) as well as in the regional lymph nodes. the endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective anti-inflammatory effects. adenosine acts via four adenosine receptors of which the a a receptor is the predominant form in t cells. adenosine levels are elevated in asthmatic lung, and adenosine can directly induce mast cell degranulation and bronchoconstriction in these patients. instead, the role of anti-inflammatory mechanisms of adenosine on t cells in asthma is unclear. aim: to study the a a receptor expression in peripheral blood cd þ t cells in asthmatic and healthy individuals using flow cytometric and quantitative real-time pcr methods. results: unstimulated cd þ cells of asthmatic patients expressed significantly lower levels (p < . ) of a a receptor in protein level (mean percentage of cells positive ae sem: . ae . , n ¼ ) compared to healthy individuals ( . % ae . , n ¼ ). double staining for cd expression showed that stimulation of cd þ cells decreased a a expression in both groups but indicated that the detected lower levels of a a in unstimulated cells of asthmatics was not due to preactivation in these patients. surprisingly, a a mrna expression in unstimulated cd þ cells was significantly higher (p < . ) in asthmatics (n ¼ ) compared to healthy controls (n ¼ ). the expression did not correlate with serum total ige levels. conclusions: asthmatic individuals express less a a adenosine receptor on their peripheral cd þ t cells. the higher mrna levels instead may point to a negative feedback regulation in the receptor expression. the role of possibly decreased adenosine-mediated anti-inflammatory effects in asthma pathogenesis require further studies on this t-cell mediated disease. the chronic inflammatory skin disease atopic eczema (ae) affects almost % of the population in many countries today. the pathogenesis of ae is not fully understood. a combination of genetic predisposition and environmental factors like microorganisms seems to contribute to the symptoms. the yeast malassezia sympodialis is part of our normal skin micro flora but can act as an allergen and elicit specific ige and t-cell reactivity in patients with ae. recently, we identified a novel major m. sympodialis allergen, designated mala s ( . kda), with sequence similarity to the mitochondrial enzyme manganese superoxide dismutase (mnsod). interestingly, mala s has a high degree of homology to human mnsod. the aim of this study was to examine the effects of recombinant mala s on antigen-presenting dendritic cells. monocytederived dendritic cells (mddcs) from healthy blood donors were cultured with or without mala s for different time periods. it was found that the maturation marker cd and the costimulatory molecules cd and cd were upregulated on the mddcs exposed to mala s for h, as demonstrated by flow cytometry. furthermore, coculture of mddcs with mala s for h induced an increased production of the inflammatory cytokines il- ( -fold), tnf-a ( -fold) and il- (sixfold), as detected by the cytometric bead array (cba) analysis. our results suggest that mala s affects the immune response through dc maturation and production of inflammatory cytokines. the potential cross-reactivity with human mnsod needs to be explored and the exact role of mala s in the pathogenesis of ae assessed in clinical studies involving skin prick and atopy patch tests. allergen-specific immunotherapy (sit) is commonly conducted with allergen extracts adsorbed to aluminium hydroxide (alum). drawbacks linked to the use of alum, such as the formation of granuloma at the site of injection, have led to suggestions of novel allergen carriers. an alternative carrier is mm carbohydrate-based particles (cbps). in mouse, allergen-coupled cbps have been demonstrated to skew the allergen-specific immune response towards a th -like activity (grönlund et al. immunology, ) . we here coupled the recombinant major cat allergen fel d to cbps (cbp-fel d ) by cyanogen-bromide activation, resulting in covalent binding. the effect of cbp-fel d on monocyte-derived dendritic cells (mddcs) from healthy human blood donors was studied. we found that the majority of the cd a þ mddcs were capable of taking up fitc-labelled cbp-fel d , as demonstrated by flow cytometry and confocal laser scanning microscopy. furthermore, incubation with cbp-fel d resulted in an upregulation of the costimulatory molecule cd on the mddcs, which was not observed with fel d or cbps alone. finally, cbp-fel d induced a fivefold increase in the release of the pro-inflammatory cytokine tumour necrosis factor (tnf)-a and a fourfold increase in the release of the chemokine interleukin- from mddcs. taken together, the effects cbps possess make them interesting as novel allergen carriers for sit. the cysteine protease der p from dust mite of the genus dermatophagoides pteronyssinus is a major type i allergen. about % of house dust mite (hdm) allergic individuals are reactive to this protease in standard assays for detection of ige. a curative treatment for atopic allergy is immunotherapy (it) with hdm extracts which are complex mixtures occasionally resulting in anaphylactic reactions. novozymes focuses on developing a recombinant variant of der p which exhibit lowered risk of ige-mediated allergic reactions, while maintaining its ability to trigger proper th-cell responses. this may provide a safer alternative for specific it of hdm allergy. a secreted recombinant form of pro-der p expressed by saccharamyces cerevisiae was obtained by fusion of the pro-enzyme to a fungal signal peptide. the n-glycosylation site of der p was mutated resulting in a deglycosylated pro-enzyme with a molecular mass of kda. protein purification procedure was developed to obtain nearly pure der p protein followed by determination of concentration by active-site-titration with the cysteine protease inhibitor e . the deglycosylated recombinant pro-der p revealed immunologic similarity to the native der p molecule when compared in basophile histamine release, ige-binding assays and t-cell proliferation assays. by in silico epitope mapping of a modelled -dimensional structure of der p , five putative igg and ige epitopes were predicted. by protein engineering, the predicted epitopes were removed one by one in der p and screening for hypoallergenic variants was performed. combining inhaled long-acting b- agonist (laba) and inhaled corticosteroid (ics) seems to offer asthma control at a lower dose of ics than achieved by ics alone. fine mapping of t-cell surface markers by flow cytometry offers a detailed status of the individual's inflammatory response. the frequency of mt (cd þ cd ra -cd l þ cd adim) and mt (cd þ cd ra -cd l -cd abright) cells in peripheral blood, and their ratio, has been shown to differ predictably in atopics and patients with leprosy, where mt correlates with a th phenotype and mt with a th phenotype. stable asthmatics, requiring fluticasone propionate (fp) - mg daily or equivalent, were randomized to receive, double-blinded, either seretide [salmeterol and fluticasone propionate (sfc, n ¼ )] mg/ mg bd or fp mg bd (n ¼ ). if asthma was controlled based on lung function and symptoms at clinic visits every weeks, ics dose was tapered until asthma exacerbated or mg was reached. the frequency and ratio of mt and mt t cells of the patients was monitored at week intervals. as treatment tapered, the frequency of mt cells decreased (p ¼ from first to final visit), whereas that of mt cells increased. the ratio of mt /mt decreased (p ¼ from first to final visit). in patients receiving laba þ ics, the fall in mt /mt ratio appeared to be more pronounced than in patients receiving ics alone. thus, the mt phenotype may be associated with stable asthma, whereas an imminent exacerbation may associate with an increase in the mt phenotype. laba may allow for a greater effect of fp on the mt ratio. activation of complement pathways, leading to production of c a and c a anaphylatoxins, has been postulated in the pathogenesis of asthma and allergic airway inflammation. the present study was undertaken to investigate the role of mannan-binding lectin (mbl), an initiator of the lectin pathway of complement, in asthma and allergic rhinitis. mbl levels and mbl-induced complement activity were determined in patients of bronchial asthma with allergic rhinitis and unrelated, age-matched controls of indian origin. mbl levels and activity were correlated with percent eosinophilia and percent predicted fev values of the patients. association of single nucleotide polymorphisms (snps) in exon and intron of the mbl with the disease, clinical markers, mbl levels and mbl-induced complement activity was analysed using standard statistical tools. significantly higher mbl levels and activity were observed in patients of bronchial asthma with allergic rhinitis as compared to the controls. we identified five snps, of which two, a g in exon and g a in intron of the mbl, were novel. snp g a was significantly associated with the disease (p ¼ . , or ¼ . , % ci: . < or < . ). individuals with 'a' allele at position showed increased mbl levels, activity and disease severity. our results suggest that 'a' allele at position leading to high mbl levels and complement activity may be contributing to the severity of bronchial asthma and allergic airway inflammation. serum resistance of borrelia burgdorferi strains belonging to the b. afzelii and b. burgdorferi sensu stricto genospecies is dependent on binding of complement inhibitor factor h. we recently reported that factor h binding by b. burgdorferi is due to inducible expression of several approximately kda plasmid-encoded, surface-exposed lipoproteins related to ospe (e.g. erpa, erpp and p ). in addition, a second class of factor h-binding proteins of approximately - kda has been described. the ospe-related lipoproteins are dramatically induced by b. burgdorferi during transmission from its tick vector into the mammalian host. the induction of ospe-related lipoproteins during mammalian infection may play a key a role in the borrelial evasion of the host's immune system. the goal of the present study was to define the factor h-binding regions of ospe-related proteins using mutagenesis, peptide mapping and surface plasmon resonance analysis (biacore). the combined studies revealed that the c-terminal regions of both human and mouse factor h (scrs - ) specifically bind to ospe-related lipoproteins. we also found fhr- , whose c-terminal scrs - are homologous to scrs - of factor h, to bind to ospe. peptide mapping revealed five putative regions (designated i-v) in ospe that could directly interact with factor h. deleting the c-terminal amino acid residues from region v of p abolished its ability to bind factor h. at the same time, however, synthetic peptides corresponding to the c-termini of ospe, p and erpp did not inhibit factor h binding to ospe. thus, the c-terminal-binding region v appears to be necessary but not sufficient for factor h binding. when a more specific mutation strategy was employed, where single amino acid residues in peptides spanning over the factor h-binding regions were mutated to alanines, we observed that lysines in the factor h-binding regions of ospe were required for factor h binding. the combined data have revealed that key lysine residues in ospe-related lipoproteins and ionic interactions are crucial for factor h interactions. furthermore, binding of ospe to the c-termini of both mouse and human factor h suggests that borrelia spirochetes utilize analogous complement resistance mechanisms in both rodents and man. in borrelia garinii strains, which in in vitro analyses have been found to be sensitive to complement killing, differences in the ospe sequences as well as in the expression of factor h-binding proteins may account for their susceptibility to serum lysis. role of yada, ail and lipopolysaccharide in serum resistance of yersinia enterocolitica serotype o: mannan-binding lectin (mbl), l-ficolin and h-ficolin are pattern recognition molecules of the innate immune system. we investigated the ability of these molecules to bind to different serotypes and noncapsulated variants of streptococcus pneumonia and staphylococcus aureus. we found that mbl binds to noncapsulated s. aureus strain (wood) but not any of the examined s. pneumoniae serotypes. l-ficolin binds to some capsulated s. pneumoniae serotypes ( a, d and f) as well as some capsulated s. aureus serotypes (type- , - , - , - and - ). h-ficolin does not bind to any of the examined s. pneumoniae and s. aureus serotypes included in this study but did bind to a strain of aerococcus viridans. when bound to bacteria, mbl and h-ficolin initiated activation of complement factor c , whereas l-ficolin did not. during this study, quantitative assays for the three proteins were developed and the concentration in plasma samples were determined and the median values were estimated at . mg of mbl/ml, . mg of l-ficolin/ml and . mg of h-ficolin/ ml, respectively. the absence of early complement components (c , c and c but not c ) is a predisposing factor for systemic lupus erythematosus (sle). recently, we demonstrated that, in c -deficient (c def.) mice, igm-containing immune complexes (igm-ic) are filtered by the splenic barrier of marginal zone macrophages (mzm), resulting in an increased immune response against antigens within these igm-ic, but this could not be observed in wildtype or c def. mice. we hypothesized that splenic cd b þ mzm play an important role in the induction of autoimmunity, and we therefore analysed their cytokine profile after isolation with the help of magnetic antibody cell sorting. mrna was isolated, and real-time pcr was performed with specific primers for murine ifn-g (ifn-g), interleukin- (il- ) and ifn-a (ifn-a). we observe a moderate increase of il- and ifn-g mrna in cd b þ cells of c def. mice compared to wildtype cells. surprisingly, the concentration of ifn-a mrna is six times higher in c def. mice. preliminary results suggest that mrna in cd b þ cells of c def. mice is even lower than that in wt. six hours following i.v. application of mg of a abstracts .................................................................................................................................................................................................. murine monoclonal igm anti-dsdna antibody, production of il- , ifn-g and ifn-a mrna is increased in cd b þ cells of both c def. and wt mice. several references described increased levels of inf-a in patients with sle. dendritic cells are discussed as a major source of ifn-a. our observation that c -deficient, sle-susceptible mice demonstrate an increased spontaneous ifn-a production by splenic cd b þ marginal zone macrophages could be an early sign and a trigger for the development of sle. this is supported by the fact that the absence of c is not a predisposing factor for sle and our observation that c def. animals display low levels of ifn-a mrna. - million people worldwide and represents one of the leading causes for liver cirrhosis and hepatocellular carcinoma. control over the hbv infection is achieved mainly by vaccination with hepatitis b surface antigen (hbsag). hbsag contains n-linked glycosylation side and is recognized by both mbl-a and mbl-c in a cadependent manner. hbsag-mbl complexes activate complement and may thus affect humoural immunity. to investigate the role of mbl in humoural responses to hbsag, we immununized mice that lack both mbl-a and mbl-c proteins with soluble hbsag. it has been shown that deficiencies in other complement components like c q, c and c result in decreased antibody responses. however, mbl double ko animals mounted dramatically increased humoural responses. after priming, mbl double kos mounted hbsag-specific igm responses, which were threefold higher than wt controls. after boosting the hbsag, total igg was -fold higher in mbl ko than in wt control animals. similar to the response to hbsag, other glycosylated soluble antigens (e.g. invertase) induced better humoural responses in mbl double ko animals, suggesting that mbl plays an important role in a negative feedback regulation of adaptive immunity. reconstitution experiments with rmbl partially rescued the ko phenotype. we propose that the clearance of glycoprotein antigens in mbl ko is handled differently from the wt, resulting in better stimulation of humoural responses. alternatively, glycoprotein-ag-mbl-rich complexes inhibit b-cell responsiveness via putative mbl receptors. the complement system is an important part of the innate immune system. the activation of complement proceeds through three different pathways that converge in the generation of c -activating enzyme complexes. complement activation via the lectin pathway is initiated when recognition molecules, mannan-binding lectin (mbl) or ficolin, bind to carbohydrate structures characteristic for microbial surfaces. in the circulation, mbl and ficolins are found in association with three structurally related mblassociated serine proteases (masp)- , - and - and a small, nonenzymatic component, map . masp- has been shown to elicit complement activation through the sequential proteolytic cleavage of c and c upon binding of mbl/masp- complexes to microbial surfaces. we have recently uncovered a polymorphism in the masp- /map gene in a patient shown to be deficient in the lectin pathway of complement activation. the polymorphism results in a single amino acid substitution in the n-terminal part of the masp- protein. recombinant wildtype masp- and masp- containing the amino acid substitution in question was produced, and the ability to activate complement was studied. the mutation had a profound impact on masp- function, resulting in the lack of complement activation through the lectin pathway. elisa-based experiments showed that the mutation leads to the impairment of complement activation through influencing the binding of masp- to mbl or ficolins. deficiencies in the lectin pathway of complement activation have so far been accounted for only by lack of functional mbl. the mutation described above is the first defect described affecting both activation through mbl and the ficolins. .................................................................................................................................................................................................. th , th and treg cell balance. dcs are present in the gut mucosa and may thus be target for modulation by gut microbes, including ingested probiotics. here, we tested the hypothesis that species of lactic acid bacteria, important members of the gut flora, differentially activate dc. a large panel of human gut-derived lactobacillus and bifidobacterium spp. was screened for dc-polarizing capacity by exposing bone marrow-derived murine dc to lethally irradiated bacteria. cytokines in culture supernatants and dc-surface maturation markers were analysed. substantial differences were found among strains in the capacity to induce interleukin- (il- ) and tumour necrosis factor (tnf)-a, while the differences for il- and il- were less pronounced. bifidobacteria tended to be weak il- and tnf-a inducers, while both strong and weak il- inducers were found among the strains of lactobacillus. remarkably, strains weak in il- induction inhibited il- and tnf-a production induced by an otherwise strong cytokine-inducing strain of lactobacillus casei, while il- production remained unaltered. selected strains were tested for induction of dc maturation markers. those lactobacilli with greatest capacity to induce il- were most effective in upregulating surface mhc class ii and cd . moreover, l. casei-induced upregulation of cd was reduced in the presence of a weak il- inducing l. reuteri. in conclusion, human lactobacillus and bifidobacterium spp. polarize differentially dc maturation. thus, the potential exists for th /th /treg-driving capacities of the gut dc to be modulated according to composition of gut flora including ingested probiotics. the intestinal micro flora is indispensable in developing and maintaining homeostasis of the gut-associated immune system. evidence indicates that lactic acid bacteria (lab), e.g. lactobacilli and bifidobacteria, have beneficial effects on the host. established health effects include increased gut maturation, antagonisms towards pathogens and immune modulation. the objective of this study is to evaluate the immunomodulating properties of a range of lab of human origin. as dendritic cells (dcs) play a pivotal role in the balance between tolerance and immunity to commensal microorganisms, in vitro-generated immature dcs serve as a suitable model for studying the immunomodulating effects of lab. human immature dcs were generated in vitro from monocytes and exposed to lethally uv-irradiated lab. the effect of various species of lab on dcs in direct contact was evaluated. furthermore, the maturation pattern of dcs separated from the bacteria by an epithelial cell layer (caco- cells), which should mimic the intestinal environment, was studied. cytokine secretion (il- , il- and tnf-a) and upregulation of maturation surface markers on dcs (cd and cd ) was measured. different lab induced diverse cytokine responses. some strains were strong il- and tnf-a inducers and others weak. all strains induced il- . different lab also differentially modulated expression of cd and cd on dcs. although some variation in the response to lab of dcs generated from different blood donors was observed, general differences in the effect of the various lab was revealed. experiments with the dc caco- coculture system are ongoing. different species of lab differentially affect dc maturation; this suggets that the gut flora plays a pivotal role in polarization of the immune response. natural killer (nk) cells are cells of the nonspecific immune system lysing altered self-cells. a noncytolytic subset of nk cells may serve a regulatory role by secreting cytokines. bacteria translocating across the gastrointestinal mucosa are presumed to gain access to nk cells, as consumption of certain lactic acid bacteria has been shown to increase in vivo nk cytotoxicity. here, we investigated how human gut flora-derived lactobacilli affect nk cells in vitro, by measuring proliferation and ifn-g production of human nk cells upon bacterial stimulation. cd -cd þ nk cells were isolated from buffy coats by negative isolation using non-nk lineage-specific antibodies and magnetic beads. nk cells were incubated with mg/ml uv-inactivated bacteria or mg/ml phytohemagglutinin (pha) for days. proliferation was assessed by incorporation of radioactive thymidine into nk-cell dna. the ifn-g concentration was measured by elisa. incubation of nk cells with a lactobacillus acidophilus strain increased the proliferation of the nk cells and induced ifn-g production, both to levels comparable to pha stimulation. the proliferative response was further enhanced with autologous monocytes present, probably because cytokines, secreted by monocytes having engulfed bacteria, stimulated the nk cells. in contrast, a lactobacillus paracasei strain caused the nk cells to proliferate only in the presence of monocytes. these results demonstrate that various strains of lactobacilli have the capacity to activate nk cells in vitro, in a monocyte-dependent or -independent way. hence, the encounter of nk cells with lactic acid bacteria will affect nk-cell activation. such activation of nk cells may potentially skew an on-going or subsequent immune response towards a th response. lactobacilli are nonpathogenic gram-positive inhabitants of the normal human intestine known for their healthpromoting effects. in our earlier work, it is shown that human monoclonal antibody isolated from sera of a patient with waldenstrom macroglobulinaemia possess innate antibody characteristics and binds to lactic acid bacteria. according to the immune network model, immunization with this bacteria could induce the perturbations in immune system that might result in production of anti-lactobacillus antibodies, human monoclonal antibody like (ab ) and anti-idiotypic antibody (ab ). in this study, balb/c mice were immunized with two doses of bacteria lactobacillus acidophilus in complete and incomplete freund's adjuvant and phosphate-buffered saline (pbs), respectively. seven days after the last immunization, sera from immunized mice were collected and the presence of lactobacillus-specific ab and ab were determined by elisas. in the sera of immunized mice, antibodies specific to bacteria lactobacillus acidophilus were shown. the concentration of lactobacillus-specific antibodies was higher in the sera of hyperimmunized mice (mice immunized with mg of igm dj) than in sera of mice immunized with times lower doses of immunogen ( . mg per doses). moreover, ab and ab antibodies were detected in the sera of lactobacillus-hyperimmunized mice. in this study, we have shown the idiotypic network interactions in mice immunized with bacteria lactobacillus acidophilus. the normal gastrointestinal flora is crucial for the maturation of the acquired immunity via effects on antigenpresenting cells (apcs). here, we have investigated how two types of apcs, monocytes and dendritic cells (dcs), react to different bacterial strains typical of the commensal intestinal flora. purified monocytes and monocyte-derived dcs were stimulated with uv-inactivated gram-positive (lactobacillus plantarum and bifidobacterium adolescentis) and gram-negative (escherichia coli and veillonella parvula) bacterial strains. monocytes produced higher levels of il- p and tnf, as detected by elisa, in response to l. plantarum than to e. coli and v. parvula. in contrast, dcs secreted high amounts of il- p , tnf, il- and il- in response to e. coli and v. parvula but were practically unresponsive to l. plantarum and b. adolescentis. the lack of response to the gram-positive strains correlated with a lower surface expression of toll-like reseptor (tlr ) on dcs compared to monocytes. the surface expression of tlr on dcs was undetectable when analysed by flow cytometry, but blocking this receptor decreased the tnf production in response to v. parvula, indicating that low tlr expression on dcs is sufficient to mount an inflammatory response to gram-negative bacteria. ifn-g increased the expression of tlr on dcs and also potentiated the cytokine response to gram-negative bacteria. our results indicate that, when monocytes differentiate into dcs, their ability to respond to different commensal bacteria dramatically changes, thereby becoming unresponsive to probiotic gram-positive bacteria. these results may have important implications for the capacity of different groups of commensal bacteria to regulate mucosal and systemic immunity. probiotic bacteria, e.g. lactobacillus spp., may improve diseases such as chronic inflammatory bowel disease. we examined cytokine production and phenotypic change after in vitro stimulation of t cells from healthy volunteers using different probiotic strains. methods: t cells were cultured from colonic biopsies from eight healthy volunteers (agnholt and kaltoft, exp clin immunogenet ; : - ) , and dendritic cells were matured from their peripheral blood mononuclear cells. t-cell cultures were stimulated with autologous bacterial sonicate or strains of lactobacillus spp., with and without the addition of dendritic cells. cytokine levels (tnf-a, ifn-g, il- and gm-csf) and phenotype (cd , cd , cd and cd ) were measured on day . results: lactobacillus spp. induced higher productions of tnf-a and il- than did autologous bacteria. in presence of dendritic cells, the production of all cytokines increased. however, the increases of ifn-g and tnf-a were more pronounced in wells with autologous bacteria than in wells with lactobacillus spp. the addition of dendritic cells upregulated cd expression without simultaneous upregulation of cd . the upregulation was pronounced after stimulation with lactobacillus rhamnosus gg compared with autologous bacteria and other lactobacilli. discussion: in presence of dendritic cells, autologous bacteria induced inflammatory cytokines, while probiotics mainly induced regulatory cytokines. lactobacillus rhamnosus gg induced a regulatory phenotype (cd þ ), in part mediated by dendritic cells. future studies will address whether this shift to a cd þ phenotype represents a differentiation into competent regulatory t cells. in a clinical context, such cells might be used for treatment of inflammatory diseases. protein microarrays will play a key role in the postgenomic era and offer a unique possibility to perform highthroughput global proteome analysis. a chip can be printed with thousands of protein probes (e.g. antibodies), the biological sample added (e.g. a proteome) and any binding detected. we aim to develop protein microarrays based on human recombinant scfv antibody fragments for global proteome analysis. the concept of comparing proteomic maps of healthy versus diseased samples will allow diseasespecific proteins to be detected. in fact, antibody microarrays will allow us to perform comparative proteome analysis on any sample format in a species-independent manner, as long as a proteome can be isolated. however, the complexity of proteomes, containing several thousands of different proteins, is a problem. here, we have designed antibody microarrays targeting the water-soluble fraction of a proteome. to this end, an anticytokine antibody array was developed and human dendritic cells (aeactivation) was used as model system. the results showed that our antibody microarrays could be used to examine the cytokine profile in complex samples. furthermore, we have taken the first steps towards comparing our results with those of other technologies on both the protein and gene level. due to the complexity of the model proteome, we also examined the possibility to prefractionate the proteome in a simple one-step procedure (based on size) prior to the labelling step. in more detail, the sample proteome was fractionated into two fractions using membrane devices with different molecular weight cut-offs. the results showed that the fractionation considerably enhanced the assay sensitivity allowing cytokines in the pg/ml range to be readily detectable. the immunomodulatory effect of heat shock protein : immunization with a dna construct based on the malarial antigen fused with a fragment of hsp primes for a th- type of response finding an appropriate adjuvant for human vaccination is crucial. heat shock proteins (hsps) act as adjuvants when coadministered with peptide antigens or given as fusion proteins. however, there is a potential risk of autoimmunity when using the complete molecules, because hsps are evolutionary conserved. to overcome this, we first evaluated the adjuvant effect against two different antigens of a less-conserved fraction of plasmodium falciparum hsp (pf c) and compared it to the whole hsp molecule from trypanosoma cruzi (tchsp ). we found that pf c exhibited similar adjuvant properties as the whole molecule. we later evaluated the adjuvant potential of pf c against the malarial antigen eb in a chimeric dna construct. no appreciable levels of eb -specific abstracts .................................................................................................................................................................................................. antibodies were detected in mice immunized only with the dna constructs. however, dna primed the immune system, because subsequent challenge with the corresponding recombinant fusion proteins elicited a strong th- antibody response. in contrast, no priming effect was observed for ex vivo ifn-g production but stimulation with the hsp-chimeric fusion protein induced a stronger secretion of ifn-g in vitro than other proteins used. these results indicate that the use of hsps is promising in the design of new vaccines. high-throughput proteomics on antibody-based microarrays: the importance of probe and surface design in analogy to dna microarrays, protein microarrays offer a new distinct possibility to perform sensitive highthroughput global proteome analysis. however, the development of the protein microarray technology will place high demands upon the design of both probes and solid supports. the analysis of thousands of heterogeneous proteins on a single microarray requires the use of uniform probes, such as antibodies, directly designed for protein microarray applications. we have recently generated a human recombinant single-chain fv antibody library, genetically constructed around one framework, the ncoder-library, containing  clones. single framework antibody fragments (sinfabs) selected from this library were successfully applied as probes for microarrays providing sensitive detection in the attomol (mass spectrometry) and the zeptomole range (fluorescence). however, the choice of framework is critical. we have shown that the selected ncoder framework displayed excellent functional on-chip stability and arrayed dehydrated probes retained their activity for several months. furthermore, we have addressed the issues of biocompatibility of the solid support and immobilization strategies for our microarray setup. an in-house-designed substrate, macroporous silicon coated with nitrocellulose (map -nc ), displayed properties equal to, or better than, those of five commercially available supports used as reference surfaces. we have also evaluated different coupling strategies, such as adsorption, covalent coupling, diffusion and affinity coupling. using a novel affinity tag, the double-(his) -tag, we increased the binding efficiency of sinfab-molecules to ni þ -coated solid supports, thereby allowing nonpurified probes to be directly applied. the mannan-binding lectin (mbl) pathway is part of the innate immune system providing a first line of defence against infections. mbl and ficolins circulate in complexes with mbl-associated serine proteases (masp- , - and - ). after recognition of a microorganism by mbl, activation of the complement system occurs. masp- and masp- share five domains (making up the so-called a-chain), whereas they have unique protease domains (b-chains). before the identification of masp- , an assay for masp was presented, based on antibodies against the a-chain of masp- . with the new knowledge of the three masps, and the sharing of domains by masp- and masp- , assays specific for the protease domains have to be constructed, if one wishes to measure the proteins individually. we present an assay for quantifying total masp- in plasma and serum samples. the assay is a sandwich-type assay using as catching antibody a monoclonal antibody against the common a-chain of masp- / and a developing secondary antibody against the c-terminal part of the protease domain of masp- . we have used this assay for estimating the normal concentration of the protein as well as the concentration in patients and also for characterizing by gel permeation chromatography the masp- protein in serum. inducible costimulator ligand (icosl) is a costimulatory molecule related to b . (cd ) and b . (cd ). b cells, monocytes, dendritic cells and endothelial cells express icosl. inducible costimulator (icos) interacts with icosl, and this interaction leads to signals involved in isotype switching and the development of immunological memory. hitherto, no polymorphisms of this gene have been described. the aim of this study was to reveal variation of the icosl gene in normal individuals. all eight exons, except exon , were sequenced with flanking introns in healthy blood donors. eight single nucleotide polymorphisms (snps) and two length polymorphisms were found. one of the snps was found in the coding regions of the gene. the base involved was located in exon and caused a conservative amino acid change from valine (gtt) to isoleucine (att). three individuals were heterozygous g/a for the exon polymorphism, while the remaining seven individuals were homozygous for the wildtype g/g. exon encodes the immunoglobulin variable (igv)-like domain of the molecule which is situated outside the cell. this means that the amino acid could be critical for the stability of the molecule or could constitute part of the binding site for icos. the results form the basis for further experiments to find possible associations of the alleles to diseases caused by immune dysregulation. especially, the exon variant is interesting and could play a role for the development of immunological diseases. besides, it would be interesting to see whether both exon alleles are expressed or only the wildtype allele is functional. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. myxovirus a (mxa) is a resistance gtpbinding protein that is specifically induced by treatment with type ifns. for example, ifn-b-induced mxa in blood leucocytes has been used as a biomarker in ifn-btreated patients with multiple sclerosis. however, the degree of specificity of mxa in this regard is unclear, and measurements of mxa protein and/or mrna are not yet suitable for routine clinical use. in an attempt to find new and better reporter genes (and, hopefully, genes and gene products with proven specificity for ifn-a and -b), microarray screenings with u a genechips (affymetrix) were carried using human blood leucocytes and the human lung carcinoma cell line a . we studied the simultaneous expression of , transcripts before and after exposure to human recombinant ifn-a and ifn-b and other antiviral and immunomodulatory cytokines. the results will be presented at the conference. interferon-a/b (ifn-a/b) is increasingly used as antiviral and immunomodulatory therapies. unfortunately, bioavailability varies with ifn species and mode of administration, and all ifn species are potentially immunogenic. assays for antiviral activity (ifn) and antiviral neutralization (antibodies, nab) have been used for some time to monitor patients on ifn biologicals. these assays require laborious titrations making them unsuitable for large-scale clinical use. our laboratories have therefore modified the antiviral assays for ifn bioactivity and nab, so that they are suitable for large-scale screening in specialized laboratories. the read-out is survival of a subcloned a cell line in the presence of an otherwise lethal amount of virus. thus, survival increases in the presence of type ifn and decreases in the presence of nab against the ifn added to the cells. mxa is induced by type ifn and can be used for measuring the nab activity. in another assay, the mxa level in the a cell line is measured. in an attempt to find a new and better reporter gene for type ifn than mxa and genes specific for either ifn-a or -b, a micro array screen was carried using the u a chip from affymetrix. the expression of , genes can be studied simultaneous with this technology. the results will be presented at the conference. in our laboratory, we have developed a database system, which we believe is of immediate interest to the general scientific community. the database represents a computerbased replacement for the laboratory notebooks used in the majority of research laboratories worldwide. in addition, the database provides an effective tool for organizing and managing laboratory information at all levels, spanning from managing and revising standard operating procedures and producing documentation of research activities to keeping track of data and conclusions. using the commercially available database toolkit software filemaker pro, we have developed a relational database solution for management of laboratory information. the system consists of a hierarchy of five interrelated databases, each pertaining to a separate type of information, namely, overall project information, information relating to individual experiment setups, documentation of daily research activity, generated data and descriptions of standard operating procedures. like other databases, each individual database consists of a number of records, each comprised of a set of fields in which information is entered. in each record, a certain field is reserved to specify the relation of the record to a record in another database at a higher level. thus, the database is essentially five databases linked by a hierarchy of one-to-many relations, organizing information in a folder-like structure. importantly, the database system allows multiple users to access and edit records simultaneously, and the data entered in one database immediately becomes accessible through the other databases. the limitations of laboratory notebooks are apparent when looking for information, which is dispersed throughout one or more notebooks, or possibly on loose sheets of paper or printouts 'somewhere'. the often complicated process of gathering laboratory data or results when writing grant applications or research papers is made considerably easier with the database system. thus, the database solution presented should be broadly attractive to researchers, irrespective of their scientific discipline. an effective sars vaccine is likely to include components that can induce specific cytotoxic t-cell (ctl) responses. the specificities of such responses are governed by hlarestricted presentation of sars-derived peptide epitopes. exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear sequences directly from genomic/proteomic sequence information. the latter was recently established when a causative coronavirus (sars cov) was isolated and full-length sequenced. here, we have combined advanced bioinformatics and high-throughput immunology to perform an hla supertype, genome-wide scan for sars-specific cytotoxic t cell epitopes. the scan includes all nine human hla supertypes in total covering > % of all major human populations. for each hla supertype, we have selected the top candidates for test in biochemical-binding assays. at this time (approximately months after the genome was established), we have tested the majority of the hla supertypes and identified almost potential vaccine candidates. these should be further validated in sars survivors and used for vaccine formulation. we suggest that immunobioinformatics may become a fast and valuable tool in rational vaccine design. rationale: major histocompatibility complex class i (mhc i) molecules monitor the protein content of the cell by binding small derived peptides and presenting them to cytotoxic cd þ t cells. the goal of the human mhc project is to predict the binding strength of any given peptide/mhc complex. this prediction allows the design of peptide-based vaccines. the prediction requires representative binding data from mhc alleles from all the nine hla supertypes. here, we describe the genetic construction, protein production and purification as well as the establishment-binding assays for two recombinant mhc supertype alleles, hla-b* and hla-b* . methods: using the quikchange multisite directed mutagenesis kit (stratagene), codon-optimized genes encoding hla-b* and hla-b* are created. the two mhc i molecules are fermented and purified by ion exchange chromatography, hydrophobic interaction chromatography and size exclusion chromatography. the binding (kd) of natural t-cell epitopes, as well as predicted peptide ligands, is described by radioactive immunoassays (rias) and enzyme-linked immunosorbent assays (elisas). the mhc molecules are biotinylated during expression. results: the expression of mhc i resulted in multiple disulfide bond isomers, which are separated by hydrophobic interaction chromatography and used in subsequent binding studies resulting in the determination of kd for various peptide ligands ranging from strong binders we have previously demonstrated that bioinformatics tools such as artificial neural networks (anns) are capable of performing pathogen-, genome-and hlawide predictions of peptide-hla interactions. these tools may therefore enable a fast and rational approach to epitope identification and thereby assist in the development of vaccines and immunotherapy. a crucial step in the generation of such bioinformatics tools is the selection of data representing the event in question (in casu peptide-hla interaction). this is particularly important when it is difficult and expensive to obtain data. herein, we demonstrate the importance in selecting information-rich data and we develop a computational method, query-bycommittee, which can perform a global identification of such information-rich data in an unbiased and automated manner. furthermore, we demonstrate how this method can be applied to an efficient iterative development strategy for these bioinformatics tools. methods: a large panel of binding affinities of peptides binding to hla a* was measured by a radioimmunoassay (ria). this data was used to develop multiple first generation anns, which formed a virtual committee. this committee was used to screen (or 'queried') for peptides, where the anns agreed ('low-qbc'), or disagreed ('high-qbc'), on their hla-binding potential. seventeen low-qbc peptides and high-qbc peptides were synthesized and tested. the high-or low-qbc data were added to the original data, and new high-or low-qbc second generation anns were developed, respectively. this procedure was repeated times. the high-qbc-enriched ann performed significantly better than the low-qbc-enriched ann in of the tests. conclusion: these results demonstrate that high-qbcenriched networks perform better than low-qbc-enriched networks in selecting informative data for developing peptide-mhc-binding predictors. this improvement in selecting data is not due to differences in network training performance but due to the difference in information content in the high-qbc experiment and in the low-qbc experiment. finally, it should be noted that this strategy could be used in many contexts where generation of data is difficult and costly. interleukin- (il- ), a pro-inflammatory cytokine that is produced by both lymphoid and nonlymphoid cells, has a critical role in modulation of innate and adaptive immunity. its primary function in stimulation of ifn-g production and stimulation of nk-cell-cytotoxic activities makes this cytokine a candidate for cancer immunotherapy. in oral cavity, this cytokine is produced by oral epithelia and carcinoma cells and is related to tumour regression in nude mice bearing salivary adenocarcinoma. however, direct effects of this cytokine on oral cancer cells have not been elucidated. in this project, we investigated il- effect on an oral carcinoma (kb) cell line. with rt-pcr technique, kb-cell line was found to express il- receptors (il- ra and il- rb), indicating that this oral carcinoma line is a target for il- study. we showed that recombinant human il- inhibited kb-cell proliferation by % at concentration of ng/ml (p < . ), whereas ldh release by these cells in treatment group and control groups was comparable, indicating that il- suppression of cell proliferation was not mediated by the induction of cell death. to further address this hypothesis, we found that il- treatment did not induce apoptotic cell death, as studied by dna laddering and tunel assays. in addition, expression pattern of cell death-controlling genes (bcl- and bax) was not altered by this cytokine. findings in these studies indicated that suppression of kb-cell proliferation may be attributed to control of cell cycle, growth arrest or induction of cell differentiation. the data presented in this project could provide an insight of how cancer cell directly responds to il- , as this cytokine is an important regulator of anticancer mechanisms. aloe emodin (ae) is a naturally occurring compound with wide spectrum of biological properties, including antimicrobial, vasorelaxant, immunosuppressive and anticancer actions. this anthraquinone induces apoptosis in several tumour cell lines with special affinity to tumours of neuroectodermal origin. high amounts of nitric oxide (no) released by activated macrophages induce tumour cell death. therefore, we explored the capacity of ae to modulate no-mediated antitumour response in vitro. interestingly, while ae markedly suppressed no release from macrophages alone, it significantly potentiated no production in cocultures of macrophages and c cells, after h of cultivation. accordingly, the viability of c cells cocultivated with macrophages was reduced in the presence of ae. moreover, the observed ae-imposed potentiation of no production in macrophages was closely related to macrophage culture cell density. according to these data, we proposed that no modulator capacity of ae strongly depended on intercellular contact, indicating that macrophage antitumour response was not compromised but even potentiated by ae. immunotherapy represents an attractive fourth-modality therapeutic approach, especially in the light of the shortcomings of conventional surgery, radiation and chemotherapies in the management of metastatic cancer. to this end, a large number of peptide antigens derived from taa have been applied in immunotherapeutic trials for the treatment of various malignancies, e.g. cancers of the breast, prostate and kidney, in addition to haematological cancers. in some cases the response rates have been impressive and no adverse autoimmunity have been observed. a major strategic difficulty associated with these trials relates to the choice of best-suited peptide antigens. the vast majority of the antigens described thus far is not vital for survival and growth of the tumour cells, and immunoselection of antigen-loss variants may therefore prove to be an additional obstacle for the clinical applicability of most of the known peptide epitopes. in this respect, the development of acquired antigen loss during immunotherapy has been demonstrated in several cases. obviously, the development of loss-variant tumour cells implies that these cells acquire a pronounced growth advantage and are left unaffected by further treatment. ideally, target antigens should be derived from proteins required for survival and growth of tumour cells, as antigens with these characteristics would not be inflicted by the development of loss-variant tumour cells. in this respect, several inhibitors of apoptosis proteins (iaps) are universally expressed among tumours and play an important role in tumour cell escape from apoptosis. we have characterized spontaneous t-cell reactivity against iapderived peptides in cancer patients. from the iap survivin, we have characterized peptides restricted to the class i molecules hla-a , a , a , a , b and b . furthermore, we have demonstrated that survivin-specific t cells infiltrate metastatic lesions and that isolated survivinspecific ctls are capable of killing hla-matched tumour cells. survivin-derived peptides are now in clinical trial, and continued work in our lab has demonstrated that other iaps are targets for spontaneous t-cell reactivity in cancer patients. we previously reported that in mice with large progressing t-cell lymphoma tumours, dysfunctions in the antitumour ctl activity occur, associated with an accumulation of splenic arginase-producing myeloid suppressor cells (mscs). in this study, we first demonstrate that both the presence and the activation state of these msc depends on tumour evolution. while in tumour regressors hardly any arginase-producing msc can be found, both the amount and the arginase activity of this population expands from early over late progressors. this gradual induction of mscs is paralleled by an increasing suppression of ctl activity and th , but not th , cytokine production. upon analysing the molecular repertoire of msc in vitro, we found, besides arginase , a well-established marker for alternatively activated myeloid cells or m , a strong upregulation of fizz and ym, two additional recently identified markers for m . further evaluation of molecular markers by microarray analysis in msc yielded genes involved in wound healing (e.g. coagulation factor xiiia), anti-inflammation (e.g. selenoprotein p), immunomodulation (e.g. pd-l ) and fat and sugar metabolism (e.g. leptin receptor). of note, many of these genes are regulated by type cytokines (il- , il- and il- ) and are therefore rather m associated. overall, our data provide new markers for msc in cancer and further establish their m activation state. study. only sp-a showed a significant expression in normal mucosa which was downregulated in crc. as the absolute signal level was below the noise threshold, these results have to be interpreted with caution and require confirmation by direct measurenment of the proteins. our results suggest that there is no major role for the human collectins in colorectal cancer. tetramerization is visualized by sds-page. conclusion: an effective method for the production of highly pure mhc i molecules has been applied to hla-b* and hla-b* , and ria and elisa binding assays for those alleles have been established background: proliferation, differentiation and apoptosis are essential processes in the normal functions of the mammary epithelium. the hypothesis examined in this study is that the transcription factor bcl- is critically important not only for regulating b-cell growth and development but also for mammary epithelial apoptosis. methodology: twenty breast cancer cases and healthy controls were used to investigate whether bcl- protein in involved in breast cancer (grade iii). full length bcl- cdna was retrovirally transduced into eph- cell line. we then used flow cytometry of brdurd-stained cells to investigate the cell-cycle duration of the control and transduced cell lines. tunel was used as a marker of apoptosis to find out differences in the frequencies of apoptotic cells in the control and transduced cell lines. finally, immunohistochemistry staining was performed to detect bcl- in breast cancer (iii). results: restoration of bcl- into eph- cells not only inhibits apoptosis but also prolongs the cell cycle and results in increased cell size and protein content. the results also indicated that the cell-cycle time of bcl- -transduced eph- cells is prolonged by about h, presumably as a result of the action of bcl- at the bcl- at the g /s transition. we found differences in the frequencies of viable and apoptotic cells in cultures of the parent eph- cells, control-transduced eph- cells and bcl- -transduced eph- cells. consistently, we demonstrated that bcl- is expressed in % of high grade of breast carcinoma, which is considered as the most aggressive of tumours. conclusion: together, these results suggest that bcl- is likely to be involved in mammary gland development and carcinogenesis. inflammatory cytokines have a critical role in modulation of both innate and adaptive immunity in response to foreign antigen. they also play an important role in anticancer immunity. for example, they can promote cell-mediated immunity against cancer cells. with their immunostimulatory effects, these cytokines are being tested for cancer treatment in the form of dna vaccine or adjuvant or therapeutic cytokines. direct effect of these cytokines on cancer cell, however, is still unclear. in this project, we investigated whether il- ( and il- can modulate cancer cell proliferation. we employed a simple nonradioactive proliferation (mtt) assay and detection of lactate dehydrogenase (ldh) to test the effect of these recombinant human cytokines on various cancer cell lines, including breast cancer cell line (mcf- ), oral carcinoma cell line (kb), colon cancer cell line (caco- ) and choriocarcinoma cell line (jar). cytokines used in this study had both inhibitory and stimulatory effect on cell proliferation. findings in this project could provide an insight of cancer cell response to these cytokines and this could lead to a consideration on using cytokine as immunotherapy for cancer treatment.capacity of ae to modulate nitric oxide production depended on intercellular contact donor t cells are involved in the antitumour effects observed after bmt. thus, patients receiving t-celldepleted bmt have a higher risk of leukaemia relapse compared to patients receiving nonmanipulated bmt, and patients experiencing graft-versus-host disease (gvhd) have a lower risk of disease relapse than patients who do not experience gvhd. although the importance of donor t cells for the curative action of bmt has been established, the exact mechanisms and molecules involved in this graft-versus-tumour effect remain largely unknown. in a recently initiated project, we have conducted a longitudinal study of t-cell clonotypes in patients who received peripheral blood stem cell grafts after nonmyeloablative conditioning. peripheral blood samples were obtained sequentially after transplant, and the mononuclear cells (mncs) were isolated and cryopreserved. cd þ t cells were isolated from the mncs by use of immunomagnetic beads or facs and analysed for the presence of clonally expanded cells by t-cell receptor clonotype mapping based on rt-pcr and denaturing gradient gel electrophoresis (dgge). using this gel-based methodology, clonally expanded t cells were monitored after transplant and compared to the clinical data of the patients. the preliminary results demonstrates the presence of clonally expanded cd þ t cells at all time points analysed. furthermore, a number of clonotypes persisted for more than months, and other clonotypes emerged during this period. the appearance of newly emerged clonotypes which coincided with clinical gvhd could indicate a role for these t cells in the pathogenesis of gvhd. background: deficiency of the mannan-binding lectin (mbl) pathway of innate immunity leads to increased susceptibility to infections. in patients with colorectal cancer, postoperative infection is associated with poor prognosis. the aim of the present study was to evaluate ( ) the relation between the mbl pathway and postoperative infectious complications and survival of patients resected for colorectal cancer and ( ) the role of mbl as acute phase reactant compared to crp. methods: preoperative mbl concentration, mbl/mblassociated serine protease (masp) activity and crp were determined in serum from patients and healthy controls. the patients were observed for years. postoperative infections, recurrence and survival were recorded. results: the mbl pathway components were increased in the patients (p < . ) compared to healthy controls. low mbl levels were predictive of pneumonia (p ¼ . ), and pneumonia (n ¼ ) was associated with poor survival (p ¼ . , hr ¼ . , % ci . - . ). mbl and mbl/ masp activity could not predict postoperative overall infections. mbl showed no correlation (spearman's r ¼ . , % ci À . - . ) with crp. conclusions: low preoperative mbl levels are predictive of pneumonia, which is associated with poorer survival. mbl concentration and mbl/masp activity was not predictive of other postoperative infections or long-term prognosis. mbl apparently is not a surrogate measure of crp. department of surgery, university hospital of erlangen, erlangen, germany. e-mail: michael.siassi@rzmail.uni-erlangen.de introduction: the human collectins, mannan-binding lectin (mbl), surfactant protein-a (sp-a) and surfactantprotein-d (sp-d) play a central role in the innate immune system. immunological responses to malignant transformation of epithelial cells gained increasing interest recently. a former study could demonstrate binding of mbl to certain colorectal carcinoma (crc) cell lines in vitro. we therefore examined the expression of human collectins in normal colon mucosa and in colorectal carcinomas. materials and methods: colon samples from crc patients and normal mucosa samples were collected immediately after surgery. the tissue was microdissected and rna isolated (qiagen, rneasy-kit). gene expression profiles were analysed using gene-chips (affymetrix, hg-u ). we analysed the data for the expression of mbl, its associated serine proteases mannan-binding lectinassociated serine protease / (masp / ), sp-a and sp-d. the signal intensity of the genes of interest was compared using the mann-whitney u-test. results: the expression of human collectins in normal human colon mucosa was generally low. only the expression of sp-a and masp- reached the noise threshold of signals. these genes were significantly downregulated in crc specimens. the expression of the other proteins showed no difference in normal mucosa and crc. conclusion: as demonstrated before, the expression of human collectins in normal colon was low in this being the first lymph node to receive drainage from the tumour area, the sentinel node offers a unique possibility to obtain tumour-reactive lymphocytes. we investigated antitumour immune responses in sentinel nodes from patients with bladder cancer, by assaying tumour-specific proliferation and tcr vb repertoires. during tumour surgery, sentinel lymph nodes were identified by peritumoural injection of blue dye. fresh specimens of tumour, sentinel and nonsentinel lymph nodes were obtained, and single-cell suspensions were prepared. cells were assayed for reactivity against autologous tumour extract in [ h]-thymidine incorporation assays and characterized by flow cytometry. parallel analyses of the expression of vb gene families were performed with padlock probes, linear oligonucleotides which upon target recognition can be converted to circular molecules by a ligase. probes were reacted with cdna prepared from magnetically separated cd þ cells, and the tcr repertoire was determined by hybridizing the products to oligonucleotide microarrays. dose-dependent proliferation in response to tumour extract could be detected in sentinel lymph nodes. common clonal expansions were detected among tumourinfiltrating lymphocytes and in sentinel lymph nodes. nonsentinel lymph nodes displayed a divergent tcr vb repertoire. these results indicate an ongoing immune response against tumour antigens in sentinel nodes, draining urinary bladder cancer. identification of sentinel lymph nodes makes it possible to obtain tumour-reactive lymphocytes for use in adoptive immunotherapy. key: cord- -pgyzluwp authors: nan title: programmed cell death date: journal: experientia doi: . /bf sha: doc_id: cord_uid: pgyzluwp nan it is widely held that all developmental cell death is of a single type (apoptosis) and that neuronal death is primarily for adjusting the number of neurons in a population to the size of their target field through competition between equals for target-derived factors. we shall draw on our research and on that of others to criticize these views and replace them by the following. at least three types of neuronal death occur, only one of which resembles apoptosis; a neuron can choose between several self-destruct mechanisms depending on the cause of its death. the purpose of the death is to regulate connectivity, not neuron number. competitors for trophic factors are unequal, and many losers have made axonal targeting errors. a neuron's survival and differentiation depend on multiple anterograde and retrograde signals. activity affects retrograde signals and some but not all anterograde ones. the pattern of activity is more important than the overall amount. in rodents, the period of naturally occuring cell death of motoneurons is followed by a period of supersensitivity to axonal injury. thus, in newborn rodents lesion of the facial nerve leads to a rapid degeneration of the injured motoneurons. we have tested whether overexpression, in rive, of the bcl- proto-oncogene was capable of preventing death of axotomized motoneurons. to address this question we used transgenic mice whose motoneurons overexpress the bcl- protein. one of the two facial nerves of newborn mice was transected on the nd- rd post-natal day. seven days after the lesion, the morphology of the facial nuclei was analyzed. in control mice, and when compared to the intact nucleus, to % of axotomized motoneurons had disappeared. in contrast, in the transgenic animals, the number of motoneurons on the lesioned side remained unchanged when compared to the eontralateral nucleus. furthermore, their axons remained visible up to the distal lesion site. these experiments show that, in rive, motoneurons overexpressing the bcl- protein survive after axotomy, and suggest that, in rive, bcl- protect neurons from experimentally induced cell death and could be a target for treatment of motoneurons degenerative diseases. messmer s., mattenberger l., sager y., blatter-garin m-c., pometta d., kate a., james r.w. drpt de mrdeeine, drpt. de pharmacologie, div. de neurophysiologie clinique, facult de mrdecine, gen~ve. clusterin is a widely expressed glycoprotein, highly conserved across species. numerous functions have been postulated for this protein. the most important are roles in lipid transport, as elusterin is associated with apolipoprotein ai in hdl, complement regulation and tissue remodelling, in particular during cell death and differentiation. using cultures of rat spinal cord neurones ( % neurons and - % non-neuronal cells), we have studied the expression of clusterin and ape e in glutamate-induced neuronal cell death to examine potential roles in lipid management. up-regulation of the two proteins was observed. clusterin and ape e appear in the conditioned medium respectively h and . h after incubation with glutamate. control studies, in the presence of a noncompetitive nmda receptor agonist showed the secretion of clusterin and ape e to be diminished by > %. no up-regulation of either protein was observed in complementary studies with exclusively non-neuronal cell cultures. the cellular origin of the secreted proteins is presently under investigation. programmed cell death and tissue remodelling are consequences of hormonally induced restructuring of the rat ventral prostate after castration and the rat mammary gland after weaning. we used the "differential display"-method (liang and pardee, , science : ) to detect and isolate edna fragments whose corresponding rnas are regulated either coincidentally, or in an organ specific fashion during mammary gland involution and postcastrational prostate regression. partial sequencing of clones revealed high, but not absolute homology of fragments with sequences, previously characterized in different biological contexts. these five encode functions which could be anticipated to be important for cell growth and/or programmed cell death, we are presently investigating the functions of several of these transcripts in cell culture and in rive. antisense oligos are being employed in vivo to determine whether these genes contribute to the phenotype of programmed cell death. b epitopes derived from the envelope gp glycoprotein (ep ) or from the viral superantigen of mmtv have been incorporated into inert or live vaccines. the inert vaccine consists of purified chimeric proteins which contain the b epitopes alone or fused to multimeric promiscuous t helper epitopes from tetanus toxin. mice were immunized subcutaneously with these chimeric proteins. the live vaccine consists of an avirulent strain of salmonella typhimurium which expresses the mmtv epitopes in the form of chimeric proteins fused to the nucleocapsid protein of hepatitis b virus. this vaccine is given to mice in one oral dose. the level, duration and isotype of the immune response generated by each vaccine have been measured and compared. the level of protection has been investigated by systemically challenging immunized mice with the relzovims. a reduced binding of oxytocin (ot) occurs with aging in some, but not all, areas of the rat brain (arsenijevic et al., experientia , , a ) . the candate putamen showed the most impressive loss of ot receptors. two other regions, the hypothalamic ventromedial nucleus (vmh) and the islands of caueja (icj) had also an important deficit of ot binding sites. on the other hand, these two regions were known to be sensitive to sex steroids. in the present work, we treated from month old rats during one month with testosterone propionate ( #g/kg s.c., once every days) dissolved in oil. three rats of the same age injected with oil only served as controls. we labelled ot receptors throughout the brain of old rats using a i-labelled ligand specific for ot receptors. analysis of autoradiograms by an image analyzer revealed that the testosterone treatment increased ot binding sites in the vmh, in the icj, and, to a lesser extent, in the bed nucleus of the stria terminalis, a region also sensitive to sex steroids, by contrast, in the caudate putamen, the disappearance of ot receptors was not compensated. in conclusion, the decrease of ot receptors occurring in vmh and icj with aging can be reversed by administration of gonadal steroids. in contrast, the loss of ot receptors in the striatum appears to depend on another mecanism. vasopressin (avp) receptors are expressed transiently in the facial nucleus during development (tribollet et el., , dev. brain res., , - ) . avp may therefore play a role in the maturation of neuromuscular connexions in the neonate rat, and possibly in the restanration of these connexions after nerve lesion in the adult. in order to investigate the latter proposition, we have sectionned the facial nerve in adult rats and used quantitative autoradiography to look at avp binding sites in the facial nucleus at various postoperative times. we observed a massive and transient increase of avp binding sites on the operated side. the number of facial avp binding sites reaches a maximum about one week after nerve section, remains stable during - weeks, then begin to decrease towards control level. the induction of avp receptors is markedly delayed if the proximal stump of the nerve is ligated. to assess whether other motor nuclei would also react to axotomy by up-regulating the expression of avp receptors, we have sectionned the hypoglossal nerve and the sciatic nerve. in both cases, the binding of avp receptor ligand increases massively in the respective motor nuclei, with a time-course similar to that found in the facial nucleus. altogether, our data suggest that central avp could be involved in the process of nerve regeneration. cytotoxic t-cell mediated apoptosis schaerer,e, karapetian,o.,adrian,m. and tschopp,j. inst.de biochimie, univ.de lausanne, epalinges. an apoptotic cell death mechanism is used by cytolytic t cells (ctl) to lyse appropriate target cells. ctl harbor cytoplasmic storage compartments, containing the lytic protein perforin and serineproteases (granzymes), whose content is released upon target cell interaction. we show that these granules are multivesieular bodies and that degranulation releases these intragranular vesicles (igv) having granzymes, t-cell receptor and yet undefined proteins associated. isolated igvs and perforin induce dna breakdown in target cells within minutes. microscopic analysis demonstrates that igv specifically interact with target cell via the t-cell receptor and that their contents is taken up by the target cell. already min. after interaction, distinct igv proteins are found in the nucleus of the target cell.one of the molecules has been identified to be granzyme a, previously reported to be involved in apoptosis. we propose that lymphocytes transfer apoptosisinducing proteins to the nucleus of the target cells using vesicles as vehicles for delivery. cytotoxic t cells kill their targets by a mechanism involving membranolysis and dna degradation (apoptosis). recently, two sets of proteins have been proposed as dna breakdown-inducing molecules in t cells: granzyme a, b and tia-i. in this study, we cloned and further characterized the tia-i mouse homologue. aa sequence comparison with the human tia- showed an overall identity of %. devoid of a signal peptide, tia is yet localized to cytotoxic granules, probably targeted via a gly-tyr-motif. as tia-i, its mouse homolcgue contains three rnabinding domains. expression of tia during development shows a very strong signal in the brain and weaker signals in thymus, heart and other organs. during embryonic development several structures that contribute to organogenesis form transiently and are later eliminated by apoptosis. this pattern of tia expression could indicate its involvement in apoptosis. prostate involution occurs after castration in rats and is associated with the death by apoptosis of a large fraction of the epithelial cells. we have isolated several genes from a prostate involution bacteriophage lambda library using differential screening methods. among these clones, one d~monstrated an especially strong signal when used as a probe against northern blots of prostate mlhna obtained before, and at different times after castration. this gene is down-regulated after castration by -fold within days. intramuscular injection of a testosterone depot resulted in complete restoration of expression within hours. upon sequencing it became apparent that this clone has a high degree of homology to a known ndah dehydrogenase encoded in mitochondrial dna. the clone failed to hybridize to any transcripts from rat organs other than prostate. we are now in the process of isolating the htm~n hc~olog to this gene for use as a biomarker in study of benign hyperplasia and developing carcinoma. this gene is a possible indicator for testosterone-independent cell populations or of cells lacking ftl~ctional testosterone receptor. during the first three postnatal weeks the rat lung undergoes the last two developmental stages, the phase of alveolarization and the phase of microvascular maturation. the latter involves a decrease of the connective tissue mass in the alveolar septa and a merging of the two capillary layers to a single one. speculating that programmed cell death may play a role during this remodeling, we searched for the presence of apoptotie cells in rat lungs between days and . lung paraffin sections were treated with y-terminal transferase, digoxigenin-dutp, and anti-digoxigeninfluorescein-f(ab)-fragments, and the number of fluorescent nuclei was compared between sections at different days. while the number of apoptotie ceils was low until the end of the second week and at day , we observed an about eight fold increase of fluorescent nuclei towards the end of the third week. we conclude that programmed cell death is involved in the structural maturation of the lung. brunner, a., wallrapp, ch., pollack, i, twardzik, t. and schneuwly, s. lehrstuhl genetik, biozentrum universit~t w~rzburg, mutants in the giant lens (g/l) gene show a strong disturbance in ommatidial development. in the absence of any gene product, additional phetoreceptors, cone cells and pigment cells develop. opposite effects can be seen in flies in which the gene product of the giant lens gene can be ectopically expressed by heat shock. a second very typical phenotype is the disturbance of photoreceptor axon guidance. molecular analysis of gil shows that it encodes a secreted protein of aa containing three evolutionary conserved cystein-motives very similar to egf-like repeats. we propose that gil functions as a secreted signal, most likely a lateral inhibitor for the development of specific cell fates and that gil, either directly or indirectly, is involved in targeting photoreceptor axons into the brain. the decrease in cellularity during scar establishment is mediated through apoptosis desmouliere, a., redard, m., darby, i., and g. gabbiani department of pathology, cmu, rue michel server, gen~ve dudng the healing of an open wound, granulation tissue formation is characterized by replication and accumulation of fibroblastic cells, many of which acquire morphological and biochemical features of smooth muscle cells and have been named myofibroblasts (sch rch et el., histology for pathologists, t ). as the wound evolves into a scar, there is an important decrease in ceuuladty, including disappearance of myofibroblasts. the question adses as to which process is responsible for myofibroblast disappearance. during a previous investigation on the expression of (z-smooth muscle actin in myofibroblasts, we have obsewed that in late phases of wound healing, many of myofibroblasts show signs of apoptosis end suggested that this type of cell death is responsible for the disappearance of myofibroblasts (darby et al., lab. invest. : , ) . we have tested this hypothesis by means of electron microscopy and morphometry and by in situ end-labeling of fragmented dna (wijsman et al., j. histochem. cytochem. : , t ) . our results show that the number of apoptotic cells increases as the wound closes and suggest that this may be the mechanism for the disappearance of myofibroblasts as well as for the evolution of granulation tissue into a scar. (supported by the swiss national science foundation, grant n~ s - r. jaggl, a. marti and b. jehn. universit~t bern, akef, tiefenaustr. , bern at weaning the mammary gland undergoes a reductive remodelling process (involution) which is associated with the cessation of milk protein gene expression and apoptosis of milk-produclng epithelial cells. this process can be reversed by returning the pups to the mother within day. elevated nuclear protein kinase a (pka) activity was observed from one day post-lactation, paralleled by increased c-los, junb, ]und and to a lesser extent c-]un mrna levels. ap- dna binding activity was transiently induced and the ap- complex was shown to consist principally of cfos/jund. oct- dna binding activity and oct- protein were gradually lost from the gland over the first four days of involution, whereas oct- m_rna levels remained unchanged. comparing nuclear extracts from normal mammary glands with nuclear extracts from glands which had been cleared of all epithelial cells three weeks after birth revealed that pka activation, ap- induction and oct- inactivation are all dependent on the presence of the epithelial compartment. the increased fos/jtm expression and the inactivation of oct- may be consequences of the increased pka activity. when involution is reversed, both, pica activity and ap- dna binding activity (and fos andjun mrna levels) are reduced to basal levels. our data suggests a role for pka and ap- on progranlmed cell death of manlnmry epithelial ceils. bcl- ~ does not require membrane attachment for its survival activity c. borner*, i. martinout, c. mattmann*, m. irmler*, e. sch&rrer*, j.-c. martinou-j-, and j. tschopp*. * institute of biochemistry, university of lausanne, epalinges, institute of molecular biology, glaxo inc., plan los ouates. cl- (z is a mitochondrial or perinuclear-associated oncoprotein that prolongs the life span of a variety of cell types by interfering with programmed cell death. how it exerts this activity is unknown but it is believed that membrane attachment is required. to identify critical regions in bcl- o~ for subcellular localization and survival activity, we created by site-directed mutagenesis, various mutations in regions which are most conserved between the different bcl- species. we show here that membrane attachment is not required for the survival activity of bcl- o< a truncation mutant of bcl- (z lacking the last amino acids (t ) including the hydrophobic domain is soluble, yet fully active in blocking apoptosis of sympathetic neurons induced by ngf deprivation or l fibroblasts induced by tnfc~ treatment. we further provide evidence for a putative functional region in bcl- which lies in the conserved domains and upstream of the hydrophobic cooh terminal tail. the breakdown of nuclear dna is considered to be a hallmark of apoptosis. we previously identified the perinuclear membrane localized dnase i as the endonuclease involved in the formation of oligonucleosomal-sized fragments (dna ladder). it is not clear how the nuclease is activated and has access to the dna. we show that in thymocytes induced to undergo apoptosis, lamin breakdown preceded dna laddering. by transfeeting hela cells with a constitutively active cdc mutant, nuclear envelope breakdown and typical apoptotic features (ehromatin condensation) were observed. moreover, co-transfection with cdc mutant and dnase i led to dna degradation. we propose that apoptosis can be induced by wrongly timed and hence abortive mitosis leading to uncontrolled nuclear membrane disintegration. s - s - platelet-derived growth factor (pdgf) is thought to play an active role in fibrosing diseases. bronchiolitis obliterans-organizing pneumonia (boop) is a condition characterized by intraluminal proliferation of connective tissue inside distal air spaces. to evaluate pdgf expression in boop we performed immunohistoehemistry on lung biopsies from patients and controls free of fibrosis. sedal sections were stained with an antibody against either pdgf or the monoeyte/macrophage marker cd , in both groups the pdgf ~ cells were essentially tissue macrophages. using point counting to measure volume fraction (vv) , pdgf-pesitive cells represented . + . % (mean+sd) of the volume occupied by lung tissue in the boop cases, and , + . % in the controls (! < , ). similarily, . + . % of the lung tissue was occupied by cd e~ macrophages in the boop cases, compared to . :~ . % in the controls (p